data_5iaz_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 5iaz _Structure_validation_residue.Date_analyzed 2016-10-08 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 728' ' ' VAL . . . . . 0.49 ' O ' ' CG1' ' A' ' 728' ' ' VAL . 9.0 p . . . . . 0 N--CA 1.491 1.594 0 CA-C-O 121.256 0.551 . . . . 0.0 110.008 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 729' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -179.93 -177.96 0.41 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.264 -0.897 . . . . 0.0 110.407 -179.952 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 730' ' ' GLY . . . . . . . . . . . . . . . 172.21 113.73 0.31 Allowed Glycine 0 N--CA 1.492 2.373 0 N-CA-C 109.074 -1.61 . . . . 0.0 109.074 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 731' ' ' VAL . . . . . . . . . . . . . 31.3 m -130.02 148.41 33.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.227 -1.161 . . . . 0.0 110.872 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 732' ' ' CYS . . . . . 0.42 ' O ' ' SG ' ' A' ' 732' ' ' CYS . 16.5 p -142.18 133.89 26.95 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.521 -0.737 . . . . 0.0 109.272 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 733' ' ' ALA . . . . . . . . . . . . . . . -111.69 132.32 54.7 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.049 -1.032 . . . . 0.0 110.746 -179.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 734' ' ' ASP . . . . . 0.442 ' CG ' ' O ' ' A' ' 734' ' ' ASP . 8.6 p-10 -116.54 116.34 27.44 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.295 -0.878 . . . . 0.0 109.777 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 735' ' ' VAL . . . . . . . . . . . . . 5.7 t -139.62 166.9 20.36 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.154 -0.966 . . . . 0.0 110.187 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 736' ' ' SER . . . . . 0.448 ' O ' ' C ' ' A' ' 737' ' ' GLU . 1.2 m -135.78 136.27 40.58 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.265 -0.897 . . . . 0.0 109.937 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 737' ' ' GLU . . . . . 0.485 ' HB2' ' HB3' ' A' ' 831' ' ' LYS . 1.2 tm-20 . . . . . 0 N--CA 1.492 1.64 0 O-C-N 121.32 -0.863 . . . . 0.0 109.86 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 757' ' ' THR . . . . . 0.496 ' CG2' ' O ' ' A' ' 816' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.575 0 CA-C-O 121.141 0.496 . . . . 0.0 109.853 . . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 758' ' ' ALA . . . . . . . . . . . . . . . -88.69 153.26 21.25 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.113 -0.992 . . . . 0.0 109.938 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 759' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -113.28 161.07 17.66 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.187 -0.946 . . . . 0.0 110.365 -179.942 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 760' ' ' VAL . . . . . . . . . . . . . 42.2 t -107.76 133.73 51.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.359 -0.838 . . . . 0.0 109.328 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 761' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -109.97 115.67 30.2 Favored 'General case' 0 C--N 1.302 -1.5 0 O-C-N 121.133 -0.98 . . . . 0.0 111.043 -179.925 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 762' ' ' LEU . . . . . 0.449 ' O ' ' HG3' ' A' ' 811' ' ' ARG . 93.1 mt -132.36 138.78 47.87 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.543 -0.723 . . . . 0.0 109.119 179.842 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 763' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -167.7 136.72 2.57 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.834 -1.166 . . . . 0.0 110.891 -179.893 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 764' ' ' CYS . . . . . . . . . . . . . 92.7 m -106.59 172.77 6.64 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.427 -0.796 . . . . 0.0 109.849 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 765' ' ' ALA . . . . . . . . . . . . . . . -67.89 166.27 24.82 Favored Pre-proline 0 N--CA 1.495 1.795 0 O-C-N 121.156 -0.965 . . . . 0.0 110.277 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 766' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -72.84 107.11 2.26 Favored 'Trans proline' 0 C--N 1.307 -1.61 0 O-C-N 123.964 1.507 . . . . 0.0 110.026 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 767' ' ' GLY . . . . . . . . . . . . . . . 132.86 -3.42 4.94 Favored Glycine 0 N--CA 1.489 2.174 0 N-CA-C 109.334 -1.506 . . . . 0.0 109.334 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 768' ' ' GLN . . . . . 0.432 ' O ' ' HG2' ' A' ' 810' ' ' GLU . 44.5 mt-30 -124.52 152.99 42.74 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.183 -1.187 . . . . 0.0 109.968 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 769' ' ' THR . . . . . . . . . . . . . 62.2 p -134.74 147.09 49.96 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.139 -0.975 . . . . 0.0 110.598 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 770' ' ' ILE . . . . . . . . . . . . . 59.1 mt -73.33 139.75 18.95 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.394 -0.816 . . . . 0.0 109.453 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 771' ' ' SER . . . . . . . . . . . . . 2.3 t -134.97 -8.17 2.35 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.974 -1.079 . . . . 0.0 111.422 -179.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 772' ' ' ALA . . . . . . . . . . . . . . . -162.96 155.97 19.32 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 120.684 -1.26 . . . . 0.0 111.734 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 773' ' ' ILE . . . . . . . . . . . . . 19.9 mm -110.69 125.65 68.0 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.687 -0.633 . . . . 0.0 109.48 179.861 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 774' ' ' LYS . . . . . 0.54 ' HG2' ' CG2' ' A' ' 838' ' ' VAL . 3.2 mmmp? -80.71 -33.47 35.28 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.078 -1.013 . . . . 0.0 110.928 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 775' ' ' PHE . . . . . . . . . . . . . 88.7 t80 -160.46 154.73 23.32 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.022 -1.049 . . . . 0.0 110.282 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 776' ' ' ALA . . . . . 0.463 ' HB3' ' O ' ' A' ' 798' ' ' SER . . . -169.21 113.55 0.55 Allowed 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.41 -0.806 . . . . 0.0 109.47 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 777' ' ' SER . . . . . 0.544 ' HA ' ' CB ' ' A' ' 798' ' ' SER . 0.6 OUTLIER -140.68 137.35 33.47 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.04 -1.038 . . . . 0.0 111.327 179.977 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 778' ' ' PHE . . . . . 0.545 ' CG ' ' O ' ' A' ' 778' ' ' PHE . 24.0 t80 -116.19 72.98 0.83 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.497 -0.752 . . . . 0.0 109.344 179.869 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 779' ' ' GLY . . . . . . . . . . . . . . . -164.46 -102.63 0.17 Allowed Glycine 0 N--CA 1.495 2.601 0 N-CA-C 109.696 -1.362 . . . . 0.0 109.696 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 780' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -133.15 77.0 68.31 Favored Pre-proline 0 N--CA 1.495 1.789 0 O-C-N 120.74 -1.447 . . . . 0.0 110.369 179.929 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 781' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -80.37 138.95 12.72 Favored 'Trans proline' 0 C--N 1.304 -1.78 0 O-C-N 124.162 1.612 . . . . 0.0 110.442 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 782' ' ' LEU . . . . . 0.513 ' CD1' ' HA2' ' A' ' 791' ' ' GLY . 1.3 mt -103.62 168.89 8.86 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.308 -0.87 . . . . 0.0 109.914 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 783' ' ' GLY . . . . . . . . . . . . . . . 91.16 -154.17 22.74 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.628 -1.389 . . . . 0.0 109.628 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 784' ' ' THR . . . . . . . . . . . . . 7.8 t -154.59 179.54 8.95 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.334 -1.098 . . . . 0.0 110.231 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 785' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -52.99 108.33 0.31 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.274 -0.892 . . . . 0.0 110.323 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 786' ' ' GLY . . . . . . . . . . . . . . . 143.89 -36.97 1.47 Allowed Glycine 0 N--CA 1.488 2.125 0 N-CA-C 109.724 -1.35 . . . . 0.0 109.724 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 787' ' ' THR . . . . . 0.423 ' O ' ' O ' ' A' ' 788' ' ' PHE . 30.8 m -157.81 47.27 0.38 Allowed 'General case' 0 C--N 1.306 -1.302 0 O-C-N 121.253 -1.145 . . . . 0.0 110.497 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 788' ' ' PHE . . . . . 0.423 ' O ' ' O ' ' A' ' 787' ' ' THR . 10.8 m-85 -46.02 170.89 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.154 -0.966 . . . . 0.0 110.201 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 789' ' ' GLN . . . . . . . . . . . . . 24.0 tt0 -166.56 142.9 4.73 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.278 -0.889 . . . . 0.0 110.034 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 790' ' ' GLN . . . . . . . . . . . . . 19.3 pt20 -56.84 152.47 12.56 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 120.975 -1.078 . . . . 0.0 110.329 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 791' ' ' GLY . . . . . 0.513 ' HA2' ' CD1' ' A' ' 782' ' ' LEU . . . -109.44 -86.33 1.75 Allowed Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.544 -1.422 . . . . 0.0 109.544 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 792' ' ' GLU . . . . . 0.414 ' HG2' ' C ' ' A' ' 791' ' ' GLY . 68.4 mm-40 -142.64 -37.97 0.37 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.207 -1.172 . . . . 0.0 110.169 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 793' ' ' CYS . . . . . . . . . . . . . 1.3 m -107.14 131.78 53.75 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.262 -0.898 . . . . 0.0 110.331 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 794' ' ' HIS . . . . . 0.421 ' CG ' ' H ' ' A' ' 796' ' ' ILE . 5.0 t60 -145.48 144.29 30.5 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.175 -0.953 . . . . 0.0 110.079 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 795' ' ' SER . . . . . 0.423 ' O ' ' N ' ' A' ' 797' ' ' ASN . 1.1 m -83.01 8.8 11.72 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.231 -0.918 . . . . 0.0 110.604 -179.91 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 796' ' ' ILE . . . . . 0.524 ' O ' ' CG2' ' A' ' 796' ' ' ILE . 90.4 mt 42.41 26.67 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 O-C-N 121.242 -0.911 . . . . 0.0 110.269 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 797' ' ' ASN . . . . . 0.437 ' OD1' ' O ' ' A' ' 796' ' ' ILE . 5.5 m120 -152.49 22.66 0.62 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.204 -0.935 . . . . 0.0 109.797 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 798' ' ' SER . . . . . 0.544 ' CB ' ' HA ' ' A' ' 777' ' ' SER . 13.2 m -84.62 2.59 40.85 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.435 -0.791 . . . . 0.0 110.452 -179.901 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 799' ' ' ASN . . . . . . . . . . . . . 6.9 t-20 -115.41 -14.84 11.58 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.196 -0.94 . . . . 0.0 110.908 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 800' ' ' SER . . . . . . . . . . . . . 16.4 m -82.09 -18.87 41.55 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 120.903 -1.123 . . . . 0.0 109.881 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 801' ' ' VAL . . . . . 0.454 HG13 ' HD2' ' A' ' 805' ' ' LYS . 45.0 t -86.44 -21.41 7.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.464 -0.772 . . . . 0.0 110.117 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 802' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -79.42 -57.39 3.72 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.137 -0.977 . . . . 0.0 110.313 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 803' ' ' GLU . . . . . 0.443 ' HG2' ' CD1' ' A' ' 807' ' ' ILE . 0.4 OUTLIER -53.82 -22.71 10.22 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.295 -0.878 . . . . 0.0 110.339 179.942 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 804' ' ' ARG . . . . . . . . . . . . . 1.9 mtm180 -91.08 -23.92 20.18 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.188 -0.945 . . . . 0.0 110.998 -180.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 805' ' ' LYS . . . . . 0.454 ' HD2' HG13 ' A' ' 801' ' ' VAL . 9.6 mttt -127.06 49.83 2.04 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.07 -1.019 . . . . 0.0 111.034 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 806' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -163.23 -71.51 0.04 OUTLIER 'General case' 0 N--CA 1.497 1.909 0 O-C-N 120.952 -1.092 . . . . 0.0 110.905 179.937 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 807' ' ' ILE . . . . . 0.443 ' CD1' ' HG2' ' A' ' 803' ' ' GLU . 90.6 mt -50.86 128.32 8.07 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 O-C-N 121.223 -0.923 . . . . 0.0 110.988 -179.918 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 808' ' ' GLY . . . . . 0.448 ' C ' ' HG ' ' A' ' 809' ' ' LEU . . . 103.89 10.84 33.92 Favored Glycine 0 N--CA 1.493 2.456 0 N-CA-C 110.127 -1.189 . . . . 0.0 110.127 179.912 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 809' ' ' LEU . . . . . 0.448 ' HG ' ' C ' ' A' ' 808' ' ' GLY . 33.1 mt -142.67 137.11 29.7 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.108 -1.231 . . . . 0.0 110.138 -179.913 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 810' ' ' GLU . . . . . 0.432 ' HG2' ' O ' ' A' ' 768' ' ' GLN . 0.7 OUTLIER -65.16 -21.92 66.85 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.224 -0.923 . . . . 0.0 109.289 179.972 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 811' ' ' ARG . . . . . 0.449 ' HG3' ' O ' ' A' ' 762' ' ' LEU . 1.1 ttp85 -128.76 151.52 49.47 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.538 -0.726 . . . . 0.0 109.747 179.866 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 812' ' ' CYS . . . . . 0.437 ' HB3' ' HB2' ' A' ' 762' ' ' LEU . 7.8 t -129.73 139.87 51.22 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.121 -0.987 . . . . 0.0 110.602 -179.944 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 813' ' ' VAL . . . . . . . . . . . . . 84.1 t -145.63 123.11 4.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.348 -0.845 . . . . 0.0 109.663 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 814' ' ' VAL . . . . . . . . . . . . . 88.7 t -133.0 129.01 57.25 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 O-C-N 121.129 -0.982 . . . . 0.0 110.73 -179.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 815' ' ' ALA . . . . . . . . . . . . . . . -88.75 127.8 35.61 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.339 -0.851 . . . . 0.0 109.755 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 816' ' ' ILE . . . . . 0.516 HD11 ' CG2' ' A' ' 833' ' ' VAL . 46.2 mt -84.3 114.01 24.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.181 -0.949 . . . . 0.0 110.436 -179.905 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 817' ' ' SER . . . . . . . . . . . . . 5.0 p -158.84 158.57 29.27 Favored Pre-proline 0 N--CA 1.495 1.777 0 O-C-N 121.356 -0.84 . . . . 0.0 109.91 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 818' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -75.29 2.65 6.54 Favored 'Trans proline' 0 C--N 1.306 -1.692 0 O-C-N 123.926 1.487 . . . . 0.0 110.772 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 819' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -111.77 7.67 20.32 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.103 -0.998 . . . . 0.0 110.253 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 820' ' ' ASN . . . . . . . . . . . . . 6.8 m-20 -121.19 -7.2 9.38 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.248 -0.907 . . . . 0.0 110.262 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 821' ' ' PHE . . . . . . . . . . . . . 4.8 m-85 -110.66 -65.96 1.12 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.261 -0.9 . . . . 0.0 110.19 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 822' ' ' GLY . . . . . . . . . . . . . . . 161.27 63.86 0.02 OUTLIER Glycine 0 N--CA 1.492 2.41 0 N-CA-C 110.006 -1.238 . . . . 0.0 110.006 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 823' ' ' GLY . . . . . . . . . . . . . . . 78.7 -150.41 34.51 Favored Glycine 0 N--CA 1.493 2.47 0 N-CA-C 110.036 -1.226 . . . . 0.0 110.036 179.907 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 824' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -109.17 141.88 24.39 Favored Pre-proline 0 N--CA 1.493 1.709 0 O-C-N 121.26 -1.141 . . . . 0.0 110.407 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 825' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -80.53 -91.2 0.0 OUTLIER 'Trans proline' 0 C--N 1.306 -1.699 0 O-C-N 124.11 1.584 . . . . 0.0 110.693 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 826' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -101.5 132.95 21.17 Favored Pre-proline 0 N--CA 1.496 1.872 0 O-C-N 121.189 -0.944 . . . . 0.0 110.372 -179.924 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 827' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -82.52 157.51 16.63 Favored 'Trans proline' 0 C--N 1.309 -1.525 0 O-C-N 123.958 1.504 . . . . 0.0 110.629 180.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 828' ' ' GLU . . . . . 0.452 ' O ' ' OE1' ' A' ' 828' ' ' GLU . 7.2 tm-20 54.47 39.13 30.83 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.243 -0.91 . . . . 0.0 110.622 179.906 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 829' ' ' VAL . . . . . 0.447 HG22 ' O ' ' A' ' 828' ' ' GLU . 20.2 t -142.81 118.3 4.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.071 -1.018 . . . . 0.0 110.369 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 830' ' ' MET . . . . . 0.413 ' C ' ' O ' ' A' ' 829' ' ' VAL . 4.7 mtt -42.71 158.32 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.246 -0.909 . . . . 0.0 109.878 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 831' ' ' LYS . . . . . 0.485 ' HB3' ' HB2' ' A' ' 737' ' ' GLU . 4.9 mtmt -115.04 110.57 19.77 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.118 -0.989 . . . . 0.0 110.877 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 832' ' ' ARG . . . . . . . . . . . . . 10.6 mtm-85 -116.38 135.31 53.97 Favored 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 179.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 833' ' ' VAL . . . . . 0.516 ' CG2' HD11 ' A' ' 816' ' ' ILE . 7.7 t -111.5 130.09 65.68 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.631 0 O-C-N 120.986 -1.071 . . . . 0.0 111.334 -179.94 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 834' ' ' ALA . . . . . . . . . . . . . . . -134.81 129.43 34.52 Favored 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 835' ' ' VAL . . . . . 0.403 ' CG1' ' N ' ' A' ' 836' ' ' GLU . 18.3 t -137.95 160.82 33.13 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 O-C-N 120.932 -1.105 . . . . 0.0 111.334 -179.869 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 836' ' ' GLU . . . . . 0.403 ' N ' ' CG1' ' A' ' 835' ' ' VAL . 0.0 OUTLIER -148.39 121.41 8.83 Favored 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 179.988 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 837' ' ' ALA . . . . . . . . . . . . . . . -109.55 155.32 21.54 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.006 -1.059 . . . . 0.0 111.016 -179.893 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 838' ' ' VAL . . . . . 0.54 ' CG2' ' HG2' ' A' ' 774' ' ' LYS . 6.0 t -111.97 114.59 47.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.422 -0.799 . . . . 0.0 109.804 179.926 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 839' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -109.42 136.76 48.31 Favored 'General case' 0 C--N 1.299 -1.611 0 O-C-N 121.128 -0.982 . . . . 0.0 110.245 -179.881 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 840' ' ' SER . . . . . 0.528 ' O ' ' CG2' ' A' ' 841' ' ' THR . 0.4 OUTLIER -136.43 -82.02 0.38 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.284 -0.885 . . . . 0.0 109.942 179.955 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 841' ' ' THR . . . . . 0.528 ' CG2' ' O ' ' A' ' 840' ' ' SER . 13.5 p . . . . . 0 N--CA 1.492 1.672 0 O-C-N 121.294 -0.878 . . . . 0.0 110.006 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 728' ' ' VAL . . . . . 0.456 ' O ' ' O ' ' A' ' 839' ' ' CYS . 3.4 p . . . . . 0 N--CA 1.492 1.652 0 CA-C-O 121.199 0.523 . . . . 0.0 110.354 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 729' ' ' SER . . . . . . . . . . . . . 75.3 p -55.01 178.58 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.243 -0.911 . . . . 0.0 110.3 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 730' ' ' GLY . . . . . 0.442 ' HA3' ' O ' ' A' ' 837' ' ' ALA . . . -113.7 -139.11 7.15 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.658 -1.377 . . . . 0.0 109.658 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 731' ' ' VAL . . . . . . . . . . . . . 30.0 t -128.44 155.5 40.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.288 -1.125 . . . . 0.0 110.254 -179.89 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 732' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -108.22 145.92 33.56 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.361 -0.837 . . . . 0.0 109.431 179.892 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 733' ' ' ALA . . . . . . . . . . . . . . . -147.11 128.56 14.96 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.021 -1.049 . . . . 0.0 110.781 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 734' ' ' ASP . . . . . 0.459 ' OD1' ' O ' ' A' ' 734' ' ' ASP . 1.5 p30 -131.72 109.23 10.02 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.454 -0.779 . . . . 0.0 109.673 179.93 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 735' ' ' VAL . . . . . 0.525 HG22 ' CG2' ' A' ' 760' ' ' VAL . 7.0 m -129.58 157.13 42.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.115 -0.991 . . . . 0.0 110.586 -179.916 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 736' ' ' SER . . . . . 0.427 ' O ' ' C ' ' A' ' 737' ' ' GLU . 70.9 m -119.43 140.15 50.89 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.436 -0.79 . . . . 0.0 109.714 179.918 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 737' ' ' GLU . . . . . 0.427 ' C ' ' O ' ' A' ' 736' ' ' SER . 11.2 tp10 . . . . . 0 N--CA 1.491 1.605 0 O-C-N 121.215 -0.928 . . . . 0.0 109.979 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 757' ' ' THR . . . . . . . . . . . . . 20.6 p . . . . . 0 N--CA 1.492 1.663 0 CA-C-O 121.364 0.602 . . . . 0.0 110.421 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 758' ' ' ALA . . . . . . . . . . . . . . . -107.92 178.96 4.36 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.328 -0.857 . . . . 0.0 110.141 180.0 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 759' ' ' LYS . . . . . . . . . . . . . 29.7 mttm -140.42 138.82 35.03 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.224 -0.923 . . . . 0.0 110.592 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 760' ' ' VAL . . . . . 0.525 ' CG2' HG22 ' A' ' 735' ' ' VAL . 41.9 t -115.67 108.71 25.96 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 O-C-N 121.427 -0.796 . . . . 0.0 109.552 179.927 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 761' ' ' HIS . . . . . 0.457 ' CB ' HG22 ' A' ' 813' ' ' VAL . 42.2 p-80 -124.96 139.63 53.65 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 120.945 -1.097 . . . . 0.0 111.468 -179.82 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 762' ' ' LEU . . . . . . . . . . . . . 12.4 mt -119.33 110.87 17.48 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 109.057 -0.719 . . . . 0.0 109.057 179.892 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 763' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.31 133.46 53.23 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.151 -0.968 . . . . 0.0 111.001 -179.865 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 764' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -111.14 164.27 13.03 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.436 -0.79 . . . . 0.0 109.856 179.925 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 765' ' ' ALA . . . . . 0.476 ' HB1' ' OE1' ' A' ' 768' ' ' GLN . . . -56.04 164.0 2.0 Allowed Pre-proline 0 N--CA 1.493 1.68 0 O-C-N 121.118 -0.989 . . . . 0.0 110.177 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 766' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -71.71 114.2 3.88 Favored 'Trans proline' 0 C--N 1.305 -1.747 0 O-C-N 123.962 1.506 . . . . 0.0 110.394 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 767' ' ' GLY . . . . . . . . . . . . . . . 123.13 -18.48 7.88 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.436 -1.466 . . . . 0.0 109.436 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 768' ' ' GLN . . . . . 0.531 ' HG3' ' CA ' ' A' ' 841' ' ' THR . 0.5 OUTLIER -110.38 130.75 55.49 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.224 -1.162 . . . . 0.0 110.176 179.975 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 769' ' ' THR . . . . . . . . . . . . . 45.7 p -118.25 148.59 42.27 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.226 -0.921 . . . . 0.0 110.364 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 770' ' ' ILE . . . . . 0.444 HG21 HG13 ' A' ' 807' ' ' ILE . 2.6 mp -66.28 141.3 18.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.297 -0.877 . . . . 0.0 110.014 179.971 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 771' ' ' SER . . . . . . . . . . . . . 11.8 p -120.6 -15.92 8.38 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.109 -0.995 . . . . 0.0 110.565 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 772' ' ' ALA . . . . . . . . . . . . . . . -169.64 171.85 7.24 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.063 -1.023 . . . . 0.0 111.029 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 773' ' ' ILE . . . . . . . . . . . . . 25.8 mm -116.6 134.27 60.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.505 -0.747 . . . . 0.0 109.603 179.912 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 774' ' ' LYS . . . . . 0.487 ' HB2' ' HB3' ' A' ' 836' ' ' GLU . 0.9 OUTLIER -83.89 -34.74 24.49 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.122 -0.986 . . . . 0.0 110.718 -179.96 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 775' ' ' PHE . . . . . 0.577 ' CZ ' ' HB2' ' A' ' 777' ' ' SER . 44.7 t80 -162.31 164.1 27.67 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.091 -1.006 . . . . 0.0 110.691 -179.956 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 776' ' ' ALA . . . . . 0.494 ' HB2' ' HA ' ' A' ' 799' ' ' ASN . . . -176.52 121.49 0.15 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.458 -0.776 . . . . 0.0 109.922 -179.964 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 777' ' ' SER . . . . . 0.577 ' HB2' ' CZ ' ' A' ' 775' ' ' PHE . 0.2 OUTLIER -140.3 137.28 34.05 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.145 -0.972 . . . . 0.0 110.69 -179.972 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 778' ' ' PHE . . . . . 0.509 ' CG ' ' O ' ' A' ' 778' ' ' PHE . 29.3 t80 -116.82 74.19 0.9 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.276 -0.89 . . . . 0.0 109.933 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 779' ' ' GLY . . . . . . . . . . . . . . . -175.53 -86.97 0.07 OUTLIER Glycine 0 N--CA 1.495 2.619 0 C-N-CA 119.486 -1.34 . . . . 0.0 110.456 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 780' ' ' THR . . . . . . . . . . . . . 13.0 p -136.86 92.59 14.33 Favored Pre-proline 0 N--CA 1.494 1.761 0 O-C-N 121.078 -1.248 . . . . 0.0 110.825 -179.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 781' ' ' PRO . . . . . 0.463 ' O ' ' HG ' ' A' ' 782' ' ' LEU . 50.9 Cg_endo -85.41 155.56 10.73 Favored 'Trans proline' 0 C--N 1.306 -1.697 0 O-C-N 124.066 1.561 . . . . 0.0 110.271 179.942 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 782' ' ' LEU . . . . . 0.483 ' HB2' ' HB2' ' A' ' 789' ' ' GLN . 1.6 mt -143.81 129.38 19.13 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.115 -0.991 . . . . 0.0 110.263 179.978 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 783' ' ' GLY . . . . . . . . . . . . . . . 121.64 -168.75 14.49 Favored Glycine 0 N--CA 1.492 2.374 0 N-CA-C 109.71 -1.356 . . . . 0.0 109.71 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 784' ' ' THR . . . . . 0.497 ' O ' ' CE1' ' A' ' 788' ' ' PHE . 0.3 OUTLIER -115.33 -146.74 0.41 Allowed 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.258 -1.142 . . . . 0.0 110.163 179.997 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 785' ' ' CYS . . . . . . . . . . . . . 54.1 t -82.07 123.12 28.65 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.225 -0.922 . . . . 0.0 110.1 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 786' ' ' GLY . . . . . . . . . . . . . . . 86.34 -1.61 87.45 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.609 -1.396 . . . . 0.0 109.609 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 787' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -140.86 36.98 1.78 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.205 -1.174 . . . . 0.0 110.062 -179.957 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 788' ' ' PHE . . . . . 0.497 ' CE1' ' O ' ' A' ' 784' ' ' THR . 28.8 m-85 -74.15 171.37 13.69 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.248 -0.908 . . . . 0.0 110.369 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 789' ' ' GLN . . . . . 0.483 ' HB2' ' HB2' ' A' ' 782' ' ' LEU . 5.8 mt-30 -143.17 97.7 3.13 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.371 -0.831 . . . . 0.0 109.961 179.971 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 790' ' ' GLN . . . . . 0.474 ' O ' ' HG3' ' A' ' 790' ' ' GLN . 14.1 pt20 -46.32 108.15 0.13 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.256 -0.903 . . . . 0.0 110.306 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 791' ' ' GLY . . . . . . . . . . . . . . . -58.38 177.15 1.86 Allowed Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.326 -1.51 . . . . 0.0 109.326 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 792' ' ' GLU . . . . . 0.499 ' CG ' ' O ' ' A' ' 792' ' ' GLU . 0.6 OUTLIER -80.4 5.38 15.16 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.205 -1.174 . . . . 0.0 110.231 179.997 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 793' ' ' CYS . . . . . . . . . . . . . 22.8 t -102.8 16.69 25.82 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.238 -0.914 . . . . 0.0 111.062 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 794' ' ' HIS . . . . . 0.601 ' CE1' ' OG ' ' A' ' 798' ' ' SER . 75.9 t60 -62.28 125.3 23.42 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.938 -1.101 . . . . 0.0 110.258 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 795' ' ' SER . . . . . . . . . . . . . 1.4 m -72.89 -130.59 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.165 -0.96 . . . . 0.0 109.605 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 796' ' ' ILE . . . . . . . . . . . . . 1.6 pt -137.94 22.9 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 120.854 -1.153 . . . . 0.0 110.363 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 797' ' ' ASN . . . . . . . . . . . . . 36.1 p30 -154.75 22.12 0.45 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.296 -0.878 . . . . 0.0 110.232 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 798' ' ' SER . . . . . 0.601 ' OG ' ' CE1' ' A' ' 794' ' ' HIS . 0.8 OUTLIER -72.44 -19.68 61.53 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.115 -0.99 . . . . 0.0 109.936 179.966 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 799' ' ' ASN . . . . . 0.494 ' HA ' ' HB2' ' A' ' 776' ' ' ALA . 2.3 t-20 -114.09 -10.36 12.83 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.32 -0.863 . . . . 0.0 110.009 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 800' ' ' SER . . . . . 0.491 ' O ' ' HB2' ' A' ' 804' ' ' ARG . 0.9 OUTLIER -89.86 -28.56 19.17 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.359 -0.838 . . . . 0.0 110.13 179.954 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 801' ' ' VAL . . . . . . . . . . . . . 24.6 t -66.59 -30.48 49.9 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.143 -0.973 . . . . 0.0 110.472 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 802' ' ' LEU . . . . . 0.48 HD23 ' N ' ' A' ' 802' ' ' LEU . 4.4 mm? -90.11 -44.84 9.53 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.231 -0.918 . . . . 0.0 110.792 -179.945 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 803' ' ' GLU . . . . . 0.519 ' HA ' ' CD1' ' A' ' 807' ' ' ILE . 32.1 tt0 -62.67 -21.94 66.09 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.125 -0.985 . . . . 0.0 110.927 -179.89 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 804' ' ' ARG . . . . . 0.491 ' HB2' ' O ' ' A' ' 800' ' ' SER . 0.0 OUTLIER -91.96 -19.4 22.47 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 120.981 -1.075 . . . . 0.0 111.055 -179.971 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 805' ' ' LYS . . . . . . . . . . . . . 12.9 ttpp -132.47 51.3 2.16 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.004 -1.06 . . . . 0.0 111.05 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 806' ' ' CYS . . . . . 0.471 ' HB2' ' O ' ' A' ' 802' ' ' LEU . 1.2 t -156.96 -33.0 0.08 Allowed 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.015 -1.053 . . . . 0.0 111.067 179.925 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 807' ' ' ILE . . . . . 0.519 ' CD1' ' HA ' ' A' ' 803' ' ' GLU . 2.5 mp -77.17 121.89 30.58 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 O-C-N 120.979 -1.076 . . . . 0.0 110.78 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 808' ' ' GLY . . . . . 0.436 ' C ' ' HG ' ' A' ' 809' ' ' LEU . . . 107.78 13.86 19.02 Favored Glycine 0 N--CA 1.494 2.521 0 N-CA-C 110.082 -1.207 . . . . 0.0 110.082 179.935 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 809' ' ' LEU . . . . . 0.436 ' HG ' ' C ' ' A' ' 808' ' ' GLY . 4.2 mt -134.5 134.84 41.92 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.076 -1.25 . . . . 0.0 110.443 179.961 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 810' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -65.82 -13.62 59.85 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.236 -0.915 . . . . 0.0 109.245 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 811' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -141.7 164.18 30.91 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.578 -0.701 . . . . 0.0 109.627 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 812' ' ' CYS . . . . . 0.432 ' O ' ' HB2' ' A' ' 761' ' ' HIS . 1.7 t -145.37 132.0 19.9 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.19 -0.944 . . . . 0.0 110.241 -179.952 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 813' ' ' VAL . . . . . 0.457 HG22 ' CB ' ' A' ' 761' ' ' HIS . 54.3 t -143.43 110.83 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.156 -0.965 . . . . 0.0 110.328 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 814' ' ' VAL . . . . . 0.427 HG11 ' N ' ' A' ' 815' ' ' ALA . 61.4 t -119.06 149.61 21.53 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.452 0 O-C-N 121.456 -0.778 . . . . 0.0 109.629 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 815' ' ' ALA . . . . . 0.427 ' N ' HG11 ' A' ' 814' ' ' VAL . . . -102.34 132.08 48.55 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.142 -0.974 . . . . 0.0 110.263 -179.989 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 816' ' ' ILE . . . . . 0.5 ' CD1' HG21 ' A' ' 760' ' ' VAL . 26.6 mt -89.62 151.72 3.44 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 121.346 -0.846 . . . . 0.0 110.384 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 817' ' ' SER . . . . . 0.402 ' CB ' ' O ' ' A' ' 816' ' ' ILE . 0.0 OUTLIER 174.74 171.93 0.27 Allowed Pre-proline 0 N--CA 1.494 1.748 0 O-C-N 121.265 -0.897 . . . . 0.0 110.129 -179.99 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 818' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -73.92 -45.11 0.4 Allowed 'Trans proline' 0 C--N 1.305 -1.748 0 O-C-N 124.017 1.535 . . . . 0.0 110.468 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 819' ' ' SER . . . . . . . . . . . . . 59.5 p -95.81 46.53 1.09 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.258 -0.901 . . . . 0.0 110.088 179.92 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 820' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -126.9 -28.68 2.9 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.274 -0.891 . . . . 0.0 110.477 -179.946 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 821' ' ' PHE . . . . . . . . . . . . . 11.9 m-85 -103.73 -72.22 0.71 Allowed 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.15 -0.969 . . . . 0.0 110.302 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 822' ' ' GLY . . . . . . . . . . . . . . . -179.83 56.94 0.08 OUTLIER Glycine 0 N--CA 1.492 2.43 0 N-CA-C 109.823 -1.311 . . . . 0.0 109.823 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 823' ' ' GLY . . . . . . . . . . . . . . . 60.33 -172.57 5.86 Favored Glycine 0 N--CA 1.494 2.507 0 N-CA-C 109.87 -1.292 . . . . 0.0 109.87 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 824' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -112.76 138.43 22.11 Favored Pre-proline 0 N--CA 1.495 1.79 0 O-C-N 121.345 -1.091 . . . . 0.0 110.168 -179.976 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 825' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_endo -84.54 -36.82 0.15 Allowed 'Trans proline' 0 C--N 1.304 -1.77 0 O-C-N 124.075 1.566 . . . . 0.0 111.08 -179.89 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 826' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -110.28 133.16 21.15 Favored Pre-proline 0 N--CA 1.504 2.256 0 O-C-N 120.971 -1.081 . . . . 0.0 110.714 -179.903 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 827' ' ' PRO . . . . . 0.451 ' O ' HG22 ' A' ' 829' ' ' VAL . 51.0 Cg_endo -87.27 167.63 7.76 Favored 'Trans proline' 0 C--N 1.309 -1.517 0 O-C-N 123.997 1.525 . . . . 0.0 110.348 179.907 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 828' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER 47.36 25.2 0.55 Allowed 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.216 -0.928 . . . . 0.0 110.897 179.978 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 829' ' ' VAL . . . . . 0.451 HG22 ' O ' ' A' ' 827' ' ' PRO . 81.9 t -127.67 125.0 64.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.0 -1.063 . . . . 0.0 110.317 -179.96 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 830' ' ' MET . . . . . . . . . . . . . 29.2 mtt -56.89 -173.13 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.179 -0.951 . . . . 0.0 109.837 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 831' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.73 127.54 8.83 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.12 -0.987 . . . . 0.0 110.878 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 832' ' ' ARG . . . . . . . . . . . . . 2.8 mtt180 -123.4 167.55 13.69 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.542 -0.724 . . . . 0.0 109.094 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 833' ' ' VAL . . . . . 0.466 HG22 HG23 ' A' ' 816' ' ' ILE . 88.9 t -124.27 109.06 21.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 120.795 -1.191 . . . . 0.0 111.399 -179.909 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 834' ' ' ALA . . . . . 0.45 ' O ' HG21 ' A' ' 835' ' ' VAL . . . -109.49 141.02 42.54 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 179.808 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 835' ' ' VAL . . . . . 0.46 ' CG1' ' N ' ' A' ' 836' ' ' GLU . 23.6 t -154.85 163.52 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 120.634 -1.291 . . . . 0.0 112.095 -179.872 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 836' ' ' GLU . . . . . 0.487 ' HB3' ' HB2' ' A' ' 774' ' ' LYS . 0.6 OUTLIER -148.27 149.19 31.43 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 107.972 -1.122 . . . . 0.0 107.972 179.974 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 837' ' ' ALA . . . . . 0.442 ' O ' ' HA3' ' A' ' 730' ' ' GLY . . . -135.66 154.18 51.38 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 120.633 -1.292 . . . . 0.0 111.899 -179.862 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 838' ' ' VAL . . . . . 0.416 ' O ' ' HA ' ' A' ' 770' ' ' ILE . 41.1 t -109.12 125.5 66.21 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 179.882 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 839' ' ' CYS . . . . . 0.456 ' O ' ' O ' ' A' ' 728' ' ' VAL . 0.5 OUTLIER -116.5 161.25 19.41 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.962 -1.086 . . . . 0.0 111.199 -179.928 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 840' ' ' SER . . . . . 0.412 ' OG ' ' C ' ' A' ' 839' ' ' CYS . 0.2 OUTLIER -168.27 140.39 2.9 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.665 -0.647 . . . . 0.0 109.501 -179.981 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 841' ' ' THR . . . . . 0.531 ' CA ' ' HG3' ' A' ' 768' ' ' GLN . 11.8 t . . . . . 0 N--CA 1.493 1.723 0 O-C-N 121.084 -1.01 . . . . 0.0 110.482 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 728' ' ' VAL . . . . . . . . . . . . . 75.2 t . . . . . 0 N--CA 1.491 1.623 0 CA-C-O 121.192 0.52 . . . . 0.0 110.221 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 729' ' ' SER . . . . . . . . . . . . . 16.1 p -167.26 167.11 14.38 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.164 -0.96 . . . . 0.0 110.501 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 730' ' ' GLY . . . . . . . . . . . . . . . -129.84 176.75 18.52 Favored Glycine 0 N--CA 1.489 2.202 0 N-CA-C 109.414 -1.475 . . . . 0.0 109.414 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 731' ' ' VAL . . . . . . . . . . . . . 2.6 m -131.7 137.88 54.1 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.283 -1.128 . . . . 0.0 110.462 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 732' ' ' CYS . . . . . . . . . . . . . 48.7 m -109.87 154.65 22.74 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.386 -0.821 . . . . 0.0 109.658 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 733' ' ' ALA . . . . . . . . . . . . . . . -167.59 114.27 0.74 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.111 -0.993 . . . . 0.0 111.001 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 734' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -111.22 120.53 42.59 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.385 -0.822 . . . . 0.0 109.444 179.894 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 735' ' ' VAL . . . . . . . . . . . . . 79.3 t -129.44 144.69 37.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.155 -0.966 . . . . 0.0 110.591 -179.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 736' ' ' SER . . . . . . . . . . . . . 2.3 m -89.97 -170.46 2.8 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.39 -0.819 . . . . 0.0 109.895 179.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 737' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 . . . . . 0 N--CA 1.494 1.74 0 O-C-N 121.203 -0.936 . . . . 0.0 110.488 179.974 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 757' ' ' THR . . . . . 0.428 ' O ' ' C ' ' A' ' 758' ' ' ALA . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.67 0 CA-C-O 121.083 0.468 . . . . 0.0 110.332 . . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 758' ' ' ALA . . . . . 0.464 ' O ' ' HG3' ' A' ' 759' ' ' LYS . . . -42.85 156.31 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.291 -0.881 . . . . 0.0 109.763 -179.997 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 759' ' ' LYS . . . . . 0.464 ' HG3' ' O ' ' A' ' 758' ' ' ALA . 18.3 mtpt -144.73 157.52 44.15 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.108 -0.995 . . . . 0.0 110.827 -179.892 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 760' ' ' VAL . . . . . 0.4 ' O ' ' HA ' ' A' ' 813' ' ' VAL . 77.9 t -107.67 132.92 53.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.395 -0.816 . . . . 0.0 108.92 179.947 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 761' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -108.87 104.82 14.15 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.065 -1.022 . . . . 0.0 111.328 -179.737 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 762' ' ' LEU . . . . . . . . . . . . . 25.8 mt -114.74 137.45 51.91 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 179.784 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 763' ' ' LYS . . . . . . . . . . . . . 18.7 ttpp -133.64 146.78 51.22 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.923 -1.111 . . . . 0.0 111.419 -179.894 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 764' ' ' CYS . . . . . 0.42 ' HB2' ' O ' ' A' ' 810' ' ' GLU . 20.7 m -141.55 155.15 45.8 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.597 -0.689 . . . . 0.0 109.434 179.86 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 765' ' ' ALA . . . . . 0.517 ' CB ' ' HD2' ' A' ' 766' ' ' PRO . . . -83.15 178.53 2.38 Favored Pre-proline 0 N--CA 1.494 1.727 0 O-C-N 121.059 -1.025 . . . . 0.0 110.354 -179.924 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 766' ' ' PRO . . . . . 0.517 ' HD2' ' CB ' ' A' ' 765' ' ' ALA . 44.0 Cg_endo -70.31 151.42 65.95 Favored 'Trans proline' 0 C--N 1.307 -1.642 0 O-C-N 123.968 1.509 . . . . 0.0 110.181 179.966 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 767' ' ' GLY . . . . . . . . . . . . . . . 70.87 3.81 52.2 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.143 -1.583 . . . . 0.0 109.143 -179.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 768' ' ' GLN . . . . . 0.47 ' HG2' ' O ' ' A' ' 840' ' ' SER . 28.4 mt-30 -123.66 117.45 25.02 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.346 -1.09 . . . . 0.0 109.838 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 769' ' ' THR . . . . . . . . . . . . . 60.5 p -127.17 148.32 50.18 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.061 -1.024 . . . . 0.0 110.295 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 770' ' ' ILE . . . . . . . . . . . . . 87.3 mt -60.76 117.25 2.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.256 -0.902 . . . . 0.0 109.777 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 771' ' ' SER . . . . . . . . . . . . . 13.9 t -107.27 -2.92 20.27 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.163 -0.961 . . . . 0.0 110.862 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 772' ' ' ALA . . . . . . . . . . . . . . . -170.81 135.19 1.07 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 120.806 -1.184 . . . . 0.0 111.313 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 773' ' ' ILE . . . . . 0.429 HD13 ' HB3' ' A' ' 802' ' ' LEU . 16.6 mm -85.38 128.16 39.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.441 -0.787 . . . . 0.0 108.93 179.815 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 774' ' ' LYS . . . . . 0.465 ' HB3' ' HB3' ' A' ' 836' ' ' GLU . 0.0 OUTLIER -79.29 -37.28 38.14 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.108 -0.995 . . . . 0.0 110.897 -179.827 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 775' ' ' PHE . . . . . . . . . . . . . 90.2 t80 -169.62 150.4 4.07 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.016 -1.052 . . . . 0.0 110.691 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 776' ' ' ALA . . . . . 0.452 ' O ' ' HB2' ' A' ' 798' ' ' SER . . . -163.93 126.28 2.45 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.469 -0.769 . . . . 0.0 109.483 179.94 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 777' ' ' SER . . . . . 0.506 ' HA ' ' CB ' ' A' ' 798' ' ' SER . 6.0 t -153.94 123.45 6.63 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.19 -0.944 . . . . 0.0 110.676 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 778' ' ' PHE . . . . . . . . . . . . . 42.6 t80 -97.15 82.8 3.23 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.395 -0.816 . . . . 0.0 109.712 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 779' ' ' GLY . . . . . . . . . . . . . . . 179.02 -121.42 0.75 Allowed Glycine 0 N--CA 1.492 2.392 0 N-CA-C 109.719 -1.352 . . . . 0.0 109.719 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 780' ' ' THR . . . . . 0.441 ' O ' ' HA3' ' A' ' 791' ' ' GLY . 44.9 p -114.61 97.2 46.15 Favored Pre-proline 0 N--CA 1.493 1.705 0 O-C-N 121.242 -1.152 . . . . 0.0 110.407 -179.949 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 781' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -79.35 175.94 10.21 Favored 'Trans proline' 0 C--N 1.304 -1.798 0 O-C-N 123.98 1.516 . . . . 0.0 110.514 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 782' ' ' LEU . . . . . 0.471 ' CD1' ' HA2' ' A' ' 791' ' ' GLY . 6.8 mt -139.05 105.4 5.27 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.344 -0.848 . . . . 0.0 110.144 -179.976 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 783' ' ' GLY . . . . . . . . . . . . . . . 102.37 -176.76 25.66 Favored Glycine 0 N--CA 1.492 2.367 0 N-CA-C 109.629 -1.389 . . . . 0.0 109.629 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 784' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -130.05 -163.08 1.27 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.205 -1.173 . . . . 0.0 110.052 179.913 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 785' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -59.86 116.69 4.29 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.059 -1.026 . . . . 0.0 109.901 -179.958 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 786' ' ' GLY . . . . . . . . . . . . . . . 137.07 -43.94 1.18 Allowed Glycine 0 N--CA 1.489 2.209 0 N-CA-C 108.575 -1.81 . . . . 0.0 108.575 -179.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 787' ' ' THR . . . . . . . . . . . . . 25.5 m -148.39 38.43 0.87 Allowed 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.554 -0.968 . . . . 0.0 109.34 179.867 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 788' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -50.4 176.31 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.814 0 CA-C-O 121.717 0.77 . . . . 0.0 111.065 -179.95 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 789' ' ' GLN . . . . . . . . . . . . . 2.2 mt-30 -161.87 170.6 19.18 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.563 -0.71 . . . . 0.0 109.508 179.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 790' ' ' GLN . . . . . 0.435 ' O ' ' C ' ' A' ' 791' ' ' GLY . 1.1 tp60 -88.81 21.05 3.2 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.985 -1.072 . . . . 0.0 110.283 -179.945 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 791' ' ' GLY . . . . . 0.471 ' HA2' ' CD1' ' A' ' 782' ' ' LEU . . . 42.34 -124.34 3.74 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.764 -1.335 . . . . 0.0 109.764 -179.953 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 792' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -133.02 -30.73 1.33 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.347 -1.09 . . . . 0.0 110.392 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 793' ' ' CYS . . . . . . . . . . . . . 5.1 t -112.07 139.44 47.59 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.187 -0.946 . . . . 0.0 110.239 -179.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 794' ' ' HIS . . . . . 0.419 ' CD2' ' HA ' ' A' ' 796' ' ' ILE . 19.0 t60 -148.81 141.57 24.58 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.3 -0.875 . . . . 0.0 109.952 179.876 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 795' ' ' SER . . . . . 0.424 ' HB3' ' HG3' ' A' ' 825' ' ' PRO . 3.7 p -81.99 10.13 7.1 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.294 -0.879 . . . . 0.0 110.382 -179.967 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 796' ' ' ILE . . . . . 0.447 ' O ' ' CG2' ' A' ' 796' ' ' ILE . 50.2 mt 45.98 23.24 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 O-C-N 121.2 -0.937 . . . . 0.0 110.405 -179.933 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 797' ' ' ASN . . . . . . . . . . . . . 2.8 t30 -150.46 17.14 0.82 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.339 -0.851 . . . . 0.0 109.815 -179.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 798' ' ' SER . . . . . 0.506 ' CB ' ' HA ' ' A' ' 777' ' ' SER . 2.0 m -81.45 -29.72 33.7 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.47 -0.769 . . . . 0.0 110.324 -179.934 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 799' ' ' ASN . . . . . . . . . . . . . 11.9 t30 -86.78 -11.38 51.16 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.276 -0.89 . . . . 0.0 110.525 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 800' ' ' SER . . . . . 0.439 ' O ' ' HB3' ' A' ' 804' ' ' ARG . 30.5 m -87.54 -20.92 25.79 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.182 -0.949 . . . . 0.0 110.166 179.955 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 801' ' ' VAL . . . . . . . . . . . . . 42.0 t -73.75 -41.75 54.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.235 -0.916 . . . . 0.0 110.188 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 802' ' ' LEU . . . . . 0.505 ' N ' ' CD2' ' A' ' 802' ' ' LEU . 4.0 mm? -75.62 -41.04 55.36 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.217 -0.927 . . . . 0.0 110.185 179.933 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 803' ' ' GLU . . . . . 0.526 ' HA ' ' CG1' ' A' ' 807' ' ' ILE . 5.5 tt0 -73.64 -18.04 61.08 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.147 -0.971 . . . . 0.0 110.663 179.948 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 804' ' ' ARG . . . . . 0.439 ' HB3' ' O ' ' A' ' 800' ' ' SER . 0.1 OUTLIER -89.2 -29.21 19.45 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.126 -0.984 . . . . 0.0 110.948 -179.979 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 805' ' ' LYS . . . . . . . . . . . . . 8.3 ttmt -122.11 -41.7 2.42 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 120.979 -1.075 . . . . 0.0 110.937 -179.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 806' ' ' CYS . . . . . 0.449 ' O ' HG12 ' A' ' 807' ' ' ILE . 0.9 OUTLIER -86.14 69.89 10.52 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.224 -0.923 . . . . 0.0 110.714 -179.994 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 807' ' ' ILE . . . . . 0.526 ' CG1' ' HA ' ' A' ' 803' ' ' GLU . 16.0 mm -149.72 121.63 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.411 0 O-C-N 121.287 -0.883 . . . . 0.0 110.512 179.934 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 808' ' ' GLY . . . . . . . . . . . . . . . 84.56 23.57 50.0 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.887 -1.285 . . . . 0.0 109.887 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 809' ' ' LEU . . . . . . . . . . . . . 72.5 mt -123.12 148.22 45.93 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.106 -1.232 . . . . 0.0 110.592 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 810' ' ' GLU . . . . . 0.42 ' O ' ' HB2' ' A' ' 764' ' ' CYS . 1.1 mp0 -83.45 1.25 42.55 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.256 -0.903 . . . . 0.0 110.032 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 811' ' ' ARG . . . . . . . . . . . . . 46.5 ttt180 -153.86 160.38 42.15 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.463 -0.773 . . . . 0.0 109.127 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 812' ' ' CYS . . . . . 0.467 ' C ' ' CG2' ' A' ' 813' ' ' VAL . 0.1 OUTLIER -155.5 143.93 20.28 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.794 -1.191 . . . . 0.0 111.735 -179.981 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 813' ' ' VAL . . . . . 0.467 ' CG2' ' C ' ' A' ' 812' ' ' CYS . 32.0 t -155.54 110.28 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 179.934 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 814' ' ' VAL . . . . . . . . . . . . . 76.0 t -108.43 120.36 59.67 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 121.198 -0.939 . . . . 0.0 110.746 -179.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 815' ' ' ALA . . . . . 0.441 ' O ' ' C ' ' A' ' 816' ' ' ILE . . . -78.01 84.69 4.27 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.425 -0.797 . . . . 0.0 110.102 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 816' ' ' ILE . . . . . 0.498 ' CD1' HG13 ' A' ' 833' ' ' VAL . 21.3 mt -39.39 143.11 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 O-C-N 121.476 -0.765 . . . . 0.0 110.602 179.97 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 817' ' ' SER . . . . . 0.45 ' OG ' ' HD2' ' A' ' 818' ' ' PRO . 0.0 OUTLIER -157.94 175.18 3.4 Favored Pre-proline 0 C--N 1.302 -1.481 0 O-C-N 121.328 -0.858 . . . . 0.0 109.958 179.944 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 818' ' ' PRO . . . . . 0.45 ' HD2' ' OG ' ' A' ' 817' ' ' SER . 42.7 Cg_endo -71.66 -71.42 0.02 OUTLIER 'Trans proline' 0 C--N 1.302 -1.871 0 O-C-N 123.941 1.495 . . . . 0.0 111.556 -179.933 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 819' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -86.85 39.09 0.83 Allowed 'General case' 0 N--CA 1.496 1.838 0 O-C-N 120.981 -1.074 . . . . 0.0 110.798 -179.895 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 820' ' ' ASN . . . . . 0.433 ' HB2' ' OG ' ' A' ' 817' ' ' SER . 0.7 OUTLIER -99.38 -34.07 10.45 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.135 -0.978 . . . . 0.0 109.888 179.987 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 821' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -99.7 -44.32 6.15 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.294 -0.879 . . . . 0.0 110.051 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 822' ' ' GLY . . . . . . . . . . . . . . . -165.01 -36.59 0.02 OUTLIER Glycine 0 N--CA 1.492 2.388 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 823' ' ' GLY . . . . . . . . . . . . . . . 134.4 -96.6 0.28 Allowed Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.698 -1.361 . . . . 0.0 109.698 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 824' ' ' ASP . . . . . . . . . . . . . 31.7 t0 -149.07 87.0 5.48 Favored Pre-proline 0 N--CA 1.492 1.658 0 O-C-N 121.3 -1.117 . . . . 0.0 110.359 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 825' ' ' PRO . . . . . 0.424 ' HG3' ' HB3' ' A' ' 795' ' ' SER . 43.8 Cg_endo -72.07 -49.54 0.3 Allowed 'Trans proline' 0 C--N 1.306 -1.682 0 O-C-N 123.945 1.497 . . . . 0.0 110.255 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 826' ' ' CYS . . . . . 0.529 ' HB3' ' HB ' ' A' ' 829' ' ' VAL . 0.0 OUTLIER -78.24 144.87 67.58 Favored Pre-proline 0 N--CA 1.489 1.478 0 O-C-N 121.241 -0.912 . . . . 0.0 109.832 179.898 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 827' ' ' PRO . . . . . 0.434 ' O ' ' C ' ' A' ' 828' ' ' GLU . 46.6 Cg_endo -74.93 115.74 4.38 Favored 'Trans proline' 0 C--N 1.302 -1.888 0 O-C-N 124.007 1.53 . . . . 0.0 111.953 -179.938 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 828' ' ' GLU . . . . . 0.434 ' C ' ' O ' ' A' ' 827' ' ' PRO . 18.3 mm-40 35.8 36.99 0.04 OUTLIER 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.735 -0.603 . . . . 0.0 111.69 179.867 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 829' ' ' VAL . . . . . 0.529 ' HB ' ' HB3' ' A' ' 826' ' ' CYS . 17.3 t -91.07 165.27 1.98 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 O-C-N 121.114 -0.991 . . . . 0.0 109.703 179.861 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 830' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -63.67 -168.9 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.118 -0.989 . . . . 0.0 110.041 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 831' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -143.44 158.33 43.73 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.229 -0.919 . . . . 0.0 110.539 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 832' ' ' ARG . . . . . 0.406 ' C ' HG23 ' A' ' 833' ' ' VAL . 0.6 OUTLIER -169.34 161.26 9.89 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.383 -0.823 . . . . 0.0 109.515 -179.958 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 833' ' ' VAL . . . . . 0.498 HG13 ' CD1' ' A' ' 816' ' ' ILE . 93.4 t -135.21 106.96 7.22 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 O-C-N 120.912 -1.117 . . . . 0.0 111.242 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 834' ' ' ALA . . . . . . . . . . . . . . . -115.87 114.53 24.82 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.444 -0.785 . . . . 0.0 108.894 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 835' ' ' VAL . . . . . . . . . . . . . 15.6 t -125.11 158.98 32.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.001 -1.062 . . . . 0.0 111.546 -179.847 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 836' ' ' GLU . . . . . 0.465 ' HB3' ' HB3' ' A' ' 774' ' ' LYS . 30.5 tt0 -147.63 143.29 27.59 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 108.056 -1.09 . . . . 0.0 108.056 179.847 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 837' ' ' ALA . . . . . . . . . . . . . . . -140.58 155.25 46.64 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 120.488 -1.383 . . . . 0.0 112.116 -179.877 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 838' ' ' VAL . . . . . . . . . . . . . 96.2 t -113.33 111.82 37.72 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 179.849 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 839' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -107.45 121.24 44.22 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.063 -1.023 . . . . 0.0 110.911 -179.848 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 840' ' ' SER . . . . . 0.527 ' O ' ' CB ' ' A' ' 841' ' ' THR . 4.6 p -140.82 -66.42 0.43 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.523 -0.736 . . . . 0.0 109.764 179.965 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 841' ' ' THR . . . . . 0.527 ' CB ' ' O ' ' A' ' 840' ' ' SER . 0.0 OUTLIER . . . . . 0 N--CA 1.5 2.057 0 O-C-N 121.482 -0.761 . . . . 0.0 109.918 179.933 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 728' ' ' VAL . . . . . 0.429 HG12 ' HA ' ' A' ' 840' ' ' SER . 0.4 OUTLIER . . . . . 0 N--CA 1.489 1.483 0 CA-C-O 121.353 0.596 . . . . 0.0 110.036 . . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 729' ' ' SER . . . . . 0.413 ' OG ' ' O ' ' A' ' 728' ' ' VAL . 0.6 OUTLIER 176.59 46.82 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.254 -0.904 . . . . 0.0 109.947 -179.95 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 730' ' ' GLY . . . . . . . . . . . . . . . -143.68 89.09 0.17 Allowed Glycine 0 N--CA 1.488 2.116 0 N-CA-C 109.986 -1.246 . . . . 0.0 109.986 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 731' ' ' VAL . . . . . . . . . . . . . 18.0 t -108.27 162.94 6.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.259 -1.142 . . . . 0.0 109.158 179.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 732' ' ' CYS . . . . . 0.442 ' SG ' ' OE1' ' A' ' 836' ' ' GLU . 0.8 OUTLIER -156.55 157.68 35.81 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 120.907 -1.12 . . . . 0.0 111.139 -179.95 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 733' ' ' ALA . . . . . . . . . . . . . . . -170.31 103.52 0.28 Allowed 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 734' ' ' ASP . . . . . 0.493 ' O ' ' CG2' ' A' ' 735' ' ' VAL . 1.8 p-10 -113.09 136.04 53.14 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.226 -0.921 . . . . 0.0 110.619 -179.872 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 735' ' ' VAL . . . . . 0.493 ' CG2' ' O ' ' A' ' 734' ' ' ASP . 89.9 t -156.13 117.34 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.361 -0.837 . . . . 0.0 110.042 179.978 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 736' ' ' SER . . . . . . . . . . . . . 80.8 p -59.18 166.55 2.1 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.136 -0.977 . . . . 0.0 110.115 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 737' ' ' GLU . . . . . 0.511 ' HA ' ' CB ' ' A' ' 758' ' ' ALA . 35.2 tt0 . . . . . 0 N--CA 1.494 1.73 0 O-C-N 121.238 -0.914 . . . . 0.0 110.164 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 757' ' ' THR . . . . . . . . . . . . . 24.2 p . . . . . 0 N--CA 1.492 1.67 0 CA-C-O 121.273 0.559 . . . . 0.0 110.452 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 758' ' ' ALA . . . . . 0.511 ' CB ' ' HA ' ' A' ' 737' ' ' GLU . . . -111.93 161.72 16.11 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.35 -0.844 . . . . 0.0 109.796 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 759' ' ' LYS . . . . . 0.457 ' HG2' ' HA ' ' A' ' 815' ' ' ALA . 6.1 mttt -131.34 162.11 30.83 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.203 -0.936 . . . . 0.0 110.418 179.951 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 760' ' ' VAL . . . . . . . . . . . . . 99.2 t -107.61 143.01 18.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.385 -0.822 . . . . 0.0 109.31 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 761' ' ' HIS . . . . . . . . . . . . . 6.1 m170 -112.53 120.71 42.53 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.08 -1.012 . . . . 0.0 111.069 -179.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 762' ' ' LEU . . . . . 0.471 ' HB2' ' O ' ' A' ' 812' ' ' CYS . 12.3 mt -127.11 141.02 51.86 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.541 -0.724 . . . . 0.0 109.081 179.955 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 763' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -158.7 147.88 18.95 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 120.905 -1.122 . . . . 0.0 111.067 -179.903 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 764' ' ' CYS . . . . . . . . . . . . . 4.2 m -124.03 171.54 9.67 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.425 -0.797 . . . . 0.0 109.674 179.907 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 765' ' ' ALA . . . . . . . . . . . . . . . -70.1 158.52 87.2 Favored Pre-proline 0 N--CA 1.493 1.724 0 O-C-N 121.038 -1.039 . . . . 0.0 109.983 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 766' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -72.04 130.17 16.23 Favored 'Trans proline' 0 C--N 1.306 -1.7 0 O-C-N 123.925 1.487 . . . . 0.0 110.067 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 767' ' ' GLY . . . . . . . . . . . . . . . 112.47 -26.63 10.8 Favored Glycine 0 N--CA 1.488 2.143 0 N-CA-C 108.974 -1.65 . . . . 0.0 108.974 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 768' ' ' GLN . . . . . 0.413 ' O ' ' CG2' ' A' ' 769' ' ' THR . 2.0 mt-30 -106.79 172.29 6.9 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.362 -1.081 . . . . 0.0 109.992 179.934 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 769' ' ' THR . . . . . 0.413 ' CG2' ' O ' ' A' ' 768' ' ' GLN . 37.4 p -153.47 147.96 26.08 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.123 -0.985 . . . . 0.0 110.384 -179.937 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 770' ' ' ILE . . . . . . . . . . . . . 12.9 mt -64.29 146.29 13.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.274 -0.891 . . . . 0.0 109.475 179.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 771' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -135.52 -0.15 2.68 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.023 -1.048 . . . . 0.0 111.053 -179.942 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 772' ' ' ALA . . . . . 0.415 ' O ' ' HB ' ' A' ' 838' ' ' VAL . . . -179.14 147.34 0.33 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.795 -1.191 . . . . 0.0 111.534 179.959 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 773' ' ' ILE . . . . . 0.416 HG13 ' HB3' ' A' ' 802' ' ' LEU . 22.7 mm -107.15 135.37 45.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 179.819 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 774' ' ' LYS . . . . . . . . . . . . . 2.3 ptpt -107.36 -6.85 16.91 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.026 -1.046 . . . . 0.0 111.712 -179.806 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 775' ' ' PHE . . . . . 0.53 ' CD2' ' N ' ' A' ' 776' ' ' ALA . 39.3 t80 -157.65 162.16 38.65 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.731 -1.231 . . . . 0.0 111.337 -179.973 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 776' ' ' ALA . . . . . 0.532 ' O ' ' CB ' ' A' ' 798' ' ' SER . . . 170.04 112.66 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 109.295 -0.632 . . . . 0.0 109.295 179.933 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 777' ' ' SER . . . . . 0.424 ' HA ' ' CE1' ' A' ' 794' ' ' HIS . 0.2 OUTLIER -140.36 120.53 13.82 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.147 -0.971 . . . . 0.0 110.78 -179.954 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 778' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -94.39 96.43 9.52 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.416 -0.803 . . . . 0.0 109.271 179.879 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 779' ' ' GLY . . . . . . . . . . . . . . . 166.82 -111.04 0.43 Allowed Glycine 0 N--CA 1.492 2.372 0 N-CA-C 110.013 -1.235 . . . . 0.0 110.013 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 780' ' ' THR . . . . . 0.471 HG23 ' HG3' ' A' ' 830' ' ' MET . 2.1 p -118.13 102.03 51.06 Favored Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 120.958 -1.319 . . . . 0.0 110.627 -179.927 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 781' ' ' PRO . . . . . 0.511 ' CG ' ' HB3' ' A' ' 832' ' ' ARG . 49.0 Cg_endo -84.58 173.09 8.73 Favored 'Trans proline' 0 C--N 1.306 -1.692 0 O-C-N 124.126 1.592 . . . . 0.0 110.221 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 782' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -145.02 113.37 6.59 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.192 -0.942 . . . . 0.0 110.165 179.903 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 783' ' ' GLY . . . . . . . . . . . . . . . 114.21 -157.5 14.93 Favored Glycine 0 N--CA 1.492 2.409 0 N-CA-C 109.451 -1.46 . . . . 0.0 109.451 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 784' ' ' THR . . . . . 0.481 ' O ' ' CE1' ' A' ' 788' ' ' PHE . 0.0 OUTLIER -136.3 -55.1 0.75 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.101 -1.235 . . . . 0.0 110.519 179.985 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 785' ' ' CYS . . . . . . . . . . . . . 11.0 t -156.97 108.27 2.38 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.215 -0.928 . . . . 0.0 110.507 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 786' ' ' GLY . . . . . . . . . . . . . . . 112.5 -14.27 25.15 Favored Glycine 0 N--CA 1.492 2.401 0 N-CA-C 109.801 -1.319 . . . . 0.0 109.801 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 787' ' ' THR . . . . . . . . . . . . . 3.7 m -136.74 29.76 2.87 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.197 -1.178 . . . . 0.0 110.556 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 788' ' ' PHE . . . . . 0.505 ' CZ ' ' HB3' ' A' ' 834' ' ' ALA . 0.7 OUTLIER -67.75 124.54 23.57 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.174 -0.954 . . . . 0.0 109.87 179.974 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 789' ' ' GLN . . . . . . . . . . . . . 9.7 tm0? -130.22 130.22 44.35 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.234 -0.916 . . . . 0.0 110.321 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 790' ' ' GLN . . . . . 0.502 ' CG ' ' O ' ' A' ' 790' ' ' GLN . 2.3 pt20 -59.73 104.14 0.26 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.292 -0.88 . . . . 0.0 110.025 -179.965 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 791' ' ' GLY . . . . . 0.44 ' O ' ' HG2' ' A' ' 792' ' ' GLU . . . -44.7 -61.96 3.11 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.661 -1.375 . . . . 0.0 109.661 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 792' ' ' GLU . . . . . 0.44 ' HG2' ' O ' ' A' ' 791' ' ' GLY . 2.2 mm-40 -171.48 -33.33 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.18 -1.188 . . . . 0.0 110.388 -179.989 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 793' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -96.46 155.27 16.84 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.163 -0.96 . . . . 0.0 110.499 -179.958 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 794' ' ' HIS . . . . . 0.424 ' CE1' ' HA ' ' A' ' 777' ' ' SER . 13.4 t60 -165.33 164.75 19.78 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.245 -0.91 . . . . 0.0 110.039 -179.966 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 795' ' ' SER . . . . . 0.516 ' O ' HG13 ' A' ' 796' ' ' ILE . 51.1 p -100.79 -7.93 23.18 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.245 -0.909 . . . . 0.0 110.36 179.978 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 796' ' ' ILE . . . . . 0.516 HG13 ' O ' ' A' ' 795' ' ' SER . 0.6 OUTLIER 64.61 11.83 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.506 2.375 0 O-C-N 121.559 -0.713 . . . . 0.0 110.258 -179.972 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 797' ' ' ASN . . . . . 0.461 ' OD1' ' O ' ' A' ' 797' ' ' ASN . 11.0 p30 -152.18 30.91 0.55 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.374 -0.829 . . . . 0.0 109.607 179.968 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 798' ' ' SER . . . . . 0.532 ' CB ' ' O ' ' A' ' 776' ' ' ALA . 3.9 m -67.36 -51.2 55.09 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.573 -0.704 . . . . 0.0 111.707 -179.874 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 799' ' ' ASN . . . . . 0.437 ' OD1' ' N ' ' A' ' 800' ' ' SER . 36.3 p30 -74.9 -17.55 60.56 Favored 'General case' 0 N--CA 1.5 2.039 0 O-C-N 121.243 -0.911 . . . . 0.0 111.803 -179.823 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 800' ' ' SER . . . . . 0.437 ' N ' ' OD1' ' A' ' 799' ' ' ASN . 29.5 t -58.88 -22.24 58.93 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 120.853 -1.154 . . . . 0.0 110.851 -179.96 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 801' ' ' VAL . . . . . . . . . . . . . 42.6 t -93.72 -18.8 6.85 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.006 0 O-C-N 121.096 -1.002 . . . . 0.0 111.051 -179.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 802' ' ' LEU . . . . . 0.479 ' N ' ' CD2' ' A' ' 802' ' ' LEU . 4.0 mm? -87.61 -21.54 25.28 Favored 'General case' 0 N--CA 1.5 2.052 0 O-C-N 121.089 -1.007 . . . . 0.0 111.176 -179.868 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 803' ' ' GLU . . . . . . . . . . . . . 24.5 mt-10 -79.31 -29.11 42.22 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.019 -1.051 . . . . 0.0 111.117 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 804' ' ' ARG . . . . . . . . . . . . . 6.8 mpt_? -92.43 -18.6 23.03 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.082 -1.011 . . . . 0.0 111.545 -179.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 805' ' ' LYS . . . . . . . . . . . . . 7.9 ttmt -129.4 52.03 2.01 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 120.84 -1.163 . . . . 0.0 111.625 -179.87 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 806' ' ' CYS . . . . . 0.411 ' HB2' ' O ' ' A' ' 802' ' ' LEU . 0.5 OUTLIER -162.63 -44.61 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.981 -1.074 . . . . 0.0 110.621 179.901 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 807' ' ' ILE . . . . . . . . . . . . . 30.6 mt -71.92 107.56 2.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.231 -0.918 . . . . 0.0 110.444 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 808' ' ' GLY . . . . . . . . . . . . . . . 122.11 8.79 7.05 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.756 -1.338 . . . . 0.0 109.756 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 809' ' ' LEU . . . . . . . . . . . . . 83.4 mt -135.39 144.91 46.84 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.232 -1.158 . . . . 0.0 110.517 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 810' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -70.88 -28.97 64.95 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.341 -0.85 . . . . 0.0 109.952 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 811' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -123.7 160.26 27.61 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.475 -0.765 . . . . 0.0 109.987 179.908 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 812' ' ' CYS . . . . . 0.471 ' O ' ' HB2' ' A' ' 762' ' ' LEU . 1.3 t -145.69 128.69 16.5 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.267 -0.896 . . . . 0.0 110.313 179.988 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 813' ' ' VAL . . . . . . . . . . . . . 4.8 t -127.13 108.88 19.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.17 -0.956 . . . . 0.0 109.934 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 814' ' ' VAL . . . . . . . . . . . . . 63.7 t -110.57 108.99 26.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.258 -0.901 . . . . 0.0 110.147 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 815' ' ' ALA . . . . . 0.457 ' HA ' ' HG2' ' A' ' 759' ' ' LYS . . . -74.32 168.15 20.22 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.285 -0.884 . . . . 0.0 110.085 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 816' ' ' ILE . . . . . 0.514 ' CG2' HG23 ' A' ' 833' ' ' VAL . 39.3 mt -121.82 131.67 72.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.253 -0.905 . . . . 0.0 110.322 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 817' ' ' SER . . . . . 0.47 ' HB3' ' O ' ' A' ' 816' ' ' ILE . 9.1 p -178.71 173.63 0.58 Allowed Pre-proline 0 C--N 1.301 -1.54 0 O-C-N 121.43 -0.794 . . . . 0.0 109.695 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 818' ' ' PRO . . . . . 0.468 ' HD2' ' HB2' ' A' ' 817' ' ' SER . 51.3 Cg_endo -79.54 12.41 2.38 Favored 'Trans proline' 0 C--N 1.304 -1.78 0 O-C-N 123.847 1.446 . . . . 0.0 111.048 179.957 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 819' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -128.81 2.53 5.4 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.971 -1.081 . . . . 0.0 110.586 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 820' ' ' ASN . . . . . 0.415 ' OD1' ' OG ' ' A' ' 817' ' ' SER . 5.7 m120 -96.36 -35.3 11.25 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.073 -1.017 . . . . 0.0 110.365 -179.932 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 821' ' ' PHE . . . . . . . . . . . . . 46.8 m-85 -104.04 -69.03 0.82 Allowed 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.277 -0.889 . . . . 0.0 110.352 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 822' ' ' GLY . . . . . . . . . . . . . . . 167.6 51.92 0.03 OUTLIER Glycine 0 N--CA 1.492 2.381 0 N-CA-C 109.617 -1.393 . . . . 0.0 109.617 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 823' ' ' GLY . . . . . . . . . . . . . . . 91.58 178.07 42.61 Favored Glycine 0 N--CA 1.493 2.453 0 N-CA-C 109.693 -1.363 . . . . 0.0 109.693 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 824' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -112.68 129.31 24.55 Favored Pre-proline 0 N--CA 1.495 1.797 0 O-C-N 121.338 -1.095 . . . . 0.0 110.236 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 825' ' ' PRO . . . . . 0.413 ' O ' ' HD3' ' A' ' 827' ' ' PRO . 49.4 Cg_endo -82.6 -47.28 0.06 OUTLIER 'Trans proline' 0 C--N 1.307 -1.621 0 O-C-N 123.857 1.451 . . . . 0.0 111.201 -179.958 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 826' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -114.7 93.36 32.97 Favored Pre-proline 0 N--CA 1.498 1.929 0 O-C-N 120.987 -1.07 . . . . 0.0 111.137 -179.892 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 827' ' ' PRO . . . . . 0.472 ' O ' ' CB ' ' A' ' 828' ' ' GLU . 50.6 Cg_endo -89.04 162.01 5.87 Favored 'Trans proline' 0 C--N 1.307 -1.623 0 O-C-N 123.903 1.475 . . . . 0.0 110.396 179.948 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 828' ' ' GLU . . . . . 0.472 ' CB ' ' O ' ' A' ' 827' ' ' PRO . 0.7 OUTLIER 67.35 16.29 10.05 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.206 -0.934 . . . . 0.0 110.806 179.971 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 829' ' ' VAL . . . . . 0.42 ' O ' ' C ' ' A' ' 830' ' ' MET . 59.1 t -127.3 148.27 32.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.061 -1.025 . . . . 0.0 110.129 -179.985 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 830' ' ' MET . . . . . 0.486 ' O ' ' HG3' ' A' ' 830' ' ' MET . 3.1 ptt? -41.89 106.54 0.06 Allowed 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.233 -0.917 . . . . 0.0 109.885 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 831' ' ' LYS . . . . . . . . . . . . . 11.5 mttm -82.03 115.43 21.17 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.164 -0.96 . . . . 0.0 111.001 -179.882 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 832' ' ' ARG . . . . . 0.511 ' HB3' ' CG ' ' A' ' 781' ' ' PRO . 2.4 mmm-85 -135.33 132.79 38.09 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 179.889 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 833' ' ' VAL . . . . . 0.514 HG23 ' CG2' ' A' ' 816' ' ' ILE . 39.3 t -108.96 130.86 61.13 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.584 0 O-C-N 121.02 -1.05 . . . . 0.0 111.034 -179.889 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 834' ' ' ALA . . . . . 0.505 ' HB3' ' CZ ' ' A' ' 788' ' ' PHE . . . -128.83 135.59 49.33 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.508 -0.745 . . . . 0.0 109.411 -179.985 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 835' ' ' VAL . . . . . . . . . . . . . 13.3 t -152.78 127.64 1.49 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.051 -1.031 . . . . 0.0 110.776 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 836' ' ' GLU . . . . . 0.442 ' OE1' ' SG ' ' A' ' 732' ' ' CYS . 3.4 mt-10 -110.58 133.38 53.36 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.452 -0.78 . . . . 0.0 109.587 179.922 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 837' ' ' ALA . . . . . . . . . . . . . . . -110.8 154.54 23.82 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.082 -1.011 . . . . 0.0 110.701 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 838' ' ' VAL . . . . . 0.415 ' HB ' ' O ' ' A' ' 772' ' ' ALA . 99.2 t -107.85 108.86 26.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.366 -0.834 . . . . 0.0 109.807 179.967 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 839' ' ' CYS . . . . . 0.415 ' O ' ' O ' ' A' ' 728' ' ' VAL . 0.0 OUTLIER -108.66 146.56 33.23 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.238 -0.914 . . . . 0.0 110.353 -179.934 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 840' ' ' SER . . . . . 0.429 ' HA ' HG12 ' A' ' 728' ' ' VAL . 0.6 OUTLIER -157.04 168.57 27.08 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.299 -0.875 . . . . 0.0 110.097 179.985 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 841' ' ' THR . . . . . . . . . . . . . 1.2 p . . . . . 0 N--CA 1.494 1.769 0 O-C-N 121.309 -0.869 . . . . 0.0 110.567 -179.979 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 728' ' ' VAL . . . . . 0.537 ' O ' ' CG1' ' A' ' 728' ' ' VAL . 9.9 t . . . . . 0 N--CA 1.492 1.643 0 CA-C-O 121.135 0.493 . . . . 0.0 110.036 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 729' ' ' SER . . . . . 0.42 ' HB3' ' HB3' ' A' ' 840' ' ' SER . 69.5 p -136.06 128.85 30.99 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.162 -0.961 . . . . 0.0 110.447 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 730' ' ' GLY . . . . . . . . . . . . . . . 132.82 74.74 0.1 Allowed Glycine 0 N--CA 1.492 2.414 0 N-CA-C 109.819 -1.312 . . . . 0.0 109.819 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 731' ' ' VAL . . . . . . . . . . . . . 48.0 t -109.66 147.43 14.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.217 -1.166 . . . . 0.0 110.039 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 732' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -120.51 151.63 39.11 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.159 -0.963 . . . . 0.0 110.568 -179.963 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 733' ' ' ALA . . . . . . . . . . . . . . . -141.26 103.09 4.36 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.413 -0.804 . . . . 0.0 109.69 179.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 734' ' ' ASP . . . . . . . . . . . . . 39.0 t70 -127.61 128.19 45.12 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.261 -0.899 . . . . 0.0 109.889 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 735' ' ' VAL . . . . . . . . . . . . . 76.7 t -146.74 134.19 14.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.031 -1.043 . . . . 0.0 110.61 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 736' ' ' SER . . . . . . . . . . . . . 2.7 m -68.26 140.9 56.02 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.359 -0.838 . . . . 0.0 109.852 179.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 737' ' ' GLU . . . . . . . . . . . . . 9.2 tm-20 . . . . . 0 N--CA 1.49 1.537 0 O-C-N 121.199 -0.938 . . . . 0.0 110.527 -179.976 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 757' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.502 2.134 0 CA-C-O 121.746 0.784 . . . . 0.0 111.573 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 758' ' ' ALA . . . . . . . . . . . . . . . -142.91 176.91 8.71 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.492 -0.755 . . . . 0.0 109.424 179.895 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 759' ' ' LYS . . . . . . . . . . . . . 8.3 mtpp -136.77 165.62 25.5 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.155 -0.966 . . . . 0.0 110.926 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 760' ' ' VAL . . . . . . . . . . . . . 46.8 t -108.38 146.65 13.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 179.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 761' ' ' HIS . . . . . . . . . . . . . 31.8 m80 -122.38 105.19 9.96 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.978 -1.076 . . . . 0.0 111.618 -179.879 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 762' ' ' LEU . . . . . 0.517 ' CB ' ' HB3' ' A' ' 812' ' ' CYS . 9.1 mt -118.14 131.21 56.43 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 179.823 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 763' ' ' LYS . . . . . . . . . . . . . 4.3 pttt -159.8 156.13 26.99 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.859 -1.151 . . . . 0.0 111.276 -179.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 764' ' ' CYS . . . . . . . . . . . . . 66.0 m -140.02 -178.14 5.32 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.577 -0.702 . . . . 0.0 109.755 179.88 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 765' ' ' ALA . . . . . . . . . . . . . . . -68.49 161.21 71.83 Favored Pre-proline 0 C--N 1.293 -1.883 0 O-C-N 121.233 -0.917 . . . . 0.0 110.895 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 766' ' ' PRO . . . . . 0.404 ' HA ' ' OE2' ' A' ' 810' ' ' GLU . 47.2 Cg_endo -72.53 83.68 1.27 Allowed 'Trans proline' 0 C--N 1.309 -1.528 0 O-C-N 124.174 1.618 . . . . 0.0 109.951 179.926 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 767' ' ' GLY . . . . . . . . . . . . . . . 150.42 -26.14 1.09 Allowed Glycine 0 N--CA 1.488 2.13 0 N-CA-C 108.293 -1.923 . . . . 0.0 108.293 -179.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 768' ' ' GLN . . . . . 0.502 ' HG2' HG21 ' A' ' 841' ' ' THR . 6.4 mt-30 -101.33 102.4 13.24 Favored 'General case' 0 N--CA 1.486 1.357 0 O-C-N 121.647 -0.914 . . . . 0.0 109.458 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 769' ' ' THR . . . . . . . . . . . . . 9.1 p -101.11 149.26 24.15 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.234 -0.916 . . . . 0.0 110.566 -179.857 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 770' ' ' ILE . . . . . 0.507 HG13 ' HB3' ' A' ' 839' ' ' CYS . 2.6 mp -63.06 148.16 11.47 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 O-C-N 121.287 -0.883 . . . . 0.0 109.97 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 771' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -137.49 -15.76 1.4 Allowed 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.1 -1.0 . . . . 0.0 111.847 -179.963 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 772' ' ' ALA . . . . . . . . . . . . . . . -144.3 136.59 26.49 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 120.698 -1.251 . . . . 0.0 111.689 -179.888 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 773' ' ' ILE . . . . . . . . . . . . . 23.1 mm -105.4 113.65 42.88 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 179.827 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 774' ' ' LYS . . . . . . . . . . . . . 27.6 ttpp -82.08 -44.96 15.88 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.077 -1.014 . . . . 0.0 111.072 -179.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 775' ' ' PHE . . . . . 0.506 ' CD2' ' HB3' ' A' ' 788' ' ' PHE . 73.2 t80 -138.88 163.53 32.06 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.013 -1.054 . . . . 0.0 111.194 -179.911 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 776' ' ' ALA . . . . . 0.475 ' CB ' ' O ' ' A' ' 798' ' ' SER . . . -179.68 93.63 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 109.392 -0.596 . . . . 0.0 109.392 179.989 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 777' ' ' SER . . . . . 0.451 ' HA ' ' CB ' ' A' ' 798' ' ' SER . 11.9 t -127.53 133.33 49.82 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.17 -0.956 . . . . 0.0 110.47 -179.871 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 778' ' ' PHE . . . . . 0.457 ' CD2' HG23 ' A' ' 833' ' ' VAL . 55.1 t80 -110.05 95.84 5.85 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.419 -0.8 . . . . 0.0 110.157 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 779' ' ' GLY . . . . . 0.476 ' HA2' ' HB2' ' A' ' 831' ' ' LYS . . . 163.12 -97.14 0.15 Allowed Glycine 0 N--CA 1.493 2.438 0 N-CA-C 109.655 -1.378 . . . . 0.0 109.655 -179.921 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 780' ' ' THR . . . . . 0.468 ' O ' ' HA3' ' A' ' 791' ' ' GLY . 6.3 p -132.52 89.23 36.73 Favored Pre-proline 0 N--CA 1.495 1.783 0 O-C-N 121.12 -1.223 . . . . 0.0 110.063 -179.954 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 781' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -76.36 169.21 22.39 Favored 'Trans proline' 0 C--N 1.303 -1.847 0 O-C-N 124.072 1.564 . . . . 0.0 110.607 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 782' ' ' LEU . . . . . 0.509 ' CD1' ' C ' ' A' ' 782' ' ' LEU . 1.9 tm? -131.11 115.11 15.98 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.25 -0.906 . . . . 0.0 110.209 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 783' ' ' GLY . . . . . . . . . . . . . . . 126.46 -173.92 18.03 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.827 -1.309 . . . . 0.0 109.827 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 784' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -119.08 -169.04 1.67 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.322 -1.105 . . . . 0.0 110.32 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 785' ' ' CYS . . . . . . . . . . . . . 3.6 t -65.1 90.66 0.09 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.369 -0.832 . . . . 0.0 110.309 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 786' ' ' GLY . . . . . . . . . . . . . . . 153.04 -22.53 0.78 Allowed Glycine 0 N--CA 1.489 2.202 0 N-CA-C 110.036 -1.226 . . . . 0.0 110.036 179.914 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 787' ' ' THR . . . . . 0.507 ' CG2' ' O ' ' A' ' 787' ' ' THR . 60.0 m -146.7 36.28 0.96 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.121 -1.223 . . . . 0.0 110.839 -179.965 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 788' ' ' PHE . . . . . 0.506 ' HB3' ' CD2' ' A' ' 775' ' ' PHE . 7.9 m-85 -54.06 112.44 0.96 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.028 -1.045 . . . . 0.0 109.769 179.995 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 789' ' ' GLN . . . . . . . . . . . . . 3.3 mt-30 -119.36 157.95 27.12 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.255 -0.903 . . . . 0.0 110.116 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 790' ' ' GLN . . . . . . . . . . . . . 16.7 mp0 -49.38 122.01 5.66 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.257 -0.902 . . . . 0.0 110.3 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 791' ' ' GLY . . . . . 0.468 ' HA3' ' O ' ' A' ' 780' ' ' THR . . . -81.05 -103.65 0.32 Allowed Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.404 -1.478 . . . . 0.0 109.404 179.938 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 792' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -130.17 -36.17 1.54 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.294 -1.121 . . . . 0.0 110.218 179.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 793' ' ' CYS . . . . . 0.429 ' HB2' ' OG1' ' A' ' 780' ' ' THR . 4.6 m -107.76 146.32 32.32 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.246 -0.909 . . . . 0.0 110.418 -179.975 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 794' ' ' HIS . . . . . 0.407 ' CE1' ' HG ' ' A' ' 798' ' ' SER . 4.4 t60 -149.06 143.92 26.36 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.372 -0.83 . . . . 0.0 110.172 179.901 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 795' ' ' SER . . . . . 0.533 ' O ' ' CG1' ' A' ' 796' ' ' ILE . 9.0 t -92.93 22.92 4.52 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.25 -0.906 . . . . 0.0 110.227 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 796' ' ' ILE . . . . . 0.533 ' CG1' ' O ' ' A' ' 795' ' ' SER . 36.8 pt 37.32 29.67 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.105 0 O-C-N 121.621 -0.675 . . . . 0.0 110.861 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 797' ' ' ASN . . . . . 0.488 ' N ' ' O ' ' A' ' 795' ' ' SER . 2.0 t-20 -157.66 19.32 0.27 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.085 -1.009 . . . . 0.0 110.269 179.946 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 798' ' ' SER . . . . . 0.475 ' O ' ' CB ' ' A' ' 776' ' ' ALA . 1.2 m -90.33 18.22 6.34 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.263 -0.898 . . . . 0.0 110.395 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 799' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -131.16 -16.88 3.11 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.073 -1.017 . . . . 0.0 111.327 -179.961 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 800' ' ' SER . . . . . . . . . . . . . 5.7 p -78.79 -53.08 7.48 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.0 -1.062 . . . . 0.0 110.544 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 801' ' ' VAL . . . . . 0.547 ' O ' ' CB ' ' A' ' 805' ' ' LYS . 55.1 t -58.63 -19.77 15.14 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.31 -0.869 . . . . 0.0 110.723 -179.948 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 802' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -81.84 -62.2 1.7 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.992 -1.067 . . . . 0.0 111.165 -179.899 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 803' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -56.54 -32.78 65.46 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.192 -0.943 . . . . 0.0 111.417 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 804' ' ' ARG . . . . . . . . . . . . . 62.6 mtm-85 -92.52 -18.88 22.58 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.045 -1.034 . . . . 0.0 111.84 -179.868 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 805' ' ' LYS . . . . . 0.547 ' CB ' ' O ' ' A' ' 801' ' ' VAL . 0.2 OUTLIER -116.83 43.0 2.35 Favored 'General case' 0 N--CA 1.501 2.095 0 O-C-N 120.815 -1.178 . . . . 0.0 111.061 -179.962 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 806' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -159.5 -55.15 0.06 Allowed 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.103 -0.998 . . . . 0.0 110.259 179.833 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 807' ' ' ILE . . . . . . . . . . . . . 61.5 mt -61.21 123.82 14.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.218 -0.926 . . . . 0.0 110.314 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 808' ' ' GLY . . . . . 0.423 ' C ' ' HG ' ' A' ' 809' ' ' LEU . . . 101.31 11.8 37.91 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.603 -1.399 . . . . 0.0 109.603 -179.941 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 809' ' ' LEU . . . . . 0.423 ' HG ' ' C ' ' A' ' 808' ' ' GLY . 59.5 mt -137.28 129.83 29.95 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.228 -1.16 . . . . 0.0 110.199 179.976 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 810' ' ' GLU . . . . . 0.404 ' OE2' ' HA ' ' A' ' 766' ' ' PRO . 24.1 tt0 -67.56 -19.73 65.31 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.325 -0.859 . . . . 0.0 110.188 179.995 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 811' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -133.65 128.7 35.63 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.386 -0.821 . . . . 0.0 110.211 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 812' ' ' CYS . . . . . 0.517 ' HB3' ' CB ' ' A' ' 762' ' ' LEU . 1.3 t -110.65 122.38 47.63 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.329 -0.857 . . . . 0.0 110.135 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 813' ' ' VAL . . . . . . . . . . . . . 25.2 t -130.45 118.62 43.65 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.14 -0.975 . . . . 0.0 110.153 -180.0 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 814' ' ' VAL . . . . . . . . . . . . . 91.6 t -134.67 120.01 30.54 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.286 -0.884 . . . . 0.0 110.156 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 815' ' ' ALA . . . . . . . . . . . . . . . -75.71 146.47 40.11 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.227 -0.921 . . . . 0.0 110.278 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 816' ' ' ILE . . . . . 0.489 HD12 ' HB ' ' A' ' 833' ' ' VAL . 84.6 mt -96.53 123.28 48.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.319 -0.863 . . . . 0.0 110.178 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 817' ' ' SER . . . . . 0.474 ' HB2' ' HD2' ' A' ' 818' ' ' PRO . 4.5 p -159.5 170.55 8.61 Favored Pre-proline 0 N--CA 1.494 1.766 0 O-C-N 121.009 -1.057 . . . . 0.0 110.561 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 818' ' ' PRO . . . . . 0.474 ' HD2' ' HB2' ' A' ' 817' ' ' SER . 47.0 Cg_endo -73.77 -2.08 11.7 Favored 'Trans proline' 0 C--N 1.308 -1.555 0 O-C-N 124.047 1.551 . . . . 0.0 110.606 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 819' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -134.65 59.91 1.72 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.206 -0.934 . . . . 0.0 110.229 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 820' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -132.48 -41.9 0.96 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.365 -0.834 . . . . 0.0 110.278 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 821' ' ' PHE . . . . . . . . . . . . . 79.8 m-85 -100.98 -68.79 0.8 Allowed 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.215 -0.928 . . . . 0.0 110.72 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 822' ' ' GLY . . . . . . . . . . . . . . . -149.05 20.76 1.24 Allowed Glycine 0 N--CA 1.492 2.422 0 C-N-CA 119.638 -1.268 . . . . 0.0 109.945 -179.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 823' ' ' GLY . . . . . 0.474 ' HA2' ' O ' ' A' ' 818' ' ' PRO . . . 102.94 -132.96 11.22 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.719 -1.352 . . . . 0.0 109.719 179.912 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 824' ' ' ASP . . . . . 0.452 ' OD1' ' HB3' ' A' ' 818' ' ' PRO . 2.2 m-20 -140.77 106.45 6.36 Favored Pre-proline 0 N--CA 1.493 1.724 0 O-C-N 121.289 -1.124 . . . . 0.0 110.246 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 825' ' ' PRO . . . . . 0.474 ' O ' ' HD3' ' A' ' 827' ' ' PRO . 44.9 Cg_endo -72.47 -88.44 0.0 OUTLIER 'Trans proline' 0 C--N 1.304 -1.774 0 O-C-N 124.085 1.571 . . . . 0.0 111.003 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 826' ' ' CYS . . . . . . . . . . . . . 97.1 m -80.6 112.18 29.29 Favored Pre-proline 0 N--CA 1.498 1.938 0 O-C-N 121.232 -0.918 . . . . 0.0 110.924 -179.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 827' ' ' PRO . . . . . 0.474 ' HD3' ' O ' ' A' ' 825' ' ' PRO . 49.7 Cg_endo -94.12 173.92 1.51 Allowed 'Trans proline' 0 C--N 1.308 -1.563 0 O-C-N 123.993 1.523 . . . . 0.0 110.251 179.956 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 828' ' ' GLU . . . . . 0.419 ' O ' HG23 ' A' ' 829' ' ' VAL . 14.4 mt-10 52.33 31.11 8.94 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.358 -0.839 . . . . 0.0 110.826 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 829' ' ' VAL . . . . . 0.494 ' O ' ' N ' ' A' ' 831' ' ' LYS . 97.9 t -137.02 113.73 12.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.013 -1.055 . . . . 0.0 110.469 -179.944 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 830' ' ' MET . . . . . 0.434 ' C ' ' O ' ' A' ' 829' ' ' VAL . 2.2 mtt -42.52 95.86 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.333 -0.854 . . . . 0.0 109.989 179.937 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 831' ' ' LYS . . . . . 0.494 ' N ' ' O ' ' A' ' 829' ' ' VAL . 1.9 pttp -109.63 139.49 44.59 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.206 -0.934 . . . . 0.0 110.925 -179.908 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 832' ' ' ARG . . . . . . . . . . . . . 10.4 ptt180 -128.45 166.57 18.5 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.416 -0.802 . . . . 0.0 109.277 179.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 833' ' ' VAL . . . . . 0.489 ' HB ' HD12 ' A' ' 816' ' ' ILE . 54.7 t -107.61 128.67 62.59 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.109 -0.994 . . . . 0.0 110.831 -179.913 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 834' ' ' ALA . . . . . . . . . . . . . . . -128.57 132.45 48.22 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 179.891 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 835' ' ' VAL . . . . . . . . . . . . . 53.2 t -141.25 150.9 19.76 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 O-C-N 120.819 -1.176 . . . . 0.0 111.538 -179.893 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 836' ' ' GLU . . . . . . . . . . . . . 4.0 tp10 -131.53 108.71 9.75 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 179.9 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 837' ' ' ALA . . . . . . . . . . . . . . . -107.87 158.87 16.97 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.037 -1.039 . . . . 0.0 110.264 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 838' ' ' VAL . . . . . . . . . . . . . 37.6 t -122.19 103.07 12.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.285 -0.884 . . . . 0.0 110.418 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 839' ' ' CYS . . . . . 0.507 ' HB3' HG13 ' A' ' 770' ' ' ILE . 3.1 p -120.19 132.29 55.31 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.4 -0.812 . . . . 0.0 109.401 179.931 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 840' ' ' SER . . . . . 0.483 ' O ' ' HA ' ' A' ' 768' ' ' GLN . 16.7 p -149.66 -168.45 3.11 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.065 -1.022 . . . . 0.0 110.881 -179.919 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 841' ' ' THR . . . . . 0.502 HG21 ' HG2' ' A' ' 768' ' ' GLN . 22.7 p . . . . . 0 N--CA 1.497 1.884 0 O-C-N 121.435 -0.791 . . . . 0.0 110.767 -179.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 728' ' ' VAL . . . . . . . . . . . . . 15.5 m . . . . . 0 N--CA 1.489 1.487 0 CA-C-O 121.196 0.522 . . . . 0.0 110.08 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 729' ' ' SER . . . . . . . . . . . . . 1.5 t -173.87 168.09 4.29 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.295 -0.878 . . . . 0.0 110.278 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 730' ' ' GLY . . . . . . . . . . . . . . . -138.1 130.11 4.86 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.404 -1.478 . . . . 0.0 109.404 179.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 731' ' ' VAL . . . . . 0.458 ' O ' HG23 ' A' ' 731' ' ' VAL . 13.6 m -110.82 124.93 68.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.237 -1.155 . . . . 0.0 110.339 -179.956 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 732' ' ' CYS . . . . . . . . . . . . . 5.1 t -109.46 112.46 24.58 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.343 -0.848 . . . . 0.0 109.582 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 733' ' ' ALA . . . . . . . . . . . . . . . -114.2 142.01 46.8 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.236 -0.915 . . . . 0.0 110.974 -179.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 734' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -155.54 118.58 4.31 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.465 -0.772 . . . . 0.0 109.483 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 735' ' ' VAL . . . . . . . . . . . . . 65.5 t -128.55 150.39 34.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.121 -0.987 . . . . 0.0 110.789 -179.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 736' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -99.88 139.73 35.13 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.323 -0.861 . . . . 0.0 109.614 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 737' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 . . . . . 0 N--CA 1.495 1.811 0 O-C-N 121.082 -1.011 . . . . 0.0 110.668 179.991 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 757' ' ' THR . . . . . . . . . . . . . 25.5 p . . . . . 0 N--CA 1.493 1.702 0 CA-C-O 121.326 0.584 . . . . 0.0 110.332 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 758' ' ' ALA . . . . . . . . . . . . . . . -98.79 176.83 5.48 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.294 -0.879 . . . . 0.0 110.224 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 759' ' ' LYS . . . . . . . . . . . . . 13.4 mtmm -141.09 144.58 35.0 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.261 -0.899 . . . . 0.0 110.44 -179.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 760' ' ' VAL . . . . . . . . . . . . . 38.5 t -106.14 133.99 49.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.333 -0.854 . . . . 0.0 108.767 179.881 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 761' ' ' HIS . . . . . 0.639 ' CE1' ' CG2' ' A' ' 813' ' ' VAL . 0.3 OUTLIER -120.47 123.12 42.19 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 120.907 -1.121 . . . . 0.0 111.893 -179.87 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 762' ' ' LEU . . . . . . . . . . . . . 12.5 mt -120.45 98.61 6.12 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 179.77 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 763' ' ' LYS . . . . . 0.519 ' CB ' ' HG2' ' A' ' 811' ' ' ARG . 0.2 OUTLIER -114.48 137.51 51.76 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.005 -1.059 . . . . 0.0 111.515 -179.8 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 764' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER -118.3 161.96 19.07 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.679 -0.638 . . . . 0.0 109.555 179.901 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 765' ' ' ALA . . . . . 0.454 ' HB3' ' HD2' ' A' ' 766' ' ' PRO . . . -50.62 167.73 0.25 Allowed Pre-proline 0 N--CA 1.495 1.775 0 O-C-N 120.978 -1.076 . . . . 0.0 110.133 -179.959 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 766' ' ' PRO . . . . . 0.454 ' HD2' ' HB3' ' A' ' 765' ' ' ALA . 45.5 Cg_endo -72.22 124.34 9.91 Favored 'Trans proline' 0 C--N 1.305 -1.734 0 O-C-N 123.972 1.512 . . . . 0.0 110.155 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 767' ' ' GLY . . . . . . . . . . . . . . . 109.67 -36.37 4.35 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.223 -1.551 . . . . 0.0 109.223 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 768' ' ' GLN . . . . . . . . . . . . . 28.8 mt-30 -87.89 115.27 25.23 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.281 -1.129 . . . . 0.0 109.894 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 769' ' ' THR . . . . . . . . . . . . . 29.4 p -109.28 167.64 9.97 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.215 -0.928 . . . . 0.0 110.292 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 770' ' ' ILE . . . . . . . . . . . . . 7.8 mt -85.61 101.25 9.75 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 121.236 -0.915 . . . . 0.0 109.807 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 771' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -89.55 -6.9 55.91 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.162 -0.961 . . . . 0.0 110.818 -179.923 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 772' ' ' ALA . . . . . 0.456 ' O ' ' HB ' ' A' ' 838' ' ' VAL . . . -165.84 142.46 5.28 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.008 -1.058 . . . . 0.0 111.278 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 773' ' ' ILE . . . . . . . . . . . . . 47.3 mm -94.61 125.87 47.15 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 O-C-N 121.392 -0.817 . . . . 0.0 109.134 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 774' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -80.17 -37.94 32.33 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.085 -1.01 . . . . 0.0 111.244 -179.895 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 775' ' ' PHE . . . . . 0.522 ' CE2' ' HB3' ' A' ' 788' ' ' PHE . 65.0 t80 -150.96 170.18 19.96 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.82 -1.175 . . . . 0.0 111.124 -179.984 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 776' ' ' ALA . . . . . 0.49 ' N ' ' CD2' ' A' ' 775' ' ' PHE . . . 170.82 116.4 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.703 -0.623 . . . . 0.0 109.346 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 777' ' ' SER . . . . . . . . . . . . . 14.5 t -151.69 131.77 13.49 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.114 -0.991 . . . . 0.0 110.724 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 778' ' ' PHE . . . . . . . . . . . . . 2.4 t80 -99.3 124.98 44.84 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.56 -0.713 . . . . 0.0 109.756 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 779' ' ' GLY . . . . . . . . . . . . . . . 130.3 -110.5 1.03 Allowed Glycine 0 N--CA 1.493 2.482 0 N-CA-C 109.85 -1.3 . . . . 0.0 109.85 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 780' ' ' THR . . . . . . . . . . . . . 11.8 p -135.37 83.57 37.49 Favored Pre-proline 0 N--CA 1.496 1.841 0 O-C-N 121.16 -1.2 . . . . 0.0 110.636 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 781' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -76.92 158.23 34.65 Favored 'Trans proline' 0 C--N 1.307 -1.639 0 O-C-N 123.856 1.45 . . . . 0.0 110.087 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 782' ' ' LEU . . . . . 0.436 ' O ' ' HA ' ' A' ' 788' ' ' PHE . 0.3 OUTLIER -96.24 123.86 40.03 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.158 -0.964 . . . . 0.0 110.241 179.958 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 783' ' ' GLY . . . . . . . . . . . . . . . 138.37 -169.33 24.33 Favored Glycine 0 N--CA 1.492 2.404 0 N-CA-C 109.688 -1.365 . . . . 0.0 109.688 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 784' ' ' THR . . . . . . . . . . . . . 3.3 m -138.31 -52.17 0.6 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.281 -1.129 . . . . 0.0 109.961 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 785' ' ' CYS . . . . . 0.556 ' HA ' ' CZ ' ' A' ' 788' ' ' PHE . 40.3 t -166.95 74.51 0.15 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.281 -0.887 . . . . 0.0 109.793 179.948 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 786' ' ' GLY . . . . . . . . . . . . . . . 130.68 -16.07 5.39 Favored Glycine 0 N--CA 1.489 2.171 0 N-CA-C 108.949 -1.66 . . . . 0.0 108.949 -179.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 787' ' ' THR . . . . . 0.464 ' O ' HG21 ' A' ' 787' ' ' THR . 18.2 m -121.78 27.36 8.19 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.477 -1.014 . . . . 0.0 109.878 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 788' ' ' PHE . . . . . 0.556 ' CZ ' ' HA ' ' A' ' 785' ' ' CYS . 35.4 m-85 -55.14 172.71 0.12 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.342 -0.849 . . . . 0.0 110.349 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 789' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER 179.23 172.48 0.86 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.362 -0.836 . . . . 0.0 109.93 -179.982 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 790' ' ' GLN . . . . . . . . . . . . . 6.2 tm0? -57.12 161.42 3.14 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.124 -0.985 . . . . 0.0 110.305 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 791' ' ' GLY . . . . . . . . . . . . . . . -136.89 -131.88 3.02 Favored Glycine 0 N--CA 1.494 2.507 0 N-CA-C 109.687 -1.365 . . . . 0.0 109.687 -179.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 792' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -107.76 -66.32 1.04 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.216 -1.167 . . . . 0.0 109.964 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 793' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -92.54 88.66 6.42 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.266 -0.896 . . . . 0.0 109.891 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 794' ' ' HIS . . . . . 0.438 ' HE1' ' CB ' ' A' ' 798' ' ' SER . 19.2 t60 -105.54 155.49 19.14 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.174 -0.954 . . . . 0.0 110.674 -179.921 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 795' ' ' SER . . . . . 0.476 ' HB2' ' HB3' ' A' ' 825' ' ' PRO . 1.3 t -115.63 111.21 20.3 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.466 -0.771 . . . . 0.0 109.942 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 796' ' ' ILE . . . . . . . . . . . . . 3.5 pt -44.3 -23.05 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 O-C-N 121.315 -0.866 . . . . 0.0 110.816 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 797' ' ' ASN . . . . . 0.409 ' N ' ' O ' ' A' ' 795' ' ' SER . 1.6 t30 -84.19 26.93 0.71 Allowed 'General case' 0 N--CA 1.499 1.991 0 O-C-N 120.988 -1.07 . . . . 0.0 111.005 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 798' ' ' SER . . . . . 0.47 ' HB3' ' O ' ' A' ' 776' ' ' ALA . 9.0 m -82.13 -31.57 30.53 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.0 -1.063 . . . . 0.0 111.11 179.942 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 799' ' ' ASN . . . . . . . . . . . . . 4.8 m120 -107.36 8.08 29.47 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.017 -1.052 . . . . 0.0 111.288 -179.893 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 800' ' ' SER . . . . . 0.422 ' O ' ' HB3' ' A' ' 804' ' ' ARG . 0.7 OUTLIER -90.33 -40.68 11.97 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.953 -1.092 . . . . 0.0 110.245 179.967 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 801' ' ' VAL . . . . . 0.562 HG23 ' CD2' ' A' ' 821' ' ' PHE . 55.5 t -74.65 -35.5 37.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.256 -0.902 . . . . 0.0 110.104 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 802' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -69.31 -57.09 5.76 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.207 -0.933 . . . . 0.0 110.051 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 803' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -62.93 -18.29 62.94 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.235 -0.916 . . . . 0.0 110.011 179.943 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 804' ' ' ARG . . . . . 0.422 ' HB3' ' O ' ' A' ' 800' ' ' SER . 12.4 ttp180 -89.55 -20.42 23.81 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.265 -0.897 . . . . 0.0 111.07 -179.968 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 805' ' ' LYS . . . . . . . . . . . . . 9.2 ttmt -141.06 53.14 1.57 Allowed 'General case' 0 N--CA 1.495 1.818 0 O-C-N 120.878 -1.139 . . . . 0.0 110.873 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 806' ' ' CYS . . . . . . . . . . . . . 1.4 t -158.94 -36.18 0.06 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.128 -0.983 . . . . 0.0 110.317 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 807' ' ' ILE . . . . . . . . . . . . . 9.5 mt -71.12 130.76 34.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.22 -0.925 . . . . 0.0 110.058 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 808' ' ' GLY . . . . . . . . . . . . . . . 91.8 16.03 52.85 Favored Glycine 0 N--CA 1.492 2.407 0 N-CA-C 109.776 -1.329 . . . . 0.0 109.776 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 809' ' ' LEU . . . . . . . . . . . . . 58.4 mt -129.22 138.97 52.01 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.188 -1.184 . . . . 0.0 110.411 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 810' ' ' GLU . . . . . 0.425 ' OE1' ' HA ' ' A' ' 766' ' ' PRO . 43.1 tt0 -69.14 -32.2 71.39 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.333 -0.854 . . . . 0.0 109.468 179.857 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 811' ' ' ARG . . . . . 0.519 ' HG2' ' CB ' ' A' ' 763' ' ' LYS . 3.3 mtm-85 -131.63 156.34 45.99 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.46 -0.775 . . . . 0.0 109.587 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 812' ' ' CYS . . . . . 0.467 ' O ' HG21 ' A' ' 813' ' ' VAL . 0.5 OUTLIER -133.03 142.4 48.78 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.13 -0.981 . . . . 0.0 110.825 -179.976 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 813' ' ' VAL . . . . . 0.639 ' CG2' ' CE1' ' A' ' 761' ' ' HIS . 51.2 t -140.45 115.51 6.9 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.337 -0.852 . . . . 0.0 109.841 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 814' ' ' VAL . . . . . . . . . . . . . 52.4 t -128.89 121.76 55.24 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 O-C-N 121.253 -0.904 . . . . 0.0 110.464 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 815' ' ' ALA . . . . . . . . . . . . . . . -80.41 142.57 34.22 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.212 -0.93 . . . . 0.0 109.918 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 816' ' ' ILE . . . . . 0.503 ' CG2' HG22 ' A' ' 833' ' ' VAL . 14.1 mt -88.03 112.65 23.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.212 -0.93 . . . . 0.0 110.376 -179.955 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 817' ' ' SER . . . . . 0.458 ' OG ' ' OD1' ' A' ' 820' ' ' ASN . 78.7 p -168.34 163.39 8.57 Favored Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 121.448 -0.782 . . . . 0.0 109.993 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 818' ' ' PRO . . . . . 0.442 ' HB3' ' OD1' ' A' ' 824' ' ' ASP . 44.4 Cg_endo -72.37 -19.38 25.4 Favored 'Trans proline' 0 C--N 1.305 -1.747 0 O-C-N 124.021 1.537 . . . . 0.0 110.372 -179.979 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 819' ' ' SER . . . . . . . . . . . . . 9.1 m -94.97 48.13 1.17 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.187 -0.945 . . . . 0.0 110.017 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 820' ' ' ASN . . . . . 0.458 ' OD1' ' OG ' ' A' ' 817' ' ' SER . 1.2 m120 -139.75 -53.8 0.54 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.266 -0.897 . . . . 0.0 110.195 -179.955 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 821' ' ' PHE . . . . . 0.562 ' CD2' HG23 ' A' ' 801' ' ' VAL . 87.6 m-85 -79.54 -33.05 42.26 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.345 -0.847 . . . . 0.0 110.316 -179.958 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 822' ' ' GLY . . . . . . . . . . . . . . . 128.09 66.93 0.13 Allowed Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.656 -1.378 . . . . 0.0 109.656 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 823' ' ' GLY . . . . . . . . . . . . . . . 98.86 -175.57 28.89 Favored Glycine 0 N--CA 1.492 2.411 0 N-CA-C 109.716 -1.354 . . . . 0.0 109.716 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 824' ' ' ASP . . . . . 0.442 ' OD1' ' HB3' ' A' ' 818' ' ' PRO . 0.2 OUTLIER -102.18 133.15 20.79 Favored Pre-proline 0 N--CA 1.493 1.692 0 O-C-N 121.24 -1.153 . . . . 0.0 110.115 179.919 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 825' ' ' PRO . . . . . 0.476 ' HB3' ' HB2' ' A' ' 795' ' ' SER . 51.7 Cg_endo -75.07 -89.7 0.01 OUTLIER 'Trans proline' 0 C--N 1.307 -1.637 0 O-C-N 123.964 1.508 . . . . 0.0 110.477 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 826' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -113.41 103.1 55.48 Favored Pre-proline 0 N--CA 1.492 1.645 0 O-C-N 121.136 -0.978 . . . . 0.0 110.177 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 827' ' ' PRO . . . . . 0.408 ' O ' ' HB3' ' A' ' 828' ' ' GLU . 45.3 Cg_endo -74.08 165.4 32.09 Favored 'Trans proline' 0 C--N 1.304 -1.808 0 O-C-N 123.994 1.523 . . . . 0.0 110.655 179.933 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 828' ' ' GLU . . . . . 0.425 ' HG2' ' O ' ' A' ' 828' ' ' GLU . 1.6 tt0 55.78 44.7 25.71 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.304 -0.873 . . . . 0.0 110.578 179.959 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 829' ' ' VAL . . . . . 0.408 ' O ' ' C ' ' A' ' 830' ' ' MET . 25.4 t -141.33 151.57 19.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.222 -0.924 . . . . 0.0 110.122 179.92 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 830' ' ' MET . . . . . 0.408 ' C ' ' O ' ' A' ' 829' ' ' VAL . 0.0 OUTLIER -43.15 121.34 2.12 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.301 -0.874 . . . . 0.0 109.944 -179.986 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 831' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.71 86.64 7.31 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.287 -0.883 . . . . 0.0 110.595 -179.953 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 832' ' ' ARG . . . . . . . . . . . . . 6.8 mpt_? -129.58 125.89 37.24 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.408 -0.808 . . . . 0.0 109.421 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 833' ' ' VAL . . . . . 0.503 HG22 ' CG2' ' A' ' 816' ' ' ILE . 54.7 t -109.73 140.59 27.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.098 -1.001 . . . . 0.0 110.829 -179.887 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 834' ' ' ALA . . . . . 0.452 ' O ' ' CG2' ' A' ' 835' ' ' VAL . . . -141.26 138.16 33.03 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.398 -0.814 . . . . 0.0 109.68 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 835' ' ' VAL . . . . . 0.452 ' CG2' ' O ' ' A' ' 834' ' ' ALA . 35.3 t -156.0 127.99 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 O-C-N 121.036 -1.04 . . . . 0.0 111.187 -179.93 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 836' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -114.25 128.67 56.47 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.439 -0.788 . . . . 0.0 109.248 179.884 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 837' ' ' ALA . . . . . . . . . . . . . . . -110.98 157.89 19.39 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.075 -1.016 . . . . 0.0 110.914 -179.853 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 838' ' ' VAL . . . . . 0.456 ' HB ' ' O ' ' A' ' 772' ' ' ALA . 98.9 t -109.28 132.39 57.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.477 -0.765 . . . . 0.0 109.662 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 839' ' ' CYS . . . . . . . . . . . . . 1.3 m -115.8 134.64 54.8 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.071 -1.018 . . . . 0.0 110.721 -179.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 840' ' ' SER . . . . . . . . . . . . . 4.5 t -139.95 -133.84 0.11 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.44 -0.787 . . . . 0.0 109.743 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 841' ' ' THR . . . . . . . . . . . . . 30.4 p . . . . . 0 N--CA 1.492 1.627 0 O-C-N 120.89 -1.131 . . . . 0.0 110.213 -179.964 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 728' ' ' VAL . . . . . . . . . . . . . 56.4 t . . . . . 0 N--CA 1.492 1.662 0 CA-C-O 121.326 0.584 . . . . 0.0 110.039 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 729' ' ' SER . . . . . . . . . . . . . 1.3 t -84.68 -149.36 0.11 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.22 -0.925 . . . . 0.0 110.482 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 730' ' ' GLY . . . . . . . . . . . . . . . 170.58 131.7 1.37 Allowed Glycine 0 N--CA 1.489 2.175 0 N-CA-C 109.216 -1.554 . . . . 0.0 109.216 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 731' ' ' VAL . . . . . . . . . . . . . 7.0 t -120.14 141.25 41.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.174 -1.192 . . . . 0.0 110.411 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 732' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -109.64 163.86 13.08 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.354 -0.841 . . . . 0.0 109.864 -179.977 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 733' ' ' ALA . . . . . . . . . . . . . . . -155.37 104.48 2.4 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.146 -0.971 . . . . 0.0 110.656 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 734' ' ' ASP . . . . . . . . . . . . . 35.3 t0 -117.7 103.69 10.26 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.376 -0.828 . . . . 0.0 109.455 179.88 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 735' ' ' VAL . . . . . 0.467 HG13 ' N ' ' A' ' 736' ' ' SER . 68.4 t -129.86 154.02 39.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.209 -0.932 . . . . 0.0 110.482 -179.895 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 736' ' ' SER . . . . . 0.467 ' N ' HG13 ' A' ' 735' ' ' VAL . 57.8 m -66.26 -173.29 0.19 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.316 -0.865 . . . . 0.0 110.474 -179.957 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 737' ' ' GLU . . . . . 0.453 ' OE1' HG21 ' A' ' 816' ' ' ILE . 28.8 tp10 . . . . . 0 N--CA 1.493 1.704 0 O-C-N 121.373 -0.83 . . . . 0.0 110.18 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 757' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.5 2.044 0 CA-C-O 121.474 0.654 . . . . 0.0 111.258 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 758' ' ' ALA . . . . . . . . . . . . . . . -91.45 174.99 7.08 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.437 -0.789 . . . . 0.0 110.333 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 759' ' ' LYS . . . . . . . . . . . . . 10.2 mttt -147.86 145.75 28.82 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.242 -0.912 . . . . 0.0 110.525 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 760' ' ' VAL . . . . . 0.445 HG21 HG13 ' A' ' 833' ' ' VAL . 97.9 t -136.97 131.13 46.2 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 O-C-N 121.471 -0.768 . . . . 0.0 109.493 179.932 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 761' ' ' HIS . . . . . 0.489 ' CB ' HG22 ' A' ' 813' ' ' VAL . 25.4 p-80 -142.69 135.18 27.77 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 120.936 -1.103 . . . . 0.0 111.002 -179.974 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 762' ' ' LEU . . . . . . . . . . . . . 3.3 mp -115.17 148.06 39.52 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.437 -0.789 . . . . 0.0 109.494 179.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 763' ' ' LYS . . . . . 0.426 ' O ' ' CG ' ' A' ' 763' ' ' LYS . 0.0 OUTLIER -133.61 105.04 6.64 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.04 -1.038 . . . . 0.0 110.616 -179.896 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 764' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -84.09 176.59 8.71 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.18 -0.95 . . . . 0.0 110.013 179.943 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 765' ' ' ALA . . . . . . . . . . . . . . . -69.6 160.55 79.14 Favored Pre-proline 0 N--CA 1.492 1.625 0 O-C-N 121.243 -0.91 . . . . 0.0 109.975 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 766' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -71.35 132.01 20.04 Favored 'Trans proline' 0 C--N 1.303 -1.847 0 O-C-N 124.053 1.554 . . . . 0.0 110.525 -179.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 767' ' ' GLY . . . . . . . . . . . . . . . 108.57 -44.95 1.39 Allowed Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 179.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 768' ' ' GLN . . . . . . . . . . . . . 2.4 mp0 -85.62 119.35 25.86 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.182 -1.187 . . . . 0.0 110.053 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 769' ' ' THR . . . . . . . . . . . . . 68.4 p -102.59 146.79 27.64 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.265 -0.897 . . . . 0.0 110.463 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 770' ' ' ILE . . . . . . . . . . . . . 48.3 mt -70.23 123.82 24.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.335 -0.853 . . . . 0.0 109.728 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 771' ' ' SER . . . . . . . . . . . . . 6.7 t -119.61 -12.83 9.23 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.148 -0.97 . . . . 0.0 110.696 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 772' ' ' ALA . . . . . 0.403 ' O ' ' HB ' ' A' ' 838' ' ' VAL . . . -148.78 130.35 14.91 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.022 -1.049 . . . . 0.0 110.735 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 773' ' ' ILE . . . . . 0.488 HG13 ' HG2' ' A' ' 803' ' ' GLU . 46.8 mm -84.33 129.87 36.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.241 -0.912 . . . . 0.0 109.715 179.949 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 774' ' ' LYS . . . . . 0.504 ' HB3' ' HB3' ' A' ' 836' ' ' GLU . 1.8 tppp? -80.12 -37.69 33.09 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.121 -0.987 . . . . 0.0 110.365 -179.924 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 775' ' ' PHE . . . . . 0.562 ' CG ' ' HB3' ' A' ' 788' ' ' PHE . 88.3 t80 -159.74 171.17 20.01 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.049 -1.032 . . . . 0.0 110.73 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 776' ' ' ALA . . . . . 0.498 ' CB ' ' O ' ' A' ' 775' ' ' PHE . . . 166.92 90.79 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.423 -0.798 . . . . 0.0 109.801 -179.986 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 777' ' ' SER . . . . . 0.432 ' HB3' ' CZ ' ' A' ' 775' ' ' PHE . 12.6 t -128.68 132.26 48.04 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.307 -0.871 . . . . 0.0 110.419 -179.928 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 778' ' ' PHE . . . . . 0.566 ' O ' ' CD1' ' A' ' 778' ' ' PHE . 72.0 t80 -100.33 82.73 2.54 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.232 -0.918 . . . . 0.0 110.383 179.943 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 779' ' ' GLY . . . . . . . . . . . . . . . 174.31 -108.91 0.28 Allowed Glycine 0 N--CA 1.491 2.348 0 C-N-CA 119.687 -1.244 . . . . 0.0 110.039 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 780' ' ' THR . . . . . . . . . . . . . 29.5 p -113.26 99.46 49.17 Favored Pre-proline 0 N--CA 1.494 1.736 0 O-C-N 121.255 -1.144 . . . . 0.0 110.431 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 781' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -79.89 125.26 5.94 Favored 'Trans proline' 0 C--N 1.305 -1.734 0 O-C-N 123.915 1.482 . . . . 0.0 110.432 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 782' ' ' LEU . . . . . 0.438 ' HB2' ' CD ' ' A' ' 789' ' ' GLN . 61.9 mt -101.9 118.77 37.61 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.278 -0.888 . . . . 0.0 109.85 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 783' ' ' GLY . . . . . . . . . . . . . . . 114.19 -179.49 18.65 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.315 -1.514 . . . . 0.0 109.315 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 784' ' ' THR . . . . . . . . . . . . . 40.9 p -112.65 -162.39 0.8 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.176 -1.191 . . . . 0.0 110.363 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 785' ' ' CYS . . . . . 0.42 ' HA ' ' CE1' ' A' ' 788' ' ' PHE . 0.5 OUTLIER -71.93 115.72 11.47 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.263 -0.898 . . . . 0.0 110.258 -179.996 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 786' ' ' GLY . . . . . . . . . . . . . . . 124.24 -30.33 4.8 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.496 -1.442 . . . . 0.0 109.496 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 787' ' ' THR . . . . . . . . . . . . . 1.2 p -131.92 27.4 4.58 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.342 -1.093 . . . . 0.0 110.094 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 788' ' ' PHE . . . . . 0.562 ' HB3' ' CG ' ' A' ' 775' ' ' PHE . 3.4 m-85 -51.23 164.39 0.18 Allowed 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.38 -0.825 . . . . 0.0 109.986 -179.97 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 789' ' ' GLN . . . . . 0.438 ' CD ' ' HB2' ' A' ' 782' ' ' LEU . 0.0 OUTLIER -175.43 127.84 0.26 Allowed 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.121 -0.987 . . . . 0.0 110.341 179.979 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 790' ' ' GLN . . . . . . . . . . . . . 1.8 pt20 -62.95 134.78 56.73 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.258 -0.901 . . . . 0.0 110.195 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 791' ' ' GLY . . . . . . . . . . . . . . . -95.28 -105.89 2.07 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.213 -1.555 . . . . 0.0 109.213 179.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 792' ' ' GLU . . . . . . . . . . . . . 29.5 tt0 -119.11 -24.99 6.3 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.258 -1.142 . . . . 0.0 109.744 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 793' ' ' CYS . . . . . 0.472 ' SG ' ' HG2' ' A' ' 825' ' ' PRO . 8.3 t -84.44 95.29 8.74 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.402 -0.811 . . . . 0.0 110.161 179.995 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 794' ' ' HIS . . . . . 0.583 ' CE1' ' OG ' ' A' ' 798' ' ' SER . 16.9 t60 -120.64 140.5 51.49 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.205 -0.934 . . . . 0.0 110.189 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 795' ' ' SER . . . . . 0.493 ' O ' ' HB ' ' A' ' 796' ' ' ILE . 28.0 t -81.16 9.22 7.16 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.173 -0.954 . . . . 0.0 110.355 -179.982 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 796' ' ' ILE . . . . . 0.493 ' HB ' ' O ' ' A' ' 795' ' ' SER . 1.4 mp 66.2 7.06 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.537 -0.727 . . . . 0.0 110.699 -179.993 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 797' ' ' ASN . . . . . 0.454 ' OD1' HG21 ' A' ' 801' ' ' VAL . 38.8 t-20 -161.05 39.25 0.15 Allowed 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.06 -1.025 . . . . 0.0 110.804 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 798' ' ' SER . . . . . 0.583 ' OG ' ' CE1' ' A' ' 794' ' ' HIS . 0.7 OUTLIER -97.02 2.35 51.33 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.144 -0.973 . . . . 0.0 110.38 -179.967 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 799' ' ' ASN . . . . . . . . . . . . . 7.1 m120 -117.17 -22.77 8.19 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.083 -1.011 . . . . 0.0 110.707 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 800' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -89.86 -31.41 17.34 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.131 -0.981 . . . . 0.0 110.536 -179.937 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 801' ' ' VAL . . . . . 0.454 HG21 ' OD1' ' A' ' 797' ' ' ASN . 97.7 t -61.85 -27.97 43.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.199 -0.938 . . . . 0.0 110.755 179.965 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 802' ' ' LEU . . . . . 0.449 ' N ' ' CD2' ' A' ' 802' ' ' LEU . 4.5 mm? -80.1 -56.56 4.14 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.164 -0.96 . . . . 0.0 110.686 -179.927 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 803' ' ' GLU . . . . . 0.547 ' HA ' ' CG1' ' A' ' 807' ' ' ILE . 3.7 mm-40 -55.51 -21.74 18.06 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.247 -0.908 . . . . 0.0 111.011 -179.962 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 804' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -93.0 -18.92 22.11 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.014 -1.054 . . . . 0.0 111.724 -179.827 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 805' ' ' LYS . . . . . 0.454 ' O ' ' SG ' ' A' ' 806' ' ' CYS . 0.0 OUTLIER -128.66 23.24 5.84 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 120.641 -1.287 . . . . 0.0 111.894 -179.939 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 806' ' ' CYS . . . . . 0.454 ' SG ' ' O ' ' A' ' 805' ' ' LYS . 1.6 m -160.93 32.17 0.15 Allowed 'General case' 0 N--CA 1.499 1.992 0 O-C-N 120.763 -1.211 . . . . 0.0 110.791 179.91 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 807' ' ' ILE . . . . . 0.547 ' CG1' ' HA ' ' A' ' 803' ' ' GLU . 14.4 mm -124.91 108.12 19.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.137 -0.977 . . . . 0.0 110.267 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 808' ' ' GLY . . . . . 0.425 ' C ' ' HG ' ' A' ' 809' ' ' LEU . . . 114.56 9.66 14.25 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.524 -1.431 . . . . 0.0 109.524 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 809' ' ' LEU . . . . . 0.425 ' HG ' ' C ' ' A' ' 808' ' ' GLY . 5.1 mt -131.56 134.47 46.1 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.319 -1.107 . . . . 0.0 110.137 179.943 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 810' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -65.42 -11.79 46.11 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.168 -0.957 . . . . 0.0 109.289 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 811' ' ' ARG . . . . . . . . . . . . . 2.3 ttt180 -158.28 129.65 6.56 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.515 -0.741 . . . . 0.0 109.661 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 812' ' ' CYS . . . . . . . . . . . . . 27.6 p -141.85 152.56 43.75 Favored 'General case' 0 C--N 1.294 -1.809 0 O-C-N 121.435 -0.79 . . . . 0.0 110.361 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 813' ' ' VAL . . . . . 0.489 HG22 ' CB ' ' A' ' 761' ' ' HIS . 94.6 t -123.27 156.99 29.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.309 -0.869 . . . . 0.0 110.192 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 814' ' ' VAL . . . . . . . . . . . . . 30.4 t -144.55 141.95 23.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.263 -0.898 . . . . 0.0 110.255 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 815' ' ' ALA . . . . . . . . . . . . . . . -102.29 128.7 48.72 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.307 -0.87 . . . . 0.0 109.957 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 816' ' ' ILE . . . . . 0.515 HD11 ' CG2' ' A' ' 833' ' ' VAL . 66.8 mt -83.38 132.83 30.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.153 -0.967 . . . . 0.0 110.25 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 817' ' ' SER . . . . . . . . . . . . . 20.3 p -163.17 164.96 15.26 Favored Pre-proline 0 N--CA 1.492 1.66 0 O-C-N 121.26 -0.9 . . . . 0.0 110.054 179.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 818' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -80.8 18.31 1.29 Allowed 'Trans proline' 0 C--N 1.307 -1.623 0 O-C-N 123.979 1.515 . . . . 0.0 111.123 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 819' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -127.18 -30.95 2.62 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 120.929 -1.107 . . . . 0.0 110.261 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 820' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 -63.5 -43.72 96.4 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.285 -0.885 . . . . 0.0 110.377 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 821' ' ' PHE . . . . . 0.469 ' HB3' ' OG ' ' A' ' 795' ' ' SER . 91.1 m-85 -88.85 -78.81 0.33 Allowed 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.236 -0.915 . . . . 0.0 110.295 179.961 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 822' ' ' GLY . . . . . . . . . . . . . . . 176.66 38.05 0.05 OUTLIER Glycine 0 N--CA 1.492 2.383 0 N-CA-C 109.827 -1.309 . . . . 0.0 109.827 -179.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 823' ' ' GLY . . . . . . . . . . . . . . . 90.14 -160.49 28.39 Favored Glycine 0 N--CA 1.492 2.401 0 N-CA-C 109.885 -1.286 . . . . 0.0 109.885 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 824' ' ' ASP . . . . . 0.457 ' OD1' ' O ' ' A' ' 824' ' ' ASP . 7.4 p30 -108.73 139.41 20.84 Favored Pre-proline 0 N--CA 1.497 1.899 0 O-C-N 121.301 -1.117 . . . . 0.0 110.359 -179.967 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 825' ' ' PRO . . . . . 0.472 ' HG2' ' SG ' ' A' ' 793' ' ' CYS . 49.3 Cg_endo -81.53 -54.63 0.04 OUTLIER 'Trans proline' 0 C--N 1.306 -1.67 0 O-C-N 124.044 1.549 . . . . 0.0 110.865 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 826' ' ' CYS . . . . . . . . . . . . . 1.8 m -123.67 110.45 29.95 Favored Pre-proline 0 N--CA 1.503 2.217 0 O-C-N 121.141 -0.974 . . . . 0.0 110.298 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 827' ' ' PRO . . . . . 0.449 ' O ' ' HB3' ' A' ' 828' ' ' GLU . 49.7 Cg_endo -86.86 163.0 9.03 Favored 'Trans proline' 0 C--N 1.304 -1.766 0 O-C-N 123.995 1.524 . . . . 0.0 110.46 179.953 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 828' ' ' GLU . . . . . 0.449 ' HB3' ' O ' ' A' ' 827' ' ' PRO . 1.5 tt0 65.9 8.73 5.55 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.225 -0.922 . . . . 0.0 110.776 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 829' ' ' VAL . . . . . . . . . . . . . 93.1 t -121.76 133.76 67.18 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 O-C-N 121.08 -1.012 . . . . 0.0 110.403 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 830' ' ' MET . . . . . 0.439 ' HA ' ' CE ' ' A' ' 830' ' ' MET . 0.5 OUTLIER -48.05 130.66 15.65 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.204 -0.935 . . . . 0.0 110.057 179.998 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 831' ' ' LYS . . . . . 0.449 ' HE2' ' HG2' ' A' ' 737' ' ' GLU . 7.8 ptmt -132.49 171.83 13.27 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.226 -0.922 . . . . 0.0 110.254 -179.934 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 832' ' ' ARG . . . . . 0.459 ' HD2' ' HA ' ' A' ' 736' ' ' SER . 0.0 OUTLIER -168.3 165.53 12.88 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.399 -0.813 . . . . 0.0 109.966 -179.985 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 833' ' ' VAL . . . . . 0.515 ' CG2' HD11 ' A' ' 816' ' ' ILE . 87.3 t -109.8 106.58 21.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.215 -0.928 . . . . 0.0 110.474 -179.932 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 834' ' ' ALA . . . . . 0.404 ' O ' HG22 ' A' ' 835' ' ' VAL . . . -109.5 129.05 55.58 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.342 -0.849 . . . . 0.0 109.705 179.932 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 835' ' ' VAL . . . . . 0.404 HG22 ' O ' ' A' ' 834' ' ' ALA . 29.8 t -142.25 152.89 18.2 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 121.138 -0.976 . . . . 0.0 110.779 -179.932 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 836' ' ' GLU . . . . . 0.504 ' HB3' ' HB3' ' A' ' 774' ' ' LYS . 1.7 tt0 -149.21 140.8 23.43 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.54 -0.725 . . . . 0.0 109.153 179.885 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 837' ' ' ALA . . . . . . . . . . . . . . . -119.6 166.36 13.25 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.051 -1.031 . . . . 0.0 111.38 -179.813 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 838' ' ' VAL . . . . . 0.403 ' HB ' ' O ' ' A' ' 772' ' ' ALA . 60.2 t -127.54 124.32 63.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.66 -0.65 . . . . 0.0 109.78 179.952 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 839' ' ' CYS . . . . . . . . . . . . . 53.3 m -109.12 131.54 54.97 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.11 -0.994 . . . . 0.0 110.518 -179.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 840' ' ' SER . . . . . 0.413 ' O ' ' OG1' ' A' ' 841' ' ' THR . 60.7 p -158.14 75.51 0.75 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.344 -0.847 . . . . 0.0 109.996 -179.988 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 841' ' ' THR . . . . . 0.413 ' OG1' ' O ' ' A' ' 840' ' ' SER . 79.9 p . . . . . 0 N--CA 1.493 1.684 0 O-C-N 121.271 -0.893 . . . . 0.0 110.167 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 728' ' ' VAL . . . . . 0.437 ' O ' HG12 ' A' ' 728' ' ' VAL . 6.2 p . . . . . 0 N--CA 1.494 1.741 0 CA-C-O 121.213 0.53 . . . . 0.0 110.555 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 729' ' ' SER . . . . . . . . . . . . . 67.3 m -126.6 -167.89 1.79 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.261 -0.899 . . . . 0.0 109.928 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 730' ' ' GLY . . . . . . . . . . . . . . . -139.9 134.66 6.7 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.672 -1.371 . . . . 0.0 109.672 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 731' ' ' VAL . . . . . 0.427 ' CG2' ' O ' ' A' ' 837' ' ' ALA . 15.4 m -121.77 133.33 68.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.376 -1.073 . . . . 0.0 110.002 179.955 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 732' ' ' CYS . . . . . 0.486 ' CB ' ' CD ' ' A' ' 836' ' ' GLU . 23.3 p -123.95 153.6 40.98 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.215 -0.928 . . . . 0.0 110.376 179.987 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 733' ' ' ALA . . . . . . . . . . . . . . . -143.15 120.17 11.38 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.314 -0.866 . . . . 0.0 109.827 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 734' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -110.86 121.18 44.7 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.159 -0.963 . . . . 0.0 110.5 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 735' ' ' VAL . . . . . . . . . . . . . 21.9 t -143.66 141.9 25.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.372 -0.83 . . . . 0.0 110.001 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 736' ' ' SER . . . . . . . . . . . . . 10.9 p -95.99 159.01 15.19 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.257 -0.902 . . . . 0.0 110.377 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 737' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.493 1.701 0 O-C-N 121.315 -0.866 . . . . 0.0 110.28 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 757' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.492 1.636 0 CA-C-O 121.345 0.593 . . . . 0.0 110.553 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 758' ' ' ALA . . . . . . . . . . . . . . . -90.79 178.43 6.05 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.402 -0.811 . . . . 0.0 109.619 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 759' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -135.97 159.78 40.65 Favored 'General case' 0 C--N 1.298 -1.673 0 O-C-N 121.064 -1.023 . . . . 0.0 110.858 -179.94 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 760' ' ' VAL . . . . . . . . . . . . . 97.5 t -105.87 167.88 3.0 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 179.842 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 761' ' ' HIS . . . . . . . . . . . . . 29.3 m80 -137.6 104.76 5.42 Favored 'General case' 0 C--N 1.299 -1.588 0 C-N-CA 118.501 -1.28 . . . . 0.0 112.263 -179.765 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 762' ' ' LEU . . . . . 0.548 ' CD1' ' HB3' ' A' ' 812' ' ' CYS . 32.1 mt -116.24 126.25 53.35 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 179.787 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 763' ' ' LYS . . . . . . . . . . . . . 6.7 tttt -134.59 137.51 43.79 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.67 -1.269 . . . . 0.0 112.147 -179.75 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 764' ' ' CYS . . . . . 0.466 ' SG ' ' HB2' ' A' ' 768' ' ' GLN . 22.4 t -136.39 143.63 44.1 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.561 -0.712 . . . . 0.0 109.554 179.824 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 765' ' ' ALA . . . . . . . . . . . . . . . -49.79 155.41 1.48 Allowed Pre-proline 0 N--CA 1.492 1.667 0 O-C-N 121.048 -1.033 . . . . 0.0 110.104 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 766' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -71.74 91.68 0.7 Allowed 'Trans proline' 0 C--N 1.306 -1.684 0 O-C-N 123.974 1.512 . . . . 0.0 110.303 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 767' ' ' GLY . . . . . . . . . . . . . . . 152.8 -27.01 0.83 Allowed Glycine 0 N--CA 1.489 2.196 0 N-CA-C 108.81 -1.716 . . . . 0.0 108.81 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 768' ' ' GLN . . . . . 0.466 ' HB2' ' SG ' ' A' ' 764' ' ' CYS . 30.0 mt-30 -104.51 128.09 52.38 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.513 -0.992 . . . . 0.0 109.682 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 769' ' ' THR . . . . . . . . . . . . . 9.6 p -113.8 152.78 30.15 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.178 -0.951 . . . . 0.0 110.556 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 770' ' ' ILE . . . . . 0.504 ' CD1' ' O ' ' A' ' 809' ' ' LEU . 2.8 mp -64.6 119.58 9.28 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.341 -0.849 . . . . 0.0 109.765 179.959 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 771' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -111.53 -1.74 15.72 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.277 -0.889 . . . . 0.0 110.493 -179.926 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 772' ' ' ALA . . . . . 0.484 ' O ' ' HB ' ' A' ' 838' ' ' VAL . . . -168.0 131.9 1.67 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.148 -0.97 . . . . 0.0 111.039 -179.936 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 773' ' ' ILE . . . . . 0.419 HG13 ' HG3' ' A' ' 803' ' ' GLU . 16.6 mm -91.16 125.64 43.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.244 -0.91 . . . . 0.0 109.163 179.871 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 774' ' ' LYS . . . . . 0.475 ' HB3' ' HB3' ' A' ' 836' ' ' GLU . 6.5 ttmt -79.77 -37.85 34.45 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.158 -0.964 . . . . 0.0 111.116 -179.894 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 775' ' ' PHE . . . . . . . . . . . . . 52.5 t80 -152.76 152.99 32.28 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.953 -1.092 . . . . 0.0 110.75 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 776' ' ' ALA . . . . . 0.465 ' O ' ' HB2' ' A' ' 798' ' ' SER . . . -174.13 112.35 0.17 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.552 -0.718 . . . . 0.0 109.624 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 777' ' ' SER . . . . . 0.551 ' HA ' ' CB ' ' A' ' 798' ' ' SER . 6.7 m -162.04 98.34 1.06 Allowed 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.177 -0.952 . . . . 0.0 110.727 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 778' ' ' PHE . . . . . 0.514 ' CD1' ' C ' ' A' ' 778' ' ' PHE . 0.9 OUTLIER -72.75 103.86 3.78 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.293 -0.88 . . . . 0.0 109.969 179.936 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 779' ' ' GLY . . . . . . . . . . . . . . . 174.88 -109.52 0.29 Allowed Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.663 -1.375 . . . . 0.0 109.663 -179.903 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 780' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -124.94 70.0 58.99 Favored Pre-proline 0 N--CA 1.492 1.647 0 O-C-N 121.292 -1.122 . . . . 0.0 110.22 -179.898 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 781' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -74.4 153.21 44.79 Favored 'Trans proline' 0 C--N 1.305 -1.721 0 O-C-N 124.039 1.547 . . . . 0.0 110.542 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 782' ' ' LEU . . . . . 0.487 ' O ' ' N ' ' A' ' 789' ' ' GLN . 1.1 mt -138.76 151.0 46.72 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.288 -0.883 . . . . 0.0 110.126 -179.954 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 783' ' ' GLY . . . . . . . . . . . . . . . 118.25 -170.77 13.8 Favored Glycine 0 N--CA 1.492 2.404 0 N-CA-C 109.643 -1.383 . . . . 0.0 109.643 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 784' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -125.41 -162.71 1.13 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.274 -1.133 . . . . 0.0 110.088 -179.988 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 785' ' ' CYS . . . . . . . . . . . . . 21.2 m -79.77 94.55 5.79 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.184 -0.947 . . . . 0.0 110.476 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 786' ' ' GLY . . . . . 0.435 ' O ' HG23 ' A' ' 787' ' ' THR . . . 137.58 -23.29 3.12 Favored Glycine 0 N--CA 1.489 2.198 0 N-CA-C 109.577 -1.409 . . . . 0.0 109.577 179.969 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 787' ' ' THR . . . . . 0.46 ' O ' ' O ' ' A' ' 788' ' ' PHE . 20.4 p -142.73 37.9 1.47 Allowed 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.305 -1.114 . . . . 0.0 110.24 -179.952 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 788' ' ' PHE . . . . . 0.46 ' O ' ' O ' ' A' ' 787' ' ' THR . 0.9 OUTLIER -46.56 175.83 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.301 -0.875 . . . . 0.0 110.501 179.963 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 789' ' ' GLN . . . . . 0.487 ' N ' ' O ' ' A' ' 782' ' ' LEU . 0.0 OUTLIER -153.91 148.42 26.19 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.45 -0.781 . . . . 0.0 110.289 -179.976 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 790' ' ' GLN . . . . . 0.532 ' OE1' ' CD2' ' A' ' 794' ' ' HIS . 0.0 OUTLIER -78.94 151.22 31.79 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.151 -0.968 . . . . 0.0 110.132 -179.995 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 791' ' ' GLY . . . . . . . . . . . . . . . -108.83 -153.54 15.94 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.529 -1.428 . . . . 0.0 109.529 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 792' ' ' GLU . . . . . . . . . . . . . 6.0 pm0 -109.83 -19.57 13.09 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.308 -1.113 . . . . 0.0 110.358 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 793' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -98.62 24.8 7.07 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.247 -0.908 . . . . 0.0 110.307 179.903 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 794' ' ' HIS . . . . . 0.532 ' CD2' ' OE1' ' A' ' 790' ' ' GLN . 7.5 t60 -68.98 149.12 49.17 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.176 -0.953 . . . . 0.0 109.899 -179.964 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 795' ' ' SER . . . . . 0.521 ' O ' ' N ' ' A' ' 797' ' ' ASN . 1.7 p -87.9 14.16 9.4 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.191 -0.943 . . . . 0.0 110.499 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 796' ' ' ILE . . . . . 0.508 ' CG1' ' C ' ' A' ' 795' ' ' SER . 3.6 pt 34.56 32.27 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.505 2.31 0 CA-C-O 121.503 0.668 . . . . 0.0 110.247 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 797' ' ' ASN . . . . . 0.521 ' N ' ' O ' ' A' ' 795' ' ' SER . 60.9 t30 -157.68 21.14 0.27 Allowed 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.486 -0.759 . . . . 0.0 109.646 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 798' ' ' SER . . . . . 0.551 ' CB ' ' HA ' ' A' ' 777' ' ' SER . 17.7 m -84.51 -33.57 23.5 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.526 -0.734 . . . . 0.0 110.636 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 799' ' ' ASN . . . . . 0.465 ' O ' ' OE1' ' A' ' 803' ' ' GLU . 11.8 t-20 -74.17 -6.66 49.03 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.282 -0.886 . . . . 0.0 110.729 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 800' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -86.52 -44.03 12.26 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.052 -1.03 . . . . 0.0 110.39 179.961 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 801' ' ' VAL . . . . . . . . . . . . . 69.5 t -72.57 -21.67 20.01 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 121.29 -0.881 . . . . 0.0 110.808 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 802' ' ' LEU . . . . . 0.451 ' O ' ' HB2' ' A' ' 806' ' ' CYS . 1.8 mm? -84.08 -43.89 14.61 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.043 -1.035 . . . . 0.0 110.612 -179.946 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 803' ' ' GLU . . . . . 0.465 ' OE1' ' O ' ' A' ' 799' ' ' ASN . 40.6 mt-10 -67.45 -24.67 65.65 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.118 -0.989 . . . . 0.0 110.416 -179.988 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 804' ' ' ARG . . . . . . . . . . . . . 13.6 mmt-85 -90.59 -24.71 20.48 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.194 -0.942 . . . . 0.0 110.827 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 805' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.95 46.86 1.85 Allowed 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.014 -1.054 . . . . 0.0 110.701 179.977 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 806' ' ' CYS . . . . . 0.451 ' HB2' ' O ' ' A' ' 802' ' ' LEU . 1.8 t -160.59 -40.27 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.216 -0.927 . . . . 0.0 110.532 179.958 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 807' ' ' ILE . . . . . 0.427 ' HA ' ' O ' ' A' ' 770' ' ' ILE . 45.2 mt -67.58 123.27 20.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.242 -0.911 . . . . 0.0 110.765 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 808' ' ' GLY . . . . . . . . . . . . . . . 111.1 -8.48 29.16 Favored Glycine 0 N--CA 1.494 2.508 0 N-CA-C 110.024 -1.23 . . . . 0.0 110.024 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 809' ' ' LEU . . . . . 0.504 ' O ' ' CD1' ' A' ' 770' ' ' ILE . 36.0 mt -120.28 139.33 52.88 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.079 -1.247 . . . . 0.0 110.614 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 810' ' ' GLU . . . . . 0.465 ' O ' ' HB3' ' A' ' 764' ' ' CYS . 5.4 pt-20 -69.03 -33.89 74.34 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.213 -0.929 . . . . 0.0 109.356 179.942 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 811' ' ' ARG . . . . . . . . . . . . . 15.3 ttp180 -112.21 157.33 21.01 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.517 -0.739 . . . . 0.0 109.443 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 812' ' ' CYS . . . . . 0.548 ' HB3' ' CD1' ' A' ' 762' ' ' LEU . 1.3 t -149.44 108.21 3.85 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.099 -1.001 . . . . 0.0 111.085 -179.928 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 813' ' ' VAL . . . . . 0.504 ' O ' ' CG1' ' A' ' 813' ' ' VAL . 4.5 p -118.4 122.92 70.71 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 121.333 -0.854 . . . . 0.0 109.268 179.946 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 814' ' ' VAL . . . . . . . . . . . . . 45.1 t -135.89 121.97 30.91 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.987 0 O-C-N 121.117 -0.989 . . . . 0.0 111.001 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 815' ' ' ALA . . . . . . . . . . . . . . . -80.33 130.17 35.0 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.358 -0.839 . . . . 0.0 109.744 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 816' ' ' ILE . . . . . 0.538 ' CG2' HG21 ' A' ' 833' ' ' VAL . 2.6 mt -80.61 113.65 20.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.122 -0.986 . . . . 0.0 110.564 -179.866 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 817' ' ' SER . . . . . 0.453 ' O ' ' OD1' ' A' ' 820' ' ' ASN . 8.8 p -143.44 162.83 40.27 Favored Pre-proline 0 N--CA 1.494 1.774 0 O-C-N 121.352 -0.842 . . . . 0.0 110.074 -179.946 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 818' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -82.4 21.05 1.02 Allowed 'Trans proline' 0 C--N 1.307 -1.656 0 O-C-N 123.978 1.515 . . . . 0.0 110.931 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 819' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -135.7 9.23 3.35 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.972 -1.08 . . . . 0.0 110.327 179.94 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 820' ' ' ASN . . . . . 0.453 ' OD1' ' O ' ' A' ' 817' ' ' SER . 8.1 p-10 -117.42 -10.16 10.75 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.224 -0.922 . . . . 0.0 110.283 -179.969 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 821' ' ' PHE . . . . . . . . . . . . . 9.2 m-85 -105.14 -22.28 13.11 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.19 -0.944 . . . . 0.0 110.237 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 822' ' ' GLY . . . . . . . . . . . . . . . 104.95 47.77 1.14 Allowed Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.739 -1.344 . . . . 0.0 109.739 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 823' ' ' GLY . . . . . . . . . . . . . . . 116.58 -134.3 11.26 Favored Glycine 0 N--CA 1.492 2.41 0 N-CA-C 109.661 -1.376 . . . . 0.0 109.661 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 824' ' ' ASP . . . . . 0.434 ' CG ' ' HD2' ' A' ' 825' ' ' PRO . 0.4 OUTLIER -172.01 157.19 4.07 Favored Pre-proline 0 N--CA 1.494 1.76 0 O-C-N 121.226 -1.161 . . . . 0.0 110.395 -179.963 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 825' ' ' PRO . . . . . 0.434 ' HD2' ' CG ' ' A' ' 824' ' ' ASP . 46.8 Cg_endo -75.2 -88.33 0.0 OUTLIER 'Trans proline' 0 C--N 1.307 -1.63 0 O-C-N 124.066 1.561 . . . . 0.0 110.544 -179.931 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 826' ' ' CYS . . . . . . . . . . . . . 3.3 p -120.66 105.11 41.48 Favored Pre-proline 0 N--CA 1.498 1.933 0 O-C-N 121.201 -0.937 . . . . 0.0 110.193 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 827' ' ' PRO . . . . . 0.523 ' O ' ' CB ' ' A' ' 828' ' ' GLU . 50.3 Cg_endo -78.12 82.48 2.43 Favored 'Trans proline' 0 C--N 1.31 -1.493 0 O-C-N 124.093 1.575 . . . . 0.0 110.73 179.959 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 828' ' ' GLU . . . . . 0.523 ' CB ' ' O ' ' A' ' 827' ' ' PRO . 0.2 OUTLIER 165.12 -23.03 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.392 -0.818 . . . . 0.0 109.987 -179.984 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 829' ' ' VAL . . . . . 0.452 ' O ' ' HG3' ' A' ' 831' ' ' LYS . 42.4 t -100.0 167.06 2.07 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.505 0 O-C-N 121.266 -0.896 . . . . 0.0 110.351 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 830' ' ' MET . . . . . 0.426 ' C ' ' O ' ' A' ' 829' ' ' VAL . 31.4 mtm -42.29 146.97 0.28 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.352 -0.842 . . . . 0.0 110.293 179.957 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 831' ' ' LYS . . . . . 0.452 ' HG3' ' O ' ' A' ' 829' ' ' VAL . 15.6 mtmm -127.61 83.0 2.12 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.262 -0.899 . . . . 0.0 110.054 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 832' ' ' ARG . . . . . . . . . . . . . 37.1 mtt180 -111.07 150.69 29.0 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.323 -0.861 . . . . 0.0 110.046 -179.895 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 833' ' ' VAL . . . . . 0.538 HG21 ' CG2' ' A' ' 816' ' ' ILE . 98.6 t -116.32 159.62 16.18 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.522 0 O-C-N 121.244 -0.91 . . . . 0.0 110.677 -179.982 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 834' ' ' ALA . . . . . . . . . . . . . . . -160.11 104.2 1.49 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.508 -0.745 . . . . 0.0 109.26 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 835' ' ' VAL . . . . . 0.456 HG12 ' N ' ' A' ' 836' ' ' GLU . 39.8 t -115.35 159.66 15.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.112 -0.993 . . . . 0.0 111.114 -179.863 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 836' ' ' GLU . . . . . 0.486 ' CD ' ' CB ' ' A' ' 732' ' ' CYS . 0.0 OUTLIER -144.34 123.96 13.27 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.574 -0.704 . . . . 0.0 109.28 179.917 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 837' ' ' ALA . . . . . 0.427 ' O ' ' CG2' ' A' ' 731' ' ' VAL . . . -111.66 144.9 40.17 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.15 -0.969 . . . . 0.0 110.704 -179.953 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 838' ' ' VAL . . . . . 0.484 ' HB ' ' O ' ' A' ' 772' ' ' ALA . 76.3 t -111.22 124.99 68.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.398 -0.814 . . . . 0.0 109.534 179.945 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 839' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -108.46 119.56 39.88 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.23 -0.919 . . . . 0.0 110.039 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 840' ' ' SER . . . . . 0.465 ' O ' ' OG1' ' A' ' 841' ' ' THR . 0.9 OUTLIER -133.66 69.06 1.48 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.34 -0.85 . . . . 0.0 109.845 179.992 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 841' ' ' THR . . . . . 0.465 ' OG1' ' O ' ' A' ' 840' ' ' SER . 30.7 p . . . . . 0 N--CA 1.491 1.625 0 O-C-N 121.443 -0.786 . . . . 0.0 110.313 179.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 728' ' ' VAL . . . . . 0.448 HG11 ' O ' ' A' ' 728' ' ' VAL . 72.8 t . . . . . 0 N--CA 1.496 1.848 0 CA-C-O 121.348 0.594 . . . . 0.0 109.999 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 729' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -77.12 -147.95 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.373 -0.83 . . . . 0.0 110.185 -179.971 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 730' ' ' GLY . . . . . . . . . . . . . . . -149.96 150.02 22.01 Favored Glycine 0 N--CA 1.488 2.108 0 N-CA-C 109.697 -1.361 . . . . 0.0 109.697 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 731' ' ' VAL . . . . . . . . . . . . . 86.4 t -111.12 157.28 12.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.334 -1.098 . . . . 0.0 109.836 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 732' ' ' CYS . . . . . . . . . . . . . 10.9 t -117.75 146.34 43.85 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.176 -0.953 . . . . 0.0 110.341 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 733' ' ' ALA . . . . . . . . . . . . . . . -142.13 116.25 9.42 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.268 -0.895 . . . . 0.0 110.356 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 734' ' ' ASP . . . . . 0.419 ' N ' ' OD1' ' A' ' 734' ' ' ASP . 0.8 OUTLIER -114.12 139.09 49.61 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.177 -0.952 . . . . 0.0 110.001 179.937 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 735' ' ' VAL . . . . . . . . . . . . . 44.9 t -147.89 124.05 2.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.214 -0.929 . . . . 0.0 110.039 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 736' ' ' SER . . . . . 0.42 ' O ' ' C ' ' A' ' 737' ' ' GLU . 0.7 OUTLIER -90.87 134.89 34.1 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.23 -0.919 . . . . 0.0 110.199 179.951 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 737' ' ' GLU . . . . . 0.42 ' C ' ' O ' ' A' ' 736' ' ' SER . 29.5 tp10 . . . . . 0 N--CA 1.495 1.793 0 O-C-N 121.275 -0.891 . . . . 0.0 110.004 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 757' ' ' THR . . . . . . . . . . . . . 1.8 p . . . . . 0 N--CA 1.496 1.841 0 CA-C-O 121.457 0.646 . . . . 0.0 110.934 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 758' ' ' ALA . . . . . . . . . . . . . . . -101.03 173.73 6.34 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.479 -0.763 . . . . 0.0 110.169 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 759' ' ' LYS . . . . . . . . . . . . . 36.2 mtpt -137.94 165.27 26.95 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.203 -0.935 . . . . 0.0 110.63 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 760' ' ' VAL . . . . . . . . . . . . . 38.4 t -109.7 139.64 31.94 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.442 -0.786 . . . . 0.0 109.642 179.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 761' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -109.97 104.2 13.07 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.068 -1.02 . . . . 0.0 110.886 -179.981 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 762' ' ' LEU . . . . . . . . . . . . . 21.2 mt -121.46 124.32 44.18 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.298 -0.876 . . . . 0.0 109.414 179.879 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 763' ' ' LYS . . . . . 0.533 ' HB3' ' CD ' ' A' ' 811' ' ' ARG . 0.0 OUTLIER -156.05 123.17 5.35 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.919 -1.113 . . . . 0.0 111.243 -179.928 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 764' ' ' CYS . . . . . 0.41 ' O ' ' C ' ' A' ' 765' ' ' ALA . 19.1 m -99.04 157.34 16.41 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.342 -0.849 . . . . 0.0 109.263 179.839 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 765' ' ' ALA . . . . . 0.41 ' C ' ' O ' ' A' ' 764' ' ' CYS . . . -42.64 159.56 0.2 Allowed Pre-proline 0 N--CA 1.495 1.818 0 O-C-N 121.076 -1.015 . . . . 0.0 109.982 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 766' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -71.23 97.3 0.75 Allowed 'Trans proline' 0 C--N 1.306 -1.667 0 O-C-N 123.913 1.48 . . . . 0.0 110.524 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 767' ' ' GLY . . . . . . . . . . . . . . . 147.53 -31.69 1.38 Allowed Glycine 0 N--CA 1.489 2.198 0 N-CA-C 109.044 -1.623 . . . . 0.0 109.044 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 768' ' ' GLN . . . . . . . . . . . . . 20.1 mt-30 -99.0 101.61 13.05 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.369 -1.077 . . . . 0.0 109.982 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 769' ' ' THR . . . . . . . . . . . . . 11.2 p -85.28 146.95 26.79 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.112 -0.992 . . . . 0.0 110.128 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 770' ' ' ILE . . . . . . . . . . . . . 35.7 mt -66.7 144.16 14.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.306 -0.871 . . . . 0.0 109.252 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 771' ' ' SER . . . . . . . . . . . . . 47.8 t -135.28 -4.69 2.35 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.873 -1.142 . . . . 0.0 111.432 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 772' ' ' ALA . . . . . . . . . . . . . . . -172.71 151.68 2.37 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 120.781 -1.199 . . . . 0.0 111.418 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 773' ' ' ILE . . . . . 0.433 HG23 ' O ' ' A' ' 836' ' ' GLU . 20.1 mm -110.75 120.28 61.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 179.888 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 774' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -80.09 -42.89 22.75 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 120.986 -1.071 . . . . 0.0 110.951 -179.835 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 775' ' ' PHE . . . . . 0.476 ' O ' ' HB3' ' A' ' 776' ' ' ALA . 67.2 t80 -134.0 152.25 51.77 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.098 -1.001 . . . . 0.0 110.668 -179.913 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 776' ' ' ALA . . . . . 0.476 ' HB3' ' O ' ' A' ' 775' ' ' PHE . . . 179.1 113.41 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.567 -0.708 . . . . 0.0 109.803 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 777' ' ' SER . . . . . 0.486 ' HA ' ' HB3' ' A' ' 798' ' ' SER . 94.5 p -148.73 126.86 12.07 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.338 -0.851 . . . . 0.0 110.475 -179.958 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 778' ' ' PHE . . . . . . . . . . . . . 12.2 t80 -94.21 116.48 28.88 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.359 -0.838 . . . . 0.0 109.949 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 779' ' ' GLY . . . . . 0.477 ' HA3' ' O ' ' A' ' 793' ' ' CYS . . . 163.97 -136.15 4.11 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.932 -1.267 . . . . 0.0 109.932 -179.958 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 780' ' ' THR . . . . . . . . . . . . . 45.7 p -123.49 64.77 30.22 Favored Pre-proline 0 N--CA 1.494 1.766 0 O-C-N 121.212 -1.17 . . . . 0.0 110.595 -179.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 781' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -74.47 170.79 19.45 Favored 'Trans proline' 0 C--N 1.304 -1.792 0 O-C-N 124.044 1.55 . . . . 0.0 110.392 179.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 782' ' ' LEU . . . . . . . . . . . . . 3.7 mt -129.86 173.91 10.23 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.198 -0.939 . . . . 0.0 110.261 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 783' ' ' GLY . . . . . . . . . . . . . . . 110.93 -169.54 13.38 Favored Glycine 0 N--CA 1.494 2.561 0 N-CA-C 109.595 -1.402 . . . . 0.0 109.595 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 784' ' ' THR . . . . . 0.512 HG21 ' N ' ' A' ' 785' ' ' CYS . 54.3 m -115.62 -92.92 0.5 Allowed 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.229 -1.159 . . . . 0.0 110.336 -179.96 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 785' ' ' CYS . . . . . 0.512 ' N ' HG21 ' A' ' 784' ' ' THR . 0.3 OUTLIER -139.5 120.05 14.1 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.175 -0.953 . . . . 0.0 110.162 -179.938 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 786' ' ' GLY . . . . . . . . . . . . . . . 95.3 -4.62 67.3 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.658 -1.377 . . . . 0.0 109.658 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 787' ' ' THR . . . . . . . . . . . . . 9.0 t -145.41 34.8 1.07 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.209 -1.171 . . . . 0.0 110.109 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 788' ' ' PHE . . . . . 0.412 ' CZ ' ' O ' ' A' ' 784' ' ' THR . 39.4 m-85 -53.41 176.22 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.342 -0.849 . . . . 0.0 110.385 179.996 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 789' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -139.66 145.28 38.24 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.335 -0.853 . . . . 0.0 110.164 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 790' ' ' GLN . . . . . . . . . . . . . 2.1 mt-30 -64.21 131.05 46.25 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.121 -0.987 . . . . 0.0 109.882 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 791' ' ' GLY . . . . . . . . . . . . . . . -92.49 -163.26 37.58 Favored Glycine 0 N--CA 1.492 2.413 0 N-CA-C 109.698 -1.361 . . . . 0.0 109.698 180.0 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 792' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -98.41 -14.0 20.33 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.337 -1.096 . . . . 0.0 110.226 -179.972 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 793' ' ' CYS . . . . . 0.477 ' O ' ' HA3' ' A' ' 779' ' ' GLY . 0.5 OUTLIER -116.86 68.59 0.74 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.352 -0.842 . . . . 0.0 110.275 179.972 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 794' ' ' HIS . . . . . 0.61 ' CE1' ' OG ' ' A' ' 798' ' ' SER . 81.6 t60 -102.59 145.64 29.34 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.171 -0.956 . . . . 0.0 110.866 -179.919 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 795' ' ' SER . . . . . 0.576 ' O ' ' CD2' ' A' ' 794' ' ' HIS . 8.5 t -91.31 174.48 7.36 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.244 -0.91 . . . . 0.0 109.275 179.874 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 796' ' ' ILE . . . . . . . . . . . . . 1.5 mt -105.52 20.48 4.11 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.912 0 O-C-N 120.859 -1.151 . . . . 0.0 110.256 -179.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 797' ' ' ASN . . . . . 0.505 ' N ' ' OD1' ' A' ' 797' ' ' ASN . 1.6 m120 -132.5 36.22 3.58 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.427 -0.796 . . . . 0.0 109.083 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 798' ' ' SER . . . . . 0.61 ' OG ' ' CE1' ' A' ' 794' ' ' HIS . 0.9 OUTLIER -65.6 -56.31 12.89 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.724 -0.61 . . . . 0.0 111.285 -179.92 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 799' ' ' ASN . . . . . . . . . . . . . 4.5 m120 -86.41 14.27 6.95 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.135 -0.978 . . . . 0.0 111.368 -179.782 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 800' ' ' SER . . . . . . . . . . . . . 7.8 t -91.28 -62.64 1.4 Allowed 'General case' 0 C--N 1.299 -1.616 0 O-C-N 120.874 -1.141 . . . . 0.0 110.269 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 801' ' ' VAL . . . . . 0.455 ' CG1' ' OD1' ' A' ' 820' ' ' ASN . 49.3 t -68.11 -19.55 24.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.274 -0.891 . . . . 0.0 110.534 -179.918 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 802' ' ' LEU . . . . . 0.51 ' N ' ' CD2' ' A' ' 802' ' ' LEU . 4.2 mm? -69.05 -51.99 33.22 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.137 -0.977 . . . . 0.0 110.739 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 803' ' ' GLU . . . . . 0.523 ' HA ' ' CD1' ' A' ' 807' ' ' ILE . 4.1 tt0 -68.84 -17.76 64.05 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.034 -1.041 . . . . 0.0 110.721 -179.955 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 804' ' ' ARG . . . . . . . . . . . . . 17.9 mtp180 -91.45 -18.53 24.05 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.225 -0.922 . . . . 0.0 111.519 -179.884 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 805' ' ' LYS . . . . . 0.454 ' O ' ' SG ' ' A' ' 806' ' ' CYS . 19.8 mttt -124.49 26.96 7.11 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 120.857 -1.152 . . . . 0.0 111.882 -179.856 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 806' ' ' CYS . . . . . 0.515 ' HA ' ' CB ' ' A' ' 812' ' ' CYS . 1.7 m -160.87 18.69 0.13 Allowed 'General case' 0 N--CA 1.501 2.111 0 O-C-N 120.737 -1.227 . . . . 0.0 111.035 179.942 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 807' ' ' ILE . . . . . 0.523 ' CD1' ' HA ' ' A' ' 803' ' ' GLU . 1.7 mp -123.27 112.51 33.86 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.902 0 O-C-N 121.001 -1.062 . . . . 0.0 110.204 179.972 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 808' ' ' GLY . . . . . . . . . . . . . . . 116.73 -4.24 19.28 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 809' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -125.99 137.81 53.7 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.275 -1.132 . . . . 0.0 110.265 -179.944 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 810' ' ' GLU . . . . . 0.479 ' HG3' ' N ' ' A' ' 811' ' ' ARG . 0.4 OUTLIER -64.87 -17.82 64.62 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.219 -0.925 . . . . 0.0 108.965 179.886 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 811' ' ' ARG . . . . . 0.533 ' CD ' ' HB3' ' A' ' 763' ' ' LYS . 13.5 ttp85 -142.48 132.86 24.94 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.674 -0.641 . . . . 0.0 109.36 179.926 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 812' ' ' CYS . . . . . 0.515 ' CB ' ' HA ' ' A' ' 806' ' ' CYS . 15.4 p -142.02 146.86 36.01 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.171 -0.956 . . . . 0.0 110.764 -179.965 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 813' ' ' VAL . . . . . . . . . . . . . 67.0 t -120.67 135.62 60.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.44 -0.788 . . . . 0.0 110.014 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 814' ' ' VAL . . . . . . . . . . . . . 9.3 t -112.2 109.79 29.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.114 -0.991 . . . . 0.0 110.477 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 815' ' ' ALA . . . . . . . . . . . . . . . -70.77 121.26 17.67 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.259 -0.901 . . . . 0.0 110.097 179.89 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 816' ' ' ILE . . . . . 0.459 HG12 HG21 ' A' ' 833' ' ' VAL . 36.1 mt -81.66 104.42 10.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.185 -0.947 . . . . 0.0 110.273 -179.966 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 817' ' ' SER . . . . . 0.458 ' HB2' ' HD2' ' A' ' 818' ' ' PRO . 77.7 p -161.71 164.2 18.33 Favored Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.268 -0.895 . . . . 0.0 110.101 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 818' ' ' PRO . . . . . 0.458 ' HD2' ' HB2' ' A' ' 817' ' ' SER . 43.6 Cg_endo -71.92 -23.65 21.83 Favored 'Trans proline' 0 C--N 1.305 -1.751 0 O-C-N 124.04 1.548 . . . . 0.0 110.13 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 819' ' ' SER . . . . . . . . . . . . . 95.1 p -85.52 42.85 0.98 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.259 -0.901 . . . . 0.0 109.872 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 820' ' ' ASN . . . . . 0.455 ' OD1' ' CG1' ' A' ' 801' ' ' VAL . 28.6 t-20 -143.32 -46.37 0.29 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.283 -0.885 . . . . 0.0 110.13 -179.94 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 821' ' ' PHE . . . . . . . . . . . . . 80.5 m-85 -89.25 8.36 30.73 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.334 -0.854 . . . . 0.0 110.349 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 822' ' ' GLY . . . . . . . . . . . . . . . 87.09 52.72 3.01 Favored Glycine 0 N--CA 1.492 2.409 0 N-CA-C 109.901 -1.28 . . . . 0.0 109.901 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 823' ' ' GLY . . . . . . . . . . . . . . . 90.85 -174.96 39.75 Favored Glycine 0 N--CA 1.494 2.518 0 N-CA-C 109.779 -1.328 . . . . 0.0 109.779 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 824' ' ' ASP . . . . . . . . . . . . . 11.0 p-10 -125.34 150.56 67.81 Favored Pre-proline 0 N--CA 1.495 1.78 0 O-C-N 121.258 -1.142 . . . . 0.0 110.154 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 825' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -77.18 -62.94 0.03 OUTLIER 'Trans proline' 0 C--N 1.306 -1.703 0 O-C-N 124.042 1.549 . . . . 0.0 110.801 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 826' ' ' CYS . . . . . . . . . . . . . 6.0 p -122.98 117.69 28.41 Favored Pre-proline 0 N--CA 1.5 2.074 0 O-C-N 121.141 -0.975 . . . . 0.0 110.785 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 827' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_endo -88.48 168.34 6.1 Favored 'Trans proline' 0 C--N 1.311 -1.427 0 O-C-N 123.952 1.501 . . . . 0.0 110.739 179.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 828' ' ' GLU . . . . . . . . . . . . . 2.2 tp10 61.37 27.58 17.18 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.393 -0.817 . . . . 0.0 110.737 179.903 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 829' ' ' VAL . . . . . 0.426 ' O ' ' HD3' ' A' ' 831' ' ' LYS . 50.3 t -131.49 115.09 27.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.088 -1.008 . . . . 0.0 110.417 179.92 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 830' ' ' MET . . . . . 0.425 ' C ' ' O ' ' A' ' 829' ' ' VAL . 19.0 ptp -43.1 123.8 2.99 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.26 -0.9 . . . . 0.0 109.382 179.918 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 831' ' ' LYS . . . . . 0.426 ' HD3' ' O ' ' A' ' 829' ' ' VAL . 0.0 OUTLIER -109.23 179.16 4.24 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.105 -0.997 . . . . 0.0 111.545 -179.876 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 832' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -159.59 141.02 12.88 Favored 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 108.053 -1.092 . . . . 0.0 108.053 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 833' ' ' VAL . . . . . 0.459 HG21 HG12 ' A' ' 816' ' ' ILE . 60.6 t -110.48 139.87 32.09 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 120.741 -1.224 . . . . 0.0 112.05 -179.836 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 834' ' ' ALA . . . . . . . . . . . . . . . -139.02 111.96 7.88 Favored 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 179.862 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 835' ' ' VAL . . . . . 0.439 ' CG1' ' N ' ' A' ' 836' ' ' GLU . 40.8 t -129.28 163.55 34.14 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 120.923 -1.11 . . . . 0.0 111.848 -179.871 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 836' ' ' GLU . . . . . 0.441 ' HB2' ' HB3' ' A' ' 775' ' ' PHE . 0.1 OUTLIER -140.25 147.15 39.57 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 179.849 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 837' ' ' ALA . . . . . . . . . . . . . . . -128.01 165.52 20.15 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 120.856 -1.152 . . . . 0.0 111.349 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 838' ' ' VAL . . . . . . . . . . . . . 75.0 t -130.4 110.62 19.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.512 -0.743 . . . . 0.0 109.287 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 839' ' ' CYS . . . . . . . . . . . . . 68.4 m -107.51 133.51 51.89 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.147 -0.97 . . . . 0.0 110.777 -179.89 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 840' ' ' SER . . . . . . . . . . . . . 35.6 p -125.33 -139.64 0.28 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.482 -0.761 . . . . 0.0 109.857 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 841' ' ' THR . . . . . . . . . . . . . 32.6 p . . . . . 0 N--CA 1.496 1.851 0 O-C-N 121.117 -0.99 . . . . 0.0 110.177 -179.966 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 728' ' ' VAL . . . . . 0.479 HG22 ' N ' ' A' ' 729' ' ' SER . 13.5 p . . . . . 0 N--CA 1.491 1.6 0 CA-C-O 121.332 0.587 . . . . 0.0 110.394 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 729' ' ' SER . . . . . 0.479 ' N ' HG22 ' A' ' 728' ' ' VAL . 89.0 p -172.57 -175.73 1.39 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.369 -0.832 . . . . 0.0 109.764 179.903 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 730' ' ' GLY . . . . . . . . . . . . . . . 155.28 65.69 0.01 OUTLIER Glycine 0 N--CA 1.489 2.203 0 C-N-CA 119.56 -1.305 . . . . 0.0 109.843 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 731' ' ' VAL . . . . . 0.531 ' CG2' ' SG ' ' A' ' 764' ' ' CYS . 6.5 t -122.65 152.02 26.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.325 -1.103 . . . . 0.0 109.983 179.966 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 732' ' ' CYS . . . . . . . . . . . . . 5.8 t -146.72 144.11 29.19 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.094 -1.004 . . . . 0.0 110.439 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 733' ' ' ALA . . . . . . . . . . . . . . . -135.89 107.73 7.08 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.344 -0.847 . . . . 0.0 109.907 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 734' ' ' ASP . . . . . . . . . . . . . 7.9 t0 -118.11 122.64 43.61 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.18 -0.95 . . . . 0.0 110.551 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 735' ' ' VAL . . . . . . . . . . . . . 45.8 t -129.15 162.45 36.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.287 -0.883 . . . . 0.0 109.856 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 736' ' ' SER . . . . . . . . . . . . . 9.7 t -110.36 139.87 45.13 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.108 -0.995 . . . . 0.0 110.441 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 737' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.629 0 O-C-N 121.343 -0.848 . . . . 0.0 110.042 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 757' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.492 1.64 0 CA-C-O 121.39 0.614 . . . . 0.0 110.585 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 758' ' ' ALA . . . . . . . . . . . . . . . -106.27 177.94 4.71 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.41 -0.806 . . . . 0.0 109.856 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 759' ' ' LYS . . . . . . . . . . . . . 3.9 mttp -132.41 147.79 52.39 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.202 -0.936 . . . . 0.0 110.499 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 760' ' ' VAL . . . . . 0.503 ' CG2' ' CD1' ' A' ' 816' ' ' ILE . 13.3 t -110.27 132.36 58.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.322 -0.861 . . . . 0.0 109.595 179.942 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 761' ' ' HIS . . . . . . . . . . . . . 29.5 m80 -120.78 119.56 33.09 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.108 -0.995 . . . . 0.0 110.923 -179.902 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 762' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -115.0 117.37 30.42 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.372 -0.83 . . . . 0.0 109.011 179.829 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 763' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -136.27 120.43 17.79 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.012 -1.055 . . . . 0.0 111.315 -179.895 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 764' ' ' CYS . . . . . 0.531 ' SG ' ' CG2' ' A' ' 731' ' ' VAL . 1.2 m -99.4 177.54 5.15 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.491 -0.755 . . . . 0.0 109.81 179.86 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 765' ' ' ALA . . . . . 0.488 ' CB ' ' OE1' ' A' ' 768' ' ' GLN . . . -60.39 161.41 13.88 Favored Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.193 -0.942 . . . . 0.0 109.856 179.969 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 766' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -69.89 136.45 32.69 Favored 'Trans proline' 0 C--N 1.306 -1.691 0 O-C-N 123.897 1.472 . . . . 0.0 110.296 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 767' ' ' GLY . . . . . . . . . . . . . . . 93.54 -30.85 6.9 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.04 -1.624 . . . . 0.0 109.04 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 768' ' ' GLN . . . . . 0.488 ' OE1' ' CB ' ' A' ' 765' ' ' ALA . 10.5 mt-30 -82.75 105.85 14.1 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.331 -1.099 . . . . 0.0 110.076 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 769' ' ' THR . . . . . . . . . . . . . 26.6 p -95.81 146.59 24.43 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.176 -0.953 . . . . 0.0 110.367 179.916 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 770' ' ' ILE . . . . . . . . . . . . . 47.8 mt -76.62 139.47 18.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.356 -0.84 . . . . 0.0 109.675 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 771' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -137.55 -2.67 1.95 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.982 -1.074 . . . . 0.0 111.272 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 772' ' ' ALA . . . . . . . . . . . . . . . -155.99 119.42 4.33 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.763 -1.21 . . . . 0.0 111.075 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 773' ' ' ILE . . . . . . . . . . . . . 33.3 mm -83.26 126.2 40.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.322 -0.862 . . . . 0.0 109.324 179.916 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 774' ' ' LYS . . . . . 0.49 ' CB ' ' OE1' ' A' ' 836' ' ' GLU . 0.1 OUTLIER -82.54 -38.62 23.48 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.111 -0.993 . . . . 0.0 110.766 -179.909 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 775' ' ' PHE . . . . . 0.548 ' CE1' ' OG ' ' A' ' 777' ' ' SER . 11.7 t80 -179.41 133.64 0.11 Allowed 'General case' 0 N--CA 1.496 1.859 0 O-C-N 120.858 -1.151 . . . . 0.0 111.374 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 776' ' ' ALA . . . . . 0.505 ' O ' ' HB3' ' A' ' 798' ' ' SER . . . -151.14 88.91 1.48 Allowed 'General case' 0 N--CA 1.495 1.785 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 179.904 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 777' ' ' SER . . . . . 0.548 ' OG ' ' CE1' ' A' ' 775' ' ' PHE . 8.7 p -102.52 165.59 11.01 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.218 -0.926 . . . . 0.0 111.425 -179.77 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 778' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -126.53 101.11 6.53 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.593 -0.692 . . . . 0.0 109.74 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 779' ' ' GLY . . . . . 0.459 ' O ' ' HG2' ' A' ' 832' ' ' ARG . . . 156.66 -109.55 0.41 Allowed Glycine 0 N--CA 1.493 2.454 0 N-CA-C 109.381 -1.488 . . . . 0.0 109.381 179.903 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 780' ' ' THR . . . . . 0.463 ' O ' ' HA3' ' A' ' 791' ' ' GLY . 76.3 p -127.78 101.19 23.8 Favored Pre-proline 0 N--CA 1.493 1.719 0 O-C-N 121.231 -1.158 . . . . 0.0 110.086 179.965 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 781' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -77.34 173.04 14.92 Favored 'Trans proline' 0 C--N 1.305 -1.751 0 O-C-N 124.082 1.569 . . . . 0.0 110.549 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 782' ' ' LEU . . . . . . . . . . . . . 1.1 mt -130.81 98.41 4.61 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.311 -0.868 . . . . 0.0 110.165 179.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 783' ' ' GLY . . . . . . . . . . . . . . . 139.49 -164.3 25.99 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 -180.0 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 784' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -119.94 -169.05 1.71 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.157 -1.202 . . . . 0.0 110.173 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 785' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -62.47 93.87 0.06 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.246 -0.909 . . . . 0.0 110.22 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 786' ' ' GLY . . . . . . . . . . . . . . . 146.3 -28.35 1.67 Allowed Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.468 -1.453 . . . . 0.0 109.468 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 787' ' ' THR . . . . . . . . . . . . . 66.3 p -127.2 27.32 5.92 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.24 -1.153 . . . . 0.0 110.207 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 788' ' ' PHE . . . . . 0.581 ' CZ ' ' HB3' ' A' ' 834' ' ' ALA . 2.9 m-85 -52.41 110.62 0.52 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.371 -0.831 . . . . 0.0 110.196 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 789' ' ' GLN . . . . . 0.453 ' HG3' ' N ' ' A' ' 790' ' ' GLN . 7.2 tp60 -127.53 153.36 46.44 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.298 -0.876 . . . . 0.0 110.058 179.965 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 790' ' ' GLN . . . . . 0.498 ' CG ' ' O ' ' A' ' 790' ' ' GLN . 7.5 pt20 -52.27 114.71 1.43 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.249 -0.907 . . . . 0.0 110.28 179.997 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 791' ' ' GLY . . . . . 0.463 ' HA3' ' O ' ' A' ' 780' ' ' THR . . . -66.47 -105.87 0.01 OUTLIER Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.384 -1.486 . . . . 0.0 109.384 -179.978 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 792' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -113.61 -31.67 6.42 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.282 -1.128 . . . . 0.0 110.128 -179.956 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 793' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -121.55 98.22 5.87 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.278 -0.889 . . . . 0.0 110.393 -179.935 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 794' ' ' HIS . . . . . 0.606 ' CE1' ' CB ' ' A' ' 798' ' ' SER . 66.3 t60 -107.29 131.17 54.5 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.122 -0.986 . . . . 0.0 109.966 179.948 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 795' ' ' SER . . . . . 0.46 ' O ' ' O ' ' A' ' 794' ' ' HIS . 6.3 t -61.59 -141.14 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.172 -0.955 . . . . 0.0 109.453 179.893 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 796' ' ' ILE . . . . . 0.412 HG22 HD12 ' A' ' 796' ' ' ILE . 3.4 mt -136.5 -43.69 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 O-C-N 121.11 -0.994 . . . . 0.0 109.707 179.942 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 797' ' ' ASN . . . . . 0.414 ' O ' ' C ' ' A' ' 798' ' ' SER . 44.8 m-20 -82.36 10.76 6.44 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.36 -0.838 . . . . 0.0 109.46 179.864 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 798' ' ' SER . . . . . 0.606 ' CB ' ' CE1' ' A' ' 794' ' ' HIS . 1.6 m -35.75 -68.69 0.12 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.747 -0.596 . . . . 0.0 111.612 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 799' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -93.95 -26.21 16.94 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.066 -1.021 . . . . 0.0 110.883 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 800' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -50.78 -22.39 2.11 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 120.973 -1.079 . . . . 0.0 110.181 179.965 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 801' ' ' VAL . . . . . 0.492 HG22 ' CD2' ' A' ' 821' ' ' PHE . 25.1 t -84.77 -41.47 15.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.275 -0.891 . . . . 0.0 110.427 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 802' ' ' LEU . . . . . 0.57 ' N ' ' CD2' ' A' ' 802' ' ' LEU . 4.0 mm? -66.2 -41.17 90.57 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.329 -0.857 . . . . 0.0 110.94 -179.933 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 803' ' ' GLU . . . . . 0.421 ' C ' ' O ' ' A' ' 802' ' ' LEU . 8.9 mt-10 -41.88 -47.63 4.28 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.216 -0.927 . . . . 0.0 110.681 -179.935 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 804' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -92.92 -28.21 16.61 Favored 'General case' 0 N--CA 1.503 2.177 0 O-C-N 121.135 -0.978 . . . . 0.0 111.987 -179.834 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 805' ' ' LYS . . . . . 0.479 ' HB2' ' O ' ' A' ' 801' ' ' VAL . 1.0 OUTLIER -89.66 26.98 1.6 Allowed 'General case' 0 N--CA 1.498 1.942 0 O-C-N 120.967 -1.083 . . . . 0.0 111.492 -179.807 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 806' ' ' CYS . . . . . 0.543 ' HA ' ' CB ' ' A' ' 812' ' ' CYS . 13.2 m -158.44 -66.64 0.09 Allowed 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.043 -1.035 . . . . 0.0 110.745 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 807' ' ' ILE . . . . . 0.419 ' C ' ' O ' ' A' ' 806' ' ' CYS . 17.5 mt -41.56 123.51 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.978 0 O-C-N 121.186 -0.947 . . . . 0.0 110.973 -179.933 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 808' ' ' GLY . . . . . 0.451 ' C ' ' HG ' ' A' ' 809' ' ' LEU . . . 115.68 -9.92 19.08 Favored Glycine 0 N--CA 1.494 2.528 0 N-CA-C 110.167 -1.173 . . . . 0.0 110.167 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 809' ' ' LEU . . . . . 0.451 ' HG ' ' C ' ' A' ' 808' ' ' GLY . 1.7 mt -132.94 151.45 52.05 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.061 -1.258 . . . . 0.0 110.306 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 810' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -73.79 -14.95 61.19 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.152 -0.968 . . . . 0.0 109.777 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 811' ' ' ARG . . . . . 0.492 ' CG ' ' O ' ' A' ' 811' ' ' ARG . 10.2 ptm180 -155.72 122.43 5.28 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.343 -0.848 . . . . 0.0 110.068 179.9 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 812' ' ' CYS . . . . . 0.543 ' CB ' ' HA ' ' A' ' 806' ' ' CYS . 31.9 p -122.73 151.71 41.31 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.227 -0.921 . . . . 0.0 110.608 -179.966 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 813' ' ' VAL . . . . . . . . . . . . . 5.8 t -121.69 152.53 25.44 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.32 -0.862 . . . . 0.0 110.329 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 814' ' ' VAL . . . . . . . . . . . . . 88.9 t -148.93 104.19 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.272 -0.892 . . . . 0.0 110.357 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 815' ' ' ALA . . . . . . . . . . . . . . . -62.21 153.64 29.82 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.19 -0.944 . . . . 0.0 110.127 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 816' ' ' ILE . . . . . 0.503 ' CD1' ' CG2' ' A' ' 760' ' ' VAL . 11.3 mt -107.5 130.77 59.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.163 -0.96 . . . . 0.0 110.109 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 817' ' ' SER . . . . . 0.438 ' OG ' ' HB2' ' A' ' 820' ' ' ASN . 1.4 p -164.11 163.64 15.17 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.259 -0.901 . . . . 0.0 110.037 179.944 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 818' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -74.48 -7.61 19.75 Favored 'Trans proline' 0 C--N 1.303 -1.857 0 O-C-N 124.08 1.568 . . . . 0.0 110.36 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 819' ' ' SER . . . . . . . . . . . . . 3.2 t -128.4 53.14 1.84 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.311 -0.868 . . . . 0.0 110.04 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 820' ' ' ASN . . . . . 0.438 ' HB2' ' OG ' ' A' ' 817' ' ' SER . 0.4 OUTLIER -129.46 -40.0 1.45 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.199 -0.938 . . . . 0.0 110.281 -179.942 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 821' ' ' PHE . . . . . 0.492 ' CD2' HG22 ' A' ' 801' ' ' VAL . 60.1 m-85 -85.93 -60.03 2.13 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.307 -0.87 . . . . 0.0 110.254 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 822' ' ' GLY . . . . . . . . . . . . . . . 155.72 37.88 0.02 OUTLIER Glycine 0 N--CA 1.492 2.422 0 N-CA-C 109.67 -1.372 . . . . 0.0 109.67 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 823' ' ' GLY . . . . . . . . . . . . . . . 137.72 -151.92 21.46 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.819 -1.313 . . . . 0.0 109.819 180.0 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 824' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -141.62 153.68 65.43 Favored Pre-proline 0 N--CA 1.494 1.731 0 O-C-N 121.332 -1.099 . . . . 0.0 110.157 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 825' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -73.33 -94.41 0.01 OUTLIER 'Trans proline' 0 C--N 1.305 -1.724 0 O-C-N 124.073 1.565 . . . . 0.0 110.505 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 826' ' ' CYS . . . . . . . . . . . . . 61.0 m -128.06 134.13 25.89 Favored Pre-proline 0 N--CA 1.494 1.741 0 O-C-N 121.136 -0.977 . . . . 0.0 110.032 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 827' ' ' PRO . . . . . 0.534 ' O ' ' CG ' ' A' ' 828' ' ' GLU . 50.8 Cg_endo -82.87 -171.58 1.18 Allowed 'Trans proline' 0 C--N 1.306 -1.683 0 O-C-N 124.156 1.608 . . . . 0.0 111.133 -179.941 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 828' ' ' GLU . . . . . 0.534 ' CG ' ' O ' ' A' ' 827' ' ' PRO . 15.5 pt-20 39.28 34.76 0.13 Allowed 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.678 -0.639 . . . . 0.0 110.65 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 829' ' ' VAL . . . . . 0.472 ' O ' ' HD2' ' A' ' 831' ' ' LYS . 23.4 t -144.1 161.34 15.48 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.309 -0.869 . . . . 0.0 109.757 179.904 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 830' ' ' MET . . . . . 0.41 ' O ' ' HD2' ' A' ' 831' ' ' LYS . 3.2 mtp -59.12 171.17 0.76 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.031 -1.043 . . . . 0.0 109.626 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 831' ' ' LYS . . . . . 0.472 ' HD2' ' O ' ' A' ' 829' ' ' VAL . 0.6 OUTLIER -147.99 128.63 14.17 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.015 -1.053 . . . . 0.0 110.967 -179.951 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 832' ' ' ARG . . . . . 0.459 ' HG2' ' O ' ' A' ' 779' ' ' GLY . 0.0 OUTLIER -156.49 152.14 27.01 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.443 -0.786 . . . . 0.0 109.65 179.926 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 833' ' ' VAL . . . . . . . . . . . . . 28.6 t -111.16 144.09 19.75 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 O-C-N 121.116 -0.99 . . . . 0.0 110.882 -179.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 834' ' ' ALA . . . . . 0.581 ' HB3' ' CZ ' ' A' ' 788' ' ' PHE . . . -147.9 136.67 21.85 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.325 -0.859 . . . . 0.0 109.291 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 835' ' ' VAL . . . . . 0.453 HG22 ' HB2' ' A' ' 776' ' ' ALA . 75.5 t -148.47 154.4 10.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 120.912 -1.118 . . . . 0.0 111.204 -179.931 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 836' ' ' GLU . . . . . 0.49 ' OE1' ' CB ' ' A' ' 774' ' ' LYS . 16.3 tt0 -141.28 117.48 10.67 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 179.944 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 837' ' ' ALA . . . . . . . . . . . . . . . -107.34 162.97 13.43 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.022 -1.049 . . . . 0.0 111.377 -179.836 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 838' ' ' VAL . . . . . . . . . . . . . 90.9 t -121.58 107.66 20.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.647 -0.658 . . . . 0.0 109.841 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 839' ' ' CYS . . . . . 0.441 ' O ' ' O ' ' A' ' 728' ' ' VAL . 15.5 p -115.74 122.29 45.04 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.065 -1.022 . . . . 0.0 110.785 -179.986 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 840' ' ' SER . . . . . 0.412 ' O ' ' HA ' ' A' ' 768' ' ' GLN . 1.2 p -106.46 150.19 26.32 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.558 -0.713 . . . . 0.0 109.579 179.907 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 841' ' ' THR . . . . . 0.453 ' HA ' ' HG2' ' A' ' 768' ' ' GLN . 5.4 t . . . . . 0 N--CA 1.492 1.63 0 O-C-N 121.121 -0.987 . . . . 0.0 110.549 -179.931 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 728' ' ' VAL . . . . . 0.405 ' O ' ' O ' ' A' ' 839' ' ' CYS . 12.0 t . . . . . 0 N--CA 1.493 1.685 0 CA-C-O 121.116 0.484 . . . . 0.0 110.083 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 729' ' ' SER . . . . . 0.487 ' HA ' ' O ' ' A' ' 839' ' ' CYS . 39.0 t -160.05 41.11 0.19 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.241 -0.912 . . . . 0.0 110.625 -179.949 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 730' ' ' GLY . . . . . . . . . . . . . . . 178.25 108.44 0.23 Allowed Glycine 0 N--CA 1.49 2.297 0 C-N-CA 119.575 -1.298 . . . . 0.0 110.154 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 731' ' ' VAL . . . . . 0.434 HG22 ' HB2' ' A' ' 839' ' ' CYS . 39.0 t -112.33 164.65 8.0 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 121.361 -1.082 . . . . 0.0 109.455 179.841 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 732' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -134.24 158.72 43.0 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.036 -1.04 . . . . 0.0 110.881 -179.876 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 733' ' ' ALA . . . . . 0.471 ' HB1' ' CD2' ' A' ' 762' ' ' LEU . . . -161.7 133.38 5.51 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.335 -0.853 . . . . 0.0 109.925 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 734' ' ' ASP . . . . . 0.463 ' O ' HG23 ' A' ' 735' ' ' VAL . 30.2 m-20 -150.15 111.14 4.34 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.119 -0.988 . . . . 0.0 110.464 179.901 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 735' ' ' VAL . . . . . 0.463 HG23 ' O ' ' A' ' 734' ' ' ASP . 40.4 t -139.99 163.45 24.27 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.326 -0.859 . . . . 0.0 109.816 179.977 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 736' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -75.87 -175.1 2.87 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.164 -0.96 . . . . 0.0 110.108 -179.973 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 737' ' ' GLU . . . . . 0.456 ' O ' ' HB3' ' A' ' 758' ' ' ALA . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.556 0 O-C-N 121.204 -0.935 . . . . 0.0 110.336 179.965 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 757' ' ' THR . . . . . . . . . . . . . 66.2 p . . . . . 0 N--CA 1.496 1.844 0 CA-C-O 121.096 0.474 . . . . 0.0 110.155 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 758' ' ' ALA . . . . . 0.456 ' HB3' ' O ' ' A' ' 737' ' ' GLU . . . -58.95 121.77 12.01 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.211 -0.931 . . . . 0.0 109.713 179.902 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 759' ' ' LYS . . . . . 0.515 ' CG ' ' HA ' ' A' ' 815' ' ' ALA . 13.6 mttt -109.16 163.34 13.44 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.145 -0.972 . . . . 0.0 110.847 -179.928 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 760' ' ' VAL . . . . . 0.52 ' CG1' HD12 ' A' ' 762' ' ' LEU . 52.1 t -106.55 131.05 57.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 179.895 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 761' ' ' HIS . . . . . . . . . . . . . 10.8 m80 -112.57 110.35 20.46 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 120.923 -1.111 . . . . 0.0 112.365 -179.736 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 762' ' ' LEU . . . . . 0.52 HD12 ' CG1' ' A' ' 760' ' ' VAL . 1.0 OUTLIER -121.79 105.0 9.98 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 107.477 -1.305 . . . . 0.0 107.477 179.788 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 763' ' ' LYS . . . . . 0.44 ' CB ' ' HG3' ' A' ' 811' ' ' ARG . 0.0 OUTLIER -129.44 150.96 50.57 Favored 'General case' 0 C--N 1.297 -1.696 0 O-C-N 120.87 -1.144 . . . . 0.0 112.168 -179.7 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 764' ' ' CYS . . . . . 0.431 ' O ' ' C ' ' A' ' 765' ' ' ALA . 18.4 m -125.08 164.11 20.92 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 109.19 -0.671 . . . . 0.0 109.19 179.875 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 765' ' ' ALA . . . . . 0.44 ' HB2' ' NE2' ' A' ' 768' ' ' GLN . . . -43.88 154.54 0.36 Allowed Pre-proline 0 N--CA 1.491 1.609 0 O-C-N 120.994 -1.067 . . . . 0.0 110.055 179.982 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 766' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -69.72 99.26 0.73 Allowed 'Trans proline' 0 C--N 1.304 -1.786 0 O-C-N 123.989 1.521 . . . . 0.0 110.089 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 767' ' ' GLY . . . . . . . . . . . . . . . 144.69 -30.77 1.81 Allowed Glycine 0 N--CA 1.488 2.139 0 N-CA-C 108.998 -1.641 . . . . 0.0 108.998 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 768' ' ' GLN . . . . . 0.533 ' HG2' ' N ' ' A' ' 841' ' ' THR . 4.1 mt-30 -85.76 156.74 20.49 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.433 -1.039 . . . . 0.0 109.875 179.908 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 769' ' ' THR . . . . . 0.46 HG23 ' HG3' ' A' ' 810' ' ' GLU . 23.0 p -138.04 145.76 42.2 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.202 -0.936 . . . . 0.0 110.296 -179.969 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 770' ' ' ILE . . . . . . . . . . . . . 70.3 mt -68.46 127.1 29.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.312 -0.868 . . . . 0.0 109.202 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 771' ' ' SER . . . . . 0.473 ' O ' ' HB1' ' A' ' 772' ' ' ALA . 8.5 p -103.6 -8.71 19.78 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.216 -0.928 . . . . 0.0 111.419 -179.893 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 772' ' ' ALA . . . . . 0.473 ' HB1' ' O ' ' A' ' 771' ' ' SER . . . -177.92 151.03 0.66 Allowed 'General case' 0 N--CA 1.495 1.796 0 O-C-N 120.73 -1.231 . . . . 0.0 111.805 -179.959 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 773' ' ' ILE . . . . . . . . . . . . . 33.6 mm -100.15 141.91 16.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 179.784 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 774' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -108.88 -24.13 11.4 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.826 -1.171 . . . . 0.0 111.733 -179.804 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 775' ' ' PHE . . . . . . . . . . . . . 80.8 t80 -154.76 161.44 41.51 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 120.726 -1.234 . . . . 0.0 111.505 -179.854 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 776' ' ' ALA . . . . . 0.449 ' O ' ' HB3' ' A' ' 798' ' ' SER . . . 178.58 111.24 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.626 -0.671 . . . . 0.0 109.485 179.964 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 777' ' ' SER . . . . . . . . . . . . . 48.3 p -144.66 113.71 6.89 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.077 -1.014 . . . . 0.0 110.681 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 778' ' ' PHE . . . . . 0.467 ' CG ' ' O ' ' A' ' 778' ' ' PHE . 8.6 t80 -91.26 78.46 5.78 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.292 -0.88 . . . . 0.0 110.046 179.943 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 779' ' ' GLY . . . . . . . . . . . . . . . -165.12 -123.26 0.64 Allowed Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.829 -1.309 . . . . 0.0 109.829 -179.946 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 780' ' ' THR . . . . . . . . . . . . . 27.9 p -120.46 78.75 28.37 Favored Pre-proline 0 N--CA 1.493 1.688 0 O-C-N 121.344 -1.092 . . . . 0.0 110.396 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 781' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -79.44 175.72 10.4 Favored 'Trans proline' 0 C--N 1.304 -1.78 0 O-C-N 123.95 1.5 . . . . 0.0 110.556 -179.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 782' ' ' LEU . . . . . . . . . . . . . 3.9 mt -143.47 134.98 26.22 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.296 -0.878 . . . . 0.0 110.032 179.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 783' ' ' GLY . . . . . . . . . . . . . . . 144.1 -174.52 24.39 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 -179.937 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 784' ' ' THR . . . . . 0.463 ' O ' ' O ' ' A' ' 785' ' ' CYS . 0.0 OUTLIER -145.64 66.82 1.21 Allowed 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.213 -1.169 . . . . 0.0 110.257 179.993 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 785' ' ' CYS . . . . . 0.463 ' O ' ' O ' ' A' ' 784' ' ' THR . 44.6 t 57.44 114.76 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.303 -0.873 . . . . 0.0 110.351 179.974 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 786' ' ' GLY . . . . . . . . . . . . . . . 109.47 -17.78 30.7 Favored Glycine 0 N--CA 1.489 2.197 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 -179.932 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 787' ' ' THR . . . . . 0.468 ' O ' HG23 ' A' ' 787' ' ' THR . 12.2 t -158.63 48.23 0.35 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.162 -1.199 . . . . 0.0 110.485 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 788' ' ' PHE . . . . . 0.436 ' CE2' ' HA ' ' A' ' 785' ' ' CYS . 41.5 m-85 -58.34 149.69 24.0 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.109 -0.994 . . . . 0.0 109.984 -179.987 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 789' ' ' GLN . . . . . . . . . . . . . 2.0 tt0 -136.04 162.22 33.51 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.158 -0.964 . . . . 0.0 110.408 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 790' ' ' GLN . . . . . 0.434 ' HG2' ' N ' ' A' ' 791' ' ' GLY . 1.8 tt0 -93.81 144.67 25.21 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.177 -0.952 . . . . 0.0 110.202 -179.993 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 791' ' ' GLY . . . . . 0.434 ' N ' ' HG2' ' A' ' 790' ' ' GLN . . . -96.95 -142.0 12.83 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.361 -1.496 . . . . 0.0 109.361 -179.955 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 792' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -93.63 -36.91 12.13 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.253 -1.145 . . . . 0.0 109.74 179.944 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 793' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -100.64 153.62 19.26 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.42 -0.8 . . . . 0.0 110.264 179.975 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 794' ' ' HIS . . . . . 0.471 ' NE2' ' O ' ' A' ' 795' ' ' SER . 26.4 t60 -176.82 143.17 0.43 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.154 -0.966 . . . . 0.0 110.266 179.956 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 795' ' ' SER . . . . . 0.471 ' O ' ' NE2' ' A' ' 794' ' ' HIS . 58.4 p -73.69 143.62 46.13 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.311 -0.868 . . . . 0.0 109.382 179.934 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 796' ' ' ILE . . . . . . . . . . . . . 9.6 mt -90.99 42.15 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.199 -0.938 . . . . 0.0 109.768 -179.916 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 797' ' ' ASN . . . . . . . . . . . . . 10.6 t30 -159.61 23.02 0.18 Allowed 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.519 -0.738 . . . . 0.0 109.597 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 798' ' ' SER . . . . . 0.449 ' HB3' ' O ' ' A' ' 776' ' ' ALA . 0.6 OUTLIER -57.75 -71.63 0.1 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.571 -0.706 . . . . 0.0 111.563 -179.878 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 799' ' ' ASN . . . . . . . . . . . . . 1.4 m120 -61.92 -7.25 3.53 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.305 -0.872 . . . . 0.0 111.861 -179.801 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 800' ' ' SER . . . . . . . . . . . . . 1.3 t -74.03 -33.41 63.74 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.775 -1.203 . . . . 0.0 110.311 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 801' ' ' VAL . . . . . . . . . . . . . 59.1 t -90.83 -18.59 7.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.244 -0.91 . . . . 0.0 110.315 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 802' ' ' LEU . . . . . 0.477 HD23 ' N ' ' A' ' 802' ' ' LEU . 3.5 mm? -81.43 -45.89 15.38 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.247 -0.908 . . . . 0.0 111.182 -179.831 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 803' ' ' GLU . . . . . 0.404 ' HA ' HD12 ' A' ' 807' ' ' ILE . 4.8 tm-20 -74.4 -21.66 59.54 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.024 -1.048 . . . . 0.0 111.232 -179.993 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 804' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -94.44 -17.35 22.57 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.06 -1.025 . . . . 0.0 112.266 -179.853 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 805' ' ' LYS . . . . . . . . . . . . . 6.4 tttt -138.49 45.04 2.07 Favored 'General case' 0 N--CA 1.503 2.187 0 O-C-N 120.466 -1.396 . . . . 0.0 112.603 -179.879 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 806' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -163.17 -37.38 0.04 OUTLIER 'General case' 0 N--CA 1.498 1.96 0 O-C-N 120.686 -1.259 . . . . 0.0 110.613 179.918 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 807' ' ' ILE . . . . . 0.404 HD12 ' HA ' ' A' ' 803' ' ' GLU . 18.3 mt -70.7 113.5 6.95 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.636 0 O-C-N 121.299 -0.875 . . . . 0.0 110.998 -179.883 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 808' ' ' GLY . . . . . 0.48 ' C ' ' HG ' ' A' ' 809' ' ' LEU . . . 119.35 19.03 4.34 Favored Glycine 0 N--CA 1.494 2.506 0 C-N-CA 119.856 -1.164 . . . . 0.0 110.506 179.88 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 809' ' ' LEU . . . . . 0.48 ' HG ' ' C ' ' A' ' 808' ' ' GLY . 40.5 mt -142.19 142.77 32.71 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 120.883 -1.363 . . . . 0.0 110.629 -179.991 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 810' ' ' GLU . . . . . 0.46 ' HG3' HG23 ' A' ' 769' ' ' THR . 2.2 mt-10 -66.8 -27.6 67.71 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.275 -0.891 . . . . 0.0 109.24 179.959 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 811' ' ' ARG . . . . . 0.44 ' HG3' ' CB ' ' A' ' 763' ' ' LYS . 6.8 ttt85 -125.35 154.49 41.75 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.508 -0.745 . . . . 0.0 109.927 179.972 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 812' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -137.34 124.03 21.09 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.211 -0.93 . . . . 0.0 110.535 -179.982 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 813' ' ' VAL . . . . . . . . . . . . . 70.8 t -130.92 103.43 7.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.226 -0.921 . . . . 0.0 110.015 179.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 814' ' ' VAL . . . . . . . . . . . . . 86.0 t -124.84 121.14 60.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.191 -0.943 . . . . 0.0 110.155 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 815' ' ' ALA . . . . . 0.515 ' HA ' ' CG ' ' A' ' 759' ' ' LYS . . . -72.21 160.91 31.63 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.283 -0.886 . . . . 0.0 110.246 179.923 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 816' ' ' ILE . . . . . 0.421 HD11 HG22 ' A' ' 760' ' ' VAL . 8.2 mt -112.91 81.59 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.267 -0.896 . . . . 0.0 109.649 179.989 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 817' ' ' SER . . . . . . . . . . . . . 5.7 p -110.48 158.36 35.62 Favored Pre-proline 0 C--N 1.297 -1.71 0 O-C-N 121.318 -0.864 . . . . 0.0 110.213 -179.921 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 818' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -77.61 12.85 1.78 Allowed 'Trans proline' 0 C--N 1.306 -1.672 0 O-C-N 124.107 1.583 . . . . 0.0 111.058 179.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 819' ' ' SER . . . . . . . . . . . . . 10.3 p -133.84 16.49 3.9 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.107 -0.995 . . . . 0.0 110.371 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 820' ' ' ASN . . . . . . . . . . . . . 19.3 t-20 -117.81 -16.82 9.94 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.138 -0.976 . . . . 0.0 110.058 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 821' ' ' PHE . . . . . . . . . . . . . 7.4 m-85 -97.21 -39.29 9.34 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.348 -0.845 . . . . 0.0 110.257 179.896 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 822' ' ' GLY . . . . . . . . . . . . . . . 174.88 -29.49 0.08 OUTLIER Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.596 -1.402 . . . . 0.0 109.596 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 823' ' ' GLY . . . . . 0.465 ' O ' ' OD2' ' A' ' 824' ' ' ASP . . . 147.78 -82.75 0.19 Allowed Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 179.983 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 824' ' ' ASP . . . . . 0.465 ' OD2' ' O ' ' A' ' 823' ' ' GLY . 1.0 OUTLIER -148.02 121.11 4.7 Favored Pre-proline 0 N--CA 1.494 1.771 0 O-C-N 121.234 -1.157 . . . . 0.0 110.385 -179.919 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 825' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -75.51 -89.91 0.01 OUTLIER 'Trans proline' 0 C--N 1.31 -1.497 0 O-C-N 123.923 1.486 . . . . 0.0 110.478 179.932 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 826' ' ' CYS . . . . . 0.522 ' HB3' ' CG2' ' A' ' 829' ' ' VAL . 2.1 m -97.17 130.74 28.99 Favored Pre-proline 0 N--CA 1.492 1.646 0 O-C-N 121.201 -0.937 . . . . 0.0 109.971 179.996 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 827' ' ' PRO . . . . . 0.42 ' O ' ' HB2' ' A' ' 828' ' ' GLU . 46.4 Cg_endo -73.41 129.31 13.7 Favored 'Trans proline' 0 C--N 1.308 -1.579 0 O-C-N 124.002 1.527 . . . . 0.0 110.927 -179.991 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 828' ' ' GLU . . . . . 0.42 ' HB2' ' O ' ' A' ' 827' ' ' PRO . 8.3 mt-10 57.24 46.3 18.93 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.392 -0.818 . . . . 0.0 110.504 179.928 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 829' ' ' VAL . . . . . 0.522 ' CG2' ' HB3' ' A' ' 826' ' ' CYS . 39.2 t -133.95 124.88 47.76 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 O-C-N 121.209 -0.932 . . . . 0.0 110.017 179.898 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 830' ' ' MET . . . . . 0.432 ' O ' ' O ' ' A' ' 829' ' ' VAL . 13.0 mmt -41.72 162.75 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.349 -0.844 . . . . 0.0 110.03 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 831' ' ' LYS . . . . . . . . . . . . . 6.4 mttt -139.71 142.47 36.86 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.063 -1.023 . . . . 0.0 111.011 -179.872 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 832' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -144.87 158.15 43.9 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.526 -0.733 . . . . 0.0 109.325 179.976 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 833' ' ' VAL . . . . . 0.418 HG21 HG21 ' A' ' 816' ' ' ILE . 62.1 t -123.13 117.19 50.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 120.846 -1.159 . . . . 0.0 111.47 -179.784 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 834' ' ' ALA . . . . . . . . . . . . . . . -125.9 117.62 23.71 Favored 'General case' 0 N--CA 1.494 1.728 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 179.799 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 835' ' ' VAL . . . . . 0.485 HG11 ' N ' ' A' ' 836' ' ' GLU . 44.4 t -127.82 165.24 27.35 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 120.9 -1.125 . . . . 0.0 111.997 -179.792 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 836' ' ' GLU . . . . . 0.485 ' N ' HG11 ' A' ' 835' ' ' VAL . 0.9 OUTLIER -152.23 123.38 7.62 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 179.952 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 837' ' ' ALA . . . . . . . . . . . . . . . -121.83 165.98 15.06 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 120.893 -1.13 . . . . 0.0 111.809 -179.757 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 838' ' ' VAL . . . . . . . . . . . . . 17.2 t -109.84 107.23 22.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.662 -0.649 . . . . 0.0 109.275 179.928 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 839' ' ' CYS . . . . . 0.487 ' O ' ' HA ' ' A' ' 729' ' ' SER . 0.0 OUTLIER -108.21 145.26 34.52 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.13 -0.981 . . . . 0.0 110.818 -179.896 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 840' ' ' SER . . . . . . . . . . . . . 1.4 p -164.35 147.51 9.21 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.37 -0.831 . . . . 0.0 110.094 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 841' ' ' THR . . . . . 0.533 ' N ' ' HG2' ' A' ' 768' ' ' GLN . 5.2 t . . . . . 0 N--CA 1.494 1.736 0 O-C-N 121.244 -0.91 . . . . 0.0 110.208 -179.948 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 728' ' ' VAL . . . . . 0.453 ' O ' ' CG1' ' A' ' 728' ' ' VAL . 12.0 p . . . . . 0 N--CA 1.489 1.519 0 CA-C-O 121.351 0.596 . . . . 0.0 110.363 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 729' ' ' SER . . . . . . . . . . . . . 5.9 m 52.3 -177.99 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.41 -0.807 . . . . 0.0 110.731 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 730' ' ' GLY . . . . . 0.491 ' C ' ' CG2' ' A' ' 731' ' ' VAL . . . -152.25 -140.93 3.21 Favored Glycine 0 N--CA 1.489 2.193 0 N-CA-C 109.041 -1.624 . . . . 0.0 109.041 179.987 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 731' ' ' VAL . . . . . 0.491 ' CG2' ' C ' ' A' ' 730' ' ' GLY . 11.9 t -153.17 165.81 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 O-C-N 121.065 -1.256 . . . . 0.0 110.26 179.968 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 732' ' ' CYS . . . . . . . . . . . . . 6.6 t -150.92 133.98 15.98 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.343 -0.848 . . . . 0.0 109.967 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 733' ' ' ALA . . . . . . . . . . . . . . . -153.19 162.32 41.44 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.18 -0.95 . . . . 0.0 110.551 -179.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 734' ' ' ASP . . . . . 0.458 ' O ' ' OD2' ' A' ' 734' ' ' ASP . 4.3 p30 -162.13 118.26 2.01 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.423 -0.798 . . . . 0.0 109.9 179.995 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 735' ' ' VAL . . . . . 0.4 HG21 ' C ' ' A' ' 734' ' ' ASP . 16.6 t -139.11 164.82 24.6 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.157 -0.964 . . . . 0.0 110.674 -179.997 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 736' ' ' SER . . . . . . . . . . . . . 8.3 p -109.83 172.9 6.59 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.36 -0.837 . . . . 0.0 109.818 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 737' ' ' GLU . . . . . 0.448 ' OE1' ' HG3' ' A' ' 831' ' ' LYS . 9.5 pt-20 . . . . . 0 N--CA 1.496 1.852 0 O-C-N 121.124 -0.985 . . . . 0.0 110.348 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 757' ' ' THR . . . . . . . . . . . . . 47.0 p . . . . . 0 N--CA 1.492 1.672 0 CA-C-O 121.368 0.604 . . . . 0.0 110.707 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 758' ' ' ALA . . . . . 0.42 ' C ' ' HG3' ' A' ' 759' ' ' LYS . . . -64.38 168.02 6.21 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.32 -0.862 . . . . 0.0 110.009 179.96 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 759' ' ' LYS . . . . . 0.42 ' HG3' ' C ' ' A' ' 758' ' ' ALA . 17.1 mttp -146.55 146.47 30.49 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.203 -0.935 . . . . 0.0 110.596 -179.928 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 760' ' ' VAL . . . . . . . . . . . . . 43.8 t -108.72 138.37 36.06 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.291 -0.881 . . . . 0.0 109.62 179.819 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 761' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -109.12 125.65 52.38 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.133 -0.979 . . . . 0.0 111.19 -179.917 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 762' ' ' LEU . . . . . 0.467 ' HB2' ' HB2' ' A' ' 812' ' ' CYS . 20.6 mt -123.39 112.16 17.22 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.464 -0.772 . . . . 0.0 109.296 179.849 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 763' ' ' LYS . . . . . . . . . . . . . 9.7 mttt -107.93 122.1 46.12 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.091 -1.006 . . . . 0.0 110.869 -179.827 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 764' ' ' CYS . . . . . 0.423 ' O ' ' C ' ' A' ' 765' ' ' ALA . 48.7 t -92.91 163.18 13.78 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.46 -0.775 . . . . 0.0 109.618 179.904 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 765' ' ' ALA . . . . . 0.484 ' HB1' ' HB2' ' A' ' 768' ' ' GLN . . . -44.08 154.81 0.36 Allowed Pre-proline 0 N--CA 1.493 1.685 0 O-C-N 121.041 -1.037 . . . . 0.0 109.992 -179.884 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 766' ' ' PRO . . . . . 0.436 ' C ' ' OE1' ' A' ' 768' ' ' GLN . 45.1 Cg_endo -70.95 112.14 3.22 Favored 'Trans proline' 0 C--N 1.306 -1.684 0 O-C-N 123.98 1.516 . . . . 0.0 110.657 -179.96 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 767' ' ' GLY . . . . . . . . . . . . . . . 98.29 -2.96 59.61 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.651 -1.379 . . . . 0.0 109.651 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 768' ' ' GLN . . . . . 0.484 ' HB2' ' HB1' ' A' ' 765' ' ' ALA . 27.6 mp0 -106.59 176.3 5.22 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.23 -1.159 . . . . 0.0 110.078 -179.913 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 769' ' ' THR . . . . . . . . . . . . . 40.6 p -145.12 159.18 43.37 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.225 -0.922 . . . . 0.0 110.502 -179.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 770' ' ' ILE . . . . . . . . . . . . . 5.6 mt -71.02 151.47 9.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.302 -0.874 . . . . 0.0 109.831 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 771' ' ' SER . . . . . . . . . . . . . 15.0 m -135.5 -9.97 2.17 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.119 -0.988 . . . . 0.0 111.152 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 772' ' ' ALA . . . . . . . . . . . . . . . -172.38 133.62 0.65 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.823 -1.173 . . . . 0.0 111.124 -179.892 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 773' ' ' ILE . . . . . . . . . . . . . 34.1 mm -86.84 120.4 36.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.367 -0.833 . . . . 0.0 109.232 179.91 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 774' ' ' LYS . . . . . . . . . . . . . 1.2 ttmp? -81.21 -38.58 26.77 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.13 -0.981 . . . . 0.0 111.024 -179.861 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 775' ' ' PHE . . . . . 0.533 ' O ' ' CB ' ' A' ' 776' ' ' ALA . 43.5 t80 -149.29 167.41 26.14 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.008 -1.057 . . . . 0.0 111.182 -179.904 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 776' ' ' ALA . . . . . 0.533 ' CB ' ' O ' ' A' ' 775' ' ' PHE . . . 163.88 59.25 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.843 0 CA-C-O 121.449 0.642 . . . . 0.0 109.328 179.975 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 777' ' ' SER . . . . . 0.532 ' HB3' ' CZ ' ' A' ' 775' ' ' PHE . 0.3 OUTLIER -89.88 154.33 19.95 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.513 -0.742 . . . . 0.0 110.776 -179.933 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 778' ' ' PHE . . . . . . . . . . . . . 7.5 t80 -121.84 89.16 3.07 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.377 -0.827 . . . . 0.0 110.137 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 779' ' ' GLY . . . . . . . . . . . . . . . 179.94 -127.72 1.15 Allowed Glycine 0 N--CA 1.493 2.464 0 N-CA-C 109.723 -1.351 . . . . 0.0 109.723 -179.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 780' ' ' THR . . . . . 0.471 ' O ' ' HA3' ' A' ' 791' ' ' GLY . 9.0 p -116.03 76.17 6.22 Favored Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.209 -1.171 . . . . 0.0 110.341 179.994 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 781' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -71.18 162.47 42.45 Favored 'Trans proline' 0 C--N 1.304 -1.812 0 O-C-N 124.013 1.533 . . . . 0.0 110.369 179.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 782' ' ' LEU . . . . . . . . . . . . . 4.5 mt -123.32 145.52 48.66 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.263 -0.898 . . . . 0.0 110.229 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 783' ' ' GLY . . . . . . . . . . . . . . . 99.86 -175.85 27.91 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.925 -1.27 . . . . 0.0 109.925 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 784' ' ' THR . . . . . 0.467 ' O ' ' O ' ' A' ' 785' ' ' CYS . 1.7 t -147.41 89.48 1.78 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.313 -1.11 . . . . 0.0 109.855 179.97 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 785' ' ' CYS . . . . . 0.467 ' O ' ' O ' ' A' ' 784' ' ' THR . 4.1 t 54.48 107.89 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.297 -0.877 . . . . 0.0 110.011 -179.966 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 786' ' ' GLY . . . . . 0.431 ' O ' HG22 ' A' ' 787' ' ' THR . . . 115.22 -31.1 6.39 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 108.957 -1.657 . . . . 0.0 108.957 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 787' ' ' THR . . . . . 0.431 HG22 ' O ' ' A' ' 786' ' ' GLY . 8.9 p -141.02 38.74 1.78 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.463 -1.022 . . . . 0.0 109.831 179.908 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 788' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -63.32 165.12 7.95 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.364 -0.835 . . . . 0.0 110.479 -179.992 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 789' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -159.36 165.67 32.79 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.374 -0.829 . . . . 0.0 109.443 179.95 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 790' ' ' GLN . . . . . 0.43 ' O ' ' C ' ' A' ' 791' ' ' GLY . 5.8 pt20 -90.25 20.57 4.31 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.014 -1.054 . . . . 0.0 110.487 -179.973 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 791' ' ' GLY . . . . . 0.471 ' HA3' ' O ' ' A' ' 780' ' ' THR . . . 41.77 -143.24 1.03 Allowed Glycine 0 N--CA 1.491 2.313 0 N-CA-C 110.067 -1.213 . . . . 0.0 110.067 -179.989 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 792' ' ' GLU . . . . . . . . . . . . . 27.8 mm-40 -95.15 -43.21 8.2 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.448 -1.031 . . . . 0.0 110.354 -179.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 793' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -108.44 134.06 51.75 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.039 -1.038 . . . . 0.0 110.075 -179.988 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 794' ' ' HIS . . . . . 0.559 ' CG ' ' N ' ' A' ' 795' ' ' SER . 68.3 t60 -139.28 169.55 17.55 Favored 'General case' 0 C--N 1.299 -1.591 0 O-C-N 121.32 -0.862 . . . . 0.0 110.176 -179.981 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 795' ' ' SER . . . . . 0.559 ' N ' ' CG ' ' A' ' 794' ' ' HIS . 0.1 OUTLIER -110.69 129.79 55.74 Favored 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 179.904 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 796' ' ' ILE . . . . . . . . . . . . . 35.9 mt -69.7 -5.62 5.33 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.619 0 O-C-N 120.915 -1.115 . . . . 0.0 109.875 -179.913 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 797' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -102.85 14.83 31.0 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.334 -0.853 . . . . 0.0 109.799 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 798' ' ' SER . . . . . 0.492 ' HB2' ' O ' ' A' ' 776' ' ' ALA . 10.8 p -58.79 -62.75 1.63 Allowed 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.463 -0.773 . . . . 0.0 111.278 179.997 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 799' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -82.54 1.43 37.94 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.261 -0.9 . . . . 0.0 110.951 -179.882 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 800' ' ' SER . . . . . 0.475 ' O ' ' HG2' ' A' ' 804' ' ' ARG . 23.3 t -84.21 -25.99 29.08 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.057 -1.027 . . . . 0.0 110.478 -179.926 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 801' ' ' VAL . . . . . . . . . . . . . 59.9 t -93.61 -27.99 4.41 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.282 -0.886 . . . . 0.0 111.445 -179.922 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 802' ' ' LEU . . . . . 0.584 ' N ' ' CD2' ' A' ' 802' ' ' LEU . 4.0 mm? -89.96 -29.67 18.32 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 120.964 -1.085 . . . . 0.0 111.152 -179.88 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 803' ' ' GLU . . . . . . . . . . . . . 11.3 tt0 -68.93 -28.12 66.37 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 120.818 -1.176 . . . . 0.0 110.942 -179.915 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 804' ' ' ARG . . . . . 0.475 ' HG2' ' O ' ' A' ' 800' ' ' SER . 0.0 OUTLIER -95.0 -17.82 21.59 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.092 -1.005 . . . . 0.0 111.804 -179.969 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 805' ' ' LYS . . . . . 0.429 ' N ' ' HG3' ' A' ' 804' ' ' ARG . 2.3 tptp -115.58 41.33 2.53 Favored 'General case' 0 N--CA 1.501 2.125 0 O-C-N 120.872 -1.143 . . . . 0.0 112.172 -179.824 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 806' ' ' CYS . . . . . 0.504 ' HB2' ' O ' ' A' ' 802' ' ' LEU . 0.5 OUTLIER -160.31 -19.25 0.06 Allowed 'General case' 0 N--CA 1.504 2.236 0 O-C-N 120.577 -1.327 . . . . 0.0 112.306 -179.981 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 807' ' ' ILE . . . . . . . . . . . . . 52.9 mt -85.66 120.49 35.85 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 O-C-N 120.665 -1.272 . . . . 0.0 111.145 -179.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 808' ' ' GLY . . . . . 0.426 ' C ' ' HG ' ' A' ' 809' ' ' LEU . . . 112.92 12.63 12.15 Favored Glycine 0 N--CA 1.494 2.531 0 N-CA-C 110.363 -1.095 . . . . 0.0 110.363 179.897 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 809' ' ' LEU . . . . . 0.426 ' HG ' ' C ' ' A' ' 808' ' ' GLY . 12.1 mt -136.29 155.31 50.27 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.033 -1.275 . . . . 0.0 110.799 -179.968 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 810' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -89.99 8.72 31.01 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.433 -0.792 . . . . 0.0 109.389 179.916 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 811' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -155.89 160.94 40.58 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 -179.976 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 812' ' ' CYS . . . . . 0.467 ' HB2' ' HB2' ' A' ' 762' ' ' LEU . 1.0 OUTLIER -143.59 132.76 23.09 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.844 -1.16 . . . . 0.0 111.233 -179.936 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 813' ' ' VAL . . . . . . . . . . . . . 89.7 t -136.2 104.63 4.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.488 -0.757 . . . . 0.0 109.554 179.935 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 814' ' ' VAL . . . . . . . . . . . . . 96.8 t -113.56 129.99 68.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.137 -0.977 . . . . 0.0 110.819 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 815' ' ' ALA . . . . . . . . . . . . . . . -85.52 141.8 29.63 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.32 -0.863 . . . . 0.0 109.387 179.933 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 816' ' ' ILE . . . . . 0.455 HG23 ' CG2' ' A' ' 833' ' ' VAL . 21.0 mt -104.5 124.12 58.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.133 -0.979 . . . . 0.0 110.651 -179.903 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 817' ' ' SER . . . . . 0.462 ' OG ' ' HD2' ' A' ' 818' ' ' PRO . 29.2 t -148.05 153.54 41.87 Favored Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 121.348 -0.845 . . . . 0.0 110.025 179.957 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 818' ' ' PRO . . . . . 0.462 ' HD2' ' OG ' ' A' ' 817' ' ' SER . 43.5 Cg_endo -70.71 -10.11 27.14 Favored 'Trans proline' 0 C--N 1.304 -1.768 0 O-C-N 123.984 1.518 . . . . 0.0 110.315 -179.954 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 819' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -125.42 59.73 1.26 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.317 -0.864 . . . . 0.0 110.014 -179.96 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 820' ' ' ASN . . . . . . . . . . . . . 1.3 m120 -148.34 -35.83 0.2 Allowed 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.361 -0.837 . . . . 0.0 110.285 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 821' ' ' PHE . . . . . . . . . . . . . 13.9 m-85 -80.16 0.76 30.92 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.145 -0.972 . . . . 0.0 110.485 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 822' ' ' GLY . . . . . . . . . . . . . . . 110.7 12.29 16.98 Favored Glycine 0 N--CA 1.493 2.448 0 N-CA-C 109.767 -1.333 . . . . 0.0 109.767 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 823' ' ' GLY . . . . . . . . . . . . . . . 108.73 -159.53 14.11 Favored Glycine 0 N--CA 1.492 2.374 0 N-CA-C 109.629 -1.388 . . . . 0.0 109.629 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 824' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -117.91 136.11 23.64 Favored Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 121.221 -1.164 . . . . 0.0 110.391 -179.997 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 825' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -72.47 -80.12 0.01 OUTLIER 'Trans proline' 0 C--N 1.307 -1.638 0 O-C-N 123.959 1.505 . . . . 0.0 110.161 179.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 826' ' ' CYS . . . . . . . . . . . . . 5.8 p -106.58 121.4 45.28 Favored Pre-proline 0 N--CA 1.498 1.957 0 O-C-N 121.11 -0.994 . . . . 0.0 109.921 179.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 827' ' ' PRO . . . . . 0.47 ' O ' ' CB ' ' A' ' 828' ' ' GLU . 43.7 Cg_endo -70.38 171.43 15.17 Favored 'Trans proline' 0 C--N 1.309 -1.523 0 O-C-N 123.942 1.496 . . . . 0.0 110.054 -179.975 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 828' ' ' GLU . . . . . 0.47 ' CB ' ' O ' ' A' ' 827' ' ' PRO . 0.0 OUTLIER 66.54 15.74 10.2 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.21 -0.931 . . . . 0.0 109.64 -179.951 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 829' ' ' VAL . . . . . . . . . . . . . 95.4 t -119.8 132.26 70.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.425 -0.797 . . . . 0.0 110.02 179.934 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 830' ' ' MET . . . . . . . . . . . . . 2.2 tpp -53.55 144.71 16.63 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.219 -0.926 . . . . 0.0 110.279 179.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 831' ' ' LYS . . . . . 0.448 ' HG3' ' OE1' ' A' ' 737' ' ' GLU . 0.0 OUTLIER -115.07 97.81 6.43 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.123 -0.986 . . . . 0.0 110.675 -179.938 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 832' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -122.17 167.94 12.59 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.419 -0.8 . . . . 0.0 109.434 179.989 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 833' ' ' VAL . . . . . 0.455 ' CG2' HG23 ' A' ' 816' ' ' ILE . 38.3 t -124.26 148.23 28.54 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 O-C-N 120.908 -1.12 . . . . 0.0 111.537 -179.915 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 834' ' ' ALA . . . . . 0.469 ' O ' ' HA ' ' A' ' 776' ' ' ALA . . . -150.69 111.65 4.32 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 179.919 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 835' ' ' VAL . . . . . 0.492 HG11 ' N ' ' A' ' 836' ' ' GLU . 41.0 t -126.7 164.67 26.59 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 O-C-N 120.977 -1.077 . . . . 0.0 112.342 -179.773 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 836' ' ' GLU . . . . . 0.492 ' N ' HG11 ' A' ' 835' ' ' VAL . 64.0 tt0 -153.87 137.57 16.09 Favored 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 179.855 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 837' ' ' ALA . . . . . . . . . . . . . . . -124.19 162.83 22.83 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 120.769 -1.207 . . . . 0.0 111.808 -179.814 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 838' ' ' VAL . . . . . . . . . . . . . 60.7 t -115.46 128.54 72.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.702 -0.624 . . . . 0.0 109.509 179.889 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 839' ' ' CYS . . . . . . . . . . . . . 5.2 m -108.25 156.36 19.45 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.998 -1.064 . . . . 0.0 110.908 -179.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 840' ' ' SER . . . . . . . . . . . . . 6.0 p -157.97 136.37 11.05 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.43 -0.794 . . . . 0.0 109.84 179.917 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 841' ' ' THR . . . . . 0.436 ' HA ' ' HG3' ' A' ' 768' ' ' GLN . 65.7 p . . . . . 0 N--CA 1.493 1.693 0 O-C-N 121.32 -0.862 . . . . 0.0 110.41 -179.954 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 728' ' ' VAL . . . . . . . . . . . . . 66.4 t . . . . . 0 N--CA 1.494 1.749 0 CA-C-O 121.175 0.512 . . . . 0.0 110.236 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 729' ' ' SER . . . . . 0.445 ' O ' ' O ' ' A' ' 730' ' ' GLY . 15.1 p -139.7 71.08 1.37 Allowed 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.258 -0.901 . . . . 0.0 110.472 -179.943 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 730' ' ' GLY . . . . . 0.471 ' HA3' ' HA ' ' A' ' 838' ' ' VAL . . . -52.1 -175.77 0.04 OUTLIER Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 179.958 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 731' ' ' VAL . . . . . . . . . . . . . 3.6 t -132.26 135.93 57.26 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.286 -1.126 . . . . 0.0 110.036 179.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 732' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -110.55 126.96 54.97 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.239 -0.913 . . . . 0.0 110.081 179.936 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 733' ' ' ALA . . . . . . . . . . . . . . . -138.92 123.0 17.95 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.211 -0.931 . . . . 0.0 110.717 -179.898 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 734' ' ' ASP . . . . . . . . . . . . . 2.2 p-10 -113.0 108.8 17.85 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.401 -0.812 . . . . 0.0 109.698 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 735' ' ' VAL . . . . . . . . . . . . . 45.7 t -111.12 164.11 7.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.226 -0.921 . . . . 0.0 110.315 -179.937 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 736' ' ' SER . . . . . . . . . . . . . 44.5 p -101.53 -178.48 3.74 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.178 -0.951 . . . . 0.0 110.264 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 737' ' ' GLU . . . . . 0.408 ' HB2' ' CG2' ' A' ' 816' ' ' ILE . 25.6 tt0 . . . . . 0 N--CA 1.494 1.737 0 O-C-N 121.341 -0.849 . . . . 0.0 110.351 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 757' ' ' THR . . . . . . . . . . . . . 71.5 p . . . . . 0 N--CA 1.496 1.868 0 CA-C-O 121.321 0.581 . . . . 0.0 110.543 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 758' ' ' ALA . . . . . . . . . . . . . . . -60.25 170.02 1.43 Allowed 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.257 -0.902 . . . . 0.0 109.525 179.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 759' ' ' LYS . . . . . . . . . . . . . 21.2 mttt -129.25 161.89 29.15 Favored 'General case' 0 C--N 1.299 -1.612 0 O-C-N 121.087 -1.008 . . . . 0.0 110.382 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 760' ' ' VAL . . . . . . . . . . . . . 28.0 t -107.24 131.79 56.38 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.343 -0.848 . . . . 0.0 108.769 179.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 761' ' ' HIS . . . . . . . . . . . . . 27.0 m170 -112.29 104.41 12.58 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.035 -1.04 . . . . 0.0 111.545 -179.872 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 762' ' ' LEU . . . . . . . . . . . . . 19.4 mt -110.32 113.42 26.06 Favored 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 179.864 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 763' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -140.03 116.98 11.04 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.712 -1.242 . . . . 0.0 111.331 -179.858 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 764' ' ' CYS . . . . . 0.463 ' O ' ' O ' ' A' ' 765' ' ' ALA . 1.5 m -95.89 146.03 24.9 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.511 -0.743 . . . . 0.0 109.05 179.938 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 765' ' ' ALA . . . . . 0.467 ' HB3' ' OE1' ' A' ' 768' ' ' GLN . . . -39.61 160.74 0.1 OUTLIER Pre-proline 0 N--CA 1.498 1.933 0 O-C-N 121.215 -0.928 . . . . 0.0 110.413 -179.992 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 766' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -69.99 102.07 1.02 Allowed 'Trans proline' 0 C--N 1.305 -1.757 0 O-C-N 123.941 1.495 . . . . 0.0 110.213 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 767' ' ' GLY . . . . . . . . . . . . . . . 132.3 -17.92 4.75 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 108.966 -1.654 . . . . 0.0 108.966 -179.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 768' ' ' GLN . . . . . 0.467 ' OE1' ' HB3' ' A' ' 765' ' ' ALA . 13.2 mt-30 -102.58 114.77 29.26 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.423 -1.045 . . . . 0.0 109.77 179.895 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 769' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -106.82 149.39 27.44 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.202 -0.936 . . . . 0.0 110.616 -179.954 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 770' ' ' ILE . . . . . . . . . . . . . 49.8 mt -72.92 150.26 8.22 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.314 -0.866 . . . . 0.0 109.545 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 771' ' ' SER . . . . . . . . . . . . . 1.3 p -140.84 3.64 1.85 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 120.995 -1.066 . . . . 0.0 111.008 179.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 772' ' ' ALA . . . . . . . . . . . . . . . -173.65 145.96 1.25 Allowed 'General case' 0 N--CA 1.495 1.783 0 O-C-N 120.902 -1.124 . . . . 0.0 111.551 -179.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 773' ' ' ILE . . . . . . . . . . . . . 38.1 mm -107.01 147.92 11.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 179.907 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 774' ' ' LYS . . . . . . . . . . . . . 9.8 tptp -113.44 -25.0 8.99 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.998 -1.064 . . . . 0.0 110.808 -179.93 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 775' ' ' PHE . . . . . . . . . . . . . 68.5 t80 -170.43 163.98 8.59 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.057 -1.027 . . . . 0.0 110.751 179.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 776' ' ' ALA . . . . . 0.515 ' O ' ' CA ' ' A' ' 798' ' ' SER . . . 175.07 72.31 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.692 -0.63 . . . . 0.0 109.406 -179.945 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 777' ' ' SER . . . . . 0.486 ' HA ' ' HB3' ' A' ' 798' ' ' SER . 1.5 t -92.66 154.23 18.49 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.328 -0.857 . . . . 0.0 110.968 -179.891 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 778' ' ' PHE . . . . . 0.578 ' O ' ' CD2' ' A' ' 778' ' ' PHE . 33.9 t80 -124.95 94.96 4.33 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.467 -0.771 . . . . 0.0 109.899 179.958 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 779' ' ' GLY . . . . . 0.409 ' C ' HG23 ' A' ' 780' ' ' THR . . . 159.18 -97.12 0.16 Allowed Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 179.99 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 780' ' ' THR . . . . . 0.457 HG22 HG11 ' A' ' 829' ' ' VAL . 52.1 p -132.8 92.58 26.12 Favored Pre-proline 0 N--CA 1.493 1.716 0 O-C-N 121.271 -1.134 . . . . 0.0 110.285 -179.94 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 781' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -75.26 173.19 14.93 Favored 'Trans proline' 0 C--N 1.305 -1.744 0 O-C-N 124.098 1.578 . . . . 0.0 110.523 179.916 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 782' ' ' LEU . . . . . 0.418 ' C ' HD21 ' A' ' 782' ' ' LEU . 2.2 tt -137.65 118.32 14.02 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.307 -0.871 . . . . 0.0 110.167 179.935 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 783' ' ' GLY . . . . . 0.428 ' HA3' HG23 ' A' ' 787' ' ' THR . . . 95.28 -176.84 34.52 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.331 -1.507 . . . . 0.0 109.331 179.98 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 784' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -117.91 -160.81 0.8 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.208 -1.172 . . . . 0.0 110.188 -179.979 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 785' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -60.56 119.16 7.54 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.306 -0.871 . . . . 0.0 110.252 -179.932 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 786' ' ' GLY . . . . . . . . . . . . . . . 114.85 -28.93 7.77 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 787' ' ' THR . . . . . 0.428 HG23 ' HA3' ' A' ' 783' ' ' GLY . 8.9 t -134.78 34.4 3.16 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.237 -1.155 . . . . 0.0 110.309 179.967 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 788' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -65.85 132.12 47.91 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.278 -0.889 . . . . 0.0 109.943 179.989 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 789' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -139.9 154.02 47.14 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.229 -0.919 . . . . 0.0 110.33 179.925 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 790' ' ' GLN . . . . . 0.419 ' OE1' ' ND1' ' A' ' 794' ' ' HIS . 1.6 mp0 -65.84 116.3 6.86 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.351 -0.843 . . . . 0.0 110.482 -179.987 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 791' ' ' GLY . . . . . . . . . . . . . . . -64.68 -105.86 0.01 OUTLIER Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.623 -1.391 . . . . 0.0 109.623 -179.945 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 792' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -127.18 -26.12 3.15 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.302 -1.117 . . . . 0.0 110.509 -179.956 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 793' ' ' CYS . . . . . 0.469 ' O ' ' HB3' ' A' ' 794' ' ' HIS . 85.7 m -100.2 -83.91 0.43 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.206 -0.933 . . . . 0.0 109.89 -179.997 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 794' ' ' HIS . . . . . 0.637 ' CE1' ' OG ' ' A' ' 798' ' ' SER . 84.9 t60 58.4 113.77 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.506 -0.746 . . . . 0.0 110.728 179.981 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 795' ' ' SER . . . . . 0.468 ' O ' ' O ' ' A' ' 794' ' ' HIS . 100.0 p -60.66 -126.6 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.301 -0.874 . . . . 0.0 109.295 179.871 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 796' ' ' ILE . . . . . 0.424 ' CG1' ' C ' ' A' ' 795' ' ' SER . 1.0 OUTLIER -148.02 -31.06 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 2.02 0 O-C-N 120.798 -1.189 . . . . 0.0 110.68 179.856 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 797' ' ' ASN . . . . . 0.441 ' O ' ' C ' ' A' ' 798' ' ' SER . 4.3 m120 -86.26 16.28 4.54 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 120.906 -1.121 . . . . 0.0 110.04 179.914 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 798' ' ' SER . . . . . 0.637 ' OG ' ' CE1' ' A' ' 794' ' ' HIS . 0.9 OUTLIER -33.56 -70.76 0.07 Allowed 'General case' 0 N--CA 1.503 2.178 0 O-C-N 121.775 -0.578 . . . . 0.0 111.8 -179.999 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 799' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -84.99 -30.02 24.55 Favored 'General case' 0 N--CA 1.501 2.086 0 O-C-N 121.155 -0.966 . . . . 0.0 111.094 -179.876 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 800' ' ' SER . . . . . . . . . . . . . 37.2 t -54.47 -16.91 2.61 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.059 -1.026 . . . . 0.0 110.743 -179.955 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 801' ' ' VAL . . . . . . . . . . . . . 85.3 t -90.97 -48.69 13.9 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.919 0 O-C-N 121.046 -1.034 . . . . 0.0 111.588 -179.851 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 802' ' ' LEU . . . . . 0.499 ' O ' ' HB2' ' A' ' 806' ' ' CYS . 4.6 mm? -75.08 -16.33 60.57 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.112 -0.993 . . . . 0.0 111.522 -179.801 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 803' ' ' GLU . . . . . 0.409 ' HA ' HD12 ' A' ' 807' ' ' ILE . 0.5 OUTLIER -81.94 -27.53 33.24 Favored 'General case' 0 C--N 1.295 -1.77 0 O-C-N 120.73 -1.232 . . . . 0.0 110.778 -179.947 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 804' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -95.4 -18.39 20.77 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.109 -0.994 . . . . 0.0 112.28 -179.918 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 805' ' ' LYS . . . . . 0.458 ' O ' ' SG ' ' A' ' 806' ' ' CYS . 4.0 ttpt -122.17 20.25 10.63 Favored 'General case' 0 N--CA 1.501 2.078 0 O-C-N 120.452 -1.405 . . . . 0.0 112.477 -179.868 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 806' ' ' CYS . . . . . 0.499 ' HB2' ' O ' ' A' ' 802' ' ' LEU . 50.0 m -152.66 51.17 0.76 Allowed 'General case' 0 N--CA 1.496 1.832 0 O-C-N 120.665 -1.272 . . . . 0.0 110.406 179.905 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 807' ' ' ILE . . . . . 0.435 ' O ' HG21 ' A' ' 807' ' ' ILE . 9.1 mt -140.42 95.04 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.484 0 O-C-N 121.524 -0.735 . . . . 0.0 109.324 179.956 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 808' ' ' GLY . . . . . . . . . . . . . . . 118.95 10.07 8.51 Favored Glycine 0 N--CA 1.489 2.199 0 N-CA-C 109.264 -1.534 . . . . 0.0 109.264 -179.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 809' ' ' LEU . . . . . . . . . . . . . 9.1 mt -117.61 157.05 27.08 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.255 -1.144 . . . . 0.0 110.191 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 810' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -86.28 -18.61 31.59 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.202 -0.936 . . . . 0.0 110.088 179.987 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 811' ' ' ARG . . . . . . . . . . . . . 26.2 ttp180 -149.79 136.09 19.0 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.323 -0.861 . . . . 0.0 110.087 179.942 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 812' ' ' CYS . . . . . 0.45 ' SG ' ' O ' ' A' ' 805' ' ' LYS . 0.1 OUTLIER -123.98 144.21 49.95 Favored 'General case' 0 C--N 1.298 -1.655 0 O-C-N 121.303 -0.873 . . . . 0.0 110.256 -179.906 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 813' ' ' VAL . . . . . 0.504 ' O ' ' CG1' ' A' ' 813' ' ' VAL . 7.0 p -137.87 123.15 24.44 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.509 0 O-C-N 121.309 -0.87 . . . . 0.0 109.622 179.888 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 814' ' ' VAL . . . . . . . . . . . . . 36.5 t -131.38 135.81 58.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.135 -0.978 . . . . 0.0 110.393 -179.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 815' ' ' ALA . . . . . 0.467 ' O ' ' OD1' ' A' ' 820' ' ' ASN . . . -82.8 146.32 29.02 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.341 -0.849 . . . . 0.0 110.024 179.972 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 816' ' ' ILE . . . . . 0.444 HG22 HG23 ' A' ' 833' ' ' VAL . 18.0 mt -95.58 111.83 26.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.213 -0.93 . . . . 0.0 110.194 -179.995 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 817' ' ' SER . . . . . 0.516 ' CB ' ' HD2' ' A' ' 818' ' ' PRO . 1.0 OUTLIER -161.73 -175.83 0.53 Allowed Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.226 -0.922 . . . . 0.0 110.219 179.937 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 818' ' ' PRO . . . . . 0.516 ' HD2' ' CB ' ' A' ' 817' ' ' SER . 50.2 Cg_endo -78.32 -37.02 0.82 Allowed 'Trans proline' 0 C--N 1.305 -1.711 0 O-C-N 124.02 1.537 . . . . 0.0 110.893 -179.853 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 819' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -83.49 22.93 0.99 Allowed 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.113 -0.992 . . . . 0.0 110.826 -179.991 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 820' ' ' ASN . . . . . 0.467 ' OD1' ' O ' ' A' ' 815' ' ' ALA . 0.7 OUTLIER -117.0 -15.01 10.61 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.11 -0.994 . . . . 0.0 110.169 179.939 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 821' ' ' PHE . . . . . . . . . . . . . 39.4 m-85 -128.01 -74.19 0.58 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.154 -0.966 . . . . 0.0 110.621 179.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 822' ' ' GLY . . . . . . . . . . . . . . . -163.17 50.84 0.31 Allowed Glycine 0 N--CA 1.493 2.477 0 N-CA-C 109.778 -1.329 . . . . 0.0 109.778 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 823' ' ' GLY . . . . . . . . . . . . . . . 72.76 -126.82 11.02 Favored Glycine 0 N--CA 1.492 2.393 0 N-CA-C 109.661 -1.376 . . . . 0.0 109.661 179.944 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 824' ' ' ASP . . . . . 0.41 ' O ' ' OD2' ' A' ' 824' ' ' ASP . 1.5 p30 -127.17 134.97 26.72 Favored Pre-proline 0 N--CA 1.494 1.742 0 O-C-N 121.241 -1.152 . . . . 0.0 110.32 179.986 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 825' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -78.95 -90.76 0.0 OUTLIER 'Trans proline' 0 C--N 1.307 -1.64 0 O-C-N 124.053 1.554 . . . . 0.0 110.616 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 826' ' ' CYS . . . . . . . . . . . . . 24.3 p -115.39 138.26 23.58 Favored Pre-proline 0 N--CA 1.496 1.851 0 O-C-N 121.21 -0.931 . . . . 0.0 111.067 -179.897 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 827' ' ' PRO . . . . . 0.475 ' O ' ' HB2' ' A' ' 828' ' ' GLU . 54.9 Cg_endo -85.16 -178.91 3.32 Favored 'Trans proline' 0 C--N 1.306 -1.687 0 O-C-N 124.121 1.59 . . . . 0.0 110.057 179.915 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 828' ' ' GLU . . . . . 0.475 ' HB2' ' O ' ' A' ' 827' ' ' PRO . 50.6 mt-10 57.88 17.38 4.24 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.566 -0.709 . . . . 0.0 111.042 179.937 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 829' ' ' VAL . . . . . 0.463 ' O ' ' O ' ' A' ' 830' ' ' MET . 72.4 t -130.4 141.42 46.33 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 O-C-N 121.079 -1.013 . . . . 0.0 110.023 179.844 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 830' ' ' MET . . . . . 0.463 ' O ' ' O ' ' A' ' 829' ' ' VAL . 0.0 OUTLIER -51.21 -175.75 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.195 -0.94 . . . . 0.0 110.126 -179.975 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 831' ' ' LYS . . . . . . . . . . . . . 9.7 mttp -142.29 108.23 5.17 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.025 -1.047 . . . . 0.0 110.896 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 832' ' ' ARG . . . . . . . . . . . . . 5.9 mtp180 -129.88 147.42 51.65 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.444 -0.785 . . . . 0.0 109.483 179.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 833' ' ' VAL . . . . . 0.444 HG23 HG22 ' A' ' 816' ' ' ILE . 92.6 t -120.15 117.57 53.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.024 -1.047 . . . . 0.0 110.731 -179.942 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 834' ' ' ALA . . . . . . . . . . . . . . . -112.99 127.92 56.36 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.284 -0.885 . . . . 0.0 109.847 179.917 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 835' ' ' VAL . . . . . 0.467 ' CG1' ' N ' ' A' ' 836' ' ' GLU . 14.9 t -126.11 165.69 23.61 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 121.11 -0.994 . . . . 0.0 110.577 -179.916 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 836' ' ' GLU . . . . . 0.467 ' N ' ' CG1' ' A' ' 835' ' ' VAL . 0.1 OUTLIER -152.88 109.69 3.46 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.377 -0.827 . . . . 0.0 109.657 -179.939 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 837' ' ' ALA . . . . . . . . . . . . . . . -111.18 162.01 15.38 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.171 -0.956 . . . . 0.0 110.532 -179.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 838' ' ' VAL . . . . . 0.471 ' HA ' ' HA3' ' A' ' 730' ' ' GLY . 39.1 t -120.02 132.87 68.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.321 -0.862 . . . . 0.0 110.07 -179.96 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 839' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -118.18 136.89 53.35 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.222 -0.924 . . . . 0.0 110.149 -179.976 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 840' ' ' SER . . . . . 0.431 ' O ' ' HG2' ' A' ' 768' ' ' GLN . 91.4 p -106.23 -145.01 0.38 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.161 -0.962 . . . . 0.0 110.031 179.975 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 841' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.494 1.727 0 O-C-N 121.062 -1.024 . . . . 0.0 110.299 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 728' ' ' VAL . . . . . 0.512 ' O ' ' CB ' ' A' ' 729' ' ' SER . 74.6 t . . . . . 0 N--CA 1.492 1.627 0 CA-C-O 121.026 0.441 . . . . 0.0 110.075 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 729' ' ' SER . . . . . 0.512 ' CB ' ' O ' ' A' ' 728' ' ' VAL . 0.3 OUTLIER 166.65 126.52 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.104 0 O-C-N 121.326 -0.859 . . . . 0.0 110.304 -179.987 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 730' ' ' GLY . . . . . 0.437 ' C ' ' CG2' ' A' ' 731' ' ' VAL . . . 142.78 76.57 0.04 OUTLIER Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.741 -1.344 . . . . 0.0 109.741 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 731' ' ' VAL . . . . . 0.437 ' CG2' ' C ' ' A' ' 730' ' ' GLY . 3.1 t -147.6 135.58 14.74 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 121.178 -1.189 . . . . 0.0 110.14 179.994 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 732' ' ' CYS . . . . . . . . . . . . . 30.4 p -153.3 138.27 17.22 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.235 -0.915 . . . . 0.0 110.094 -179.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 733' ' ' ALA . . . . . 0.437 ' HB3' HD12 ' A' ' 762' ' ' LEU . . . -111.92 131.21 55.52 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.266 -0.896 . . . . 0.0 110.397 179.992 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 734' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -119.7 105.37 11.1 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.296 -0.878 . . . . 0.0 110.037 179.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 735' ' ' VAL . . . . . 0.487 HG13 ' N ' ' A' ' 736' ' ' SER . 61.1 t -128.42 162.83 34.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.151 -0.968 . . . . 0.0 110.298 -179.942 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 736' ' ' SER . . . . . 0.487 ' N ' HG13 ' A' ' 735' ' ' VAL . 6.6 p -109.17 -165.75 1.05 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.206 -0.934 . . . . 0.0 110.007 -179.962 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 737' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.495 1.813 0 O-C-N 121.266 -0.896 . . . . 0.0 110.731 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 757' ' ' THR . . . . . . . . . . . . . 37.2 p . . . . . 0 N--CA 1.505 2.306 0 CA-C-O 121.872 0.844 . . . . 0.0 112.285 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 758' ' ' ALA . . . . . . . . . . . . . . . -109.75 179.04 4.24 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.753 -0.592 . . . . 0.0 109.703 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 759' ' ' LYS . . . . . . . . . . . . . 18.0 mtpt -141.77 150.72 42.11 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.062 -1.024 . . . . 0.0 110.946 179.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 760' ' ' VAL . . . . . . . . . . . . . 5.4 t -108.06 131.42 58.5 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 179.884 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 761' ' ' HIS . . . . . . . . . . . . . 3.7 m170 -117.35 103.77 10.47 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.998 -1.064 . . . . 0.0 111.575 -179.878 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 762' ' ' LEU . . . . . 0.496 ' HB2' ' HB3' ' A' ' 812' ' ' CYS . 0.2 OUTLIER -109.43 103.11 11.96 Favored 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 179.818 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 763' ' ' LYS . . . . . . . . . . . . . 9.5 ttmt -109.95 165.53 11.65 Favored 'General case' 0 N--CA 1.5 2.073 0 O-C-N 121.096 -1.002 . . . . 0.0 111.766 -179.729 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 764' ' ' CYS . . . . . . . . . . . . . 7.9 m -132.18 175.58 9.13 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.705 -0.622 . . . . 0.0 109.837 179.893 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 765' ' ' ALA . . . . . . . . . . . . . . . -71.25 171.66 8.26 Favored Pre-proline 0 N--CA 1.495 1.789 0 O-C-N 121.181 -0.95 . . . . 0.0 109.946 179.937 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 766' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -72.47 129.03 14.22 Favored 'Trans proline' 0 C--N 1.306 -1.66 0 O-C-N 123.849 1.447 . . . . 0.0 110.159 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 767' ' ' GLY . . . . . . . . . . . . . . . 89.53 11.38 64.25 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.349 -1.5 . . . . 0.0 109.349 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 768' ' ' GLN . . . . . . . . . . . . . 2.7 mt-30 -129.1 135.07 48.4 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.304 -1.115 . . . . 0.0 110.216 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 769' ' ' THR . . . . . 0.533 ' CG2' ' HG3' ' A' ' 810' ' ' GLU . 7.7 p -133.31 147.56 51.88 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.204 -0.935 . . . . 0.0 110.32 179.958 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 770' ' ' ILE . . . . . 0.453 HG21 ' HB3' ' A' ' 837' ' ' ALA . 4.3 mt -64.35 149.46 11.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.253 -0.904 . . . . 0.0 109.454 179.997 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 771' ' ' SER . . . . . 0.413 ' N ' HG22 ' A' ' 770' ' ' ILE . 24.4 p -134.34 1.05 3.14 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 120.955 -1.09 . . . . 0.0 110.717 -179.88 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 772' ' ' ALA . . . . . . . . . . . . . . . -177.49 132.1 0.16 Allowed 'General case' 0 N--CA 1.495 1.779 0 O-C-N 120.998 -1.064 . . . . 0.0 111.111 -179.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 773' ' ' ILE . . . . . . . . . . . . . 32.5 mm -87.65 124.24 40.8 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 O-C-N 121.327 -0.858 . . . . 0.0 109.673 179.919 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 774' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.32 -40.19 18.24 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.186 -0.946 . . . . 0.0 110.725 -179.978 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 775' ' ' PHE . . . . . 0.504 ' O ' ' CB ' ' A' ' 776' ' ' ALA . 75.5 t80 -145.58 162.97 36.22 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.031 -1.043 . . . . 0.0 110.942 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 776' ' ' ALA . . . . . 0.504 ' CB ' ' O ' ' A' ' 775' ' ' PHE . . . 167.13 117.79 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.425 -0.797 . . . . 0.0 109.715 179.98 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 777' ' ' SER . . . . . 0.45 ' HA ' ' OG ' ' A' ' 798' ' ' SER . 17.2 m -151.29 136.33 17.43 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.992 -1.068 . . . . 0.0 110.775 -179.953 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 778' ' ' PHE . . . . . . . . . . . . . 46.7 t80 -103.61 107.17 17.91 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.387 -0.821 . . . . 0.0 110.101 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 779' ' ' GLY . . . . . . . . . . . . . . . 162.82 -101.45 0.19 Allowed Glycine 0 N--CA 1.492 2.43 0 N-CA-C 109.514 -1.434 . . . . 0.0 109.514 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 780' ' ' THR . . . . . . . . . . . . . 53.8 p -134.52 101.54 11.97 Favored Pre-proline 0 N--CA 1.495 1.79 0 O-C-N 121.243 -1.151 . . . . 0.0 110.201 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 781' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -77.8 148.07 25.07 Favored 'Trans proline' 0 C--N 1.306 -1.69 0 O-C-N 123.935 1.492 . . . . 0.0 110.593 -179.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 782' ' ' LEU . . . . . 0.409 HD22 ' HA ' ' A' ' 782' ' ' LEU . 7.3 mt -108.02 79.42 1.27 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.308 -0.87 . . . . 0.0 109.75 179.973 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 783' ' ' GLY . . . . . . . . . . . . . . . 123.38 -174.52 16.58 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 108.911 -1.675 . . . . 0.0 108.911 -179.929 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 784' ' ' THR . . . . . . . . . . . . . 37.9 p -122.61 -161.35 0.94 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.1 -1.235 . . . . 0.0 110.287 179.933 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 785' ' ' CYS . . . . . 0.559 ' HA ' ' CE1' ' A' ' 788' ' ' PHE . 6.8 t -57.32 92.94 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.186 -0.946 . . . . 0.0 110.263 179.955 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 786' ' ' GLY . . . . . . . . . . . . . . . 151.48 -28.22 0.96 Allowed Glycine 0 N--CA 1.492 2.388 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 -179.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 787' ' ' THR . . . . . 0.497 ' CG2' ' O ' ' A' ' 787' ' ' THR . 51.5 m -143.61 30.29 1.36 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.297 -1.12 . . . . 0.0 110.141 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 788' ' ' PHE . . . . . 0.559 ' CE1' ' HA ' ' A' ' 785' ' ' CYS . 6.2 m-85 -51.16 155.03 1.41 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.238 -0.914 . . . . 0.0 110.285 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 789' ' ' GLN . . . . . 0.462 ' HB2' ' O ' ' A' ' 788' ' ' PHE . 1.1 tp60 -177.82 124.84 0.12 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.392 -0.817 . . . . 0.0 110.234 179.977 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 790' ' ' GLN . . . . . 0.438 ' C ' ' O ' ' A' ' 789' ' ' GLN . 1.4 mt-30 -40.16 123.54 1.71 Allowed 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.451 -0.78 . . . . 0.0 110.383 -179.969 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 791' ' ' GLY . . . . . . . . . . . . . . . -74.95 -132.03 0.27 Allowed Glycine 0 N--CA 1.491 2.362 0 N-CA-C 109.332 -1.507 . . . . 0.0 109.332 179.905 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 792' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -106.92 3.47 26.23 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.165 -1.197 . . . . 0.0 110.197 179.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 793' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -141.08 118.91 11.76 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.326 -0.859 . . . . 0.0 110.008 -179.991 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 794' ' ' HIS . . . . . 0.457 ' CE1' ' OG ' ' A' ' 798' ' ' SER . 81.8 t60 -138.07 148.13 44.74 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.294 -0.879 . . . . 0.0 110.148 -179.987 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 795' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -76.8 -136.53 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.296 -0.878 . . . . 0.0 109.66 179.996 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 796' ' ' ILE . . . . . . . . . . . . . 3.8 pt -146.1 12.04 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 O-C-N 121.09 -1.006 . . . . 0.0 110.044 179.905 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 797' ' ' ASN . . . . . . . . . . . . . 7.5 p30 -150.6 30.0 0.67 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.383 -0.823 . . . . 0.0 109.722 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 798' ' ' SER . . . . . 0.481 ' HB3' ' O ' ' A' ' 776' ' ' ALA . 0.7 OUTLIER -57.61 -27.43 62.75 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.522 -0.736 . . . . 0.0 111.102 -179.943 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 799' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -100.83 -22.27 14.89 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 120.924 -1.11 . . . . 0.0 110.501 -179.898 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 800' ' ' SER . . . . . . . . . . . . . 47.4 t -69.45 -18.69 63.75 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.121 -0.987 . . . . 0.0 110.324 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 801' ' ' VAL . . . . . . . . . . . . . 94.2 t -84.45 -46.56 17.75 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 121.23 -0.919 . . . . 0.0 110.863 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 802' ' ' LEU . . . . . 0.417 ' N ' ' CD2' ' A' ' 802' ' ' LEU . 4.1 mm? -72.6 -42.98 63.94 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.18 -0.95 . . . . 0.0 111.019 -179.946 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 803' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -51.61 -31.12 23.78 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.046 -1.034 . . . . 0.0 110.648 -179.955 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 804' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -92.34 -21.38 20.29 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.105 -0.997 . . . . 0.0 111.279 -179.949 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 805' ' ' LYS . . . . . 0.471 ' O ' ' SG ' ' A' ' 812' ' ' CYS . 0.9 OUTLIER -111.92 28.75 8.47 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 120.912 -1.118 . . . . 0.0 111.216 -179.864 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 806' ' ' CYS . . . . . 0.418 ' O ' ' C ' ' A' ' 807' ' ' ILE . 0.1 OUTLIER -152.92 -74.46 0.13 Allowed 'General case' 0 N--CA 1.497 1.895 0 O-C-N 120.914 -1.116 . . . . 0.0 111.055 179.984 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 807' ' ' ILE . . . . . 0.418 ' C ' ' O ' ' A' ' 806' ' ' CYS . 29.3 mt -41.65 121.36 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.192 -0.943 . . . . 0.0 110.901 -179.883 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 808' ' ' GLY . . . . . 0.471 ' O ' HD23 ' A' ' 809' ' ' LEU . . . 99.0 13.45 39.71 Favored Glycine 0 N--CA 1.492 2.432 0 N-CA-C 110.369 -1.092 . . . . 0.0 110.369 179.94 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 809' ' ' LEU . . . . . 0.471 HD23 ' O ' ' A' ' 808' ' ' GLY . 91.9 mt -143.3 132.82 23.57 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 120.992 -1.299 . . . . 0.0 110.496 179.982 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 810' ' ' GLU . . . . . 0.533 ' HG3' ' CG2' ' A' ' 769' ' ' THR . 1.0 OUTLIER -63.46 -30.61 71.71 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.271 -0.893 . . . . 0.0 109.383 -179.969 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 811' ' ' ARG . . . . . 0.513 ' HB3' ' NH2' ' A' ' 811' ' ' ARG . 0.5 OUTLIER -117.85 156.6 28.11 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.618 -0.676 . . . . 0.0 109.886 179.958 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 812' ' ' CYS . . . . . 0.496 ' HB3' ' HB2' ' A' ' 762' ' ' LEU . 3.4 t -131.37 137.25 48.64 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.238 -0.914 . . . . 0.0 110.646 -179.925 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 813' ' ' VAL . . . . . 0.506 ' O ' ' CG1' ' A' ' 813' ' ' VAL . 8.6 p -139.17 119.28 14.38 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.326 -0.859 . . . . 0.0 109.687 179.932 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 814' ' ' VAL . . . . . . . . . . . . . 38.6 t -128.52 165.58 27.77 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.233 -0.917 . . . . 0.0 110.537 -179.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 815' ' ' ALA . . . . . . . . . . . . . . . -122.76 147.16 46.83 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.356 -0.84 . . . . 0.0 109.504 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 816' ' ' ILE . . . . . 0.462 HG22 HG23 ' A' ' 833' ' ' VAL . 88.2 mt -105.2 116.2 48.54 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 O-C-N 121.067 -1.02 . . . . 0.0 110.558 -179.972 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 817' ' ' SER . . . . . 0.432 ' HB2' ' HD2' ' A' ' 818' ' ' PRO . 1.4 p -164.13 169.4 8.16 Favored Pre-proline 0 N--CA 1.492 1.66 0 O-C-N 121.334 -0.854 . . . . 0.0 110.123 179.95 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 818' ' ' PRO . . . . . 0.432 ' HD2' ' HB2' ' A' ' 817' ' ' SER . 43.4 Cg_endo -69.12 -16.54 40.34 Favored 'Trans proline' 0 C--N 1.304 -1.802 0 O-C-N 123.976 1.514 . . . . 0.0 110.504 179.993 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 819' ' ' SER . . . . . . . . . . . . . 14.5 p -106.54 31.7 5.04 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.151 -0.968 . . . . 0.0 110.345 -179.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 820' ' ' ASN . . . . . . . . . . . . . 7.8 t-20 -113.53 -28.13 7.63 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.26 -0.9 . . . . 0.0 110.283 -179.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 821' ' ' PHE . . . . . . . . . . . . . 94.6 m-85 -116.19 -77.82 0.57 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.25 -0.906 . . . . 0.0 110.471 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 822' ' ' GLY . . . . . . . . . . . . . . . -152.72 42.69 0.67 Allowed Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.643 -1.383 . . . . 0.0 109.643 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 823' ' ' GLY . . . . . 0.429 ' HA2' ' O ' ' A' ' 818' ' ' PRO . . . 85.95 -117.81 4.68 Favored Glycine 0 N--CA 1.492 2.408 0 N-CA-C 109.464 -1.455 . . . . 0.0 109.464 179.993 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 824' ' ' ASP . . . . . . . . . . . . . 6.6 t0 -137.92 105.88 8.14 Favored Pre-proline 0 N--CA 1.493 1.721 0 O-C-N 121.199 -1.177 . . . . 0.0 110.282 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 825' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -74.83 -60.72 0.04 OUTLIER 'Trans proline' 0 C--N 1.307 -1.623 0 O-C-N 124.086 1.571 . . . . 0.0 110.687 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 826' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -109.83 100.44 42.89 Favored Pre-proline 0 N--CA 1.499 2.007 0 O-C-N 121.109 -0.994 . . . . 0.0 110.65 -179.949 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 827' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -83.33 166.89 13.98 Favored 'Trans proline' 0 C--N 1.305 -1.718 0 O-C-N 124.039 1.547 . . . . 0.0 110.459 179.925 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 828' ' ' GLU . . . . . 0.456 ' O ' HG22 ' A' ' 829' ' ' VAL . 10.2 mm-40 48.53 42.4 18.78 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.227 -0.921 . . . . 0.0 110.355 179.975 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 829' ' ' VAL . . . . . 0.456 HG22 ' O ' ' A' ' 828' ' ' GLU . 44.2 t -139.83 145.46 26.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.222 -0.924 . . . . 0.0 110.205 -179.996 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 830' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -51.15 99.49 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.175 -0.953 . . . . 0.0 110.215 179.962 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 831' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -71.69 132.69 44.91 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.223 -0.923 . . . . 0.0 110.711 -179.941 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 832' ' ' ARG . . . . . . . . . . . . . 2.5 ttt180 -150.64 149.7 30.19 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.536 -0.727 . . . . 0.0 109.397 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 833' ' ' VAL . . . . . 0.462 HG23 HG22 ' A' ' 816' ' ' ILE . 71.9 t -118.68 140.95 40.58 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 120.994 -1.067 . . . . 0.0 111.113 -179.899 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 834' ' ' ALA . . . . . 0.464 ' O ' ' CG2' ' A' ' 835' ' ' VAL . . . -143.61 136.88 27.9 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.551 -0.718 . . . . 0.0 109.384 179.911 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 835' ' ' VAL . . . . . 0.464 ' CG2' ' O ' ' A' ' 834' ' ' ALA . 23.6 t -156.36 145.53 11.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 120.937 -1.102 . . . . 0.0 111.484 -179.9 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 836' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -135.18 128.11 31.41 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 179.864 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 837' ' ' ALA . . . . . 0.453 ' HB3' HG21 ' A' ' 770' ' ' ILE . . . -116.6 161.76 18.66 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.96 -1.087 . . . . 0.0 111.32 -179.892 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 838' ' ' VAL . . . . . . . . . . . . . 66.2 t -109.78 114.57 47.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.663 -0.648 . . . . 0.0 109.539 179.942 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 839' ' ' CYS . . . . . 0.478 ' O ' ' O ' ' A' ' 728' ' ' VAL . 0.1 OUTLIER -108.96 144.22 37.2 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.019 -1.051 . . . . 0.0 110.88 -179.968 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 840' ' ' SER . . . . . . . . . . . . . 79.8 p -171.52 178.67 3.1 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.42 -0.8 . . . . 0.0 110.037 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 841' ' ' THR . . . . . . . . . . . . . 11.1 p . . . . . 0 N--CA 1.495 1.78 0 O-C-N 121.159 -0.963 . . . . 0.0 110.178 -179.975 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 728' ' ' VAL . . . . . . . . . . . . . 35.8 m . . . . . 0 N--CA 1.492 1.645 0 CA-C-O 121.216 0.532 . . . . 0.0 110.057 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 729' ' ' SER . . . . . . . . . . . . . 24.4 m -128.48 -154.17 0.62 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.26 -0.9 . . . . 0.0 110.269 -179.949 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 730' ' ' GLY . . . . . . . . . . . . . . . -148.27 111.01 0.52 Allowed Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 179.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 731' ' ' VAL . . . . . 0.418 HG11 ' N ' ' A' ' 732' ' ' CYS . 41.3 t -114.22 151.96 15.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.196 -1.179 . . . . 0.0 110.457 179.991 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 732' ' ' CYS . . . . . 0.418 ' N ' HG11 ' A' ' 731' ' ' VAL . 14.1 p -159.91 143.91 14.49 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.431 -0.793 . . . . 0.0 109.536 -179.968 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 733' ' ' ALA . . . . . . . . . . . . . . . -121.52 136.37 54.96 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.121 -0.987 . . . . 0.0 110.434 -179.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 734' ' ' ASP . . . . . 0.424 ' CG ' ' O ' ' A' ' 734' ' ' ASP . 5.2 p-10 -123.73 106.15 10.28 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.273 -0.892 . . . . 0.0 109.94 179.953 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 735' ' ' VAL . . . . . . . . . . . . . 5.7 t -132.12 128.86 59.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.181 -0.949 . . . . 0.0 110.277 -179.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 736' ' ' SER . . . . . . . . . . . . . 4.8 p -69.65 158.98 34.29 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.308 -0.87 . . . . 0.0 110.128 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 737' ' ' GLU . . . . . . . . . . . . . 7.7 tm-20 . . . . . 0 N--CA 1.493 1.705 0 O-C-N 121.269 -0.894 . . . . 0.0 110.187 -179.984 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 757' ' ' THR . . . . . . . . . . . . . 1.2 p . . . . . 0 N--CA 1.494 1.761 0 CA-C-O 121.279 0.562 . . . . 0.0 110.219 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 758' ' ' ALA . . . . . . . . . . . . . . . -119.97 171.71 8.25 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.327 -0.858 . . . . 0.0 109.856 179.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 759' ' ' LYS . . . . . 0.452 ' HG2' ' HA ' ' A' ' 815' ' ' ALA . 18.2 mttm -142.87 161.07 39.07 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.195 -0.941 . . . . 0.0 110.571 179.989 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 760' ' ' VAL . . . . . 0.47 HG22 HD13 ' A' ' 816' ' ' ILE . 11.5 t -112.52 155.57 13.74 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.408 -0.808 . . . . 0.0 109.388 179.93 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 761' ' ' HIS . . . . . 0.447 ' N ' HG11 ' A' ' 760' ' ' VAL . 0.9 OUTLIER -133.34 119.74 20.11 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.957 -1.089 . . . . 0.0 111.024 179.995 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 762' ' ' LEU . . . . . . . . . . . . . 8.1 mt -114.54 134.78 54.77 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.484 -0.76 . . . . 0.0 109.561 179.935 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 763' ' ' LYS . . . . . . . . . . . . . 6.7 tttm -142.35 125.43 16.3 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.023 -1.048 . . . . 0.0 110.588 179.915 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 764' ' ' CYS . . . . . 0.471 ' O ' ' OE2' ' A' ' 810' ' ' GLU . 0.1 OUTLIER -104.41 -173.25 2.26 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.467 -0.77 . . . . 0.0 109.765 179.949 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 765' ' ' ALA . . . . . . . . . . . . . . . -66.05 148.93 98.16 Favored Pre-proline 0 C--N 1.296 -1.754 0 O-C-N 121.27 -0.894 . . . . 0.0 110.298 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 766' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -72.34 96.39 0.81 Allowed 'Trans proline' 0 C--N 1.307 -1.622 0 O-C-N 123.991 1.521 . . . . 0.0 110.293 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 767' ' ' GLY . . . . . . . . . . . . . . . 141.65 -21.55 2.53 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 108.907 -1.677 . . . . 0.0 108.907 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 768' ' ' GLN . . . . . . . . . . . . . 23.5 mt-30 -110.86 145.84 37.54 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.472 -1.016 . . . . 0.0 109.688 179.905 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 769' ' ' THR . . . . . . . . . . . . . 82.3 p -121.95 146.61 46.97 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.234 -0.916 . . . . 0.0 110.669 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 770' ' ' ILE . . . . . 0.468 HD12 ' O ' ' A' ' 806' ' ' CYS . 21.3 mt -49.62 142.82 2.13 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 121.395 -0.816 . . . . 0.0 109.669 179.898 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 771' ' ' SER . . . . . 0.4 ' O ' ' CB ' ' A' ' 772' ' ' ALA . 22.0 p -124.56 -5.45 7.62 Favored 'General case' 0 C--N 1.299 -1.597 0 O-C-N 121.092 -1.005 . . . . 0.0 110.724 -179.903 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 772' ' ' ALA . . . . . 0.4 ' CB ' ' O ' ' A' ' 771' ' ' SER . . . 174.62 146.62 0.07 Allowed 'General case' 0 N--CA 1.492 1.653 0 C-N-CA 118.879 -1.128 . . . . 0.0 111.949 -179.986 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 773' ' ' ILE . . . . . . . . . . . . . 11.7 mm -108.16 149.0 11.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 179.819 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 774' ' ' LYS . . . . . . . . . . . . . 66.8 mttt -132.35 -18.45 2.54 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.509 -1.369 . . . . 0.0 112.206 -179.801 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 775' ' ' PHE . . . . . 0.565 ' CE2' ' HB3' ' A' ' 788' ' ' PHE . 43.2 t80 -140.09 168.69 19.23 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.58 -1.325 . . . . 0.0 110.999 -179.904 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 776' ' ' ALA . . . . . 0.536 ' CB ' ' HB3' ' A' ' 798' ' ' SER . . . 164.15 125.87 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.818 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 -179.991 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 777' ' ' SER . . . . . 0.586 ' HA ' ' CE1' ' A' ' 794' ' ' HIS . 0.5 OUTLIER -148.94 106.21 3.62 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.956 -1.09 . . . . 0.0 111.522 -179.906 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 778' ' ' PHE . . . . . 0.411 ' CE2' ' SD ' ' A' ' 830' ' ' MET . 89.6 t80 -85.76 123.94 31.71 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.125 -0.984 . . . . 0.0 109.539 179.908 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 779' ' ' GLY . . . . . 0.508 ' O ' ' HB2' ' A' ' 832' ' ' ARG . . . 138.15 -107.07 0.55 Allowed Glycine 0 N--CA 1.493 2.473 0 C-N-CA 119.496 -1.335 . . . . 0.0 109.99 179.998 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 780' ' ' THR . . . . . . . . . . . . . 35.1 p -133.19 88.16 36.79 Favored Pre-proline 0 N--CA 1.494 1.768 0 O-C-N 120.85 -1.382 . . . . 0.0 111.028 -179.893 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 781' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_endo -83.35 177.72 6.26 Favored 'Trans proline' 0 C--N 1.308 -1.565 0 O-C-N 123.938 1.494 . . . . 0.0 110.534 179.878 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 782' ' ' LEU . . . . . 0.523 ' CD1' ' HA2' ' A' ' 791' ' ' GLY . 1.0 OUTLIER -135.93 174.74 10.28 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.202 -0.936 . . . . 0.0 110.257 179.951 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 783' ' ' GLY . . . . . . . . . . . . . . . 59.34 -166.07 9.08 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.864 -1.295 . . . . 0.0 109.864 179.935 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 784' ' ' THR . . . . . 0.531 HG22 ' N ' ' A' ' 785' ' ' CYS . 9.3 t -133.3 -128.02 0.17 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.373 -1.075 . . . . 0.0 109.904 179.934 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 785' ' ' CYS . . . . . 0.531 ' N ' HG22 ' A' ' 784' ' ' THR . 1.9 t -92.84 96.58 10.22 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 120.752 -1.218 . . . . 0.0 110.206 -179.967 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 786' ' ' GLY . . . . . . . . . . . . . . . 139.72 -24.68 2.74 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.383 -1.487 . . . . 0.0 109.383 179.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 787' ' ' THR . . . . . 0.443 ' CG2' ' O ' ' A' ' 787' ' ' THR . 99.8 m -139.72 37.95 2.01 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.18 -1.188 . . . . 0.0 110.142 179.964 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 788' ' ' PHE . . . . . 0.565 ' HB3' ' CE2' ' A' ' 775' ' ' PHE . 0.3 OUTLIER -65.75 116.97 7.5 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.304 -0.873 . . . . 0.0 109.899 179.92 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 789' ' ' GLN . . . . . . . . . . . . . 5.3 tm0? -119.11 153.04 35.45 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.252 -0.905 . . . . 0.0 110.261 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 790' ' ' GLN . . . . . . . . . . . . . 4.1 tt0 -73.05 120.74 19.1 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.293 -0.879 . . . . 0.0 110.12 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 791' ' ' GLY . . . . . 0.523 ' HA2' ' CD1' ' A' ' 782' ' ' LEU . . . -74.21 -116.0 0.08 OUTLIER Glycine 0 N--CA 1.494 2.509 0 N-CA-C 109.867 -1.293 . . . . 0.0 109.867 -179.942 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 792' ' ' GLU . . . . . . . . . . . . . 19.8 mt-10 -118.99 -23.82 6.75 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.225 -1.162 . . . . 0.0 110.35 -179.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 793' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -122.88 121.85 37.19 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.165 -0.96 . . . . 0.0 110.507 -179.936 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 794' ' ' HIS . . . . . 0.586 ' CE1' ' HA ' ' A' ' 777' ' ' SER . 24.2 t60 -149.06 149.35 30.95 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.292 -0.88 . . . . 0.0 109.789 -180.0 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 795' ' ' SER . . . . . 0.473 ' O ' ' NE2' ' A' ' 794' ' ' HIS . 17.1 t -91.94 149.2 21.67 Favored 'General case' 0 C--N 1.299 -1.626 0 O-C-N 121.276 -0.89 . . . . 0.0 109.618 179.889 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 796' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -87.89 15.42 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 O-C-N 121.174 -0.953 . . . . 0.0 110.017 -179.918 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 797' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 -125.59 27.02 6.59 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.387 -0.82 . . . . 0.0 109.714 179.927 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 798' ' ' SER . . . . . 0.536 ' HB3' ' CB ' ' A' ' 776' ' ' ALA . 0.5 OUTLIER -68.25 -35.03 77.28 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.479 -0.763 . . . . 0.0 111.005 179.933 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 799' ' ' ASN . . . . . 0.511 ' N ' ' OD1' ' A' ' 799' ' ' ASN . 1.3 m120 -100.62 11.78 38.77 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.104 -0.997 . . . . 0.0 111.175 -179.859 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 800' ' ' SER . . . . . . . . . . . . . 75.0 p -93.12 -27.38 16.97 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 120.997 -1.065 . . . . 0.0 110.609 -179.925 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 801' ' ' VAL . . . . . . . . . . . . . 40.2 t -88.99 -19.67 7.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.278 -0.889 . . . . 0.0 110.467 -179.925 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 802' ' ' LEU . . . . . 0.492 ' O ' ' HB2' ' A' ' 806' ' ' CYS . 4.1 mm? -79.48 -48.8 13.28 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.187 -0.945 . . . . 0.0 110.837 179.986 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 803' ' ' GLU . . . . . . . . . . . . . 17.5 mt-10 -64.0 -18.71 64.57 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.001 -1.062 . . . . 0.0 111.036 -179.918 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 804' ' ' ARG . . . . . . . . . . . . . 51.9 ttp180 -92.46 -22.14 19.78 Favored 'General case' 0 C--N 1.297 -1.692 0 O-C-N 121.073 -1.017 . . . . 0.0 112.25 -179.844 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 805' ' ' LYS . . . . . 0.445 ' O ' ' SG ' ' A' ' 806' ' ' CYS . 5.8 tttm -140.12 54.96 1.63 Allowed 'General case' 0 N--CA 1.501 2.115 0 O-C-N 120.444 -1.41 . . . . 0.0 112.537 -179.856 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 806' ' ' CYS . . . . . 0.537 ' HA ' ' CB ' ' A' ' 812' ' ' CYS . 1.2 m -163.73 -50.68 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.801 0 O-C-N 120.842 -1.161 . . . . 0.0 110.319 179.722 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 807' ' ' ILE . . . . . . . . . . . . . 55.5 mt -61.62 129.47 24.6 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 O-C-N 121.112 -0.992 . . . . 0.0 110.156 179.905 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 808' ' ' GLY . . . . . 0.411 ' C ' ' HG ' ' A' ' 809' ' ' LEU . . . 104.76 1.86 42.89 Favored Glycine 0 N--CA 1.492 2.431 0 N-CA-C 109.616 -1.394 . . . . 0.0 109.616 179.957 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 809' ' ' LEU . . . . . 0.411 ' HG ' ' C ' ' A' ' 808' ' ' GLY . 4.2 mt -133.03 144.33 49.98 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.157 -1.202 . . . . 0.0 110.308 179.906 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 810' ' ' GLU . . . . . 0.471 ' OE2' ' O ' ' A' ' 764' ' ' CYS . 3.4 tm-20 -70.43 -20.56 62.9 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.219 -0.926 . . . . 0.0 109.653 180.0 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 811' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -156.47 121.59 4.69 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 179.907 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 812' ' ' CYS . . . . . 0.537 ' CB ' ' HA ' ' A' ' 806' ' ' CYS . 26.1 p -123.1 156.7 34.42 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 120.996 -1.065 . . . . 0.0 111.388 -179.972 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 813' ' ' VAL . . . . . . . . . . . . . 38.8 t -120.43 135.24 61.32 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.624 -0.672 . . . . 0.0 109.632 179.925 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 814' ' ' VAL . . . . . . . . . . . . . 48.2 t -112.41 153.09 14.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.095 -1.003 . . . . 0.0 110.551 -179.927 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 815' ' ' ALA . . . . . 0.452 ' HA ' ' HG2' ' A' ' 759' ' ' LYS . . . -104.49 118.37 36.43 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.27 -0.893 . . . . 0.0 109.893 179.985 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 816' ' ' ILE . . . . . 0.47 HD13 HG22 ' A' ' 760' ' ' VAL . 25.1 mt -85.25 108.41 17.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.18 -0.95 . . . . 0.0 110.489 -179.945 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 817' ' ' SER . . . . . . . . . . . . . 44.5 p -157.59 165.87 17.79 Favored Pre-proline 0 N--CA 1.494 1.75 0 O-C-N 121.366 -0.834 . . . . 0.0 109.978 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 818' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_endo -79.44 9.9 3.25 Favored 'Trans proline' 0 C--N 1.305 -1.728 0 O-C-N 123.885 1.466 . . . . 0.0 111.037 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 819' ' ' SER . . . . . . . . . . . . . 27.5 t -131.89 12.18 4.77 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.061 -1.025 . . . . 0.0 110.305 -179.932 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 820' ' ' ASN . . . . . . . . . . . . . 45.8 t-20 -114.12 -2.7 13.38 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.266 -0.897 . . . . 0.0 110.052 179.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 821' ' ' PHE . . . . . . . . . . . . . 8.1 m-85 -112.38 -79.46 0.58 Allowed 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.324 -0.86 . . . . 0.0 110.238 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 822' ' ' GLY . . . . . . . . . . . . . . . -171.22 54.2 0.18 Allowed Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.619 -1.392 . . . . 0.0 109.619 -179.949 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 823' ' ' GLY . . . . . . . . . . . . . . . 78.38 176.61 47.22 Favored Glycine 0 N--CA 1.492 2.399 0 N-CA-C 109.727 -1.349 . . . . 0.0 109.727 179.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 824' ' ' ASP . . . . . . . . . . . . . 15.7 p-10 -70.89 117.47 56.31 Favored Pre-proline 0 N--CA 1.494 1.728 0 O-C-N 121.243 -1.151 . . . . 0.0 110.216 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 825' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -79.59 -65.24 0.02 OUTLIER 'Trans proline' 0 C--N 1.308 -1.565 0 O-C-N 123.97 1.511 . . . . 0.0 110.946 -179.922 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 826' ' ' CYS . . . . . 0.451 ' HB3' ' HB ' ' A' ' 829' ' ' VAL . 22.8 m -97.44 153.64 38.29 Favored Pre-proline 0 N--CA 1.498 1.951 0 O-C-N 121.11 -0.993 . . . . 0.0 110.952 -179.937 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 827' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -78.99 95.96 1.08 Allowed 'Trans proline' 0 C--N 1.313 -1.303 0 O-C-N 124.07 1.563 . . . . 0.0 110.673 179.963 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 828' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER 52.41 18.67 0.97 Allowed 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.152 -0.968 . . . . 0.0 110.404 179.923 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 829' ' ' VAL . . . . . 0.451 ' HB ' ' HB3' ' A' ' 826' ' ' CYS . 66.7 t -119.41 80.86 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.198 -0.939 . . . . 0.0 110.223 179.953 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 830' ' ' MET . . . . . 0.447 ' SD ' ' O ' ' A' ' 830' ' ' MET . 0.0 OUTLIER -178.43 128.65 0.12 Allowed 'General case' 0 C--N 1.304 -1.381 0 O-C-N 121.131 -0.981 . . . . 0.0 110.777 -179.902 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 831' ' ' LYS . . . . . 0.46 ' O ' ' CG ' ' A' ' 832' ' ' ARG . 2.9 tttm -170.58 57.05 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.391 -0.818 . . . . 0.0 110.093 179.906 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 832' ' ' ARG . . . . . 0.508 ' HB2' ' O ' ' A' ' 779' ' ' GLY . 0.5 OUTLIER -167.62 125.32 1.21 Allowed 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.466 -0.771 . . . . 0.0 109.392 -179.996 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 833' ' ' VAL . . . . . . . . . . . . . 58.8 t -112.47 103.26 15.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.045 -1.035 . . . . 0.0 111.055 -179.959 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 834' ' ' ALA . . . . . 0.557 ' HB2' ' CZ ' ' A' ' 788' ' ' PHE . . . -111.16 122.02 46.79 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.471 -0.768 . . . . 0.0 109.099 179.928 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 835' ' ' VAL . . . . . . . . . . . . . 34.7 t -139.3 143.24 31.6 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 O-C-N 120.828 -1.17 . . . . 0.0 111.648 -179.934 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 836' ' ' GLU . . . . . 0.446 ' HB2' ' HB3' ' A' ' 775' ' ' PHE . 1.3 mt-10 -115.5 160.24 20.18 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 179.807 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 837' ' ' ALA . . . . . . . . . . . . . . . -154.64 156.8 37.13 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 120.612 -1.305 . . . . 0.0 111.258 -179.944 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 838' ' ' VAL . . . . . . . . . . . . . 22.0 t -109.24 137.2 42.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.505 -0.747 . . . . 0.0 109.965 179.926 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 839' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -128.32 133.2 48.66 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.142 -0.974 . . . . 0.0 110.132 179.988 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 840' ' ' SER . . . . . . . . . . . . . 24.8 t -159.83 -177.37 6.29 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.281 -0.887 . . . . 0.0 109.939 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 841' ' ' THR . . . . . . . . . . . . . 67.1 p . . . . . 0 N--CA 1.49 1.567 0 O-C-N 121.149 -0.97 . . . . 0.0 109.926 179.981 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 728' ' ' VAL . . . . . 0.524 ' CG2' ' O ' ' A' ' 839' ' ' CYS . 7.6 p . . . . . 0 N--CA 1.493 1.685 0 CA-C-O 121.288 0.566 . . . . 0.0 110.141 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 729' ' ' SER . . . . . 0.46 ' O ' HG12 ' A' ' 731' ' ' VAL . 0.5 OUTLIER -107.47 90.5 3.32 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.263 -0.898 . . . . 0.0 110.343 179.928 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 730' ' ' GLY . . . . . 0.451 ' O ' ' CG1' ' A' ' 731' ' ' VAL . . . -44.4 153.25 0.46 Allowed Glycine 0 N--CA 1.492 2.417 0 N-CA-C 109.298 -1.521 . . . . 0.0 109.298 179.996 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 731' ' ' VAL . . . . . 0.46 HG12 ' O ' ' A' ' 729' ' ' SER . 2.4 m -158.48 120.42 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 121.105 -1.233 . . . . 0.0 110.767 179.937 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 732' ' ' CYS . . . . . . . . . . . . . 26.8 p -116.04 130.86 57.0 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.448 -0.783 . . . . 0.0 109.297 179.902 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 733' ' ' ALA . . . . . . . . . . . . . . . -107.77 160.55 15.64 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.106 -0.996 . . . . 0.0 110.609 -179.878 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 734' ' ' ASP . . . . . 0.526 ' OD2' ' CZ ' ' A' ' 832' ' ' ARG . 0.9 OUTLIER -164.36 105.36 0.86 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.414 -0.804 . . . . 0.0 109.444 179.941 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 735' ' ' VAL . . . . . 0.442 ' O ' ' CG ' ' A' ' 832' ' ' ARG . 37.4 t -116.04 163.39 13.31 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 121.089 -1.007 . . . . 0.0 110.715 -179.939 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 736' ' ' SER . . . . . . . . . . . . . 22.5 p -99.16 158.78 15.45 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.425 -0.797 . . . . 0.0 110.029 179.954 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 737' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.493 1.702 0 O-C-N 121.216 -0.927 . . . . 0.0 110.457 179.944 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 757' ' ' THR . . . . . 0.47 ' OG1' ' O ' ' A' ' 816' ' ' ILE . 66.9 p . . . . . 0 N--CA 1.495 1.779 0 CA-C-O 121.364 0.602 . . . . 0.0 110.593 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 758' ' ' ALA . . . . . . . . . . . . . . . -55.85 176.45 0.07 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.412 -0.805 . . . . 0.0 110.052 179.944 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 759' ' ' LYS . . . . . 0.553 ' CA ' HD12 ' A' ' 816' ' ' ILE . 9.1 mttp -139.14 167.47 21.98 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.231 -0.918 . . . . 0.0 110.357 179.978 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 760' ' ' VAL . . . . . 0.448 ' O ' HG21 ' A' ' 813' ' ' VAL . 5.5 t -105.52 162.49 4.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.372 -0.83 . . . . 0.0 109.392 179.919 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 761' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -140.35 105.93 5.11 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 120.846 -1.159 . . . . 0.0 111.261 -179.867 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 762' ' ' LEU . . . . . 0.498 ' HB2' ' HB3' ' A' ' 812' ' ' CYS . 0.5 OUTLIER -110.64 103.23 11.78 Favored 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 179.827 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 763' ' ' LYS . . . . . . . . . . . . . 4.4 ttpt -110.6 135.49 51.15 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.202 -0.936 . . . . 0.0 111.46 -179.812 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 764' ' ' CYS . . . . . 0.476 ' HB2' ' O ' ' A' ' 810' ' ' GLU . 1.3 m -126.63 139.89 52.83 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.533 -0.73 . . . . 0.0 109.568 179.856 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 765' ' ' ALA . . . . . 0.445 ' O ' ' O ' ' A' ' 764' ' ' CYS . . . -39.72 161.16 0.09 OUTLIER Pre-proline 0 N--CA 1.496 1.843 0 O-C-N 121.359 -0.838 . . . . 0.0 110.604 -179.98 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 766' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -70.78 113.72 3.63 Favored 'Trans proline' 0 C--N 1.306 -1.706 0 O-C-N 124.121 1.59 . . . . 0.0 110.082 -179.93 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 767' ' ' GLY . . . . . . . . . . . . . . . 118.04 -26.01 8.09 Favored Glycine 0 N--CA 1.488 2.162 0 N-CA-C 108.904 -1.679 . . . . 0.0 108.904 -179.896 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 768' ' ' GLN . . . . . 0.482 ' HA ' ' HA ' ' A' ' 841' ' ' THR . 1.3 tt0 -90.55 119.65 30.99 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.428 -1.042 . . . . 0.0 109.838 179.93 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 769' ' ' THR . . . . . . . . . . . . . 9.4 p -112.22 147.21 36.71 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.227 -0.921 . . . . 0.0 110.474 -179.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 770' ' ' ILE . . . . . 0.42 ' HB ' ' HA ' ' A' ' 807' ' ' ILE . 3.5 mp -65.88 145.37 13.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.252 -0.905 . . . . 0.0 109.292 179.946 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 771' ' ' SER . . . . . . . . . . . . . 36.8 p -136.33 -5.45 2.06 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 120.955 -1.091 . . . . 0.0 111.6 -179.923 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 772' ' ' ALA . . . . . . . . . . . . . . . -171.24 148.02 2.59 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 120.608 -1.307 . . . . 0.0 111.941 -179.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 773' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -120.48 132.27 70.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 N-CA-C 108.482 -0.932 . . . . 0.0 108.482 179.829 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 774' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -103.4 -34.75 8.62 Favored 'General case' 0 N--CA 1.504 2.239 0 O-C-N 120.995 -1.066 . . . . 0.0 110.342 -179.918 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 775' ' ' PHE . . . . . . . . . . . . . 52.2 t80 -126.15 152.7 45.61 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 120.925 -1.11 . . . . 0.0 110.15 179.92 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 776' ' ' ALA . . . . . 0.525 ' CB ' ' HB3' ' A' ' 799' ' ' ASN . . . 175.69 105.9 0.02 OUTLIER 'General case' 0 C--N 1.3 -1.564 0 O-C-N 121.425 -0.797 . . . . 0.0 109.664 -179.969 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 777' ' ' SER . . . . . 0.409 ' HG ' ' CE1' ' A' ' 794' ' ' HIS . 0.4 OUTLIER -137.6 137.84 38.91 Favored 'General case' 0 C--N 1.299 -1.623 0 O-C-N 121.387 -0.82 . . . . 0.0 109.885 -179.975 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 778' ' ' PHE . . . . . . . . . . . . . 65.3 t80 -112.0 98.58 7.45 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.222 -0.924 . . . . 0.0 110.241 -179.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 779' ' ' GLY . . . . . 0.437 ' O ' ' HA ' ' A' ' 831' ' ' LYS . . . 167.85 -93.5 0.11 Allowed Glycine 0 N--CA 1.489 2.197 0 N-CA-C 109.419 -1.472 . . . . 0.0 109.419 179.979 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 780' ' ' THR . . . . . 0.418 HG23 ' O ' ' A' ' 779' ' ' GLY . 60.6 p -141.11 81.67 15.65 Favored Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 121.273 -1.134 . . . . 0.0 110.253 179.945 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 781' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -72.06 154.63 57.57 Favored 'Trans proline' 0 C--N 1.303 -1.818 0 O-C-N 124.02 1.537 . . . . 0.0 110.287 -179.966 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 782' ' ' LEU . . . . . . . . . . . . . 21.4 mt -119.59 116.61 26.38 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.285 -0.884 . . . . 0.0 109.966 179.952 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 783' ' ' GLY . . . . . . . . . . . . . . . 111.5 168.21 18.52 Favored Glycine 0 N--CA 1.488 2.114 0 N-CA-C 109.345 -1.502 . . . . 0.0 109.345 -179.903 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 784' ' ' THR . . . . . 0.513 ' O ' ' CG2' ' A' ' 784' ' ' THR . 14.1 t -152.79 109.22 3.41 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.213 -1.169 . . . . 0.0 110.24 -179.995 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 785' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER 46.88 80.84 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.362 -0.836 . . . . 0.0 110.736 179.964 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 786' ' ' GLY . . . . . . . . . . . . . . . 135.62 -20.58 3.67 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.745 -1.342 . . . . 0.0 109.745 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 787' ' ' THR . . . . . . . . . . . . . 1.9 m -154.86 44.93 0.51 Allowed 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.059 -1.259 . . . . 0.0 110.591 -179.867 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 788' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -69.25 138.99 54.42 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.088 -1.008 . . . . 0.0 109.919 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 789' ' ' GLN . . . . . . . . . . . . . 37.2 tt0 -163.37 134.0 4.55 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.24 -0.913 . . . . 0.0 110.116 179.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 790' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -46.35 157.47 0.13 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.386 -0.821 . . . . 0.0 110.236 179.954 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 791' ' ' GLY . . . . . . . . . . . . . . . -113.87 -139.6 7.26 Favored Glycine 0 N--CA 1.489 2.184 0 N-CA-C 109.516 -1.434 . . . . 0.0 109.516 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 792' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -106.62 -30.86 8.75 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.203 -1.175 . . . . 0.0 110.199 179.946 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 793' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -104.3 107.45 18.38 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.271 -0.893 . . . . 0.0 110.191 -179.956 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 794' ' ' HIS . . . . . 0.45 ' CG ' ' N ' ' A' ' 795' ' ' SER . 86.3 t60 -134.01 171.69 13.85 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.223 -0.923 . . . . 0.0 110.489 -179.988 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 795' ' ' SER . . . . . 0.45 ' N ' ' CG ' ' A' ' 794' ' ' HIS . 93.3 p -120.52 -137.37 0.33 Allowed 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.336 -0.852 . . . . 0.0 110.183 179.98 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 796' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -134.81 -29.72 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.96 0 O-C-N 121.108 -0.995 . . . . 0.0 110.806 179.996 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 797' ' ' ASN . . . . . 0.428 ' HA ' ' HB3' ' A' ' 800' ' ' SER . 1.4 m-20 -96.56 26.46 4.43 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.078 -1.014 . . . . 0.0 110.104 -179.973 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 798' ' ' SER . . . . . 0.492 ' HB2' ' O ' ' A' ' 776' ' ' ALA . 0.8 OUTLIER -51.71 -71.32 0.07 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.329 -0.857 . . . . 0.0 110.955 -179.968 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 799' ' ' ASN . . . . . 0.525 ' HB3' ' CB ' ' A' ' 776' ' ' ALA . 51.6 p30 -85.78 -15.59 41.57 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.293 -0.879 . . . . 0.0 111.101 -179.956 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 800' ' ' SER . . . . . 0.514 ' N ' ' OD1' ' A' ' 799' ' ' ASN . 12.9 t -59.18 -41.58 88.8 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.083 -1.01 . . . . 0.0 110.62 -179.966 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 801' ' ' VAL . . . . . . . . . . . . . 34.9 t -72.2 -26.46 24.89 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.14 -0.975 . . . . 0.0 110.505 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 802' ' ' LEU . . . . . 0.475 ' O ' ' HB2' ' A' ' 806' ' ' CYS . 3.4 mm? -74.2 -59.83 2.55 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.257 -0.902 . . . . 0.0 110.641 -179.944 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 803' ' ' GLU . . . . . 0.413 ' HG3' HD12 ' A' ' 807' ' ' ILE . 20.2 tt0 -54.06 -18.45 3.65 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.115 -0.991 . . . . 0.0 110.683 179.887 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 804' ' ' ARG . . . . . . . . . . . . . 56.3 ttt180 -90.08 -27.22 19.81 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.126 -0.984 . . . . 0.0 111.026 -179.914 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 805' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.76 43.97 2.83 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 120.968 -1.083 . . . . 0.0 110.968 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 806' ' ' CYS . . . . . 0.475 ' HB2' ' O ' ' A' ' 802' ' ' LEU . 0.2 OUTLIER -147.51 -72.3 0.21 Allowed 'General case' 0 N--CA 1.494 1.743 0 O-C-N 120.952 -1.092 . . . . 0.0 110.485 179.993 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 807' ' ' ILE . . . . . 0.42 ' HA ' ' HB ' ' A' ' 770' ' ' ILE . 31.9 mt -47.14 136.58 2.96 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 O-C-N 121.052 -1.03 . . . . 0.0 110.472 -179.955 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 808' ' ' GLY . . . . . . . . . . . . . . . 93.23 5.52 63.7 Favored Glycine 0 N--CA 1.492 2.387 0 N-CA-C 110.229 -1.148 . . . . 0.0 110.229 179.967 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 809' ' ' LEU . . . . . 0.414 ' O ' ' CD1' ' A' ' 770' ' ' ILE . 41.5 mt -137.62 135.26 36.42 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.039 -1.271 . . . . 0.0 110.612 -179.987 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 810' ' ' GLU . . . . . 0.476 ' O ' ' HB2' ' A' ' 764' ' ' CYS . 57.3 mm-40 -64.45 -34.16 77.56 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.27 -0.894 . . . . 0.0 108.792 179.94 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 811' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -111.37 165.48 11.93 Favored 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 179.934 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 812' ' ' CYS . . . . . 0.498 ' HB3' ' HB2' ' A' ' 762' ' ' LEU . 49.5 t -159.66 102.28 1.51 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.861 -1.149 . . . . 0.0 110.608 -179.883 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 813' ' ' VAL . . . . . 0.448 HG21 ' O ' ' A' ' 760' ' ' VAL . 11.9 p -115.8 136.82 51.44 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.178 -0.951 . . . . 0.0 109.981 179.964 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 814' ' ' VAL . . . . . . . . . . . . . 17.7 t -134.4 164.72 33.47 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 O-C-N 121.171 -0.956 . . . . 0.0 110.435 -179.939 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 815' ' ' ALA . . . . . 0.406 ' HA ' ' HG2' ' A' ' 759' ' ' LYS . . . -97.27 157.14 16.11 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.26 -0.9 . . . . 0.0 109.928 179.971 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 816' ' ' ILE . . . . . 0.553 HD12 ' CA ' ' A' ' 759' ' ' LYS . 20.3 mt -117.12 63.62 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.168 -0.957 . . . . 0.0 109.846 179.984 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 817' ' ' SER . . . . . 0.454 ' OG ' ' HB2' ' A' ' 820' ' ' ASN . 0.0 OUTLIER -116.15 165.98 13.56 Favored Pre-proline 0 N--CA 1.494 1.728 0 O-C-N 121.432 -0.792 . . . . 0.0 110.716 -179.875 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 818' ' ' PRO . . . . . 0.458 ' HB2' ' OD1' ' A' ' 824' ' ' ASP . 49.0 Cg_endo -76.92 -44.94 0.19 Allowed 'Trans proline' 0 C--N 1.307 -1.657 0 O-C-N 124.181 1.622 . . . . 0.0 110.573 -179.954 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 819' ' ' SER . . . . . . . . . . . . . 66.3 m -88.46 15.33 8.04 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.271 -0.893 . . . . 0.0 110.238 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 820' ' ' ASN . . . . . 0.454 ' HB2' ' OG ' ' A' ' 817' ' ' SER . 2.1 m120 -101.47 -16.51 16.8 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.225 -0.922 . . . . 0.0 110.449 179.985 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 821' ' ' PHE . . . . . . . . . . . . . 5.2 m-85 -93.32 -91.9 0.18 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.051 -1.031 . . . . 0.0 110.44 179.968 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 822' ' ' GLY . . . . . . . . . . . . . . . -152.97 14.93 0.68 Allowed Glycine 0 N--CA 1.492 2.39 0 C-N-CA 119.551 -1.309 . . . . 0.0 110.266 -179.991 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 823' ' ' GLY . . . . . . . . . . . . . . . 154.74 -170.66 33.07 Favored Glycine 0 N--CA 1.493 2.486 0 O-C-N 121.008 -1.289 . . . . 0.0 110.068 179.941 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 824' ' ' ASP . . . . . 0.458 ' OD1' ' HB2' ' A' ' 818' ' ' PRO . 0.2 OUTLIER -113.33 105.44 55.26 Favored Pre-proline 0 N--CA 1.494 1.73 0 O-C-N 121.379 -1.071 . . . . 0.0 110.14 -179.972 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 825' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -76.31 -64.9 0.02 OUTLIER 'Trans proline' 0 C--N 1.304 -1.775 0 O-C-N 123.994 1.523 . . . . 0.0 110.789 -179.963 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 826' ' ' CYS . . . . . . . . . . . . . 98.3 m -125.19 98.62 35.37 Favored Pre-proline 0 N--CA 1.495 1.794 0 O-C-N 121.119 -0.988 . . . . 0.0 110.414 179.953 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 827' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_endo -82.77 153.38 15.09 Favored 'Trans proline' 0 C--N 1.303 -1.847 0 O-C-N 124.062 1.559 . . . . 0.0 110.612 -179.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 828' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 62.26 17.85 9.66 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.304 -0.872 . . . . 0.0 110.521 179.995 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 829' ' ' VAL . . . . . 0.431 ' O ' ' C ' ' A' ' 830' ' ' MET . 66.4 t -127.5 111.21 24.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.225 -0.922 . . . . 0.0 110.283 179.981 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 830' ' ' MET . . . . . 0.431 ' C ' ' O ' ' A' ' 829' ' ' VAL . 2.9 mmt -42.41 125.49 3.21 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.278 -0.889 . . . . 0.0 109.672 -179.992 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 831' ' ' LYS . . . . . 0.437 ' HA ' ' O ' ' A' ' 779' ' ' GLY . 1.2 ptpt -128.85 133.62 48.03 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.047 -1.033 . . . . 0.0 111.151 -179.938 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 832' ' ' ARG . . . . . 0.526 ' CZ ' ' OD2' ' A' ' 734' ' ' ASP . 20.2 ttt180 -108.55 158.89 17.16 Favored 'General case' 0 N--CA 1.489 1.475 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 179.946 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 833' ' ' VAL . . . . . 0.53 HG21 ' CG2' ' A' ' 816' ' ' ILE . 8.3 t -111.85 126.68 69.26 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 120.976 -1.078 . . . . 0.0 111.133 -179.877 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 834' ' ' ALA . . . . . . . . . . . . . . . -131.08 134.15 46.34 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 179.924 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 835' ' ' VAL . . . . . . . . . . . . . 5.9 t -145.02 150.91 15.59 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 O-C-N 120.933 -1.105 . . . . 0.0 111.275 -179.919 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 836' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -127.13 110.82 13.31 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 179.9 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 837' ' ' ALA . . . . . . . . . . . . . . . -110.26 159.33 17.5 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.066 -1.021 . . . . 0.0 111.106 -179.848 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 838' ' ' VAL . . . . . . . . . . . . . 92.1 t -115.29 122.15 68.65 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.475 0 O-C-N 121.498 -0.751 . . . . 0.0 109.731 179.961 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 839' ' ' CYS . . . . . 0.524 ' O ' ' CG2' ' A' ' 728' ' ' VAL . 0.0 OUTLIER -108.95 122.56 47.48 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.247 -0.908 . . . . 0.0 110.532 -179.925 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 840' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -121.08 119.39 32.3 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.268 -0.895 . . . . 0.0 109.799 179.963 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 841' ' ' THR . . . . . 0.482 ' HA ' ' HA ' ' A' ' 768' ' ' GLN . 14.6 t . . . . . 0 N--CA 1.492 1.654 0 O-C-N 121.103 -0.998 . . . . 0.0 110.569 -179.927 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 728' ' ' VAL . . . . . 0.565 ' CG1' ' N ' ' A' ' 729' ' ' SER . 1.0 OUTLIER . . . . . 0 N--CA 1.49 1.548 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 . . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 729' ' ' SER . . . . . 0.565 ' N ' ' CG1' ' A' ' 728' ' ' VAL . 2.4 m -178.53 -163.59 0.07 Allowed 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.102 -0.999 . . . . 0.0 110.601 -179.984 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 730' ' ' GLY . . . . . . . . . . . . . . . -152.67 -166.27 14.14 Favored Glycine 0 N--CA 1.496 2.698 0 N-CA-C 109.381 -1.488 . . . . 0.0 109.381 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 731' ' ' VAL . . . . . 0.413 ' CG1' ' N ' ' A' ' 732' ' ' CYS . 73.7 t -140.33 165.95 20.34 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 O-C-N 121.064 -1.256 . . . . 0.0 110.508 179.978 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 732' ' ' CYS . . . . . 0.413 ' N ' ' CG1' ' A' ' 731' ' ' VAL . 82.1 m -111.8 156.99 21.1 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.32 -0.863 . . . . 0.0 110.094 179.999 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 733' ' ' ALA . . . . . 0.423 ' O ' ' HA ' ' A' ' 834' ' ' ALA . . . -141.68 106.72 4.95 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.144 -0.973 . . . . 0.0 110.439 -179.997 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 734' ' ' ASP . . . . . 0.449 ' N ' ' OD1' ' A' ' 734' ' ' ASP . 5.2 m-20 -118.16 124.52 48.18 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.372 -0.83 . . . . 0.0 109.944 -180.0 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 735' ' ' VAL . . . . . 0.434 ' CG1' ' N ' ' A' ' 736' ' ' SER . 51.5 t -125.79 166.91 20.99 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 O-C-N 121.197 -0.94 . . . . 0.0 110.181 179.985 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 736' ' ' SER . . . . . 0.434 ' N ' ' CG1' ' A' ' 735' ' ' VAL . 10.2 p -113.36 45.18 1.43 Allowed 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.248 -0.907 . . . . 0.0 110.573 -179.984 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 737' ' ' GLU . . . . . 0.458 ' OE1' ' HB3' ' A' ' 831' ' ' LYS . 2.1 tt0 . . . . . 0 N--CA 1.502 2.127 0 O-C-N 121.469 -0.77 . . . . 0.0 111.273 179.911 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 757' ' ' THR . . . . . . . . . . . . . 61.9 p . . . . . 0 N--CA 1.492 1.632 0 CA-C-O 121.091 0.472 . . . . 0.0 109.858 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 758' ' ' ALA . . . . . . . . . . . . . . . -112.69 175.59 5.37 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.08 -1.012 . . . . 0.0 110.244 179.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 759' ' ' LYS . . . . . . . . . . . . . 11.4 mtmt -146.71 150.69 35.87 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.257 -0.902 . . . . 0.0 110.968 -179.899 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 760' ' ' VAL . . . . . 0.413 HG21 HG22 ' A' ' 735' ' ' VAL . 3.6 t -110.38 144.84 17.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.514 -0.741 . . . . 0.0 109.316 179.865 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 761' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -118.76 114.16 22.25 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.076 -1.015 . . . . 0.0 110.564 179.949 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 762' ' ' LEU . . . . . 0.459 ' HB2' ' HB3' ' A' ' 812' ' ' CYS . 0.4 OUTLIER -108.54 157.19 18.69 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.426 -0.796 . . . . 0.0 109.653 179.955 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 763' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -158.84 106.97 1.87 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.158 -0.964 . . . . 0.0 110.6 -179.976 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 764' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -88.21 166.54 14.29 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.364 -0.835 . . . . 0.0 109.915 -179.998 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 765' ' ' ALA . . . . . . . . . . . . . . . -63.55 154.24 80.32 Favored Pre-proline 0 N--CA 1.493 1.676 0 O-C-N 121.147 -0.971 . . . . 0.0 110.157 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 766' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -69.06 125.14 12.13 Favored 'Trans proline' 0 C--N 1.305 -1.735 0 O-C-N 124.016 1.535 . . . . 0.0 110.348 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 767' ' ' GLY . . . . . . . . . . . . . . . 108.69 -15.21 34.79 Favored Glycine 0 N--CA 1.489 2.21 0 N-CA-C 109.366 -1.493 . . . . 0.0 109.366 -179.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 768' ' ' GLN . . . . . 0.444 ' HB3' ' HB3' ' A' ' 839' ' ' CYS . 0.9 OUTLIER -114.32 140.72 48.39 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.338 -1.095 . . . . 0.0 110.236 179.96 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 769' ' ' THR . . . . . . . . . . . . . 69.7 p -121.48 150.4 41.63 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.295 -0.878 . . . . 0.0 110.393 -179.906 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 770' ' ' ILE . . . . . . . . . . . . . 16.9 mt -66.26 131.18 32.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.262 -0.899 . . . . 0.0 109.689 179.958 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 771' ' ' SER . . . . . . . . . . . . . 80.2 p -129.1 -0.3 5.2 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.101 -0.999 . . . . 0.0 110.836 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 772' ' ' ALA . . . . . 0.476 ' O ' ' HB ' ' A' ' 838' ' ' VAL . . . 177.95 127.4 0.05 Allowed 'General case' 0 N--CA 1.495 1.792 0 O-C-N 120.824 -1.173 . . . . 0.0 111.576 179.998 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 773' ' ' ILE . . . . . 0.524 HD11 ' N ' ' A' ' 773' ' ' ILE . 1.4 mp -87.17 123.44 39.98 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 N-CA-C 108.644 -0.873 . . . . 0.0 108.644 179.804 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 774' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -85.43 -31.56 22.8 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.027 -1.046 . . . . 0.0 111.88 -179.816 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 775' ' ' PHE . . . . . 0.644 ' CE2' ' CB ' ' A' ' 788' ' ' PHE . 90.6 t80 -147.61 171.82 14.99 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 120.645 -1.284 . . . . 0.0 111.325 -179.988 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 776' ' ' ALA . . . . . 0.504 ' N ' ' CG ' ' A' ' 775' ' ' PHE . . . -179.52 136.7 0.12 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.544 -0.723 . . . . 0.0 109.546 -179.989 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 777' ' ' SER . . . . . 0.45 ' HB3' ' HB3' ' A' ' 781' ' ' PRO . 0.3 OUTLIER -148.44 127.04 12.43 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.119 -0.988 . . . . 0.0 110.373 -179.966 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 778' ' ' PHE . . . . . 0.614 ' CG ' ' O ' ' A' ' 778' ' ' PHE . 4.5 t80 -109.66 63.01 0.6 Allowed 'General case' 0 C--N 1.3 -1.555 0 CA-C-O 122.0 0.905 . . . . 0.0 108.957 179.935 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 779' ' ' GLY . . . . . . . . . . . . . . . -172.73 -111.02 0.25 Allowed Glycine 0 N--CA 1.488 2.152 0 N-CA-C 109.449 -1.461 . . . . 0.0 109.449 -179.945 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 780' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -115.14 81.39 7.91 Favored Pre-proline 0 N--CA 1.494 1.733 0 O-C-N 121.218 -1.166 . . . . 0.0 110.443 179.961 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 781' ' ' PRO . . . . . 0.45 ' HB3' ' HB3' ' A' ' 777' ' ' SER . 48.7 Cg_endo -77.93 143.87 21.04 Favored 'Trans proline' 0 C--N 1.304 -1.768 0 O-C-N 124.027 1.54 . . . . 0.0 109.872 179.961 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 782' ' ' LEU . . . . . 0.527 ' CD1' ' HA3' ' A' ' 791' ' ' GLY . 4.6 mt -137.22 148.39 46.45 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.109 -0.994 . . . . 0.0 110.373 -179.963 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 783' ' ' GLY . . . . . . . . . . . . . . . 138.26 -124.54 2.95 Favored Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.468 -1.453 . . . . 0.0 109.468 -179.984 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 784' ' ' THR . . . . . . . . . . . . . 15.5 m -154.82 -75.42 0.11 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.217 -1.166 . . . . 0.0 110.393 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 785' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -153.46 99.53 2.34 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.307 -0.87 . . . . 0.0 110.254 179.971 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 786' ' ' GLY . . . . . . . . . . . . . . . 98.04 -17.19 59.08 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.716 -1.354 . . . . 0.0 109.716 -179.95 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 787' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -113.5 23.76 12.86 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.213 -1.169 . . . . 0.0 110.275 179.958 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 788' ' ' PHE . . . . . 0.644 ' CB ' ' CE2' ' A' ' 775' ' ' PHE . 10.8 m-85 -50.66 170.79 0.03 OUTLIER 'General case' 0 C--N 1.299 -1.599 0 O-C-N 121.192 -0.942 . . . . 0.0 109.588 -179.967 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 789' ' ' GLN . . . . . 0.532 ' O ' ' N ' ' A' ' 791' ' ' GLY . 5.0 tp60 -164.8 118.52 1.3 Allowed 'General case' 0 C--N 1.298 -1.663 0 O-C-N 121.257 -0.902 . . . . 0.0 109.957 179.99 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 790' ' ' GLN . . . . . . . . . . . . . 1.8 pt20 -49.08 89.79 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.376 -0.828 . . . . 0.0 110.039 179.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 791' ' ' GLY . . . . . 0.532 ' N ' ' O ' ' A' ' 789' ' ' GLN . . . -43.4 -59.54 3.53 Favored Glycine 0 N--CA 1.488 2.152 0 N-CA-C 109.519 -1.433 . . . . 0.0 109.519 -179.987 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 792' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -152.56 -24.49 0.17 Allowed 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.273 -1.133 . . . . 0.0 111.419 179.973 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 793' ' ' CYS . . . . . . . . . . . . . 1.2 m -118.59 148.52 42.6 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 120.744 -1.222 . . . . 0.0 110.876 179.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 794' ' ' HIS . . . . . 0.49 ' NE2' ' HA ' ' A' ' 796' ' ' ILE . 5.4 t60 -169.41 146.76 3.51 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.488 -0.758 . . . . 0.0 109.808 179.917 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 795' ' ' SER . . . . . 0.467 ' O ' ' HB ' ' A' ' 796' ' ' ILE . 1.0 OUTLIER -90.06 1.2 56.6 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.194 -0.941 . . . . 0.0 111.338 -179.886 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 796' ' ' ILE . . . . . 0.534 ' O ' ' CG2' ' A' ' 796' ' ' ILE . 21.2 mm 55.95 16.85 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 O-C-N 120.985 -1.072 . . . . 0.0 110.068 -179.975 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 797' ' ' ASN . . . . . 0.455 ' OD1' ' OG ' ' A' ' 800' ' ' SER . 2.2 t-20 -151.08 26.5 0.71 Allowed 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.277 -0.889 . . . . 0.0 109.859 179.974 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 798' ' ' SER . . . . . 0.46 ' HB2' ' O ' ' A' ' 776' ' ' ALA . 21.0 m -71.26 -14.91 62.39 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.323 -0.861 . . . . 0.0 111.395 -179.966 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 799' ' ' ASN . . . . . . . . . . . . . 24.4 p30 -105.0 -5.32 21.07 Favored 'General case' 0 N--CA 1.5 2.06 0 O-C-N 121.004 -1.06 . . . . 0.0 111.184 -179.928 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 800' ' ' SER . . . . . 0.455 ' OG ' ' OD1' ' A' ' 797' ' ' ASN . 49.7 m -82.83 -16.82 46.25 Favored 'General case' 0 C--N 1.293 -1.874 0 O-C-N 121.167 -0.958 . . . . 0.0 110.771 -179.972 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 801' ' ' VAL . . . . . 0.456 HG21 ' O ' ' A' ' 820' ' ' ASN . 40.6 t -91.27 -19.67 7.02 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 O-C-N 121.15 -0.968 . . . . 0.0 111.178 -179.911 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 802' ' ' LEU . . . . . 0.453 HD12 HG22 ' A' ' 814' ' ' VAL . 3.9 mm? -88.55 -48.09 7.83 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.005 -1.059 . . . . 0.0 111.247 -179.837 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 803' ' ' GLU . . . . . 0.492 ' HA ' HD13 ' A' ' 807' ' ' ILE . 37.5 tt0 -56.85 -16.96 7.68 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.946 -1.096 . . . . 0.0 110.38 179.949 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 804' ' ' ARG . . . . . . . . . . . . . 2.9 ttt180 -91.16 -26.31 19.14 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.202 -0.936 . . . . 0.0 111.81 -179.908 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 805' ' ' LYS . . . . . . . . . . . . . 1.1 ttpt -140.84 60.57 1.52 Allowed 'General case' 0 N--CA 1.497 1.89 0 O-C-N 120.756 -1.215 . . . . 0.0 111.196 -179.87 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 806' ' ' CYS . . . . . . . . . . . . . 3.4 t -162.46 -25.68 0.04 OUTLIER 'General case' 0 N--CA 1.501 2.108 0 O-C-N 121.069 -1.019 . . . . 0.0 111.649 179.898 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 807' ' ' ILE . . . . . 0.492 HD13 ' HA ' ' A' ' 803' ' ' GLU . 30.1 mt -83.4 135.85 23.98 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 O-C-N 120.741 -1.224 . . . . 0.0 111.381 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 808' ' ' GLY . . . . . 0.467 ' C ' ' HG ' ' A' ' 809' ' ' LEU . . . 109.92 -5.2 30.62 Favored Glycine 0 N--CA 1.492 2.394 0 C-N-CA 120.094 -1.05 . . . . 0.0 110.792 179.875 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 809' ' ' LEU . . . . . 0.467 ' HG ' ' C ' ' A' ' 808' ' ' GLY . 1.3 mp -136.17 143.46 44.45 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 120.792 -1.417 . . . . 0.0 110.688 -179.92 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 810' ' ' GLU . . . . . 0.523 ' HG3' ' N ' ' A' ' 811' ' ' ARG . 0.0 OUTLIER -70.27 -21.56 62.95 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.246 -0.909 . . . . 0.0 108.709 179.866 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 811' ' ' ARG . . . . . 0.523 ' N ' ' HG3' ' A' ' 810' ' ' GLU . 1.6 ttt180 -115.65 149.73 37.86 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.625 -0.672 . . . . 0.0 109.22 179.89 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 812' ' ' CYS . . . . . 0.459 ' HB3' ' HB2' ' A' ' 762' ' ' LEU . 9.7 t -134.54 146.56 49.78 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.954 -1.091 . . . . 0.0 110.921 -179.887 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 813' ' ' VAL . . . . . . . . . . . . . 46.0 t -135.63 104.56 4.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.536 -0.727 . . . . 0.0 109.172 179.955 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 814' ' ' VAL . . . . . 0.453 HG22 HD12 ' A' ' 802' ' ' LEU . 41.0 t -110.73 115.5 50.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.269 -0.894 . . . . 0.0 111.304 -179.881 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 815' ' ' ALA . . . . . . . . . . . . . . . -79.96 131.81 35.9 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.262 -0.899 . . . . 0.0 109.0 179.901 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 816' ' ' ILE . . . . . 0.52 ' CD1' HG21 ' A' ' 833' ' ' VAL . 59.5 mt -87.0 134.13 28.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.105 -0.997 . . . . 0.0 111.045 -179.887 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 817' ' ' SER . . . . . 0.474 ' OG ' ' HB2' ' A' ' 820' ' ' ASN . 2.9 p -164.9 171.22 5.65 Favored Pre-proline 0 N--CA 1.494 1.732 0 O-C-N 121.416 -0.802 . . . . 0.0 109.699 179.934 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 818' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -78.87 -29.9 3.16 Favored 'Trans proline' 0 C--N 1.306 -1.674 0 O-C-N 123.797 1.42 . . . . 0.0 110.374 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 819' ' ' SER . . . . . . . . . . . . . 46.5 m -87.24 7.71 27.27 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.273 -0.892 . . . . 0.0 110.338 -179.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 820' ' ' ASN . . . . . 0.474 ' HB2' ' OG ' ' A' ' 817' ' ' SER . 0.4 OUTLIER -105.64 -8.43 17.92 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.154 -0.966 . . . . 0.0 110.007 -179.97 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 821' ' ' PHE . . . . . . . . . . . . . 31.8 m-85 -125.61 -74.49 0.6 Allowed 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.237 -0.914 . . . . 0.0 110.334 179.961 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 822' ' ' GLY . . . . . . . . . . . . . . . -178.16 57.75 0.09 OUTLIER Glycine 0 N--CA 1.492 2.375 0 N-CA-C 109.454 -1.458 . . . . 0.0 109.454 -179.98 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 823' ' ' GLY . . . . . . . . . . . . . . . 64.05 -122.85 26.8 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 -179.983 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 824' ' ' ASP . . . . . . . . . . . . . 89.4 m-20 -132.31 130.77 22.04 Favored Pre-proline 0 N--CA 1.495 1.806 0 O-C-N 121.327 -1.102 . . . . 0.0 109.985 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 825' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -82.05 -89.95 0.0 OUTLIER 'Trans proline' 0 C--N 1.308 -1.592 0 O-C-N 123.903 1.475 . . . . 0.0 111.062 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 826' ' ' CYS . . . . . . . . . . . . . 17.7 p -111.21 124.88 31.7 Favored Pre-proline 0 N--CA 1.497 1.879 0 O-C-N 121.256 -0.902 . . . . 0.0 111.12 -179.901 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 827' ' ' PRO . . . . . 0.488 ' O ' ' HB2' ' A' ' 828' ' ' GLU . 49.6 Cg_endo -81.16 -174.03 2.06 Favored 'Trans proline' 0 C--N 1.305 -1.719 0 O-C-N 123.962 1.506 . . . . 0.0 109.562 179.777 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 828' ' ' GLU . . . . . 0.488 ' HB2' ' O ' ' A' ' 827' ' ' PRO . 3.7 mm-40 58.79 14.48 3.24 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.475 -0.765 . . . . 0.0 109.611 -179.941 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 829' ' ' VAL . . . . . 0.459 ' O ' ' O ' ' A' ' 830' ' ' MET . 74.9 t -130.58 129.99 64.65 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.332 0 O-C-N 121.575 -0.703 . . . . 0.0 109.388 -179.983 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 830' ' ' MET . . . . . 0.459 ' O ' ' O ' ' A' ' 829' ' ' VAL . 33.8 mmt -52.82 -170.19 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.271 -0.893 . . . . 0.0 110.202 -179.964 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 831' ' ' LYS . . . . . 0.458 ' HB3' ' OE1' ' A' ' 737' ' ' GLU . 9.4 mttp -147.43 149.58 32.99 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 120.94 -1.1 . . . . 0.0 110.702 -179.913 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 832' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -161.86 149.18 14.31 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.602 -0.686 . . . . 0.0 109.151 179.924 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 833' ' ' VAL . . . . . 0.52 HG21 ' CD1' ' A' ' 816' ' ' ILE . 70.2 t -111.87 107.47 23.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 120.911 -1.118 . . . . 0.0 111.375 -179.973 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 834' ' ' ALA . . . . . 0.423 ' HA ' ' O ' ' A' ' 733' ' ' ALA . . . -109.97 128.71 55.55 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.375 -0.828 . . . . 0.0 109.172 179.857 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 835' ' ' VAL . . . . . . . . . . . . . 3.0 t -138.08 145.56 28.46 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 O-C-N 120.808 -1.183 . . . . 0.0 111.232 -179.855 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 836' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -124.48 117.93 25.49 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 179.873 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 837' ' ' ALA . . . . . . . . . . . . . . . -107.94 155.57 20.17 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.156 -0.965 . . . . 0.0 111.233 -179.807 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 838' ' ' VAL . . . . . 0.476 ' HB ' ' O ' ' A' ' 772' ' ' ALA . 71.9 t -112.33 110.99 34.23 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.375 0 O-C-N 121.545 -0.722 . . . . 0.0 109.361 179.938 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 839' ' ' CYS . . . . . 0.444 ' HB3' ' HB3' ' A' ' 768' ' ' GLN . 1.2 m -105.44 108.93 20.71 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.123 -0.986 . . . . 0.0 110.216 -179.915 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 840' ' ' SER . . . . . 0.475 ' O ' HG21 ' A' ' 841' ' ' THR . 14.8 t -99.17 -89.21 0.32 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.315 -0.865 . . . . 0.0 110.25 179.994 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 841' ' ' THR . . . . . 0.475 HG21 ' O ' ' A' ' 840' ' ' SER . 62.9 p . . . . . 0 N--CA 1.495 1.805 0 O-C-N 121.194 -0.942 . . . . 0.0 110.578 -179.977 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 728' ' ' VAL . . . . . 0.471 ' O ' ' HB2' ' A' ' 729' ' ' SER . 1.3 t . . . . . 0 N--CA 1.485 1.283 0 CA-C-O 121.355 0.598 . . . . 0.0 109.959 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 729' ' ' SER . . . . . 0.471 ' HB2' ' O ' ' A' ' 728' ' ' VAL . 2.2 m 58.16 168.62 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.484 -0.76 . . . . 0.0 110.788 179.827 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 730' ' ' GLY . . . . . 0.48 ' C ' ' CG2' ' A' ' 731' ' ' VAL . . . -131.32 -161.35 10.18 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.065 -1.614 . . . . 0.0 109.065 179.938 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 731' ' ' VAL . . . . . 0.542 HG11 ' CD2' ' A' ' 762' ' ' LEU . 4.8 t -150.58 137.39 13.0 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 121.149 -1.207 . . . . 0.0 110.324 179.989 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 732' ' ' CYS . . . . . . . . . . . . . 20.3 m -128.25 143.71 51.06 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.309 -0.869 . . . . 0.0 109.868 179.964 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 733' ' ' ALA . . . . . . . . . . . . . . . -148.38 105.06 3.57 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.989 -1.069 . . . . 0.0 110.735 -179.948 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 734' ' ' ASP . . . . . 0.47 ' OD1' ' O ' ' A' ' 734' ' ' ASP . 1.0 OUTLIER -110.39 104.01 12.73 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.352 -0.843 . . . . 0.0 109.979 179.924 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 735' ' ' VAL . . . . . 0.482 ' O ' ' HB ' ' A' ' 833' ' ' VAL . 77.0 t -129.68 123.33 56.95 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 121.125 -0.984 . . . . 0.0 110.243 -179.967 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 736' ' ' SER . . . . . 0.461 ' HA ' ' HA ' ' A' ' 832' ' ' ARG . 5.4 p -84.24 158.74 21.16 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.088 -1.007 . . . . 0.0 110.362 -179.959 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 737' ' ' GLU . . . . . 0.464 ' HB3' ' HG3' ' A' ' 831' ' ' LYS . 24.5 tt0 . . . . . 0 N--CA 1.494 1.769 0 O-C-N 121.271 -0.893 . . . . 0.0 109.992 179.981 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 757' ' ' THR . . . . . . . . . . . . . 60.9 p . . . . . 0 N--CA 1.494 1.755 0 CA-C-O 121.386 0.613 . . . . 0.0 110.246 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 758' ' ' ALA . . . . . . . . . . . . . . . -111.9 157.93 20.06 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.295 -0.878 . . . . 0.0 110.238 179.955 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 759' ' ' LYS . . . . . . . . . . . . . 1.3 ttmt -113.51 155.0 26.15 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.338 -0.851 . . . . 0.0 109.928 -179.974 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 760' ' ' VAL . . . . . . . . . . . . . 16.8 t -109.06 136.87 43.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.246 -0.909 . . . . 0.0 109.729 179.926 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 761' ' ' HIS . . . . . . . . . . . . . 3.5 m80 -109.52 107.34 17.42 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.147 -0.97 . . . . 0.0 110.467 -179.984 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 762' ' ' LEU . . . . . 0.542 ' CD2' HG11 ' A' ' 731' ' ' VAL . 2.0 mt -109.54 148.13 31.77 Favored 'General case' 0 C--N 1.299 -1.607 0 O-C-N 121.65 -0.656 . . . . 0.0 109.502 179.944 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 763' ' ' LYS . . . . . . . . . . . . . 3.3 ttpt -158.39 121.46 3.83 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.131 -0.98 . . . . 0.0 110.091 179.997 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 764' ' ' CYS . . . . . 0.442 ' O ' ' C ' ' A' ' 765' ' ' ALA . 12.7 t -82.06 157.77 24.02 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.262 -0.899 . . . . 0.0 110.001 179.958 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 765' ' ' ALA . . . . . 0.461 ' HB1' ' OE1' ' A' ' 768' ' ' GLN . . . -41.29 162.36 0.12 Allowed Pre-proline 0 N--CA 1.495 1.799 0 O-C-N 121.263 -0.898 . . . . 0.0 110.325 -179.966 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 766' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -73.16 99.75 1.14 Allowed 'Trans proline' 0 C--N 1.304 -1.799 0 O-C-N 124.025 1.54 . . . . 0.0 110.185 -179.979 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 767' ' ' GLY . . . . . . . . . . . . . . . 117.76 1.0 17.58 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.486 -1.446 . . . . 0.0 109.486 -179.962 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 768' ' ' GLN . . . . . 0.501 ' CG ' ' O ' ' A' ' 840' ' ' SER . 10.7 mp0 -116.47 154.47 30.29 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.219 -1.165 . . . . 0.0 110.273 179.938 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 769' ' ' THR . . . . . 0.403 HG22 ' C ' ' A' ' 768' ' ' GLN . 43.1 p -129.02 147.54 50.9 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.184 -0.948 . . . . 0.0 110.359 -179.978 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 770' ' ' ILE . . . . . . . . . . . . . 37.0 mt -58.99 133.17 24.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.308 -0.87 . . . . 0.0 109.751 179.952 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 771' ' ' SER . . . . . . . . . . . . . 51.7 p -108.47 -17.0 14.09 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.236 -0.915 . . . . 0.0 110.861 -179.889 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 772' ' ' ALA . . . . . . . . . . . . . . . -177.77 171.84 1.79 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.875 -1.141 . . . . 0.0 111.271 -179.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 773' ' ' ILE . . . . . . . . . . . . . 42.6 mm -123.72 129.49 74.45 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 179.858 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 774' ' ' LYS . . . . . 0.408 ' HD2' HG22 ' A' ' 838' ' ' VAL . 5.9 mtpt -95.03 -35.47 11.93 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 121.033 -1.042 . . . . 0.0 111.537 -179.848 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 775' ' ' PHE . . . . . 0.569 ' CZ ' ' HB3' ' A' ' 788' ' ' PHE . 60.1 t80 -149.06 172.34 14.92 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 120.686 -1.259 . . . . 0.0 111.465 -179.948 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 776' ' ' ALA . . . . . 0.556 ' N ' ' CD2' ' A' ' 775' ' ' PHE . . . 169.3 119.93 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 109.187 -0.672 . . . . 0.0 109.187 -179.971 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 777' ' ' SER . . . . . 0.482 ' HA ' ' CB ' ' A' ' 798' ' ' SER . 44.4 t -143.69 137.2 28.02 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 120.978 -1.076 . . . . 0.0 111.172 -179.891 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 778' ' ' PHE . . . . . 0.57 ' CG ' ' O ' ' A' ' 778' ' ' PHE . 1.4 t80 -107.34 72.37 0.87 Allowed 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.422 -0.799 . . . . 0.0 109.73 179.925 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 779' ' ' GLY . . . . . . . . . . . . . . . -174.24 -120.6 0.59 Allowed Glycine 0 N--CA 1.492 2.405 0 N-CA-C 109.961 -1.255 . . . . 0.0 109.961 179.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 780' ' ' THR . . . . . 0.445 ' OG1' ' HA3' ' A' ' 791' ' ' GLY . 24.8 p -117.11 81.46 12.79 Favored Pre-proline 0 N--CA 1.494 1.775 0 O-C-N 121.197 -1.178 . . . . 0.0 110.553 179.984 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 781' ' ' PRO . . . . . 0.4 ' HA ' ' O ' ' A' ' 789' ' ' GLN . 46.8 Cg_endo -80.48 144.43 15.97 Favored 'Trans proline' 0 C--N 1.304 -1.805 0 O-C-N 124.054 1.555 . . . . 0.0 110.229 -179.983 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 782' ' ' LEU . . . . . . . . . . . . . 36.8 mt -120.32 148.91 43.12 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.176 -0.953 . . . . 0.0 110.331 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 783' ' ' GLY . . . . . . . . . . . . . . . 112.2 -139.29 15.54 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.546 -1.422 . . . . 0.0 109.546 -179.962 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 784' ' ' THR . . . . . . . . . . . . . 10.8 t -161.12 -173.26 3.78 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.254 -1.144 . . . . 0.0 110.138 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 785' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -64.37 107.15 1.27 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.191 -0.943 . . . . 0.0 110.204 -179.975 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 786' ' ' GLY . . . . . . . . . . . . . . . 131.36 -31.65 3.09 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.2 -1.56 . . . . 0.0 109.2 179.981 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 787' ' ' THR . . . . . . . . . . . . . 25.2 p -144.38 39.81 1.31 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.32 -1.106 . . . . 0.0 110.088 -179.942 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 788' ' ' PHE . . . . . 0.569 ' HB3' ' CZ ' ' A' ' 775' ' ' PHE . 1.9 m-85 -50.97 171.55 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.328 -0.858 . . . . 0.0 110.229 179.935 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 789' ' ' GLN . . . . . 0.4 ' O ' ' HA ' ' A' ' 781' ' ' PRO . 26.4 tt0 -161.05 169.57 22.22 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.114 -0.991 . . . . 0.0 110.424 -179.989 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 790' ' ' GLN . . . . . 0.463 ' O ' ' HG3' ' A' ' 790' ' ' GLN . 0.0 OUTLIER -94.89 147.96 22.82 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.23 -0.919 . . . . 0.0 110.041 -179.992 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 791' ' ' GLY . . . . . 0.445 ' HA3' ' OG1' ' A' ' 780' ' ' THR . . . -97.4 -150.67 26.88 Favored Glycine 0 N--CA 1.492 2.393 0 N-CA-C 109.516 -1.434 . . . . 0.0 109.516 179.943 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 792' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -70.08 -19.66 63.25 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.255 -1.144 . . . . 0.0 109.973 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 793' ' ' CYS . . . . . 0.475 ' SG ' ' N ' ' A' ' 794' ' ' HIS . 1.8 t -136.72 164.86 27.26 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.337 -0.852 . . . . 0.0 110.051 -179.963 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 794' ' ' HIS . . . . . 0.596 ' CE1' ' O ' ' A' ' 795' ' ' SER . 0.2 OUTLIER 179.5 154.65 0.5 Allowed 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.285 -0.884 . . . . 0.0 109.861 179.976 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 795' ' ' SER . . . . . 0.596 ' O ' ' CE1' ' A' ' 794' ' ' HIS . 1.8 t -91.78 107.61 19.33 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.324 -0.86 . . . . 0.0 110.15 179.993 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 796' ' ' ILE . . . . . 0.436 ' C ' ' O ' ' A' ' 795' ' ' SER . 6.5 pt -38.63 -25.05 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.939 0 O-C-N 121.372 -0.83 . . . . 0.0 111.23 179.981 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 797' ' ' ASN . . . . . 0.532 ' N ' ' O ' ' A' ' 795' ' ' SER . 19.3 p30 -107.85 51.74 0.73 Allowed 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.003 -1.06 . . . . 0.0 111.313 -179.894 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 798' ' ' SER . . . . . 0.494 ' OG ' ' O ' ' A' ' 795' ' ' SER . 4.3 m -102.8 26.42 8.08 Favored 'General case' 0 N--CA 1.497 1.925 0 O-C-N 120.697 -1.252 . . . . 0.0 110.403 179.939 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 799' ' ' ASN . . . . . . . . . . . . . 38.4 m-80 -138.07 -46.97 0.53 Allowed 'General case' 0 N--CA 1.496 1.831 0 O-C-N 120.998 -1.064 . . . . 0.0 110.874 -179.905 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 800' ' ' SER . . . . . . . . . . . . . 8.7 t -62.78 -33.12 74.52 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.118 -0.989 . . . . 0.0 110.385 -179.93 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 801' ' ' VAL . . . . . . . . . . . . . 97.8 t -51.92 -52.06 25.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.285 -0.884 . . . . 0.0 110.582 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 802' ' ' LEU . . . . . 0.473 HD12 ' SG ' ' A' ' 806' ' ' CYS . 1.1 mm? -63.15 -43.48 98.2 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.206 -0.934 . . . . 0.0 110.861 179.996 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 803' ' ' GLU . . . . . . . . . . . . . 24.7 tt0 -55.33 -21.1 13.62 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.232 -0.918 . . . . 0.0 110.646 -179.959 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 804' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -92.14 -23.22 19.49 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.234 -0.916 . . . . 0.0 110.98 -179.969 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 805' ' ' LYS . . . . . 0.4 ' O ' ' SG ' ' A' ' 812' ' ' CYS . 5.0 mmmt -130.77 52.57 2.03 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.017 -1.052 . . . . 0.0 110.892 -179.904 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 806' ' ' CYS . . . . . 0.473 ' SG ' HD12 ' A' ' 802' ' ' LEU . 0.3 OUTLIER -160.95 -72.19 0.06 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.035 -1.041 . . . . 0.0 110.903 179.986 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 807' ' ' ILE . . . . . . . . . . . . . 94.4 mt -55.28 128.74 15.85 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 121.223 -0.923 . . . . 0.0 110.776 -179.921 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 808' ' ' GLY . . . . . 0.465 ' C ' ' HG ' ' A' ' 809' ' ' LEU . . . 106.83 1.16 36.58 Favored Glycine 0 N--CA 1.495 2.576 0 N-CA-C 110.385 -1.086 . . . . 0.0 110.385 179.906 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 809' ' ' LEU . . . . . 0.465 ' HG ' ' C ' ' A' ' 808' ' ' GLY . 1.0 OUTLIER -131.83 160.61 35.15 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 120.831 -1.393 . . . . 0.0 110.534 -179.958 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 810' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -83.78 -9.49 58.76 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.329 -0.857 . . . . 0.0 109.583 179.91 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 811' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -143.62 164.93 29.03 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.39 -0.819 . . . . 0.0 109.193 -179.987 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 812' ' ' CYS . . . . . 0.4 ' SG ' ' O ' ' A' ' 805' ' ' LYS . 7.9 t -143.77 126.99 16.62 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.922 -1.111 . . . . 0.0 111.268 -179.852 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 813' ' ' VAL . . . . . . . . . . . . . 98.3 t -128.45 115.11 36.54 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.298 -0.877 . . . . 0.0 109.225 179.809 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 814' ' ' VAL . . . . . . . . . . . . . 97.9 t -123.28 129.21 74.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.134 -0.978 . . . . 0.0 110.772 -179.876 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 815' ' ' ALA . . . . . . . . . . . . . . . -86.69 158.82 19.35 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.323 -0.861 . . . . 0.0 109.623 179.909 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 816' ' ' ILE . . . . . 0.454 HG23 ' HB2' ' A' ' 737' ' ' GLU . 75.9 mt -109.65 133.02 56.24 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.577 0 O-C-N 121.218 -0.926 . . . . 0.0 110.575 -179.985 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 817' ' ' SER . . . . . 0.502 ' OG ' ' CB ' ' A' ' 820' ' ' ASN . 0.1 OUTLIER -165.98 170.45 5.8 Favored Pre-proline 0 N--CA 1.488 1.447 0 O-C-N 121.267 -0.896 . . . . 0.0 109.888 179.978 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 818' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -78.16 -63.63 0.02 OUTLIER 'Trans proline' 0 C--N 1.303 -1.834 0 O-C-N 123.982 1.517 . . . . 0.0 111.497 -179.886 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 819' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -70.24 -1.1 9.31 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 120.986 -1.071 . . . . 0.0 111.215 -179.849 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 820' ' ' ASN . . . . . 0.502 ' CB ' ' OG ' ' A' ' 817' ' ' SER . 27.9 t-20 -84.49 -20.79 31.1 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 120.952 -1.093 . . . . 0.0 109.999 179.977 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 821' ' ' PHE . . . . . . . . . . . . . 5.5 m-85 -108.45 -59.3 1.88 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.232 -0.918 . . . . 0.0 110.562 -179.903 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 822' ' ' GLY . . . . . . . . . . . . . . . -144.13 -55.65 0.03 OUTLIER Glycine 0 N--CA 1.491 2.366 0 N-CA-C 109.773 -1.331 . . . . 0.0 109.773 179.965 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 823' ' ' GLY . . . . . . . . . . . . . . . 137.77 108.32 0.85 Allowed Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.661 -1.376 . . . . 0.0 109.661 -179.958 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 824' ' ' ASP . . . . . 0.517 ' N ' ' HD3' ' A' ' 825' ' ' PRO . 4.2 m-20 43.11 59.93 10.99 Favored Pre-proline 0 N--CA 1.494 1.736 0 O-C-N 121.343 -1.092 . . . . 0.0 110.73 -179.976 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 825' ' ' PRO . . . . . 0.517 ' HD3' ' N ' ' A' ' 824' ' ' ASP . 47.8 Cg_endo -84.29 -54.91 0.03 OUTLIER 'Trans proline' 0 C--N 1.304 -1.784 0 O-C-N 123.926 1.487 . . . . 0.0 110.261 179.998 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 826' ' ' CYS . . . . . 0.471 ' SG ' HG12 ' A' ' 829' ' ' VAL . 0.5 OUTLIER -131.56 85.24 53.02 Favored Pre-proline 0 N--CA 1.496 1.838 0 O-C-N 121.267 -0.896 . . . . 0.0 110.375 -179.993 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 827' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo -86.64 151.11 8.81 Favored 'Trans proline' 0 C--N 1.306 -1.671 0 O-C-N 123.919 1.484 . . . . 0.0 111.287 -179.969 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 828' ' ' GLU . . . . . 0.437 ' O ' HG21 ' A' ' 829' ' ' VAL . 3.7 mm-40 45.28 48.99 10.28 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.426 -0.796 . . . . 0.0 111.111 179.968 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 829' ' ' VAL . . . . . 0.515 ' O ' ' N ' ' A' ' 831' ' ' LYS . 20.4 t -147.44 137.95 17.34 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.583 0 O-C-N 121.164 -0.96 . . . . 0.0 110.173 179.899 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 830' ' ' MET . . . . . 0.441 ' C ' ' O ' ' A' ' 829' ' ' VAL . 0.2 OUTLIER -42.31 95.11 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.419 -0.8 . . . . 0.0 109.618 179.976 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 831' ' ' LYS . . . . . 0.515 ' N ' ' O ' ' A' ' 829' ' ' VAL . 0.0 OUTLIER -94.61 150.22 20.46 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.186 -0.946 . . . . 0.0 110.565 -179.938 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 832' ' ' ARG . . . . . 0.461 ' HA ' ' HA ' ' A' ' 736' ' ' SER . 0.0 OUTLIER -156.94 151.76 25.84 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.404 -0.81 . . . . 0.0 109.662 179.97 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 833' ' ' VAL . . . . . 0.482 ' HB ' ' O ' ' A' ' 735' ' ' VAL . 66.6 t -115.79 106.1 19.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 120.979 -1.075 . . . . 0.0 110.955 179.978 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 834' ' ' ALA . . . . . 0.419 ' HB2' ' CZ ' ' A' ' 788' ' ' PHE . . . -108.87 132.95 53.53 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.307 -0.87 . . . . 0.0 109.092 179.922 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 835' ' ' VAL . . . . . . . . . . . . . 73.1 t -141.16 133.03 28.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.012 -1.055 . . . . 0.0 111.323 -179.94 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 836' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -125.53 112.64 16.45 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 179.897 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 837' ' ' ALA . . . . . . . . . . . . . . . -108.91 162.67 13.99 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.146 -0.971 . . . . 0.0 111.089 -179.926 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 838' ' ' VAL . . . . . 0.408 HG22 ' HD2' ' A' ' 774' ' ' LYS . 38.6 t -111.84 119.15 59.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.524 -0.735 . . . . 0.0 109.727 -179.946 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 839' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -105.71 146.18 30.11 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.9 -1.125 . . . . 0.0 110.94 179.946 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 840' ' ' SER . . . . . 0.501 ' O ' ' CG ' ' A' ' 768' ' ' GLN . 79.1 p -138.94 -152.22 0.41 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.498 -0.752 . . . . 0.0 109.775 -179.991 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 841' ' ' THR . . . . . . . . . . . . . 69.6 p . . . . . 0 N--CA 1.492 1.648 0 O-C-N 121.186 -0.946 . . . . 0.0 109.993 179.977 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 728' ' ' VAL . . . . . 0.401 ' O ' ' O ' ' A' ' 729' ' ' SER . 43.0 t . . . . . 0 N--CA 1.489 1.505 0 CA-C-O 121.264 0.554 . . . . 0.0 110.177 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 729' ' ' SER . . . . . 0.401 ' O ' ' O ' ' A' ' 728' ' ' VAL . 40.5 m 51.78 179.21 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.18 -0.95 . . . . 0.0 110.034 -179.972 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 730' ' ' GLY . . . . . . . . . . . . . . . -152.8 -158.8 8.69 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.622 -1.391 . . . . 0.0 109.622 -179.938 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 731' ' ' VAL . . . . . 0.511 ' CG2' ' SG ' ' A' ' 764' ' ' CYS . 18.0 t -140.1 144.65 27.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.21 -1.171 . . . . 0.0 110.506 179.99 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 732' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -135.96 143.15 44.71 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.432 -0.793 . . . . 0.0 109.729 179.952 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 733' ' ' ALA . . . . . . . . . . . . . . . -148.44 122.74 9.61 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.123 -0.986 . . . . 0.0 110.726 179.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 734' ' ' ASP . . . . . 0.461 ' O ' ' OD2' ' A' ' 734' ' ' ASP . 19.3 p-10 -129.92 106.06 8.41 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.326 -0.859 . . . . 0.0 109.877 179.953 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 735' ' ' VAL . . . . . 0.52 HG11 ' N ' ' A' ' 736' ' ' SER . 61.3 t -126.8 159.32 36.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.107 -0.996 . . . . 0.0 110.428 -179.951 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 736' ' ' SER . . . . . 0.52 ' N ' HG11 ' A' ' 735' ' ' VAL . 24.6 m -109.51 127.29 54.34 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.321 -0.862 . . . . 0.0 109.932 179.992 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 737' ' ' GLU . . . . . 0.449 ' HB2' ' HB3' ' A' ' 831' ' ' LYS . 14.9 tp10 . . . . . 0 N--CA 1.495 1.787 0 O-C-N 121.296 -0.878 . . . . 0.0 110.433 179.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 757' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.751 0 CA-C-O 121.337 0.589 . . . . 0.0 110.217 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 758' ' ' ALA . . . . . 0.444 ' HB3' ' CD1' ' A' ' 816' ' ' ILE . . . -98.9 172.26 7.54 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.32 -0.862 . . . . 0.0 109.855 179.939 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 759' ' ' LYS . . . . . . . . . . . . . 6.4 mttm -150.74 136.58 18.22 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.115 -0.991 . . . . 0.0 110.41 179.959 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 760' ' ' VAL . . . . . 0.431 HG12 HD13 ' A' ' 762' ' ' LEU . 42.1 t -106.6 136.65 40.58 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.305 -0.872 . . . . 0.0 109.263 179.941 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 761' ' ' HIS . . . . . . . . . . . . . 68.1 m80 -109.71 104.15 13.1 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.198 -0.939 . . . . 0.0 110.981 -179.947 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 762' ' ' LEU . . . . . 0.431 HD13 HG12 ' A' ' 760' ' ' VAL . 39.4 mt -119.13 101.77 8.25 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.33 -0.857 . . . . 0.0 108.951 179.905 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 763' ' ' LYS . . . . . 0.454 ' HB3' ' HG3' ' A' ' 811' ' ' ARG . 6.6 pttm -135.66 140.86 44.82 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.077 -1.015 . . . . 0.0 110.803 -179.956 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 764' ' ' CYS . . . . . 0.511 ' SG ' ' CG2' ' A' ' 731' ' ' VAL . 0.5 OUTLIER -113.47 157.77 21.55 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.407 -0.808 . . . . 0.0 109.891 179.983 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 765' ' ' ALA . . . . . 0.465 ' HB1' ' HG3' ' A' ' 768' ' ' GLN . . . -44.73 169.71 0.06 OUTLIER Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 121.197 -0.939 . . . . 0.0 110.218 179.963 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 766' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -71.13 113.04 3.46 Favored 'Trans proline' 0 C--N 1.304 -1.787 0 O-C-N 123.961 1.506 . . . . 0.0 110.4 179.958 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 767' ' ' GLY . . . . . . . . . . . . . . . 110.07 -24.82 17.82 Favored Glycine 0 N--CA 1.488 2.16 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 -179.942 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 768' ' ' GLN . . . . . 0.465 ' HG3' ' HB1' ' A' ' 765' ' ' ALA . 3.1 mt-30 -87.77 99.84 12.4 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.238 -1.154 . . . . 0.0 110.117 -179.99 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 769' ' ' THR . . . . . . . . . . . . . 64.1 p -94.78 154.14 17.42 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.257 -0.902 . . . . 0.0 110.375 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 770' ' ' ILE . . . . . 0.407 ' HA ' ' O ' ' A' ' 838' ' ' VAL . 11.3 mt -78.11 144.89 10.65 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.356 -0.84 . . . . 0.0 110.005 -179.999 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 771' ' ' SER . . . . . . . . . . . . . 1.8 t -137.02 -5.3 1.89 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.147 -0.971 . . . . 0.0 111.158 -179.915 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 772' ' ' ALA . . . . . . . . . . . . . . . -162.18 123.38 2.65 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.859 -1.151 . . . . 0.0 111.014 -179.906 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 773' ' ' ILE . . . . . . . . . . . . . 32.9 mm -85.67 124.48 40.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.286 -0.884 . . . . 0.0 109.551 179.889 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 774' ' ' LYS . . . . . . . . . . . . . 18.9 mmtt -80.44 -42.26 22.98 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.246 -0.909 . . . . 0.0 110.757 -179.904 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 775' ' ' PHE . . . . . 0.479 ' O ' ' CB ' ' A' ' 776' ' ' ALA . 59.3 t80 -154.04 173.0 16.61 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.027 -1.045 . . . . 0.0 111.078 -179.974 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 776' ' ' ALA . . . . . 0.526 ' O ' ' CB ' ' A' ' 798' ' ' SER . . . 168.39 89.08 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.588 -0.695 . . . . 0.0 109.548 179.959 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 777' ' ' SER . . . . . 0.547 ' HA ' ' CB ' ' A' ' 798' ' ' SER . 59.5 p -122.66 137.7 54.82 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.231 -0.918 . . . . 0.0 110.504 -179.906 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 778' ' ' PHE . . . . . . . . . . . . . 15.7 t80 -104.18 104.32 14.22 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.245 -0.909 . . . . 0.0 110.066 179.963 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 779' ' ' GLY . . . . . . . . . . . . . . . 161.64 -113.55 0.57 Allowed Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.457 -1.457 . . . . 0.0 109.457 -179.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 780' ' ' THR . . . . . . . . . . . . . 12.0 p -118.56 72.86 10.75 Favored Pre-proline 0 N--CA 1.492 1.67 0 O-C-N 121.203 -1.175 . . . . 0.0 110.127 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 781' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -73.27 161.16 43.55 Favored 'Trans proline' 0 C--N 1.307 -1.629 0 O-C-N 123.952 1.501 . . . . 0.0 110.296 179.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 782' ' ' LEU . . . . . 0.547 ' CD1' ' CA ' ' A' ' 791' ' ' GLY . 1.2 mp -132.61 169.36 16.73 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.233 -0.917 . . . . 0.0 110.159 179.984 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 783' ' ' GLY . . . . . . . . . . . . . . . 95.61 -167.67 26.0 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.354 -1.498 . . . . 0.0 109.354 -179.994 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 784' ' ' THR . . . . . 0.574 ' O ' ' CZ ' ' A' ' 788' ' ' PHE . 1.2 p -133.62 -65.69 0.67 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.187 -1.184 . . . . 0.0 110.337 -179.981 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 785' ' ' CYS . . . . . . . . . . . . . 7.8 t -156.19 128.49 7.6 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.166 -0.959 . . . . 0.0 110.445 179.988 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 786' ' ' GLY . . . . . . . . . . . . . . . 92.25 -13.18 67.77 Favored Glycine 0 N--CA 1.492 2.384 0 N-CA-C 109.7 -1.36 . . . . 0.0 109.7 -179.973 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 787' ' ' THR . . . . . . . . . . . . . 7.5 t -141.21 31.99 1.73 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.206 -1.173 . . . . 0.0 110.612 -179.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 788' ' ' PHE . . . . . 0.574 ' CZ ' ' O ' ' A' ' 784' ' ' THR . 0.7 OUTLIER -61.02 129.23 40.37 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.094 -1.004 . . . . 0.0 109.671 179.982 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 789' ' ' GLN . . . . . . . . . . . . . 5.2 pt20 -133.23 161.06 35.46 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.075 -1.016 . . . . 0.0 110.258 -179.967 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 790' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -75.27 144.36 42.57 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.233 -0.917 . . . . 0.0 110.406 -179.931 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 791' ' ' GLY . . . . . 0.547 ' CA ' ' CD1' ' A' ' 782' ' ' LEU . . . -96.56 -46.1 2.59 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 -179.98 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 792' ' ' GLU . . . . . 0.46 ' HB3' ' O ' ' A' ' 791' ' ' GLY . 15.8 pt-20 179.17 -27.63 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.158 -1.201 . . . . 0.0 110.93 -179.921 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 793' ' ' CYS . . . . . 0.46 ' O ' ' HB2' ' A' ' 794' ' ' HIS . 1.7 m -102.72 164.1 11.83 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.058 -1.026 . . . . 0.0 110.979 -179.92 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 794' ' ' HIS . . . . . 0.498 ' CE1' ' OG ' ' A' ' 798' ' ' SER . 32.3 t60 179.56 135.52 0.1 Allowed 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.466 -0.771 . . . . 0.0 109.727 179.941 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 795' ' ' SER . . . . . 0.419 ' O ' ' N ' ' A' ' 797' ' ' ASN . 0.2 OUTLIER -90.87 23.78 3.01 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.19 -0.944 . . . . 0.0 110.884 -179.909 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 796' ' ' ILE . . . . . 0.5 HG21 ' O ' ' A' ' 796' ' ' ILE . 40.9 mt 42.65 27.29 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 O-C-N 121.125 -0.984 . . . . 0.0 110.018 179.958 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 797' ' ' ASN . . . . . 0.419 ' N ' ' O ' ' A' ' 795' ' ' SER . 1.2 t-20 -157.25 26.88 0.3 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.246 -0.909 . . . . 0.0 109.611 179.972 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 798' ' ' SER . . . . . 0.547 ' CB ' ' HA ' ' A' ' 777' ' ' SER . 2.8 m -84.28 -19.65 33.46 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.396 -0.815 . . . . 0.0 110.515 -179.96 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 799' ' ' ASN . . . . . 0.42 ' OD1' ' HB2' ' A' ' 776' ' ' ALA . 63.9 m-80 -108.87 -1.06 19.43 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.276 -0.89 . . . . 0.0 110.751 -179.996 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 800' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -91.83 -31.34 15.76 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.21 -0.931 . . . . 0.0 110.434 -179.962 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 801' ' ' VAL . . . . . 0.406 HG23 ' CD2' ' A' ' 821' ' ' PHE . 95.7 t -79.93 -17.93 12.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.359 -0.838 . . . . 0.0 110.089 -179.949 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 802' ' ' LEU . . . . . 0.488 ' N ' ' CD2' ' A' ' 802' ' ' LEU . 4.5 mm? -87.71 -60.43 1.97 Allowed 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.317 -0.864 . . . . 0.0 110.838 -179.955 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 803' ' ' GLU . . . . . 0.524 ' CG ' HD12 ' A' ' 807' ' ' ILE . 1.1 tt0 -57.3 -20.23 27.14 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.113 -0.992 . . . . 0.0 110.527 -179.988 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 804' ' ' ARG . . . . . . . . . . . . . 48.2 ttt85 -93.8 -20.21 20.3 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.268 -0.895 . . . . 0.0 111.757 -179.896 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 805' ' ' LYS . . . . . 0.448 ' O ' ' SG ' ' A' ' 806' ' ' CYS . 8.8 tttm -126.29 40.13 3.79 Favored 'General case' 0 N--CA 1.501 2.108 0 O-C-N 120.765 -1.21 . . . . 0.0 111.502 -179.887 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 806' ' ' CYS . . . . . 0.448 ' SG ' ' O ' ' A' ' 805' ' ' LYS . 1.3 m -163.55 -55.06 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.038 -1.039 . . . . 0.0 110.235 179.892 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 807' ' ' ILE . . . . . 0.524 HD12 ' CG ' ' A' ' 803' ' ' GLU . 5.6 mt -51.09 119.15 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.315 -0.866 . . . . 0.0 110.432 -179.965 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 808' ' ' GLY . . . . . 0.424 ' C ' ' HG ' ' A' ' 809' ' ' LEU . . . 111.14 6.93 25.51 Favored Glycine 0 N--CA 1.492 2.415 0 N-CA-C 109.803 -1.319 . . . . 0.0 109.803 179.923 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 809' ' ' LEU . . . . . 0.424 ' HG ' ' C ' ' A' ' 808' ' ' GLY . 15.9 mt -136.25 148.88 48.25 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.203 -1.175 . . . . 0.0 110.311 -179.971 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 810' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -76.38 -19.09 58.49 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.253 -0.904 . . . . 0.0 109.558 179.881 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 811' ' ' ARG . . . . . 0.454 ' HG3' ' HB3' ' A' ' 763' ' ' LYS . 1.0 OUTLIER -152.78 133.74 14.07 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.527 -0.733 . . . . 0.0 109.665 179.923 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 812' ' ' CYS . . . . . . . . . . . . . 27.6 p -152.02 141.48 21.62 Favored 'General case' 0 C--N 1.296 -1.759 0 O-C-N 121.334 -0.854 . . . . 0.0 110.64 -179.927 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 813' ' ' VAL . . . . . 0.416 ' C ' HG23 ' A' ' 814' ' ' VAL . 24.2 t -110.21 152.97 12.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.277 -0.89 . . . . 0.0 109.843 -179.983 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 814' ' ' VAL . . . . . 0.416 HG23 ' C ' ' A' ' 813' ' ' VAL . 22.0 t -131.79 106.46 11.56 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 O-C-N 121.042 -1.036 . . . . 0.0 110.458 -179.936 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 815' ' ' ALA . . . . . . . . . . . . . . . -67.13 143.32 56.7 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.254 -0.904 . . . . 0.0 109.964 179.939 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 816' ' ' ILE . . . . . 0.475 HD13 ' CG2' ' A' ' 833' ' ' VAL . 20.8 mt -100.02 104.48 16.17 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.211 -0.931 . . . . 0.0 110.156 -179.928 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 817' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -144.61 153.73 55.26 Favored Pre-proline 0 N--CA 1.496 1.835 0 O-C-N 121.322 -0.861 . . . . 0.0 110.279 179.958 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 818' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -76.65 -25.73 9.08 Favored 'Trans proline' 0 C--N 1.309 -1.508 0 O-C-N 123.897 1.472 . . . . 0.0 110.391 -179.999 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 819' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -90.97 18.32 6.81 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.228 -0.92 . . . . 0.0 109.873 179.958 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 820' ' ' ASN . . . . . . . . . . . . . 31.0 t30 -116.16 -32.11 5.45 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.338 -0.851 . . . . 0.0 110.396 -179.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 821' ' ' PHE . . . . . 0.406 ' CD2' HG23 ' A' ' 801' ' ' VAL . 54.3 m-85 -86.07 -79.62 0.25 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.16 -0.963 . . . . 0.0 110.008 179.999 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 822' ' ' GLY . . . . . . . . . . . . . . . -177.76 56.5 0.1 OUTLIER Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.213 -1.555 . . . . 0.0 109.213 -179.97 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 823' ' ' GLY . . . . . . . . . . . . . . . 99.01 -149.65 19.12 Favored Glycine 0 N--CA 1.487 2.041 0 N-CA-C 109.353 -1.499 . . . . 0.0 109.353 179.972 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 824' ' ' ASP . . . . . 0.488 ' OD2' ' N ' ' A' ' 824' ' ' ASP . 0.8 OUTLIER -121.59 142.02 34.83 Favored Pre-proline 0 N--CA 1.492 1.649 0 O-C-N 121.23 -1.159 . . . . 0.0 110.332 179.943 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 825' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -75.61 -89.63 0.0 OUTLIER 'Trans proline' 0 C--N 1.306 -1.675 0 O-C-N 124.105 1.581 . . . . 0.0 110.888 -179.947 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 826' ' ' CYS . . . . . 0.467 ' HB3' HG22 ' A' ' 829' ' ' VAL . 79.0 m -113.62 120.72 38.88 Favored Pre-proline 0 N--CA 1.494 1.748 0 O-C-N 121.196 -0.94 . . . . 0.0 110.475 -179.953 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 827' ' ' PRO . . . . . 0.476 ' O ' ' CB ' ' A' ' 828' ' ' GLU . 49.1 Cg_endo -75.58 142.47 26.19 Favored 'Trans proline' 0 C--N 1.306 -1.66 0 O-C-N 123.839 1.442 . . . . 0.0 110.33 179.938 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 828' ' ' GLU . . . . . 0.476 ' CB ' ' O ' ' A' ' 827' ' ' PRO . 0.8 OUTLIER 67.36 38.65 3.18 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.256 -0.903 . . . . 0.0 110.35 -179.991 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 829' ' ' VAL . . . . . 0.467 HG22 ' HB3' ' A' ' 826' ' ' CYS . 24.0 t -136.05 132.92 50.46 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.174 -0.954 . . . . 0.0 110.291 -179.945 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 830' ' ' MET . . . . . 0.414 ' C ' ' O ' ' A' ' 829' ' ' VAL . 17.4 mtt -43.96 127.88 5.46 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.289 -0.882 . . . . 0.0 110.012 179.95 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 831' ' ' LYS . . . . . 0.453 ' HD3' ' O ' ' A' ' 829' ' ' VAL . 0.0 OUTLIER -94.08 112.99 24.87 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.144 -0.973 . . . . 0.0 110.511 -179.983 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 832' ' ' ARG . . . . . . . . . . . . . 33.4 mtp85 -125.12 139.83 53.42 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.317 -0.864 . . . . 0.0 109.823 179.914 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 833' ' ' VAL . . . . . 0.475 ' CG2' HD13 ' A' ' 816' ' ' ILE . 42.8 t -112.32 105.1 18.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.15 -0.969 . . . . 0.0 110.567 -179.914 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 834' ' ' ALA . . . . . . . . . . . . . . . -113.5 116.43 29.57 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.377 -0.827 . . . . 0.0 109.786 179.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 835' ' ' VAL . . . . . . . . . . . . . 29.4 t -130.51 156.75 42.72 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.176 -0.953 . . . . 0.0 110.544 -179.93 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 836' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -149.21 113.14 5.13 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.489 -0.757 . . . . 0.0 109.652 179.954 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 837' ' ' ALA . . . . . . . . . . . . . . . -110.22 163.42 13.64 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.098 -1.001 . . . . 0.0 110.465 -179.983 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 838' ' ' VAL . . . . . 0.407 ' O ' ' HA ' ' A' ' 770' ' ' ILE . 74.5 t -114.09 156.72 14.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.339 -0.851 . . . . 0.0 110.203 -179.968 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 839' ' ' CYS . . . . . . . . . . . . . 1.2 m -136.59 148.0 47.27 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.322 -0.861 . . . . 0.0 110.194 179.978 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 840' ' ' SER . . . . . 0.464 ' O ' ' CG2' ' A' ' 841' ' ' THR . 9.6 t -119.09 -99.36 0.44 Allowed 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.272 -0.892 . . . . 0.0 110.678 -179.953 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 841' ' ' THR . . . . . 0.464 ' CG2' ' O ' ' A' ' 840' ' ' SER . 19.5 p . . . . . 0 N--CA 1.493 1.688 0 O-C-N 121.008 -1.057 . . . . 0.0 110.191 -179.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 728' ' ' VAL . . . . . 0.478 ' O ' ' HB2' ' A' ' 729' ' ' SER . 68.2 t . . . . . 0 N--CA 1.493 1.676 0 CA-C-O 120.968 0.413 . . . . 0.0 110.178 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 729' ' ' SER . . . . . 0.48 ' HA ' ' O ' ' A' ' 839' ' ' CYS . 14.8 t -178.98 125.37 0.09 Allowed 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.147 -0.971 . . . . 0.0 110.891 179.947 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 730' ' ' GLY . . . . . . . . . . . . . . . 103.45 116.53 4.21 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 110.194 -1.162 . . . . 0.0 110.194 179.947 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 731' ' ' VAL . . . . . 0.521 ' CG2' ' O ' ' A' ' 837' ' ' ALA . 3.5 m -147.87 161.81 7.04 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.367 -1.078 . . . . 0.0 109.27 179.92 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 732' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -148.51 161.29 41.94 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.001 -1.062 . . . . 0.0 110.955 -179.978 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 733' ' ' ALA . . . . . . . . . . . . . . . -163.51 104.35 0.95 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.536 -0.728 . . . . 0.0 109.416 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 734' ' ' ASP . . . . . 0.503 ' O ' ' CG2' ' A' ' 735' ' ' VAL . 1.8 t70 -117.25 121.51 41.37 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.235 -0.916 . . . . 0.0 110.79 -179.959 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 735' ' ' VAL . . . . . 0.503 ' CG2' ' O ' ' A' ' 734' ' ' ASP . 49.0 t -156.09 148.61 11.67 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 O-C-N 121.326 -0.859 . . . . 0.0 109.796 179.926 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 736' ' ' SER . . . . . . . . . . . . . 90.7 p -98.77 -167.61 1.51 Allowed 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.114 -0.991 . . . . 0.0 110.588 -179.909 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 737' ' ' GLU . . . . . 0.478 ' HA ' ' HB2' ' A' ' 758' ' ' ALA . 0.8 OUTLIER . . . . . 0 N--CA 1.493 1.724 0 O-C-N 121.272 -0.892 . . . . 0.0 110.027 179.983 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 757' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.489 1.498 0 CA-C-O 121.39 0.614 . . . . 0.0 110.522 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 758' ' ' ALA . . . . . 0.478 ' HB2' ' HA ' ' A' ' 737' ' ' GLU . . . -88.97 172.33 9.22 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.257 -0.902 . . . . 0.0 109.866 179.96 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 759' ' ' LYS . . . . . 0.469 ' HE3' HG23 ' A' ' 813' ' ' VAL . 3.1 mtmt -142.91 162.95 34.12 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.069 -1.02 . . . . 0.0 110.644 -179.962 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 760' ' ' VAL . . . . . 0.53 ' O ' ' CG2' ' A' ' 813' ' ' VAL . 95.2 t -109.22 157.12 9.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.417 -0.802 . . . . 0.0 109.124 179.874 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 761' ' ' HIS . . . . . 0.5 ' N ' HG12 ' A' ' 760' ' ' VAL . 35.2 m80 -128.53 113.91 16.08 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.937 -1.102 . . . . 0.0 111.369 -179.89 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 762' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -122.38 106.45 11.08 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 179.892 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 763' ' ' LYS . . . . . . . . . . . . . 5.4 ttmt -131.2 135.45 47.41 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.977 -1.077 . . . . 0.0 111.199 -179.833 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 764' ' ' CYS . . . . . . . . . . . . . 59.5 m -106.58 175.58 5.45 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.566 -0.709 . . . . 0.0 109.801 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 765' ' ' ALA . . . . . . . . . . . . . . . -55.21 167.96 0.62 Allowed Pre-proline 0 N--CA 1.494 1.771 0 O-C-N 121.216 -0.927 . . . . 0.0 110.497 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 766' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -73.43 110.17 3.0 Favored 'Trans proline' 0 C--N 1.304 -1.778 0 O-C-N 124.211 1.638 . . . . 0.0 110.309 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 767' ' ' GLY . . . . . . . . . . . . . . . 117.32 -30.69 6.13 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.711 -1.356 . . . . 0.0 109.711 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 768' ' ' GLN . . . . . 0.455 ' OE1' HG22 ' A' ' 841' ' ' THR . 44.5 mm-40 -85.88 162.01 18.8 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.183 -1.187 . . . . 0.0 110.245 -179.926 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 769' ' ' THR . . . . . 0.435 HG21 ' OE1' ' A' ' 810' ' ' GLU . 64.9 p -146.43 146.99 30.79 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.248 -0.907 . . . . 0.0 110.214 -179.986 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 770' ' ' ILE . . . . . 0.456 HG13 ' SG ' ' A' ' 839' ' ' CYS . 1.8 mp -69.06 147.79 11.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.35 -0.843 . . . . 0.0 109.13 179.942 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 771' ' ' SER . . . . . . . . . . . . . 34.8 m -130.75 -11.85 3.84 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 120.882 -1.136 . . . . 0.0 111.794 -179.891 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 772' ' ' ALA . . . . . . . . . . . . . . . -161.75 153.5 19.01 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 120.743 -1.223 . . . . 0.0 111.492 -179.927 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 773' ' ' ILE . . . . . . . . . . . . . 15.1 mm -113.97 125.17 71.2 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.534 -0.729 . . . . 0.0 109.372 179.901 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 774' ' ' LYS . . . . . 0.538 ' HG3' ' N ' ' A' ' 775' ' ' PHE . 0.5 OUTLIER -89.69 -36.13 15.4 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.089 -1.007 . . . . 0.0 110.815 -179.892 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 775' ' ' PHE . . . . . 0.538 ' N ' ' HG3' ' A' ' 774' ' ' LYS . 65.2 t80 -137.47 149.78 47.09 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.982 -1.074 . . . . 0.0 110.746 -179.924 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 776' ' ' ALA . . . . . 0.447 ' HB2' ' HB3' ' A' ' 799' ' ' ASN . . . -179.03 106.74 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.548 -0.72 . . . . 0.0 109.531 179.954 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 777' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -139.69 136.67 34.49 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.13 -0.981 . . . . 0.0 110.55 -179.877 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 778' ' ' PHE . . . . . . . . . . . . . 86.4 t80 -104.27 76.38 1.32 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.427 -0.796 . . . . 0.0 109.915 179.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 779' ' ' GLY . . . . . . . . . . . . . . . -171.34 -109.77 0.23 Allowed Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.755 -1.338 . . . . 0.0 109.755 -179.989 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 780' ' ' THR . . . . . . . . . . . . . 2.9 p -112.54 92.42 19.71 Favored Pre-proline 0 N--CA 1.494 1.732 0 O-C-N 121.259 -1.142 . . . . 0.0 110.662 -179.992 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 781' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -79.04 127.63 7.8 Favored 'Trans proline' 0 C--N 1.305 -1.73 0 O-C-N 124.064 1.56 . . . . 0.0 110.19 -179.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 782' ' ' LEU . . . . . . . . . . . . . 2.6 mt -96.68 108.3 20.9 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.137 -0.977 . . . . 0.0 110.356 179.989 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 783' ' ' GLY . . . . . . . . . . . . . . . 120.99 -154.31 16.45 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.643 -1.383 . . . . 0.0 109.643 -179.995 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 784' ' ' THR . . . . . 0.574 ' O ' ' CZ ' ' A' ' 788' ' ' PHE . 9.9 t -151.09 -40.54 0.12 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.279 -1.13 . . . . 0.0 110.137 -179.959 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 785' ' ' CYS . . . . . 0.402 ' N ' ' CG2' ' A' ' 784' ' ' THR . 16.2 t -166.95 118.97 0.94 Allowed 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.306 -0.871 . . . . 0.0 109.692 -179.982 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 786' ' ' GLY . . . . . . . . . . . . . . . 85.84 -9.18 69.65 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.335 -1.506 . . . . 0.0 109.335 -179.96 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 787' ' ' THR . . . . . . . . . . . . . 18.7 p -139.56 33.94 2.04 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.23 -1.159 . . . . 0.0 110.174 -179.965 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 788' ' ' PHE . . . . . 0.574 ' CZ ' ' O ' ' A' ' 784' ' ' THR . 7.2 m-85 -71.18 174.69 6.05 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.228 -0.92 . . . . 0.0 110.337 179.98 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 789' ' ' GLN . . . . . 0.485 ' CG ' ' O ' ' A' ' 788' ' ' PHE . 0.0 OUTLIER 179.44 167.14 1.09 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.185 -0.947 . . . . 0.0 110.327 -179.971 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 790' ' ' GLN . . . . . . . . . . . . . 31.5 mt-30 -99.05 143.84 28.87 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.258 -0.901 . . . . 0.0 110.181 179.952 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 791' ' ' GLY . . . . . . . . . . . . . . . -101.89 -109.41 3.26 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.577 -1.409 . . . . 0.0 109.577 179.993 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 792' ' ' GLU . . . . . . . . . . . . . 8.5 mt-10 -129.65 15.4 5.94 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.322 -1.105 . . . . 0.0 110.068 -179.993 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 793' ' ' CYS . . . . . . . . . . . . . 1.7 m -147.53 122.78 10.24 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.279 -0.888 . . . . 0.0 110.224 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 794' ' ' HIS . . . . . 0.609 ' CD2' ' O ' ' A' ' 795' ' ' SER . 77.4 t60 -147.91 144.3 27.97 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.188 -0.945 . . . . 0.0 110.798 -179.97 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 795' ' ' SER . . . . . 0.609 ' O ' ' CD2' ' A' ' 794' ' ' HIS . 27.2 t -88.42 167.86 13.12 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 179.853 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 796' ' ' ILE . . . . . . . . . . . . . 3.1 mt -90.19 -22.76 6.27 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.837 0 O-C-N 120.47 -1.394 . . . . 0.0 110.286 -179.859 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 797' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -102.43 51.54 0.81 Allowed 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.167 -0.958 . . . . 0.0 109.407 179.943 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 798' ' ' SER . . . . . 0.572 ' OG ' ' CE1' ' A' ' 794' ' ' HIS . 0.3 OUTLIER -83.64 -45.08 13.86 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.407 -0.808 . . . . 0.0 111.339 -179.858 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 799' ' ' ASN . . . . . 0.447 ' HB3' ' HB2' ' A' ' 776' ' ' ALA . 7.3 p30 -105.63 -14.2 15.34 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 120.889 -1.132 . . . . 0.0 111.012 -179.838 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 800' ' ' SER . . . . . . . . . . . . . 22.4 t -65.69 -19.1 65.77 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.069 -1.019 . . . . 0.0 110.37 -179.989 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 801' ' ' VAL . . . . . . . . . . . . . 96.2 t -83.86 -23.21 8.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.122 -0.986 . . . . 0.0 110.104 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 802' ' ' LEU . . . . . 0.542 ' N ' ' CD2' ' A' ' 802' ' ' LEU . 3.4 mm? -80.48 -62.32 1.71 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.346 -0.846 . . . . 0.0 110.337 179.969 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 803' ' ' GLU . . . . . 0.405 ' HA ' ' CD1' ' A' ' 807' ' ' ILE . 1.2 tm-20 -52.03 -17.88 1.2 Allowed 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.128 -0.983 . . . . 0.0 110.887 -179.983 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 804' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.29 -31.21 17.04 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 120.97 -1.082 . . . . 0.0 111.471 -179.92 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 805' ' ' LYS . . . . . . . . . . . . . 7.3 mttm -137.1 51.8 1.95 Allowed 'General case' 0 N--CA 1.498 1.961 0 O-C-N 120.756 -1.215 . . . . 0.0 111.313 -179.935 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 806' ' ' CYS . . . . . 0.521 ' HA ' ' CB ' ' A' ' 812' ' ' CYS . 1.1 m -162.75 -54.93 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.101 -0.999 . . . . 0.0 110.204 179.902 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 807' ' ' ILE . . . . . 0.405 ' CD1' ' HA ' ' A' ' 803' ' ' GLU . 61.6 mt -65.26 103.21 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.239 -0.913 . . . . 0.0 110.077 179.973 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 808' ' ' GLY . . . . . 0.435 ' C ' ' HG ' ' A' ' 809' ' ' LEU . . . 127.0 11.37 3.52 Favored Glycine 0 N--CA 1.492 2.377 0 N-CA-C 110.009 -1.236 . . . . 0.0 110.009 179.972 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 809' ' ' LEU . . . . . 0.435 ' HG ' ' C ' ' A' ' 808' ' ' GLY . 1.5 mt -133.23 150.13 51.96 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.111 -1.229 . . . . 0.0 110.245 179.972 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 810' ' ' GLU . . . . . 0.435 ' OE1' HG21 ' A' ' 769' ' ' THR . 0.2 OUTLIER -65.74 -26.74 67.87 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.192 -0.943 . . . . 0.0 109.255 179.914 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 811' ' ' ARG . . . . . 0.463 ' O ' ' HG3' ' A' ' 811' ' ' ARG . 4.1 ppt_? -161.23 120.58 2.56 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.629 -0.67 . . . . 0.0 109.198 179.89 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 812' ' ' CYS . . . . . 0.521 ' CB ' ' HA ' ' A' ' 806' ' ' CYS . 24.0 p -121.55 156.87 31.95 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 120.996 -1.065 . . . . 0.0 111.428 -179.856 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 813' ' ' VAL . . . . . 0.53 ' CG2' ' O ' ' A' ' 760' ' ' VAL . 9.9 p -139.4 126.46 24.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 179.966 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 814' ' ' VAL . . . . . . . . . . . . . 44.3 t -110.18 130.13 63.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.077 -1.015 . . . . 0.0 110.779 -179.936 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 815' ' ' ALA . . . . . 0.431 ' HA ' ' HD2' ' A' ' 759' ' ' LYS . . . -78.37 125.02 28.76 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.347 -0.846 . . . . 0.0 109.806 179.959 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 816' ' ' ILE . . . . . 0.443 HD13 ' HB ' ' A' ' 833' ' ' VAL . 96.4 mt -79.17 111.74 16.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.274 -0.891 . . . . 0.0 110.359 -179.949 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 817' ' ' SER . . . . . 0.418 ' OG ' ' HB2' ' A' ' 820' ' ' ASN . 0.0 OUTLIER -152.03 166.71 14.66 Favored Pre-proline 0 N--CA 1.493 1.692 0 O-C-N 121.348 -0.845 . . . . 0.0 110.016 179.961 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 818' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -76.35 -57.28 0.05 OUTLIER 'Trans proline' 0 C--N 1.307 -1.651 0 O-C-N 123.931 1.49 . . . . 0.0 110.665 -179.94 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 819' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -66.06 -9.85 34.69 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.184 -0.947 . . . . 0.0 110.524 -179.981 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 820' ' ' ASN . . . . . 0.418 ' HB2' ' OG ' ' A' ' 817' ' ' SER . 17.2 t30 -92.92 -16.4 25.22 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.117 -0.989 . . . . 0.0 110.317 -179.997 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 821' ' ' PHE . . . . . . . . . . . . . 1.9 m-85 -109.53 -79.04 0.58 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.241 -0.912 . . . . 0.0 110.211 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 822' ' ' GLY . . . . . . . . . . . . . . . 176.41 42.19 0.06 OUTLIER Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.493 -1.443 . . . . 0.0 109.493 179.956 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 823' ' ' GLY . . . . . . . . . . . . . . . 79.05 -162.6 48.54 Favored Glycine 0 N--CA 1.492 2.431 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 -179.979 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 824' ' ' ASP . . . . . . . . . . . . . 4.2 p30 -121.86 152.84 59.94 Favored Pre-proline 0 N--CA 1.493 1.723 0 O-C-N 121.254 -1.145 . . . . 0.0 110.149 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 825' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -78.76 -84.68 0.0 OUTLIER 'Trans proline' 0 C--N 1.304 -1.787 0 O-C-N 124.0 1.526 . . . . 0.0 110.751 -179.896 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 826' ' ' CYS . . . . . . . . . . . . . 28.5 p -105.85 142.75 25.46 Favored Pre-proline 0 N--CA 1.492 1.674 0 O-C-N 121.125 -0.985 . . . . 0.0 110.656 -179.913 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 827' ' ' PRO . . . . . 0.466 ' O ' ' HB2' ' A' ' 828' ' ' GLU . 50.3 Cg_endo -85.15 -179.14 3.43 Favored 'Trans proline' 0 C--N 1.303 -1.817 0 O-C-N 124.209 1.636 . . . . 0.0 109.983 179.895 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 828' ' ' GLU . . . . . 0.466 ' HB2' ' O ' ' A' ' 827' ' ' PRO . 7.5 mt-10 58.55 14.94 3.29 Favored 'General case' 0 C--N 1.297 -1.697 0 O-C-N 121.331 -0.856 . . . . 0.0 109.894 -179.978 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 829' ' ' VAL . . . . . 0.466 ' O ' ' O ' ' A' ' 830' ' ' MET . 60.8 t -128.85 122.5 57.01 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.405 0 O-C-N 121.333 -0.855 . . . . 0.0 110.205 -179.965 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 830' ' ' MET . . . . . 0.466 ' O ' ' O ' ' A' ' 829' ' ' VAL . 0.0 OUTLIER -48.79 176.9 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.022 -1.049 . . . . 0.0 109.531 -179.986 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 831' ' ' LYS . . . . . . . . . . . . . 6.2 mptt -138.82 110.1 6.92 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.977 -1.077 . . . . 0.0 110.873 -179.898 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 832' ' ' ARG . . . . . . . . . . . . . 73.9 mtp85 -115.84 157.59 24.21 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.382 -0.824 . . . . 0.0 109.43 179.904 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 833' ' ' VAL . . . . . 0.443 ' HB ' HD13 ' A' ' 816' ' ' ILE . 65.0 t -122.82 104.4 14.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.042 -1.036 . . . . 0.0 110.855 -179.997 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 834' ' ' ALA . . . . . . . . . . . . . . . -109.16 124.25 50.53 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.34 -0.85 . . . . 0.0 109.171 179.944 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 835' ' ' VAL . . . . . . . . . . . . . 11.8 t -138.9 142.81 33.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.059 -1.026 . . . . 0.0 111.346 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 836' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 -126.62 135.61 51.44 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 179.93 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 837' ' ' ALA . . . . . 0.521 ' O ' ' CG2' ' A' ' 731' ' ' VAL . . . -118.72 164.49 15.29 Favored 'General case' 0 C--N 1.298 -1.632 0 O-C-N 120.966 -1.084 . . . . 0.0 111.087 -179.85 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 838' ' ' VAL . . . . . . . . . . . . . 24.9 t -116.96 105.32 18.02 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 179.96 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 839' ' ' CYS . . . . . 0.48 ' O ' ' HA ' ' A' ' 729' ' ' SER . 0.1 OUTLIER -106.51 152.83 23.15 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.204 -0.935 . . . . 0.0 110.865 -179.82 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 840' ' ' SER . . . . . 0.49 ' O ' HG21 ' A' ' 841' ' ' THR . 2.7 p -164.08 -91.89 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.402 -0.811 . . . . 0.0 109.813 179.861 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 841' ' ' THR . . . . . 0.49 HG21 ' O ' ' A' ' 840' ' ' SER . 8.8 p . . . . . 0 N--CA 1.49 1.533 0 O-C-N 121.38 -0.825 . . . . 0.0 109.736 -179.996 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 728' ' ' VAL . . . . . 0.425 ' O ' HG23 ' A' ' 728' ' ' VAL . 34.2 m . . . . . 0 N--CA 1.493 1.706 0 CA-C-O 121.312 0.577 . . . . 0.0 110.415 . . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 729' ' ' SER . . . . . 0.469 ' O ' HG23 ' A' ' 731' ' ' VAL . 12.1 t -127.39 74.41 1.51 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.275 -0.891 . . . . 0.0 110.217 179.965 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 730' ' ' GLY . . . . . 0.439 ' C ' HG23 ' A' ' 731' ' ' VAL . . . -62.38 114.69 7.07 Favored Glycine 0 N--CA 1.493 2.436 0 N-CA-C 109.222 -1.551 . . . . 0.0 109.222 179.989 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 731' ' ' VAL . . . . . 0.469 HG23 ' O ' ' A' ' 729' ' ' SER . 21.8 t -129.39 137.22 57.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.189 -1.183 . . . . 0.0 110.592 -179.986 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 732' ' ' CYS . . . . . . . . . . . . . 4.9 p -129.32 146.06 51.27 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.434 -0.791 . . . . 0.0 109.366 179.967 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 733' ' ' ALA . . . . . 0.526 ' CB ' HG12 ' A' ' 760' ' ' VAL . . . -110.45 104.22 12.95 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 120.952 -1.093 . . . . 0.0 111.351 -179.978 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 734' ' ' ASP . . . . . 0.45 ' OD1' ' O ' ' A' ' 734' ' ' ASP . 0.6 OUTLIER -110.07 100.9 9.76 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.339 -0.851 . . . . 0.0 108.865 179.895 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 735' ' ' VAL . . . . . . . . . . . . . 14.4 m -140.08 152.82 22.14 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 121.229 -0.92 . . . . 0.0 110.941 -179.885 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 736' ' ' SER . . . . . 0.542 ' O ' ' CB ' ' A' ' 758' ' ' ALA . 3.3 m -82.33 177.05 8.97 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 179.839 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 737' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 . . . . . 0 N--CA 1.493 1.709 0 O-C-N 120.738 -1.226 . . . . 0.0 110.213 -179.993 . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 757' ' ' THR . . . . . 0.447 ' HB ' ' O ' ' A' ' 816' ' ' ILE . 32.1 p . . . . . 0 N--CA 1.489 1.515 0 CA-C-O 121.151 0.501 . . . . 0.0 110.205 . . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 758' ' ' ALA . . . . . 0.542 ' CB ' ' O ' ' A' ' 736' ' ' SER . . . -102.83 -179.18 3.89 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.181 -0.949 . . . . 0.0 110.153 179.99 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 759' ' ' LYS . . . . . . . . . . . . . 9.6 mtpp -133.81 161.99 33.21 Favored 'General case' 0 C--N 1.297 -1.686 0 O-C-N 121.452 -0.78 . . . . 0.0 110.233 179.997 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 760' ' ' VAL . . . . . 0.526 HG12 ' CB ' ' A' ' 733' ' ' ALA . 39.8 t -125.55 114.85 41.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.344 -0.847 . . . . 0.0 109.191 179.927 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 761' ' ' HIS . . . . . . . . . . . . . 1.5 t-160 -110.64 114.44 27.84 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 120.914 -1.117 . . . . 0.0 111.185 -179.964 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 762' ' ' LEU . . . . . . . . . . . . . 17.8 mt -111.2 103.66 12.1 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.508 -0.745 . . . . 0.0 109.327 179.825 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 763' ' ' LYS . . . . . . . . . . . . . 5.3 pttp -117.81 136.87 53.12 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.098 -1.001 . . . . 0.0 110.925 -179.889 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 764' ' ' CYS . . . . . . . . . . . . . 86.2 m -105.32 173.46 6.3 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.372 -0.83 . . . . 0.0 109.673 179.927 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 765' ' ' ALA . . . . . . . . . . . . . . . -67.88 160.91 71.25 Favored Pre-proline 0 N--CA 1.494 1.745 0 O-C-N 121.18 -0.95 . . . . 0.0 110.44 179.969 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 766' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -72.02 96.1 0.77 Allowed 'Trans proline' 0 C--N 1.308 -1.584 0 O-C-N 124.006 1.53 . . . . 0.0 110.117 179.959 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 767' ' ' GLY . . . . . . . . . . . . . . . 140.21 -31.95 2.22 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 108.762 -1.735 . . . . 0.0 108.762 -179.999 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 768' ' ' GLN . . . . . 0.442 ' HG3' ' HB ' ' A' ' 841' ' ' THR . 12.8 mp0 -93.64 152.34 19.06 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.559 -0.965 . . . . 0.0 109.421 179.956 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 769' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -129.91 151.62 50.28 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.046 -1.034 . . . . 0.0 110.741 -179.976 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 770' ' ' ILE . . . . . 0.437 HD13 ' O ' ' A' ' 809' ' ' LEU . 30.9 mt -76.48 152.78 5.87 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.433 -0.792 . . . . 0.0 109.537 179.85 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 771' ' ' SER . . . . . . . . . . . . . 3.3 m -146.57 -15.88 0.43 Allowed 'General case' 0 N--CA 1.494 1.749 0 O-C-N 120.845 -1.159 . . . . 0.0 112.597 -179.903 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 772' ' ' ALA . . . . . . . . . . . . . . . -158.34 150.05 21.35 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 120.235 -1.54 . . . . 0.0 112.438 -179.912 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 773' ' ' ILE . . . . . . . . . . . . . 14.5 mm -116.21 118.39 58.62 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 179.863 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 774' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -84.13 -38.31 20.87 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 120.957 -1.09 . . . . 0.0 111.895 -179.826 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 775' ' ' PHE . . . . . 0.431 ' O ' ' CB ' ' A' ' 776' ' ' ALA . 58.4 t80 -129.52 166.64 19.25 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 120.712 -1.243 . . . . 0.0 111.468 -179.942 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 776' ' ' ALA . . . . . 0.528 ' HB1' ' CA ' ' A' ' 799' ' ' ASN . . . 171.76 101.48 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.736 -0.603 . . . . 0.0 109.382 179.962 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 777' ' ' SER . . . . . . . . . . . . . 29.1 t -134.55 125.63 27.67 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.37 -0.831 . . . . 0.0 110.204 -179.882 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 778' ' ' PHE . . . . . 0.543 ' CZ ' ' O ' ' A' ' 817' ' ' SER . 2.2 t80 -111.12 81.35 1.42 Allowed 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.421 -0.799 . . . . 0.0 109.887 179.934 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 779' ' ' GLY . . . . . . . . . . . . . . . -179.49 -89.97 0.08 OUTLIER Glycine 0 N--CA 1.493 2.449 0 N-CA-C 109.526 -1.429 . . . . 0.0 109.526 -179.946 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 780' ' ' THR . . . . . 0.472 ' O ' ' HA3' ' A' ' 791' ' ' GLY . 38.8 p -123.17 83.0 51.52 Favored Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.048 -1.266 . . . . 0.0 110.675 179.992 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 781' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -74.45 123.54 8.23 Favored 'Trans proline' 0 C--N 1.304 -1.809 0 O-C-N 124.077 1.567 . . . . 0.0 109.952 179.989 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 782' ' ' LEU . . . . . 0.438 HD12 ' HA2' ' A' ' 791' ' ' GLY . 10.8 mt -111.1 83.83 1.83 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.237 -0.914 . . . . 0.0 110.412 -179.959 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 783' ' ' GLY . . . . . 0.438 ' C ' HG23 ' A' ' 784' ' ' THR . . . 148.45 -173.63 28.38 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.549 -1.42 . . . . 0.0 109.549 -179.944 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 784' ' ' THR . . . . . 0.546 ' O ' ' CD2' ' A' ' 788' ' ' PHE . 80.3 p -132.41 -148.41 0.34 Allowed 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.275 -1.132 . . . . 0.0 110.375 -179.97 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 785' ' ' CYS . . . . . . . . . . . . . 4.2 t -70.87 106.88 3.77 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.227 -0.92 . . . . 0.0 109.889 179.984 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 786' ' ' GLY . . . . . . . . . . . . . . . 114.31 -26.25 9.87 Favored Glycine 0 N--CA 1.488 2.135 0 N-CA-C 109.246 -1.542 . . . . 0.0 109.246 -179.965 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 787' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -124.46 25.95 7.46 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.326 -1.103 . . . . 0.0 110.581 -179.958 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 788' ' ' PHE . . . . . 0.546 ' CD2' ' O ' ' A' ' 784' ' ' THR . 2.4 m-85 -71.46 112.43 7.58 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.225 -0.922 . . . . 0.0 109.616 -179.95 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 789' ' ' GLN . . . . . . . . . . . . . 14.4 tp60 -125.71 137.19 53.82 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.143 -0.973 . . . . 0.0 110.593 -179.962 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 790' ' ' GLN . . . . . 0.411 ' O ' ' HG3' ' A' ' 790' ' ' GLN . 19.3 pt20 -41.32 139.4 1.03 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.477 -0.764 . . . . 0.0 110.316 179.928 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 791' ' ' GLY . . . . . 0.472 ' HA3' ' O ' ' A' ' 780' ' ' THR . . . -89.59 -153.92 28.64 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.356 -1.498 . . . . 0.0 109.356 -179.999 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 792' ' ' GLU . . . . . . . . . . . . . 26.6 pt-20 -87.55 -35.18 18.29 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.22 -1.165 . . . . 0.0 109.744 179.951 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 793' ' ' CYS . . . . . 0.447 ' SG ' ' HB2' ' A' ' 825' ' ' PRO . 0.5 OUTLIER -109.87 100.72 9.65 Favored 'General case' 0 C--N 1.307 -1.255 0 O-C-N 121.271 -0.893 . . . . 0.0 110.604 179.997 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 794' ' ' HIS . . . . . . . . . . . . . 4.4 t60 -108.69 143.08 38.26 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.091 -1.006 . . . . 0.0 109.826 -179.998 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 795' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -80.19 5.88 13.3 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.321 -0.862 . . . . 0.0 110.021 -179.964 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 796' ' ' ILE . . . . . 0.437 HG22 ' O ' ' A' ' 796' ' ' ILE . 31.4 mt 46.37 24.23 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.162 -0.961 . . . . 0.0 109.86 -179.988 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 797' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -159.6 22.53 0.18 Allowed 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.485 -0.759 . . . . 0.0 109.542 -179.976 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 798' ' ' SER . . . . . 0.475 ' HB2' ' O ' ' A' ' 776' ' ' ALA . 1.1 m -88.31 0.09 56.55 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.414 -0.804 . . . . 0.0 110.19 -179.982 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 799' ' ' ASN . . . . . 0.528 ' CA ' ' HB1' ' A' ' 776' ' ' ALA . 60.6 t-20 -124.66 1.34 8.2 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.254 -0.903 . . . . 0.0 109.954 179.973 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 800' ' ' SER . . . . . . . . . . . . . 1.5 t -91.64 -40.17 11.46 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.371 -0.831 . . . . 0.0 110.452 -179.869 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 801' ' ' VAL . . . . . 0.482 HG23 ' HA ' ' A' ' 821' ' ' PHE . 93.2 t -67.55 -19.54 25.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.3 -0.875 . . . . 0.0 110.799 -179.945 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 802' ' ' LEU . . . . . . . . . . . . . 78.7 mt -87.72 -49.74 6.93 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.011 -1.056 . . . . 0.0 110.979 -179.882 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 803' ' ' GLU . . . . . 0.438 ' HG2' HD13 ' A' ' 807' ' ' ILE . 18.6 mt-10 -54.23 -27.21 33.09 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.157 -0.964 . . . . 0.0 111.045 -179.909 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 804' ' ' ARG . . . . . . . . . . . . . 1.6 mpt_? -91.62 -18.32 24.21 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.017 -1.052 . . . . 0.0 111.264 -179.905 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 805' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.66 12.89 19.83 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 120.91 -1.119 . . . . 0.0 111.331 -179.926 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 806' ' ' CYS . . . . . 0.414 ' O ' ' C ' ' A' ' 807' ' ' ILE . 21.0 m -141.38 -67.99 0.4 Allowed 'General case' 0 N--CA 1.496 1.855 0 O-C-N 120.851 -1.156 . . . . 0.0 110.58 -179.971 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 807' ' ' ILE . . . . . 0.438 HD13 ' HG2' ' A' ' 803' ' ' GLU . 42.9 mt -41.24 103.68 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 O-C-N 121.258 -0.901 . . . . 0.0 110.477 -179.986 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 808' ' ' GLY . . . . . 0.468 ' O ' HD21 ' A' ' 809' ' ' LEU . . . 127.06 4.84 5.88 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.613 -1.395 . . . . 0.0 109.613 -179.984 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 809' ' ' LEU . . . . . 0.468 HD21 ' O ' ' A' ' 808' ' ' GLY . 81.4 mt -139.77 149.2 43.28 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.252 -1.146 . . . . 0.0 109.982 179.997 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 810' ' ' GLU . . . . . . . . . . . . . 2.1 pt-20 -78.93 1.47 23.57 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.173 -0.954 . . . . 0.0 109.593 179.981 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 811' ' ' ARG . . . . . . . . . . . . . 21.8 ttp180 -170.13 135.7 1.36 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.41 -0.806 . . . . 0.0 110.014 179.986 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 812' ' ' CYS . . . . . . . . . . . . . 21.9 p -155.12 150.22 26.92 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.401 -0.812 . . . . 0.0 110.292 -179.979 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 813' ' ' VAL . . . . . 0.484 ' C ' ' CG2' ' A' ' 814' ' ' VAL . 11.9 p -131.78 153.99 39.58 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 O-C-N 121.29 -0.881 . . . . 0.0 110.335 -179.991 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 814' ' ' VAL . . . . . 0.484 ' CG2' ' C ' ' A' ' 813' ' ' VAL . 11.1 t -151.59 106.58 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 O-C-N 121.314 -0.866 . . . . 0.0 110.241 179.982 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 815' ' ' ALA . . . . . . . . . . . . . . . -54.02 170.92 0.11 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.234 -0.917 . . . . 0.0 110.384 179.942 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 816' ' ' ILE . . . . . 0.508 ' CG2' HG22 ' A' ' 833' ' ' VAL . 80.5 mt -121.73 141.73 40.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.351 -0.843 . . . . 0.0 109.887 -179.995 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 817' ' ' SER . . . . . 0.543 ' O ' ' CZ ' ' A' ' 778' ' ' PHE . 0.3 OUTLIER -173.91 -178.06 0.37 Allowed Pre-proline 0 N--CA 1.494 1.762 0 O-C-N 121.12 -0.988 . . . . 0.0 110.64 -179.899 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 818' ' ' PRO . . . . . 0.531 ' HD2' ' CB ' ' A' ' 817' ' ' SER . 42.8 Cg_endo -72.9 -76.12 0.01 OUTLIER 'Trans proline' 0 C--N 1.313 -1.329 0 O-C-N 124.043 1.549 . . . . 0.0 111.302 -179.93 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 819' ' ' SER . . . . . . . . . . . . . 40.8 t -84.33 51.93 2.22 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.055 -1.028 . . . . 0.0 110.351 -179.972 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 820' ' ' ASN . . . . . 0.468 ' HB2' ' OG ' ' A' ' 817' ' ' SER . 2.1 t30 -101.92 -49.25 4.01 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.256 -0.903 . . . . 0.0 109.777 179.961 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 821' ' ' PHE . . . . . 0.482 ' HA ' HG23 ' A' ' 801' ' ' VAL . 27.4 m-85 -77.26 -23.83 51.17 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.204 -0.935 . . . . 0.0 109.764 179.981 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 822' ' ' GLY . . . . . . . . . . . . . . . 93.95 55.69 1.48 Allowed Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 -179.972 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 823' ' ' GLY . . . . . . . . . . . . . . . 168.31 144.82 4.32 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.654 -1.378 . . . . 0.0 109.654 -179.987 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 824' ' ' ASP . . . . . 0.433 ' OD1' ' O ' ' A' ' 824' ' ' ASP . 11.1 p-10 -144.07 122.3 6.91 Favored Pre-proline 0 N--CA 1.493 1.712 0 O-C-N 121.325 -1.103 . . . . 0.0 110.041 179.999 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 825' ' ' PRO . . . . . 0.447 ' HB2' ' SG ' ' A' ' 793' ' ' CYS . 43.9 Cg_endo -75.59 -78.28 0.01 OUTLIER 'Trans proline' 0 C--N 1.307 -1.632 0 O-C-N 123.88 1.463 . . . . 0.0 110.583 -179.952 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 826' ' ' CYS . . . . . . . . . . . . . 5.8 p -125.18 128.46 24.77 Favored Pre-proline 0 N--CA 1.494 1.772 0 O-C-N 121.111 -0.993 . . . . 0.0 110.101 -179.971 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 827' ' ' PRO . . . . . 0.465 ' O ' HG22 ' A' ' 829' ' ' VAL . 48.7 Cg_endo -85.7 177.0 5.11 Favored 'Trans proline' 0 C--N 1.305 -1.726 0 O-C-N 123.883 1.465 . . . . 0.0 110.513 -179.995 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 828' ' ' GLU . . . . . 0.464 ' HB2' ' O ' ' A' ' 827' ' ' PRO . 34.9 mt-10 56.72 23.59 8.06 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.457 -0.777 . . . . 0.0 110.338 -179.958 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 829' ' ' VAL . . . . . 0.465 HG22 ' O ' ' A' ' 827' ' ' PRO . 53.3 t -125.44 135.46 63.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.437 -0.79 . . . . 0.0 109.734 179.929 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 830' ' ' MET . . . . . 0.435 ' C ' ' O ' ' A' ' 829' ' ' VAL . 33.5 ttm -41.26 146.14 0.21 Allowed 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.269 -0.895 . . . . 0.0 109.83 -179.997 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 831' ' ' LYS . . . . . . . . . . . . . 27.6 mttp -134.46 106.47 7.06 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.042 -1.036 . . . . 0.0 111.165 -179.941 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 832' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -108.36 166.13 10.99 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.463 -0.773 . . . . 0.0 109.005 179.805 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 833' ' ' VAL . . . . . 0.508 HG22 ' CG2' ' A' ' 816' ' ' ILE . 69.4 t -116.19 145.44 21.93 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.602 0 O-C-N 120.879 -1.138 . . . . 0.0 110.967 -179.94 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 834' ' ' ALA . . . . . 0.536 ' HB1' ' CE1' ' A' ' 788' ' ' PHE . . . -155.5 128.15 7.93 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.635 -0.666 . . . . 0.0 109.449 179.954 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 835' ' ' VAL . . . . . 0.445 ' CG1' ' N ' ' A' ' 836' ' ' GLU . 21.7 t -148.14 163.94 5.77 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.026 0 O-C-N 120.973 -1.079 . . . . 0.0 111.439 -179.887 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 836' ' ' GLU . . . . . 0.445 ' N ' ' CG1' ' A' ' 835' ' ' VAL . 6.1 tt0 -145.89 141.38 27.77 Favored 'General case' 0 N--CA 1.496 1.864 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 179.96 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 837' ' ' ALA . . . . . . . . . . . . . . . -134.56 156.71 48.19 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 120.929 -1.107 . . . . 0.0 111.061 -179.966 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 838' ' ' VAL . . . . . . . . . . . . . 69.7 t -114.3 102.96 14.61 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.725 0 O-C-N 121.428 -0.795 . . . . 0.0 109.734 179.97 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 839' ' ' CYS . . . . . 0.43 ' SG ' ' CG1' ' A' ' 770' ' ' ILE . 0.1 OUTLIER -108.88 139.73 43.32 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.071 -1.018 . . . . 0.0 110.822 -179.97 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 840' ' ' SER . . . . . . . . . . . . . 17.8 m -150.22 -168.52 3.13 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.365 -0.835 . . . . 0.0 110.02 179.944 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 841' ' ' THR . . . . . 0.442 ' HB ' ' HG3' ' A' ' 768' ' ' GLN . 8.9 t . . . . . 0 N--CA 1.494 1.775 0 O-C-N 121.221 -0.925 . . . . 0.0 110.288 -179.986 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 728' ' ' VAL . . . . . 0.472 ' O ' ' HB3' ' A' ' 729' ' ' SER . 11.0 p . . . . . 0 N--CA 1.493 1.704 0 CA-C-O 121.343 0.592 . . . . 0.0 110.65 . . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 729' ' ' SER . . . . . 0.472 ' HB3' ' O ' ' A' ' 728' ' ' VAL . 10.6 t 57.92 142.67 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.47 -0.769 . . . . 0.0 111.193 179.959 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 730' ' ' GLY . . . . . . . . . . . . . . . -132.4 159.73 23.48 Favored Glycine 0 N--CA 1.492 2.424 0 N-CA-C 109.012 -1.635 . . . . 0.0 109.012 179.915 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 731' ' ' VAL . . . . . . . . . . . . . 35.7 m -133.37 150.78 32.64 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 O-C-N 121.125 -1.221 . . . . 0.0 110.79 -179.992 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 732' ' ' CYS . . . . . . . . . . . . . 2.4 m -128.82 135.02 48.57 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.489 -0.757 . . . . 0.0 109.647 -179.968 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 733' ' ' ALA . . . . . 0.521 ' CB ' HD22 ' A' ' 762' ' ' LEU . . . -131.87 105.3 7.37 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.922 -1.111 . . . . 0.0 110.946 -179.913 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 734' ' ' ASP . . . . . 0.417 ' OD1' ' HB3' ' A' ' 834' ' ' ALA . 0.6 OUTLIER -113.66 107.76 16.21 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.339 -0.851 . . . . 0.0 109.088 179.911 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 735' ' ' VAL . . . . . . . . . . . . . 47.9 t -139.73 120.58 14.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.047 -1.033 . . . . 0.0 111.274 -179.926 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 736' ' ' SER . . . . . 0.417 ' O ' ' C ' ' A' ' 737' ' ' GLU . 54.4 p -100.72 -176.38 3.17 Favored 'General case' 0 C--N 1.297 -1.68 0 O-C-N 121.454 -0.779 . . . . 0.0 108.898 179.848 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 737' ' ' GLU . . . . . 0.417 ' C ' ' O ' ' A' ' 736' ' ' SER . 0.7 OUTLIER . . . . . 0 N--CA 1.493 1.716 0 O-C-N 121.113 -0.992 . . . . 0.0 109.604 179.962 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 757' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.498 1.928 0 CA-C-O 121.318 0.58 . . . . 0.0 110.24 . . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 758' ' ' ALA . . . . . . . . . . . . . . . -90.8 165.0 13.88 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.169 -0.957 . . . . 0.0 110.516 -179.906 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 759' ' ' LYS . . . . . 0.47 ' HG2' ' HA ' ' A' ' 815' ' ' ALA . 3.2 mttp -130.39 165.01 23.47 Favored 'General case' 0 C--N 1.302 -1.5 0 O-C-N 121.424 -0.797 . . . . 0.0 109.839 -179.95 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 760' ' ' VAL . . . . . . . . . . . . . 41.6 t -106.37 153.74 7.62 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.518 0 O-C-N 121.25 -0.906 . . . . 0.0 109.459 179.953 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 761' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -147.87 116.83 6.79 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.051 -1.031 . . . . 0.0 111.219 -179.953 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 762' ' ' LEU . . . . . 0.521 HD22 ' CB ' ' A' ' 733' ' ' ALA . 32.0 mt -110.5 164.48 12.66 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.423 -0.798 . . . . 0.0 108.849 179.888 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 763' ' ' LYS . . . . . . . . . . . . . 14.9 mttt -154.04 128.98 9.5 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.78 -1.2 . . . . 0.0 110.944 -179.928 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 764' ' ' CYS . . . . . 0.433 ' O ' ' C ' ' A' ' 765' ' ' ALA . 10.4 t -103.83 143.78 32.37 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.489 -0.757 . . . . 0.0 109.601 179.996 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 765' ' ' ALA . . . . . 0.433 ' C ' ' O ' ' A' ' 764' ' ' CYS . . . -42.08 150.39 0.38 Allowed Pre-proline 0 N--CA 1.492 1.664 0 O-C-N 121.196 -0.94 . . . . 0.0 110.25 -179.945 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 766' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -70.11 95.95 0.6 Allowed 'Trans proline' 0 C--N 1.306 -1.683 0 O-C-N 124.016 1.535 . . . . 0.0 110.035 -179.923 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 767' ' ' GLY . . . . . . . . . . . . . . . 139.47 -17.76 3.08 Favored Glycine 0 N--CA 1.486 1.972 0 N-CA-C 109.029 -1.628 . . . . 0.0 109.029 -179.936 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 768' ' ' GLN . . . . . . . . . . . . . 20.7 mt-30 -108.61 174.74 5.74 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.362 -1.081 . . . . 0.0 110.133 179.981 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 769' ' ' THR . . . . . . . . . . . . . 8.9 p -144.85 147.97 33.44 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.207 -0.933 . . . . 0.0 110.454 -179.913 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 770' ' ' ILE . . . . . . . . . . . . . 72.1 mt -68.18 145.88 13.28 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.264 -0.898 . . . . 0.0 109.563 179.944 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 771' ' ' SER . . . . . . . . . . . . . 13.5 p -143.47 -3.0 0.94 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.955 -1.09 . . . . 0.0 111.951 -179.956 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 772' ' ' ALA . . . . . . . . . . . . . . . -165.98 143.25 5.41 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 120.559 -1.338 . . . . 0.0 111.648 -179.955 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 773' ' ' ILE . . . . . 0.424 HG23 ' HB3' ' A' ' 802' ' ' LEU . 34.9 mm -105.36 120.41 56.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 179.755 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 774' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.59 -43.55 22.72 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.045 -1.035 . . . . 0.0 111.077 -179.812 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 775' ' ' PHE . . . . . 0.579 ' CZ ' ' HB3' ' A' ' 788' ' ' PHE . 79.3 t80 -149.81 166.42 29.54 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 120.893 -1.129 . . . . 0.0 111.367 -179.925 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 776' ' ' ALA . . . . . 0.48 ' HB1' ' O ' ' A' ' 775' ' ' PHE . . . 174.21 126.2 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 -179.967 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 777' ' ' SER . . . . . . . . . . . . . 2.1 t -148.31 135.02 19.9 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.968 -1.083 . . . . 0.0 111.342 -179.956 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 778' ' ' PHE . . . . . . . . . . . . . 90.1 t80 -103.4 109.46 21.1 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.616 -0.677 . . . . 0.0 109.667 179.95 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 779' ' ' GLY . . . . . . . . . . . . . . . 148.52 -98.87 0.19 Allowed Glycine 0 N--CA 1.492 2.37 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 -179.907 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 780' ' ' THR . . . . . 0.467 ' O ' ' HA3' ' A' ' 791' ' ' GLY . 1.5 p -144.03 91.46 6.53 Favored Pre-proline 0 N--CA 1.494 1.743 0 O-C-N 121.153 -1.204 . . . . 0.0 110.608 179.928 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 781' ' ' PRO . . . . . 0.506 ' HG3' ' HB2' ' A' ' 834' ' ' ALA . 47.7 Cg_endo -82.57 154.36 15.78 Favored 'Trans proline' 0 C--N 1.304 -1.794 0 O-C-N 123.89 1.468 . . . . 0.0 110.269 179.931 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 782' ' ' LEU . . . . . 0.544 ' CD1' ' HA2' ' A' ' 791' ' ' GLY . 0.1 OUTLIER -127.76 125.33 39.7 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.082 -1.011 . . . . 0.0 110.508 -179.906 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 783' ' ' GLY . . . . . 0.418 ' C ' HG22 ' A' ' 784' ' ' THR . . . 128.24 -168.62 20.07 Favored Glycine 0 N--CA 1.488 2.166 0 N-CA-C 109.779 -1.328 . . . . 0.0 109.779 179.973 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 784' ' ' THR . . . . . 0.471 ' O ' ' HB2' ' A' ' 785' ' ' CYS . 24.1 p -142.93 72.19 1.36 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.323 -1.104 . . . . 0.0 109.834 179.969 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 785' ' ' CYS . . . . . 0.471 ' HB2' ' O ' ' A' ' 784' ' ' THR . 2.2 m 58.88 118.05 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.362 -0.836 . . . . 0.0 109.989 -179.973 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 786' ' ' GLY . . . . . . . . . . . . . . . 102.7 -37.33 3.75 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.061 -1.616 . . . . 0.0 109.061 -179.899 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 787' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -126.12 23.38 7.1 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.347 -1.09 . . . . 0.0 109.801 179.974 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 788' ' ' PHE . . . . . 0.579 ' HB3' ' CZ ' ' A' ' 775' ' ' PHE . 0.3 OUTLIER -56.4 149.76 16.2 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.511 -0.743 . . . . 0.0 110.009 179.987 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 789' ' ' GLN . . . . . . . . . . . . . 2.3 mm-40 -134.65 173.69 11.39 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.255 -0.903 . . . . 0.0 110.126 -179.991 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 790' ' ' GLN . . . . . 0.408 ' O ' ' C ' ' A' ' 791' ' ' GLY . 0.0 OUTLIER -86.45 16.04 4.91 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.318 -0.864 . . . . 0.0 109.993 179.961 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 791' ' ' GLY . . . . . 0.544 ' HA2' ' CD1' ' A' ' 782' ' ' LEU . . . 42.45 -120.1 2.28 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.744 -1.343 . . . . 0.0 109.744 -179.963 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 792' ' ' GLU . . . . . . . . . . . . . 12.8 mt-10 -117.26 -30.64 5.54 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.272 -1.134 . . . . 0.0 110.562 179.991 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 793' ' ' CYS . . . . . . . . . . . . . 2.5 t -126.65 156.77 40.48 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.255 -0.903 . . . . 0.0 110.232 -179.979 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 794' ' ' HIS . . . . . 0.51 ' NE2' ' O ' ' A' ' 795' ' ' SER . 49.9 t60 -170.08 150.49 3.76 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.374 -0.829 . . . . 0.0 110.229 -179.994 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 795' ' ' SER . . . . . 0.51 ' O ' ' NE2' ' A' ' 794' ' ' HIS . 3.1 t -99.68 158.07 16.03 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.394 -0.816 . . . . 0.0 109.466 179.948 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 796' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -92.07 37.24 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.087 0 O-C-N 121.005 -1.059 . . . . 0.0 109.847 -179.926 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 797' ' ' ASN . . . . . . . . . . . . . 18.9 m120 -148.06 22.92 1.08 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.383 -0.823 . . . . 0.0 109.93 179.997 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 798' ' ' SER . . . . . 0.469 ' HB3' ' O ' ' A' ' 776' ' ' ALA . 13.9 m -69.54 -50.35 45.76 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.306 -0.871 . . . . 0.0 110.637 179.991 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 799' ' ' ASN . . . . . . . . . . . . . 53.6 m-20 -76.33 -31.96 58.42 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.302 -0.874 . . . . 0.0 110.619 -179.944 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 800' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -56.63 -25.78 54.14 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.246 -0.909 . . . . 0.0 110.999 -179.93 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 801' ' ' VAL . . . . . 0.507 HG22 ' CD2' ' A' ' 821' ' ' PHE . 40.7 t -87.36 -21.66 7.13 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 O-C-N 121.067 -1.02 . . . . 0.0 110.769 -179.944 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 802' ' ' LEU . . . . . 0.479 HD12 HG11 ' A' ' 835' ' ' VAL . 4.1 mm? -93.07 -20.91 20.07 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.092 -1.005 . . . . 0.0 111.18 -179.942 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 803' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -83.51 -37.92 22.44 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.314 -0.866 . . . . 0.0 111.292 -179.858 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 804' ' ' ARG . . . . . . . . . . . . . 2.1 mtm180 -91.61 -25.61 19.09 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 120.997 -1.064 . . . . 0.0 111.62 -179.915 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 805' ' ' LYS . . . . . . . . . . . . . 2.0 tttp -110.53 44.53 1.24 Allowed 'General case' 0 N--CA 1.497 1.88 0 O-C-N 120.859 -1.15 . . . . 0.0 110.814 -179.939 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 806' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -160.52 -66.97 0.07 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.129 -0.982 . . . . 0.0 110.342 179.945 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 807' ' ' ILE . . . . . . . . . . . . . 30.1 mt -52.18 128.81 11.36 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.078 -1.014 . . . . 0.0 110.467 -179.998 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 808' ' ' GLY . . . . . 0.431 ' C ' ' HG ' ' A' ' 809' ' ' LEU . . . 105.24 9.48 33.82 Favored Glycine 0 N--CA 1.491 2.34 0 C-N-CA 119.918 -1.134 . . . . 0.0 110.284 179.915 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 809' ' ' LEU . . . . . 0.431 ' HG ' ' C ' ' A' ' 808' ' ' GLY . 43.7 mt -138.72 142.6 38.9 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.015 -1.285 . . . . 0.0 110.511 179.979 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 810' ' ' GLU . . . . . . . . . . . . . 5.0 mp0 -67.93 -20.88 65.12 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.182 -0.949 . . . . 0.0 109.418 179.998 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 811' ' ' ARG . . . . . . . . . . . . . 24.6 mtm180 -136.52 157.21 47.32 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.605 -0.684 . . . . 0.0 109.643 179.965 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 812' ' ' CYS . . . . . . . . . . . . . 3.2 t -131.12 146.71 52.45 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.198 -0.939 . . . . 0.0 110.193 -179.971 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 813' ' ' VAL . . . . . 0.542 ' O ' ' CG1' ' A' ' 813' ' ' VAL . 4.6 p -148.69 116.92 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.151 -0.968 . . . . 0.0 110.024 179.926 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 814' ' ' VAL . . . . . . . . . . . . . 6.7 t -131.39 111.73 19.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.193 -0.942 . . . . 0.0 110.077 179.959 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 815' ' ' ALA . . . . . 0.47 ' HA ' ' HG2' ' A' ' 759' ' ' LYS . . . -61.74 166.79 4.05 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.335 -0.853 . . . . 0.0 110.556 -179.955 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 816' ' ' ILE . . . . . 0.504 HG23 ' CG2' ' A' ' 833' ' ' VAL . 70.7 mt -119.7 112.89 38.97 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 121.378 -0.826 . . . . 0.0 110.102 179.953 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 817' ' ' SER . . . . . 0.521 ' CB ' ' HD2' ' A' ' 818' ' ' PRO . 0.7 OUTLIER -161.89 -177.36 0.7 Allowed Pre-proline 0 N--CA 1.494 1.744 0 O-C-N 121.101 -1.0 . . . . 0.0 110.313 179.97 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 818' ' ' PRO . . . . . 0.521 ' HD2' ' CB ' ' A' ' 817' ' ' SER . 48.3 Cg_endo -75.34 -48.84 0.15 Allowed 'Trans proline' 0 C--N 1.309 -1.546 0 O-C-N 123.991 1.522 . . . . 0.0 110.77 -179.971 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 819' ' ' SER . . . . . . . . . . . . . 2.8 t -92.76 71.06 4.84 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.334 -0.854 . . . . 0.0 110.411 -179.944 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 820' ' ' ASN . . . . . . . . . . . . . 5.4 t-20 -143.58 -43.23 0.28 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.137 -0.977 . . . . 0.0 110.129 -179.973 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 821' ' ' PHE . . . . . 0.507 ' CD2' HG22 ' A' ' 801' ' ' VAL . 33.3 m-85 -83.08 -57.29 3.34 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.428 -0.795 . . . . 0.0 110.501 -179.949 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 822' ' ' GLY . . . . . . . . . . . . . . . 147.21 66.76 0.01 OUTLIER Glycine 0 N--CA 1.491 2.349 0 C-N-CA 119.512 -1.328 . . . . 0.0 110.111 179.953 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 823' ' ' GLY . . . . . . . . . . . . . . . 120.4 170.5 14.26 Favored Glycine 0 N--CA 1.493 2.497 0 O-C-N 121.12 -1.224 . . . . 0.0 110.267 179.917 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 824' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -132.05 65.82 76.17 Favored Pre-proline 0 N--CA 1.494 1.733 0 O-C-N 121.583 -0.951 . . . . 0.0 109.814 179.986 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 825' ' ' PRO . . . . . 0.436 ' C ' ' HD3' ' A' ' 827' ' ' PRO . 48.7 Cg_endo -74.43 -3.42 13.82 Favored 'Trans proline' 0 C--N 1.305 -1.732 0 O-C-N 124.195 1.629 . . . . 0.0 111.122 -179.915 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 826' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER -126.44 64.83 57.25 Favored Pre-proline 0 N--CA 1.499 2.016 0 O-C-N 120.984 -1.072 . . . . 0.0 110.184 -179.944 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 827' ' ' PRO . . . . . 0.436 ' HD3' ' C ' ' A' ' 825' ' ' PRO . 50.0 Cg_endo -82.36 153.53 16.08 Favored 'Trans proline' 0 C--N 1.311 -1.416 0 O-C-N 123.897 1.472 . . . . 0.0 110.886 179.989 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 828' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 57.71 39.77 27.0 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.448 -0.782 . . . . 0.0 110.781 -179.993 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 829' ' ' VAL . . . . . 0.417 ' O ' ' C ' ' A' ' 830' ' ' MET . 54.3 t -137.45 139.76 42.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.176 -0.953 . . . . 0.0 110.116 179.974 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 830' ' ' MET . . . . . 0.417 ' C ' ' O ' ' A' ' 829' ' ' VAL . 0.2 OUTLIER -44.33 144.61 0.97 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.238 -0.913 . . . . 0.0 109.816 -179.911 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 831' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.2 105.79 18.05 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.233 -0.917 . . . . 0.0 110.689 -179.972 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 832' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -128.2 116.68 20.27 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.493 -0.754 . . . . 0.0 109.404 179.945 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 833' ' ' VAL . . . . . 0.504 ' CG2' HG23 ' A' ' 816' ' ' ILE . 3.3 t -109.86 116.87 53.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.165 -0.959 . . . . 0.0 110.876 -179.931 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 834' ' ' ALA . . . . . 0.506 ' HB2' ' HG3' ' A' ' 781' ' ' PRO . . . -118.25 148.87 41.99 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.478 -0.764 . . . . 0.0 109.229 179.949 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 835' ' ' VAL . . . . . 0.482 HG13 ' N ' ' A' ' 836' ' ' GLU . 46.7 t -155.06 162.84 1.72 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.519 0 O-C-N 120.904 -1.123 . . . . 0.0 111.051 -179.914 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 836' ' ' GLU . . . . . 0.482 ' N ' HG13 ' A' ' 835' ' ' VAL . 2.6 tt0 -145.76 118.12 8.45 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.629 -0.669 . . . . 0.0 109.587 179.934 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 837' ' ' ALA . . . . . . . . . . . . . . . -108.12 161.17 15.22 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.152 -0.968 . . . . 0.0 110.372 -179.947 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 838' ' ' VAL . . . . . . . . . . . . . 38.8 t -128.28 130.7 69.47 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.394 -0.816 . . . . 0.0 110.0 179.926 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 839' ' ' CYS . . . . . . . . . . . . . 2.5 m -109.82 146.47 34.99 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.179 -0.95 . . . . 0.0 110.343 -179.961 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 840' ' ' SER . . . . . . . . . . . . . 67.2 p -131.01 -169.83 2.24 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.351 -0.843 . . . . 0.0 109.861 179.938 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 841' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.617 0 O-C-N 121.221 -0.925 . . . . 0.0 110.143 -179.96 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 728' ' ' VAL . . . . . 0.439 ' O ' ' O ' ' A' ' 839' ' ' CYS . 32.5 t . . . . . 0 N--CA 1.492 1.637 0 CA-C-O 121.096 0.474 . . . . 0.0 110.07 . . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 729' ' ' SER . . . . . 0.429 ' OG ' ' O ' ' A' ' 728' ' ' VAL . 0.9 OUTLIER 178.1 120.88 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.127 -0.983 . . . . 0.0 110.432 -179.95 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 730' ' ' GLY . . . . . 0.412 ' C ' HG21 ' A' ' 731' ' ' VAL . . . 149.34 99.32 0.2 Allowed Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.767 -1.333 . . . . 0.0 109.767 -179.979 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 731' ' ' VAL . . . . . 0.412 HG21 ' C ' ' A' ' 730' ' ' GLY . 73.1 t -142.15 148.98 19.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.282 -1.128 . . . . 0.0 109.869 179.979 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 732' ' ' CYS . . . . . . . . . . . . . 92.5 m -122.62 166.3 15.08 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.256 -0.902 . . . . 0.0 110.922 -179.971 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 733' ' ' ALA . . . . . . . . . . . . . . . -160.96 102.09 1.28 Allowed 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 179.883 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 734' ' ' ASP . . . . . 0.455 ' C ' ' CG2' ' A' ' 735' ' ' VAL . 3.2 t70 -131.28 122.64 26.81 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.174 -0.954 . . . . 0.0 110.366 -179.944 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 735' ' ' VAL . . . . . 0.455 ' CG2' ' C ' ' A' ' 734' ' ' ASP . 40.6 t -153.25 153.06 9.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.35 -0.844 . . . . 0.0 110.152 179.979 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 736' ' ' SER . . . . . . . . . . . . . 12.3 t -110.31 152.25 26.41 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.159 -0.963 . . . . 0.0 110.207 -179.962 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 737' ' ' GLU . . . . . 0.464 ' HG3' ' HG3' ' A' ' 831' ' ' LYS . 2.1 tm-20 . . . . . 0 N--CA 1.493 1.703 0 O-C-N 121.226 -0.921 . . . . 0.0 110.225 179.981 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 757' ' ' THR . . . . . . . . . . . . . 39.0 p . . . . . 0 N--CA 1.491 1.582 0 CA-C-O 121.368 0.604 . . . . 0.0 110.098 . . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 758' ' ' ALA . . . . . 0.468 ' HB3' HD13 ' A' ' 816' ' ' ILE . . . -114.13 176.14 5.17 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.218 -0.926 . . . . 0.0 110.007 179.974 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 759' ' ' LYS . . . . . . . . . . . . . 32.2 mtmt -144.44 161.99 37.64 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.213 -0.929 . . . . 0.0 110.345 -179.963 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 760' ' ' VAL . . . . . . . . . . . . . 59.6 t -109.28 158.61 9.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.435 -0.791 . . . . 0.0 109.276 179.971 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 761' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -122.47 122.61 39.36 Favored 'General case' 0 C--N 1.298 -1.641 0 O-C-N 121.051 -1.03 . . . . 0.0 110.912 179.978 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 762' ' ' LEU . . . . . 0.478 ' HB2' ' O ' ' A' ' 812' ' ' CYS . 5.6 mt -141.4 135.97 30.92 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.462 -0.774 . . . . 0.0 109.323 179.918 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 763' ' ' LYS . . . . . . . . . . . . . 3.8 mtmt -150.38 151.17 32.42 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.009 -1.057 . . . . 0.0 110.944 -179.938 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 764' ' ' CYS . . . . . . . . . . . . . 9.2 m -127.54 172.88 10.32 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.538 -0.726 . . . . 0.0 109.622 179.963 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 765' ' ' ALA . . . . . . . . . . . . . . . -68.11 158.49 83.9 Favored Pre-proline 0 N--CA 1.493 1.681 0 O-C-N 121.109 -0.994 . . . . 0.0 109.947 179.947 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 766' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -72.33 119.02 5.88 Favored 'Trans proline' 0 C--N 1.306 -1.703 0 O-C-N 123.932 1.491 . . . . 0.0 110.338 179.987 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 767' ' ' GLY . . . . . . . . . . . . . . . 112.98 -6.67 25.52 Favored Glycine 0 N--CA 1.489 2.201 0 N-CA-C 109.485 -1.446 . . . . 0.0 109.485 -179.911 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 768' ' ' GLN . . . . . . . . . . . . . 33.6 mt-30 -114.27 169.75 8.8 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.145 -1.209 . . . . 0.0 110.463 179.969 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 769' ' ' THR . . . . . . . . . . . . . 70.5 p -152.2 149.47 28.77 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.358 -0.839 . . . . 0.0 109.866 -179.97 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 770' ' ' ILE . . . . . 0.405 ' HB ' ' HA ' ' A' ' 807' ' ' ILE . 26.9 mt -70.27 141.38 17.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.088 -1.008 . . . . 0.0 109.722 -179.985 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 771' ' ' SER . . . . . . . . . . . . . 1.6 p -126.44 -13.18 6.08 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.168 -0.958 . . . . 0.0 110.587 -179.943 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 772' ' ' ALA . . . . . . . . . . . . . . . -158.08 159.66 36.52 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 120.97 -1.081 . . . . 0.0 111.426 -179.906 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 773' ' ' ILE . . . . . . . . . . . . . 34.8 mm -124.15 123.31 66.32 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 O-C-N 121.644 -0.66 . . . . 0.0 109.296 179.936 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 774' ' ' LYS . . . . . 0.528 ' HG3' ' CG2' ' A' ' 838' ' ' VAL . 0.3 OUTLIER -80.82 -41.4 23.35 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.125 -0.984 . . . . 0.0 110.933 -179.869 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 775' ' ' PHE . . . . . 0.514 ' O ' ' CB ' ' A' ' 776' ' ' ALA . 48.7 t80 -135.5 173.59 11.55 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.069 -1.019 . . . . 0.0 111.088 -179.892 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 776' ' ' ALA . . . . . 0.514 ' CB ' ' O ' ' A' ' 775' ' ' PHE . . . 166.47 87.03 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.644 -0.66 . . . . 0.0 109.314 179.999 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 777' ' ' SER . . . . . 0.478 ' OG ' ' CZ ' ' A' ' 775' ' ' PHE . 16.1 p -119.61 129.84 54.81 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.236 -0.915 . . . . 0.0 110.709 -179.892 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 778' ' ' PHE . . . . . 0.595 ' CD2' HG23 ' A' ' 833' ' ' VAL . 39.4 t80 -104.72 78.54 1.45 Allowed 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.294 -0.879 . . . . 0.0 110.024 179.944 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 779' ' ' GLY . . . . . 0.431 ' C ' ' HD3' ' A' ' 781' ' ' PRO . . . -168.79 -105.42 0.18 Allowed Glycine 0 N--CA 1.492 2.408 0 N-CA-C 109.686 -1.366 . . . . 0.0 109.686 179.997 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 780' ' ' THR . . . . . . . . . . . . . 2.4 p -121.17 63.24 12.16 Favored Pre-proline 0 N--CA 1.493 1.686 0 O-C-N 121.229 -1.159 . . . . 0.0 110.548 -179.973 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 781' ' ' PRO . . . . . 0.459 ' HD2' ' HB3' ' A' ' 832' ' ' ARG . 46.1 Cg_endo -75.98 146.66 29.51 Favored 'Trans proline' 0 C--N 1.305 -1.726 0 O-C-N 124.068 1.562 . . . . 0.0 111.142 179.983 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 782' ' ' LEU . . . . . 0.521 ' CD2' ' O ' ' A' ' 790' ' ' GLN . 1.8 pt? -149.54 159.56 44.21 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.452 -0.78 . . . . 0.0 109.64 179.928 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 783' ' ' GLY . . . . . . . . . . . . . . . 140.48 -131.22 4.91 Favored Glycine 0 N--CA 1.496 2.66 0 N-CA-C 109.591 -1.404 . . . . 0.0 109.591 -179.96 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 784' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -162.14 -158.02 0.51 Allowed 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.121 -1.223 . . . . 0.0 110.68 -179.969 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 785' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -72.95 119.32 17.03 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.366 -0.834 . . . . 0.0 110.54 -179.989 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 786' ' ' GLY . . . . . . . . . . . . . . . 82.63 -10.63 55.5 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.895 -1.282 . . . . 0.0 109.895 -179.98 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 787' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -124.25 30.0 6.2 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.13 -1.218 . . . . 0.0 110.133 -179.989 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 788' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -58.62 91.82 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.276 -0.89 . . . . 0.0 110.387 -180.0 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 789' ' ' GLN . . . . . . . . . . . . . 4.1 tt0 -75.5 -177.24 3.53 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.405 -0.809 . . . . 0.0 110.162 -179.957 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 790' ' ' GLN . . . . . 0.521 ' O ' ' CD2' ' A' ' 782' ' ' LEU . 0.0 OUTLIER -108.05 174.01 6.07 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.443 -0.786 . . . . 0.0 110.307 179.992 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 791' ' ' GLY . . . . . . . . . . . . . . . -106.87 -140.82 9.87 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.519 -1.432 . . . . 0.0 109.519 179.945 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 792' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -105.17 -24.03 12.81 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.174 -1.192 . . . . 0.0 110.144 -179.967 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 793' ' ' CYS . . . . . . . . . . . . . 5.7 t -126.22 145.66 50.3 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.281 -0.887 . . . . 0.0 109.974 -179.887 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 794' ' ' HIS . . . . . 0.492 ' CE1' ' OG ' ' A' ' 798' ' ' SER . 73.0 t60 -139.46 156.11 47.15 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.18 -0.95 . . . . 0.0 110.146 -179.943 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 795' ' ' SER . . . . . . . . . . . . . 1.3 t -81.56 -141.62 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.322 -0.861 . . . . 0.0 110.165 179.995 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 796' ' ' ILE . . . . . . . . . . . . . 1.5 pt -145.53 12.71 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.241 -0.912 . . . . 0.0 110.038 -179.971 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 797' ' ' ASN . . . . . . . . . . . . . 31.5 m120 -148.99 29.16 0.82 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.328 -0.857 . . . . 0.0 110.08 179.999 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 798' ' ' SER . . . . . 0.514 ' CB ' ' O ' ' A' ' 776' ' ' ALA . 7.6 m -71.41 -30.47 66.13 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.218 -0.926 . . . . 0.0 110.625 -179.995 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 799' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -102.33 -7.89 21.67 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.244 -0.91 . . . . 0.0 110.349 179.967 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 800' ' ' SER . . . . . . . . . . . . . 5.8 p -90.46 -22.3 21.46 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.174 -0.954 . . . . 0.0 110.477 179.987 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 801' ' ' VAL . . . . . 0.507 HG22 ' CD2' ' A' ' 821' ' ' PHE . 55.6 t -81.59 -39.05 16.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.104 -0.997 . . . . 0.0 109.949 179.977 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 802' ' ' LEU . . . . . 0.496 ' N ' HD21 ' A' ' 802' ' ' LEU . 4.3 mm? -70.6 -56.29 6.84 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.33 -0.856 . . . . 0.0 110.536 -179.95 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 803' ' ' GLU . . . . . 0.45 ' HG2' HD13 ' A' ' 807' ' ' ILE . 2.3 tt0 -48.97 -19.8 0.44 Allowed 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.158 -0.964 . . . . 0.0 110.946 -179.921 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 804' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.71 -46.8 8.03 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.993 -1.067 . . . . 0.0 111.328 -179.893 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 805' ' ' LYS . . . . . 0.481 ' HG2' ' O ' ' A' ' 801' ' ' VAL . 0.0 OUTLIER -115.93 47.53 1.36 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.952 -1.092 . . . . 0.0 111.329 -179.829 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 806' ' ' CYS . . . . . 0.419 ' SG ' HD13 ' A' ' 802' ' ' LEU . 2.4 t -150.22 -44.52 0.13 Allowed 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.056 -1.028 . . . . 0.0 110.225 179.937 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 807' ' ' ILE . . . . . 0.45 HD13 ' HG2' ' A' ' 803' ' ' GLU . 36.7 mt -80.89 129.17 37.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.188 -0.945 . . . . 0.0 110.151 -179.95 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 808' ' ' GLY . . . . . . . . . . . . . . . 110.86 -9.27 29.74 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 109.897 -1.281 . . . . 0.0 109.897 179.988 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 809' ' ' LEU . . . . . . . . . . . . . 7.8 mt -113.64 154.51 27.1 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.05 -1.265 . . . . 0.0 110.77 -179.979 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 810' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -69.93 -29.74 66.97 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.321 -0.862 . . . . 0.0 109.237 179.869 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 811' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -132.42 165.03 25.21 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.606 -0.684 . . . . 0.0 109.527 -179.993 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 812' ' ' CYS . . . . . 0.478 ' O ' ' HB2' ' A' ' 762' ' ' LEU . 22.8 t -143.12 135.12 26.93 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.079 -1.013 . . . . 0.0 110.839 179.986 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 813' ' ' VAL . . . . . 0.442 ' O ' ' CG1' ' A' ' 813' ' ' VAL . 3.0 p -144.16 129.45 14.82 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 O-C-N 121.464 -0.772 . . . . 0.0 109.192 179.856 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 814' ' ' VAL . . . . . 0.447 HG21 ' HE2' ' A' ' 805' ' ' LYS . 30.2 t -134.59 145.59 32.35 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.068 -1.02 . . . . 0.0 110.849 -179.895 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 815' ' ' ALA . . . . . . . . . . . . . . . -87.28 165.3 15.75 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.404 -0.81 . . . . 0.0 109.965 179.934 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 816' ' ' ILE . . . . . 0.468 HD13 ' HB3' ' A' ' 758' ' ' ALA . 71.9 mt -111.05 101.15 12.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.121 -0.987 . . . . 0.0 110.28 -179.94 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 817' ' ' SER . . . . . 0.458 ' HB2' ' HD2' ' A' ' 818' ' ' PRO . 1.4 p -155.25 176.34 2.59 Favored Pre-proline 0 N--CA 1.494 1.774 0 O-C-N 121.395 -0.815 . . . . 0.0 110.179 179.955 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 818' ' ' PRO . . . . . 0.458 ' HD2' ' HB2' ' A' ' 817' ' ' SER . 48.4 Cg_endo -76.18 -59.95 0.04 OUTLIER 'Trans proline' 0 C--N 1.309 -1.548 0 O-C-N 123.998 1.525 . . . . 0.0 111.19 -179.888 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 819' ' ' SER . . . . . . . . . . . . . 36.8 t -58.55 -42.45 87.9 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.19 -0.944 . . . . 0.0 110.59 -179.968 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 820' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -47.19 -23.83 0.59 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.218 -0.926 . . . . 0.0 110.322 -179.954 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 821' ' ' PHE . . . . . 0.507 ' CD2' HG22 ' A' ' 801' ' ' VAL . 15.6 m-85 -107.07 -96.08 0.37 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.146 -0.971 . . . . 0.0 110.715 -179.928 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 822' ' ' GLY . . . . . . . . . . . . . . . -141.8 8.18 2.49 Favored Glycine 0 N--CA 1.491 2.339 0 C-N-CA 119.648 -1.263 . . . . 0.0 110.163 -179.971 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 823' ' ' GLY . . . . . . . . . . . . . . . 124.59 -123.08 4.97 Favored Glycine 0 N--CA 1.492 2.376 0 O-C-N 120.999 -1.295 . . . . 0.0 109.966 179.972 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 824' ' ' ASP . . . . . . . . . . . . . 69.8 m-20 -80.42 134.99 53.98 Favored Pre-proline 0 N--CA 1.496 1.826 0 O-C-N 121.286 -1.126 . . . . 0.0 110.476 -179.943 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 825' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_endo -83.83 -64.05 0.02 OUTLIER 'Trans proline' 0 C--N 1.308 -1.586 0 O-C-N 123.963 1.507 . . . . 0.0 110.425 179.905 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 826' ' ' CYS . . . . . 0.43 ' HB3' ' HB ' ' A' ' 829' ' ' VAL . 0.7 OUTLIER -147.42 149.71 35.25 Favored Pre-proline 0 N--CA 1.494 1.76 0 O-C-N 121.325 -0.859 . . . . 0.0 110.319 179.96 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 827' ' ' PRO . . . . . 0.444 ' O ' ' HB2' ' A' ' 828' ' ' GLU . 46.8 Cg_endo -74.3 134.57 19.26 Favored 'Trans proline' 0 C--N 1.305 -1.713 0 O-C-N 123.977 1.514 . . . . 0.0 110.694 -179.961 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 828' ' ' GLU . . . . . 0.444 ' HB2' ' O ' ' A' ' 827' ' ' PRO . 64.8 mm-40 55.77 39.7 30.76 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.315 -0.866 . . . . 0.0 110.43 179.984 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 829' ' ' VAL . . . . . 0.43 ' HB ' ' HB3' ' A' ' 826' ' ' CYS . 18.1 t -142.48 136.61 28.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.177 -0.952 . . . . 0.0 110.373 179.987 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 830' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -63.26 -149.66 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.245 -0.909 . . . . 0.0 109.856 -179.993 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 831' ' ' LYS . . . . . 0.464 ' HG3' ' HG3' ' A' ' 737' ' ' GLU . 0.0 OUTLIER -145.34 94.92 2.58 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 120.962 -1.086 . . . . 0.0 110.834 179.962 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 832' ' ' ARG . . . . . 0.459 ' HB3' ' HD2' ' A' ' 781' ' ' PRO . 0.0 OUTLIER -109.56 166.75 10.65 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.305 -0.872 . . . . 0.0 109.408 179.911 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 833' ' ' VAL . . . . . 0.595 HG23 ' CD2' ' A' ' 778' ' ' PHE . 37.0 t -142.93 120.7 6.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 120.928 -1.108 . . . . 0.0 111.763 -179.914 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 834' ' ' ALA . . . . . . . . . . . . . . . -125.31 104.1 8.3 Favored 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 107.87 -1.159 . . . . 0.0 107.87 179.769 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 835' ' ' VAL . . . . . 0.5 HG13 ' N ' ' A' ' 836' ' ' GLU . 67.1 t -109.5 153.56 11.23 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.579 0 O-C-N 121.153 -0.967 . . . . 0.0 112.453 -179.674 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 836' ' ' GLU . . . . . 0.5 ' N ' HG13 ' A' ' 835' ' ' VAL . 31.2 tt0 -135.11 122.41 21.69 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 107.185 -1.413 . . . . 0.0 107.185 179.694 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 837' ' ' ALA . . . . . . . . . . . . . . . -113.62 161.81 16.99 Favored 'General case' 0 N--CA 1.501 2.087 0 O-C-N 120.719 -1.238 . . . . 0.0 112.722 -179.669 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 838' ' ' VAL . . . . . 0.528 ' CG2' ' HG3' ' A' ' 774' ' ' LYS . 23.9 t -118.75 105.56 17.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 179.852 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 839' ' ' CYS . . . . . 0.439 ' O ' ' O ' ' A' ' 728' ' ' VAL . 0.0 OUTLIER -107.98 140.71 40.72 Favored 'General case' 0 C--N 1.3 -1.585 0 O-C-N 120.975 -1.078 . . . . 0.0 110.462 -179.867 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 840' ' ' SER . . . . . . . . . . . . . 71.2 p -163.76 177.7 8.45 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.474 -0.766 . . . . 0.0 110.047 179.962 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 841' ' ' THR . . . . . . . . . . . . . 11.6 p . . . . . 0 N--CA 1.492 1.659 0 O-C-N 121.101 -0.999 . . . . 0.0 110.199 -179.956 . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 728' ' ' VAL . . . . . 0.465 ' O ' ' CG1' ' A' ' 728' ' ' VAL . 9.5 p . . . . . 0 N--CA 1.491 1.618 0 CA-C-O 121.263 0.554 . . . . 0.0 110.403 . . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 729' ' ' SER . . . . . . . . . . . . . 36.2 t -63.88 159.45 19.68 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.146 -0.971 . . . . 0.0 110.068 -179.997 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 730' ' ' GLY . . . . . . . . . . . . . . . -113.95 155.67 16.16 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.494 -1.443 . . . . 0.0 109.494 -179.995 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 731' ' ' VAL . . . . . 0.494 HG13 ' N ' ' A' ' 732' ' ' CYS . 73.4 t -119.73 158.91 21.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.142 -1.21 . . . . 0.0 110.086 -179.932 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 732' ' ' CYS . . . . . 0.494 ' N ' HG13 ' A' ' 731' ' ' VAL . 0.5 OUTLIER -131.09 125.14 32.38 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.177 -0.952 . . . . 0.0 110.02 179.996 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 733' ' ' ALA . . . . . . . . . . . . . . . -115.25 109.57 18.16 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.236 -0.915 . . . . 0.0 110.377 179.973 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 734' ' ' ASP . . . . . 0.404 ' O ' ' CG2' ' A' ' 735' ' ' VAL . 5.0 t0 -118.11 108.93 15.8 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.19 -0.944 . . . . 0.0 110.159 -179.987 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 735' ' ' VAL . . . . . 0.404 ' CG2' ' O ' ' A' ' 734' ' ' ASP . 96.3 t -152.1 145.39 15.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.287 -0.883 . . . . 0.0 110.182 179.998 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 736' ' ' SER . . . . . . . . . . . . . 66.6 p -93.18 -161.99 0.89 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.175 -0.953 . . . . 0.0 110.386 179.898 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 737' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 . . . . . 0 N--CA 1.494 1.763 0 O-C-N 121.292 -0.88 . . . . 0.0 110.26 179.955 . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 757' ' ' THR . . . . . . . . . . . . . 29.4 p . . . . . 0 N--CA 1.491 1.59 0 CA-C-O 121.289 0.566 . . . . 0.0 110.38 . . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 758' ' ' ALA . . . . . . . . . . . . . . . -140.85 166.14 25.59 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.393 -0.817 . . . . 0.0 109.758 -179.987 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 759' ' ' LYS . . . . . . . . . . . . . 8.2 mttt -113.38 166.31 11.61 Favored 'General case' 0 C--N 1.299 -1.618 0 O-C-N 121.232 -0.918 . . . . 0.0 110.3 179.993 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 760' ' ' VAL . . . . . . . . . . . . . 80.3 t -105.56 150.11 8.51 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.463 0 O-C-N 121.311 -0.868 . . . . 0.0 108.873 179.91 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 761' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -125.73 103.95 8.09 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 120.916 -1.115 . . . . 0.0 111.607 -179.812 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 762' ' ' LEU . . . . . 0.462 ' HB2' ' O ' ' A' ' 812' ' ' CYS . 17.8 mt -118.04 100.46 7.56 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 179.829 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 763' ' ' LYS . . . . . 0.412 ' HG2' ' CB ' ' A' ' 811' ' ' ARG . 0.0 OUTLIER -124.12 139.88 53.51 Favored 'General case' 0 C--N 1.3 -1.562 0 O-C-N 121.085 -1.009 . . . . 0.0 111.298 -179.829 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 764' ' ' CYS . . . . . 0.437 ' O ' ' C ' ' A' ' 765' ' ' ALA . 3.0 t -125.76 145.12 50.34 Favored 'General case' 0 C--N 1.299 -1.603 0 O-C-N 121.623 -0.673 . . . . 0.0 109.409 179.881 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 765' ' ' ALA . . . . . 0.437 ' C ' ' O ' ' A' ' 764' ' ' CYS . . . -41.1 161.78 0.12 Allowed Pre-proline 0 N--CA 1.495 1.782 0 O-C-N 121.164 -0.96 . . . . 0.0 110.494 179.983 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 766' ' ' PRO . . . . . 0.424 ' HD2' ' HB1' ' A' ' 765' ' ' ALA . 43.9 Cg_endo -70.55 102.47 1.16 Allowed 'Trans proline' 0 C--N 1.305 -1.726 0 O-C-N 123.94 1.495 . . . . 0.0 110.28 -179.963 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 767' ' ' GLY . . . . . . . . . . . . . . . 133.18 -21.71 4.08 Favored Glycine 0 N--CA 1.488 2.102 0 N-CA-C 109.025 -1.63 . . . . 0.0 109.025 -179.978 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 768' ' ' GLN . . . . . 0.513 ' HG2' ' CG2' ' A' ' 841' ' ' THR . 22.6 mt-30 -101.64 131.8 47.67 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.48 -1.012 . . . . 0.0 110.076 -179.999 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 769' ' ' THR . . . . . . . . . . . . . 16.9 p -125.57 147.37 49.31 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.113 -0.992 . . . . 0.0 110.232 179.965 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 770' ' ' ILE . . . . . 0.455 HG22 ' N ' ' A' ' 771' ' ' SER . 22.4 mt -59.92 166.88 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.205 -0.934 . . . . 0.0 109.639 179.964 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 771' ' ' SER . . . . . 0.455 ' N ' HG22 ' A' ' 770' ' ' ILE . 0.1 OUTLIER -160.33 -30.92 0.06 Allowed 'General case' 0 C--N 1.299 -1.621 0 O-C-N 121.094 -1.004 . . . . 0.0 111.152 -179.948 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 772' ' ' ALA . . . . . . . . . . . . . . . -135.78 122.67 21.25 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.852 -1.155 . . . . 0.0 111.402 -179.858 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 773' ' ' ILE . . . . . . . . . . . . . 38.2 mm -95.74 100.95 11.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.448 -0.783 . . . . 0.0 109.021 179.918 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 774' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.94 -37.89 28.71 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.163 -0.961 . . . . 0.0 111.284 -179.928 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 775' ' ' PHE . . . . . 0.49 ' O ' ' CB ' ' A' ' 776' ' ' ALA . 44.1 t80 -122.65 160.66 25.34 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 120.957 -1.089 . . . . 0.0 111.305 -179.843 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 776' ' ' ALA . . . . . 0.49 ' CB ' ' O ' ' A' ' 775' ' ' PHE . . . 166.28 100.64 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.607 -0.683 . . . . 0.0 109.616 179.989 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 777' ' ' SER . . . . . 0.47 ' HA ' ' HB3' ' A' ' 798' ' ' SER . 1.6 p -136.08 142.03 44.28 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.347 -0.846 . . . . 0.0 110.369 -179.909 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 778' ' ' PHE . . . . . 0.496 ' O ' ' CD2' ' A' ' 778' ' ' PHE . 68.8 t80 -120.87 73.74 1.03 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.44 -0.787 . . . . 0.0 110.298 -179.996 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 779' ' ' GLY . . . . . . . . . . . . . . . -161.57 -108.01 0.22 Allowed Glycine 0 N--CA 1.492 2.39 0 N-CA-C 109.544 -1.422 . . . . 0.0 109.544 -179.983 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 780' ' ' THR . . . . . . . . . . . . . 81.8 p -121.07 81.97 36.54 Favored Pre-proline 0 N--CA 1.489 1.506 0 O-C-N 121.187 -1.184 . . . . 0.0 110.161 -179.982 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 781' ' ' PRO . . . . . 0.459 ' CG ' ' HB3' ' A' ' 832' ' ' ARG . 47.5 Cg_endo -75.7 166.8 27.65 Favored 'Trans proline' 0 C--N 1.305 -1.733 0 O-C-N 124.103 1.581 . . . . 0.0 110.36 -179.974 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 782' ' ' LEU . . . . . . . . . . . . . 6.7 mt -140.74 131.81 26.27 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.252 -0.905 . . . . 0.0 110.134 179.999 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 783' ' ' GLY . . . . . . . . . . . . . . . 114.93 -165.86 12.11 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.638 -1.385 . . . . 0.0 109.638 -179.948 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 784' ' ' THR . . . . . . . . . . . . . 12.3 p -135.78 -50.1 0.71 Allowed 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.292 -1.123 . . . . 0.0 110.114 179.941 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 785' ' ' CYS . . . . . . . . . . . . . 22.5 t -173.26 87.84 0.07 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.291 -0.881 . . . . 0.0 109.854 -180.0 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 786' ' ' GLY . . . . . . . . . . . . . . . 142.34 -26.74 2.28 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 108.902 -1.679 . . . . 0.0 108.902 -179.897 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 787' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -127.17 30.19 5.46 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.487 -1.008 . . . . 0.0 109.82 179.989 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 788' ' ' PHE . . . . . 0.577 ' CE2' ' HB1' ' A' ' 834' ' ' ALA . 2.2 m-85 -51.93 121.08 6.07 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.307 -0.871 . . . . 0.0 110.245 179.993 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 789' ' ' GLN . . . . . . . . . . . . . 13.2 tt0 -133.74 120.76 20.97 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.302 -0.874 . . . . 0.0 110.274 -179.978 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 790' ' ' GLN . . . . . 0.468 ' CG ' ' O ' ' A' ' 790' ' ' GLN . 9.3 pt20 -64.96 126.21 27.31 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.251 -0.906 . . . . 0.0 110.549 -179.949 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 791' ' ' GLY . . . . . . . . . . . . . . . -69.43 -122.47 0.03 OUTLIER Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.311 -1.516 . . . . 0.0 109.311 179.948 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 792' ' ' GLU . . . . . . . . . . . . . 11.9 mt-10 -126.26 8.72 7.24 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.149 -1.207 . . . . 0.0 110.279 179.963 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 793' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -129.46 96.36 4.26 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.239 -0.913 . . . . 0.0 109.771 179.874 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 794' ' ' HIS . . . . . 0.589 ' CD2' ' O ' ' A' ' 795' ' ' SER . 77.6 t60 -124.78 139.62 53.68 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.179 -0.95 . . . . 0.0 110.488 -179.934 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 795' ' ' SER . . . . . 0.589 ' O ' ' CD2' ' A' ' 794' ' ' HIS . 4.1 t -82.75 168.87 16.78 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.318 -0.864 . . . . 0.0 109.078 179.99 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 796' ' ' ILE . . . . . . . . . . . . . 1.7 mt -94.97 -7.88 9.79 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 O-C-N 120.857 -1.152 . . . . 0.0 110.095 -179.971 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 797' ' ' ASN . . . . . . . . . . . . . 4.8 m120 -107.38 38.65 2.08 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.288 -0.883 . . . . 0.0 109.387 179.877 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 798' ' ' SER . . . . . 0.552 ' OG ' ' CE1' ' A' ' 794' ' ' HIS . 70.6 m -82.08 -52.54 6.91 Favored 'General case' 0 N--CA 1.485 1.317 0 O-C-N 121.51 -0.743 . . . . 0.0 111.184 -179.983 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 799' ' ' ASN . . . . . . . . . . . . . 47.2 t-20 -98.37 12.04 36.17 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.074 -1.017 . . . . 0.0 111.134 -179.923 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 800' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -89.29 -45.06 9.8 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.075 -1.015 . . . . 0.0 110.355 179.959 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 801' ' ' VAL . . . . . . . . . . . . . 8.7 t -74.96 -19.32 16.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.171 -0.956 . . . . 0.0 110.342 -179.974 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 802' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -74.2 -57.23 4.09 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.284 -0.885 . . . . 0.0 110.721 179.976 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 803' ' ' GLU . . . . . 0.426 ' CD ' HD13 ' A' ' 807' ' ' ILE . 0.9 OUTLIER -63.43 -18.33 63.61 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.213 -0.929 . . . . 0.0 110.543 -179.935 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 804' ' ' ARG . . . . . . . . . . . . . 3.2 mtm-85 -92.41 -16.74 25.52 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.237 -0.914 . . . . 0.0 112.066 -179.805 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 805' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.59 39.28 1.69 Allowed 'General case' 0 N--CA 1.502 2.143 0 O-C-N 120.466 -1.396 . . . . 0.0 112.594 -179.809 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 806' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -164.39 22.95 0.06 Allowed 'General case' 0 N--CA 1.501 2.112 0 O-C-N 120.58 -1.325 . . . . 0.0 111.024 179.921 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 807' ' ' ILE . . . . . 0.426 HD13 ' CD ' ' A' ' 803' ' ' GLU . 4.4 mt -125.32 119.33 55.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.093 -1.004 . . . . 0.0 109.939 179.914 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 808' ' ' GLY . . . . . . . . . . . . . . . 110.93 7.91 24.69 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.059 -1.616 . . . . 0.0 109.059 -179.889 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 809' ' ' LEU . . . . . . . . . . . . . 29.7 mt -123.65 138.34 54.55 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.287 -1.125 . . . . 0.0 109.876 179.968 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 810' ' ' GLU . . . . . . . . . . . . . 15.0 mp0 -63.04 -22.36 66.8 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.067 -1.021 . . . . 0.0 109.329 -179.992 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 811' ' ' ARG . . . . . 0.412 ' CB ' ' HG2' ' A' ' 763' ' ' LYS . 0.0 OUTLIER -154.56 122.88 6.03 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.519 -0.738 . . . . 0.0 109.881 179.94 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 812' ' ' CYS . . . . . 0.462 ' O ' ' HB2' ' A' ' 762' ' ' LEU . 6.0 p -129.47 139.07 51.71 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.126 -0.984 . . . . 0.0 110.241 -179.94 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 813' ' ' VAL . . . . . . . . . . . . . 53.4 t -121.79 139.79 47.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.204 -0.935 . . . . 0.0 110.308 -179.952 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 814' ' ' VAL . . . . . . . . . . . . . 58.0 t -124.71 134.52 66.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.253 -0.905 . . . . 0.0 110.279 179.989 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 815' ' ' ALA . . . . . . . . . . . . . . . -82.32 149.56 27.7 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.288 -0.883 . . . . 0.0 109.927 -179.99 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 816' ' ' ILE . . . . . . . . . . . . . 22.0 mt -109.96 125.04 67.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.172 -0.955 . . . . 0.0 110.285 179.954 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 817' ' ' SER . . . . . 0.454 ' HB2' ' HD2' ' A' ' 818' ' ' PRO . 2.9 p -172.96 170.74 2.0 Favored Pre-proline 0 N--CA 1.492 1.659 0 O-C-N 121.148 -0.97 . . . . 0.0 110.314 179.993 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 818' ' ' PRO . . . . . 0.46 ' O ' ' HB3' ' A' ' 819' ' ' SER . 47.6 Cg_endo -74.84 158.39 42.82 Favored 'Trans proline' 0 C--N 1.305 -1.737 0 O-C-N 124.144 1.602 . . . . 0.0 110.743 -179.875 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 819' ' ' SER . . . . . 0.46 ' HB3' ' O ' ' A' ' 818' ' ' PRO . 7.5 t 63.01 9.85 4.05 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.361 -0.837 . . . . 0.0 110.842 179.983 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 820' ' ' ASN . . . . . . . . . . . . . 2.4 t30 -96.72 -44.18 7.21 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.097 -1.002 . . . . 0.0 110.208 179.988 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 821' ' ' PHE . . . . . . . . . . . . . 4.0 m-85 -89.94 -45.31 9.3 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.19 -0.944 . . . . 0.0 110.184 179.985 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 822' ' ' GLY . . . . . . . . . . . . . . . -167.43 -35.98 0.02 OUTLIER Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.61 -1.396 . . . . 0.0 109.61 -179.966 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 823' ' ' GLY . . . . . . . . . . . . . . . 159.82 -119.21 0.87 Allowed Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.648 -1.381 . . . . 0.0 109.648 -179.96 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 824' ' ' ASP . . . . . 0.463 ' OD1' ' O ' ' A' ' 824' ' ' ASP . 43.8 p-10 -148.19 101.76 3.58 Favored Pre-proline 0 N--CA 1.498 1.938 0 O-C-N 121.308 -1.113 . . . . 0.0 109.952 -179.997 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 825' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_endo -83.74 -53.22 0.03 OUTLIER 'Trans proline' 0 C--N 1.307 -1.631 0 O-C-N 123.907 1.477 . . . . 0.0 111.037 -179.968 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 826' ' ' CYS . . . . . 0.456 ' SG ' HG11 ' A' ' 829' ' ' VAL . 0.1 OUTLIER -77.56 129.1 78.09 Favored Pre-proline 0 N--CA 1.497 1.885 0 O-C-N 121.077 -1.014 . . . . 0.0 110.737 -179.876 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 827' ' ' PRO . . . . . 0.421 ' O ' ' C ' ' A' ' 828' ' ' GLU . 51.2 Cg_endo -87.86 135.07 3.32 Favored 'Trans proline' 0 C--N 1.31 -1.461 0 O-C-N 123.911 1.479 . . . . 0.0 111.086 -179.97 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 828' ' ' GLU . . . . . 0.421 ' C ' ' O ' ' A' ' 827' ' ' PRO . 0.3 OUTLIER 39.29 47.57 1.48 Allowed 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.428 -0.795 . . . . 0.0 110.937 179.863 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 829' ' ' VAL . . . . . 0.456 HG11 ' SG ' ' A' ' 826' ' ' CYS . 56.1 t -123.06 132.03 72.16 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.925 0 O-C-N 121.13 -0.981 . . . . 0.0 110.56 179.929 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 830' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -53.63 108.51 0.35 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.246 -0.909 . . . . 0.0 109.743 179.981 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 831' ' ' LYS . . . . . . . . . . . . . 5.0 mmtp -79.72 143.6 34.4 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.161 -0.962 . . . . 0.0 110.314 -179.944 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 832' ' ' ARG . . . . . 0.459 ' HB3' ' CG ' ' A' ' 781' ' ' PRO . 2.7 ttm180 -146.24 161.19 40.81 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.378 -0.826 . . . . 0.0 109.638 -179.979 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 833' ' ' VAL . . . . . . . . . . . . . 59.7 t -124.64 109.21 21.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.125 -0.984 . . . . 0.0 110.89 -179.967 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 834' ' ' ALA . . . . . 0.577 ' HB1' ' CE2' ' A' ' 788' ' ' PHE . . . -111.35 129.87 55.86 Favored 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 179.831 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 835' ' ' VAL . . . . . . . . . . . . . 68.3 t -140.35 160.2 25.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 120.817 -1.177 . . . . 0.0 111.718 -179.888 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 836' ' ' GLU . . . . . 0.415 ' HB2' ' HB3' ' A' ' 775' ' ' PHE . 0.2 OUTLIER -151.92 103.9 2.95 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 179.851 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 837' ' ' ALA . . . . . . . . . . . . . . . -111.23 164.07 13.27 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.008 -1.058 . . . . 0.0 111.798 -179.851 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 838' ' ' VAL . . . . . . . . . . . . . 93.4 t -112.6 131.3 64.51 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.327 0 N-CA-C 109.427 -0.582 . . . . 0.0 109.427 179.882 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 839' ' ' CYS . . . . . 0.444 ' O ' ' HA ' ' A' ' 728' ' ' VAL . 2.0 t -108.76 120.26 41.97 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.002 -1.061 . . . . 0.0 110.571 -179.965 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 840' ' ' SER . . . . . . . . . . . . . 10.1 t -123.97 159.12 30.47 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.418 -0.802 . . . . 0.0 110.065 179.977 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 841' ' ' THR . . . . . 0.513 ' CG2' ' HG2' ' A' ' 768' ' ' GLN . 22.2 p . . . . . 0 N--CA 1.494 1.738 0 O-C-N 121.154 -0.967 . . . . 0.0 110.295 179.99 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 728' ' ' VAL . . . . . 0.468 ' O ' HG12 ' A' ' 728' ' ' VAL . 7.7 p . . . . . 0 N--CA 1.491 1.618 0 CA-C-O 121.228 0.537 . . . . 0.0 110.253 . . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 729' ' ' SER . . . . . . . . . . . . . 1.9 t -66.93 166.67 13.07 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.179 -0.951 . . . . 0.0 109.981 179.98 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 730' ' ' GLY . . . . . . . . . . . . . . . -144.32 132.38 4.79 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.114 -1.594 . . . . 0.0 109.114 179.939 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 731' ' ' VAL . . . . . . . . . . . . . 21.0 m -150.9 117.49 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.425 0 O-C-N 121.018 -1.284 . . . . 0.0 110.845 -179.935 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 732' ' ' CYS . . . . . 0.425 ' O ' ' SG ' ' A' ' 732' ' ' CYS . 15.5 p -109.22 133.85 52.51 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.31 -0.869 . . . . 0.0 109.322 179.841 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 733' ' ' ALA . . . . . . . . . . . . . . . -109.24 123.44 49.27 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.091 -1.006 . . . . 0.0 110.669 -179.862 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 734' ' ' ASP . . . . . . . . . . . . . 12.2 t0 -111.71 114.47 27.51 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.378 -0.826 . . . . 0.0 110.124 179.941 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 735' ' ' VAL . . . . . . . . . . . . . 16.6 t -122.99 155.34 28.6 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.222 -0.924 . . . . 0.0 110.338 -179.993 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 736' ' ' SER . . . . . 0.433 ' O ' ' C ' ' A' ' 737' ' ' GLU . 0.1 OUTLIER -106.15 105.5 15.56 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.263 -0.898 . . . . 0.0 109.807 -179.98 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 737' ' ' GLU . . . . . 0.488 ' CB ' ' HA ' ' A' ' 831' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.496 1.856 0 O-C-N 121.457 -0.777 . . . . 0.0 110.851 -179.963 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 757' ' ' THR . . . . . . . . . . . . . 3.7 p . . . . . 0 N--CA 1.492 1.666 0 CA-C-O 121.279 0.561 . . . . 0.0 110.391 . . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 758' ' ' ALA . . . . . . . . . . . . . . . -87.62 169.92 11.73 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.329 -0.857 . . . . 0.0 109.979 179.981 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 759' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.46 155.69 47.42 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.1 -1.0 . . . . 0.0 110.584 -179.983 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 760' ' ' VAL . . . . . . . . . . . . . 47.3 t -109.54 139.14 33.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.42 -0.8 . . . . 0.0 109.523 179.939 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 761' ' ' HIS . . . . . . . . . . . . . 1.7 m170 -114.3 111.27 21.23 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.142 -0.973 . . . . 0.0 111.083 -179.978 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 762' ' ' LEU . . . . . . . . . . . . . 1.8 mt -129.6 117.45 20.42 Favored 'General case' 0 N--CA 1.493 1.69 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 -179.99 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 763' ' ' LYS . . . . . 0.428 ' N ' ' CD ' ' A' ' 763' ' ' LYS . 0.0 OUTLIER -142.56 166.44 24.65 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.009 -1.057 . . . . 0.0 111.324 -179.912 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 764' ' ' CYS . . . . . 0.407 ' O ' ' C ' ' A' ' 765' ' ' ALA . 1.4 m -141.37 140.74 33.77 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.677 -0.639 . . . . 0.0 109.458 179.943 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 765' ' ' ALA . . . . . 0.407 ' C ' ' O ' ' A' ' 764' ' ' CYS . . . -44.49 160.98 0.23 Allowed Pre-proline 0 N--CA 1.495 1.806 0 O-C-N 121.109 -0.994 . . . . 0.0 110.341 -179.986 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 766' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -71.34 103.39 1.4 Allowed 'Trans proline' 0 C--N 1.309 -1.5 0 O-C-N 124.004 1.528 . . . . 0.0 110.079 180.0 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 767' ' ' GLY . . . . . . . . . . . . . . . 143.61 -29.21 2.01 Favored Glycine 0 N--CA 1.488 2.118 0 N-CA-C 108.864 -1.694 . . . . 0.0 108.864 179.971 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 768' ' ' GLN . . . . . . . . . . . . . 1.5 mt-30 -113.59 115.26 27.65 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.311 -1.111 . . . . 0.0 109.599 179.975 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 769' ' ' THR . . . . . . . . . . . . . 67.2 p -99.75 145.94 27.11 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.187 -0.946 . . . . 0.0 110.576 -179.937 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 770' ' ' ILE . . . . . . . . . . . . . 35.8 mt -60.6 113.45 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 O-C-N 121.32 -0.863 . . . . 0.0 109.197 179.983 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 771' ' ' SER . . . . . 0.471 ' O ' ' HB2' ' A' ' 772' ' ' ALA . 39.2 t -91.61 -7.58 49.69 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.231 -0.918 . . . . 0.0 111.485 -179.835 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 772' ' ' ALA . . . . . 0.471 ' HB2' ' O ' ' A' ' 771' ' ' SER . . . 179.75 146.14 0.21 Allowed 'General case' 0 N--CA 1.496 1.839 0 O-C-N 120.765 -1.209 . . . . 0.0 111.475 -179.924 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 773' ' ' ILE . . . . . . . . . . . . . 31.9 mm -87.93 135.4 25.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.495 -0.753 . . . . 0.0 109.135 179.892 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 774' ' ' LYS . . . . . 0.562 ' HB3' ' CB ' ' A' ' 836' ' ' GLU . 0.4 OUTLIER -78.14 -35.53 48.88 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.119 -0.988 . . . . 0.0 110.768 -179.897 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 775' ' ' PHE . . . . . 0.517 ' CZ ' ' HB3' ' A' ' 777' ' ' SER . 44.9 t80 176.16 150.86 0.14 Allowed 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.173 -0.955 . . . . 0.0 110.897 -179.988 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 776' ' ' ALA . . . . . 0.457 ' O ' ' HB3' ' A' ' 798' ' ' SER . . . -143.65 145.78 32.73 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.472 -0.767 . . . . 0.0 108.959 179.872 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 777' ' ' SER . . . . . 0.517 ' HB3' ' CZ ' ' A' ' 775' ' ' PHE . 67.6 p -154.09 119.03 4.99 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.877 -1.14 . . . . 0.0 111.575 -179.949 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 778' ' ' PHE . . . . . 0.478 ' CZ ' ' HG2' ' A' ' 830' ' ' MET . 40.8 t80 -105.39 120.15 40.87 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.466 -0.771 . . . . 0.0 109.496 179.918 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 779' ' ' GLY . . . . . 0.528 ' HA2' ' HA ' ' A' ' 830' ' ' MET . . . 133.49 -100.0 0.38 Allowed Glycine 0 N--CA 1.487 2.075 0 C-N-CA 119.604 -1.284 . . . . 0.0 109.912 179.991 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 780' ' ' THR . . . . . . . . . . . . . 43.5 p -136.62 93.92 13.75 Favored Pre-proline 0 N--CA 1.495 1.781 0 O-C-N 121.133 -1.216 . . . . 0.0 110.593 -179.924 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 781' ' ' PRO . . . . . 0.485 ' CD ' ' HB3' ' A' ' 832' ' ' ARG . 51.6 Cg_endo -81.77 157.91 18.63 Favored 'Trans proline' 0 C--N 1.307 -1.643 0 O-C-N 124.004 1.528 . . . . 0.0 110.605 179.921 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 782' ' ' LEU . . . . . 0.419 HD12 ' HA2' ' A' ' 791' ' ' GLY . 0.8 OUTLIER -112.78 133.89 54.56 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.278 -0.889 . . . . 0.0 110.081 179.989 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 783' ' ' GLY . . . . . . . . . . . . . . . 84.03 -170.37 47.34 Favored Glycine 0 N--CA 1.493 2.487 0 N-CA-C 109.784 -1.326 . . . . 0.0 109.784 179.987 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 784' ' ' THR . . . . . 0.435 ' O ' ' CE1' ' A' ' 788' ' ' PHE . 44.0 p -127.68 -141.82 0.27 Allowed 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.264 -1.139 . . . . 0.0 110.529 -179.99 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 785' ' ' CYS . . . . . 0.406 ' HA ' ' CE1' ' A' ' 788' ' ' PHE . 38.4 m -78.52 100.56 6.95 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.278 -0.889 . . . . 0.0 110.379 -179.942 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 786' ' ' GLY . . . . . . . . . . . . . . . 140.46 -13.52 2.98 Favored Glycine 0 N--CA 1.493 2.452 0 N-CA-C 110.012 -1.235 . . . . 0.0 110.012 -179.988 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 787' ' ' THR . . . . . . . . . . . . . 9.0 t -159.52 36.62 0.19 Allowed 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.036 -1.273 . . . . 0.0 110.809 -179.978 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 788' ' ' PHE . . . . . 0.459 ' O ' ' HB2' ' A' ' 789' ' ' GLN . 14.4 m-85 -61.29 158.66 13.8 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.07 -1.019 . . . . 0.0 109.909 179.972 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 789' ' ' GLN . . . . . 0.459 ' HB2' ' O ' ' A' ' 788' ' ' PHE . 24.4 tt0 179.25 157.46 0.56 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.175 -0.953 . . . . 0.0 110.218 -179.994 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 790' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -52.17 137.81 27.26 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.252 -0.905 . . . . 0.0 110.362 -179.999 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 791' ' ' GLY . . . . . 0.419 ' HA2' HD12 ' A' ' 782' ' ' LEU . . . -111.75 -107.9 2.97 Favored Glycine 0 N--CA 1.493 2.466 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 -179.986 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 792' ' ' GLU . . . . . . . . . . . . . 39.1 tp10 -90.49 -53.02 4.61 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.194 -1.18 . . . . 0.0 110.277 179.944 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 793' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -136.08 117.69 14.91 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.263 -0.898 . . . . 0.0 110.081 179.983 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 794' ' ' HIS . . . . . . . . . . . . . 40.5 t60 -120.2 150.51 40.54 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.252 -0.905 . . . . 0.0 110.381 -179.975 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 795' ' ' SER . . . . . 0.463 ' OG ' ' HG3' ' A' ' 825' ' ' PRO . 2.6 m -94.94 117.44 30.15 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.425 -0.797 . . . . 0.0 109.483 179.896 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 796' ' ' ILE . . . . . . . . . . . . . 6.7 mt -58.3 -13.57 3.08 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.875 0 O-C-N 121.158 -0.964 . . . . 0.0 110.775 -179.947 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 797' ' ' ASN . . . . . 0.405 ' O ' ' OG ' ' A' ' 800' ' ' SER . 3.6 m-20 -89.96 21.48 3.63 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.062 -1.024 . . . . 0.0 110.414 179.906 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 798' ' ' SER . . . . . 0.498 ' OG ' ' HA ' ' A' ' 777' ' ' SER . 0.5 OUTLIER -70.0 -33.72 72.4 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.176 -0.953 . . . . 0.0 110.806 -179.995 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 799' ' ' ASN . . . . . . . . . . . . . 7.5 m-20 -97.94 6.21 47.99 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.26 -0.9 . . . . 0.0 111.024 -179.856 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 800' ' ' SER . . . . . 0.405 ' OG ' ' O ' ' A' ' 797' ' ' ASN . 6.1 p -90.69 -29.41 17.72 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.97 -1.081 . . . . 0.0 110.396 -179.979 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 801' ' ' VAL . . . . . . . . . . . . . 15.6 t -88.03 -19.66 7.69 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.293 -0.879 . . . . 0.0 110.588 179.957 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 802' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -90.64 -48.44 7.06 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.107 -0.996 . . . . 0.0 110.572 -179.896 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 803' ' ' GLU . . . . . . . . . . . . . 20.8 mt-10 -58.61 -26.78 64.05 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.185 -0.947 . . . . 0.0 110.987 -179.895 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 804' ' ' ARG . . . . . . . . . . . . . 16.7 ttt-85 -86.63 -28.3 23.29 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 120.988 -1.07 . . . . 0.0 110.849 -179.892 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 805' ' ' LYS . . . . . 0.434 ' O ' ' SG ' ' A' ' 812' ' ' CYS . 2.1 mttm -122.28 31.81 6.02 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.055 -1.028 . . . . 0.0 110.615 179.985 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 806' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -162.2 41.44 0.13 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.151 -0.968 . . . . 0.0 110.4 -179.969 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 807' ' ' ILE . . . . . 0.407 ' O ' ' CG2' ' A' ' 807' ' ' ILE . 9.8 mm -140.59 84.23 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.248 -0.908 . . . . 0.0 110.428 -179.994 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 808' ' ' GLY . . . . . 0.438 ' C ' ' HG ' ' A' ' 809' ' ' LEU . . . 117.84 32.41 1.43 Allowed Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.751 -1.34 . . . . 0.0 109.751 -179.998 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 809' ' ' LEU . . . . . 0.438 ' HG ' ' C ' ' A' ' 808' ' ' GLY . 14.9 mt -137.61 138.12 39.2 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.195 -1.179 . . . . 0.0 110.318 -179.96 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 810' ' ' GLU . . . . . . . . . . . . . 11.5 mp0 -61.01 -33.09 72.72 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.058 -1.026 . . . . 0.0 108.684 179.937 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 811' ' ' ARG . . . . . . . . . . . . . 18.1 ttm180 -125.69 167.69 14.78 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 179.835 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 812' ' ' CYS . . . . . 0.434 ' SG ' ' O ' ' A' ' 805' ' ' LYS . 9.3 t -166.04 116.27 1.0 Allowed 'General case' 0 C--N 1.3 -1.569 0 O-C-N 120.803 -1.185 . . . . 0.0 111.046 -179.903 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 813' ' ' VAL . . . . . . . . . . . . . 75.2 t -117.63 138.45 48.27 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.472 -0.768 . . . . 0.0 109.384 179.951 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 814' ' ' VAL . . . . . . . . . . . . . 4.4 t -125.56 158.04 34.49 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.077 -1.015 . . . . 0.0 110.561 -179.917 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 815' ' ' ALA . . . . . . . . . . . . . . . -117.65 135.01 54.29 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.26 -0.9 . . . . 0.0 110.117 -179.983 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 816' ' ' ILE . . . . . 0.42 HD12 HG22 ' A' ' 833' ' ' VAL . 9.7 mt -107.52 137.22 39.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.263 -0.898 . . . . 0.0 110.276 -179.946 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 817' ' ' SER . . . . . 0.495 ' CB ' ' HD2' ' A' ' 818' ' ' PRO . 0.0 OUTLIER -161.85 -179.81 1.13 Allowed Pre-proline 0 N--CA 1.495 1.781 0 O-C-N 121.232 -0.917 . . . . 0.0 110.031 179.985 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 818' ' ' PRO . . . . . 0.495 ' HD2' ' CB ' ' A' ' 817' ' ' SER . 48.0 Cg_endo -75.45 -38.27 1.48 Allowed 'Trans proline' 0 C--N 1.305 -1.724 0 O-C-N 124.055 1.555 . . . . 0.0 110.525 -179.975 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 819' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -116.51 47.36 1.45 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.23 -0.919 . . . . 0.0 110.296 -179.909 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 820' ' ' ASN . . . . . . . . . . . . . 2.0 m120 -129.71 0.78 4.91 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.178 -0.951 . . . . 0.0 110.206 179.97 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 821' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -125.32 -39.19 2.22 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.269 -0.894 . . . . 0.0 110.258 -179.941 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 822' ' ' GLY . . . . . . . . . . . . . . . -164.52 -52.37 0.02 OUTLIER Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.684 -1.367 . . . . 0.0 109.684 -179.997 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 823' ' ' GLY . . . . . . . . . . . . . . . 158.51 -68.54 0.27 Allowed Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.717 -1.353 . . . . 0.0 109.717 -179.934 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 824' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -171.22 88.91 0.46 Allowed Pre-proline 0 N--CA 1.493 1.684 0 O-C-N 121.262 -1.14 . . . . 0.0 110.431 -179.994 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 825' ' ' PRO . . . . . 0.463 ' HG3' ' OG ' ' A' ' 795' ' ' SER . 44.8 Cg_endo -75.08 -62.79 0.03 OUTLIER 'Trans proline' 0 C--N 1.304 -1.806 0 O-C-N 123.947 1.498 . . . . 0.0 110.317 179.971 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 826' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -116.93 118.92 35.83 Favored Pre-proline 0 N--CA 1.493 1.688 0 O-C-N 121.305 -0.872 . . . . 0.0 109.632 -179.996 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 827' ' ' PRO . . . . . 0.424 ' O ' ' HB2' ' A' ' 828' ' ' GLU . 48.2 Cg_endo -75.24 141.01 25.45 Favored 'Trans proline' 0 C--N 1.308 -1.58 0 O-C-N 123.885 1.466 . . . . 0.0 110.866 -179.887 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 828' ' ' GLU . . . . . 0.424 ' HB2' ' O ' ' A' ' 827' ' ' PRO . 0.6 OUTLIER 58.41 14.16 2.81 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.486 -0.759 . . . . 0.0 110.508 179.99 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 829' ' ' VAL . . . . . . . . . . . . . 54.0 t -137.59 82.03 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.165 -0.96 . . . . 0.0 110.217 -179.959 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 830' ' ' MET . . . . . 0.528 ' HA ' ' HA2' ' A' ' 779' ' ' GLY . 0.2 OUTLIER -176.26 107.65 0.08 Allowed 'General case' 0 N--CA 1.487 1.398 0 O-C-N 120.929 -1.107 . . . . 0.0 111.348 179.991 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 831' ' ' LYS . . . . . 0.488 ' HA ' ' CB ' ' A' ' 737' ' ' GLU . 20.6 ttpp -170.93 53.1 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.235 -0.915 . . . . 0.0 110.736 179.95 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 832' ' ' ARG . . . . . 0.485 ' HB3' ' CD ' ' A' ' 781' ' ' PRO . 1.7 mtt180 -172.97 107.16 0.16 Allowed 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.274 -0.891 . . . . 0.0 109.846 179.957 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 833' ' ' VAL . . . . . 0.42 HG22 HD12 ' A' ' 816' ' ' ILE . 3.8 t -107.35 109.25 27.5 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 O-C-N 121.111 -0.993 . . . . 0.0 110.836 -179.96 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 834' ' ' ALA . . . . . . . . . . . . . . . -109.62 136.47 48.94 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.371 -0.831 . . . . 0.0 109.34 179.934 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 835' ' ' VAL . . . . . . . . . . . . . 38.1 t -147.05 156.94 10.51 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.069 -1.02 . . . . 0.0 110.946 -179.95 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 836' ' ' GLU . . . . . 0.562 ' CB ' ' HB3' ' A' ' 774' ' ' LYS . 1.7 mp0 -135.2 158.89 43.21 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 179.845 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 837' ' ' ALA . . . . . . . . . . . . . . . -138.44 154.59 48.86 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 120.802 -1.186 . . . . 0.0 111.54 -179.772 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 838' ' ' VAL . . . . . . . . . . . . . 21.3 t -121.85 109.57 24.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.692 -0.63 . . . . 0.0 109.376 179.88 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 839' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -108.1 129.42 55.15 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.115 -0.991 . . . . 0.0 110.522 -179.96 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 840' ' ' SER . . . . . . . . . . . . . 54.1 p -125.53 -161.03 1.0 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.282 -0.886 . . . . 0.0 110.221 179.989 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 841' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.491 1.611 0 O-C-N 121.285 -0.884 . . . . 0.0 110.493 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 726' ' ' ARG . . . . . . . . . . . . . 1.9 mmm180 . . . . . 0 N--CA 1.493 1.676 0 CA-C-O 121.233 0.54 . . . . 0.0 110.142 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 727' ' ' THR . . . . . 0.436 ' HA ' ' HB2' ' A' ' 840' ' ' SER . 97.5 m -52.77 117.33 2.85 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.355 -0.841 . . . . 0.0 110.318 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 728' ' ' VAL . . . . . 0.49 ' O ' ' CG1' ' A' ' 728' ' ' VAL . 9.0 p -158.37 55.48 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.302 -0.874 . . . . 0.0 110.008 179.918 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 729' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -179.93 -177.96 0.41 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.264 -0.897 . . . . 0.0 110.407 -179.952 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 730' ' ' GLY . . . . . . . . . . . . . . . 172.21 113.73 0.31 Allowed Glycine 0 N--CA 1.492 2.373 0 N-CA-C 109.074 -1.61 . . . . 0.0 109.074 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 731' ' ' VAL . . . . . . . . . . . . . 31.3 m -130.02 148.41 33.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.227 -1.161 . . . . 0.0 110.872 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 732' ' ' CYS . . . . . 0.42 ' O ' ' SG ' ' A' ' 732' ' ' CYS . 16.5 p -142.18 133.89 26.95 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.521 -0.737 . . . . 0.0 109.272 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 733' ' ' ALA . . . . . . . . . . . . . . . -111.69 132.32 54.7 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.049 -1.032 . . . . 0.0 110.746 -179.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 734' ' ' ASP . . . . . 0.442 ' CG ' ' O ' ' A' ' 734' ' ' ASP . 8.6 p-10 -116.54 116.34 27.44 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.295 -0.878 . . . . 0.0 109.777 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 735' ' ' VAL . . . . . . . . . . . . . 5.7 t -139.62 166.9 20.36 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.154 -0.966 . . . . 0.0 110.187 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 736' ' ' SER . . . . . 0.448 ' O ' ' C ' ' A' ' 737' ' ' GLU . 1.2 m -135.78 136.27 40.58 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.265 -0.897 . . . . 0.0 109.937 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 737' ' ' GLU . . . . . 0.485 ' HB2' ' HB3' ' A' ' 831' ' ' LYS . 1.2 tm-20 -42.26 149.62 0.16 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.32 -0.863 . . . . 0.0 109.86 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 738' ' ' TYR . . . . . . . . . . . . . 45.7 t80 -165.56 123.2 1.52 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.257 -0.902 . . . . 0.0 110.047 -179.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 739' ' ' HIS . . . . . 0.66 ' O ' ' CG ' ' A' ' 739' ' ' HIS . 0.2 OUTLIER -173.67 48.44 0.07 OUTLIER Pre-proline 0 N--CA 1.489 1.523 0 O-C-N 121.269 -0.895 . . . . 0.0 110.364 179.977 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 740' ' ' PRO . . . . . 0.541 ' HG2' ' CD1' ' A' ' 742' ' ' ILE . 37.9 Cg_endo -62.0 151.56 80.76 Favored 'Trans proline' 0 C--N 1.299 -2.046 0 O-C-N 123.204 1.108 . . . . 0.0 109.64 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 741' ' ' ASN . . . . . 0.487 ' CG ' ' O ' ' A' ' 741' ' ' ASN . 7.4 p30 -65.02 99.77 0.38 Allowed 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.069 -1.019 . . . . 0.0 109.852 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 742' ' ' ILE . . . . . 0.541 ' CD1' ' HG2' ' A' ' 740' ' ' PRO . 1.4 mt -124.33 102.16 10.36 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 120.819 -1.176 . . . . 0.0 110.226 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 743' ' ' LYS . . . . . 0.427 ' HA ' ' HD2' ' A' ' 743' ' ' LYS . 31.6 mmmt -98.11 63.23 1.58 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.103 -0.998 . . . . 0.0 109.577 179.85 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 744' ' ' ASN . . . . . 0.408 ' CB ' ' O ' ' A' ' 743' ' ' LYS . 0.0 OUTLIER 172.81 101.46 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.634 -0.666 . . . . 0.0 109.562 -179.937 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 745' ' ' TRP . . . . . 0.587 ' CG ' ' O ' ' A' ' 745' ' ' TRP . 69.5 t-105 -160.72 43.98 0.18 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.071 -1.018 . . . . 0.0 110.627 -179.953 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 746' ' ' GLN . . . . . 0.461 ' HB3' ' O ' ' A' ' 745' ' ' TRP . 1.5 pt20 176.96 113.32 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.169 -0.957 . . . . 0.0 110.156 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 747' ' ' ILE . . . . . . . . . . . . . 3.5 mp -115.71 46.8 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.155 -0.966 . . . . 0.0 110.293 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 748' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -136.25 -166.4 1.87 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.277 -0.889 . . . . 0.0 109.949 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 749' ' ' SER . . . . . . . . . . . . . 67.0 m -88.17 28.81 1.02 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.145 -0.972 . . . . 0.0 110.181 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 750' ' ' TYR . . . . . . . . . . . . . 12.1 t80 -118.12 169.73 9.45 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.346 -0.846 . . . . 0.0 109.837 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 751' ' ' GLY . . . . . . . . . . . . . . . -165.09 147.4 12.45 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.664 -1.374 . . . . 0.0 109.664 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 752' ' ' GLU . . . . . 0.457 ' HG2' ' OE1' ' A' ' 754' ' ' GLU . 1.2 tt0 -169.14 73.3 0.73 Allowed Pre-proline 0 C--N 1.301 -1.534 0 O-C-N 121.343 -1.092 . . . . 0.0 110.036 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 753' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_endo -79.07 45.06 1.82 Allowed 'Trans proline' 0 C--N 1.309 -1.509 0 O-C-N 124.296 1.682 . . . . 0.0 110.863 179.874 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 754' ' ' GLU . . . . . 0.457 ' OE1' ' HG2' ' A' ' 752' ' ' GLU . 6.2 pt-20 -127.07 50.55 1.97 Allowed 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.064 -1.023 . . . . 0.0 110.026 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 755' ' ' PHE . . . . . . . . . . . . . 16.3 t80 -151.98 76.0 1.16 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.212 -0.93 . . . . 0.0 110.638 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 756' ' ' HIS . . . . . 0.454 ' O ' HG22 ' A' ' 757' ' ' THR . 0.0 OUTLIER -107.98 39.32 1.97 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.22 -0.925 . . . . 0.0 109.625 179.897 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 757' ' ' THR . . . . . 0.496 ' CG2' ' O ' ' A' ' 816' ' ' ILE . 0.0 OUTLIER -170.97 167.12 7.4 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.417 -0.802 . . . . 0.0 109.853 179.935 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 758' ' ' ALA . . . . . . . . . . . . . . . -88.69 153.26 21.25 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.113 -0.992 . . . . 0.0 109.938 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 759' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -113.28 161.07 17.66 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.187 -0.946 . . . . 0.0 110.365 -179.942 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 760' ' ' VAL . . . . . . . . . . . . . 42.2 t -107.76 133.73 51.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.359 -0.838 . . . . 0.0 109.328 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 761' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -109.97 115.67 30.2 Favored 'General case' 0 C--N 1.302 -1.5 0 O-C-N 121.133 -0.98 . . . . 0.0 111.043 -179.925 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 762' ' ' LEU . . . . . 0.449 ' O ' ' HG3' ' A' ' 811' ' ' ARG . 93.1 mt -132.36 138.78 47.87 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.543 -0.723 . . . . 0.0 109.119 179.842 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 763' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -167.7 136.72 2.57 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.834 -1.166 . . . . 0.0 110.891 -179.893 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 764' ' ' CYS . . . . . . . . . . . . . 92.7 m -106.59 172.77 6.64 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.427 -0.796 . . . . 0.0 109.849 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 765' ' ' ALA . . . . . . . . . . . . . . . -67.89 166.27 24.82 Favored Pre-proline 0 N--CA 1.495 1.795 0 O-C-N 121.156 -0.965 . . . . 0.0 110.277 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 766' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -72.84 107.11 2.26 Favored 'Trans proline' 0 C--N 1.307 -1.61 0 O-C-N 123.964 1.507 . . . . 0.0 110.026 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 767' ' ' GLY . . . . . . . . . . . . . . . 132.86 -3.42 4.94 Favored Glycine 0 N--CA 1.489 2.174 0 N-CA-C 109.334 -1.506 . . . . 0.0 109.334 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 768' ' ' GLN . . . . . 0.432 ' O ' ' HG2' ' A' ' 810' ' ' GLU . 44.5 mt-30 -124.52 152.99 42.74 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.183 -1.187 . . . . 0.0 109.968 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 769' ' ' THR . . . . . . . . . . . . . 62.2 p -134.74 147.09 49.96 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.139 -0.975 . . . . 0.0 110.598 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 770' ' ' ILE . . . . . . . . . . . . . 59.1 mt -73.33 139.75 18.95 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.394 -0.816 . . . . 0.0 109.453 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 771' ' ' SER . . . . . . . . . . . . . 2.3 t -134.97 -8.17 2.35 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.974 -1.079 . . . . 0.0 111.422 -179.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 772' ' ' ALA . . . . . . . . . . . . . . . -162.96 155.97 19.32 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 120.684 -1.26 . . . . 0.0 111.734 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 773' ' ' ILE . . . . . . . . . . . . . 19.9 mm -110.69 125.65 68.0 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.687 -0.633 . . . . 0.0 109.48 179.861 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 774' ' ' LYS . . . . . 0.54 ' HG2' ' CG2' ' A' ' 838' ' ' VAL . 3.2 mmmp? -80.71 -33.47 35.28 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.078 -1.013 . . . . 0.0 110.928 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 775' ' ' PHE . . . . . . . . . . . . . 88.7 t80 -160.46 154.73 23.32 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.022 -1.049 . . . . 0.0 110.282 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 776' ' ' ALA . . . . . 0.463 ' HB3' ' O ' ' A' ' 798' ' ' SER . . . -169.21 113.55 0.55 Allowed 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.41 -0.806 . . . . 0.0 109.47 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 777' ' ' SER . . . . . 0.544 ' HA ' ' CB ' ' A' ' 798' ' ' SER . 0.6 OUTLIER -140.68 137.35 33.47 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.04 -1.038 . . . . 0.0 111.327 179.977 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 778' ' ' PHE . . . . . 0.545 ' CG ' ' O ' ' A' ' 778' ' ' PHE . 24.0 t80 -116.19 72.98 0.83 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.497 -0.752 . . . . 0.0 109.344 179.869 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 779' ' ' GLY . . . . . . . . . . . . . . . -164.46 -102.63 0.17 Allowed Glycine 0 N--CA 1.495 2.601 0 N-CA-C 109.696 -1.362 . . . . 0.0 109.696 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 780' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -133.15 77.0 68.31 Favored Pre-proline 0 N--CA 1.495 1.789 0 O-C-N 120.74 -1.447 . . . . 0.0 110.369 179.929 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 781' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -80.37 138.95 12.72 Favored 'Trans proline' 0 C--N 1.304 -1.78 0 O-C-N 124.162 1.612 . . . . 0.0 110.442 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 782' ' ' LEU . . . . . 0.513 ' CD1' ' HA2' ' A' ' 791' ' ' GLY . 1.3 mt -103.62 168.89 8.86 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.308 -0.87 . . . . 0.0 109.914 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 783' ' ' GLY . . . . . . . . . . . . . . . 91.16 -154.17 22.74 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.628 -1.389 . . . . 0.0 109.628 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 784' ' ' THR . . . . . . . . . . . . . 7.8 t -154.59 179.54 8.95 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.334 -1.098 . . . . 0.0 110.231 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 785' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -52.99 108.33 0.31 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.274 -0.892 . . . . 0.0 110.323 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 786' ' ' GLY . . . . . . . . . . . . . . . 143.89 -36.97 1.47 Allowed Glycine 0 N--CA 1.488 2.125 0 N-CA-C 109.724 -1.35 . . . . 0.0 109.724 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 787' ' ' THR . . . . . 0.423 ' O ' ' O ' ' A' ' 788' ' ' PHE . 30.8 m -157.81 47.27 0.38 Allowed 'General case' 0 C--N 1.306 -1.302 0 O-C-N 121.253 -1.145 . . . . 0.0 110.497 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 788' ' ' PHE . . . . . 0.423 ' O ' ' O ' ' A' ' 787' ' ' THR . 10.8 m-85 -46.02 170.89 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.154 -0.966 . . . . 0.0 110.201 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 789' ' ' GLN . . . . . . . . . . . . . 24.0 tt0 -166.56 142.9 4.73 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.278 -0.889 . . . . 0.0 110.034 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 790' ' ' GLN . . . . . . . . . . . . . 19.3 pt20 -56.84 152.47 12.56 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 120.975 -1.078 . . . . 0.0 110.329 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 791' ' ' GLY . . . . . 0.513 ' HA2' ' CD1' ' A' ' 782' ' ' LEU . . . -109.44 -86.33 1.75 Allowed Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.544 -1.422 . . . . 0.0 109.544 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 792' ' ' GLU . . . . . 0.414 ' HG2' ' C ' ' A' ' 791' ' ' GLY . 68.4 mm-40 -142.64 -37.97 0.37 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.207 -1.172 . . . . 0.0 110.169 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 793' ' ' CYS . . . . . . . . . . . . . 1.3 m -107.14 131.78 53.75 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.262 -0.898 . . . . 0.0 110.331 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 794' ' ' HIS . . . . . 0.421 ' CG ' ' H ' ' A' ' 796' ' ' ILE . 5.0 t60 -145.48 144.29 30.5 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.175 -0.953 . . . . 0.0 110.079 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 795' ' ' SER . . . . . 0.423 ' O ' ' N ' ' A' ' 797' ' ' ASN . 1.1 m -83.01 8.8 11.72 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.231 -0.918 . . . . 0.0 110.604 -179.91 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 796' ' ' ILE . . . . . 0.524 ' O ' ' CG2' ' A' ' 796' ' ' ILE . 90.4 mt 42.41 26.67 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 O-C-N 121.242 -0.911 . . . . 0.0 110.269 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 797' ' ' ASN . . . . . 0.437 ' OD1' ' O ' ' A' ' 796' ' ' ILE . 5.5 m120 -152.49 22.66 0.62 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.204 -0.935 . . . . 0.0 109.797 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 798' ' ' SER . . . . . 0.544 ' CB ' ' HA ' ' A' ' 777' ' ' SER . 13.2 m -84.62 2.59 40.85 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.435 -0.791 . . . . 0.0 110.452 -179.901 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 799' ' ' ASN . . . . . . . . . . . . . 6.9 t-20 -115.41 -14.84 11.58 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.196 -0.94 . . . . 0.0 110.908 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 800' ' ' SER . . . . . . . . . . . . . 16.4 m -82.09 -18.87 41.55 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 120.903 -1.123 . . . . 0.0 109.881 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 801' ' ' VAL . . . . . 0.454 HG13 ' HD2' ' A' ' 805' ' ' LYS . 45.0 t -86.44 -21.41 7.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.464 -0.772 . . . . 0.0 110.117 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 802' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -79.42 -57.39 3.72 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.137 -0.977 . . . . 0.0 110.313 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 803' ' ' GLU . . . . . 0.443 ' HG2' ' CD1' ' A' ' 807' ' ' ILE . 0.4 OUTLIER -53.82 -22.71 10.22 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.295 -0.878 . . . . 0.0 110.339 179.942 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 804' ' ' ARG . . . . . . . . . . . . . 1.9 mtm180 -91.08 -23.92 20.18 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.188 -0.945 . . . . 0.0 110.998 -180.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 805' ' ' LYS . . . . . 0.454 ' HD2' HG13 ' A' ' 801' ' ' VAL . 9.6 mttt -127.06 49.83 2.04 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.07 -1.019 . . . . 0.0 111.034 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 806' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -163.23 -71.51 0.04 OUTLIER 'General case' 0 N--CA 1.497 1.909 0 O-C-N 120.952 -1.092 . . . . 0.0 110.905 179.937 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 807' ' ' ILE . . . . . 0.443 ' CD1' ' HG2' ' A' ' 803' ' ' GLU . 90.6 mt -50.86 128.32 8.07 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 O-C-N 121.223 -0.923 . . . . 0.0 110.988 -179.918 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 808' ' ' GLY . . . . . 0.448 ' C ' ' HG ' ' A' ' 809' ' ' LEU . . . 103.89 10.84 33.92 Favored Glycine 0 N--CA 1.493 2.456 0 N-CA-C 110.127 -1.189 . . . . 0.0 110.127 179.912 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 809' ' ' LEU . . . . . 0.448 ' HG ' ' C ' ' A' ' 808' ' ' GLY . 33.1 mt -142.67 137.11 29.7 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.108 -1.231 . . . . 0.0 110.138 -179.913 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 810' ' ' GLU . . . . . 0.432 ' HG2' ' O ' ' A' ' 768' ' ' GLN . 0.7 OUTLIER -65.16 -21.92 66.85 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.224 -0.923 . . . . 0.0 109.289 179.972 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 811' ' ' ARG . . . . . 0.449 ' HG3' ' O ' ' A' ' 762' ' ' LEU . 1.1 ttp85 -128.76 151.52 49.47 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.538 -0.726 . . . . 0.0 109.747 179.866 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 812' ' ' CYS . . . . . 0.437 ' HB3' ' HB2' ' A' ' 762' ' ' LEU . 7.8 t -129.73 139.87 51.22 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.121 -0.987 . . . . 0.0 110.602 -179.944 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 813' ' ' VAL . . . . . . . . . . . . . 84.1 t -145.63 123.11 4.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.348 -0.845 . . . . 0.0 109.663 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 814' ' ' VAL . . . . . . . . . . . . . 88.7 t -133.0 129.01 57.25 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 O-C-N 121.129 -0.982 . . . . 0.0 110.73 -179.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 815' ' ' ALA . . . . . . . . . . . . . . . -88.75 127.8 35.61 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.339 -0.851 . . . . 0.0 109.755 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 816' ' ' ILE . . . . . 0.516 HD11 ' CG2' ' A' ' 833' ' ' VAL . 46.2 mt -84.3 114.01 24.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.181 -0.949 . . . . 0.0 110.436 -179.905 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 817' ' ' SER . . . . . . . . . . . . . 5.0 p -158.84 158.57 29.27 Favored Pre-proline 0 N--CA 1.495 1.777 0 O-C-N 121.356 -0.84 . . . . 0.0 109.91 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 818' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -75.29 2.65 6.54 Favored 'Trans proline' 0 C--N 1.306 -1.692 0 O-C-N 123.926 1.487 . . . . 0.0 110.772 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 819' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -111.77 7.67 20.32 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.103 -0.998 . . . . 0.0 110.253 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 820' ' ' ASN . . . . . . . . . . . . . 6.8 m-20 -121.19 -7.2 9.38 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.248 -0.907 . . . . 0.0 110.262 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 821' ' ' PHE . . . . . . . . . . . . . 4.8 m-85 -110.66 -65.96 1.12 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.261 -0.9 . . . . 0.0 110.19 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 822' ' ' GLY . . . . . . . . . . . . . . . 161.27 63.86 0.02 OUTLIER Glycine 0 N--CA 1.492 2.41 0 N-CA-C 110.006 -1.238 . . . . 0.0 110.006 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 823' ' ' GLY . . . . . . . . . . . . . . . 78.7 -150.41 34.51 Favored Glycine 0 N--CA 1.493 2.47 0 N-CA-C 110.036 -1.226 . . . . 0.0 110.036 179.907 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 824' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -109.17 141.88 24.39 Favored Pre-proline 0 N--CA 1.493 1.709 0 O-C-N 121.26 -1.141 . . . . 0.0 110.407 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 825' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -80.53 -91.2 0.0 OUTLIER 'Trans proline' 0 C--N 1.306 -1.699 0 O-C-N 124.11 1.584 . . . . 0.0 110.693 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 826' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -101.5 132.95 21.17 Favored Pre-proline 0 N--CA 1.496 1.872 0 O-C-N 121.189 -0.944 . . . . 0.0 110.372 -179.924 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 827' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -82.52 157.51 16.63 Favored 'Trans proline' 0 C--N 1.309 -1.525 0 O-C-N 123.958 1.504 . . . . 0.0 110.629 180.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 828' ' ' GLU . . . . . 0.452 ' O ' ' OE1' ' A' ' 828' ' ' GLU . 7.2 tm-20 54.47 39.13 30.83 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.243 -0.91 . . . . 0.0 110.622 179.906 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 829' ' ' VAL . . . . . 0.447 HG22 ' O ' ' A' ' 828' ' ' GLU . 20.2 t -142.81 118.3 4.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.071 -1.018 . . . . 0.0 110.369 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 830' ' ' MET . . . . . 0.413 ' C ' ' O ' ' A' ' 829' ' ' VAL . 4.7 mtt -42.71 158.32 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.246 -0.909 . . . . 0.0 109.878 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 831' ' ' LYS . . . . . 0.485 ' HB3' ' HB2' ' A' ' 737' ' ' GLU . 4.9 mtmt -115.04 110.57 19.77 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.118 -0.989 . . . . 0.0 110.877 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 832' ' ' ARG . . . . . . . . . . . . . 10.6 mtm-85 -116.38 135.31 53.97 Favored 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 179.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 833' ' ' VAL . . . . . 0.516 ' CG2' HD11 ' A' ' 816' ' ' ILE . 7.7 t -111.5 130.09 65.68 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.631 0 O-C-N 120.986 -1.071 . . . . 0.0 111.334 -179.94 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 834' ' ' ALA . . . . . . . . . . . . . . . -134.81 129.43 34.52 Favored 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 835' ' ' VAL . . . . . 0.403 ' CG1' ' N ' ' A' ' 836' ' ' GLU . 18.3 t -137.95 160.82 33.13 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 O-C-N 120.932 -1.105 . . . . 0.0 111.334 -179.869 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 836' ' ' GLU . . . . . 0.403 ' N ' ' CG1' ' A' ' 835' ' ' VAL . 0.0 OUTLIER -148.39 121.41 8.83 Favored 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 179.988 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 837' ' ' ALA . . . . . . . . . . . . . . . -109.55 155.32 21.54 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.006 -1.059 . . . . 0.0 111.016 -179.893 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 838' ' ' VAL . . . . . 0.54 ' CG2' ' HG2' ' A' ' 774' ' ' LYS . 6.0 t -111.97 114.59 47.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.422 -0.799 . . . . 0.0 109.804 179.926 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 839' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -109.42 136.76 48.31 Favored 'General case' 0 C--N 1.299 -1.611 0 O-C-N 121.128 -0.982 . . . . 0.0 110.245 -179.881 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 840' ' ' SER . . . . . 0.528 ' O ' ' CG2' ' A' ' 841' ' ' THR . 0.4 OUTLIER -136.43 -82.02 0.38 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.284 -0.885 . . . . 0.0 109.942 179.955 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 841' ' ' THR . . . . . 0.528 ' CG2' ' O ' ' A' ' 840' ' ' SER . 13.5 p -159.98 -176.91 5.96 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.294 -0.878 . . . . 0.0 110.006 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 842' ' ' ALA . . . . . . . . . . . . . . . -72.88 151.12 42.1 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.228 -0.92 . . . . 0.0 110.229 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 843' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.685 0 CA-C-O 118.026 -0.988 . . . . 0.0 110.221 -179.996 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 726' ' ' ARG . . . . . 0.437 ' NE ' ' HA ' ' A' ' 726' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.682 0 CA-C-O 121.274 0.559 . . . . 0.0 110.23 . . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 727' ' ' THR . . . . . . . . . . . . . 11.8 t -124.49 160.7 27.69 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.23 -0.919 . . . . 0.0 110.183 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 728' ' ' VAL . . . . . 0.456 ' O ' ' O ' ' A' ' 839' ' ' CYS . 3.4 p -151.29 147.31 15.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.221 -0.924 . . . . 0.0 110.354 -179.981 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 729' ' ' SER . . . . . . . . . . . . . 75.3 p -55.01 178.58 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.243 -0.911 . . . . 0.0 110.3 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 730' ' ' GLY . . . . . 0.442 ' HA3' ' O ' ' A' ' 837' ' ' ALA . . . -113.7 -139.11 7.15 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.658 -1.377 . . . . 0.0 109.658 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 731' ' ' VAL . . . . . . . . . . . . . 30.0 t -128.44 155.5 40.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.288 -1.125 . . . . 0.0 110.254 -179.89 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 732' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -108.22 145.92 33.56 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.361 -0.837 . . . . 0.0 109.431 179.892 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 733' ' ' ALA . . . . . . . . . . . . . . . -147.11 128.56 14.96 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.021 -1.049 . . . . 0.0 110.781 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 734' ' ' ASP . . . . . 0.459 ' OD1' ' O ' ' A' ' 734' ' ' ASP . 1.5 p30 -131.72 109.23 10.02 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.454 -0.779 . . . . 0.0 109.673 179.93 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 735' ' ' VAL . . . . . 0.525 HG22 ' CG2' ' A' ' 760' ' ' VAL . 7.0 m -129.58 157.13 42.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.115 -0.991 . . . . 0.0 110.586 -179.916 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 736' ' ' SER . . . . . 0.427 ' O ' ' C ' ' A' ' 737' ' ' GLU . 70.9 m -119.43 140.15 50.89 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.436 -0.79 . . . . 0.0 109.714 179.918 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 737' ' ' GLU . . . . . 0.427 ' C ' ' O ' ' A' ' 736' ' ' SER . 11.2 tp10 -41.9 110.74 0.18 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.215 -0.928 . . . . 0.0 109.979 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 738' ' ' TYR . . . . . 0.445 ' HB2' ' HB1' ' A' ' 758' ' ' ALA . 57.2 t80 -67.15 125.12 25.05 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.307 -0.87 . . . . 0.0 110.034 -179.926 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 739' ' ' HIS . . . . . . . . . . . . . 20.8 t-80 -175.27 97.77 0.27 Allowed Pre-proline 0 N--CA 1.489 1.478 0 O-C-N 121.246 -0.909 . . . . 0.0 110.379 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 740' ' ' PRO . . . . . 0.588 ' O ' ' CB ' ' A' ' 741' ' ' ASN . 50.1 Cg_endo -78.05 7.29 4.09 Favored 'Trans proline' 0 C--N 1.307 -1.612 0 O-C-N 124.008 1.531 . . . . 0.0 110.602 179.966 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 741' ' ' ASN . . . . . 0.588 ' CB ' ' O ' ' A' ' 740' ' ' PRO . 1.8 t-20 82.23 -52.93 0.22 Allowed 'General case' 0 N--CA 1.511 2.621 0 O-C-N 121.822 -0.549 . . . . 0.0 110.399 -179.987 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 742' ' ' ILE . . . . . 0.463 ' O ' ' O ' ' A' ' 741' ' ' ASN . 15.7 mt 59.93 133.81 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.109 -0.994 . . . . 0.0 110.28 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 743' ' ' LYS . . . . . 0.456 ' O ' ' HB3' ' A' ' 744' ' ' ASN . 30.3 pttt -125.11 145.25 50.02 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.151 -0.968 . . . . 0.0 109.952 179.934 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 744' ' ' ASN . . . . . 0.456 ' HB3' ' O ' ' A' ' 743' ' ' LYS . 10.5 t-20 59.99 62.07 1.74 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.242 -0.911 . . . . 0.0 109.944 -179.965 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 745' ' ' TRP . . . . . 0.445 ' O ' ' HB2' ' A' ' 746' ' ' GLN . 40.1 p90 -80.01 3.26 20.7 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.439 -0.788 . . . . 0.0 110.098 -179.956 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 746' ' ' GLN . . . . . 0.457 ' O ' HG13 ' A' ' 747' ' ' ILE . 0.0 OUTLIER 66.73 152.69 0.07 Allowed 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.343 -0.848 . . . . 0.0 111.834 179.831 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 747' ' ' ILE . . . . . 0.571 ' O ' ' CG2' ' A' ' 747' ' ' ILE . 25.4 mt -157.13 36.65 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.94 0 CA-C-O 121.619 0.723 . . . . 0.0 109.078 179.942 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 748' ' ' GLU . . . . . 0.493 ' HG2' ' N ' ' A' ' 749' ' ' SER . 29.5 tt0 -101.17 -99.25 0.26 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.925 -1.109 . . . . 0.0 111.014 -179.888 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 749' ' ' SER . . . . . 0.493 ' N ' ' HG2' ' A' ' 748' ' ' GLU . 8.4 t -111.55 13.95 21.34 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.012 -1.055 . . . . 0.0 110.691 -179.955 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 750' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -92.2 -79.31 0.39 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.142 -0.974 . . . . 0.0 110.207 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 751' ' ' GLY . . . . . . . . . . . . . . . 85.55 -72.72 2.69 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.598 -1.401 . . . . 0.0 109.598 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 752' ' ' GLU . . . . . 0.455 ' HG2' ' HD2' ' A' ' 753' ' ' PRO . 0.8 OUTLIER 58.47 172.17 0.05 OUTLIER Pre-proline 0 N--CA 1.493 1.69 0 O-C-N 121.215 -1.168 . . . . 0.0 110.182 -179.944 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 753' ' ' PRO . . . . . 0.455 ' HD2' ' HG2' ' A' ' 752' ' ' GLU . 46.9 Cg_endo -74.19 138.68 25.54 Favored 'Trans proline' 0 C--N 1.305 -1.739 0 O-C-N 123.966 1.509 . . . . 0.0 110.418 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 754' ' ' GLU . . . . . . . . . . . . . 21.9 tt0 -120.65 67.62 0.85 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.281 -0.887 . . . . 0.0 110.121 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 755' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -128.48 47.66 2.41 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.238 -0.914 . . . . 0.0 110.465 -179.945 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 756' ' ' HIS . . . . . 0.445 ' O ' HG21 ' A' ' 757' ' ' THR . 0.7 OUTLIER -77.67 98.16 5.36 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.161 -0.962 . . . . 0.0 110.065 -179.962 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 757' ' ' THR . . . . . 0.445 HG21 ' O ' ' A' ' 756' ' ' HIS . 20.6 p -144.78 -178.33 5.96 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.254 -0.903 . . . . 0.0 110.421 -179.971 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 758' ' ' ALA . . . . . 0.445 ' HB1' ' HB2' ' A' ' 738' ' ' TYR . . . -107.92 178.96 4.36 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.328 -0.857 . . . . 0.0 110.141 180.0 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 759' ' ' LYS . . . . . . . . . . . . . 29.7 mttm -140.42 138.82 35.03 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.224 -0.923 . . . . 0.0 110.592 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 760' ' ' VAL . . . . . 0.525 ' CG2' HG22 ' A' ' 735' ' ' VAL . 41.9 t -115.67 108.71 25.96 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 O-C-N 121.427 -0.796 . . . . 0.0 109.552 179.927 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 761' ' ' HIS . . . . . 0.457 ' CB ' HG22 ' A' ' 813' ' ' VAL . 42.2 p-80 -124.96 139.63 53.65 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 120.945 -1.097 . . . . 0.0 111.468 -179.82 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 762' ' ' LEU . . . . . . . . . . . . . 12.4 mt -119.33 110.87 17.48 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 109.057 -0.719 . . . . 0.0 109.057 179.892 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 763' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.31 133.46 53.23 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.151 -0.968 . . . . 0.0 111.001 -179.865 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 764' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -111.14 164.27 13.03 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.436 -0.79 . . . . 0.0 109.856 179.925 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 765' ' ' ALA . . . . . 0.476 ' HB1' ' OE1' ' A' ' 768' ' ' GLN . . . -56.04 164.0 2.0 Allowed Pre-proline 0 N--CA 1.493 1.68 0 O-C-N 121.118 -0.989 . . . . 0.0 110.177 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 766' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -71.71 114.2 3.88 Favored 'Trans proline' 0 C--N 1.305 -1.747 0 O-C-N 123.962 1.506 . . . . 0.0 110.394 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 767' ' ' GLY . . . . . . . . . . . . . . . 123.13 -18.48 7.88 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.436 -1.466 . . . . 0.0 109.436 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 768' ' ' GLN . . . . . 0.531 ' HG3' ' CA ' ' A' ' 841' ' ' THR . 0.5 OUTLIER -110.38 130.75 55.49 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.224 -1.162 . . . . 0.0 110.176 179.975 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 769' ' ' THR . . . . . . . . . . . . . 45.7 p -118.25 148.59 42.27 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.226 -0.921 . . . . 0.0 110.364 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 770' ' ' ILE . . . . . 0.444 HG21 HG13 ' A' ' 807' ' ' ILE . 2.6 mp -66.28 141.3 18.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.297 -0.877 . . . . 0.0 110.014 179.971 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 771' ' ' SER . . . . . . . . . . . . . 11.8 p -120.6 -15.92 8.38 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.109 -0.995 . . . . 0.0 110.565 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 772' ' ' ALA . . . . . . . . . . . . . . . -169.64 171.85 7.24 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.063 -1.023 . . . . 0.0 111.029 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 773' ' ' ILE . . . . . . . . . . . . . 25.8 mm -116.6 134.27 60.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.505 -0.747 . . . . 0.0 109.603 179.912 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 774' ' ' LYS . . . . . 0.487 ' HB2' ' HB3' ' A' ' 836' ' ' GLU . 0.9 OUTLIER -83.89 -34.74 24.49 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.122 -0.986 . . . . 0.0 110.718 -179.96 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 775' ' ' PHE . . . . . 0.577 ' CZ ' ' HB2' ' A' ' 777' ' ' SER . 44.7 t80 -162.31 164.1 27.67 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.091 -1.006 . . . . 0.0 110.691 -179.956 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 776' ' ' ALA . . . . . 0.494 ' HB2' ' HA ' ' A' ' 799' ' ' ASN . . . -176.52 121.49 0.15 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.458 -0.776 . . . . 0.0 109.922 -179.964 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 777' ' ' SER . . . . . 0.577 ' HB2' ' CZ ' ' A' ' 775' ' ' PHE . 0.2 OUTLIER -140.3 137.28 34.05 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.145 -0.972 . . . . 0.0 110.69 -179.972 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 778' ' ' PHE . . . . . 0.509 ' CG ' ' O ' ' A' ' 778' ' ' PHE . 29.3 t80 -116.82 74.19 0.9 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.276 -0.89 . . . . 0.0 109.933 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 779' ' ' GLY . . . . . . . . . . . . . . . -175.53 -86.97 0.07 OUTLIER Glycine 0 N--CA 1.495 2.619 0 C-N-CA 119.486 -1.34 . . . . 0.0 110.456 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 780' ' ' THR . . . . . . . . . . . . . 13.0 p -136.86 92.59 14.33 Favored Pre-proline 0 N--CA 1.494 1.761 0 O-C-N 121.078 -1.248 . . . . 0.0 110.825 -179.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 781' ' ' PRO . . . . . 0.463 ' O ' ' HG ' ' A' ' 782' ' ' LEU . 50.9 Cg_endo -85.41 155.56 10.73 Favored 'Trans proline' 0 C--N 1.306 -1.697 0 O-C-N 124.066 1.561 . . . . 0.0 110.271 179.942 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 782' ' ' LEU . . . . . 0.483 ' HB2' ' HB2' ' A' ' 789' ' ' GLN . 1.6 mt -143.81 129.38 19.13 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.115 -0.991 . . . . 0.0 110.263 179.978 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 783' ' ' GLY . . . . . . . . . . . . . . . 121.64 -168.75 14.49 Favored Glycine 0 N--CA 1.492 2.374 0 N-CA-C 109.71 -1.356 . . . . 0.0 109.71 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 784' ' ' THR . . . . . 0.497 ' O ' ' CE1' ' A' ' 788' ' ' PHE . 0.3 OUTLIER -115.33 -146.74 0.41 Allowed 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.258 -1.142 . . . . 0.0 110.163 179.997 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 785' ' ' CYS . . . . . . . . . . . . . 54.1 t -82.07 123.12 28.65 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.225 -0.922 . . . . 0.0 110.1 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 786' ' ' GLY . . . . . . . . . . . . . . . 86.34 -1.61 87.45 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.609 -1.396 . . . . 0.0 109.609 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 787' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -140.86 36.98 1.78 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.205 -1.174 . . . . 0.0 110.062 -179.957 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 788' ' ' PHE . . . . . 0.497 ' CE1' ' O ' ' A' ' 784' ' ' THR . 28.8 m-85 -74.15 171.37 13.69 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.248 -0.908 . . . . 0.0 110.369 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 789' ' ' GLN . . . . . 0.483 ' HB2' ' HB2' ' A' ' 782' ' ' LEU . 5.8 mt-30 -143.17 97.7 3.13 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.371 -0.831 . . . . 0.0 109.961 179.971 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 790' ' ' GLN . . . . . 0.474 ' O ' ' HG3' ' A' ' 790' ' ' GLN . 14.1 pt20 -46.32 108.15 0.13 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.256 -0.903 . . . . 0.0 110.306 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 791' ' ' GLY . . . . . . . . . . . . . . . -58.38 177.15 1.86 Allowed Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.326 -1.51 . . . . 0.0 109.326 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 792' ' ' GLU . . . . . 0.499 ' CG ' ' O ' ' A' ' 792' ' ' GLU . 0.6 OUTLIER -80.4 5.38 15.16 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.205 -1.174 . . . . 0.0 110.231 179.997 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 793' ' ' CYS . . . . . . . . . . . . . 22.8 t -102.8 16.69 25.82 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.238 -0.914 . . . . 0.0 111.062 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 794' ' ' HIS . . . . . 0.601 ' CE1' ' OG ' ' A' ' 798' ' ' SER . 75.9 t60 -62.28 125.3 23.42 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.938 -1.101 . . . . 0.0 110.258 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 795' ' ' SER . . . . . . . . . . . . . 1.4 m -72.89 -130.59 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.165 -0.96 . . . . 0.0 109.605 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 796' ' ' ILE . . . . . . . . . . . . . 1.6 pt -137.94 22.9 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 120.854 -1.153 . . . . 0.0 110.363 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 797' ' ' ASN . . . . . . . . . . . . . 36.1 p30 -154.75 22.12 0.45 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.296 -0.878 . . . . 0.0 110.232 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 798' ' ' SER . . . . . 0.601 ' OG ' ' CE1' ' A' ' 794' ' ' HIS . 0.8 OUTLIER -72.44 -19.68 61.53 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.115 -0.99 . . . . 0.0 109.936 179.966 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 799' ' ' ASN . . . . . 0.494 ' HA ' ' HB2' ' A' ' 776' ' ' ALA . 2.3 t-20 -114.09 -10.36 12.83 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.32 -0.863 . . . . 0.0 110.009 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 800' ' ' SER . . . . . 0.491 ' O ' ' HB2' ' A' ' 804' ' ' ARG . 0.9 OUTLIER -89.86 -28.56 19.17 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.359 -0.838 . . . . 0.0 110.13 179.954 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 801' ' ' VAL . . . . . . . . . . . . . 24.6 t -66.59 -30.48 49.9 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.143 -0.973 . . . . 0.0 110.472 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 802' ' ' LEU . . . . . 0.48 HD23 ' N ' ' A' ' 802' ' ' LEU . 4.4 mm? -90.11 -44.84 9.53 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.231 -0.918 . . . . 0.0 110.792 -179.945 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 803' ' ' GLU . . . . . 0.519 ' HA ' ' CD1' ' A' ' 807' ' ' ILE . 32.1 tt0 -62.67 -21.94 66.09 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.125 -0.985 . . . . 0.0 110.927 -179.89 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 804' ' ' ARG . . . . . 0.491 ' HB2' ' O ' ' A' ' 800' ' ' SER . 0.0 OUTLIER -91.96 -19.4 22.47 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 120.981 -1.075 . . . . 0.0 111.055 -179.971 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 805' ' ' LYS . . . . . . . . . . . . . 12.9 ttpp -132.47 51.3 2.16 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.004 -1.06 . . . . 0.0 111.05 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 806' ' ' CYS . . . . . 0.471 ' HB2' ' O ' ' A' ' 802' ' ' LEU . 1.2 t -156.96 -33.0 0.08 Allowed 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.015 -1.053 . . . . 0.0 111.067 179.925 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 807' ' ' ILE . . . . . 0.519 ' CD1' ' HA ' ' A' ' 803' ' ' GLU . 2.5 mp -77.17 121.89 30.58 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 O-C-N 120.979 -1.076 . . . . 0.0 110.78 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 808' ' ' GLY . . . . . 0.436 ' C ' ' HG ' ' A' ' 809' ' ' LEU . . . 107.78 13.86 19.02 Favored Glycine 0 N--CA 1.494 2.521 0 N-CA-C 110.082 -1.207 . . . . 0.0 110.082 179.935 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 809' ' ' LEU . . . . . 0.436 ' HG ' ' C ' ' A' ' 808' ' ' GLY . 4.2 mt -134.5 134.84 41.92 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.076 -1.25 . . . . 0.0 110.443 179.961 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 810' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -65.82 -13.62 59.85 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.236 -0.915 . . . . 0.0 109.245 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 811' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -141.7 164.18 30.91 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.578 -0.701 . . . . 0.0 109.627 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 812' ' ' CYS . . . . . 0.432 ' O ' ' HB2' ' A' ' 761' ' ' HIS . 1.7 t -145.37 132.0 19.9 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.19 -0.944 . . . . 0.0 110.241 -179.952 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 813' ' ' VAL . . . . . 0.457 HG22 ' CB ' ' A' ' 761' ' ' HIS . 54.3 t -143.43 110.83 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.156 -0.965 . . . . 0.0 110.328 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 814' ' ' VAL . . . . . 0.427 HG11 ' N ' ' A' ' 815' ' ' ALA . 61.4 t -119.06 149.61 21.53 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.452 0 O-C-N 121.456 -0.778 . . . . 0.0 109.629 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 815' ' ' ALA . . . . . 0.427 ' N ' HG11 ' A' ' 814' ' ' VAL . . . -102.34 132.08 48.55 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.142 -0.974 . . . . 0.0 110.263 -179.989 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 816' ' ' ILE . . . . . 0.5 ' CD1' HG21 ' A' ' 760' ' ' VAL . 26.6 mt -89.62 151.72 3.44 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 121.346 -0.846 . . . . 0.0 110.384 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 817' ' ' SER . . . . . 0.402 ' CB ' ' O ' ' A' ' 816' ' ' ILE . 0.0 OUTLIER 174.74 171.93 0.27 Allowed Pre-proline 0 N--CA 1.494 1.748 0 O-C-N 121.265 -0.897 . . . . 0.0 110.129 -179.99 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 818' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -73.92 -45.11 0.4 Allowed 'Trans proline' 0 C--N 1.305 -1.748 0 O-C-N 124.017 1.535 . . . . 0.0 110.468 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 819' ' ' SER . . . . . . . . . . . . . 59.5 p -95.81 46.53 1.09 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.258 -0.901 . . . . 0.0 110.088 179.92 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 820' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -126.9 -28.68 2.9 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.274 -0.891 . . . . 0.0 110.477 -179.946 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 821' ' ' PHE . . . . . . . . . . . . . 11.9 m-85 -103.73 -72.22 0.71 Allowed 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.15 -0.969 . . . . 0.0 110.302 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 822' ' ' GLY . . . . . . . . . . . . . . . -179.83 56.94 0.08 OUTLIER Glycine 0 N--CA 1.492 2.43 0 N-CA-C 109.823 -1.311 . . . . 0.0 109.823 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 823' ' ' GLY . . . . . . . . . . . . . . . 60.33 -172.57 5.86 Favored Glycine 0 N--CA 1.494 2.507 0 N-CA-C 109.87 -1.292 . . . . 0.0 109.87 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 824' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -112.76 138.43 22.11 Favored Pre-proline 0 N--CA 1.495 1.79 0 O-C-N 121.345 -1.091 . . . . 0.0 110.168 -179.976 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 825' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_endo -84.54 -36.82 0.15 Allowed 'Trans proline' 0 C--N 1.304 -1.77 0 O-C-N 124.075 1.566 . . . . 0.0 111.08 -179.89 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 826' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -110.28 133.16 21.15 Favored Pre-proline 0 N--CA 1.504 2.256 0 O-C-N 120.971 -1.081 . . . . 0.0 110.714 -179.903 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 827' ' ' PRO . . . . . 0.451 ' O ' HG22 ' A' ' 829' ' ' VAL . 51.0 Cg_endo -87.27 167.63 7.76 Favored 'Trans proline' 0 C--N 1.309 -1.517 0 O-C-N 123.997 1.525 . . . . 0.0 110.348 179.907 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 828' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER 47.36 25.2 0.55 Allowed 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.216 -0.928 . . . . 0.0 110.897 179.978 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 829' ' ' VAL . . . . . 0.451 HG22 ' O ' ' A' ' 827' ' ' PRO . 81.9 t -127.67 125.0 64.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.0 -1.063 . . . . 0.0 110.317 -179.96 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 830' ' ' MET . . . . . . . . . . . . . 29.2 mtt -56.89 -173.13 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.179 -0.951 . . . . 0.0 109.837 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 831' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.73 127.54 8.83 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.12 -0.987 . . . . 0.0 110.878 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 832' ' ' ARG . . . . . . . . . . . . . 2.8 mtt180 -123.4 167.55 13.69 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.542 -0.724 . . . . 0.0 109.094 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 833' ' ' VAL . . . . . 0.466 HG22 HG23 ' A' ' 816' ' ' ILE . 88.9 t -124.27 109.06 21.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 120.795 -1.191 . . . . 0.0 111.399 -179.909 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 834' ' ' ALA . . . . . 0.45 ' O ' HG21 ' A' ' 835' ' ' VAL . . . -109.49 141.02 42.54 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 179.808 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 835' ' ' VAL . . . . . 0.46 ' CG1' ' N ' ' A' ' 836' ' ' GLU . 23.6 t -154.85 163.52 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 120.634 -1.291 . . . . 0.0 112.095 -179.872 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 836' ' ' GLU . . . . . 0.487 ' HB3' ' HB2' ' A' ' 774' ' ' LYS . 0.6 OUTLIER -148.27 149.19 31.43 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 107.972 -1.122 . . . . 0.0 107.972 179.974 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 837' ' ' ALA . . . . . 0.442 ' O ' ' HA3' ' A' ' 730' ' ' GLY . . . -135.66 154.18 51.38 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 120.633 -1.292 . . . . 0.0 111.899 -179.862 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 838' ' ' VAL . . . . . 0.416 ' O ' ' HA ' ' A' ' 770' ' ' ILE . 41.1 t -109.12 125.5 66.21 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 179.882 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 839' ' ' CYS . . . . . 0.456 ' O ' ' O ' ' A' ' 728' ' ' VAL . 0.5 OUTLIER -116.5 161.25 19.41 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.962 -1.086 . . . . 0.0 111.199 -179.928 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 840' ' ' SER . . . . . 0.412 ' OG ' ' C ' ' A' ' 839' ' ' CYS . 0.2 OUTLIER -168.27 140.39 2.9 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.665 -0.647 . . . . 0.0 109.501 -179.981 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 841' ' ' THR . . . . . 0.531 ' CA ' ' HG3' ' A' ' 768' ' ' GLN . 11.8 t -78.03 173.98 11.61 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.084 -1.01 . . . . 0.0 110.482 -179.972 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 842' ' ' ALA . . . . . . . . . . . . . . . -45.16 118.36 1.66 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.302 -0.874 . . . . 0.0 110.192 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 843' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.696 0 CA-C-O 118.013 -0.994 . . . . 0.0 110.262 179.995 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 726' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.492 1.648 0 CA-C-O 121.269 0.557 . . . . 0.0 110.14 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 727' ' ' THR . . . . . . . . . . . . . 1.7 m 62.64 152.18 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.265 -0.897 . . . . 0.0 110.15 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 728' ' ' VAL . . . . . . . . . . . . . 75.2 t -97.64 -67.88 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.224 -0.922 . . . . 0.0 110.221 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 729' ' ' SER . . . . . . . . . . . . . 16.1 p -167.26 167.11 14.38 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.164 -0.96 . . . . 0.0 110.501 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 730' ' ' GLY . . . . . . . . . . . . . . . -129.84 176.75 18.52 Favored Glycine 0 N--CA 1.489 2.202 0 N-CA-C 109.414 -1.475 . . . . 0.0 109.414 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 731' ' ' VAL . . . . . . . . . . . . . 2.6 m -131.7 137.88 54.1 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.283 -1.128 . . . . 0.0 110.462 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 732' ' ' CYS . . . . . . . . . . . . . 48.7 m -109.87 154.65 22.74 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.386 -0.821 . . . . 0.0 109.658 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 733' ' ' ALA . . . . . . . . . . . . . . . -167.59 114.27 0.74 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.111 -0.993 . . . . 0.0 111.001 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 734' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -111.22 120.53 42.59 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.385 -0.822 . . . . 0.0 109.444 179.894 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 735' ' ' VAL . . . . . . . . . . . . . 79.3 t -129.44 144.69 37.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.155 -0.966 . . . . 0.0 110.591 -179.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 736' ' ' SER . . . . . . . . . . . . . 2.3 m -89.97 -170.46 2.8 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.39 -0.819 . . . . 0.0 109.895 179.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 737' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -108.08 158.19 17.62 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.203 -0.936 . . . . 0.0 110.488 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 738' ' ' TYR . . . . . 0.468 ' CD2' ' CD1' ' A' ' 755' ' ' PHE . 51.6 t80 -122.52 -57.23 1.75 Allowed 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.361 -0.837 . . . . 0.0 109.785 179.967 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 739' ' ' HIS . . . . . 0.445 ' O ' ' O ' ' A' ' 738' ' ' TYR . 8.6 t-160 52.94 104.28 0.03 OUTLIER Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 121.322 -0.861 . . . . 0.0 110.752 179.981 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 740' ' ' PRO . . . . . 0.482 ' HD3' ' O ' ' A' ' 756' ' ' HIS . 50.9 Cg_endo -79.31 77.01 4.25 Favored 'Trans proline' 0 C--N 1.306 -1.697 0 O-C-N 124.094 1.576 . . . . 0.0 110.38 179.945 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 741' ' ' ASN . . . . . 0.461 ' O ' ' O ' ' A' ' 742' ' ' ILE . 42.3 t30 -134.0 -38.53 0.88 Allowed 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.021 -1.05 . . . . 0.0 110.406 -179.955 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 742' ' ' ILE . . . . . 0.489 ' O ' ' HB3' ' A' ' 743' ' ' LYS . 18.5 mt -50.62 -102.48 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 121.285 -0.884 . . . . 0.0 110.329 -179.944 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 743' ' ' LYS . . . . . 0.489 ' HB3' ' O ' ' A' ' 742' ' ' ILE . 5.9 pttp 170.96 -39.28 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.074 0 O-C-N 121.111 -0.993 . . . . 0.0 109.914 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 744' ' ' ASN . . . . . 0.415 ' O ' ' C ' ' A' ' 745' ' ' TRP . 0.8 OUTLIER -164.19 90.29 0.58 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.378 -0.826 . . . . 0.0 109.63 179.973 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 745' ' ' TRP . . . . . 0.415 ' C ' ' O ' ' A' ' 744' ' ' ASN . 4.9 m0 -42.02 156.72 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.308 -0.87 . . . . 0.0 110.642 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 746' ' ' GLN . . . . . . . . . . . . . 4.1 mt-30 -120.17 107.88 13.55 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.458 -0.776 . . . . 0.0 110.09 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 747' ' ' ILE . . . . . . . . . . . . . 6.1 pt -139.48 -176.24 1.19 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.267 -0.895 . . . . 0.0 110.091 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 748' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -96.71 34.08 1.74 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.213 -0.93 . . . . 0.0 110.469 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 749' ' ' SER . . . . . 0.477 ' O ' ' O ' ' A' ' 750' ' ' TYR . 80.9 p -146.92 -43.29 0.18 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.195 -0.941 . . . . 0.0 110.211 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 750' ' ' TYR . . . . . 0.477 ' O ' ' O ' ' A' ' 749' ' ' SER . 27.6 m-85 57.72 124.32 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.413 -0.805 . . . . 0.0 110.61 179.96 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 751' ' ' GLY . . . . . . . . . . . . . . . 135.91 91.78 0.34 Allowed Glycine 0 N--CA 1.489 2.178 0 C-N-CA 119.62 -1.276 . . . . 0.0 110.329 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 752' ' ' GLU . . . . . 0.517 ' CG ' ' O ' ' A' ' 752' ' ' GLU . 16.2 pt-20 -105.92 117.24 58.17 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.349 -1.089 . . . . 0.0 109.208 179.856 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 753' ' ' PRO . . . . . 0.476 ' O ' ' O ' ' A' ' 754' ' ' GLU . 47.6 Cg_endo -75.23 71.86 4.99 Favored 'Trans proline' 0 C--N 1.309 -1.551 0 O-C-N 123.99 1.521 . . . . 0.0 111.547 -179.927 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 754' ' ' GLU . . . . . 0.476 ' O ' ' O ' ' A' ' 753' ' ' PRO . 2.2 tm-20 56.78 134.23 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.361 -0.837 . . . . 0.0 111.528 179.903 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 755' ' ' PHE . . . . . 0.468 ' CD1' ' CD2' ' A' ' 738' ' ' TYR . 4.3 t80 178.23 137.1 0.08 Allowed 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.386 -0.821 . . . . 0.0 110.144 179.91 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 756' ' ' HIS . . . . . 0.482 ' O ' ' HD3' ' A' ' 740' ' ' PRO . 38.5 m80 -135.32 -53.71 0.78 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.244 -0.91 . . . . 0.0 110.339 -179.904 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 757' ' ' THR . . . . . 0.428 ' O ' ' C ' ' A' ' 758' ' ' ALA . 0.0 OUTLIER -130.49 117.1 19.12 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.207 -0.933 . . . . 0.0 110.332 -179.974 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 758' ' ' ALA . . . . . 0.464 ' O ' ' HG3' ' A' ' 759' ' ' LYS . . . -42.85 156.31 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.291 -0.881 . . . . 0.0 109.763 -179.997 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 759' ' ' LYS . . . . . 0.464 ' HG3' ' O ' ' A' ' 758' ' ' ALA . 18.3 mtpt -144.73 157.52 44.15 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.108 -0.995 . . . . 0.0 110.827 -179.892 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 760' ' ' VAL . . . . . 0.4 ' O ' ' HA ' ' A' ' 813' ' ' VAL . 77.9 t -107.67 132.92 53.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.395 -0.816 . . . . 0.0 108.92 179.947 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 761' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -108.87 104.82 14.15 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.065 -1.022 . . . . 0.0 111.328 -179.737 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 762' ' ' LEU . . . . . . . . . . . . . 25.8 mt -114.74 137.45 51.91 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 179.784 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 763' ' ' LYS . . . . . . . . . . . . . 18.7 ttpp -133.64 146.78 51.22 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.923 -1.111 . . . . 0.0 111.419 -179.894 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 764' ' ' CYS . . . . . 0.42 ' HB2' ' O ' ' A' ' 810' ' ' GLU . 20.7 m -141.55 155.15 45.8 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.597 -0.689 . . . . 0.0 109.434 179.86 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 765' ' ' ALA . . . . . 0.517 ' CB ' ' HD2' ' A' ' 766' ' ' PRO . . . -83.15 178.53 2.38 Favored Pre-proline 0 N--CA 1.494 1.727 0 O-C-N 121.059 -1.025 . . . . 0.0 110.354 -179.924 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 766' ' ' PRO . . . . . 0.517 ' HD2' ' CB ' ' A' ' 765' ' ' ALA . 44.0 Cg_endo -70.31 151.42 65.95 Favored 'Trans proline' 0 C--N 1.307 -1.642 0 O-C-N 123.968 1.509 . . . . 0.0 110.181 179.966 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 767' ' ' GLY . . . . . . . . . . . . . . . 70.87 3.81 52.2 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.143 -1.583 . . . . 0.0 109.143 -179.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 768' ' ' GLN . . . . . 0.47 ' HG2' ' O ' ' A' ' 840' ' ' SER . 28.4 mt-30 -123.66 117.45 25.02 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.346 -1.09 . . . . 0.0 109.838 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 769' ' ' THR . . . . . . . . . . . . . 60.5 p -127.17 148.32 50.18 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.061 -1.024 . . . . 0.0 110.295 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 770' ' ' ILE . . . . . . . . . . . . . 87.3 mt -60.76 117.25 2.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.256 -0.902 . . . . 0.0 109.777 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 771' ' ' SER . . . . . . . . . . . . . 13.9 t -107.27 -2.92 20.27 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.163 -0.961 . . . . 0.0 110.862 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 772' ' ' ALA . . . . . . . . . . . . . . . -170.81 135.19 1.07 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 120.806 -1.184 . . . . 0.0 111.313 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 773' ' ' ILE . . . . . 0.429 HD13 ' HB3' ' A' ' 802' ' ' LEU . 16.6 mm -85.38 128.16 39.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.441 -0.787 . . . . 0.0 108.93 179.815 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 774' ' ' LYS . . . . . 0.465 ' HB3' ' HB3' ' A' ' 836' ' ' GLU . 0.0 OUTLIER -79.29 -37.28 38.14 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.108 -0.995 . . . . 0.0 110.897 -179.827 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 775' ' ' PHE . . . . . . . . . . . . . 90.2 t80 -169.62 150.4 4.07 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.016 -1.052 . . . . 0.0 110.691 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 776' ' ' ALA . . . . . 0.452 ' O ' ' HB2' ' A' ' 798' ' ' SER . . . -163.93 126.28 2.45 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.469 -0.769 . . . . 0.0 109.483 179.94 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 777' ' ' SER . . . . . 0.506 ' HA ' ' CB ' ' A' ' 798' ' ' SER . 6.0 t -153.94 123.45 6.63 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.19 -0.944 . . . . 0.0 110.676 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 778' ' ' PHE . . . . . . . . . . . . . 42.6 t80 -97.15 82.8 3.23 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.395 -0.816 . . . . 0.0 109.712 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 779' ' ' GLY . . . . . . . . . . . . . . . 179.02 -121.42 0.75 Allowed Glycine 0 N--CA 1.492 2.392 0 N-CA-C 109.719 -1.352 . . . . 0.0 109.719 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 780' ' ' THR . . . . . 0.441 ' O ' ' HA3' ' A' ' 791' ' ' GLY . 44.9 p -114.61 97.2 46.15 Favored Pre-proline 0 N--CA 1.493 1.705 0 O-C-N 121.242 -1.152 . . . . 0.0 110.407 -179.949 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 781' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -79.35 175.94 10.21 Favored 'Trans proline' 0 C--N 1.304 -1.798 0 O-C-N 123.98 1.516 . . . . 0.0 110.514 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 782' ' ' LEU . . . . . 0.471 ' CD1' ' HA2' ' A' ' 791' ' ' GLY . 6.8 mt -139.05 105.4 5.27 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.344 -0.848 . . . . 0.0 110.144 -179.976 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 783' ' ' GLY . . . . . . . . . . . . . . . 102.37 -176.76 25.66 Favored Glycine 0 N--CA 1.492 2.367 0 N-CA-C 109.629 -1.389 . . . . 0.0 109.629 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 784' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -130.05 -163.08 1.27 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.205 -1.173 . . . . 0.0 110.052 179.913 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 785' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -59.86 116.69 4.29 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.059 -1.026 . . . . 0.0 109.901 -179.958 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 786' ' ' GLY . . . . . . . . . . . . . . . 137.07 -43.94 1.18 Allowed Glycine 0 N--CA 1.489 2.209 0 N-CA-C 108.575 -1.81 . . . . 0.0 108.575 -179.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 787' ' ' THR . . . . . . . . . . . . . 25.5 m -148.39 38.43 0.87 Allowed 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.554 -0.968 . . . . 0.0 109.34 179.867 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 788' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -50.4 176.31 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.814 0 CA-C-O 121.717 0.77 . . . . 0.0 111.065 -179.95 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 789' ' ' GLN . . . . . . . . . . . . . 2.2 mt-30 -161.87 170.6 19.18 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.563 -0.71 . . . . 0.0 109.508 179.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 790' ' ' GLN . . . . . 0.435 ' O ' ' C ' ' A' ' 791' ' ' GLY . 1.1 tp60 -88.81 21.05 3.2 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.985 -1.072 . . . . 0.0 110.283 -179.945 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 791' ' ' GLY . . . . . 0.471 ' HA2' ' CD1' ' A' ' 782' ' ' LEU . . . 42.34 -124.34 3.74 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.764 -1.335 . . . . 0.0 109.764 -179.953 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 792' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -133.02 -30.73 1.33 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.347 -1.09 . . . . 0.0 110.392 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 793' ' ' CYS . . . . . . . . . . . . . 5.1 t -112.07 139.44 47.59 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.187 -0.946 . . . . 0.0 110.239 -179.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 794' ' ' HIS . . . . . 0.419 ' CD2' ' HA ' ' A' ' 796' ' ' ILE . 19.0 t60 -148.81 141.57 24.58 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.3 -0.875 . . . . 0.0 109.952 179.876 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 795' ' ' SER . . . . . 0.424 ' HB3' ' HG3' ' A' ' 825' ' ' PRO . 3.7 p -81.99 10.13 7.1 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.294 -0.879 . . . . 0.0 110.382 -179.967 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 796' ' ' ILE . . . . . 0.447 ' O ' ' CG2' ' A' ' 796' ' ' ILE . 50.2 mt 45.98 23.24 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 O-C-N 121.2 -0.937 . . . . 0.0 110.405 -179.933 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 797' ' ' ASN . . . . . . . . . . . . . 2.8 t30 -150.46 17.14 0.82 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.339 -0.851 . . . . 0.0 109.815 -179.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 798' ' ' SER . . . . . 0.506 ' CB ' ' HA ' ' A' ' 777' ' ' SER . 2.0 m -81.45 -29.72 33.7 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.47 -0.769 . . . . 0.0 110.324 -179.934 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 799' ' ' ASN . . . . . . . . . . . . . 11.9 t30 -86.78 -11.38 51.16 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.276 -0.89 . . . . 0.0 110.525 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 800' ' ' SER . . . . . 0.439 ' O ' ' HB3' ' A' ' 804' ' ' ARG . 30.5 m -87.54 -20.92 25.79 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.182 -0.949 . . . . 0.0 110.166 179.955 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 801' ' ' VAL . . . . . . . . . . . . . 42.0 t -73.75 -41.75 54.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.235 -0.916 . . . . 0.0 110.188 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 802' ' ' LEU . . . . . 0.505 ' N ' ' CD2' ' A' ' 802' ' ' LEU . 4.0 mm? -75.62 -41.04 55.36 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.217 -0.927 . . . . 0.0 110.185 179.933 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 803' ' ' GLU . . . . . 0.526 ' HA ' ' CG1' ' A' ' 807' ' ' ILE . 5.5 tt0 -73.64 -18.04 61.08 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.147 -0.971 . . . . 0.0 110.663 179.948 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 804' ' ' ARG . . . . . 0.439 ' HB3' ' O ' ' A' ' 800' ' ' SER . 0.1 OUTLIER -89.2 -29.21 19.45 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.126 -0.984 . . . . 0.0 110.948 -179.979 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 805' ' ' LYS . . . . . . . . . . . . . 8.3 ttmt -122.11 -41.7 2.42 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 120.979 -1.075 . . . . 0.0 110.937 -179.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 806' ' ' CYS . . . . . 0.449 ' O ' HG12 ' A' ' 807' ' ' ILE . 0.9 OUTLIER -86.14 69.89 10.52 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.224 -0.923 . . . . 0.0 110.714 -179.994 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 807' ' ' ILE . . . . . 0.526 ' CG1' ' HA ' ' A' ' 803' ' ' GLU . 16.0 mm -149.72 121.63 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.411 0 O-C-N 121.287 -0.883 . . . . 0.0 110.512 179.934 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 808' ' ' GLY . . . . . . . . . . . . . . . 84.56 23.57 50.0 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.887 -1.285 . . . . 0.0 109.887 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 809' ' ' LEU . . . . . . . . . . . . . 72.5 mt -123.12 148.22 45.93 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.106 -1.232 . . . . 0.0 110.592 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 810' ' ' GLU . . . . . 0.42 ' O ' ' HB2' ' A' ' 764' ' ' CYS . 1.1 mp0 -83.45 1.25 42.55 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.256 -0.903 . . . . 0.0 110.032 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 811' ' ' ARG . . . . . . . . . . . . . 46.5 ttt180 -153.86 160.38 42.15 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.463 -0.773 . . . . 0.0 109.127 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 812' ' ' CYS . . . . . 0.467 ' C ' ' CG2' ' A' ' 813' ' ' VAL . 0.1 OUTLIER -155.5 143.93 20.28 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.794 -1.191 . . . . 0.0 111.735 -179.981 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 813' ' ' VAL . . . . . 0.467 ' CG2' ' C ' ' A' ' 812' ' ' CYS . 32.0 t -155.54 110.28 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 179.934 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 814' ' ' VAL . . . . . . . . . . . . . 76.0 t -108.43 120.36 59.67 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 121.198 -0.939 . . . . 0.0 110.746 -179.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 815' ' ' ALA . . . . . 0.441 ' O ' ' C ' ' A' ' 816' ' ' ILE . . . -78.01 84.69 4.27 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.425 -0.797 . . . . 0.0 110.102 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 816' ' ' ILE . . . . . 0.498 ' CD1' HG13 ' A' ' 833' ' ' VAL . 21.3 mt -39.39 143.11 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 O-C-N 121.476 -0.765 . . . . 0.0 110.602 179.97 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 817' ' ' SER . . . . . 0.45 ' OG ' ' HD2' ' A' ' 818' ' ' PRO . 0.0 OUTLIER -157.94 175.18 3.4 Favored Pre-proline 0 C--N 1.302 -1.481 0 O-C-N 121.328 -0.858 . . . . 0.0 109.958 179.944 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 818' ' ' PRO . . . . . 0.45 ' HD2' ' OG ' ' A' ' 817' ' ' SER . 42.7 Cg_endo -71.66 -71.42 0.02 OUTLIER 'Trans proline' 0 C--N 1.302 -1.871 0 O-C-N 123.941 1.495 . . . . 0.0 111.556 -179.933 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 819' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -86.85 39.09 0.83 Allowed 'General case' 0 N--CA 1.496 1.838 0 O-C-N 120.981 -1.074 . . . . 0.0 110.798 -179.895 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 820' ' ' ASN . . . . . 0.433 ' HB2' ' OG ' ' A' ' 817' ' ' SER . 0.7 OUTLIER -99.38 -34.07 10.45 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.135 -0.978 . . . . 0.0 109.888 179.987 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 821' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -99.7 -44.32 6.15 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.294 -0.879 . . . . 0.0 110.051 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 822' ' ' GLY . . . . . . . . . . . . . . . -165.01 -36.59 0.02 OUTLIER Glycine 0 N--CA 1.492 2.388 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 823' ' ' GLY . . . . . . . . . . . . . . . 134.4 -96.6 0.28 Allowed Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.698 -1.361 . . . . 0.0 109.698 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 824' ' ' ASP . . . . . . . . . . . . . 31.7 t0 -149.07 87.0 5.48 Favored Pre-proline 0 N--CA 1.492 1.658 0 O-C-N 121.3 -1.117 . . . . 0.0 110.359 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 825' ' ' PRO . . . . . 0.424 ' HG3' ' HB3' ' A' ' 795' ' ' SER . 43.8 Cg_endo -72.07 -49.54 0.3 Allowed 'Trans proline' 0 C--N 1.306 -1.682 0 O-C-N 123.945 1.497 . . . . 0.0 110.255 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 826' ' ' CYS . . . . . 0.529 ' HB3' ' HB ' ' A' ' 829' ' ' VAL . 0.0 OUTLIER -78.24 144.87 67.58 Favored Pre-proline 0 N--CA 1.489 1.478 0 O-C-N 121.241 -0.912 . . . . 0.0 109.832 179.898 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 827' ' ' PRO . . . . . 0.434 ' O ' ' C ' ' A' ' 828' ' ' GLU . 46.6 Cg_endo -74.93 115.74 4.38 Favored 'Trans proline' 0 C--N 1.302 -1.888 0 O-C-N 124.007 1.53 . . . . 0.0 111.953 -179.938 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 828' ' ' GLU . . . . . 0.434 ' C ' ' O ' ' A' ' 827' ' ' PRO . 18.3 mm-40 35.8 36.99 0.04 OUTLIER 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.735 -0.603 . . . . 0.0 111.69 179.867 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 829' ' ' VAL . . . . . 0.529 ' HB ' ' HB3' ' A' ' 826' ' ' CYS . 17.3 t -91.07 165.27 1.98 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 O-C-N 121.114 -0.991 . . . . 0.0 109.703 179.861 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 830' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -63.67 -168.9 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.118 -0.989 . . . . 0.0 110.041 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 831' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -143.44 158.33 43.73 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.229 -0.919 . . . . 0.0 110.539 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 832' ' ' ARG . . . . . 0.406 ' C ' HG23 ' A' ' 833' ' ' VAL . 0.6 OUTLIER -169.34 161.26 9.89 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.383 -0.823 . . . . 0.0 109.515 -179.958 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 833' ' ' VAL . . . . . 0.498 HG13 ' CD1' ' A' ' 816' ' ' ILE . 93.4 t -135.21 106.96 7.22 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 O-C-N 120.912 -1.117 . . . . 0.0 111.242 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 834' ' ' ALA . . . . . . . . . . . . . . . -115.87 114.53 24.82 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.444 -0.785 . . . . 0.0 108.894 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 835' ' ' VAL . . . . . . . . . . . . . 15.6 t -125.11 158.98 32.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.001 -1.062 . . . . 0.0 111.546 -179.847 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 836' ' ' GLU . . . . . 0.465 ' HB3' ' HB3' ' A' ' 774' ' ' LYS . 30.5 tt0 -147.63 143.29 27.59 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 108.056 -1.09 . . . . 0.0 108.056 179.847 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 837' ' ' ALA . . . . . . . . . . . . . . . -140.58 155.25 46.64 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 120.488 -1.383 . . . . 0.0 112.116 -179.877 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 838' ' ' VAL . . . . . . . . . . . . . 96.2 t -113.33 111.82 37.72 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 179.849 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 839' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -107.45 121.24 44.22 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.063 -1.023 . . . . 0.0 110.911 -179.848 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 840' ' ' SER . . . . . 0.527 ' O ' ' CB ' ' A' ' 841' ' ' THR . 4.6 p -140.82 -66.42 0.43 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.523 -0.736 . . . . 0.0 109.764 179.965 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 841' ' ' THR . . . . . 0.527 ' CB ' ' O ' ' A' ' 840' ' ' SER . 0.0 OUTLIER 165.54 164.02 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.482 -0.761 . . . . 0.0 109.918 179.933 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 842' ' ' ALA . . . . . . . . . . . . . . . -68.08 85.76 0.25 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.238 -0.914 . . . . 0.0 110.163 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 843' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.719 0 CA-C-O 118.012 -0.994 . . . . 0.0 110.292 179.949 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 726' ' ' ARG . . . . . 0.476 ' NH1' ' CG2' ' A' ' 841' ' ' THR . 1.6 tmt_? . . . . . 0 N--CA 1.493 1.681 0 CA-C-O 121.267 0.556 . . . . 0.0 110.151 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 727' ' ' THR . . . . . . . . . . . . . 1.6 m -131.15 145.72 52.08 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.246 -0.909 . . . . 0.0 110.162 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 728' ' ' VAL . . . . . 0.429 HG12 ' HA ' ' A' ' 840' ' ' SER . 0.4 OUTLIER -138.47 160.21 31.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.244 -0.91 . . . . 0.0 110.036 179.97 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 729' ' ' SER . . . . . 0.413 ' OG ' ' O ' ' A' ' 728' ' ' VAL . 0.6 OUTLIER 176.59 46.82 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.254 -0.904 . . . . 0.0 109.947 -179.95 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 730' ' ' GLY . . . . . . . . . . . . . . . -143.68 89.09 0.17 Allowed Glycine 0 N--CA 1.488 2.116 0 N-CA-C 109.986 -1.246 . . . . 0.0 109.986 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 731' ' ' VAL . . . . . . . . . . . . . 18.0 t -108.27 162.94 6.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.259 -1.142 . . . . 0.0 109.158 179.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 732' ' ' CYS . . . . . 0.442 ' SG ' ' OE1' ' A' ' 836' ' ' GLU . 0.8 OUTLIER -156.55 157.68 35.81 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 120.907 -1.12 . . . . 0.0 111.139 -179.95 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 733' ' ' ALA . . . . . . . . . . . . . . . -170.31 103.52 0.28 Allowed 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 734' ' ' ASP . . . . . 0.493 ' O ' ' CG2' ' A' ' 735' ' ' VAL . 1.8 p-10 -113.09 136.04 53.14 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.226 -0.921 . . . . 0.0 110.619 -179.872 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 735' ' ' VAL . . . . . 0.493 ' CG2' ' O ' ' A' ' 734' ' ' ASP . 89.9 t -156.13 117.34 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.361 -0.837 . . . . 0.0 110.042 179.978 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 736' ' ' SER . . . . . . . . . . . . . 80.8 p -59.18 166.55 2.1 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.136 -0.977 . . . . 0.0 110.115 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 737' ' ' GLU . . . . . 0.511 ' HA ' ' CB ' ' A' ' 758' ' ' ALA . 35.2 tt0 -111.87 149.81 31.3 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.238 -0.914 . . . . 0.0 110.164 179.981 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 738' ' ' TYR . . . . . 0.429 ' O ' ' HB3' ' A' ' 739' ' ' HIS . 7.3 t80 -111.85 -128.22 0.29 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.269 -0.895 . . . . 0.0 110.253 -179.982 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 739' ' ' HIS . . . . . 0.5 ' O ' ' CG ' ' A' ' 739' ' ' HIS . 13.2 t-160 55.37 60.94 8.96 Favored Pre-proline 0 N--CA 1.494 1.739 0 O-C-N 120.997 -1.064 . . . . 0.0 110.1 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 740' ' ' PRO . . . . . 0.47 ' O ' HD11 ' A' ' 742' ' ' ILE . 47.8 Cg_endo -75.11 109.99 3.03 Favored 'Trans proline' 0 C--N 1.301 -1.937 0 O-C-N 124.075 1.566 . . . . 0.0 110.272 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 741' ' ' ASN . . . . . 0.437 ' C ' ' O ' ' A' ' 740' ' ' PRO . 4.1 m120 -42.88 129.81 4.3 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.158 -0.964 . . . . 0.0 109.865 179.929 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 742' ' ' ILE . . . . . 0.47 HD11 ' O ' ' A' ' 740' ' ' PRO . 3.5 mp -113.45 146.4 18.11 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 O-C-N 121.171 -0.956 . . . . 0.0 110.973 -179.911 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 743' ' ' LYS . . . . . 0.42 ' O ' ' HB2' ' A' ' 744' ' ' ASN . 0.1 OUTLIER -103.81 117.0 33.32 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.296 -0.877 . . . . 0.0 109.016 179.955 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 744' ' ' ASN . . . . . 0.469 ' O ' ' C ' ' A' ' 745' ' ' TRP . 0.7 OUTLIER 61.77 77.26 0.34 Allowed 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.006 -1.059 . . . . 0.0 108.892 -179.884 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 745' ' ' TRP . . . . . 0.469 ' C ' ' O ' ' A' ' 744' ' ' ASN . 3.8 m-90 -31.87 -61.88 0.22 Allowed 'General case' 0 N--CA 1.501 2.091 0 O-C-N 121.857 -0.527 . . . . 0.0 111.41 -179.926 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 746' ' ' GLN . . . . . 0.462 ' HB2' ' O ' ' A' ' 745' ' ' TRP . 43.3 mt-30 56.44 57.83 4.63 Favored 'General case' 0 C--N 1.298 -1.649 0 O-C-N 121.295 -0.878 . . . . 0.0 110.226 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 747' ' ' ILE . . . . . 0.41 HG23 ' O ' ' A' ' 749' ' ' SER . 4.1 tp -125.25 149.36 29.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.154 -0.966 . . . . 0.0 110.205 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 748' ' ' GLU . . . . . . . . . . . . . 14.5 mm-40 -63.07 -68.18 0.36 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.234 -0.916 . . . . 0.0 110.238 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 749' ' ' SER . . . . . 0.41 ' O ' HG23 ' A' ' 747' ' ' ILE . 12.8 m -69.92 141.77 53.04 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.23 -0.919 . . . . 0.0 110.039 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 750' ' ' TYR . . . . . . . . . . . . . 52.6 m-85 -106.57 144.38 33.33 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.327 -0.858 . . . . 0.0 110.297 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 751' ' ' GLY . . . . . . . . . . . . . . . 73.57 140.13 0.48 Allowed Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.602 -1.399 . . . . 0.0 109.602 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 752' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -164.57 67.86 1.39 Allowed Pre-proline 0 N--CA 1.492 1.651 0 O-C-N 121.312 -1.111 . . . . 0.0 110.029 179.988 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 753' ' ' PRO . . . . . 0.457 ' O ' ' HB2' ' A' ' 754' ' ' GLU . 45.6 Cg_endo -73.45 110.75 3.13 Favored 'Trans proline' 0 C--N 1.305 -1.723 0 O-C-N 124.059 1.557 . . . . 0.0 110.462 -179.894 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 754' ' ' GLU . . . . . 0.458 ' HA ' ' OE1' ' A' ' 754' ' ' GLU . 5.2 tp10 178.42 -81.78 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.381 -0.824 . . . . 0.0 109.997 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 755' ' ' PHE . . . . . 0.407 ' N ' ' HG3' ' A' ' 754' ' ' GLU . 50.2 t80 -111.44 116.92 31.73 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.253 -0.904 . . . . 0.0 109.97 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 756' ' ' HIS . . . . . . . . . . . . . 2.3 t-160 -129.1 -69.58 0.7 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.112 -0.993 . . . . 0.0 110.396 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 757' ' ' THR . . . . . 0.44 HG21 ' HB2' ' A' ' 739' ' ' HIS . 24.2 p -101.3 -169.82 1.75 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.27 -0.894 . . . . 0.0 110.452 -179.958 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 758' ' ' ALA . . . . . 0.511 ' CB ' ' HA ' ' A' ' 737' ' ' GLU . . . -111.93 161.72 16.11 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.35 -0.844 . . . . 0.0 109.796 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 759' ' ' LYS . . . . . 0.457 ' HG2' ' HA ' ' A' ' 815' ' ' ALA . 6.1 mttt -131.34 162.11 30.83 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.203 -0.936 . . . . 0.0 110.418 179.951 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 760' ' ' VAL . . . . . . . . . . . . . 99.2 t -107.61 143.01 18.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.385 -0.822 . . . . 0.0 109.31 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 761' ' ' HIS . . . . . . . . . . . . . 6.1 m170 -112.53 120.71 42.53 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.08 -1.012 . . . . 0.0 111.069 -179.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 762' ' ' LEU . . . . . 0.471 ' HB2' ' O ' ' A' ' 812' ' ' CYS . 12.3 mt -127.11 141.02 51.86 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.541 -0.724 . . . . 0.0 109.081 179.955 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 763' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -158.7 147.88 18.95 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 120.905 -1.122 . . . . 0.0 111.067 -179.903 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 764' ' ' CYS . . . . . . . . . . . . . 4.2 m -124.03 171.54 9.67 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.425 -0.797 . . . . 0.0 109.674 179.907 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 765' ' ' ALA . . . . . . . . . . . . . . . -70.1 158.52 87.2 Favored Pre-proline 0 N--CA 1.493 1.724 0 O-C-N 121.038 -1.039 . . . . 0.0 109.983 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 766' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -72.04 130.17 16.23 Favored 'Trans proline' 0 C--N 1.306 -1.7 0 O-C-N 123.925 1.487 . . . . 0.0 110.067 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 767' ' ' GLY . . . . . . . . . . . . . . . 112.47 -26.63 10.8 Favored Glycine 0 N--CA 1.488 2.143 0 N-CA-C 108.974 -1.65 . . . . 0.0 108.974 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 768' ' ' GLN . . . . . 0.413 ' O ' ' CG2' ' A' ' 769' ' ' THR . 2.0 mt-30 -106.79 172.29 6.9 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.362 -1.081 . . . . 0.0 109.992 179.934 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 769' ' ' THR . . . . . 0.413 ' CG2' ' O ' ' A' ' 768' ' ' GLN . 37.4 p -153.47 147.96 26.08 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.123 -0.985 . . . . 0.0 110.384 -179.937 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 770' ' ' ILE . . . . . . . . . . . . . 12.9 mt -64.29 146.29 13.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.274 -0.891 . . . . 0.0 109.475 179.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 771' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -135.52 -0.15 2.68 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.023 -1.048 . . . . 0.0 111.053 -179.942 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 772' ' ' ALA . . . . . 0.415 ' O ' ' HB ' ' A' ' 838' ' ' VAL . . . -179.14 147.34 0.33 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.795 -1.191 . . . . 0.0 111.534 179.959 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 773' ' ' ILE . . . . . 0.416 HG13 ' HB3' ' A' ' 802' ' ' LEU . 22.7 mm -107.15 135.37 45.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 179.819 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 774' ' ' LYS . . . . . . . . . . . . . 2.3 ptpt -107.36 -6.85 16.91 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.026 -1.046 . . . . 0.0 111.712 -179.806 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 775' ' ' PHE . . . . . 0.53 ' CD2' ' N ' ' A' ' 776' ' ' ALA . 39.3 t80 -157.65 162.16 38.65 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.731 -1.231 . . . . 0.0 111.337 -179.973 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 776' ' ' ALA . . . . . 0.532 ' O ' ' CB ' ' A' ' 798' ' ' SER . . . 170.04 112.66 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 109.295 -0.632 . . . . 0.0 109.295 179.933 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 777' ' ' SER . . . . . 0.424 ' HA ' ' CE1' ' A' ' 794' ' ' HIS . 0.2 OUTLIER -140.36 120.53 13.82 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.147 -0.971 . . . . 0.0 110.78 -179.954 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 778' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -94.39 96.43 9.52 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.416 -0.803 . . . . 0.0 109.271 179.879 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 779' ' ' GLY . . . . . . . . . . . . . . . 166.82 -111.04 0.43 Allowed Glycine 0 N--CA 1.492 2.372 0 N-CA-C 110.013 -1.235 . . . . 0.0 110.013 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 780' ' ' THR . . . . . 0.471 HG23 ' HG3' ' A' ' 830' ' ' MET . 2.1 p -118.13 102.03 51.06 Favored Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 120.958 -1.319 . . . . 0.0 110.627 -179.927 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 781' ' ' PRO . . . . . 0.511 ' CG ' ' HB3' ' A' ' 832' ' ' ARG . 49.0 Cg_endo -84.58 173.09 8.73 Favored 'Trans proline' 0 C--N 1.306 -1.692 0 O-C-N 124.126 1.592 . . . . 0.0 110.221 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 782' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -145.02 113.37 6.59 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.192 -0.942 . . . . 0.0 110.165 179.903 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 783' ' ' GLY . . . . . . . . . . . . . . . 114.21 -157.5 14.93 Favored Glycine 0 N--CA 1.492 2.409 0 N-CA-C 109.451 -1.46 . . . . 0.0 109.451 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 784' ' ' THR . . . . . 0.481 ' O ' ' CE1' ' A' ' 788' ' ' PHE . 0.0 OUTLIER -136.3 -55.1 0.75 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.101 -1.235 . . . . 0.0 110.519 179.985 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 785' ' ' CYS . . . . . . . . . . . . . 11.0 t -156.97 108.27 2.38 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.215 -0.928 . . . . 0.0 110.507 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 786' ' ' GLY . . . . . . . . . . . . . . . 112.5 -14.27 25.15 Favored Glycine 0 N--CA 1.492 2.401 0 N-CA-C 109.801 -1.319 . . . . 0.0 109.801 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 787' ' ' THR . . . . . . . . . . . . . 3.7 m -136.74 29.76 2.87 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.197 -1.178 . . . . 0.0 110.556 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 788' ' ' PHE . . . . . 0.505 ' CZ ' ' HB3' ' A' ' 834' ' ' ALA . 0.7 OUTLIER -67.75 124.54 23.57 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.174 -0.954 . . . . 0.0 109.87 179.974 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 789' ' ' GLN . . . . . . . . . . . . . 9.7 tm0? -130.22 130.22 44.35 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.234 -0.916 . . . . 0.0 110.321 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 790' ' ' GLN . . . . . 0.502 ' CG ' ' O ' ' A' ' 790' ' ' GLN . 2.3 pt20 -59.73 104.14 0.26 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.292 -0.88 . . . . 0.0 110.025 -179.965 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 791' ' ' GLY . . . . . 0.44 ' O ' ' HG2' ' A' ' 792' ' ' GLU . . . -44.7 -61.96 3.11 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.661 -1.375 . . . . 0.0 109.661 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 792' ' ' GLU . . . . . 0.44 ' HG2' ' O ' ' A' ' 791' ' ' GLY . 2.2 mm-40 -171.48 -33.33 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.18 -1.188 . . . . 0.0 110.388 -179.989 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 793' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -96.46 155.27 16.84 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.163 -0.96 . . . . 0.0 110.499 -179.958 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 794' ' ' HIS . . . . . 0.424 ' CE1' ' HA ' ' A' ' 777' ' ' SER . 13.4 t60 -165.33 164.75 19.78 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.245 -0.91 . . . . 0.0 110.039 -179.966 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 795' ' ' SER . . . . . 0.516 ' O ' HG13 ' A' ' 796' ' ' ILE . 51.1 p -100.79 -7.93 23.18 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.245 -0.909 . . . . 0.0 110.36 179.978 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 796' ' ' ILE . . . . . 0.516 HG13 ' O ' ' A' ' 795' ' ' SER . 0.6 OUTLIER 64.61 11.83 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.506 2.375 0 O-C-N 121.559 -0.713 . . . . 0.0 110.258 -179.972 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 797' ' ' ASN . . . . . 0.461 ' OD1' ' O ' ' A' ' 797' ' ' ASN . 11.0 p30 -152.18 30.91 0.55 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.374 -0.829 . . . . 0.0 109.607 179.968 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 798' ' ' SER . . . . . 0.532 ' CB ' ' O ' ' A' ' 776' ' ' ALA . 3.9 m -67.36 -51.2 55.09 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.573 -0.704 . . . . 0.0 111.707 -179.874 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 799' ' ' ASN . . . . . 0.437 ' OD1' ' N ' ' A' ' 800' ' ' SER . 36.3 p30 -74.9 -17.55 60.56 Favored 'General case' 0 N--CA 1.5 2.039 0 O-C-N 121.243 -0.911 . . . . 0.0 111.803 -179.823 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 800' ' ' SER . . . . . 0.437 ' N ' ' OD1' ' A' ' 799' ' ' ASN . 29.5 t -58.88 -22.24 58.93 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 120.853 -1.154 . . . . 0.0 110.851 -179.96 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 801' ' ' VAL . . . . . . . . . . . . . 42.6 t -93.72 -18.8 6.85 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.006 0 O-C-N 121.096 -1.002 . . . . 0.0 111.051 -179.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 802' ' ' LEU . . . . . 0.479 ' N ' ' CD2' ' A' ' 802' ' ' LEU . 4.0 mm? -87.61 -21.54 25.28 Favored 'General case' 0 N--CA 1.5 2.052 0 O-C-N 121.089 -1.007 . . . . 0.0 111.176 -179.868 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 803' ' ' GLU . . . . . . . . . . . . . 24.5 mt-10 -79.31 -29.11 42.22 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.019 -1.051 . . . . 0.0 111.117 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 804' ' ' ARG . . . . . . . . . . . . . 6.8 mpt_? -92.43 -18.6 23.03 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.082 -1.011 . . . . 0.0 111.545 -179.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 805' ' ' LYS . . . . . . . . . . . . . 7.9 ttmt -129.4 52.03 2.01 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 120.84 -1.163 . . . . 0.0 111.625 -179.87 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 806' ' ' CYS . . . . . 0.411 ' HB2' ' O ' ' A' ' 802' ' ' LEU . 0.5 OUTLIER -162.63 -44.61 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.981 -1.074 . . . . 0.0 110.621 179.901 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 807' ' ' ILE . . . . . . . . . . . . . 30.6 mt -71.92 107.56 2.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.231 -0.918 . . . . 0.0 110.444 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 808' ' ' GLY . . . . . . . . . . . . . . . 122.11 8.79 7.05 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.756 -1.338 . . . . 0.0 109.756 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 809' ' ' LEU . . . . . . . . . . . . . 83.4 mt -135.39 144.91 46.84 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.232 -1.158 . . . . 0.0 110.517 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 810' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -70.88 -28.97 64.95 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.341 -0.85 . . . . 0.0 109.952 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 811' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -123.7 160.26 27.61 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.475 -0.765 . . . . 0.0 109.987 179.908 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 812' ' ' CYS . . . . . 0.471 ' O ' ' HB2' ' A' ' 762' ' ' LEU . 1.3 t -145.69 128.69 16.5 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.267 -0.896 . . . . 0.0 110.313 179.988 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 813' ' ' VAL . . . . . . . . . . . . . 4.8 t -127.13 108.88 19.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.17 -0.956 . . . . 0.0 109.934 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 814' ' ' VAL . . . . . . . . . . . . . 63.7 t -110.57 108.99 26.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.258 -0.901 . . . . 0.0 110.147 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 815' ' ' ALA . . . . . 0.457 ' HA ' ' HG2' ' A' ' 759' ' ' LYS . . . -74.32 168.15 20.22 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.285 -0.884 . . . . 0.0 110.085 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 816' ' ' ILE . . . . . 0.514 ' CG2' HG23 ' A' ' 833' ' ' VAL . 39.3 mt -121.82 131.67 72.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.253 -0.905 . . . . 0.0 110.322 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 817' ' ' SER . . . . . 0.47 ' HB3' ' O ' ' A' ' 816' ' ' ILE . 9.1 p -178.71 173.63 0.58 Allowed Pre-proline 0 C--N 1.301 -1.54 0 O-C-N 121.43 -0.794 . . . . 0.0 109.695 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 818' ' ' PRO . . . . . 0.468 ' HD2' ' HB2' ' A' ' 817' ' ' SER . 51.3 Cg_endo -79.54 12.41 2.38 Favored 'Trans proline' 0 C--N 1.304 -1.78 0 O-C-N 123.847 1.446 . . . . 0.0 111.048 179.957 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 819' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -128.81 2.53 5.4 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.971 -1.081 . . . . 0.0 110.586 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 820' ' ' ASN . . . . . 0.415 ' OD1' ' OG ' ' A' ' 817' ' ' SER . 5.7 m120 -96.36 -35.3 11.25 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.073 -1.017 . . . . 0.0 110.365 -179.932 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 821' ' ' PHE . . . . . . . . . . . . . 46.8 m-85 -104.04 -69.03 0.82 Allowed 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.277 -0.889 . . . . 0.0 110.352 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 822' ' ' GLY . . . . . . . . . . . . . . . 167.6 51.92 0.03 OUTLIER Glycine 0 N--CA 1.492 2.381 0 N-CA-C 109.617 -1.393 . . . . 0.0 109.617 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 823' ' ' GLY . . . . . . . . . . . . . . . 91.58 178.07 42.61 Favored Glycine 0 N--CA 1.493 2.453 0 N-CA-C 109.693 -1.363 . . . . 0.0 109.693 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 824' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -112.68 129.31 24.55 Favored Pre-proline 0 N--CA 1.495 1.797 0 O-C-N 121.338 -1.095 . . . . 0.0 110.236 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 825' ' ' PRO . . . . . 0.413 ' O ' ' HD3' ' A' ' 827' ' ' PRO . 49.4 Cg_endo -82.6 -47.28 0.06 OUTLIER 'Trans proline' 0 C--N 1.307 -1.621 0 O-C-N 123.857 1.451 . . . . 0.0 111.201 -179.958 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 826' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -114.7 93.36 32.97 Favored Pre-proline 0 N--CA 1.498 1.929 0 O-C-N 120.987 -1.07 . . . . 0.0 111.137 -179.892 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 827' ' ' PRO . . . . . 0.472 ' O ' ' CB ' ' A' ' 828' ' ' GLU . 50.6 Cg_endo -89.04 162.01 5.87 Favored 'Trans proline' 0 C--N 1.307 -1.623 0 O-C-N 123.903 1.475 . . . . 0.0 110.396 179.948 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 828' ' ' GLU . . . . . 0.472 ' CB ' ' O ' ' A' ' 827' ' ' PRO . 0.7 OUTLIER 67.35 16.29 10.05 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.206 -0.934 . . . . 0.0 110.806 179.971 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 829' ' ' VAL . . . . . 0.42 ' O ' ' C ' ' A' ' 830' ' ' MET . 59.1 t -127.3 148.27 32.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.061 -1.025 . . . . 0.0 110.129 -179.985 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 830' ' ' MET . . . . . 0.486 ' O ' ' HG3' ' A' ' 830' ' ' MET . 3.1 ptt? -41.89 106.54 0.06 Allowed 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.233 -0.917 . . . . 0.0 109.885 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 831' ' ' LYS . . . . . . . . . . . . . 11.5 mttm -82.03 115.43 21.17 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.164 -0.96 . . . . 0.0 111.001 -179.882 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 832' ' ' ARG . . . . . 0.511 ' HB3' ' CG ' ' A' ' 781' ' ' PRO . 2.4 mmm-85 -135.33 132.79 38.09 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 179.889 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 833' ' ' VAL . . . . . 0.514 HG23 ' CG2' ' A' ' 816' ' ' ILE . 39.3 t -108.96 130.86 61.13 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.584 0 O-C-N 121.02 -1.05 . . . . 0.0 111.034 -179.889 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 834' ' ' ALA . . . . . 0.505 ' HB3' ' CZ ' ' A' ' 788' ' ' PHE . . . -128.83 135.59 49.33 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.508 -0.745 . . . . 0.0 109.411 -179.985 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 835' ' ' VAL . . . . . . . . . . . . . 13.3 t -152.78 127.64 1.49 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.051 -1.031 . . . . 0.0 110.776 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 836' ' ' GLU . . . . . 0.442 ' OE1' ' SG ' ' A' ' 732' ' ' CYS . 3.4 mt-10 -110.58 133.38 53.36 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.452 -0.78 . . . . 0.0 109.587 179.922 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 837' ' ' ALA . . . . . . . . . . . . . . . -110.8 154.54 23.82 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.082 -1.011 . . . . 0.0 110.701 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 838' ' ' VAL . . . . . 0.415 ' HB ' ' O ' ' A' ' 772' ' ' ALA . 99.2 t -107.85 108.86 26.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.366 -0.834 . . . . 0.0 109.807 179.967 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 839' ' ' CYS . . . . . 0.415 ' O ' ' O ' ' A' ' 728' ' ' VAL . 0.0 OUTLIER -108.66 146.56 33.23 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.238 -0.914 . . . . 0.0 110.353 -179.934 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 840' ' ' SER . . . . . 0.429 ' HA ' HG12 ' A' ' 728' ' ' VAL . 0.6 OUTLIER -157.04 168.57 27.08 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.299 -0.875 . . . . 0.0 110.097 179.985 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 841' ' ' THR . . . . . 0.476 ' CG2' ' NH1' ' A' ' 726' ' ' ARG . 1.2 p -67.32 157.08 34.84 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.309 -0.869 . . . . 0.0 110.567 -179.979 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 842' ' ' ALA . . . . . . . . . . . . . . . -138.76 90.27 2.43 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.441 -0.787 . . . . 0.0 109.988 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 843' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.676 0 CA-C-O 118.011 -0.995 . . . . 0.0 110.171 180.0 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 726' ' ' ARG . . . . . . . . . . . . . 8.5 tpp85 . . . . . 0 N--CA 1.492 1.667 0 CA-C-O 121.234 0.54 . . . . 0.0 110.193 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 727' ' ' THR . . . . . . . . . . . . . 5.8 m -123.71 146.51 48.21 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.313 -0.867 . . . . 0.0 110.276 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 728' ' ' VAL . . . . . 0.537 ' O ' ' CG1' ' A' ' 728' ' ' VAL . 9.9 t -94.97 76.35 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.21 -0.931 . . . . 0.0 110.036 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 729' ' ' SER . . . . . 0.42 ' HB3' ' HB3' ' A' ' 840' ' ' SER . 69.5 p -136.06 128.85 30.99 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.162 -0.961 . . . . 0.0 110.447 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 730' ' ' GLY . . . . . . . . . . . . . . . 132.82 74.74 0.1 Allowed Glycine 0 N--CA 1.492 2.414 0 N-CA-C 109.819 -1.312 . . . . 0.0 109.819 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 731' ' ' VAL . . . . . . . . . . . . . 48.0 t -109.66 147.43 14.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.217 -1.166 . . . . 0.0 110.039 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 732' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -120.51 151.63 39.11 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.159 -0.963 . . . . 0.0 110.568 -179.963 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 733' ' ' ALA . . . . . . . . . . . . . . . -141.26 103.09 4.36 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.413 -0.804 . . . . 0.0 109.69 179.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 734' ' ' ASP . . . . . . . . . . . . . 39.0 t70 -127.61 128.19 45.12 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.261 -0.899 . . . . 0.0 109.889 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 735' ' ' VAL . . . . . . . . . . . . . 76.7 t -146.74 134.19 14.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.031 -1.043 . . . . 0.0 110.61 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 736' ' ' SER . . . . . . . . . . . . . 2.7 m -68.26 140.9 56.02 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.359 -0.838 . . . . 0.0 109.852 179.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 737' ' ' GLU . . . . . . . . . . . . . 9.2 tm-20 -89.76 139.46 30.55 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.199 -0.938 . . . . 0.0 110.527 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 738' ' ' TYR . . . . . 0.622 ' CZ ' ' NE2' ' A' ' 739' ' ' HIS . 49.8 t80 -98.1 125.62 43.17 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.358 -0.839 . . . . 0.0 109.601 179.926 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 739' ' ' HIS . . . . . 0.622 ' NE2' ' CZ ' ' A' ' 738' ' ' TYR . 0.7 OUTLIER -44.27 167.34 0.1 OUTLIER Pre-proline 0 N--CA 1.493 1.72 0 O-C-N 121.09 -1.006 . . . . 0.0 110.429 -179.931 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 740' ' ' PRO . . . . . 0.442 ' HD2' ' HB2' ' A' ' 739' ' ' HIS . 48.6 Cg_endo -82.3 -50.5 0.05 OUTLIER 'Trans proline' 0 C--N 1.307 -1.649 0 O-C-N 123.926 1.487 . . . . 0.0 111.516 -179.901 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 741' ' ' ASN . . . . . 0.472 ' O ' ' CG1' ' A' ' 742' ' ' ILE . 6.8 m-20 -157.43 115.89 3.2 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 120.781 -1.199 . . . . 0.0 111.508 -179.896 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 742' ' ' ILE . . . . . 0.554 ' HB ' ' CE1' ' A' ' 739' ' ' HIS . 11.2 mt -155.13 17.14 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 O-C-N 121.133 -0.979 . . . . 0.0 110.222 179.813 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 743' ' ' LYS . . . . . . . . . . . . . 1.3 mmtt 45.47 -97.71 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.187 -0.945 . . . . 0.0 110.476 179.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 744' ' ' ASN . . . . . 0.408 ' N ' ' O ' ' A' ' 742' ' ' ILE . 2.0 m-80 -112.01 143.06 43.64 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.017 -1.052 . . . . 0.0 110.383 -179.925 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 745' ' ' TRP . . . . . 0.492 ' CD1' ' N ' ' A' ' 745' ' ' TRP . 11.1 m0 -74.82 -158.53 0.08 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.264 -0.898 . . . . 0.0 109.875 -179.961 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 746' ' ' GLN . . . . . . . . . . . . . 3.7 mt-30 -62.94 129.92 42.51 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.189 -0.944 . . . . 0.0 110.094 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 747' ' ' ILE . . . . . . . . . . . . . 15.0 mm -85.66 97.51 5.8 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 O-C-N 121.276 -0.89 . . . . 0.0 110.258 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 748' ' ' GLU . . . . . 0.489 ' HG3' ' N ' ' A' ' 749' ' ' SER . 11.6 pt-20 -171.61 -35.64 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.12 -0.988 . . . . 0.0 110.373 -179.955 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 749' ' ' SER . . . . . 0.489 ' N ' ' HG3' ' A' ' 748' ' ' GLU . 89.1 p -170.98 54.21 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.134 -0.979 . . . . 0.0 110.257 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 750' ' ' TYR . . . . . . . . . . . . . 1.4 m-85 -121.52 177.23 5.3 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.207 -0.933 . . . . 0.0 110.291 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 751' ' ' GLY . . . . . . . . . . . . . . . 169.76 58.11 0.04 OUTLIER Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 -179.882 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 752' ' ' GLU . . . . . . . . . . . . . 19.0 tt0 -143.08 68.17 17.66 Favored Pre-proline 0 N--CA 1.493 1.683 0 O-C-N 121.218 -1.166 . . . . 0.0 110.186 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 753' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -77.95 72.46 6.15 Favored 'Trans proline' 0 C--N 1.305 -1.711 0 O-C-N 124.058 1.557 . . . . 0.0 110.544 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 754' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -60.9 -156.72 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.112 -0.993 . . . . 0.0 109.864 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 755' ' ' PHE . . . . . 0.484 ' CD1' ' N ' ' A' ' 756' ' ' HIS . 48.3 p90 -121.96 -154.27 0.59 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.989 -1.069 . . . . 0.0 110.942 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 756' ' ' HIS . . . . . 0.497 ' O ' ' O ' ' A' ' 757' ' ' THR . 5.1 t-80 -64.71 116.79 6.61 Favored 'General case' 0 N--CA 1.501 2.102 0 O-C-N 121.293 -0.879 . . . . 0.0 112.073 -179.825 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 757' ' ' THR . . . . . 0.497 ' O ' ' O ' ' A' ' 756' ' ' HIS . 0.8 OUTLIER 35.58 -162.02 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.134 0 CA-C-O 121.746 0.784 . . . . 0.0 111.573 179.866 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 758' ' ' ALA . . . . . . . . . . . . . . . -142.91 176.91 8.71 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.492 -0.755 . . . . 0.0 109.424 179.895 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 759' ' ' LYS . . . . . . . . . . . . . 8.3 mtpp -136.77 165.62 25.5 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.155 -0.966 . . . . 0.0 110.926 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 760' ' ' VAL . . . . . . . . . . . . . 46.8 t -108.38 146.65 13.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 179.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 761' ' ' HIS . . . . . . . . . . . . . 31.8 m80 -122.38 105.19 9.96 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.978 -1.076 . . . . 0.0 111.618 -179.879 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 762' ' ' LEU . . . . . 0.517 ' CB ' ' HB3' ' A' ' 812' ' ' CYS . 9.1 mt -118.14 131.21 56.43 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 179.823 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 763' ' ' LYS . . . . . . . . . . . . . 4.3 pttt -159.8 156.13 26.99 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.859 -1.151 . . . . 0.0 111.276 -179.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 764' ' ' CYS . . . . . . . . . . . . . 66.0 m -140.02 -178.14 5.32 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.577 -0.702 . . . . 0.0 109.755 179.88 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 765' ' ' ALA . . . . . . . . . . . . . . . -68.49 161.21 71.83 Favored Pre-proline 0 C--N 1.293 -1.883 0 O-C-N 121.233 -0.917 . . . . 0.0 110.895 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 766' ' ' PRO . . . . . 0.404 ' HA ' ' OE2' ' A' ' 810' ' ' GLU . 47.2 Cg_endo -72.53 83.68 1.27 Allowed 'Trans proline' 0 C--N 1.309 -1.528 0 O-C-N 124.174 1.618 . . . . 0.0 109.951 179.926 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 767' ' ' GLY . . . . . . . . . . . . . . . 150.42 -26.14 1.09 Allowed Glycine 0 N--CA 1.488 2.13 0 N-CA-C 108.293 -1.923 . . . . 0.0 108.293 -179.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 768' ' ' GLN . . . . . 0.502 ' HG2' HG21 ' A' ' 841' ' ' THR . 6.4 mt-30 -101.33 102.4 13.24 Favored 'General case' 0 N--CA 1.486 1.357 0 O-C-N 121.647 -0.914 . . . . 0.0 109.458 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 769' ' ' THR . . . . . . . . . . . . . 9.1 p -101.11 149.26 24.15 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.234 -0.916 . . . . 0.0 110.566 -179.857 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 770' ' ' ILE . . . . . 0.507 HG13 ' HB3' ' A' ' 839' ' ' CYS . 2.6 mp -63.06 148.16 11.47 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 O-C-N 121.287 -0.883 . . . . 0.0 109.97 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 771' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -137.49 -15.76 1.4 Allowed 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.1 -1.0 . . . . 0.0 111.847 -179.963 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 772' ' ' ALA . . . . . . . . . . . . . . . -144.3 136.59 26.49 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 120.698 -1.251 . . . . 0.0 111.689 -179.888 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 773' ' ' ILE . . . . . . . . . . . . . 23.1 mm -105.4 113.65 42.88 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 179.827 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 774' ' ' LYS . . . . . . . . . . . . . 27.6 ttpp -82.08 -44.96 15.88 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.077 -1.014 . . . . 0.0 111.072 -179.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 775' ' ' PHE . . . . . 0.506 ' CD2' ' HB3' ' A' ' 788' ' ' PHE . 73.2 t80 -138.88 163.53 32.06 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.013 -1.054 . . . . 0.0 111.194 -179.911 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 776' ' ' ALA . . . . . 0.475 ' CB ' ' O ' ' A' ' 798' ' ' SER . . . -179.68 93.63 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 109.392 -0.596 . . . . 0.0 109.392 179.989 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 777' ' ' SER . . . . . 0.451 ' HA ' ' CB ' ' A' ' 798' ' ' SER . 11.9 t -127.53 133.33 49.82 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.17 -0.956 . . . . 0.0 110.47 -179.871 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 778' ' ' PHE . . . . . 0.457 ' CD2' HG23 ' A' ' 833' ' ' VAL . 55.1 t80 -110.05 95.84 5.85 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.419 -0.8 . . . . 0.0 110.157 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 779' ' ' GLY . . . . . 0.476 ' HA2' ' HB2' ' A' ' 831' ' ' LYS . . . 163.12 -97.14 0.15 Allowed Glycine 0 N--CA 1.493 2.438 0 N-CA-C 109.655 -1.378 . . . . 0.0 109.655 -179.921 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 780' ' ' THR . . . . . 0.468 ' O ' ' HA3' ' A' ' 791' ' ' GLY . 6.3 p -132.52 89.23 36.73 Favored Pre-proline 0 N--CA 1.495 1.783 0 O-C-N 121.12 -1.223 . . . . 0.0 110.063 -179.954 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 781' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -76.36 169.21 22.39 Favored 'Trans proline' 0 C--N 1.303 -1.847 0 O-C-N 124.072 1.564 . . . . 0.0 110.607 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 782' ' ' LEU . . . . . 0.509 ' CD1' ' C ' ' A' ' 782' ' ' LEU . 1.9 tm? -131.11 115.11 15.98 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.25 -0.906 . . . . 0.0 110.209 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 783' ' ' GLY . . . . . . . . . . . . . . . 126.46 -173.92 18.03 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.827 -1.309 . . . . 0.0 109.827 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 784' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -119.08 -169.04 1.67 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.322 -1.105 . . . . 0.0 110.32 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 785' ' ' CYS . . . . . . . . . . . . . 3.6 t -65.1 90.66 0.09 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.369 -0.832 . . . . 0.0 110.309 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 786' ' ' GLY . . . . . . . . . . . . . . . 153.04 -22.53 0.78 Allowed Glycine 0 N--CA 1.489 2.202 0 N-CA-C 110.036 -1.226 . . . . 0.0 110.036 179.914 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 787' ' ' THR . . . . . 0.507 ' CG2' ' O ' ' A' ' 787' ' ' THR . 60.0 m -146.7 36.28 0.96 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.121 -1.223 . . . . 0.0 110.839 -179.965 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 788' ' ' PHE . . . . . 0.506 ' HB3' ' CD2' ' A' ' 775' ' ' PHE . 7.9 m-85 -54.06 112.44 0.96 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.028 -1.045 . . . . 0.0 109.769 179.995 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 789' ' ' GLN . . . . . . . . . . . . . 3.3 mt-30 -119.36 157.95 27.12 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.255 -0.903 . . . . 0.0 110.116 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 790' ' ' GLN . . . . . . . . . . . . . 16.7 mp0 -49.38 122.01 5.66 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.257 -0.902 . . . . 0.0 110.3 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 791' ' ' GLY . . . . . 0.468 ' HA3' ' O ' ' A' ' 780' ' ' THR . . . -81.05 -103.65 0.32 Allowed Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.404 -1.478 . . . . 0.0 109.404 179.938 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 792' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -130.17 -36.17 1.54 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.294 -1.121 . . . . 0.0 110.218 179.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 793' ' ' CYS . . . . . 0.429 ' HB2' ' OG1' ' A' ' 780' ' ' THR . 4.6 m -107.76 146.32 32.32 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.246 -0.909 . . . . 0.0 110.418 -179.975 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 794' ' ' HIS . . . . . 0.407 ' CE1' ' HG ' ' A' ' 798' ' ' SER . 4.4 t60 -149.06 143.92 26.36 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.372 -0.83 . . . . 0.0 110.172 179.901 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 795' ' ' SER . . . . . 0.533 ' O ' ' CG1' ' A' ' 796' ' ' ILE . 9.0 t -92.93 22.92 4.52 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.25 -0.906 . . . . 0.0 110.227 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 796' ' ' ILE . . . . . 0.533 ' CG1' ' O ' ' A' ' 795' ' ' SER . 36.8 pt 37.32 29.67 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.105 0 O-C-N 121.621 -0.675 . . . . 0.0 110.861 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 797' ' ' ASN . . . . . 0.488 ' N ' ' O ' ' A' ' 795' ' ' SER . 2.0 t-20 -157.66 19.32 0.27 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.085 -1.009 . . . . 0.0 110.269 179.946 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 798' ' ' SER . . . . . 0.475 ' O ' ' CB ' ' A' ' 776' ' ' ALA . 1.2 m -90.33 18.22 6.34 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.263 -0.898 . . . . 0.0 110.395 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 799' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -131.16 -16.88 3.11 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.073 -1.017 . . . . 0.0 111.327 -179.961 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 800' ' ' SER . . . . . . . . . . . . . 5.7 p -78.79 -53.08 7.48 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.0 -1.062 . . . . 0.0 110.544 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 801' ' ' VAL . . . . . 0.547 ' O ' ' CB ' ' A' ' 805' ' ' LYS . 55.1 t -58.63 -19.77 15.14 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.31 -0.869 . . . . 0.0 110.723 -179.948 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 802' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -81.84 -62.2 1.7 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.992 -1.067 . . . . 0.0 111.165 -179.899 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 803' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -56.54 -32.78 65.46 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.192 -0.943 . . . . 0.0 111.417 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 804' ' ' ARG . . . . . . . . . . . . . 62.6 mtm-85 -92.52 -18.88 22.58 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.045 -1.034 . . . . 0.0 111.84 -179.868 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 805' ' ' LYS . . . . . 0.547 ' CB ' ' O ' ' A' ' 801' ' ' VAL . 0.2 OUTLIER -116.83 43.0 2.35 Favored 'General case' 0 N--CA 1.501 2.095 0 O-C-N 120.815 -1.178 . . . . 0.0 111.061 -179.962 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 806' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -159.5 -55.15 0.06 Allowed 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.103 -0.998 . . . . 0.0 110.259 179.833 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 807' ' ' ILE . . . . . . . . . . . . . 61.5 mt -61.21 123.82 14.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.218 -0.926 . . . . 0.0 110.314 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 808' ' ' GLY . . . . . 0.423 ' C ' ' HG ' ' A' ' 809' ' ' LEU . . . 101.31 11.8 37.91 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.603 -1.399 . . . . 0.0 109.603 -179.941 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 809' ' ' LEU . . . . . 0.423 ' HG ' ' C ' ' A' ' 808' ' ' GLY . 59.5 mt -137.28 129.83 29.95 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.228 -1.16 . . . . 0.0 110.199 179.976 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 810' ' ' GLU . . . . . 0.404 ' OE2' ' HA ' ' A' ' 766' ' ' PRO . 24.1 tt0 -67.56 -19.73 65.31 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.325 -0.859 . . . . 0.0 110.188 179.995 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 811' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -133.65 128.7 35.63 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.386 -0.821 . . . . 0.0 110.211 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 812' ' ' CYS . . . . . 0.517 ' HB3' ' CB ' ' A' ' 762' ' ' LEU . 1.3 t -110.65 122.38 47.63 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.329 -0.857 . . . . 0.0 110.135 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 813' ' ' VAL . . . . . . . . . . . . . 25.2 t -130.45 118.62 43.65 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.14 -0.975 . . . . 0.0 110.153 -180.0 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 814' ' ' VAL . . . . . . . . . . . . . 91.6 t -134.67 120.01 30.54 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.286 -0.884 . . . . 0.0 110.156 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 815' ' ' ALA . . . . . . . . . . . . . . . -75.71 146.47 40.11 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.227 -0.921 . . . . 0.0 110.278 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 816' ' ' ILE . . . . . 0.489 HD12 ' HB ' ' A' ' 833' ' ' VAL . 84.6 mt -96.53 123.28 48.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.319 -0.863 . . . . 0.0 110.178 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 817' ' ' SER . . . . . 0.474 ' HB2' ' HD2' ' A' ' 818' ' ' PRO . 4.5 p -159.5 170.55 8.61 Favored Pre-proline 0 N--CA 1.494 1.766 0 O-C-N 121.009 -1.057 . . . . 0.0 110.561 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 818' ' ' PRO . . . . . 0.474 ' HD2' ' HB2' ' A' ' 817' ' ' SER . 47.0 Cg_endo -73.77 -2.08 11.7 Favored 'Trans proline' 0 C--N 1.308 -1.555 0 O-C-N 124.047 1.551 . . . . 0.0 110.606 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 819' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -134.65 59.91 1.72 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.206 -0.934 . . . . 0.0 110.229 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 820' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -132.48 -41.9 0.96 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.365 -0.834 . . . . 0.0 110.278 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 821' ' ' PHE . . . . . . . . . . . . . 79.8 m-85 -100.98 -68.79 0.8 Allowed 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.215 -0.928 . . . . 0.0 110.72 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 822' ' ' GLY . . . . . . . . . . . . . . . -149.05 20.76 1.24 Allowed Glycine 0 N--CA 1.492 2.422 0 C-N-CA 119.638 -1.268 . . . . 0.0 109.945 -179.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 823' ' ' GLY . . . . . 0.474 ' HA2' ' O ' ' A' ' 818' ' ' PRO . . . 102.94 -132.96 11.22 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.719 -1.352 . . . . 0.0 109.719 179.912 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 824' ' ' ASP . . . . . 0.452 ' OD1' ' HB3' ' A' ' 818' ' ' PRO . 2.2 m-20 -140.77 106.45 6.36 Favored Pre-proline 0 N--CA 1.493 1.724 0 O-C-N 121.289 -1.124 . . . . 0.0 110.246 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 825' ' ' PRO . . . . . 0.474 ' O ' ' HD3' ' A' ' 827' ' ' PRO . 44.9 Cg_endo -72.47 -88.44 0.0 OUTLIER 'Trans proline' 0 C--N 1.304 -1.774 0 O-C-N 124.085 1.571 . . . . 0.0 111.003 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 826' ' ' CYS . . . . . . . . . . . . . 97.1 m -80.6 112.18 29.29 Favored Pre-proline 0 N--CA 1.498 1.938 0 O-C-N 121.232 -0.918 . . . . 0.0 110.924 -179.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 827' ' ' PRO . . . . . 0.474 ' HD3' ' O ' ' A' ' 825' ' ' PRO . 49.7 Cg_endo -94.12 173.92 1.51 Allowed 'Trans proline' 0 C--N 1.308 -1.563 0 O-C-N 123.993 1.523 . . . . 0.0 110.251 179.956 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 828' ' ' GLU . . . . . 0.419 ' O ' HG23 ' A' ' 829' ' ' VAL . 14.4 mt-10 52.33 31.11 8.94 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.358 -0.839 . . . . 0.0 110.826 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 829' ' ' VAL . . . . . 0.494 ' O ' ' N ' ' A' ' 831' ' ' LYS . 97.9 t -137.02 113.73 12.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.013 -1.055 . . . . 0.0 110.469 -179.944 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 830' ' ' MET . . . . . 0.434 ' C ' ' O ' ' A' ' 829' ' ' VAL . 2.2 mtt -42.52 95.86 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.333 -0.854 . . . . 0.0 109.989 179.937 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 831' ' ' LYS . . . . . 0.494 ' N ' ' O ' ' A' ' 829' ' ' VAL . 1.9 pttp -109.63 139.49 44.59 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.206 -0.934 . . . . 0.0 110.925 -179.908 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 832' ' ' ARG . . . . . . . . . . . . . 10.4 ptt180 -128.45 166.57 18.5 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.416 -0.802 . . . . 0.0 109.277 179.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 833' ' ' VAL . . . . . 0.489 ' HB ' HD12 ' A' ' 816' ' ' ILE . 54.7 t -107.61 128.67 62.59 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.109 -0.994 . . . . 0.0 110.831 -179.913 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 834' ' ' ALA . . . . . . . . . . . . . . . -128.57 132.45 48.22 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 179.891 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 835' ' ' VAL . . . . . . . . . . . . . 53.2 t -141.25 150.9 19.76 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 O-C-N 120.819 -1.176 . . . . 0.0 111.538 -179.893 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 836' ' ' GLU . . . . . . . . . . . . . 4.0 tp10 -131.53 108.71 9.75 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 179.9 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 837' ' ' ALA . . . . . . . . . . . . . . . -107.87 158.87 16.97 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.037 -1.039 . . . . 0.0 110.264 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 838' ' ' VAL . . . . . . . . . . . . . 37.6 t -122.19 103.07 12.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.285 -0.884 . . . . 0.0 110.418 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 839' ' ' CYS . . . . . 0.507 ' HB3' HG13 ' A' ' 770' ' ' ILE . 3.1 p -120.19 132.29 55.31 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.4 -0.812 . . . . 0.0 109.401 179.931 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 840' ' ' SER . . . . . 0.483 ' O ' ' HA ' ' A' ' 768' ' ' GLN . 16.7 p -149.66 -168.45 3.11 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.065 -1.022 . . . . 0.0 110.881 -179.919 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 841' ' ' THR . . . . . 0.502 HG21 ' HG2' ' A' ' 768' ' ' GLN . 22.7 p -76.67 130.65 38.07 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.435 -0.791 . . . . 0.0 110.767 -179.91 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 842' ' ' ALA . . . . . 0.415 ' C ' ' O ' ' A' ' 841' ' ' THR . . . 41.92 75.76 0.08 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.389 -0.819 . . . . 0.0 110.36 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 843' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.667 0 CA-C-O 117.958 -1.02 . . . . 0.0 110.171 -179.996 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 726' ' ' ARG . . . . . . . . . . . . . 6.3 ttm180 . . . . . 0 N--CA 1.492 1.653 0 CA-C-O 121.213 0.53 . . . . 0.0 110.275 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 727' ' ' THR . . . . . 0.444 ' O ' HG13 ' A' ' 728' ' ' VAL . 2.5 m -79.21 123.26 27.24 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.249 -0.907 . . . . 0.0 110.199 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 728' ' ' VAL . . . . . 0.444 HG13 ' O ' ' A' ' 727' ' ' THR . 15.5 m -147.35 172.18 2.84 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.523 0 O-C-N 121.318 -0.864 . . . . 0.0 110.08 179.935 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 729' ' ' SER . . . . . . . . . . . . . 1.5 t -173.87 168.09 4.29 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.295 -0.878 . . . . 0.0 110.278 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 730' ' ' GLY . . . . . . . . . . . . . . . -138.1 130.11 4.86 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.404 -1.478 . . . . 0.0 109.404 179.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 731' ' ' VAL . . . . . 0.458 ' O ' HG23 ' A' ' 731' ' ' VAL . 13.6 m -110.82 124.93 68.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.237 -1.155 . . . . 0.0 110.339 -179.956 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 732' ' ' CYS . . . . . . . . . . . . . 5.1 t -109.46 112.46 24.58 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.343 -0.848 . . . . 0.0 109.582 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 733' ' ' ALA . . . . . . . . . . . . . . . -114.2 142.01 46.8 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.236 -0.915 . . . . 0.0 110.974 -179.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 734' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -155.54 118.58 4.31 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.465 -0.772 . . . . 0.0 109.483 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 735' ' ' VAL . . . . . . . . . . . . . 65.5 t -128.55 150.39 34.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.121 -0.987 . . . . 0.0 110.789 -179.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 736' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -99.88 139.73 35.13 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.323 -0.861 . . . . 0.0 109.614 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 737' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -64.29 139.91 58.81 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.082 -1.011 . . . . 0.0 110.668 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 738' ' ' TYR . . . . . 0.549 ' CD1' ' C ' ' A' ' 738' ' ' TYR . 8.4 p90 -164.22 154.81 15.09 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.267 -0.896 . . . . 0.0 110.267 179.973 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 739' ' ' HIS . . . . . 0.573 ' CE1' ' HB3' ' A' ' 741' ' ' ASN . 0.6 OUTLIER -97.55 168.28 10.4 Favored Pre-proline 0 N--CA 1.496 1.864 0 O-C-N 121.282 -0.886 . . . . 0.0 110.404 179.997 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 740' ' ' PRO . . . . . 0.465 ' HD3' ' HA ' ' A' ' 756' ' ' HIS . 49.2 Cg_endo -82.06 17.95 1.47 Allowed 'Trans proline' 0 C--N 1.309 -1.544 0 O-C-N 123.947 1.499 . . . . 0.0 110.997 -179.956 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 741' ' ' ASN . . . . . 0.573 ' HB3' ' CE1' ' A' ' 739' ' ' HIS . 1.5 t-20 -77.1 108.56 10.27 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.115 -0.991 . . . . 0.0 110.112 179.899 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 742' ' ' ILE . . . . . 0.435 HD12 ' O ' ' A' ' 740' ' ' PRO . 2.1 mp -138.39 162.18 30.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.229 -0.92 . . . . 0.0 110.147 -179.984 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 743' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.41 -42.26 6.04 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.204 -0.935 . . . . 0.0 110.712 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 744' ' ' ASN . . . . . . . . . . . . . 13.3 m-80 -60.29 -12.73 9.78 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.034 -1.041 . . . . 0.0 110.088 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 745' ' ' TRP . . . . . . . . . . . . . 26.2 t90 -73.7 97.55 2.71 Favored 'General case' 0 C--N 1.299 -1.627 0 O-C-N 121.439 -0.788 . . . . 0.0 110.079 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 746' ' ' GLN . . . . . 0.536 ' O ' ' CG2' ' A' ' 747' ' ' ILE . 2.1 mm-40 -130.37 45.36 2.82 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.236 -0.915 . . . . 0.0 110.442 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 747' ' ' ILE . . . . . 0.536 ' CG2' ' O ' ' A' ' 746' ' ' GLN . 1.2 tp 36.93 46.61 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.129 0 O-C-N 121.647 -0.658 . . . . 0.0 110.79 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 748' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -106.8 -41.37 5.24 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.182 -0.949 . . . . 0.0 110.221 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 749' ' ' SER . . . . . . . . . . . . . 20.7 p -168.06 26.55 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.251 -0.906 . . . . 0.0 110.094 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 750' ' ' TYR . . . . . . . . . . . . . 22.5 m-85 -107.83 -73.73 0.68 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.299 -0.876 . . . . 0.0 110.318 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 751' ' ' GLY . . . . . . . . . . . . . . . 153.95 -135.55 4.83 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.6 -1.4 . . . . 0.0 109.6 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 752' ' ' GLU . . . . . . . . . . . . . 16.1 tt0 -176.68 100.36 0.24 Allowed Pre-proline 0 N--CA 1.494 1.728 0 O-C-N 121.279 -1.13 . . . . 0.0 110.19 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 753' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -73.24 157.65 49.82 Favored 'Trans proline' 0 C--N 1.305 -1.756 0 O-C-N 124.035 1.545 . . . . 0.0 110.42 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 754' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -127.89 61.23 1.43 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.223 -0.923 . . . . 0.0 110.255 179.988 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 755' ' ' PHE . . . . . 0.434 ' O ' ' HG3' ' A' ' 740' ' ' PRO . 0.5 OUTLIER -164.43 -165.59 0.98 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.263 -0.898 . . . . 0.0 110.18 179.987 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 756' ' ' HIS . . . . . 0.465 ' HA ' ' HD3' ' A' ' 740' ' ' PRO . 1.8 t60 -149.74 27.21 0.81 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.287 -0.883 . . . . 0.0 110.194 179.997 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 757' ' ' THR . . . . . 0.402 HG23 ' C ' ' A' ' 756' ' ' HIS . 25.5 p -141.73 175.02 10.03 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.222 -0.924 . . . . 0.0 110.332 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 758' ' ' ALA . . . . . . . . . . . . . . . -98.79 176.83 5.48 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.294 -0.879 . . . . 0.0 110.224 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 759' ' ' LYS . . . . . . . . . . . . . 13.4 mtmm -141.09 144.58 35.0 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.261 -0.899 . . . . 0.0 110.44 -179.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 760' ' ' VAL . . . . . . . . . . . . . 38.5 t -106.14 133.99 49.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.333 -0.854 . . . . 0.0 108.767 179.881 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 761' ' ' HIS . . . . . 0.639 ' CE1' ' CG2' ' A' ' 813' ' ' VAL . 0.3 OUTLIER -120.47 123.12 42.19 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 120.907 -1.121 . . . . 0.0 111.893 -179.87 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 762' ' ' LEU . . . . . . . . . . . . . 12.5 mt -120.45 98.61 6.12 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 179.77 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 763' ' ' LYS . . . . . 0.519 ' CB ' ' HG2' ' A' ' 811' ' ' ARG . 0.2 OUTLIER -114.48 137.51 51.76 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.005 -1.059 . . . . 0.0 111.515 -179.8 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 764' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER -118.3 161.96 19.07 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.679 -0.638 . . . . 0.0 109.555 179.901 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 765' ' ' ALA . . . . . 0.454 ' HB3' ' HD2' ' A' ' 766' ' ' PRO . . . -50.62 167.73 0.25 Allowed Pre-proline 0 N--CA 1.495 1.775 0 O-C-N 120.978 -1.076 . . . . 0.0 110.133 -179.959 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 766' ' ' PRO . . . . . 0.454 ' HD2' ' HB3' ' A' ' 765' ' ' ALA . 45.5 Cg_endo -72.22 124.34 9.91 Favored 'Trans proline' 0 C--N 1.305 -1.734 0 O-C-N 123.972 1.512 . . . . 0.0 110.155 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 767' ' ' GLY . . . . . . . . . . . . . . . 109.67 -36.37 4.35 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.223 -1.551 . . . . 0.0 109.223 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 768' ' ' GLN . . . . . . . . . . . . . 28.8 mt-30 -87.89 115.27 25.23 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.281 -1.129 . . . . 0.0 109.894 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 769' ' ' THR . . . . . . . . . . . . . 29.4 p -109.28 167.64 9.97 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.215 -0.928 . . . . 0.0 110.292 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 770' ' ' ILE . . . . . . . . . . . . . 7.8 mt -85.61 101.25 9.75 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 121.236 -0.915 . . . . 0.0 109.807 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 771' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -89.55 -6.9 55.91 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.162 -0.961 . . . . 0.0 110.818 -179.923 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 772' ' ' ALA . . . . . 0.456 ' O ' ' HB ' ' A' ' 838' ' ' VAL . . . -165.84 142.46 5.28 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.008 -1.058 . . . . 0.0 111.278 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 773' ' ' ILE . . . . . . . . . . . . . 47.3 mm -94.61 125.87 47.15 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 O-C-N 121.392 -0.817 . . . . 0.0 109.134 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 774' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -80.17 -37.94 32.33 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.085 -1.01 . . . . 0.0 111.244 -179.895 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 775' ' ' PHE . . . . . 0.522 ' CE2' ' HB3' ' A' ' 788' ' ' PHE . 65.0 t80 -150.96 170.18 19.96 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.82 -1.175 . . . . 0.0 111.124 -179.984 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 776' ' ' ALA . . . . . 0.49 ' N ' ' CD2' ' A' ' 775' ' ' PHE . . . 170.82 116.4 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.703 -0.623 . . . . 0.0 109.346 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 777' ' ' SER . . . . . . . . . . . . . 14.5 t -151.69 131.77 13.49 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.114 -0.991 . . . . 0.0 110.724 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 778' ' ' PHE . . . . . . . . . . . . . 2.4 t80 -99.3 124.98 44.84 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.56 -0.713 . . . . 0.0 109.756 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 779' ' ' GLY . . . . . . . . . . . . . . . 130.3 -110.5 1.03 Allowed Glycine 0 N--CA 1.493 2.482 0 N-CA-C 109.85 -1.3 . . . . 0.0 109.85 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 780' ' ' THR . . . . . . . . . . . . . 11.8 p -135.37 83.57 37.49 Favored Pre-proline 0 N--CA 1.496 1.841 0 O-C-N 121.16 -1.2 . . . . 0.0 110.636 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 781' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -76.92 158.23 34.65 Favored 'Trans proline' 0 C--N 1.307 -1.639 0 O-C-N 123.856 1.45 . . . . 0.0 110.087 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 782' ' ' LEU . . . . . 0.436 ' O ' ' HA ' ' A' ' 788' ' ' PHE . 0.3 OUTLIER -96.24 123.86 40.03 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.158 -0.964 . . . . 0.0 110.241 179.958 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 783' ' ' GLY . . . . . . . . . . . . . . . 138.37 -169.33 24.33 Favored Glycine 0 N--CA 1.492 2.404 0 N-CA-C 109.688 -1.365 . . . . 0.0 109.688 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 784' ' ' THR . . . . . . . . . . . . . 3.3 m -138.31 -52.17 0.6 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.281 -1.129 . . . . 0.0 109.961 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 785' ' ' CYS . . . . . 0.556 ' HA ' ' CZ ' ' A' ' 788' ' ' PHE . 40.3 t -166.95 74.51 0.15 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.281 -0.887 . . . . 0.0 109.793 179.948 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 786' ' ' GLY . . . . . . . . . . . . . . . 130.68 -16.07 5.39 Favored Glycine 0 N--CA 1.489 2.171 0 N-CA-C 108.949 -1.66 . . . . 0.0 108.949 -179.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 787' ' ' THR . . . . . 0.464 ' O ' HG21 ' A' ' 787' ' ' THR . 18.2 m -121.78 27.36 8.19 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.477 -1.014 . . . . 0.0 109.878 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 788' ' ' PHE . . . . . 0.556 ' CZ ' ' HA ' ' A' ' 785' ' ' CYS . 35.4 m-85 -55.14 172.71 0.12 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.342 -0.849 . . . . 0.0 110.349 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 789' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER 179.23 172.48 0.86 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.362 -0.836 . . . . 0.0 109.93 -179.982 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 790' ' ' GLN . . . . . . . . . . . . . 6.2 tm0? -57.12 161.42 3.14 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.124 -0.985 . . . . 0.0 110.305 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 791' ' ' GLY . . . . . . . . . . . . . . . -136.89 -131.88 3.02 Favored Glycine 0 N--CA 1.494 2.507 0 N-CA-C 109.687 -1.365 . . . . 0.0 109.687 -179.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 792' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -107.76 -66.32 1.04 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.216 -1.167 . . . . 0.0 109.964 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 793' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -92.54 88.66 6.42 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.266 -0.896 . . . . 0.0 109.891 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 794' ' ' HIS . . . . . 0.438 ' HE1' ' CB ' ' A' ' 798' ' ' SER . 19.2 t60 -105.54 155.49 19.14 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.174 -0.954 . . . . 0.0 110.674 -179.921 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 795' ' ' SER . . . . . 0.476 ' HB2' ' HB3' ' A' ' 825' ' ' PRO . 1.3 t -115.63 111.21 20.3 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.466 -0.771 . . . . 0.0 109.942 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 796' ' ' ILE . . . . . . . . . . . . . 3.5 pt -44.3 -23.05 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 O-C-N 121.315 -0.866 . . . . 0.0 110.816 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 797' ' ' ASN . . . . . 0.409 ' N ' ' O ' ' A' ' 795' ' ' SER . 1.6 t30 -84.19 26.93 0.71 Allowed 'General case' 0 N--CA 1.499 1.991 0 O-C-N 120.988 -1.07 . . . . 0.0 111.005 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 798' ' ' SER . . . . . 0.47 ' HB3' ' O ' ' A' ' 776' ' ' ALA . 9.0 m -82.13 -31.57 30.53 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.0 -1.063 . . . . 0.0 111.11 179.942 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 799' ' ' ASN . . . . . . . . . . . . . 4.8 m120 -107.36 8.08 29.47 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.017 -1.052 . . . . 0.0 111.288 -179.893 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 800' ' ' SER . . . . . 0.422 ' O ' ' HB3' ' A' ' 804' ' ' ARG . 0.7 OUTLIER -90.33 -40.68 11.97 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.953 -1.092 . . . . 0.0 110.245 179.967 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 801' ' ' VAL . . . . . 0.562 HG23 ' CD2' ' A' ' 821' ' ' PHE . 55.5 t -74.65 -35.5 37.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.256 -0.902 . . . . 0.0 110.104 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 802' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -69.31 -57.09 5.76 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.207 -0.933 . . . . 0.0 110.051 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 803' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -62.93 -18.29 62.94 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.235 -0.916 . . . . 0.0 110.011 179.943 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 804' ' ' ARG . . . . . 0.422 ' HB3' ' O ' ' A' ' 800' ' ' SER . 12.4 ttp180 -89.55 -20.42 23.81 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.265 -0.897 . . . . 0.0 111.07 -179.968 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 805' ' ' LYS . . . . . . . . . . . . . 9.2 ttmt -141.06 53.14 1.57 Allowed 'General case' 0 N--CA 1.495 1.818 0 O-C-N 120.878 -1.139 . . . . 0.0 110.873 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 806' ' ' CYS . . . . . . . . . . . . . 1.4 t -158.94 -36.18 0.06 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.128 -0.983 . . . . 0.0 110.317 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 807' ' ' ILE . . . . . . . . . . . . . 9.5 mt -71.12 130.76 34.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.22 -0.925 . . . . 0.0 110.058 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 808' ' ' GLY . . . . . . . . . . . . . . . 91.8 16.03 52.85 Favored Glycine 0 N--CA 1.492 2.407 0 N-CA-C 109.776 -1.329 . . . . 0.0 109.776 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 809' ' ' LEU . . . . . . . . . . . . . 58.4 mt -129.22 138.97 52.01 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.188 -1.184 . . . . 0.0 110.411 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 810' ' ' GLU . . . . . 0.425 ' OE1' ' HA ' ' A' ' 766' ' ' PRO . 43.1 tt0 -69.14 -32.2 71.39 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.333 -0.854 . . . . 0.0 109.468 179.857 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 811' ' ' ARG . . . . . 0.519 ' HG2' ' CB ' ' A' ' 763' ' ' LYS . 3.3 mtm-85 -131.63 156.34 45.99 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.46 -0.775 . . . . 0.0 109.587 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 812' ' ' CYS . . . . . 0.467 ' O ' HG21 ' A' ' 813' ' ' VAL . 0.5 OUTLIER -133.03 142.4 48.78 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.13 -0.981 . . . . 0.0 110.825 -179.976 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 813' ' ' VAL . . . . . 0.639 ' CG2' ' CE1' ' A' ' 761' ' ' HIS . 51.2 t -140.45 115.51 6.9 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.337 -0.852 . . . . 0.0 109.841 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 814' ' ' VAL . . . . . . . . . . . . . 52.4 t -128.89 121.76 55.24 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 O-C-N 121.253 -0.904 . . . . 0.0 110.464 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 815' ' ' ALA . . . . . . . . . . . . . . . -80.41 142.57 34.22 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.212 -0.93 . . . . 0.0 109.918 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 816' ' ' ILE . . . . . 0.503 ' CG2' HG22 ' A' ' 833' ' ' VAL . 14.1 mt -88.03 112.65 23.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.212 -0.93 . . . . 0.0 110.376 -179.955 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 817' ' ' SER . . . . . 0.458 ' OG ' ' OD1' ' A' ' 820' ' ' ASN . 78.7 p -168.34 163.39 8.57 Favored Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 121.448 -0.782 . . . . 0.0 109.993 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 818' ' ' PRO . . . . . 0.442 ' HB3' ' OD1' ' A' ' 824' ' ' ASP . 44.4 Cg_endo -72.37 -19.38 25.4 Favored 'Trans proline' 0 C--N 1.305 -1.747 0 O-C-N 124.021 1.537 . . . . 0.0 110.372 -179.979 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 819' ' ' SER . . . . . . . . . . . . . 9.1 m -94.97 48.13 1.17 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.187 -0.945 . . . . 0.0 110.017 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 820' ' ' ASN . . . . . 0.458 ' OD1' ' OG ' ' A' ' 817' ' ' SER . 1.2 m120 -139.75 -53.8 0.54 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.266 -0.897 . . . . 0.0 110.195 -179.955 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 821' ' ' PHE . . . . . 0.562 ' CD2' HG23 ' A' ' 801' ' ' VAL . 87.6 m-85 -79.54 -33.05 42.26 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.345 -0.847 . . . . 0.0 110.316 -179.958 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 822' ' ' GLY . . . . . . . . . . . . . . . 128.09 66.93 0.13 Allowed Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.656 -1.378 . . . . 0.0 109.656 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 823' ' ' GLY . . . . . . . . . . . . . . . 98.86 -175.57 28.89 Favored Glycine 0 N--CA 1.492 2.411 0 N-CA-C 109.716 -1.354 . . . . 0.0 109.716 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 824' ' ' ASP . . . . . 0.442 ' OD1' ' HB3' ' A' ' 818' ' ' PRO . 0.2 OUTLIER -102.18 133.15 20.79 Favored Pre-proline 0 N--CA 1.493 1.692 0 O-C-N 121.24 -1.153 . . . . 0.0 110.115 179.919 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 825' ' ' PRO . . . . . 0.476 ' HB3' ' HB2' ' A' ' 795' ' ' SER . 51.7 Cg_endo -75.07 -89.7 0.01 OUTLIER 'Trans proline' 0 C--N 1.307 -1.637 0 O-C-N 123.964 1.508 . . . . 0.0 110.477 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 826' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -113.41 103.1 55.48 Favored Pre-proline 0 N--CA 1.492 1.645 0 O-C-N 121.136 -0.978 . . . . 0.0 110.177 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 827' ' ' PRO . . . . . 0.408 ' O ' ' HB3' ' A' ' 828' ' ' GLU . 45.3 Cg_endo -74.08 165.4 32.09 Favored 'Trans proline' 0 C--N 1.304 -1.808 0 O-C-N 123.994 1.523 . . . . 0.0 110.655 179.933 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 828' ' ' GLU . . . . . 0.425 ' HG2' ' O ' ' A' ' 828' ' ' GLU . 1.6 tt0 55.78 44.7 25.71 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.304 -0.873 . . . . 0.0 110.578 179.959 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 829' ' ' VAL . . . . . 0.408 ' O ' ' C ' ' A' ' 830' ' ' MET . 25.4 t -141.33 151.57 19.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.222 -0.924 . . . . 0.0 110.122 179.92 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 830' ' ' MET . . . . . 0.408 ' C ' ' O ' ' A' ' 829' ' ' VAL . 0.0 OUTLIER -43.15 121.34 2.12 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.301 -0.874 . . . . 0.0 109.944 -179.986 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 831' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.71 86.64 7.31 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.287 -0.883 . . . . 0.0 110.595 -179.953 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 832' ' ' ARG . . . . . . . . . . . . . 6.8 mpt_? -129.58 125.89 37.24 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.408 -0.808 . . . . 0.0 109.421 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 833' ' ' VAL . . . . . 0.503 HG22 ' CG2' ' A' ' 816' ' ' ILE . 54.7 t -109.73 140.59 27.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.098 -1.001 . . . . 0.0 110.829 -179.887 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 834' ' ' ALA . . . . . 0.452 ' O ' ' CG2' ' A' ' 835' ' ' VAL . . . -141.26 138.16 33.03 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.398 -0.814 . . . . 0.0 109.68 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 835' ' ' VAL . . . . . 0.452 ' CG2' ' O ' ' A' ' 834' ' ' ALA . 35.3 t -156.0 127.99 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 O-C-N 121.036 -1.04 . . . . 0.0 111.187 -179.93 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 836' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -114.25 128.67 56.47 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.439 -0.788 . . . . 0.0 109.248 179.884 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 837' ' ' ALA . . . . . . . . . . . . . . . -110.98 157.89 19.39 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.075 -1.016 . . . . 0.0 110.914 -179.853 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 838' ' ' VAL . . . . . 0.456 ' HB ' ' O ' ' A' ' 772' ' ' ALA . 98.9 t -109.28 132.39 57.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.477 -0.765 . . . . 0.0 109.662 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 839' ' ' CYS . . . . . . . . . . . . . 1.3 m -115.8 134.64 54.8 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.071 -1.018 . . . . 0.0 110.721 -179.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 840' ' ' SER . . . . . . . . . . . . . 4.5 t -139.95 -133.84 0.11 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.44 -0.787 . . . . 0.0 109.743 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 841' ' ' THR . . . . . . . . . . . . . 30.4 p -121.99 166.59 14.24 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.89 -1.131 . . . . 0.0 110.213 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 842' ' ' ALA . . . . . . . . . . . . . . . -121.65 138.19 54.44 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.252 -0.905 . . . . 0.0 109.977 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 843' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.624 0 CA-C-O 118.07 -0.967 . . . . 0.0 110.256 -179.949 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 726' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.644 0 CA-C-O 121.213 0.53 . . . . 0.0 110.281 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 727' ' ' THR . . . . . 0.508 HG21 ' CG2' ' A' ' 841' ' ' THR . 2.0 t -122.07 75.56 1.23 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.229 -0.919 . . . . 0.0 110.289 -179.982 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 728' ' ' VAL . . . . . . . . . . . . . 56.4 t -123.29 96.84 4.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.311 -0.868 . . . . 0.0 110.039 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 729' ' ' SER . . . . . . . . . . . . . 1.3 t -84.68 -149.36 0.11 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.22 -0.925 . . . . 0.0 110.482 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 730' ' ' GLY . . . . . . . . . . . . . . . 170.58 131.7 1.37 Allowed Glycine 0 N--CA 1.489 2.175 0 N-CA-C 109.216 -1.554 . . . . 0.0 109.216 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 731' ' ' VAL . . . . . . . . . . . . . 7.0 t -120.14 141.25 41.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.174 -1.192 . . . . 0.0 110.411 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 732' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -109.64 163.86 13.08 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.354 -0.841 . . . . 0.0 109.864 -179.977 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 733' ' ' ALA . . . . . . . . . . . . . . . -155.37 104.48 2.4 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.146 -0.971 . . . . 0.0 110.656 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 734' ' ' ASP . . . . . . . . . . . . . 35.3 t0 -117.7 103.69 10.26 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.376 -0.828 . . . . 0.0 109.455 179.88 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 735' ' ' VAL . . . . . 0.467 HG13 ' N ' ' A' ' 736' ' ' SER . 68.4 t -129.86 154.02 39.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.209 -0.932 . . . . 0.0 110.482 -179.895 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 736' ' ' SER . . . . . 0.467 ' N ' HG13 ' A' ' 735' ' ' VAL . 57.8 m -66.26 -173.29 0.19 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.316 -0.865 . . . . 0.0 110.474 -179.957 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 737' ' ' GLU . . . . . 0.533 ' HG3' ' N ' ' A' ' 738' ' ' TYR . 28.8 tp10 -105.89 166.84 10.2 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.373 -0.83 . . . . 0.0 110.18 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 738' ' ' TYR . . . . . 0.533 ' N ' ' HG3' ' A' ' 737' ' ' GLU . 0.0 OUTLIER -65.33 165.53 11.59 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.224 -0.922 . . . . 0.0 109.133 -179.996 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 739' ' ' HIS . . . . . 0.586 ' CD2' ' O ' ' A' ' 739' ' ' HIS . 0.4 OUTLIER -164.74 148.1 7.47 Favored Pre-proline 0 C--N 1.301 -1.521 0 O-C-N 121.114 -0.991 . . . . 0.0 110.794 -179.878 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 740' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_endo -84.65 14.06 2.57 Favored 'Trans proline' 0 C--N 1.304 -1.791 0 O-C-N 124.105 1.581 . . . . 0.0 109.891 179.864 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 741' ' ' ASN . . . . . 0.445 ' HB2' ' ND1' ' A' ' 739' ' ' HIS . 1.5 m120 -79.19 75.42 5.73 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.343 -0.848 . . . . 0.0 110.467 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 742' ' ' ILE . . . . . 0.435 HG13 ' C ' ' A' ' 741' ' ' ASN . 24.9 mt -149.98 96.18 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.333 -0.854 . . . . 0.0 109.772 179.9 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 743' ' ' LYS . . . . . 0.409 ' O ' ' HB3' ' A' ' 744' ' ' ASN . 0.0 OUTLIER -113.01 159.17 19.41 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.174 -0.954 . . . . 0.0 110.652 -179.859 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 744' ' ' ASN . . . . . 0.409 ' HB3' ' O ' ' A' ' 743' ' ' LYS . 26.8 t-20 63.05 39.86 9.69 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.368 -0.832 . . . . 0.0 110.65 179.921 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 745' ' ' TRP . . . . . 0.449 ' O ' ' O ' ' A' ' 746' ' ' GLN . 22.0 p90 -88.73 -18.89 26.87 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.163 -0.96 . . . . 0.0 109.862 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 746' ' ' GLN . . . . . 0.449 ' O ' ' O ' ' A' ' 745' ' ' TRP . 0.0 OUTLIER 60.0 139.48 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.341 -0.849 . . . . 0.0 110.631 179.916 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 747' ' ' ILE . . . . . 0.456 ' O ' HG13 ' A' ' 747' ' ' ILE . 9.9 tp -101.95 22.03 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.306 -0.871 . . . . 0.0 109.884 179.948 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 748' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -116.22 -41.54 3.13 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.491 -0.755 . . . . 0.0 109.787 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 749' ' ' SER . . . . . 0.444 ' OG ' ' O ' ' A' ' 749' ' ' SER . 0.1 OUTLIER -125.68 92.59 3.64 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.438 -0.789 . . . . 0.0 109.853 179.954 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 750' ' ' TYR . . . . . 0.407 ' C ' ' O ' ' A' ' 749' ' ' SER . 55.6 m-85 -41.16 101.62 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.352 -0.842 . . . . 0.0 110.269 -179.991 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 751' ' ' GLY . . . . . . . . . . . . . . . -131.11 -174.72 13.75 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.48 -1.448 . . . . 0.0 109.48 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 752' ' ' GLU . . . . . 0.459 ' HB3' ' HD2' ' A' ' 753' ' ' PRO . 1.1 mt-10 54.62 176.08 0.03 OUTLIER Pre-proline 0 N--CA 1.493 1.675 0 O-C-N 121.169 -1.195 . . . . 0.0 109.966 -179.942 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 753' ' ' PRO . . . . . 0.459 ' HD2' ' HB3' ' A' ' 752' ' ' GLU . 45.1 Cg_endo -70.95 103.72 1.4 Allowed 'Trans proline' 0 C--N 1.306 -1.668 0 O-C-N 123.942 1.496 . . . . 0.0 110.516 179.936 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 754' ' ' GLU . . . . . . . . . . . . . 2.5 tm-20 -151.13 82.27 1.32 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.289 -0.882 . . . . 0.0 110.139 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 755' ' ' PHE . . . . . 0.52 ' CD2' ' O ' ' A' ' 757' ' ' THR . 9.2 p90 -117.46 25.4 10.46 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.233 -0.917 . . . . 0.0 110.034 179.972 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 756' ' ' HIS . . . . . 0.476 ' HB2' ' O ' ' A' ' 755' ' ' PHE . 11.1 m170 59.8 105.58 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.407 -0.808 . . . . 0.0 110.987 179.923 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 757' ' ' THR . . . . . 0.52 ' O ' ' CD2' ' A' ' 755' ' ' PHE . 0.0 OUTLIER 45.29 -176.49 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.044 0 O-C-N 121.495 -0.753 . . . . 0.0 111.258 179.938 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 758' ' ' ALA . . . . . . . . . . . . . . . -91.45 174.99 7.08 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.437 -0.789 . . . . 0.0 110.333 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 759' ' ' LYS . . . . . . . . . . . . . 10.2 mttt -147.86 145.75 28.82 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.242 -0.912 . . . . 0.0 110.525 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 760' ' ' VAL . . . . . 0.445 HG21 HG13 ' A' ' 833' ' ' VAL . 97.9 t -136.97 131.13 46.2 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 O-C-N 121.471 -0.768 . . . . 0.0 109.493 179.932 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 761' ' ' HIS . . . . . 0.489 ' CB ' HG22 ' A' ' 813' ' ' VAL . 25.4 p-80 -142.69 135.18 27.77 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 120.936 -1.103 . . . . 0.0 111.002 -179.974 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 762' ' ' LEU . . . . . . . . . . . . . 3.3 mp -115.17 148.06 39.52 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.437 -0.789 . . . . 0.0 109.494 179.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 763' ' ' LYS . . . . . 0.426 ' O ' ' CG ' ' A' ' 763' ' ' LYS . 0.0 OUTLIER -133.61 105.04 6.64 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.04 -1.038 . . . . 0.0 110.616 -179.896 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 764' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -84.09 176.59 8.71 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.18 -0.95 . . . . 0.0 110.013 179.943 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 765' ' ' ALA . . . . . . . . . . . . . . . -69.6 160.55 79.14 Favored Pre-proline 0 N--CA 1.492 1.625 0 O-C-N 121.243 -0.91 . . . . 0.0 109.975 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 766' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -71.35 132.01 20.04 Favored 'Trans proline' 0 C--N 1.303 -1.847 0 O-C-N 124.053 1.554 . . . . 0.0 110.525 -179.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 767' ' ' GLY . . . . . . . . . . . . . . . 108.57 -44.95 1.39 Allowed Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 179.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 768' ' ' GLN . . . . . . . . . . . . . 2.4 mp0 -85.62 119.35 25.86 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.182 -1.187 . . . . 0.0 110.053 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 769' ' ' THR . . . . . . . . . . . . . 68.4 p -102.59 146.79 27.64 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.265 -0.897 . . . . 0.0 110.463 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 770' ' ' ILE . . . . . . . . . . . . . 48.3 mt -70.23 123.82 24.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.335 -0.853 . . . . 0.0 109.728 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 771' ' ' SER . . . . . . . . . . . . . 6.7 t -119.61 -12.83 9.23 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.148 -0.97 . . . . 0.0 110.696 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 772' ' ' ALA . . . . . 0.403 ' O ' ' HB ' ' A' ' 838' ' ' VAL . . . -148.78 130.35 14.91 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.022 -1.049 . . . . 0.0 110.735 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 773' ' ' ILE . . . . . 0.488 HG13 ' HG2' ' A' ' 803' ' ' GLU . 46.8 mm -84.33 129.87 36.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.241 -0.912 . . . . 0.0 109.715 179.949 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 774' ' ' LYS . . . . . 0.504 ' HB3' ' HB3' ' A' ' 836' ' ' GLU . 1.8 tppp? -80.12 -37.69 33.09 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.121 -0.987 . . . . 0.0 110.365 -179.924 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 775' ' ' PHE . . . . . 0.562 ' CG ' ' HB3' ' A' ' 788' ' ' PHE . 88.3 t80 -159.74 171.17 20.01 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.049 -1.032 . . . . 0.0 110.73 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 776' ' ' ALA . . . . . 0.498 ' CB ' ' O ' ' A' ' 775' ' ' PHE . . . 166.92 90.79 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.423 -0.798 . . . . 0.0 109.801 -179.986 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 777' ' ' SER . . . . . 0.432 ' HB3' ' CZ ' ' A' ' 775' ' ' PHE . 12.6 t -128.68 132.26 48.04 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.307 -0.871 . . . . 0.0 110.419 -179.928 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 778' ' ' PHE . . . . . 0.566 ' O ' ' CD1' ' A' ' 778' ' ' PHE . 72.0 t80 -100.33 82.73 2.54 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.232 -0.918 . . . . 0.0 110.383 179.943 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 779' ' ' GLY . . . . . . . . . . . . . . . 174.31 -108.91 0.28 Allowed Glycine 0 N--CA 1.491 2.348 0 C-N-CA 119.687 -1.244 . . . . 0.0 110.039 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 780' ' ' THR . . . . . . . . . . . . . 29.5 p -113.26 99.46 49.17 Favored Pre-proline 0 N--CA 1.494 1.736 0 O-C-N 121.255 -1.144 . . . . 0.0 110.431 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 781' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -79.89 125.26 5.94 Favored 'Trans proline' 0 C--N 1.305 -1.734 0 O-C-N 123.915 1.482 . . . . 0.0 110.432 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 782' ' ' LEU . . . . . 0.438 ' HB2' ' CD ' ' A' ' 789' ' ' GLN . 61.9 mt -101.9 118.77 37.61 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.278 -0.888 . . . . 0.0 109.85 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 783' ' ' GLY . . . . . . . . . . . . . . . 114.19 -179.49 18.65 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.315 -1.514 . . . . 0.0 109.315 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 784' ' ' THR . . . . . . . . . . . . . 40.9 p -112.65 -162.39 0.8 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.176 -1.191 . . . . 0.0 110.363 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 785' ' ' CYS . . . . . 0.42 ' HA ' ' CE1' ' A' ' 788' ' ' PHE . 0.5 OUTLIER -71.93 115.72 11.47 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.263 -0.898 . . . . 0.0 110.258 -179.996 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 786' ' ' GLY . . . . . . . . . . . . . . . 124.24 -30.33 4.8 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.496 -1.442 . . . . 0.0 109.496 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 787' ' ' THR . . . . . . . . . . . . . 1.2 p -131.92 27.4 4.58 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.342 -1.093 . . . . 0.0 110.094 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 788' ' ' PHE . . . . . 0.562 ' HB3' ' CG ' ' A' ' 775' ' ' PHE . 3.4 m-85 -51.23 164.39 0.18 Allowed 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.38 -0.825 . . . . 0.0 109.986 -179.97 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 789' ' ' GLN . . . . . 0.438 ' CD ' ' HB2' ' A' ' 782' ' ' LEU . 0.0 OUTLIER -175.43 127.84 0.26 Allowed 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.121 -0.987 . . . . 0.0 110.341 179.979 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 790' ' ' GLN . . . . . . . . . . . . . 1.8 pt20 -62.95 134.78 56.73 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.258 -0.901 . . . . 0.0 110.195 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 791' ' ' GLY . . . . . . . . . . . . . . . -95.28 -105.89 2.07 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.213 -1.555 . . . . 0.0 109.213 179.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 792' ' ' GLU . . . . . . . . . . . . . 29.5 tt0 -119.11 -24.99 6.3 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.258 -1.142 . . . . 0.0 109.744 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 793' ' ' CYS . . . . . 0.472 ' SG ' ' HG2' ' A' ' 825' ' ' PRO . 8.3 t -84.44 95.29 8.74 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.402 -0.811 . . . . 0.0 110.161 179.995 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 794' ' ' HIS . . . . . 0.583 ' CE1' ' OG ' ' A' ' 798' ' ' SER . 16.9 t60 -120.64 140.5 51.49 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.205 -0.934 . . . . 0.0 110.189 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 795' ' ' SER . . . . . 0.493 ' O ' ' HB ' ' A' ' 796' ' ' ILE . 28.0 t -81.16 9.22 7.16 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.173 -0.954 . . . . 0.0 110.355 -179.982 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 796' ' ' ILE . . . . . 0.493 ' HB ' ' O ' ' A' ' 795' ' ' SER . 1.4 mp 66.2 7.06 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.537 -0.727 . . . . 0.0 110.699 -179.993 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 797' ' ' ASN . . . . . 0.454 ' OD1' HG21 ' A' ' 801' ' ' VAL . 38.8 t-20 -161.05 39.25 0.15 Allowed 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.06 -1.025 . . . . 0.0 110.804 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 798' ' ' SER . . . . . 0.583 ' OG ' ' CE1' ' A' ' 794' ' ' HIS . 0.7 OUTLIER -97.02 2.35 51.33 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.144 -0.973 . . . . 0.0 110.38 -179.967 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 799' ' ' ASN . . . . . . . . . . . . . 7.1 m120 -117.17 -22.77 8.19 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.083 -1.011 . . . . 0.0 110.707 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 800' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -89.86 -31.41 17.34 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.131 -0.981 . . . . 0.0 110.536 -179.937 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 801' ' ' VAL . . . . . 0.454 HG21 ' OD1' ' A' ' 797' ' ' ASN . 97.7 t -61.85 -27.97 43.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.199 -0.938 . . . . 0.0 110.755 179.965 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 802' ' ' LEU . . . . . 0.449 ' N ' ' CD2' ' A' ' 802' ' ' LEU . 4.5 mm? -80.1 -56.56 4.14 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.164 -0.96 . . . . 0.0 110.686 -179.927 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 803' ' ' GLU . . . . . 0.547 ' HA ' ' CG1' ' A' ' 807' ' ' ILE . 3.7 mm-40 -55.51 -21.74 18.06 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.247 -0.908 . . . . 0.0 111.011 -179.962 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 804' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -93.0 -18.92 22.11 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.014 -1.054 . . . . 0.0 111.724 -179.827 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 805' ' ' LYS . . . . . 0.454 ' O ' ' SG ' ' A' ' 806' ' ' CYS . 0.0 OUTLIER -128.66 23.24 5.84 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 120.641 -1.287 . . . . 0.0 111.894 -179.939 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 806' ' ' CYS . . . . . 0.454 ' SG ' ' O ' ' A' ' 805' ' ' LYS . 1.6 m -160.93 32.17 0.15 Allowed 'General case' 0 N--CA 1.499 1.992 0 O-C-N 120.763 -1.211 . . . . 0.0 110.791 179.91 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 807' ' ' ILE . . . . . 0.547 ' CG1' ' HA ' ' A' ' 803' ' ' GLU . 14.4 mm -124.91 108.12 19.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.137 -0.977 . . . . 0.0 110.267 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 808' ' ' GLY . . . . . 0.425 ' C ' ' HG ' ' A' ' 809' ' ' LEU . . . 114.56 9.66 14.25 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.524 -1.431 . . . . 0.0 109.524 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 809' ' ' LEU . . . . . 0.425 ' HG ' ' C ' ' A' ' 808' ' ' GLY . 5.1 mt -131.56 134.47 46.1 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.319 -1.107 . . . . 0.0 110.137 179.943 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 810' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -65.42 -11.79 46.11 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.168 -0.957 . . . . 0.0 109.289 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 811' ' ' ARG . . . . . . . . . . . . . 2.3 ttt180 -158.28 129.65 6.56 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.515 -0.741 . . . . 0.0 109.661 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 812' ' ' CYS . . . . . . . . . . . . . 27.6 p -141.85 152.56 43.75 Favored 'General case' 0 C--N 1.294 -1.809 0 O-C-N 121.435 -0.79 . . . . 0.0 110.361 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 813' ' ' VAL . . . . . 0.489 HG22 ' CB ' ' A' ' 761' ' ' HIS . 94.6 t -123.27 156.99 29.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.309 -0.869 . . . . 0.0 110.192 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 814' ' ' VAL . . . . . . . . . . . . . 30.4 t -144.55 141.95 23.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.263 -0.898 . . . . 0.0 110.255 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 815' ' ' ALA . . . . . . . . . . . . . . . -102.29 128.7 48.72 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.307 -0.87 . . . . 0.0 109.957 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 816' ' ' ILE . . . . . 0.515 HD11 ' CG2' ' A' ' 833' ' ' VAL . 66.8 mt -83.38 132.83 30.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.153 -0.967 . . . . 0.0 110.25 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 817' ' ' SER . . . . . . . . . . . . . 20.3 p -163.17 164.96 15.26 Favored Pre-proline 0 N--CA 1.492 1.66 0 O-C-N 121.26 -0.9 . . . . 0.0 110.054 179.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 818' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -80.8 18.31 1.29 Allowed 'Trans proline' 0 C--N 1.307 -1.623 0 O-C-N 123.979 1.515 . . . . 0.0 111.123 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 819' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -127.18 -30.95 2.62 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 120.929 -1.107 . . . . 0.0 110.261 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 820' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 -63.5 -43.72 96.4 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.285 -0.885 . . . . 0.0 110.377 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 821' ' ' PHE . . . . . 0.469 ' HB3' ' OG ' ' A' ' 795' ' ' SER . 91.1 m-85 -88.85 -78.81 0.33 Allowed 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.236 -0.915 . . . . 0.0 110.295 179.961 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 822' ' ' GLY . . . . . . . . . . . . . . . 176.66 38.05 0.05 OUTLIER Glycine 0 N--CA 1.492 2.383 0 N-CA-C 109.827 -1.309 . . . . 0.0 109.827 -179.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 823' ' ' GLY . . . . . . . . . . . . . . . 90.14 -160.49 28.39 Favored Glycine 0 N--CA 1.492 2.401 0 N-CA-C 109.885 -1.286 . . . . 0.0 109.885 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 824' ' ' ASP . . . . . 0.457 ' OD1' ' O ' ' A' ' 824' ' ' ASP . 7.4 p30 -108.73 139.41 20.84 Favored Pre-proline 0 N--CA 1.497 1.899 0 O-C-N 121.301 -1.117 . . . . 0.0 110.359 -179.967 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 825' ' ' PRO . . . . . 0.472 ' HG2' ' SG ' ' A' ' 793' ' ' CYS . 49.3 Cg_endo -81.53 -54.63 0.04 OUTLIER 'Trans proline' 0 C--N 1.306 -1.67 0 O-C-N 124.044 1.549 . . . . 0.0 110.865 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 826' ' ' CYS . . . . . . . . . . . . . 1.8 m -123.67 110.45 29.95 Favored Pre-proline 0 N--CA 1.503 2.217 0 O-C-N 121.141 -0.974 . . . . 0.0 110.298 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 827' ' ' PRO . . . . . 0.449 ' O ' ' HB3' ' A' ' 828' ' ' GLU . 49.7 Cg_endo -86.86 163.0 9.03 Favored 'Trans proline' 0 C--N 1.304 -1.766 0 O-C-N 123.995 1.524 . . . . 0.0 110.46 179.953 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 828' ' ' GLU . . . . . 0.449 ' HB3' ' O ' ' A' ' 827' ' ' PRO . 1.5 tt0 65.9 8.73 5.55 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.225 -0.922 . . . . 0.0 110.776 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 829' ' ' VAL . . . . . . . . . . . . . 93.1 t -121.76 133.76 67.18 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 O-C-N 121.08 -1.012 . . . . 0.0 110.403 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 830' ' ' MET . . . . . 0.439 ' HA ' ' CE ' ' A' ' 830' ' ' MET . 0.5 OUTLIER -48.05 130.66 15.65 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.204 -0.935 . . . . 0.0 110.057 179.998 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 831' ' ' LYS . . . . . 0.449 ' HE2' ' HG2' ' A' ' 737' ' ' GLU . 7.8 ptmt -132.49 171.83 13.27 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.226 -0.922 . . . . 0.0 110.254 -179.934 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 832' ' ' ARG . . . . . 0.459 ' HD2' ' HA ' ' A' ' 736' ' ' SER . 0.0 OUTLIER -168.3 165.53 12.88 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.399 -0.813 . . . . 0.0 109.966 -179.985 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 833' ' ' VAL . . . . . 0.515 ' CG2' HD11 ' A' ' 816' ' ' ILE . 87.3 t -109.8 106.58 21.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.215 -0.928 . . . . 0.0 110.474 -179.932 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 834' ' ' ALA . . . . . 0.404 ' O ' HG22 ' A' ' 835' ' ' VAL . . . -109.5 129.05 55.58 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.342 -0.849 . . . . 0.0 109.705 179.932 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 835' ' ' VAL . . . . . 0.404 HG22 ' O ' ' A' ' 834' ' ' ALA . 29.8 t -142.25 152.89 18.2 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 121.138 -0.976 . . . . 0.0 110.779 -179.932 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 836' ' ' GLU . . . . . 0.504 ' HB3' ' HB3' ' A' ' 774' ' ' LYS . 1.7 tt0 -149.21 140.8 23.43 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.54 -0.725 . . . . 0.0 109.153 179.885 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 837' ' ' ALA . . . . . . . . . . . . . . . -119.6 166.36 13.25 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.051 -1.031 . . . . 0.0 111.38 -179.813 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 838' ' ' VAL . . . . . 0.403 ' HB ' ' O ' ' A' ' 772' ' ' ALA . 60.2 t -127.54 124.32 63.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.66 -0.65 . . . . 0.0 109.78 179.952 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 839' ' ' CYS . . . . . . . . . . . . . 53.3 m -109.12 131.54 54.97 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.11 -0.994 . . . . 0.0 110.518 -179.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 840' ' ' SER . . . . . 0.413 ' O ' ' OG1' ' A' ' 841' ' ' THR . 60.7 p -158.14 75.51 0.75 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.344 -0.847 . . . . 0.0 109.996 -179.988 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 841' ' ' THR . . . . . 0.508 ' CG2' HG21 ' A' ' 727' ' ' THR . 79.9 p 42.39 -160.71 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.271 -0.893 . . . . 0.0 110.167 -179.993 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 842' ' ' ALA . . . . . . . . . . . . . . . -81.03 149.59 29.21 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.279 -0.888 . . . . 0.0 110.379 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 843' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.674 0 CA-C-O 117.981 -1.009 . . . . 0.0 110.232 179.986 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 726' ' ' ARG . . . . . . . . . . . . . 42.3 mtm-85 . . . . . 0 N--CA 1.493 1.677 0 CA-C-O 121.186 0.517 . . . . 0.0 110.159 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 727' ' ' THR . . . . . . . . . . . . . 37.7 m 52.9 84.86 0.05 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.288 -0.882 . . . . 0.0 110.321 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 728' ' ' VAL . . . . . 0.437 ' O ' HG12 ' A' ' 728' ' ' VAL . 6.2 p -161.03 132.15 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 121.173 -0.955 . . . . 0.0 110.555 -179.928 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 729' ' ' SER . . . . . . . . . . . . . 67.3 m -126.6 -167.89 1.79 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.261 -0.899 . . . . 0.0 109.928 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 730' ' ' GLY . . . . . . . . . . . . . . . -139.9 134.66 6.7 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.672 -1.371 . . . . 0.0 109.672 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 731' ' ' VAL . . . . . 0.427 ' CG2' ' O ' ' A' ' 837' ' ' ALA . 15.4 m -121.77 133.33 68.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.376 -1.073 . . . . 0.0 110.002 179.955 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 732' ' ' CYS . . . . . 0.486 ' CB ' ' CD ' ' A' ' 836' ' ' GLU . 23.3 p -123.95 153.6 40.98 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.215 -0.928 . . . . 0.0 110.376 179.987 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 733' ' ' ALA . . . . . . . . . . . . . . . -143.15 120.17 11.38 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.314 -0.866 . . . . 0.0 109.827 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 734' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -110.86 121.18 44.7 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.159 -0.963 . . . . 0.0 110.5 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 735' ' ' VAL . . . . . . . . . . . . . 21.9 t -143.66 141.9 25.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.372 -0.83 . . . . 0.0 110.001 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 736' ' ' SER . . . . . . . . . . . . . 10.9 p -95.99 159.01 15.19 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.257 -0.902 . . . . 0.0 110.377 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 737' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -67.42 146.95 53.51 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.315 -0.866 . . . . 0.0 110.28 179.955 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 738' ' ' TYR . . . . . 0.455 ' O ' ' HB2' ' A' ' 739' ' ' HIS . 2.2 t80 -94.03 121.07 35.14 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.135 -0.978 . . . . 0.0 110.362 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 739' ' ' HIS . . . . . 0.455 ' HB2' ' O ' ' A' ' 738' ' ' TYR . 46.1 t-80 -178.3 88.71 0.23 Allowed Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 121.381 -0.825 . . . . 0.0 109.981 179.962 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 740' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -69.46 -91.75 0.0 OUTLIER 'Trans proline' 0 C--N 1.301 -1.922 0 O-C-N 123.991 1.522 . . . . 0.0 110.352 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 741' ' ' ASN . . . . . . . . . . . . . 8.3 t30 -164.5 109.65 0.97 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.307 -0.871 . . . . 0.0 109.801 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 742' ' ' ILE . . . . . . . . . . . . . 52.9 mt -132.31 154.38 39.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.167 -0.958 . . . . 0.0 110.589 -179.918 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 743' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -153.69 -39.17 0.1 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.413 -0.804 . . . . 0.0 109.791 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 744' ' ' ASN . . . . . . . . . . . . . 63.9 t30 -68.57 89.32 0.36 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.336 -0.852 . . . . 0.0 109.828 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 745' ' ' TRP . . . . . . . . . . . . . 16.6 t90 -165.82 -33.04 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.249 -0.907 . . . . 0.0 110.49 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 746' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -84.6 50.89 1.99 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.172 -0.955 . . . . 0.0 110.353 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 747' ' ' ILE . . . . . 0.515 ' N ' ' CD1' ' A' ' 747' ' ' ILE . 3.4 mp -85.52 48.96 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.229 -0.919 . . . . 0.0 109.886 179.878 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 748' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 56.56 39.73 29.75 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.297 -0.877 . . . . 0.0 109.941 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 749' ' ' SER . . . . . 0.554 ' C ' ' CG ' ' A' ' 750' ' ' TYR . 10.5 p -160.27 -42.74 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.318 -0.864 . . . . 0.0 110.192 179.943 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 750' ' ' TYR . . . . . 0.554 ' CG ' ' C ' ' A' ' 749' ' ' SER . 9.6 p90 33.94 96.0 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.44 0 O-C-N 121.69 -0.631 . . . . 0.0 110.942 -179.976 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 751' ' ' GLY . . . . . 0.464 ' O ' ' HB3' ' A' ' 752' ' ' GLU . . . -134.89 -152.35 6.53 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.846 -1.302 . . . . 0.0 109.846 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 752' ' ' GLU . . . . . 0.464 ' HB3' ' O ' ' A' ' 751' ' ' GLY . 4.4 tp10 64.86 96.16 0.05 OUTLIER Pre-proline 0 N--CA 1.495 1.789 0 O-C-N 121.336 -1.096 . . . . 0.0 110.337 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 753' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -77.37 118.17 4.56 Favored 'Trans proline' 0 C--N 1.305 -1.735 0 O-C-N 124.108 1.583 . . . . 0.0 110.247 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 754' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -164.11 166.85 20.89 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.179 -0.951 . . . . 0.0 110.322 -179.954 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 755' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -101.81 156.26 17.62 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.236 -0.915 . . . . 0.0 110.235 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 756' ' ' HIS . . . . . 0.527 ' ND1' ' O ' ' A' ' 756' ' ' HIS . 18.8 p80 -149.72 51.98 0.93 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.221 -0.925 . . . . 0.0 110.319 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 757' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -136.96 168.01 20.4 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.086 -1.009 . . . . 0.0 110.553 -179.931 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 758' ' ' ALA . . . . . . . . . . . . . . . -90.79 178.43 6.05 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.402 -0.811 . . . . 0.0 109.619 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 759' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -135.97 159.78 40.65 Favored 'General case' 0 C--N 1.298 -1.673 0 O-C-N 121.064 -1.023 . . . . 0.0 110.858 -179.94 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 760' ' ' VAL . . . . . . . . . . . . . 97.5 t -105.87 167.88 3.0 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 179.842 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 761' ' ' HIS . . . . . . . . . . . . . 29.3 m80 -137.6 104.76 5.42 Favored 'General case' 0 C--N 1.299 -1.588 0 C-N-CA 118.501 -1.28 . . . . 0.0 112.263 -179.765 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 762' ' ' LEU . . . . . 0.548 ' CD1' ' HB3' ' A' ' 812' ' ' CYS . 32.1 mt -116.24 126.25 53.35 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 179.787 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 763' ' ' LYS . . . . . . . . . . . . . 6.7 tttt -134.59 137.51 43.79 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.67 -1.269 . . . . 0.0 112.147 -179.75 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 764' ' ' CYS . . . . . 0.466 ' SG ' ' HB2' ' A' ' 768' ' ' GLN . 22.4 t -136.39 143.63 44.1 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.561 -0.712 . . . . 0.0 109.554 179.824 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 765' ' ' ALA . . . . . . . . . . . . . . . -49.79 155.41 1.48 Allowed Pre-proline 0 N--CA 1.492 1.667 0 O-C-N 121.048 -1.033 . . . . 0.0 110.104 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 766' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -71.74 91.68 0.7 Allowed 'Trans proline' 0 C--N 1.306 -1.684 0 O-C-N 123.974 1.512 . . . . 0.0 110.303 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 767' ' ' GLY . . . . . . . . . . . . . . . 152.8 -27.01 0.83 Allowed Glycine 0 N--CA 1.489 2.196 0 N-CA-C 108.81 -1.716 . . . . 0.0 108.81 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 768' ' ' GLN . . . . . 0.466 ' HB2' ' SG ' ' A' ' 764' ' ' CYS . 30.0 mt-30 -104.51 128.09 52.38 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.513 -0.992 . . . . 0.0 109.682 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 769' ' ' THR . . . . . . . . . . . . . 9.6 p -113.8 152.78 30.15 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.178 -0.951 . . . . 0.0 110.556 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 770' ' ' ILE . . . . . 0.504 ' CD1' ' O ' ' A' ' 809' ' ' LEU . 2.8 mp -64.6 119.58 9.28 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.341 -0.849 . . . . 0.0 109.765 179.959 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 771' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -111.53 -1.74 15.72 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.277 -0.889 . . . . 0.0 110.493 -179.926 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 772' ' ' ALA . . . . . 0.484 ' O ' ' HB ' ' A' ' 838' ' ' VAL . . . -168.0 131.9 1.67 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.148 -0.97 . . . . 0.0 111.039 -179.936 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 773' ' ' ILE . . . . . 0.419 HG13 ' HG3' ' A' ' 803' ' ' GLU . 16.6 mm -91.16 125.64 43.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.244 -0.91 . . . . 0.0 109.163 179.871 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 774' ' ' LYS . . . . . 0.475 ' HB3' ' HB3' ' A' ' 836' ' ' GLU . 6.5 ttmt -79.77 -37.85 34.45 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.158 -0.964 . . . . 0.0 111.116 -179.894 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 775' ' ' PHE . . . . . . . . . . . . . 52.5 t80 -152.76 152.99 32.28 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.953 -1.092 . . . . 0.0 110.75 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 776' ' ' ALA . . . . . 0.465 ' O ' ' HB2' ' A' ' 798' ' ' SER . . . -174.13 112.35 0.17 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.552 -0.718 . . . . 0.0 109.624 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 777' ' ' SER . . . . . 0.551 ' HA ' ' CB ' ' A' ' 798' ' ' SER . 6.7 m -162.04 98.34 1.06 Allowed 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.177 -0.952 . . . . 0.0 110.727 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 778' ' ' PHE . . . . . 0.514 ' CD1' ' C ' ' A' ' 778' ' ' PHE . 0.9 OUTLIER -72.75 103.86 3.78 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.293 -0.88 . . . . 0.0 109.969 179.936 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 779' ' ' GLY . . . . . . . . . . . . . . . 174.88 -109.52 0.29 Allowed Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.663 -1.375 . . . . 0.0 109.663 -179.903 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 780' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -124.94 70.0 58.99 Favored Pre-proline 0 N--CA 1.492 1.647 0 O-C-N 121.292 -1.122 . . . . 0.0 110.22 -179.898 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 781' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -74.4 153.21 44.79 Favored 'Trans proline' 0 C--N 1.305 -1.721 0 O-C-N 124.039 1.547 . . . . 0.0 110.542 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 782' ' ' LEU . . . . . 0.487 ' O ' ' N ' ' A' ' 789' ' ' GLN . 1.1 mt -138.76 151.0 46.72 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.288 -0.883 . . . . 0.0 110.126 -179.954 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 783' ' ' GLY . . . . . . . . . . . . . . . 118.25 -170.77 13.8 Favored Glycine 0 N--CA 1.492 2.404 0 N-CA-C 109.643 -1.383 . . . . 0.0 109.643 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 784' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -125.41 -162.71 1.13 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.274 -1.133 . . . . 0.0 110.088 -179.988 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 785' ' ' CYS . . . . . . . . . . . . . 21.2 m -79.77 94.55 5.79 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.184 -0.947 . . . . 0.0 110.476 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 786' ' ' GLY . . . . . 0.435 ' O ' HG23 ' A' ' 787' ' ' THR . . . 137.58 -23.29 3.12 Favored Glycine 0 N--CA 1.489 2.198 0 N-CA-C 109.577 -1.409 . . . . 0.0 109.577 179.969 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 787' ' ' THR . . . . . 0.46 ' O ' ' O ' ' A' ' 788' ' ' PHE . 20.4 p -142.73 37.9 1.47 Allowed 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.305 -1.114 . . . . 0.0 110.24 -179.952 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 788' ' ' PHE . . . . . 0.46 ' O ' ' O ' ' A' ' 787' ' ' THR . 0.9 OUTLIER -46.56 175.83 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.301 -0.875 . . . . 0.0 110.501 179.963 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 789' ' ' GLN . . . . . 0.487 ' N ' ' O ' ' A' ' 782' ' ' LEU . 0.0 OUTLIER -153.91 148.42 26.19 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.45 -0.781 . . . . 0.0 110.289 -179.976 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 790' ' ' GLN . . . . . 0.532 ' OE1' ' CD2' ' A' ' 794' ' ' HIS . 0.0 OUTLIER -78.94 151.22 31.79 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.151 -0.968 . . . . 0.0 110.132 -179.995 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 791' ' ' GLY . . . . . . . . . . . . . . . -108.83 -153.54 15.94 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.529 -1.428 . . . . 0.0 109.529 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 792' ' ' GLU . . . . . . . . . . . . . 6.0 pm0 -109.83 -19.57 13.09 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.308 -1.113 . . . . 0.0 110.358 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 793' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -98.62 24.8 7.07 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.247 -0.908 . . . . 0.0 110.307 179.903 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 794' ' ' HIS . . . . . 0.532 ' CD2' ' OE1' ' A' ' 790' ' ' GLN . 7.5 t60 -68.98 149.12 49.17 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.176 -0.953 . . . . 0.0 109.899 -179.964 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 795' ' ' SER . . . . . 0.521 ' O ' ' N ' ' A' ' 797' ' ' ASN . 1.7 p -87.9 14.16 9.4 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.191 -0.943 . . . . 0.0 110.499 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 796' ' ' ILE . . . . . 0.508 ' CG1' ' C ' ' A' ' 795' ' ' SER . 3.6 pt 34.56 32.27 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.505 2.31 0 CA-C-O 121.503 0.668 . . . . 0.0 110.247 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 797' ' ' ASN . . . . . 0.521 ' N ' ' O ' ' A' ' 795' ' ' SER . 60.9 t30 -157.68 21.14 0.27 Allowed 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.486 -0.759 . . . . 0.0 109.646 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 798' ' ' SER . . . . . 0.551 ' CB ' ' HA ' ' A' ' 777' ' ' SER . 17.7 m -84.51 -33.57 23.5 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.526 -0.734 . . . . 0.0 110.636 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 799' ' ' ASN . . . . . 0.465 ' O ' ' OE1' ' A' ' 803' ' ' GLU . 11.8 t-20 -74.17 -6.66 49.03 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.282 -0.886 . . . . 0.0 110.729 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 800' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -86.52 -44.03 12.26 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.052 -1.03 . . . . 0.0 110.39 179.961 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 801' ' ' VAL . . . . . . . . . . . . . 69.5 t -72.57 -21.67 20.01 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 121.29 -0.881 . . . . 0.0 110.808 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 802' ' ' LEU . . . . . 0.451 ' O ' ' HB2' ' A' ' 806' ' ' CYS . 1.8 mm? -84.08 -43.89 14.61 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.043 -1.035 . . . . 0.0 110.612 -179.946 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 803' ' ' GLU . . . . . 0.465 ' OE1' ' O ' ' A' ' 799' ' ' ASN . 40.6 mt-10 -67.45 -24.67 65.65 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.118 -0.989 . . . . 0.0 110.416 -179.988 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 804' ' ' ARG . . . . . . . . . . . . . 13.6 mmt-85 -90.59 -24.71 20.48 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.194 -0.942 . . . . 0.0 110.827 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 805' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.95 46.86 1.85 Allowed 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.014 -1.054 . . . . 0.0 110.701 179.977 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 806' ' ' CYS . . . . . 0.451 ' HB2' ' O ' ' A' ' 802' ' ' LEU . 1.8 t -160.59 -40.27 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.216 -0.927 . . . . 0.0 110.532 179.958 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 807' ' ' ILE . . . . . 0.427 ' HA ' ' O ' ' A' ' 770' ' ' ILE . 45.2 mt -67.58 123.27 20.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.242 -0.911 . . . . 0.0 110.765 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 808' ' ' GLY . . . . . . . . . . . . . . . 111.1 -8.48 29.16 Favored Glycine 0 N--CA 1.494 2.508 0 N-CA-C 110.024 -1.23 . . . . 0.0 110.024 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 809' ' ' LEU . . . . . 0.504 ' O ' ' CD1' ' A' ' 770' ' ' ILE . 36.0 mt -120.28 139.33 52.88 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.079 -1.247 . . . . 0.0 110.614 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 810' ' ' GLU . . . . . 0.465 ' O ' ' HB3' ' A' ' 764' ' ' CYS . 5.4 pt-20 -69.03 -33.89 74.34 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.213 -0.929 . . . . 0.0 109.356 179.942 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 811' ' ' ARG . . . . . . . . . . . . . 15.3 ttp180 -112.21 157.33 21.01 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.517 -0.739 . . . . 0.0 109.443 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 812' ' ' CYS . . . . . 0.548 ' HB3' ' CD1' ' A' ' 762' ' ' LEU . 1.3 t -149.44 108.21 3.85 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.099 -1.001 . . . . 0.0 111.085 -179.928 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 813' ' ' VAL . . . . . 0.504 ' O ' ' CG1' ' A' ' 813' ' ' VAL . 4.5 p -118.4 122.92 70.71 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 121.333 -0.854 . . . . 0.0 109.268 179.946 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 814' ' ' VAL . . . . . . . . . . . . . 45.1 t -135.89 121.97 30.91 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.987 0 O-C-N 121.117 -0.989 . . . . 0.0 111.001 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 815' ' ' ALA . . . . . . . . . . . . . . . -80.33 130.17 35.0 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.358 -0.839 . . . . 0.0 109.744 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 816' ' ' ILE . . . . . 0.538 ' CG2' HG21 ' A' ' 833' ' ' VAL . 2.6 mt -80.61 113.65 20.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.122 -0.986 . . . . 0.0 110.564 -179.866 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 817' ' ' SER . . . . . 0.453 ' O ' ' OD1' ' A' ' 820' ' ' ASN . 8.8 p -143.44 162.83 40.27 Favored Pre-proline 0 N--CA 1.494 1.774 0 O-C-N 121.352 -0.842 . . . . 0.0 110.074 -179.946 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 818' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -82.4 21.05 1.02 Allowed 'Trans proline' 0 C--N 1.307 -1.656 0 O-C-N 123.978 1.515 . . . . 0.0 110.931 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 819' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -135.7 9.23 3.35 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.972 -1.08 . . . . 0.0 110.327 179.94 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 820' ' ' ASN . . . . . 0.453 ' OD1' ' O ' ' A' ' 817' ' ' SER . 8.1 p-10 -117.42 -10.16 10.75 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.224 -0.922 . . . . 0.0 110.283 -179.969 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 821' ' ' PHE . . . . . . . . . . . . . 9.2 m-85 -105.14 -22.28 13.11 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.19 -0.944 . . . . 0.0 110.237 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 822' ' ' GLY . . . . . . . . . . . . . . . 104.95 47.77 1.14 Allowed Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.739 -1.344 . . . . 0.0 109.739 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 823' ' ' GLY . . . . . . . . . . . . . . . 116.58 -134.3 11.26 Favored Glycine 0 N--CA 1.492 2.41 0 N-CA-C 109.661 -1.376 . . . . 0.0 109.661 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 824' ' ' ASP . . . . . 0.434 ' CG ' ' HD2' ' A' ' 825' ' ' PRO . 0.4 OUTLIER -172.01 157.19 4.07 Favored Pre-proline 0 N--CA 1.494 1.76 0 O-C-N 121.226 -1.161 . . . . 0.0 110.395 -179.963 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 825' ' ' PRO . . . . . 0.434 ' HD2' ' CG ' ' A' ' 824' ' ' ASP . 46.8 Cg_endo -75.2 -88.33 0.0 OUTLIER 'Trans proline' 0 C--N 1.307 -1.63 0 O-C-N 124.066 1.561 . . . . 0.0 110.544 -179.931 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 826' ' ' CYS . . . . . . . . . . . . . 3.3 p -120.66 105.11 41.48 Favored Pre-proline 0 N--CA 1.498 1.933 0 O-C-N 121.201 -0.937 . . . . 0.0 110.193 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 827' ' ' PRO . . . . . 0.523 ' O ' ' CB ' ' A' ' 828' ' ' GLU . 50.3 Cg_endo -78.12 82.48 2.43 Favored 'Trans proline' 0 C--N 1.31 -1.493 0 O-C-N 124.093 1.575 . . . . 0.0 110.73 179.959 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 828' ' ' GLU . . . . . 0.523 ' CB ' ' O ' ' A' ' 827' ' ' PRO . 0.2 OUTLIER 165.12 -23.03 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.392 -0.818 . . . . 0.0 109.987 -179.984 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 829' ' ' VAL . . . . . 0.452 ' O ' ' HG3' ' A' ' 831' ' ' LYS . 42.4 t -100.0 167.06 2.07 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.505 0 O-C-N 121.266 -0.896 . . . . 0.0 110.351 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 830' ' ' MET . . . . . 0.426 ' C ' ' O ' ' A' ' 829' ' ' VAL . 31.4 mtm -42.29 146.97 0.28 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.352 -0.842 . . . . 0.0 110.293 179.957 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 831' ' ' LYS . . . . . 0.452 ' HG3' ' O ' ' A' ' 829' ' ' VAL . 15.6 mtmm -127.61 83.0 2.12 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.262 -0.899 . . . . 0.0 110.054 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 832' ' ' ARG . . . . . . . . . . . . . 37.1 mtt180 -111.07 150.69 29.0 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.323 -0.861 . . . . 0.0 110.046 -179.895 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 833' ' ' VAL . . . . . 0.538 HG21 ' CG2' ' A' ' 816' ' ' ILE . 98.6 t -116.32 159.62 16.18 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.522 0 O-C-N 121.244 -0.91 . . . . 0.0 110.677 -179.982 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 834' ' ' ALA . . . . . . . . . . . . . . . -160.11 104.2 1.49 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.508 -0.745 . . . . 0.0 109.26 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 835' ' ' VAL . . . . . 0.456 HG12 ' N ' ' A' ' 836' ' ' GLU . 39.8 t -115.35 159.66 15.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.112 -0.993 . . . . 0.0 111.114 -179.863 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 836' ' ' GLU . . . . . 0.486 ' CD ' ' CB ' ' A' ' 732' ' ' CYS . 0.0 OUTLIER -144.34 123.96 13.27 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.574 -0.704 . . . . 0.0 109.28 179.917 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 837' ' ' ALA . . . . . 0.427 ' O ' ' CG2' ' A' ' 731' ' ' VAL . . . -111.66 144.9 40.17 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.15 -0.969 . . . . 0.0 110.704 -179.953 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 838' ' ' VAL . . . . . 0.484 ' HB ' ' O ' ' A' ' 772' ' ' ALA . 76.3 t -111.22 124.99 68.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.398 -0.814 . . . . 0.0 109.534 179.945 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 839' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -108.46 119.56 39.88 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.23 -0.919 . . . . 0.0 110.039 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 840' ' ' SER . . . . . 0.465 ' O ' ' OG1' ' A' ' 841' ' ' THR . 0.9 OUTLIER -133.66 69.06 1.48 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.34 -0.85 . . . . 0.0 109.845 179.992 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 841' ' ' THR . . . . . 0.465 ' OG1' ' O ' ' A' ' 840' ' ' SER . 30.7 p 47.03 -175.25 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.443 -0.786 . . . . 0.0 110.313 179.921 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 842' ' ' ALA . . . . . 0.467 ' O ' ' HB1' ' A' ' 843' ' ' ALA . . . -149.93 71.13 1.07 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.317 -0.864 . . . . 0.0 109.873 -180.0 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 843' ' ' ALA . . . . . 0.467 ' HB1' ' O ' ' A' ' 842' ' ' ALA . . . . . . . . 0 N--CA 1.491 1.595 0 CA-C-O 118.028 -0.987 . . . . 0.0 110.069 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 726' ' ' ARG . . . . . . . . . . . . . 6.7 mtm180 . . . . . 0 N--CA 1.492 1.666 0 CA-C-O 121.265 0.555 . . . . 0.0 110.08 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 727' ' ' THR . . . . . . . . . . . . . 87.6 m -92.96 108.7 20.2 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.473 -0.767 . . . . 0.0 110.489 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 728' ' ' VAL . . . . . 0.448 HG11 ' O ' ' A' ' 728' ' ' VAL . 72.8 t -140.61 61.83 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 O-C-N 121.197 -0.939 . . . . 0.0 109.999 179.949 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 729' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -77.12 -147.95 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.373 -0.83 . . . . 0.0 110.185 -179.971 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 730' ' ' GLY . . . . . . . . . . . . . . . -149.96 150.02 22.01 Favored Glycine 0 N--CA 1.488 2.108 0 N-CA-C 109.697 -1.361 . . . . 0.0 109.697 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 731' ' ' VAL . . . . . . . . . . . . . 86.4 t -111.12 157.28 12.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.334 -1.098 . . . . 0.0 109.836 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 732' ' ' CYS . . . . . . . . . . . . . 10.9 t -117.75 146.34 43.85 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.176 -0.953 . . . . 0.0 110.341 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 733' ' ' ALA . . . . . . . . . . . . . . . -142.13 116.25 9.42 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.268 -0.895 . . . . 0.0 110.356 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 734' ' ' ASP . . . . . 0.419 ' N ' ' OD1' ' A' ' 734' ' ' ASP . 0.8 OUTLIER -114.12 139.09 49.61 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.177 -0.952 . . . . 0.0 110.001 179.937 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 735' ' ' VAL . . . . . . . . . . . . . 44.9 t -147.89 124.05 2.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.214 -0.929 . . . . 0.0 110.039 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 736' ' ' SER . . . . . 0.42 ' O ' ' C ' ' A' ' 737' ' ' GLU . 0.7 OUTLIER -90.87 134.89 34.1 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.23 -0.919 . . . . 0.0 110.199 179.951 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 737' ' ' GLU . . . . . 0.42 ' C ' ' O ' ' A' ' 736' ' ' SER . 29.5 tp10 -41.74 115.8 0.7 Allowed 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.275 -0.891 . . . . 0.0 110.004 179.96 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 738' ' ' TYR . . . . . 0.477 ' O ' ' CG ' ' A' ' 738' ' ' TYR . 2.7 t80 -114.36 95.87 5.49 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.225 -0.922 . . . . 0.0 110.409 -179.947 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 739' ' ' HIS . . . . . 0.557 ' CD2' ' HD2' ' A' ' 740' ' ' PRO . 30.4 t-80 -103.0 131.89 21.69 Favored Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.343 -0.848 . . . . 0.0 109.733 179.907 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 740' ' ' PRO . . . . . 0.557 ' HD2' ' CD2' ' A' ' 739' ' ' HIS . 42.0 Cg_endo -67.63 87.55 0.35 Allowed 'Trans proline' 0 C--N 1.302 -1.885 0 O-C-N 123.853 1.449 . . . . 0.0 110.149 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 741' ' ' ASN . . . . . 0.433 ' C ' ' O ' ' A' ' 740' ' ' PRO . 46.5 m-20 -40.84 128.13 2.62 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.376 -0.828 . . . . 0.0 110.34 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 742' ' ' ILE . . . . . 0.473 HD13 ' O ' ' A' ' 740' ' ' PRO . 6.6 mm -85.82 -9.16 11.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.298 -0.876 . . . . 0.0 109.999 179.962 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 743' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -68.94 -21.8 64.17 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.338 -0.851 . . . . 0.0 109.969 -179.981 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 744' ' ' ASN . . . . . 0.478 ' N ' ' OD1' ' A' ' 744' ' ' ASN . 20.1 p-10 -162.87 70.67 0.27 Allowed 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.368 -0.832 . . . . 0.0 110.061 179.953 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 745' ' ' TRP . . . . . 0.479 ' CD1' ' N ' ' A' ' 745' ' ' TRP . 0.3 OUTLIER -82.21 31.44 0.39 Allowed 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.382 -0.824 . . . . 0.0 111.527 179.997 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 746' ' ' GLN . . . . . 0.504 ' O ' ' HG3' ' A' ' 746' ' ' GLN . 15.3 pt20 -158.86 89.54 0.95 Allowed 'General case' 0 N--CA 1.497 1.877 0 O-C-N 120.963 -1.085 . . . . 0.0 110.163 179.87 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 747' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -104.26 -151.66 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 2.025 0 O-C-N 120.989 -1.069 . . . . 0.0 110.046 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 748' ' ' GLU . . . . . 0.503 ' HG2' ' N ' ' A' ' 749' ' ' SER . 0.6 OUTLIER -63.02 -18.77 63.69 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.309 -0.869 . . . . 0.0 110.093 179.972 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 749' ' ' SER . . . . . 0.503 ' N ' ' HG2' ' A' ' 748' ' ' GLU . 16.4 m -99.05 124.88 44.36 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.384 -0.822 . . . . 0.0 110.281 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 750' ' ' TYR . . . . . . . . . . . . . 28.7 m-85 -69.39 172.97 6.33 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.22 -0.925 . . . . 0.0 110.387 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 751' ' ' GLY . . . . . . . . . . . . . . . 123.74 158.75 10.24 Favored Glycine 0 N--CA 1.492 2.389 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 752' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -141.76 127.6 10.93 Favored Pre-proline 0 N--CA 1.493 1.689 0 O-C-N 121.163 -1.198 . . . . 0.0 110.368 -179.967 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 753' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -71.08 101.24 1.07 Allowed 'Trans proline' 0 C--N 1.309 -1.531 0 O-C-N 123.819 1.431 . . . . 0.0 110.324 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 754' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -83.73 -37.4 22.73 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.285 -0.884 . . . . 0.0 110.364 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 755' ' ' PHE . . . . . 0.483 ' C ' ' CG ' ' A' ' 756' ' ' HIS . 0.2 OUTLIER -73.7 -157.24 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.177 -0.952 . . . . 0.0 110.187 -179.973 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 756' ' ' HIS . . . . . 0.492 ' O ' ' CG2' ' A' ' 757' ' ' THR . 2.2 m-70 -150.54 16.54 0.8 Allowed 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.241 -0.912 . . . . 0.0 110.108 -179.944 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 757' ' ' THR . . . . . 0.492 ' CG2' ' O ' ' A' ' 756' ' ' HIS . 1.8 p -161.2 -177.71 6.23 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.003 -1.061 . . . . 0.0 110.934 -179.952 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 758' ' ' ALA . . . . . 0.476 ' HB1' ' HB3' ' A' ' 738' ' ' TYR . . . -101.03 173.73 6.34 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.479 -0.763 . . . . 0.0 110.169 179.942 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 759' ' ' LYS . . . . . . . . . . . . . 36.2 mtpt -137.94 165.27 26.95 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.203 -0.935 . . . . 0.0 110.63 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 760' ' ' VAL . . . . . . . . . . . . . 38.4 t -109.7 139.64 31.94 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.442 -0.786 . . . . 0.0 109.642 179.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 761' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -109.97 104.2 13.07 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.068 -1.02 . . . . 0.0 110.886 -179.981 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 762' ' ' LEU . . . . . . . . . . . . . 21.2 mt -121.46 124.32 44.18 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.298 -0.876 . . . . 0.0 109.414 179.879 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 763' ' ' LYS . . . . . 0.533 ' HB3' ' CD ' ' A' ' 811' ' ' ARG . 0.0 OUTLIER -156.05 123.17 5.35 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.919 -1.113 . . . . 0.0 111.243 -179.928 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 764' ' ' CYS . . . . . 0.41 ' O ' ' C ' ' A' ' 765' ' ' ALA . 19.1 m -99.04 157.34 16.41 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.342 -0.849 . . . . 0.0 109.263 179.839 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 765' ' ' ALA . . . . . 0.41 ' C ' ' O ' ' A' ' 764' ' ' CYS . . . -42.64 159.56 0.2 Allowed Pre-proline 0 N--CA 1.495 1.818 0 O-C-N 121.076 -1.015 . . . . 0.0 109.982 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 766' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -71.23 97.3 0.75 Allowed 'Trans proline' 0 C--N 1.306 -1.667 0 O-C-N 123.913 1.48 . . . . 0.0 110.524 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 767' ' ' GLY . . . . . . . . . . . . . . . 147.53 -31.69 1.38 Allowed Glycine 0 N--CA 1.489 2.198 0 N-CA-C 109.044 -1.623 . . . . 0.0 109.044 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 768' ' ' GLN . . . . . . . . . . . . . 20.1 mt-30 -99.0 101.61 13.05 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.369 -1.077 . . . . 0.0 109.982 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 769' ' ' THR . . . . . . . . . . . . . 11.2 p -85.28 146.95 26.79 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.112 -0.992 . . . . 0.0 110.128 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 770' ' ' ILE . . . . . . . . . . . . . 35.7 mt -66.7 144.16 14.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.306 -0.871 . . . . 0.0 109.252 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 771' ' ' SER . . . . . . . . . . . . . 47.8 t -135.28 -4.69 2.35 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.873 -1.142 . . . . 0.0 111.432 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 772' ' ' ALA . . . . . . . . . . . . . . . -172.71 151.68 2.37 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 120.781 -1.199 . . . . 0.0 111.418 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 773' ' ' ILE . . . . . 0.433 HG23 ' O ' ' A' ' 836' ' ' GLU . 20.1 mm -110.75 120.28 61.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 179.888 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 774' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -80.09 -42.89 22.75 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 120.986 -1.071 . . . . 0.0 110.951 -179.835 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 775' ' ' PHE . . . . . 0.476 ' O ' ' HB3' ' A' ' 776' ' ' ALA . 67.2 t80 -134.0 152.25 51.77 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.098 -1.001 . . . . 0.0 110.668 -179.913 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 776' ' ' ALA . . . . . 0.476 ' HB3' ' O ' ' A' ' 775' ' ' PHE . . . 179.1 113.41 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.567 -0.708 . . . . 0.0 109.803 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 777' ' ' SER . . . . . 0.486 ' HA ' ' HB3' ' A' ' 798' ' ' SER . 94.5 p -148.73 126.86 12.07 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.338 -0.851 . . . . 0.0 110.475 -179.958 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 778' ' ' PHE . . . . . . . . . . . . . 12.2 t80 -94.21 116.48 28.88 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.359 -0.838 . . . . 0.0 109.949 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 779' ' ' GLY . . . . . 0.477 ' HA3' ' O ' ' A' ' 793' ' ' CYS . . . 163.97 -136.15 4.11 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.932 -1.267 . . . . 0.0 109.932 -179.958 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 780' ' ' THR . . . . . . . . . . . . . 45.7 p -123.49 64.77 30.22 Favored Pre-proline 0 N--CA 1.494 1.766 0 O-C-N 121.212 -1.17 . . . . 0.0 110.595 -179.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 781' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -74.47 170.79 19.45 Favored 'Trans proline' 0 C--N 1.304 -1.792 0 O-C-N 124.044 1.55 . . . . 0.0 110.392 179.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 782' ' ' LEU . . . . . . . . . . . . . 3.7 mt -129.86 173.91 10.23 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.198 -0.939 . . . . 0.0 110.261 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 783' ' ' GLY . . . . . . . . . . . . . . . 110.93 -169.54 13.38 Favored Glycine 0 N--CA 1.494 2.561 0 N-CA-C 109.595 -1.402 . . . . 0.0 109.595 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 784' ' ' THR . . . . . 0.512 HG21 ' N ' ' A' ' 785' ' ' CYS . 54.3 m -115.62 -92.92 0.5 Allowed 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.229 -1.159 . . . . 0.0 110.336 -179.96 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 785' ' ' CYS . . . . . 0.512 ' N ' HG21 ' A' ' 784' ' ' THR . 0.3 OUTLIER -139.5 120.05 14.1 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.175 -0.953 . . . . 0.0 110.162 -179.938 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 786' ' ' GLY . . . . . . . . . . . . . . . 95.3 -4.62 67.3 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.658 -1.377 . . . . 0.0 109.658 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 787' ' ' THR . . . . . . . . . . . . . 9.0 t -145.41 34.8 1.07 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.209 -1.171 . . . . 0.0 110.109 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 788' ' ' PHE . . . . . 0.412 ' CZ ' ' O ' ' A' ' 784' ' ' THR . 39.4 m-85 -53.41 176.22 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.342 -0.849 . . . . 0.0 110.385 179.996 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 789' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -139.66 145.28 38.24 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.335 -0.853 . . . . 0.0 110.164 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 790' ' ' GLN . . . . . . . . . . . . . 2.1 mt-30 -64.21 131.05 46.25 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.121 -0.987 . . . . 0.0 109.882 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 791' ' ' GLY . . . . . . . . . . . . . . . -92.49 -163.26 37.58 Favored Glycine 0 N--CA 1.492 2.413 0 N-CA-C 109.698 -1.361 . . . . 0.0 109.698 180.0 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 792' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -98.41 -14.0 20.33 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.337 -1.096 . . . . 0.0 110.226 -179.972 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 793' ' ' CYS . . . . . 0.477 ' O ' ' HA3' ' A' ' 779' ' ' GLY . 0.5 OUTLIER -116.86 68.59 0.74 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.352 -0.842 . . . . 0.0 110.275 179.972 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 794' ' ' HIS . . . . . 0.61 ' CE1' ' OG ' ' A' ' 798' ' ' SER . 81.6 t60 -102.59 145.64 29.34 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.171 -0.956 . . . . 0.0 110.866 -179.919 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 795' ' ' SER . . . . . 0.576 ' O ' ' CD2' ' A' ' 794' ' ' HIS . 8.5 t -91.31 174.48 7.36 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.244 -0.91 . . . . 0.0 109.275 179.874 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 796' ' ' ILE . . . . . . . . . . . . . 1.5 mt -105.52 20.48 4.11 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.912 0 O-C-N 120.859 -1.151 . . . . 0.0 110.256 -179.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 797' ' ' ASN . . . . . 0.505 ' N ' ' OD1' ' A' ' 797' ' ' ASN . 1.6 m120 -132.5 36.22 3.58 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.427 -0.796 . . . . 0.0 109.083 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 798' ' ' SER . . . . . 0.61 ' OG ' ' CE1' ' A' ' 794' ' ' HIS . 0.9 OUTLIER -65.6 -56.31 12.89 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.724 -0.61 . . . . 0.0 111.285 -179.92 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 799' ' ' ASN . . . . . . . . . . . . . 4.5 m120 -86.41 14.27 6.95 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.135 -0.978 . . . . 0.0 111.368 -179.782 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 800' ' ' SER . . . . . . . . . . . . . 7.8 t -91.28 -62.64 1.4 Allowed 'General case' 0 C--N 1.299 -1.616 0 O-C-N 120.874 -1.141 . . . . 0.0 110.269 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 801' ' ' VAL . . . . . 0.455 ' CG1' ' OD1' ' A' ' 820' ' ' ASN . 49.3 t -68.11 -19.55 24.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.274 -0.891 . . . . 0.0 110.534 -179.918 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 802' ' ' LEU . . . . . 0.51 ' N ' ' CD2' ' A' ' 802' ' ' LEU . 4.2 mm? -69.05 -51.99 33.22 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.137 -0.977 . . . . 0.0 110.739 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 803' ' ' GLU . . . . . 0.523 ' HA ' ' CD1' ' A' ' 807' ' ' ILE . 4.1 tt0 -68.84 -17.76 64.05 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.034 -1.041 . . . . 0.0 110.721 -179.955 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 804' ' ' ARG . . . . . . . . . . . . . 17.9 mtp180 -91.45 -18.53 24.05 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.225 -0.922 . . . . 0.0 111.519 -179.884 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 805' ' ' LYS . . . . . 0.454 ' O ' ' SG ' ' A' ' 806' ' ' CYS . 19.8 mttt -124.49 26.96 7.11 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 120.857 -1.152 . . . . 0.0 111.882 -179.856 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 806' ' ' CYS . . . . . 0.515 ' HA ' ' CB ' ' A' ' 812' ' ' CYS . 1.7 m -160.87 18.69 0.13 Allowed 'General case' 0 N--CA 1.501 2.111 0 O-C-N 120.737 -1.227 . . . . 0.0 111.035 179.942 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 807' ' ' ILE . . . . . 0.523 ' CD1' ' HA ' ' A' ' 803' ' ' GLU . 1.7 mp -123.27 112.51 33.86 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.902 0 O-C-N 121.001 -1.062 . . . . 0.0 110.204 179.972 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 808' ' ' GLY . . . . . . . . . . . . . . . 116.73 -4.24 19.28 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 809' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -125.99 137.81 53.7 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.275 -1.132 . . . . 0.0 110.265 -179.944 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 810' ' ' GLU . . . . . 0.479 ' HG3' ' N ' ' A' ' 811' ' ' ARG . 0.4 OUTLIER -64.87 -17.82 64.62 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.219 -0.925 . . . . 0.0 108.965 179.886 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 811' ' ' ARG . . . . . 0.533 ' CD ' ' HB3' ' A' ' 763' ' ' LYS . 13.5 ttp85 -142.48 132.86 24.94 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.674 -0.641 . . . . 0.0 109.36 179.926 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 812' ' ' CYS . . . . . 0.515 ' CB ' ' HA ' ' A' ' 806' ' ' CYS . 15.4 p -142.02 146.86 36.01 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.171 -0.956 . . . . 0.0 110.764 -179.965 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 813' ' ' VAL . . . . . . . . . . . . . 67.0 t -120.67 135.62 60.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.44 -0.788 . . . . 0.0 110.014 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 814' ' ' VAL . . . . . . . . . . . . . 9.3 t -112.2 109.79 29.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.114 -0.991 . . . . 0.0 110.477 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 815' ' ' ALA . . . . . . . . . . . . . . . -70.77 121.26 17.67 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.259 -0.901 . . . . 0.0 110.097 179.89 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 816' ' ' ILE . . . . . 0.459 HG12 HG21 ' A' ' 833' ' ' VAL . 36.1 mt -81.66 104.42 10.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.185 -0.947 . . . . 0.0 110.273 -179.966 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 817' ' ' SER . . . . . 0.458 ' HB2' ' HD2' ' A' ' 818' ' ' PRO . 77.7 p -161.71 164.2 18.33 Favored Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.268 -0.895 . . . . 0.0 110.101 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 818' ' ' PRO . . . . . 0.458 ' HD2' ' HB2' ' A' ' 817' ' ' SER . 43.6 Cg_endo -71.92 -23.65 21.83 Favored 'Trans proline' 0 C--N 1.305 -1.751 0 O-C-N 124.04 1.548 . . . . 0.0 110.13 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 819' ' ' SER . . . . . . . . . . . . . 95.1 p -85.52 42.85 0.98 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.259 -0.901 . . . . 0.0 109.872 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 820' ' ' ASN . . . . . 0.455 ' OD1' ' CG1' ' A' ' 801' ' ' VAL . 28.6 t-20 -143.32 -46.37 0.29 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.283 -0.885 . . . . 0.0 110.13 -179.94 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 821' ' ' PHE . . . . . . . . . . . . . 80.5 m-85 -89.25 8.36 30.73 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.334 -0.854 . . . . 0.0 110.349 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 822' ' ' GLY . . . . . . . . . . . . . . . 87.09 52.72 3.01 Favored Glycine 0 N--CA 1.492 2.409 0 N-CA-C 109.901 -1.28 . . . . 0.0 109.901 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 823' ' ' GLY . . . . . . . . . . . . . . . 90.85 -174.96 39.75 Favored Glycine 0 N--CA 1.494 2.518 0 N-CA-C 109.779 -1.328 . . . . 0.0 109.779 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 824' ' ' ASP . . . . . . . . . . . . . 11.0 p-10 -125.34 150.56 67.81 Favored Pre-proline 0 N--CA 1.495 1.78 0 O-C-N 121.258 -1.142 . . . . 0.0 110.154 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 825' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -77.18 -62.94 0.03 OUTLIER 'Trans proline' 0 C--N 1.306 -1.703 0 O-C-N 124.042 1.549 . . . . 0.0 110.801 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 826' ' ' CYS . . . . . . . . . . . . . 6.0 p -122.98 117.69 28.41 Favored Pre-proline 0 N--CA 1.5 2.074 0 O-C-N 121.141 -0.975 . . . . 0.0 110.785 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 827' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_endo -88.48 168.34 6.1 Favored 'Trans proline' 0 C--N 1.311 -1.427 0 O-C-N 123.952 1.501 . . . . 0.0 110.739 179.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 828' ' ' GLU . . . . . . . . . . . . . 2.2 tp10 61.37 27.58 17.18 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.393 -0.817 . . . . 0.0 110.737 179.903 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 829' ' ' VAL . . . . . 0.426 ' O ' ' HD3' ' A' ' 831' ' ' LYS . 50.3 t -131.49 115.09 27.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.088 -1.008 . . . . 0.0 110.417 179.92 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 830' ' ' MET . . . . . 0.425 ' C ' ' O ' ' A' ' 829' ' ' VAL . 19.0 ptp -43.1 123.8 2.99 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.26 -0.9 . . . . 0.0 109.382 179.918 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 831' ' ' LYS . . . . . 0.426 ' HD3' ' O ' ' A' ' 829' ' ' VAL . 0.0 OUTLIER -109.23 179.16 4.24 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.105 -0.997 . . . . 0.0 111.545 -179.876 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 832' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -159.59 141.02 12.88 Favored 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 108.053 -1.092 . . . . 0.0 108.053 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 833' ' ' VAL . . . . . 0.459 HG21 HG12 ' A' ' 816' ' ' ILE . 60.6 t -110.48 139.87 32.09 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 120.741 -1.224 . . . . 0.0 112.05 -179.836 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 834' ' ' ALA . . . . . . . . . . . . . . . -139.02 111.96 7.88 Favored 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 179.862 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 835' ' ' VAL . . . . . 0.439 ' CG1' ' N ' ' A' ' 836' ' ' GLU . 40.8 t -129.28 163.55 34.14 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 120.923 -1.11 . . . . 0.0 111.848 -179.871 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 836' ' ' GLU . . . . . 0.441 ' HB2' ' HB3' ' A' ' 775' ' ' PHE . 0.1 OUTLIER -140.25 147.15 39.57 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 179.849 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 837' ' ' ALA . . . . . . . . . . . . . . . -128.01 165.52 20.15 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 120.856 -1.152 . . . . 0.0 111.349 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 838' ' ' VAL . . . . . . . . . . . . . 75.0 t -130.4 110.62 19.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.512 -0.743 . . . . 0.0 109.287 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 839' ' ' CYS . . . . . . . . . . . . . 68.4 m -107.51 133.51 51.89 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.147 -0.97 . . . . 0.0 110.777 -179.89 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 840' ' ' SER . . . . . . . . . . . . . 35.6 p -125.33 -139.64 0.28 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.482 -0.761 . . . . 0.0 109.857 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 841' ' ' THR . . . . . . . . . . . . . 32.6 p -131.94 144.17 50.64 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.117 -0.99 . . . . 0.0 110.177 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 842' ' ' ALA . . . . . 0.416 ' O ' ' OXT' ' A' ' 843' ' ' ALA . . . -115.52 73.67 0.85 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.38 -0.825 . . . . 0.0 110.174 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 843' ' ' ALA . . . . . 0.416 ' OXT' ' O ' ' A' ' 842' ' ' ALA . . . . . . . . 0 N--CA 1.491 1.62 0 CA-C-O 118.029 -0.986 . . . . 0.0 110.205 -179.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 726' ' ' ARG . . . . . . . . . . . . . 11.3 ptp85 . . . . . 0 N--CA 1.492 1.634 0 CA-C-O 121.279 0.561 . . . . 0.0 110.266 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 727' ' ' THR . . . . . . . . . . . . . 3.0 m -110.46 119.87 40.6 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.325 -0.859 . . . . 0.0 110.158 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 728' ' ' VAL . . . . . 0.479 HG22 ' N ' ' A' ' 729' ' ' SER . 13.5 p -128.25 155.72 40.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.264 -0.898 . . . . 0.0 110.394 -179.956 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 729' ' ' SER . . . . . 0.479 ' N ' HG22 ' A' ' 728' ' ' VAL . 89.0 p -172.57 -175.73 1.39 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.369 -0.832 . . . . 0.0 109.764 179.903 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 730' ' ' GLY . . . . . . . . . . . . . . . 155.28 65.69 0.01 OUTLIER Glycine 0 N--CA 1.489 2.203 0 C-N-CA 119.56 -1.305 . . . . 0.0 109.843 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 731' ' ' VAL . . . . . 0.531 ' CG2' ' SG ' ' A' ' 764' ' ' CYS . 6.5 t -122.65 152.02 26.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.325 -1.103 . . . . 0.0 109.983 179.966 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 732' ' ' CYS . . . . . . . . . . . . . 5.8 t -146.72 144.11 29.19 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.094 -1.004 . . . . 0.0 110.439 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 733' ' ' ALA . . . . . . . . . . . . . . . -135.89 107.73 7.08 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.344 -0.847 . . . . 0.0 109.907 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 734' ' ' ASP . . . . . . . . . . . . . 7.9 t0 -118.11 122.64 43.61 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.18 -0.95 . . . . 0.0 110.551 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 735' ' ' VAL . . . . . . . . . . . . . 45.8 t -129.15 162.45 36.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.287 -0.883 . . . . 0.0 109.856 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 736' ' ' SER . . . . . . . . . . . . . 9.7 t -110.36 139.87 45.13 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.108 -0.995 . . . . 0.0 110.441 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 737' ' ' GLU . . . . . 0.437 ' OE2' ' N ' ' A' ' 738' ' ' TYR . 0.0 OUTLIER -70.26 179.01 2.57 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.343 -0.848 . . . . 0.0 110.042 -179.994 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 738' ' ' TYR . . . . . 0.437 ' N ' ' OE2' ' A' ' 737' ' ' GLU . 22.0 t80 -164.55 115.73 1.23 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.203 -0.936 . . . . 0.0 110.197 179.987 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 739' ' ' HIS . . . . . . . . . . . . . 24.8 t-80 -170.54 101.31 0.43 Allowed Pre-proline 0 N--CA 1.492 1.648 0 O-C-N 121.292 -0.88 . . . . 0.0 110.221 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 740' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -74.97 154.4 42.6 Favored 'Trans proline' 0 C--N 1.304 -1.765 0 O-C-N 124.02 1.537 . . . . 0.0 110.323 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 741' ' ' ASN . . . . . . . . . . . . . 24.8 t-20 -70.16 119.37 14.25 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.2 -0.938 . . . . 0.0 110.028 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 742' ' ' ILE . . . . . 0.462 ' O ' ' HB2' ' A' ' 743' ' ' LYS . 11.8 pt -146.38 179.93 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.209 -0.932 . . . . 0.0 110.493 -179.913 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 743' ' ' LYS . . . . . 0.462 ' HB2' ' O ' ' A' ' 742' ' ' ILE . 44.1 tptt 174.15 -29.56 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.489 -0.757 . . . . 0.0 109.691 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 744' ' ' ASN . . . . . . . . . . . . . 3.6 t30 -143.28 119.08 10.52 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.39 -0.818 . . . . 0.0 109.519 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 745' ' ' TRP . . . . . . . . . . . . . 8.2 m95 -121.07 -59.8 1.7 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.104 -0.997 . . . . 0.0 110.848 -179.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 746' ' ' GLN . . . . . 0.429 ' O ' HG13 ' A' ' 747' ' ' ILE . 0.1 OUTLIER -116.81 168.72 9.96 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.041 -1.037 . . . . 0.0 110.72 -179.962 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 747' ' ' ILE . . . . . 0.457 ' O ' HG21 ' A' ' 747' ' ' ILE . 4.2 mp -142.72 56.18 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.356 -0.84 . . . . 0.0 110.198 179.972 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 748' ' ' GLU . . . . . . . . . . . . . 69.1 tt0 -140.86 -75.39 0.32 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.255 -0.903 . . . . 0.0 110.061 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 749' ' ' SER . . . . . . . . . . . . . 21.8 t -171.9 36.08 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.246 -0.909 . . . . 0.0 110.305 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 750' ' ' TYR . . . . . . . . . . . . . 49.1 m-85 -133.57 147.32 51.54 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.166 -0.958 . . . . 0.0 110.397 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 751' ' ' GLY . . . . . . . . . . . . . . . -110.68 -163.12 18.5 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 752' ' ' GLU . . . . . . . . . . . . . 3.5 tp10 -114.7 97.39 46.9 Favored Pre-proline 0 N--CA 1.494 1.769 0 O-C-N 121.316 -1.108 . . . . 0.0 110.159 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 753' ' ' PRO . . . . . 0.454 ' O ' ' HB3' ' A' ' 754' ' ' GLU . 50.5 Cg_endo -79.82 102.98 1.52 Allowed 'Trans proline' 0 C--N 1.307 -1.645 0 O-C-N 124.048 1.552 . . . . 0.0 110.7 -179.936 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 754' ' ' GLU . . . . . 0.517 ' HG3' ' CE1' ' A' ' 756' ' ' HIS . 6.7 pt-20 -177.81 -177.43 0.64 Allowed 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.24 -0.913 . . . . 0.0 110.336 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 755' ' ' PHE . . . . . 0.446 ' O ' ' CD2' ' A' ' 756' ' ' HIS . 0.2 OUTLIER -95.61 164.56 12.73 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.279 -0.888 . . . . 0.0 110.17 -179.965 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 756' ' ' HIS . . . . . 0.517 ' CE1' ' HG3' ' A' ' 754' ' ' GLU . 41.9 m80 -148.18 13.08 0.97 Allowed 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.176 -0.952 . . . . 0.0 110.547 -179.989 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 757' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -146.88 168.31 21.75 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.129 -0.982 . . . . 0.0 110.585 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 758' ' ' ALA . . . . . . . . . . . . . . . -106.27 177.94 4.71 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.41 -0.806 . . . . 0.0 109.856 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 759' ' ' LYS . . . . . . . . . . . . . 3.9 mttp -132.41 147.79 52.39 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.202 -0.936 . . . . 0.0 110.499 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 760' ' ' VAL . . . . . 0.503 ' CG2' ' CD1' ' A' ' 816' ' ' ILE . 13.3 t -110.27 132.36 58.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.322 -0.861 . . . . 0.0 109.595 179.942 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 761' ' ' HIS . . . . . . . . . . . . . 29.5 m80 -120.78 119.56 33.09 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.108 -0.995 . . . . 0.0 110.923 -179.902 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 762' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -115.0 117.37 30.42 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.372 -0.83 . . . . 0.0 109.011 179.829 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 763' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -136.27 120.43 17.79 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.012 -1.055 . . . . 0.0 111.315 -179.895 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 764' ' ' CYS . . . . . 0.531 ' SG ' ' CG2' ' A' ' 731' ' ' VAL . 1.2 m -99.4 177.54 5.15 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.491 -0.755 . . . . 0.0 109.81 179.86 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 765' ' ' ALA . . . . . 0.488 ' CB ' ' OE1' ' A' ' 768' ' ' GLN . . . -60.39 161.41 13.88 Favored Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.193 -0.942 . . . . 0.0 109.856 179.969 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 766' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -69.89 136.45 32.69 Favored 'Trans proline' 0 C--N 1.306 -1.691 0 O-C-N 123.897 1.472 . . . . 0.0 110.296 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 767' ' ' GLY . . . . . . . . . . . . . . . 93.54 -30.85 6.9 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.04 -1.624 . . . . 0.0 109.04 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 768' ' ' GLN . . . . . 0.488 ' OE1' ' CB ' ' A' ' 765' ' ' ALA . 10.5 mt-30 -82.75 105.85 14.1 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.331 -1.099 . . . . 0.0 110.076 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 769' ' ' THR . . . . . . . . . . . . . 26.6 p -95.81 146.59 24.43 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.176 -0.953 . . . . 0.0 110.367 179.916 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 770' ' ' ILE . . . . . . . . . . . . . 47.8 mt -76.62 139.47 18.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.356 -0.84 . . . . 0.0 109.675 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 771' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -137.55 -2.67 1.95 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.982 -1.074 . . . . 0.0 111.272 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 772' ' ' ALA . . . . . . . . . . . . . . . -155.99 119.42 4.33 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.763 -1.21 . . . . 0.0 111.075 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 773' ' ' ILE . . . . . . . . . . . . . 33.3 mm -83.26 126.2 40.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.322 -0.862 . . . . 0.0 109.324 179.916 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 774' ' ' LYS . . . . . 0.49 ' CB ' ' OE1' ' A' ' 836' ' ' GLU . 0.1 OUTLIER -82.54 -38.62 23.48 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.111 -0.993 . . . . 0.0 110.766 -179.909 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 775' ' ' PHE . . . . . 0.548 ' CE1' ' OG ' ' A' ' 777' ' ' SER . 11.7 t80 -179.41 133.64 0.11 Allowed 'General case' 0 N--CA 1.496 1.859 0 O-C-N 120.858 -1.151 . . . . 0.0 111.374 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 776' ' ' ALA . . . . . 0.505 ' O ' ' HB3' ' A' ' 798' ' ' SER . . . -151.14 88.91 1.48 Allowed 'General case' 0 N--CA 1.495 1.785 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 179.904 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 777' ' ' SER . . . . . 0.548 ' OG ' ' CE1' ' A' ' 775' ' ' PHE . 8.7 p -102.52 165.59 11.01 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.218 -0.926 . . . . 0.0 111.425 -179.77 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 778' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -126.53 101.11 6.53 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.593 -0.692 . . . . 0.0 109.74 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 779' ' ' GLY . . . . . 0.459 ' O ' ' HG2' ' A' ' 832' ' ' ARG . . . 156.66 -109.55 0.41 Allowed Glycine 0 N--CA 1.493 2.454 0 N-CA-C 109.381 -1.488 . . . . 0.0 109.381 179.903 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 780' ' ' THR . . . . . 0.463 ' O ' ' HA3' ' A' ' 791' ' ' GLY . 76.3 p -127.78 101.19 23.8 Favored Pre-proline 0 N--CA 1.493 1.719 0 O-C-N 121.231 -1.158 . . . . 0.0 110.086 179.965 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 781' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -77.34 173.04 14.92 Favored 'Trans proline' 0 C--N 1.305 -1.751 0 O-C-N 124.082 1.569 . . . . 0.0 110.549 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 782' ' ' LEU . . . . . . . . . . . . . 1.1 mt -130.81 98.41 4.61 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.311 -0.868 . . . . 0.0 110.165 179.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 783' ' ' GLY . . . . . . . . . . . . . . . 139.49 -164.3 25.99 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 -180.0 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 784' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -119.94 -169.05 1.71 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.157 -1.202 . . . . 0.0 110.173 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 785' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -62.47 93.87 0.06 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.246 -0.909 . . . . 0.0 110.22 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 786' ' ' GLY . . . . . . . . . . . . . . . 146.3 -28.35 1.67 Allowed Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.468 -1.453 . . . . 0.0 109.468 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 787' ' ' THR . . . . . . . . . . . . . 66.3 p -127.2 27.32 5.92 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.24 -1.153 . . . . 0.0 110.207 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 788' ' ' PHE . . . . . 0.581 ' CZ ' ' HB3' ' A' ' 834' ' ' ALA . 2.9 m-85 -52.41 110.62 0.52 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.371 -0.831 . . . . 0.0 110.196 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 789' ' ' GLN . . . . . 0.453 ' HG3' ' N ' ' A' ' 790' ' ' GLN . 7.2 tp60 -127.53 153.36 46.44 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.298 -0.876 . . . . 0.0 110.058 179.965 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 790' ' ' GLN . . . . . 0.498 ' CG ' ' O ' ' A' ' 790' ' ' GLN . 7.5 pt20 -52.27 114.71 1.43 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.249 -0.907 . . . . 0.0 110.28 179.997 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 791' ' ' GLY . . . . . 0.463 ' HA3' ' O ' ' A' ' 780' ' ' THR . . . -66.47 -105.87 0.01 OUTLIER Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.384 -1.486 . . . . 0.0 109.384 -179.978 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 792' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -113.61 -31.67 6.42 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.282 -1.128 . . . . 0.0 110.128 -179.956 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 793' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -121.55 98.22 5.87 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.278 -0.889 . . . . 0.0 110.393 -179.935 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 794' ' ' HIS . . . . . 0.606 ' CE1' ' CB ' ' A' ' 798' ' ' SER . 66.3 t60 -107.29 131.17 54.5 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.122 -0.986 . . . . 0.0 109.966 179.948 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 795' ' ' SER . . . . . 0.46 ' O ' ' O ' ' A' ' 794' ' ' HIS . 6.3 t -61.59 -141.14 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.172 -0.955 . . . . 0.0 109.453 179.893 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 796' ' ' ILE . . . . . 0.412 HG22 HD12 ' A' ' 796' ' ' ILE . 3.4 mt -136.5 -43.69 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 O-C-N 121.11 -0.994 . . . . 0.0 109.707 179.942 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 797' ' ' ASN . . . . . 0.414 ' O ' ' C ' ' A' ' 798' ' ' SER . 44.8 m-20 -82.36 10.76 6.44 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.36 -0.838 . . . . 0.0 109.46 179.864 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 798' ' ' SER . . . . . 0.606 ' CB ' ' CE1' ' A' ' 794' ' ' HIS . 1.6 m -35.75 -68.69 0.12 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.747 -0.596 . . . . 0.0 111.612 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 799' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -93.95 -26.21 16.94 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.066 -1.021 . . . . 0.0 110.883 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 800' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -50.78 -22.39 2.11 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 120.973 -1.079 . . . . 0.0 110.181 179.965 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 801' ' ' VAL . . . . . 0.492 HG22 ' CD2' ' A' ' 821' ' ' PHE . 25.1 t -84.77 -41.47 15.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.275 -0.891 . . . . 0.0 110.427 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 802' ' ' LEU . . . . . 0.57 ' N ' ' CD2' ' A' ' 802' ' ' LEU . 4.0 mm? -66.2 -41.17 90.57 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.329 -0.857 . . . . 0.0 110.94 -179.933 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 803' ' ' GLU . . . . . 0.421 ' C ' ' O ' ' A' ' 802' ' ' LEU . 8.9 mt-10 -41.88 -47.63 4.28 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.216 -0.927 . . . . 0.0 110.681 -179.935 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 804' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -92.92 -28.21 16.61 Favored 'General case' 0 N--CA 1.503 2.177 0 O-C-N 121.135 -0.978 . . . . 0.0 111.987 -179.834 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 805' ' ' LYS . . . . . 0.479 ' HB2' ' O ' ' A' ' 801' ' ' VAL . 1.0 OUTLIER -89.66 26.98 1.6 Allowed 'General case' 0 N--CA 1.498 1.942 0 O-C-N 120.967 -1.083 . . . . 0.0 111.492 -179.807 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 806' ' ' CYS . . . . . 0.543 ' HA ' ' CB ' ' A' ' 812' ' ' CYS . 13.2 m -158.44 -66.64 0.09 Allowed 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.043 -1.035 . . . . 0.0 110.745 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 807' ' ' ILE . . . . . 0.419 ' C ' ' O ' ' A' ' 806' ' ' CYS . 17.5 mt -41.56 123.51 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.978 0 O-C-N 121.186 -0.947 . . . . 0.0 110.973 -179.933 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 808' ' ' GLY . . . . . 0.451 ' C ' ' HG ' ' A' ' 809' ' ' LEU . . . 115.68 -9.92 19.08 Favored Glycine 0 N--CA 1.494 2.528 0 N-CA-C 110.167 -1.173 . . . . 0.0 110.167 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 809' ' ' LEU . . . . . 0.451 ' HG ' ' C ' ' A' ' 808' ' ' GLY . 1.7 mt -132.94 151.45 52.05 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.061 -1.258 . . . . 0.0 110.306 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 810' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -73.79 -14.95 61.19 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.152 -0.968 . . . . 0.0 109.777 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 811' ' ' ARG . . . . . 0.492 ' CG ' ' O ' ' A' ' 811' ' ' ARG . 10.2 ptm180 -155.72 122.43 5.28 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.343 -0.848 . . . . 0.0 110.068 179.9 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 812' ' ' CYS . . . . . 0.543 ' CB ' ' HA ' ' A' ' 806' ' ' CYS . 31.9 p -122.73 151.71 41.31 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.227 -0.921 . . . . 0.0 110.608 -179.966 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 813' ' ' VAL . . . . . . . . . . . . . 5.8 t -121.69 152.53 25.44 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.32 -0.862 . . . . 0.0 110.329 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 814' ' ' VAL . . . . . . . . . . . . . 88.9 t -148.93 104.19 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.272 -0.892 . . . . 0.0 110.357 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 815' ' ' ALA . . . . . . . . . . . . . . . -62.21 153.64 29.82 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.19 -0.944 . . . . 0.0 110.127 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 816' ' ' ILE . . . . . 0.503 ' CD1' ' CG2' ' A' ' 760' ' ' VAL . 11.3 mt -107.5 130.77 59.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.163 -0.96 . . . . 0.0 110.109 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 817' ' ' SER . . . . . 0.438 ' OG ' ' HB2' ' A' ' 820' ' ' ASN . 1.4 p -164.11 163.64 15.17 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.259 -0.901 . . . . 0.0 110.037 179.944 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 818' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -74.48 -7.61 19.75 Favored 'Trans proline' 0 C--N 1.303 -1.857 0 O-C-N 124.08 1.568 . . . . 0.0 110.36 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 819' ' ' SER . . . . . . . . . . . . . 3.2 t -128.4 53.14 1.84 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.311 -0.868 . . . . 0.0 110.04 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 820' ' ' ASN . . . . . 0.438 ' HB2' ' OG ' ' A' ' 817' ' ' SER . 0.4 OUTLIER -129.46 -40.0 1.45 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.199 -0.938 . . . . 0.0 110.281 -179.942 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 821' ' ' PHE . . . . . 0.492 ' CD2' HG22 ' A' ' 801' ' ' VAL . 60.1 m-85 -85.93 -60.03 2.13 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.307 -0.87 . . . . 0.0 110.254 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 822' ' ' GLY . . . . . . . . . . . . . . . 155.72 37.88 0.02 OUTLIER Glycine 0 N--CA 1.492 2.422 0 N-CA-C 109.67 -1.372 . . . . 0.0 109.67 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 823' ' ' GLY . . . . . . . . . . . . . . . 137.72 -151.92 21.46 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.819 -1.313 . . . . 0.0 109.819 180.0 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 824' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -141.62 153.68 65.43 Favored Pre-proline 0 N--CA 1.494 1.731 0 O-C-N 121.332 -1.099 . . . . 0.0 110.157 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 825' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -73.33 -94.41 0.01 OUTLIER 'Trans proline' 0 C--N 1.305 -1.724 0 O-C-N 124.073 1.565 . . . . 0.0 110.505 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 826' ' ' CYS . . . . . . . . . . . . . 61.0 m -128.06 134.13 25.89 Favored Pre-proline 0 N--CA 1.494 1.741 0 O-C-N 121.136 -0.977 . . . . 0.0 110.032 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 827' ' ' PRO . . . . . 0.534 ' O ' ' CG ' ' A' ' 828' ' ' GLU . 50.8 Cg_endo -82.87 -171.58 1.18 Allowed 'Trans proline' 0 C--N 1.306 -1.683 0 O-C-N 124.156 1.608 . . . . 0.0 111.133 -179.941 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 828' ' ' GLU . . . . . 0.534 ' CG ' ' O ' ' A' ' 827' ' ' PRO . 15.5 pt-20 39.28 34.76 0.13 Allowed 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.678 -0.639 . . . . 0.0 110.65 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 829' ' ' VAL . . . . . 0.472 ' O ' ' HD2' ' A' ' 831' ' ' LYS . 23.4 t -144.1 161.34 15.48 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.309 -0.869 . . . . 0.0 109.757 179.904 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 830' ' ' MET . . . . . 0.41 ' O ' ' HD2' ' A' ' 831' ' ' LYS . 3.2 mtp -59.12 171.17 0.76 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.031 -1.043 . . . . 0.0 109.626 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 831' ' ' LYS . . . . . 0.472 ' HD2' ' O ' ' A' ' 829' ' ' VAL . 0.6 OUTLIER -147.99 128.63 14.17 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.015 -1.053 . . . . 0.0 110.967 -179.951 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 832' ' ' ARG . . . . . 0.459 ' HG2' ' O ' ' A' ' 779' ' ' GLY . 0.0 OUTLIER -156.49 152.14 27.01 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.443 -0.786 . . . . 0.0 109.65 179.926 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 833' ' ' VAL . . . . . . . . . . . . . 28.6 t -111.16 144.09 19.75 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 O-C-N 121.116 -0.99 . . . . 0.0 110.882 -179.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 834' ' ' ALA . . . . . 0.581 ' HB3' ' CZ ' ' A' ' 788' ' ' PHE . . . -147.9 136.67 21.85 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.325 -0.859 . . . . 0.0 109.291 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 835' ' ' VAL . . . . . 0.453 HG22 ' HB2' ' A' ' 776' ' ' ALA . 75.5 t -148.47 154.4 10.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 120.912 -1.118 . . . . 0.0 111.204 -179.931 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 836' ' ' GLU . . . . . 0.49 ' OE1' ' CB ' ' A' ' 774' ' ' LYS . 16.3 tt0 -141.28 117.48 10.67 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 179.944 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 837' ' ' ALA . . . . . . . . . . . . . . . -107.34 162.97 13.43 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.022 -1.049 . . . . 0.0 111.377 -179.836 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 838' ' ' VAL . . . . . . . . . . . . . 90.9 t -121.58 107.66 20.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.647 -0.658 . . . . 0.0 109.841 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 839' ' ' CYS . . . . . 0.441 ' O ' ' O ' ' A' ' 728' ' ' VAL . 15.5 p -115.74 122.29 45.04 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.065 -1.022 . . . . 0.0 110.785 -179.986 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 840' ' ' SER . . . . . 0.412 ' O ' ' HA ' ' A' ' 768' ' ' GLN . 1.2 p -106.46 150.19 26.32 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.558 -0.713 . . . . 0.0 109.579 179.907 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 841' ' ' THR . . . . . 0.453 ' HA ' ' HG2' ' A' ' 768' ' ' GLN . 5.4 t -71.64 165.02 24.83 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.121 -0.987 . . . . 0.0 110.549 -179.931 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 842' ' ' ALA . . . . . . . . . . . . . . . -138.6 73.79 1.45 Allowed 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.476 -0.765 . . . . 0.0 110.007 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 843' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 1.761 0 CA-C-O 118.034 -0.984 . . . . 0.0 110.222 179.966 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 726' ' ' ARG . . . . . . . . . . . . . 12.1 ttm180 . . . . . 0 N--CA 1.492 1.626 0 CA-C-O 121.227 0.537 . . . . 0.0 110.233 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 727' ' ' THR . . . . . . . . . . . . . 40.3 m -153.27 105.6 2.89 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.282 -0.886 . . . . 0.0 110.327 -179.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 728' ' ' VAL . . . . . 0.405 ' O ' ' O ' ' A' ' 839' ' ' CYS . 12.0 t -94.73 138.85 19.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.252 -0.905 . . . . 0.0 110.083 -179.945 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 729' ' ' SER . . . . . 0.487 ' HA ' ' O ' ' A' ' 839' ' ' CYS . 39.0 t -160.05 41.11 0.19 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.241 -0.912 . . . . 0.0 110.625 -179.949 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 730' ' ' GLY . . . . . . . . . . . . . . . 178.25 108.44 0.23 Allowed Glycine 0 N--CA 1.49 2.297 0 C-N-CA 119.575 -1.298 . . . . 0.0 110.154 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 731' ' ' VAL . . . . . 0.434 HG22 ' HB2' ' A' ' 839' ' ' CYS . 39.0 t -112.33 164.65 8.0 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 121.361 -1.082 . . . . 0.0 109.455 179.841 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 732' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -134.24 158.72 43.0 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.036 -1.04 . . . . 0.0 110.881 -179.876 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 733' ' ' ALA . . . . . 0.471 ' HB1' ' CD2' ' A' ' 762' ' ' LEU . . . -161.7 133.38 5.51 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.335 -0.853 . . . . 0.0 109.925 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 734' ' ' ASP . . . . . 0.463 ' O ' HG23 ' A' ' 735' ' ' VAL . 30.2 m-20 -150.15 111.14 4.34 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.119 -0.988 . . . . 0.0 110.464 179.901 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 735' ' ' VAL . . . . . 0.463 HG23 ' O ' ' A' ' 734' ' ' ASP . 40.4 t -139.99 163.45 24.27 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.326 -0.859 . . . . 0.0 109.816 179.977 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 736' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -75.87 -175.1 2.87 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.164 -0.96 . . . . 0.0 110.108 -179.973 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 737' ' ' GLU . . . . . 0.456 ' O ' ' HB3' ' A' ' 758' ' ' ALA . 0.0 OUTLIER -98.9 -160.21 0.79 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.204 -0.935 . . . . 0.0 110.336 179.965 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 738' ' ' TYR . . . . . 0.513 ' CG ' ' N ' ' A' ' 739' ' ' HIS . 9.1 t80 -80.18 167.04 20.83 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.418 -0.801 . . . . 0.0 110.525 -179.948 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 739' ' ' HIS . . . . . 0.595 ' CD2' ' O ' ' A' ' 739' ' ' HIS . 0.3 OUTLIER -156.88 136.78 8.61 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.397 -0.814 . . . . 0.0 110.088 179.938 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 740' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -78.13 -18.33 12.87 Favored 'Trans proline' 0 C--N 1.307 -1.62 0 O-C-N 123.983 1.518 . . . . 0.0 111.063 -179.87 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 741' ' ' ASN . . . . . 0.551 ' O ' ' CE1' ' A' ' 739' ' ' HIS . 10.4 t-20 -100.1 145.58 27.8 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.108 -0.995 . . . . 0.0 110.325 -179.94 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 742' ' ' ILE . . . . . . . . . . . . . 32.4 mm -98.69 123.65 51.4 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 O-C-N 121.243 -0.911 . . . . 0.0 110.344 179.956 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 743' ' ' LYS . . . . . 0.456 ' HE2' ' HA ' ' A' ' 743' ' ' LYS . 0.1 OUTLIER -145.02 11.02 1.35 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.194 -0.941 . . . . 0.0 110.28 179.991 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 744' ' ' ASN . . . . . . . . . . . . . 31.3 p30 -104.14 7.72 36.27 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.235 -0.916 . . . . 0.0 110.073 -179.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 745' ' ' TRP . . . . . 0.567 ' CZ3' ' HG2' ' A' ' 748' ' ' GLU . 0.0 OUTLIER -133.72 124.74 27.21 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.293 -0.879 . . . . 0.0 110.013 179.961 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 746' ' ' GLN . . . . . . . . . . . . . 2.3 tp60 -140.38 30.95 1.92 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.22 -0.925 . . . . 0.0 110.309 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 747' ' ' ILE . . . . . 0.517 ' O ' ' CG2' ' A' ' 747' ' ' ILE . 28.5 mt -134.4 15.54 1.23 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.109 -0.995 . . . . 0.0 110.077 179.967 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 748' ' ' GLU . . . . . 0.567 ' HG2' ' CZ3' ' A' ' 745' ' ' TRP . 18.7 mp0 -120.22 -155.48 0.62 Allowed 'General case' 0 C--N 1.295 -1.792 0 O-C-N 121.369 -0.832 . . . . 0.0 109.626 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 749' ' ' SER . . . . . 0.477 ' O ' ' HB2' ' A' ' 750' ' ' TYR . 40.0 t -83.43 17.83 2.02 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.013 -1.055 . . . . 0.0 110.518 179.982 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 750' ' ' TYR . . . . . 0.477 ' HB2' ' O ' ' A' ' 749' ' ' SER . 28.6 m-85 59.17 110.67 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.262 -0.899 . . . . 0.0 110.858 179.903 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 751' ' ' GLY . . . . . . . . . . . . . . . 99.57 86.82 1.91 Allowed Glycine 0 N--CA 1.491 2.326 0 N-CA-C 110.069 -1.213 . . . . 0.0 110.069 179.939 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 752' ' ' GLU . . . . . . . . . . . . . 5.9 tm-20 -96.7 127.22 40.23 Favored Pre-proline 0 N--CA 1.493 1.71 0 O-C-N 121.203 -1.175 . . . . 0.0 109.844 179.897 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 753' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo -78.49 144.61 20.24 Favored 'Trans proline' 0 C--N 1.308 -1.582 0 O-C-N 123.938 1.494 . . . . 0.0 111.213 -179.943 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 754' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER 59.61 50.65 7.08 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.483 -0.761 . . . . 0.0 111.218 179.951 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 755' ' ' PHE . . . . . . . . . . . . . 45.9 p90 -78.18 -167.59 1.07 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.083 -1.011 . . . . 0.0 109.296 179.917 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 756' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -128.04 172.1 11.25 Favored 'General case' 0 N--CA 1.503 2.178 0 O-C-N 120.808 -1.183 . . . . 0.0 111.433 -179.921 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 757' ' ' THR . . . . . 0.469 HG23 ' CD2' ' A' ' 738' ' ' TYR . 66.2 p -97.4 159.05 15.15 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.617 -0.677 . . . . 0.0 110.155 179.984 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 758' ' ' ALA . . . . . 0.456 ' HB3' ' O ' ' A' ' 737' ' ' GLU . . . -58.95 121.77 12.01 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.211 -0.931 . . . . 0.0 109.713 179.902 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 759' ' ' LYS . . . . . 0.515 ' CG ' ' HA ' ' A' ' 815' ' ' ALA . 13.6 mttt -109.16 163.34 13.44 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.145 -0.972 . . . . 0.0 110.847 -179.928 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 760' ' ' VAL . . . . . 0.52 ' CG1' HD12 ' A' ' 762' ' ' LEU . 52.1 t -106.55 131.05 57.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 179.895 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 761' ' ' HIS . . . . . . . . . . . . . 10.8 m80 -112.57 110.35 20.46 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 120.923 -1.111 . . . . 0.0 112.365 -179.736 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 762' ' ' LEU . . . . . 0.52 HD12 ' CG1' ' A' ' 760' ' ' VAL . 1.0 OUTLIER -121.79 105.0 9.98 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 107.477 -1.305 . . . . 0.0 107.477 179.788 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 763' ' ' LYS . . . . . 0.44 ' CB ' ' HG3' ' A' ' 811' ' ' ARG . 0.0 OUTLIER -129.44 150.96 50.57 Favored 'General case' 0 C--N 1.297 -1.696 0 O-C-N 120.87 -1.144 . . . . 0.0 112.168 -179.7 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 764' ' ' CYS . . . . . 0.431 ' O ' ' C ' ' A' ' 765' ' ' ALA . 18.4 m -125.08 164.11 20.92 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 109.19 -0.671 . . . . 0.0 109.19 179.875 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 765' ' ' ALA . . . . . 0.44 ' HB2' ' NE2' ' A' ' 768' ' ' GLN . . . -43.88 154.54 0.36 Allowed Pre-proline 0 N--CA 1.491 1.609 0 O-C-N 120.994 -1.067 . . . . 0.0 110.055 179.982 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 766' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -69.72 99.26 0.73 Allowed 'Trans proline' 0 C--N 1.304 -1.786 0 O-C-N 123.989 1.521 . . . . 0.0 110.089 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 767' ' ' GLY . . . . . . . . . . . . . . . 144.69 -30.77 1.81 Allowed Glycine 0 N--CA 1.488 2.139 0 N-CA-C 108.998 -1.641 . . . . 0.0 108.998 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 768' ' ' GLN . . . . . 0.533 ' HG2' ' N ' ' A' ' 841' ' ' THR . 4.1 mt-30 -85.76 156.74 20.49 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.433 -1.039 . . . . 0.0 109.875 179.908 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 769' ' ' THR . . . . . 0.46 HG23 ' HG3' ' A' ' 810' ' ' GLU . 23.0 p -138.04 145.76 42.2 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.202 -0.936 . . . . 0.0 110.296 -179.969 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 770' ' ' ILE . . . . . . . . . . . . . 70.3 mt -68.46 127.1 29.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.312 -0.868 . . . . 0.0 109.202 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 771' ' ' SER . . . . . 0.473 ' O ' ' HB1' ' A' ' 772' ' ' ALA . 8.5 p -103.6 -8.71 19.78 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.216 -0.928 . . . . 0.0 111.419 -179.893 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 772' ' ' ALA . . . . . 0.473 ' HB1' ' O ' ' A' ' 771' ' ' SER . . . -177.92 151.03 0.66 Allowed 'General case' 0 N--CA 1.495 1.796 0 O-C-N 120.73 -1.231 . . . . 0.0 111.805 -179.959 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 773' ' ' ILE . . . . . . . . . . . . . 33.6 mm -100.15 141.91 16.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 179.784 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 774' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -108.88 -24.13 11.4 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.826 -1.171 . . . . 0.0 111.733 -179.804 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 775' ' ' PHE . . . . . . . . . . . . . 80.8 t80 -154.76 161.44 41.51 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 120.726 -1.234 . . . . 0.0 111.505 -179.854 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 776' ' ' ALA . . . . . 0.449 ' O ' ' HB3' ' A' ' 798' ' ' SER . . . 178.58 111.24 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.626 -0.671 . . . . 0.0 109.485 179.964 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 777' ' ' SER . . . . . . . . . . . . . 48.3 p -144.66 113.71 6.89 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.077 -1.014 . . . . 0.0 110.681 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 778' ' ' PHE . . . . . 0.467 ' CG ' ' O ' ' A' ' 778' ' ' PHE . 8.6 t80 -91.26 78.46 5.78 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.292 -0.88 . . . . 0.0 110.046 179.943 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 779' ' ' GLY . . . . . . . . . . . . . . . -165.12 -123.26 0.64 Allowed Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.829 -1.309 . . . . 0.0 109.829 -179.946 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 780' ' ' THR . . . . . . . . . . . . . 27.9 p -120.46 78.75 28.37 Favored Pre-proline 0 N--CA 1.493 1.688 0 O-C-N 121.344 -1.092 . . . . 0.0 110.396 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 781' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -79.44 175.72 10.4 Favored 'Trans proline' 0 C--N 1.304 -1.78 0 O-C-N 123.95 1.5 . . . . 0.0 110.556 -179.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 782' ' ' LEU . . . . . . . . . . . . . 3.9 mt -143.47 134.98 26.22 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.296 -0.878 . . . . 0.0 110.032 179.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 783' ' ' GLY . . . . . . . . . . . . . . . 144.1 -174.52 24.39 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 -179.937 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 784' ' ' THR . . . . . 0.463 ' O ' ' O ' ' A' ' 785' ' ' CYS . 0.0 OUTLIER -145.64 66.82 1.21 Allowed 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.213 -1.169 . . . . 0.0 110.257 179.993 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 785' ' ' CYS . . . . . 0.463 ' O ' ' O ' ' A' ' 784' ' ' THR . 44.6 t 57.44 114.76 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.303 -0.873 . . . . 0.0 110.351 179.974 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 786' ' ' GLY . . . . . . . . . . . . . . . 109.47 -17.78 30.7 Favored Glycine 0 N--CA 1.489 2.197 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 -179.932 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 787' ' ' THR . . . . . 0.468 ' O ' HG23 ' A' ' 787' ' ' THR . 12.2 t -158.63 48.23 0.35 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.162 -1.199 . . . . 0.0 110.485 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 788' ' ' PHE . . . . . 0.436 ' CE2' ' HA ' ' A' ' 785' ' ' CYS . 41.5 m-85 -58.34 149.69 24.0 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.109 -0.994 . . . . 0.0 109.984 -179.987 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 789' ' ' GLN . . . . . . . . . . . . . 2.0 tt0 -136.04 162.22 33.51 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.158 -0.964 . . . . 0.0 110.408 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 790' ' ' GLN . . . . . 0.434 ' HG2' ' N ' ' A' ' 791' ' ' GLY . 1.8 tt0 -93.81 144.67 25.21 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.177 -0.952 . . . . 0.0 110.202 -179.993 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 791' ' ' GLY . . . . . 0.434 ' N ' ' HG2' ' A' ' 790' ' ' GLN . . . -96.95 -142.0 12.83 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.361 -1.496 . . . . 0.0 109.361 -179.955 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 792' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -93.63 -36.91 12.13 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.253 -1.145 . . . . 0.0 109.74 179.944 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 793' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -100.64 153.62 19.26 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.42 -0.8 . . . . 0.0 110.264 179.975 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 794' ' ' HIS . . . . . 0.471 ' NE2' ' O ' ' A' ' 795' ' ' SER . 26.4 t60 -176.82 143.17 0.43 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.154 -0.966 . . . . 0.0 110.266 179.956 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 795' ' ' SER . . . . . 0.471 ' O ' ' NE2' ' A' ' 794' ' ' HIS . 58.4 p -73.69 143.62 46.13 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.311 -0.868 . . . . 0.0 109.382 179.934 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 796' ' ' ILE . . . . . . . . . . . . . 9.6 mt -90.99 42.15 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.199 -0.938 . . . . 0.0 109.768 -179.916 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 797' ' ' ASN . . . . . . . . . . . . . 10.6 t30 -159.61 23.02 0.18 Allowed 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.519 -0.738 . . . . 0.0 109.597 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 798' ' ' SER . . . . . 0.449 ' HB3' ' O ' ' A' ' 776' ' ' ALA . 0.6 OUTLIER -57.75 -71.63 0.1 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.571 -0.706 . . . . 0.0 111.563 -179.878 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 799' ' ' ASN . . . . . . . . . . . . . 1.4 m120 -61.92 -7.25 3.53 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.305 -0.872 . . . . 0.0 111.861 -179.801 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 800' ' ' SER . . . . . . . . . . . . . 1.3 t -74.03 -33.41 63.74 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.775 -1.203 . . . . 0.0 110.311 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 801' ' ' VAL . . . . . . . . . . . . . 59.1 t -90.83 -18.59 7.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.244 -0.91 . . . . 0.0 110.315 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 802' ' ' LEU . . . . . 0.477 HD23 ' N ' ' A' ' 802' ' ' LEU . 3.5 mm? -81.43 -45.89 15.38 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.247 -0.908 . . . . 0.0 111.182 -179.831 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 803' ' ' GLU . . . . . 0.404 ' HA ' HD12 ' A' ' 807' ' ' ILE . 4.8 tm-20 -74.4 -21.66 59.54 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.024 -1.048 . . . . 0.0 111.232 -179.993 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 804' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -94.44 -17.35 22.57 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.06 -1.025 . . . . 0.0 112.266 -179.853 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 805' ' ' LYS . . . . . . . . . . . . . 6.4 tttt -138.49 45.04 2.07 Favored 'General case' 0 N--CA 1.503 2.187 0 O-C-N 120.466 -1.396 . . . . 0.0 112.603 -179.879 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 806' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -163.17 -37.38 0.04 OUTLIER 'General case' 0 N--CA 1.498 1.96 0 O-C-N 120.686 -1.259 . . . . 0.0 110.613 179.918 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 807' ' ' ILE . . . . . 0.404 HD12 ' HA ' ' A' ' 803' ' ' GLU . 18.3 mt -70.7 113.5 6.95 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.636 0 O-C-N 121.299 -0.875 . . . . 0.0 110.998 -179.883 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 808' ' ' GLY . . . . . 0.48 ' C ' ' HG ' ' A' ' 809' ' ' LEU . . . 119.35 19.03 4.34 Favored Glycine 0 N--CA 1.494 2.506 0 C-N-CA 119.856 -1.164 . . . . 0.0 110.506 179.88 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 809' ' ' LEU . . . . . 0.48 ' HG ' ' C ' ' A' ' 808' ' ' GLY . 40.5 mt -142.19 142.77 32.71 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 120.883 -1.363 . . . . 0.0 110.629 -179.991 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 810' ' ' GLU . . . . . 0.46 ' HG3' HG23 ' A' ' 769' ' ' THR . 2.2 mt-10 -66.8 -27.6 67.71 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.275 -0.891 . . . . 0.0 109.24 179.959 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 811' ' ' ARG . . . . . 0.44 ' HG3' ' CB ' ' A' ' 763' ' ' LYS . 6.8 ttt85 -125.35 154.49 41.75 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.508 -0.745 . . . . 0.0 109.927 179.972 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 812' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -137.34 124.03 21.09 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.211 -0.93 . . . . 0.0 110.535 -179.982 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 813' ' ' VAL . . . . . . . . . . . . . 70.8 t -130.92 103.43 7.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.226 -0.921 . . . . 0.0 110.015 179.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 814' ' ' VAL . . . . . . . . . . . . . 86.0 t -124.84 121.14 60.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.191 -0.943 . . . . 0.0 110.155 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 815' ' ' ALA . . . . . 0.515 ' HA ' ' CG ' ' A' ' 759' ' ' LYS . . . -72.21 160.91 31.63 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.283 -0.886 . . . . 0.0 110.246 179.923 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 816' ' ' ILE . . . . . 0.421 HD11 HG22 ' A' ' 760' ' ' VAL . 8.2 mt -112.91 81.59 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.267 -0.896 . . . . 0.0 109.649 179.989 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 817' ' ' SER . . . . . . . . . . . . . 5.7 p -110.48 158.36 35.62 Favored Pre-proline 0 C--N 1.297 -1.71 0 O-C-N 121.318 -0.864 . . . . 0.0 110.213 -179.921 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 818' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -77.61 12.85 1.78 Allowed 'Trans proline' 0 C--N 1.306 -1.672 0 O-C-N 124.107 1.583 . . . . 0.0 111.058 179.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 819' ' ' SER . . . . . . . . . . . . . 10.3 p -133.84 16.49 3.9 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.107 -0.995 . . . . 0.0 110.371 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 820' ' ' ASN . . . . . . . . . . . . . 19.3 t-20 -117.81 -16.82 9.94 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.138 -0.976 . . . . 0.0 110.058 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 821' ' ' PHE . . . . . . . . . . . . . 7.4 m-85 -97.21 -39.29 9.34 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.348 -0.845 . . . . 0.0 110.257 179.896 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 822' ' ' GLY . . . . . . . . . . . . . . . 174.88 -29.49 0.08 OUTLIER Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.596 -1.402 . . . . 0.0 109.596 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 823' ' ' GLY . . . . . 0.465 ' O ' ' OD2' ' A' ' 824' ' ' ASP . . . 147.78 -82.75 0.19 Allowed Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 179.983 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 824' ' ' ASP . . . . . 0.465 ' OD2' ' O ' ' A' ' 823' ' ' GLY . 1.0 OUTLIER -148.02 121.11 4.7 Favored Pre-proline 0 N--CA 1.494 1.771 0 O-C-N 121.234 -1.157 . . . . 0.0 110.385 -179.919 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 825' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -75.51 -89.91 0.01 OUTLIER 'Trans proline' 0 C--N 1.31 -1.497 0 O-C-N 123.923 1.486 . . . . 0.0 110.478 179.932 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 826' ' ' CYS . . . . . 0.522 ' HB3' ' CG2' ' A' ' 829' ' ' VAL . 2.1 m -97.17 130.74 28.99 Favored Pre-proline 0 N--CA 1.492 1.646 0 O-C-N 121.201 -0.937 . . . . 0.0 109.971 179.996 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 827' ' ' PRO . . . . . 0.42 ' O ' ' HB2' ' A' ' 828' ' ' GLU . 46.4 Cg_endo -73.41 129.31 13.7 Favored 'Trans proline' 0 C--N 1.308 -1.579 0 O-C-N 124.002 1.527 . . . . 0.0 110.927 -179.991 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 828' ' ' GLU . . . . . 0.42 ' HB2' ' O ' ' A' ' 827' ' ' PRO . 8.3 mt-10 57.24 46.3 18.93 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.392 -0.818 . . . . 0.0 110.504 179.928 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 829' ' ' VAL . . . . . 0.522 ' CG2' ' HB3' ' A' ' 826' ' ' CYS . 39.2 t -133.95 124.88 47.76 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 O-C-N 121.209 -0.932 . . . . 0.0 110.017 179.898 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 830' ' ' MET . . . . . 0.432 ' O ' ' O ' ' A' ' 829' ' ' VAL . 13.0 mmt -41.72 162.75 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.349 -0.844 . . . . 0.0 110.03 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 831' ' ' LYS . . . . . . . . . . . . . 6.4 mttt -139.71 142.47 36.86 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.063 -1.023 . . . . 0.0 111.011 -179.872 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 832' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -144.87 158.15 43.9 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.526 -0.733 . . . . 0.0 109.325 179.976 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 833' ' ' VAL . . . . . 0.418 HG21 HG21 ' A' ' 816' ' ' ILE . 62.1 t -123.13 117.19 50.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 120.846 -1.159 . . . . 0.0 111.47 -179.784 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 834' ' ' ALA . . . . . . . . . . . . . . . -125.9 117.62 23.71 Favored 'General case' 0 N--CA 1.494 1.728 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 179.799 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 835' ' ' VAL . . . . . 0.485 HG11 ' N ' ' A' ' 836' ' ' GLU . 44.4 t -127.82 165.24 27.35 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 120.9 -1.125 . . . . 0.0 111.997 -179.792 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 836' ' ' GLU . . . . . 0.485 ' N ' HG11 ' A' ' 835' ' ' VAL . 0.9 OUTLIER -152.23 123.38 7.62 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 179.952 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 837' ' ' ALA . . . . . . . . . . . . . . . -121.83 165.98 15.06 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 120.893 -1.13 . . . . 0.0 111.809 -179.757 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 838' ' ' VAL . . . . . . . . . . . . . 17.2 t -109.84 107.23 22.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.662 -0.649 . . . . 0.0 109.275 179.928 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 839' ' ' CYS . . . . . 0.487 ' O ' ' HA ' ' A' ' 729' ' ' SER . 0.0 OUTLIER -108.21 145.26 34.52 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.13 -0.981 . . . . 0.0 110.818 -179.896 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 840' ' ' SER . . . . . . . . . . . . . 1.4 p -164.35 147.51 9.21 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.37 -0.831 . . . . 0.0 110.094 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 841' ' ' THR . . . . . 0.533 ' N ' ' HG2' ' A' ' 768' ' ' GLN . 5.2 t -77.58 173.51 11.94 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.244 -0.91 . . . . 0.0 110.208 -179.948 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 842' ' ' ALA . . . . . . . . . . . . . . . -94.76 168.8 10.59 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.195 -0.941 . . . . 0.0 110.173 179.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 843' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.69 0 CA-C-O 117.982 -1.009 . . . . 0.0 110.071 -179.985 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 726' ' ' ARG . . . . . . . . . . . . . 17.8 mmm180 . . . . . 0 N--CA 1.493 1.708 0 CA-C-O 121.478 0.656 . . . . 0.0 110.022 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 727' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -151.33 147.17 26.61 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.427 -0.795 . . . . 0.0 109.795 179.99 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 728' ' ' VAL . . . . . 0.453 ' O ' ' CG1' ' A' ' 728' ' ' VAL . 12.0 p -133.3 78.43 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.199 -0.938 . . . . 0.0 110.363 179.963 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 729' ' ' SER . . . . . . . . . . . . . 5.9 m 52.3 -177.99 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.41 -0.807 . . . . 0.0 110.731 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 730' ' ' GLY . . . . . 0.491 ' C ' ' CG2' ' A' ' 731' ' ' VAL . . . -152.25 -140.93 3.21 Favored Glycine 0 N--CA 1.489 2.193 0 N-CA-C 109.041 -1.624 . . . . 0.0 109.041 179.987 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 731' ' ' VAL . . . . . 0.491 ' CG2' ' C ' ' A' ' 730' ' ' GLY . 11.9 t -153.17 165.81 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 O-C-N 121.065 -1.256 . . . . 0.0 110.26 179.968 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 732' ' ' CYS . . . . . . . . . . . . . 6.6 t -150.92 133.98 15.98 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.343 -0.848 . . . . 0.0 109.967 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 733' ' ' ALA . . . . . . . . . . . . . . . -153.19 162.32 41.44 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.18 -0.95 . . . . 0.0 110.551 -179.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 734' ' ' ASP . . . . . 0.458 ' O ' ' OD2' ' A' ' 734' ' ' ASP . 4.3 p30 -162.13 118.26 2.01 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.423 -0.798 . . . . 0.0 109.9 179.995 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 735' ' ' VAL . . . . . 0.4 HG21 ' C ' ' A' ' 734' ' ' ASP . 16.6 t -139.11 164.82 24.6 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.157 -0.964 . . . . 0.0 110.674 -179.997 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 736' ' ' SER . . . . . . . . . . . . . 8.3 p -109.83 172.9 6.59 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.36 -0.837 . . . . 0.0 109.818 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 737' ' ' GLU . . . . . 0.448 ' OE1' ' HG3' ' A' ' 831' ' ' LYS . 9.5 pt-20 -69.06 -168.7 0.15 Allowed 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.124 -0.985 . . . . 0.0 110.348 179.985 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 738' ' ' TYR . . . . . 0.439 ' N ' ' HG3' ' A' ' 737' ' ' GLU . 84.3 t80 -147.05 -74.7 0.2 Allowed 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.327 -0.858 . . . . 0.0 109.869 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 739' ' ' HIS . . . . . 0.505 ' NE2' ' OD1' ' A' ' 741' ' ' ASN . 3.0 t60 58.52 107.38 0.03 OUTLIER Pre-proline 0 N--CA 1.492 1.67 0 O-C-N 121.2 -0.937 . . . . 0.0 110.551 179.921 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 740' ' ' PRO . . . . . 0.512 ' HD3' ' O ' ' A' ' 756' ' ' HIS . 49.3 Cg_endo -81.29 71.15 7.1 Favored 'Trans proline' 0 C--N 1.307 -1.642 0 O-C-N 124.006 1.53 . . . . 0.0 110.127 -179.963 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 741' ' ' ASN . . . . . 0.505 ' OD1' ' NE2' ' A' ' 739' ' ' HIS . 0.1 OUTLIER -104.39 69.45 0.91 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.205 -0.935 . . . . 0.0 110.445 179.973 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 742' ' ' ILE . . . . . 0.524 HD11 ' N ' ' A' ' 742' ' ' ILE . 0.1 OUTLIER -139.23 141.13 36.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.25 -0.906 . . . . 0.0 110.022 179.936 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 743' ' ' LYS . . . . . . . . . . . . . 27.3 tttt -122.45 -28.13 4.32 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.169 -0.957 . . . . 0.0 110.492 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 744' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -88.33 34.08 0.75 Allowed 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.168 -0.957 . . . . 0.0 110.344 179.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 745' ' ' TRP . . . . . 0.577 ' CD1' ' HB2' ' A' ' 746' ' ' GLN . 47.4 t-105 -85.18 -56.63 3.45 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.323 -0.861 . . . . 0.0 110.054 -179.992 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 746' ' ' GLN . . . . . 0.577 ' HB2' ' CD1' ' A' ' 745' ' ' TRP . 4.3 tp60 -151.86 102.03 2.8 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.237 -0.914 . . . . 0.0 110.194 179.983 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 747' ' ' ILE . . . . . . . . . . . . . 57.1 mt -105.55 58.28 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.223 -0.923 . . . . 0.0 110.013 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 748' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -124.84 -73.23 0.64 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.246 -0.909 . . . . 0.0 110.282 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 749' ' ' SER . . . . . . . . . . . . . 1.9 p -170.82 33.91 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.182 -0.949 . . . . 0.0 110.317 -179.935 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 750' ' ' TYR . . . . . . . . . . . . . 25.0 m-85 -106.45 -94.77 0.37 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.198 -0.939 . . . . 0.0 110.34 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 751' ' ' GLY . . . . . . . . . . . . . . . 80.69 135.16 1.54 Allowed Glycine 0 N--CA 1.492 2.417 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 752' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -153.81 60.0 2.83 Favored Pre-proline 0 N--CA 1.493 1.677 0 O-C-N 121.282 -1.128 . . . . 0.0 110.272 179.977 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 753' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -73.15 78.17 2.28 Favored 'Trans proline' 0 C--N 1.305 -1.713 0 O-C-N 124.07 1.563 . . . . 0.0 110.442 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 754' ' ' GLU . . . . . . . . . . . . . 23.5 tt0 -130.96 25.2 4.97 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.174 -0.954 . . . . 0.0 110.19 179.931 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 755' ' ' PHE . . . . . 0.444 ' CD1' ' N ' ' A' ' 756' ' ' HIS . 21.1 t80 -154.13 164.69 38.1 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.314 -0.866 . . . . 0.0 109.999 179.964 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 756' ' ' HIS . . . . . 0.512 ' O ' ' HD3' ' A' ' 740' ' ' PRO . 1.1 t-160 -148.24 -71.58 0.21 Allowed 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.144 -0.973 . . . . 0.0 110.731 -179.947 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 757' ' ' THR . . . . . . . . . . . . . 47.0 p -115.77 151.93 34.25 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.825 -1.172 . . . . 0.0 110.707 -179.915 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 758' ' ' ALA . . . . . 0.42 ' C ' ' HG3' ' A' ' 759' ' ' LYS . . . -64.38 168.02 6.21 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.32 -0.862 . . . . 0.0 110.009 179.96 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 759' ' ' LYS . . . . . 0.42 ' HG3' ' C ' ' A' ' 758' ' ' ALA . 17.1 mttp -146.55 146.47 30.49 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.203 -0.935 . . . . 0.0 110.596 -179.928 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 760' ' ' VAL . . . . . . . . . . . . . 43.8 t -108.72 138.37 36.06 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.291 -0.881 . . . . 0.0 109.62 179.819 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 761' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -109.12 125.65 52.38 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.133 -0.979 . . . . 0.0 111.19 -179.917 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 762' ' ' LEU . . . . . 0.467 ' HB2' ' HB2' ' A' ' 812' ' ' CYS . 20.6 mt -123.39 112.16 17.22 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.464 -0.772 . . . . 0.0 109.296 179.849 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 763' ' ' LYS . . . . . . . . . . . . . 9.7 mttt -107.93 122.1 46.12 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.091 -1.006 . . . . 0.0 110.869 -179.827 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 764' ' ' CYS . . . . . 0.423 ' O ' ' C ' ' A' ' 765' ' ' ALA . 48.7 t -92.91 163.18 13.78 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.46 -0.775 . . . . 0.0 109.618 179.904 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 765' ' ' ALA . . . . . 0.484 ' HB1' ' HB2' ' A' ' 768' ' ' GLN . . . -44.08 154.81 0.36 Allowed Pre-proline 0 N--CA 1.493 1.685 0 O-C-N 121.041 -1.037 . . . . 0.0 109.992 -179.884 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 766' ' ' PRO . . . . . 0.436 ' C ' ' OE1' ' A' ' 768' ' ' GLN . 45.1 Cg_endo -70.95 112.14 3.22 Favored 'Trans proline' 0 C--N 1.306 -1.684 0 O-C-N 123.98 1.516 . . . . 0.0 110.657 -179.96 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 767' ' ' GLY . . . . . . . . . . . . . . . 98.29 -2.96 59.61 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.651 -1.379 . . . . 0.0 109.651 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 768' ' ' GLN . . . . . 0.484 ' HB2' ' HB1' ' A' ' 765' ' ' ALA . 27.6 mp0 -106.59 176.3 5.22 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.23 -1.159 . . . . 0.0 110.078 -179.913 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 769' ' ' THR . . . . . . . . . . . . . 40.6 p -145.12 159.18 43.37 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.225 -0.922 . . . . 0.0 110.502 -179.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 770' ' ' ILE . . . . . . . . . . . . . 5.6 mt -71.02 151.47 9.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.302 -0.874 . . . . 0.0 109.831 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 771' ' ' SER . . . . . . . . . . . . . 15.0 m -135.5 -9.97 2.17 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.119 -0.988 . . . . 0.0 111.152 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 772' ' ' ALA . . . . . . . . . . . . . . . -172.38 133.62 0.65 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.823 -1.173 . . . . 0.0 111.124 -179.892 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 773' ' ' ILE . . . . . . . . . . . . . 34.1 mm -86.84 120.4 36.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.367 -0.833 . . . . 0.0 109.232 179.91 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 774' ' ' LYS . . . . . . . . . . . . . 1.2 ttmp? -81.21 -38.58 26.77 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.13 -0.981 . . . . 0.0 111.024 -179.861 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 775' ' ' PHE . . . . . 0.533 ' O ' ' CB ' ' A' ' 776' ' ' ALA . 43.5 t80 -149.29 167.41 26.14 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.008 -1.057 . . . . 0.0 111.182 -179.904 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 776' ' ' ALA . . . . . 0.533 ' CB ' ' O ' ' A' ' 775' ' ' PHE . . . 163.88 59.25 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.843 0 CA-C-O 121.449 0.642 . . . . 0.0 109.328 179.975 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 777' ' ' SER . . . . . 0.532 ' HB3' ' CZ ' ' A' ' 775' ' ' PHE . 0.3 OUTLIER -89.88 154.33 19.95 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.513 -0.742 . . . . 0.0 110.776 -179.933 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 778' ' ' PHE . . . . . . . . . . . . . 7.5 t80 -121.84 89.16 3.07 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.377 -0.827 . . . . 0.0 110.137 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 779' ' ' GLY . . . . . . . . . . . . . . . 179.94 -127.72 1.15 Allowed Glycine 0 N--CA 1.493 2.464 0 N-CA-C 109.723 -1.351 . . . . 0.0 109.723 -179.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 780' ' ' THR . . . . . 0.471 ' O ' ' HA3' ' A' ' 791' ' ' GLY . 9.0 p -116.03 76.17 6.22 Favored Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.209 -1.171 . . . . 0.0 110.341 179.994 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 781' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -71.18 162.47 42.45 Favored 'Trans proline' 0 C--N 1.304 -1.812 0 O-C-N 124.013 1.533 . . . . 0.0 110.369 179.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 782' ' ' LEU . . . . . . . . . . . . . 4.5 mt -123.32 145.52 48.66 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.263 -0.898 . . . . 0.0 110.229 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 783' ' ' GLY . . . . . . . . . . . . . . . 99.86 -175.85 27.91 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.925 -1.27 . . . . 0.0 109.925 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 784' ' ' THR . . . . . 0.467 ' O ' ' O ' ' A' ' 785' ' ' CYS . 1.7 t -147.41 89.48 1.78 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.313 -1.11 . . . . 0.0 109.855 179.97 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 785' ' ' CYS . . . . . 0.467 ' O ' ' O ' ' A' ' 784' ' ' THR . 4.1 t 54.48 107.89 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.297 -0.877 . . . . 0.0 110.011 -179.966 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 786' ' ' GLY . . . . . 0.431 ' O ' HG22 ' A' ' 787' ' ' THR . . . 115.22 -31.1 6.39 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 108.957 -1.657 . . . . 0.0 108.957 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 787' ' ' THR . . . . . 0.431 HG22 ' O ' ' A' ' 786' ' ' GLY . 8.9 p -141.02 38.74 1.78 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.463 -1.022 . . . . 0.0 109.831 179.908 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 788' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -63.32 165.12 7.95 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.364 -0.835 . . . . 0.0 110.479 -179.992 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 789' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -159.36 165.67 32.79 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.374 -0.829 . . . . 0.0 109.443 179.95 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 790' ' ' GLN . . . . . 0.43 ' O ' ' C ' ' A' ' 791' ' ' GLY . 5.8 pt20 -90.25 20.57 4.31 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.014 -1.054 . . . . 0.0 110.487 -179.973 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 791' ' ' GLY . . . . . 0.471 ' HA3' ' O ' ' A' ' 780' ' ' THR . . . 41.77 -143.24 1.03 Allowed Glycine 0 N--CA 1.491 2.313 0 N-CA-C 110.067 -1.213 . . . . 0.0 110.067 -179.989 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 792' ' ' GLU . . . . . . . . . . . . . 27.8 mm-40 -95.15 -43.21 8.2 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.448 -1.031 . . . . 0.0 110.354 -179.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 793' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -108.44 134.06 51.75 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.039 -1.038 . . . . 0.0 110.075 -179.988 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 794' ' ' HIS . . . . . 0.559 ' CG ' ' N ' ' A' ' 795' ' ' SER . 68.3 t60 -139.28 169.55 17.55 Favored 'General case' 0 C--N 1.299 -1.591 0 O-C-N 121.32 -0.862 . . . . 0.0 110.176 -179.981 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 795' ' ' SER . . . . . 0.559 ' N ' ' CG ' ' A' ' 794' ' ' HIS . 0.1 OUTLIER -110.69 129.79 55.74 Favored 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 179.904 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 796' ' ' ILE . . . . . . . . . . . . . 35.9 mt -69.7 -5.62 5.33 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.619 0 O-C-N 120.915 -1.115 . . . . 0.0 109.875 -179.913 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 797' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -102.85 14.83 31.0 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.334 -0.853 . . . . 0.0 109.799 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 798' ' ' SER . . . . . 0.492 ' HB2' ' O ' ' A' ' 776' ' ' ALA . 10.8 p -58.79 -62.75 1.63 Allowed 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.463 -0.773 . . . . 0.0 111.278 179.997 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 799' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -82.54 1.43 37.94 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.261 -0.9 . . . . 0.0 110.951 -179.882 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 800' ' ' SER . . . . . 0.475 ' O ' ' HG2' ' A' ' 804' ' ' ARG . 23.3 t -84.21 -25.99 29.08 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.057 -1.027 . . . . 0.0 110.478 -179.926 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 801' ' ' VAL . . . . . . . . . . . . . 59.9 t -93.61 -27.99 4.41 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.282 -0.886 . . . . 0.0 111.445 -179.922 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 802' ' ' LEU . . . . . 0.584 ' N ' ' CD2' ' A' ' 802' ' ' LEU . 4.0 mm? -89.96 -29.67 18.32 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 120.964 -1.085 . . . . 0.0 111.152 -179.88 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 803' ' ' GLU . . . . . . . . . . . . . 11.3 tt0 -68.93 -28.12 66.37 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 120.818 -1.176 . . . . 0.0 110.942 -179.915 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 804' ' ' ARG . . . . . 0.475 ' HG2' ' O ' ' A' ' 800' ' ' SER . 0.0 OUTLIER -95.0 -17.82 21.59 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.092 -1.005 . . . . 0.0 111.804 -179.969 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 805' ' ' LYS . . . . . 0.429 ' N ' ' HG3' ' A' ' 804' ' ' ARG . 2.3 tptp -115.58 41.33 2.53 Favored 'General case' 0 N--CA 1.501 2.125 0 O-C-N 120.872 -1.143 . . . . 0.0 112.172 -179.824 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 806' ' ' CYS . . . . . 0.504 ' HB2' ' O ' ' A' ' 802' ' ' LEU . 0.5 OUTLIER -160.31 -19.25 0.06 Allowed 'General case' 0 N--CA 1.504 2.236 0 O-C-N 120.577 -1.327 . . . . 0.0 112.306 -179.981 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 807' ' ' ILE . . . . . . . . . . . . . 52.9 mt -85.66 120.49 35.85 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 O-C-N 120.665 -1.272 . . . . 0.0 111.145 -179.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 808' ' ' GLY . . . . . 0.426 ' C ' ' HG ' ' A' ' 809' ' ' LEU . . . 112.92 12.63 12.15 Favored Glycine 0 N--CA 1.494 2.531 0 N-CA-C 110.363 -1.095 . . . . 0.0 110.363 179.897 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 809' ' ' LEU . . . . . 0.426 ' HG ' ' C ' ' A' ' 808' ' ' GLY . 12.1 mt -136.29 155.31 50.27 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.033 -1.275 . . . . 0.0 110.799 -179.968 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 810' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -89.99 8.72 31.01 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.433 -0.792 . . . . 0.0 109.389 179.916 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 811' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -155.89 160.94 40.58 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 -179.976 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 812' ' ' CYS . . . . . 0.467 ' HB2' ' HB2' ' A' ' 762' ' ' LEU . 1.0 OUTLIER -143.59 132.76 23.09 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.844 -1.16 . . . . 0.0 111.233 -179.936 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 813' ' ' VAL . . . . . . . . . . . . . 89.7 t -136.2 104.63 4.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.488 -0.757 . . . . 0.0 109.554 179.935 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 814' ' ' VAL . . . . . . . . . . . . . 96.8 t -113.56 129.99 68.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.137 -0.977 . . . . 0.0 110.819 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 815' ' ' ALA . . . . . . . . . . . . . . . -85.52 141.8 29.63 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.32 -0.863 . . . . 0.0 109.387 179.933 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 816' ' ' ILE . . . . . 0.455 HG23 ' CG2' ' A' ' 833' ' ' VAL . 21.0 mt -104.5 124.12 58.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.133 -0.979 . . . . 0.0 110.651 -179.903 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 817' ' ' SER . . . . . 0.462 ' OG ' ' HD2' ' A' ' 818' ' ' PRO . 29.2 t -148.05 153.54 41.87 Favored Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 121.348 -0.845 . . . . 0.0 110.025 179.957 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 818' ' ' PRO . . . . . 0.462 ' HD2' ' OG ' ' A' ' 817' ' ' SER . 43.5 Cg_endo -70.71 -10.11 27.14 Favored 'Trans proline' 0 C--N 1.304 -1.768 0 O-C-N 123.984 1.518 . . . . 0.0 110.315 -179.954 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 819' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -125.42 59.73 1.26 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.317 -0.864 . . . . 0.0 110.014 -179.96 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 820' ' ' ASN . . . . . . . . . . . . . 1.3 m120 -148.34 -35.83 0.2 Allowed 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.361 -0.837 . . . . 0.0 110.285 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 821' ' ' PHE . . . . . . . . . . . . . 13.9 m-85 -80.16 0.76 30.92 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.145 -0.972 . . . . 0.0 110.485 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 822' ' ' GLY . . . . . . . . . . . . . . . 110.7 12.29 16.98 Favored Glycine 0 N--CA 1.493 2.448 0 N-CA-C 109.767 -1.333 . . . . 0.0 109.767 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 823' ' ' GLY . . . . . . . . . . . . . . . 108.73 -159.53 14.11 Favored Glycine 0 N--CA 1.492 2.374 0 N-CA-C 109.629 -1.388 . . . . 0.0 109.629 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 824' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -117.91 136.11 23.64 Favored Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 121.221 -1.164 . . . . 0.0 110.391 -179.997 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 825' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -72.47 -80.12 0.01 OUTLIER 'Trans proline' 0 C--N 1.307 -1.638 0 O-C-N 123.959 1.505 . . . . 0.0 110.161 179.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 826' ' ' CYS . . . . . . . . . . . . . 5.8 p -106.58 121.4 45.28 Favored Pre-proline 0 N--CA 1.498 1.957 0 O-C-N 121.11 -0.994 . . . . 0.0 109.921 179.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 827' ' ' PRO . . . . . 0.47 ' O ' ' CB ' ' A' ' 828' ' ' GLU . 43.7 Cg_endo -70.38 171.43 15.17 Favored 'Trans proline' 0 C--N 1.309 -1.523 0 O-C-N 123.942 1.496 . . . . 0.0 110.054 -179.975 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 828' ' ' GLU . . . . . 0.47 ' CB ' ' O ' ' A' ' 827' ' ' PRO . 0.0 OUTLIER 66.54 15.74 10.2 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.21 -0.931 . . . . 0.0 109.64 -179.951 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 829' ' ' VAL . . . . . . . . . . . . . 95.4 t -119.8 132.26 70.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.425 -0.797 . . . . 0.0 110.02 179.934 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 830' ' ' MET . . . . . . . . . . . . . 2.2 tpp -53.55 144.71 16.63 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.219 -0.926 . . . . 0.0 110.279 179.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 831' ' ' LYS . . . . . 0.448 ' HG3' ' OE1' ' A' ' 737' ' ' GLU . 0.0 OUTLIER -115.07 97.81 6.43 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.123 -0.986 . . . . 0.0 110.675 -179.938 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 832' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -122.17 167.94 12.59 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.419 -0.8 . . . . 0.0 109.434 179.989 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 833' ' ' VAL . . . . . 0.455 ' CG2' HG23 ' A' ' 816' ' ' ILE . 38.3 t -124.26 148.23 28.54 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 O-C-N 120.908 -1.12 . . . . 0.0 111.537 -179.915 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 834' ' ' ALA . . . . . 0.469 ' O ' ' HA ' ' A' ' 776' ' ' ALA . . . -150.69 111.65 4.32 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 179.919 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 835' ' ' VAL . . . . . 0.492 HG11 ' N ' ' A' ' 836' ' ' GLU . 41.0 t -126.7 164.67 26.59 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 O-C-N 120.977 -1.077 . . . . 0.0 112.342 -179.773 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 836' ' ' GLU . . . . . 0.492 ' N ' HG11 ' A' ' 835' ' ' VAL . 64.0 tt0 -153.87 137.57 16.09 Favored 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 179.855 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 837' ' ' ALA . . . . . . . . . . . . . . . -124.19 162.83 22.83 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 120.769 -1.207 . . . . 0.0 111.808 -179.814 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 838' ' ' VAL . . . . . . . . . . . . . 60.7 t -115.46 128.54 72.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.702 -0.624 . . . . 0.0 109.509 179.889 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 839' ' ' CYS . . . . . . . . . . . . . 5.2 m -108.25 156.36 19.45 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.998 -1.064 . . . . 0.0 110.908 -179.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 840' ' ' SER . . . . . . . . . . . . . 6.0 p -157.97 136.37 11.05 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.43 -0.794 . . . . 0.0 109.84 179.917 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 841' ' ' THR . . . . . 0.436 ' HA ' ' HG3' ' A' ' 768' ' ' GLN . 65.7 p -64.64 102.86 0.61 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.32 -0.862 . . . . 0.0 110.41 -179.954 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 842' ' ' ALA . . . . . . . . . . . . . . . -89.85 75.04 7.33 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.29 -0.881 . . . . 0.0 110.116 179.938 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 843' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 1.753 0 CA-C-O 118.013 -0.994 . . . . 0.0 110.211 -179.97 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 726' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.492 1.666 0 CA-C-O 121.177 0.513 . . . . 0.0 110.321 . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 727' ' ' THR . . . . . . . . . . . . . 90.3 m -100.3 151.26 21.69 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.177 -0.952 . . . . 0.0 110.173 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 728' ' ' VAL . . . . . . . . . . . . . 66.4 t -135.18 125.22 43.89 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 O-C-N 121.257 -0.902 . . . . 0.0 110.236 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 729' ' ' SER . . . . . 0.445 ' O ' ' O ' ' A' ' 730' ' ' GLY . 15.1 p -139.7 71.08 1.37 Allowed 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.258 -0.901 . . . . 0.0 110.472 -179.943 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 730' ' ' GLY . . . . . 0.471 ' HA3' ' HA ' ' A' ' 838' ' ' VAL . . . -52.1 -175.77 0.04 OUTLIER Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 179.958 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 731' ' ' VAL . . . . . . . . . . . . . 3.6 t -132.26 135.93 57.26 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.286 -1.126 . . . . 0.0 110.036 179.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 732' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -110.55 126.96 54.97 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.239 -0.913 . . . . 0.0 110.081 179.936 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 733' ' ' ALA . . . . . . . . . . . . . . . -138.92 123.0 17.95 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.211 -0.931 . . . . 0.0 110.717 -179.898 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 734' ' ' ASP . . . . . . . . . . . . . 2.2 p-10 -113.0 108.8 17.85 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.401 -0.812 . . . . 0.0 109.698 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 735' ' ' VAL . . . . . . . . . . . . . 45.7 t -111.12 164.11 7.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.226 -0.921 . . . . 0.0 110.315 -179.937 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 736' ' ' SER . . . . . . . . . . . . . 44.5 p -101.53 -178.48 3.74 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.178 -0.951 . . . . 0.0 110.264 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 737' ' ' GLU . . . . . 0.408 ' HB2' ' CG2' ' A' ' 816' ' ' ILE . 25.6 tt0 -127.08 106.15 9.07 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.341 -0.849 . . . . 0.0 110.351 179.963 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 738' ' ' TYR . . . . . 0.603 ' CG ' ' N ' ' A' ' 739' ' ' HIS . 29.8 p90 -171.13 -42.67 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.216 -0.928 . . . . 0.0 110.577 -179.962 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 739' ' ' HIS . . . . . 0.603 ' N ' ' CG ' ' A' ' 738' ' ' TYR . 0.5 OUTLIER -176.12 134.26 0.43 Allowed Pre-proline 0 N--CA 1.494 1.73 0 O-C-N 121.204 -0.935 . . . . 0.0 110.505 -179.923 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 740' ' ' PRO . . . . . 0.499 ' O ' ' CB ' ' A' ' 741' ' ' ASN . 48.3 Cg_endo -75.94 -13.96 19.32 Favored 'Trans proline' 0 C--N 1.307 -1.656 0 O-C-N 123.973 1.512 . . . . 0.0 110.432 179.94 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 741' ' ' ASN . . . . . 0.499 ' CB ' ' O ' ' A' ' 740' ' ' PRO . 4.8 m-20 70.91 75.94 0.19 Allowed 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.355 -0.84 . . . . 0.0 110.132 179.995 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 742' ' ' ILE . . . . . 0.457 ' O ' ' HG2' ' A' ' 743' ' ' LYS . 3.8 mp -55.52 -72.58 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.262 -0.899 . . . . 0.0 110.224 -179.976 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 743' ' ' LYS . . . . . 0.457 ' HG2' ' O ' ' A' ' 742' ' ' ILE . 1.2 mmpt? -141.38 -161.51 1.23 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.276 -0.89 . . . . 0.0 110.307 -179.899 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 744' ' ' ASN . . . . . 0.423 ' O ' ' CG ' ' A' ' 744' ' ' ASN . 8.6 p-10 -94.16 59.07 2.61 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.245 -0.91 . . . . 0.0 110.16 179.986 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 745' ' ' TRP . . . . . 0.502 ' CZ2' ' O ' ' A' ' 748' ' ' GLU . 1.0 OUTLIER -101.98 -165.09 1.15 Allowed 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.251 -0.906 . . . . 0.0 110.263 179.959 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 746' ' ' GLN . . . . . 0.421 ' C ' ' O ' ' A' ' 745' ' ' TRP . 0.7 OUTLIER -43.06 150.74 0.16 Allowed 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.301 -0.875 . . . . 0.0 109.965 -179.936 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 747' ' ' ILE . . . . . 0.559 ' O ' ' CG2' ' A' ' 747' ' ' ILE . 9.6 mm -85.17 13.04 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.258 -0.901 . . . . 0.0 110.21 179.953 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 748' ' ' GLU . . . . . 0.502 ' O ' ' CZ2' ' A' ' 745' ' ' TRP . 8.5 mm-40 -118.19 -168.35 1.51 Allowed 'General case' 0 C--N 1.291 -1.969 0 O-C-N 121.14 -0.975 . . . . 0.0 110.108 -179.883 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 749' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -144.4 60.2 1.34 Allowed 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.242 -0.911 . . . . 0.0 110.406 179.966 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 750' ' ' TYR . . . . . 0.429 ' CD1' ' N ' ' A' ' 750' ' ' TYR . 29.7 p90 -129.63 -3.67 4.76 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.112 -0.993 . . . . 0.0 110.519 179.991 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 751' ' ' GLY . . . . . 0.418 ' O ' ' OE2' ' A' ' 752' ' ' GLU . . . -103.02 -23.24 8.7 Favored Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.365 -1.494 . . . . 0.0 109.365 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 752' ' ' GLU . . . . . 0.418 ' OE2' ' O ' ' A' ' 751' ' ' GLY . 0.3 OUTLIER -167.33 60.45 0.53 Allowed Pre-proline 0 N--CA 1.492 1.645 0 O-C-N 121.323 -1.104 . . . . 0.0 109.744 179.951 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 753' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -73.74 80.88 1.96 Allowed 'Trans proline' 0 C--N 1.304 -1.771 0 O-C-N 124.12 1.59 . . . . 0.0 110.804 -179.916 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 754' ' ' GLU . . . . . . . . . . . . . 9.9 mt-10 -95.25 -26.16 16.06 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.132 -0.98 . . . . 0.0 109.8 179.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 755' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -135.08 145.8 48.28 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.332 -0.855 . . . . 0.0 109.967 179.965 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 756' ' ' HIS . . . . . 0.585 ' CG ' ' O ' ' A' ' 756' ' ' HIS . 26.5 t-80 -152.19 31.03 0.54 Allowed 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.091 -1.005 . . . . 0.0 110.703 179.994 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 757' ' ' THR . . . . . 0.435 HG22 ' C ' ' A' ' 756' ' ' HIS . 71.5 p -149.77 125.46 10.39 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.002 -1.061 . . . . 0.0 110.543 179.918 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 758' ' ' ALA . . . . . . . . . . . . . . . -60.25 170.02 1.43 Allowed 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.257 -0.902 . . . . 0.0 109.525 179.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 759' ' ' LYS . . . . . . . . . . . . . 21.2 mttt -129.25 161.89 29.15 Favored 'General case' 0 C--N 1.299 -1.612 0 O-C-N 121.087 -1.008 . . . . 0.0 110.382 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 760' ' ' VAL . . . . . . . . . . . . . 28.0 t -107.24 131.79 56.38 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.343 -0.848 . . . . 0.0 108.769 179.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 761' ' ' HIS . . . . . . . . . . . . . 27.0 m170 -112.29 104.41 12.58 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.035 -1.04 . . . . 0.0 111.545 -179.872 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 762' ' ' LEU . . . . . . . . . . . . . 19.4 mt -110.32 113.42 26.06 Favored 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 179.864 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 763' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -140.03 116.98 11.04 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.712 -1.242 . . . . 0.0 111.331 -179.858 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 764' ' ' CYS . . . . . 0.463 ' O ' ' O ' ' A' ' 765' ' ' ALA . 1.5 m -95.89 146.03 24.9 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.511 -0.743 . . . . 0.0 109.05 179.938 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 765' ' ' ALA . . . . . 0.467 ' HB3' ' OE1' ' A' ' 768' ' ' GLN . . . -39.61 160.74 0.1 OUTLIER Pre-proline 0 N--CA 1.498 1.933 0 O-C-N 121.215 -0.928 . . . . 0.0 110.413 -179.992 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 766' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -69.99 102.07 1.02 Allowed 'Trans proline' 0 C--N 1.305 -1.757 0 O-C-N 123.941 1.495 . . . . 0.0 110.213 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 767' ' ' GLY . . . . . . . . . . . . . . . 132.3 -17.92 4.75 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 108.966 -1.654 . . . . 0.0 108.966 -179.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 768' ' ' GLN . . . . . 0.467 ' OE1' ' HB3' ' A' ' 765' ' ' ALA . 13.2 mt-30 -102.58 114.77 29.26 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.423 -1.045 . . . . 0.0 109.77 179.895 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 769' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -106.82 149.39 27.44 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.202 -0.936 . . . . 0.0 110.616 -179.954 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 770' ' ' ILE . . . . . . . . . . . . . 49.8 mt -72.92 150.26 8.22 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.314 -0.866 . . . . 0.0 109.545 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 771' ' ' SER . . . . . . . . . . . . . 1.3 p -140.84 3.64 1.85 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 120.995 -1.066 . . . . 0.0 111.008 179.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 772' ' ' ALA . . . . . . . . . . . . . . . -173.65 145.96 1.25 Allowed 'General case' 0 N--CA 1.495 1.783 0 O-C-N 120.902 -1.124 . . . . 0.0 111.551 -179.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 773' ' ' ILE . . . . . . . . . . . . . 38.1 mm -107.01 147.92 11.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 179.907 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 774' ' ' LYS . . . . . . . . . . . . . 9.8 tptp -113.44 -25.0 8.99 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.998 -1.064 . . . . 0.0 110.808 -179.93 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 775' ' ' PHE . . . . . . . . . . . . . 68.5 t80 -170.43 163.98 8.59 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.057 -1.027 . . . . 0.0 110.751 179.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 776' ' ' ALA . . . . . 0.515 ' O ' ' CA ' ' A' ' 798' ' ' SER . . . 175.07 72.31 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.692 -0.63 . . . . 0.0 109.406 -179.945 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 777' ' ' SER . . . . . 0.486 ' HA ' ' HB3' ' A' ' 798' ' ' SER . 1.5 t -92.66 154.23 18.49 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.328 -0.857 . . . . 0.0 110.968 -179.891 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 778' ' ' PHE . . . . . 0.578 ' O ' ' CD2' ' A' ' 778' ' ' PHE . 33.9 t80 -124.95 94.96 4.33 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.467 -0.771 . . . . 0.0 109.899 179.958 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 779' ' ' GLY . . . . . 0.409 ' C ' HG23 ' A' ' 780' ' ' THR . . . 159.18 -97.12 0.16 Allowed Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 179.99 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 780' ' ' THR . . . . . 0.457 HG22 HG11 ' A' ' 829' ' ' VAL . 52.1 p -132.8 92.58 26.12 Favored Pre-proline 0 N--CA 1.493 1.716 0 O-C-N 121.271 -1.134 . . . . 0.0 110.285 -179.94 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 781' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -75.26 173.19 14.93 Favored 'Trans proline' 0 C--N 1.305 -1.744 0 O-C-N 124.098 1.578 . . . . 0.0 110.523 179.916 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 782' ' ' LEU . . . . . 0.418 ' C ' HD21 ' A' ' 782' ' ' LEU . 2.2 tt -137.65 118.32 14.02 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.307 -0.871 . . . . 0.0 110.167 179.935 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 783' ' ' GLY . . . . . 0.428 ' HA3' HG23 ' A' ' 787' ' ' THR . . . 95.28 -176.84 34.52 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.331 -1.507 . . . . 0.0 109.331 179.98 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 784' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -117.91 -160.81 0.8 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.208 -1.172 . . . . 0.0 110.188 -179.979 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 785' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -60.56 119.16 7.54 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.306 -0.871 . . . . 0.0 110.252 -179.932 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 786' ' ' GLY . . . . . . . . . . . . . . . 114.85 -28.93 7.77 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 787' ' ' THR . . . . . 0.428 HG23 ' HA3' ' A' ' 783' ' ' GLY . 8.9 t -134.78 34.4 3.16 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.237 -1.155 . . . . 0.0 110.309 179.967 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 788' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -65.85 132.12 47.91 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.278 -0.889 . . . . 0.0 109.943 179.989 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 789' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -139.9 154.02 47.14 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.229 -0.919 . . . . 0.0 110.33 179.925 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 790' ' ' GLN . . . . . 0.419 ' OE1' ' ND1' ' A' ' 794' ' ' HIS . 1.6 mp0 -65.84 116.3 6.86 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.351 -0.843 . . . . 0.0 110.482 -179.987 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 791' ' ' GLY . . . . . . . . . . . . . . . -64.68 -105.86 0.01 OUTLIER Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.623 -1.391 . . . . 0.0 109.623 -179.945 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 792' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -127.18 -26.12 3.15 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.302 -1.117 . . . . 0.0 110.509 -179.956 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 793' ' ' CYS . . . . . 0.469 ' O ' ' HB3' ' A' ' 794' ' ' HIS . 85.7 m -100.2 -83.91 0.43 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.206 -0.933 . . . . 0.0 109.89 -179.997 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 794' ' ' HIS . . . . . 0.637 ' CE1' ' OG ' ' A' ' 798' ' ' SER . 84.9 t60 58.4 113.77 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.506 -0.746 . . . . 0.0 110.728 179.981 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 795' ' ' SER . . . . . 0.468 ' O ' ' O ' ' A' ' 794' ' ' HIS . 100.0 p -60.66 -126.6 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.301 -0.874 . . . . 0.0 109.295 179.871 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 796' ' ' ILE . . . . . 0.424 ' CG1' ' C ' ' A' ' 795' ' ' SER . 1.0 OUTLIER -148.02 -31.06 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 2.02 0 O-C-N 120.798 -1.189 . . . . 0.0 110.68 179.856 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 797' ' ' ASN . . . . . 0.441 ' O ' ' C ' ' A' ' 798' ' ' SER . 4.3 m120 -86.26 16.28 4.54 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 120.906 -1.121 . . . . 0.0 110.04 179.914 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 798' ' ' SER . . . . . 0.637 ' OG ' ' CE1' ' A' ' 794' ' ' HIS . 0.9 OUTLIER -33.56 -70.76 0.07 Allowed 'General case' 0 N--CA 1.503 2.178 0 O-C-N 121.775 -0.578 . . . . 0.0 111.8 -179.999 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 799' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -84.99 -30.02 24.55 Favored 'General case' 0 N--CA 1.501 2.086 0 O-C-N 121.155 -0.966 . . . . 0.0 111.094 -179.876 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 800' ' ' SER . . . . . . . . . . . . . 37.2 t -54.47 -16.91 2.61 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.059 -1.026 . . . . 0.0 110.743 -179.955 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 801' ' ' VAL . . . . . . . . . . . . . 85.3 t -90.97 -48.69 13.9 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.919 0 O-C-N 121.046 -1.034 . . . . 0.0 111.588 -179.851 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 802' ' ' LEU . . . . . 0.499 ' O ' ' HB2' ' A' ' 806' ' ' CYS . 4.6 mm? -75.08 -16.33 60.57 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.112 -0.993 . . . . 0.0 111.522 -179.801 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 803' ' ' GLU . . . . . 0.409 ' HA ' HD12 ' A' ' 807' ' ' ILE . 0.5 OUTLIER -81.94 -27.53 33.24 Favored 'General case' 0 C--N 1.295 -1.77 0 O-C-N 120.73 -1.232 . . . . 0.0 110.778 -179.947 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 804' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -95.4 -18.39 20.77 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.109 -0.994 . . . . 0.0 112.28 -179.918 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 805' ' ' LYS . . . . . 0.458 ' O ' ' SG ' ' A' ' 806' ' ' CYS . 4.0 ttpt -122.17 20.25 10.63 Favored 'General case' 0 N--CA 1.501 2.078 0 O-C-N 120.452 -1.405 . . . . 0.0 112.477 -179.868 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 806' ' ' CYS . . . . . 0.499 ' HB2' ' O ' ' A' ' 802' ' ' LEU . 50.0 m -152.66 51.17 0.76 Allowed 'General case' 0 N--CA 1.496 1.832 0 O-C-N 120.665 -1.272 . . . . 0.0 110.406 179.905 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 807' ' ' ILE . . . . . 0.435 ' O ' HG21 ' A' ' 807' ' ' ILE . 9.1 mt -140.42 95.04 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.484 0 O-C-N 121.524 -0.735 . . . . 0.0 109.324 179.956 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 808' ' ' GLY . . . . . . . . . . . . . . . 118.95 10.07 8.51 Favored Glycine 0 N--CA 1.489 2.199 0 N-CA-C 109.264 -1.534 . . . . 0.0 109.264 -179.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 809' ' ' LEU . . . . . . . . . . . . . 9.1 mt -117.61 157.05 27.08 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.255 -1.144 . . . . 0.0 110.191 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 810' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -86.28 -18.61 31.59 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.202 -0.936 . . . . 0.0 110.088 179.987 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 811' ' ' ARG . . . . . . . . . . . . . 26.2 ttp180 -149.79 136.09 19.0 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.323 -0.861 . . . . 0.0 110.087 179.942 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 812' ' ' CYS . . . . . 0.45 ' SG ' ' O ' ' A' ' 805' ' ' LYS . 0.1 OUTLIER -123.98 144.21 49.95 Favored 'General case' 0 C--N 1.298 -1.655 0 O-C-N 121.303 -0.873 . . . . 0.0 110.256 -179.906 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 813' ' ' VAL . . . . . 0.504 ' O ' ' CG1' ' A' ' 813' ' ' VAL . 7.0 p -137.87 123.15 24.44 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.509 0 O-C-N 121.309 -0.87 . . . . 0.0 109.622 179.888 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 814' ' ' VAL . . . . . . . . . . . . . 36.5 t -131.38 135.81 58.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.135 -0.978 . . . . 0.0 110.393 -179.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 815' ' ' ALA . . . . . 0.467 ' O ' ' OD1' ' A' ' 820' ' ' ASN . . . -82.8 146.32 29.02 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.341 -0.849 . . . . 0.0 110.024 179.972 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 816' ' ' ILE . . . . . 0.444 HG22 HG23 ' A' ' 833' ' ' VAL . 18.0 mt -95.58 111.83 26.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.213 -0.93 . . . . 0.0 110.194 -179.995 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 817' ' ' SER . . . . . 0.516 ' CB ' ' HD2' ' A' ' 818' ' ' PRO . 1.0 OUTLIER -161.73 -175.83 0.53 Allowed Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.226 -0.922 . . . . 0.0 110.219 179.937 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 818' ' ' PRO . . . . . 0.516 ' HD2' ' CB ' ' A' ' 817' ' ' SER . 50.2 Cg_endo -78.32 -37.02 0.82 Allowed 'Trans proline' 0 C--N 1.305 -1.711 0 O-C-N 124.02 1.537 . . . . 0.0 110.893 -179.853 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 819' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -83.49 22.93 0.99 Allowed 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.113 -0.992 . . . . 0.0 110.826 -179.991 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 820' ' ' ASN . . . . . 0.467 ' OD1' ' O ' ' A' ' 815' ' ' ALA . 0.7 OUTLIER -117.0 -15.01 10.61 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.11 -0.994 . . . . 0.0 110.169 179.939 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 821' ' ' PHE . . . . . . . . . . . . . 39.4 m-85 -128.01 -74.19 0.58 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.154 -0.966 . . . . 0.0 110.621 179.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 822' ' ' GLY . . . . . . . . . . . . . . . -163.17 50.84 0.31 Allowed Glycine 0 N--CA 1.493 2.477 0 N-CA-C 109.778 -1.329 . . . . 0.0 109.778 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 823' ' ' GLY . . . . . . . . . . . . . . . 72.76 -126.82 11.02 Favored Glycine 0 N--CA 1.492 2.393 0 N-CA-C 109.661 -1.376 . . . . 0.0 109.661 179.944 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 824' ' ' ASP . . . . . 0.41 ' O ' ' OD2' ' A' ' 824' ' ' ASP . 1.5 p30 -127.17 134.97 26.72 Favored Pre-proline 0 N--CA 1.494 1.742 0 O-C-N 121.241 -1.152 . . . . 0.0 110.32 179.986 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 825' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -78.95 -90.76 0.0 OUTLIER 'Trans proline' 0 C--N 1.307 -1.64 0 O-C-N 124.053 1.554 . . . . 0.0 110.616 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 826' ' ' CYS . . . . . . . . . . . . . 24.3 p -115.39 138.26 23.58 Favored Pre-proline 0 N--CA 1.496 1.851 0 O-C-N 121.21 -0.931 . . . . 0.0 111.067 -179.897 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 827' ' ' PRO . . . . . 0.475 ' O ' ' HB2' ' A' ' 828' ' ' GLU . 54.9 Cg_endo -85.16 -178.91 3.32 Favored 'Trans proline' 0 C--N 1.306 -1.687 0 O-C-N 124.121 1.59 . . . . 0.0 110.057 179.915 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 828' ' ' GLU . . . . . 0.475 ' HB2' ' O ' ' A' ' 827' ' ' PRO . 50.6 mt-10 57.88 17.38 4.24 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.566 -0.709 . . . . 0.0 111.042 179.937 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 829' ' ' VAL . . . . . 0.463 ' O ' ' O ' ' A' ' 830' ' ' MET . 72.4 t -130.4 141.42 46.33 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 O-C-N 121.079 -1.013 . . . . 0.0 110.023 179.844 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 830' ' ' MET . . . . . 0.463 ' O ' ' O ' ' A' ' 829' ' ' VAL . 0.0 OUTLIER -51.21 -175.75 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.195 -0.94 . . . . 0.0 110.126 -179.975 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 831' ' ' LYS . . . . . . . . . . . . . 9.7 mttp -142.29 108.23 5.17 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.025 -1.047 . . . . 0.0 110.896 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 832' ' ' ARG . . . . . . . . . . . . . 5.9 mtp180 -129.88 147.42 51.65 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.444 -0.785 . . . . 0.0 109.483 179.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 833' ' ' VAL . . . . . 0.444 HG23 HG22 ' A' ' 816' ' ' ILE . 92.6 t -120.15 117.57 53.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.024 -1.047 . . . . 0.0 110.731 -179.942 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 834' ' ' ALA . . . . . . . . . . . . . . . -112.99 127.92 56.36 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.284 -0.885 . . . . 0.0 109.847 179.917 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 835' ' ' VAL . . . . . 0.467 ' CG1' ' N ' ' A' ' 836' ' ' GLU . 14.9 t -126.11 165.69 23.61 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 121.11 -0.994 . . . . 0.0 110.577 -179.916 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 836' ' ' GLU . . . . . 0.467 ' N ' ' CG1' ' A' ' 835' ' ' VAL . 0.1 OUTLIER -152.88 109.69 3.46 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.377 -0.827 . . . . 0.0 109.657 -179.939 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 837' ' ' ALA . . . . . . . . . . . . . . . -111.18 162.01 15.38 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.171 -0.956 . . . . 0.0 110.532 -179.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 838' ' ' VAL . . . . . 0.471 ' HA ' ' HA3' ' A' ' 730' ' ' GLY . 39.1 t -120.02 132.87 68.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.321 -0.862 . . . . 0.0 110.07 -179.96 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 839' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -118.18 136.89 53.35 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.222 -0.924 . . . . 0.0 110.149 -179.976 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 840' ' ' SER . . . . . 0.431 ' O ' ' HG2' ' A' ' 768' ' ' GLN . 91.4 p -106.23 -145.01 0.38 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.161 -0.962 . . . . 0.0 110.031 179.975 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 841' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -145.86 152.26 39.2 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.062 -1.024 . . . . 0.0 110.299 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 842' ' ' ALA . . . . . . . . . . . . . . . 44.2 68.14 0.58 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.254 -0.904 . . . . 0.0 110.162 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 843' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.621 0 CA-C-O 117.985 -1.007 . . . . 0.0 110.22 -179.995 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 726' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.678 0 CA-C-O 121.312 0.577 . . . . 0.0 110.213 . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 727' ' ' THR . . . . . 0.506 ' CG2' ' HB2' ' A' ' 840' ' ' SER . 3.4 m -53.64 164.31 0.55 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.188 -0.945 . . . . 0.0 110.214 -179.994 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 728' ' ' VAL . . . . . 0.512 ' O ' ' CB ' ' A' ' 729' ' ' SER . 74.6 t -106.98 165.03 4.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.28 -0.888 . . . . 0.0 110.075 179.988 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 729' ' ' SER . . . . . 0.512 ' CB ' ' O ' ' A' ' 728' ' ' VAL . 0.3 OUTLIER 166.65 126.52 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.104 0 O-C-N 121.326 -0.859 . . . . 0.0 110.304 -179.987 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 730' ' ' GLY . . . . . 0.437 ' C ' ' CG2' ' A' ' 731' ' ' VAL . . . 142.78 76.57 0.04 OUTLIER Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.741 -1.344 . . . . 0.0 109.741 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 731' ' ' VAL . . . . . 0.437 ' CG2' ' C ' ' A' ' 730' ' ' GLY . 3.1 t -147.6 135.58 14.74 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 121.178 -1.189 . . . . 0.0 110.14 179.994 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 732' ' ' CYS . . . . . . . . . . . . . 30.4 p -153.3 138.27 17.22 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.235 -0.915 . . . . 0.0 110.094 -179.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 733' ' ' ALA . . . . . 0.437 ' HB3' HD12 ' A' ' 762' ' ' LEU . . . -111.92 131.21 55.52 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.266 -0.896 . . . . 0.0 110.397 179.992 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 734' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -119.7 105.37 11.1 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.296 -0.878 . . . . 0.0 110.037 179.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 735' ' ' VAL . . . . . 0.487 HG13 ' N ' ' A' ' 736' ' ' SER . 61.1 t -128.42 162.83 34.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.151 -0.968 . . . . 0.0 110.298 -179.942 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 736' ' ' SER . . . . . 0.487 ' N ' HG13 ' A' ' 735' ' ' VAL . 6.6 p -109.17 -165.75 1.05 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.206 -0.934 . . . . 0.0 110.007 -179.962 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 737' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -86.1 176.38 8.03 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.266 -0.896 . . . . 0.0 110.731 -179.975 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 738' ' ' TYR . . . . . . . . . . . . . 45.8 t80 -154.62 149.28 26.45 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.382 -0.824 . . . . 0.0 110.124 179.946 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 739' ' ' HIS . . . . . 0.618 ' CD2' ' N ' ' A' ' 739' ' ' HIS . 1.7 p80 -164.65 166.8 10.9 Favored Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 121.344 -0.847 . . . . 0.0 109.604 -179.985 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 740' ' ' PRO . . . . . 0.507 ' HD2' ' HB2' ' A' ' 739' ' ' HIS . 40.6 Cg_endo -66.42 83.04 0.29 Allowed 'Trans proline' 0 C--N 1.31 -1.496 0 O-C-N 123.864 1.455 . . . . 0.0 110.166 179.975 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 741' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -167.64 24.05 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.428 -0.795 . . . . 0.0 109.918 179.958 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 742' ' ' ILE . . . . . 0.425 ' O ' ' C ' ' A' ' 743' ' ' LYS . 12.2 mm -133.63 39.61 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.233 -0.917 . . . . 0.0 110.06 179.945 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 743' ' ' LYS . . . . . 0.425 ' C ' ' O ' ' A' ' 742' ' ' ILE . 0.0 OUTLIER -42.9 164.63 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.3 -0.875 . . . . 0.0 110.411 -179.962 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 744' ' ' ASN . . . . . . . . . . . . . 21.5 t-20 48.6 47.04 20.96 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.419 -0.801 . . . . 0.0 110.669 179.909 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 745' ' ' TRP . . . . . 0.513 ' CG ' ' O ' ' A' ' 745' ' ' TRP . 26.5 t-105 -98.28 1.36 47.08 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.238 -0.914 . . . . 0.0 109.824 179.878 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 746' ' ' GLN . . . . . . . . . . . . . 15.4 mm100 -119.67 131.08 55.34 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.27 -0.894 . . . . 0.0 110.088 -179.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 747' ' ' ILE . . . . . 0.479 ' O ' ' CG2' ' A' ' 747' ' ' ILE . 3.6 mp -92.8 19.64 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 121.164 -0.96 . . . . 0.0 110.471 -179.997 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 748' ' ' GLU . . . . . . . . . . . . . 19.4 tp10 -124.7 -29.55 3.41 Favored 'General case' 0 C--N 1.295 -1.769 0 O-C-N 121.31 -0.869 . . . . 0.0 109.905 179.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 749' ' ' SER . . . . . 0.489 ' CB ' ' OE2' ' A' ' 752' ' ' GLU . 3.3 m -126.12 167.26 15.63 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.245 -0.91 . . . . 0.0 109.826 179.986 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 750' ' ' TYR . . . . . 0.496 ' CD1' ' N ' ' A' ' 750' ' ' TYR . 20.7 m-85 -126.17 74.21 1.42 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.202 -0.937 . . . . 0.0 110.302 180.0 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 751' ' ' GLY . . . . . 0.434 ' O ' ' C ' ' A' ' 752' ' ' GLU . . . 137.09 -4.48 3.5 Favored Glycine 0 N--CA 1.492 2.426 0 N-CA-C 109.781 -1.328 . . . . 0.0 109.781 179.942 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 752' ' ' GLU . . . . . 0.489 ' OE2' ' CB ' ' A' ' 749' ' ' SER . 0.8 OUTLIER -39.92 121.03 1.51 Allowed Pre-proline 0 N--CA 1.497 1.924 0 O-C-N 121.359 -1.083 . . . . 0.0 110.233 -179.978 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 753' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -77.02 125.94 8.33 Favored 'Trans proline' 0 C--N 1.308 -1.561 0 O-C-N 123.89 1.468 . . . . 0.0 111.157 -179.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 754' ' ' GLU . . . . . . . . . . . . . 41.9 mp0 -94.88 -150.08 0.3 Allowed 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.305 -0.872 . . . . 0.0 109.387 179.908 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 755' ' ' PHE . . . . . 0.597 ' CZ ' ' HA ' ' A' ' 758' ' ' ALA . 16.0 p90 -139.57 94.68 2.81 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 120.823 -1.173 . . . . 0.0 111.059 179.903 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 756' ' ' HIS . . . . . 0.474 ' C ' ' O ' ' A' ' 755' ' ' PHE . 1.8 t60 12.27 -81.91 0.0 OUTLIER 'General case' 0 N--CA 1.514 2.771 0 N-CA-C 114.08 1.141 . . . . 0.0 114.08 179.922 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 757' ' ' THR . . . . . 0.563 ' O ' ' CE1' ' A' ' 755' ' ' PHE . 37.2 p -81.94 -175.01 5.38 Favored 'General case' 0 N--CA 1.505 2.306 0 O-C-N 120.702 -1.249 . . . . 0.0 112.285 -179.683 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 758' ' ' ALA . . . . . 0.597 ' HA ' ' CZ ' ' A' ' 755' ' ' PHE . . . -109.75 179.04 4.24 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.753 -0.592 . . . . 0.0 109.703 179.97 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 759' ' ' LYS . . . . . . . . . . . . . 18.0 mtpt -141.77 150.72 42.11 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.062 -1.024 . . . . 0.0 110.946 179.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 760' ' ' VAL . . . . . . . . . . . . . 5.4 t -108.06 131.42 58.5 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 179.884 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 761' ' ' HIS . . . . . . . . . . . . . 3.7 m170 -117.35 103.77 10.47 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.998 -1.064 . . . . 0.0 111.575 -179.878 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 762' ' ' LEU . . . . . 0.496 ' HB2' ' HB3' ' A' ' 812' ' ' CYS . 0.2 OUTLIER -109.43 103.11 11.96 Favored 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 179.818 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 763' ' ' LYS . . . . . . . . . . . . . 9.5 ttmt -109.95 165.53 11.65 Favored 'General case' 0 N--CA 1.5 2.073 0 O-C-N 121.096 -1.002 . . . . 0.0 111.766 -179.729 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 764' ' ' CYS . . . . . . . . . . . . . 7.9 m -132.18 175.58 9.13 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.705 -0.622 . . . . 0.0 109.837 179.893 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 765' ' ' ALA . . . . . . . . . . . . . . . -71.25 171.66 8.26 Favored Pre-proline 0 N--CA 1.495 1.789 0 O-C-N 121.181 -0.95 . . . . 0.0 109.946 179.937 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 766' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -72.47 129.03 14.22 Favored 'Trans proline' 0 C--N 1.306 -1.66 0 O-C-N 123.849 1.447 . . . . 0.0 110.159 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 767' ' ' GLY . . . . . . . . . . . . . . . 89.53 11.38 64.25 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.349 -1.5 . . . . 0.0 109.349 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 768' ' ' GLN . . . . . . . . . . . . . 2.7 mt-30 -129.1 135.07 48.4 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.304 -1.115 . . . . 0.0 110.216 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 769' ' ' THR . . . . . 0.533 ' CG2' ' HG3' ' A' ' 810' ' ' GLU . 7.7 p -133.31 147.56 51.88 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.204 -0.935 . . . . 0.0 110.32 179.958 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 770' ' ' ILE . . . . . 0.453 HG21 ' HB3' ' A' ' 837' ' ' ALA . 4.3 mt -64.35 149.46 11.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.253 -0.904 . . . . 0.0 109.454 179.997 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 771' ' ' SER . . . . . 0.413 ' N ' HG22 ' A' ' 770' ' ' ILE . 24.4 p -134.34 1.05 3.14 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 120.955 -1.09 . . . . 0.0 110.717 -179.88 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 772' ' ' ALA . . . . . . . . . . . . . . . -177.49 132.1 0.16 Allowed 'General case' 0 N--CA 1.495 1.779 0 O-C-N 120.998 -1.064 . . . . 0.0 111.111 -179.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 773' ' ' ILE . . . . . . . . . . . . . 32.5 mm -87.65 124.24 40.8 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 O-C-N 121.327 -0.858 . . . . 0.0 109.673 179.919 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 774' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.32 -40.19 18.24 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.186 -0.946 . . . . 0.0 110.725 -179.978 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 775' ' ' PHE . . . . . 0.504 ' O ' ' CB ' ' A' ' 776' ' ' ALA . 75.5 t80 -145.58 162.97 36.22 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.031 -1.043 . . . . 0.0 110.942 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 776' ' ' ALA . . . . . 0.504 ' CB ' ' O ' ' A' ' 775' ' ' PHE . . . 167.13 117.79 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.425 -0.797 . . . . 0.0 109.715 179.98 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 777' ' ' SER . . . . . 0.45 ' HA ' ' OG ' ' A' ' 798' ' ' SER . 17.2 m -151.29 136.33 17.43 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.992 -1.068 . . . . 0.0 110.775 -179.953 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 778' ' ' PHE . . . . . . . . . . . . . 46.7 t80 -103.61 107.17 17.91 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.387 -0.821 . . . . 0.0 110.101 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 779' ' ' GLY . . . . . . . . . . . . . . . 162.82 -101.45 0.19 Allowed Glycine 0 N--CA 1.492 2.43 0 N-CA-C 109.514 -1.434 . . . . 0.0 109.514 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 780' ' ' THR . . . . . . . . . . . . . 53.8 p -134.52 101.54 11.97 Favored Pre-proline 0 N--CA 1.495 1.79 0 O-C-N 121.243 -1.151 . . . . 0.0 110.201 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 781' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -77.8 148.07 25.07 Favored 'Trans proline' 0 C--N 1.306 -1.69 0 O-C-N 123.935 1.492 . . . . 0.0 110.593 -179.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 782' ' ' LEU . . . . . 0.409 HD22 ' HA ' ' A' ' 782' ' ' LEU . 7.3 mt -108.02 79.42 1.27 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.308 -0.87 . . . . 0.0 109.75 179.973 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 783' ' ' GLY . . . . . . . . . . . . . . . 123.38 -174.52 16.58 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 108.911 -1.675 . . . . 0.0 108.911 -179.929 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 784' ' ' THR . . . . . . . . . . . . . 37.9 p -122.61 -161.35 0.94 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.1 -1.235 . . . . 0.0 110.287 179.933 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 785' ' ' CYS . . . . . 0.559 ' HA ' ' CE1' ' A' ' 788' ' ' PHE . 6.8 t -57.32 92.94 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.186 -0.946 . . . . 0.0 110.263 179.955 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 786' ' ' GLY . . . . . . . . . . . . . . . 151.48 -28.22 0.96 Allowed Glycine 0 N--CA 1.492 2.388 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 -179.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 787' ' ' THR . . . . . 0.497 ' CG2' ' O ' ' A' ' 787' ' ' THR . 51.5 m -143.61 30.29 1.36 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.297 -1.12 . . . . 0.0 110.141 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 788' ' ' PHE . . . . . 0.559 ' CE1' ' HA ' ' A' ' 785' ' ' CYS . 6.2 m-85 -51.16 155.03 1.41 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.238 -0.914 . . . . 0.0 110.285 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 789' ' ' GLN . . . . . 0.462 ' HB2' ' O ' ' A' ' 788' ' ' PHE . 1.1 tp60 -177.82 124.84 0.12 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.392 -0.817 . . . . 0.0 110.234 179.977 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 790' ' ' GLN . . . . . 0.438 ' C ' ' O ' ' A' ' 789' ' ' GLN . 1.4 mt-30 -40.16 123.54 1.71 Allowed 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.451 -0.78 . . . . 0.0 110.383 -179.969 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 791' ' ' GLY . . . . . . . . . . . . . . . -74.95 -132.03 0.27 Allowed Glycine 0 N--CA 1.491 2.362 0 N-CA-C 109.332 -1.507 . . . . 0.0 109.332 179.905 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 792' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -106.92 3.47 26.23 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.165 -1.197 . . . . 0.0 110.197 179.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 793' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -141.08 118.91 11.76 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.326 -0.859 . . . . 0.0 110.008 -179.991 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 794' ' ' HIS . . . . . 0.457 ' CE1' ' OG ' ' A' ' 798' ' ' SER . 81.8 t60 -138.07 148.13 44.74 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.294 -0.879 . . . . 0.0 110.148 -179.987 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 795' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -76.8 -136.53 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.296 -0.878 . . . . 0.0 109.66 179.996 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 796' ' ' ILE . . . . . . . . . . . . . 3.8 pt -146.1 12.04 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 O-C-N 121.09 -1.006 . . . . 0.0 110.044 179.905 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 797' ' ' ASN . . . . . . . . . . . . . 7.5 p30 -150.6 30.0 0.67 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.383 -0.823 . . . . 0.0 109.722 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 798' ' ' SER . . . . . 0.481 ' HB3' ' O ' ' A' ' 776' ' ' ALA . 0.7 OUTLIER -57.61 -27.43 62.75 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.522 -0.736 . . . . 0.0 111.102 -179.943 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 799' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -100.83 -22.27 14.89 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 120.924 -1.11 . . . . 0.0 110.501 -179.898 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 800' ' ' SER . . . . . . . . . . . . . 47.4 t -69.45 -18.69 63.75 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.121 -0.987 . . . . 0.0 110.324 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 801' ' ' VAL . . . . . . . . . . . . . 94.2 t -84.45 -46.56 17.75 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 121.23 -0.919 . . . . 0.0 110.863 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 802' ' ' LEU . . . . . 0.417 ' N ' ' CD2' ' A' ' 802' ' ' LEU . 4.1 mm? -72.6 -42.98 63.94 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.18 -0.95 . . . . 0.0 111.019 -179.946 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 803' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -51.61 -31.12 23.78 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.046 -1.034 . . . . 0.0 110.648 -179.955 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 804' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -92.34 -21.38 20.29 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.105 -0.997 . . . . 0.0 111.279 -179.949 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 805' ' ' LYS . . . . . 0.471 ' O ' ' SG ' ' A' ' 812' ' ' CYS . 0.9 OUTLIER -111.92 28.75 8.47 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 120.912 -1.118 . . . . 0.0 111.216 -179.864 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 806' ' ' CYS . . . . . 0.418 ' O ' ' C ' ' A' ' 807' ' ' ILE . 0.1 OUTLIER -152.92 -74.46 0.13 Allowed 'General case' 0 N--CA 1.497 1.895 0 O-C-N 120.914 -1.116 . . . . 0.0 111.055 179.984 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 807' ' ' ILE . . . . . 0.418 ' C ' ' O ' ' A' ' 806' ' ' CYS . 29.3 mt -41.65 121.36 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.192 -0.943 . . . . 0.0 110.901 -179.883 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 808' ' ' GLY . . . . . 0.471 ' O ' HD23 ' A' ' 809' ' ' LEU . . . 99.0 13.45 39.71 Favored Glycine 0 N--CA 1.492 2.432 0 N-CA-C 110.369 -1.092 . . . . 0.0 110.369 179.94 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 809' ' ' LEU . . . . . 0.471 HD23 ' O ' ' A' ' 808' ' ' GLY . 91.9 mt -143.3 132.82 23.57 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 120.992 -1.299 . . . . 0.0 110.496 179.982 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 810' ' ' GLU . . . . . 0.533 ' HG3' ' CG2' ' A' ' 769' ' ' THR . 1.0 OUTLIER -63.46 -30.61 71.71 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.271 -0.893 . . . . 0.0 109.383 -179.969 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 811' ' ' ARG . . . . . 0.513 ' HB3' ' NH2' ' A' ' 811' ' ' ARG . 0.5 OUTLIER -117.85 156.6 28.11 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.618 -0.676 . . . . 0.0 109.886 179.958 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 812' ' ' CYS . . . . . 0.496 ' HB3' ' HB2' ' A' ' 762' ' ' LEU . 3.4 t -131.37 137.25 48.64 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.238 -0.914 . . . . 0.0 110.646 -179.925 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 813' ' ' VAL . . . . . 0.506 ' O ' ' CG1' ' A' ' 813' ' ' VAL . 8.6 p -139.17 119.28 14.38 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.326 -0.859 . . . . 0.0 109.687 179.932 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 814' ' ' VAL . . . . . . . . . . . . . 38.6 t -128.52 165.58 27.77 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.233 -0.917 . . . . 0.0 110.537 -179.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 815' ' ' ALA . . . . . . . . . . . . . . . -122.76 147.16 46.83 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.356 -0.84 . . . . 0.0 109.504 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 816' ' ' ILE . . . . . 0.462 HG22 HG23 ' A' ' 833' ' ' VAL . 88.2 mt -105.2 116.2 48.54 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 O-C-N 121.067 -1.02 . . . . 0.0 110.558 -179.972 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 817' ' ' SER . . . . . 0.432 ' HB2' ' HD2' ' A' ' 818' ' ' PRO . 1.4 p -164.13 169.4 8.16 Favored Pre-proline 0 N--CA 1.492 1.66 0 O-C-N 121.334 -0.854 . . . . 0.0 110.123 179.95 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 818' ' ' PRO . . . . . 0.432 ' HD2' ' HB2' ' A' ' 817' ' ' SER . 43.4 Cg_endo -69.12 -16.54 40.34 Favored 'Trans proline' 0 C--N 1.304 -1.802 0 O-C-N 123.976 1.514 . . . . 0.0 110.504 179.993 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 819' ' ' SER . . . . . . . . . . . . . 14.5 p -106.54 31.7 5.04 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.151 -0.968 . . . . 0.0 110.345 -179.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 820' ' ' ASN . . . . . . . . . . . . . 7.8 t-20 -113.53 -28.13 7.63 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.26 -0.9 . . . . 0.0 110.283 -179.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 821' ' ' PHE . . . . . . . . . . . . . 94.6 m-85 -116.19 -77.82 0.57 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.25 -0.906 . . . . 0.0 110.471 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 822' ' ' GLY . . . . . . . . . . . . . . . -152.72 42.69 0.67 Allowed Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.643 -1.383 . . . . 0.0 109.643 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 823' ' ' GLY . . . . . 0.429 ' HA2' ' O ' ' A' ' 818' ' ' PRO . . . 85.95 -117.81 4.68 Favored Glycine 0 N--CA 1.492 2.408 0 N-CA-C 109.464 -1.455 . . . . 0.0 109.464 179.993 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 824' ' ' ASP . . . . . . . . . . . . . 6.6 t0 -137.92 105.88 8.14 Favored Pre-proline 0 N--CA 1.493 1.721 0 O-C-N 121.199 -1.177 . . . . 0.0 110.282 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 825' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -74.83 -60.72 0.04 OUTLIER 'Trans proline' 0 C--N 1.307 -1.623 0 O-C-N 124.086 1.571 . . . . 0.0 110.687 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 826' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -109.83 100.44 42.89 Favored Pre-proline 0 N--CA 1.499 2.007 0 O-C-N 121.109 -0.994 . . . . 0.0 110.65 -179.949 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 827' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -83.33 166.89 13.98 Favored 'Trans proline' 0 C--N 1.305 -1.718 0 O-C-N 124.039 1.547 . . . . 0.0 110.459 179.925 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 828' ' ' GLU . . . . . 0.456 ' O ' HG22 ' A' ' 829' ' ' VAL . 10.2 mm-40 48.53 42.4 18.78 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.227 -0.921 . . . . 0.0 110.355 179.975 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 829' ' ' VAL . . . . . 0.456 HG22 ' O ' ' A' ' 828' ' ' GLU . 44.2 t -139.83 145.46 26.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.222 -0.924 . . . . 0.0 110.205 -179.996 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 830' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -51.15 99.49 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.175 -0.953 . . . . 0.0 110.215 179.962 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 831' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -71.69 132.69 44.91 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.223 -0.923 . . . . 0.0 110.711 -179.941 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 832' ' ' ARG . . . . . . . . . . . . . 2.5 ttt180 -150.64 149.7 30.19 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.536 -0.727 . . . . 0.0 109.397 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 833' ' ' VAL . . . . . 0.462 HG23 HG22 ' A' ' 816' ' ' ILE . 71.9 t -118.68 140.95 40.58 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 120.994 -1.067 . . . . 0.0 111.113 -179.899 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 834' ' ' ALA . . . . . 0.464 ' O ' ' CG2' ' A' ' 835' ' ' VAL . . . -143.61 136.88 27.9 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.551 -0.718 . . . . 0.0 109.384 179.911 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 835' ' ' VAL . . . . . 0.464 ' CG2' ' O ' ' A' ' 834' ' ' ALA . 23.6 t -156.36 145.53 11.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 120.937 -1.102 . . . . 0.0 111.484 -179.9 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 836' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -135.18 128.11 31.41 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 179.864 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 837' ' ' ALA . . . . . 0.453 ' HB3' HG21 ' A' ' 770' ' ' ILE . . . -116.6 161.76 18.66 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.96 -1.087 . . . . 0.0 111.32 -179.892 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 838' ' ' VAL . . . . . . . . . . . . . 66.2 t -109.78 114.57 47.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.663 -0.648 . . . . 0.0 109.539 179.942 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 839' ' ' CYS . . . . . 0.478 ' O ' ' O ' ' A' ' 728' ' ' VAL . 0.1 OUTLIER -108.96 144.22 37.2 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.019 -1.051 . . . . 0.0 110.88 -179.968 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 840' ' ' SER . . . . . 0.506 ' HB2' ' CG2' ' A' ' 727' ' ' THR . 79.8 p -171.52 178.67 3.1 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.42 -0.8 . . . . 0.0 110.037 -179.999 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 841' ' ' THR . . . . . . . . . . . . . 11.1 p -66.6 115.7 6.74 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.159 -0.963 . . . . 0.0 110.178 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 842' ' ' ALA . . . . . . . . . . . . . . . -161.2 119.46 2.42 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.276 -0.89 . . . . 0.0 110.252 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 843' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.652 0 CA-C-O 118.019 -0.991 . . . . 0.0 110.262 179.978 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 726' ' ' ARG . . . . . 0.462 ' HA ' ' CG2' ' A' ' 841' ' ' THR . 2.0 tpt85 . . . . . 0 N--CA 1.492 1.662 0 CA-C-O 121.203 0.525 . . . . 0.0 110.309 . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 727' ' ' THR . . . . . . . . . . . . . 20.8 m -150.66 162.2 41.14 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.286 -0.884 . . . . 0.0 110.187 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 728' ' ' VAL . . . . . . . . . . . . . 35.8 m -136.99 134.56 48.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.252 -0.905 . . . . 0.0 110.057 179.933 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 729' ' ' SER . . . . . . . . . . . . . 24.4 m -128.48 -154.17 0.62 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.26 -0.9 . . . . 0.0 110.269 -179.949 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 730' ' ' GLY . . . . . . . . . . . . . . . -148.27 111.01 0.52 Allowed Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 179.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 731' ' ' VAL . . . . . 0.418 HG11 ' N ' ' A' ' 732' ' ' CYS . 41.3 t -114.22 151.96 15.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.196 -1.179 . . . . 0.0 110.457 179.991 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 732' ' ' CYS . . . . . 0.418 ' N ' HG11 ' A' ' 731' ' ' VAL . 14.1 p -159.91 143.91 14.49 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.431 -0.793 . . . . 0.0 109.536 -179.968 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 733' ' ' ALA . . . . . . . . . . . . . . . -121.52 136.37 54.96 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.121 -0.987 . . . . 0.0 110.434 -179.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 734' ' ' ASP . . . . . 0.424 ' CG ' ' O ' ' A' ' 734' ' ' ASP . 5.2 p-10 -123.73 106.15 10.28 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.273 -0.892 . . . . 0.0 109.94 179.953 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 735' ' ' VAL . . . . . . . . . . . . . 5.7 t -132.12 128.86 59.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.181 -0.949 . . . . 0.0 110.277 -179.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 736' ' ' SER . . . . . . . . . . . . . 4.8 p -69.65 158.98 34.29 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.308 -0.87 . . . . 0.0 110.128 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 737' ' ' GLU . . . . . . . . . . . . . 7.7 tm-20 -89.75 148.95 22.95 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.269 -0.894 . . . . 0.0 110.187 -179.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 738' ' ' TYR . . . . . 0.444 ' O ' ' HB2' ' A' ' 739' ' ' HIS . 43.2 t80 -101.17 117.81 35.73 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.206 -0.933 . . . . 0.0 110.313 179.971 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 739' ' ' HIS . . . . . 0.444 ' HB2' ' O ' ' A' ' 738' ' ' TYR . 20.6 t-80 -177.49 86.26 0.24 Allowed Pre-proline 0 N--CA 1.494 1.742 0 O-C-N 121.213 -0.929 . . . . 0.0 110.2 -179.996 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 740' ' ' PRO . . . . . 0.475 ' O ' ' HB2' ' A' ' 741' ' ' ASN . 52.1 Cg_endo -82.33 17.34 1.6 Allowed 'Trans proline' 0 C--N 1.305 -1.717 0 O-C-N 124.075 1.566 . . . . 0.0 110.769 179.915 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 741' ' ' ASN . . . . . 0.475 ' HB2' ' O ' ' A' ' 740' ' ' PRO . 14.1 m120 56.91 159.37 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.125 -0.984 . . . . 0.0 110.055 -179.979 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 742' ' ' ILE . . . . . 0.536 ' CG2' ' O ' ' A' ' 742' ' ' ILE . 1.8 mp -130.52 76.17 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.079 -1.013 . . . . 0.0 110.479 179.942 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 743' ' ' LYS . . . . . . . . . . . . . 48.1 mttt -112.5 -18.38 12.43 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.33 -0.856 . . . . 0.0 109.202 179.881 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 744' ' ' ASN . . . . . 0.529 ' O ' ' N ' ' A' ' 746' ' ' GLN . 8.4 t-20 -166.66 31.29 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 179.983 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 745' ' ' TRP . . . . . 0.578 ' CG ' ' O ' ' A' ' 745' ' ' TRP . 1.8 p-90 -43.25 87.11 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.697 0 CA-C-O 121.308 0.575 . . . . 0.0 111.817 -179.888 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 746' ' ' GLN . . . . . 0.529 ' N ' ' O ' ' A' ' 744' ' ' ASN . 14.3 mm100 56.05 134.12 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.474 -0.766 . . . . 0.0 111.511 179.874 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 747' ' ' ILE . . . . . . . . . . . . . 6.1 tt -144.94 20.39 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.131 -0.981 . . . . 0.0 109.846 179.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 748' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -124.53 -59.84 1.43 Allowed 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.52 -0.738 . . . . 0.0 109.985 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 749' ' ' SER . . . . . 0.586 ' O ' ' CG ' ' A' ' 750' ' ' TYR . 0.9 OUTLIER -107.26 111.09 23.31 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.238 -0.914 . . . . 0.0 109.438 -179.999 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 750' ' ' TYR . . . . . 0.586 ' CG ' ' O ' ' A' ' 749' ' ' SER . 27.4 p90 36.44 -156.56 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.172 0 O-C-N 121.591 -0.693 . . . . 0.0 110.185 -179.902 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 751' ' ' GLY . . . . . . . . . . . . . . . -154.67 -163.87 12.4 Favored Glycine 0 N--CA 1.489 2.21 0 N-CA-C 109.457 -1.457 . . . . 0.0 109.457 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 752' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -131.96 94.82 23.56 Favored Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.235 -1.156 . . . . 0.0 109.946 -179.966 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 753' ' ' PRO . . . . . 0.475 ' O ' ' HB2' ' A' ' 754' ' ' GLU . 48.3 Cg_endo -77.97 171.3 17.45 Favored 'Trans proline' 0 C--N 1.303 -1.849 0 O-C-N 124.02 1.537 . . . . 0.0 110.457 -179.897 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 754' ' ' GLU . . . . . 0.475 ' HB2' ' O ' ' A' ' 753' ' ' PRO . 5.1 mm-40 58.4 148.16 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.418 -0.801 . . . . 0.0 110.669 -179.99 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 755' ' ' PHE . . . . . 0.599 ' CD2' ' N ' ' A' ' 756' ' ' HIS . 47.9 p90 -178.72 -38.15 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.376 -0.828 . . . . 0.0 109.6 179.975 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 756' ' ' HIS . . . . . 0.599 ' N ' ' CD2' ' A' ' 755' ' ' PHE . 0.1 OUTLIER 41.08 -163.76 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.545 -0.722 . . . . 0.0 110.639 179.955 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 757' ' ' THR . . . . . . . . . . . . . 1.2 p -103.83 -161.98 0.87 Allowed 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.444 -0.785 . . . . 0.0 110.219 -179.977 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 758' ' ' ALA . . . . . . . . . . . . . . . -119.97 171.71 8.25 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.327 -0.858 . . . . 0.0 109.856 179.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 759' ' ' LYS . . . . . 0.452 ' HG2' ' HA ' ' A' ' 815' ' ' ALA . 18.2 mttm -142.87 161.07 39.07 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.195 -0.941 . . . . 0.0 110.571 179.989 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 760' ' ' VAL . . . . . 0.47 HG22 HD13 ' A' ' 816' ' ' ILE . 11.5 t -112.52 155.57 13.74 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.408 -0.808 . . . . 0.0 109.388 179.93 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 761' ' ' HIS . . . . . 0.447 ' N ' HG11 ' A' ' 760' ' ' VAL . 0.9 OUTLIER -133.34 119.74 20.11 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.957 -1.089 . . . . 0.0 111.024 179.995 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 762' ' ' LEU . . . . . . . . . . . . . 8.1 mt -114.54 134.78 54.77 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.484 -0.76 . . . . 0.0 109.561 179.935 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 763' ' ' LYS . . . . . . . . . . . . . 6.7 tttm -142.35 125.43 16.3 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.023 -1.048 . . . . 0.0 110.588 179.915 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 764' ' ' CYS . . . . . 0.471 ' O ' ' OE2' ' A' ' 810' ' ' GLU . 0.1 OUTLIER -104.41 -173.25 2.26 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.467 -0.77 . . . . 0.0 109.765 179.949 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 765' ' ' ALA . . . . . . . . . . . . . . . -66.05 148.93 98.16 Favored Pre-proline 0 C--N 1.296 -1.754 0 O-C-N 121.27 -0.894 . . . . 0.0 110.298 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 766' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -72.34 96.39 0.81 Allowed 'Trans proline' 0 C--N 1.307 -1.622 0 O-C-N 123.991 1.521 . . . . 0.0 110.293 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 767' ' ' GLY . . . . . . . . . . . . . . . 141.65 -21.55 2.53 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 108.907 -1.677 . . . . 0.0 108.907 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 768' ' ' GLN . . . . . . . . . . . . . 23.5 mt-30 -110.86 145.84 37.54 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.472 -1.016 . . . . 0.0 109.688 179.905 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 769' ' ' THR . . . . . . . . . . . . . 82.3 p -121.95 146.61 46.97 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.234 -0.916 . . . . 0.0 110.669 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 770' ' ' ILE . . . . . 0.468 HD12 ' O ' ' A' ' 806' ' ' CYS . 21.3 mt -49.62 142.82 2.13 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 121.395 -0.816 . . . . 0.0 109.669 179.898 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 771' ' ' SER . . . . . 0.4 ' O ' ' CB ' ' A' ' 772' ' ' ALA . 22.0 p -124.56 -5.45 7.62 Favored 'General case' 0 C--N 1.299 -1.597 0 O-C-N 121.092 -1.005 . . . . 0.0 110.724 -179.903 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 772' ' ' ALA . . . . . 0.4 ' CB ' ' O ' ' A' ' 771' ' ' SER . . . 174.62 146.62 0.07 Allowed 'General case' 0 N--CA 1.492 1.653 0 C-N-CA 118.879 -1.128 . . . . 0.0 111.949 -179.986 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 773' ' ' ILE . . . . . . . . . . . . . 11.7 mm -108.16 149.0 11.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 179.819 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 774' ' ' LYS . . . . . . . . . . . . . 66.8 mttt -132.35 -18.45 2.54 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.509 -1.369 . . . . 0.0 112.206 -179.801 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 775' ' ' PHE . . . . . 0.565 ' CE2' ' HB3' ' A' ' 788' ' ' PHE . 43.2 t80 -140.09 168.69 19.23 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.58 -1.325 . . . . 0.0 110.999 -179.904 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 776' ' ' ALA . . . . . 0.536 ' CB ' ' HB3' ' A' ' 798' ' ' SER . . . 164.15 125.87 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.818 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 -179.991 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 777' ' ' SER . . . . . 0.586 ' HA ' ' CE1' ' A' ' 794' ' ' HIS . 0.5 OUTLIER -148.94 106.21 3.62 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.956 -1.09 . . . . 0.0 111.522 -179.906 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 778' ' ' PHE . . . . . 0.411 ' CE2' ' SD ' ' A' ' 830' ' ' MET . 89.6 t80 -85.76 123.94 31.71 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.125 -0.984 . . . . 0.0 109.539 179.908 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 779' ' ' GLY . . . . . 0.508 ' O ' ' HB2' ' A' ' 832' ' ' ARG . . . 138.15 -107.07 0.55 Allowed Glycine 0 N--CA 1.493 2.473 0 C-N-CA 119.496 -1.335 . . . . 0.0 109.99 179.998 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 780' ' ' THR . . . . . . . . . . . . . 35.1 p -133.19 88.16 36.79 Favored Pre-proline 0 N--CA 1.494 1.768 0 O-C-N 120.85 -1.382 . . . . 0.0 111.028 -179.893 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 781' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_endo -83.35 177.72 6.26 Favored 'Trans proline' 0 C--N 1.308 -1.565 0 O-C-N 123.938 1.494 . . . . 0.0 110.534 179.878 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 782' ' ' LEU . . . . . 0.523 ' CD1' ' HA2' ' A' ' 791' ' ' GLY . 1.0 OUTLIER -135.93 174.74 10.28 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.202 -0.936 . . . . 0.0 110.257 179.951 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 783' ' ' GLY . . . . . . . . . . . . . . . 59.34 -166.07 9.08 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.864 -1.295 . . . . 0.0 109.864 179.935 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 784' ' ' THR . . . . . 0.531 HG22 ' N ' ' A' ' 785' ' ' CYS . 9.3 t -133.3 -128.02 0.17 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.373 -1.075 . . . . 0.0 109.904 179.934 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 785' ' ' CYS . . . . . 0.531 ' N ' HG22 ' A' ' 784' ' ' THR . 1.9 t -92.84 96.58 10.22 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 120.752 -1.218 . . . . 0.0 110.206 -179.967 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 786' ' ' GLY . . . . . . . . . . . . . . . 139.72 -24.68 2.74 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.383 -1.487 . . . . 0.0 109.383 179.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 787' ' ' THR . . . . . 0.443 ' CG2' ' O ' ' A' ' 787' ' ' THR . 99.8 m -139.72 37.95 2.01 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.18 -1.188 . . . . 0.0 110.142 179.964 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 788' ' ' PHE . . . . . 0.565 ' HB3' ' CE2' ' A' ' 775' ' ' PHE . 0.3 OUTLIER -65.75 116.97 7.5 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.304 -0.873 . . . . 0.0 109.899 179.92 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 789' ' ' GLN . . . . . . . . . . . . . 5.3 tm0? -119.11 153.04 35.45 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.252 -0.905 . . . . 0.0 110.261 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 790' ' ' GLN . . . . . . . . . . . . . 4.1 tt0 -73.05 120.74 19.1 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.293 -0.879 . . . . 0.0 110.12 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 791' ' ' GLY . . . . . 0.523 ' HA2' ' CD1' ' A' ' 782' ' ' LEU . . . -74.21 -116.0 0.08 OUTLIER Glycine 0 N--CA 1.494 2.509 0 N-CA-C 109.867 -1.293 . . . . 0.0 109.867 -179.942 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 792' ' ' GLU . . . . . . . . . . . . . 19.8 mt-10 -118.99 -23.82 6.75 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.225 -1.162 . . . . 0.0 110.35 -179.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 793' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -122.88 121.85 37.19 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.165 -0.96 . . . . 0.0 110.507 -179.936 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 794' ' ' HIS . . . . . 0.586 ' CE1' ' HA ' ' A' ' 777' ' ' SER . 24.2 t60 -149.06 149.35 30.95 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.292 -0.88 . . . . 0.0 109.789 -180.0 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 795' ' ' SER . . . . . 0.473 ' O ' ' NE2' ' A' ' 794' ' ' HIS . 17.1 t -91.94 149.2 21.67 Favored 'General case' 0 C--N 1.299 -1.626 0 O-C-N 121.276 -0.89 . . . . 0.0 109.618 179.889 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 796' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -87.89 15.42 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 O-C-N 121.174 -0.953 . . . . 0.0 110.017 -179.918 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 797' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 -125.59 27.02 6.59 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.387 -0.82 . . . . 0.0 109.714 179.927 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 798' ' ' SER . . . . . 0.536 ' HB3' ' CB ' ' A' ' 776' ' ' ALA . 0.5 OUTLIER -68.25 -35.03 77.28 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.479 -0.763 . . . . 0.0 111.005 179.933 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 799' ' ' ASN . . . . . 0.511 ' N ' ' OD1' ' A' ' 799' ' ' ASN . 1.3 m120 -100.62 11.78 38.77 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.104 -0.997 . . . . 0.0 111.175 -179.859 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 800' ' ' SER . . . . . . . . . . . . . 75.0 p -93.12 -27.38 16.97 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 120.997 -1.065 . . . . 0.0 110.609 -179.925 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 801' ' ' VAL . . . . . . . . . . . . . 40.2 t -88.99 -19.67 7.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.278 -0.889 . . . . 0.0 110.467 -179.925 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 802' ' ' LEU . . . . . 0.492 ' O ' ' HB2' ' A' ' 806' ' ' CYS . 4.1 mm? -79.48 -48.8 13.28 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.187 -0.945 . . . . 0.0 110.837 179.986 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 803' ' ' GLU . . . . . . . . . . . . . 17.5 mt-10 -64.0 -18.71 64.57 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.001 -1.062 . . . . 0.0 111.036 -179.918 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 804' ' ' ARG . . . . . . . . . . . . . 51.9 ttp180 -92.46 -22.14 19.78 Favored 'General case' 0 C--N 1.297 -1.692 0 O-C-N 121.073 -1.017 . . . . 0.0 112.25 -179.844 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 805' ' ' LYS . . . . . 0.445 ' O ' ' SG ' ' A' ' 806' ' ' CYS . 5.8 tttm -140.12 54.96 1.63 Allowed 'General case' 0 N--CA 1.501 2.115 0 O-C-N 120.444 -1.41 . . . . 0.0 112.537 -179.856 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 806' ' ' CYS . . . . . 0.537 ' HA ' ' CB ' ' A' ' 812' ' ' CYS . 1.2 m -163.73 -50.68 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.801 0 O-C-N 120.842 -1.161 . . . . 0.0 110.319 179.722 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 807' ' ' ILE . . . . . . . . . . . . . 55.5 mt -61.62 129.47 24.6 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 O-C-N 121.112 -0.992 . . . . 0.0 110.156 179.905 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 808' ' ' GLY . . . . . 0.411 ' C ' ' HG ' ' A' ' 809' ' ' LEU . . . 104.76 1.86 42.89 Favored Glycine 0 N--CA 1.492 2.431 0 N-CA-C 109.616 -1.394 . . . . 0.0 109.616 179.957 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 809' ' ' LEU . . . . . 0.411 ' HG ' ' C ' ' A' ' 808' ' ' GLY . 4.2 mt -133.03 144.33 49.98 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.157 -1.202 . . . . 0.0 110.308 179.906 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 810' ' ' GLU . . . . . 0.471 ' OE2' ' O ' ' A' ' 764' ' ' CYS . 3.4 tm-20 -70.43 -20.56 62.9 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.219 -0.926 . . . . 0.0 109.653 180.0 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 811' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -156.47 121.59 4.69 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 179.907 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 812' ' ' CYS . . . . . 0.537 ' CB ' ' HA ' ' A' ' 806' ' ' CYS . 26.1 p -123.1 156.7 34.42 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 120.996 -1.065 . . . . 0.0 111.388 -179.972 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 813' ' ' VAL . . . . . . . . . . . . . 38.8 t -120.43 135.24 61.32 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.624 -0.672 . . . . 0.0 109.632 179.925 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 814' ' ' VAL . . . . . . . . . . . . . 48.2 t -112.41 153.09 14.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.095 -1.003 . . . . 0.0 110.551 -179.927 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 815' ' ' ALA . . . . . 0.452 ' HA ' ' HG2' ' A' ' 759' ' ' LYS . . . -104.49 118.37 36.43 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.27 -0.893 . . . . 0.0 109.893 179.985 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 816' ' ' ILE . . . . . 0.47 HD13 HG22 ' A' ' 760' ' ' VAL . 25.1 mt -85.25 108.41 17.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.18 -0.95 . . . . 0.0 110.489 -179.945 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 817' ' ' SER . . . . . . . . . . . . . 44.5 p -157.59 165.87 17.79 Favored Pre-proline 0 N--CA 1.494 1.75 0 O-C-N 121.366 -0.834 . . . . 0.0 109.978 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 818' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_endo -79.44 9.9 3.25 Favored 'Trans proline' 0 C--N 1.305 -1.728 0 O-C-N 123.885 1.466 . . . . 0.0 111.037 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 819' ' ' SER . . . . . . . . . . . . . 27.5 t -131.89 12.18 4.77 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.061 -1.025 . . . . 0.0 110.305 -179.932 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 820' ' ' ASN . . . . . . . . . . . . . 45.8 t-20 -114.12 -2.7 13.38 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.266 -0.897 . . . . 0.0 110.052 179.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 821' ' ' PHE . . . . . . . . . . . . . 8.1 m-85 -112.38 -79.46 0.58 Allowed 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.324 -0.86 . . . . 0.0 110.238 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 822' ' ' GLY . . . . . . . . . . . . . . . -171.22 54.2 0.18 Allowed Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.619 -1.392 . . . . 0.0 109.619 -179.949 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 823' ' ' GLY . . . . . . . . . . . . . . . 78.38 176.61 47.22 Favored Glycine 0 N--CA 1.492 2.399 0 N-CA-C 109.727 -1.349 . . . . 0.0 109.727 179.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 824' ' ' ASP . . . . . . . . . . . . . 15.7 p-10 -70.89 117.47 56.31 Favored Pre-proline 0 N--CA 1.494 1.728 0 O-C-N 121.243 -1.151 . . . . 0.0 110.216 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 825' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -79.59 -65.24 0.02 OUTLIER 'Trans proline' 0 C--N 1.308 -1.565 0 O-C-N 123.97 1.511 . . . . 0.0 110.946 -179.922 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 826' ' ' CYS . . . . . 0.451 ' HB3' ' HB ' ' A' ' 829' ' ' VAL . 22.8 m -97.44 153.64 38.29 Favored Pre-proline 0 N--CA 1.498 1.951 0 O-C-N 121.11 -0.993 . . . . 0.0 110.952 -179.937 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 827' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -78.99 95.96 1.08 Allowed 'Trans proline' 0 C--N 1.313 -1.303 0 O-C-N 124.07 1.563 . . . . 0.0 110.673 179.963 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 828' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER 52.41 18.67 0.97 Allowed 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.152 -0.968 . . . . 0.0 110.404 179.923 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 829' ' ' VAL . . . . . 0.451 ' HB ' ' HB3' ' A' ' 826' ' ' CYS . 66.7 t -119.41 80.86 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.198 -0.939 . . . . 0.0 110.223 179.953 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 830' ' ' MET . . . . . 0.447 ' SD ' ' O ' ' A' ' 830' ' ' MET . 0.0 OUTLIER -178.43 128.65 0.12 Allowed 'General case' 0 C--N 1.304 -1.381 0 O-C-N 121.131 -0.981 . . . . 0.0 110.777 -179.902 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 831' ' ' LYS . . . . . 0.46 ' O ' ' CG ' ' A' ' 832' ' ' ARG . 2.9 tttm -170.58 57.05 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.391 -0.818 . . . . 0.0 110.093 179.906 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 832' ' ' ARG . . . . . 0.508 ' HB2' ' O ' ' A' ' 779' ' ' GLY . 0.5 OUTLIER -167.62 125.32 1.21 Allowed 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.466 -0.771 . . . . 0.0 109.392 -179.996 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 833' ' ' VAL . . . . . . . . . . . . . 58.8 t -112.47 103.26 15.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.045 -1.035 . . . . 0.0 111.055 -179.959 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 834' ' ' ALA . . . . . 0.557 ' HB2' ' CZ ' ' A' ' 788' ' ' PHE . . . -111.16 122.02 46.79 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.471 -0.768 . . . . 0.0 109.099 179.928 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 835' ' ' VAL . . . . . . . . . . . . . 34.7 t -139.3 143.24 31.6 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 O-C-N 120.828 -1.17 . . . . 0.0 111.648 -179.934 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 836' ' ' GLU . . . . . 0.446 ' HB2' ' HB3' ' A' ' 775' ' ' PHE . 1.3 mt-10 -115.5 160.24 20.18 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 179.807 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 837' ' ' ALA . . . . . . . . . . . . . . . -154.64 156.8 37.13 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 120.612 -1.305 . . . . 0.0 111.258 -179.944 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 838' ' ' VAL . . . . . . . . . . . . . 22.0 t -109.24 137.2 42.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.505 -0.747 . . . . 0.0 109.965 179.926 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 839' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -128.32 133.2 48.66 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.142 -0.974 . . . . 0.0 110.132 179.988 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 840' ' ' SER . . . . . . . . . . . . . 24.8 t -159.83 -177.37 6.29 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.281 -0.887 . . . . 0.0 109.939 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 841' ' ' THR . . . . . 0.462 ' CG2' ' HA ' ' A' ' 726' ' ' ARG . 67.1 p -73.86 163.27 28.15 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.149 -0.97 . . . . 0.0 109.926 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 842' ' ' ALA . . . . . 0.44 ' HB3' ' O ' ' A' ' 841' ' ' THR . . . 60.43 147.7 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.193 -0.942 . . . . 0.0 110.298 -179.95 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 843' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 1.735 0 CA-C-O 118.028 -0.987 . . . . 0.0 110.28 -179.981 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 726' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.631 0 CA-C-O 121.26 0.552 . . . . 0.0 110.255 . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 727' ' ' THR . . . . . . . . . . . . . 94.5 m -109.59 153.88 23.55 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.188 -0.945 . . . . 0.0 110.176 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 728' ' ' VAL . . . . . 0.524 ' CG2' ' O ' ' A' ' 839' ' ' CYS . 7.6 p -159.12 139.23 3.8 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.2 -0.938 . . . . 0.0 110.141 -179.963 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 729' ' ' SER . . . . . 0.46 ' O ' HG12 ' A' ' 731' ' ' VAL . 0.5 OUTLIER -107.47 90.5 3.32 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.263 -0.898 . . . . 0.0 110.343 179.928 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 730' ' ' GLY . . . . . 0.451 ' O ' ' CG1' ' A' ' 731' ' ' VAL . . . -44.4 153.25 0.46 Allowed Glycine 0 N--CA 1.492 2.417 0 N-CA-C 109.298 -1.521 . . . . 0.0 109.298 179.996 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 731' ' ' VAL . . . . . 0.46 HG12 ' O ' ' A' ' 729' ' ' SER . 2.4 m -158.48 120.42 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 121.105 -1.233 . . . . 0.0 110.767 179.937 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 732' ' ' CYS . . . . . . . . . . . . . 26.8 p -116.04 130.86 57.0 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.448 -0.783 . . . . 0.0 109.297 179.902 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 733' ' ' ALA . . . . . . . . . . . . . . . -107.77 160.55 15.64 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.106 -0.996 . . . . 0.0 110.609 -179.878 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 734' ' ' ASP . . . . . 0.526 ' OD2' ' CZ ' ' A' ' 832' ' ' ARG . 0.9 OUTLIER -164.36 105.36 0.86 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.414 -0.804 . . . . 0.0 109.444 179.941 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 735' ' ' VAL . . . . . 0.442 ' O ' ' CG ' ' A' ' 832' ' ' ARG . 37.4 t -116.04 163.39 13.31 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 121.089 -1.007 . . . . 0.0 110.715 -179.939 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 736' ' ' SER . . . . . . . . . . . . . 22.5 p -99.16 158.78 15.45 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.425 -0.797 . . . . 0.0 110.029 179.954 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 737' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -77.04 170.06 17.21 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.216 -0.927 . . . . 0.0 110.457 179.944 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 738' ' ' TYR . . . . . 0.573 ' CZ ' ' HG3' ' A' ' 740' ' ' PRO . 2.8 t80 -143.88 117.37 9.14 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.412 -0.805 . . . . 0.0 109.354 179.97 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 739' ' ' HIS . . . . . 0.519 ' NE2' ' CD1' ' A' ' 742' ' ' ILE . 19.7 t-80 -151.15 92.6 3.76 Favored Pre-proline 0 N--CA 1.496 1.854 0 O-C-N 121.099 -1.0 . . . . 0.0 110.859 -179.904 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 740' ' ' PRO . . . . . 0.573 ' HG3' ' CZ ' ' A' ' 738' ' ' TYR . 50.4 Cg_endo -88.42 46.56 1.13 Allowed 'Trans proline' 0 C--N 1.307 -1.626 0 O-C-N 123.945 1.497 . . . . 0.0 110.084 179.871 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 741' ' ' ASN . . . . . 0.487 ' CB ' ' O ' ' A' ' 740' ' ' PRO . 0.2 OUTLIER 68.0 115.92 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.175 -0.953 . . . . 0.0 109.889 -179.929 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 742' ' ' ILE . . . . . 0.54 ' HA ' ' CE1' ' A' ' 755' ' ' PHE . 96.9 mt -91.59 167.62 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 O-C-N 121.149 -0.969 . . . . 0.0 110.895 179.997 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 743' ' ' LYS . . . . . 0.45 ' N ' ' CG2' ' A' ' 742' ' ' ILE . 29.8 tttt -167.41 160.09 12.99 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.604 -0.685 . . . . 0.0 109.521 -179.978 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 744' ' ' ASN . . . . . 0.446 ' N ' ' HG2' ' A' ' 743' ' ' LYS . 6.2 m-20 45.09 76.05 0.1 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.106 -0.996 . . . . 0.0 109.945 -179.977 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 745' ' ' TRP . . . . . 0.467 ' C ' ' CD1' ' A' ' 745' ' ' TRP . 8.5 t90 -84.27 -70.65 0.56 Allowed 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.201 -0.937 . . . . 0.0 110.175 -179.987 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 746' ' ' GLN . . . . . . . . . . . . . 7.1 tp60 -125.54 78.39 1.73 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.344 -0.847 . . . . 0.0 110.377 -179.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 747' ' ' ILE . . . . . 0.438 ' O ' ' CB ' ' A' ' 748' ' ' GLU . 38.1 mm -104.49 150.26 7.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.18 -0.95 . . . . 0.0 109.827 179.922 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 748' ' ' GLU . . . . . 0.528 ' HB3' ' CD1' ' A' ' 750' ' ' TYR . 0.3 OUTLIER 66.09 -142.15 0.18 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.188 -0.945 . . . . 0.0 110.032 179.995 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 749' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -112.23 -36.11 5.42 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.07 -1.019 . . . . 0.0 110.71 -179.986 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 750' ' ' TYR . . . . . 0.569 ' CG ' ' N ' ' A' ' 751' ' ' GLY . 32.0 p90 -59.26 -44.68 92.4 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.177 -0.952 . . . . 0.0 110.787 179.999 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 751' ' ' GLY . . . . . 0.569 ' N ' ' CG ' ' A' ' 750' ' ' TYR . . . 77.75 -78.99 1.45 Allowed Glycine 0 N--CA 1.497 2.756 0 N-CA-C 109.665 -1.374 . . . . 0.0 109.665 -179.97 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 752' ' ' GLU . . . . . 0.553 ' HB2' ' CD2' ' A' ' 750' ' ' TYR . 2.6 tt0 74.59 72.91 0.22 Allowed Pre-proline 0 N--CA 1.505 2.28 0 O-C-N 121.406 -1.055 . . . . 0.0 111.055 179.905 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 753' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_endo -83.71 58.01 5.78 Favored 'Trans proline' 0 C--N 1.308 -1.555 0 O-C-N 124.025 1.539 . . . . 0.0 109.622 179.923 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 754' ' ' GLU . . . . . 0.437 ' HA ' ' OE1' ' A' ' 754' ' ' GLU . 0.0 OUTLIER -83.92 -22.66 31.47 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.305 -0.872 . . . . 0.0 111.02 -179.893 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 755' ' ' PHE . . . . . 0.54 ' CE1' ' HA ' ' A' ' 742' ' ' ILE . 0.2 OUTLIER -54.5 121.0 7.44 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.136 -0.977 . . . . 0.0 110.741 -179.886 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 756' ' ' HIS . . . . . . . . . . . . . 1.2 t-160 -135.97 -166.96 1.95 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.35 -0.844 . . . . 0.0 109.858 179.966 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 757' ' ' THR . . . . . 0.47 ' OG1' ' O ' ' A' ' 816' ' ' ILE . 66.9 p -136.25 -169.04 2.35 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.174 -0.954 . . . . 0.0 110.593 -179.924 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 758' ' ' ALA . . . . . . . . . . . . . . . -55.85 176.45 0.07 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.412 -0.805 . . . . 0.0 110.052 179.944 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 759' ' ' LYS . . . . . 0.553 ' CA ' HD12 ' A' ' 816' ' ' ILE . 9.1 mttp -139.14 167.47 21.98 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.231 -0.918 . . . . 0.0 110.357 179.978 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 760' ' ' VAL . . . . . 0.448 ' O ' HG21 ' A' ' 813' ' ' VAL . 5.5 t -105.52 162.49 4.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.372 -0.83 . . . . 0.0 109.392 179.919 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 761' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -140.35 105.93 5.11 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 120.846 -1.159 . . . . 0.0 111.261 -179.867 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 762' ' ' LEU . . . . . 0.498 ' HB2' ' HB3' ' A' ' 812' ' ' CYS . 0.5 OUTLIER -110.64 103.23 11.78 Favored 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 179.827 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 763' ' ' LYS . . . . . . . . . . . . . 4.4 ttpt -110.6 135.49 51.15 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.202 -0.936 . . . . 0.0 111.46 -179.812 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 764' ' ' CYS . . . . . 0.476 ' HB2' ' O ' ' A' ' 810' ' ' GLU . 1.3 m -126.63 139.89 52.83 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.533 -0.73 . . . . 0.0 109.568 179.856 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 765' ' ' ALA . . . . . 0.445 ' O ' ' O ' ' A' ' 764' ' ' CYS . . . -39.72 161.16 0.09 OUTLIER Pre-proline 0 N--CA 1.496 1.843 0 O-C-N 121.359 -0.838 . . . . 0.0 110.604 -179.98 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 766' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -70.78 113.72 3.63 Favored 'Trans proline' 0 C--N 1.306 -1.706 0 O-C-N 124.121 1.59 . . . . 0.0 110.082 -179.93 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 767' ' ' GLY . . . . . . . . . . . . . . . 118.04 -26.01 8.09 Favored Glycine 0 N--CA 1.488 2.162 0 N-CA-C 108.904 -1.679 . . . . 0.0 108.904 -179.896 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 768' ' ' GLN . . . . . 0.482 ' HA ' ' HA ' ' A' ' 841' ' ' THR . 1.3 tt0 -90.55 119.65 30.99 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.428 -1.042 . . . . 0.0 109.838 179.93 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 769' ' ' THR . . . . . . . . . . . . . 9.4 p -112.22 147.21 36.71 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.227 -0.921 . . . . 0.0 110.474 -179.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 770' ' ' ILE . . . . . 0.42 ' HB ' ' HA ' ' A' ' 807' ' ' ILE . 3.5 mp -65.88 145.37 13.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.252 -0.905 . . . . 0.0 109.292 179.946 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 771' ' ' SER . . . . . . . . . . . . . 36.8 p -136.33 -5.45 2.06 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 120.955 -1.091 . . . . 0.0 111.6 -179.923 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 772' ' ' ALA . . . . . . . . . . . . . . . -171.24 148.02 2.59 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 120.608 -1.307 . . . . 0.0 111.941 -179.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 773' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -120.48 132.27 70.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 N-CA-C 108.482 -0.932 . . . . 0.0 108.482 179.829 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 774' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -103.4 -34.75 8.62 Favored 'General case' 0 N--CA 1.504 2.239 0 O-C-N 120.995 -1.066 . . . . 0.0 110.342 -179.918 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 775' ' ' PHE . . . . . . . . . . . . . 52.2 t80 -126.15 152.7 45.61 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 120.925 -1.11 . . . . 0.0 110.15 179.92 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 776' ' ' ALA . . . . . 0.525 ' CB ' ' HB3' ' A' ' 799' ' ' ASN . . . 175.69 105.9 0.02 OUTLIER 'General case' 0 C--N 1.3 -1.564 0 O-C-N 121.425 -0.797 . . . . 0.0 109.664 -179.969 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 777' ' ' SER . . . . . 0.409 ' HG ' ' CE1' ' A' ' 794' ' ' HIS . 0.4 OUTLIER -137.6 137.84 38.91 Favored 'General case' 0 C--N 1.299 -1.623 0 O-C-N 121.387 -0.82 . . . . 0.0 109.885 -179.975 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 778' ' ' PHE . . . . . . . . . . . . . 65.3 t80 -112.0 98.58 7.45 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.222 -0.924 . . . . 0.0 110.241 -179.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 779' ' ' GLY . . . . . 0.437 ' O ' ' HA ' ' A' ' 831' ' ' LYS . . . 167.85 -93.5 0.11 Allowed Glycine 0 N--CA 1.489 2.197 0 N-CA-C 109.419 -1.472 . . . . 0.0 109.419 179.979 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 780' ' ' THR . . . . . 0.418 HG23 ' O ' ' A' ' 779' ' ' GLY . 60.6 p -141.11 81.67 15.65 Favored Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 121.273 -1.134 . . . . 0.0 110.253 179.945 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 781' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -72.06 154.63 57.57 Favored 'Trans proline' 0 C--N 1.303 -1.818 0 O-C-N 124.02 1.537 . . . . 0.0 110.287 -179.966 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 782' ' ' LEU . . . . . . . . . . . . . 21.4 mt -119.59 116.61 26.38 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.285 -0.884 . . . . 0.0 109.966 179.952 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 783' ' ' GLY . . . . . . . . . . . . . . . 111.5 168.21 18.52 Favored Glycine 0 N--CA 1.488 2.114 0 N-CA-C 109.345 -1.502 . . . . 0.0 109.345 -179.903 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 784' ' ' THR . . . . . 0.513 ' O ' ' CG2' ' A' ' 784' ' ' THR . 14.1 t -152.79 109.22 3.41 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.213 -1.169 . . . . 0.0 110.24 -179.995 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 785' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER 46.88 80.84 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.362 -0.836 . . . . 0.0 110.736 179.964 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 786' ' ' GLY . . . . . . . . . . . . . . . 135.62 -20.58 3.67 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.745 -1.342 . . . . 0.0 109.745 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 787' ' ' THR . . . . . . . . . . . . . 1.9 m -154.86 44.93 0.51 Allowed 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.059 -1.259 . . . . 0.0 110.591 -179.867 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 788' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -69.25 138.99 54.42 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.088 -1.008 . . . . 0.0 109.919 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 789' ' ' GLN . . . . . . . . . . . . . 37.2 tt0 -163.37 134.0 4.55 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.24 -0.913 . . . . 0.0 110.116 179.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 790' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -46.35 157.47 0.13 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.386 -0.821 . . . . 0.0 110.236 179.954 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 791' ' ' GLY . . . . . . . . . . . . . . . -113.87 -139.6 7.26 Favored Glycine 0 N--CA 1.489 2.184 0 N-CA-C 109.516 -1.434 . . . . 0.0 109.516 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 792' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -106.62 -30.86 8.75 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.203 -1.175 . . . . 0.0 110.199 179.946 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 793' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -104.3 107.45 18.38 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.271 -0.893 . . . . 0.0 110.191 -179.956 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 794' ' ' HIS . . . . . 0.45 ' CG ' ' N ' ' A' ' 795' ' ' SER . 86.3 t60 -134.01 171.69 13.85 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.223 -0.923 . . . . 0.0 110.489 -179.988 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 795' ' ' SER . . . . . 0.45 ' N ' ' CG ' ' A' ' 794' ' ' HIS . 93.3 p -120.52 -137.37 0.33 Allowed 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.336 -0.852 . . . . 0.0 110.183 179.98 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 796' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -134.81 -29.72 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.96 0 O-C-N 121.108 -0.995 . . . . 0.0 110.806 179.996 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 797' ' ' ASN . . . . . 0.428 ' HA ' ' HB3' ' A' ' 800' ' ' SER . 1.4 m-20 -96.56 26.46 4.43 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.078 -1.014 . . . . 0.0 110.104 -179.973 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 798' ' ' SER . . . . . 0.492 ' HB2' ' O ' ' A' ' 776' ' ' ALA . 0.8 OUTLIER -51.71 -71.32 0.07 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.329 -0.857 . . . . 0.0 110.955 -179.968 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 799' ' ' ASN . . . . . 0.525 ' HB3' ' CB ' ' A' ' 776' ' ' ALA . 51.6 p30 -85.78 -15.59 41.57 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.293 -0.879 . . . . 0.0 111.101 -179.956 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 800' ' ' SER . . . . . 0.514 ' N ' ' OD1' ' A' ' 799' ' ' ASN . 12.9 t -59.18 -41.58 88.8 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.083 -1.01 . . . . 0.0 110.62 -179.966 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 801' ' ' VAL . . . . . . . . . . . . . 34.9 t -72.2 -26.46 24.89 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.14 -0.975 . . . . 0.0 110.505 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 802' ' ' LEU . . . . . 0.475 ' O ' ' HB2' ' A' ' 806' ' ' CYS . 3.4 mm? -74.2 -59.83 2.55 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.257 -0.902 . . . . 0.0 110.641 -179.944 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 803' ' ' GLU . . . . . 0.413 ' HG3' HD12 ' A' ' 807' ' ' ILE . 20.2 tt0 -54.06 -18.45 3.65 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.115 -0.991 . . . . 0.0 110.683 179.887 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 804' ' ' ARG . . . . . . . . . . . . . 56.3 ttt180 -90.08 -27.22 19.81 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.126 -0.984 . . . . 0.0 111.026 -179.914 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 805' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.76 43.97 2.83 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 120.968 -1.083 . . . . 0.0 110.968 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 806' ' ' CYS . . . . . 0.475 ' HB2' ' O ' ' A' ' 802' ' ' LEU . 0.2 OUTLIER -147.51 -72.3 0.21 Allowed 'General case' 0 N--CA 1.494 1.743 0 O-C-N 120.952 -1.092 . . . . 0.0 110.485 179.993 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 807' ' ' ILE . . . . . 0.42 ' HA ' ' HB ' ' A' ' 770' ' ' ILE . 31.9 mt -47.14 136.58 2.96 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 O-C-N 121.052 -1.03 . . . . 0.0 110.472 -179.955 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 808' ' ' GLY . . . . . . . . . . . . . . . 93.23 5.52 63.7 Favored Glycine 0 N--CA 1.492 2.387 0 N-CA-C 110.229 -1.148 . . . . 0.0 110.229 179.967 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 809' ' ' LEU . . . . . 0.414 ' O ' ' CD1' ' A' ' 770' ' ' ILE . 41.5 mt -137.62 135.26 36.42 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.039 -1.271 . . . . 0.0 110.612 -179.987 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 810' ' ' GLU . . . . . 0.476 ' O ' ' HB2' ' A' ' 764' ' ' CYS . 57.3 mm-40 -64.45 -34.16 77.56 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.27 -0.894 . . . . 0.0 108.792 179.94 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 811' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -111.37 165.48 11.93 Favored 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 179.934 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 812' ' ' CYS . . . . . 0.498 ' HB3' ' HB2' ' A' ' 762' ' ' LEU . 49.5 t -159.66 102.28 1.51 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.861 -1.149 . . . . 0.0 110.608 -179.883 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 813' ' ' VAL . . . . . 0.448 HG21 ' O ' ' A' ' 760' ' ' VAL . 11.9 p -115.8 136.82 51.44 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.178 -0.951 . . . . 0.0 109.981 179.964 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 814' ' ' VAL . . . . . . . . . . . . . 17.7 t -134.4 164.72 33.47 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 O-C-N 121.171 -0.956 . . . . 0.0 110.435 -179.939 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 815' ' ' ALA . . . . . 0.406 ' HA ' ' HG2' ' A' ' 759' ' ' LYS . . . -97.27 157.14 16.11 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.26 -0.9 . . . . 0.0 109.928 179.971 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 816' ' ' ILE . . . . . 0.553 HD12 ' CA ' ' A' ' 759' ' ' LYS . 20.3 mt -117.12 63.62 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.168 -0.957 . . . . 0.0 109.846 179.984 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 817' ' ' SER . . . . . 0.454 ' OG ' ' HB2' ' A' ' 820' ' ' ASN . 0.0 OUTLIER -116.15 165.98 13.56 Favored Pre-proline 0 N--CA 1.494 1.728 0 O-C-N 121.432 -0.792 . . . . 0.0 110.716 -179.875 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 818' ' ' PRO . . . . . 0.458 ' HB2' ' OD1' ' A' ' 824' ' ' ASP . 49.0 Cg_endo -76.92 -44.94 0.19 Allowed 'Trans proline' 0 C--N 1.307 -1.657 0 O-C-N 124.181 1.622 . . . . 0.0 110.573 -179.954 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 819' ' ' SER . . . . . . . . . . . . . 66.3 m -88.46 15.33 8.04 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.271 -0.893 . . . . 0.0 110.238 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 820' ' ' ASN . . . . . 0.454 ' HB2' ' OG ' ' A' ' 817' ' ' SER . 2.1 m120 -101.47 -16.51 16.8 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.225 -0.922 . . . . 0.0 110.449 179.985 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 821' ' ' PHE . . . . . . . . . . . . . 5.2 m-85 -93.32 -91.9 0.18 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.051 -1.031 . . . . 0.0 110.44 179.968 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 822' ' ' GLY . . . . . . . . . . . . . . . -152.97 14.93 0.68 Allowed Glycine 0 N--CA 1.492 2.39 0 C-N-CA 119.551 -1.309 . . . . 0.0 110.266 -179.991 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 823' ' ' GLY . . . . . . . . . . . . . . . 154.74 -170.66 33.07 Favored Glycine 0 N--CA 1.493 2.486 0 O-C-N 121.008 -1.289 . . . . 0.0 110.068 179.941 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 824' ' ' ASP . . . . . 0.458 ' OD1' ' HB2' ' A' ' 818' ' ' PRO . 0.2 OUTLIER -113.33 105.44 55.26 Favored Pre-proline 0 N--CA 1.494 1.73 0 O-C-N 121.379 -1.071 . . . . 0.0 110.14 -179.972 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 825' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -76.31 -64.9 0.02 OUTLIER 'Trans proline' 0 C--N 1.304 -1.775 0 O-C-N 123.994 1.523 . . . . 0.0 110.789 -179.963 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 826' ' ' CYS . . . . . . . . . . . . . 98.3 m -125.19 98.62 35.37 Favored Pre-proline 0 N--CA 1.495 1.794 0 O-C-N 121.119 -0.988 . . . . 0.0 110.414 179.953 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 827' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_endo -82.77 153.38 15.09 Favored 'Trans proline' 0 C--N 1.303 -1.847 0 O-C-N 124.062 1.559 . . . . 0.0 110.612 -179.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 828' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 62.26 17.85 9.66 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.304 -0.872 . . . . 0.0 110.521 179.995 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 829' ' ' VAL . . . . . 0.431 ' O ' ' C ' ' A' ' 830' ' ' MET . 66.4 t -127.5 111.21 24.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.225 -0.922 . . . . 0.0 110.283 179.981 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 830' ' ' MET . . . . . 0.431 ' C ' ' O ' ' A' ' 829' ' ' VAL . 2.9 mmt -42.41 125.49 3.21 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.278 -0.889 . . . . 0.0 109.672 -179.992 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 831' ' ' LYS . . . . . 0.437 ' HA ' ' O ' ' A' ' 779' ' ' GLY . 1.2 ptpt -128.85 133.62 48.03 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.047 -1.033 . . . . 0.0 111.151 -179.938 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 832' ' ' ARG . . . . . 0.526 ' CZ ' ' OD2' ' A' ' 734' ' ' ASP . 20.2 ttt180 -108.55 158.89 17.16 Favored 'General case' 0 N--CA 1.489 1.475 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 179.946 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 833' ' ' VAL . . . . . 0.53 HG21 ' CG2' ' A' ' 816' ' ' ILE . 8.3 t -111.85 126.68 69.26 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 120.976 -1.078 . . . . 0.0 111.133 -179.877 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 834' ' ' ALA . . . . . . . . . . . . . . . -131.08 134.15 46.34 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 179.924 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 835' ' ' VAL . . . . . . . . . . . . . 5.9 t -145.02 150.91 15.59 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 O-C-N 120.933 -1.105 . . . . 0.0 111.275 -179.919 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 836' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -127.13 110.82 13.31 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 179.9 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 837' ' ' ALA . . . . . . . . . . . . . . . -110.26 159.33 17.5 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.066 -1.021 . . . . 0.0 111.106 -179.848 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 838' ' ' VAL . . . . . . . . . . . . . 92.1 t -115.29 122.15 68.65 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.475 0 O-C-N 121.498 -0.751 . . . . 0.0 109.731 179.961 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 839' ' ' CYS . . . . . 0.524 ' O ' ' CG2' ' A' ' 728' ' ' VAL . 0.0 OUTLIER -108.95 122.56 47.48 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.247 -0.908 . . . . 0.0 110.532 -179.925 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 840' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -121.08 119.39 32.3 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.268 -0.895 . . . . 0.0 109.799 179.963 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 841' ' ' THR . . . . . 0.482 ' HA ' ' HA ' ' A' ' 768' ' ' GLN . 14.6 t -53.34 155.89 2.61 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.103 -0.998 . . . . 0.0 110.569 -179.927 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 842' ' ' ALA . . . . . . . . . . . . . . . -145.8 121.52 10.51 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.385 -0.822 . . . . 0.0 110.158 179.94 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 843' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.582 0 CA-C-O 117.954 -1.022 . . . . 0.0 110.262 179.964 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 726' ' ' ARG . . . . . . . . . . . . . 3.2 mmt85 . . . . . 0 N--CA 1.492 1.639 0 CA-C-O 121.23 0.538 . . . . 0.0 110.06 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 727' ' ' THR . . . . . . . . . . . . . 1.8 m -96.86 112.89 24.45 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.16 -0.962 . . . . 0.0 110.664 -179.961 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 728' ' ' VAL . . . . . 0.565 ' CG1' ' N ' ' A' ' 729' ' ' SER . 1.0 OUTLIER -96.36 -75.04 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.177 -0.952 . . . . 0.0 109.757 -179.969 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 729' ' ' SER . . . . . 0.565 ' N ' ' CG1' ' A' ' 728' ' ' VAL . 2.4 m -178.53 -163.59 0.07 Allowed 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.102 -0.999 . . . . 0.0 110.601 -179.984 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 730' ' ' GLY . . . . . . . . . . . . . . . -152.67 -166.27 14.14 Favored Glycine 0 N--CA 1.496 2.698 0 N-CA-C 109.381 -1.488 . . . . 0.0 109.381 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 731' ' ' VAL . . . . . 0.413 ' CG1' ' N ' ' A' ' 732' ' ' CYS . 73.7 t -140.33 165.95 20.34 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 O-C-N 121.064 -1.256 . . . . 0.0 110.508 179.978 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 732' ' ' CYS . . . . . 0.413 ' N ' ' CG1' ' A' ' 731' ' ' VAL . 82.1 m -111.8 156.99 21.1 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.32 -0.863 . . . . 0.0 110.094 179.999 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 733' ' ' ALA . . . . . 0.423 ' O ' ' HA ' ' A' ' 834' ' ' ALA . . . -141.68 106.72 4.95 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.144 -0.973 . . . . 0.0 110.439 -179.997 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 734' ' ' ASP . . . . . 0.449 ' N ' ' OD1' ' A' ' 734' ' ' ASP . 5.2 m-20 -118.16 124.52 48.18 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.372 -0.83 . . . . 0.0 109.944 -180.0 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 735' ' ' VAL . . . . . 0.434 ' CG1' ' N ' ' A' ' 736' ' ' SER . 51.5 t -125.79 166.91 20.99 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 O-C-N 121.197 -0.94 . . . . 0.0 110.181 179.985 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 736' ' ' SER . . . . . 0.434 ' N ' ' CG1' ' A' ' 735' ' ' VAL . 10.2 p -113.36 45.18 1.43 Allowed 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.248 -0.907 . . . . 0.0 110.573 -179.984 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 737' ' ' GLU . . . . . 0.458 ' OE1' ' HB3' ' A' ' 831' ' ' LYS . 2.1 tt0 36.03 -152.38 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.127 0 O-C-N 121.469 -0.77 . . . . 0.0 111.273 179.911 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 738' ' ' TYR . . . . . 0.605 ' CZ ' ' HG3' ' A' ' 740' ' ' PRO . 56.7 t80 -168.77 -96.76 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.413 -0.804 . . . . 0.0 109.907 -179.898 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 739' ' ' HIS . . . . . 0.404 ' CD2' HD22 ' A' ' 741' ' ' ASN . 1.0 OUTLIER 44.65 88.28 0.1 Allowed Pre-proline 0 N--CA 1.502 2.134 0 O-C-N 121.053 -1.029 . . . . 0.0 110.983 179.996 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 740' ' ' PRO . . . . . 0.605 ' HG3' ' CZ ' ' A' ' 738' ' ' TYR . 55.8 Cg_endo -92.23 55.48 0.68 Allowed 'Trans proline' 0 C--N 1.308 -1.596 0 O-C-N 124.021 1.538 . . . . 0.0 111.062 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 741' ' ' ASN . . . . . 0.473 ' O ' ' HB ' ' A' ' 742' ' ' ILE . 7.7 p30 -162.34 -41.87 0.04 OUTLIER 'General case' 0 N--CA 1.497 1.884 0 O-C-N 120.636 -1.29 . . . . 0.0 111.411 -179.994 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 742' ' ' ILE . . . . . 0.485 ' CG2' ' N ' ' A' ' 743' ' ' LYS . 3.6 mp 55.49 173.37 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.009 -1.057 . . . . 0.0 109.443 -179.909 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 743' ' ' LYS . . . . . 0.485 ' N ' ' CG2' ' A' ' 742' ' ' ILE . 11.9 ttmm -87.75 149.75 24.01 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 120.961 -1.087 . . . . 0.0 110.821 -179.942 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 744' ' ' ASN . . . . . 0.467 ' HB2' ' O ' ' A' ' 743' ' ' LYS . 9.6 m120 59.13 124.36 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.482 -0.761 . . . . 0.0 110.811 179.943 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 745' ' ' TRP . . . . . 0.418 ' CD1' ' O ' ' A' ' 744' ' ' ASN . 0.0 OUTLIER -173.23 -175.6 1.21 Allowed 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.456 -0.778 . . . . 0.0 110.203 179.978 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 746' ' ' GLN . . . . . 0.448 ' O ' ' HB ' ' A' ' 747' ' ' ILE . 7.3 mm100 -137.29 -162.56 1.31 Allowed 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.264 -0.898 . . . . 0.0 110.236 179.974 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 747' ' ' ILE . . . . . 0.448 ' HB ' ' O ' ' A' ' 746' ' ' GLN . 65.4 mt 57.38 92.7 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 121.146 -0.971 . . . . 0.0 110.339 -179.976 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 748' ' ' GLU . . . . . 0.444 ' C ' ' O ' ' A' ' 747' ' ' ILE . 0.2 OUTLIER 40.09 76.7 0.06 Allowed 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.443 -0.785 . . . . 0.0 110.262 -179.999 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 749' ' ' SER . . . . . . . . . . . . . 3.3 t -156.62 -77.03 0.09 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.208 -0.933 . . . . 0.0 110.275 -179.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 750' ' ' TYR . . . . . . . . . . . . . 17.8 m-85 45.51 90.78 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.216 -0.928 . . . . 0.0 110.223 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 751' ' ' GLY . . . . . 0.465 ' O ' ' HG3' ' A' ' 752' ' ' GLU . . . 82.48 133.98 1.95 Allowed Glycine 0 N--CA 1.492 2.406 0 N-CA-C 109.786 -1.326 . . . . 0.0 109.786 179.954 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 752' ' ' GLU . . . . . 0.465 ' HG3' ' O ' ' A' ' 751' ' ' GLY . 6.5 mt-10 -144.69 97.13 5.03 Favored Pre-proline 0 N--CA 1.495 1.785 0 O-C-N 121.32 -1.106 . . . . 0.0 110.028 179.952 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 753' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -74.89 -175.56 2.4 Favored 'Trans proline' 0 C--N 1.305 -1.742 0 O-C-N 124.05 1.553 . . . . 0.0 110.768 179.965 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 754' ' ' GLU . . . . . . . . . . . . . 2.4 tp10 -91.92 126.78 37.14 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.312 -0.868 . . . . 0.0 109.924 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 755' ' ' PHE . . . . . 0.541 ' CD1' ' N ' ' A' ' 755' ' ' PHE . 18.2 p90 -143.29 -135.28 0.09 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.295 -0.878 . . . . 0.0 110.102 -179.979 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 756' ' ' HIS . . . . . 0.416 ' C ' ' O ' ' A' ' 755' ' ' PHE . 3.1 t-160 -42.68 124.78 3.14 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 120.86 -1.15 . . . . 0.0 110.505 179.978 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 757' ' ' THR . . . . . 0.442 HG21 ' O ' ' A' ' 755' ' ' PHE . 61.9 p -112.47 -148.93 0.44 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.399 -0.813 . . . . 0.0 109.858 179.925 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 758' ' ' ALA . . . . . . . . . . . . . . . -112.69 175.59 5.37 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.08 -1.012 . . . . 0.0 110.244 179.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 759' ' ' LYS . . . . . . . . . . . . . 11.4 mtmt -146.71 150.69 35.87 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.257 -0.902 . . . . 0.0 110.968 -179.899 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 760' ' ' VAL . . . . . 0.413 HG21 HG22 ' A' ' 735' ' ' VAL . 3.6 t -110.38 144.84 17.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.514 -0.741 . . . . 0.0 109.316 179.865 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 761' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -118.76 114.16 22.25 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.076 -1.015 . . . . 0.0 110.564 179.949 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 762' ' ' LEU . . . . . 0.459 ' HB2' ' HB3' ' A' ' 812' ' ' CYS . 0.4 OUTLIER -108.54 157.19 18.69 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.426 -0.796 . . . . 0.0 109.653 179.955 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 763' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -158.84 106.97 1.87 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.158 -0.964 . . . . 0.0 110.6 -179.976 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 764' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -88.21 166.54 14.29 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.364 -0.835 . . . . 0.0 109.915 -179.998 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 765' ' ' ALA . . . . . . . . . . . . . . . -63.55 154.24 80.32 Favored Pre-proline 0 N--CA 1.493 1.676 0 O-C-N 121.147 -0.971 . . . . 0.0 110.157 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 766' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -69.06 125.14 12.13 Favored 'Trans proline' 0 C--N 1.305 -1.735 0 O-C-N 124.016 1.535 . . . . 0.0 110.348 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 767' ' ' GLY . . . . . . . . . . . . . . . 108.69 -15.21 34.79 Favored Glycine 0 N--CA 1.489 2.21 0 N-CA-C 109.366 -1.493 . . . . 0.0 109.366 -179.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 768' ' ' GLN . . . . . 0.444 ' HB3' ' HB3' ' A' ' 839' ' ' CYS . 0.9 OUTLIER -114.32 140.72 48.39 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.338 -1.095 . . . . 0.0 110.236 179.96 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 769' ' ' THR . . . . . . . . . . . . . 69.7 p -121.48 150.4 41.63 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.295 -0.878 . . . . 0.0 110.393 -179.906 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 770' ' ' ILE . . . . . . . . . . . . . 16.9 mt -66.26 131.18 32.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.262 -0.899 . . . . 0.0 109.689 179.958 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 771' ' ' SER . . . . . . . . . . . . . 80.2 p -129.1 -0.3 5.2 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.101 -0.999 . . . . 0.0 110.836 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 772' ' ' ALA . . . . . 0.476 ' O ' ' HB ' ' A' ' 838' ' ' VAL . . . 177.95 127.4 0.05 Allowed 'General case' 0 N--CA 1.495 1.792 0 O-C-N 120.824 -1.173 . . . . 0.0 111.576 179.998 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 773' ' ' ILE . . . . . 0.524 HD11 ' N ' ' A' ' 773' ' ' ILE . 1.4 mp -87.17 123.44 39.98 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 N-CA-C 108.644 -0.873 . . . . 0.0 108.644 179.804 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 774' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -85.43 -31.56 22.8 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.027 -1.046 . . . . 0.0 111.88 -179.816 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 775' ' ' PHE . . . . . 0.644 ' CE2' ' CB ' ' A' ' 788' ' ' PHE . 90.6 t80 -147.61 171.82 14.99 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 120.645 -1.284 . . . . 0.0 111.325 -179.988 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 776' ' ' ALA . . . . . 0.504 ' N ' ' CG ' ' A' ' 775' ' ' PHE . . . -179.52 136.7 0.12 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.544 -0.723 . . . . 0.0 109.546 -179.989 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 777' ' ' SER . . . . . 0.45 ' HB3' ' HB3' ' A' ' 781' ' ' PRO . 0.3 OUTLIER -148.44 127.04 12.43 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.119 -0.988 . . . . 0.0 110.373 -179.966 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 778' ' ' PHE . . . . . 0.614 ' CG ' ' O ' ' A' ' 778' ' ' PHE . 4.5 t80 -109.66 63.01 0.6 Allowed 'General case' 0 C--N 1.3 -1.555 0 CA-C-O 122.0 0.905 . . . . 0.0 108.957 179.935 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 779' ' ' GLY . . . . . . . . . . . . . . . -172.73 -111.02 0.25 Allowed Glycine 0 N--CA 1.488 2.152 0 N-CA-C 109.449 -1.461 . . . . 0.0 109.449 -179.945 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 780' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -115.14 81.39 7.91 Favored Pre-proline 0 N--CA 1.494 1.733 0 O-C-N 121.218 -1.166 . . . . 0.0 110.443 179.961 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 781' ' ' PRO . . . . . 0.45 ' HB3' ' HB3' ' A' ' 777' ' ' SER . 48.7 Cg_endo -77.93 143.87 21.04 Favored 'Trans proline' 0 C--N 1.304 -1.768 0 O-C-N 124.027 1.54 . . . . 0.0 109.872 179.961 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 782' ' ' LEU . . . . . 0.527 ' CD1' ' HA3' ' A' ' 791' ' ' GLY . 4.6 mt -137.22 148.39 46.45 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.109 -0.994 . . . . 0.0 110.373 -179.963 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 783' ' ' GLY . . . . . . . . . . . . . . . 138.26 -124.54 2.95 Favored Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.468 -1.453 . . . . 0.0 109.468 -179.984 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 784' ' ' THR . . . . . . . . . . . . . 15.5 m -154.82 -75.42 0.11 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.217 -1.166 . . . . 0.0 110.393 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 785' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -153.46 99.53 2.34 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.307 -0.87 . . . . 0.0 110.254 179.971 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 786' ' ' GLY . . . . . . . . . . . . . . . 98.04 -17.19 59.08 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.716 -1.354 . . . . 0.0 109.716 -179.95 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 787' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -113.5 23.76 12.86 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.213 -1.169 . . . . 0.0 110.275 179.958 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 788' ' ' PHE . . . . . 0.644 ' CB ' ' CE2' ' A' ' 775' ' ' PHE . 10.8 m-85 -50.66 170.79 0.03 OUTLIER 'General case' 0 C--N 1.299 -1.599 0 O-C-N 121.192 -0.942 . . . . 0.0 109.588 -179.967 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 789' ' ' GLN . . . . . 0.532 ' O ' ' N ' ' A' ' 791' ' ' GLY . 5.0 tp60 -164.8 118.52 1.3 Allowed 'General case' 0 C--N 1.298 -1.663 0 O-C-N 121.257 -0.902 . . . . 0.0 109.957 179.99 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 790' ' ' GLN . . . . . . . . . . . . . 1.8 pt20 -49.08 89.79 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.376 -0.828 . . . . 0.0 110.039 179.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 791' ' ' GLY . . . . . 0.532 ' N ' ' O ' ' A' ' 789' ' ' GLN . . . -43.4 -59.54 3.53 Favored Glycine 0 N--CA 1.488 2.152 0 N-CA-C 109.519 -1.433 . . . . 0.0 109.519 -179.987 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 792' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -152.56 -24.49 0.17 Allowed 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.273 -1.133 . . . . 0.0 111.419 179.973 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 793' ' ' CYS . . . . . . . . . . . . . 1.2 m -118.59 148.52 42.6 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 120.744 -1.222 . . . . 0.0 110.876 179.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 794' ' ' HIS . . . . . 0.49 ' NE2' ' HA ' ' A' ' 796' ' ' ILE . 5.4 t60 -169.41 146.76 3.51 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.488 -0.758 . . . . 0.0 109.808 179.917 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 795' ' ' SER . . . . . 0.467 ' O ' ' HB ' ' A' ' 796' ' ' ILE . 1.0 OUTLIER -90.06 1.2 56.6 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.194 -0.941 . . . . 0.0 111.338 -179.886 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 796' ' ' ILE . . . . . 0.534 ' O ' ' CG2' ' A' ' 796' ' ' ILE . 21.2 mm 55.95 16.85 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 O-C-N 120.985 -1.072 . . . . 0.0 110.068 -179.975 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 797' ' ' ASN . . . . . 0.455 ' OD1' ' OG ' ' A' ' 800' ' ' SER . 2.2 t-20 -151.08 26.5 0.71 Allowed 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.277 -0.889 . . . . 0.0 109.859 179.974 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 798' ' ' SER . . . . . 0.46 ' HB2' ' O ' ' A' ' 776' ' ' ALA . 21.0 m -71.26 -14.91 62.39 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.323 -0.861 . . . . 0.0 111.395 -179.966 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 799' ' ' ASN . . . . . . . . . . . . . 24.4 p30 -105.0 -5.32 21.07 Favored 'General case' 0 N--CA 1.5 2.06 0 O-C-N 121.004 -1.06 . . . . 0.0 111.184 -179.928 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 800' ' ' SER . . . . . 0.455 ' OG ' ' OD1' ' A' ' 797' ' ' ASN . 49.7 m -82.83 -16.82 46.25 Favored 'General case' 0 C--N 1.293 -1.874 0 O-C-N 121.167 -0.958 . . . . 0.0 110.771 -179.972 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 801' ' ' VAL . . . . . 0.456 HG21 ' O ' ' A' ' 820' ' ' ASN . 40.6 t -91.27 -19.67 7.02 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 O-C-N 121.15 -0.968 . . . . 0.0 111.178 -179.911 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 802' ' ' LEU . . . . . 0.453 HD12 HG22 ' A' ' 814' ' ' VAL . 3.9 mm? -88.55 -48.09 7.83 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.005 -1.059 . . . . 0.0 111.247 -179.837 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 803' ' ' GLU . . . . . 0.492 ' HA ' HD13 ' A' ' 807' ' ' ILE . 37.5 tt0 -56.85 -16.96 7.68 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.946 -1.096 . . . . 0.0 110.38 179.949 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 804' ' ' ARG . . . . . . . . . . . . . 2.9 ttt180 -91.16 -26.31 19.14 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.202 -0.936 . . . . 0.0 111.81 -179.908 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 805' ' ' LYS . . . . . . . . . . . . . 1.1 ttpt -140.84 60.57 1.52 Allowed 'General case' 0 N--CA 1.497 1.89 0 O-C-N 120.756 -1.215 . . . . 0.0 111.196 -179.87 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 806' ' ' CYS . . . . . . . . . . . . . 3.4 t -162.46 -25.68 0.04 OUTLIER 'General case' 0 N--CA 1.501 2.108 0 O-C-N 121.069 -1.019 . . . . 0.0 111.649 179.898 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 807' ' ' ILE . . . . . 0.492 HD13 ' HA ' ' A' ' 803' ' ' GLU . 30.1 mt -83.4 135.85 23.98 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 O-C-N 120.741 -1.224 . . . . 0.0 111.381 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 808' ' ' GLY . . . . . 0.467 ' C ' ' HG ' ' A' ' 809' ' ' LEU . . . 109.92 -5.2 30.62 Favored Glycine 0 N--CA 1.492 2.394 0 C-N-CA 120.094 -1.05 . . . . 0.0 110.792 179.875 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 809' ' ' LEU . . . . . 0.467 ' HG ' ' C ' ' A' ' 808' ' ' GLY . 1.3 mp -136.17 143.46 44.45 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 120.792 -1.417 . . . . 0.0 110.688 -179.92 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 810' ' ' GLU . . . . . 0.523 ' HG3' ' N ' ' A' ' 811' ' ' ARG . 0.0 OUTLIER -70.27 -21.56 62.95 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.246 -0.909 . . . . 0.0 108.709 179.866 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 811' ' ' ARG . . . . . 0.523 ' N ' ' HG3' ' A' ' 810' ' ' GLU . 1.6 ttt180 -115.65 149.73 37.86 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.625 -0.672 . . . . 0.0 109.22 179.89 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 812' ' ' CYS . . . . . 0.459 ' HB3' ' HB2' ' A' ' 762' ' ' LEU . 9.7 t -134.54 146.56 49.78 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.954 -1.091 . . . . 0.0 110.921 -179.887 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 813' ' ' VAL . . . . . . . . . . . . . 46.0 t -135.63 104.56 4.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.536 -0.727 . . . . 0.0 109.172 179.955 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 814' ' ' VAL . . . . . 0.453 HG22 HD12 ' A' ' 802' ' ' LEU . 41.0 t -110.73 115.5 50.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.269 -0.894 . . . . 0.0 111.304 -179.881 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 815' ' ' ALA . . . . . . . . . . . . . . . -79.96 131.81 35.9 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.262 -0.899 . . . . 0.0 109.0 179.901 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 816' ' ' ILE . . . . . 0.52 ' CD1' HG21 ' A' ' 833' ' ' VAL . 59.5 mt -87.0 134.13 28.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.105 -0.997 . . . . 0.0 111.045 -179.887 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 817' ' ' SER . . . . . 0.474 ' OG ' ' HB2' ' A' ' 820' ' ' ASN . 2.9 p -164.9 171.22 5.65 Favored Pre-proline 0 N--CA 1.494 1.732 0 O-C-N 121.416 -0.802 . . . . 0.0 109.699 179.934 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 818' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -78.87 -29.9 3.16 Favored 'Trans proline' 0 C--N 1.306 -1.674 0 O-C-N 123.797 1.42 . . . . 0.0 110.374 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 819' ' ' SER . . . . . . . . . . . . . 46.5 m -87.24 7.71 27.27 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.273 -0.892 . . . . 0.0 110.338 -179.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 820' ' ' ASN . . . . . 0.474 ' HB2' ' OG ' ' A' ' 817' ' ' SER . 0.4 OUTLIER -105.64 -8.43 17.92 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.154 -0.966 . . . . 0.0 110.007 -179.97 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 821' ' ' PHE . . . . . . . . . . . . . 31.8 m-85 -125.61 -74.49 0.6 Allowed 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.237 -0.914 . . . . 0.0 110.334 179.961 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 822' ' ' GLY . . . . . . . . . . . . . . . -178.16 57.75 0.09 OUTLIER Glycine 0 N--CA 1.492 2.375 0 N-CA-C 109.454 -1.458 . . . . 0.0 109.454 -179.98 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 823' ' ' GLY . . . . . . . . . . . . . . . 64.05 -122.85 26.8 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 -179.983 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 824' ' ' ASP . . . . . . . . . . . . . 89.4 m-20 -132.31 130.77 22.04 Favored Pre-proline 0 N--CA 1.495 1.806 0 O-C-N 121.327 -1.102 . . . . 0.0 109.985 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 825' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -82.05 -89.95 0.0 OUTLIER 'Trans proline' 0 C--N 1.308 -1.592 0 O-C-N 123.903 1.475 . . . . 0.0 111.062 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 826' ' ' CYS . . . . . . . . . . . . . 17.7 p -111.21 124.88 31.7 Favored Pre-proline 0 N--CA 1.497 1.879 0 O-C-N 121.256 -0.902 . . . . 0.0 111.12 -179.901 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 827' ' ' PRO . . . . . 0.488 ' O ' ' HB2' ' A' ' 828' ' ' GLU . 49.6 Cg_endo -81.16 -174.03 2.06 Favored 'Trans proline' 0 C--N 1.305 -1.719 0 O-C-N 123.962 1.506 . . . . 0.0 109.562 179.777 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 828' ' ' GLU . . . . . 0.488 ' HB2' ' O ' ' A' ' 827' ' ' PRO . 3.7 mm-40 58.79 14.48 3.24 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.475 -0.765 . . . . 0.0 109.611 -179.941 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 829' ' ' VAL . . . . . 0.459 ' O ' ' O ' ' A' ' 830' ' ' MET . 74.9 t -130.58 129.99 64.65 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.332 0 O-C-N 121.575 -0.703 . . . . 0.0 109.388 -179.983 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 830' ' ' MET . . . . . 0.459 ' O ' ' O ' ' A' ' 829' ' ' VAL . 33.8 mmt -52.82 -170.19 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.271 -0.893 . . . . 0.0 110.202 -179.964 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 831' ' ' LYS . . . . . 0.458 ' HB3' ' OE1' ' A' ' 737' ' ' GLU . 9.4 mttp -147.43 149.58 32.99 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 120.94 -1.1 . . . . 0.0 110.702 -179.913 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 832' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -161.86 149.18 14.31 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.602 -0.686 . . . . 0.0 109.151 179.924 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 833' ' ' VAL . . . . . 0.52 HG21 ' CD1' ' A' ' 816' ' ' ILE . 70.2 t -111.87 107.47 23.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 120.911 -1.118 . . . . 0.0 111.375 -179.973 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 834' ' ' ALA . . . . . 0.423 ' HA ' ' O ' ' A' ' 733' ' ' ALA . . . -109.97 128.71 55.55 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.375 -0.828 . . . . 0.0 109.172 179.857 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 835' ' ' VAL . . . . . . . . . . . . . 3.0 t -138.08 145.56 28.46 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 O-C-N 120.808 -1.183 . . . . 0.0 111.232 -179.855 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 836' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -124.48 117.93 25.49 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 179.873 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 837' ' ' ALA . . . . . . . . . . . . . . . -107.94 155.57 20.17 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.156 -0.965 . . . . 0.0 111.233 -179.807 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 838' ' ' VAL . . . . . 0.476 ' HB ' ' O ' ' A' ' 772' ' ' ALA . 71.9 t -112.33 110.99 34.23 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.375 0 O-C-N 121.545 -0.722 . . . . 0.0 109.361 179.938 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 839' ' ' CYS . . . . . 0.444 ' HB3' ' HB3' ' A' ' 768' ' ' GLN . 1.2 m -105.44 108.93 20.71 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.123 -0.986 . . . . 0.0 110.216 -179.915 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 840' ' ' SER . . . . . 0.475 ' O ' HG21 ' A' ' 841' ' ' THR . 14.8 t -99.17 -89.21 0.32 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.315 -0.865 . . . . 0.0 110.25 179.994 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 841' ' ' THR . . . . . 0.475 HG21 ' O ' ' A' ' 840' ' ' SER . 62.9 p -154.29 -157.98 0.82 Allowed 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.194 -0.942 . . . . 0.0 110.578 -179.977 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 842' ' ' ALA . . . . . 0.429 ' C ' ' O ' ' A' ' 841' ' ' THR . . . -41.27 147.33 0.16 Allowed 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.407 -0.808 . . . . 0.0 110.549 -179.967 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 843' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.642 0 CA-C-O 118.018 -0.992 . . . . 0.0 110.138 -179.936 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 726' ' ' ARG . . . . . 0.425 ' HD2' ' HB ' ' A' ' 727' ' ' THR . 0.0 OUTLIER . . . . . 0 N--CA 1.496 1.854 0 CA-C-O 121.057 0.456 . . . . 0.0 110.495 . . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 727' ' ' THR . . . . . 0.425 ' HB ' ' HD2' ' A' ' 726' ' ' ARG . 27.7 m -132.65 103.16 5.99 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.142 -0.974 . . . . 0.0 109.441 -179.993 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 728' ' ' VAL . . . . . 0.471 ' O ' ' HB2' ' A' ' 729' ' ' SER . 1.3 t -77.87 99.77 2.81 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.781 0 O-C-N 121.292 -0.88 . . . . 0.0 109.959 -179.951 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 729' ' ' SER . . . . . 0.471 ' HB2' ' O ' ' A' ' 728' ' ' VAL . 2.2 m 58.16 168.62 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.484 -0.76 . . . . 0.0 110.788 179.827 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 730' ' ' GLY . . . . . 0.48 ' C ' ' CG2' ' A' ' 731' ' ' VAL . . . -131.32 -161.35 10.18 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.065 -1.614 . . . . 0.0 109.065 179.938 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 731' ' ' VAL . . . . . 0.542 HG11 ' CD2' ' A' ' 762' ' ' LEU . 4.8 t -150.58 137.39 13.0 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 121.149 -1.207 . . . . 0.0 110.324 179.989 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 732' ' ' CYS . . . . . . . . . . . . . 20.3 m -128.25 143.71 51.06 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.309 -0.869 . . . . 0.0 109.868 179.964 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 733' ' ' ALA . . . . . . . . . . . . . . . -148.38 105.06 3.57 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.989 -1.069 . . . . 0.0 110.735 -179.948 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 734' ' ' ASP . . . . . 0.47 ' OD1' ' O ' ' A' ' 734' ' ' ASP . 1.0 OUTLIER -110.39 104.01 12.73 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.352 -0.843 . . . . 0.0 109.979 179.924 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 735' ' ' VAL . . . . . 0.482 ' O ' ' HB ' ' A' ' 833' ' ' VAL . 77.0 t -129.68 123.33 56.95 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 121.125 -0.984 . . . . 0.0 110.243 -179.967 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 736' ' ' SER . . . . . 0.461 ' HA ' ' HA ' ' A' ' 832' ' ' ARG . 5.4 p -84.24 158.74 21.16 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.088 -1.007 . . . . 0.0 110.362 -179.959 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 737' ' ' GLU . . . . . 0.464 ' HB3' ' HG3' ' A' ' 831' ' ' LYS . 24.5 tt0 -86.74 143.55 27.49 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.271 -0.893 . . . . 0.0 109.992 179.981 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 738' ' ' TYR . . . . . 0.577 ' CE1' ' HD3' ' A' ' 740' ' ' PRO . 52.4 p90 -171.2 -158.32 0.14 Allowed 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.056 -1.028 . . . . 0.0 110.78 -179.943 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 739' ' ' HIS . . . . . 0.46 ' HB2' ' HA ' ' A' ' 756' ' ' HIS . 4.0 t-80 -145.89 101.36 4.23 Favored Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.595 -0.691 . . . . 0.0 109.155 179.933 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 740' ' ' PRO . . . . . 0.577 ' HD3' ' CE1' ' A' ' 738' ' ' TYR . 49.6 Cg_endo -78.96 25.22 0.57 Allowed 'Trans proline' 0 C--N 1.306 -1.7 0 O-C-N 124.024 1.539 . . . . 0.0 111.947 -179.887 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 741' ' ' ASN . . . . . 0.461 ' O ' ' O ' ' A' ' 740' ' ' PRO . 57.7 t-20 42.74 92.28 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.798 0 O-C-N 120.889 -1.132 . . . . 0.0 110.088 179.959 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 742' ' ' ILE . . . . . . . . . . . . . 3.8 mt -75.27 94.08 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.237 -0.914 . . . . 0.0 110.644 -179.922 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 743' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.08 -60.91 2.8 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.029 -1.045 . . . . 0.0 108.979 179.898 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 744' ' ' ASN . . . . . . . . . . . . . 45.1 m-80 -51.38 133.89 28.9 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.342 -0.849 . . . . 0.0 108.836 179.928 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 745' ' ' TRP . . . . . 0.534 ' CZ2' ' O ' ' A' ' 750' ' ' TYR . 0.1 OUTLIER -169.37 22.0 0.02 OUTLIER 'General case' 0 C--N 1.3 -1.585 0 O-C-N 120.91 -1.119 . . . . 0.0 111.228 -179.922 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 746' ' ' GLN . . . . . 0.471 ' O ' ' HB ' ' A' ' 747' ' ' ILE . 5.1 mm-40 -92.26 -148.28 0.23 Allowed 'General case' 0 C--N 1.298 -1.639 0 O-C-N 121.038 -1.039 . . . . 0.0 109.653 -179.95 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 747' ' ' ILE . . . . . 0.517 ' O ' ' CB ' ' A' ' 748' ' ' GLU . 2.6 mt 55.13 105.57 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.067 -1.021 . . . . 0.0 109.538 -179.957 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 748' ' ' GLU . . . . . 0.517 ' CB ' ' O ' ' A' ' 747' ' ' ILE . 0.1 OUTLIER 70.53 -140.76 0.06 Allowed 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.067 -1.021 . . . . 0.0 109.325 -179.873 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 749' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -145.44 120.63 10.16 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 120.8 -1.187 . . . . 0.0 110.463 179.974 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 750' ' ' TYR . . . . . 0.534 ' O ' ' CZ2' ' A' ' 745' ' ' TRP . 3.5 m-85 -117.84 97.56 5.9 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.297 -0.877 . . . . 0.0 109.996 179.968 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 751' ' ' GLY . . . . . . . . . . . . . . . -92.69 94.58 1.91 Allowed Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 -179.949 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 752' ' ' GLU . . . . . . . . . . . . . 6.7 tt0 -136.78 118.17 11.23 Favored Pre-proline 0 N--CA 1.493 1.706 0 O-C-N 121.298 -1.119 . . . . 0.0 109.878 179.98 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 753' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -72.61 -163.06 0.14 Allowed 'Trans proline' 0 C--N 1.308 -1.602 0 O-C-N 123.908 1.478 . . . . 0.0 110.659 -179.964 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 754' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -68.85 101.41 1.35 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.318 -0.864 . . . . 0.0 110.388 -179.936 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 755' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -128.86 86.68 2.47 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.238 -0.914 . . . . 0.0 110.271 -179.996 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 756' ' ' HIS . . . . . 0.517 ' CD2' ' O ' ' A' ' 756' ' ' HIS . 9.7 p-80 -59.32 104.47 0.26 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.223 -0.923 . . . . 0.0 110.173 179.97 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 757' ' ' THR . . . . . 0.442 ' N ' ' O ' ' A' ' 738' ' ' TYR . 60.9 p -147.96 121.65 9.24 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.153 -0.967 . . . . 0.0 110.246 -179.979 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 758' ' ' ALA . . . . . 0.454 ' HB2' ' CE2' ' A' ' 738' ' ' TYR . . . -111.9 157.93 20.06 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.295 -0.878 . . . . 0.0 110.238 179.955 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 759' ' ' LYS . . . . . . . . . . . . . 1.3 ttmt -113.51 155.0 26.15 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.338 -0.851 . . . . 0.0 109.928 -179.974 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 760' ' ' VAL . . . . . . . . . . . . . 16.8 t -109.06 136.87 43.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.246 -0.909 . . . . 0.0 109.729 179.926 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 761' ' ' HIS . . . . . . . . . . . . . 3.5 m80 -109.52 107.34 17.42 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.147 -0.97 . . . . 0.0 110.467 -179.984 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 762' ' ' LEU . . . . . 0.542 ' CD2' HG11 ' A' ' 731' ' ' VAL . 2.0 mt -109.54 148.13 31.77 Favored 'General case' 0 C--N 1.299 -1.607 0 O-C-N 121.65 -0.656 . . . . 0.0 109.502 179.944 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 763' ' ' LYS . . . . . . . . . . . . . 3.3 ttpt -158.39 121.46 3.83 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.131 -0.98 . . . . 0.0 110.091 179.997 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 764' ' ' CYS . . . . . 0.442 ' O ' ' C ' ' A' ' 765' ' ' ALA . 12.7 t -82.06 157.77 24.02 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.262 -0.899 . . . . 0.0 110.001 179.958 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 765' ' ' ALA . . . . . 0.461 ' HB1' ' OE1' ' A' ' 768' ' ' GLN . . . -41.29 162.36 0.12 Allowed Pre-proline 0 N--CA 1.495 1.799 0 O-C-N 121.263 -0.898 . . . . 0.0 110.325 -179.966 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 766' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -73.16 99.75 1.14 Allowed 'Trans proline' 0 C--N 1.304 -1.799 0 O-C-N 124.025 1.54 . . . . 0.0 110.185 -179.979 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 767' ' ' GLY . . . . . . . . . . . . . . . 117.76 1.0 17.58 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.486 -1.446 . . . . 0.0 109.486 -179.962 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 768' ' ' GLN . . . . . 0.501 ' CG ' ' O ' ' A' ' 840' ' ' SER . 10.7 mp0 -116.47 154.47 30.29 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.219 -1.165 . . . . 0.0 110.273 179.938 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 769' ' ' THR . . . . . 0.403 HG22 ' C ' ' A' ' 768' ' ' GLN . 43.1 p -129.02 147.54 50.9 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.184 -0.948 . . . . 0.0 110.359 -179.978 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 770' ' ' ILE . . . . . . . . . . . . . 37.0 mt -58.99 133.17 24.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.308 -0.87 . . . . 0.0 109.751 179.952 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 771' ' ' SER . . . . . . . . . . . . . 51.7 p -108.47 -17.0 14.09 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.236 -0.915 . . . . 0.0 110.861 -179.889 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 772' ' ' ALA . . . . . . . . . . . . . . . -177.77 171.84 1.79 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.875 -1.141 . . . . 0.0 111.271 -179.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 773' ' ' ILE . . . . . . . . . . . . . 42.6 mm -123.72 129.49 74.45 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 179.858 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 774' ' ' LYS . . . . . 0.408 ' HD2' HG22 ' A' ' 838' ' ' VAL . 5.9 mtpt -95.03 -35.47 11.93 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 121.033 -1.042 . . . . 0.0 111.537 -179.848 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 775' ' ' PHE . . . . . 0.569 ' CZ ' ' HB3' ' A' ' 788' ' ' PHE . 60.1 t80 -149.06 172.34 14.92 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 120.686 -1.259 . . . . 0.0 111.465 -179.948 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 776' ' ' ALA . . . . . 0.556 ' N ' ' CD2' ' A' ' 775' ' ' PHE . . . 169.3 119.93 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 109.187 -0.672 . . . . 0.0 109.187 -179.971 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 777' ' ' SER . . . . . 0.482 ' HA ' ' CB ' ' A' ' 798' ' ' SER . 44.4 t -143.69 137.2 28.02 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 120.978 -1.076 . . . . 0.0 111.172 -179.891 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 778' ' ' PHE . . . . . 0.57 ' CG ' ' O ' ' A' ' 778' ' ' PHE . 1.4 t80 -107.34 72.37 0.87 Allowed 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.422 -0.799 . . . . 0.0 109.73 179.925 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 779' ' ' GLY . . . . . . . . . . . . . . . -174.24 -120.6 0.59 Allowed Glycine 0 N--CA 1.492 2.405 0 N-CA-C 109.961 -1.255 . . . . 0.0 109.961 179.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 780' ' ' THR . . . . . 0.445 ' OG1' ' HA3' ' A' ' 791' ' ' GLY . 24.8 p -117.11 81.46 12.79 Favored Pre-proline 0 N--CA 1.494 1.775 0 O-C-N 121.197 -1.178 . . . . 0.0 110.553 179.984 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 781' ' ' PRO . . . . . 0.4 ' HA ' ' O ' ' A' ' 789' ' ' GLN . 46.8 Cg_endo -80.48 144.43 15.97 Favored 'Trans proline' 0 C--N 1.304 -1.805 0 O-C-N 124.054 1.555 . . . . 0.0 110.229 -179.983 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 782' ' ' LEU . . . . . . . . . . . . . 36.8 mt -120.32 148.91 43.12 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.176 -0.953 . . . . 0.0 110.331 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 783' ' ' GLY . . . . . . . . . . . . . . . 112.2 -139.29 15.54 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.546 -1.422 . . . . 0.0 109.546 -179.962 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 784' ' ' THR . . . . . . . . . . . . . 10.8 t -161.12 -173.26 3.78 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.254 -1.144 . . . . 0.0 110.138 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 785' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -64.37 107.15 1.27 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.191 -0.943 . . . . 0.0 110.204 -179.975 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 786' ' ' GLY . . . . . . . . . . . . . . . 131.36 -31.65 3.09 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.2 -1.56 . . . . 0.0 109.2 179.981 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 787' ' ' THR . . . . . . . . . . . . . 25.2 p -144.38 39.81 1.31 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.32 -1.106 . . . . 0.0 110.088 -179.942 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 788' ' ' PHE . . . . . 0.569 ' HB3' ' CZ ' ' A' ' 775' ' ' PHE . 1.9 m-85 -50.97 171.55 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.328 -0.858 . . . . 0.0 110.229 179.935 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 789' ' ' GLN . . . . . 0.4 ' O ' ' HA ' ' A' ' 781' ' ' PRO . 26.4 tt0 -161.05 169.57 22.22 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.114 -0.991 . . . . 0.0 110.424 -179.989 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 790' ' ' GLN . . . . . 0.463 ' O ' ' HG3' ' A' ' 790' ' ' GLN . 0.0 OUTLIER -94.89 147.96 22.82 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.23 -0.919 . . . . 0.0 110.041 -179.992 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 791' ' ' GLY . . . . . 0.445 ' HA3' ' OG1' ' A' ' 780' ' ' THR . . . -97.4 -150.67 26.88 Favored Glycine 0 N--CA 1.492 2.393 0 N-CA-C 109.516 -1.434 . . . . 0.0 109.516 179.943 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 792' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -70.08 -19.66 63.25 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.255 -1.144 . . . . 0.0 109.973 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 793' ' ' CYS . . . . . 0.475 ' SG ' ' N ' ' A' ' 794' ' ' HIS . 1.8 t -136.72 164.86 27.26 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.337 -0.852 . . . . 0.0 110.051 -179.963 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 794' ' ' HIS . . . . . 0.596 ' CE1' ' O ' ' A' ' 795' ' ' SER . 0.2 OUTLIER 179.5 154.65 0.5 Allowed 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.285 -0.884 . . . . 0.0 109.861 179.976 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 795' ' ' SER . . . . . 0.596 ' O ' ' CE1' ' A' ' 794' ' ' HIS . 1.8 t -91.78 107.61 19.33 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.324 -0.86 . . . . 0.0 110.15 179.993 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 796' ' ' ILE . . . . . 0.436 ' C ' ' O ' ' A' ' 795' ' ' SER . 6.5 pt -38.63 -25.05 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.939 0 O-C-N 121.372 -0.83 . . . . 0.0 111.23 179.981 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 797' ' ' ASN . . . . . 0.532 ' N ' ' O ' ' A' ' 795' ' ' SER . 19.3 p30 -107.85 51.74 0.73 Allowed 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.003 -1.06 . . . . 0.0 111.313 -179.894 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 798' ' ' SER . . . . . 0.494 ' OG ' ' O ' ' A' ' 795' ' ' SER . 4.3 m -102.8 26.42 8.08 Favored 'General case' 0 N--CA 1.497 1.925 0 O-C-N 120.697 -1.252 . . . . 0.0 110.403 179.939 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 799' ' ' ASN . . . . . . . . . . . . . 38.4 m-80 -138.07 -46.97 0.53 Allowed 'General case' 0 N--CA 1.496 1.831 0 O-C-N 120.998 -1.064 . . . . 0.0 110.874 -179.905 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 800' ' ' SER . . . . . . . . . . . . . 8.7 t -62.78 -33.12 74.52 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.118 -0.989 . . . . 0.0 110.385 -179.93 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 801' ' ' VAL . . . . . . . . . . . . . 97.8 t -51.92 -52.06 25.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.285 -0.884 . . . . 0.0 110.582 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 802' ' ' LEU . . . . . 0.473 HD12 ' SG ' ' A' ' 806' ' ' CYS . 1.1 mm? -63.15 -43.48 98.2 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.206 -0.934 . . . . 0.0 110.861 179.996 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 803' ' ' GLU . . . . . . . . . . . . . 24.7 tt0 -55.33 -21.1 13.62 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.232 -0.918 . . . . 0.0 110.646 -179.959 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 804' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -92.14 -23.22 19.49 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.234 -0.916 . . . . 0.0 110.98 -179.969 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 805' ' ' LYS . . . . . 0.4 ' O ' ' SG ' ' A' ' 812' ' ' CYS . 5.0 mmmt -130.77 52.57 2.03 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.017 -1.052 . . . . 0.0 110.892 -179.904 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 806' ' ' CYS . . . . . 0.473 ' SG ' HD12 ' A' ' 802' ' ' LEU . 0.3 OUTLIER -160.95 -72.19 0.06 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.035 -1.041 . . . . 0.0 110.903 179.986 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 807' ' ' ILE . . . . . . . . . . . . . 94.4 mt -55.28 128.74 15.85 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 121.223 -0.923 . . . . 0.0 110.776 -179.921 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 808' ' ' GLY . . . . . 0.465 ' C ' ' HG ' ' A' ' 809' ' ' LEU . . . 106.83 1.16 36.58 Favored Glycine 0 N--CA 1.495 2.576 0 N-CA-C 110.385 -1.086 . . . . 0.0 110.385 179.906 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 809' ' ' LEU . . . . . 0.465 ' HG ' ' C ' ' A' ' 808' ' ' GLY . 1.0 OUTLIER -131.83 160.61 35.15 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 120.831 -1.393 . . . . 0.0 110.534 -179.958 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 810' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -83.78 -9.49 58.76 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.329 -0.857 . . . . 0.0 109.583 179.91 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 811' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -143.62 164.93 29.03 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.39 -0.819 . . . . 0.0 109.193 -179.987 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 812' ' ' CYS . . . . . 0.4 ' SG ' ' O ' ' A' ' 805' ' ' LYS . 7.9 t -143.77 126.99 16.62 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.922 -1.111 . . . . 0.0 111.268 -179.852 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 813' ' ' VAL . . . . . . . . . . . . . 98.3 t -128.45 115.11 36.54 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.298 -0.877 . . . . 0.0 109.225 179.809 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 814' ' ' VAL . . . . . . . . . . . . . 97.9 t -123.28 129.21 74.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.134 -0.978 . . . . 0.0 110.772 -179.876 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 815' ' ' ALA . . . . . . . . . . . . . . . -86.69 158.82 19.35 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.323 -0.861 . . . . 0.0 109.623 179.909 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 816' ' ' ILE . . . . . 0.454 HG23 ' HB2' ' A' ' 737' ' ' GLU . 75.9 mt -109.65 133.02 56.24 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.577 0 O-C-N 121.218 -0.926 . . . . 0.0 110.575 -179.985 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 817' ' ' SER . . . . . 0.502 ' OG ' ' CB ' ' A' ' 820' ' ' ASN . 0.1 OUTLIER -165.98 170.45 5.8 Favored Pre-proline 0 N--CA 1.488 1.447 0 O-C-N 121.267 -0.896 . . . . 0.0 109.888 179.978 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 818' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -78.16 -63.63 0.02 OUTLIER 'Trans proline' 0 C--N 1.303 -1.834 0 O-C-N 123.982 1.517 . . . . 0.0 111.497 -179.886 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 819' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -70.24 -1.1 9.31 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 120.986 -1.071 . . . . 0.0 111.215 -179.849 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 820' ' ' ASN . . . . . 0.502 ' CB ' ' OG ' ' A' ' 817' ' ' SER . 27.9 t-20 -84.49 -20.79 31.1 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 120.952 -1.093 . . . . 0.0 109.999 179.977 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 821' ' ' PHE . . . . . . . . . . . . . 5.5 m-85 -108.45 -59.3 1.88 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.232 -0.918 . . . . 0.0 110.562 -179.903 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 822' ' ' GLY . . . . . . . . . . . . . . . -144.13 -55.65 0.03 OUTLIER Glycine 0 N--CA 1.491 2.366 0 N-CA-C 109.773 -1.331 . . . . 0.0 109.773 179.965 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 823' ' ' GLY . . . . . . . . . . . . . . . 137.77 108.32 0.85 Allowed Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.661 -1.376 . . . . 0.0 109.661 -179.958 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 824' ' ' ASP . . . . . 0.517 ' N ' ' HD3' ' A' ' 825' ' ' PRO . 4.2 m-20 43.11 59.93 10.99 Favored Pre-proline 0 N--CA 1.494 1.736 0 O-C-N 121.343 -1.092 . . . . 0.0 110.73 -179.976 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 825' ' ' PRO . . . . . 0.517 ' HD3' ' N ' ' A' ' 824' ' ' ASP . 47.8 Cg_endo -84.29 -54.91 0.03 OUTLIER 'Trans proline' 0 C--N 1.304 -1.784 0 O-C-N 123.926 1.487 . . . . 0.0 110.261 179.998 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 826' ' ' CYS . . . . . 0.471 ' SG ' HG12 ' A' ' 829' ' ' VAL . 0.5 OUTLIER -131.56 85.24 53.02 Favored Pre-proline 0 N--CA 1.496 1.838 0 O-C-N 121.267 -0.896 . . . . 0.0 110.375 -179.993 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 827' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo -86.64 151.11 8.81 Favored 'Trans proline' 0 C--N 1.306 -1.671 0 O-C-N 123.919 1.484 . . . . 0.0 111.287 -179.969 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 828' ' ' GLU . . . . . 0.437 ' O ' HG21 ' A' ' 829' ' ' VAL . 3.7 mm-40 45.28 48.99 10.28 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.426 -0.796 . . . . 0.0 111.111 179.968 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 829' ' ' VAL . . . . . 0.515 ' O ' ' N ' ' A' ' 831' ' ' LYS . 20.4 t -147.44 137.95 17.34 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.583 0 O-C-N 121.164 -0.96 . . . . 0.0 110.173 179.899 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 830' ' ' MET . . . . . 0.441 ' C ' ' O ' ' A' ' 829' ' ' VAL . 0.2 OUTLIER -42.31 95.11 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.419 -0.8 . . . . 0.0 109.618 179.976 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 831' ' ' LYS . . . . . 0.515 ' N ' ' O ' ' A' ' 829' ' ' VAL . 0.0 OUTLIER -94.61 150.22 20.46 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.186 -0.946 . . . . 0.0 110.565 -179.938 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 832' ' ' ARG . . . . . 0.461 ' HA ' ' HA ' ' A' ' 736' ' ' SER . 0.0 OUTLIER -156.94 151.76 25.84 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.404 -0.81 . . . . 0.0 109.662 179.97 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 833' ' ' VAL . . . . . 0.482 ' HB ' ' O ' ' A' ' 735' ' ' VAL . 66.6 t -115.79 106.1 19.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 120.979 -1.075 . . . . 0.0 110.955 179.978 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 834' ' ' ALA . . . . . 0.419 ' HB2' ' CZ ' ' A' ' 788' ' ' PHE . . . -108.87 132.95 53.53 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.307 -0.87 . . . . 0.0 109.092 179.922 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 835' ' ' VAL . . . . . . . . . . . . . 73.1 t -141.16 133.03 28.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.012 -1.055 . . . . 0.0 111.323 -179.94 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 836' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -125.53 112.64 16.45 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 179.897 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 837' ' ' ALA . . . . . . . . . . . . . . . -108.91 162.67 13.99 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.146 -0.971 . . . . 0.0 111.089 -179.926 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 838' ' ' VAL . . . . . 0.408 HG22 ' HD2' ' A' ' 774' ' ' LYS . 38.6 t -111.84 119.15 59.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.524 -0.735 . . . . 0.0 109.727 -179.946 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 839' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -105.71 146.18 30.11 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.9 -1.125 . . . . 0.0 110.94 179.946 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 840' ' ' SER . . . . . 0.501 ' O ' ' CG ' ' A' ' 768' ' ' GLN . 79.1 p -138.94 -152.22 0.41 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.498 -0.752 . . . . 0.0 109.775 -179.991 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 841' ' ' THR . . . . . . . . . . . . . 69.6 p -121.63 -175.94 3.2 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.186 -0.946 . . . . 0.0 109.993 179.977 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 842' ' ' ALA . . . . . . . . . . . . . . . -108.49 99.3 8.7 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.157 -0.964 . . . . 0.0 110.331 -179.991 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 843' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.679 0 CA-C-O 118.052 -0.975 . . . . 0.0 110.198 179.962 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 726' ' ' ARG . . . . . 0.515 ' O ' ' CG2' ' A' ' 727' ' ' THR . 1.9 ttt180 . . . . . 0 N--CA 1.492 1.66 0 CA-C-O 121.027 0.442 . . . . 0.0 110.183 . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 727' ' ' THR . . . . . 0.515 ' CG2' ' O ' ' A' ' 726' ' ' ARG . 0.4 OUTLIER 73.73 179.08 0.22 Allowed 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.2 -0.937 . . . . 0.0 110.116 179.987 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 728' ' ' VAL . . . . . 0.401 ' O ' ' O ' ' A' ' 729' ' ' SER . 43.0 t -124.6 117.47 50.55 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.654 0 O-C-N 121.43 -0.794 . . . . 0.0 110.177 179.969 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 729' ' ' SER . . . . . 0.401 ' O ' ' O ' ' A' ' 728' ' ' VAL . 40.5 m 51.78 179.21 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.18 -0.95 . . . . 0.0 110.034 -179.972 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 730' ' ' GLY . . . . . . . . . . . . . . . -152.8 -158.8 8.69 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.622 -1.391 . . . . 0.0 109.622 -179.938 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 731' ' ' VAL . . . . . 0.511 ' CG2' ' SG ' ' A' ' 764' ' ' CYS . 18.0 t -140.1 144.65 27.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.21 -1.171 . . . . 0.0 110.506 179.99 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 732' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -135.96 143.15 44.71 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.432 -0.793 . . . . 0.0 109.729 179.952 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 733' ' ' ALA . . . . . . . . . . . . . . . -148.44 122.74 9.61 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.123 -0.986 . . . . 0.0 110.726 179.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 734' ' ' ASP . . . . . 0.461 ' O ' ' OD2' ' A' ' 734' ' ' ASP . 19.3 p-10 -129.92 106.06 8.41 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.326 -0.859 . . . . 0.0 109.877 179.953 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 735' ' ' VAL . . . . . 0.52 HG11 ' N ' ' A' ' 736' ' ' SER . 61.3 t -126.8 159.32 36.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.107 -0.996 . . . . 0.0 110.428 -179.951 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 736' ' ' SER . . . . . 0.52 ' N ' HG11 ' A' ' 735' ' ' VAL . 24.6 m -109.51 127.29 54.34 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.321 -0.862 . . . . 0.0 109.932 179.992 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 737' ' ' GLU . . . . . 0.449 ' HB2' ' HB3' ' A' ' 831' ' ' LYS . 14.9 tp10 -41.8 149.59 0.13 Allowed 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.296 -0.878 . . . . 0.0 110.433 179.992 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 738' ' ' TYR . . . . . 0.417 ' O ' ' O ' ' A' ' 739' ' ' HIS . 21.0 t80 -109.46 -73.22 0.69 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.286 -0.884 . . . . 0.0 110.111 179.952 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 739' ' ' HIS . . . . . 0.417 ' O ' ' O ' ' A' ' 738' ' ' TYR . 2.9 t60 59.87 116.12 0.02 OUTLIER Pre-proline 0 N--CA 1.494 1.751 0 O-C-N 121.252 -0.905 . . . . 0.0 110.488 179.936 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 740' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_endo -80.32 69.37 7.98 Favored 'Trans proline' 0 C--N 1.309 -1.51 0 O-C-N 124.008 1.531 . . . . 0.0 110.118 179.832 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 741' ' ' ASN . . . . . . . . . . . . . 28.2 p30 -104.22 63.96 0.76 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.204 -0.935 . . . . 0.0 110.321 -179.951 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 742' ' ' ILE . . . . . 0.455 HD12 ' N ' ' A' ' 742' ' ' ILE . 5.1 mp -113.9 158.66 14.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.26 -0.9 . . . . 0.0 109.951 -179.981 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 743' ' ' LYS . . . . . . . . . . . . . 30.9 ttmt -85.23 -71.63 0.52 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.11 -0.994 . . . . 0.0 109.878 179.949 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 744' ' ' ASN . . . . . 0.464 ' OD1' ' O ' ' A' ' 744' ' ' ASN . 14.3 p30 -91.27 127.98 36.91 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.09 -1.006 . . . . 0.0 109.458 179.935 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 745' ' ' TRP . . . . . 0.538 ' HA ' ' CE3' ' A' ' 745' ' ' TRP . 0.1 OUTLIER -154.42 15.12 0.45 Allowed 'General case' 0 C--N 1.296 -1.719 0 O-C-N 121.441 -0.787 . . . . 0.0 110.723 -179.894 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 746' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -94.17 134.54 36.51 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.085 -1.009 . . . . 0.0 109.868 179.951 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 747' ' ' ILE . . . . . . . . . . . . . 14.8 pt -139.33 -160.56 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.243 -0.911 . . . . 0.0 110.408 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 748' ' ' GLU . . . . . . . . . . . . . 13.4 mt-10 -81.87 -10.6 59.26 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.39 -0.819 . . . . 0.0 110.064 -179.982 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 749' ' ' SER . . . . . 0.455 ' O ' ' HB2' ' A' ' 750' ' ' TYR . 3.1 t -90.55 -19.43 23.77 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.207 -0.933 . . . . 0.0 110.127 179.998 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 750' ' ' TYR . . . . . 0.455 ' HB2' ' O ' ' A' ' 749' ' ' SER . 80.2 m-85 55.8 163.33 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.199 -0.938 . . . . 0.0 110.237 179.99 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 751' ' ' GLY . . . . . 0.431 ' C ' ' HD2' ' A' ' 753' ' ' PRO . . . 44.0 44.94 7.54 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 -179.992 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 752' ' ' GLU . . . . . 0.609 ' N ' ' CD ' ' A' ' 753' ' ' PRO . 4.6 tp10 -59.72 -41.01 83.65 Favored Pre-proline 0 N--CA 1.489 1.501 0 O-C-N 121.309 -1.112 . . . . 0.0 111.317 -179.955 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 753' ' ' PRO . . . . . 0.609 ' CD ' ' N ' ' A' ' 752' ' ' GLU . 47.0 Cg_endo -77.59 100.86 1.43 Allowed 'Trans proline' 0 C--N 1.312 -1.356 0 O-C-N 123.491 1.258 . . . . 0.0 110.435 -179.971 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 754' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -80.72 -15.9 55.31 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.304 -0.873 . . . . 0.0 110.311 -179.975 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 755' ' ' PHE . . . . . 0.412 ' CZ ' ' HD2' ' A' ' 759' ' ' LYS . 0.8 OUTLIER -143.66 139.78 29.74 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.203 -0.936 . . . . 0.0 110.203 179.931 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 756' ' ' HIS . . . . . 0.433 ' C ' ' OG1' ' A' ' 757' ' ' THR . 14.9 p-80 -117.3 48.02 1.41 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.31 -0.869 . . . . 0.0 110.212 179.947 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 757' ' ' THR . . . . . 0.433 ' OG1' ' C ' ' A' ' 756' ' ' HIS . 0.0 OUTLIER -175.78 172.5 2.5 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.231 -0.918 . . . . 0.0 110.217 179.96 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 758' ' ' ALA . . . . . 0.444 ' HB3' ' CD1' ' A' ' 816' ' ' ILE . . . -98.9 172.26 7.54 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.32 -0.862 . . . . 0.0 109.855 179.939 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 759' ' ' LYS . . . . . 0.412 ' HD2' ' CZ ' ' A' ' 755' ' ' PHE . 6.4 mttm -150.74 136.58 18.22 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.115 -0.991 . . . . 0.0 110.41 179.959 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 760' ' ' VAL . . . . . 0.431 HG12 HD13 ' A' ' 762' ' ' LEU . 42.1 t -106.6 136.65 40.58 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.305 -0.872 . . . . 0.0 109.263 179.941 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 761' ' ' HIS . . . . . . . . . . . . . 68.1 m80 -109.71 104.15 13.1 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.198 -0.939 . . . . 0.0 110.981 -179.947 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 762' ' ' LEU . . . . . 0.431 HD13 HG12 ' A' ' 760' ' ' VAL . 39.4 mt -119.13 101.77 8.25 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.33 -0.857 . . . . 0.0 108.951 179.905 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 763' ' ' LYS . . . . . 0.454 ' HB3' ' HG3' ' A' ' 811' ' ' ARG . 6.6 pttm -135.66 140.86 44.82 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.077 -1.015 . . . . 0.0 110.803 -179.956 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 764' ' ' CYS . . . . . 0.511 ' SG ' ' CG2' ' A' ' 731' ' ' VAL . 0.5 OUTLIER -113.47 157.77 21.55 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.407 -0.808 . . . . 0.0 109.891 179.983 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 765' ' ' ALA . . . . . 0.465 ' HB1' ' HG3' ' A' ' 768' ' ' GLN . . . -44.73 169.71 0.06 OUTLIER Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 121.197 -0.939 . . . . 0.0 110.218 179.963 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 766' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -71.13 113.04 3.46 Favored 'Trans proline' 0 C--N 1.304 -1.787 0 O-C-N 123.961 1.506 . . . . 0.0 110.4 179.958 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 767' ' ' GLY . . . . . 0.496 ' O ' ' CB ' ' A' ' 842' ' ' ALA . . . 110.07 -24.82 17.82 Favored Glycine 0 N--CA 1.488 2.16 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 -179.942 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 768' ' ' GLN . . . . . 0.465 ' HG3' ' HB1' ' A' ' 765' ' ' ALA . 3.1 mt-30 -87.77 99.84 12.4 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.238 -1.154 . . . . 0.0 110.117 -179.99 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 769' ' ' THR . . . . . . . . . . . . . 64.1 p -94.78 154.14 17.42 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.257 -0.902 . . . . 0.0 110.375 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 770' ' ' ILE . . . . . 0.407 ' HA ' ' O ' ' A' ' 838' ' ' VAL . 11.3 mt -78.11 144.89 10.65 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.356 -0.84 . . . . 0.0 110.005 -179.999 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 771' ' ' SER . . . . . . . . . . . . . 1.8 t -137.02 -5.3 1.89 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.147 -0.971 . . . . 0.0 111.158 -179.915 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 772' ' ' ALA . . . . . . . . . . . . . . . -162.18 123.38 2.65 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.859 -1.151 . . . . 0.0 111.014 -179.906 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 773' ' ' ILE . . . . . . . . . . . . . 32.9 mm -85.67 124.48 40.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.286 -0.884 . . . . 0.0 109.551 179.889 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 774' ' ' LYS . . . . . . . . . . . . . 18.9 mmtt -80.44 -42.26 22.98 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.246 -0.909 . . . . 0.0 110.757 -179.904 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 775' ' ' PHE . . . . . 0.479 ' O ' ' CB ' ' A' ' 776' ' ' ALA . 59.3 t80 -154.04 173.0 16.61 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.027 -1.045 . . . . 0.0 111.078 -179.974 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 776' ' ' ALA . . . . . 0.526 ' O ' ' CB ' ' A' ' 798' ' ' SER . . . 168.39 89.08 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.588 -0.695 . . . . 0.0 109.548 179.959 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 777' ' ' SER . . . . . 0.547 ' HA ' ' CB ' ' A' ' 798' ' ' SER . 59.5 p -122.66 137.7 54.82 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.231 -0.918 . . . . 0.0 110.504 -179.906 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 778' ' ' PHE . . . . . . . . . . . . . 15.7 t80 -104.18 104.32 14.22 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.245 -0.909 . . . . 0.0 110.066 179.963 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 779' ' ' GLY . . . . . . . . . . . . . . . 161.64 -113.55 0.57 Allowed Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.457 -1.457 . . . . 0.0 109.457 -179.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 780' ' ' THR . . . . . . . . . . . . . 12.0 p -118.56 72.86 10.75 Favored Pre-proline 0 N--CA 1.492 1.67 0 O-C-N 121.203 -1.175 . . . . 0.0 110.127 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 781' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -73.27 161.16 43.55 Favored 'Trans proline' 0 C--N 1.307 -1.629 0 O-C-N 123.952 1.501 . . . . 0.0 110.296 179.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 782' ' ' LEU . . . . . 0.547 ' CD1' ' CA ' ' A' ' 791' ' ' GLY . 1.2 mp -132.61 169.36 16.73 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.233 -0.917 . . . . 0.0 110.159 179.984 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 783' ' ' GLY . . . . . . . . . . . . . . . 95.61 -167.67 26.0 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.354 -1.498 . . . . 0.0 109.354 -179.994 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 784' ' ' THR . . . . . 0.574 ' O ' ' CZ ' ' A' ' 788' ' ' PHE . 1.2 p -133.62 -65.69 0.67 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.187 -1.184 . . . . 0.0 110.337 -179.981 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 785' ' ' CYS . . . . . . . . . . . . . 7.8 t -156.19 128.49 7.6 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.166 -0.959 . . . . 0.0 110.445 179.988 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 786' ' ' GLY . . . . . . . . . . . . . . . 92.25 -13.18 67.77 Favored Glycine 0 N--CA 1.492 2.384 0 N-CA-C 109.7 -1.36 . . . . 0.0 109.7 -179.973 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 787' ' ' THR . . . . . . . . . . . . . 7.5 t -141.21 31.99 1.73 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.206 -1.173 . . . . 0.0 110.612 -179.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 788' ' ' PHE . . . . . 0.574 ' CZ ' ' O ' ' A' ' 784' ' ' THR . 0.7 OUTLIER -61.02 129.23 40.37 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.094 -1.004 . . . . 0.0 109.671 179.982 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 789' ' ' GLN . . . . . . . . . . . . . 5.2 pt20 -133.23 161.06 35.46 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.075 -1.016 . . . . 0.0 110.258 -179.967 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 790' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -75.27 144.36 42.57 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.233 -0.917 . . . . 0.0 110.406 -179.931 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 791' ' ' GLY . . . . . 0.547 ' CA ' ' CD1' ' A' ' 782' ' ' LEU . . . -96.56 -46.1 2.59 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 -179.98 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 792' ' ' GLU . . . . . 0.46 ' HB3' ' O ' ' A' ' 791' ' ' GLY . 15.8 pt-20 179.17 -27.63 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.158 -1.201 . . . . 0.0 110.93 -179.921 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 793' ' ' CYS . . . . . 0.46 ' O ' ' HB2' ' A' ' 794' ' ' HIS . 1.7 m -102.72 164.1 11.83 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.058 -1.026 . . . . 0.0 110.979 -179.92 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 794' ' ' HIS . . . . . 0.498 ' CE1' ' OG ' ' A' ' 798' ' ' SER . 32.3 t60 179.56 135.52 0.1 Allowed 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.466 -0.771 . . . . 0.0 109.727 179.941 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 795' ' ' SER . . . . . 0.419 ' O ' ' N ' ' A' ' 797' ' ' ASN . 0.2 OUTLIER -90.87 23.78 3.01 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.19 -0.944 . . . . 0.0 110.884 -179.909 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 796' ' ' ILE . . . . . 0.5 HG21 ' O ' ' A' ' 796' ' ' ILE . 40.9 mt 42.65 27.29 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 O-C-N 121.125 -0.984 . . . . 0.0 110.018 179.958 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 797' ' ' ASN . . . . . 0.419 ' N ' ' O ' ' A' ' 795' ' ' SER . 1.2 t-20 -157.25 26.88 0.3 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.246 -0.909 . . . . 0.0 109.611 179.972 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 798' ' ' SER . . . . . 0.547 ' CB ' ' HA ' ' A' ' 777' ' ' SER . 2.8 m -84.28 -19.65 33.46 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.396 -0.815 . . . . 0.0 110.515 -179.96 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 799' ' ' ASN . . . . . 0.42 ' OD1' ' HB2' ' A' ' 776' ' ' ALA . 63.9 m-80 -108.87 -1.06 19.43 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.276 -0.89 . . . . 0.0 110.751 -179.996 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 800' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -91.83 -31.34 15.76 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.21 -0.931 . . . . 0.0 110.434 -179.962 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 801' ' ' VAL . . . . . 0.406 HG23 ' CD2' ' A' ' 821' ' ' PHE . 95.7 t -79.93 -17.93 12.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.359 -0.838 . . . . 0.0 110.089 -179.949 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 802' ' ' LEU . . . . . 0.488 ' N ' ' CD2' ' A' ' 802' ' ' LEU . 4.5 mm? -87.71 -60.43 1.97 Allowed 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.317 -0.864 . . . . 0.0 110.838 -179.955 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 803' ' ' GLU . . . . . 0.524 ' CG ' HD12 ' A' ' 807' ' ' ILE . 1.1 tt0 -57.3 -20.23 27.14 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.113 -0.992 . . . . 0.0 110.527 -179.988 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 804' ' ' ARG . . . . . . . . . . . . . 48.2 ttt85 -93.8 -20.21 20.3 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.268 -0.895 . . . . 0.0 111.757 -179.896 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 805' ' ' LYS . . . . . 0.448 ' O ' ' SG ' ' A' ' 806' ' ' CYS . 8.8 tttm -126.29 40.13 3.79 Favored 'General case' 0 N--CA 1.501 2.108 0 O-C-N 120.765 -1.21 . . . . 0.0 111.502 -179.887 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 806' ' ' CYS . . . . . 0.448 ' SG ' ' O ' ' A' ' 805' ' ' LYS . 1.3 m -163.55 -55.06 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.038 -1.039 . . . . 0.0 110.235 179.892 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 807' ' ' ILE . . . . . 0.524 HD12 ' CG ' ' A' ' 803' ' ' GLU . 5.6 mt -51.09 119.15 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.315 -0.866 . . . . 0.0 110.432 -179.965 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 808' ' ' GLY . . . . . 0.424 ' C ' ' HG ' ' A' ' 809' ' ' LEU . . . 111.14 6.93 25.51 Favored Glycine 0 N--CA 1.492 2.415 0 N-CA-C 109.803 -1.319 . . . . 0.0 109.803 179.923 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 809' ' ' LEU . . . . . 0.424 ' HG ' ' C ' ' A' ' 808' ' ' GLY . 15.9 mt -136.25 148.88 48.25 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.203 -1.175 . . . . 0.0 110.311 -179.971 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 810' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -76.38 -19.09 58.49 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.253 -0.904 . . . . 0.0 109.558 179.881 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 811' ' ' ARG . . . . . 0.454 ' HG3' ' HB3' ' A' ' 763' ' ' LYS . 1.0 OUTLIER -152.78 133.74 14.07 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.527 -0.733 . . . . 0.0 109.665 179.923 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 812' ' ' CYS . . . . . . . . . . . . . 27.6 p -152.02 141.48 21.62 Favored 'General case' 0 C--N 1.296 -1.759 0 O-C-N 121.334 -0.854 . . . . 0.0 110.64 -179.927 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 813' ' ' VAL . . . . . 0.416 ' C ' HG23 ' A' ' 814' ' ' VAL . 24.2 t -110.21 152.97 12.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.277 -0.89 . . . . 0.0 109.843 -179.983 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 814' ' ' VAL . . . . . 0.416 HG23 ' C ' ' A' ' 813' ' ' VAL . 22.0 t -131.79 106.46 11.56 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 O-C-N 121.042 -1.036 . . . . 0.0 110.458 -179.936 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 815' ' ' ALA . . . . . . . . . . . . . . . -67.13 143.32 56.7 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.254 -0.904 . . . . 0.0 109.964 179.939 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 816' ' ' ILE . . . . . 0.475 HD13 ' CG2' ' A' ' 833' ' ' VAL . 20.8 mt -100.02 104.48 16.17 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.211 -0.931 . . . . 0.0 110.156 -179.928 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 817' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -144.61 153.73 55.26 Favored Pre-proline 0 N--CA 1.496 1.835 0 O-C-N 121.322 -0.861 . . . . 0.0 110.279 179.958 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 818' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -76.65 -25.73 9.08 Favored 'Trans proline' 0 C--N 1.309 -1.508 0 O-C-N 123.897 1.472 . . . . 0.0 110.391 -179.999 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 819' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -90.97 18.32 6.81 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.228 -0.92 . . . . 0.0 109.873 179.958 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 820' ' ' ASN . . . . . . . . . . . . . 31.0 t30 -116.16 -32.11 5.45 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.338 -0.851 . . . . 0.0 110.396 -179.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 821' ' ' PHE . . . . . 0.406 ' CD2' HG23 ' A' ' 801' ' ' VAL . 54.3 m-85 -86.07 -79.62 0.25 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.16 -0.963 . . . . 0.0 110.008 179.999 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 822' ' ' GLY . . . . . . . . . . . . . . . -177.76 56.5 0.1 OUTLIER Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.213 -1.555 . . . . 0.0 109.213 -179.97 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 823' ' ' GLY . . . . . . . . . . . . . . . 99.01 -149.65 19.12 Favored Glycine 0 N--CA 1.487 2.041 0 N-CA-C 109.353 -1.499 . . . . 0.0 109.353 179.972 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 824' ' ' ASP . . . . . 0.488 ' OD2' ' N ' ' A' ' 824' ' ' ASP . 0.8 OUTLIER -121.59 142.02 34.83 Favored Pre-proline 0 N--CA 1.492 1.649 0 O-C-N 121.23 -1.159 . . . . 0.0 110.332 179.943 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 825' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -75.61 -89.63 0.0 OUTLIER 'Trans proline' 0 C--N 1.306 -1.675 0 O-C-N 124.105 1.581 . . . . 0.0 110.888 -179.947 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 826' ' ' CYS . . . . . 0.467 ' HB3' HG22 ' A' ' 829' ' ' VAL . 79.0 m -113.62 120.72 38.88 Favored Pre-proline 0 N--CA 1.494 1.748 0 O-C-N 121.196 -0.94 . . . . 0.0 110.475 -179.953 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 827' ' ' PRO . . . . . 0.476 ' O ' ' CB ' ' A' ' 828' ' ' GLU . 49.1 Cg_endo -75.58 142.47 26.19 Favored 'Trans proline' 0 C--N 1.306 -1.66 0 O-C-N 123.839 1.442 . . . . 0.0 110.33 179.938 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 828' ' ' GLU . . . . . 0.476 ' CB ' ' O ' ' A' ' 827' ' ' PRO . 0.8 OUTLIER 67.36 38.65 3.18 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.256 -0.903 . . . . 0.0 110.35 -179.991 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 829' ' ' VAL . . . . . 0.467 HG22 ' HB3' ' A' ' 826' ' ' CYS . 24.0 t -136.05 132.92 50.46 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.174 -0.954 . . . . 0.0 110.291 -179.945 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 830' ' ' MET . . . . . 0.414 ' C ' ' O ' ' A' ' 829' ' ' VAL . 17.4 mtt -43.96 127.88 5.46 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.289 -0.882 . . . . 0.0 110.012 179.95 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 831' ' ' LYS . . . . . 0.453 ' HD3' ' O ' ' A' ' 829' ' ' VAL . 0.0 OUTLIER -94.08 112.99 24.87 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.144 -0.973 . . . . 0.0 110.511 -179.983 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 832' ' ' ARG . . . . . . . . . . . . . 33.4 mtp85 -125.12 139.83 53.42 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.317 -0.864 . . . . 0.0 109.823 179.914 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 833' ' ' VAL . . . . . 0.475 ' CG2' HD13 ' A' ' 816' ' ' ILE . 42.8 t -112.32 105.1 18.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.15 -0.969 . . . . 0.0 110.567 -179.914 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 834' ' ' ALA . . . . . . . . . . . . . . . -113.5 116.43 29.57 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.377 -0.827 . . . . 0.0 109.786 179.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 835' ' ' VAL . . . . . . . . . . . . . 29.4 t -130.51 156.75 42.72 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.176 -0.953 . . . . 0.0 110.544 -179.93 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 836' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -149.21 113.14 5.13 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.489 -0.757 . . . . 0.0 109.652 179.954 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 837' ' ' ALA . . . . . . . . . . . . . . . -110.22 163.42 13.64 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.098 -1.001 . . . . 0.0 110.465 -179.983 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 838' ' ' VAL . . . . . 0.407 ' O ' ' HA ' ' A' ' 770' ' ' ILE . 74.5 t -114.09 156.72 14.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.339 -0.851 . . . . 0.0 110.203 -179.968 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 839' ' ' CYS . . . . . . . . . . . . . 1.2 m -136.59 148.0 47.27 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.322 -0.861 . . . . 0.0 110.194 179.978 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 840' ' ' SER . . . . . 0.464 ' O ' ' CG2' ' A' ' 841' ' ' THR . 9.6 t -119.09 -99.36 0.44 Allowed 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.272 -0.892 . . . . 0.0 110.678 -179.953 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 841' ' ' THR . . . . . 0.464 ' CG2' ' O ' ' A' ' 840' ' ' SER . 19.5 p -156.58 153.43 28.63 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.008 -1.057 . . . . 0.0 110.191 -179.975 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 842' ' ' ALA . . . . . 0.496 ' CB ' ' O ' ' A' ' 767' ' ' GLY . . . 176.84 171.69 0.48 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.264 -0.897 . . . . 0.0 110.243 179.941 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 843' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.684 0 CA-C-O 117.961 -1.019 . . . . 0.0 110.159 -179.976 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 726' ' ' ARG . . . . . 0.452 ' O ' ' O ' ' A' ' 727' ' ' THR . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.688 0 CA-C-O 121.197 0.523 . . . . 0.0 110.111 . . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 727' ' ' THR . . . . . 0.452 ' O ' ' O ' ' A' ' 726' ' ' ARG . 31.4 m 58.31 114.21 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.157 -0.965 . . . . 0.0 110.023 -179.995 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 728' ' ' VAL . . . . . 0.478 ' O ' ' HB2' ' A' ' 729' ' ' SER . 68.2 t -138.48 120.87 18.29 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.199 -0.938 . . . . 0.0 110.178 -179.997 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 729' ' ' SER . . . . . 0.48 ' HA ' ' O ' ' A' ' 839' ' ' CYS . 14.8 t -178.98 125.37 0.09 Allowed 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.147 -0.971 . . . . 0.0 110.891 179.947 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 730' ' ' GLY . . . . . . . . . . . . . . . 103.45 116.53 4.21 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 110.194 -1.162 . . . . 0.0 110.194 179.947 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 731' ' ' VAL . . . . . 0.521 ' CG2' ' O ' ' A' ' 837' ' ' ALA . 3.5 m -147.87 161.81 7.04 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.367 -1.078 . . . . 0.0 109.27 179.92 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 732' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -148.51 161.29 41.94 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.001 -1.062 . . . . 0.0 110.955 -179.978 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 733' ' ' ALA . . . . . . . . . . . . . . . -163.51 104.35 0.95 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.536 -0.728 . . . . 0.0 109.416 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 734' ' ' ASP . . . . . 0.503 ' O ' ' CG2' ' A' ' 735' ' ' VAL . 1.8 t70 -117.25 121.51 41.37 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.235 -0.916 . . . . 0.0 110.79 -179.959 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 735' ' ' VAL . . . . . 0.503 ' CG2' ' O ' ' A' ' 734' ' ' ASP . 49.0 t -156.09 148.61 11.67 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 O-C-N 121.326 -0.859 . . . . 0.0 109.796 179.926 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 736' ' ' SER . . . . . . . . . . . . . 90.7 p -98.77 -167.61 1.51 Allowed 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.114 -0.991 . . . . 0.0 110.588 -179.909 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 737' ' ' GLU . . . . . 0.478 ' HA ' ' HB2' ' A' ' 758' ' ' ALA . 0.8 OUTLIER -93.28 171.93 8.61 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.272 -0.892 . . . . 0.0 110.027 179.983 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 738' ' ' TYR . . . . . 0.452 ' O ' ' OE1' ' A' ' 737' ' ' GLU . 30.0 t80 -116.12 -90.82 0.54 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.129 -0.982 . . . . 0.0 110.427 179.972 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 739' ' ' HIS . . . . . 0.47 ' HB3' ' OE1' ' A' ' 737' ' ' GLU . 4.6 t-80 55.82 105.94 0.03 OUTLIER Pre-proline 0 N--CA 1.49 1.546 0 O-C-N 121.099 -1.0 . . . . 0.0 110.451 179.982 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 740' ' ' PRO . . . . . 0.484 ' HG2' HD12 ' A' ' 742' ' ' ILE . 47.2 Cg_endo -85.73 -160.38 0.11 Allowed 'Trans proline' 0 C--N 1.303 -1.816 0 O-C-N 123.914 1.481 . . . . 0.0 110.002 179.923 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 741' ' ' ASN . . . . . 0.454 ' O ' HG13 ' A' ' 742' ' ' ILE . 9.2 p30 -127.93 112.35 14.59 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.141 -0.974 . . . . 0.0 110.075 179.945 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 742' ' ' ILE . . . . . 0.562 ' CD1' ' N ' ' A' ' 742' ' ' ILE . 1.5 mp -144.26 57.23 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 O-C-N 121.007 -1.058 . . . . 0.0 110.106 -179.983 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 743' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.4 3.83 50.85 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.276 -0.89 . . . . 0.0 110.264 -179.94 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 744' ' ' ASN . . . . . . . . . . . . . 51.3 p-10 -153.58 43.11 0.58 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.362 -0.836 . . . . 0.0 109.955 179.969 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 745' ' ' TRP . . . . . 0.55 ' CG ' ' CG2' ' A' ' 742' ' ' ILE . 1.9 m95 -82.56 -41.18 19.91 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.394 -0.816 . . . . 0.0 110.383 -179.981 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 746' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -137.97 131.72 31.24 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.113 -0.992 . . . . 0.0 110.395 -179.997 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 747' ' ' ILE . . . . . 0.458 ' O ' ' HG2' ' A' ' 748' ' ' GLU . 14.6 mm -123.47 122.54 65.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.404 -0.81 . . . . 0.0 110.334 179.975 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 748' ' ' GLU . . . . . 0.458 ' HG2' ' O ' ' A' ' 747' ' ' ILE . 1.4 mm-40 -150.75 -58.31 0.17 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.342 -0.848 . . . . 0.0 109.562 -179.999 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 749' ' ' SER . . . . . 0.462 ' O ' ' HB3' ' A' ' 750' ' ' TYR . 1.1 p -154.41 18.29 0.48 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.558 -0.714 . . . . 0.0 109.685 179.922 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 750' ' ' TYR . . . . . 0.536 ' CD2' ' O ' ' A' ' 751' ' ' GLY . 2.7 p90 -178.5 -149.59 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.376 -0.827 . . . . 0.0 110.048 -179.879 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 751' ' ' GLY . . . . . 0.536 ' O ' ' CD2' ' A' ' 750' ' ' TYR . . . -137.08 167.19 24.74 Favored Glycine 0 N--CA 1.492 2.382 0 N-CA-C 109.017 -1.633 . . . . 0.0 109.017 179.981 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 752' ' ' GLU . . . . . 0.537 ' N ' ' CD ' ' A' ' 753' ' ' PRO . 11.3 tt0 -149.7 49.61 0.68 Allowed Pre-proline 0 N--CA 1.491 1.601 0 O-C-N 121.022 -1.281 . . . . 0.0 110.634 -179.958 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 753' ' ' PRO . . . . . 0.537 ' CD ' ' N ' ' A' ' 752' ' ' GLU . 44.5 Cg_endo -72.28 135.63 25.08 Favored 'Trans proline' 0 C--N 1.305 -1.744 0 O-C-N 123.86 1.452 . . . . 0.0 110.007 179.942 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 754' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -91.54 174.46 7.36 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.175 -0.953 . . . . 0.0 110.334 -179.966 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 755' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -138.97 62.68 1.53 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.348 -0.845 . . . . 0.0 110.136 179.991 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 756' ' ' HIS . . . . . 0.45 ' O ' HG21 ' A' ' 757' ' ' THR . 2.0 t-80 -68.91 177.33 2.65 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.214 -0.929 . . . . 0.0 110.277 -179.983 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 757' ' ' THR . . . . . 0.45 HG21 ' O ' ' A' ' 756' ' ' HIS . 0.6 OUTLIER -166.06 157.53 13.69 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.338 -0.851 . . . . 0.0 110.522 179.995 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 758' ' ' ALA . . . . . 0.478 ' HB2' ' HA ' ' A' ' 737' ' ' GLU . . . -88.97 172.33 9.22 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.257 -0.902 . . . . 0.0 109.866 179.96 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 759' ' ' LYS . . . . . 0.469 ' HE3' HG23 ' A' ' 813' ' ' VAL . 3.1 mtmt -142.91 162.95 34.12 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.069 -1.02 . . . . 0.0 110.644 -179.962 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 760' ' ' VAL . . . . . 0.53 ' O ' ' CG2' ' A' ' 813' ' ' VAL . 95.2 t -109.22 157.12 9.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.417 -0.802 . . . . 0.0 109.124 179.874 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 761' ' ' HIS . . . . . 0.5 ' N ' HG12 ' A' ' 760' ' ' VAL . 35.2 m80 -128.53 113.91 16.08 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.937 -1.102 . . . . 0.0 111.369 -179.89 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 762' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -122.38 106.45 11.08 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 179.892 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 763' ' ' LYS . . . . . . . . . . . . . 5.4 ttmt -131.2 135.45 47.41 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.977 -1.077 . . . . 0.0 111.199 -179.833 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 764' ' ' CYS . . . . . . . . . . . . . 59.5 m -106.58 175.58 5.45 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.566 -0.709 . . . . 0.0 109.801 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 765' ' ' ALA . . . . . . . . . . . . . . . -55.21 167.96 0.62 Allowed Pre-proline 0 N--CA 1.494 1.771 0 O-C-N 121.216 -0.927 . . . . 0.0 110.497 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 766' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -73.43 110.17 3.0 Favored 'Trans proline' 0 C--N 1.304 -1.778 0 O-C-N 124.211 1.638 . . . . 0.0 110.309 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 767' ' ' GLY . . . . . . . . . . . . . . . 117.32 -30.69 6.13 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.711 -1.356 . . . . 0.0 109.711 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 768' ' ' GLN . . . . . 0.455 ' OE1' HG22 ' A' ' 841' ' ' THR . 44.5 mm-40 -85.88 162.01 18.8 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.183 -1.187 . . . . 0.0 110.245 -179.926 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 769' ' ' THR . . . . . 0.435 HG21 ' OE1' ' A' ' 810' ' ' GLU . 64.9 p -146.43 146.99 30.79 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.248 -0.907 . . . . 0.0 110.214 -179.986 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 770' ' ' ILE . . . . . 0.456 HG13 ' SG ' ' A' ' 839' ' ' CYS . 1.8 mp -69.06 147.79 11.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.35 -0.843 . . . . 0.0 109.13 179.942 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 771' ' ' SER . . . . . 0.424 ' CB ' ' HB1' ' A' ' 843' ' ' ALA . 34.8 m -130.75 -11.85 3.84 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 120.882 -1.136 . . . . 0.0 111.794 -179.891 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 772' ' ' ALA . . . . . . . . . . . . . . . -161.75 153.5 19.01 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 120.743 -1.223 . . . . 0.0 111.492 -179.927 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 773' ' ' ILE . . . . . . . . . . . . . 15.1 mm -113.97 125.17 71.2 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.534 -0.729 . . . . 0.0 109.372 179.901 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 774' ' ' LYS . . . . . 0.538 ' HG3' ' N ' ' A' ' 775' ' ' PHE . 0.5 OUTLIER -89.69 -36.13 15.4 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.089 -1.007 . . . . 0.0 110.815 -179.892 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 775' ' ' PHE . . . . . 0.538 ' N ' ' HG3' ' A' ' 774' ' ' LYS . 65.2 t80 -137.47 149.78 47.09 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.982 -1.074 . . . . 0.0 110.746 -179.924 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 776' ' ' ALA . . . . . 0.447 ' HB2' ' HB3' ' A' ' 799' ' ' ASN . . . -179.03 106.74 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.548 -0.72 . . . . 0.0 109.531 179.954 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 777' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -139.69 136.67 34.49 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.13 -0.981 . . . . 0.0 110.55 -179.877 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 778' ' ' PHE . . . . . . . . . . . . . 86.4 t80 -104.27 76.38 1.32 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.427 -0.796 . . . . 0.0 109.915 179.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 779' ' ' GLY . . . . . . . . . . . . . . . -171.34 -109.77 0.23 Allowed Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.755 -1.338 . . . . 0.0 109.755 -179.989 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 780' ' ' THR . . . . . . . . . . . . . 2.9 p -112.54 92.42 19.71 Favored Pre-proline 0 N--CA 1.494 1.732 0 O-C-N 121.259 -1.142 . . . . 0.0 110.662 -179.992 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 781' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -79.04 127.63 7.8 Favored 'Trans proline' 0 C--N 1.305 -1.73 0 O-C-N 124.064 1.56 . . . . 0.0 110.19 -179.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 782' ' ' LEU . . . . . . . . . . . . . 2.6 mt -96.68 108.3 20.9 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.137 -0.977 . . . . 0.0 110.356 179.989 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 783' ' ' GLY . . . . . . . . . . . . . . . 120.99 -154.31 16.45 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.643 -1.383 . . . . 0.0 109.643 -179.995 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 784' ' ' THR . . . . . 0.574 ' O ' ' CZ ' ' A' ' 788' ' ' PHE . 9.9 t -151.09 -40.54 0.12 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.279 -1.13 . . . . 0.0 110.137 -179.959 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 785' ' ' CYS . . . . . 0.402 ' N ' ' CG2' ' A' ' 784' ' ' THR . 16.2 t -166.95 118.97 0.94 Allowed 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.306 -0.871 . . . . 0.0 109.692 -179.982 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 786' ' ' GLY . . . . . . . . . . . . . . . 85.84 -9.18 69.65 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.335 -1.506 . . . . 0.0 109.335 -179.96 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 787' ' ' THR . . . . . . . . . . . . . 18.7 p -139.56 33.94 2.04 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.23 -1.159 . . . . 0.0 110.174 -179.965 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 788' ' ' PHE . . . . . 0.574 ' CZ ' ' O ' ' A' ' 784' ' ' THR . 7.2 m-85 -71.18 174.69 6.05 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.228 -0.92 . . . . 0.0 110.337 179.98 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 789' ' ' GLN . . . . . 0.485 ' CG ' ' O ' ' A' ' 788' ' ' PHE . 0.0 OUTLIER 179.44 167.14 1.09 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.185 -0.947 . . . . 0.0 110.327 -179.971 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 790' ' ' GLN . . . . . . . . . . . . . 31.5 mt-30 -99.05 143.84 28.87 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.258 -0.901 . . . . 0.0 110.181 179.952 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 791' ' ' GLY . . . . . . . . . . . . . . . -101.89 -109.41 3.26 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.577 -1.409 . . . . 0.0 109.577 179.993 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 792' ' ' GLU . . . . . . . . . . . . . 8.5 mt-10 -129.65 15.4 5.94 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.322 -1.105 . . . . 0.0 110.068 -179.993 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 793' ' ' CYS . . . . . . . . . . . . . 1.7 m -147.53 122.78 10.24 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.279 -0.888 . . . . 0.0 110.224 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 794' ' ' HIS . . . . . 0.609 ' CD2' ' O ' ' A' ' 795' ' ' SER . 77.4 t60 -147.91 144.3 27.97 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.188 -0.945 . . . . 0.0 110.798 -179.97 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 795' ' ' SER . . . . . 0.609 ' O ' ' CD2' ' A' ' 794' ' ' HIS . 27.2 t -88.42 167.86 13.12 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 179.853 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 796' ' ' ILE . . . . . . . . . . . . . 3.1 mt -90.19 -22.76 6.27 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.837 0 O-C-N 120.47 -1.394 . . . . 0.0 110.286 -179.859 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 797' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -102.43 51.54 0.81 Allowed 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.167 -0.958 . . . . 0.0 109.407 179.943 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 798' ' ' SER . . . . . 0.572 ' OG ' ' CE1' ' A' ' 794' ' ' HIS . 0.3 OUTLIER -83.64 -45.08 13.86 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.407 -0.808 . . . . 0.0 111.339 -179.858 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 799' ' ' ASN . . . . . 0.447 ' HB3' ' HB2' ' A' ' 776' ' ' ALA . 7.3 p30 -105.63 -14.2 15.34 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 120.889 -1.132 . . . . 0.0 111.012 -179.838 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 800' ' ' SER . . . . . . . . . . . . . 22.4 t -65.69 -19.1 65.77 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.069 -1.019 . . . . 0.0 110.37 -179.989 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 801' ' ' VAL . . . . . . . . . . . . . 96.2 t -83.86 -23.21 8.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.122 -0.986 . . . . 0.0 110.104 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 802' ' ' LEU . . . . . 0.542 ' N ' ' CD2' ' A' ' 802' ' ' LEU . 3.4 mm? -80.48 -62.32 1.71 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.346 -0.846 . . . . 0.0 110.337 179.969 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 803' ' ' GLU . . . . . 0.405 ' HA ' ' CD1' ' A' ' 807' ' ' ILE . 1.2 tm-20 -52.03 -17.88 1.2 Allowed 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.128 -0.983 . . . . 0.0 110.887 -179.983 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 804' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.29 -31.21 17.04 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 120.97 -1.082 . . . . 0.0 111.471 -179.92 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 805' ' ' LYS . . . . . . . . . . . . . 7.3 mttm -137.1 51.8 1.95 Allowed 'General case' 0 N--CA 1.498 1.961 0 O-C-N 120.756 -1.215 . . . . 0.0 111.313 -179.935 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 806' ' ' CYS . . . . . 0.521 ' HA ' ' CB ' ' A' ' 812' ' ' CYS . 1.1 m -162.75 -54.93 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.101 -0.999 . . . . 0.0 110.204 179.902 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 807' ' ' ILE . . . . . 0.405 ' CD1' ' HA ' ' A' ' 803' ' ' GLU . 61.6 mt -65.26 103.21 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.239 -0.913 . . . . 0.0 110.077 179.973 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 808' ' ' GLY . . . . . 0.435 ' C ' ' HG ' ' A' ' 809' ' ' LEU . . . 127.0 11.37 3.52 Favored Glycine 0 N--CA 1.492 2.377 0 N-CA-C 110.009 -1.236 . . . . 0.0 110.009 179.972 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 809' ' ' LEU . . . . . 0.435 ' HG ' ' C ' ' A' ' 808' ' ' GLY . 1.5 mt -133.23 150.13 51.96 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.111 -1.229 . . . . 0.0 110.245 179.972 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 810' ' ' GLU . . . . . 0.435 ' OE1' HG21 ' A' ' 769' ' ' THR . 0.2 OUTLIER -65.74 -26.74 67.87 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.192 -0.943 . . . . 0.0 109.255 179.914 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 811' ' ' ARG . . . . . 0.463 ' O ' ' HG3' ' A' ' 811' ' ' ARG . 4.1 ppt_? -161.23 120.58 2.56 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.629 -0.67 . . . . 0.0 109.198 179.89 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 812' ' ' CYS . . . . . 0.521 ' CB ' ' HA ' ' A' ' 806' ' ' CYS . 24.0 p -121.55 156.87 31.95 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 120.996 -1.065 . . . . 0.0 111.428 -179.856 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 813' ' ' VAL . . . . . 0.53 ' CG2' ' O ' ' A' ' 760' ' ' VAL . 9.9 p -139.4 126.46 24.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 179.966 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 814' ' ' VAL . . . . . . . . . . . . . 44.3 t -110.18 130.13 63.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.077 -1.015 . . . . 0.0 110.779 -179.936 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 815' ' ' ALA . . . . . 0.431 ' HA ' ' HD2' ' A' ' 759' ' ' LYS . . . -78.37 125.02 28.76 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.347 -0.846 . . . . 0.0 109.806 179.959 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 816' ' ' ILE . . . . . 0.443 HD13 ' HB ' ' A' ' 833' ' ' VAL . 96.4 mt -79.17 111.74 16.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.274 -0.891 . . . . 0.0 110.359 -179.949 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 817' ' ' SER . . . . . 0.418 ' OG ' ' HB2' ' A' ' 820' ' ' ASN . 0.0 OUTLIER -152.03 166.71 14.66 Favored Pre-proline 0 N--CA 1.493 1.692 0 O-C-N 121.348 -0.845 . . . . 0.0 110.016 179.961 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 818' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -76.35 -57.28 0.05 OUTLIER 'Trans proline' 0 C--N 1.307 -1.651 0 O-C-N 123.931 1.49 . . . . 0.0 110.665 -179.94 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 819' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -66.06 -9.85 34.69 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.184 -0.947 . . . . 0.0 110.524 -179.981 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 820' ' ' ASN . . . . . 0.418 ' HB2' ' OG ' ' A' ' 817' ' ' SER . 17.2 t30 -92.92 -16.4 25.22 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.117 -0.989 . . . . 0.0 110.317 -179.997 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 821' ' ' PHE . . . . . . . . . . . . . 1.9 m-85 -109.53 -79.04 0.58 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.241 -0.912 . . . . 0.0 110.211 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 822' ' ' GLY . . . . . . . . . . . . . . . 176.41 42.19 0.06 OUTLIER Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.493 -1.443 . . . . 0.0 109.493 179.956 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 823' ' ' GLY . . . . . . . . . . . . . . . 79.05 -162.6 48.54 Favored Glycine 0 N--CA 1.492 2.431 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 -179.979 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 824' ' ' ASP . . . . . . . . . . . . . 4.2 p30 -121.86 152.84 59.94 Favored Pre-proline 0 N--CA 1.493 1.723 0 O-C-N 121.254 -1.145 . . . . 0.0 110.149 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 825' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -78.76 -84.68 0.0 OUTLIER 'Trans proline' 0 C--N 1.304 -1.787 0 O-C-N 124.0 1.526 . . . . 0.0 110.751 -179.896 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 826' ' ' CYS . . . . . . . . . . . . . 28.5 p -105.85 142.75 25.46 Favored Pre-proline 0 N--CA 1.492 1.674 0 O-C-N 121.125 -0.985 . . . . 0.0 110.656 -179.913 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 827' ' ' PRO . . . . . 0.466 ' O ' ' HB2' ' A' ' 828' ' ' GLU . 50.3 Cg_endo -85.15 -179.14 3.43 Favored 'Trans proline' 0 C--N 1.303 -1.817 0 O-C-N 124.209 1.636 . . . . 0.0 109.983 179.895 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 828' ' ' GLU . . . . . 0.466 ' HB2' ' O ' ' A' ' 827' ' ' PRO . 7.5 mt-10 58.55 14.94 3.29 Favored 'General case' 0 C--N 1.297 -1.697 0 O-C-N 121.331 -0.856 . . . . 0.0 109.894 -179.978 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 829' ' ' VAL . . . . . 0.466 ' O ' ' O ' ' A' ' 830' ' ' MET . 60.8 t -128.85 122.5 57.01 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.405 0 O-C-N 121.333 -0.855 . . . . 0.0 110.205 -179.965 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 830' ' ' MET . . . . . 0.466 ' O ' ' O ' ' A' ' 829' ' ' VAL . 0.0 OUTLIER -48.79 176.9 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.022 -1.049 . . . . 0.0 109.531 -179.986 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 831' ' ' LYS . . . . . . . . . . . . . 6.2 mptt -138.82 110.1 6.92 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.977 -1.077 . . . . 0.0 110.873 -179.898 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 832' ' ' ARG . . . . . . . . . . . . . 73.9 mtp85 -115.84 157.59 24.21 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.382 -0.824 . . . . 0.0 109.43 179.904 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 833' ' ' VAL . . . . . 0.443 ' HB ' HD13 ' A' ' 816' ' ' ILE . 65.0 t -122.82 104.4 14.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.042 -1.036 . . . . 0.0 110.855 -179.997 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 834' ' ' ALA . . . . . . . . . . . . . . . -109.16 124.25 50.53 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.34 -0.85 . . . . 0.0 109.171 179.944 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 835' ' ' VAL . . . . . . . . . . . . . 11.8 t -138.9 142.81 33.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.059 -1.026 . . . . 0.0 111.346 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 836' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 -126.62 135.61 51.44 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 179.93 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 837' ' ' ALA . . . . . 0.521 ' O ' ' CG2' ' A' ' 731' ' ' VAL . . . -118.72 164.49 15.29 Favored 'General case' 0 C--N 1.298 -1.632 0 O-C-N 120.966 -1.084 . . . . 0.0 111.087 -179.85 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 838' ' ' VAL . . . . . . . . . . . . . 24.9 t -116.96 105.32 18.02 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 179.96 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 839' ' ' CYS . . . . . 0.48 ' O ' ' HA ' ' A' ' 729' ' ' SER . 0.1 OUTLIER -106.51 152.83 23.15 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.204 -0.935 . . . . 0.0 110.865 -179.82 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 840' ' ' SER . . . . . 0.49 ' O ' HG21 ' A' ' 841' ' ' THR . 2.7 p -164.08 -91.89 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.402 -0.811 . . . . 0.0 109.813 179.861 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 841' ' ' THR . . . . . 0.49 HG21 ' O ' ' A' ' 840' ' ' SER . 8.8 p -154.42 75.51 1.0 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.38 -0.825 . . . . 0.0 109.736 -179.996 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 842' ' ' ALA . . . . . 0.47 ' O ' ' O ' ' A' ' 841' ' ' THR . . . 57.49 152.69 0.01 OUTLIER 'General case' 0 C--N 1.293 -1.878 0 O-C-N 121.582 -0.699 . . . . 0.0 110.341 -179.914 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 843' ' ' ALA . . . . . 0.424 ' HB1' ' CB ' ' A' ' 771' ' ' SER . . . . . . . . 0 N--CA 1.494 1.725 0 O-C-N 121.062 -1.024 . . . . 0.0 110.079 179.985 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 726' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.492 1.639 0 CA-C-O 121.285 0.564 . . . . 0.0 110.272 . . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 727' ' ' THR . . . . . . . . . . . . . 38.7 m -138.85 139.32 38.11 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.219 -0.926 . . . . 0.0 110.071 -179.963 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 728' ' ' VAL . . . . . 0.425 ' O ' HG23 ' A' ' 728' ' ' VAL . 34.2 m -130.0 145.99 34.8 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.231 -0.918 . . . . 0.0 110.415 -179.963 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 729' ' ' SER . . . . . 0.469 ' O ' HG23 ' A' ' 731' ' ' VAL . 12.1 t -127.39 74.41 1.51 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.275 -0.891 . . . . 0.0 110.217 179.965 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 730' ' ' GLY . . . . . 0.439 ' C ' HG23 ' A' ' 731' ' ' VAL . . . -62.38 114.69 7.07 Favored Glycine 0 N--CA 1.493 2.436 0 N-CA-C 109.222 -1.551 . . . . 0.0 109.222 179.989 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 731' ' ' VAL . . . . . 0.469 HG23 ' O ' ' A' ' 729' ' ' SER . 21.8 t -129.39 137.22 57.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.189 -1.183 . . . . 0.0 110.592 -179.986 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 732' ' ' CYS . . . . . . . . . . . . . 4.9 p -129.32 146.06 51.27 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.434 -0.791 . . . . 0.0 109.366 179.967 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 733' ' ' ALA . . . . . 0.526 ' CB ' HG12 ' A' ' 760' ' ' VAL . . . -110.45 104.22 12.95 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 120.952 -1.093 . . . . 0.0 111.351 -179.978 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 734' ' ' ASP . . . . . 0.45 ' OD1' ' O ' ' A' ' 734' ' ' ASP . 0.6 OUTLIER -110.07 100.9 9.76 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.339 -0.851 . . . . 0.0 108.865 179.895 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 735' ' ' VAL . . . . . . . . . . . . . 14.4 m -140.08 152.82 22.14 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 121.229 -0.92 . . . . 0.0 110.941 -179.885 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 736' ' ' SER . . . . . 0.542 ' O ' ' CB ' ' A' ' 758' ' ' ALA . 3.3 m -82.33 177.05 8.97 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 179.839 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 737' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -96.72 76.84 2.83 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 120.738 -1.226 . . . . 0.0 110.213 -179.993 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 738' ' ' TYR . . . . . . . . . . . . . 13.1 t80 -161.42 145.91 13.27 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.37 -0.831 . . . . 0.0 110.194 179.986 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 739' ' ' HIS . . . . . 0.614 ' CE1' HD11 ' A' ' 742' ' ' ILE . 4.6 t-80 -90.11 149.56 41.73 Favored Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.289 -0.882 . . . . 0.0 110.247 179.985 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 740' ' ' PRO . . . . . 0.6 ' HD2' ' CG ' ' A' ' 739' ' ' HIS . 48.5 Cg_endo -71.79 -96.64 0.01 OUTLIER 'Trans proline' 0 C--N 1.313 -1.327 0 O-C-N 123.829 1.436 . . . . 0.0 110.361 -179.951 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 741' ' ' ASN . . . . . 0.457 ' O ' HG23 ' A' ' 742' ' ' ILE . 47.2 m-80 -159.15 140.98 13.45 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.156 -0.965 . . . . 0.0 110.518 -179.981 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 742' ' ' ILE . . . . . 0.614 HD11 ' CE1' ' A' ' 739' ' ' HIS . 0.1 OUTLIER -149.52 85.83 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.267 -0.895 . . . . 0.0 109.997 179.973 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 743' ' ' LYS . . . . . 0.422 ' O ' ' HB2' ' A' ' 744' ' ' ASN . 0.6 OUTLIER -82.93 42.21 0.78 Allowed 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.292 -0.88 . . . . 0.0 109.868 179.908 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 744' ' ' ASN . . . . . 0.422 ' HB2' ' O ' ' A' ' 743' ' ' LYS . 1.6 t-20 -179.95 35.28 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.303 -0.873 . . . . 0.0 109.784 -179.989 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 745' ' ' TRP . . . . . 0.426 ' O ' ' C ' ' A' ' 746' ' ' GLN . 51.9 t-105 -96.29 -20.22 18.68 Favored 'General case' 0 C--N 1.299 -1.617 0 O-C-N 121.431 -0.793 . . . . 0.0 109.708 -179.975 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 746' ' ' GLN . . . . . 0.426 ' C ' ' O ' ' A' ' 745' ' ' TRP . 2.8 mt-30 -39.89 130.51 2.0 Favored 'General case' 0 C--N 1.298 -1.661 0 O-C-N 121.667 -0.645 . . . . 0.0 110.997 179.944 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 747' ' ' ILE . . . . . 0.505 ' O ' ' CG2' ' A' ' 747' ' ' ILE . 10.5 tt -80.25 102.06 5.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.15 -0.969 . . . . 0.0 109.041 179.864 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 748' ' ' GLU . . . . . 0.462 ' HB2' ' O ' ' A' ' 747' ' ' ILE . 0.6 OUTLIER 66.95 -84.65 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.357 -0.839 . . . . 0.0 109.646 -179.898 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 749' ' ' SER . . . . . 0.565 ' O ' ' CD2' ' A' ' 750' ' ' TYR . 74.9 m -145.37 79.71 1.58 Allowed 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.054 -1.029 . . . . 0.0 110.55 179.983 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 750' ' ' TYR . . . . . 0.565 ' CD2' ' O ' ' A' ' 749' ' ' SER . 36.7 m-85 -148.4 -160.65 1.2 Allowed 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.204 -0.935 . . . . 0.0 110.16 179.954 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 751' ' ' GLY . . . . . . . . . . . . . . . -134.5 178.53 18.37 Favored Glycine 0 N--CA 1.493 2.489 0 C-N-CA 119.697 -1.239 . . . . 0.0 110.335 -179.999 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 752' ' ' GLU . . . . . 0.474 ' OE2' HG13 ' A' ' 742' ' ' ILE . 10.0 mt-10 -103.73 137.37 19.22 Favored Pre-proline 0 N--CA 1.495 1.781 0 O-C-N 121.529 -0.983 . . . . 0.0 110.327 -179.982 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 753' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -71.65 179.65 4.51 Favored 'Trans proline' 0 C--N 1.306 -1.658 0 O-C-N 123.874 1.46 . . . . 0.0 110.324 179.945 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 754' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -92.56 58.09 3.06 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.168 -0.957 . . . . 0.0 110.668 -179.909 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 755' ' ' PHE . . . . . 0.567 ' CZ ' ' HD2' ' A' ' 818' ' ' PRO . 0.1 OUTLIER -125.93 66.62 1.19 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.236 -0.915 . . . . 0.0 110.012 179.958 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 756' ' ' HIS . . . . . . . . . . . . . 3.4 m80 -75.3 80.52 2.39 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.354 -0.841 . . . . 0.0 109.958 -179.971 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 757' ' ' THR . . . . . 0.447 ' HB ' ' O ' ' A' ' 816' ' ' ILE . 32.1 p -115.74 174.82 5.82 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.325 -0.859 . . . . 0.0 110.205 179.957 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 758' ' ' ALA . . . . . 0.542 ' CB ' ' O ' ' A' ' 736' ' ' SER . . . -102.83 -179.18 3.89 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.181 -0.949 . . . . 0.0 110.153 179.99 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 759' ' ' LYS . . . . . . . . . . . . . 9.6 mtpp -133.81 161.99 33.21 Favored 'General case' 0 C--N 1.297 -1.686 0 O-C-N 121.452 -0.78 . . . . 0.0 110.233 179.997 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 760' ' ' VAL . . . . . 0.526 HG12 ' CB ' ' A' ' 733' ' ' ALA . 39.8 t -125.55 114.85 41.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.344 -0.847 . . . . 0.0 109.191 179.927 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 761' ' ' HIS . . . . . . . . . . . . . 1.5 t-160 -110.64 114.44 27.84 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 120.914 -1.117 . . . . 0.0 111.185 -179.964 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 762' ' ' LEU . . . . . . . . . . . . . 17.8 mt -111.2 103.66 12.1 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.508 -0.745 . . . . 0.0 109.327 179.825 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 763' ' ' LYS . . . . . . . . . . . . . 5.3 pttp -117.81 136.87 53.12 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.098 -1.001 . . . . 0.0 110.925 -179.889 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 764' ' ' CYS . . . . . . . . . . . . . 86.2 m -105.32 173.46 6.3 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.372 -0.83 . . . . 0.0 109.673 179.927 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 765' ' ' ALA . . . . . . . . . . . . . . . -67.88 160.91 71.25 Favored Pre-proline 0 N--CA 1.494 1.745 0 O-C-N 121.18 -0.95 . . . . 0.0 110.44 179.969 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 766' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -72.02 96.1 0.77 Allowed 'Trans proline' 0 C--N 1.308 -1.584 0 O-C-N 124.006 1.53 . . . . 0.0 110.117 179.959 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 767' ' ' GLY . . . . . . . . . . . . . . . 140.21 -31.95 2.22 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 108.762 -1.735 . . . . 0.0 108.762 -179.999 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 768' ' ' GLN . . . . . 0.442 ' HG3' ' HB ' ' A' ' 841' ' ' THR . 12.8 mp0 -93.64 152.34 19.06 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.559 -0.965 . . . . 0.0 109.421 179.956 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 769' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -129.91 151.62 50.28 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.046 -1.034 . . . . 0.0 110.741 -179.976 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 770' ' ' ILE . . . . . 0.437 HD13 ' O ' ' A' ' 809' ' ' LEU . 30.9 mt -76.48 152.78 5.87 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.433 -0.792 . . . . 0.0 109.537 179.85 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 771' ' ' SER . . . . . . . . . . . . . 3.3 m -146.57 -15.88 0.43 Allowed 'General case' 0 N--CA 1.494 1.749 0 O-C-N 120.845 -1.159 . . . . 0.0 112.597 -179.903 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 772' ' ' ALA . . . . . . . . . . . . . . . -158.34 150.05 21.35 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 120.235 -1.54 . . . . 0.0 112.438 -179.912 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 773' ' ' ILE . . . . . . . . . . . . . 14.5 mm -116.21 118.39 58.62 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 179.863 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 774' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -84.13 -38.31 20.87 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 120.957 -1.09 . . . . 0.0 111.895 -179.826 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 775' ' ' PHE . . . . . 0.431 ' O ' ' CB ' ' A' ' 776' ' ' ALA . 58.4 t80 -129.52 166.64 19.25 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 120.712 -1.243 . . . . 0.0 111.468 -179.942 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 776' ' ' ALA . . . . . 0.528 ' HB1' ' CA ' ' A' ' 799' ' ' ASN . . . 171.76 101.48 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.736 -0.603 . . . . 0.0 109.382 179.962 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 777' ' ' SER . . . . . . . . . . . . . 29.1 t -134.55 125.63 27.67 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.37 -0.831 . . . . 0.0 110.204 -179.882 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 778' ' ' PHE . . . . . 0.543 ' CZ ' ' O ' ' A' ' 817' ' ' SER . 2.2 t80 -111.12 81.35 1.42 Allowed 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.421 -0.799 . . . . 0.0 109.887 179.934 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 779' ' ' GLY . . . . . . . . . . . . . . . -179.49 -89.97 0.08 OUTLIER Glycine 0 N--CA 1.493 2.449 0 N-CA-C 109.526 -1.429 . . . . 0.0 109.526 -179.946 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 780' ' ' THR . . . . . 0.472 ' O ' ' HA3' ' A' ' 791' ' ' GLY . 38.8 p -123.17 83.0 51.52 Favored Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.048 -1.266 . . . . 0.0 110.675 179.992 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 781' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -74.45 123.54 8.23 Favored 'Trans proline' 0 C--N 1.304 -1.809 0 O-C-N 124.077 1.567 . . . . 0.0 109.952 179.989 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 782' ' ' LEU . . . . . 0.438 HD12 ' HA2' ' A' ' 791' ' ' GLY . 10.8 mt -111.1 83.83 1.83 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.237 -0.914 . . . . 0.0 110.412 -179.959 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 783' ' ' GLY . . . . . 0.438 ' C ' HG23 ' A' ' 784' ' ' THR . . . 148.45 -173.63 28.38 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.549 -1.42 . . . . 0.0 109.549 -179.944 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 784' ' ' THR . . . . . 0.546 ' O ' ' CD2' ' A' ' 788' ' ' PHE . 80.3 p -132.41 -148.41 0.34 Allowed 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.275 -1.132 . . . . 0.0 110.375 -179.97 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 785' ' ' CYS . . . . . . . . . . . . . 4.2 t -70.87 106.88 3.77 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.227 -0.92 . . . . 0.0 109.889 179.984 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 786' ' ' GLY . . . . . . . . . . . . . . . 114.31 -26.25 9.87 Favored Glycine 0 N--CA 1.488 2.135 0 N-CA-C 109.246 -1.542 . . . . 0.0 109.246 -179.965 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 787' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -124.46 25.95 7.46 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.326 -1.103 . . . . 0.0 110.581 -179.958 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 788' ' ' PHE . . . . . 0.546 ' CD2' ' O ' ' A' ' 784' ' ' THR . 2.4 m-85 -71.46 112.43 7.58 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.225 -0.922 . . . . 0.0 109.616 -179.95 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 789' ' ' GLN . . . . . . . . . . . . . 14.4 tp60 -125.71 137.19 53.82 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.143 -0.973 . . . . 0.0 110.593 -179.962 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 790' ' ' GLN . . . . . 0.411 ' O ' ' HG3' ' A' ' 790' ' ' GLN . 19.3 pt20 -41.32 139.4 1.03 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.477 -0.764 . . . . 0.0 110.316 179.928 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 791' ' ' GLY . . . . . 0.472 ' HA3' ' O ' ' A' ' 780' ' ' THR . . . -89.59 -153.92 28.64 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.356 -1.498 . . . . 0.0 109.356 -179.999 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 792' ' ' GLU . . . . . . . . . . . . . 26.6 pt-20 -87.55 -35.18 18.29 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.22 -1.165 . . . . 0.0 109.744 179.951 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 793' ' ' CYS . . . . . 0.447 ' SG ' ' HB2' ' A' ' 825' ' ' PRO . 0.5 OUTLIER -109.87 100.72 9.65 Favored 'General case' 0 C--N 1.307 -1.255 0 O-C-N 121.271 -0.893 . . . . 0.0 110.604 179.997 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 794' ' ' HIS . . . . . . . . . . . . . 4.4 t60 -108.69 143.08 38.26 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.091 -1.006 . . . . 0.0 109.826 -179.998 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 795' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -80.19 5.88 13.3 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.321 -0.862 . . . . 0.0 110.021 -179.964 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 796' ' ' ILE . . . . . 0.437 HG22 ' O ' ' A' ' 796' ' ' ILE . 31.4 mt 46.37 24.23 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.162 -0.961 . . . . 0.0 109.86 -179.988 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 797' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -159.6 22.53 0.18 Allowed 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.485 -0.759 . . . . 0.0 109.542 -179.976 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 798' ' ' SER . . . . . 0.475 ' HB2' ' O ' ' A' ' 776' ' ' ALA . 1.1 m -88.31 0.09 56.55 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.414 -0.804 . . . . 0.0 110.19 -179.982 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 799' ' ' ASN . . . . . 0.528 ' CA ' ' HB1' ' A' ' 776' ' ' ALA . 60.6 t-20 -124.66 1.34 8.2 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.254 -0.903 . . . . 0.0 109.954 179.973 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 800' ' ' SER . . . . . . . . . . . . . 1.5 t -91.64 -40.17 11.46 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.371 -0.831 . . . . 0.0 110.452 -179.869 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 801' ' ' VAL . . . . . 0.482 HG23 ' HA ' ' A' ' 821' ' ' PHE . 93.2 t -67.55 -19.54 25.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.3 -0.875 . . . . 0.0 110.799 -179.945 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 802' ' ' LEU . . . . . . . . . . . . . 78.7 mt -87.72 -49.74 6.93 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.011 -1.056 . . . . 0.0 110.979 -179.882 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 803' ' ' GLU . . . . . 0.438 ' HG2' HD13 ' A' ' 807' ' ' ILE . 18.6 mt-10 -54.23 -27.21 33.09 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.157 -0.964 . . . . 0.0 111.045 -179.909 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 804' ' ' ARG . . . . . . . . . . . . . 1.6 mpt_? -91.62 -18.32 24.21 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.017 -1.052 . . . . 0.0 111.264 -179.905 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 805' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.66 12.89 19.83 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 120.91 -1.119 . . . . 0.0 111.331 -179.926 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 806' ' ' CYS . . . . . 0.414 ' O ' ' C ' ' A' ' 807' ' ' ILE . 21.0 m -141.38 -67.99 0.4 Allowed 'General case' 0 N--CA 1.496 1.855 0 O-C-N 120.851 -1.156 . . . . 0.0 110.58 -179.971 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 807' ' ' ILE . . . . . 0.438 HD13 ' HG2' ' A' ' 803' ' ' GLU . 42.9 mt -41.24 103.68 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 O-C-N 121.258 -0.901 . . . . 0.0 110.477 -179.986 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 808' ' ' GLY . . . . . 0.468 ' O ' HD21 ' A' ' 809' ' ' LEU . . . 127.06 4.84 5.88 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.613 -1.395 . . . . 0.0 109.613 -179.984 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 809' ' ' LEU . . . . . 0.468 HD21 ' O ' ' A' ' 808' ' ' GLY . 81.4 mt -139.77 149.2 43.28 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.252 -1.146 . . . . 0.0 109.982 179.997 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 810' ' ' GLU . . . . . . . . . . . . . 2.1 pt-20 -78.93 1.47 23.57 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.173 -0.954 . . . . 0.0 109.593 179.981 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 811' ' ' ARG . . . . . . . . . . . . . 21.8 ttp180 -170.13 135.7 1.36 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.41 -0.806 . . . . 0.0 110.014 179.986 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 812' ' ' CYS . . . . . . . . . . . . . 21.9 p -155.12 150.22 26.92 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.401 -0.812 . . . . 0.0 110.292 -179.979 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 813' ' ' VAL . . . . . 0.484 ' C ' ' CG2' ' A' ' 814' ' ' VAL . 11.9 p -131.78 153.99 39.58 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 O-C-N 121.29 -0.881 . . . . 0.0 110.335 -179.991 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 814' ' ' VAL . . . . . 0.484 ' CG2' ' C ' ' A' ' 813' ' ' VAL . 11.1 t -151.59 106.58 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 O-C-N 121.314 -0.866 . . . . 0.0 110.241 179.982 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 815' ' ' ALA . . . . . . . . . . . . . . . -54.02 170.92 0.11 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.234 -0.917 . . . . 0.0 110.384 179.942 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 816' ' ' ILE . . . . . 0.508 ' CG2' HG22 ' A' ' 833' ' ' VAL . 80.5 mt -121.73 141.73 40.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.351 -0.843 . . . . 0.0 109.887 -179.995 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 817' ' ' SER . . . . . 0.543 ' O ' ' CZ ' ' A' ' 778' ' ' PHE . 0.3 OUTLIER -173.91 -178.06 0.37 Allowed Pre-proline 0 N--CA 1.494 1.762 0 O-C-N 121.12 -0.988 . . . . 0.0 110.64 -179.899 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 818' ' ' PRO . . . . . 0.567 ' HD2' ' CZ ' ' A' ' 755' ' ' PHE . 42.8 Cg_endo -72.9 -76.12 0.01 OUTLIER 'Trans proline' 0 C--N 1.313 -1.329 0 O-C-N 124.043 1.549 . . . . 0.0 111.302 -179.93 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 819' ' ' SER . . . . . . . . . . . . . 40.8 t -84.33 51.93 2.22 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.055 -1.028 . . . . 0.0 110.351 -179.972 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 820' ' ' ASN . . . . . 0.468 ' HB2' ' OG ' ' A' ' 817' ' ' SER . 2.1 t30 -101.92 -49.25 4.01 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.256 -0.903 . . . . 0.0 109.777 179.961 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 821' ' ' PHE . . . . . 0.482 ' HA ' HG23 ' A' ' 801' ' ' VAL . 27.4 m-85 -77.26 -23.83 51.17 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.204 -0.935 . . . . 0.0 109.764 179.981 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 822' ' ' GLY . . . . . . . . . . . . . . . 93.95 55.69 1.48 Allowed Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 -179.972 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 823' ' ' GLY . . . . . . . . . . . . . . . 168.31 144.82 4.32 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.654 -1.378 . . . . 0.0 109.654 -179.987 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 824' ' ' ASP . . . . . 0.433 ' OD1' ' O ' ' A' ' 824' ' ' ASP . 11.1 p-10 -144.07 122.3 6.91 Favored Pre-proline 0 N--CA 1.493 1.712 0 O-C-N 121.325 -1.103 . . . . 0.0 110.041 179.999 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 825' ' ' PRO . . . . . 0.447 ' HB2' ' SG ' ' A' ' 793' ' ' CYS . 43.9 Cg_endo -75.59 -78.28 0.01 OUTLIER 'Trans proline' 0 C--N 1.307 -1.632 0 O-C-N 123.88 1.463 . . . . 0.0 110.583 -179.952 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 826' ' ' CYS . . . . . . . . . . . . . 5.8 p -125.18 128.46 24.77 Favored Pre-proline 0 N--CA 1.494 1.772 0 O-C-N 121.111 -0.993 . . . . 0.0 110.101 -179.971 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 827' ' ' PRO . . . . . 0.465 ' O ' HG22 ' A' ' 829' ' ' VAL . 48.7 Cg_endo -85.7 177.0 5.11 Favored 'Trans proline' 0 C--N 1.305 -1.726 0 O-C-N 123.883 1.465 . . . . 0.0 110.513 -179.995 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 828' ' ' GLU . . . . . 0.464 ' HB2' ' O ' ' A' ' 827' ' ' PRO . 34.9 mt-10 56.72 23.59 8.06 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.457 -0.777 . . . . 0.0 110.338 -179.958 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 829' ' ' VAL . . . . . 0.465 HG22 ' O ' ' A' ' 827' ' ' PRO . 53.3 t -125.44 135.46 63.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.437 -0.79 . . . . 0.0 109.734 179.929 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 830' ' ' MET . . . . . 0.435 ' C ' ' O ' ' A' ' 829' ' ' VAL . 33.5 ttm -41.26 146.14 0.21 Allowed 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.269 -0.895 . . . . 0.0 109.83 -179.997 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 831' ' ' LYS . . . . . . . . . . . . . 27.6 mttp -134.46 106.47 7.06 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.042 -1.036 . . . . 0.0 111.165 -179.941 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 832' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -108.36 166.13 10.99 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.463 -0.773 . . . . 0.0 109.005 179.805 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 833' ' ' VAL . . . . . 0.508 HG22 ' CG2' ' A' ' 816' ' ' ILE . 69.4 t -116.19 145.44 21.93 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.602 0 O-C-N 120.879 -1.138 . . . . 0.0 110.967 -179.94 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 834' ' ' ALA . . . . . 0.536 ' HB1' ' CE1' ' A' ' 788' ' ' PHE . . . -155.5 128.15 7.93 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.635 -0.666 . . . . 0.0 109.449 179.954 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 835' ' ' VAL . . . . . 0.445 ' CG1' ' N ' ' A' ' 836' ' ' GLU . 21.7 t -148.14 163.94 5.77 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.026 0 O-C-N 120.973 -1.079 . . . . 0.0 111.439 -179.887 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 836' ' ' GLU . . . . . 0.445 ' N ' ' CG1' ' A' ' 835' ' ' VAL . 6.1 tt0 -145.89 141.38 27.77 Favored 'General case' 0 N--CA 1.496 1.864 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 179.96 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 837' ' ' ALA . . . . . . . . . . . . . . . -134.56 156.71 48.19 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 120.929 -1.107 . . . . 0.0 111.061 -179.966 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 838' ' ' VAL . . . . . . . . . . . . . 69.7 t -114.3 102.96 14.61 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.725 0 O-C-N 121.428 -0.795 . . . . 0.0 109.734 179.97 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 839' ' ' CYS . . . . . 0.43 ' SG ' ' CG1' ' A' ' 770' ' ' ILE . 0.1 OUTLIER -108.88 139.73 43.32 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.071 -1.018 . . . . 0.0 110.822 -179.97 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 840' ' ' SER . . . . . . . . . . . . . 17.8 m -150.22 -168.52 3.13 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.365 -0.835 . . . . 0.0 110.02 179.944 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 841' ' ' THR . . . . . 0.442 ' HB ' ' HG3' ' A' ' 768' ' ' GLN . 8.9 t -115.0 167.19 11.02 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.221 -0.925 . . . . 0.0 110.288 -179.986 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 842' ' ' ALA . . . . . . . . . . . . . . . -53.24 110.83 0.59 Allowed 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.246 -0.909 . . . . 0.0 110.352 179.999 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 843' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.641 0 CA-C-O 118.014 -0.993 . . . . 0.0 110.175 179.993 . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 726' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.493 1.681 0 CA-C-O 121.247 0.546 . . . . 0.0 110.198 . . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 727' ' ' THR . . . . . . . . . . . . . 9.3 t -162.93 151.96 14.89 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.354 -0.841 . . . . 0.0 110.02 -179.992 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 728' ' ' VAL . . . . . 0.472 ' O ' ' HB3' ' A' ' 729' ' ' SER . 11.0 p -160.51 154.91 3.88 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.215 -0.928 . . . . 0.0 110.65 -179.995 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 729' ' ' SER . . . . . 0.472 ' HB3' ' O ' ' A' ' 728' ' ' VAL . 10.6 t 57.92 142.67 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.47 -0.769 . . . . 0.0 111.193 179.959 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 730' ' ' GLY . . . . . . . . . . . . . . . -132.4 159.73 23.48 Favored Glycine 0 N--CA 1.492 2.424 0 N-CA-C 109.012 -1.635 . . . . 0.0 109.012 179.915 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 731' ' ' VAL . . . . . . . . . . . . . 35.7 m -133.37 150.78 32.64 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 O-C-N 121.125 -1.221 . . . . 0.0 110.79 -179.992 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 732' ' ' CYS . . . . . . . . . . . . . 2.4 m -128.82 135.02 48.57 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.489 -0.757 . . . . 0.0 109.647 -179.968 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 733' ' ' ALA . . . . . 0.521 ' CB ' HD22 ' A' ' 762' ' ' LEU . . . -131.87 105.3 7.37 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.922 -1.111 . . . . 0.0 110.946 -179.913 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 734' ' ' ASP . . . . . 0.417 ' OD1' ' HB3' ' A' ' 834' ' ' ALA . 0.6 OUTLIER -113.66 107.76 16.21 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.339 -0.851 . . . . 0.0 109.088 179.911 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 735' ' ' VAL . . . . . . . . . . . . . 47.9 t -139.73 120.58 14.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.047 -1.033 . . . . 0.0 111.274 -179.926 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 736' ' ' SER . . . . . 0.417 ' O ' ' C ' ' A' ' 737' ' ' GLU . 54.4 p -100.72 -176.38 3.17 Favored 'General case' 0 C--N 1.297 -1.68 0 O-C-N 121.454 -0.779 . . . . 0.0 108.898 179.848 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 737' ' ' GLU . . . . . 0.417 ' C ' ' O ' ' A' ' 736' ' ' SER . 0.7 OUTLIER -44.12 160.94 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.113 -0.992 . . . . 0.0 109.604 179.962 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 738' ' ' TYR . . . . . 0.663 ' CG ' ' N ' ' A' ' 739' ' ' HIS . 0.4 OUTLIER -129.83 -52.8 1.14 Allowed 'General case' 0 N--CA 1.497 1.878 0 O-C-N 120.821 -1.174 . . . . 0.0 110.988 179.986 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 739' ' ' HIS . . . . . 0.663 ' N ' ' CG ' ' A' ' 738' ' ' TYR . 10.2 t-80 57.39 129.1 0.01 OUTLIER Pre-proline 0 N--CA 1.499 1.998 0 O-C-N 121.375 -0.828 . . . . 0.0 110.216 -179.898 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 740' ' ' PRO . . . . . 0.43 ' HD2' ' CD2' ' A' ' 739' ' ' HIS . 45.7 Cg_endo -71.12 151.54 61.4 Favored 'Trans proline' 0 C--N 1.307 -1.614 0 O-C-N 123.495 1.26 . . . . 0.0 110.542 179.953 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 741' ' ' ASN . . . . . 0.403 ' O ' ' HB ' ' A' ' 742' ' ' ILE . 0.2 OUTLIER -71.3 -31.85 67.94 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.302 -0.874 . . . . 0.0 110.441 -179.992 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 742' ' ' ILE . . . . . 0.458 HG21 ' N ' ' A' ' 743' ' ' LYS . 43.7 mt 56.4 164.88 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 O-C-N 121.211 -0.93 . . . . 0.0 110.688 -179.971 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 743' ' ' LYS . . . . . 0.518 ' O ' ' CZ3' ' A' ' 745' ' ' TRP . 1.0 OUTLIER -157.53 -53.91 0.07 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.396 -0.815 . . . . 0.0 109.807 179.954 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 744' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -104.74 118.91 37.75 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.198 -0.939 . . . . 0.0 109.678 179.926 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 745' ' ' TRP . . . . . 0.583 ' CG ' ' O ' ' A' ' 745' ' ' TRP . 1.2 p90 -169.39 116.57 0.6 Allowed 'General case' 0 C--N 1.304 -1.386 0 O-C-N 121.237 -0.914 . . . . 0.0 110.614 -179.965 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 746' ' ' GLN . . . . . 0.413 ' N ' ' OE2' ' A' ' 752' ' ' GLU . 4.3 mt-30 -52.97 158.43 1.43 Allowed 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.29 -0.881 . . . . 0.0 110.44 -179.963 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 747' ' ' ILE . . . . . 0.47 ' O ' ' CG2' ' A' ' 747' ' ' ILE . 3.6 tt -176.81 100.96 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.327 -0.858 . . . . 0.0 110.286 -179.989 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 748' ' ' GLU . . . . . . . . . . . . . 14.0 mt-10 -121.09 -58.84 1.77 Allowed 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.298 -0.876 . . . . 0.0 109.941 179.968 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 749' ' ' SER . . . . . 0.449 ' C ' ' CD2' ' A' ' 750' ' ' TYR . 0.1 OUTLIER -138.77 9.06 2.6 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.231 -0.918 . . . . 0.0 110.165 -179.968 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 750' ' ' TYR . . . . . 0.625 ' N ' ' CD2' ' A' ' 750' ' ' TYR . 0.1 OUTLIER -143.55 -77.24 0.23 Allowed 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.248 -0.908 . . . . 0.0 110.069 -179.976 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 751' ' ' GLY . . . . . . . . . . . . . . . 116.5 -174.39 15.21 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.564 -1.415 . . . . 0.0 109.564 179.964 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 752' ' ' GLU . . . . . 0.413 ' OE2' ' N ' ' A' ' 746' ' ' GLN . 7.9 mt-10 -114.72 137.37 22.73 Favored Pre-proline 0 N--CA 1.494 1.734 0 O-C-N 121.241 -1.152 . . . . 0.0 110.187 -179.964 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 753' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -75.07 131.74 14.55 Favored 'Trans proline' 0 C--N 1.305 -1.715 0 O-C-N 124.02 1.537 . . . . 0.0 110.67 179.969 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 754' ' ' GLU . . . . . . . . . . . . . 6.1 tt0 -162.09 166.24 26.06 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.349 -0.844 . . . . 0.0 110.12 -179.997 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 755' ' ' PHE . . . . . . . . . . . . . 4.9 m-85 -103.69 163.67 12.17 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.27 -0.894 . . . . 0.0 110.27 179.968 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 756' ' ' HIS . . . . . 0.41 ' HB2' ' HA ' ' A' ' 739' ' ' HIS . 0.5 OUTLIER -160.75 35.36 0.15 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.304 -0.872 . . . . 0.0 110.299 -179.975 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 757' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -89.2 141.03 28.87 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.295 -0.878 . . . . 0.0 110.24 -179.975 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 758' ' ' ALA . . . . . . . . . . . . . . . -90.8 165.0 13.88 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.169 -0.957 . . . . 0.0 110.516 -179.906 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 759' ' ' LYS . . . . . 0.47 ' HG2' ' HA ' ' A' ' 815' ' ' ALA . 3.2 mttp -130.39 165.01 23.47 Favored 'General case' 0 C--N 1.302 -1.5 0 O-C-N 121.424 -0.797 . . . . 0.0 109.839 -179.95 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 760' ' ' VAL . . . . . . . . . . . . . 41.6 t -106.37 153.74 7.62 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.518 0 O-C-N 121.25 -0.906 . . . . 0.0 109.459 179.953 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 761' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -147.87 116.83 6.79 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.051 -1.031 . . . . 0.0 111.219 -179.953 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 762' ' ' LEU . . . . . 0.521 HD22 ' CB ' ' A' ' 733' ' ' ALA . 32.0 mt -110.5 164.48 12.66 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.423 -0.798 . . . . 0.0 108.849 179.888 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 763' ' ' LYS . . . . . . . . . . . . . 14.9 mttt -154.04 128.98 9.5 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.78 -1.2 . . . . 0.0 110.944 -179.928 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 764' ' ' CYS . . . . . 0.433 ' O ' ' C ' ' A' ' 765' ' ' ALA . 10.4 t -103.83 143.78 32.37 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.489 -0.757 . . . . 0.0 109.601 179.996 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 765' ' ' ALA . . . . . 0.433 ' C ' ' O ' ' A' ' 764' ' ' CYS . . . -42.08 150.39 0.38 Allowed Pre-proline 0 N--CA 1.492 1.664 0 O-C-N 121.196 -0.94 . . . . 0.0 110.25 -179.945 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 766' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -70.11 95.95 0.6 Allowed 'Trans proline' 0 C--N 1.306 -1.683 0 O-C-N 124.016 1.535 . . . . 0.0 110.035 -179.923 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 767' ' ' GLY . . . . . . . . . . . . . . . 139.47 -17.76 3.08 Favored Glycine 0 N--CA 1.486 1.972 0 N-CA-C 109.029 -1.628 . . . . 0.0 109.029 -179.936 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 768' ' ' GLN . . . . . . . . . . . . . 20.7 mt-30 -108.61 174.74 5.74 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.362 -1.081 . . . . 0.0 110.133 179.981 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 769' ' ' THR . . . . . . . . . . . . . 8.9 p -144.85 147.97 33.44 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.207 -0.933 . . . . 0.0 110.454 -179.913 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 770' ' ' ILE . . . . . . . . . . . . . 72.1 mt -68.18 145.88 13.28 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.264 -0.898 . . . . 0.0 109.563 179.944 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 771' ' ' SER . . . . . . . . . . . . . 13.5 p -143.47 -3.0 0.94 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.955 -1.09 . . . . 0.0 111.951 -179.956 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 772' ' ' ALA . . . . . . . . . . . . . . . -165.98 143.25 5.41 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 120.559 -1.338 . . . . 0.0 111.648 -179.955 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 773' ' ' ILE . . . . . 0.424 HG23 ' HB3' ' A' ' 802' ' ' LEU . 34.9 mm -105.36 120.41 56.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 179.755 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 774' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.59 -43.55 22.72 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.045 -1.035 . . . . 0.0 111.077 -179.812 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 775' ' ' PHE . . . . . 0.579 ' CZ ' ' HB3' ' A' ' 788' ' ' PHE . 79.3 t80 -149.81 166.42 29.54 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 120.893 -1.129 . . . . 0.0 111.367 -179.925 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 776' ' ' ALA . . . . . 0.48 ' HB1' ' O ' ' A' ' 775' ' ' PHE . . . 174.21 126.2 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 -179.967 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 777' ' ' SER . . . . . . . . . . . . . 2.1 t -148.31 135.02 19.9 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.968 -1.083 . . . . 0.0 111.342 -179.956 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 778' ' ' PHE . . . . . . . . . . . . . 90.1 t80 -103.4 109.46 21.1 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.616 -0.677 . . . . 0.0 109.667 179.95 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 779' ' ' GLY . . . . . . . . . . . . . . . 148.52 -98.87 0.19 Allowed Glycine 0 N--CA 1.492 2.37 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 -179.907 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 780' ' ' THR . . . . . 0.467 ' O ' ' HA3' ' A' ' 791' ' ' GLY . 1.5 p -144.03 91.46 6.53 Favored Pre-proline 0 N--CA 1.494 1.743 0 O-C-N 121.153 -1.204 . . . . 0.0 110.608 179.928 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 781' ' ' PRO . . . . . 0.506 ' HG3' ' HB2' ' A' ' 834' ' ' ALA . 47.7 Cg_endo -82.57 154.36 15.78 Favored 'Trans proline' 0 C--N 1.304 -1.794 0 O-C-N 123.89 1.468 . . . . 0.0 110.269 179.931 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 782' ' ' LEU . . . . . 0.544 ' CD1' ' HA2' ' A' ' 791' ' ' GLY . 0.1 OUTLIER -127.76 125.33 39.7 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.082 -1.011 . . . . 0.0 110.508 -179.906 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 783' ' ' GLY . . . . . 0.418 ' C ' HG22 ' A' ' 784' ' ' THR . . . 128.24 -168.62 20.07 Favored Glycine 0 N--CA 1.488 2.166 0 N-CA-C 109.779 -1.328 . . . . 0.0 109.779 179.973 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 784' ' ' THR . . . . . 0.471 ' O ' ' HB2' ' A' ' 785' ' ' CYS . 24.1 p -142.93 72.19 1.36 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.323 -1.104 . . . . 0.0 109.834 179.969 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 785' ' ' CYS . . . . . 0.471 ' HB2' ' O ' ' A' ' 784' ' ' THR . 2.2 m 58.88 118.05 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.362 -0.836 . . . . 0.0 109.989 -179.973 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 786' ' ' GLY . . . . . . . . . . . . . . . 102.7 -37.33 3.75 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.061 -1.616 . . . . 0.0 109.061 -179.899 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 787' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -126.12 23.38 7.1 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.347 -1.09 . . . . 0.0 109.801 179.974 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 788' ' ' PHE . . . . . 0.579 ' HB3' ' CZ ' ' A' ' 775' ' ' PHE . 0.3 OUTLIER -56.4 149.76 16.2 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.511 -0.743 . . . . 0.0 110.009 179.987 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 789' ' ' GLN . . . . . . . . . . . . . 2.3 mm-40 -134.65 173.69 11.39 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.255 -0.903 . . . . 0.0 110.126 -179.991 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 790' ' ' GLN . . . . . 0.408 ' O ' ' C ' ' A' ' 791' ' ' GLY . 0.0 OUTLIER -86.45 16.04 4.91 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.318 -0.864 . . . . 0.0 109.993 179.961 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 791' ' ' GLY . . . . . 0.544 ' HA2' ' CD1' ' A' ' 782' ' ' LEU . . . 42.45 -120.1 2.28 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.744 -1.343 . . . . 0.0 109.744 -179.963 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 792' ' ' GLU . . . . . . . . . . . . . 12.8 mt-10 -117.26 -30.64 5.54 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.272 -1.134 . . . . 0.0 110.562 179.991 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 793' ' ' CYS . . . . . . . . . . . . . 2.5 t -126.65 156.77 40.48 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.255 -0.903 . . . . 0.0 110.232 -179.979 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 794' ' ' HIS . . . . . 0.51 ' NE2' ' O ' ' A' ' 795' ' ' SER . 49.9 t60 -170.08 150.49 3.76 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.374 -0.829 . . . . 0.0 110.229 -179.994 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 795' ' ' SER . . . . . 0.51 ' O ' ' NE2' ' A' ' 794' ' ' HIS . 3.1 t -99.68 158.07 16.03 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.394 -0.816 . . . . 0.0 109.466 179.948 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 796' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -92.07 37.24 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.087 0 O-C-N 121.005 -1.059 . . . . 0.0 109.847 -179.926 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 797' ' ' ASN . . . . . . . . . . . . . 18.9 m120 -148.06 22.92 1.08 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.383 -0.823 . . . . 0.0 109.93 179.997 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 798' ' ' SER . . . . . 0.469 ' HB3' ' O ' ' A' ' 776' ' ' ALA . 13.9 m -69.54 -50.35 45.76 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.306 -0.871 . . . . 0.0 110.637 179.991 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 799' ' ' ASN . . . . . . . . . . . . . 53.6 m-20 -76.33 -31.96 58.42 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.302 -0.874 . . . . 0.0 110.619 -179.944 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 800' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -56.63 -25.78 54.14 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.246 -0.909 . . . . 0.0 110.999 -179.93 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 801' ' ' VAL . . . . . 0.507 HG22 ' CD2' ' A' ' 821' ' ' PHE . 40.7 t -87.36 -21.66 7.13 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 O-C-N 121.067 -1.02 . . . . 0.0 110.769 -179.944 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 802' ' ' LEU . . . . . 0.479 HD12 HG11 ' A' ' 835' ' ' VAL . 4.1 mm? -93.07 -20.91 20.07 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.092 -1.005 . . . . 0.0 111.18 -179.942 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 803' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -83.51 -37.92 22.44 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.314 -0.866 . . . . 0.0 111.292 -179.858 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 804' ' ' ARG . . . . . . . . . . . . . 2.1 mtm180 -91.61 -25.61 19.09 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 120.997 -1.064 . . . . 0.0 111.62 -179.915 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 805' ' ' LYS . . . . . . . . . . . . . 2.0 tttp -110.53 44.53 1.24 Allowed 'General case' 0 N--CA 1.497 1.88 0 O-C-N 120.859 -1.15 . . . . 0.0 110.814 -179.939 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 806' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -160.52 -66.97 0.07 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.129 -0.982 . . . . 0.0 110.342 179.945 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 807' ' ' ILE . . . . . . . . . . . . . 30.1 mt -52.18 128.81 11.36 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.078 -1.014 . . . . 0.0 110.467 -179.998 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 808' ' ' GLY . . . . . 0.431 ' C ' ' HG ' ' A' ' 809' ' ' LEU . . . 105.24 9.48 33.82 Favored Glycine 0 N--CA 1.491 2.34 0 C-N-CA 119.918 -1.134 . . . . 0.0 110.284 179.915 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 809' ' ' LEU . . . . . 0.431 ' HG ' ' C ' ' A' ' 808' ' ' GLY . 43.7 mt -138.72 142.6 38.9 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.015 -1.285 . . . . 0.0 110.511 179.979 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 810' ' ' GLU . . . . . . . . . . . . . 5.0 mp0 -67.93 -20.88 65.12 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.182 -0.949 . . . . 0.0 109.418 179.998 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 811' ' ' ARG . . . . . . . . . . . . . 24.6 mtm180 -136.52 157.21 47.32 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.605 -0.684 . . . . 0.0 109.643 179.965 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 812' ' ' CYS . . . . . . . . . . . . . 3.2 t -131.12 146.71 52.45 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.198 -0.939 . . . . 0.0 110.193 -179.971 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 813' ' ' VAL . . . . . 0.542 ' O ' ' CG1' ' A' ' 813' ' ' VAL . 4.6 p -148.69 116.92 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.151 -0.968 . . . . 0.0 110.024 179.926 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 814' ' ' VAL . . . . . . . . . . . . . 6.7 t -131.39 111.73 19.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.193 -0.942 . . . . 0.0 110.077 179.959 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 815' ' ' ALA . . . . . 0.47 ' HA ' ' HG2' ' A' ' 759' ' ' LYS . . . -61.74 166.79 4.05 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.335 -0.853 . . . . 0.0 110.556 -179.955 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 816' ' ' ILE . . . . . 0.504 HG23 ' CG2' ' A' ' 833' ' ' VAL . 70.7 mt -119.7 112.89 38.97 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 121.378 -0.826 . . . . 0.0 110.102 179.953 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 817' ' ' SER . . . . . 0.521 ' CB ' ' HD2' ' A' ' 818' ' ' PRO . 0.7 OUTLIER -161.89 -177.36 0.7 Allowed Pre-proline 0 N--CA 1.494 1.744 0 O-C-N 121.101 -1.0 . . . . 0.0 110.313 179.97 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 818' ' ' PRO . . . . . 0.521 ' HD2' ' CB ' ' A' ' 817' ' ' SER . 48.3 Cg_endo -75.34 -48.84 0.15 Allowed 'Trans proline' 0 C--N 1.309 -1.546 0 O-C-N 123.991 1.522 . . . . 0.0 110.77 -179.971 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 819' ' ' SER . . . . . . . . . . . . . 2.8 t -92.76 71.06 4.84 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.334 -0.854 . . . . 0.0 110.411 -179.944 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 820' ' ' ASN . . . . . . . . . . . . . 5.4 t-20 -143.58 -43.23 0.28 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.137 -0.977 . . . . 0.0 110.129 -179.973 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 821' ' ' PHE . . . . . 0.507 ' CD2' HG22 ' A' ' 801' ' ' VAL . 33.3 m-85 -83.08 -57.29 3.34 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.428 -0.795 . . . . 0.0 110.501 -179.949 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 822' ' ' GLY . . . . . . . . . . . . . . . 147.21 66.76 0.01 OUTLIER Glycine 0 N--CA 1.491 2.349 0 C-N-CA 119.512 -1.328 . . . . 0.0 110.111 179.953 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 823' ' ' GLY . . . . . . . . . . . . . . . 120.4 170.5 14.26 Favored Glycine 0 N--CA 1.493 2.497 0 O-C-N 121.12 -1.224 . . . . 0.0 110.267 179.917 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 824' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -132.05 65.82 76.17 Favored Pre-proline 0 N--CA 1.494 1.733 0 O-C-N 121.583 -0.951 . . . . 0.0 109.814 179.986 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 825' ' ' PRO . . . . . 0.436 ' C ' ' HD3' ' A' ' 827' ' ' PRO . 48.7 Cg_endo -74.43 -3.42 13.82 Favored 'Trans proline' 0 C--N 1.305 -1.732 0 O-C-N 124.195 1.629 . . . . 0.0 111.122 -179.915 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 826' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER -126.44 64.83 57.25 Favored Pre-proline 0 N--CA 1.499 2.016 0 O-C-N 120.984 -1.072 . . . . 0.0 110.184 -179.944 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 827' ' ' PRO . . . . . 0.436 ' HD3' ' C ' ' A' ' 825' ' ' PRO . 50.0 Cg_endo -82.36 153.53 16.08 Favored 'Trans proline' 0 C--N 1.311 -1.416 0 O-C-N 123.897 1.472 . . . . 0.0 110.886 179.989 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 828' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 57.71 39.77 27.0 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.448 -0.782 . . . . 0.0 110.781 -179.993 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 829' ' ' VAL . . . . . 0.417 ' O ' ' C ' ' A' ' 830' ' ' MET . 54.3 t -137.45 139.76 42.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.176 -0.953 . . . . 0.0 110.116 179.974 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 830' ' ' MET . . . . . 0.417 ' C ' ' O ' ' A' ' 829' ' ' VAL . 0.2 OUTLIER -44.33 144.61 0.97 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.238 -0.913 . . . . 0.0 109.816 -179.911 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 831' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.2 105.79 18.05 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.233 -0.917 . . . . 0.0 110.689 -179.972 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 832' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -128.2 116.68 20.27 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.493 -0.754 . . . . 0.0 109.404 179.945 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 833' ' ' VAL . . . . . 0.504 ' CG2' HG23 ' A' ' 816' ' ' ILE . 3.3 t -109.86 116.87 53.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.165 -0.959 . . . . 0.0 110.876 -179.931 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 834' ' ' ALA . . . . . 0.506 ' HB2' ' HG3' ' A' ' 781' ' ' PRO . . . -118.25 148.87 41.99 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.478 -0.764 . . . . 0.0 109.229 179.949 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 835' ' ' VAL . . . . . 0.482 HG13 ' N ' ' A' ' 836' ' ' GLU . 46.7 t -155.06 162.84 1.72 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.519 0 O-C-N 120.904 -1.123 . . . . 0.0 111.051 -179.914 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 836' ' ' GLU . . . . . 0.482 ' N ' HG13 ' A' ' 835' ' ' VAL . 2.6 tt0 -145.76 118.12 8.45 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.629 -0.669 . . . . 0.0 109.587 179.934 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 837' ' ' ALA . . . . . . . . . . . . . . . -108.12 161.17 15.22 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.152 -0.968 . . . . 0.0 110.372 -179.947 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 838' ' ' VAL . . . . . . . . . . . . . 38.8 t -128.28 130.7 69.47 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.394 -0.816 . . . . 0.0 110.0 179.926 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 839' ' ' CYS . . . . . . . . . . . . . 2.5 m -109.82 146.47 34.99 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.179 -0.95 . . . . 0.0 110.343 -179.961 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 840' ' ' SER . . . . . . . . . . . . . 67.2 p -131.01 -169.83 2.24 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.351 -0.843 . . . . 0.0 109.861 179.938 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 841' ' ' THR . . . . . 0.459 ' O ' ' CB ' ' A' ' 842' ' ' ALA . 0.2 OUTLIER -111.23 20.03 17.76 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.221 -0.925 . . . . 0.0 110.143 -179.96 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 842' ' ' ALA . . . . . 0.459 ' CB ' ' O ' ' A' ' 841' ' ' THR . . . 66.91 166.34 0.22 Allowed 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.536 -0.727 . . . . 0.0 110.435 179.914 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 843' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.577 0 CA-C-O 117.973 -1.013 . . . . 0.0 110.158 -179.98 . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 726' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.699 0 CA-C-O 121.265 0.555 . . . . 0.0 110.263 . . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 727' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -127.97 171.49 11.78 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.324 -0.86 . . . . 0.0 110.268 179.992 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 728' ' ' VAL . . . . . 0.439 ' O ' ' O ' ' A' ' 839' ' ' CYS . 32.5 t -149.77 159.78 5.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.254 -0.904 . . . . 0.0 110.07 -179.962 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 729' ' ' SER . . . . . 0.429 ' OG ' ' O ' ' A' ' 728' ' ' VAL . 0.9 OUTLIER 178.1 120.88 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.127 -0.983 . . . . 0.0 110.432 -179.95 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 730' ' ' GLY . . . . . 0.412 ' C ' HG21 ' A' ' 731' ' ' VAL . . . 149.34 99.32 0.2 Allowed Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.767 -1.333 . . . . 0.0 109.767 -179.979 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 731' ' ' VAL . . . . . 0.412 HG21 ' C ' ' A' ' 730' ' ' GLY . 73.1 t -142.15 148.98 19.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.282 -1.128 . . . . 0.0 109.869 179.979 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 732' ' ' CYS . . . . . . . . . . . . . 92.5 m -122.62 166.3 15.08 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.256 -0.902 . . . . 0.0 110.922 -179.971 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 733' ' ' ALA . . . . . . . . . . . . . . . -160.96 102.09 1.28 Allowed 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 179.883 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 734' ' ' ASP . . . . . 0.455 ' C ' ' CG2' ' A' ' 735' ' ' VAL . 3.2 t70 -131.28 122.64 26.81 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.174 -0.954 . . . . 0.0 110.366 -179.944 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 735' ' ' VAL . . . . . 0.455 ' CG2' ' C ' ' A' ' 734' ' ' ASP . 40.6 t -153.25 153.06 9.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.35 -0.844 . . . . 0.0 110.152 179.979 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 736' ' ' SER . . . . . . . . . . . . . 12.3 t -110.31 152.25 26.41 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.159 -0.963 . . . . 0.0 110.207 -179.962 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 737' ' ' GLU . . . . . 0.465 ' OE2' ' HB2' ' A' ' 739' ' ' HIS . 2.1 tm-20 -52.59 -176.59 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.226 -0.921 . . . . 0.0 110.225 179.981 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 738' ' ' TYR . . . . . 0.461 ' O ' ' HB3' ' A' ' 739' ' ' HIS . 7.5 t80 -126.61 -47.91 1.55 Allowed 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.21 -0.931 . . . . 0.0 110.437 179.998 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 739' ' ' HIS . . . . . 0.524 ' O ' ' CD1' ' A' ' 742' ' ' ILE . 19.6 t-160 62.77 103.47 0.03 OUTLIER Pre-proline 0 N--CA 1.493 1.709 0 O-C-N 121.292 -0.88 . . . . 0.0 110.424 179.941 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 740' ' ' PRO . . . . . 0.469 ' HD3' ' O ' ' A' ' 756' ' ' HIS . 48.7 Cg_endo -86.54 51.42 2.54 Favored 'Trans proline' 0 C--N 1.303 -1.842 0 O-C-N 123.954 1.502 . . . . 0.0 110.152 179.977 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 741' ' ' ASN . . . . . 0.458 ' O ' HG13 ' A' ' 742' ' ' ILE . 15.3 t30 -160.63 80.01 0.65 Allowed 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.143 -0.973 . . . . 0.0 110.682 -179.976 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 742' ' ' ILE . . . . . 0.524 ' CD1' ' O ' ' A' ' 739' ' ' HIS . 4.3 mp -144.26 -97.28 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.233 -0.917 . . . . 0.0 110.024 179.933 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 743' ' ' LYS . . . . . 0.458 ' N ' HG21 ' A' ' 742' ' ' ILE . 0.0 OUTLIER 174.6 -71.92 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.134 -0.978 . . . . 0.0 109.656 179.984 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 744' ' ' ASN . . . . . 0.466 ' O ' ' O ' ' A' ' 745' ' ' TRP . 0.5 OUTLIER -86.3 3.9 41.34 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.322 -0.861 . . . . 0.0 109.938 179.951 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 745' ' ' TRP . . . . . 0.466 ' O ' ' O ' ' A' ' 744' ' ' ASN . 28.1 m95 41.19 -165.53 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.348 -0.845 . . . . 0.0 110.635 179.944 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 746' ' ' GLN . . . . . . . . . . . . . 17.6 mt-30 -152.83 34.08 0.49 Allowed 'General case' 0 C--N 1.3 -1.576 0 O-C-N 121.247 -0.908 . . . . 0.0 110.133 -179.932 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 747' ' ' ILE . . . . . 0.521 ' CG2' ' N ' ' A' ' 748' ' ' GLU . 2.1 mp -116.14 170.79 5.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.237 -0.914 . . . . 0.0 110.331 179.987 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 748' ' ' GLU . . . . . 0.521 ' N ' ' CG2' ' A' ' 747' ' ' ILE . 2.2 mp0 -87.61 31.53 0.75 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.253 -0.904 . . . . 0.0 110.352 -179.939 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 749' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -156.58 93.85 1.42 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.224 -0.922 . . . . 0.0 110.226 -179.977 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 750' ' ' TYR . . . . . . . . . . . . . 76.6 m-85 -55.45 147.53 17.34 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.264 -0.897 . . . . 0.0 110.146 179.994 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 751' ' ' GLY . . . . . 0.421 ' O ' ' C ' ' A' ' 752' ' ' GLU . . . 101.9 124.67 5.45 Favored Glycine 0 N--CA 1.488 2.155 0 N-CA-C 109.08 -1.608 . . . . 0.0 109.08 -179.979 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 752' ' ' GLU . . . . . 0.421 ' C ' ' O ' ' A' ' 751' ' ' GLY . 3.0 pt-20 -42.89 108.78 0.68 Allowed Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.278 -1.131 . . . . 0.0 110.285 -179.995 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 753' ' ' PRO . . . . . 0.561 ' O ' ' CG ' ' A' ' 754' ' ' GLU . 49.2 Cg_endo -78.79 70.84 7.23 Favored 'Trans proline' 0 C--N 1.309 -1.548 0 O-C-N 124.055 1.555 . . . . 0.0 110.702 -179.952 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 754' ' ' GLU . . . . . 0.561 ' CG ' ' O ' ' A' ' 753' ' ' PRO . 4.5 pt-20 42.56 -177.56 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.309 0 CA-C-O 121.663 0.744 . . . . 0.0 111.579 179.967 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 755' ' ' PHE . . . . . 0.477 ' CZ ' ' HD3' ' A' ' 759' ' ' LYS . 0.2 OUTLIER 50.8 171.24 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.446 -0.784 . . . . 0.0 110.955 179.979 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 756' ' ' HIS . . . . . 0.469 ' O ' ' HD3' ' A' ' 740' ' ' PRO . 57.5 m80 -126.98 -32.72 2.51 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.36 -0.838 . . . . 0.0 109.772 179.968 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 757' ' ' THR . . . . . . . . . . . . . 39.0 p -108.77 -159.33 0.68 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.368 -0.833 . . . . 0.0 110.098 179.972 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 758' ' ' ALA . . . . . 0.468 ' HB3' HD13 ' A' ' 816' ' ' ILE . . . -114.13 176.14 5.17 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.218 -0.926 . . . . 0.0 110.007 179.974 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 759' ' ' LYS . . . . . 0.477 ' HD3' ' CZ ' ' A' ' 755' ' ' PHE . 32.2 mtmt -144.44 161.99 37.64 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.213 -0.929 . . . . 0.0 110.345 -179.963 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 760' ' ' VAL . . . . . . . . . . . . . 59.6 t -109.28 158.61 9.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.435 -0.791 . . . . 0.0 109.276 179.971 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 761' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -122.47 122.61 39.36 Favored 'General case' 0 C--N 1.298 -1.641 0 O-C-N 121.051 -1.03 . . . . 0.0 110.912 179.978 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 762' ' ' LEU . . . . . 0.478 ' HB2' ' O ' ' A' ' 812' ' ' CYS . 5.6 mt -141.4 135.97 30.92 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.462 -0.774 . . . . 0.0 109.323 179.918 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 763' ' ' LYS . . . . . . . . . . . . . 3.8 mtmt -150.38 151.17 32.42 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.009 -1.057 . . . . 0.0 110.944 -179.938 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 764' ' ' CYS . . . . . . . . . . . . . 9.2 m -127.54 172.88 10.32 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.538 -0.726 . . . . 0.0 109.622 179.963 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 765' ' ' ALA . . . . . . . . . . . . . . . -68.11 158.49 83.9 Favored Pre-proline 0 N--CA 1.493 1.681 0 O-C-N 121.109 -0.994 . . . . 0.0 109.947 179.947 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 766' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -72.33 119.02 5.88 Favored 'Trans proline' 0 C--N 1.306 -1.703 0 O-C-N 123.932 1.491 . . . . 0.0 110.338 179.987 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 767' ' ' GLY . . . . . . . . . . . . . . . 112.98 -6.67 25.52 Favored Glycine 0 N--CA 1.489 2.201 0 N-CA-C 109.485 -1.446 . . . . 0.0 109.485 -179.911 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 768' ' ' GLN . . . . . . . . . . . . . 33.6 mt-30 -114.27 169.75 8.8 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.145 -1.209 . . . . 0.0 110.463 179.969 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 769' ' ' THR . . . . . . . . . . . . . 70.5 p -152.2 149.47 28.77 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.358 -0.839 . . . . 0.0 109.866 -179.97 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 770' ' ' ILE . . . . . 0.405 ' HB ' ' HA ' ' A' ' 807' ' ' ILE . 26.9 mt -70.27 141.38 17.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.088 -1.008 . . . . 0.0 109.722 -179.985 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 771' ' ' SER . . . . . . . . . . . . . 1.6 p -126.44 -13.18 6.08 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.168 -0.958 . . . . 0.0 110.587 -179.943 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 772' ' ' ALA . . . . . . . . . . . . . . . -158.08 159.66 36.52 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 120.97 -1.081 . . . . 0.0 111.426 -179.906 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 773' ' ' ILE . . . . . . . . . . . . . 34.8 mm -124.15 123.31 66.32 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 O-C-N 121.644 -0.66 . . . . 0.0 109.296 179.936 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 774' ' ' LYS . . . . . 0.528 ' HG3' ' CG2' ' A' ' 838' ' ' VAL . 0.3 OUTLIER -80.82 -41.4 23.35 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.125 -0.984 . . . . 0.0 110.933 -179.869 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 775' ' ' PHE . . . . . 0.514 ' O ' ' CB ' ' A' ' 776' ' ' ALA . 48.7 t80 -135.5 173.59 11.55 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.069 -1.019 . . . . 0.0 111.088 -179.892 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 776' ' ' ALA . . . . . 0.514 ' CB ' ' O ' ' A' ' 775' ' ' PHE . . . 166.47 87.03 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.644 -0.66 . . . . 0.0 109.314 179.999 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 777' ' ' SER . . . . . 0.478 ' OG ' ' CZ ' ' A' ' 775' ' ' PHE . 16.1 p -119.61 129.84 54.81 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.236 -0.915 . . . . 0.0 110.709 -179.892 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 778' ' ' PHE . . . . . 0.595 ' CD2' HG23 ' A' ' 833' ' ' VAL . 39.4 t80 -104.72 78.54 1.45 Allowed 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.294 -0.879 . . . . 0.0 110.024 179.944 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 779' ' ' GLY . . . . . 0.431 ' C ' ' HD3' ' A' ' 781' ' ' PRO . . . -168.79 -105.42 0.18 Allowed Glycine 0 N--CA 1.492 2.408 0 N-CA-C 109.686 -1.366 . . . . 0.0 109.686 179.997 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 780' ' ' THR . . . . . . . . . . . . . 2.4 p -121.17 63.24 12.16 Favored Pre-proline 0 N--CA 1.493 1.686 0 O-C-N 121.229 -1.159 . . . . 0.0 110.548 -179.973 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 781' ' ' PRO . . . . . 0.459 ' HD2' ' HB3' ' A' ' 832' ' ' ARG . 46.1 Cg_endo -75.98 146.66 29.51 Favored 'Trans proline' 0 C--N 1.305 -1.726 0 O-C-N 124.068 1.562 . . . . 0.0 111.142 179.983 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 782' ' ' LEU . . . . . 0.521 ' CD2' ' O ' ' A' ' 790' ' ' GLN . 1.8 pt? -149.54 159.56 44.21 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.452 -0.78 . . . . 0.0 109.64 179.928 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 783' ' ' GLY . . . . . . . . . . . . . . . 140.48 -131.22 4.91 Favored Glycine 0 N--CA 1.496 2.66 0 N-CA-C 109.591 -1.404 . . . . 0.0 109.591 -179.96 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 784' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -162.14 -158.02 0.51 Allowed 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.121 -1.223 . . . . 0.0 110.68 -179.969 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 785' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -72.95 119.32 17.03 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.366 -0.834 . . . . 0.0 110.54 -179.989 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 786' ' ' GLY . . . . . . . . . . . . . . . 82.63 -10.63 55.5 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.895 -1.282 . . . . 0.0 109.895 -179.98 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 787' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -124.25 30.0 6.2 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.13 -1.218 . . . . 0.0 110.133 -179.989 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 788' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -58.62 91.82 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.276 -0.89 . . . . 0.0 110.387 -180.0 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 789' ' ' GLN . . . . . . . . . . . . . 4.1 tt0 -75.5 -177.24 3.53 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.405 -0.809 . . . . 0.0 110.162 -179.957 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 790' ' ' GLN . . . . . 0.521 ' O ' ' CD2' ' A' ' 782' ' ' LEU . 0.0 OUTLIER -108.05 174.01 6.07 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.443 -0.786 . . . . 0.0 110.307 179.992 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 791' ' ' GLY . . . . . . . . . . . . . . . -106.87 -140.82 9.87 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.519 -1.432 . . . . 0.0 109.519 179.945 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 792' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -105.17 -24.03 12.81 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.174 -1.192 . . . . 0.0 110.144 -179.967 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 793' ' ' CYS . . . . . . . . . . . . . 5.7 t -126.22 145.66 50.3 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.281 -0.887 . . . . 0.0 109.974 -179.887 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 794' ' ' HIS . . . . . 0.492 ' CE1' ' OG ' ' A' ' 798' ' ' SER . 73.0 t60 -139.46 156.11 47.15 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.18 -0.95 . . . . 0.0 110.146 -179.943 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 795' ' ' SER . . . . . . . . . . . . . 1.3 t -81.56 -141.62 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.322 -0.861 . . . . 0.0 110.165 179.995 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 796' ' ' ILE . . . . . . . . . . . . . 1.5 pt -145.53 12.71 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.241 -0.912 . . . . 0.0 110.038 -179.971 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 797' ' ' ASN . . . . . . . . . . . . . 31.5 m120 -148.99 29.16 0.82 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.328 -0.857 . . . . 0.0 110.08 179.999 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 798' ' ' SER . . . . . 0.514 ' CB ' ' O ' ' A' ' 776' ' ' ALA . 7.6 m -71.41 -30.47 66.13 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.218 -0.926 . . . . 0.0 110.625 -179.995 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 799' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -102.33 -7.89 21.67 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.244 -0.91 . . . . 0.0 110.349 179.967 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 800' ' ' SER . . . . . . . . . . . . . 5.8 p -90.46 -22.3 21.46 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.174 -0.954 . . . . 0.0 110.477 179.987 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 801' ' ' VAL . . . . . 0.507 HG22 ' CD2' ' A' ' 821' ' ' PHE . 55.6 t -81.59 -39.05 16.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.104 -0.997 . . . . 0.0 109.949 179.977 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 802' ' ' LEU . . . . . 0.496 ' N ' HD21 ' A' ' 802' ' ' LEU . 4.3 mm? -70.6 -56.29 6.84 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.33 -0.856 . . . . 0.0 110.536 -179.95 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 803' ' ' GLU . . . . . 0.45 ' HG2' HD13 ' A' ' 807' ' ' ILE . 2.3 tt0 -48.97 -19.8 0.44 Allowed 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.158 -0.964 . . . . 0.0 110.946 -179.921 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 804' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.71 -46.8 8.03 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.993 -1.067 . . . . 0.0 111.328 -179.893 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 805' ' ' LYS . . . . . 0.481 ' HG2' ' O ' ' A' ' 801' ' ' VAL . 0.0 OUTLIER -115.93 47.53 1.36 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.952 -1.092 . . . . 0.0 111.329 -179.829 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 806' ' ' CYS . . . . . 0.419 ' SG ' HD13 ' A' ' 802' ' ' LEU . 2.4 t -150.22 -44.52 0.13 Allowed 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.056 -1.028 . . . . 0.0 110.225 179.937 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 807' ' ' ILE . . . . . 0.45 HD13 ' HG2' ' A' ' 803' ' ' GLU . 36.7 mt -80.89 129.17 37.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.188 -0.945 . . . . 0.0 110.151 -179.95 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 808' ' ' GLY . . . . . . . . . . . . . . . 110.86 -9.27 29.74 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 109.897 -1.281 . . . . 0.0 109.897 179.988 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 809' ' ' LEU . . . . . . . . . . . . . 7.8 mt -113.64 154.51 27.1 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.05 -1.265 . . . . 0.0 110.77 -179.979 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 810' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -69.93 -29.74 66.97 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.321 -0.862 . . . . 0.0 109.237 179.869 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 811' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -132.42 165.03 25.21 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.606 -0.684 . . . . 0.0 109.527 -179.993 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 812' ' ' CYS . . . . . 0.478 ' O ' ' HB2' ' A' ' 762' ' ' LEU . 22.8 t -143.12 135.12 26.93 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.079 -1.013 . . . . 0.0 110.839 179.986 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 813' ' ' VAL . . . . . 0.442 ' O ' ' CG1' ' A' ' 813' ' ' VAL . 3.0 p -144.16 129.45 14.82 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 O-C-N 121.464 -0.772 . . . . 0.0 109.192 179.856 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 814' ' ' VAL . . . . . 0.447 HG21 ' HE2' ' A' ' 805' ' ' LYS . 30.2 t -134.59 145.59 32.35 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.068 -1.02 . . . . 0.0 110.849 -179.895 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 815' ' ' ALA . . . . . . . . . . . . . . . -87.28 165.3 15.75 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.404 -0.81 . . . . 0.0 109.965 179.934 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 816' ' ' ILE . . . . . 0.468 HD13 ' HB3' ' A' ' 758' ' ' ALA . 71.9 mt -111.05 101.15 12.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.121 -0.987 . . . . 0.0 110.28 -179.94 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 817' ' ' SER . . . . . 0.458 ' HB2' ' HD2' ' A' ' 818' ' ' PRO . 1.4 p -155.25 176.34 2.59 Favored Pre-proline 0 N--CA 1.494 1.774 0 O-C-N 121.395 -0.815 . . . . 0.0 110.179 179.955 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 818' ' ' PRO . . . . . 0.458 ' HD2' ' HB2' ' A' ' 817' ' ' SER . 48.4 Cg_endo -76.18 -59.95 0.04 OUTLIER 'Trans proline' 0 C--N 1.309 -1.548 0 O-C-N 123.998 1.525 . . . . 0.0 111.19 -179.888 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 819' ' ' SER . . . . . . . . . . . . . 36.8 t -58.55 -42.45 87.9 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.19 -0.944 . . . . 0.0 110.59 -179.968 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 820' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -47.19 -23.83 0.59 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.218 -0.926 . . . . 0.0 110.322 -179.954 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 821' ' ' PHE . . . . . 0.507 ' CD2' HG22 ' A' ' 801' ' ' VAL . 15.6 m-85 -107.07 -96.08 0.37 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.146 -0.971 . . . . 0.0 110.715 -179.928 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 822' ' ' GLY . . . . . . . . . . . . . . . -141.8 8.18 2.49 Favored Glycine 0 N--CA 1.491 2.339 0 C-N-CA 119.648 -1.263 . . . . 0.0 110.163 -179.971 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 823' ' ' GLY . . . . . . . . . . . . . . . 124.59 -123.08 4.97 Favored Glycine 0 N--CA 1.492 2.376 0 O-C-N 120.999 -1.295 . . . . 0.0 109.966 179.972 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 824' ' ' ASP . . . . . . . . . . . . . 69.8 m-20 -80.42 134.99 53.98 Favored Pre-proline 0 N--CA 1.496 1.826 0 O-C-N 121.286 -1.126 . . . . 0.0 110.476 -179.943 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 825' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_endo -83.83 -64.05 0.02 OUTLIER 'Trans proline' 0 C--N 1.308 -1.586 0 O-C-N 123.963 1.507 . . . . 0.0 110.425 179.905 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 826' ' ' CYS . . . . . 0.43 ' HB3' ' HB ' ' A' ' 829' ' ' VAL . 0.7 OUTLIER -147.42 149.71 35.25 Favored Pre-proline 0 N--CA 1.494 1.76 0 O-C-N 121.325 -0.859 . . . . 0.0 110.319 179.96 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 827' ' ' PRO . . . . . 0.444 ' O ' ' HB2' ' A' ' 828' ' ' GLU . 46.8 Cg_endo -74.3 134.57 19.26 Favored 'Trans proline' 0 C--N 1.305 -1.713 0 O-C-N 123.977 1.514 . . . . 0.0 110.694 -179.961 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 828' ' ' GLU . . . . . 0.444 ' HB2' ' O ' ' A' ' 827' ' ' PRO . 64.8 mm-40 55.77 39.7 30.76 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.315 -0.866 . . . . 0.0 110.43 179.984 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 829' ' ' VAL . . . . . 0.43 ' HB ' ' HB3' ' A' ' 826' ' ' CYS . 18.1 t -142.48 136.61 28.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.177 -0.952 . . . . 0.0 110.373 179.987 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 830' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -63.26 -149.66 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.245 -0.909 . . . . 0.0 109.856 -179.993 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 831' ' ' LYS . . . . . 0.464 ' HG3' ' HG3' ' A' ' 737' ' ' GLU . 0.0 OUTLIER -145.34 94.92 2.58 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 120.962 -1.086 . . . . 0.0 110.834 179.962 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 832' ' ' ARG . . . . . 0.459 ' HB3' ' HD2' ' A' ' 781' ' ' PRO . 0.0 OUTLIER -109.56 166.75 10.65 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.305 -0.872 . . . . 0.0 109.408 179.911 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 833' ' ' VAL . . . . . 0.595 HG23 ' CD2' ' A' ' 778' ' ' PHE . 37.0 t -142.93 120.7 6.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 120.928 -1.108 . . . . 0.0 111.763 -179.914 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 834' ' ' ALA . . . . . . . . . . . . . . . -125.31 104.1 8.3 Favored 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 107.87 -1.159 . . . . 0.0 107.87 179.769 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 835' ' ' VAL . . . . . 0.5 HG13 ' N ' ' A' ' 836' ' ' GLU . 67.1 t -109.5 153.56 11.23 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.579 0 O-C-N 121.153 -0.967 . . . . 0.0 112.453 -179.674 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 836' ' ' GLU . . . . . 0.5 ' N ' HG13 ' A' ' 835' ' ' VAL . 31.2 tt0 -135.11 122.41 21.69 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 107.185 -1.413 . . . . 0.0 107.185 179.694 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 837' ' ' ALA . . . . . . . . . . . . . . . -113.62 161.81 16.99 Favored 'General case' 0 N--CA 1.501 2.087 0 O-C-N 120.719 -1.238 . . . . 0.0 112.722 -179.669 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 838' ' ' VAL . . . . . 0.528 ' CG2' ' HG3' ' A' ' 774' ' ' LYS . 23.9 t -118.75 105.56 17.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 179.852 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 839' ' ' CYS . . . . . 0.439 ' O ' ' O ' ' A' ' 728' ' ' VAL . 0.0 OUTLIER -107.98 140.71 40.72 Favored 'General case' 0 C--N 1.3 -1.585 0 O-C-N 120.975 -1.078 . . . . 0.0 110.462 -179.867 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 840' ' ' SER . . . . . . . . . . . . . 71.2 p -163.76 177.7 8.45 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.474 -0.766 . . . . 0.0 110.047 179.962 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 841' ' ' THR . . . . . 0.455 ' O ' ' O ' ' A' ' 842' ' ' ALA . 11.6 p -87.58 108.0 18.86 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.101 -0.999 . . . . 0.0 110.199 -179.956 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 842' ' ' ALA . . . . . 0.455 ' O ' ' O ' ' A' ' 841' ' ' THR . . . 53.66 169.28 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.232 -0.917 . . . . 0.0 110.134 179.985 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 843' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.674 0 CA-C-O 117.978 -1.011 . . . . 0.0 110.283 179.976 . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A ' 726' ' ' ARG . . . . . . . . . . . . . 35.8 mtm180 . . . . . 0 N--CA 1.492 1.662 0 CA-C-O 121.215 0.531 . . . . 0.0 110.224 . . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A ' 727' ' ' THR . . . . . 0.457 HG22 ' OE1' ' A' ' 768' ' ' GLN . 7.0 m -75.2 88.15 2.48 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.224 -0.922 . . . . 0.0 110.099 179.988 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 728' ' ' VAL . . . . . 0.465 ' O ' ' CG1' ' A' ' 728' ' ' VAL . 9.5 p -121.68 61.58 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.223 -0.923 . . . . 0.0 110.403 180.0 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 729' ' ' SER . . . . . . . . . . . . . 36.2 t -63.88 159.45 19.68 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.146 -0.971 . . . . 0.0 110.068 -179.997 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 730' ' ' GLY . . . . . . . . . . . . . . . -113.95 155.67 16.16 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.494 -1.443 . . . . 0.0 109.494 -179.995 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 731' ' ' VAL . . . . . 0.494 HG13 ' N ' ' A' ' 732' ' ' CYS . 73.4 t -119.73 158.91 21.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.142 -1.21 . . . . 0.0 110.086 -179.932 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 732' ' ' CYS . . . . . 0.494 ' N ' HG13 ' A' ' 731' ' ' VAL . 0.5 OUTLIER -131.09 125.14 32.38 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.177 -0.952 . . . . 0.0 110.02 179.996 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 733' ' ' ALA . . . . . . . . . . . . . . . -115.25 109.57 18.16 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.236 -0.915 . . . . 0.0 110.377 179.973 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 734' ' ' ASP . . . . . 0.404 ' O ' ' CG2' ' A' ' 735' ' ' VAL . 5.0 t0 -118.11 108.93 15.8 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.19 -0.944 . . . . 0.0 110.159 -179.987 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 735' ' ' VAL . . . . . 0.404 ' CG2' ' O ' ' A' ' 734' ' ' ASP . 96.3 t -152.1 145.39 15.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.287 -0.883 . . . . 0.0 110.182 179.998 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 736' ' ' SER . . . . . . . . . . . . . 66.6 p -93.18 -161.99 0.89 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.175 -0.953 . . . . 0.0 110.386 179.898 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 737' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 -115.25 72.26 0.79 Allowed 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.292 -0.88 . . . . 0.0 110.26 179.955 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 738' ' ' TYR . . . . . . . . . . . . . 70.9 t80 -171.36 141.63 1.59 Allowed 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.275 -0.891 . . . . 0.0 110.122 179.99 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 739' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -92.97 118.91 68.02 Favored Pre-proline 0 N--CA 1.493 1.693 0 O-C-N 121.118 -0.989 . . . . 0.0 110.234 179.993 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 740' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -78.23 -17.9 12.97 Favored 'Trans proline' 0 C--N 1.308 -1.59 0 O-C-N 123.892 1.47 . . . . 0.0 111.103 -179.954 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 741' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -172.92 130.07 0.5 Allowed 'General case' 0 N--CA 1.497 1.92 0 O-C-N 120.863 -1.148 . . . . 0.0 110.95 -179.965 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 742' ' ' ILE . . . . . 0.429 ' O ' ' N ' ' A' ' 744' ' ' ASN . 1.8 pt -130.42 -16.57 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.013 0 O-C-N 121.335 -0.853 . . . . 0.0 110.45 179.963 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 743' ' ' LYS . . . . . 0.471 ' HG2' ' N ' ' A' ' 744' ' ' ASN . 0.9 OUTLIER 52.52 -92.13 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.035 -1.041 . . . . 0.0 110.346 -179.962 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 744' ' ' ASN . . . . . 0.471 ' N ' ' HG2' ' A' ' 743' ' ' LYS . 87.5 m-20 -133.23 119.11 19.41 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.25 -0.906 . . . . 0.0 110.114 -179.984 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 745' ' ' TRP . . . . . . . . . . . . . 7.8 m95 -56.79 150.81 15.43 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.213 -0.929 . . . . 0.0 110.405 179.971 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 746' ' ' GLN . . . . . . . . . . . . . 28.2 tp60 -127.87 85.75 2.39 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.263 -0.898 . . . . 0.0 110.045 179.937 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 747' ' ' ILE . . . . . . . . . . . . . 43.9 pt -136.07 -171.63 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.319 -0.863 . . . . 0.0 110.376 -179.972 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 748' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -83.8 -41.46 17.54 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.256 -0.903 . . . . 0.0 110.189 179.876 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 749' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -80.06 176.82 9.4 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.324 -0.86 . . . . 0.0 110.224 179.958 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 750' ' ' TYR . . . . . . . . . . . . . 28.1 m-85 -131.49 175.34 9.23 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.208 -0.932 . . . . 0.0 110.223 -179.97 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 751' ' ' GLY . . . . . . . . . . . . . . . 122.0 174.04 14.54 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.625 -1.39 . . . . 0.0 109.625 -179.991 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 752' ' ' GLU . . . . . . . . . . . . . 6.2 tt0 -122.24 115.92 29.95 Favored Pre-proline 0 N--CA 1.492 1.656 0 O-C-N 121.3 -1.117 . . . . 0.0 110.02 -179.998 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 753' ' ' PRO . . . . . 0.451 ' HB2' ' CD1' ' A' ' 755' ' ' PHE . 46.7 Cg_endo -73.5 159.56 46.07 Favored 'Trans proline' 0 C--N 1.308 -1.567 0 O-C-N 123.955 1.502 . . . . 0.0 110.525 -179.928 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 754' ' ' GLU . . . . . . . . . . . . . 7.2 mt-10 -119.46 29.69 7.49 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.276 -0.89 . . . . 0.0 110.289 179.992 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 755' ' ' PHE . . . . . 0.451 ' CD1' ' HB2' ' A' ' 753' ' ' PRO . 18.8 p90 -128.43 136.68 51.2 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.189 -0.944 . . . . 0.0 110.48 -179.984 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 756' ' ' HIS . . . . . . . . . . . . . 70.7 m80 -112.73 130.33 56.1 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.296 -0.878 . . . . 0.0 109.826 179.938 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 757' ' ' THR . . . . . . . . . . . . . 29.4 p -153.13 -170.39 3.61 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.199 -0.938 . . . . 0.0 110.38 -179.957 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 758' ' ' ALA . . . . . . . . . . . . . . . -140.85 166.14 25.59 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.393 -0.817 . . . . 0.0 109.758 -179.987 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 759' ' ' LYS . . . . . . . . . . . . . 8.2 mttt -113.38 166.31 11.61 Favored 'General case' 0 C--N 1.299 -1.618 0 O-C-N 121.232 -0.918 . . . . 0.0 110.3 179.993 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 760' ' ' VAL . . . . . . . . . . . . . 80.3 t -105.56 150.11 8.51 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.463 0 O-C-N 121.311 -0.868 . . . . 0.0 108.873 179.91 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 761' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -125.73 103.95 8.09 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 120.916 -1.115 . . . . 0.0 111.607 -179.812 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 762' ' ' LEU . . . . . 0.462 ' HB2' ' O ' ' A' ' 812' ' ' CYS . 17.8 mt -118.04 100.46 7.56 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 179.829 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 763' ' ' LYS . . . . . 0.412 ' HG2' ' CB ' ' A' ' 811' ' ' ARG . 0.0 OUTLIER -124.12 139.88 53.51 Favored 'General case' 0 C--N 1.3 -1.562 0 O-C-N 121.085 -1.009 . . . . 0.0 111.298 -179.829 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 764' ' ' CYS . . . . . 0.437 ' O ' ' C ' ' A' ' 765' ' ' ALA . 3.0 t -125.76 145.12 50.34 Favored 'General case' 0 C--N 1.299 -1.603 0 O-C-N 121.623 -0.673 . . . . 0.0 109.409 179.881 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 765' ' ' ALA . . . . . 0.437 ' C ' ' O ' ' A' ' 764' ' ' CYS . . . -41.1 161.78 0.12 Allowed Pre-proline 0 N--CA 1.495 1.782 0 O-C-N 121.164 -0.96 . . . . 0.0 110.494 179.983 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 766' ' ' PRO . . . . . 0.424 ' HD2' ' HB1' ' A' ' 765' ' ' ALA . 43.9 Cg_endo -70.55 102.47 1.16 Allowed 'Trans proline' 0 C--N 1.305 -1.726 0 O-C-N 123.94 1.495 . . . . 0.0 110.28 -179.963 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 767' ' ' GLY . . . . . . . . . . . . . . . 133.18 -21.71 4.08 Favored Glycine 0 N--CA 1.488 2.102 0 N-CA-C 109.025 -1.63 . . . . 0.0 109.025 -179.978 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 768' ' ' GLN . . . . . 0.513 ' HG2' ' CG2' ' A' ' 841' ' ' THR . 22.6 mt-30 -101.64 131.8 47.67 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.48 -1.012 . . . . 0.0 110.076 -179.999 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 769' ' ' THR . . . . . . . . . . . . . 16.9 p -125.57 147.37 49.31 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.113 -0.992 . . . . 0.0 110.232 179.965 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 770' ' ' ILE . . . . . 0.455 HG22 ' N ' ' A' ' 771' ' ' SER . 22.4 mt -59.92 166.88 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.205 -0.934 . . . . 0.0 109.639 179.964 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 771' ' ' SER . . . . . 0.455 ' N ' HG22 ' A' ' 770' ' ' ILE . 0.1 OUTLIER -160.33 -30.92 0.06 Allowed 'General case' 0 C--N 1.299 -1.621 0 O-C-N 121.094 -1.004 . . . . 0.0 111.152 -179.948 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 772' ' ' ALA . . . . . . . . . . . . . . . -135.78 122.67 21.25 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.852 -1.155 . . . . 0.0 111.402 -179.858 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 773' ' ' ILE . . . . . . . . . . . . . 38.2 mm -95.74 100.95 11.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.448 -0.783 . . . . 0.0 109.021 179.918 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 774' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.94 -37.89 28.71 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.163 -0.961 . . . . 0.0 111.284 -179.928 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 775' ' ' PHE . . . . . 0.49 ' O ' ' CB ' ' A' ' 776' ' ' ALA . 44.1 t80 -122.65 160.66 25.34 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 120.957 -1.089 . . . . 0.0 111.305 -179.843 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 776' ' ' ALA . . . . . 0.49 ' CB ' ' O ' ' A' ' 775' ' ' PHE . . . 166.28 100.64 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.607 -0.683 . . . . 0.0 109.616 179.989 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 777' ' ' SER . . . . . 0.47 ' HA ' ' HB3' ' A' ' 798' ' ' SER . 1.6 p -136.08 142.03 44.28 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.347 -0.846 . . . . 0.0 110.369 -179.909 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 778' ' ' PHE . . . . . 0.496 ' O ' ' CD2' ' A' ' 778' ' ' PHE . 68.8 t80 -120.87 73.74 1.03 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.44 -0.787 . . . . 0.0 110.298 -179.996 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 779' ' ' GLY . . . . . . . . . . . . . . . -161.57 -108.01 0.22 Allowed Glycine 0 N--CA 1.492 2.39 0 N-CA-C 109.544 -1.422 . . . . 0.0 109.544 -179.983 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 780' ' ' THR . . . . . . . . . . . . . 81.8 p -121.07 81.97 36.54 Favored Pre-proline 0 N--CA 1.489 1.506 0 O-C-N 121.187 -1.184 . . . . 0.0 110.161 -179.982 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 781' ' ' PRO . . . . . 0.459 ' CG ' ' HB3' ' A' ' 832' ' ' ARG . 47.5 Cg_endo -75.7 166.8 27.65 Favored 'Trans proline' 0 C--N 1.305 -1.733 0 O-C-N 124.103 1.581 . . . . 0.0 110.36 -179.974 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 782' ' ' LEU . . . . . . . . . . . . . 6.7 mt -140.74 131.81 26.27 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.252 -0.905 . . . . 0.0 110.134 179.999 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 783' ' ' GLY . . . . . . . . . . . . . . . 114.93 -165.86 12.11 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.638 -1.385 . . . . 0.0 109.638 -179.948 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 784' ' ' THR . . . . . . . . . . . . . 12.3 p -135.78 -50.1 0.71 Allowed 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.292 -1.123 . . . . 0.0 110.114 179.941 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 785' ' ' CYS . . . . . . . . . . . . . 22.5 t -173.26 87.84 0.07 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.291 -0.881 . . . . 0.0 109.854 -180.0 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 786' ' ' GLY . . . . . . . . . . . . . . . 142.34 -26.74 2.28 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 108.902 -1.679 . . . . 0.0 108.902 -179.897 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 787' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -127.17 30.19 5.46 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.487 -1.008 . . . . 0.0 109.82 179.989 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 788' ' ' PHE . . . . . 0.577 ' CE2' ' HB1' ' A' ' 834' ' ' ALA . 2.2 m-85 -51.93 121.08 6.07 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.307 -0.871 . . . . 0.0 110.245 179.993 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 789' ' ' GLN . . . . . . . . . . . . . 13.2 tt0 -133.74 120.76 20.97 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.302 -0.874 . . . . 0.0 110.274 -179.978 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 790' ' ' GLN . . . . . 0.468 ' CG ' ' O ' ' A' ' 790' ' ' GLN . 9.3 pt20 -64.96 126.21 27.31 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.251 -0.906 . . . . 0.0 110.549 -179.949 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 791' ' ' GLY . . . . . . . . . . . . . . . -69.43 -122.47 0.03 OUTLIER Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.311 -1.516 . . . . 0.0 109.311 179.948 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 792' ' ' GLU . . . . . . . . . . . . . 11.9 mt-10 -126.26 8.72 7.24 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.149 -1.207 . . . . 0.0 110.279 179.963 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 793' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -129.46 96.36 4.26 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.239 -0.913 . . . . 0.0 109.771 179.874 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 794' ' ' HIS . . . . . 0.589 ' CD2' ' O ' ' A' ' 795' ' ' SER . 77.6 t60 -124.78 139.62 53.68 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.179 -0.95 . . . . 0.0 110.488 -179.934 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 795' ' ' SER . . . . . 0.589 ' O ' ' CD2' ' A' ' 794' ' ' HIS . 4.1 t -82.75 168.87 16.78 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.318 -0.864 . . . . 0.0 109.078 179.99 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 796' ' ' ILE . . . . . . . . . . . . . 1.7 mt -94.97 -7.88 9.79 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 O-C-N 120.857 -1.152 . . . . 0.0 110.095 -179.971 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 797' ' ' ASN . . . . . . . . . . . . . 4.8 m120 -107.38 38.65 2.08 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.288 -0.883 . . . . 0.0 109.387 179.877 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 798' ' ' SER . . . . . 0.552 ' OG ' ' CE1' ' A' ' 794' ' ' HIS . 70.6 m -82.08 -52.54 6.91 Favored 'General case' 0 N--CA 1.485 1.317 0 O-C-N 121.51 -0.743 . . . . 0.0 111.184 -179.983 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 799' ' ' ASN . . . . . . . . . . . . . 47.2 t-20 -98.37 12.04 36.17 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.074 -1.017 . . . . 0.0 111.134 -179.923 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 800' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -89.29 -45.06 9.8 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.075 -1.015 . . . . 0.0 110.355 179.959 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 801' ' ' VAL . . . . . . . . . . . . . 8.7 t -74.96 -19.32 16.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.171 -0.956 . . . . 0.0 110.342 -179.974 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 802' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -74.2 -57.23 4.09 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.284 -0.885 . . . . 0.0 110.721 179.976 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 803' ' ' GLU . . . . . 0.426 ' CD ' HD13 ' A' ' 807' ' ' ILE . 0.9 OUTLIER -63.43 -18.33 63.61 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.213 -0.929 . . . . 0.0 110.543 -179.935 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 804' ' ' ARG . . . . . . . . . . . . . 3.2 mtm-85 -92.41 -16.74 25.52 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.237 -0.914 . . . . 0.0 112.066 -179.805 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 805' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.59 39.28 1.69 Allowed 'General case' 0 N--CA 1.502 2.143 0 O-C-N 120.466 -1.396 . . . . 0.0 112.594 -179.809 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 806' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -164.39 22.95 0.06 Allowed 'General case' 0 N--CA 1.501 2.112 0 O-C-N 120.58 -1.325 . . . . 0.0 111.024 179.921 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 807' ' ' ILE . . . . . 0.426 HD13 ' CD ' ' A' ' 803' ' ' GLU . 4.4 mt -125.32 119.33 55.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.093 -1.004 . . . . 0.0 109.939 179.914 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 808' ' ' GLY . . . . . . . . . . . . . . . 110.93 7.91 24.69 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.059 -1.616 . . . . 0.0 109.059 -179.889 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 809' ' ' LEU . . . . . . . . . . . . . 29.7 mt -123.65 138.34 54.55 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.287 -1.125 . . . . 0.0 109.876 179.968 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 810' ' ' GLU . . . . . . . . . . . . . 15.0 mp0 -63.04 -22.36 66.8 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.067 -1.021 . . . . 0.0 109.329 -179.992 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 811' ' ' ARG . . . . . 0.412 ' CB ' ' HG2' ' A' ' 763' ' ' LYS . 0.0 OUTLIER -154.56 122.88 6.03 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.519 -0.738 . . . . 0.0 109.881 179.94 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 812' ' ' CYS . . . . . 0.462 ' O ' ' HB2' ' A' ' 762' ' ' LEU . 6.0 p -129.47 139.07 51.71 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.126 -0.984 . . . . 0.0 110.241 -179.94 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 813' ' ' VAL . . . . . . . . . . . . . 53.4 t -121.79 139.79 47.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.204 -0.935 . . . . 0.0 110.308 -179.952 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 814' ' ' VAL . . . . . . . . . . . . . 58.0 t -124.71 134.52 66.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.253 -0.905 . . . . 0.0 110.279 179.989 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 815' ' ' ALA . . . . . . . . . . . . . . . -82.32 149.56 27.7 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.288 -0.883 . . . . 0.0 109.927 -179.99 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 816' ' ' ILE . . . . . . . . . . . . . 22.0 mt -109.96 125.04 67.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.172 -0.955 . . . . 0.0 110.285 179.954 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 817' ' ' SER . . . . . 0.454 ' HB2' ' HD2' ' A' ' 818' ' ' PRO . 2.9 p -172.96 170.74 2.0 Favored Pre-proline 0 N--CA 1.492 1.659 0 O-C-N 121.148 -0.97 . . . . 0.0 110.314 179.993 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 818' ' ' PRO . . . . . 0.46 ' O ' ' HB3' ' A' ' 819' ' ' SER . 47.6 Cg_endo -74.84 158.39 42.82 Favored 'Trans proline' 0 C--N 1.305 -1.737 0 O-C-N 124.144 1.602 . . . . 0.0 110.743 -179.875 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 819' ' ' SER . . . . . 0.46 ' HB3' ' O ' ' A' ' 818' ' ' PRO . 7.5 t 63.01 9.85 4.05 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.361 -0.837 . . . . 0.0 110.842 179.983 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 820' ' ' ASN . . . . . . . . . . . . . 2.4 t30 -96.72 -44.18 7.21 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.097 -1.002 . . . . 0.0 110.208 179.988 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 821' ' ' PHE . . . . . . . . . . . . . 4.0 m-85 -89.94 -45.31 9.3 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.19 -0.944 . . . . 0.0 110.184 179.985 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 822' ' ' GLY . . . . . . . . . . . . . . . -167.43 -35.98 0.02 OUTLIER Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.61 -1.396 . . . . 0.0 109.61 -179.966 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 823' ' ' GLY . . . . . . . . . . . . . . . 159.82 -119.21 0.87 Allowed Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.648 -1.381 . . . . 0.0 109.648 -179.96 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 824' ' ' ASP . . . . . 0.463 ' OD1' ' O ' ' A' ' 824' ' ' ASP . 43.8 p-10 -148.19 101.76 3.58 Favored Pre-proline 0 N--CA 1.498 1.938 0 O-C-N 121.308 -1.113 . . . . 0.0 109.952 -179.997 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 825' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_endo -83.74 -53.22 0.03 OUTLIER 'Trans proline' 0 C--N 1.307 -1.631 0 O-C-N 123.907 1.477 . . . . 0.0 111.037 -179.968 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 826' ' ' CYS . . . . . 0.456 ' SG ' HG11 ' A' ' 829' ' ' VAL . 0.1 OUTLIER -77.56 129.1 78.09 Favored Pre-proline 0 N--CA 1.497 1.885 0 O-C-N 121.077 -1.014 . . . . 0.0 110.737 -179.876 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 827' ' ' PRO . . . . . 0.421 ' O ' ' C ' ' A' ' 828' ' ' GLU . 51.2 Cg_endo -87.86 135.07 3.32 Favored 'Trans proline' 0 C--N 1.31 -1.461 0 O-C-N 123.911 1.479 . . . . 0.0 111.086 -179.97 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 828' ' ' GLU . . . . . 0.421 ' C ' ' O ' ' A' ' 827' ' ' PRO . 0.3 OUTLIER 39.29 47.57 1.48 Allowed 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.428 -0.795 . . . . 0.0 110.937 179.863 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 829' ' ' VAL . . . . . 0.456 HG11 ' SG ' ' A' ' 826' ' ' CYS . 56.1 t -123.06 132.03 72.16 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.925 0 O-C-N 121.13 -0.981 . . . . 0.0 110.56 179.929 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 830' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -53.63 108.51 0.35 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.246 -0.909 . . . . 0.0 109.743 179.981 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 831' ' ' LYS . . . . . . . . . . . . . 5.0 mmtp -79.72 143.6 34.4 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.161 -0.962 . . . . 0.0 110.314 -179.944 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 832' ' ' ARG . . . . . 0.459 ' HB3' ' CG ' ' A' ' 781' ' ' PRO . 2.7 ttm180 -146.24 161.19 40.81 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.378 -0.826 . . . . 0.0 109.638 -179.979 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 833' ' ' VAL . . . . . . . . . . . . . 59.7 t -124.64 109.21 21.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.125 -0.984 . . . . 0.0 110.89 -179.967 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 834' ' ' ALA . . . . . 0.577 ' HB1' ' CE2' ' A' ' 788' ' ' PHE . . . -111.35 129.87 55.86 Favored 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 179.831 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 835' ' ' VAL . . . . . . . . . . . . . 68.3 t -140.35 160.2 25.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 120.817 -1.177 . . . . 0.0 111.718 -179.888 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 836' ' ' GLU . . . . . 0.415 ' HB2' ' HB3' ' A' ' 775' ' ' PHE . 0.2 OUTLIER -151.92 103.9 2.95 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 179.851 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 837' ' ' ALA . . . . . . . . . . . . . . . -111.23 164.07 13.27 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.008 -1.058 . . . . 0.0 111.798 -179.851 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 838' ' ' VAL . . . . . . . . . . . . . 93.4 t -112.6 131.3 64.51 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.327 0 N-CA-C 109.427 -0.582 . . . . 0.0 109.427 179.882 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 839' ' ' CYS . . . . . 0.444 ' O ' ' HA ' ' A' ' 728' ' ' VAL . 2.0 t -108.76 120.26 41.97 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.002 -1.061 . . . . 0.0 110.571 -179.965 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 840' ' ' SER . . . . . . . . . . . . . 10.1 t -123.97 159.12 30.47 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.418 -0.802 . . . . 0.0 110.065 179.977 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 841' ' ' THR . . . . . 0.513 ' CG2' ' HG2' ' A' ' 768' ' ' GLN . 22.2 p -90.13 156.49 18.31 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.154 -0.967 . . . . 0.0 110.295 179.99 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 842' ' ' ALA . . . . . 0.433 ' O ' ' C ' ' A' ' 843' ' ' ALA . . . -53.17 175.22 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.296 -0.877 . . . . 0.0 110.229 -179.993 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 843' ' ' ALA . . . . . 0.433 ' C ' ' O ' ' A' ' 842' ' ' ALA . . . . . . . . 0 N--CA 1.492 1.658 0 CA-C-O 118.067 -0.968 . . . . 0.0 110.338 179.95 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 726' ' ' ARG . . . . . 0.447 ' HG3' HG13 ' A' ' 728' ' ' VAL . 13.5 ptt180 . . . . . 0 N--CA 1.493 1.721 0 CA-C-O 121.117 0.484 . . . . 0.0 110.328 . . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 727' ' ' THR . . . . . 0.429 ' C ' ' O ' ' A' ' 726' ' ' ARG . 32.6 p 42.05 58.62 2.85 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.373 -0.829 . . . . 0.0 110.286 179.931 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 728' ' ' VAL . . . . . 0.468 ' O ' HG12 ' A' ' 728' ' ' VAL . 7.7 p -163.05 103.22 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.298 -1.666 0 O-C-N 121.461 -0.774 . . . . 0.0 110.253 -179.961 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 729' ' ' SER . . . . . . . . . . . . . 1.9 t -66.93 166.67 13.07 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.179 -0.951 . . . . 0.0 109.981 179.98 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 730' ' ' GLY . . . . . . . . . . . . . . . -144.32 132.38 4.79 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.114 -1.594 . . . . 0.0 109.114 179.939 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 731' ' ' VAL . . . . . . . . . . . . . 21.0 m -150.9 117.49 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.425 0 O-C-N 121.018 -1.284 . . . . 0.0 110.845 -179.935 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 732' ' ' CYS . . . . . 0.425 ' O ' ' SG ' ' A' ' 732' ' ' CYS . 15.5 p -109.22 133.85 52.51 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.31 -0.869 . . . . 0.0 109.322 179.841 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 733' ' ' ALA . . . . . . . . . . . . . . . -109.24 123.44 49.27 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.091 -1.006 . . . . 0.0 110.669 -179.862 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 734' ' ' ASP . . . . . . . . . . . . . 12.2 t0 -111.71 114.47 27.51 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.378 -0.826 . . . . 0.0 110.124 179.941 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 735' ' ' VAL . . . . . . . . . . . . . 16.6 t -122.99 155.34 28.6 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.222 -0.924 . . . . 0.0 110.338 -179.993 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 736' ' ' SER . . . . . 0.433 ' O ' ' C ' ' A' ' 737' ' ' GLU . 0.1 OUTLIER -106.15 105.5 15.56 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.263 -0.898 . . . . 0.0 109.807 -179.98 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 737' ' ' GLU . . . . . 0.488 ' CB ' ' HA ' ' A' ' 831' ' ' LYS . 0.0 OUTLIER -39.05 138.92 0.52 Allowed 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.457 -0.777 . . . . 0.0 110.851 -179.963 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 738' ' ' TYR . . . . . 0.461 ' CD1' ' HD3' ' A' ' 740' ' ' PRO . 14.9 t80 -98.81 -115.64 0.15 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.44 -0.787 . . . . 0.0 109.62 179.954 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 739' ' ' HIS . . . . . 0.459 ' C ' ' O ' ' A' ' 738' ' ' TYR . 0.5 OUTLIER 37.85 54.23 3.72 Favored Pre-proline 0 N--CA 1.498 1.945 0 O-C-N 121.129 -0.982 . . . . 0.0 110.921 -179.994 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 740' ' ' PRO . . . . . 0.461 ' HD3' ' CD1' ' A' ' 738' ' ' TYR . 42.9 Cg_endo -70.8 -19.84 30.67 Favored 'Trans proline' 0 C--N 1.306 -1.675 0 O-C-N 123.858 1.452 . . . . 0.0 109.41 179.904 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 741' ' ' ASN . . . . . 0.481 ' O ' ' O ' ' A' ' 742' ' ' ILE . 10.1 m-20 -164.06 -73.69 0.04 OUTLIER 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 109.176 -0.675 . . . . 0.0 109.176 179.877 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 742' ' ' ILE . . . . . 0.481 ' O ' ' O ' ' A' ' 741' ' ' ASN . 31.9 mm 50.08 109.9 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 O-C-N 121.541 -0.724 . . . . 0.0 111.221 179.897 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 743' ' ' LYS . . . . . 0.441 ' HD3' ' O ' ' A' ' 742' ' ' ILE . 0.0 OUTLIER -176.51 -36.71 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.221 -0.925 . . . . 0.0 109.672 179.993 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 744' ' ' ASN . . . . . 0.433 ' O ' ' C ' ' A' ' 745' ' ' TRP . 55.7 t30 -117.78 26.27 9.8 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.513 -0.742 . . . . 0.0 109.487 179.896 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 745' ' ' TRP . . . . . 0.622 ' CD1' ' N ' ' A' ' 746' ' ' GLN . 44.1 p90 -40.45 -45.51 2.24 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.621 -0.675 . . . . 0.0 110.277 -179.932 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 746' ' ' GLN . . . . . 0.622 ' N ' ' CD1' ' A' ' 745' ' ' TRP . 27.8 pt20 -95.82 120.75 36.63 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.102 -0.999 . . . . 0.0 109.273 179.863 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 747' ' ' ILE . . . . . 0.613 ' HB ' ' CZ ' ' A' ' 750' ' ' TYR . 13.1 mt -86.1 75.75 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.614 0 O-C-N 121.214 -0.929 . . . . 0.0 110.642 -179.914 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 748' ' ' GLU . . . . . 0.566 ' CB ' ' O ' ' A' ' 747' ' ' ILE . 1.1 tt0 79.91 -47.01 0.33 Allowed 'General case' 0 N--CA 1.505 2.29 0 O-C-N 121.908 -0.495 . . . . 0.0 111.97 179.879 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 749' ' ' SER . . . . . . . . . . . . . 73.6 m -152.56 -22.98 0.17 Allowed 'General case' 0 N--CA 1.5 2.03 0 O-C-N 120.431 -1.418 . . . . 0.0 112.747 -179.919 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 750' ' ' TYR . . . . . 0.613 ' CZ ' ' HB ' ' A' ' 747' ' ' ILE . 45.8 p90 -110.58 134.89 52.0 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 120.367 -1.458 . . . . 0.0 111.471 -179.898 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 751' ' ' GLY . . . . . . . . . . . . . . . 152.65 104.38 0.26 Allowed Glycine 0 N--CA 1.495 2.624 0 N-CA-C 108.84 -1.704 . . . . 0.0 108.84 -179.948 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 752' ' ' GLU . . . . . 0.461 ' O ' ' HG2' ' A' ' 752' ' ' GLU . 45.1 tt0 -123.44 77.25 54.28 Favored Pre-proline 0 N--CA 1.498 1.971 0 O-C-N 121.084 -1.245 . . . . 0.0 111.147 -179.909 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 753' ' ' PRO . . . . . 0.511 ' HG3' ' HB2' ' A' ' 745' ' ' TRP . 49.2 Cg_endo -89.94 122.53 1.06 Allowed 'Trans proline' 0 C--N 1.302 -1.879 0 O-C-N 123.813 1.428 . . . . 0.0 110.307 179.972 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 754' ' ' GLU . . . . . . . . . . . . . 6.1 tt0 -95.67 5.84 50.43 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.189 -0.944 . . . . 0.0 110.074 179.969 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 755' ' ' PHE . . . . . . . . . . . . . 11.4 t80 -118.12 109.53 16.53 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.355 -0.841 . . . . 0.0 109.92 179.956 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 756' ' ' HIS . . . . . 0.404 ' O ' HG23 ' A' ' 757' ' ' THR . 29.8 m170 -118.07 -13.71 9.97 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.189 -0.944 . . . . 0.0 110.423 -179.977 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 757' ' ' THR . . . . . 0.404 HG23 ' O ' ' A' ' 756' ' ' HIS . 3.7 p -150.11 161.55 42.15 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.181 -0.95 . . . . 0.0 110.391 -179.989 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 758' ' ' ALA . . . . . . . . . . . . . . . -87.62 169.92 11.73 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.329 -0.857 . . . . 0.0 109.979 179.981 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 759' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.46 155.69 47.42 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.1 -1.0 . . . . 0.0 110.584 -179.983 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 760' ' ' VAL . . . . . . . . . . . . . 47.3 t -109.54 139.14 33.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.42 -0.8 . . . . 0.0 109.523 179.939 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 761' ' ' HIS . . . . . . . . . . . . . 1.7 m170 -114.3 111.27 21.23 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.142 -0.973 . . . . 0.0 111.083 -179.978 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 762' ' ' LEU . . . . . . . . . . . . . 1.8 mt -129.6 117.45 20.42 Favored 'General case' 0 N--CA 1.493 1.69 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 -179.99 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 763' ' ' LYS . . . . . 0.428 ' N ' ' CD ' ' A' ' 763' ' ' LYS . 0.0 OUTLIER -142.56 166.44 24.65 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.009 -1.057 . . . . 0.0 111.324 -179.912 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 764' ' ' CYS . . . . . 0.407 ' O ' ' C ' ' A' ' 765' ' ' ALA . 1.4 m -141.37 140.74 33.77 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.677 -0.639 . . . . 0.0 109.458 179.943 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 765' ' ' ALA . . . . . 0.407 ' C ' ' O ' ' A' ' 764' ' ' CYS . . . -44.49 160.98 0.23 Allowed Pre-proline 0 N--CA 1.495 1.806 0 O-C-N 121.109 -0.994 . . . . 0.0 110.341 -179.986 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 766' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -71.34 103.39 1.4 Allowed 'Trans proline' 0 C--N 1.309 -1.5 0 O-C-N 124.004 1.528 . . . . 0.0 110.079 180.0 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 767' ' ' GLY . . . . . . . . . . . . . . . 143.61 -29.21 2.01 Favored Glycine 0 N--CA 1.488 2.118 0 N-CA-C 108.864 -1.694 . . . . 0.0 108.864 179.971 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 768' ' ' GLN . . . . . . . . . . . . . 1.5 mt-30 -113.59 115.26 27.65 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.311 -1.111 . . . . 0.0 109.599 179.975 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 769' ' ' THR . . . . . . . . . . . . . 67.2 p -99.75 145.94 27.11 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.187 -0.946 . . . . 0.0 110.576 -179.937 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 770' ' ' ILE . . . . . . . . . . . . . 35.8 mt -60.6 113.45 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 O-C-N 121.32 -0.863 . . . . 0.0 109.197 179.983 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 771' ' ' SER . . . . . 0.471 ' O ' ' HB2' ' A' ' 772' ' ' ALA . 39.2 t -91.61 -7.58 49.69 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.231 -0.918 . . . . 0.0 111.485 -179.835 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 772' ' ' ALA . . . . . 0.471 ' HB2' ' O ' ' A' ' 771' ' ' SER . . . 179.75 146.14 0.21 Allowed 'General case' 0 N--CA 1.496 1.839 0 O-C-N 120.765 -1.209 . . . . 0.0 111.475 -179.924 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 773' ' ' ILE . . . . . . . . . . . . . 31.9 mm -87.93 135.4 25.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.495 -0.753 . . . . 0.0 109.135 179.892 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 774' ' ' LYS . . . . . 0.562 ' HB3' ' CB ' ' A' ' 836' ' ' GLU . 0.4 OUTLIER -78.14 -35.53 48.88 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.119 -0.988 . . . . 0.0 110.768 -179.897 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 775' ' ' PHE . . . . . 0.517 ' CZ ' ' HB3' ' A' ' 777' ' ' SER . 44.9 t80 176.16 150.86 0.14 Allowed 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.173 -0.955 . . . . 0.0 110.897 -179.988 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 776' ' ' ALA . . . . . 0.457 ' O ' ' HB3' ' A' ' 798' ' ' SER . . . -143.65 145.78 32.73 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.472 -0.767 . . . . 0.0 108.959 179.872 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 777' ' ' SER . . . . . 0.517 ' HB3' ' CZ ' ' A' ' 775' ' ' PHE . 67.6 p -154.09 119.03 4.99 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.877 -1.14 . . . . 0.0 111.575 -179.949 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 778' ' ' PHE . . . . . 0.478 ' CZ ' ' HG2' ' A' ' 830' ' ' MET . 40.8 t80 -105.39 120.15 40.87 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.466 -0.771 . . . . 0.0 109.496 179.918 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 779' ' ' GLY . . . . . 0.528 ' HA2' ' HA ' ' A' ' 830' ' ' MET . . . 133.49 -100.0 0.38 Allowed Glycine 0 N--CA 1.487 2.075 0 C-N-CA 119.604 -1.284 . . . . 0.0 109.912 179.991 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 780' ' ' THR . . . . . . . . . . . . . 43.5 p -136.62 93.92 13.75 Favored Pre-proline 0 N--CA 1.495 1.781 0 O-C-N 121.133 -1.216 . . . . 0.0 110.593 -179.924 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 781' ' ' PRO . . . . . 0.485 ' CD ' ' HB3' ' A' ' 832' ' ' ARG . 51.6 Cg_endo -81.77 157.91 18.63 Favored 'Trans proline' 0 C--N 1.307 -1.643 0 O-C-N 124.004 1.528 . . . . 0.0 110.605 179.921 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 782' ' ' LEU . . . . . 0.419 HD12 ' HA2' ' A' ' 791' ' ' GLY . 0.8 OUTLIER -112.78 133.89 54.56 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.278 -0.889 . . . . 0.0 110.081 179.989 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 783' ' ' GLY . . . . . . . . . . . . . . . 84.03 -170.37 47.34 Favored Glycine 0 N--CA 1.493 2.487 0 N-CA-C 109.784 -1.326 . . . . 0.0 109.784 179.987 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 784' ' ' THR . . . . . 0.435 ' O ' ' CE1' ' A' ' 788' ' ' PHE . 44.0 p -127.68 -141.82 0.27 Allowed 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.264 -1.139 . . . . 0.0 110.529 -179.99 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 785' ' ' CYS . . . . . 0.406 ' HA ' ' CE1' ' A' ' 788' ' ' PHE . 38.4 m -78.52 100.56 6.95 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.278 -0.889 . . . . 0.0 110.379 -179.942 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 786' ' ' GLY . . . . . . . . . . . . . . . 140.46 -13.52 2.98 Favored Glycine 0 N--CA 1.493 2.452 0 N-CA-C 110.012 -1.235 . . . . 0.0 110.012 -179.988 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 787' ' ' THR . . . . . . . . . . . . . 9.0 t -159.52 36.62 0.19 Allowed 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.036 -1.273 . . . . 0.0 110.809 -179.978 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 788' ' ' PHE . . . . . 0.459 ' O ' ' HB2' ' A' ' 789' ' ' GLN . 14.4 m-85 -61.29 158.66 13.8 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.07 -1.019 . . . . 0.0 109.909 179.972 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 789' ' ' GLN . . . . . 0.459 ' HB2' ' O ' ' A' ' 788' ' ' PHE . 24.4 tt0 179.25 157.46 0.56 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.175 -0.953 . . . . 0.0 110.218 -179.994 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 790' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -52.17 137.81 27.26 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.252 -0.905 . . . . 0.0 110.362 -179.999 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 791' ' ' GLY . . . . . 0.419 ' HA2' HD12 ' A' ' 782' ' ' LEU . . . -111.75 -107.9 2.97 Favored Glycine 0 N--CA 1.493 2.466 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 -179.986 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 792' ' ' GLU . . . . . . . . . . . . . 39.1 tp10 -90.49 -53.02 4.61 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.194 -1.18 . . . . 0.0 110.277 179.944 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 793' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -136.08 117.69 14.91 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.263 -0.898 . . . . 0.0 110.081 179.983 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 794' ' ' HIS . . . . . . . . . . . . . 40.5 t60 -120.2 150.51 40.54 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.252 -0.905 . . . . 0.0 110.381 -179.975 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 795' ' ' SER . . . . . 0.463 ' OG ' ' HG3' ' A' ' 825' ' ' PRO . 2.6 m -94.94 117.44 30.15 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.425 -0.797 . . . . 0.0 109.483 179.896 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 796' ' ' ILE . . . . . . . . . . . . . 6.7 mt -58.3 -13.57 3.08 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.875 0 O-C-N 121.158 -0.964 . . . . 0.0 110.775 -179.947 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 797' ' ' ASN . . . . . 0.405 ' O ' ' OG ' ' A' ' 800' ' ' SER . 3.6 m-20 -89.96 21.48 3.63 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.062 -1.024 . . . . 0.0 110.414 179.906 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 798' ' ' SER . . . . . 0.498 ' OG ' ' HA ' ' A' ' 777' ' ' SER . 0.5 OUTLIER -70.0 -33.72 72.4 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.176 -0.953 . . . . 0.0 110.806 -179.995 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 799' ' ' ASN . . . . . . . . . . . . . 7.5 m-20 -97.94 6.21 47.99 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.26 -0.9 . . . . 0.0 111.024 -179.856 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 800' ' ' SER . . . . . 0.405 ' OG ' ' O ' ' A' ' 797' ' ' ASN . 6.1 p -90.69 -29.41 17.72 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.97 -1.081 . . . . 0.0 110.396 -179.979 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 801' ' ' VAL . . . . . . . . . . . . . 15.6 t -88.03 -19.66 7.69 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.293 -0.879 . . . . 0.0 110.588 179.957 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 802' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -90.64 -48.44 7.06 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.107 -0.996 . . . . 0.0 110.572 -179.896 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 803' ' ' GLU . . . . . . . . . . . . . 20.8 mt-10 -58.61 -26.78 64.05 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.185 -0.947 . . . . 0.0 110.987 -179.895 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 804' ' ' ARG . . . . . . . . . . . . . 16.7 ttt-85 -86.63 -28.3 23.29 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 120.988 -1.07 . . . . 0.0 110.849 -179.892 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 805' ' ' LYS . . . . . 0.434 ' O ' ' SG ' ' A' ' 812' ' ' CYS . 2.1 mttm -122.28 31.81 6.02 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.055 -1.028 . . . . 0.0 110.615 179.985 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 806' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -162.2 41.44 0.13 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.151 -0.968 . . . . 0.0 110.4 -179.969 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 807' ' ' ILE . . . . . 0.407 ' O ' ' CG2' ' A' ' 807' ' ' ILE . 9.8 mm -140.59 84.23 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.248 -0.908 . . . . 0.0 110.428 -179.994 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 808' ' ' GLY . . . . . 0.438 ' C ' ' HG ' ' A' ' 809' ' ' LEU . . . 117.84 32.41 1.43 Allowed Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.751 -1.34 . . . . 0.0 109.751 -179.998 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 809' ' ' LEU . . . . . 0.438 ' HG ' ' C ' ' A' ' 808' ' ' GLY . 14.9 mt -137.61 138.12 39.2 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.195 -1.179 . . . . 0.0 110.318 -179.96 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 810' ' ' GLU . . . . . . . . . . . . . 11.5 mp0 -61.01 -33.09 72.72 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.058 -1.026 . . . . 0.0 108.684 179.937 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 811' ' ' ARG . . . . . . . . . . . . . 18.1 ttm180 -125.69 167.69 14.78 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 179.835 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 812' ' ' CYS . . . . . 0.434 ' SG ' ' O ' ' A' ' 805' ' ' LYS . 9.3 t -166.04 116.27 1.0 Allowed 'General case' 0 C--N 1.3 -1.569 0 O-C-N 120.803 -1.185 . . . . 0.0 111.046 -179.903 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 813' ' ' VAL . . . . . . . . . . . . . 75.2 t -117.63 138.45 48.27 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.472 -0.768 . . . . 0.0 109.384 179.951 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 814' ' ' VAL . . . . . . . . . . . . . 4.4 t -125.56 158.04 34.49 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.077 -1.015 . . . . 0.0 110.561 -179.917 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 815' ' ' ALA . . . . . . . . . . . . . . . -117.65 135.01 54.29 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.26 -0.9 . . . . 0.0 110.117 -179.983 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 816' ' ' ILE . . . . . 0.42 HD12 HG22 ' A' ' 833' ' ' VAL . 9.7 mt -107.52 137.22 39.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.263 -0.898 . . . . 0.0 110.276 -179.946 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 817' ' ' SER . . . . . 0.495 ' CB ' ' HD2' ' A' ' 818' ' ' PRO . 0.0 OUTLIER -161.85 -179.81 1.13 Allowed Pre-proline 0 N--CA 1.495 1.781 0 O-C-N 121.232 -0.917 . . . . 0.0 110.031 179.985 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 818' ' ' PRO . . . . . 0.495 ' HD2' ' CB ' ' A' ' 817' ' ' SER . 48.0 Cg_endo -75.45 -38.27 1.48 Allowed 'Trans proline' 0 C--N 1.305 -1.724 0 O-C-N 124.055 1.555 . . . . 0.0 110.525 -179.975 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 819' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -116.51 47.36 1.45 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.23 -0.919 . . . . 0.0 110.296 -179.909 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 820' ' ' ASN . . . . . . . . . . . . . 2.0 m120 -129.71 0.78 4.91 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.178 -0.951 . . . . 0.0 110.206 179.97 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 821' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -125.32 -39.19 2.22 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.269 -0.894 . . . . 0.0 110.258 -179.941 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 822' ' ' GLY . . . . . . . . . . . . . . . -164.52 -52.37 0.02 OUTLIER Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.684 -1.367 . . . . 0.0 109.684 -179.997 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 823' ' ' GLY . . . . . . . . . . . . . . . 158.51 -68.54 0.27 Allowed Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.717 -1.353 . . . . 0.0 109.717 -179.934 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 824' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -171.22 88.91 0.46 Allowed Pre-proline 0 N--CA 1.493 1.684 0 O-C-N 121.262 -1.14 . . . . 0.0 110.431 -179.994 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 825' ' ' PRO . . . . . 0.463 ' HG3' ' OG ' ' A' ' 795' ' ' SER . 44.8 Cg_endo -75.08 -62.79 0.03 OUTLIER 'Trans proline' 0 C--N 1.304 -1.806 0 O-C-N 123.947 1.498 . . . . 0.0 110.317 179.971 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 826' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -116.93 118.92 35.83 Favored Pre-proline 0 N--CA 1.493 1.688 0 O-C-N 121.305 -0.872 . . . . 0.0 109.632 -179.996 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 827' ' ' PRO . . . . . 0.424 ' O ' ' HB2' ' A' ' 828' ' ' GLU . 48.2 Cg_endo -75.24 141.01 25.45 Favored 'Trans proline' 0 C--N 1.308 -1.58 0 O-C-N 123.885 1.466 . . . . 0.0 110.866 -179.887 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 828' ' ' GLU . . . . . 0.424 ' HB2' ' O ' ' A' ' 827' ' ' PRO . 0.6 OUTLIER 58.41 14.16 2.81 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.486 -0.759 . . . . 0.0 110.508 179.99 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 829' ' ' VAL . . . . . . . . . . . . . 54.0 t -137.59 82.03 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.165 -0.96 . . . . 0.0 110.217 -179.959 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 830' ' ' MET . . . . . 0.528 ' HA ' ' HA2' ' A' ' 779' ' ' GLY . 0.2 OUTLIER -176.26 107.65 0.08 Allowed 'General case' 0 N--CA 1.487 1.398 0 O-C-N 120.929 -1.107 . . . . 0.0 111.348 179.991 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 831' ' ' LYS . . . . . 0.488 ' HA ' ' CB ' ' A' ' 737' ' ' GLU . 20.6 ttpp -170.93 53.1 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.235 -0.915 . . . . 0.0 110.736 179.95 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 832' ' ' ARG . . . . . 0.485 ' HB3' ' CD ' ' A' ' 781' ' ' PRO . 1.7 mtt180 -172.97 107.16 0.16 Allowed 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.274 -0.891 . . . . 0.0 109.846 179.957 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 833' ' ' VAL . . . . . 0.42 HG22 HD12 ' A' ' 816' ' ' ILE . 3.8 t -107.35 109.25 27.5 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 O-C-N 121.111 -0.993 . . . . 0.0 110.836 -179.96 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 834' ' ' ALA . . . . . . . . . . . . . . . -109.62 136.47 48.94 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.371 -0.831 . . . . 0.0 109.34 179.934 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 835' ' ' VAL . . . . . . . . . . . . . 38.1 t -147.05 156.94 10.51 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.069 -1.02 . . . . 0.0 110.946 -179.95 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 836' ' ' GLU . . . . . 0.562 ' CB ' ' HB3' ' A' ' 774' ' ' LYS . 1.7 mp0 -135.2 158.89 43.21 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 179.845 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 837' ' ' ALA . . . . . . . . . . . . . . . -138.44 154.59 48.86 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 120.802 -1.186 . . . . 0.0 111.54 -179.772 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 838' ' ' VAL . . . . . . . . . . . . . 21.3 t -121.85 109.57 24.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.692 -0.63 . . . . 0.0 109.376 179.88 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 839' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -108.1 129.42 55.15 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.115 -0.991 . . . . 0.0 110.522 -179.96 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 840' ' ' SER . . . . . . . . . . . . . 54.1 p -125.53 -161.03 1.0 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.282 -0.886 . . . . 0.0 110.221 179.989 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 841' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -102.64 9.33 39.36 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.285 -0.884 . . . . 0.0 110.493 -179.985 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 842' ' ' ALA . . . . . . . . . . . . . . . -161.06 157.03 25.44 Favored 'General case' 0 C--N 1.293 -1.851 0 O-C-N 121.426 -0.796 . . . . 0.0 110.325 179.98 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 843' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.711 0 CA-C-O 118.052 -0.975 . . . . 0.0 110.235 -179.988 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 728' ' ' VAL . . . . . 0.747 ' O ' HG13 ' A' ' 728' ' ' VAL . 9.0 p . . . . . 0 N--CA 1.491 1.594 0 CA-C-O 121.256 0.551 . . . . 0.0 110.008 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 729' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -179.93 -177.96 0.41 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.264 -0.897 . . . . 0.0 110.407 -179.952 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 730' ' ' GLY . . . . . . . . . . . . . . . 172.21 113.73 0.31 Allowed Glycine 0 N--CA 1.492 2.373 0 N-CA-C 109.074 -1.61 . . . . 0.0 109.074 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 731' ' ' VAL . . . . . . . . . . . . . 31.3 m -130.02 148.41 33.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.227 -1.161 . . . . 0.0 110.872 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 732' ' ' CYS . . . . . 0.42 ' O ' ' SG ' ' A' ' 732' ' ' CYS . 16.5 p -142.18 133.89 26.95 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.521 -0.737 . . . . 0.0 109.272 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 733' ' ' ALA . . . . . 0.522 ' HB2' HD21 ' A' ' 762' ' ' LEU . . . -111.69 132.32 54.7 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.049 -1.032 . . . . 0.0 110.746 -179.911 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 734' ' ' ASP . . . . . 0.442 ' CG ' ' O ' ' A' ' 734' ' ' ASP . 8.6 p-10 -116.54 116.34 27.44 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.295 -0.878 . . . . 0.0 109.777 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 735' ' ' VAL . . . . . . . . . . . . . 5.7 t -139.62 166.9 20.36 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.154 -0.966 . . . . 0.0 110.187 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 736' ' ' SER . . . . . 0.448 ' O ' ' C ' ' A' ' 737' ' ' GLU . 1.2 m -135.78 136.27 40.58 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.265 -0.897 . . . . 0.0 109.937 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 737' ' ' GLU . . . . . 0.535 ' HB2' ' HB3' ' A' ' 831' ' ' LYS . 1.2 tm-20 . . . . . 0 N--CA 1.492 1.64 0 O-C-N 121.32 -0.863 . . . . 0.0 109.86 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 757' ' ' THR . . . . . 0.539 HG21 ' O ' ' A' ' 816' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.575 0 CA-C-O 121.141 0.496 . . . . 0.0 109.853 . . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 758' ' ' ALA . . . . . . . . . . . . . . . -88.69 153.26 21.25 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.113 -0.992 . . . . 0.0 109.938 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 759' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -113.28 161.07 17.66 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.187 -0.946 . . . . 0.0 110.365 -179.942 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 760' ' ' VAL . . . . . . . . . . . . . 42.2 t -107.76 133.73 51.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.359 -0.838 . . . . 0.0 109.328 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 761' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -109.97 115.67 30.2 Favored 'General case' 0 C--N 1.302 -1.5 0 O-C-N 121.133 -0.98 . . . . 0.0 111.043 -179.925 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 762' ' ' LEU . . . . . 0.522 HD21 ' HB2' ' A' ' 733' ' ' ALA . 93.1 mt -132.36 138.78 47.87 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.543 -0.723 . . . . 0.0 109.119 179.842 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 763' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -167.7 136.72 2.57 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.834 -1.166 . . . . 0.0 110.891 -179.893 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 764' ' ' CYS . . . . . . . . . . . . . 92.7 m -106.59 172.77 6.64 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.427 -0.796 . . . . 0.0 109.849 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 765' ' ' ALA . . . . . 0.724 ' HB3' ' OE1' ' A' ' 768' ' ' GLN . . . -67.89 166.27 24.82 Favored Pre-proline 0 N--CA 1.495 1.795 0 O-C-N 121.156 -0.965 . . . . 0.0 110.277 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 766' ' ' PRO . . . . . 0.543 ' HD2' ' HB1' ' A' ' 765' ' ' ALA . 45.6 Cg_endo -72.84 107.11 2.26 Favored 'Trans proline' 0 C--N 1.307 -1.61 0 O-C-N 123.964 1.507 . . . . 0.0 110.026 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 767' ' ' GLY . . . . . . . . . . . . . . . 132.86 -3.42 4.94 Favored Glycine 0 N--CA 1.489 2.174 0 N-CA-C 109.334 -1.506 . . . . 0.0 109.334 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 768' ' ' GLN . . . . . 0.724 ' OE1' ' HB3' ' A' ' 765' ' ' ALA . 44.5 mt-30 -124.52 152.99 42.74 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.183 -1.187 . . . . 0.0 109.968 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 769' ' ' THR . . . . . . . . . . . . . 62.2 p -134.74 147.09 49.96 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.139 -0.975 . . . . 0.0 110.598 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 770' ' ' ILE . . . . . . . . . . . . . 59.1 mt -73.33 139.75 18.95 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.394 -0.816 . . . . 0.0 109.453 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 771' ' ' SER . . . . . . . . . . . . . 2.3 t -134.97 -8.17 2.35 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.974 -1.079 . . . . 0.0 111.422 -179.888 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 772' ' ' ALA . . . . . . . . . . . . . . . -162.96 155.97 19.32 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 120.684 -1.26 . . . . 0.0 111.734 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 773' ' ' ILE . . . . . . . . . . . . . 19.9 mm -110.69 125.65 68.0 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.687 -0.633 . . . . 0.0 109.48 179.861 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 774' ' ' LYS . . . . . 0.569 ' HG2' ' CG2' ' A' ' 838' ' ' VAL . 3.2 mmmp? -80.71 -33.47 35.28 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.078 -1.013 . . . . 0.0 110.928 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 775' ' ' PHE . . . . . . . . . . . . . 88.7 t80 -160.46 154.73 23.32 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.022 -1.049 . . . . 0.0 110.282 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 776' ' ' ALA . . . . . 0.456 ' O ' ' HB2' ' A' ' 798' ' ' SER . . . -169.21 113.55 0.55 Allowed 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.41 -0.806 . . . . 0.0 109.47 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 777' ' ' SER . . . . . 0.589 ' HA ' ' CB ' ' A' ' 798' ' ' SER . 0.6 OUTLIER -140.68 137.35 33.47 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.04 -1.038 . . . . 0.0 111.327 179.977 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 778' ' ' PHE . . . . . 0.545 ' CG ' ' O ' ' A' ' 778' ' ' PHE . 24.0 t80 -116.19 72.98 0.83 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.497 -0.752 . . . . 0.0 109.344 179.869 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 779' ' ' GLY . . . . . . . . . . . . . . . -164.46 -102.63 0.17 Allowed Glycine 0 N--CA 1.495 2.601 0 N-CA-C 109.696 -1.362 . . . . 0.0 109.696 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 780' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -133.15 77.0 68.31 Favored Pre-proline 0 N--CA 1.495 1.789 0 O-C-N 120.74 -1.447 . . . . 0.0 110.369 179.929 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 781' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -80.37 138.95 12.72 Favored 'Trans proline' 0 C--N 1.304 -1.78 0 O-C-N 124.162 1.612 . . . . 0.0 110.442 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 782' ' ' LEU . . . . . 0.564 HD12 ' HA2' ' A' ' 791' ' ' GLY . 1.3 mt -103.62 168.89 8.86 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.308 -0.87 . . . . 0.0 109.914 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 783' ' ' GLY . . . . . . . . . . . . . . . 91.16 -154.17 22.74 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.628 -1.389 . . . . 0.0 109.628 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 784' ' ' THR . . . . . . . . . . . . . 7.8 t -154.59 179.54 8.95 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.334 -1.098 . . . . 0.0 110.231 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 785' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -52.99 108.33 0.31 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.274 -0.892 . . . . 0.0 110.323 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 786' ' ' GLY . . . . . . . . . . . . . . . 143.89 -36.97 1.47 Allowed Glycine 0 N--CA 1.488 2.125 0 N-CA-C 109.724 -1.35 . . . . 0.0 109.724 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 787' ' ' THR . . . . . 0.508 HG22 ' O ' ' A' ' 787' ' ' THR . 30.8 m -157.81 47.27 0.38 Allowed 'General case' 0 C--N 1.306 -1.302 0 O-C-N 121.253 -1.145 . . . . 0.0 110.497 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 788' ' ' PHE . . . . . 0.423 ' O ' ' O ' ' A' ' 787' ' ' THR . 10.8 m-85 -46.02 170.89 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.154 -0.966 . . . . 0.0 110.201 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 789' ' ' GLN . . . . . . . . . . . . . 24.0 tt0 -166.56 142.9 4.73 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.278 -0.889 . . . . 0.0 110.034 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 790' ' ' GLN . . . . . . . . . . . . . 19.3 pt20 -56.84 152.47 12.56 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 120.975 -1.078 . . . . 0.0 110.329 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 791' ' ' GLY . . . . . 0.564 ' HA2' HD12 ' A' ' 782' ' ' LEU . . . -109.44 -86.33 1.75 Allowed Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.544 -1.422 . . . . 0.0 109.544 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 792' ' ' GLU . . . . . 0.403 ' HG2' ' C ' ' A' ' 791' ' ' GLY . 68.4 mm-40 -142.64 -37.97 0.37 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.207 -1.172 . . . . 0.0 110.169 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 793' ' ' CYS . . . . . . . . . . . . . 1.3 m -107.14 131.78 53.75 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.262 -0.898 . . . . 0.0 110.331 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 794' ' ' HIS . . . . . 0.628 ' CE1' ' HA ' ' A' ' 796' ' ' ILE . 8.7 t-160 -145.48 144.29 30.5 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.175 -0.953 . . . . 0.0 110.079 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 795' ' ' SER . . . . . 0.47 ' N ' ' CD2' ' A' ' 794' ' ' HIS . 1.1 m -83.01 8.8 11.72 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.231 -0.918 . . . . 0.0 110.604 -179.91 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 796' ' ' ILE . . . . . 0.764 HG22 ' O ' ' A' ' 796' ' ' ILE . 90.4 mt 42.41 26.67 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 O-C-N 121.242 -0.911 . . . . 0.0 110.269 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 797' ' ' ASN . . . . . 0.437 ' OD1' ' O ' ' A' ' 796' ' ' ILE . 5.5 m120 -152.49 22.66 0.62 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.204 -0.935 . . . . 0.0 109.797 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 798' ' ' SER . . . . . 0.589 ' CB ' ' HA ' ' A' ' 777' ' ' SER . 13.2 m -84.62 2.59 40.85 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.435 -0.791 . . . . 0.0 110.452 -179.901 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 799' ' ' ASN . . . . . . . . . . . . . 6.9 t-20 -115.41 -14.84 11.58 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.196 -0.94 . . . . 0.0 110.908 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 800' ' ' SER . . . . . . . . . . . . . 16.4 m -82.09 -18.87 41.55 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 120.903 -1.123 . . . . 0.0 109.881 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 801' ' ' VAL . . . . . 0.435 ' O ' ' HD2' ' A' ' 805' ' ' LYS . 45.0 t -86.44 -21.41 7.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.464 -0.772 . . . . 0.0 110.117 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 802' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -79.42 -57.39 3.72 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.137 -0.977 . . . . 0.0 110.313 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 803' ' ' GLU . . . . . 0.879 ' HG2' HD12 ' A' ' 807' ' ' ILE . 0.4 OUTLIER -53.82 -22.71 10.22 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.295 -0.878 . . . . 0.0 110.339 179.942 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 804' ' ' ARG . . . . . . . . . . . . . 1.9 mtm180 -91.08 -23.92 20.18 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.188 -0.945 . . . . 0.0 110.998 -180.0 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 805' ' ' LYS . . . . . 0.435 ' HD2' ' O ' ' A' ' 801' ' ' VAL . 9.6 mttt -127.06 49.83 2.04 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.07 -1.019 . . . . 0.0 111.034 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 806' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -163.23 -71.51 0.04 OUTLIER 'General case' 0 N--CA 1.497 1.909 0 O-C-N 120.952 -1.092 . . . . 0.0 110.905 179.937 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 807' ' ' ILE . . . . . 0.879 HD12 ' HG2' ' A' ' 803' ' ' GLU . 90.6 mt -50.86 128.32 8.07 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 O-C-N 121.223 -0.923 . . . . 0.0 110.988 -179.918 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 808' ' ' GLY . . . . . 0.66 ' O ' HD23 ' A' ' 809' ' ' LEU . . . 103.89 10.84 33.92 Favored Glycine 0 N--CA 1.493 2.456 0 N-CA-C 110.127 -1.189 . . . . 0.0 110.127 179.912 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 809' ' ' LEU . . . . . 0.66 HD23 ' O ' ' A' ' 808' ' ' GLY . 33.1 mt -142.67 137.11 29.7 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.108 -1.231 . . . . 0.0 110.138 -179.913 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 810' ' ' GLU . . . . . 0.444 ' HG2' ' O ' ' A' ' 768' ' ' GLN . 0.7 OUTLIER -65.16 -21.92 66.85 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.224 -0.923 . . . . 0.0 109.289 179.972 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 811' ' ' ARG . . . . . 0.471 ' HG3' ' O ' ' A' ' 762' ' ' LEU . 1.1 ttp85 -128.76 151.52 49.47 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.538 -0.726 . . . . 0.0 109.747 179.866 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 812' ' ' CYS . . . . . 0.465 ' HB3' ' HB2' ' A' ' 762' ' ' LEU . 7.8 t -129.73 139.87 51.22 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.121 -0.987 . . . . 0.0 110.602 -179.944 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 813' ' ' VAL . . . . . . . . . . . . . 84.1 t -145.63 123.11 4.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.348 -0.845 . . . . 0.0 109.663 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 814' ' ' VAL . . . . . . . . . . . . . 88.7 t -133.0 129.01 57.25 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 O-C-N 121.129 -0.982 . . . . 0.0 110.73 -179.916 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 815' ' ' ALA . . . . . . . . . . . . . . . -88.75 127.8 35.61 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.339 -0.851 . . . . 0.0 109.755 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 816' ' ' ILE . . . . . 1.014 HD13 HG21 ' A' ' 833' ' ' VAL . 46.2 mt -84.3 114.01 24.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.181 -0.949 . . . . 0.0 110.436 -179.905 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 817' ' ' SER . . . . . . . . . . . . . 5.0 p -158.84 158.57 29.27 Favored Pre-proline 0 N--CA 1.495 1.777 0 O-C-N 121.356 -0.84 . . . . 0.0 109.91 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 818' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -75.29 2.65 6.54 Favored 'Trans proline' 0 C--N 1.306 -1.692 0 O-C-N 123.926 1.487 . . . . 0.0 110.772 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 819' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -111.77 7.67 20.32 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.103 -0.998 . . . . 0.0 110.253 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 820' ' ' ASN . . . . . . . . . . . . . 6.8 m-20 -121.19 -7.2 9.38 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.248 -0.907 . . . . 0.0 110.262 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 821' ' ' PHE . . . . . . . . . . . . . 4.8 m-85 -110.66 -65.96 1.12 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.261 -0.9 . . . . 0.0 110.19 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 822' ' ' GLY . . . . . . . . . . . . . . . 161.27 63.86 0.02 OUTLIER Glycine 0 N--CA 1.492 2.41 0 N-CA-C 110.006 -1.238 . . . . 0.0 110.006 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 823' ' ' GLY . . . . . . . . . . . . . . . 78.7 -150.41 34.51 Favored Glycine 0 N--CA 1.493 2.47 0 N-CA-C 110.036 -1.226 . . . . 0.0 110.036 179.907 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 824' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -109.17 141.88 24.39 Favored Pre-proline 0 N--CA 1.493 1.709 0 O-C-N 121.26 -1.141 . . . . 0.0 110.407 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 825' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -80.53 -91.2 0.0 OUTLIER 'Trans proline' 0 C--N 1.306 -1.699 0 O-C-N 124.11 1.584 . . . . 0.0 110.693 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 826' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -101.5 132.95 21.17 Favored Pre-proline 0 N--CA 1.496 1.872 0 O-C-N 121.189 -0.944 . . . . 0.0 110.372 -179.924 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 827' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -82.52 157.51 16.63 Favored 'Trans proline' 0 C--N 1.309 -1.525 0 O-C-N 123.958 1.504 . . . . 0.0 110.629 180.0 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 828' ' ' GLU . . . . . 0.452 ' O ' ' OE1' ' A' ' 828' ' ' GLU . 7.2 tm-20 54.47 39.13 30.83 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.243 -0.91 . . . . 0.0 110.622 179.906 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 829' ' ' VAL . . . . . 0.413 ' O ' ' C ' ' A' ' 830' ' ' MET . 20.2 t -142.81 118.3 4.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.071 -1.018 . . . . 0.0 110.369 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 830' ' ' MET . . . . . 0.413 ' C ' ' O ' ' A' ' 829' ' ' VAL . 4.7 mtt -42.71 158.32 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.246 -0.909 . . . . 0.0 109.878 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 831' ' ' LYS . . . . . 0.535 ' HB3' ' HB2' ' A' ' 737' ' ' GLU . 4.9 mtmt -115.04 110.57 19.77 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.118 -0.989 . . . . 0.0 110.877 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 832' ' ' ARG . . . . . . . . . . . . . 10.6 mtm-85 -116.38 135.31 53.97 Favored 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 179.927 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 833' ' ' VAL . . . . . 1.014 HG21 HD13 ' A' ' 816' ' ' ILE . 7.7 t -111.5 130.09 65.68 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.631 0 O-C-N 120.986 -1.071 . . . . 0.0 111.334 -179.94 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 834' ' ' ALA . . . . . . . . . . . . . . . -134.81 129.43 34.52 Favored 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 835' ' ' VAL . . . . . 0.403 ' CG1' ' N ' ' A' ' 836' ' ' GLU . 18.3 t -137.95 160.82 33.13 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 O-C-N 120.932 -1.105 . . . . 0.0 111.334 -179.869 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 836' ' ' GLU . . . . . 0.403 ' N ' ' CG1' ' A' ' 835' ' ' VAL . 0.0 OUTLIER -148.39 121.41 8.83 Favored 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 179.988 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 837' ' ' ALA . . . . . . . . . . . . . . . -109.55 155.32 21.54 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.006 -1.059 . . . . 0.0 111.016 -179.893 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 838' ' ' VAL . . . . . 0.569 ' CG2' ' HG2' ' A' ' 774' ' ' LYS . 6.0 t -111.97 114.59 47.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.422 -0.799 . . . . 0.0 109.804 179.926 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 839' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -109.42 136.76 48.31 Favored 'General case' 0 C--N 1.299 -1.611 0 O-C-N 121.128 -0.982 . . . . 0.0 110.245 -179.881 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 840' ' ' SER . . . . . 0.718 ' O ' HG23 ' A' ' 841' ' ' THR . 0.4 OUTLIER -136.43 -82.02 0.38 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.284 -0.885 . . . . 0.0 109.942 179.955 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 841' ' ' THR . . . . . 0.718 HG23 ' O ' ' A' ' 840' ' ' SER . 13.5 p . . . . . 0 N--CA 1.492 1.672 0 O-C-N 121.294 -0.878 . . . . 0.0 110.006 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 728' ' ' VAL . . . . . 0.456 ' O ' ' O ' ' A' ' 839' ' ' CYS . 3.4 p . . . . . 0 N--CA 1.492 1.652 0 CA-C-O 121.199 0.523 . . . . 0.0 110.354 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 729' ' ' SER . . . . . . . . . . . . . 75.3 p -55.01 178.58 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.243 -0.911 . . . . 0.0 110.3 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 730' ' ' GLY . . . . . 0.447 ' HA2' ' HB2' ' A' ' 839' ' ' CYS . . . -113.7 -139.11 7.15 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.658 -1.377 . . . . 0.0 109.658 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 731' ' ' VAL . . . . . . . . . . . . . 30.0 t -128.44 155.5 40.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.288 -1.125 . . . . 0.0 110.254 -179.89 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 732' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -108.22 145.92 33.56 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.361 -0.837 . . . . 0.0 109.431 179.892 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 733' ' ' ALA . . . . . . . . . . . . . . . -147.11 128.56 14.96 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.021 -1.049 . . . . 0.0 110.781 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 734' ' ' ASP . . . . . 0.459 ' OD1' ' O ' ' A' ' 734' ' ' ASP . 1.5 p30 -131.72 109.23 10.02 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.454 -0.779 . . . . 0.0 109.673 179.93 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 735' ' ' VAL . . . . . 0.972 HG21 HG22 ' A' ' 760' ' ' VAL . 7.0 m -129.58 157.13 42.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.115 -0.991 . . . . 0.0 110.586 -179.916 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 736' ' ' SER . . . . . 0.427 ' O ' ' C ' ' A' ' 737' ' ' GLU . 70.9 m -119.43 140.15 50.89 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.436 -0.79 . . . . 0.0 109.714 179.918 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 737' ' ' GLU . . . . . 0.427 ' C ' ' O ' ' A' ' 736' ' ' SER . 11.2 tp10 . . . . . 0 N--CA 1.491 1.605 0 O-C-N 121.215 -0.928 . . . . 0.0 109.979 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 757' ' ' THR . . . . . . . . . . . . . 20.6 p . . . . . 0 N--CA 1.492 1.663 0 CA-C-O 121.364 0.602 . . . . 0.0 110.421 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 758' ' ' ALA . . . . . . . . . . . . . . . -107.92 178.96 4.36 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.328 -0.857 . . . . 0.0 110.141 180.0 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 759' ' ' LYS . . . . . . . . . . . . . 29.7 mttm -140.42 138.82 35.03 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.224 -0.923 . . . . 0.0 110.592 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 760' ' ' VAL . . . . . 0.972 HG22 HG21 ' A' ' 735' ' ' VAL . 41.9 t -115.67 108.71 25.96 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 O-C-N 121.427 -0.796 . . . . 0.0 109.552 179.927 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 761' ' ' HIS . . . . . 0.503 ' CB ' HG22 ' A' ' 813' ' ' VAL . 42.2 p-80 -124.96 139.63 53.65 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 120.945 -1.097 . . . . 0.0 111.468 -179.82 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 762' ' ' LEU . . . . . 0.514 HD13 ' HB2' ' A' ' 837' ' ' ALA . 12.4 mt -119.33 110.87 17.48 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 109.057 -0.719 . . . . 0.0 109.057 179.892 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 763' ' ' LYS . . . . . 0.405 ' HA ' ' HA ' ' A' ' 811' ' ' ARG . 0.0 OUTLIER -110.31 133.46 53.23 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.151 -0.968 . . . . 0.0 111.001 -179.865 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 764' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -111.14 164.27 13.03 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.436 -0.79 . . . . 0.0 109.856 179.925 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 765' ' ' ALA . . . . . 0.539 ' HB3' ' OE1' ' A' ' 768' ' ' GLN . . . -56.04 164.0 2.0 Allowed Pre-proline 0 N--CA 1.493 1.68 0 O-C-N 121.118 -0.989 . . . . 0.0 110.177 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 766' ' ' PRO . . . . . 0.486 ' HD2' ' HB1' ' A' ' 765' ' ' ALA . 45.2 Cg_endo -71.71 114.2 3.88 Favored 'Trans proline' 0 C--N 1.305 -1.747 0 O-C-N 123.962 1.506 . . . . 0.0 110.394 179.984 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 767' ' ' GLY . . . . . . . . . . . . . . . 123.13 -18.48 7.88 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.436 -1.466 . . . . 0.0 109.436 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 768' ' ' GLN . . . . . 0.554 ' HG3' ' CA ' ' A' ' 841' ' ' THR . 0.5 OUTLIER -110.38 130.75 55.49 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.224 -1.162 . . . . 0.0 110.176 179.975 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 769' ' ' THR . . . . . . . . . . . . . 45.7 p -118.25 148.59 42.27 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.226 -0.921 . . . . 0.0 110.364 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 770' ' ' ILE . . . . . 0.563 HG22 HG13 ' A' ' 807' ' ' ILE . 2.6 mp -66.28 141.3 18.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.297 -0.877 . . . . 0.0 110.014 179.971 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 771' ' ' SER . . . . . . . . . . . . . 11.8 p -120.6 -15.92 8.38 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.109 -0.995 . . . . 0.0 110.565 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 772' ' ' ALA . . . . . 0.506 ' O ' HD13 ' A' ' 773' ' ' ILE . . . -169.64 171.85 7.24 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.063 -1.023 . . . . 0.0 111.029 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 773' ' ' ILE . . . . . 0.506 HD13 ' O ' ' A' ' 772' ' ' ALA . 25.8 mm -116.6 134.27 60.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.505 -0.747 . . . . 0.0 109.603 179.912 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 774' ' ' LYS . . . . . 0.515 ' HB2' ' HB3' ' A' ' 836' ' ' GLU . 0.9 OUTLIER -83.89 -34.74 24.49 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.122 -0.986 . . . . 0.0 110.718 -179.96 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 775' ' ' PHE . . . . . 0.586 ' CZ ' ' HB2' ' A' ' 777' ' ' SER . 44.7 t80 -162.31 164.1 27.67 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.091 -1.006 . . . . 0.0 110.691 -179.956 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 776' ' ' ALA . . . . . 0.671 ' HB1' ' O ' ' A' ' 798' ' ' SER . . . -176.52 121.49 0.15 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.458 -0.776 . . . . 0.0 109.922 -179.964 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 777' ' ' SER . . . . . 0.586 ' HB2' ' CZ ' ' A' ' 775' ' ' PHE . 0.2 OUTLIER -140.3 137.28 34.05 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.145 -0.972 . . . . 0.0 110.69 -179.972 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 778' ' ' PHE . . . . . 0.509 ' CG ' ' O ' ' A' ' 778' ' ' PHE . 29.3 t80 -116.82 74.19 0.9 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.276 -0.89 . . . . 0.0 109.933 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 779' ' ' GLY . . . . . . . . . . . . . . . -175.53 -86.97 0.07 OUTLIER Glycine 0 N--CA 1.495 2.619 0 C-N-CA 119.486 -1.34 . . . . 0.0 110.456 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 780' ' ' THR . . . . . . . . . . . . . 13.0 p -136.86 92.59 14.33 Favored Pre-proline 0 N--CA 1.494 1.761 0 O-C-N 121.078 -1.248 . . . . 0.0 110.825 -179.928 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 781' ' ' PRO . . . . . 0.47 ' O ' ' HG ' ' A' ' 782' ' ' LEU . 50.9 Cg_endo -85.41 155.56 10.73 Favored 'Trans proline' 0 C--N 1.306 -1.697 0 O-C-N 124.066 1.561 . . . . 0.0 110.271 179.942 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 782' ' ' LEU . . . . . 0.527 ' HB2' ' HB2' ' A' ' 789' ' ' GLN . 1.6 mt -143.81 129.38 19.13 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.115 -0.991 . . . . 0.0 110.263 179.978 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 783' ' ' GLY . . . . . . . . . . . . . . . 121.64 -168.75 14.49 Favored Glycine 0 N--CA 1.492 2.374 0 N-CA-C 109.71 -1.356 . . . . 0.0 109.71 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 784' ' ' THR . . . . . 0.497 ' O ' ' CE1' ' A' ' 788' ' ' PHE . 0.3 OUTLIER -115.33 -146.74 0.41 Allowed 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.258 -1.142 . . . . 0.0 110.163 179.997 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 785' ' ' CYS . . . . . . . . . . . . . 54.1 t -82.07 123.12 28.65 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.225 -0.922 . . . . 0.0 110.1 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 786' ' ' GLY . . . . . . . . . . . . . . . 86.34 -1.61 87.45 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.609 -1.396 . . . . 0.0 109.609 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 787' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -140.86 36.98 1.78 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.205 -1.174 . . . . 0.0 110.062 -179.957 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 788' ' ' PHE . . . . . 0.497 ' CE1' ' O ' ' A' ' 784' ' ' THR . 28.8 m-85 -74.15 171.37 13.69 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.248 -0.908 . . . . 0.0 110.369 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 789' ' ' GLN . . . . . 0.527 ' HB2' ' HB2' ' A' ' 782' ' ' LEU . 5.8 mt-30 -143.17 97.7 3.13 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.371 -0.831 . . . . 0.0 109.961 179.971 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 790' ' ' GLN . . . . . 0.49 ' O ' ' HG3' ' A' ' 790' ' ' GLN . 14.1 pt20 -46.32 108.15 0.13 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.256 -0.903 . . . . 0.0 110.306 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 791' ' ' GLY . . . . . . . . . . . . . . . -58.38 177.15 1.86 Allowed Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.326 -1.51 . . . . 0.0 109.326 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 792' ' ' GLU . . . . . 0.499 ' CG ' ' O ' ' A' ' 792' ' ' GLU . 0.6 OUTLIER -80.4 5.38 15.16 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.205 -1.174 . . . . 0.0 110.231 179.997 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 793' ' ' CYS . . . . . . . . . . . . . 22.8 t -102.8 16.69 25.82 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.238 -0.914 . . . . 0.0 111.062 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 794' ' ' HIS . . . . . 0.466 ' CD2' ' HG ' ' A' ' 798' ' ' SER . 31.8 t-80 -62.28 125.3 23.42 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.938 -1.101 . . . . 0.0 110.258 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 795' ' ' SER . . . . . . . . . . . . . 1.4 m -72.89 -130.59 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.165 -0.96 . . . . 0.0 109.605 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 796' ' ' ILE . . . . . . . . . . . . . 1.6 pt -137.94 22.9 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 120.854 -1.153 . . . . 0.0 110.363 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 797' ' ' ASN . . . . . . . . . . . . . 36.1 p30 -154.75 22.12 0.45 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.296 -0.878 . . . . 0.0 110.232 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 798' ' ' SER . . . . . 0.671 ' O ' ' HB1' ' A' ' 776' ' ' ALA . 0.8 OUTLIER -72.44 -19.68 61.53 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.115 -0.99 . . . . 0.0 109.936 179.966 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 799' ' ' ASN . . . . . 0.451 ' CG ' ' HB3' ' A' ' 776' ' ' ALA . 2.3 t-20 -114.09 -10.36 12.83 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.32 -0.863 . . . . 0.0 110.009 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 800' ' ' SER . . . . . 0.512 ' O ' ' HB2' ' A' ' 804' ' ' ARG . 0.9 OUTLIER -89.86 -28.56 19.17 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.359 -0.838 . . . . 0.0 110.13 179.954 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 801' ' ' VAL . . . . . 0.496 HG12 HD22 ' A' ' 802' ' ' LEU . 24.6 t -66.59 -30.48 49.9 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.143 -0.973 . . . . 0.0 110.472 -179.964 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 802' ' ' LEU . . . . . 0.497 ' O ' ' HB2' ' A' ' 806' ' ' CYS . 4.4 mm? -90.11 -44.84 9.53 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.231 -0.918 . . . . 0.0 110.792 -179.945 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 803' ' ' GLU . . . . . 0.571 ' HA ' ' CD1' ' A' ' 807' ' ' ILE . 32.1 tt0 -62.67 -21.94 66.09 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.125 -0.985 . . . . 0.0 110.927 -179.89 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 804' ' ' ARG . . . . . 0.512 ' HB2' ' O ' ' A' ' 800' ' ' SER . 0.0 OUTLIER -91.96 -19.4 22.47 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 120.981 -1.075 . . . . 0.0 111.055 -179.971 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 805' ' ' LYS . . . . . . . . . . . . . 12.9 ttpp -132.47 51.3 2.16 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.004 -1.06 . . . . 0.0 111.05 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 806' ' ' CYS . . . . . 0.497 ' HB2' ' O ' ' A' ' 802' ' ' LEU . 1.2 t -156.96 -33.0 0.08 Allowed 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.015 -1.053 . . . . 0.0 111.067 179.925 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 807' ' ' ILE . . . . . 0.571 ' CD1' ' HA ' ' A' ' 803' ' ' GLU . 2.5 mp -77.17 121.89 30.58 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 O-C-N 120.979 -1.076 . . . . 0.0 110.78 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 808' ' ' GLY . . . . . 0.444 ' C ' ' HG ' ' A' ' 809' ' ' LEU . . . 107.78 13.86 19.02 Favored Glycine 0 N--CA 1.494 2.521 0 N-CA-C 110.082 -1.207 . . . . 0.0 110.082 179.935 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 809' ' ' LEU . . . . . 0.444 ' HG ' ' C ' ' A' ' 808' ' ' GLY . 4.2 mt -134.5 134.84 41.92 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.076 -1.25 . . . . 0.0 110.443 179.961 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 810' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -65.82 -13.62 59.85 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.236 -0.915 . . . . 0.0 109.245 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 811' ' ' ARG . . . . . 0.405 ' HA ' ' HA ' ' A' ' 763' ' ' LYS . 0.4 OUTLIER -141.7 164.18 30.91 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.578 -0.701 . . . . 0.0 109.627 179.968 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 812' ' ' CYS . . . . . 0.439 ' O ' ' HB2' ' A' ' 761' ' ' HIS . 1.7 t -145.37 132.0 19.9 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.19 -0.944 . . . . 0.0 110.241 -179.952 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 813' ' ' VAL . . . . . 0.503 HG22 ' CB ' ' A' ' 761' ' ' HIS . 54.3 t -143.43 110.83 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.156 -0.965 . . . . 0.0 110.328 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 814' ' ' VAL . . . . . . . . . . . . . 61.4 t -119.06 149.61 21.53 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.452 0 O-C-N 121.456 -0.778 . . . . 0.0 109.629 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 815' ' ' ALA . . . . . . . . . . . . . . . -102.34 132.08 48.55 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.142 -0.974 . . . . 0.0 110.263 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 816' ' ' ILE . . . . . 0.947 HD11 HG23 ' A' ' 760' ' ' VAL . 26.6 mt -89.62 151.72 3.44 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 121.346 -0.846 . . . . 0.0 110.384 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 817' ' ' SER . . . . . 0.402 ' CB ' ' O ' ' A' ' 816' ' ' ILE . 0.0 OUTLIER 174.74 171.93 0.27 Allowed Pre-proline 0 N--CA 1.494 1.748 0 O-C-N 121.265 -0.897 . . . . 0.0 110.129 -179.99 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 818' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -73.92 -45.11 0.4 Allowed 'Trans proline' 0 C--N 1.305 -1.748 0 O-C-N 124.017 1.535 . . . . 0.0 110.468 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 819' ' ' SER . . . . . . . . . . . . . 59.5 p -95.81 46.53 1.09 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.258 -0.901 . . . . 0.0 110.088 179.92 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 820' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -126.9 -28.68 2.9 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.274 -0.891 . . . . 0.0 110.477 -179.946 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 821' ' ' PHE . . . . . 0.435 ' CD2' HG21 ' A' ' 801' ' ' VAL . 11.9 m-85 -103.73 -72.22 0.71 Allowed 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.15 -0.969 . . . . 0.0 110.302 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 822' ' ' GLY . . . . . . . . . . . . . . . -179.83 56.94 0.08 OUTLIER Glycine 0 N--CA 1.492 2.43 0 N-CA-C 109.823 -1.311 . . . . 0.0 109.823 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 823' ' ' GLY . . . . . . . . . . . . . . . 60.33 -172.57 5.86 Favored Glycine 0 N--CA 1.494 2.507 0 N-CA-C 109.87 -1.292 . . . . 0.0 109.87 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 824' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -112.76 138.43 22.11 Favored Pre-proline 0 N--CA 1.495 1.79 0 O-C-N 121.345 -1.091 . . . . 0.0 110.168 -179.976 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 825' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_endo -84.54 -36.82 0.15 Allowed 'Trans proline' 0 C--N 1.304 -1.77 0 O-C-N 124.075 1.566 . . . . 0.0 111.08 -179.89 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 826' ' ' CYS . . . . . 0.432 ' HA ' ' HD3' ' A' ' 827' ' ' PRO . 0.8 OUTLIER -110.28 133.16 21.15 Favored Pre-proline 0 N--CA 1.504 2.256 0 O-C-N 120.971 -1.081 . . . . 0.0 110.714 -179.903 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 827' ' ' PRO . . . . . 0.799 ' O ' HG23 ' A' ' 829' ' ' VAL . 51.0 Cg_endo -87.27 167.63 7.76 Favored 'Trans proline' 0 C--N 1.309 -1.517 0 O-C-N 123.997 1.525 . . . . 0.0 110.348 179.907 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 828' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER 47.36 25.2 0.55 Allowed 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.216 -0.928 . . . . 0.0 110.897 179.978 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 829' ' ' VAL . . . . . 0.799 HG23 ' O ' ' A' ' 827' ' ' PRO . 81.9 t -127.67 125.0 64.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.0 -1.063 . . . . 0.0 110.317 -179.96 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 830' ' ' MET . . . . . . . . . . . . . 29.2 mtt -56.89 -173.13 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.179 -0.951 . . . . 0.0 109.837 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 831' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.73 127.54 8.83 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.12 -0.987 . . . . 0.0 110.878 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 832' ' ' ARG . . . . . . . . . . . . . 2.8 mtt180 -123.4 167.55 13.69 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.542 -0.724 . . . . 0.0 109.094 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 833' ' ' VAL . . . . . 0.615 HG21 ' CG2' ' A' ' 816' ' ' ILE . 88.9 t -124.27 109.06 21.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 120.795 -1.191 . . . . 0.0 111.399 -179.909 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 834' ' ' ALA . . . . . 0.587 ' O ' HG23 ' A' ' 835' ' ' VAL . . . -109.49 141.02 42.54 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 179.808 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 835' ' ' VAL . . . . . 0.587 HG23 ' O ' ' A' ' 834' ' ' ALA . 23.6 t -154.85 163.52 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 120.634 -1.291 . . . . 0.0 112.095 -179.872 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 836' ' ' GLU . . . . . 0.515 ' HB3' ' HB2' ' A' ' 774' ' ' LYS . 0.6 OUTLIER -148.27 149.19 31.43 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 107.972 -1.122 . . . . 0.0 107.972 179.974 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 837' ' ' ALA . . . . . 0.514 ' HB2' HD13 ' A' ' 762' ' ' LEU . . . -135.66 154.18 51.38 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 120.633 -1.292 . . . . 0.0 111.899 -179.862 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 838' ' ' VAL . . . . . 0.451 ' O ' ' HA ' ' A' ' 770' ' ' ILE . 41.1 t -109.12 125.5 66.21 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 179.882 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 839' ' ' CYS . . . . . 0.456 ' O ' ' O ' ' A' ' 728' ' ' VAL . 0.5 OUTLIER -116.5 161.25 19.41 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.962 -1.086 . . . . 0.0 111.199 -179.928 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 840' ' ' SER . . . . . 0.412 ' OG ' ' C ' ' A' ' 839' ' ' CYS . 0.2 OUTLIER -168.27 140.39 2.9 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.665 -0.647 . . . . 0.0 109.501 -179.981 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 841' ' ' THR . . . . . 0.554 ' CA ' ' HG3' ' A' ' 768' ' ' GLN . 11.8 t . . . . . 0 N--CA 1.493 1.723 0 O-C-N 121.084 -1.01 . . . . 0.0 110.482 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 728' ' ' VAL . . . . . . . . . . . . . 75.2 t . . . . . 0 N--CA 1.491 1.623 0 CA-C-O 121.192 0.52 . . . . 0.0 110.221 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 729' ' ' SER . . . . . . . . . . . . . 16.1 p -167.26 167.11 14.38 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.164 -0.96 . . . . 0.0 110.501 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 730' ' ' GLY . . . . . . . . . . . . . . . -129.84 176.75 18.52 Favored Glycine 0 N--CA 1.489 2.202 0 N-CA-C 109.414 -1.475 . . . . 0.0 109.414 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 731' ' ' VAL . . . . . . . . . . . . . 2.6 m -131.7 137.88 54.1 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.283 -1.128 . . . . 0.0 110.462 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 732' ' ' CYS . . . . . . . . . . . . . 48.7 m -109.87 154.65 22.74 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.386 -0.821 . . . . 0.0 109.658 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 733' ' ' ALA . . . . . . . . . . . . . . . -167.59 114.27 0.74 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.111 -0.993 . . . . 0.0 111.001 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 734' ' ' ASP . . . . . 0.442 ' OD1' HG22 ' A' ' 784' ' ' THR . 1.6 m-20 -111.22 120.53 42.59 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.385 -0.822 . . . . 0.0 109.444 179.894 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 735' ' ' VAL . . . . . . . . . . . . . 79.3 t -129.44 144.69 37.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.155 -0.966 . . . . 0.0 110.591 -179.919 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 736' ' ' SER . . . . . . . . . . . . . 2.3 m -89.97 -170.46 2.8 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.39 -0.819 . . . . 0.0 109.895 179.913 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 737' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 . . . . . 0 N--CA 1.494 1.74 0 O-C-N 121.203 -0.936 . . . . 0.0 110.488 179.974 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 757' ' ' THR . . . . . 0.428 ' O ' ' C ' ' A' ' 758' ' ' ALA . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.67 0 CA-C-O 121.083 0.468 . . . . 0.0 110.332 . . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 758' ' ' ALA . . . . . 0.464 ' O ' ' HG3' ' A' ' 759' ' ' LYS . . . -42.85 156.31 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.291 -0.881 . . . . 0.0 109.763 -179.997 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 759' ' ' LYS . . . . . 0.464 ' HG3' ' O ' ' A' ' 758' ' ' ALA . 18.3 mtpt -144.73 157.52 44.15 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.108 -0.995 . . . . 0.0 110.827 -179.892 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 760' ' ' VAL . . . . . 0.416 ' O ' ' HA ' ' A' ' 813' ' ' VAL . 77.9 t -107.67 132.92 53.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.395 -0.816 . . . . 0.0 108.92 179.947 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 761' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -108.87 104.82 14.15 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.065 -1.022 . . . . 0.0 111.328 -179.737 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 762' ' ' LEU . . . . . . . . . . . . . 25.8 mt -114.74 137.45 51.91 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 179.784 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 763' ' ' LYS . . . . . . . . . . . . . 18.7 ttpp -133.64 146.78 51.22 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.923 -1.111 . . . . 0.0 111.419 -179.894 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 764' ' ' CYS . . . . . 0.425 ' HB2' ' O ' ' A' ' 810' ' ' GLU . 20.7 m -141.55 155.15 45.8 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.597 -0.689 . . . . 0.0 109.434 179.86 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 765' ' ' ALA . . . . . 0.948 ' HB1' ' HD2' ' A' ' 766' ' ' PRO . . . -83.15 178.53 2.38 Favored Pre-proline 0 N--CA 1.494 1.727 0 O-C-N 121.059 -1.025 . . . . 0.0 110.354 -179.924 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 766' ' ' PRO . . . . . 0.948 ' HD2' ' HB1' ' A' ' 765' ' ' ALA . 44.0 Cg_endo -70.31 151.42 65.95 Favored 'Trans proline' 0 C--N 1.307 -1.642 0 O-C-N 123.968 1.509 . . . . 0.0 110.181 179.966 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 767' ' ' GLY . . . . . . . . . . . . . . . 70.87 3.81 52.2 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.143 -1.583 . . . . 0.0 109.143 -179.94 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 768' ' ' GLN . . . . . 0.488 ' HG2' ' O ' ' A' ' 840' ' ' SER . 28.4 mt-30 -123.66 117.45 25.02 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.346 -1.09 . . . . 0.0 109.838 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 769' ' ' THR . . . . . . . . . . . . . 60.5 p -127.17 148.32 50.18 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.061 -1.024 . . . . 0.0 110.295 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 770' ' ' ILE . . . . . . . . . . . . . 87.3 mt -60.76 117.25 2.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.256 -0.902 . . . . 0.0 109.777 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 771' ' ' SER . . . . . . . . . . . . . 13.9 t -107.27 -2.92 20.27 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.163 -0.961 . . . . 0.0 110.862 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 772' ' ' ALA . . . . . . . . . . . . . . . -170.81 135.19 1.07 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 120.806 -1.184 . . . . 0.0 111.313 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 773' ' ' ILE . . . . . 0.552 HD12 ' HB3' ' A' ' 802' ' ' LEU . 16.6 mm -85.38 128.16 39.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.441 -0.787 . . . . 0.0 108.93 179.815 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 774' ' ' LYS . . . . . 0.457 ' HB3' ' HB3' ' A' ' 836' ' ' GLU . 0.0 OUTLIER -79.29 -37.28 38.14 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.108 -0.995 . . . . 0.0 110.897 -179.827 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 775' ' ' PHE . . . . . . . . . . . . . 90.2 t80 -169.62 150.4 4.07 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.016 -1.052 . . . . 0.0 110.691 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 776' ' ' ALA . . . . . 0.479 ' O ' ' HB2' ' A' ' 798' ' ' SER . . . -163.93 126.28 2.45 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.469 -0.769 . . . . 0.0 109.483 179.94 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 777' ' ' SER . . . . . 0.532 ' HA ' ' CB ' ' A' ' 798' ' ' SER . 6.0 t -153.94 123.45 6.63 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.19 -0.944 . . . . 0.0 110.676 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 778' ' ' PHE . . . . . . . . . . . . . 42.6 t80 -97.15 82.8 3.23 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.395 -0.816 . . . . 0.0 109.712 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 779' ' ' GLY . . . . . . . . . . . . . . . 179.02 -121.42 0.75 Allowed Glycine 0 N--CA 1.492 2.392 0 N-CA-C 109.719 -1.352 . . . . 0.0 109.719 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 780' ' ' THR . . . . . 0.454 ' O ' ' HA3' ' A' ' 791' ' ' GLY . 44.9 p -114.61 97.2 46.15 Favored Pre-proline 0 N--CA 1.493 1.705 0 O-C-N 121.242 -1.152 . . . . 0.0 110.407 -179.949 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 781' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -79.35 175.94 10.21 Favored 'Trans proline' 0 C--N 1.304 -1.798 0 O-C-N 123.98 1.516 . . . . 0.0 110.514 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 782' ' ' LEU . . . . . 0.767 HD12 ' HA2' ' A' ' 791' ' ' GLY . 6.8 mt -139.05 105.4 5.27 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.344 -0.848 . . . . 0.0 110.144 -179.976 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 783' ' ' GLY . . . . . . . . . . . . . . . 102.37 -176.76 25.66 Favored Glycine 0 N--CA 1.492 2.367 0 N-CA-C 109.629 -1.389 . . . . 0.0 109.629 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 784' ' ' THR . . . . . 0.442 HG22 ' OD1' ' A' ' 734' ' ' ASP . 0.6 OUTLIER -130.05 -163.08 1.27 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.205 -1.173 . . . . 0.0 110.052 179.913 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 785' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -59.86 116.69 4.29 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.059 -1.026 . . . . 0.0 109.901 -179.958 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 786' ' ' GLY . . . . . . . . . . . . . . . 137.07 -43.94 1.18 Allowed Glycine 0 N--CA 1.489 2.209 0 N-CA-C 108.575 -1.81 . . . . 0.0 108.575 -179.913 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 787' ' ' THR . . . . . 0.471 HG22 ' O ' ' A' ' 787' ' ' THR . 25.5 m -148.39 38.43 0.87 Allowed 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.554 -0.968 . . . . 0.0 109.34 179.867 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 788' ' ' PHE . . . . . 0.421 ' CE2' ' HA ' ' A' ' 784' ' ' THR . 0.2 OUTLIER -50.4 176.31 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.814 0 CA-C-O 121.717 0.77 . . . . 0.0 111.065 -179.95 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 789' ' ' GLN . . . . . . . . . . . . . 2.2 mt-30 -161.87 170.6 19.18 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.563 -0.71 . . . . 0.0 109.508 179.951 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 790' ' ' GLN . . . . . 0.435 ' O ' ' C ' ' A' ' 791' ' ' GLY . 1.1 tp60 -88.81 21.05 3.2 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.985 -1.072 . . . . 0.0 110.283 -179.945 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 791' ' ' GLY . . . . . 0.767 ' HA2' HD12 ' A' ' 782' ' ' LEU . . . 42.34 -124.34 3.74 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.764 -1.335 . . . . 0.0 109.764 -179.953 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 792' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -133.02 -30.73 1.33 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.347 -1.09 . . . . 0.0 110.392 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 793' ' ' CYS . . . . . . . . . . . . . 5.1 t -112.07 139.44 47.59 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.187 -0.946 . . . . 0.0 110.239 -179.913 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 794' ' ' HIS . . . . . 0.594 ' CE1' ' HA ' ' A' ' 796' ' ' ILE . 10.3 t-80 -148.81 141.57 24.58 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.3 -0.875 . . . . 0.0 109.952 179.876 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 795' ' ' SER . . . . . 0.431 ' HB3' ' HG3' ' A' ' 825' ' ' PRO . 3.7 p -81.99 10.13 7.1 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.294 -0.879 . . . . 0.0 110.382 -179.967 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 796' ' ' ILE . . . . . 0.694 HG22 ' O ' ' A' ' 796' ' ' ILE . 50.2 mt 45.98 23.24 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 O-C-N 121.2 -0.937 . . . . 0.0 110.405 -179.933 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 797' ' ' ASN . . . . . 0.594 ' O ' HG23 ' A' ' 801' ' ' VAL . 2.8 t30 -150.46 17.14 0.82 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.339 -0.851 . . . . 0.0 109.815 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 798' ' ' SER . . . . . 0.532 ' CB ' ' HA ' ' A' ' 777' ' ' SER . 2.0 m -81.45 -29.72 33.7 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.47 -0.769 . . . . 0.0 110.324 -179.934 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 799' ' ' ASN . . . . . . . . . . . . . 11.9 t30 -86.78 -11.38 51.16 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.276 -0.89 . . . . 0.0 110.525 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 800' ' ' SER . . . . . 0.466 ' O ' ' HB3' ' A' ' 804' ' ' ARG . 30.5 m -87.54 -20.92 25.79 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.182 -0.949 . . . . 0.0 110.166 179.955 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 801' ' ' VAL . . . . . 0.711 HG11 ' CE2' ' A' ' 821' ' ' PHE . 42.0 t -73.75 -41.75 54.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.235 -0.916 . . . . 0.0 110.188 -179.959 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 802' ' ' LEU . . . . . 0.654 HD22 ' N ' ' A' ' 802' ' ' LEU . 4.0 mm? -75.62 -41.04 55.36 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.217 -0.927 . . . . 0.0 110.185 179.933 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 803' ' ' GLU . . . . . 0.585 ' HA ' ' CG1' ' A' ' 807' ' ' ILE . 5.5 tt0 -73.64 -18.04 61.08 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.147 -0.971 . . . . 0.0 110.663 179.948 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 804' ' ' ARG . . . . . 0.466 ' HB3' ' O ' ' A' ' 800' ' ' SER . 0.1 OUTLIER -89.2 -29.21 19.45 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.126 -0.984 . . . . 0.0 110.948 -179.979 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 805' ' ' LYS . . . . . . . . . . . . . 8.3 ttmt -122.11 -41.7 2.42 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 120.979 -1.075 . . . . 0.0 110.937 -179.944 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 806' ' ' CYS . . . . . 0.434 ' O ' HG12 ' A' ' 807' ' ' ILE . 0.9 OUTLIER -86.14 69.89 10.52 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.224 -0.923 . . . . 0.0 110.714 -179.994 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 807' ' ' ILE . . . . . 0.585 ' CG1' ' HA ' ' A' ' 803' ' ' GLU . 16.0 mm -149.72 121.63 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.411 0 O-C-N 121.287 -0.883 . . . . 0.0 110.512 179.934 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 808' ' ' GLY . . . . . . . . . . . . . . . 84.56 23.57 50.0 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.887 -1.285 . . . . 0.0 109.887 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 809' ' ' LEU . . . . . . . . . . . . . 72.5 mt -123.12 148.22 45.93 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.106 -1.232 . . . . 0.0 110.592 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 810' ' ' GLU . . . . . 0.425 ' O ' ' HB2' ' A' ' 764' ' ' CYS . 1.1 mp0 -83.45 1.25 42.55 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.256 -0.903 . . . . 0.0 110.032 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 811' ' ' ARG . . . . . . . . . . . . . 46.5 ttt180 -153.86 160.38 42.15 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.463 -0.773 . . . . 0.0 109.127 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 812' ' ' CYS . . . . . 0.574 ' C ' HG23 ' A' ' 813' ' ' VAL . 0.1 OUTLIER -155.5 143.93 20.28 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.794 -1.191 . . . . 0.0 111.735 -179.981 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 813' ' ' VAL . . . . . 0.574 HG23 ' C ' ' A' ' 812' ' ' CYS . 32.0 t -155.54 110.28 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 179.934 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 814' ' ' VAL . . . . . . . . . . . . . 76.0 t -108.43 120.36 59.67 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 121.198 -0.939 . . . . 0.0 110.746 -179.922 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 815' ' ' ALA . . . . . 0.441 ' O ' ' C ' ' A' ' 816' ' ' ILE . . . -78.01 84.69 4.27 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.425 -0.797 . . . . 0.0 110.102 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 816' ' ' ILE . . . . . 0.618 HD11 HG11 ' A' ' 833' ' ' VAL . 21.3 mt -39.39 143.11 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 O-C-N 121.476 -0.765 . . . . 0.0 110.602 179.97 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 817' ' ' SER . . . . . 0.44 ' OG ' ' HD2' ' A' ' 818' ' ' PRO . 0.0 OUTLIER -157.94 175.18 3.4 Favored Pre-proline 0 C--N 1.302 -1.481 0 O-C-N 121.328 -0.858 . . . . 0.0 109.958 179.944 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 818' ' ' PRO . . . . . 0.44 ' HD2' ' OG ' ' A' ' 817' ' ' SER . 42.7 Cg_endo -71.66 -71.42 0.02 OUTLIER 'Trans proline' 0 C--N 1.302 -1.871 0 O-C-N 123.941 1.495 . . . . 0.0 111.556 -179.933 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 819' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -86.85 39.09 0.83 Allowed 'General case' 0 N--CA 1.496 1.838 0 O-C-N 120.981 -1.074 . . . . 0.0 110.798 -179.895 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 820' ' ' ASN . . . . . 0.426 ' HB2' ' OG ' ' A' ' 817' ' ' SER . 0.7 OUTLIER -99.38 -34.07 10.45 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.135 -0.978 . . . . 0.0 109.888 179.987 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 821' ' ' PHE . . . . . 0.711 ' CE2' HG11 ' A' ' 801' ' ' VAL . 3.2 m-85 -99.7 -44.32 6.15 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.294 -0.879 . . . . 0.0 110.051 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 822' ' ' GLY . . . . . . . . . . . . . . . -165.01 -36.59 0.02 OUTLIER Glycine 0 N--CA 1.492 2.388 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 823' ' ' GLY . . . . . . . . . . . . . . . 134.4 -96.6 0.28 Allowed Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.698 -1.361 . . . . 0.0 109.698 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 824' ' ' ASP . . . . . . . . . . . . . 31.7 t0 -149.07 87.0 5.48 Favored Pre-proline 0 N--CA 1.492 1.658 0 O-C-N 121.3 -1.117 . . . . 0.0 110.359 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 825' ' ' PRO . . . . . 0.431 ' HG3' ' HB3' ' A' ' 795' ' ' SER . 43.8 Cg_endo -72.07 -49.54 0.3 Allowed 'Trans proline' 0 C--N 1.306 -1.682 0 O-C-N 123.945 1.497 . . . . 0.0 110.255 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 826' ' ' CYS . . . . . 0.72 ' SG ' HG21 ' A' ' 829' ' ' VAL . 0.0 OUTLIER -78.24 144.87 67.58 Favored Pre-proline 0 N--CA 1.489 1.478 0 O-C-N 121.241 -0.912 . . . . 0.0 109.832 179.898 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 827' ' ' PRO . . . . . 0.57 ' O ' HG23 ' A' ' 829' ' ' VAL . 46.6 Cg_endo -74.93 115.74 4.38 Favored 'Trans proline' 0 C--N 1.302 -1.888 0 O-C-N 124.007 1.53 . . . . 0.0 111.953 -179.938 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 828' ' ' GLU . . . . . 0.434 ' C ' ' O ' ' A' ' 827' ' ' PRO . 18.3 mm-40 35.8 36.99 0.04 OUTLIER 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.735 -0.603 . . . . 0.0 111.69 179.867 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 829' ' ' VAL . . . . . 0.72 HG21 ' SG ' ' A' ' 826' ' ' CYS . 17.3 t -91.07 165.27 1.98 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 O-C-N 121.114 -0.991 . . . . 0.0 109.703 179.861 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 830' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -63.67 -168.9 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.118 -0.989 . . . . 0.0 110.041 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 831' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -143.44 158.33 43.73 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.229 -0.919 . . . . 0.0 110.539 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 832' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -169.34 161.26 9.89 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.383 -0.823 . . . . 0.0 109.515 -179.958 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 833' ' ' VAL . . . . . 0.618 HG11 HD11 ' A' ' 816' ' ' ILE . 93.4 t -135.21 106.96 7.22 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 O-C-N 120.912 -1.117 . . . . 0.0 111.242 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 834' ' ' ALA . . . . . . . . . . . . . . . -115.87 114.53 24.82 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.444 -0.785 . . . . 0.0 108.894 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 835' ' ' VAL . . . . . . . . . . . . . 15.6 t -125.11 158.98 32.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.001 -1.062 . . . . 0.0 111.546 -179.847 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 836' ' ' GLU . . . . . 0.457 ' HB3' ' HB3' ' A' ' 774' ' ' LYS . 30.5 tt0 -147.63 143.29 27.59 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 108.056 -1.09 . . . . 0.0 108.056 179.847 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 837' ' ' ALA . . . . . . . . . . . . . . . -140.58 155.25 46.64 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 120.488 -1.383 . . . . 0.0 112.116 -179.877 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 838' ' ' VAL . . . . . . . . . . . . . 96.2 t -113.33 111.82 37.72 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 179.849 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 839' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -107.45 121.24 44.22 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.063 -1.023 . . . . 0.0 110.911 -179.848 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 840' ' ' SER . . . . . 0.716 ' C ' HG22 ' A' ' 841' ' ' THR . 4.6 p -140.82 -66.42 0.43 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.523 -0.736 . . . . 0.0 109.764 179.965 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 841' ' ' THR . . . . . 0.716 HG22 ' C ' ' A' ' 840' ' ' SER . 0.0 OUTLIER . . . . . 0 N--CA 1.5 2.057 0 O-C-N 121.482 -0.761 . . . . 0.0 109.918 179.933 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 728' ' ' VAL . . . . . 0.466 HG12 ' HA ' ' A' ' 840' ' ' SER . 0.4 OUTLIER . . . . . 0 N--CA 1.489 1.483 0 CA-C-O 121.353 0.596 . . . . 0.0 110.036 . . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 729' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER 176.59 46.82 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.254 -0.904 . . . . 0.0 109.947 -179.95 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 730' ' ' GLY . . . . . . . . . . . . . . . -143.68 89.09 0.17 Allowed Glycine 0 N--CA 1.488 2.116 0 N-CA-C 109.986 -1.246 . . . . 0.0 109.986 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 731' ' ' VAL . . . . . . . . . . . . . 18.0 t -108.27 162.94 6.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.259 -1.142 . . . . 0.0 109.158 179.912 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 732' ' ' CYS . . . . . 0.442 ' SG ' ' OE1' ' A' ' 836' ' ' GLU . 0.8 OUTLIER -156.55 157.68 35.81 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 120.907 -1.12 . . . . 0.0 111.139 -179.95 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 733' ' ' ALA . . . . . . . . . . . . . . . -170.31 103.52 0.28 Allowed 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 734' ' ' ASP . . . . . 0.578 ' C ' HG23 ' A' ' 735' ' ' VAL . 1.8 p-10 -113.09 136.04 53.14 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.226 -0.921 . . . . 0.0 110.619 -179.872 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 735' ' ' VAL . . . . . 0.65 HG11 ' O ' ' A' ' 759' ' ' LYS . 89.9 t -156.13 117.34 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.361 -0.837 . . . . 0.0 110.042 179.978 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 736' ' ' SER . . . . . . . . . . . . . 80.8 p -59.18 166.55 2.1 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.136 -0.977 . . . . 0.0 110.115 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 737' ' ' GLU . . . . . 0.723 ' HA ' ' HB3' ' A' ' 758' ' ' ALA . 35.2 tt0 . . . . . 0 N--CA 1.494 1.73 0 O-C-N 121.238 -0.914 . . . . 0.0 110.164 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 757' ' ' THR . . . . . . . . . . . . . 24.2 p . . . . . 0 N--CA 1.492 1.67 0 CA-C-O 121.273 0.559 . . . . 0.0 110.452 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 758' ' ' ALA . . . . . 0.723 ' HB3' ' HA ' ' A' ' 737' ' ' GLU . . . -111.93 161.72 16.11 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.35 -0.844 . . . . 0.0 109.796 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 759' ' ' LYS . . . . . 0.677 ' HE3' ' HB2' ' A' ' 815' ' ' ALA . 6.1 mttt -131.34 162.11 30.83 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.203 -0.936 . . . . 0.0 110.418 179.951 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 760' ' ' VAL . . . . . . . . . . . . . 99.2 t -107.61 143.01 18.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.385 -0.822 . . . . 0.0 109.31 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 761' ' ' HIS . . . . . . . . . . . . . 6.1 m170 -112.53 120.71 42.53 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.08 -1.012 . . . . 0.0 111.069 -179.921 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 762' ' ' LEU . . . . . 0.482 ' HB2' ' O ' ' A' ' 812' ' ' CYS . 12.3 mt -127.11 141.02 51.86 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.541 -0.724 . . . . 0.0 109.081 179.955 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 763' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -158.7 147.88 18.95 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 120.905 -1.122 . . . . 0.0 111.067 -179.903 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 764' ' ' CYS . . . . . . . . . . . . . 4.2 m -124.03 171.54 9.67 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.425 -0.797 . . . . 0.0 109.674 179.907 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 765' ' ' ALA . . . . . . . . . . . . . . . -70.1 158.52 87.2 Favored Pre-proline 0 N--CA 1.493 1.724 0 O-C-N 121.038 -1.039 . . . . 0.0 109.983 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 766' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -72.04 130.17 16.23 Favored 'Trans proline' 0 C--N 1.306 -1.7 0 O-C-N 123.925 1.487 . . . . 0.0 110.067 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 767' ' ' GLY . . . . . . . . . . . . . . . 112.47 -26.63 10.8 Favored Glycine 0 N--CA 1.488 2.143 0 N-CA-C 108.974 -1.65 . . . . 0.0 108.974 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 768' ' ' GLN . . . . . 0.493 ' C ' HG23 ' A' ' 769' ' ' THR . 2.0 mt-30 -106.79 172.29 6.9 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.362 -1.081 . . . . 0.0 109.992 179.934 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 769' ' ' THR . . . . . 0.493 HG23 ' C ' ' A' ' 768' ' ' GLN . 37.4 p -153.47 147.96 26.08 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.123 -0.985 . . . . 0.0 110.384 -179.937 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 770' ' ' ILE . . . . . . . . . . . . . 12.9 mt -64.29 146.29 13.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.274 -0.891 . . . . 0.0 109.475 179.936 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 771' ' ' SER . . . . . 0.523 ' O ' ' HB2' ' A' ' 772' ' ' ALA . 0.1 OUTLIER -135.52 -0.15 2.68 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.023 -1.048 . . . . 0.0 111.053 -179.942 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 772' ' ' ALA . . . . . 0.523 ' HB2' ' O ' ' A' ' 771' ' ' SER . . . -179.14 147.34 0.33 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.795 -1.191 . . . . 0.0 111.534 179.959 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 773' ' ' ILE . . . . . 0.423 HG13 ' HB3' ' A' ' 802' ' ' LEU . 22.7 mm -107.15 135.37 45.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 179.819 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 774' ' ' LYS . . . . . . . . . . . . . 2.3 ptpt -107.36 -6.85 16.91 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.026 -1.046 . . . . 0.0 111.712 -179.806 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 775' ' ' PHE . . . . . 0.661 ' O ' ' HB2' ' A' ' 776' ' ' ALA . 39.3 t80 -157.65 162.16 38.65 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.731 -1.231 . . . . 0.0 111.337 -179.973 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 776' ' ' ALA . . . . . 0.661 ' HB2' ' O ' ' A' ' 775' ' ' PHE . . . 170.04 112.66 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 109.295 -0.632 . . . . 0.0 109.295 179.933 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 777' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -140.36 120.53 13.82 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.147 -0.971 . . . . 0.0 110.78 -179.954 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 778' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -94.39 96.43 9.52 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.416 -0.803 . . . . 0.0 109.271 179.879 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 779' ' ' GLY . . . . . . . . . . . . . . . 166.82 -111.04 0.43 Allowed Glycine 0 N--CA 1.492 2.372 0 N-CA-C 110.013 -1.235 . . . . 0.0 110.013 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 780' ' ' THR . . . . . 0.622 HG22 ' HG3' ' A' ' 830' ' ' MET . 2.1 p -118.13 102.03 51.06 Favored Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 120.958 -1.319 . . . . 0.0 110.627 -179.927 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 781' ' ' PRO . . . . . 0.529 ' CG ' ' HB3' ' A' ' 832' ' ' ARG . 49.0 Cg_endo -84.58 173.09 8.73 Favored 'Trans proline' 0 C--N 1.306 -1.692 0 O-C-N 124.126 1.592 . . . . 0.0 110.221 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 782' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -145.02 113.37 6.59 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.192 -0.942 . . . . 0.0 110.165 179.903 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 783' ' ' GLY . . . . . . . . . . . . . . . 114.21 -157.5 14.93 Favored Glycine 0 N--CA 1.492 2.409 0 N-CA-C 109.451 -1.46 . . . . 0.0 109.451 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 784' ' ' THR . . . . . 0.481 ' O ' ' CE1' ' A' ' 788' ' ' PHE . 0.0 OUTLIER -136.3 -55.1 0.75 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.101 -1.235 . . . . 0.0 110.519 179.985 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 785' ' ' CYS . . . . . . . . . . . . . 11.0 t -156.97 108.27 2.38 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.215 -0.928 . . . . 0.0 110.507 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 786' ' ' GLY . . . . . . . . . . . . . . . 112.5 -14.27 25.15 Favored Glycine 0 N--CA 1.492 2.401 0 N-CA-C 109.801 -1.319 . . . . 0.0 109.801 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 787' ' ' THR . . . . . . . . . . . . . 3.7 m -136.74 29.76 2.87 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.197 -1.178 . . . . 0.0 110.556 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 788' ' ' PHE . . . . . 0.514 ' HB3' ' CZ ' ' A' ' 775' ' ' PHE . 0.7 OUTLIER -67.75 124.54 23.57 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.174 -0.954 . . . . 0.0 109.87 179.974 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 789' ' ' GLN . . . . . . . . . . . . . 9.7 tm0? -130.22 130.22 44.35 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.234 -0.916 . . . . 0.0 110.321 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 790' ' ' GLN . . . . . 0.502 ' CG ' ' O ' ' A' ' 790' ' ' GLN . 13.1 pt20 -59.73 104.14 0.26 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.292 -0.88 . . . . 0.0 110.025 -179.965 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 791' ' ' GLY . . . . . 0.446 ' O ' ' HG2' ' A' ' 792' ' ' GLU . . . -44.7 -61.96 3.11 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.661 -1.375 . . . . 0.0 109.661 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 792' ' ' GLU . . . . . 0.446 ' HG2' ' O ' ' A' ' 791' ' ' GLY . 2.2 mm-40 -171.48 -33.33 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.18 -1.188 . . . . 0.0 110.388 -179.989 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 793' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -96.46 155.27 16.84 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.163 -0.96 . . . . 0.0 110.499 -179.958 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 794' ' ' HIS . . . . . 0.535 ' CD2' ' H ' ' A' ' 795' ' ' SER . 11.3 t-160 -165.33 164.75 19.78 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.245 -0.91 . . . . 0.0 110.039 -179.966 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 795' ' ' SER . . . . . 0.753 ' C ' HG23 ' A' ' 796' ' ' ILE . 51.1 p -100.79 -7.93 23.18 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.245 -0.909 . . . . 0.0 110.36 179.978 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 796' ' ' ILE . . . . . 0.753 HG23 ' C ' ' A' ' 795' ' ' SER . 0.6 OUTLIER 64.61 11.83 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.506 2.375 0 O-C-N 121.559 -0.713 . . . . 0.0 110.258 -179.972 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 797' ' ' ASN . . . . . 0.461 ' OD1' ' O ' ' A' ' 797' ' ' ASN . 11.0 p30 -152.18 30.91 0.55 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.374 -0.829 . . . . 0.0 109.607 179.968 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 798' ' ' SER . . . . . 0.532 ' CB ' ' O ' ' A' ' 776' ' ' ALA . 3.9 m -67.36 -51.2 55.09 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.573 -0.704 . . . . 0.0 111.707 -179.874 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 799' ' ' ASN . . . . . 0.437 ' OD1' ' N ' ' A' ' 800' ' ' SER . 36.3 p30 -74.9 -17.55 60.56 Favored 'General case' 0 N--CA 1.5 2.039 0 O-C-N 121.243 -0.911 . . . . 0.0 111.803 -179.823 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 800' ' ' SER . . . . . 0.437 ' N ' ' OD1' ' A' ' 799' ' ' ASN . 29.5 t -58.88 -22.24 58.93 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 120.853 -1.154 . . . . 0.0 110.851 -179.96 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 801' ' ' VAL . . . . . . . . . . . . . 42.6 t -93.72 -18.8 6.85 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.006 0 O-C-N 121.096 -1.002 . . . . 0.0 111.051 -179.921 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 802' ' ' LEU . . . . . 0.484 HD11 HG21 ' A' ' 814' ' ' VAL . 4.0 mm? -87.61 -21.54 25.28 Favored 'General case' 0 N--CA 1.5 2.052 0 O-C-N 121.089 -1.007 . . . . 0.0 111.176 -179.868 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 803' ' ' GLU . . . . . . . . . . . . . 24.5 mt-10 -79.31 -29.11 42.22 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.019 -1.051 . . . . 0.0 111.117 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 804' ' ' ARG . . . . . . . . . . . . . 6.8 mpt_? -92.43 -18.6 23.03 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.082 -1.011 . . . . 0.0 111.545 -179.924 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 805' ' ' LYS . . . . . . . . . . . . . 7.9 ttmt -129.4 52.03 2.01 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 120.84 -1.163 . . . . 0.0 111.625 -179.87 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 806' ' ' CYS . . . . . 0.436 ' HB2' ' O ' ' A' ' 802' ' ' LEU . 0.5 OUTLIER -162.63 -44.61 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.981 -1.074 . . . . 0.0 110.621 179.901 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 807' ' ' ILE . . . . . . . . . . . . . 30.6 mt -71.92 107.56 2.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.231 -0.918 . . . . 0.0 110.444 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 808' ' ' GLY . . . . . . . . . . . . . . . 122.11 8.79 7.05 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.756 -1.338 . . . . 0.0 109.756 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 809' ' ' LEU . . . . . . . . . . . . . 83.4 mt -135.39 144.91 46.84 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.232 -1.158 . . . . 0.0 110.517 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 810' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -70.88 -28.97 64.95 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.341 -0.85 . . . . 0.0 109.952 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 811' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -123.7 160.26 27.61 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.475 -0.765 . . . . 0.0 109.987 179.908 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 812' ' ' CYS . . . . . 0.482 ' O ' ' HB2' ' A' ' 762' ' ' LEU . 1.3 t -145.69 128.69 16.5 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.267 -0.896 . . . . 0.0 110.313 179.988 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 813' ' ' VAL . . . . . . . . . . . . . 4.8 t -127.13 108.88 19.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.17 -0.956 . . . . 0.0 109.934 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 814' ' ' VAL . . . . . 0.484 HG21 HD11 ' A' ' 802' ' ' LEU . 63.7 t -110.57 108.99 26.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.258 -0.901 . . . . 0.0 110.147 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 815' ' ' ALA . . . . . 0.677 ' HB2' ' HE3' ' A' ' 759' ' ' LYS . . . -74.32 168.15 20.22 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.285 -0.884 . . . . 0.0 110.085 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 816' ' ' ILE . . . . . 0.822 HD13 HG21 ' A' ' 833' ' ' VAL . 39.3 mt -121.82 131.67 72.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.253 -0.905 . . . . 0.0 110.322 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 817' ' ' SER . . . . . 0.475 ' HB2' ' HD2' ' A' ' 818' ' ' PRO . 9.1 p -178.71 173.63 0.58 Allowed Pre-proline 0 C--N 1.301 -1.54 0 O-C-N 121.43 -0.794 . . . . 0.0 109.695 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 818' ' ' PRO . . . . . 0.475 ' HD2' ' HB2' ' A' ' 817' ' ' SER . 51.3 Cg_endo -79.54 12.41 2.38 Favored 'Trans proline' 0 C--N 1.304 -1.78 0 O-C-N 123.847 1.446 . . . . 0.0 111.048 179.957 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 819' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -128.81 2.53 5.4 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.971 -1.081 . . . . 0.0 110.586 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 820' ' ' ASN . . . . . . . . . . . . . 5.7 m120 -96.36 -35.3 11.25 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.073 -1.017 . . . . 0.0 110.365 -179.932 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 821' ' ' PHE . . . . . . . . . . . . . 46.8 m-85 -104.04 -69.03 0.82 Allowed 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.277 -0.889 . . . . 0.0 110.352 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 822' ' ' GLY . . . . . . . . . . . . . . . 167.6 51.92 0.03 OUTLIER Glycine 0 N--CA 1.492 2.381 0 N-CA-C 109.617 -1.393 . . . . 0.0 109.617 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 823' ' ' GLY . . . . . . . . . . . . . . . 91.58 178.07 42.61 Favored Glycine 0 N--CA 1.493 2.453 0 N-CA-C 109.693 -1.363 . . . . 0.0 109.693 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 824' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -112.68 129.31 24.55 Favored Pre-proline 0 N--CA 1.495 1.797 0 O-C-N 121.338 -1.095 . . . . 0.0 110.236 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 825' ' ' PRO . . . . . 0.436 ' O ' ' HD3' ' A' ' 827' ' ' PRO . 49.4 Cg_endo -82.6 -47.28 0.06 OUTLIER 'Trans proline' 0 C--N 1.307 -1.621 0 O-C-N 123.857 1.451 . . . . 0.0 111.201 -179.958 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 826' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -114.7 93.36 32.97 Favored Pre-proline 0 N--CA 1.498 1.929 0 O-C-N 120.987 -1.07 . . . . 0.0 111.137 -179.892 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 827' ' ' PRO . . . . . 0.472 ' O ' ' CB ' ' A' ' 828' ' ' GLU . 50.6 Cg_endo -89.04 162.01 5.87 Favored 'Trans proline' 0 C--N 1.307 -1.623 0 O-C-N 123.903 1.475 . . . . 0.0 110.396 179.948 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 828' ' ' GLU . . . . . 0.472 ' CB ' ' O ' ' A' ' 827' ' ' PRO . 0.7 OUTLIER 67.35 16.29 10.05 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.206 -0.934 . . . . 0.0 110.806 179.971 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 829' ' ' VAL . . . . . 0.42 ' O ' ' C ' ' A' ' 830' ' ' MET . 59.1 t -127.3 148.27 32.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.061 -1.025 . . . . 0.0 110.129 -179.985 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 830' ' ' MET . . . . . 0.622 ' HG3' HG22 ' A' ' 780' ' ' THR . 3.1 ptt? -41.89 106.54 0.06 Allowed 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.233 -0.917 . . . . 0.0 109.885 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 831' ' ' LYS . . . . . . . . . . . . . 11.5 mttm -82.03 115.43 21.17 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.164 -0.96 . . . . 0.0 111.001 -179.882 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 832' ' ' ARG . . . . . 0.529 ' HB3' ' CG ' ' A' ' 781' ' ' PRO . 2.4 mmm-85 -135.33 132.79 38.09 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 179.889 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 833' ' ' VAL . . . . . 0.822 HG21 HD13 ' A' ' 816' ' ' ILE . 39.3 t -108.96 130.86 61.13 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.584 0 O-C-N 121.02 -1.05 . . . . 0.0 111.034 -179.889 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 834' ' ' ALA . . . . . 0.506 ' O ' HG23 ' A' ' 835' ' ' VAL . . . -128.83 135.59 49.33 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.508 -0.745 . . . . 0.0 109.411 -179.985 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 835' ' ' VAL . . . . . 0.506 HG23 ' O ' ' A' ' 834' ' ' ALA . 13.3 t -152.78 127.64 1.49 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.051 -1.031 . . . . 0.0 110.776 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 836' ' ' GLU . . . . . 0.442 ' OE1' ' SG ' ' A' ' 732' ' ' CYS . 3.4 mt-10 -110.58 133.38 53.36 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.452 -0.78 . . . . 0.0 109.587 179.922 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 837' ' ' ALA . . . . . . . . . . . . . . . -110.8 154.54 23.82 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.082 -1.011 . . . . 0.0 110.701 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 838' ' ' VAL . . . . . 0.422 ' HB ' ' O ' ' A' ' 772' ' ' ALA . 99.2 t -107.85 108.86 26.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.366 -0.834 . . . . 0.0 109.807 179.967 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 839' ' ' CYS . . . . . 0.415 ' O ' ' O ' ' A' ' 728' ' ' VAL . 0.0 OUTLIER -108.66 146.56 33.23 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.238 -0.914 . . . . 0.0 110.353 -179.934 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 840' ' ' SER . . . . . 0.466 ' HA ' HG12 ' A' ' 728' ' ' VAL . 0.6 OUTLIER -157.04 168.57 27.08 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.299 -0.875 . . . . 0.0 110.097 179.985 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 841' ' ' THR . . . . . . . . . . . . . 1.2 p . . . . . 0 N--CA 1.494 1.769 0 O-C-N 121.309 -0.869 . . . . 0.0 110.567 -179.979 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 728' ' ' VAL . . . . . 0.789 ' O ' HG12 ' A' ' 728' ' ' VAL . 9.9 t . . . . . 0 N--CA 1.492 1.643 0 CA-C-O 121.135 0.493 . . . . 0.0 110.036 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 729' ' ' SER . . . . . 0.444 ' HB3' ' HB3' ' A' ' 840' ' ' SER . 69.5 p -136.06 128.85 30.99 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.162 -0.961 . . . . 0.0 110.447 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 730' ' ' GLY . . . . . . . . . . . . . . . 132.82 74.74 0.1 Allowed Glycine 0 N--CA 1.492 2.414 0 N-CA-C 109.819 -1.312 . . . . 0.0 109.819 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 731' ' ' VAL . . . . . . . . . . . . . 48.0 t -109.66 147.43 14.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.217 -1.166 . . . . 0.0 110.039 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 732' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -120.51 151.63 39.11 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.159 -0.963 . . . . 0.0 110.568 -179.963 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 733' ' ' ALA . . . . . . . . . . . . . . . -141.26 103.09 4.36 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.413 -0.804 . . . . 0.0 109.69 179.923 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 734' ' ' ASP . . . . . 0.41 ' C ' HG23 ' A' ' 735' ' ' VAL . 39.0 t70 -127.61 128.19 45.12 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.261 -0.899 . . . . 0.0 109.889 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 735' ' ' VAL . . . . . 0.41 HG23 ' C ' ' A' ' 734' ' ' ASP . 76.7 t -146.74 134.19 14.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.031 -1.043 . . . . 0.0 110.61 179.933 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 736' ' ' SER . . . . . . . . . . . . . 2.7 m -68.26 140.9 56.02 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.359 -0.838 . . . . 0.0 109.852 179.931 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 737' ' ' GLU . . . . . . . . . . . . . 9.2 tm-20 . . . . . 0 N--CA 1.49 1.537 0 O-C-N 121.199 -0.938 . . . . 0.0 110.527 -179.976 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 757' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.502 2.134 0 CA-C-O 121.746 0.784 . . . . 0.0 111.573 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 758' ' ' ALA . . . . . . . . . . . . . . . -142.91 176.91 8.71 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.492 -0.755 . . . . 0.0 109.424 179.895 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 759' ' ' LYS . . . . . . . . . . . . . 8.3 mtpp -136.77 165.62 25.5 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.155 -0.966 . . . . 0.0 110.926 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 760' ' ' VAL . . . . . 0.433 HG23 HG13 ' A' ' 816' ' ' ILE . 46.8 t -108.38 146.65 13.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 179.91 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 761' ' ' HIS . . . . . . . . . . . . . 31.8 m80 -122.38 105.19 9.96 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.978 -1.076 . . . . 0.0 111.618 -179.879 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 762' ' ' LEU . . . . . 0.535 ' CB ' ' HB3' ' A' ' 812' ' ' CYS . 9.1 mt -118.14 131.21 56.43 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 179.823 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 763' ' ' LYS . . . . . . . . . . . . . 4.3 pttt -159.8 156.13 26.99 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.859 -1.151 . . . . 0.0 111.276 -179.932 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 764' ' ' CYS . . . . . . . . . . . . . 66.0 m -140.02 -178.14 5.32 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.577 -0.702 . . . . 0.0 109.755 179.88 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 765' ' ' ALA . . . . . 0.475 ' HB3' ' CD ' ' A' ' 768' ' ' GLN . . . -68.49 161.21 71.83 Favored Pre-proline 0 C--N 1.293 -1.883 0 O-C-N 121.233 -0.917 . . . . 0.0 110.895 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 766' ' ' PRO . . . . . 0.403 ' HD2' ' HB1' ' A' ' 765' ' ' ALA . 47.2 Cg_endo -72.53 83.68 1.27 Allowed 'Trans proline' 0 C--N 1.309 -1.528 0 O-C-N 124.174 1.618 . . . . 0.0 109.951 179.926 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 767' ' ' GLY . . . . . . . . . . . . . . . 150.42 -26.14 1.09 Allowed Glycine 0 N--CA 1.488 2.13 0 N-CA-C 108.293 -1.923 . . . . 0.0 108.293 -179.918 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 768' ' ' GLN . . . . . 0.502 ' HA ' ' O ' ' A' ' 840' ' ' SER . 11.9 mt-30 -101.33 102.4 13.24 Favored 'General case' 0 N--CA 1.486 1.357 0 O-C-N 121.647 -0.914 . . . . 0.0 109.458 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 769' ' ' THR . . . . . . . . . . . . . 9.1 p -101.11 149.26 24.15 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.234 -0.916 . . . . 0.0 110.566 -179.857 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 770' ' ' ILE . . . . . 0.563 HG13 ' HB3' ' A' ' 839' ' ' CYS . 2.6 mp -63.06 148.16 11.47 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 O-C-N 121.287 -0.883 . . . . 0.0 109.97 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 771' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -137.49 -15.76 1.4 Allowed 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.1 -1.0 . . . . 0.0 111.847 -179.963 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 772' ' ' ALA . . . . . . . . . . . . . . . -144.3 136.59 26.49 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 120.698 -1.251 . . . . 0.0 111.689 -179.888 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 773' ' ' ILE . . . . . 0.41 HD12 HG23 ' A' ' 773' ' ' ILE . 23.1 mm -105.4 113.65 42.88 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 179.827 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 774' ' ' LYS . . . . . . . . . . . . . 27.6 ttpp -82.08 -44.96 15.88 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.077 -1.014 . . . . 0.0 111.072 -179.925 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 775' ' ' PHE . . . . . 0.531 ' CD2' ' HB3' ' A' ' 788' ' ' PHE . 73.2 t80 -138.88 163.53 32.06 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.013 -1.054 . . . . 0.0 111.194 -179.911 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 776' ' ' ALA . . . . . 0.502 ' HB1' ' O ' ' A' ' 798' ' ' SER . . . -179.68 93.63 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 109.392 -0.596 . . . . 0.0 109.392 179.989 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 777' ' ' SER . . . . . 0.493 ' HA ' ' CB ' ' A' ' 798' ' ' SER . 11.9 t -127.53 133.33 49.82 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.17 -0.956 . . . . 0.0 110.47 -179.871 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 778' ' ' PHE . . . . . 0.76 ' HE2' HG23 ' A' ' 816' ' ' ILE . 55.1 t80 -110.05 95.84 5.85 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.419 -0.8 . . . . 0.0 110.157 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 779' ' ' GLY . . . . . 0.49 ' HA2' ' HB2' ' A' ' 831' ' ' LYS . . . 163.12 -97.14 0.15 Allowed Glycine 0 N--CA 1.493 2.438 0 N-CA-C 109.655 -1.378 . . . . 0.0 109.655 -179.921 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 780' ' ' THR . . . . . 0.468 ' O ' ' HA3' ' A' ' 791' ' ' GLY . 6.3 p -132.52 89.23 36.73 Favored Pre-proline 0 N--CA 1.495 1.783 0 O-C-N 121.12 -1.223 . . . . 0.0 110.063 -179.954 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 781' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -76.36 169.21 22.39 Favored 'Trans proline' 0 C--N 1.303 -1.847 0 O-C-N 124.072 1.564 . . . . 0.0 110.607 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 782' ' ' LEU . . . . . 0.781 HD13 ' C ' ' A' ' 782' ' ' LEU . 1.9 tm? -131.11 115.11 15.98 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.25 -0.906 . . . . 0.0 110.209 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 783' ' ' GLY . . . . . 0.433 ' N ' HD22 ' A' ' 782' ' ' LEU . . . 126.46 -173.92 18.03 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.827 -1.309 . . . . 0.0 109.827 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 784' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -119.08 -169.04 1.67 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.322 -1.105 . . . . 0.0 110.32 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 785' ' ' CYS . . . . . . . . . . . . . 3.6 t -65.1 90.66 0.09 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.369 -0.832 . . . . 0.0 110.309 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 786' ' ' GLY . . . . . . . . . . . . . . . 153.04 -22.53 0.78 Allowed Glycine 0 N--CA 1.489 2.202 0 N-CA-C 110.036 -1.226 . . . . 0.0 110.036 179.914 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 787' ' ' THR . . . . . 0.784 HG22 ' O ' ' A' ' 787' ' ' THR . 60.0 m -146.7 36.28 0.96 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.121 -1.223 . . . . 0.0 110.839 -179.965 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 788' ' ' PHE . . . . . 0.531 ' HB3' ' CD2' ' A' ' 775' ' ' PHE . 7.9 m-85 -54.06 112.44 0.96 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.028 -1.045 . . . . 0.0 109.769 179.995 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 789' ' ' GLN . . . . . . . . . . . . . 3.3 mt-30 -119.36 157.95 27.12 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.255 -0.903 . . . . 0.0 110.116 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 790' ' ' GLN . . . . . . . . . . . . . 16.7 mp0 -49.38 122.01 5.66 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.257 -0.902 . . . . 0.0 110.3 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 791' ' ' GLY . . . . . 0.468 ' HA3' ' O ' ' A' ' 780' ' ' THR . . . -81.05 -103.65 0.32 Allowed Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.404 -1.478 . . . . 0.0 109.404 179.938 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 792' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -130.17 -36.17 1.54 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.294 -1.121 . . . . 0.0 110.218 179.939 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 793' ' ' CYS . . . . . 0.434 ' HB2' ' OG1' ' A' ' 780' ' ' THR . 4.6 m -107.76 146.32 32.32 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.246 -0.909 . . . . 0.0 110.418 -179.975 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 794' ' ' HIS . . . . . . . . . . . . . 17.3 t-160 -149.06 143.92 26.36 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.372 -0.83 . . . . 0.0 110.172 179.901 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 795' ' ' SER . . . . . 0.533 ' O ' ' CG1' ' A' ' 796' ' ' ILE . 9.0 t -92.93 22.92 4.52 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.25 -0.906 . . . . 0.0 110.227 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 796' ' ' ILE . . . . . 0.533 ' CG1' ' O ' ' A' ' 795' ' ' SER . 36.8 pt 37.32 29.67 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.105 0 O-C-N 121.621 -0.675 . . . . 0.0 110.861 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 797' ' ' ASN . . . . . 0.488 ' N ' ' O ' ' A' ' 795' ' ' SER . 2.0 t-20 -157.66 19.32 0.27 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.085 -1.009 . . . . 0.0 110.269 179.946 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 798' ' ' SER . . . . . 0.502 ' O ' ' HB1' ' A' ' 776' ' ' ALA . 1.2 m -90.33 18.22 6.34 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.263 -0.898 . . . . 0.0 110.395 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 799' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -131.16 -16.88 3.11 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.073 -1.017 . . . . 0.0 111.327 -179.961 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 800' ' ' SER . . . . . . . . . . . . . 5.7 p -78.79 -53.08 7.48 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.0 -1.062 . . . . 0.0 110.544 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 801' ' ' VAL . . . . . 0.547 ' O ' ' CB ' ' A' ' 805' ' ' LYS . 55.1 t -58.63 -19.77 15.14 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.31 -0.869 . . . . 0.0 110.723 -179.948 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 802' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -81.84 -62.2 1.7 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.992 -1.067 . . . . 0.0 111.165 -179.899 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 803' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -56.54 -32.78 65.46 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.192 -0.943 . . . . 0.0 111.417 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 804' ' ' ARG . . . . . . . . . . . . . 62.6 mtm-85 -92.52 -18.88 22.58 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.045 -1.034 . . . . 0.0 111.84 -179.868 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 805' ' ' LYS . . . . . 0.547 ' CB ' ' O ' ' A' ' 801' ' ' VAL . 0.2 OUTLIER -116.83 43.0 2.35 Favored 'General case' 0 N--CA 1.501 2.095 0 O-C-N 120.815 -1.178 . . . . 0.0 111.061 -179.962 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 806' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -159.5 -55.15 0.06 Allowed 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.103 -0.998 . . . . 0.0 110.259 179.833 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 807' ' ' ILE . . . . . . . . . . . . . 61.5 mt -61.21 123.82 14.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.218 -0.926 . . . . 0.0 110.314 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 808' ' ' GLY . . . . . 0.43 ' C ' ' HG ' ' A' ' 809' ' ' LEU . . . 101.31 11.8 37.91 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.603 -1.399 . . . . 0.0 109.603 -179.941 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 809' ' ' LEU . . . . . 0.43 ' HG ' ' C ' ' A' ' 808' ' ' GLY . 59.5 mt -137.28 129.83 29.95 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.228 -1.16 . . . . 0.0 110.199 179.976 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 810' ' ' GLU . . . . . . . . . . . . . 24.1 tt0 -67.56 -19.73 65.31 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.325 -0.859 . . . . 0.0 110.188 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 811' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -133.65 128.7 35.63 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.386 -0.821 . . . . 0.0 110.211 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 812' ' ' CYS . . . . . 0.535 ' HB3' ' CB ' ' A' ' 762' ' ' LEU . 1.3 t -110.65 122.38 47.63 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.329 -0.857 . . . . 0.0 110.135 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 813' ' ' VAL . . . . . . . . . . . . . 25.2 t -130.45 118.62 43.65 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.14 -0.975 . . . . 0.0 110.153 -180.0 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 814' ' ' VAL . . . . . . . . . . . . . 91.6 t -134.67 120.01 30.54 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.286 -0.884 . . . . 0.0 110.156 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 815' ' ' ALA . . . . . . . . . . . . . . . -75.71 146.47 40.11 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.227 -0.921 . . . . 0.0 110.278 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 816' ' ' ILE . . . . . 0.76 HG23 ' HE2' ' A' ' 778' ' ' PHE . 84.6 mt -96.53 123.28 48.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.319 -0.863 . . . . 0.0 110.178 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 817' ' ' SER . . . . . 0.477 ' HB2' ' HD2' ' A' ' 818' ' ' PRO . 4.5 p -159.5 170.55 8.61 Favored Pre-proline 0 N--CA 1.494 1.766 0 O-C-N 121.009 -1.057 . . . . 0.0 110.561 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 818' ' ' PRO . . . . . 0.477 ' HD2' ' HB2' ' A' ' 817' ' ' SER . 47.0 Cg_endo -73.77 -2.08 11.7 Favored 'Trans proline' 0 C--N 1.308 -1.555 0 O-C-N 124.047 1.551 . . . . 0.0 110.606 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 819' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -134.65 59.91 1.72 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.206 -0.934 . . . . 0.0 110.229 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 820' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -132.48 -41.9 0.96 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.365 -0.834 . . . . 0.0 110.278 -179.967 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 821' ' ' PHE . . . . . . . . . . . . . 79.8 m-85 -100.98 -68.79 0.8 Allowed 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.215 -0.928 . . . . 0.0 110.72 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 822' ' ' GLY . . . . . . . . . . . . . . . -149.05 20.76 1.24 Allowed Glycine 0 N--CA 1.492 2.422 0 C-N-CA 119.638 -1.268 . . . . 0.0 109.945 -179.904 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 823' ' ' GLY . . . . . 0.47 ' HA2' ' O ' ' A' ' 818' ' ' PRO . . . 102.94 -132.96 11.22 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.719 -1.352 . . . . 0.0 109.719 179.912 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 824' ' ' ASP . . . . . 0.471 ' OD1' ' HB3' ' A' ' 818' ' ' PRO . 2.2 m-20 -140.77 106.45 6.36 Favored Pre-proline 0 N--CA 1.493 1.724 0 O-C-N 121.289 -1.124 . . . . 0.0 110.246 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 825' ' ' PRO . . . . . 0.468 ' O ' ' HD3' ' A' ' 827' ' ' PRO . 44.9 Cg_endo -72.47 -88.44 0.0 OUTLIER 'Trans proline' 0 C--N 1.304 -1.774 0 O-C-N 124.085 1.571 . . . . 0.0 111.003 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 826' ' ' CYS . . . . . . . . . . . . . 97.1 m -80.6 112.18 29.29 Favored Pre-proline 0 N--CA 1.498 1.938 0 O-C-N 121.232 -0.918 . . . . 0.0 110.924 -179.908 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 827' ' ' PRO . . . . . 0.726 ' O ' HG23 ' A' ' 829' ' ' VAL . 49.7 Cg_endo -94.12 173.92 1.51 Allowed 'Trans proline' 0 C--N 1.308 -1.563 0 O-C-N 123.993 1.523 . . . . 0.0 110.251 179.956 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 828' ' ' GLU . . . . . . . . . . . . . 14.4 mt-10 52.33 31.11 8.94 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.358 -0.839 . . . . 0.0 110.826 179.945 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 829' ' ' VAL . . . . . 0.726 HG23 ' O ' ' A' ' 827' ' ' PRO . 97.9 t -137.02 113.73 12.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.013 -1.055 . . . . 0.0 110.469 -179.944 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 830' ' ' MET . . . . . 0.434 ' C ' ' O ' ' A' ' 829' ' ' VAL . 2.2 mtt -42.52 95.86 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.333 -0.854 . . . . 0.0 109.989 179.937 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 831' ' ' LYS . . . . . 0.494 ' N ' ' O ' ' A' ' 829' ' ' VAL . 1.9 pttp -109.63 139.49 44.59 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.206 -0.934 . . . . 0.0 110.925 -179.908 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 832' ' ' ARG . . . . . . . . . . . . . 10.4 ptt180 -128.45 166.57 18.5 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.416 -0.802 . . . . 0.0 109.277 179.917 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 833' ' ' VAL . . . . . 0.503 HG22 ' CD2' ' A' ' 778' ' ' PHE . 54.7 t -107.61 128.67 62.59 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.109 -0.994 . . . . 0.0 110.831 -179.913 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 834' ' ' ALA . . . . . . . . . . . . . . . -128.57 132.45 48.22 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 179.891 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 835' ' ' VAL . . . . . . . . . . . . . 53.2 t -141.25 150.9 19.76 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 O-C-N 120.819 -1.176 . . . . 0.0 111.538 -179.893 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 836' ' ' GLU . . . . . . . . . . . . . 4.0 tp10 -131.53 108.71 9.75 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 179.9 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 837' ' ' ALA . . . . . . . . . . . . . . . -107.87 158.87 16.97 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.037 -1.039 . . . . 0.0 110.264 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 838' ' ' VAL . . . . . . . . . . . . . 37.6 t -122.19 103.07 12.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.285 -0.884 . . . . 0.0 110.418 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 839' ' ' CYS . . . . . 0.563 ' HB3' HG13 ' A' ' 770' ' ' ILE . 3.1 p -120.19 132.29 55.31 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.4 -0.812 . . . . 0.0 109.401 179.931 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 840' ' ' SER . . . . . 0.502 ' O ' ' HA ' ' A' ' 768' ' ' GLN . 16.7 p -149.66 -168.45 3.11 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.065 -1.022 . . . . 0.0 110.881 -179.919 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 841' ' ' THR . . . . . 0.487 ' N ' ' HG2' ' A' ' 768' ' ' GLN . 22.7 p . . . . . 0 N--CA 1.497 1.884 0 O-C-N 121.435 -0.791 . . . . 0.0 110.767 -179.91 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 728' ' ' VAL . . . . . . . . . . . . . 15.5 m . . . . . 0 N--CA 1.489 1.487 0 CA-C-O 121.196 0.522 . . . . 0.0 110.08 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 729' ' ' SER . . . . . . . . . . . . . 1.5 t -173.87 168.09 4.29 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.295 -0.878 . . . . 0.0 110.278 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 730' ' ' GLY . . . . . . . . . . . . . . . -138.1 130.11 4.86 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.404 -1.478 . . . . 0.0 109.404 179.931 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 731' ' ' VAL . . . . . 0.619 ' CG2' ' HB3' ' A' ' 837' ' ' ALA . 13.6 m -110.82 124.93 68.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.237 -1.155 . . . . 0.0 110.339 -179.956 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 732' ' ' CYS . . . . . . . . . . . . . 5.1 t -109.46 112.46 24.58 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.343 -0.848 . . . . 0.0 109.582 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 733' ' ' ALA . . . . . . . . . . . . . . . -114.2 142.01 46.8 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.236 -0.915 . . . . 0.0 110.974 -179.924 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 734' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -155.54 118.58 4.31 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.465 -0.772 . . . . 0.0 109.483 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 735' ' ' VAL . . . . . . . . . . . . . 65.5 t -128.55 150.39 34.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.121 -0.987 . . . . 0.0 110.789 -179.934 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 736' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -99.88 139.73 35.13 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.323 -0.861 . . . . 0.0 109.614 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 737' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 . . . . . 0 N--CA 1.495 1.811 0 O-C-N 121.082 -1.011 . . . . 0.0 110.668 179.991 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 757' ' ' THR . . . . . . . . . . . . . 25.5 p . . . . . 0 N--CA 1.493 1.702 0 CA-C-O 121.326 0.584 . . . . 0.0 110.332 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 758' ' ' ALA . . . . . 0.565 ' HB3' HD12 ' A' ' 816' ' ' ILE . . . -98.79 176.83 5.48 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.294 -0.879 . . . . 0.0 110.224 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 759' ' ' LYS . . . . . . . . . . . . . 13.4 mtmm -141.09 144.58 35.0 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.261 -0.899 . . . . 0.0 110.44 -179.934 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 760' ' ' VAL . . . . . . . . . . . . . 38.5 t -106.14 133.99 49.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.333 -0.854 . . . . 0.0 108.767 179.881 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 761' ' ' HIS . . . . . 0.69 ' NE2' HG22 ' A' ' 813' ' ' VAL . 0.3 OUTLIER -120.47 123.12 42.19 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 120.907 -1.121 . . . . 0.0 111.893 -179.87 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 762' ' ' LEU . . . . . . . . . . . . . 12.5 mt -120.45 98.61 6.12 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 179.77 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 763' ' ' LYS . . . . . 0.533 ' CB ' ' HG2' ' A' ' 811' ' ' ARG . 0.2 OUTLIER -114.48 137.51 51.76 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.005 -1.059 . . . . 0.0 111.515 -179.8 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 764' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER -118.3 161.96 19.07 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.679 -0.638 . . . . 0.0 109.555 179.901 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 765' ' ' ALA . . . . . 0.579 ' HB1' ' HD2' ' A' ' 766' ' ' PRO . . . -50.62 167.73 0.25 Allowed Pre-proline 0 N--CA 1.495 1.775 0 O-C-N 120.978 -1.076 . . . . 0.0 110.133 -179.959 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 766' ' ' PRO . . . . . 0.579 ' HD2' ' HB1' ' A' ' 765' ' ' ALA . 45.5 Cg_endo -72.22 124.34 9.91 Favored 'Trans proline' 0 C--N 1.305 -1.734 0 O-C-N 123.972 1.512 . . . . 0.0 110.155 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 767' ' ' GLY . . . . . . . . . . . . . . . 109.67 -36.37 4.35 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.223 -1.551 . . . . 0.0 109.223 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 768' ' ' GLN . . . . . . . . . . . . . 28.8 mt-30 -87.89 115.27 25.23 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.281 -1.129 . . . . 0.0 109.894 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 769' ' ' THR . . . . . . . . . . . . . 29.4 p -109.28 167.64 9.97 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.215 -0.928 . . . . 0.0 110.292 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 770' ' ' ILE . . . . . . . . . . . . . 7.8 mt -85.61 101.25 9.75 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 121.236 -0.915 . . . . 0.0 109.807 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 771' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -89.55 -6.9 55.91 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.162 -0.961 . . . . 0.0 110.818 -179.923 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 772' ' ' ALA . . . . . 0.464 ' O ' ' HB ' ' A' ' 838' ' ' VAL . . . -165.84 142.46 5.28 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.008 -1.058 . . . . 0.0 111.278 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 773' ' ' ILE . . . . . 0.409 HG13 ' HG2' ' A' ' 803' ' ' GLU . 47.3 mm -94.61 125.87 47.15 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 O-C-N 121.392 -0.817 . . . . 0.0 109.134 179.944 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 774' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -80.17 -37.94 32.33 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.085 -1.01 . . . . 0.0 111.244 -179.895 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 775' ' ' PHE . . . . . 0.642 ' O ' ' HB2' ' A' ' 776' ' ' ALA . 65.0 t80 -150.96 170.18 19.96 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.82 -1.175 . . . . 0.0 111.124 -179.984 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 776' ' ' ALA . . . . . 0.642 ' HB2' ' O ' ' A' ' 775' ' ' PHE . . . 170.82 116.4 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.703 -0.623 . . . . 0.0 109.346 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 777' ' ' SER . . . . . . . . . . . . . 14.5 t -151.69 131.77 13.49 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.114 -0.991 . . . . 0.0 110.724 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 778' ' ' PHE . . . . . . . . . . . . . 2.4 t80 -99.3 124.98 44.84 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.56 -0.713 . . . . 0.0 109.756 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 779' ' ' GLY . . . . . . . . . . . . . . . 130.3 -110.5 1.03 Allowed Glycine 0 N--CA 1.493 2.482 0 N-CA-C 109.85 -1.3 . . . . 0.0 109.85 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 780' ' ' THR . . . . . . . . . . . . . 11.8 p -135.37 83.57 37.49 Favored Pre-proline 0 N--CA 1.496 1.841 0 O-C-N 121.16 -1.2 . . . . 0.0 110.636 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 781' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -76.92 158.23 34.65 Favored 'Trans proline' 0 C--N 1.307 -1.639 0 O-C-N 123.856 1.45 . . . . 0.0 110.087 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 782' ' ' LEU . . . . . 0.496 ' O ' ' HA ' ' A' ' 788' ' ' PHE . 0.3 OUTLIER -96.24 123.86 40.03 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.158 -0.964 . . . . 0.0 110.241 179.958 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 783' ' ' GLY . . . . . . . . . . . . . . . 138.37 -169.33 24.33 Favored Glycine 0 N--CA 1.492 2.404 0 N-CA-C 109.688 -1.365 . . . . 0.0 109.688 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 784' ' ' THR . . . . . . . . . . . . . 3.3 m -138.31 -52.17 0.6 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.281 -1.129 . . . . 0.0 109.961 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 785' ' ' CYS . . . . . 0.558 ' HA ' ' CZ ' ' A' ' 788' ' ' PHE . 40.3 t -166.95 74.51 0.15 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.281 -0.887 . . . . 0.0 109.793 179.948 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 786' ' ' GLY . . . . . . . . . . . . . . . 130.68 -16.07 5.39 Favored Glycine 0 N--CA 1.489 2.171 0 N-CA-C 108.949 -1.66 . . . . 0.0 108.949 -179.932 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 787' ' ' THR . . . . . 0.451 HG22 ' O ' ' A' ' 787' ' ' THR . 18.2 m -121.78 27.36 8.19 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.477 -1.014 . . . . 0.0 109.878 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 788' ' ' PHE . . . . . 0.558 ' CZ ' ' HA ' ' A' ' 785' ' ' CYS . 35.4 m-85 -55.14 172.71 0.12 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.342 -0.849 . . . . 0.0 110.349 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 789' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER 179.23 172.48 0.86 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.362 -0.836 . . . . 0.0 109.93 -179.982 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 790' ' ' GLN . . . . . . . . . . . . . 6.2 tm0? -57.12 161.42 3.14 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.124 -0.985 . . . . 0.0 110.305 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 791' ' ' GLY . . . . . . . . . . . . . . . -136.89 -131.88 3.02 Favored Glycine 0 N--CA 1.494 2.507 0 N-CA-C 109.687 -1.365 . . . . 0.0 109.687 -179.919 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 792' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -107.76 -66.32 1.04 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.216 -1.167 . . . . 0.0 109.964 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 793' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -92.54 88.66 6.42 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.266 -0.896 . . . . 0.0 109.891 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 794' ' ' HIS . . . . . 0.435 ' HE1' ' CB ' ' A' ' 798' ' ' SER . 19.2 t60 -105.54 155.49 19.14 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.174 -0.954 . . . . 0.0 110.674 -179.921 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 795' ' ' SER . . . . . 0.535 ' HB2' ' HB3' ' A' ' 825' ' ' PRO . 1.3 t -115.63 111.21 20.3 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.466 -0.771 . . . . 0.0 109.942 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 796' ' ' ILE . . . . . . . . . . . . . 3.5 pt -44.3 -23.05 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 O-C-N 121.315 -0.866 . . . . 0.0 110.816 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 797' ' ' ASN . . . . . 0.409 ' N ' ' O ' ' A' ' 795' ' ' SER . 1.6 t30 -84.19 26.93 0.71 Allowed 'General case' 0 N--CA 1.499 1.991 0 O-C-N 120.988 -1.07 . . . . 0.0 111.005 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 798' ' ' SER . . . . . 0.487 ' HB3' ' O ' ' A' ' 776' ' ' ALA . 9.0 m -82.13 -31.57 30.53 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.0 -1.063 . . . . 0.0 111.11 179.942 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 799' ' ' ASN . . . . . 0.479 ' OD1' ' HB3' ' A' ' 776' ' ' ALA . 4.8 m120 -107.36 8.08 29.47 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.017 -1.052 . . . . 0.0 111.288 -179.893 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 800' ' ' SER . . . . . 0.448 ' O ' ' HB3' ' A' ' 804' ' ' ARG . 0.7 OUTLIER -90.33 -40.68 11.97 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.953 -1.092 . . . . 0.0 110.245 179.967 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 801' ' ' VAL . . . . . 0.63 HG21 ' CD2' ' A' ' 821' ' ' PHE . 55.5 t -74.65 -35.5 37.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.256 -0.902 . . . . 0.0 110.104 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 802' ' ' LEU . . . . . 0.492 HD13 ' HA ' ' A' ' 802' ' ' LEU . 4.0 mm? -69.31 -57.09 5.76 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.207 -0.933 . . . . 0.0 110.051 179.947 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 803' ' ' GLU . . . . . 0.409 ' HG2' HG13 ' A' ' 773' ' ' ILE . 0.7 OUTLIER -62.93 -18.29 62.94 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.235 -0.916 . . . . 0.0 110.011 179.943 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 804' ' ' ARG . . . . . 0.448 ' HB3' ' O ' ' A' ' 800' ' ' SER . 12.4 ttp180 -89.55 -20.42 23.81 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.265 -0.897 . . . . 0.0 111.07 -179.968 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 805' ' ' LYS . . . . . . . . . . . . . 9.2 ttmt -141.06 53.14 1.57 Allowed 'General case' 0 N--CA 1.495 1.818 0 O-C-N 120.878 -1.139 . . . . 0.0 110.873 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 806' ' ' CYS . . . . . 0.413 ' HB2' ' O ' ' A' ' 802' ' ' LEU . 1.4 t -158.94 -36.18 0.06 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.128 -0.983 . . . . 0.0 110.317 179.942 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 807' ' ' ILE . . . . . . . . . . . . . 9.5 mt -71.12 130.76 34.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.22 -0.925 . . . . 0.0 110.058 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 808' ' ' GLY . . . . . . . . . . . . . . . 91.8 16.03 52.85 Favored Glycine 0 N--CA 1.492 2.407 0 N-CA-C 109.776 -1.329 . . . . 0.0 109.776 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 809' ' ' LEU . . . . . . . . . . . . . 58.4 mt -129.22 138.97 52.01 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.188 -1.184 . . . . 0.0 110.411 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 810' ' ' GLU . . . . . 0.434 ' OE1' ' HA ' ' A' ' 766' ' ' PRO . 43.1 tt0 -69.14 -32.2 71.39 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.333 -0.854 . . . . 0.0 109.468 179.857 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 811' ' ' ARG . . . . . 0.533 ' HG2' ' CB ' ' A' ' 763' ' ' LYS . 3.3 mtm-85 -131.63 156.34 45.99 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.46 -0.775 . . . . 0.0 109.587 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 812' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -133.03 142.4 48.78 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.13 -0.981 . . . . 0.0 110.825 -179.976 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 813' ' ' VAL . . . . . 0.69 HG22 ' NE2' ' A' ' 761' ' ' HIS . 51.2 t -140.45 115.51 6.9 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.337 -0.852 . . . . 0.0 109.841 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 814' ' ' VAL . . . . . . . . . . . . . 52.4 t -128.89 121.76 55.24 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 O-C-N 121.253 -0.904 . . . . 0.0 110.464 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 815' ' ' ALA . . . . . . . . . . . . . . . -80.41 142.57 34.22 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.212 -0.93 . . . . 0.0 109.918 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 816' ' ' ILE . . . . . 0.565 HD12 ' HB3' ' A' ' 758' ' ' ALA . 14.1 mt -88.03 112.65 23.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.212 -0.93 . . . . 0.0 110.376 -179.955 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 817' ' ' SER . . . . . 0.458 ' OG ' ' OD1' ' A' ' 820' ' ' ASN . 78.7 p -168.34 163.39 8.57 Favored Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 121.448 -0.782 . . . . 0.0 109.993 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 818' ' ' PRO . . . . . 0.47 ' HB3' ' OD1' ' A' ' 824' ' ' ASP . 44.4 Cg_endo -72.37 -19.38 25.4 Favored 'Trans proline' 0 C--N 1.305 -1.747 0 O-C-N 124.021 1.537 . . . . 0.0 110.372 -179.979 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 819' ' ' SER . . . . . . . . . . . . . 9.1 m -94.97 48.13 1.17 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.187 -0.945 . . . . 0.0 110.017 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 820' ' ' ASN . . . . . 0.458 ' OD1' ' OG ' ' A' ' 817' ' ' SER . 1.2 m120 -139.75 -53.8 0.54 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.266 -0.897 . . . . 0.0 110.195 -179.955 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 821' ' ' PHE . . . . . 0.63 ' CD2' HG21 ' A' ' 801' ' ' VAL . 87.6 m-85 -79.54 -33.05 42.26 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.345 -0.847 . . . . 0.0 110.316 -179.958 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 822' ' ' GLY . . . . . . . . . . . . . . . 128.09 66.93 0.13 Allowed Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.656 -1.378 . . . . 0.0 109.656 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 823' ' ' GLY . . . . . . . . . . . . . . . 98.86 -175.57 28.89 Favored Glycine 0 N--CA 1.492 2.411 0 N-CA-C 109.716 -1.354 . . . . 0.0 109.716 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 824' ' ' ASP . . . . . 0.47 ' OD1' ' HB3' ' A' ' 818' ' ' PRO . 0.2 OUTLIER -102.18 133.15 20.79 Favored Pre-proline 0 N--CA 1.493 1.692 0 O-C-N 121.24 -1.153 . . . . 0.0 110.115 179.919 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 825' ' ' PRO . . . . . 0.535 ' HB3' ' HB2' ' A' ' 795' ' ' SER . 51.7 Cg_endo -75.07 -89.7 0.01 OUTLIER 'Trans proline' 0 C--N 1.307 -1.637 0 O-C-N 123.964 1.508 . . . . 0.0 110.477 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 826' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -113.41 103.1 55.48 Favored Pre-proline 0 N--CA 1.492 1.645 0 O-C-N 121.136 -0.978 . . . . 0.0 110.177 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 827' ' ' PRO . . . . . 0.411 ' O ' ' HB3' ' A' ' 828' ' ' GLU . 45.3 Cg_endo -74.08 165.4 32.09 Favored 'Trans proline' 0 C--N 1.304 -1.808 0 O-C-N 123.994 1.523 . . . . 0.0 110.655 179.933 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 828' ' ' GLU . . . . . 0.411 ' HB3' ' O ' ' A' ' 827' ' ' PRO . 1.6 tt0 55.78 44.7 25.71 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.304 -0.873 . . . . 0.0 110.578 179.959 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 829' ' ' VAL . . . . . 0.408 ' O ' ' C ' ' A' ' 830' ' ' MET . 25.4 t -141.33 151.57 19.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.222 -0.924 . . . . 0.0 110.122 179.92 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 830' ' ' MET . . . . . 0.408 ' C ' ' O ' ' A' ' 829' ' ' VAL . 0.0 OUTLIER -43.15 121.34 2.12 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.301 -0.874 . . . . 0.0 109.944 -179.986 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 831' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.71 86.64 7.31 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.287 -0.883 . . . . 0.0 110.595 -179.953 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 832' ' ' ARG . . . . . . . . . . . . . 6.8 mpt_? -129.58 125.89 37.24 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.408 -0.808 . . . . 0.0 109.421 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 833' ' ' VAL . . . . . 0.509 HG21 ' CG2' ' A' ' 816' ' ' ILE . 54.7 t -109.73 140.59 27.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.098 -1.001 . . . . 0.0 110.829 -179.887 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 834' ' ' ALA . . . . . 0.599 ' O ' HG23 ' A' ' 835' ' ' VAL . . . -141.26 138.16 33.03 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.398 -0.814 . . . . 0.0 109.68 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 835' ' ' VAL . . . . . 0.599 HG23 ' O ' ' A' ' 834' ' ' ALA . 35.3 t -156.0 127.99 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 O-C-N 121.036 -1.04 . . . . 0.0 111.187 -179.93 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 836' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -114.25 128.67 56.47 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.439 -0.788 . . . . 0.0 109.248 179.884 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 837' ' ' ALA . . . . . 0.619 ' HB3' ' CG2' ' A' ' 731' ' ' VAL . . . -110.98 157.89 19.39 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.075 -1.016 . . . . 0.0 110.914 -179.853 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 838' ' ' VAL . . . . . 0.464 ' HB ' ' O ' ' A' ' 772' ' ' ALA . 98.9 t -109.28 132.39 57.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.477 -0.765 . . . . 0.0 109.662 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 839' ' ' CYS . . . . . . . . . . . . . 1.3 m -115.8 134.64 54.8 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.071 -1.018 . . . . 0.0 110.721 -179.93 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 840' ' ' SER . . . . . . . . . . . . . 4.5 t -139.95 -133.84 0.11 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.44 -0.787 . . . . 0.0 109.743 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 841' ' ' THR . . . . . . . . . . . . . 30.4 p . . . . . 0 N--CA 1.492 1.627 0 O-C-N 120.89 -1.131 . . . . 0.0 110.213 -179.964 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 728' ' ' VAL . . . . . . . . . . . . . 56.4 t . . . . . 0 N--CA 1.492 1.662 0 CA-C-O 121.326 0.584 . . . . 0.0 110.039 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 729' ' ' SER . . . . . . . . . . . . . 1.3 t -84.68 -149.36 0.11 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.22 -0.925 . . . . 0.0 110.482 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 730' ' ' GLY . . . . . . . . . . . . . . . 170.58 131.7 1.37 Allowed Glycine 0 N--CA 1.489 2.175 0 N-CA-C 109.216 -1.554 . . . . 0.0 109.216 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 731' ' ' VAL . . . . . . . . . . . . . 7.0 t -120.14 141.25 41.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.174 -1.192 . . . . 0.0 110.411 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 732' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -109.64 163.86 13.08 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.354 -0.841 . . . . 0.0 109.864 -179.977 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 733' ' ' ALA . . . . . . . . . . . . . . . -155.37 104.48 2.4 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.146 -0.971 . . . . 0.0 110.656 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 734' ' ' ASP . . . . . . . . . . . . . 35.3 t0 -117.7 103.69 10.26 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.376 -0.828 . . . . 0.0 109.455 179.88 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 735' ' ' VAL . . . . . . . . . . . . . 68.4 t -129.86 154.02 39.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.209 -0.932 . . . . 0.0 110.482 -179.895 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 736' ' ' SER . . . . . 0.433 ' HA ' ' HD2' ' A' ' 832' ' ' ARG . 57.8 m -66.26 -173.29 0.19 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.316 -0.865 . . . . 0.0 110.474 -179.957 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 737' ' ' GLU . . . . . 0.455 ' OE1' HG21 ' A' ' 816' ' ' ILE . 28.8 tp10 . . . . . 0 N--CA 1.493 1.704 0 O-C-N 121.373 -0.83 . . . . 0.0 110.18 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 757' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.5 2.044 0 CA-C-O 121.474 0.654 . . . . 0.0 111.258 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 758' ' ' ALA . . . . . . . . . . . . . . . -91.45 174.99 7.08 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.437 -0.789 . . . . 0.0 110.333 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 759' ' ' LYS . . . . . . . . . . . . . 10.2 mttt -147.86 145.75 28.82 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.242 -0.912 . . . . 0.0 110.525 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 760' ' ' VAL . . . . . 0.43 ' CG2' HD11 ' A' ' 816' ' ' ILE . 97.9 t -136.97 131.13 46.2 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 O-C-N 121.471 -0.768 . . . . 0.0 109.493 179.932 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 761' ' ' HIS . . . . . 0.665 ' HB2' HG22 ' A' ' 813' ' ' VAL . 25.4 p-80 -142.69 135.18 27.77 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 120.936 -1.103 . . . . 0.0 111.002 -179.974 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 762' ' ' LEU . . . . . . . . . . . . . 3.3 mp -115.17 148.06 39.52 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.437 -0.789 . . . . 0.0 109.494 179.953 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 763' ' ' LYS . . . . . 0.426 ' O ' ' CG ' ' A' ' 763' ' ' LYS . 0.0 OUTLIER -133.61 105.04 6.64 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.04 -1.038 . . . . 0.0 110.616 -179.896 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 764' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -84.09 176.59 8.71 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.18 -0.95 . . . . 0.0 110.013 179.943 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 765' ' ' ALA . . . . . . . . . . . . . . . -69.6 160.55 79.14 Favored Pre-proline 0 N--CA 1.492 1.625 0 O-C-N 121.243 -0.91 . . . . 0.0 109.975 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 766' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -71.35 132.01 20.04 Favored 'Trans proline' 0 C--N 1.303 -1.847 0 O-C-N 124.053 1.554 . . . . 0.0 110.525 -179.951 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 767' ' ' GLY . . . . . . . . . . . . . . . 108.57 -44.95 1.39 Allowed Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 179.953 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 768' ' ' GLN . . . . . 0.414 ' HB3' ' HB3' ' A' ' 839' ' ' CYS . 2.4 mp0 -85.62 119.35 25.86 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.182 -1.187 . . . . 0.0 110.053 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 769' ' ' THR . . . . . . . . . . . . . 68.4 p -102.59 146.79 27.64 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.265 -0.897 . . . . 0.0 110.463 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 770' ' ' ILE . . . . . . . . . . . . . 48.3 mt -70.23 123.82 24.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.335 -0.853 . . . . 0.0 109.728 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 771' ' ' SER . . . . . . . . . . . . . 6.7 t -119.61 -12.83 9.23 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.148 -0.97 . . . . 0.0 110.696 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 772' ' ' ALA . . . . . 0.408 ' O ' ' HB ' ' A' ' 838' ' ' VAL . . . -148.78 130.35 14.91 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.022 -1.049 . . . . 0.0 110.735 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 773' ' ' ILE . . . . . 0.531 HG13 ' HG2' ' A' ' 803' ' ' GLU . 46.8 mm -84.33 129.87 36.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.241 -0.912 . . . . 0.0 109.715 179.949 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 774' ' ' LYS . . . . . 0.509 ' HB3' ' HB3' ' A' ' 836' ' ' GLU . 1.8 tppp? -80.12 -37.69 33.09 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.121 -0.987 . . . . 0.0 110.365 -179.924 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 775' ' ' PHE . . . . . 0.704 ' O ' ' HB2' ' A' ' 776' ' ' ALA . 88.3 t80 -159.74 171.17 20.01 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.049 -1.032 . . . . 0.0 110.73 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 776' ' ' ALA . . . . . 0.704 ' HB2' ' O ' ' A' ' 775' ' ' PHE . . . 166.92 90.79 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.423 -0.798 . . . . 0.0 109.801 -179.986 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 777' ' ' SER . . . . . 0.451 ' HB3' ' CZ ' ' A' ' 775' ' ' PHE . 12.6 t -128.68 132.26 48.04 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.307 -0.871 . . . . 0.0 110.419 -179.928 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 778' ' ' PHE . . . . . 0.566 ' O ' ' CD1' ' A' ' 778' ' ' PHE . 72.0 t80 -100.33 82.73 2.54 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.232 -0.918 . . . . 0.0 110.383 179.943 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 779' ' ' GLY . . . . . . . . . . . . . . . 174.31 -108.91 0.28 Allowed Glycine 0 N--CA 1.491 2.348 0 C-N-CA 119.687 -1.244 . . . . 0.0 110.039 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 780' ' ' THR . . . . . . . . . . . . . 29.5 p -113.26 99.46 49.17 Favored Pre-proline 0 N--CA 1.494 1.736 0 O-C-N 121.255 -1.144 . . . . 0.0 110.431 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 781' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -79.89 125.26 5.94 Favored 'Trans proline' 0 C--N 1.305 -1.734 0 O-C-N 123.915 1.482 . . . . 0.0 110.432 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 782' ' ' LEU . . . . . 0.457 ' HB2' ' CD ' ' A' ' 789' ' ' GLN . 61.9 mt -101.9 118.77 37.61 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.278 -0.888 . . . . 0.0 109.85 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 783' ' ' GLY . . . . . . . . . . . . . . . 114.19 -179.49 18.65 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.315 -1.514 . . . . 0.0 109.315 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 784' ' ' THR . . . . . . . . . . . . . 40.9 p -112.65 -162.39 0.8 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.176 -1.191 . . . . 0.0 110.363 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 785' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -71.93 115.72 11.47 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.263 -0.898 . . . . 0.0 110.258 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 786' ' ' GLY . . . . . . . . . . . . . . . 124.24 -30.33 4.8 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.496 -1.442 . . . . 0.0 109.496 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 787' ' ' THR . . . . . . . . . . . . . 1.2 p -131.92 27.4 4.58 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.342 -1.093 . . . . 0.0 110.094 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 788' ' ' PHE . . . . . 0.583 ' HB3' ' CG ' ' A' ' 775' ' ' PHE . 3.4 m-85 -51.23 164.39 0.18 Allowed 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.38 -0.825 . . . . 0.0 109.986 -179.97 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 789' ' ' GLN . . . . . 0.457 ' CD ' ' HB2' ' A' ' 782' ' ' LEU . 0.9 OUTLIER -175.43 127.84 0.26 Allowed 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.121 -0.987 . . . . 0.0 110.341 179.979 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 790' ' ' GLN . . . . . . . . . . . . . 1.8 pt20 -62.95 134.78 56.73 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.258 -0.901 . . . . 0.0 110.195 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 791' ' ' GLY . . . . . . . . . . . . . . . -95.28 -105.89 2.07 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.213 -1.555 . . . . 0.0 109.213 179.953 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 792' ' ' GLU . . . . . . . . . . . . . 29.5 tt0 -119.11 -24.99 6.3 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.258 -1.142 . . . . 0.0 109.744 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 793' ' ' CYS . . . . . 0.482 ' SG ' ' HG2' ' A' ' 825' ' ' PRO . 8.3 t -84.44 95.29 8.74 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.402 -0.811 . . . . 0.0 110.161 179.995 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 794' ' ' HIS . . . . . 0.449 ' CD2' ' HG ' ' A' ' 798' ' ' SER . 8.4 t-160 -120.64 140.5 51.49 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.205 -0.934 . . . . 0.0 110.189 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 795' ' ' SER . . . . . 0.544 ' C ' HD12 ' A' ' 796' ' ' ILE . 28.0 t -81.16 9.22 7.16 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.173 -0.954 . . . . 0.0 110.355 -179.982 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 796' ' ' ILE . . . . . 0.544 HD12 ' C ' ' A' ' 795' ' ' SER . 1.4 mp 66.2 7.06 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.537 -0.727 . . . . 0.0 110.699 -179.993 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 797' ' ' ASN . . . . . 0.44 ' O ' HG23 ' A' ' 801' ' ' VAL . 38.8 t-20 -161.05 39.25 0.15 Allowed 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.06 -1.025 . . . . 0.0 110.804 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 798' ' ' SER . . . . . 0.455 ' O ' ' O ' ' A' ' 776' ' ' ALA . 0.7 OUTLIER -97.02 2.35 51.33 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.144 -0.973 . . . . 0.0 110.38 -179.967 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 799' ' ' ASN . . . . . . . . . . . . . 7.1 m120 -117.17 -22.77 8.19 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.083 -1.011 . . . . 0.0 110.707 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 800' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -89.86 -31.41 17.34 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.131 -0.981 . . . . 0.0 110.536 -179.937 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 801' ' ' VAL . . . . . 0.44 HG23 ' O ' ' A' ' 797' ' ' ASN . 97.7 t -61.85 -27.97 43.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.199 -0.938 . . . . 0.0 110.755 179.965 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 802' ' ' LEU . . . . . 0.456 HD22 ' N ' ' A' ' 802' ' ' LEU . 4.5 mm? -80.1 -56.56 4.14 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.164 -0.96 . . . . 0.0 110.686 -179.927 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 803' ' ' GLU . . . . . 0.592 ' HA ' ' CG1' ' A' ' 807' ' ' ILE . 3.7 mm-40 -55.51 -21.74 18.06 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.247 -0.908 . . . . 0.0 111.011 -179.962 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 804' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -93.0 -18.92 22.11 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.014 -1.054 . . . . 0.0 111.724 -179.827 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 805' ' ' LYS . . . . . 0.454 ' O ' ' SG ' ' A' ' 806' ' ' CYS . 0.0 OUTLIER -128.66 23.24 5.84 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 120.641 -1.287 . . . . 0.0 111.894 -179.939 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 806' ' ' CYS . . . . . 0.454 ' SG ' ' O ' ' A' ' 805' ' ' LYS . 1.6 m -160.93 32.17 0.15 Allowed 'General case' 0 N--CA 1.499 1.992 0 O-C-N 120.763 -1.211 . . . . 0.0 110.791 179.91 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 807' ' ' ILE . . . . . 0.592 ' CG1' ' HA ' ' A' ' 803' ' ' GLU . 14.4 mm -124.91 108.12 19.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.137 -0.977 . . . . 0.0 110.267 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 808' ' ' GLY . . . . . 0.433 ' C ' ' HG ' ' A' ' 809' ' ' LEU . . . 114.56 9.66 14.25 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.524 -1.431 . . . . 0.0 109.524 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 809' ' ' LEU . . . . . 0.433 ' HG ' ' C ' ' A' ' 808' ' ' GLY . 5.1 mt -131.56 134.47 46.1 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.319 -1.107 . . . . 0.0 110.137 179.943 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 810' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -65.42 -11.79 46.11 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.168 -0.957 . . . . 0.0 109.289 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 811' ' ' ARG . . . . . . . . . . . . . 2.3 ttt180 -158.28 129.65 6.56 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.515 -0.741 . . . . 0.0 109.661 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 812' ' ' CYS . . . . . . . . . . . . . 27.6 p -141.85 152.56 43.75 Favored 'General case' 0 C--N 1.294 -1.809 0 O-C-N 121.435 -0.79 . . . . 0.0 110.361 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 813' ' ' VAL . . . . . 0.665 HG22 ' HB2' ' A' ' 761' ' ' HIS . 94.6 t -123.27 156.99 29.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.309 -0.869 . . . . 0.0 110.192 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 814' ' ' VAL . . . . . 0.421 HG23 ' C ' ' A' ' 813' ' ' VAL . 30.4 t -144.55 141.95 23.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.263 -0.898 . . . . 0.0 110.255 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 815' ' ' ALA . . . . . . . . . . . . . . . -102.29 128.7 48.72 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.307 -0.87 . . . . 0.0 109.957 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 816' ' ' ILE . . . . . 1.018 HD13 HG21 ' A' ' 833' ' ' VAL . 66.8 mt -83.38 132.83 30.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.153 -0.967 . . . . 0.0 110.25 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 817' ' ' SER . . . . . . . . . . . . . 20.3 p -163.17 164.96 15.26 Favored Pre-proline 0 N--CA 1.492 1.66 0 O-C-N 121.26 -0.9 . . . . 0.0 110.054 179.936 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 818' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -80.8 18.31 1.29 Allowed 'Trans proline' 0 C--N 1.307 -1.623 0 O-C-N 123.979 1.515 . . . . 0.0 111.123 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 819' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -127.18 -30.95 2.62 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 120.929 -1.107 . . . . 0.0 110.261 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 820' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 -63.5 -43.72 96.4 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.285 -0.885 . . . . 0.0 110.377 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 821' ' ' PHE . . . . . 0.494 ' HB3' ' OG ' ' A' ' 795' ' ' SER . 91.1 m-85 -88.85 -78.81 0.33 Allowed 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.236 -0.915 . . . . 0.0 110.295 179.961 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 822' ' ' GLY . . . . . . . . . . . . . . . 176.66 38.05 0.05 OUTLIER Glycine 0 N--CA 1.492 2.383 0 N-CA-C 109.827 -1.309 . . . . 0.0 109.827 -179.908 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 823' ' ' GLY . . . . . . . . . . . . . . . 90.14 -160.49 28.39 Favored Glycine 0 N--CA 1.492 2.401 0 N-CA-C 109.885 -1.286 . . . . 0.0 109.885 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 824' ' ' ASP . . . . . 0.457 ' OD1' ' O ' ' A' ' 824' ' ' ASP . 7.4 p30 -108.73 139.41 20.84 Favored Pre-proline 0 N--CA 1.497 1.899 0 O-C-N 121.301 -1.117 . . . . 0.0 110.359 -179.967 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 825' ' ' PRO . . . . . 0.482 ' HG2' ' SG ' ' A' ' 793' ' ' CYS . 49.3 Cg_endo -81.53 -54.63 0.04 OUTLIER 'Trans proline' 0 C--N 1.306 -1.67 0 O-C-N 124.044 1.549 . . . . 0.0 110.865 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 826' ' ' CYS . . . . . . . . . . . . . 1.8 m -123.67 110.45 29.95 Favored Pre-proline 0 N--CA 1.503 2.217 0 O-C-N 121.141 -0.974 . . . . 0.0 110.298 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 827' ' ' PRO . . . . . 0.458 ' O ' ' HB3' ' A' ' 828' ' ' GLU . 49.7 Cg_endo -86.86 163.0 9.03 Favored 'Trans proline' 0 C--N 1.304 -1.766 0 O-C-N 123.995 1.524 . . . . 0.0 110.46 179.953 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 828' ' ' GLU . . . . . 0.458 ' HB3' ' O ' ' A' ' 827' ' ' PRO . 1.5 tt0 65.9 8.73 5.55 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.225 -0.922 . . . . 0.0 110.776 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 829' ' ' VAL . . . . . . . . . . . . . 93.1 t -121.76 133.76 67.18 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 O-C-N 121.08 -1.012 . . . . 0.0 110.403 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 830' ' ' MET . . . . . 0.44 ' HA ' ' CE ' ' A' ' 830' ' ' MET . 0.5 OUTLIER -48.05 130.66 15.65 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.204 -0.935 . . . . 0.0 110.057 179.998 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 831' ' ' LYS . . . . . 0.435 ' HE2' ' HG2' ' A' ' 737' ' ' GLU . 7.8 ptmt -132.49 171.83 13.27 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.226 -0.922 . . . . 0.0 110.254 -179.934 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 832' ' ' ARG . . . . . 0.433 ' HD2' ' HA ' ' A' ' 736' ' ' SER . 0.0 OUTLIER -168.3 165.53 12.88 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.399 -0.813 . . . . 0.0 109.966 -179.985 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 833' ' ' VAL . . . . . 1.018 HG21 HD13 ' A' ' 816' ' ' ILE . 87.3 t -109.8 106.58 21.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.215 -0.928 . . . . 0.0 110.474 -179.932 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 834' ' ' ALA . . . . . . . . . . . . . . . -109.5 129.05 55.58 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.342 -0.849 . . . . 0.0 109.705 179.932 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 835' ' ' VAL . . . . . . . . . . . . . 29.8 t -142.25 152.89 18.2 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 121.138 -0.976 . . . . 0.0 110.779 -179.932 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 836' ' ' GLU . . . . . 0.509 ' HB3' ' HB3' ' A' ' 774' ' ' LYS . 1.7 tt0 -149.21 140.8 23.43 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.54 -0.725 . . . . 0.0 109.153 179.885 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 837' ' ' ALA . . . . . . . . . . . . . . . -119.6 166.36 13.25 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.051 -1.031 . . . . 0.0 111.38 -179.813 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 838' ' ' VAL . . . . . 0.408 ' HB ' ' O ' ' A' ' 772' ' ' ALA . 60.2 t -127.54 124.32 63.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.66 -0.65 . . . . 0.0 109.78 179.952 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 839' ' ' CYS . . . . . 0.414 ' HB3' ' HB3' ' A' ' 768' ' ' GLN . 53.3 m -109.12 131.54 54.97 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.11 -0.994 . . . . 0.0 110.518 -179.925 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 840' ' ' SER . . . . . 0.411 ' O ' ' C ' ' A' ' 841' ' ' THR . 60.7 p -158.14 75.51 0.75 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.344 -0.847 . . . . 0.0 109.996 -179.988 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 841' ' ' THR . . . . . 0.411 ' C ' ' O ' ' A' ' 840' ' ' SER . 79.9 p . . . . . 0 N--CA 1.493 1.684 0 O-C-N 121.271 -0.893 . . . . 0.0 110.167 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 728' ' ' VAL . . . . . 0.405 HG13 ' O ' ' A' ' 728' ' ' VAL . 6.2 p . . . . . 0 N--CA 1.494 1.741 0 CA-C-O 121.213 0.53 . . . . 0.0 110.555 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 729' ' ' SER . . . . . . . . . . . . . 67.3 m -126.6 -167.89 1.79 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.261 -0.899 . . . . 0.0 109.928 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 730' ' ' GLY . . . . . . . . . . . . . . . -139.9 134.66 6.7 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.672 -1.371 . . . . 0.0 109.672 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 731' ' ' VAL . . . . . 0.573 HG22 ' O ' ' A' ' 837' ' ' ALA . 15.4 m -121.77 133.33 68.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.376 -1.073 . . . . 0.0 110.002 179.955 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 732' ' ' CYS . . . . . 0.486 ' CB ' ' CD ' ' A' ' 836' ' ' GLU . 23.3 p -123.95 153.6 40.98 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.215 -0.928 . . . . 0.0 110.376 179.987 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 733' ' ' ALA . . . . . . . . . . . . . . . -143.15 120.17 11.38 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.314 -0.866 . . . . 0.0 109.827 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 734' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -110.86 121.18 44.7 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.159 -0.963 . . . . 0.0 110.5 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 735' ' ' VAL . . . . . . . . . . . . . 21.9 t -143.66 141.9 25.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.372 -0.83 . . . . 0.0 110.001 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 736' ' ' SER . . . . . . . . . . . . . 10.9 p -95.99 159.01 15.19 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.257 -0.902 . . . . 0.0 110.377 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 737' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.493 1.701 0 O-C-N 121.315 -0.866 . . . . 0.0 110.28 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 757' ' ' THR . . . . . 0.434 HG21 ' HB3' ' A' ' 817' ' ' SER . 0.8 OUTLIER . . . . . 0 N--CA 1.492 1.636 0 CA-C-O 121.345 0.593 . . . . 0.0 110.553 . . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 758' ' ' ALA . . . . . . . . . . . . . . . -90.79 178.43 6.05 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.402 -0.811 . . . . 0.0 109.619 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 759' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -135.97 159.78 40.65 Favored 'General case' 0 C--N 1.298 -1.673 0 O-C-N 121.064 -1.023 . . . . 0.0 110.858 -179.94 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 760' ' ' VAL . . . . . 0.494 HG12 ' N ' ' A' ' 761' ' ' HIS . 97.5 t -105.87 167.88 3.0 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 179.842 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 761' ' ' HIS . . . . . 0.494 ' N ' HG12 ' A' ' 760' ' ' VAL . 29.3 m80 -137.6 104.76 5.42 Favored 'General case' 0 C--N 1.299 -1.588 0 C-N-CA 118.501 -1.28 . . . . 0.0 112.263 -179.765 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 762' ' ' LEU . . . . . 0.6 HD12 ' HB3' ' A' ' 812' ' ' CYS . 32.1 mt -116.24 126.25 53.35 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 179.787 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 763' ' ' LYS . . . . . . . . . . . . . 6.7 tttt -134.59 137.51 43.79 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.67 -1.269 . . . . 0.0 112.147 -179.75 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 764' ' ' CYS . . . . . 0.495 ' HB3' ' O ' ' A' ' 810' ' ' GLU . 22.4 t -136.39 143.63 44.1 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.561 -0.712 . . . . 0.0 109.554 179.824 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 765' ' ' ALA . . . . . . . . . . . . . . . -49.79 155.41 1.48 Allowed Pre-proline 0 N--CA 1.492 1.667 0 O-C-N 121.048 -1.033 . . . . 0.0 110.104 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 766' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -71.74 91.68 0.7 Allowed 'Trans proline' 0 C--N 1.306 -1.684 0 O-C-N 123.974 1.512 . . . . 0.0 110.303 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 767' ' ' GLY . . . . . . . . . . . . . . . 152.8 -27.01 0.83 Allowed Glycine 0 N--CA 1.489 2.196 0 N-CA-C 108.81 -1.716 . . . . 0.0 108.81 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 768' ' ' GLN . . . . . 0.492 ' HB2' ' SG ' ' A' ' 764' ' ' CYS . 30.0 mt-30 -104.51 128.09 52.38 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.513 -0.992 . . . . 0.0 109.682 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 769' ' ' THR . . . . . . . . . . . . . 9.6 p -113.8 152.78 30.15 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.178 -0.951 . . . . 0.0 110.556 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 770' ' ' ILE . . . . . 0.872 HD12 ' O ' ' A' ' 809' ' ' LEU . 2.8 mp -64.6 119.58 9.28 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.341 -0.849 . . . . 0.0 109.765 179.959 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 771' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -111.53 -1.74 15.72 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.277 -0.889 . . . . 0.0 110.493 -179.926 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 772' ' ' ALA . . . . . 0.495 ' O ' ' HB ' ' A' ' 838' ' ' VAL . . . -168.0 131.9 1.67 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.148 -0.97 . . . . 0.0 111.039 -179.936 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 773' ' ' ILE . . . . . 0.464 HG13 ' HG3' ' A' ' 803' ' ' GLU . 16.6 mm -91.16 125.64 43.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.244 -0.91 . . . . 0.0 109.163 179.871 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 774' ' ' LYS . . . . . 0.497 ' HB3' ' HB3' ' A' ' 836' ' ' GLU . 6.5 ttmt -79.77 -37.85 34.45 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.158 -0.964 . . . . 0.0 111.116 -179.894 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 775' ' ' PHE . . . . . . . . . . . . . 52.5 t80 -152.76 152.99 32.28 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.953 -1.092 . . . . 0.0 110.75 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 776' ' ' ALA . . . . . 0.494 ' O ' ' HB2' ' A' ' 798' ' ' SER . . . -174.13 112.35 0.17 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.552 -0.718 . . . . 0.0 109.624 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 777' ' ' SER . . . . . 0.712 ' HB3' ' CD2' ' A' ' 794' ' ' HIS . 6.7 m -162.04 98.34 1.06 Allowed 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.177 -0.952 . . . . 0.0 110.727 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 778' ' ' PHE . . . . . 0.514 ' CD1' ' C ' ' A' ' 778' ' ' PHE . 0.9 OUTLIER -72.75 103.86 3.78 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.293 -0.88 . . . . 0.0 109.969 179.936 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 779' ' ' GLY . . . . . . . . . . . . . . . 174.88 -109.52 0.29 Allowed Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.663 -1.375 . . . . 0.0 109.663 -179.903 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 780' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -124.94 70.0 58.99 Favored Pre-proline 0 N--CA 1.492 1.647 0 O-C-N 121.292 -1.122 . . . . 0.0 110.22 -179.898 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 781' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -74.4 153.21 44.79 Favored 'Trans proline' 0 C--N 1.305 -1.721 0 O-C-N 124.039 1.547 . . . . 0.0 110.542 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 782' ' ' LEU . . . . . 0.487 ' O ' ' N ' ' A' ' 789' ' ' GLN . 1.1 mt -138.76 151.0 46.72 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.288 -0.883 . . . . 0.0 110.126 -179.954 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 783' ' ' GLY . . . . . . . . . . . . . . . 118.25 -170.77 13.8 Favored Glycine 0 N--CA 1.492 2.404 0 N-CA-C 109.643 -1.383 . . . . 0.0 109.643 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 784' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -125.41 -162.71 1.13 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.274 -1.133 . . . . 0.0 110.088 -179.988 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 785' ' ' CYS . . . . . . . . . . . . . 21.2 m -79.77 94.55 5.79 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.184 -0.947 . . . . 0.0 110.476 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 786' ' ' GLY . . . . . . . . . . . . . . . 137.58 -23.29 3.12 Favored Glycine 0 N--CA 1.489 2.198 0 N-CA-C 109.577 -1.409 . . . . 0.0 109.577 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 787' ' ' THR . . . . . 0.46 ' O ' ' O ' ' A' ' 788' ' ' PHE . 20.4 p -142.73 37.9 1.47 Allowed 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.305 -1.114 . . . . 0.0 110.24 -179.952 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 788' ' ' PHE . . . . . 0.46 ' O ' ' O ' ' A' ' 787' ' ' THR . 0.9 OUTLIER -46.56 175.83 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.301 -0.875 . . . . 0.0 110.501 179.963 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 789' ' ' GLN . . . . . 0.487 ' N ' ' O ' ' A' ' 782' ' ' LEU . 0.0 OUTLIER -153.91 148.42 26.19 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.45 -0.781 . . . . 0.0 110.289 -179.976 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 790' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -78.94 151.22 31.79 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.151 -0.968 . . . . 0.0 110.132 -179.995 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 791' ' ' GLY . . . . . . . . . . . . . . . -108.83 -153.54 15.94 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.529 -1.428 . . . . 0.0 109.529 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 792' ' ' GLU . . . . . . . . . . . . . 6.0 pm0 -109.83 -19.57 13.09 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.308 -1.113 . . . . 0.0 110.358 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 793' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -98.62 24.8 7.07 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.247 -0.908 . . . . 0.0 110.307 179.903 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 794' ' ' HIS . . . . . 0.712 ' CD2' ' HB3' ' A' ' 777' ' ' SER . 8.8 t-160 -68.98 149.12 49.17 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.176 -0.953 . . . . 0.0 109.899 -179.964 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 795' ' ' SER . . . . . 0.521 ' O ' ' N ' ' A' ' 797' ' ' ASN . 1.7 p -87.9 14.16 9.4 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.191 -0.943 . . . . 0.0 110.499 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 796' ' ' ILE . . . . . 0.617 ' HA ' ' CE1' ' A' ' 794' ' ' HIS . 3.6 pt 34.56 32.27 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.505 2.31 0 CA-C-O 121.503 0.668 . . . . 0.0 110.247 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 797' ' ' ASN . . . . . 0.521 ' N ' ' O ' ' A' ' 795' ' ' SER . 60.9 t30 -157.68 21.14 0.27 Allowed 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.486 -0.759 . . . . 0.0 109.646 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 798' ' ' SER . . . . . 0.573 ' CB ' ' HA ' ' A' ' 777' ' ' SER . 17.7 m -84.51 -33.57 23.5 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.526 -0.734 . . . . 0.0 110.636 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 799' ' ' ASN . . . . . 0.465 ' O ' ' OE1' ' A' ' 803' ' ' GLU . 11.8 t-20 -74.17 -6.66 49.03 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.282 -0.886 . . . . 0.0 110.729 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 800' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -86.52 -44.03 12.26 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.052 -1.03 . . . . 0.0 110.39 179.961 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 801' ' ' VAL . . . . . . . . . . . . . 69.5 t -72.57 -21.67 20.01 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 121.29 -0.881 . . . . 0.0 110.808 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 802' ' ' LEU . . . . . 0.475 ' O ' ' HB2' ' A' ' 806' ' ' CYS . 1.8 mm? -84.08 -43.89 14.61 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.043 -1.035 . . . . 0.0 110.612 -179.946 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 803' ' ' GLU . . . . . 0.569 ' O ' HD12 ' A' ' 807' ' ' ILE . 40.6 mt-10 -67.45 -24.67 65.65 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.118 -0.989 . . . . 0.0 110.416 -179.988 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 804' ' ' ARG . . . . . . . . . . . . . 13.6 mmt-85 -90.59 -24.71 20.48 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.194 -0.942 . . . . 0.0 110.827 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 805' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.95 46.86 1.85 Allowed 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.014 -1.054 . . . . 0.0 110.701 179.977 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 806' ' ' CYS . . . . . 0.475 ' HB2' ' O ' ' A' ' 802' ' ' LEU . 1.8 t -160.59 -40.27 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.216 -0.927 . . . . 0.0 110.532 179.958 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 807' ' ' ILE . . . . . 0.569 HD12 ' O ' ' A' ' 803' ' ' GLU . 45.2 mt -67.58 123.27 20.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.242 -0.911 . . . . 0.0 110.765 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 808' ' ' GLY . . . . . . . . . . . . . . . 111.1 -8.48 29.16 Favored Glycine 0 N--CA 1.494 2.508 0 N-CA-C 110.024 -1.23 . . . . 0.0 110.024 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 809' ' ' LEU . . . . . 0.872 ' O ' HD12 ' A' ' 770' ' ' ILE . 36.0 mt -120.28 139.33 52.88 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.079 -1.247 . . . . 0.0 110.614 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 810' ' ' GLU . . . . . 0.495 ' O ' ' HB3' ' A' ' 764' ' ' CYS . 5.4 pt-20 -69.03 -33.89 74.34 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.213 -0.929 . . . . 0.0 109.356 179.942 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 811' ' ' ARG . . . . . . . . . . . . . 15.3 ttp180 -112.21 157.33 21.01 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.517 -0.739 . . . . 0.0 109.443 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 812' ' ' CYS . . . . . 0.6 ' HB3' HD12 ' A' ' 762' ' ' LEU . 1.3 t -149.44 108.21 3.85 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.099 -1.001 . . . . 0.0 111.085 -179.928 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 813' ' ' VAL . . . . . 0.576 HG13 ' O ' ' A' ' 813' ' ' VAL . 4.5 p -118.4 122.92 70.71 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 121.333 -0.854 . . . . 0.0 109.268 179.946 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 814' ' ' VAL . . . . . . . . . . . . . 45.1 t -135.89 121.97 30.91 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.987 0 O-C-N 121.117 -0.989 . . . . 0.0 111.001 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 815' ' ' ALA . . . . . . . . . . . . . . . -80.33 130.17 35.0 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.358 -0.839 . . . . 0.0 109.744 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 816' ' ' ILE . . . . . 0.842 HG21 HG21 ' A' ' 833' ' ' VAL . 2.6 mt -80.61 113.65 20.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.122 -0.986 . . . . 0.0 110.564 -179.866 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 817' ' ' SER . . . . . 0.453 ' O ' ' OD1' ' A' ' 820' ' ' ASN . 8.8 p -143.44 162.83 40.27 Favored Pre-proline 0 N--CA 1.494 1.774 0 O-C-N 121.352 -0.842 . . . . 0.0 110.074 -179.946 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 818' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -82.4 21.05 1.02 Allowed 'Trans proline' 0 C--N 1.307 -1.656 0 O-C-N 123.978 1.515 . . . . 0.0 110.931 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 819' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -135.7 9.23 3.35 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.972 -1.08 . . . . 0.0 110.327 179.94 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 820' ' ' ASN . . . . . 0.453 ' OD1' ' O ' ' A' ' 817' ' ' SER . 8.1 p-10 -117.42 -10.16 10.75 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.224 -0.922 . . . . 0.0 110.283 -179.969 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 821' ' ' PHE . . . . . . . . . . . . . 9.2 m-85 -105.14 -22.28 13.11 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.19 -0.944 . . . . 0.0 110.237 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 822' ' ' GLY . . . . . . . . . . . . . . . 104.95 47.77 1.14 Allowed Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.739 -1.344 . . . . 0.0 109.739 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 823' ' ' GLY . . . . . . . . . . . . . . . 116.58 -134.3 11.26 Favored Glycine 0 N--CA 1.492 2.41 0 N-CA-C 109.661 -1.376 . . . . 0.0 109.661 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 824' ' ' ASP . . . . . 0.452 ' CG ' ' HD2' ' A' ' 825' ' ' PRO . 0.4 OUTLIER -172.01 157.19 4.07 Favored Pre-proline 0 N--CA 1.494 1.76 0 O-C-N 121.226 -1.161 . . . . 0.0 110.395 -179.963 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 825' ' ' PRO . . . . . 0.452 ' HD2' ' CG ' ' A' ' 824' ' ' ASP . 46.8 Cg_endo -75.2 -88.33 0.0 OUTLIER 'Trans proline' 0 C--N 1.307 -1.63 0 O-C-N 124.066 1.561 . . . . 0.0 110.544 -179.931 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 826' ' ' CYS . . . . . . . . . . . . . 3.3 p -120.66 105.11 41.48 Favored Pre-proline 0 N--CA 1.498 1.933 0 O-C-N 121.201 -0.937 . . . . 0.0 110.193 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 827' ' ' PRO . . . . . 0.523 ' O ' ' CB ' ' A' ' 828' ' ' GLU . 50.3 Cg_endo -78.12 82.48 2.43 Favored 'Trans proline' 0 C--N 1.31 -1.493 0 O-C-N 124.093 1.575 . . . . 0.0 110.73 179.959 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 828' ' ' GLU . . . . . 0.523 ' CB ' ' O ' ' A' ' 827' ' ' PRO . 0.2 OUTLIER 165.12 -23.03 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.392 -0.818 . . . . 0.0 109.987 -179.984 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 829' ' ' VAL . . . . . 0.463 ' O ' ' HG3' ' A' ' 831' ' ' LYS . 42.4 t -100.0 167.06 2.07 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.505 0 O-C-N 121.266 -0.896 . . . . 0.0 110.351 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 830' ' ' MET . . . . . 0.45 ' N ' HG12 ' A' ' 829' ' ' VAL . 31.4 mtm -42.29 146.97 0.28 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.352 -0.842 . . . . 0.0 110.293 179.957 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 831' ' ' LYS . . . . . 0.463 ' HG3' ' O ' ' A' ' 829' ' ' VAL . 15.6 mtmm -127.61 83.0 2.12 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.262 -0.899 . . . . 0.0 110.054 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 832' ' ' ARG . . . . . . . . . . . . . 37.1 mtt180 -111.07 150.69 29.0 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.323 -0.861 . . . . 0.0 110.046 -179.895 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 833' ' ' VAL . . . . . 0.842 HG21 HG21 ' A' ' 816' ' ' ILE . 98.6 t -116.32 159.62 16.18 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.522 0 O-C-N 121.244 -0.91 . . . . 0.0 110.677 -179.982 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 834' ' ' ALA . . . . . 0.435 ' HB1' ' CZ ' ' A' ' 788' ' ' PHE . . . -160.11 104.2 1.49 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.508 -0.745 . . . . 0.0 109.26 179.965 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 835' ' ' VAL . . . . . . . . . . . . . 39.8 t -115.35 159.66 15.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.112 -0.993 . . . . 0.0 111.114 -179.863 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 836' ' ' GLU . . . . . 0.497 ' HB3' ' HB3' ' A' ' 774' ' ' LYS . 0.0 OUTLIER -144.34 123.96 13.27 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.574 -0.704 . . . . 0.0 109.28 179.917 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 837' ' ' ALA . . . . . 0.573 ' O ' HG22 ' A' ' 731' ' ' VAL . . . -111.66 144.9 40.17 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.15 -0.969 . . . . 0.0 110.704 -179.953 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 838' ' ' VAL . . . . . 0.495 ' HB ' ' O ' ' A' ' 772' ' ' ALA . 76.3 t -111.22 124.99 68.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.398 -0.814 . . . . 0.0 109.534 179.945 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 839' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -108.46 119.56 39.88 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.23 -0.919 . . . . 0.0 110.039 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 840' ' ' SER . . . . . 0.455 ' O ' ' O ' ' A' ' 841' ' ' THR . 0.9 OUTLIER -133.66 69.06 1.48 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.34 -0.85 . . . . 0.0 109.845 179.992 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 841' ' ' THR . . . . . 0.455 ' O ' ' O ' ' A' ' 840' ' ' SER . 30.7 p . . . . . 0 N--CA 1.491 1.625 0 O-C-N 121.443 -0.786 . . . . 0.0 110.313 179.921 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 728' ' ' VAL . . . . . 0.687 ' O ' HG12 ' A' ' 728' ' ' VAL . 72.8 t . . . . . 0 N--CA 1.496 1.848 0 CA-C-O 121.348 0.594 . . . . 0.0 109.999 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 729' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -77.12 -147.95 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.373 -0.83 . . . . 0.0 110.185 -179.971 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 730' ' ' GLY . . . . . . . . . . . . . . . -149.96 150.02 22.01 Favored Glycine 0 N--CA 1.488 2.108 0 N-CA-C 109.697 -1.361 . . . . 0.0 109.697 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 731' ' ' VAL . . . . . . . . . . . . . 86.4 t -111.12 157.28 12.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.334 -1.098 . . . . 0.0 109.836 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 732' ' ' CYS . . . . . . . . . . . . . 10.9 t -117.75 146.34 43.85 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.176 -0.953 . . . . 0.0 110.341 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 733' ' ' ALA . . . . . 0.651 ' HB2' HD21 ' A' ' 762' ' ' LEU . . . -142.13 116.25 9.42 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.268 -0.895 . . . . 0.0 110.356 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 734' ' ' ASP . . . . . 0.458 ' C ' HG23 ' A' ' 735' ' ' VAL . 0.8 OUTLIER -114.12 139.09 49.61 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.177 -0.952 . . . . 0.0 110.001 179.937 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 735' ' ' VAL . . . . . 0.458 HG23 ' C ' ' A' ' 734' ' ' ASP . 44.9 t -147.89 124.05 2.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.214 -0.929 . . . . 0.0 110.039 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 736' ' ' SER . . . . . 0.42 ' O ' ' C ' ' A' ' 737' ' ' GLU . 0.7 OUTLIER -90.87 134.89 34.1 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.23 -0.919 . . . . 0.0 110.199 179.951 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 737' ' ' GLU . . . . . 0.42 ' C ' ' O ' ' A' ' 736' ' ' SER . 29.5 tp10 . . . . . 0 N--CA 1.495 1.793 0 O-C-N 121.275 -0.891 . . . . 0.0 110.004 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 757' ' ' THR . . . . . . . . . . . . . 1.8 p . . . . . 0 N--CA 1.496 1.841 0 CA-C-O 121.457 0.646 . . . . 0.0 110.934 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 758' ' ' ALA . . . . . . . . . . . . . . . -101.03 173.73 6.34 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.479 -0.763 . . . . 0.0 110.169 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 759' ' ' LYS . . . . . . . . . . . . . 36.2 mtpt -137.94 165.27 26.95 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.203 -0.935 . . . . 0.0 110.63 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 760' ' ' VAL . . . . . . . . . . . . . 38.4 t -109.7 139.64 31.94 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.442 -0.786 . . . . 0.0 109.642 179.938 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 761' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -109.97 104.2 13.07 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.068 -1.02 . . . . 0.0 110.886 -179.981 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 762' ' ' LEU . . . . . 0.651 HD21 ' HB2' ' A' ' 733' ' ' ALA . 21.2 mt -121.46 124.32 44.18 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.298 -0.876 . . . . 0.0 109.414 179.879 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 763' ' ' LYS . . . . . 0.563 ' HB3' ' CD ' ' A' ' 811' ' ' ARG . 0.0 OUTLIER -156.05 123.17 5.35 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.919 -1.113 . . . . 0.0 111.243 -179.928 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 764' ' ' CYS . . . . . 0.41 ' O ' ' C ' ' A' ' 765' ' ' ALA . 19.1 m -99.04 157.34 16.41 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.342 -0.849 . . . . 0.0 109.263 179.839 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 765' ' ' ALA . . . . . 0.41 ' C ' ' O ' ' A' ' 764' ' ' CYS . . . -42.64 159.56 0.2 Allowed Pre-proline 0 N--CA 1.495 1.818 0 O-C-N 121.076 -1.015 . . . . 0.0 109.982 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 766' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -71.23 97.3 0.75 Allowed 'Trans proline' 0 C--N 1.306 -1.667 0 O-C-N 123.913 1.48 . . . . 0.0 110.524 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 767' ' ' GLY . . . . . . . . . . . . . . . 147.53 -31.69 1.38 Allowed Glycine 0 N--CA 1.489 2.198 0 N-CA-C 109.044 -1.623 . . . . 0.0 109.044 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 768' ' ' GLN . . . . . 0.434 ' HB3' ' HB3' ' A' ' 839' ' ' CYS . 20.1 mt-30 -99.0 101.61 13.05 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.369 -1.077 . . . . 0.0 109.982 179.953 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 769' ' ' THR . . . . . . . . . . . . . 11.2 p -85.28 146.95 26.79 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.112 -0.992 . . . . 0.0 110.128 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 770' ' ' ILE . . . . . . . . . . . . . 35.7 mt -66.7 144.16 14.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.306 -0.871 . . . . 0.0 109.252 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 771' ' ' SER . . . . . . . . . . . . . 47.8 t -135.28 -4.69 2.35 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.873 -1.142 . . . . 0.0 111.432 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 772' ' ' ALA . . . . . . . . . . . . . . . -172.71 151.68 2.37 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 120.781 -1.199 . . . . 0.0 111.418 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 773' ' ' ILE . . . . . . . . . . . . . 20.1 mm -110.75 120.28 61.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 179.888 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 774' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -80.09 -42.89 22.75 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 120.986 -1.071 . . . . 0.0 110.951 -179.835 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 775' ' ' PHE . . . . . 0.499 ' O ' ' HB2' ' A' ' 776' ' ' ALA . 67.2 t80 -134.0 152.25 51.77 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.098 -1.001 . . . . 0.0 110.668 -179.913 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 776' ' ' ALA . . . . . 0.499 ' HB2' ' O ' ' A' ' 775' ' ' PHE . . . 179.1 113.41 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.567 -0.708 . . . . 0.0 109.803 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 777' ' ' SER . . . . . 0.523 ' HB2' ' CD2' ' A' ' 794' ' ' HIS . 94.5 p -148.73 126.86 12.07 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.338 -0.851 . . . . 0.0 110.475 -179.958 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 778' ' ' PHE . . . . . 0.583 ' HE1' HG23 ' A' ' 816' ' ' ILE . 12.2 t80 -94.21 116.48 28.88 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.359 -0.838 . . . . 0.0 109.949 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 779' ' ' GLY . . . . . 0.505 ' HA3' ' O ' ' A' ' 793' ' ' CYS . . . 163.97 -136.15 4.11 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.932 -1.267 . . . . 0.0 109.932 -179.958 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 780' ' ' THR . . . . . . . . . . . . . 45.7 p -123.49 64.77 30.22 Favored Pre-proline 0 N--CA 1.494 1.766 0 O-C-N 121.212 -1.17 . . . . 0.0 110.595 -179.93 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 781' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -74.47 170.79 19.45 Favored 'Trans proline' 0 C--N 1.304 -1.792 0 O-C-N 124.044 1.55 . . . . 0.0 110.392 179.927 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 782' ' ' LEU . . . . . . . . . . . . . 3.7 mt -129.86 173.91 10.23 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.198 -0.939 . . . . 0.0 110.261 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 783' ' ' GLY . . . . . . . . . . . . . . . 110.93 -169.54 13.38 Favored Glycine 0 N--CA 1.494 2.561 0 N-CA-C 109.595 -1.402 . . . . 0.0 109.595 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 784' ' ' THR . . . . . 0.52 HG22 ' N ' ' A' ' 785' ' ' CYS . 54.3 m -115.62 -92.92 0.5 Allowed 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.229 -1.159 . . . . 0.0 110.336 -179.96 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 785' ' ' CYS . . . . . 0.52 ' N ' HG22 ' A' ' 784' ' ' THR . 0.3 OUTLIER -139.5 120.05 14.1 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.175 -0.953 . . . . 0.0 110.162 -179.938 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 786' ' ' GLY . . . . . . . . . . . . . . . 95.3 -4.62 67.3 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.658 -1.377 . . . . 0.0 109.658 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 787' ' ' THR . . . . . . . . . . . . . 9.0 t -145.41 34.8 1.07 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.209 -1.171 . . . . 0.0 110.109 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 788' ' ' PHE . . . . . 0.412 ' CZ ' ' O ' ' A' ' 784' ' ' THR . 39.4 m-85 -53.41 176.22 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.342 -0.849 . . . . 0.0 110.385 179.996 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 789' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -139.66 145.28 38.24 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.335 -0.853 . . . . 0.0 110.164 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 790' ' ' GLN . . . . . . . . . . . . . 2.1 mt-30 -64.21 131.05 46.25 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.121 -0.987 . . . . 0.0 109.882 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 791' ' ' GLY . . . . . . . . . . . . . . . -92.49 -163.26 37.58 Favored Glycine 0 N--CA 1.492 2.413 0 N-CA-C 109.698 -1.361 . . . . 0.0 109.698 180.0 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 792' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -98.41 -14.0 20.33 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.337 -1.096 . . . . 0.0 110.226 -179.972 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 793' ' ' CYS . . . . . 0.505 ' O ' ' HA3' ' A' ' 779' ' ' GLY . 0.5 OUTLIER -116.86 68.59 0.74 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.352 -0.842 . . . . 0.0 110.275 179.972 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 794' ' ' HIS . . . . . 0.532 ' CE1' ' O ' ' A' ' 795' ' ' SER . 38.2 t-80 -102.59 145.64 29.34 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.171 -0.956 . . . . 0.0 110.866 -179.919 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 795' ' ' SER . . . . . 0.532 ' O ' ' CE1' ' A' ' 794' ' ' HIS . 8.5 t -91.31 174.48 7.36 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.244 -0.91 . . . . 0.0 109.275 179.874 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 796' ' ' ILE . . . . . . . . . . . . . 1.5 mt -105.52 20.48 4.11 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.912 0 O-C-N 120.859 -1.151 . . . . 0.0 110.256 -179.929 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 797' ' ' ASN . . . . . 0.505 ' N ' ' OD1' ' A' ' 797' ' ' ASN . 1.6 m120 -132.5 36.22 3.58 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.427 -0.796 . . . . 0.0 109.083 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 798' ' ' SER . . . . . 0.596 ' O ' HD23 ' A' ' 802' ' ' LEU . 0.9 OUTLIER -65.6 -56.31 12.89 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.724 -0.61 . . . . 0.0 111.285 -179.92 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 799' ' ' ASN . . . . . . . . . . . . . 4.5 m120 -86.41 14.27 6.95 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.135 -0.978 . . . . 0.0 111.368 -179.782 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 800' ' ' SER . . . . . . . . . . . . . 7.8 t -91.28 -62.64 1.4 Allowed 'General case' 0 C--N 1.299 -1.616 0 O-C-N 120.874 -1.141 . . . . 0.0 110.269 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 801' ' ' VAL . . . . . 1.003 HG11 ' OD1' ' A' ' 820' ' ' ASN . 49.3 t -68.11 -19.55 24.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.274 -0.891 . . . . 0.0 110.534 -179.918 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 802' ' ' LEU . . . . . 0.596 HD23 ' O ' ' A' ' 798' ' ' SER . 4.2 mm? -69.05 -51.99 33.22 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.137 -0.977 . . . . 0.0 110.739 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 803' ' ' GLU . . . . . 0.757 ' HA ' HD13 ' A' ' 807' ' ' ILE . 4.1 tt0 -68.84 -17.76 64.05 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.034 -1.041 . . . . 0.0 110.721 -179.955 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 804' ' ' ARG . . . . . . . . . . . . . 17.9 mtp180 -91.45 -18.53 24.05 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.225 -0.922 . . . . 0.0 111.519 -179.884 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 805' ' ' LYS . . . . . 0.454 ' O ' ' SG ' ' A' ' 806' ' ' CYS . 19.8 mttt -124.49 26.96 7.11 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 120.857 -1.152 . . . . 0.0 111.882 -179.856 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 806' ' ' CYS . . . . . 0.831 ' C ' HD12 ' A' ' 807' ' ' ILE . 1.7 m -160.87 18.69 0.13 Allowed 'General case' 0 N--CA 1.501 2.111 0 O-C-N 120.737 -1.227 . . . . 0.0 111.035 179.942 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 807' ' ' ILE . . . . . 0.831 HD12 ' C ' ' A' ' 806' ' ' CYS . 1.7 mp -123.27 112.51 33.86 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.902 0 O-C-N 121.001 -1.062 . . . . 0.0 110.204 179.972 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 808' ' ' GLY . . . . . . . . . . . . . . . 116.73 -4.24 19.28 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 809' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -125.99 137.81 53.7 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.275 -1.132 . . . . 0.0 110.265 -179.944 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 810' ' ' GLU . . . . . 0.473 ' HG3' ' N ' ' A' ' 811' ' ' ARG . 0.4 OUTLIER -64.87 -17.82 64.62 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.219 -0.925 . . . . 0.0 108.965 179.886 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 811' ' ' ARG . . . . . 0.563 ' CD ' ' HB3' ' A' ' 763' ' ' LYS . 13.5 ttp85 -142.48 132.86 24.94 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.674 -0.641 . . . . 0.0 109.36 179.926 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 812' ' ' CYS . . . . . 0.497 ' CB ' ' HA ' ' A' ' 806' ' ' CYS . 15.4 p -142.02 146.86 36.01 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.171 -0.956 . . . . 0.0 110.764 -179.965 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 813' ' ' VAL . . . . . . . . . . . . . 67.0 t -120.67 135.62 60.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.44 -0.788 . . . . 0.0 110.014 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 814' ' ' VAL . . . . . . . . . . . . . 9.3 t -112.2 109.79 29.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.114 -0.991 . . . . 0.0 110.477 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 815' ' ' ALA . . . . . . . . . . . . . . . -70.77 121.26 17.67 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.259 -0.901 . . . . 0.0 110.097 179.89 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 816' ' ' ILE . . . . . 0.583 HG23 ' HE1' ' A' ' 778' ' ' PHE . 36.1 mt -81.66 104.42 10.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.185 -0.947 . . . . 0.0 110.273 -179.966 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 817' ' ' SER . . . . . 0.466 ' HB2' ' HD2' ' A' ' 818' ' ' PRO . 77.7 p -161.71 164.2 18.33 Favored Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.268 -0.895 . . . . 0.0 110.101 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 818' ' ' PRO . . . . . 0.466 ' HD2' ' HB2' ' A' ' 817' ' ' SER . 43.6 Cg_endo -71.92 -23.65 21.83 Favored 'Trans proline' 0 C--N 1.305 -1.751 0 O-C-N 124.04 1.548 . . . . 0.0 110.13 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 819' ' ' SER . . . . . . . . . . . . . 95.1 p -85.52 42.85 0.98 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.259 -0.901 . . . . 0.0 109.872 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 820' ' ' ASN . . . . . 1.003 ' OD1' HG11 ' A' ' 801' ' ' VAL . 28.6 t-20 -143.32 -46.37 0.29 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.283 -0.885 . . . . 0.0 110.13 -179.94 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 821' ' ' PHE . . . . . . . . . . . . . 80.5 m-85 -89.25 8.36 30.73 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.334 -0.854 . . . . 0.0 110.349 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 822' ' ' GLY . . . . . . . . . . . . . . . 87.09 52.72 3.01 Favored Glycine 0 N--CA 1.492 2.409 0 N-CA-C 109.901 -1.28 . . . . 0.0 109.901 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 823' ' ' GLY . . . . . . . . . . . . . . . 90.85 -174.96 39.75 Favored Glycine 0 N--CA 1.494 2.518 0 N-CA-C 109.779 -1.328 . . . . 0.0 109.779 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 824' ' ' ASP . . . . . . . . . . . . . 11.0 p-10 -125.34 150.56 67.81 Favored Pre-proline 0 N--CA 1.495 1.78 0 O-C-N 121.258 -1.142 . . . . 0.0 110.154 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 825' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -77.18 -62.94 0.03 OUTLIER 'Trans proline' 0 C--N 1.306 -1.703 0 O-C-N 124.042 1.549 . . . . 0.0 110.801 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 826' ' ' CYS . . . . . . . . . . . . . 6.0 p -122.98 117.69 28.41 Favored Pre-proline 0 N--CA 1.5 2.074 0 O-C-N 121.141 -0.975 . . . . 0.0 110.785 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 827' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_endo -88.48 168.34 6.1 Favored 'Trans proline' 0 C--N 1.311 -1.427 0 O-C-N 123.952 1.501 . . . . 0.0 110.739 179.941 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 828' ' ' GLU . . . . . . . . . . . . . 2.2 tp10 61.37 27.58 17.18 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.393 -0.817 . . . . 0.0 110.737 179.903 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 829' ' ' VAL . . . . . 0.44 ' O ' ' HD3' ' A' ' 831' ' ' LYS . 50.3 t -131.49 115.09 27.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.088 -1.008 . . . . 0.0 110.417 179.92 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 830' ' ' MET . . . . . 0.425 ' C ' ' O ' ' A' ' 829' ' ' VAL . 19.0 ptp -43.1 123.8 2.99 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.26 -0.9 . . . . 0.0 109.382 179.918 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 831' ' ' LYS . . . . . 0.44 ' HD3' ' O ' ' A' ' 829' ' ' VAL . 0.0 OUTLIER -109.23 179.16 4.24 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.105 -0.997 . . . . 0.0 111.545 -179.876 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 832' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -159.59 141.02 12.88 Favored 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 108.053 -1.092 . . . . 0.0 108.053 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 833' ' ' VAL . . . . . 0.484 HG21 HG12 ' A' ' 816' ' ' ILE . 60.6 t -110.48 139.87 32.09 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 120.741 -1.224 . . . . 0.0 112.05 -179.836 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 834' ' ' ALA . . . . . . . . . . . . . . . -139.02 111.96 7.88 Favored 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 179.862 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 835' ' ' VAL . . . . . 0.448 HG12 ' N ' ' A' ' 836' ' ' GLU . 40.8 t -129.28 163.55 34.14 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 120.923 -1.11 . . . . 0.0 111.848 -179.871 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 836' ' ' GLU . . . . . 0.466 ' HB2' ' HB3' ' A' ' 775' ' ' PHE . 0.1 OUTLIER -140.25 147.15 39.57 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 179.849 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 837' ' ' ALA . . . . . . . . . . . . . . . -128.01 165.52 20.15 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 120.856 -1.152 . . . . 0.0 111.349 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 838' ' ' VAL . . . . . . . . . . . . . 75.0 t -130.4 110.62 19.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.512 -0.743 . . . . 0.0 109.287 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 839' ' ' CYS . . . . . 0.434 ' HB3' ' HB3' ' A' ' 768' ' ' GLN . 68.4 m -107.51 133.51 51.89 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.147 -0.97 . . . . 0.0 110.777 -179.89 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 840' ' ' SER . . . . . . . . . . . . . 35.6 p -125.33 -139.64 0.28 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.482 -0.761 . . . . 0.0 109.857 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 841' ' ' THR . . . . . . . . . . . . . 32.6 p . . . . . 0 N--CA 1.496 1.851 0 O-C-N 121.117 -0.99 . . . . 0.0 110.177 -179.966 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 728' ' ' VAL . . . . . 0.441 ' O ' ' O ' ' A' ' 839' ' ' CYS . 13.5 p . . . . . 0 N--CA 1.491 1.6 0 CA-C-O 121.332 0.587 . . . . 0.0 110.394 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 729' ' ' SER . . . . . 0.408 ' HB2' ' HA ' ' A' ' 838' ' ' VAL . 89.0 p -172.57 -175.73 1.39 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.369 -0.832 . . . . 0.0 109.764 179.903 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 730' ' ' GLY . . . . . . . . . . . . . . . 155.28 65.69 0.01 OUTLIER Glycine 0 N--CA 1.489 2.203 0 C-N-CA 119.56 -1.305 . . . . 0.0 109.843 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 731' ' ' VAL . . . . . 1.007 HG21 ' SG ' ' A' ' 764' ' ' CYS . 6.5 t -122.65 152.02 26.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.325 -1.103 . . . . 0.0 109.983 179.966 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 732' ' ' CYS . . . . . . . . . . . . . 5.8 t -146.72 144.11 29.19 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.094 -1.004 . . . . 0.0 110.439 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 733' ' ' ALA . . . . . . . . . . . . . . . -135.89 107.73 7.08 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.344 -0.847 . . . . 0.0 109.907 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 734' ' ' ASP . . . . . . . . . . . . . 7.9 t0 -118.11 122.64 43.61 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.18 -0.95 . . . . 0.0 110.551 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 735' ' ' VAL . . . . . . . . . . . . . 45.8 t -129.15 162.45 36.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.287 -0.883 . . . . 0.0 109.856 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 736' ' ' SER . . . . . . . . . . . . . 9.7 t -110.36 139.87 45.13 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.108 -0.995 . . . . 0.0 110.441 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 737' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.629 0 O-C-N 121.343 -0.848 . . . . 0.0 110.042 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 757' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.492 1.64 0 CA-C-O 121.39 0.614 . . . . 0.0 110.585 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 758' ' ' ALA . . . . . . . . . . . . . . . -106.27 177.94 4.71 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.41 -0.806 . . . . 0.0 109.856 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 759' ' ' LYS . . . . . . . . . . . . . 3.9 mttp -132.41 147.79 52.39 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.202 -0.936 . . . . 0.0 110.499 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 760' ' ' VAL . . . . . 0.886 ' CG2' HD11 ' A' ' 816' ' ' ILE . 13.3 t -110.27 132.36 58.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.322 -0.861 . . . . 0.0 109.595 179.942 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 761' ' ' HIS . . . . . . . . . . . . . 29.5 m80 -120.78 119.56 33.09 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.108 -0.995 . . . . 0.0 110.923 -179.902 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 762' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -115.0 117.37 30.42 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.372 -0.83 . . . . 0.0 109.011 179.829 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 763' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -136.27 120.43 17.79 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.012 -1.055 . . . . 0.0 111.315 -179.895 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 764' ' ' CYS . . . . . 1.007 ' SG ' HG21 ' A' ' 731' ' ' VAL . 1.2 m -99.4 177.54 5.15 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.491 -0.755 . . . . 0.0 109.81 179.86 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 765' ' ' ALA . . . . . 0.798 ' HB3' ' OE1' ' A' ' 768' ' ' GLN . . . -60.39 161.41 13.88 Favored Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.193 -0.942 . . . . 0.0 109.856 179.969 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 766' ' ' PRO . . . . . 0.402 ' HD2' ' HB1' ' A' ' 765' ' ' ALA . 44.1 Cg_endo -69.89 136.45 32.69 Favored 'Trans proline' 0 C--N 1.306 -1.691 0 O-C-N 123.897 1.472 . . . . 0.0 110.296 179.976 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 767' ' ' GLY . . . . . . . . . . . . . . . 93.54 -30.85 6.9 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.04 -1.624 . . . . 0.0 109.04 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 768' ' ' GLN . . . . . 0.798 ' OE1' ' HB3' ' A' ' 765' ' ' ALA . 10.5 mt-30 -82.75 105.85 14.1 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.331 -1.099 . . . . 0.0 110.076 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 769' ' ' THR . . . . . . . . . . . . . 26.6 p -95.81 146.59 24.43 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.176 -0.953 . . . . 0.0 110.367 179.916 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 770' ' ' ILE . . . . . . . . . . . . . 47.8 mt -76.62 139.47 18.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.356 -0.84 . . . . 0.0 109.675 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 771' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -137.55 -2.67 1.95 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.982 -1.074 . . . . 0.0 111.272 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 772' ' ' ALA . . . . . . . . . . . . . . . -155.99 119.42 4.33 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.763 -1.21 . . . . 0.0 111.075 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 773' ' ' ILE . . . . . . . . . . . . . 33.3 mm -83.26 126.2 40.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.322 -0.862 . . . . 0.0 109.324 179.916 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 774' ' ' LYS . . . . . 0.49 ' CB ' ' OE1' ' A' ' 836' ' ' GLU . 0.1 OUTLIER -82.54 -38.62 23.48 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.111 -0.993 . . . . 0.0 110.766 -179.909 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 775' ' ' PHE . . . . . 0.474 ' HB2' ' O ' ' A' ' 774' ' ' LYS . 11.7 t80 -179.41 133.64 0.11 Allowed 'General case' 0 N--CA 1.496 1.859 0 O-C-N 120.858 -1.151 . . . . 0.0 111.374 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 776' ' ' ALA . . . . . 0.502 ' O ' ' HB3' ' A' ' 798' ' ' SER . . . -151.14 88.91 1.48 Allowed 'General case' 0 N--CA 1.495 1.785 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 179.904 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 777' ' ' SER . . . . . 0.526 ' HA ' ' OG ' ' A' ' 798' ' ' SER . 8.7 p -102.52 165.59 11.01 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.218 -0.926 . . . . 0.0 111.425 -179.77 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 778' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -126.53 101.11 6.53 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.593 -0.692 . . . . 0.0 109.74 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 779' ' ' GLY . . . . . 0.482 ' O ' ' HG2' ' A' ' 832' ' ' ARG . . . 156.66 -109.55 0.41 Allowed Glycine 0 N--CA 1.493 2.454 0 N-CA-C 109.381 -1.488 . . . . 0.0 109.381 179.903 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 780' ' ' THR . . . . . 0.459 ' O ' ' HA3' ' A' ' 791' ' ' GLY . 76.3 p -127.78 101.19 23.8 Favored Pre-proline 0 N--CA 1.493 1.719 0 O-C-N 121.231 -1.158 . . . . 0.0 110.086 179.965 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 781' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -77.34 173.04 14.92 Favored 'Trans proline' 0 C--N 1.305 -1.751 0 O-C-N 124.082 1.569 . . . . 0.0 110.549 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 782' ' ' LEU . . . . . . . . . . . . . 1.1 mt -130.81 98.41 4.61 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.311 -0.868 . . . . 0.0 110.165 179.944 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 783' ' ' GLY . . . . . . . . . . . . . . . 139.49 -164.3 25.99 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 -180.0 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 784' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -119.94 -169.05 1.71 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.157 -1.202 . . . . 0.0 110.173 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 785' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -62.47 93.87 0.06 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.246 -0.909 . . . . 0.0 110.22 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 786' ' ' GLY . . . . . . . . . . . . . . . 146.3 -28.35 1.67 Allowed Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.468 -1.453 . . . . 0.0 109.468 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 787' ' ' THR . . . . . . . . . . . . . 66.3 p -127.2 27.32 5.92 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.24 -1.153 . . . . 0.0 110.207 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 788' ' ' PHE . . . . . 0.454 ' HB3' ' CD1' ' A' ' 775' ' ' PHE . 2.9 m-85 -52.41 110.62 0.52 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.371 -0.831 . . . . 0.0 110.196 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 789' ' ' GLN . . . . . 0.466 ' HA ' ' CE2' ' A' ' 775' ' ' PHE . 7.2 tp60 -127.53 153.36 46.44 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.298 -0.876 . . . . 0.0 110.058 179.965 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 790' ' ' GLN . . . . . 0.498 ' CG ' ' O ' ' A' ' 790' ' ' GLN . 7.5 pt20 -52.27 114.71 1.43 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.249 -0.907 . . . . 0.0 110.28 179.997 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 791' ' ' GLY . . . . . 0.459 ' HA3' ' O ' ' A' ' 780' ' ' THR . . . -66.47 -105.87 0.01 OUTLIER Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.384 -1.486 . . . . 0.0 109.384 -179.978 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 792' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -113.61 -31.67 6.42 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.282 -1.128 . . . . 0.0 110.128 -179.956 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 793' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -121.55 98.22 5.87 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.278 -0.889 . . . . 0.0 110.393 -179.935 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 794' ' ' HIS . . . . . 0.471 ' CE1' ' HB2' ' A' ' 798' ' ' SER . 30.8 t-80 -107.29 131.17 54.5 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.122 -0.986 . . . . 0.0 109.966 179.948 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 795' ' ' SER . . . . . 0.46 ' O ' ' O ' ' A' ' 794' ' ' HIS . 6.3 t -61.59 -141.14 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.172 -0.955 . . . . 0.0 109.453 179.893 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 796' ' ' ILE . . . . . . . . . . . . . 3.4 mt -136.5 -43.69 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 O-C-N 121.11 -0.994 . . . . 0.0 109.707 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 797' ' ' ASN . . . . . 0.414 ' O ' ' C ' ' A' ' 798' ' ' SER . 44.8 m-20 -82.36 10.76 6.44 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.36 -0.838 . . . . 0.0 109.46 179.864 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 798' ' ' SER . . . . . 0.526 ' OG ' ' HA ' ' A' ' 777' ' ' SER . 1.6 m -35.75 -68.69 0.12 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.747 -0.596 . . . . 0.0 111.612 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 799' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -93.95 -26.21 16.94 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.066 -1.021 . . . . 0.0 110.883 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 800' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -50.78 -22.39 2.11 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 120.973 -1.079 . . . . 0.0 110.181 179.965 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 801' ' ' VAL . . . . . 0.548 HG21 ' CD2' ' A' ' 821' ' ' PHE . 25.1 t -84.77 -41.47 15.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.275 -0.891 . . . . 0.0 110.427 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 802' ' ' LEU . . . . . 0.57 ' N ' ' CD2' ' A' ' 802' ' ' LEU . 4.0 mm? -66.2 -41.17 90.57 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.329 -0.857 . . . . 0.0 110.94 -179.933 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 803' ' ' GLU . . . . . 0.421 ' C ' ' O ' ' A' ' 802' ' ' LEU . 8.9 mt-10 -41.88 -47.63 4.28 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.216 -0.927 . . . . 0.0 110.681 -179.935 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 804' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -92.92 -28.21 16.61 Favored 'General case' 0 N--CA 1.503 2.177 0 O-C-N 121.135 -0.978 . . . . 0.0 111.987 -179.834 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 805' ' ' LYS . . . . . 0.478 ' O ' ' SG ' ' A' ' 806' ' ' CYS . 1.0 OUTLIER -89.66 26.98 1.6 Allowed 'General case' 0 N--CA 1.498 1.942 0 O-C-N 120.967 -1.083 . . . . 0.0 111.492 -179.807 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 806' ' ' CYS . . . . . 0.529 ' HA ' ' CB ' ' A' ' 812' ' ' CYS . 13.2 m -158.44 -66.64 0.09 Allowed 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.043 -1.035 . . . . 0.0 110.745 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 807' ' ' ILE . . . . . 0.419 ' C ' ' O ' ' A' ' 806' ' ' CYS . 17.5 mt -41.56 123.51 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.978 0 O-C-N 121.186 -0.947 . . . . 0.0 110.973 -179.933 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 808' ' ' GLY . . . . . 0.461 ' C ' ' HG ' ' A' ' 809' ' ' LEU . . . 115.68 -9.92 19.08 Favored Glycine 0 N--CA 1.494 2.528 0 N-CA-C 110.167 -1.173 . . . . 0.0 110.167 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 809' ' ' LEU . . . . . 0.461 ' HG ' ' C ' ' A' ' 808' ' ' GLY . 1.7 mt -132.94 151.45 52.05 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.061 -1.258 . . . . 0.0 110.306 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 810' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -73.79 -14.95 61.19 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.152 -0.968 . . . . 0.0 109.777 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 811' ' ' ARG . . . . . 0.492 ' CG ' ' O ' ' A' ' 811' ' ' ARG . 10.2 ptm180 -155.72 122.43 5.28 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.343 -0.848 . . . . 0.0 110.068 179.9 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 812' ' ' CYS . . . . . 0.529 ' CB ' ' HA ' ' A' ' 806' ' ' CYS . 31.9 p -122.73 151.71 41.31 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.227 -0.921 . . . . 0.0 110.608 -179.966 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 813' ' ' VAL . . . . . 0.52 HG13 ' O ' ' A' ' 760' ' ' VAL . 5.8 t -121.69 152.53 25.44 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.32 -0.862 . . . . 0.0 110.329 -179.963 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 814' ' ' VAL . . . . . 0.481 HG23 ' C ' ' A' ' 813' ' ' VAL . 88.9 t -148.93 104.19 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.272 -0.892 . . . . 0.0 110.357 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 815' ' ' ALA . . . . . . . . . . . . . . . -62.21 153.64 29.82 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.19 -0.944 . . . . 0.0 110.127 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 816' ' ' ILE . . . . . 0.886 HD11 ' CG2' ' A' ' 760' ' ' VAL . 11.3 mt -107.5 130.77 59.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.163 -0.96 . . . . 0.0 110.109 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 817' ' ' SER . . . . . 0.443 ' OG ' ' HB2' ' A' ' 820' ' ' ASN . 1.4 p -164.11 163.64 15.17 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.259 -0.901 . . . . 0.0 110.037 179.944 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 818' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -74.48 -7.61 19.75 Favored 'Trans proline' 0 C--N 1.303 -1.857 0 O-C-N 124.08 1.568 . . . . 0.0 110.36 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 819' ' ' SER . . . . . . . . . . . . . 3.2 t -128.4 53.14 1.84 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.311 -0.868 . . . . 0.0 110.04 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 820' ' ' ASN . . . . . 0.443 ' HB2' ' OG ' ' A' ' 817' ' ' SER . 0.4 OUTLIER -129.46 -40.0 1.45 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.199 -0.938 . . . . 0.0 110.281 -179.942 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 821' ' ' PHE . . . . . 0.548 ' CD2' HG21 ' A' ' 801' ' ' VAL . 60.1 m-85 -85.93 -60.03 2.13 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.307 -0.87 . . . . 0.0 110.254 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 822' ' ' GLY . . . . . . . . . . . . . . . 155.72 37.88 0.02 OUTLIER Glycine 0 N--CA 1.492 2.422 0 N-CA-C 109.67 -1.372 . . . . 0.0 109.67 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 823' ' ' GLY . . . . . . . . . . . . . . . 137.72 -151.92 21.46 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.819 -1.313 . . . . 0.0 109.819 180.0 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 824' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -141.62 153.68 65.43 Favored Pre-proline 0 N--CA 1.494 1.731 0 O-C-N 121.332 -1.099 . . . . 0.0 110.157 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 825' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -73.33 -94.41 0.01 OUTLIER 'Trans proline' 0 C--N 1.305 -1.724 0 O-C-N 124.073 1.565 . . . . 0.0 110.505 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 826' ' ' CYS . . . . . . . . . . . . . 61.0 m -128.06 134.13 25.89 Favored Pre-proline 0 N--CA 1.494 1.741 0 O-C-N 121.136 -0.977 . . . . 0.0 110.032 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 827' ' ' PRO . . . . . 0.534 ' O ' ' CG ' ' A' ' 828' ' ' GLU . 50.8 Cg_endo -82.87 -171.58 1.18 Allowed 'Trans proline' 0 C--N 1.306 -1.683 0 O-C-N 124.156 1.608 . . . . 0.0 111.133 -179.941 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 828' ' ' GLU . . . . . 0.534 ' CG ' ' O ' ' A' ' 827' ' ' PRO . 15.5 pt-20 39.28 34.76 0.13 Allowed 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.678 -0.639 . . . . 0.0 110.65 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 829' ' ' VAL . . . . . 0.497 ' O ' ' HD2' ' A' ' 831' ' ' LYS . 23.4 t -144.1 161.34 15.48 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.309 -0.869 . . . . 0.0 109.757 179.904 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 830' ' ' MET . . . . . 0.425 ' O ' ' HD2' ' A' ' 831' ' ' LYS . 3.2 mtp -59.12 171.17 0.76 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.031 -1.043 . . . . 0.0 109.626 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 831' ' ' LYS . . . . . 0.497 ' HD2' ' O ' ' A' ' 829' ' ' VAL . 0.6 OUTLIER -147.99 128.63 14.17 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.015 -1.053 . . . . 0.0 110.967 -179.951 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 832' ' ' ARG . . . . . 0.482 ' HG2' ' O ' ' A' ' 779' ' ' GLY . 0.0 OUTLIER -156.49 152.14 27.01 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.443 -0.786 . . . . 0.0 109.65 179.926 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 833' ' ' VAL . . . . . 0.424 HG21 ' CG2' ' A' ' 816' ' ' ILE . 28.6 t -111.16 144.09 19.75 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 O-C-N 121.116 -0.99 . . . . 0.0 110.882 -179.928 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 834' ' ' ALA . . . . . 0.442 ' C ' HG23 ' A' ' 835' ' ' VAL . . . -147.9 136.67 21.85 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.325 -0.859 . . . . 0.0 109.291 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 835' ' ' VAL . . . . . 0.442 HG23 ' C ' ' A' ' 834' ' ' ALA . 75.5 t -148.47 154.4 10.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 120.912 -1.118 . . . . 0.0 111.204 -179.931 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 836' ' ' GLU . . . . . 0.49 ' OE1' ' CB ' ' A' ' 774' ' ' LYS . 16.3 tt0 -141.28 117.48 10.67 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 179.944 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 837' ' ' ALA . . . . . . . . . . . . . . . -107.34 162.97 13.43 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.022 -1.049 . . . . 0.0 111.377 -179.836 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 838' ' ' VAL . . . . . 0.408 ' HA ' ' HB2' ' A' ' 729' ' ' SER . 90.9 t -121.58 107.66 20.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.647 -0.658 . . . . 0.0 109.841 179.98 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 839' ' ' CYS . . . . . 0.441 ' O ' ' O ' ' A' ' 728' ' ' VAL . 15.5 p -115.74 122.29 45.04 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.065 -1.022 . . . . 0.0 110.785 -179.986 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 840' ' ' SER . . . . . 0.447 ' O ' ' HA ' ' A' ' 768' ' ' GLN . 1.2 p -106.46 150.19 26.32 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.558 -0.713 . . . . 0.0 109.579 179.907 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 841' ' ' THR . . . . . 0.431 ' HA ' ' HA ' ' A' ' 768' ' ' GLN . 5.4 t . . . . . 0 N--CA 1.492 1.63 0 O-C-N 121.121 -0.987 . . . . 0.0 110.549 -179.931 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 728' ' ' VAL . . . . . 0.405 ' O ' ' O ' ' A' ' 839' ' ' CYS . 12.0 t . . . . . 0 N--CA 1.493 1.685 0 CA-C-O 121.116 0.484 . . . . 0.0 110.083 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 729' ' ' SER . . . . . 0.483 ' HA ' ' O ' ' A' ' 839' ' ' CYS . 39.0 t -160.05 41.11 0.19 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.241 -0.912 . . . . 0.0 110.625 -179.949 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 730' ' ' GLY . . . . . . . . . . . . . . . 178.25 108.44 0.23 Allowed Glycine 0 N--CA 1.49 2.297 0 C-N-CA 119.575 -1.298 . . . . 0.0 110.154 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 731' ' ' VAL . . . . . . . . . . . . . 39.0 t -112.33 164.65 8.0 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 121.361 -1.082 . . . . 0.0 109.455 179.841 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 732' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -134.24 158.72 43.0 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.036 -1.04 . . . . 0.0 110.881 -179.876 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 733' ' ' ALA . . . . . 0.672 ' CB ' HD21 ' A' ' 762' ' ' LEU . . . -161.7 133.38 5.51 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.335 -0.853 . . . . 0.0 109.925 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 734' ' ' ASP . . . . . . . . . . . . . 30.2 m-20 -150.15 111.14 4.34 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.119 -0.988 . . . . 0.0 110.464 179.901 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 735' ' ' VAL . . . . . . . . . . . . . 40.4 t -139.99 163.45 24.27 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.326 -0.859 . . . . 0.0 109.816 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 736' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -75.87 -175.1 2.87 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.164 -0.96 . . . . 0.0 110.108 -179.973 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 737' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.556 0 O-C-N 121.204 -0.935 . . . . 0.0 110.336 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 757' ' ' THR . . . . . . . . . . . . . 66.2 p . . . . . 0 N--CA 1.496 1.844 0 CA-C-O 121.096 0.474 . . . . 0.0 110.155 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 758' ' ' ALA . . . . . 0.719 ' O ' HD12 ' A' ' 816' ' ' ILE . . . -58.95 121.77 12.01 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.211 -0.931 . . . . 0.0 109.713 179.902 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 759' ' ' LYS . . . . . 0.472 ' CG ' ' HA ' ' A' ' 815' ' ' ALA . 13.6 mttt -109.16 163.34 13.44 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.145 -0.972 . . . . 0.0 110.847 -179.928 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 760' ' ' VAL . . . . . 0.617 ' CG2' HD11 ' A' ' 816' ' ' ILE . 52.1 t -106.55 131.05 57.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 179.895 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 761' ' ' HIS . . . . . . . . . . . . . 10.8 m80 -112.57 110.35 20.46 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 120.923 -1.111 . . . . 0.0 112.365 -179.736 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 762' ' ' LEU . . . . . 0.672 HD21 ' CB ' ' A' ' 733' ' ' ALA . 1.0 OUTLIER -121.79 105.0 9.98 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 107.477 -1.305 . . . . 0.0 107.477 179.788 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 763' ' ' LYS . . . . . 0.468 ' HB3' ' HG3' ' A' ' 811' ' ' ARG . 0.0 OUTLIER -129.44 150.96 50.57 Favored 'General case' 0 C--N 1.297 -1.696 0 O-C-N 120.87 -1.144 . . . . 0.0 112.168 -179.7 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 764' ' ' CYS . . . . . 0.431 ' O ' ' C ' ' A' ' 765' ' ' ALA . 18.4 m -125.08 164.11 20.92 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 109.19 -0.671 . . . . 0.0 109.19 179.875 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 765' ' ' ALA . . . . . 0.431 ' C ' ' O ' ' A' ' 764' ' ' CYS . . . -43.88 154.54 0.36 Allowed Pre-proline 0 N--CA 1.491 1.609 0 O-C-N 120.994 -1.067 . . . . 0.0 110.055 179.982 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 766' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -69.72 99.26 0.73 Allowed 'Trans proline' 0 C--N 1.304 -1.786 0 O-C-N 123.989 1.521 . . . . 0.0 110.089 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 767' ' ' GLY . . . . . . . . . . . . . . . 144.69 -30.77 1.81 Allowed Glycine 0 N--CA 1.488 2.139 0 N-CA-C 108.998 -1.641 . . . . 0.0 108.998 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 768' ' ' GLN . . . . . 0.557 ' HG2' ' N ' ' A' ' 841' ' ' THR . 2.8 mt-30 -85.76 156.74 20.49 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.433 -1.039 . . . . 0.0 109.875 179.908 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 769' ' ' THR . . . . . 0.512 HG22 ' HG3' ' A' ' 810' ' ' GLU . 23.0 p -138.04 145.76 42.2 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.202 -0.936 . . . . 0.0 110.296 -179.969 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 770' ' ' ILE . . . . . . . . . . . . . 70.3 mt -68.46 127.1 29.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.312 -0.868 . . . . 0.0 109.202 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 771' ' ' SER . . . . . 0.485 ' O ' ' HB2' ' A' ' 772' ' ' ALA . 8.5 p -103.6 -8.71 19.78 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.216 -0.928 . . . . 0.0 111.419 -179.893 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 772' ' ' ALA . . . . . 0.485 ' HB2' ' O ' ' A' ' 771' ' ' SER . . . -177.92 151.03 0.66 Allowed 'General case' 0 N--CA 1.495 1.796 0 O-C-N 120.73 -1.231 . . . . 0.0 111.805 -179.959 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 773' ' ' ILE . . . . . 0.402 HG23 HD12 ' A' ' 773' ' ' ILE . 33.6 mm -100.15 141.91 16.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 179.784 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 774' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -108.88 -24.13 11.4 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.826 -1.171 . . . . 0.0 111.733 -179.804 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 775' ' ' PHE . . . . . 0.486 ' O ' ' HB2' ' A' ' 776' ' ' ALA . 80.8 t80 -154.76 161.44 41.51 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 120.726 -1.234 . . . . 0.0 111.505 -179.854 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 776' ' ' ALA . . . . . 0.486 ' HB2' ' O ' ' A' ' 775' ' ' PHE . . . 178.58 111.24 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.626 -0.671 . . . . 0.0 109.485 179.964 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 777' ' ' SER . . . . . 0.424 ' HA ' ' OG ' ' A' ' 798' ' ' SER . 48.3 p -144.66 113.71 6.89 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.077 -1.014 . . . . 0.0 110.681 -179.966 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 778' ' ' PHE . . . . . 0.467 ' CG ' ' O ' ' A' ' 778' ' ' PHE . 8.6 t80 -91.26 78.46 5.78 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.292 -0.88 . . . . 0.0 110.046 179.943 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 779' ' ' GLY . . . . . . . . . . . . . . . -165.12 -123.26 0.64 Allowed Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.829 -1.309 . . . . 0.0 109.829 -179.946 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 780' ' ' THR . . . . . . . . . . . . . 27.9 p -120.46 78.75 28.37 Favored Pre-proline 0 N--CA 1.493 1.688 0 O-C-N 121.344 -1.092 . . . . 0.0 110.396 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 781' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -79.44 175.72 10.4 Favored 'Trans proline' 0 C--N 1.304 -1.78 0 O-C-N 123.95 1.5 . . . . 0.0 110.556 -179.961 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 782' ' ' LEU . . . . . . . . . . . . . 3.9 mt -143.47 134.98 26.22 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.296 -0.878 . . . . 0.0 110.032 179.954 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 783' ' ' GLY . . . . . . . . . . . . . . . 144.1 -174.52 24.39 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 -179.937 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 784' ' ' THR . . . . . 0.463 ' O ' ' O ' ' A' ' 785' ' ' CYS . 0.0 OUTLIER -145.64 66.82 1.21 Allowed 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.213 -1.169 . . . . 0.0 110.257 179.993 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 785' ' ' CYS . . . . . 0.463 ' O ' ' O ' ' A' ' 784' ' ' THR . 44.6 t 57.44 114.76 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.303 -0.873 . . . . 0.0 110.351 179.974 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 786' ' ' GLY . . . . . . . . . . . . . . . 109.47 -17.78 30.7 Favored Glycine 0 N--CA 1.489 2.197 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 -179.932 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 787' ' ' THR . . . . . 0.481 ' O ' HG23 ' A' ' 787' ' ' THR . 12.2 t -158.63 48.23 0.35 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.162 -1.199 . . . . 0.0 110.485 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 788' ' ' PHE . . . . . 0.443 ' CE2' ' HA ' ' A' ' 785' ' ' CYS . 41.5 m-85 -58.34 149.69 24.0 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.109 -0.994 . . . . 0.0 109.984 -179.987 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 789' ' ' GLN . . . . . . . . . . . . . 2.0 tt0 -136.04 162.22 33.51 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.158 -0.964 . . . . 0.0 110.408 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 790' ' ' GLN . . . . . 0.428 ' HG2' ' N ' ' A' ' 791' ' ' GLY . 1.8 tt0 -93.81 144.67 25.21 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.177 -0.952 . . . . 0.0 110.202 -179.993 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 791' ' ' GLY . . . . . 0.428 ' N ' ' HG2' ' A' ' 790' ' ' GLN . . . -96.95 -142.0 12.83 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.361 -1.496 . . . . 0.0 109.361 -179.955 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 792' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -93.63 -36.91 12.13 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.253 -1.145 . . . . 0.0 109.74 179.944 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 793' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -100.64 153.62 19.26 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.42 -0.8 . . . . 0.0 110.264 179.975 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 794' ' ' HIS . . . . . 0.671 ' CE1' ' O ' ' A' ' 795' ' ' SER . 7.3 t-80 -176.82 143.17 0.43 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.154 -0.966 . . . . 0.0 110.266 179.956 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 795' ' ' SER . . . . . 0.671 ' O ' ' CE1' ' A' ' 794' ' ' HIS . 58.4 p -73.69 143.62 46.13 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.311 -0.868 . . . . 0.0 109.382 179.934 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 796' ' ' ILE . . . . . . . . . . . . . 9.6 mt -90.99 42.15 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.199 -0.938 . . . . 0.0 109.768 -179.916 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 797' ' ' ASN . . . . . . . . . . . . . 10.6 t30 -159.61 23.02 0.18 Allowed 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.519 -0.738 . . . . 0.0 109.597 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 798' ' ' SER . . . . . 0.456 ' HB3' ' O ' ' A' ' 776' ' ' ALA . 0.6 OUTLIER -57.75 -71.63 0.1 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.571 -0.706 . . . . 0.0 111.563 -179.878 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 799' ' ' ASN . . . . . 0.464 ' OD1' ' HB3' ' A' ' 776' ' ' ALA . 1.4 m120 -61.92 -7.25 3.53 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.305 -0.872 . . . . 0.0 111.861 -179.801 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 800' ' ' SER . . . . . . . . . . . . . 1.3 t -74.03 -33.41 63.74 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.775 -1.203 . . . . 0.0 110.311 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 801' ' ' VAL . . . . . . . . . . . . . 59.1 t -90.83 -18.59 7.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.244 -0.91 . . . . 0.0 110.315 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 802' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -81.43 -45.89 15.38 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.247 -0.908 . . . . 0.0 111.182 -179.831 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 803' ' ' GLU . . . . . 0.647 ' HG2' HD12 ' A' ' 807' ' ' ILE . 4.8 tm-20 -74.4 -21.66 59.54 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.024 -1.048 . . . . 0.0 111.232 -179.993 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 804' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -94.44 -17.35 22.57 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.06 -1.025 . . . . 0.0 112.266 -179.853 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 805' ' ' LYS . . . . . . . . . . . . . 6.4 tttt -138.49 45.04 2.07 Favored 'General case' 0 N--CA 1.503 2.187 0 O-C-N 120.466 -1.396 . . . . 0.0 112.603 -179.879 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 806' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -163.17 -37.38 0.04 OUTLIER 'General case' 0 N--CA 1.498 1.96 0 O-C-N 120.686 -1.259 . . . . 0.0 110.613 179.918 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 807' ' ' ILE . . . . . 0.647 HD12 ' HG2' ' A' ' 803' ' ' GLU . 18.3 mt -70.7 113.5 6.95 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.636 0 O-C-N 121.299 -0.875 . . . . 0.0 110.998 -179.883 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 808' ' ' GLY . . . . . 0.491 ' C ' ' HG ' ' A' ' 809' ' ' LEU . . . 119.35 19.03 4.34 Favored Glycine 0 N--CA 1.494 2.506 0 C-N-CA 119.856 -1.164 . . . . 0.0 110.506 179.88 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 809' ' ' LEU . . . . . 0.491 ' HG ' ' C ' ' A' ' 808' ' ' GLY . 40.5 mt -142.19 142.77 32.71 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 120.883 -1.363 . . . . 0.0 110.629 -179.991 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 810' ' ' GLU . . . . . 0.512 ' HG3' HG22 ' A' ' 769' ' ' THR . 2.2 mt-10 -66.8 -27.6 67.71 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.275 -0.891 . . . . 0.0 109.24 179.959 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 811' ' ' ARG . . . . . 0.468 ' HG3' ' HB3' ' A' ' 763' ' ' LYS . 6.8 ttt85 -125.35 154.49 41.75 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.508 -0.745 . . . . 0.0 109.927 179.972 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 812' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -137.34 124.03 21.09 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.211 -0.93 . . . . 0.0 110.535 -179.982 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 813' ' ' VAL . . . . . . . . . . . . . 70.8 t -130.92 103.43 7.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.226 -0.921 . . . . 0.0 110.015 179.953 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 814' ' ' VAL . . . . . . . . . . . . . 86.0 t -124.84 121.14 60.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.191 -0.943 . . . . 0.0 110.155 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 815' ' ' ALA . . . . . 0.472 ' HA ' ' CG ' ' A' ' 759' ' ' LYS . . . -72.21 160.91 31.63 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.283 -0.886 . . . . 0.0 110.246 179.923 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 816' ' ' ILE . . . . . 0.78 HG21 HG21 ' A' ' 833' ' ' VAL . 8.2 mt -112.91 81.59 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.267 -0.896 . . . . 0.0 109.649 179.989 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 817' ' ' SER . . . . . . . . . . . . . 5.7 p -110.48 158.36 35.62 Favored Pre-proline 0 C--N 1.297 -1.71 0 O-C-N 121.318 -0.864 . . . . 0.0 110.213 -179.921 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 818' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -77.61 12.85 1.78 Allowed 'Trans proline' 0 C--N 1.306 -1.672 0 O-C-N 124.107 1.583 . . . . 0.0 111.058 179.962 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 819' ' ' SER . . . . . . . . . . . . . 10.3 p -133.84 16.49 3.9 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.107 -0.995 . . . . 0.0 110.371 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 820' ' ' ASN . . . . . . . . . . . . . 19.3 t-20 -117.81 -16.82 9.94 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.138 -0.976 . . . . 0.0 110.058 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 821' ' ' PHE . . . . . . . . . . . . . 7.4 m-85 -97.21 -39.29 9.34 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.348 -0.845 . . . . 0.0 110.257 179.896 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 822' ' ' GLY . . . . . . . . . . . . . . . 174.88 -29.49 0.08 OUTLIER Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.596 -1.402 . . . . 0.0 109.596 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 823' ' ' GLY . . . . . 0.465 ' O ' ' OD2' ' A' ' 824' ' ' ASP . . . 147.78 -82.75 0.19 Allowed Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 179.983 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 824' ' ' ASP . . . . . 0.465 ' OD2' ' O ' ' A' ' 823' ' ' GLY . 1.0 OUTLIER -148.02 121.11 4.7 Favored Pre-proline 0 N--CA 1.494 1.771 0 O-C-N 121.234 -1.157 . . . . 0.0 110.385 -179.919 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 825' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -75.51 -89.91 0.01 OUTLIER 'Trans proline' 0 C--N 1.31 -1.497 0 O-C-N 123.923 1.486 . . . . 0.0 110.478 179.932 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 826' ' ' CYS . . . . . 0.606 ' HB3' HG21 ' A' ' 829' ' ' VAL . 2.1 m -97.17 130.74 28.99 Favored Pre-proline 0 N--CA 1.492 1.646 0 O-C-N 121.201 -0.937 . . . . 0.0 109.971 179.996 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 827' ' ' PRO . . . . . 0.418 ' O ' ' HB2' ' A' ' 828' ' ' GLU . 46.4 Cg_endo -73.41 129.31 13.7 Favored 'Trans proline' 0 C--N 1.308 -1.579 0 O-C-N 124.002 1.527 . . . . 0.0 110.927 -179.991 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 828' ' ' GLU . . . . . 0.418 ' HB2' ' O ' ' A' ' 827' ' ' PRO . 8.3 mt-10 57.24 46.3 18.93 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.392 -0.818 . . . . 0.0 110.504 179.928 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 829' ' ' VAL . . . . . 0.606 HG21 ' HB3' ' A' ' 826' ' ' CYS . 39.2 t -133.95 124.88 47.76 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 O-C-N 121.209 -0.932 . . . . 0.0 110.017 179.898 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 830' ' ' MET . . . . . 0.432 ' O ' ' O ' ' A' ' 829' ' ' VAL . 13.0 mmt -41.72 162.75 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.349 -0.844 . . . . 0.0 110.03 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 831' ' ' LYS . . . . . . . . . . . . . 6.4 mttt -139.71 142.47 36.86 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.063 -1.023 . . . . 0.0 111.011 -179.872 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 832' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -144.87 158.15 43.9 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.526 -0.733 . . . . 0.0 109.325 179.976 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 833' ' ' VAL . . . . . 0.78 HG21 HG21 ' A' ' 816' ' ' ILE . 62.1 t -123.13 117.19 50.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 120.846 -1.159 . . . . 0.0 111.47 -179.784 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 834' ' ' ALA . . . . . . . . . . . . . . . -125.9 117.62 23.71 Favored 'General case' 0 N--CA 1.494 1.728 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 179.799 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 835' ' ' VAL . . . . . 0.494 HG12 ' N ' ' A' ' 836' ' ' GLU . 44.4 t -127.82 165.24 27.35 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 120.9 -1.125 . . . . 0.0 111.997 -179.792 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 836' ' ' GLU . . . . . 0.494 ' N ' HG12 ' A' ' 835' ' ' VAL . 0.9 OUTLIER -152.23 123.38 7.62 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 179.952 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 837' ' ' ALA . . . . . . . . . . . . . . . -121.83 165.98 15.06 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 120.893 -1.13 . . . . 0.0 111.809 -179.757 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 838' ' ' VAL . . . . . . . . . . . . . 17.2 t -109.84 107.23 22.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.662 -0.649 . . . . 0.0 109.275 179.928 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 839' ' ' CYS . . . . . 0.483 ' O ' ' HA ' ' A' ' 729' ' ' SER . 0.0 OUTLIER -108.21 145.26 34.52 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.13 -0.981 . . . . 0.0 110.818 -179.896 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 840' ' ' SER . . . . . . . . . . . . . 1.4 p -164.35 147.51 9.21 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.37 -0.831 . . . . 0.0 110.094 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 841' ' ' THR . . . . . 0.557 ' N ' ' HG2' ' A' ' 768' ' ' GLN . 5.2 t . . . . . 0 N--CA 1.494 1.736 0 O-C-N 121.244 -0.91 . . . . 0.0 110.208 -179.948 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 728' ' ' VAL . . . . . 0.713 ' O ' HG13 ' A' ' 728' ' ' VAL . 12.0 p . . . . . 0 N--CA 1.489 1.519 0 CA-C-O 121.351 0.596 . . . . 0.0 110.363 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 729' ' ' SER . . . . . . . . . . . . . 5.9 m 52.3 -177.99 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.41 -0.807 . . . . 0.0 110.731 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 730' ' ' GLY . . . . . 0.523 ' C ' HG23 ' A' ' 731' ' ' VAL . . . -152.25 -140.93 3.21 Favored Glycine 0 N--CA 1.489 2.193 0 N-CA-C 109.041 -1.624 . . . . 0.0 109.041 179.987 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 731' ' ' VAL . . . . . 0.523 HG23 ' C ' ' A' ' 730' ' ' GLY . 11.9 t -153.17 165.81 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 O-C-N 121.065 -1.256 . . . . 0.0 110.26 179.968 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 732' ' ' CYS . . . . . . . . . . . . . 6.6 t -150.92 133.98 15.98 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.343 -0.848 . . . . 0.0 109.967 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 733' ' ' ALA . . . . . . . . . . . . . . . -153.19 162.32 41.44 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.18 -0.95 . . . . 0.0 110.551 -179.969 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 734' ' ' ASP . . . . . 0.458 ' O ' ' OD2' ' A' ' 734' ' ' ASP . 4.3 p30 -162.13 118.26 2.01 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.423 -0.798 . . . . 0.0 109.9 179.995 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 735' ' ' VAL . . . . . . . . . . . . . 16.6 t -139.11 164.82 24.6 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.157 -0.964 . . . . 0.0 110.674 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 736' ' ' SER . . . . . . . . . . . . . 8.3 p -109.83 172.9 6.59 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.36 -0.837 . . . . 0.0 109.818 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 737' ' ' GLU . . . . . 0.467 ' OE1' ' HG3' ' A' ' 831' ' ' LYS . 9.5 pt-20 . . . . . 0 N--CA 1.496 1.852 0 O-C-N 121.124 -0.985 . . . . 0.0 110.348 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 757' ' ' THR . . . . . . . . . . . . . 47.0 p . . . . . 0 N--CA 1.492 1.672 0 CA-C-O 121.368 0.604 . . . . 0.0 110.707 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 758' ' ' ALA . . . . . 0.431 ' C ' ' HG3' ' A' ' 759' ' ' LYS . . . -64.38 168.02 6.21 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.32 -0.862 . . . . 0.0 110.009 179.96 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 759' ' ' LYS . . . . . 0.431 ' HG3' ' C ' ' A' ' 758' ' ' ALA . 17.1 mttp -146.55 146.47 30.49 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.203 -0.935 . . . . 0.0 110.596 -179.928 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 760' ' ' VAL . . . . . . . . . . . . . 43.8 t -108.72 138.37 36.06 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.291 -0.881 . . . . 0.0 109.62 179.819 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 761' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -109.12 125.65 52.38 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.133 -0.979 . . . . 0.0 111.19 -179.917 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 762' ' ' LEU . . . . . 0.513 ' HB2' ' HB2' ' A' ' 812' ' ' CYS . 20.6 mt -123.39 112.16 17.22 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.464 -0.772 . . . . 0.0 109.296 179.849 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 763' ' ' LYS . . . . . . . . . . . . . 9.7 mttt -107.93 122.1 46.12 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.091 -1.006 . . . . 0.0 110.869 -179.827 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 764' ' ' CYS . . . . . 0.423 ' O ' ' C ' ' A' ' 765' ' ' ALA . 48.7 t -92.91 163.18 13.78 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.46 -0.775 . . . . 0.0 109.618 179.904 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 765' ' ' ALA . . . . . 0.583 ' HB3' ' HB2' ' A' ' 768' ' ' GLN . . . -44.08 154.81 0.36 Allowed Pre-proline 0 N--CA 1.493 1.685 0 O-C-N 121.041 -1.037 . . . . 0.0 109.992 -179.884 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 766' ' ' PRO . . . . . 0.436 ' C ' ' OE1' ' A' ' 768' ' ' GLN . 45.1 Cg_endo -70.95 112.14 3.22 Favored 'Trans proline' 0 C--N 1.306 -1.684 0 O-C-N 123.98 1.516 . . . . 0.0 110.657 -179.96 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 767' ' ' GLY . . . . . . . . . . . . . . . 98.29 -2.96 59.61 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.651 -1.379 . . . . 0.0 109.651 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 768' ' ' GLN . . . . . 0.583 ' HB2' ' HB3' ' A' ' 765' ' ' ALA . 27.6 mp0 -106.59 176.3 5.22 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.23 -1.159 . . . . 0.0 110.078 -179.913 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 769' ' ' THR . . . . . . . . . . . . . 40.6 p -145.12 159.18 43.37 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.225 -0.922 . . . . 0.0 110.502 -179.952 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 770' ' ' ILE . . . . . . . . . . . . . 5.6 mt -71.02 151.47 9.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.302 -0.874 . . . . 0.0 109.831 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 771' ' ' SER . . . . . . . . . . . . . 15.0 m -135.5 -9.97 2.17 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.119 -0.988 . . . . 0.0 111.152 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 772' ' ' ALA . . . . . . . . . . . . . . . -172.38 133.62 0.65 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.823 -1.173 . . . . 0.0 111.124 -179.892 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 773' ' ' ILE . . . . . . . . . . . . . 34.1 mm -86.84 120.4 36.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.367 -0.833 . . . . 0.0 109.232 179.91 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 774' ' ' LYS . . . . . . . . . . . . . 1.2 ttmp? -81.21 -38.58 26.77 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.13 -0.981 . . . . 0.0 111.024 -179.861 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 775' ' ' PHE . . . . . 0.735 ' O ' ' HB2' ' A' ' 776' ' ' ALA . 43.5 t80 -149.29 167.41 26.14 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.008 -1.057 . . . . 0.0 111.182 -179.904 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 776' ' ' ALA . . . . . 0.735 ' HB2' ' O ' ' A' ' 775' ' ' PHE . . . 163.88 59.25 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.843 0 CA-C-O 121.449 0.642 . . . . 0.0 109.328 179.975 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 777' ' ' SER . . . . . 0.545 ' HB3' ' CZ ' ' A' ' 775' ' ' PHE . 0.3 OUTLIER -89.88 154.33 19.95 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.513 -0.742 . . . . 0.0 110.776 -179.933 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 778' ' ' PHE . . . . . 0.409 ' CD2' HG22 ' A' ' 833' ' ' VAL . 7.5 t80 -121.84 89.16 3.07 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.377 -0.827 . . . . 0.0 110.137 -179.994 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 779' ' ' GLY . . . . . . . . . . . . . . . 179.94 -127.72 1.15 Allowed Glycine 0 N--CA 1.493 2.464 0 N-CA-C 109.723 -1.351 . . . . 0.0 109.723 -179.952 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 780' ' ' THR . . . . . 0.491 ' O ' ' HA3' ' A' ' 791' ' ' GLY . 9.0 p -116.03 76.17 6.22 Favored Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.209 -1.171 . . . . 0.0 110.341 179.994 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 781' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -71.18 162.47 42.45 Favored 'Trans proline' 0 C--N 1.304 -1.812 0 O-C-N 124.013 1.533 . . . . 0.0 110.369 179.982 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 782' ' ' LEU . . . . . . . . . . . . . 4.5 mt -123.32 145.52 48.66 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.263 -0.898 . . . . 0.0 110.229 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 783' ' ' GLY . . . . . . . . . . . . . . . 99.86 -175.85 27.91 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.925 -1.27 . . . . 0.0 109.925 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 784' ' ' THR . . . . . 0.471 ' O ' HG23 ' A' ' 784' ' ' THR . 1.7 t -147.41 89.48 1.78 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.313 -1.11 . . . . 0.0 109.855 179.97 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 785' ' ' CYS . . . . . 0.467 ' O ' ' O ' ' A' ' 784' ' ' THR . 4.1 t 54.48 107.89 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.297 -0.877 . . . . 0.0 110.011 -179.966 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 786' ' ' GLY . . . . . . . . . . . . . . . 115.22 -31.1 6.39 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 108.957 -1.657 . . . . 0.0 108.957 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 787' ' ' THR . . . . . . . . . . . . . 8.9 p -141.02 38.74 1.78 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.463 -1.022 . . . . 0.0 109.831 179.908 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 788' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -63.32 165.12 7.95 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.364 -0.835 . . . . 0.0 110.479 -179.992 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 789' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -159.36 165.67 32.79 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.374 -0.829 . . . . 0.0 109.443 179.95 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 790' ' ' GLN . . . . . 0.43 ' O ' ' C ' ' A' ' 791' ' ' GLY . 5.8 pt20 -90.25 20.57 4.31 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.014 -1.054 . . . . 0.0 110.487 -179.973 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 791' ' ' GLY . . . . . 0.491 ' HA3' ' O ' ' A' ' 780' ' ' THR . . . 41.77 -143.24 1.03 Allowed Glycine 0 N--CA 1.491 2.313 0 N-CA-C 110.067 -1.213 . . . . 0.0 110.067 -179.989 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 792' ' ' GLU . . . . . . . . . . . . . 27.8 mm-40 -95.15 -43.21 8.2 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.448 -1.031 . . . . 0.0 110.354 -179.957 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 793' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -108.44 134.06 51.75 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.039 -1.038 . . . . 0.0 110.075 -179.988 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 794' ' ' HIS . . . . . 0.559 ' CG ' ' N ' ' A' ' 795' ' ' SER . 68.3 t60 -139.28 169.55 17.55 Favored 'General case' 0 C--N 1.299 -1.591 0 O-C-N 121.32 -0.862 . . . . 0.0 110.176 -179.981 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 795' ' ' SER . . . . . 0.559 ' N ' ' CG ' ' A' ' 794' ' ' HIS . 0.1 OUTLIER -110.69 129.79 55.74 Favored 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 179.904 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 796' ' ' ILE . . . . . . . . . . . . . 35.9 mt -69.7 -5.62 5.33 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.619 0 O-C-N 120.915 -1.115 . . . . 0.0 109.875 -179.913 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 797' ' ' ASN . . . . . . . . . . . . . 16.1 t30 -102.85 14.83 31.0 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.334 -0.853 . . . . 0.0 109.799 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 798' ' ' SER . . . . . 0.512 ' HB2' ' O ' ' A' ' 776' ' ' ALA . 10.8 p -58.79 -62.75 1.63 Allowed 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.463 -0.773 . . . . 0.0 111.278 179.997 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 799' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -82.54 1.43 37.94 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.261 -0.9 . . . . 0.0 110.951 -179.882 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 800' ' ' SER . . . . . 0.485 ' O ' ' HG2' ' A' ' 804' ' ' ARG . 23.3 t -84.21 -25.99 29.08 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.057 -1.027 . . . . 0.0 110.478 -179.926 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 801' ' ' VAL . . . . . 0.407 ' C ' HD22 ' A' ' 802' ' ' LEU . 59.9 t -93.61 -27.99 4.41 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.282 -0.886 . . . . 0.0 111.445 -179.922 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 802' ' ' LEU . . . . . 0.643 ' CD1' HG21 ' A' ' 814' ' ' VAL . 4.0 mm? -89.96 -29.67 18.32 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 120.964 -1.085 . . . . 0.0 111.152 -179.88 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 803' ' ' GLU . . . . . . . . . . . . . 11.3 tt0 -68.93 -28.12 66.37 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 120.818 -1.176 . . . . 0.0 110.942 -179.915 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 804' ' ' ARG . . . . . 0.485 ' HG2' ' O ' ' A' ' 800' ' ' SER . 0.0 OUTLIER -95.0 -17.82 21.59 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.092 -1.005 . . . . 0.0 111.804 -179.969 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 805' ' ' LYS . . . . . 0.433 ' N ' ' HG3' ' A' ' 804' ' ' ARG . 2.3 tptp -115.58 41.33 2.53 Favored 'General case' 0 N--CA 1.501 2.125 0 O-C-N 120.872 -1.143 . . . . 0.0 112.172 -179.824 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 806' ' ' CYS . . . . . 0.524 ' HB2' ' O ' ' A' ' 802' ' ' LEU . 0.5 OUTLIER -160.31 -19.25 0.06 Allowed 'General case' 0 N--CA 1.504 2.236 0 O-C-N 120.577 -1.327 . . . . 0.0 112.306 -179.981 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 807' ' ' ILE . . . . . . . . . . . . . 52.9 mt -85.66 120.49 35.85 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 O-C-N 120.665 -1.272 . . . . 0.0 111.145 -179.962 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 808' ' ' GLY . . . . . 0.434 ' C ' ' HG ' ' A' ' 809' ' ' LEU . . . 112.92 12.63 12.15 Favored Glycine 0 N--CA 1.494 2.531 0 N-CA-C 110.363 -1.095 . . . . 0.0 110.363 179.897 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 809' ' ' LEU . . . . . 0.434 ' HG ' ' C ' ' A' ' 808' ' ' GLY . 12.1 mt -136.29 155.31 50.27 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.033 -1.275 . . . . 0.0 110.799 -179.968 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 810' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -89.99 8.72 31.01 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.433 -0.792 . . . . 0.0 109.389 179.916 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 811' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -155.89 160.94 40.58 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 -179.976 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 812' ' ' CYS . . . . . 0.513 ' HB2' ' HB2' ' A' ' 762' ' ' LEU . 1.0 OUTLIER -143.59 132.76 23.09 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.844 -1.16 . . . . 0.0 111.233 -179.936 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 813' ' ' VAL . . . . . . . . . . . . . 89.7 t -136.2 104.63 4.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.488 -0.757 . . . . 0.0 109.554 179.935 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 814' ' ' VAL . . . . . 0.643 HG21 ' CD1' ' A' ' 802' ' ' LEU . 96.8 t -113.56 129.99 68.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.137 -0.977 . . . . 0.0 110.819 -179.966 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 815' ' ' ALA . . . . . . . . . . . . . . . -85.52 141.8 29.63 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.32 -0.863 . . . . 0.0 109.387 179.933 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 816' ' ' ILE . . . . . 0.522 ' CG2' HG21 ' A' ' 833' ' ' VAL . 21.0 mt -104.5 124.12 58.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.133 -0.979 . . . . 0.0 110.651 -179.903 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 817' ' ' SER . . . . . 0.46 ' OG ' ' HD2' ' A' ' 818' ' ' PRO . 29.2 t -148.05 153.54 41.87 Favored Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 121.348 -0.845 . . . . 0.0 110.025 179.957 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 818' ' ' PRO . . . . . 0.46 ' HD2' ' OG ' ' A' ' 817' ' ' SER . 43.5 Cg_endo -70.71 -10.11 27.14 Favored 'Trans proline' 0 C--N 1.304 -1.768 0 O-C-N 123.984 1.518 . . . . 0.0 110.315 -179.954 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 819' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -125.42 59.73 1.26 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.317 -0.864 . . . . 0.0 110.014 -179.96 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 820' ' ' ASN . . . . . . . . . . . . . 1.3 m120 -148.34 -35.83 0.2 Allowed 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.361 -0.837 . . . . 0.0 110.285 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 821' ' ' PHE . . . . . . . . . . . . . 13.9 m-85 -80.16 0.76 30.92 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.145 -0.972 . . . . 0.0 110.485 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 822' ' ' GLY . . . . . . . . . . . . . . . 110.7 12.29 16.98 Favored Glycine 0 N--CA 1.493 2.448 0 N-CA-C 109.767 -1.333 . . . . 0.0 109.767 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 823' ' ' GLY . . . . . . . . . . . . . . . 108.73 -159.53 14.11 Favored Glycine 0 N--CA 1.492 2.374 0 N-CA-C 109.629 -1.388 . . . . 0.0 109.629 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 824' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -117.91 136.11 23.64 Favored Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 121.221 -1.164 . . . . 0.0 110.391 -179.997 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 825' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -72.47 -80.12 0.01 OUTLIER 'Trans proline' 0 C--N 1.307 -1.638 0 O-C-N 123.959 1.505 . . . . 0.0 110.161 179.961 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 826' ' ' CYS . . . . . 0.696 ' SG ' HG21 ' A' ' 829' ' ' VAL . 5.8 p -106.58 121.4 45.28 Favored Pre-proline 0 N--CA 1.498 1.957 0 O-C-N 121.11 -0.994 . . . . 0.0 109.921 179.93 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 827' ' ' PRO . . . . . 0.47 ' O ' ' CB ' ' A' ' 828' ' ' GLU . 43.7 Cg_endo -70.38 171.43 15.17 Favored 'Trans proline' 0 C--N 1.309 -1.523 0 O-C-N 123.942 1.496 . . . . 0.0 110.054 -179.975 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 828' ' ' GLU . . . . . 0.47 ' CB ' ' O ' ' A' ' 827' ' ' PRO . 0.0 OUTLIER 66.54 15.74 10.2 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.21 -0.931 . . . . 0.0 109.64 -179.951 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 829' ' ' VAL . . . . . 0.696 HG21 ' SG ' ' A' ' 826' ' ' CYS . 95.4 t -119.8 132.26 70.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.425 -0.797 . . . . 0.0 110.02 179.934 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 830' ' ' MET . . . . . . . . . . . . . 2.2 tpp -53.55 144.71 16.63 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.219 -0.926 . . . . 0.0 110.279 179.961 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 831' ' ' LYS . . . . . 0.467 ' HG3' ' OE1' ' A' ' 737' ' ' GLU . 0.0 OUTLIER -115.07 97.81 6.43 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.123 -0.986 . . . . 0.0 110.675 -179.938 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 832' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -122.17 167.94 12.59 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.419 -0.8 . . . . 0.0 109.434 179.989 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 833' ' ' VAL . . . . . 0.522 HG21 ' CG2' ' A' ' 816' ' ' ILE . 38.3 t -124.26 148.23 28.54 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 O-C-N 120.908 -1.12 . . . . 0.0 111.537 -179.915 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 834' ' ' ALA . . . . . 0.488 ' O ' ' HA ' ' A' ' 776' ' ' ALA . . . -150.69 111.65 4.32 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 179.919 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 835' ' ' VAL . . . . . 0.554 HG22 ' CB ' ' A' ' 776' ' ' ALA . 41.0 t -126.7 164.67 26.59 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 O-C-N 120.977 -1.077 . . . . 0.0 112.342 -179.773 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 836' ' ' GLU . . . . . 0.47 ' N ' ' CG1' ' A' ' 835' ' ' VAL . 64.0 tt0 -153.87 137.57 16.09 Favored 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 179.855 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 837' ' ' ALA . . . . . . . . . . . . . . . -124.19 162.83 22.83 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 120.769 -1.207 . . . . 0.0 111.808 -179.814 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 838' ' ' VAL . . . . . . . . . . . . . 60.7 t -115.46 128.54 72.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.702 -0.624 . . . . 0.0 109.509 179.889 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 839' ' ' CYS . . . . . . . . . . . . . 5.2 m -108.25 156.36 19.45 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.998 -1.064 . . . . 0.0 110.908 -179.957 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 840' ' ' SER . . . . . 0.625 ' HA ' HG12 ' A' ' 728' ' ' VAL . 6.0 p -157.97 136.37 11.05 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.43 -0.794 . . . . 0.0 109.84 179.917 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 841' ' ' THR . . . . . 0.429 ' HA ' ' HG3' ' A' ' 768' ' ' GLN . 65.7 p . . . . . 0 N--CA 1.493 1.693 0 O-C-N 121.32 -0.862 . . . . 0.0 110.41 -179.954 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 728' ' ' VAL . . . . . . . . . . . . . 66.4 t . . . . . 0 N--CA 1.494 1.749 0 CA-C-O 121.175 0.512 . . . . 0.0 110.236 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 729' ' ' SER . . . . . 0.445 ' O ' ' O ' ' A' ' 730' ' ' GLY . 15.1 p -139.7 71.08 1.37 Allowed 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.258 -0.901 . . . . 0.0 110.472 -179.943 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 730' ' ' GLY . . . . . 0.517 ' HA3' ' HA ' ' A' ' 838' ' ' VAL . . . -52.1 -175.77 0.04 OUTLIER Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 179.958 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 731' ' ' VAL . . . . . . . . . . . . . 3.6 t -132.26 135.93 57.26 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.286 -1.126 . . . . 0.0 110.036 179.994 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 732' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -110.55 126.96 54.97 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.239 -0.913 . . . . 0.0 110.081 179.936 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 733' ' ' ALA . . . . . . . . . . . . . . . -138.92 123.0 17.95 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.211 -0.931 . . . . 0.0 110.717 -179.898 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 734' ' ' ASP . . . . . . . . . . . . . 2.2 p-10 -113.0 108.8 17.85 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.401 -0.812 . . . . 0.0 109.698 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 735' ' ' VAL . . . . . 0.428 HG12 ' N ' ' A' ' 736' ' ' SER . 45.7 t -111.12 164.11 7.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.226 -0.921 . . . . 0.0 110.315 -179.937 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 736' ' ' SER . . . . . 0.428 ' N ' HG12 ' A' ' 735' ' ' VAL . 44.5 p -101.53 -178.48 3.74 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.178 -0.951 . . . . 0.0 110.264 -179.96 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 737' ' ' GLU . . . . . 0.505 ' HB2' HG21 ' A' ' 816' ' ' ILE . 25.6 tt0 . . . . . 0 N--CA 1.494 1.737 0 O-C-N 121.341 -0.849 . . . . 0.0 110.351 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 757' ' ' THR . . . . . . . . . . . . . 71.5 p . . . . . 0 N--CA 1.496 1.868 0 CA-C-O 121.321 0.581 . . . . 0.0 110.543 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 758' ' ' ALA . . . . . . . . . . . . . . . -60.25 170.02 1.43 Allowed 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.257 -0.902 . . . . 0.0 109.525 179.958 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 759' ' ' LYS . . . . . . . . . . . . . 21.2 mttt -129.25 161.89 29.15 Favored 'General case' 0 C--N 1.299 -1.612 0 O-C-N 121.087 -1.008 . . . . 0.0 110.382 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 760' ' ' VAL . . . . . . . . . . . . . 28.0 t -107.24 131.79 56.38 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.343 -0.848 . . . . 0.0 108.769 179.958 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 761' ' ' HIS . . . . . . . . . . . . . 27.0 m170 -112.29 104.41 12.58 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.035 -1.04 . . . . 0.0 111.545 -179.872 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 762' ' ' LEU . . . . . . . . . . . . . 19.4 mt -110.32 113.42 26.06 Favored 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 179.864 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 763' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -140.03 116.98 11.04 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.712 -1.242 . . . . 0.0 111.331 -179.858 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 764' ' ' CYS . . . . . 0.463 ' O ' ' O ' ' A' ' 765' ' ' ALA . 1.5 m -95.89 146.03 24.9 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.511 -0.743 . . . . 0.0 109.05 179.938 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 765' ' ' ALA . . . . . 0.626 ' HB3' ' OE1' ' A' ' 768' ' ' GLN . . . -39.61 160.74 0.1 OUTLIER Pre-proline 0 N--CA 1.498 1.933 0 O-C-N 121.215 -0.928 . . . . 0.0 110.413 -179.992 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 766' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -69.99 102.07 1.02 Allowed 'Trans proline' 0 C--N 1.305 -1.757 0 O-C-N 123.941 1.495 . . . . 0.0 110.213 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 767' ' ' GLY . . . . . . . . . . . . . . . 132.3 -17.92 4.75 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 108.966 -1.654 . . . . 0.0 108.966 -179.951 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 768' ' ' GLN . . . . . 0.626 ' OE1' ' HB3' ' A' ' 765' ' ' ALA . 13.2 mt-30 -102.58 114.77 29.26 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.423 -1.045 . . . . 0.0 109.77 179.895 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 769' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -106.82 149.39 27.44 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.202 -0.936 . . . . 0.0 110.616 -179.954 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 770' ' ' ILE . . . . . . . . . . . . . 49.8 mt -72.92 150.26 8.22 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.314 -0.866 . . . . 0.0 109.545 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 771' ' ' SER . . . . . . . . . . . . . 1.3 p -140.84 3.64 1.85 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 120.995 -1.066 . . . . 0.0 111.008 179.973 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 772' ' ' ALA . . . . . . . . . . . . . . . -173.65 145.96 1.25 Allowed 'General case' 0 N--CA 1.495 1.783 0 O-C-N 120.902 -1.124 . . . . 0.0 111.551 -179.946 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 773' ' ' ILE . . . . . 0.401 HD12 HG23 ' A' ' 773' ' ' ILE . 38.1 mm -107.01 147.92 11.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 179.907 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 774' ' ' LYS . . . . . . . . . . . . . 9.8 tptp -113.44 -25.0 8.99 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.998 -1.064 . . . . 0.0 110.808 -179.93 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 775' ' ' PHE . . . . . 0.588 ' O ' ' HB2' ' A' ' 776' ' ' ALA . 68.5 t80 -170.43 163.98 8.59 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.057 -1.027 . . . . 0.0 110.751 179.994 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 776' ' ' ALA . . . . . 0.588 ' HB2' ' O ' ' A' ' 775' ' ' PHE . . . 175.07 72.31 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.692 -0.63 . . . . 0.0 109.406 -179.945 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 777' ' ' SER . . . . . 0.449 ' HA ' ' HB3' ' A' ' 798' ' ' SER . 1.5 t -92.66 154.23 18.49 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.328 -0.857 . . . . 0.0 110.968 -179.891 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 778' ' ' PHE . . . . . 0.578 ' O ' ' CD2' ' A' ' 778' ' ' PHE . 33.9 t80 -124.95 94.96 4.33 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.467 -0.771 . . . . 0.0 109.899 179.958 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 779' ' ' GLY . . . . . . . . . . . . . . . 159.18 -97.12 0.16 Allowed Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 179.99 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 780' ' ' THR . . . . . 0.466 HG21 HG11 ' A' ' 829' ' ' VAL . 52.1 p -132.8 92.58 26.12 Favored Pre-proline 0 N--CA 1.493 1.716 0 O-C-N 121.271 -1.134 . . . . 0.0 110.285 -179.94 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 781' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -75.26 173.19 14.93 Favored 'Trans proline' 0 C--N 1.305 -1.744 0 O-C-N 124.098 1.578 . . . . 0.0 110.523 179.916 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 782' ' ' LEU . . . . . . . . . . . . . 2.2 tt -137.65 118.32 14.02 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.307 -0.871 . . . . 0.0 110.167 179.935 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 783' ' ' GLY . . . . . 0.409 ' HA3' HG23 ' A' ' 787' ' ' THR . . . 95.28 -176.84 34.52 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.331 -1.507 . . . . 0.0 109.331 179.98 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 784' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -117.91 -160.81 0.8 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.208 -1.172 . . . . 0.0 110.188 -179.979 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 785' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -60.56 119.16 7.54 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.306 -0.871 . . . . 0.0 110.252 -179.932 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 786' ' ' GLY . . . . . . . . . . . . . . . 114.85 -28.93 7.77 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 787' ' ' THR . . . . . 0.409 HG23 ' HA3' ' A' ' 783' ' ' GLY . 8.9 t -134.78 34.4 3.16 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.237 -1.155 . . . . 0.0 110.309 179.967 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 788' ' ' PHE . . . . . 0.493 ' CZ ' ' HB1' ' A' ' 834' ' ' ALA . 1.0 OUTLIER -65.85 132.12 47.91 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.278 -0.889 . . . . 0.0 109.943 179.989 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 789' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -139.9 154.02 47.14 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.229 -0.919 . . . . 0.0 110.33 179.925 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 790' ' ' GLN . . . . . 0.419 ' OE1' ' ND1' ' A' ' 794' ' ' HIS . 1.6 mp0 -65.84 116.3 6.86 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.351 -0.843 . . . . 0.0 110.482 -179.987 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 791' ' ' GLY . . . . . . . . . . . . . . . -64.68 -105.86 0.01 OUTLIER Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.623 -1.391 . . . . 0.0 109.623 -179.945 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 792' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -127.18 -26.12 3.15 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.302 -1.117 . . . . 0.0 110.509 -179.956 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 793' ' ' CYS . . . . . 0.474 ' O ' ' HB3' ' A' ' 794' ' ' HIS . 85.7 m -100.2 -83.91 0.43 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.206 -0.933 . . . . 0.0 109.89 -179.997 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 794' ' ' HIS . . . . . 0.637 ' CE1' ' OG ' ' A' ' 798' ' ' SER . 84.9 t60 58.4 113.77 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.506 -0.746 . . . . 0.0 110.728 179.981 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 795' ' ' SER . . . . . 0.468 ' O ' ' O ' ' A' ' 794' ' ' HIS . 100.0 p -60.66 -126.6 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.301 -0.874 . . . . 0.0 109.295 179.871 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 796' ' ' ILE . . . . . 0.424 ' CG1' ' C ' ' A' ' 795' ' ' SER . 1.0 OUTLIER -148.02 -31.06 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 2.02 0 O-C-N 120.798 -1.189 . . . . 0.0 110.68 179.856 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 797' ' ' ASN . . . . . 0.667 ' O ' HG23 ' A' ' 801' ' ' VAL . 4.3 m120 -86.26 16.28 4.54 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 120.906 -1.121 . . . . 0.0 110.04 179.914 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 798' ' ' SER . . . . . 0.637 ' OG ' ' CE1' ' A' ' 794' ' ' HIS . 0.9 OUTLIER -33.56 -70.76 0.07 Allowed 'General case' 0 N--CA 1.503 2.178 0 O-C-N 121.775 -0.578 . . . . 0.0 111.8 -179.999 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 799' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -84.99 -30.02 24.55 Favored 'General case' 0 N--CA 1.501 2.086 0 O-C-N 121.155 -0.966 . . . . 0.0 111.094 -179.876 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 800' ' ' SER . . . . . . . . . . . . . 37.2 t -54.47 -16.91 2.61 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.059 -1.026 . . . . 0.0 110.743 -179.955 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 801' ' ' VAL . . . . . 0.667 HG23 ' O ' ' A' ' 797' ' ' ASN . 85.3 t -90.97 -48.69 13.9 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.919 0 O-C-N 121.046 -1.034 . . . . 0.0 111.588 -179.851 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 802' ' ' LEU . . . . . 0.516 HD22 ' N ' ' A' ' 802' ' ' LEU . 4.6 mm? -75.08 -16.33 60.57 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.112 -0.993 . . . . 0.0 111.522 -179.801 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 803' ' ' GLU . . . . . 0.906 ' O ' HD12 ' A' ' 807' ' ' ILE . 0.5 OUTLIER -81.94 -27.53 33.24 Favored 'General case' 0 C--N 1.295 -1.77 0 O-C-N 120.73 -1.232 . . . . 0.0 110.778 -179.947 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 804' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -95.4 -18.39 20.77 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.109 -0.994 . . . . 0.0 112.28 -179.918 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 805' ' ' LYS . . . . . 0.458 ' O ' ' SG ' ' A' ' 806' ' ' CYS . 4.0 ttpt -122.17 20.25 10.63 Favored 'General case' 0 N--CA 1.501 2.078 0 O-C-N 120.452 -1.405 . . . . 0.0 112.477 -179.868 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 806' ' ' CYS . . . . . 0.512 ' HB2' ' O ' ' A' ' 802' ' ' LEU . 50.0 m -152.66 51.17 0.76 Allowed 'General case' 0 N--CA 1.496 1.832 0 O-C-N 120.665 -1.272 . . . . 0.0 110.406 179.905 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 807' ' ' ILE . . . . . 0.906 HD12 ' O ' ' A' ' 803' ' ' GLU . 9.1 mt -140.42 95.04 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.484 0 O-C-N 121.524 -0.735 . . . . 0.0 109.324 179.956 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 808' ' ' GLY . . . . . . . . . . . . . . . 118.95 10.07 8.51 Favored Glycine 0 N--CA 1.489 2.199 0 N-CA-C 109.264 -1.534 . . . . 0.0 109.264 -179.946 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 809' ' ' LEU . . . . . . . . . . . . . 9.1 mt -117.61 157.05 27.08 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.255 -1.144 . . . . 0.0 110.191 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 810' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -86.28 -18.61 31.59 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.202 -0.936 . . . . 0.0 110.088 179.987 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 811' ' ' ARG . . . . . . . . . . . . . 26.2 ttp180 -149.79 136.09 19.0 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.323 -0.861 . . . . 0.0 110.087 179.942 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 812' ' ' CYS . . . . . 0.45 ' SG ' ' O ' ' A' ' 805' ' ' LYS . 0.1 OUTLIER -123.98 144.21 49.95 Favored 'General case' 0 C--N 1.298 -1.655 0 O-C-N 121.303 -0.873 . . . . 0.0 110.256 -179.906 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 813' ' ' VAL . . . . . 0.598 HG13 ' O ' ' A' ' 813' ' ' VAL . 7.0 p -137.87 123.15 24.44 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.509 0 O-C-N 121.309 -0.87 . . . . 0.0 109.622 179.888 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 814' ' ' VAL . . . . . . . . . . . . . 36.5 t -131.38 135.81 58.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.135 -0.978 . . . . 0.0 110.393 -179.946 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 815' ' ' ALA . . . . . 0.617 ' O ' ' ND2' ' A' ' 820' ' ' ASN . . . -82.8 146.32 29.02 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.341 -0.849 . . . . 0.0 110.024 179.972 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 816' ' ' ILE . . . . . 0.863 HG23 HG21 ' A' ' 833' ' ' VAL . 18.0 mt -95.58 111.83 26.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.213 -0.93 . . . . 0.0 110.194 -179.995 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 817' ' ' SER . . . . . 0.527 ' CB ' ' HD2' ' A' ' 818' ' ' PRO . 1.0 OUTLIER -161.73 -175.83 0.53 Allowed Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.226 -0.922 . . . . 0.0 110.219 179.937 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 818' ' ' PRO . . . . . 0.527 ' HD2' ' CB ' ' A' ' 817' ' ' SER . 50.2 Cg_endo -78.32 -37.02 0.82 Allowed 'Trans proline' 0 C--N 1.305 -1.711 0 O-C-N 124.02 1.537 . . . . 0.0 110.893 -179.853 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 819' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -83.49 22.93 0.99 Allowed 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.113 -0.992 . . . . 0.0 110.826 -179.991 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 820' ' ' ASN . . . . . 0.617 ' ND2' ' O ' ' A' ' 815' ' ' ALA . 2.1 m-20 -117.0 -15.01 10.61 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.11 -0.994 . . . . 0.0 110.169 179.939 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 821' ' ' PHE . . . . . . . . . . . . . 39.4 m-85 -128.01 -74.19 0.58 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.154 -0.966 . . . . 0.0 110.621 179.987 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 822' ' ' GLY . . . . . . . . . . . . . . . -163.17 50.84 0.31 Allowed Glycine 0 N--CA 1.493 2.477 0 N-CA-C 109.778 -1.329 . . . . 0.0 109.778 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 823' ' ' GLY . . . . . . . . . . . . . . . 72.76 -126.82 11.02 Favored Glycine 0 N--CA 1.492 2.393 0 N-CA-C 109.661 -1.376 . . . . 0.0 109.661 179.944 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 824' ' ' ASP . . . . . 0.41 ' O ' ' OD2' ' A' ' 824' ' ' ASP . 1.5 p30 -127.17 134.97 26.72 Favored Pre-proline 0 N--CA 1.494 1.742 0 O-C-N 121.241 -1.152 . . . . 0.0 110.32 179.986 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 825' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -78.95 -90.76 0.0 OUTLIER 'Trans proline' 0 C--N 1.307 -1.64 0 O-C-N 124.053 1.554 . . . . 0.0 110.616 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 826' ' ' CYS . . . . . 0.452 ' HA ' ' HD3' ' A' ' 827' ' ' PRO . 24.3 p -115.39 138.26 23.58 Favored Pre-proline 0 N--CA 1.496 1.851 0 O-C-N 121.21 -0.931 . . . . 0.0 111.067 -179.897 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 827' ' ' PRO . . . . . 0.469 ' O ' ' HB2' ' A' ' 828' ' ' GLU . 54.9 Cg_endo -85.16 -178.91 3.32 Favored 'Trans proline' 0 C--N 1.306 -1.687 0 O-C-N 124.121 1.59 . . . . 0.0 110.057 179.915 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 828' ' ' GLU . . . . . 0.469 ' HB2' ' O ' ' A' ' 827' ' ' PRO . 50.6 mt-10 57.88 17.38 4.24 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.566 -0.709 . . . . 0.0 111.042 179.937 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 829' ' ' VAL . . . . . 0.466 HG11 HG21 ' A' ' 780' ' ' THR . 72.4 t -130.4 141.42 46.33 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 O-C-N 121.079 -1.013 . . . . 0.0 110.023 179.844 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 830' ' ' MET . . . . . 0.463 ' O ' ' O ' ' A' ' 829' ' ' VAL . 0.0 OUTLIER -51.21 -175.75 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.195 -0.94 . . . . 0.0 110.126 -179.975 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 831' ' ' LYS . . . . . . . . . . . . . 9.7 mttp -142.29 108.23 5.17 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.025 -1.047 . . . . 0.0 110.896 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 832' ' ' ARG . . . . . . . . . . . . . 5.9 mtp180 -129.88 147.42 51.65 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.444 -0.785 . . . . 0.0 109.483 179.957 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 833' ' ' VAL . . . . . 0.863 HG21 HG23 ' A' ' 816' ' ' ILE . 92.6 t -120.15 117.57 53.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.024 -1.047 . . . . 0.0 110.731 -179.942 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 834' ' ' ALA . . . . . 0.493 ' HB1' ' CZ ' ' A' ' 788' ' ' PHE . . . -112.99 127.92 56.36 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.284 -0.885 . . . . 0.0 109.847 179.917 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 835' ' ' VAL . . . . . 0.467 ' CG1' ' N ' ' A' ' 836' ' ' GLU . 14.9 t -126.11 165.69 23.61 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 121.11 -0.994 . . . . 0.0 110.577 -179.916 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 836' ' ' GLU . . . . . 0.467 ' N ' ' CG1' ' A' ' 835' ' ' VAL . 0.1 OUTLIER -152.88 109.69 3.46 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.377 -0.827 . . . . 0.0 109.657 -179.939 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 837' ' ' ALA . . . . . . . . . . . . . . . -111.18 162.01 15.38 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.171 -0.956 . . . . 0.0 110.532 -179.979 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 838' ' ' VAL . . . . . 0.517 ' HA ' ' HA3' ' A' ' 730' ' ' GLY . 39.1 t -120.02 132.87 68.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.321 -0.862 . . . . 0.0 110.07 -179.96 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 839' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -118.18 136.89 53.35 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.222 -0.924 . . . . 0.0 110.149 -179.976 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 840' ' ' SER . . . . . 0.44 ' O ' ' HG2' ' A' ' 768' ' ' GLN . 91.4 p -106.23 -145.01 0.38 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.161 -0.962 . . . . 0.0 110.031 179.975 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 841' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.494 1.727 0 O-C-N 121.062 -1.024 . . . . 0.0 110.299 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 728' ' ' VAL . . . . . 0.512 ' O ' ' CB ' ' A' ' 729' ' ' SER . 74.6 t . . . . . 0 N--CA 1.492 1.627 0 CA-C-O 121.026 0.441 . . . . 0.0 110.075 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 729' ' ' SER . . . . . 0.512 ' CB ' ' O ' ' A' ' 728' ' ' VAL . 0.3 OUTLIER 166.65 126.52 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.104 0 O-C-N 121.326 -0.859 . . . . 0.0 110.304 -179.987 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 730' ' ' GLY . . . . . 0.437 ' C ' ' CG2' ' A' ' 731' ' ' VAL . . . 142.78 76.57 0.04 OUTLIER Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.741 -1.344 . . . . 0.0 109.741 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 731' ' ' VAL . . . . . 0.437 ' CG2' ' C ' ' A' ' 730' ' ' GLY . 3.1 t -147.6 135.58 14.74 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 121.178 -1.189 . . . . 0.0 110.14 179.994 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 732' ' ' CYS . . . . . . . . . . . . . 30.4 p -153.3 138.27 17.22 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.235 -0.915 . . . . 0.0 110.094 -179.961 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 733' ' ' ALA . . . . . . . . . . . . . . . -111.92 131.21 55.52 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.266 -0.896 . . . . 0.0 110.397 179.992 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 734' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -119.7 105.37 11.1 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.296 -0.878 . . . . 0.0 110.037 179.941 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 735' ' ' VAL . . . . . 0.423 HG12 ' N ' ' A' ' 736' ' ' SER . 61.1 t -128.42 162.83 34.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.151 -0.968 . . . . 0.0 110.298 -179.942 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 736' ' ' SER . . . . . 0.423 ' N ' HG12 ' A' ' 735' ' ' VAL . 6.6 p -109.17 -165.75 1.05 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.206 -0.934 . . . . 0.0 110.007 -179.962 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 737' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.495 1.813 0 O-C-N 121.266 -0.896 . . . . 0.0 110.731 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 757' ' ' THR . . . . . . . . . . . . . 37.2 p . . . . . 0 N--CA 1.505 2.306 0 CA-C-O 121.872 0.844 . . . . 0.0 112.285 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 758' ' ' ALA . . . . . . . . . . . . . . . -109.75 179.04 4.24 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.753 -0.592 . . . . 0.0 109.703 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 759' ' ' LYS . . . . . . . . . . . . . 18.0 mtpt -141.77 150.72 42.11 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.062 -1.024 . . . . 0.0 110.946 179.979 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 760' ' ' VAL . . . . . . . . . . . . . 5.4 t -108.06 131.42 58.5 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 179.884 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 761' ' ' HIS . . . . . . . . . . . . . 3.7 m170 -117.35 103.77 10.47 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.998 -1.064 . . . . 0.0 111.575 -179.878 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 762' ' ' LEU . . . . . 0.538 ' HB2' ' HB3' ' A' ' 812' ' ' CYS . 0.2 OUTLIER -109.43 103.11 11.96 Favored 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 179.818 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 763' ' ' LYS . . . . . . . . . . . . . 9.5 ttmt -109.95 165.53 11.65 Favored 'General case' 0 N--CA 1.5 2.073 0 O-C-N 121.096 -1.002 . . . . 0.0 111.766 -179.729 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 764' ' ' CYS . . . . . . . . . . . . . 7.9 m -132.18 175.58 9.13 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.705 -0.622 . . . . 0.0 109.837 179.893 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 765' ' ' ALA . . . . . 0.704 ' HB1' ' HD2' ' A' ' 766' ' ' PRO . . . -71.25 171.66 8.26 Favored Pre-proline 0 N--CA 1.495 1.789 0 O-C-N 121.181 -0.95 . . . . 0.0 109.946 179.937 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 766' ' ' PRO . . . . . 0.704 ' HD2' ' HB1' ' A' ' 765' ' ' ALA . 46.1 Cg_endo -72.47 129.03 14.22 Favored 'Trans proline' 0 C--N 1.306 -1.66 0 O-C-N 123.849 1.447 . . . . 0.0 110.159 179.99 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 767' ' ' GLY . . . . . . . . . . . . . . . 89.53 11.38 64.25 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.349 -1.5 . . . . 0.0 109.349 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 768' ' ' GLN . . . . . . . . . . . . . 2.7 mt-30 -129.1 135.07 48.4 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.304 -1.115 . . . . 0.0 110.216 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 769' ' ' THR . . . . . 0.53 ' CG2' ' HG3' ' A' ' 810' ' ' GLU . 7.7 p -133.31 147.56 51.88 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.204 -0.935 . . . . 0.0 110.32 179.958 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 770' ' ' ILE . . . . . 0.467 HD13 ' SG ' ' A' ' 806' ' ' CYS . 4.3 mt -64.35 149.46 11.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.253 -0.904 . . . . 0.0 109.454 179.997 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 771' ' ' SER . . . . . 0.466 ' O ' ' HB2' ' A' ' 772' ' ' ALA . 24.4 p -134.34 1.05 3.14 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 120.955 -1.09 . . . . 0.0 110.717 -179.88 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 772' ' ' ALA . . . . . 0.466 ' HB2' ' O ' ' A' ' 771' ' ' SER . . . -177.49 132.1 0.16 Allowed 'General case' 0 N--CA 1.495 1.779 0 O-C-N 120.998 -1.064 . . . . 0.0 111.111 -179.964 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 773' ' ' ILE . . . . . . . . . . . . . 32.5 mm -87.65 124.24 40.8 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 O-C-N 121.327 -0.858 . . . . 0.0 109.673 179.919 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 774' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.32 -40.19 18.24 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.186 -0.946 . . . . 0.0 110.725 -179.978 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 775' ' ' PHE . . . . . 0.728 ' O ' ' HB2' ' A' ' 776' ' ' ALA . 75.5 t80 -145.58 162.97 36.22 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.031 -1.043 . . . . 0.0 110.942 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 776' ' ' ALA . . . . . 0.728 ' HB2' ' O ' ' A' ' 775' ' ' PHE . . . 167.13 117.79 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.425 -0.797 . . . . 0.0 109.715 179.98 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 777' ' ' SER . . . . . 0.493 ' HA ' ' OG ' ' A' ' 798' ' ' SER . 17.2 m -151.29 136.33 17.43 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.992 -1.068 . . . . 0.0 110.775 -179.953 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 778' ' ' PHE . . . . . . . . . . . . . 46.7 t80 -103.61 107.17 17.91 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.387 -0.821 . . . . 0.0 110.101 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 779' ' ' GLY . . . . . . . . . . . . . . . 162.82 -101.45 0.19 Allowed Glycine 0 N--CA 1.492 2.43 0 N-CA-C 109.514 -1.434 . . . . 0.0 109.514 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 780' ' ' THR . . . . . . . . . . . . . 53.8 p -134.52 101.54 11.97 Favored Pre-proline 0 N--CA 1.495 1.79 0 O-C-N 121.243 -1.151 . . . . 0.0 110.201 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 781' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -77.8 148.07 25.07 Favored 'Trans proline' 0 C--N 1.306 -1.69 0 O-C-N 123.935 1.492 . . . . 0.0 110.593 -179.97 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 782' ' ' LEU . . . . . 0.494 ' HA ' HD23 ' A' ' 782' ' ' LEU . 7.3 mt -108.02 79.42 1.27 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.308 -0.87 . . . . 0.0 109.75 179.973 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 783' ' ' GLY . . . . . . . . . . . . . . . 123.38 -174.52 16.58 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 108.911 -1.675 . . . . 0.0 108.911 -179.929 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 784' ' ' THR . . . . . . . . . . . . . 37.9 p -122.61 -161.35 0.94 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.1 -1.235 . . . . 0.0 110.287 179.933 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 785' ' ' CYS . . . . . 0.52 ' HA ' ' CE1' ' A' ' 788' ' ' PHE . 6.8 t -57.32 92.94 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.186 -0.946 . . . . 0.0 110.263 179.955 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 786' ' ' GLY . . . . . . . . . . . . . . . 151.48 -28.22 0.96 Allowed Glycine 0 N--CA 1.492 2.388 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 -179.995 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 787' ' ' THR . . . . . 0.757 HG22 ' O ' ' A' ' 787' ' ' THR . 51.5 m -143.61 30.29 1.36 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.297 -1.12 . . . . 0.0 110.141 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 788' ' ' PHE . . . . . 0.52 ' CE1' ' HA ' ' A' ' 785' ' ' CYS . 6.2 m-85 -51.16 155.03 1.41 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.238 -0.914 . . . . 0.0 110.285 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 789' ' ' GLN . . . . . 0.458 ' HB2' ' O ' ' A' ' 788' ' ' PHE . 1.8 tp-100 -177.82 124.84 0.12 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.392 -0.817 . . . . 0.0 110.234 179.977 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 790' ' ' GLN . . . . . 0.438 ' C ' ' O ' ' A' ' 789' ' ' GLN . 1.4 mt-30 -40.16 123.54 1.71 Allowed 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.451 -0.78 . . . . 0.0 110.383 -179.969 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 791' ' ' GLY . . . . . . . . . . . . . . . -74.95 -132.03 0.27 Allowed Glycine 0 N--CA 1.491 2.362 0 N-CA-C 109.332 -1.507 . . . . 0.0 109.332 179.905 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 792' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -106.92 3.47 26.23 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.165 -1.197 . . . . 0.0 110.197 179.971 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 793' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -141.08 118.91 11.76 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.326 -0.859 . . . . 0.0 110.008 -179.991 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 794' ' ' HIS . . . . . 0.428 ' CE1' ' HB2' ' A' ' 798' ' ' SER . 29.7 t-80 -138.07 148.13 44.74 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.294 -0.879 . . . . 0.0 110.148 -179.987 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 795' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -76.8 -136.53 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.296 -0.878 . . . . 0.0 109.66 179.996 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 796' ' ' ILE . . . . . . . . . . . . . 3.8 pt -146.1 12.04 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 O-C-N 121.09 -1.006 . . . . 0.0 110.044 179.905 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 797' ' ' ASN . . . . . . . . . . . . . 7.5 p30 -150.6 30.0 0.67 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.383 -0.823 . . . . 0.0 109.722 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 798' ' ' SER . . . . . 0.496 ' HB3' ' O ' ' A' ' 776' ' ' ALA . 0.7 OUTLIER -57.61 -27.43 62.75 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.522 -0.736 . . . . 0.0 111.102 -179.943 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 799' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -100.83 -22.27 14.89 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 120.924 -1.11 . . . . 0.0 110.501 -179.898 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 800' ' ' SER . . . . . . . . . . . . . 47.4 t -69.45 -18.69 63.75 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.121 -0.987 . . . . 0.0 110.324 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 801' ' ' VAL . . . . . . . . . . . . . 94.2 t -84.45 -46.56 17.75 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 121.23 -0.919 . . . . 0.0 110.863 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 802' ' ' LEU . . . . . 0.527 HD22 ' N ' ' A' ' 802' ' ' LEU . 4.1 mm? -72.6 -42.98 63.94 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.18 -0.95 . . . . 0.0 111.019 -179.946 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 803' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -51.61 -31.12 23.78 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.046 -1.034 . . . . 0.0 110.648 -179.955 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 804' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -92.34 -21.38 20.29 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.105 -0.997 . . . . 0.0 111.279 -179.949 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 805' ' ' LYS . . . . . 0.471 ' O ' ' SG ' ' A' ' 812' ' ' CYS . 0.9 OUTLIER -111.92 28.75 8.47 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 120.912 -1.118 . . . . 0.0 111.216 -179.864 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 806' ' ' CYS . . . . . 0.467 ' SG ' HD13 ' A' ' 770' ' ' ILE . 0.1 OUTLIER -152.92 -74.46 0.13 Allowed 'General case' 0 N--CA 1.497 1.895 0 O-C-N 120.914 -1.116 . . . . 0.0 111.055 179.984 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 807' ' ' ILE . . . . . 0.418 ' C ' ' O ' ' A' ' 806' ' ' CYS . 29.3 mt -41.65 121.36 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.192 -0.943 . . . . 0.0 110.901 -179.883 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 808' ' ' GLY . . . . . 0.439 ' C ' ' HG ' ' A' ' 809' ' ' LEU . . . 99.0 13.45 39.71 Favored Glycine 0 N--CA 1.492 2.432 0 N-CA-C 110.369 -1.092 . . . . 0.0 110.369 179.94 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 809' ' ' LEU . . . . . 0.439 ' HG ' ' C ' ' A' ' 808' ' ' GLY . 91.9 mt -143.3 132.82 23.57 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 120.992 -1.299 . . . . 0.0 110.496 179.982 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 810' ' ' GLU . . . . . 0.53 ' HG3' ' CG2' ' A' ' 769' ' ' THR . 1.0 OUTLIER -63.46 -30.61 71.71 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.271 -0.893 . . . . 0.0 109.383 -179.969 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 811' ' ' ARG . . . . . 0.528 ' HB3' ' NH2' ' A' ' 811' ' ' ARG . 0.5 OUTLIER -117.85 156.6 28.11 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.618 -0.676 . . . . 0.0 109.886 179.958 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 812' ' ' CYS . . . . . 0.538 ' HB3' ' HB2' ' A' ' 762' ' ' LEU . 3.4 t -131.37 137.25 48.64 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.238 -0.914 . . . . 0.0 110.646 -179.925 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 813' ' ' VAL . . . . . 0.672 HG13 ' O ' ' A' ' 813' ' ' VAL . 8.6 p -139.17 119.28 14.38 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.326 -0.859 . . . . 0.0 109.687 179.932 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 814' ' ' VAL . . . . . 0.441 HG21 HD11 ' A' ' 802' ' ' LEU . 38.6 t -128.52 165.58 27.77 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.233 -0.917 . . . . 0.0 110.537 -179.974 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 815' ' ' ALA . . . . . 0.438 ' N ' HG12 ' A' ' 814' ' ' VAL . . . -122.76 147.16 46.83 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.356 -0.84 . . . . 0.0 109.504 179.97 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 816' ' ' ILE . . . . . . . . . . . . . 88.2 mt -105.2 116.2 48.54 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 O-C-N 121.067 -1.02 . . . . 0.0 110.558 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 817' ' ' SER . . . . . 0.425 ' HB2' ' HD2' ' A' ' 818' ' ' PRO . 1.4 p -164.13 169.4 8.16 Favored Pre-proline 0 N--CA 1.492 1.66 0 O-C-N 121.334 -0.854 . . . . 0.0 110.123 179.95 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 818' ' ' PRO . . . . . 0.425 ' HD2' ' HB2' ' A' ' 817' ' ' SER . 43.4 Cg_endo -69.12 -16.54 40.34 Favored 'Trans proline' 0 C--N 1.304 -1.802 0 O-C-N 123.976 1.514 . . . . 0.0 110.504 179.993 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 819' ' ' SER . . . . . . . . . . . . . 14.5 p -106.54 31.7 5.04 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.151 -0.968 . . . . 0.0 110.345 -179.974 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 820' ' ' ASN . . . . . . . . . . . . . 7.8 t-20 -113.53 -28.13 7.63 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.26 -0.9 . . . . 0.0 110.283 -179.974 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 821' ' ' PHE . . . . . . . . . . . . . 94.6 m-85 -116.19 -77.82 0.57 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.25 -0.906 . . . . 0.0 110.471 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 822' ' ' GLY . . . . . . . . . . . . . . . -152.72 42.69 0.67 Allowed Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.643 -1.383 . . . . 0.0 109.643 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 823' ' ' GLY . . . . . 0.414 ' HA2' ' O ' ' A' ' 818' ' ' PRO . . . 85.95 -117.81 4.68 Favored Glycine 0 N--CA 1.492 2.408 0 N-CA-C 109.464 -1.455 . . . . 0.0 109.464 179.993 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 824' ' ' ASP . . . . . . . . . . . . . 6.6 t0 -137.92 105.88 8.14 Favored Pre-proline 0 N--CA 1.493 1.721 0 O-C-N 121.199 -1.177 . . . . 0.0 110.282 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 825' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -74.83 -60.72 0.04 OUTLIER 'Trans proline' 0 C--N 1.307 -1.623 0 O-C-N 124.086 1.571 . . . . 0.0 110.687 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 826' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -109.83 100.44 42.89 Favored Pre-proline 0 N--CA 1.499 2.007 0 O-C-N 121.109 -0.994 . . . . 0.0 110.65 -179.949 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 827' ' ' PRO . . . . . 0.622 ' O ' HG23 ' A' ' 829' ' ' VAL . 48.9 Cg_endo -83.33 166.89 13.98 Favored 'Trans proline' 0 C--N 1.305 -1.718 0 O-C-N 124.039 1.547 . . . . 0.0 110.459 179.925 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 828' ' ' GLU . . . . . . . . . . . . . 10.2 mm-40 48.53 42.4 18.78 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.227 -0.921 . . . . 0.0 110.355 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 829' ' ' VAL . . . . . 0.622 HG23 ' O ' ' A' ' 827' ' ' PRO . 44.2 t -139.83 145.46 26.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.222 -0.924 . . . . 0.0 110.205 -179.996 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 830' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -51.15 99.49 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.175 -0.953 . . . . 0.0 110.215 179.962 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 831' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -71.69 132.69 44.91 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.223 -0.923 . . . . 0.0 110.711 -179.941 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 832' ' ' ARG . . . . . . . . . . . . . 2.5 ttt180 -150.64 149.7 30.19 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.536 -0.727 . . . . 0.0 109.397 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 833' ' ' VAL . . . . . . . . . . . . . 71.9 t -118.68 140.95 40.58 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 120.994 -1.067 . . . . 0.0 111.113 -179.899 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 834' ' ' ALA . . . . . 0.648 ' O ' HG23 ' A' ' 835' ' ' VAL . . . -143.61 136.88 27.9 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.551 -0.718 . . . . 0.0 109.384 179.911 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 835' ' ' VAL . . . . . 0.648 HG23 ' O ' ' A' ' 834' ' ' ALA . 23.6 t -156.36 145.53 11.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 120.937 -1.102 . . . . 0.0 111.484 -179.9 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 836' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -135.18 128.11 31.41 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 179.864 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 837' ' ' ALA . . . . . . . . . . . . . . . -116.6 161.76 18.66 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.96 -1.087 . . . . 0.0 111.32 -179.892 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 838' ' ' VAL . . . . . . . . . . . . . 66.2 t -109.78 114.57 47.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.663 -0.648 . . . . 0.0 109.539 179.942 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 839' ' ' CYS . . . . . 0.478 ' O ' ' O ' ' A' ' 728' ' ' VAL . 0.1 OUTLIER -108.96 144.22 37.2 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.019 -1.051 . . . . 0.0 110.88 -179.968 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 840' ' ' SER . . . . . . . . . . . . . 79.8 p -171.52 178.67 3.1 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.42 -0.8 . . . . 0.0 110.037 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 841' ' ' THR . . . . . . . . . . . . . 11.1 p . . . . . 0 N--CA 1.495 1.78 0 O-C-N 121.159 -0.963 . . . . 0.0 110.178 -179.975 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 728' ' ' VAL . . . . . . . . . . . . . 35.8 m . . . . . 0 N--CA 1.492 1.645 0 CA-C-O 121.216 0.532 . . . . 0.0 110.057 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 729' ' ' SER . . . . . . . . . . . . . 24.4 m -128.48 -154.17 0.62 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.26 -0.9 . . . . 0.0 110.269 -179.949 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 730' ' ' GLY . . . . . . . . . . . . . . . -148.27 111.01 0.52 Allowed Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 179.967 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 731' ' ' VAL . . . . . . . . . . . . . 41.3 t -114.22 151.96 15.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.196 -1.179 . . . . 0.0 110.457 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 732' ' ' CYS . . . . . 0.404 ' HA ' ' O ' ' A' ' 835' ' ' VAL . 14.1 p -159.91 143.91 14.49 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.431 -0.793 . . . . 0.0 109.536 -179.968 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 733' ' ' ALA . . . . . . . . . . . . . . . -121.52 136.37 54.96 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.121 -0.987 . . . . 0.0 110.434 -179.953 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 734' ' ' ASP . . . . . 0.424 ' CG ' ' O ' ' A' ' 734' ' ' ASP . 5.2 p-10 -123.73 106.15 10.28 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.273 -0.892 . . . . 0.0 109.94 179.953 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 735' ' ' VAL . . . . . . . . . . . . . 5.7 t -132.12 128.86 59.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.181 -0.949 . . . . 0.0 110.277 -179.967 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 736' ' ' SER . . . . . . . . . . . . . 4.8 p -69.65 158.98 34.29 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.308 -0.87 . . . . 0.0 110.128 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 737' ' ' GLU . . . . . . . . . . . . . 7.7 tm-20 . . . . . 0 N--CA 1.493 1.705 0 O-C-N 121.269 -0.894 . . . . 0.0 110.187 -179.984 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 757' ' ' THR . . . . . . . . . . . . . 1.2 p . . . . . 0 N--CA 1.494 1.761 0 CA-C-O 121.279 0.562 . . . . 0.0 110.219 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 758' ' ' ALA . . . . . . . . . . . . . . . -119.97 171.71 8.25 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.327 -0.858 . . . . 0.0 109.856 179.952 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 759' ' ' LYS . . . . . 0.469 ' HG2' ' HA ' ' A' ' 815' ' ' ALA . 18.2 mttm -142.87 161.07 39.07 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.195 -0.941 . . . . 0.0 110.571 179.989 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 760' ' ' VAL . . . . . 1.001 ' CG2' HD11 ' A' ' 816' ' ' ILE . 11.5 t -112.52 155.57 13.74 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.408 -0.808 . . . . 0.0 109.388 179.93 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 761' ' ' HIS . . . . . 0.456 ' CD2' HG22 ' A' ' 813' ' ' VAL . 0.9 OUTLIER -133.34 119.74 20.11 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.957 -1.089 . . . . 0.0 111.024 179.995 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 762' ' ' LEU . . . . . . . . . . . . . 8.1 mt -114.54 134.78 54.77 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.484 -0.76 . . . . 0.0 109.561 179.935 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 763' ' ' LYS . . . . . . . . . . . . . 6.7 tttm -142.35 125.43 16.3 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.023 -1.048 . . . . 0.0 110.588 179.915 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 764' ' ' CYS . . . . . 0.471 ' O ' ' OE2' ' A' ' 810' ' ' GLU . 0.1 OUTLIER -104.41 -173.25 2.26 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.467 -0.77 . . . . 0.0 109.765 179.949 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 765' ' ' ALA . . . . . . . . . . . . . . . -66.05 148.93 98.16 Favored Pre-proline 0 C--N 1.296 -1.754 0 O-C-N 121.27 -0.894 . . . . 0.0 110.298 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 766' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -72.34 96.39 0.81 Allowed 'Trans proline' 0 C--N 1.307 -1.622 0 O-C-N 123.991 1.521 . . . . 0.0 110.293 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 767' ' ' GLY . . . . . . . . . . . . . . . 141.65 -21.55 2.53 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 108.907 -1.677 . . . . 0.0 108.907 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 768' ' ' GLN . . . . . 0.41 ' O ' ' HG2' ' A' ' 810' ' ' GLU . 73.2 mt-30 -110.86 145.84 37.54 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.472 -1.016 . . . . 0.0 109.688 179.905 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 769' ' ' THR . . . . . . . . . . . . . 82.3 p -121.95 146.61 46.97 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.234 -0.916 . . . . 0.0 110.669 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 770' ' ' ILE . . . . . . . . . . . . . 21.3 mt -49.62 142.82 2.13 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 121.395 -0.816 . . . . 0.0 109.669 179.898 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 771' ' ' SER . . . . . 0.655 ' O ' ' HB2' ' A' ' 772' ' ' ALA . 22.0 p -124.56 -5.45 7.62 Favored 'General case' 0 C--N 1.299 -1.597 0 O-C-N 121.092 -1.005 . . . . 0.0 110.724 -179.903 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 772' ' ' ALA . . . . . 0.655 ' HB2' ' O ' ' A' ' 771' ' ' SER . . . 174.62 146.62 0.07 Allowed 'General case' 0 N--CA 1.492 1.653 0 C-N-CA 118.879 -1.128 . . . . 0.0 111.949 -179.986 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 773' ' ' ILE . . . . . . . . . . . . . 11.7 mm -108.16 149.0 11.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 179.819 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 774' ' ' LYS . . . . . . . . . . . . . 66.8 mttt -132.35 -18.45 2.54 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.509 -1.369 . . . . 0.0 112.206 -179.801 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 775' ' ' PHE . . . . . 0.739 ' O ' ' HB2' ' A' ' 776' ' ' ALA . 43.2 t80 -140.09 168.69 19.23 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.58 -1.325 . . . . 0.0 110.999 -179.904 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 776' ' ' ALA . . . . . 0.739 ' HB2' ' O ' ' A' ' 775' ' ' PHE . . . 164.15 125.87 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.818 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 -179.991 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 777' ' ' SER . . . . . 0.572 ' HA ' ' CE1' ' A' ' 794' ' ' HIS . 0.5 OUTLIER -148.94 106.21 3.62 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.956 -1.09 . . . . 0.0 111.522 -179.906 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 778' ' ' PHE . . . . . 0.411 ' CE2' ' SD ' ' A' ' 830' ' ' MET . 89.6 t80 -85.76 123.94 31.71 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.125 -0.984 . . . . 0.0 109.539 179.908 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 779' ' ' GLY . . . . . 0.523 ' O ' ' HB2' ' A' ' 832' ' ' ARG . . . 138.15 -107.07 0.55 Allowed Glycine 0 N--CA 1.493 2.473 0 C-N-CA 119.496 -1.335 . . . . 0.0 109.99 179.998 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 780' ' ' THR . . . . . . . . . . . . . 35.1 p -133.19 88.16 36.79 Favored Pre-proline 0 N--CA 1.494 1.768 0 O-C-N 120.85 -1.382 . . . . 0.0 111.028 -179.893 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 781' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_endo -83.35 177.72 6.26 Favored 'Trans proline' 0 C--N 1.308 -1.565 0 O-C-N 123.938 1.494 . . . . 0.0 110.534 179.878 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 782' ' ' LEU . . . . . 0.545 ' CD1' ' HA2' ' A' ' 791' ' ' GLY . 1.0 OUTLIER -135.93 174.74 10.28 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.202 -0.936 . . . . 0.0 110.257 179.951 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 783' ' ' GLY . . . . . . . . . . . . . . . 59.34 -166.07 9.08 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.864 -1.295 . . . . 0.0 109.864 179.935 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 784' ' ' THR . . . . . 0.564 HG23 ' N ' ' A' ' 785' ' ' CYS . 9.3 t -133.3 -128.02 0.17 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.373 -1.075 . . . . 0.0 109.904 179.934 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 785' ' ' CYS . . . . . 0.564 ' N ' HG23 ' A' ' 784' ' ' THR . 1.9 t -92.84 96.58 10.22 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 120.752 -1.218 . . . . 0.0 110.206 -179.967 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 786' ' ' GLY . . . . . . . . . . . . . . . 139.72 -24.68 2.74 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.383 -1.487 . . . . 0.0 109.383 179.982 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 787' ' ' THR . . . . . 0.732 HG22 ' O ' ' A' ' 787' ' ' THR . 99.8 m -139.72 37.95 2.01 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.18 -1.188 . . . . 0.0 110.142 179.964 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 788' ' ' PHE . . . . . 0.572 ' HB3' ' CE2' ' A' ' 775' ' ' PHE . 0.3 OUTLIER -65.75 116.97 7.5 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.304 -0.873 . . . . 0.0 109.899 179.92 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 789' ' ' GLN . . . . . . . . . . . . . 5.3 tm0? -119.11 153.04 35.45 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.252 -0.905 . . . . 0.0 110.261 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 790' ' ' GLN . . . . . . . . . . . . . 4.1 tt0 -73.05 120.74 19.1 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.293 -0.879 . . . . 0.0 110.12 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 791' ' ' GLY . . . . . 0.545 ' HA2' ' CD1' ' A' ' 782' ' ' LEU . . . -74.21 -116.0 0.08 OUTLIER Glycine 0 N--CA 1.494 2.509 0 N-CA-C 109.867 -1.293 . . . . 0.0 109.867 -179.942 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 792' ' ' GLU . . . . . . . . . . . . . 19.8 mt-10 -118.99 -23.82 6.75 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.225 -1.162 . . . . 0.0 110.35 -179.989 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 793' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -122.88 121.85 37.19 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.165 -0.96 . . . . 0.0 110.507 -179.936 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 794' ' ' HIS . . . . . 0.572 ' CE1' ' HA ' ' A' ' 777' ' ' SER . 24.2 t60 -149.06 149.35 30.95 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.292 -0.88 . . . . 0.0 109.789 -180.0 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 795' ' ' SER . . . . . 0.473 ' O ' ' NE2' ' A' ' 794' ' ' HIS . 17.1 t -91.94 149.2 21.67 Favored 'General case' 0 C--N 1.299 -1.626 0 O-C-N 121.276 -0.89 . . . . 0.0 109.618 179.889 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 796' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -87.89 15.42 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 O-C-N 121.174 -0.953 . . . . 0.0 110.017 -179.918 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 797' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 -125.59 27.02 6.59 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.387 -0.82 . . . . 0.0 109.714 179.927 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 798' ' ' SER . . . . . 0.567 ' HB3' ' HB3' ' A' ' 776' ' ' ALA . 0.5 OUTLIER -68.25 -35.03 77.28 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.479 -0.763 . . . . 0.0 111.005 179.933 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 799' ' ' ASN . . . . . 0.511 ' N ' ' OD1' ' A' ' 799' ' ' ASN . 1.3 m120 -100.62 11.78 38.77 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.104 -0.997 . . . . 0.0 111.175 -179.859 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 800' ' ' SER . . . . . . . . . . . . . 75.0 p -93.12 -27.38 16.97 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 120.997 -1.065 . . . . 0.0 110.609 -179.925 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 801' ' ' VAL . . . . . . . . . . . . . 40.2 t -88.99 -19.67 7.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.278 -0.889 . . . . 0.0 110.467 -179.925 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 802' ' ' LEU . . . . . 0.504 ' O ' ' HB2' ' A' ' 806' ' ' CYS . 4.1 mm? -79.48 -48.8 13.28 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.187 -0.945 . . . . 0.0 110.837 179.986 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 803' ' ' GLU . . . . . . . . . . . . . 17.5 mt-10 -64.0 -18.71 64.57 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.001 -1.062 . . . . 0.0 111.036 -179.918 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 804' ' ' ARG . . . . . . . . . . . . . 51.9 ttp180 -92.46 -22.14 19.78 Favored 'General case' 0 C--N 1.297 -1.692 0 O-C-N 121.073 -1.017 . . . . 0.0 112.25 -179.844 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 805' ' ' LYS . . . . . 0.445 ' O ' ' SG ' ' A' ' 806' ' ' CYS . 5.8 tttm -140.12 54.96 1.63 Allowed 'General case' 0 N--CA 1.501 2.115 0 O-C-N 120.444 -1.41 . . . . 0.0 112.537 -179.856 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 806' ' ' CYS . . . . . 0.534 ' HA ' ' CB ' ' A' ' 812' ' ' CYS . 1.2 m -163.73 -50.68 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.801 0 O-C-N 120.842 -1.161 . . . . 0.0 110.319 179.722 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 807' ' ' ILE . . . . . . . . . . . . . 55.5 mt -61.62 129.47 24.6 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 O-C-N 121.112 -0.992 . . . . 0.0 110.156 179.905 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 808' ' ' GLY . . . . . 0.417 ' C ' ' HG ' ' A' ' 809' ' ' LEU . . . 104.76 1.86 42.89 Favored Glycine 0 N--CA 1.492 2.431 0 N-CA-C 109.616 -1.394 . . . . 0.0 109.616 179.957 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 809' ' ' LEU . . . . . 0.417 ' HG ' ' C ' ' A' ' 808' ' ' GLY . 4.2 mt -133.03 144.33 49.98 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.157 -1.202 . . . . 0.0 110.308 179.906 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 810' ' ' GLU . . . . . 0.471 ' OE2' ' O ' ' A' ' 764' ' ' CYS . 3.4 tm-20 -70.43 -20.56 62.9 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.219 -0.926 . . . . 0.0 109.653 180.0 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 811' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -156.47 121.59 4.69 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 179.907 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 812' ' ' CYS . . . . . 0.534 ' CB ' ' HA ' ' A' ' 806' ' ' CYS . 26.1 p -123.1 156.7 34.42 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 120.996 -1.065 . . . . 0.0 111.388 -179.972 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 813' ' ' VAL . . . . . 0.456 HG22 ' CD2' ' A' ' 761' ' ' HIS . 38.8 t -120.43 135.24 61.32 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.624 -0.672 . . . . 0.0 109.632 179.925 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 814' ' ' VAL . . . . . . . . . . . . . 48.2 t -112.41 153.09 14.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.095 -1.003 . . . . 0.0 110.551 -179.927 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 815' ' ' ALA . . . . . 0.584 ' HB3' ' OD1' ' A' ' 820' ' ' ASN . . . -104.49 118.37 36.43 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.27 -0.893 . . . . 0.0 109.893 179.985 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 816' ' ' ILE . . . . . 1.096 HD13 HG21 ' A' ' 833' ' ' VAL . 25.1 mt -85.25 108.41 17.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.18 -0.95 . . . . 0.0 110.489 -179.945 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 817' ' ' SER . . . . . . . . . . . . . 44.5 p -157.59 165.87 17.79 Favored Pre-proline 0 N--CA 1.494 1.75 0 O-C-N 121.366 -0.834 . . . . 0.0 109.978 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 818' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_endo -79.44 9.9 3.25 Favored 'Trans proline' 0 C--N 1.305 -1.728 0 O-C-N 123.885 1.466 . . . . 0.0 111.037 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 819' ' ' SER . . . . . . . . . . . . . 27.5 t -131.89 12.18 4.77 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.061 -1.025 . . . . 0.0 110.305 -179.932 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 820' ' ' ASN . . . . . 0.584 ' OD1' ' HB3' ' A' ' 815' ' ' ALA . 0.2 OUTLIER -114.12 -2.7 13.38 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.266 -0.897 . . . . 0.0 110.052 179.945 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 821' ' ' PHE . . . . . . . . . . . . . 8.1 m-85 -112.38 -79.46 0.58 Allowed 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.324 -0.86 . . . . 0.0 110.238 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 822' ' ' GLY . . . . . . . . . . . . . . . -171.22 54.2 0.18 Allowed Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.619 -1.392 . . . . 0.0 109.619 -179.949 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 823' ' ' GLY . . . . . . . . . . . . . . . 78.38 176.61 47.22 Favored Glycine 0 N--CA 1.492 2.399 0 N-CA-C 109.727 -1.349 . . . . 0.0 109.727 179.936 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 824' ' ' ASP . . . . . . . . . . . . . 15.7 p-10 -70.89 117.47 56.31 Favored Pre-proline 0 N--CA 1.494 1.728 0 O-C-N 121.243 -1.151 . . . . 0.0 110.216 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 825' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -79.59 -65.24 0.02 OUTLIER 'Trans proline' 0 C--N 1.308 -1.565 0 O-C-N 123.97 1.511 . . . . 0.0 110.946 -179.922 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 826' ' ' CYS . . . . . 0.462 ' HB3' ' HB ' ' A' ' 829' ' ' VAL . 22.8 m -97.44 153.64 38.29 Favored Pre-proline 0 N--CA 1.498 1.951 0 O-C-N 121.11 -0.993 . . . . 0.0 110.952 -179.937 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 827' ' ' PRO . . . . . 0.891 ' O ' HG23 ' A' ' 829' ' ' VAL . 50.1 Cg_endo -78.99 95.96 1.08 Allowed 'Trans proline' 0 C--N 1.313 -1.303 0 O-C-N 124.07 1.563 . . . . 0.0 110.673 179.963 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 828' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER 52.41 18.67 0.97 Allowed 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.152 -0.968 . . . . 0.0 110.404 179.923 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 829' ' ' VAL . . . . . 0.891 HG23 ' O ' ' A' ' 827' ' ' PRO . 66.7 t -119.41 80.86 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.198 -0.939 . . . . 0.0 110.223 179.953 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 830' ' ' MET . . . . . 0.464 ' CB ' ' HA2' ' A' ' 779' ' ' GLY . 0.0 OUTLIER -178.43 128.65 0.12 Allowed 'General case' 0 C--N 1.304 -1.381 0 O-C-N 121.131 -0.981 . . . . 0.0 110.777 -179.902 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 831' ' ' LYS . . . . . 0.46 ' O ' ' CG ' ' A' ' 832' ' ' ARG . 2.9 tttm -170.58 57.05 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.391 -0.818 . . . . 0.0 110.093 179.906 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 832' ' ' ARG . . . . . 0.523 ' HB2' ' O ' ' A' ' 779' ' ' GLY . 0.5 OUTLIER -167.62 125.32 1.21 Allowed 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.466 -0.771 . . . . 0.0 109.392 -179.996 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 833' ' ' VAL . . . . . 1.096 HG21 HD13 ' A' ' 816' ' ' ILE . 58.8 t -112.47 103.26 15.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.045 -1.035 . . . . 0.0 111.055 -179.959 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 834' ' ' ALA . . . . . 0.572 ' HB1' ' CZ ' ' A' ' 788' ' ' PHE . . . -111.16 122.02 46.79 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.471 -0.768 . . . . 0.0 109.099 179.928 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 835' ' ' VAL . . . . . 0.404 ' O ' ' HA ' ' A' ' 732' ' ' CYS . 34.7 t -139.3 143.24 31.6 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 O-C-N 120.828 -1.17 . . . . 0.0 111.648 -179.934 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 836' ' ' GLU . . . . . 0.481 ' HB2' ' HB3' ' A' ' 775' ' ' PHE . 1.3 mt-10 -115.5 160.24 20.18 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 179.807 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 837' ' ' ALA . . . . . . . . . . . . . . . -154.64 156.8 37.13 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 120.612 -1.305 . . . . 0.0 111.258 -179.944 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 838' ' ' VAL . . . . . . . . . . . . . 22.0 t -109.24 137.2 42.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.505 -0.747 . . . . 0.0 109.965 179.926 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 839' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -128.32 133.2 48.66 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.142 -0.974 . . . . 0.0 110.132 179.988 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 840' ' ' SER . . . . . . . . . . . . . 24.8 t -159.83 -177.37 6.29 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.281 -0.887 . . . . 0.0 109.939 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 841' ' ' THR . . . . . . . . . . . . . 67.1 p . . . . . 0 N--CA 1.49 1.567 0 O-C-N 121.149 -0.97 . . . . 0.0 109.926 179.981 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 728' ' ' VAL . . . . . 1.002 HG23 ' O ' ' A' ' 839' ' ' CYS . 7.6 p . . . . . 0 N--CA 1.493 1.685 0 CA-C-O 121.288 0.566 . . . . 0.0 110.141 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 729' ' ' SER . . . . . 0.454 ' O ' HG13 ' A' ' 731' ' ' VAL . 0.5 OUTLIER -107.47 90.5 3.32 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.263 -0.898 . . . . 0.0 110.343 179.928 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 730' ' ' GLY . . . . . 0.688 ' O ' HG13 ' A' ' 731' ' ' VAL . . . -44.4 153.25 0.46 Allowed Glycine 0 N--CA 1.492 2.417 0 N-CA-C 109.298 -1.521 . . . . 0.0 109.298 179.996 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 731' ' ' VAL . . . . . 0.688 HG13 ' O ' ' A' ' 730' ' ' GLY . 2.4 m -158.48 120.42 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 121.105 -1.233 . . . . 0.0 110.767 179.937 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 732' ' ' CYS . . . . . . . . . . . . . 26.8 p -116.04 130.86 57.0 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.448 -0.783 . . . . 0.0 109.297 179.902 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 733' ' ' ALA . . . . . . . . . . . . . . . -107.77 160.55 15.64 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.106 -0.996 . . . . 0.0 110.609 -179.878 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 734' ' ' ASP . . . . . 0.526 ' OD2' ' CZ ' ' A' ' 832' ' ' ARG . 0.9 OUTLIER -164.36 105.36 0.86 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.414 -0.804 . . . . 0.0 109.444 179.941 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 735' ' ' VAL . . . . . 0.442 ' O ' ' CG ' ' A' ' 832' ' ' ARG . 37.4 t -116.04 163.39 13.31 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 121.089 -1.007 . . . . 0.0 110.715 -179.939 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 736' ' ' SER . . . . . 0.411 ' N ' HG12 ' A' ' 735' ' ' VAL . 22.5 p -99.16 158.78 15.45 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.425 -0.797 . . . . 0.0 110.029 179.954 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 737' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.493 1.702 0 O-C-N 121.216 -0.927 . . . . 0.0 110.457 179.944 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 757' ' ' THR . . . . . 0.47 ' OG1' ' O ' ' A' ' 816' ' ' ILE . 66.9 p . . . . . 0 N--CA 1.495 1.779 0 CA-C-O 121.364 0.602 . . . . 0.0 110.593 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 758' ' ' ALA . . . . . . . . . . . . . . . -55.85 176.45 0.07 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.412 -0.805 . . . . 0.0 110.052 179.944 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 759' ' ' LYS . . . . . 0.414 ' HG2' ' HA ' ' A' ' 815' ' ' ALA . 9.1 mttp -139.14 167.47 21.98 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.231 -0.918 . . . . 0.0 110.357 179.978 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 760' ' ' VAL . . . . . 0.409 ' HA ' HG21 ' A' ' 735' ' ' VAL . 5.5 t -105.52 162.49 4.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.372 -0.83 . . . . 0.0 109.392 179.919 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 761' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -140.35 105.93 5.11 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 120.846 -1.159 . . . . 0.0 111.261 -179.867 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 762' ' ' LEU . . . . . 0.529 ' HB2' ' HB3' ' A' ' 812' ' ' CYS . 0.5 OUTLIER -110.64 103.23 11.78 Favored 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 179.827 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 763' ' ' LYS . . . . . . . . . . . . . 4.4 ttpt -110.6 135.49 51.15 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.202 -0.936 . . . . 0.0 111.46 -179.812 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 764' ' ' CYS . . . . . 0.483 ' HB2' ' O ' ' A' ' 810' ' ' GLU . 1.3 m -126.63 139.89 52.83 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.533 -0.73 . . . . 0.0 109.568 179.856 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 765' ' ' ALA . . . . . 0.445 ' O ' ' O ' ' A' ' 764' ' ' CYS . . . -39.72 161.16 0.09 OUTLIER Pre-proline 0 N--CA 1.496 1.843 0 O-C-N 121.359 -0.838 . . . . 0.0 110.604 -179.98 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 766' ' ' PRO . . . . . 0.404 ' HD2' ' HB1' ' A' ' 765' ' ' ALA . 43.4 Cg_endo -70.78 113.72 3.63 Favored 'Trans proline' 0 C--N 1.306 -1.706 0 O-C-N 124.121 1.59 . . . . 0.0 110.082 -179.93 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 767' ' ' GLY . . . . . . . . . . . . . . . 118.04 -26.01 8.09 Favored Glycine 0 N--CA 1.488 2.162 0 N-CA-C 108.904 -1.679 . . . . 0.0 108.904 -179.896 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 768' ' ' GLN . . . . . 0.461 ' HA ' ' HA ' ' A' ' 841' ' ' THR . 1.3 tt0 -90.55 119.65 30.99 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.428 -1.042 . . . . 0.0 109.838 179.93 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 769' ' ' THR . . . . . . . . . . . . . 9.4 p -112.22 147.21 36.71 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.227 -0.921 . . . . 0.0 110.474 -179.964 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 770' ' ' ILE . . . . . 0.565 HD12 ' O ' ' A' ' 809' ' ' LEU . 3.5 mp -65.88 145.37 13.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.252 -0.905 . . . . 0.0 109.292 179.946 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 771' ' ' SER . . . . . . . . . . . . . 36.8 p -136.33 -5.45 2.06 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 120.955 -1.091 . . . . 0.0 111.6 -179.923 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 772' ' ' ALA . . . . . . . . . . . . . . . -171.24 148.02 2.59 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 120.608 -1.307 . . . . 0.0 111.941 -179.999 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 773' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -120.48 132.27 70.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 N-CA-C 108.482 -0.932 . . . . 0.0 108.482 179.829 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 774' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -103.4 -34.75 8.62 Favored 'General case' 0 N--CA 1.504 2.239 0 O-C-N 120.995 -1.066 . . . . 0.0 110.342 -179.918 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 775' ' ' PHE . . . . . 0.585 ' O ' ' HB2' ' A' ' 776' ' ' ALA . 52.2 t80 -126.15 152.7 45.61 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 120.925 -1.11 . . . . 0.0 110.15 179.92 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 776' ' ' ALA . . . . . 0.939 ' HB3' ' HB3' ' A' ' 799' ' ' ASN . . . 175.69 105.9 0.02 OUTLIER 'General case' 0 C--N 1.3 -1.564 0 O-C-N 121.425 -0.797 . . . . 0.0 109.664 -179.969 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 777' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -137.6 137.84 38.91 Favored 'General case' 0 C--N 1.299 -1.623 0 O-C-N 121.387 -0.82 . . . . 0.0 109.885 -179.975 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 778' ' ' PHE . . . . . 0.432 ' CD2' HG22 ' A' ' 833' ' ' VAL . 65.3 t80 -112.0 98.58 7.45 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.222 -0.924 . . . . 0.0 110.241 -179.964 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 779' ' ' GLY . . . . . 0.455 ' O ' ' HA ' ' A' ' 831' ' ' LYS . . . 167.85 -93.5 0.11 Allowed Glycine 0 N--CA 1.489 2.197 0 N-CA-C 109.419 -1.472 . . . . 0.0 109.419 179.979 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 780' ' ' THR . . . . . . . . . . . . . 60.6 p -141.11 81.67 15.65 Favored Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 121.273 -1.134 . . . . 0.0 110.253 179.945 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 781' ' ' PRO . . . . . 0.446 ' O ' HD23 ' A' ' 782' ' ' LEU . 44.7 Cg_endo -72.06 154.63 57.57 Favored 'Trans proline' 0 C--N 1.303 -1.818 0 O-C-N 124.02 1.537 . . . . 0.0 110.287 -179.966 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 782' ' ' LEU . . . . . 0.446 HD23 ' O ' ' A' ' 781' ' ' PRO . 21.4 mt -119.59 116.61 26.38 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.285 -0.884 . . . . 0.0 109.966 179.952 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 783' ' ' GLY . . . . . . . . . . . . . . . 111.5 168.21 18.52 Favored Glycine 0 N--CA 1.488 2.114 0 N-CA-C 109.345 -1.502 . . . . 0.0 109.345 -179.903 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 784' ' ' THR . . . . . 0.748 ' O ' HG23 ' A' ' 784' ' ' THR . 14.1 t -152.79 109.22 3.41 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.213 -1.169 . . . . 0.0 110.24 -179.995 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 785' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER 46.88 80.84 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.362 -0.836 . . . . 0.0 110.736 179.964 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 786' ' ' GLY . . . . . . . . . . . . . . . 135.62 -20.58 3.67 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.745 -1.342 . . . . 0.0 109.745 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 787' ' ' THR . . . . . . . . . . . . . 1.9 m -154.86 44.93 0.51 Allowed 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.059 -1.259 . . . . 0.0 110.591 -179.867 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 788' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -69.25 138.99 54.42 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.088 -1.008 . . . . 0.0 109.919 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 789' ' ' GLN . . . . . . . . . . . . . 37.2 tt0 -163.37 134.0 4.55 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.24 -0.913 . . . . 0.0 110.116 179.999 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 790' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -46.35 157.47 0.13 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.386 -0.821 . . . . 0.0 110.236 179.954 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 791' ' ' GLY . . . . . . . . . . . . . . . -113.87 -139.6 7.26 Favored Glycine 0 N--CA 1.489 2.184 0 N-CA-C 109.516 -1.434 . . . . 0.0 109.516 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 792' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -106.62 -30.86 8.75 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.203 -1.175 . . . . 0.0 110.199 179.946 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 793' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -104.3 107.45 18.38 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.271 -0.893 . . . . 0.0 110.191 -179.956 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 794' ' ' HIS . . . . . 0.45 ' CG ' ' N ' ' A' ' 795' ' ' SER . 46.1 t-80 -134.01 171.69 13.85 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.223 -0.923 . . . . 0.0 110.489 -179.988 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 795' ' ' SER . . . . . 0.45 ' N ' ' CG ' ' A' ' 794' ' ' HIS . 93.3 p -120.52 -137.37 0.33 Allowed 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.336 -0.852 . . . . 0.0 110.183 179.98 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 796' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -134.81 -29.72 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.96 0 O-C-N 121.108 -0.995 . . . . 0.0 110.806 179.996 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 797' ' ' ASN . . . . . 0.495 ' HA ' ' HB3' ' A' ' 800' ' ' SER . 1.4 m-20 -96.56 26.46 4.43 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.078 -1.014 . . . . 0.0 110.104 -179.973 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 798' ' ' SER . . . . . 0.511 ' HB2' ' O ' ' A' ' 776' ' ' ALA . 0.8 OUTLIER -51.71 -71.32 0.07 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.329 -0.857 . . . . 0.0 110.955 -179.968 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 799' ' ' ASN . . . . . 0.939 ' HB3' ' HB3' ' A' ' 776' ' ' ALA . 51.6 p30 -85.78 -15.59 41.57 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.293 -0.879 . . . . 0.0 111.101 -179.956 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 800' ' ' SER . . . . . 0.514 ' N ' ' OD1' ' A' ' 799' ' ' ASN . 12.9 t -59.18 -41.58 88.8 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.083 -1.01 . . . . 0.0 110.62 -179.966 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 801' ' ' VAL . . . . . . . . . . . . . 34.9 t -72.2 -26.46 24.89 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.14 -0.975 . . . . 0.0 110.505 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 802' ' ' LEU . . . . . 0.496 ' O ' ' HB2' ' A' ' 806' ' ' CYS . 3.4 mm? -74.2 -59.83 2.55 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.257 -0.902 . . . . 0.0 110.641 -179.944 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 803' ' ' GLU . . . . . 0.579 ' HG3' HD12 ' A' ' 807' ' ' ILE . 20.2 tt0 -54.06 -18.45 3.65 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.115 -0.991 . . . . 0.0 110.683 179.887 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 804' ' ' ARG . . . . . . . . . . . . . 56.3 ttt180 -90.08 -27.22 19.81 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.126 -0.984 . . . . 0.0 111.026 -179.914 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 805' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.76 43.97 2.83 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 120.968 -1.083 . . . . 0.0 110.968 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 806' ' ' CYS . . . . . 0.496 ' HB2' ' O ' ' A' ' 802' ' ' LEU . 0.2 OUTLIER -147.51 -72.3 0.21 Allowed 'General case' 0 N--CA 1.494 1.743 0 O-C-N 120.952 -1.092 . . . . 0.0 110.485 179.993 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 807' ' ' ILE . . . . . 0.579 HD12 ' HG3' ' A' ' 803' ' ' GLU . 31.9 mt -47.14 136.58 2.96 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 O-C-N 121.052 -1.03 . . . . 0.0 110.472 -179.955 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 808' ' ' GLY . . . . . 0.401 ' C ' ' HG ' ' A' ' 809' ' ' LEU . . . 93.23 5.52 63.7 Favored Glycine 0 N--CA 1.492 2.387 0 N-CA-C 110.229 -1.148 . . . . 0.0 110.229 179.967 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 809' ' ' LEU . . . . . 0.565 ' O ' HD12 ' A' ' 770' ' ' ILE . 41.5 mt -137.62 135.26 36.42 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.039 -1.271 . . . . 0.0 110.612 -179.987 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 810' ' ' GLU . . . . . 0.483 ' O ' ' HB2' ' A' ' 764' ' ' CYS . 57.3 mm-40 -64.45 -34.16 77.56 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.27 -0.894 . . . . 0.0 108.792 179.94 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 811' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -111.37 165.48 11.93 Favored 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 179.934 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 812' ' ' CYS . . . . . 0.529 ' HB3' ' HB2' ' A' ' 762' ' ' LEU . 49.5 t -159.66 102.28 1.51 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.861 -1.149 . . . . 0.0 110.608 -179.883 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 813' ' ' VAL . . . . . . . . . . . . . 11.9 p -115.8 136.82 51.44 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.178 -0.951 . . . . 0.0 109.981 179.964 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 814' ' ' VAL . . . . . . . . . . . . . 17.7 t -134.4 164.72 33.47 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 O-C-N 121.171 -0.956 . . . . 0.0 110.435 -179.939 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 815' ' ' ALA . . . . . 0.414 ' HA ' ' HG2' ' A' ' 759' ' ' LYS . . . -97.27 157.14 16.11 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.26 -0.9 . . . . 0.0 109.928 179.971 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 816' ' ' ILE . . . . . 0.791 HG23 ' CG2' ' A' ' 833' ' ' VAL . 20.3 mt -117.12 63.62 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.168 -0.957 . . . . 0.0 109.846 179.984 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 817' ' ' SER . . . . . 0.447 ' OG ' ' HB2' ' A' ' 820' ' ' ASN . 0.0 OUTLIER -116.15 165.98 13.56 Favored Pre-proline 0 N--CA 1.494 1.728 0 O-C-N 121.432 -0.792 . . . . 0.0 110.716 -179.875 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 818' ' ' PRO . . . . . 0.473 ' HB2' ' OD1' ' A' ' 824' ' ' ASP . 49.0 Cg_endo -76.92 -44.94 0.19 Allowed 'Trans proline' 0 C--N 1.307 -1.657 0 O-C-N 124.181 1.622 . . . . 0.0 110.573 -179.954 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 819' ' ' SER . . . . . . . . . . . . . 66.3 m -88.46 15.33 8.04 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.271 -0.893 . . . . 0.0 110.238 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 820' ' ' ASN . . . . . 0.447 ' HB2' ' OG ' ' A' ' 817' ' ' SER . 2.1 m120 -101.47 -16.51 16.8 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.225 -0.922 . . . . 0.0 110.449 179.985 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 821' ' ' PHE . . . . . . . . . . . . . 5.2 m-85 -93.32 -91.9 0.18 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.051 -1.031 . . . . 0.0 110.44 179.968 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 822' ' ' GLY . . . . . . . . . . . . . . . -152.97 14.93 0.68 Allowed Glycine 0 N--CA 1.492 2.39 0 C-N-CA 119.551 -1.309 . . . . 0.0 110.266 -179.991 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 823' ' ' GLY . . . . . . . . . . . . . . . 154.74 -170.66 33.07 Favored Glycine 0 N--CA 1.493 2.486 0 O-C-N 121.008 -1.289 . . . . 0.0 110.068 179.941 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 824' ' ' ASP . . . . . 0.473 ' OD1' ' HB2' ' A' ' 818' ' ' PRO . 0.2 OUTLIER -113.33 105.44 55.26 Favored Pre-proline 0 N--CA 1.494 1.73 0 O-C-N 121.379 -1.071 . . . . 0.0 110.14 -179.972 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 825' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -76.31 -64.9 0.02 OUTLIER 'Trans proline' 0 C--N 1.304 -1.775 0 O-C-N 123.994 1.523 . . . . 0.0 110.789 -179.963 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 826' ' ' CYS . . . . . . . . . . . . . 98.3 m -125.19 98.62 35.37 Favored Pre-proline 0 N--CA 1.495 1.794 0 O-C-N 121.119 -0.988 . . . . 0.0 110.414 179.953 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 827' ' ' PRO . . . . . 0.563 ' O ' HG23 ' A' ' 829' ' ' VAL . 50.7 Cg_endo -82.77 153.38 15.09 Favored 'Trans proline' 0 C--N 1.303 -1.847 0 O-C-N 124.062 1.559 . . . . 0.0 110.612 -179.983 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 828' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 62.26 17.85 9.66 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.304 -0.872 . . . . 0.0 110.521 179.995 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 829' ' ' VAL . . . . . 0.563 HG23 ' O ' ' A' ' 827' ' ' PRO . 66.4 t -127.5 111.21 24.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.225 -0.922 . . . . 0.0 110.283 179.981 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 830' ' ' MET . . . . . 0.431 ' C ' ' O ' ' A' ' 829' ' ' VAL . 2.9 mmt -42.41 125.49 3.21 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.278 -0.889 . . . . 0.0 109.672 -179.992 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 831' ' ' LYS . . . . . 0.455 ' HA ' ' O ' ' A' ' 779' ' ' GLY . 1.2 ptpt -128.85 133.62 48.03 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.047 -1.033 . . . . 0.0 111.151 -179.938 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 832' ' ' ARG . . . . . 0.526 ' CZ ' ' OD2' ' A' ' 734' ' ' ASP . 20.2 ttt180 -108.55 158.89 17.16 Favored 'General case' 0 N--CA 1.489 1.475 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 179.946 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 833' ' ' VAL . . . . . 0.791 ' CG2' HG23 ' A' ' 816' ' ' ILE . 8.3 t -111.85 126.68 69.26 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 120.976 -1.078 . . . . 0.0 111.133 -179.877 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 834' ' ' ALA . . . . . . . . . . . . . . . -131.08 134.15 46.34 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 179.924 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 835' ' ' VAL . . . . . . . . . . . . . 5.9 t -145.02 150.91 15.59 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 O-C-N 120.933 -1.105 . . . . 0.0 111.275 -179.919 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 836' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -127.13 110.82 13.31 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 179.9 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 837' ' ' ALA . . . . . . . . . . . . . . . -110.26 159.33 17.5 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.066 -1.021 . . . . 0.0 111.106 -179.848 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 838' ' ' VAL . . . . . . . . . . . . . 92.1 t -115.29 122.15 68.65 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.475 0 O-C-N 121.498 -0.751 . . . . 0.0 109.731 179.961 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 839' ' ' CYS . . . . . 1.002 ' O ' HG23 ' A' ' 728' ' ' VAL . 0.0 OUTLIER -108.95 122.56 47.48 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.247 -0.908 . . . . 0.0 110.532 -179.925 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 840' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -121.08 119.39 32.3 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.268 -0.895 . . . . 0.0 109.799 179.963 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 841' ' ' THR . . . . . 0.461 ' HA ' ' HA ' ' A' ' 768' ' ' GLN . 14.6 t . . . . . 0 N--CA 1.492 1.654 0 O-C-N 121.103 -0.998 . . . . 0.0 110.569 -179.927 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 728' ' ' VAL . . . . . 0.816 HG12 ' N ' ' A' ' 729' ' ' SER . 1.0 OUTLIER . . . . . 0 N--CA 1.49 1.548 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 . . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 729' ' ' SER . . . . . 0.816 ' N ' HG12 ' A' ' 728' ' ' VAL . 2.4 m -178.53 -163.59 0.07 Allowed 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.102 -0.999 . . . . 0.0 110.601 -179.984 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 730' ' ' GLY . . . . . . . . . . . . . . . -152.67 -166.27 14.14 Favored Glycine 0 N--CA 1.496 2.698 0 N-CA-C 109.381 -1.488 . . . . 0.0 109.381 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 731' ' ' VAL . . . . . 0.507 HG12 ' N ' ' A' ' 732' ' ' CYS . 73.7 t -140.33 165.95 20.34 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 O-C-N 121.064 -1.256 . . . . 0.0 110.508 179.978 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 732' ' ' CYS . . . . . 0.507 ' N ' HG12 ' A' ' 731' ' ' VAL . 82.1 m -111.8 156.99 21.1 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.32 -0.863 . . . . 0.0 110.094 179.999 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 733' ' ' ALA . . . . . 0.458 ' O ' ' HA ' ' A' ' 834' ' ' ALA . . . -141.68 106.72 4.95 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.144 -0.973 . . . . 0.0 110.439 -179.997 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 734' ' ' ASP . . . . . 0.449 ' N ' ' OD1' ' A' ' 734' ' ' ASP . 5.2 m-20 -118.16 124.52 48.18 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.372 -0.83 . . . . 0.0 109.944 -180.0 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 735' ' ' VAL . . . . . 0.981 HG21 HG22 ' A' ' 760' ' ' VAL . 51.5 t -125.79 166.91 20.99 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 O-C-N 121.197 -0.94 . . . . 0.0 110.181 179.985 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 736' ' ' SER . . . . . 0.507 ' N ' HG12 ' A' ' 735' ' ' VAL . 10.2 p -113.36 45.18 1.43 Allowed 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.248 -0.907 . . . . 0.0 110.573 -179.984 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 737' ' ' GLU . . . . . 0.472 ' OE1' ' HB3' ' A' ' 831' ' ' LYS . 2.1 tt0 . . . . . 0 N--CA 1.502 2.127 0 O-C-N 121.469 -0.77 . . . . 0.0 111.273 179.911 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 757' ' ' THR . . . . . . . . . . . . . 61.9 p . . . . . 0 N--CA 1.492 1.632 0 CA-C-O 121.091 0.472 . . . . 0.0 109.858 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 758' ' ' ALA . . . . . . . . . . . . . . . -112.69 175.59 5.37 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.08 -1.012 . . . . 0.0 110.244 179.97 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 759' ' ' LYS . . . . . . . . . . . . . 11.4 mtmt -146.71 150.69 35.87 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.257 -0.902 . . . . 0.0 110.968 -179.899 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 760' ' ' VAL . . . . . 0.981 HG22 HG21 ' A' ' 735' ' ' VAL . 3.6 t -110.38 144.84 17.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.514 -0.741 . . . . 0.0 109.316 179.865 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 761' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -118.76 114.16 22.25 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.076 -1.015 . . . . 0.0 110.564 179.949 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 762' ' ' LEU . . . . . 0.489 ' HB2' ' HB3' ' A' ' 812' ' ' CYS . 0.4 OUTLIER -108.54 157.19 18.69 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.426 -0.796 . . . . 0.0 109.653 179.955 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 763' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -158.84 106.97 1.87 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.158 -0.964 . . . . 0.0 110.6 -179.976 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 764' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -88.21 166.54 14.29 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.364 -0.835 . . . . 0.0 109.915 -179.998 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 765' ' ' ALA . . . . . . . . . . . . . . . -63.55 154.24 80.32 Favored Pre-proline 0 N--CA 1.493 1.676 0 O-C-N 121.147 -0.971 . . . . 0.0 110.157 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 766' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -69.06 125.14 12.13 Favored 'Trans proline' 0 C--N 1.305 -1.735 0 O-C-N 124.016 1.535 . . . . 0.0 110.348 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 767' ' ' GLY . . . . . . . . . . . . . . . 108.69 -15.21 34.79 Favored Glycine 0 N--CA 1.489 2.21 0 N-CA-C 109.366 -1.493 . . . . 0.0 109.366 -179.963 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 768' ' ' GLN . . . . . 0.459 ' HB3' ' HB3' ' A' ' 839' ' ' CYS . 0.9 OUTLIER -114.32 140.72 48.39 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.338 -1.095 . . . . 0.0 110.236 179.96 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 769' ' ' THR . . . . . . . . . . . . . 69.7 p -121.48 150.4 41.63 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.295 -0.878 . . . . 0.0 110.393 -179.906 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 770' ' ' ILE . . . . . . . . . . . . . 16.9 mt -66.26 131.18 32.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.262 -0.899 . . . . 0.0 109.689 179.958 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 771' ' ' SER . . . . . 0.584 ' O ' ' HB2' ' A' ' 772' ' ' ALA . 80.2 p -129.1 -0.3 5.2 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.101 -0.999 . . . . 0.0 110.836 -179.993 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 772' ' ' ALA . . . . . 0.584 ' HB2' ' O ' ' A' ' 771' ' ' SER . . . 177.95 127.4 0.05 Allowed 'General case' 0 N--CA 1.495 1.792 0 O-C-N 120.824 -1.173 . . . . 0.0 111.576 179.998 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 773' ' ' ILE . . . . . . . . . . . . . 1.4 mp -87.17 123.44 39.98 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 N-CA-C 108.644 -0.873 . . . . 0.0 108.644 179.804 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 774' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -85.43 -31.56 22.8 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.027 -1.046 . . . . 0.0 111.88 -179.816 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 775' ' ' PHE . . . . . 0.644 ' CE2' ' CB ' ' A' ' 788' ' ' PHE . 90.6 t80 -147.61 171.82 14.99 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 120.645 -1.284 . . . . 0.0 111.325 -179.988 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 776' ' ' ALA . . . . . 0.512 ' HB1' ' O ' ' A' ' 798' ' ' SER . . . -179.52 136.7 0.12 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.544 -0.723 . . . . 0.0 109.546 -179.989 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 777' ' ' SER . . . . . 0.467 ' HB3' ' HB3' ' A' ' 781' ' ' PRO . 0.3 OUTLIER -148.44 127.04 12.43 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.119 -0.988 . . . . 0.0 110.373 -179.966 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 778' ' ' PHE . . . . . 0.614 ' CG ' ' O ' ' A' ' 778' ' ' PHE . 4.5 t80 -109.66 63.01 0.6 Allowed 'General case' 0 C--N 1.3 -1.555 0 CA-C-O 122.0 0.905 . . . . 0.0 108.957 179.935 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 779' ' ' GLY . . . . . . . . . . . . . . . -172.73 -111.02 0.25 Allowed Glycine 0 N--CA 1.488 2.152 0 N-CA-C 109.449 -1.461 . . . . 0.0 109.449 -179.945 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 780' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -115.14 81.39 7.91 Favored Pre-proline 0 N--CA 1.494 1.733 0 O-C-N 121.218 -1.166 . . . . 0.0 110.443 179.961 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 781' ' ' PRO . . . . . 0.467 ' HB3' ' HB3' ' A' ' 777' ' ' SER . 48.7 Cg_endo -77.93 143.87 21.04 Favored 'Trans proline' 0 C--N 1.304 -1.768 0 O-C-N 124.027 1.54 . . . . 0.0 109.872 179.961 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 782' ' ' LEU . . . . . 0.592 HD12 ' HA3' ' A' ' 791' ' ' GLY . 4.6 mt -137.22 148.39 46.45 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.109 -0.994 . . . . 0.0 110.373 -179.963 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 783' ' ' GLY . . . . . . . . . . . . . . . 138.26 -124.54 2.95 Favored Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.468 -1.453 . . . . 0.0 109.468 -179.984 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 784' ' ' THR . . . . . 0.425 HG22 ' N ' ' A' ' 785' ' ' CYS . 15.5 m -154.82 -75.42 0.11 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.217 -1.166 . . . . 0.0 110.393 -179.999 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 785' ' ' CYS . . . . . 0.425 ' N ' HG22 ' A' ' 784' ' ' THR . 1.0 OUTLIER -153.46 99.53 2.34 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.307 -0.87 . . . . 0.0 110.254 179.971 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 786' ' ' GLY . . . . . . . . . . . . . . . 98.04 -17.19 59.08 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.716 -1.354 . . . . 0.0 109.716 -179.95 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 787' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -113.5 23.76 12.86 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.213 -1.169 . . . . 0.0 110.275 179.958 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 788' ' ' PHE . . . . . 0.644 ' CB ' ' CE2' ' A' ' 775' ' ' PHE . 10.8 m-85 -50.66 170.79 0.03 OUTLIER 'General case' 0 C--N 1.299 -1.599 0 O-C-N 121.192 -0.942 . . . . 0.0 109.588 -179.967 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 789' ' ' GLN . . . . . 0.532 ' O ' ' N ' ' A' ' 791' ' ' GLY . 5.0 tp60 -164.8 118.52 1.3 Allowed 'General case' 0 C--N 1.298 -1.663 0 O-C-N 121.257 -0.902 . . . . 0.0 109.957 179.99 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 790' ' ' GLN . . . . . . . . . . . . . 1.8 pt20 -49.08 89.79 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.376 -0.828 . . . . 0.0 110.039 179.97 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 791' ' ' GLY . . . . . 0.592 ' HA3' HD12 ' A' ' 782' ' ' LEU . . . -43.4 -59.54 3.53 Favored Glycine 0 N--CA 1.488 2.152 0 N-CA-C 109.519 -1.433 . . . . 0.0 109.519 -179.987 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 792' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -152.56 -24.49 0.17 Allowed 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.273 -1.133 . . . . 0.0 111.419 179.973 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 793' ' ' CYS . . . . . . . . . . . . . 1.2 m -118.59 148.52 42.6 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 120.744 -1.222 . . . . 0.0 110.876 179.967 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 794' ' ' HIS . . . . . 0.492 ' NE2' ' HA ' ' A' ' 796' ' ' ILE . 5.4 t60 -169.41 146.76 3.51 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.488 -0.758 . . . . 0.0 109.808 179.917 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 795' ' ' SER . . . . . 0.474 ' O ' ' HB ' ' A' ' 796' ' ' ILE . 1.0 OUTLIER -90.06 1.2 56.6 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.194 -0.941 . . . . 0.0 111.338 -179.886 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 796' ' ' ILE . . . . . 0.715 HG22 ' O ' ' A' ' 796' ' ' ILE . 21.2 mm 55.95 16.85 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 O-C-N 120.985 -1.072 . . . . 0.0 110.068 -179.975 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 797' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -151.08 26.5 0.71 Allowed 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.277 -0.889 . . . . 0.0 109.859 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 798' ' ' SER . . . . . 0.512 ' O ' ' HB1' ' A' ' 776' ' ' ALA . 21.0 m -71.26 -14.91 62.39 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.323 -0.861 . . . . 0.0 111.395 -179.966 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 799' ' ' ASN . . . . . . . . . . . . . 24.4 p30 -105.0 -5.32 21.07 Favored 'General case' 0 N--CA 1.5 2.06 0 O-C-N 121.004 -1.06 . . . . 0.0 111.184 -179.928 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 800' ' ' SER . . . . . . . . . . . . . 49.7 m -82.83 -16.82 46.25 Favored 'General case' 0 C--N 1.293 -1.874 0 O-C-N 121.167 -0.958 . . . . 0.0 110.771 -179.972 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 801' ' ' VAL . . . . . . . . . . . . . 40.6 t -91.27 -19.67 7.02 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 O-C-N 121.15 -0.968 . . . . 0.0 111.178 -179.911 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 802' ' ' LEU . . . . . 0.591 HD11 HG21 ' A' ' 814' ' ' VAL . 3.9 mm? -88.55 -48.09 7.83 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.005 -1.059 . . . . 0.0 111.247 -179.837 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 803' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -56.85 -16.96 7.68 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.946 -1.096 . . . . 0.0 110.38 179.949 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 804' ' ' ARG . . . . . . . . . . . . . 2.9 ttt180 -91.16 -26.31 19.14 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.202 -0.936 . . . . 0.0 111.81 -179.908 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 805' ' ' LYS . . . . . . . . . . . . . 1.1 ttpt -140.84 60.57 1.52 Allowed 'General case' 0 N--CA 1.497 1.89 0 O-C-N 120.756 -1.215 . . . . 0.0 111.196 -179.87 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 806' ' ' CYS . . . . . . . . . . . . . 3.4 t -162.46 -25.68 0.04 OUTLIER 'General case' 0 N--CA 1.501 2.108 0 O-C-N 121.069 -1.019 . . . . 0.0 111.649 179.898 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 807' ' ' ILE . . . . . . . . . . . . . 30.1 mt -83.4 135.85 23.98 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 O-C-N 120.741 -1.224 . . . . 0.0 111.381 -179.97 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 808' ' ' GLY . . . . . 0.479 ' C ' ' HG ' ' A' ' 809' ' ' LEU . . . 109.92 -5.2 30.62 Favored Glycine 0 N--CA 1.492 2.394 0 C-N-CA 120.094 -1.05 . . . . 0.0 110.792 179.875 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 809' ' ' LEU . . . . . 0.479 ' HG ' ' C ' ' A' ' 808' ' ' GLY . 1.3 mp -136.17 143.46 44.45 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 120.792 -1.417 . . . . 0.0 110.688 -179.92 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 810' ' ' GLU . . . . . 0.522 ' HG3' ' N ' ' A' ' 811' ' ' ARG . 0.0 OUTLIER -70.27 -21.56 62.95 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.246 -0.909 . . . . 0.0 108.709 179.866 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 811' ' ' ARG . . . . . 0.522 ' N ' ' HG3' ' A' ' 810' ' ' GLU . 1.6 ttt180 -115.65 149.73 37.86 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.625 -0.672 . . . . 0.0 109.22 179.89 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 812' ' ' CYS . . . . . 0.489 ' HB3' ' HB2' ' A' ' 762' ' ' LEU . 9.7 t -134.54 146.56 49.78 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.954 -1.091 . . . . 0.0 110.921 -179.887 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 813' ' ' VAL . . . . . . . . . . . . . 46.0 t -135.63 104.56 4.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.536 -0.727 . . . . 0.0 109.172 179.955 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 814' ' ' VAL . . . . . 0.591 HG21 HD11 ' A' ' 802' ' ' LEU . 41.0 t -110.73 115.5 50.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.269 -0.894 . . . . 0.0 111.304 -179.881 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 815' ' ' ALA . . . . . . . . . . . . . . . -79.96 131.81 35.9 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.262 -0.899 . . . . 0.0 109.0 179.901 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 816' ' ' ILE . . . . . 0.861 ' CD1' HG21 ' A' ' 833' ' ' VAL . 59.5 mt -87.0 134.13 28.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.105 -0.997 . . . . 0.0 111.045 -179.887 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 817' ' ' SER . . . . . 0.469 ' OG ' ' HB2' ' A' ' 820' ' ' ASN . 2.9 p -164.9 171.22 5.65 Favored Pre-proline 0 N--CA 1.494 1.732 0 O-C-N 121.416 -0.802 . . . . 0.0 109.699 179.934 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 818' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -78.87 -29.9 3.16 Favored 'Trans proline' 0 C--N 1.306 -1.674 0 O-C-N 123.797 1.42 . . . . 0.0 110.374 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 819' ' ' SER . . . . . . . . . . . . . 46.5 m -87.24 7.71 27.27 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.273 -0.892 . . . . 0.0 110.338 -179.963 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 820' ' ' ASN . . . . . 0.469 ' HB2' ' OG ' ' A' ' 817' ' ' SER . 0.4 OUTLIER -105.64 -8.43 17.92 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.154 -0.966 . . . . 0.0 110.007 -179.97 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 821' ' ' PHE . . . . . . . . . . . . . 31.8 m-85 -125.61 -74.49 0.6 Allowed 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.237 -0.914 . . . . 0.0 110.334 179.961 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 822' ' ' GLY . . . . . . . . . . . . . . . -178.16 57.75 0.09 OUTLIER Glycine 0 N--CA 1.492 2.375 0 N-CA-C 109.454 -1.458 . . . . 0.0 109.454 -179.98 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 823' ' ' GLY . . . . . . . . . . . . . . . 64.05 -122.85 26.8 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 -179.983 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 824' ' ' ASP . . . . . . . . . . . . . 89.4 m-20 -132.31 130.77 22.04 Favored Pre-proline 0 N--CA 1.495 1.806 0 O-C-N 121.327 -1.102 . . . . 0.0 109.985 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 825' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -82.05 -89.95 0.0 OUTLIER 'Trans proline' 0 C--N 1.308 -1.592 0 O-C-N 123.903 1.475 . . . . 0.0 111.062 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 826' ' ' CYS . . . . . . . . . . . . . 17.7 p -111.21 124.88 31.7 Favored Pre-proline 0 N--CA 1.497 1.879 0 O-C-N 121.256 -0.902 . . . . 0.0 111.12 -179.901 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 827' ' ' PRO . . . . . 0.489 ' O ' ' HB2' ' A' ' 828' ' ' GLU . 49.6 Cg_endo -81.16 -174.03 2.06 Favored 'Trans proline' 0 C--N 1.305 -1.719 0 O-C-N 123.962 1.506 . . . . 0.0 109.562 179.777 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 828' ' ' GLU . . . . . 0.489 ' HB2' ' O ' ' A' ' 827' ' ' PRO . 3.7 mm-40 58.79 14.48 3.24 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.475 -0.765 . . . . 0.0 109.611 -179.941 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 829' ' ' VAL . . . . . 0.459 ' O ' ' O ' ' A' ' 830' ' ' MET . 74.9 t -130.58 129.99 64.65 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.332 0 O-C-N 121.575 -0.703 . . . . 0.0 109.388 -179.983 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 830' ' ' MET . . . . . 0.459 ' O ' ' O ' ' A' ' 829' ' ' VAL . 33.8 mmt -52.82 -170.19 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.271 -0.893 . . . . 0.0 110.202 -179.964 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 831' ' ' LYS . . . . . 0.472 ' HB3' ' OE1' ' A' ' 737' ' ' GLU . 9.4 mttp -147.43 149.58 32.99 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 120.94 -1.1 . . . . 0.0 110.702 -179.913 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 832' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -161.86 149.18 14.31 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.602 -0.686 . . . . 0.0 109.151 179.924 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 833' ' ' VAL . . . . . 0.861 HG21 ' CD1' ' A' ' 816' ' ' ILE . 70.2 t -111.87 107.47 23.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 120.911 -1.118 . . . . 0.0 111.375 -179.973 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 834' ' ' ALA . . . . . 0.458 ' HA ' ' O ' ' A' ' 733' ' ' ALA . . . -109.97 128.71 55.55 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.375 -0.828 . . . . 0.0 109.172 179.857 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 835' ' ' VAL . . . . . . . . . . . . . 3.0 t -138.08 145.56 28.46 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 O-C-N 120.808 -1.183 . . . . 0.0 111.232 -179.855 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 836' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -124.48 117.93 25.49 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 179.873 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 837' ' ' ALA . . . . . . . . . . . . . . . -107.94 155.57 20.17 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.156 -0.965 . . . . 0.0 111.233 -179.807 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 838' ' ' VAL . . . . . 0.483 ' HB ' ' O ' ' A' ' 772' ' ' ALA . 71.9 t -112.33 110.99 34.23 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.375 0 O-C-N 121.545 -0.722 . . . . 0.0 109.361 179.938 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 839' ' ' CYS . . . . . 0.459 ' HB3' ' HB3' ' A' ' 768' ' ' GLN . 1.2 m -105.44 108.93 20.71 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.123 -0.986 . . . . 0.0 110.216 -179.915 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 840' ' ' SER . . . . . 0.575 ' C ' HG23 ' A' ' 841' ' ' THR . 14.8 t -99.17 -89.21 0.32 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.315 -0.865 . . . . 0.0 110.25 179.994 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 841' ' ' THR . . . . . 0.575 HG23 ' C ' ' A' ' 840' ' ' SER . 62.9 p . . . . . 0 N--CA 1.495 1.805 0 O-C-N 121.194 -0.942 . . . . 0.0 110.578 -179.977 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 728' ' ' VAL . . . . . 0.693 ' O ' HG12 ' A' ' 728' ' ' VAL . 1.3 t . . . . . 0 N--CA 1.485 1.283 0 CA-C-O 121.355 0.598 . . . . 0.0 109.959 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 729' ' ' SER . . . . . 0.478 ' HB2' ' O ' ' A' ' 728' ' ' VAL . 2.2 m 58.16 168.62 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.484 -0.76 . . . . 0.0 110.788 179.827 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 730' ' ' GLY . . . . . 0.486 ' C ' HG23 ' A' ' 731' ' ' VAL . . . -131.32 -161.35 10.18 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.065 -1.614 . . . . 0.0 109.065 179.938 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 731' ' ' VAL . . . . . 0.486 HG23 ' C ' ' A' ' 730' ' ' GLY . 4.8 t -150.58 137.39 13.0 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 121.149 -1.207 . . . . 0.0 110.324 179.989 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 732' ' ' CYS . . . . . . . . . . . . . 20.3 m -128.25 143.71 51.06 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.309 -0.869 . . . . 0.0 109.868 179.964 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 733' ' ' ALA . . . . . . . . . . . . . . . -148.38 105.06 3.57 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.989 -1.069 . . . . 0.0 110.735 -179.948 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 734' ' ' ASP . . . . . 0.47 ' OD1' ' O ' ' A' ' 734' ' ' ASP . 1.0 OUTLIER -110.39 104.01 12.73 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.352 -0.843 . . . . 0.0 109.979 179.924 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 735' ' ' VAL . . . . . 0.493 ' O ' ' HB ' ' A' ' 833' ' ' VAL . 77.0 t -129.68 123.33 56.95 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 121.125 -0.984 . . . . 0.0 110.243 -179.967 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 736' ' ' SER . . . . . 0.499 ' HA ' ' HA ' ' A' ' 832' ' ' ARG . 5.4 p -84.24 158.74 21.16 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.088 -1.007 . . . . 0.0 110.362 -179.959 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 737' ' ' GLU . . . . . 0.584 ' HB2' HG21 ' A' ' 816' ' ' ILE . 24.5 tt0 . . . . . 0 N--CA 1.494 1.769 0 O-C-N 121.271 -0.893 . . . . 0.0 109.992 179.981 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 757' ' ' THR . . . . . . . . . . . . . 60.9 p . . . . . 0 N--CA 1.494 1.755 0 CA-C-O 121.386 0.613 . . . . 0.0 110.246 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 758' ' ' ALA . . . . . . . . . . . . . . . -111.9 157.93 20.06 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.295 -0.878 . . . . 0.0 110.238 179.955 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 759' ' ' LYS . . . . . . . . . . . . . 1.3 ttmt -113.51 155.0 26.15 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.338 -0.851 . . . . 0.0 109.928 -179.974 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 760' ' ' VAL . . . . . . . . . . . . . 16.8 t -109.06 136.87 43.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.246 -0.909 . . . . 0.0 109.729 179.926 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 761' ' ' HIS . . . . . . . . . . . . . 3.5 m80 -109.52 107.34 17.42 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.147 -0.97 . . . . 0.0 110.467 -179.984 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 762' ' ' LEU . . . . . . . . . . . . . 2.0 mt -109.54 148.13 31.77 Favored 'General case' 0 C--N 1.299 -1.607 0 O-C-N 121.65 -0.656 . . . . 0.0 109.502 179.944 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 763' ' ' LYS . . . . . . . . . . . . . 3.3 ttpt -158.39 121.46 3.83 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.131 -0.98 . . . . 0.0 110.091 179.997 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 764' ' ' CYS . . . . . 0.442 ' O ' ' C ' ' A' ' 765' ' ' ALA . 12.7 t -82.06 157.77 24.02 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.262 -0.899 . . . . 0.0 110.001 179.958 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 765' ' ' ALA . . . . . 0.442 ' C ' ' O ' ' A' ' 764' ' ' CYS . . . -41.29 162.36 0.12 Allowed Pre-proline 0 N--CA 1.495 1.799 0 O-C-N 121.263 -0.898 . . . . 0.0 110.325 -179.966 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 766' ' ' PRO . . . . . 0.412 ' HD2' ' HB1' ' A' ' 765' ' ' ALA . 45.8 Cg_endo -73.16 99.75 1.14 Allowed 'Trans proline' 0 C--N 1.304 -1.799 0 O-C-N 124.025 1.54 . . . . 0.0 110.185 -179.979 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 767' ' ' GLY . . . . . . . . . . . . . . . 117.76 1.0 17.58 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.486 -1.446 . . . . 0.0 109.486 -179.962 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 768' ' ' GLN . . . . . 0.501 ' CG ' ' O ' ' A' ' 840' ' ' SER . 10.7 mp0 -116.47 154.47 30.29 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.219 -1.165 . . . . 0.0 110.273 179.938 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 769' ' ' THR . . . . . . . . . . . . . 43.1 p -129.02 147.54 50.9 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.184 -0.948 . . . . 0.0 110.359 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 770' ' ' ILE . . . . . . . . . . . . . 37.0 mt -58.99 133.17 24.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.308 -0.87 . . . . 0.0 109.751 179.952 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 771' ' ' SER . . . . . 0.476 ' O ' ' HB2' ' A' ' 772' ' ' ALA . 51.7 p -108.47 -17.0 14.09 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.236 -0.915 . . . . 0.0 110.861 -179.889 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 772' ' ' ALA . . . . . 0.476 ' HB2' ' O ' ' A' ' 771' ' ' SER . . . -177.77 171.84 1.79 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.875 -1.141 . . . . 0.0 111.271 -179.999 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 773' ' ' ILE . . . . . . . . . . . . . 42.6 mm -123.72 129.49 74.45 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 179.858 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 774' ' ' LYS . . . . . . . . . . . . . 5.9 mtpt -95.03 -35.47 11.93 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 121.033 -1.042 . . . . 0.0 111.537 -179.848 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 775' ' ' PHE . . . . . 0.674 ' O ' ' HB2' ' A' ' 776' ' ' ALA . 60.1 t80 -149.06 172.34 14.92 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 120.686 -1.259 . . . . 0.0 111.465 -179.948 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 776' ' ' ALA . . . . . 0.674 ' HB2' ' O ' ' A' ' 775' ' ' PHE . . . 169.3 119.93 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 109.187 -0.672 . . . . 0.0 109.187 -179.971 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 777' ' ' SER . . . . . 0.554 ' HA ' ' HB3' ' A' ' 798' ' ' SER . 44.4 t -143.69 137.2 28.02 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 120.978 -1.076 . . . . 0.0 111.172 -179.891 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 778' ' ' PHE . . . . . 0.57 ' CG ' ' O ' ' A' ' 778' ' ' PHE . 1.4 t80 -107.34 72.37 0.87 Allowed 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.422 -0.799 . . . . 0.0 109.73 179.925 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 779' ' ' GLY . . . . . . . . . . . . . . . -174.24 -120.6 0.59 Allowed Glycine 0 N--CA 1.492 2.405 0 N-CA-C 109.961 -1.255 . . . . 0.0 109.961 179.989 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 780' ' ' THR . . . . . 0.644 HG22 ' O ' ' A' ' 830' ' ' MET . 24.8 p -117.11 81.46 12.79 Favored Pre-proline 0 N--CA 1.494 1.775 0 O-C-N 121.197 -1.178 . . . . 0.0 110.553 179.984 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 781' ' ' PRO . . . . . 0.427 ' HA ' ' O ' ' A' ' 789' ' ' GLN . 46.8 Cg_endo -80.48 144.43 15.97 Favored 'Trans proline' 0 C--N 1.304 -1.805 0 O-C-N 124.054 1.555 . . . . 0.0 110.229 -179.983 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 782' ' ' LEU . . . . . . . . . . . . . 36.8 mt -120.32 148.91 43.12 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.176 -0.953 . . . . 0.0 110.331 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 783' ' ' GLY . . . . . . . . . . . . . . . 112.2 -139.29 15.54 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.546 -1.422 . . . . 0.0 109.546 -179.962 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 784' ' ' THR . . . . . . . . . . . . . 10.8 t -161.12 -173.26 3.78 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.254 -1.144 . . . . 0.0 110.138 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 785' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -64.37 107.15 1.27 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.191 -0.943 . . . . 0.0 110.204 -179.975 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 786' ' ' GLY . . . . . . . . . . . . . . . 131.36 -31.65 3.09 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.2 -1.56 . . . . 0.0 109.2 179.981 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 787' ' ' THR . . . . . . . . . . . . . 25.2 p -144.38 39.81 1.31 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.32 -1.106 . . . . 0.0 110.088 -179.942 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 788' ' ' PHE . . . . . 0.583 ' HB3' ' CZ ' ' A' ' 775' ' ' PHE . 1.9 m-85 -50.97 171.55 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.328 -0.858 . . . . 0.0 110.229 179.935 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 789' ' ' GLN . . . . . 0.427 ' O ' ' HA ' ' A' ' 781' ' ' PRO . 26.4 tt0 -161.05 169.57 22.22 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.114 -0.991 . . . . 0.0 110.424 -179.989 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 790' ' ' GLN . . . . . 0.454 ' O ' ' HG3' ' A' ' 790' ' ' GLN . 0.0 OUTLIER -94.89 147.96 22.82 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.23 -0.919 . . . . 0.0 110.041 -179.992 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 791' ' ' GLY . . . . . 0.443 ' HA3' ' OG1' ' A' ' 780' ' ' THR . . . -97.4 -150.67 26.88 Favored Glycine 0 N--CA 1.492 2.393 0 N-CA-C 109.516 -1.434 . . . . 0.0 109.516 179.943 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 792' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -70.08 -19.66 63.25 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.255 -1.144 . . . . 0.0 109.973 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 793' ' ' CYS . . . . . 0.475 ' SG ' ' N ' ' A' ' 794' ' ' HIS . 1.8 t -136.72 164.86 27.26 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.337 -0.852 . . . . 0.0 110.051 -179.963 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 794' ' ' HIS . . . . . 0.644 ' CD2' ' N ' ' A' ' 795' ' ' SER . 0.7 OUTLIER 179.5 154.65 0.5 Allowed 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.285 -0.884 . . . . 0.0 109.861 179.976 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 795' ' ' SER . . . . . 0.644 ' N ' ' CD2' ' A' ' 794' ' ' HIS . 1.8 t -91.78 107.61 19.33 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.324 -0.86 . . . . 0.0 110.15 179.993 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 796' ' ' ILE . . . . . 0.436 ' C ' ' O ' ' A' ' 795' ' ' SER . 6.5 pt -38.63 -25.05 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.939 0 O-C-N 121.372 -0.83 . . . . 0.0 111.23 179.981 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 797' ' ' ASN . . . . . 0.532 ' N ' ' O ' ' A' ' 795' ' ' SER . 19.3 p30 -107.85 51.74 0.73 Allowed 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.003 -1.06 . . . . 0.0 111.313 -179.894 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 798' ' ' SER . . . . . 0.554 ' HB3' ' HA ' ' A' ' 777' ' ' SER . 4.3 m -102.8 26.42 8.08 Favored 'General case' 0 N--CA 1.497 1.925 0 O-C-N 120.697 -1.252 . . . . 0.0 110.403 179.939 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 799' ' ' ASN . . . . . . . . . . . . . 38.4 m-80 -138.07 -46.97 0.53 Allowed 'General case' 0 N--CA 1.496 1.831 0 O-C-N 120.998 -1.064 . . . . 0.0 110.874 -179.905 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 800' ' ' SER . . . . . . . . . . . . . 8.7 t -62.78 -33.12 74.52 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.118 -0.989 . . . . 0.0 110.385 -179.93 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 801' ' ' VAL . . . . . . . . . . . . . 97.8 t -51.92 -52.06 25.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.285 -0.884 . . . . 0.0 110.582 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 802' ' ' LEU . . . . . 0.464 ' O ' ' HB2' ' A' ' 806' ' ' CYS . 1.1 mm? -63.15 -43.48 98.2 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.206 -0.934 . . . . 0.0 110.861 179.996 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 803' ' ' GLU . . . . . . . . . . . . . 24.7 tt0 -55.33 -21.1 13.62 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.232 -0.918 . . . . 0.0 110.646 -179.959 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 804' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -92.14 -23.22 19.49 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.234 -0.916 . . . . 0.0 110.98 -179.969 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 805' ' ' LYS . . . . . 0.4 ' O ' ' SG ' ' A' ' 812' ' ' CYS . 5.0 mmmt -130.77 52.57 2.03 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.017 -1.052 . . . . 0.0 110.892 -179.904 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 806' ' ' CYS . . . . . 0.546 ' O ' HD12 ' A' ' 809' ' ' LEU . 0.3 OUTLIER -160.95 -72.19 0.06 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.035 -1.041 . . . . 0.0 110.903 179.986 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 807' ' ' ILE . . . . . . . . . . . . . 94.4 mt -55.28 128.74 15.85 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 121.223 -0.923 . . . . 0.0 110.776 -179.921 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 808' ' ' GLY . . . . . 0.475 ' C ' ' HG ' ' A' ' 809' ' ' LEU . . . 106.83 1.16 36.58 Favored Glycine 0 N--CA 1.495 2.576 0 N-CA-C 110.385 -1.086 . . . . 0.0 110.385 179.906 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 809' ' ' LEU . . . . . 0.546 HD12 ' O ' ' A' ' 806' ' ' CYS . 1.0 OUTLIER -131.83 160.61 35.15 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 120.831 -1.393 . . . . 0.0 110.534 -179.958 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 810' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -83.78 -9.49 58.76 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.329 -0.857 . . . . 0.0 109.583 179.91 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 811' ' ' ARG . . . . . 0.533 ' NH1' HD22 ' A' ' 809' ' ' LEU . 0.1 OUTLIER -143.62 164.93 29.03 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.39 -0.819 . . . . 0.0 109.193 -179.987 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 812' ' ' CYS . . . . . 0.4 ' SG ' ' O ' ' A' ' 805' ' ' LYS . 7.9 t -143.77 126.99 16.62 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.922 -1.111 . . . . 0.0 111.268 -179.852 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 813' ' ' VAL . . . . . . . . . . . . . 98.3 t -128.45 115.11 36.54 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.298 -0.877 . . . . 0.0 109.225 179.809 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 814' ' ' VAL . . . . . . . . . . . . . 97.9 t -123.28 129.21 74.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.134 -0.978 . . . . 0.0 110.772 -179.876 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 815' ' ' ALA . . . . . . . . . . . . . . . -86.69 158.82 19.35 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.323 -0.861 . . . . 0.0 109.623 179.909 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 816' ' ' ILE . . . . . 0.78 HD13 HG21 ' A' ' 833' ' ' VAL . 75.9 mt -109.65 133.02 56.24 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.577 0 O-C-N 121.218 -0.926 . . . . 0.0 110.575 -179.985 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 817' ' ' SER . . . . . 0.502 ' OG ' ' CB ' ' A' ' 820' ' ' ASN . 0.1 OUTLIER -165.98 170.45 5.8 Favored Pre-proline 0 N--CA 1.488 1.447 0 O-C-N 121.267 -0.896 . . . . 0.0 109.888 179.978 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 818' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -78.16 -63.63 0.02 OUTLIER 'Trans proline' 0 C--N 1.303 -1.834 0 O-C-N 123.982 1.517 . . . . 0.0 111.497 -179.886 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 819' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -70.24 -1.1 9.31 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 120.986 -1.071 . . . . 0.0 111.215 -179.849 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 820' ' ' ASN . . . . . 0.502 ' CB ' ' OG ' ' A' ' 817' ' ' SER . 27.9 t-20 -84.49 -20.79 31.1 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 120.952 -1.093 . . . . 0.0 109.999 179.977 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 821' ' ' PHE . . . . . . . . . . . . . 5.5 m-85 -108.45 -59.3 1.88 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.232 -0.918 . . . . 0.0 110.562 -179.903 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 822' ' ' GLY . . . . . . . . . . . . . . . -144.13 -55.65 0.03 OUTLIER Glycine 0 N--CA 1.491 2.366 0 N-CA-C 109.773 -1.331 . . . . 0.0 109.773 179.965 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 823' ' ' GLY . . . . . . . . . . . . . . . 137.77 108.32 0.85 Allowed Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.661 -1.376 . . . . 0.0 109.661 -179.958 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 824' ' ' ASP . . . . . 0.521 ' N ' ' HD3' ' A' ' 825' ' ' PRO . 4.2 m-20 43.11 59.93 10.99 Favored Pre-proline 0 N--CA 1.494 1.736 0 O-C-N 121.343 -1.092 . . . . 0.0 110.73 -179.976 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 825' ' ' PRO . . . . . 0.521 ' HD3' ' N ' ' A' ' 824' ' ' ASP . 47.8 Cg_endo -84.29 -54.91 0.03 OUTLIER 'Trans proline' 0 C--N 1.304 -1.784 0 O-C-N 123.926 1.487 . . . . 0.0 110.261 179.998 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 826' ' ' CYS . . . . . 0.4 ' SG ' HG11 ' A' ' 829' ' ' VAL . 0.5 OUTLIER -131.56 85.24 53.02 Favored Pre-proline 0 N--CA 1.496 1.838 0 O-C-N 121.267 -0.896 . . . . 0.0 110.375 -179.993 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 827' ' ' PRO . . . . . 0.448 ' O ' HG23 ' A' ' 829' ' ' VAL . 50.5 Cg_endo -86.64 151.11 8.81 Favored 'Trans proline' 0 C--N 1.306 -1.671 0 O-C-N 123.919 1.484 . . . . 0.0 111.287 -179.969 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 828' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 45.28 48.99 10.28 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.426 -0.796 . . . . 0.0 111.111 179.968 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 829' ' ' VAL . . . . . 0.515 ' O ' ' N ' ' A' ' 831' ' ' LYS . 20.4 t -147.44 137.95 17.34 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.583 0 O-C-N 121.164 -0.96 . . . . 0.0 110.173 179.899 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 830' ' ' MET . . . . . 0.644 ' O ' HG22 ' A' ' 780' ' ' THR . 0.2 OUTLIER -42.31 95.11 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.419 -0.8 . . . . 0.0 109.618 179.976 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 831' ' ' LYS . . . . . 0.515 ' N ' ' O ' ' A' ' 829' ' ' VAL . 0.0 OUTLIER -94.61 150.22 20.46 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.186 -0.946 . . . . 0.0 110.565 -179.938 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 832' ' ' ARG . . . . . 0.499 ' HA ' ' HA ' ' A' ' 736' ' ' SER . 0.0 OUTLIER -156.94 151.76 25.84 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.404 -0.81 . . . . 0.0 109.662 179.97 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 833' ' ' VAL . . . . . 0.78 HG21 HD13 ' A' ' 816' ' ' ILE . 66.6 t -115.79 106.1 19.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 120.979 -1.075 . . . . 0.0 110.955 179.978 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 834' ' ' ALA . . . . . 0.447 ' HB1' ' CZ ' ' A' ' 788' ' ' PHE . . . -108.87 132.95 53.53 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.307 -0.87 . . . . 0.0 109.092 179.922 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 835' ' ' VAL . . . . . . . . . . . . . 73.1 t -141.16 133.03 28.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.012 -1.055 . . . . 0.0 111.323 -179.94 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 836' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -125.53 112.64 16.45 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 179.897 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 837' ' ' ALA . . . . . . . . . . . . . . . -108.91 162.67 13.99 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.146 -0.971 . . . . 0.0 111.089 -179.926 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 838' ' ' VAL . . . . . . . . . . . . . 38.6 t -111.84 119.15 59.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.524 -0.735 . . . . 0.0 109.727 -179.946 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 839' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -105.71 146.18 30.11 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.9 -1.125 . . . . 0.0 110.94 179.946 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 840' ' ' SER . . . . . 0.501 ' O ' ' CG ' ' A' ' 768' ' ' GLN . 79.1 p -138.94 -152.22 0.41 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.498 -0.752 . . . . 0.0 109.775 -179.991 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 841' ' ' THR . . . . . . . . . . . . . 69.6 p . . . . . 0 N--CA 1.492 1.648 0 O-C-N 121.186 -0.946 . . . . 0.0 109.993 179.977 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 728' ' ' VAL . . . . . 0.401 ' O ' ' O ' ' A' ' 729' ' ' SER . 43.0 t . . . . . 0 N--CA 1.489 1.505 0 CA-C-O 121.264 0.554 . . . . 0.0 110.177 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 729' ' ' SER . . . . . 0.401 ' O ' ' O ' ' A' ' 728' ' ' VAL . 40.5 m 51.78 179.21 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.18 -0.95 . . . . 0.0 110.034 -179.972 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 730' ' ' GLY . . . . . . . . . . . . . . . -152.8 -158.8 8.69 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.622 -1.391 . . . . 0.0 109.622 -179.938 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 731' ' ' VAL . . . . . 0.511 ' CG2' ' SG ' ' A' ' 764' ' ' CYS . 18.0 t -140.1 144.65 27.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.21 -1.171 . . . . 0.0 110.506 179.99 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 732' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -135.96 143.15 44.71 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.432 -0.793 . . . . 0.0 109.729 179.952 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 733' ' ' ALA . . . . . . . . . . . . . . . -148.44 122.74 9.61 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.123 -0.986 . . . . 0.0 110.726 179.997 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 734' ' ' ASP . . . . . 0.461 ' O ' ' OD2' ' A' ' 734' ' ' ASP . 19.3 p-10 -129.92 106.06 8.41 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.326 -0.859 . . . . 0.0 109.877 179.953 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 735' ' ' VAL . . . . . . . . . . . . . 61.3 t -126.8 159.32 36.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.107 -0.996 . . . . 0.0 110.428 -179.951 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 736' ' ' SER . . . . . 0.428 ' O ' ' C ' ' A' ' 737' ' ' GLU . 24.6 m -109.51 127.29 54.34 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.321 -0.862 . . . . 0.0 109.932 179.992 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 737' ' ' GLU . . . . . 0.476 ' HB2' ' HB3' ' A' ' 831' ' ' LYS . 14.9 tp10 . . . . . 0 N--CA 1.495 1.787 0 O-C-N 121.296 -0.878 . . . . 0.0 110.433 179.992 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 757' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.751 0 CA-C-O 121.337 0.589 . . . . 0.0 110.217 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 758' ' ' ALA . . . . . 0.89 ' HB3' ' HB ' ' A' ' 816' ' ' ILE . . . -98.9 172.26 7.54 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.32 -0.862 . . . . 0.0 109.855 179.939 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 759' ' ' LYS . . . . . . . . . . . . . 6.4 mttm -150.74 136.58 18.22 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.115 -0.991 . . . . 0.0 110.41 179.959 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 760' ' ' VAL . . . . . . . . . . . . . 42.1 t -106.6 136.65 40.58 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.305 -0.872 . . . . 0.0 109.263 179.941 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 761' ' ' HIS . . . . . . . . . . . . . 68.1 m80 -109.71 104.15 13.1 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.198 -0.939 . . . . 0.0 110.981 -179.947 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 762' ' ' LEU . . . . . . . . . . . . . 39.4 mt -119.13 101.77 8.25 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.33 -0.857 . . . . 0.0 108.951 179.905 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 763' ' ' LYS . . . . . 0.489 ' HB3' ' HG3' ' A' ' 811' ' ' ARG . 6.6 pttm -135.66 140.86 44.82 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.077 -1.015 . . . . 0.0 110.803 -179.956 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 764' ' ' CYS . . . . . 0.511 ' SG ' ' CG2' ' A' ' 731' ' ' VAL . 0.5 OUTLIER -113.47 157.77 21.55 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.407 -0.808 . . . . 0.0 109.891 179.983 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 765' ' ' ALA . . . . . 0.775 ' HB3' ' HG3' ' A' ' 768' ' ' GLN . . . -44.73 169.71 0.06 OUTLIER Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 121.197 -0.939 . . . . 0.0 110.218 179.963 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 766' ' ' PRO . . . . . 0.659 ' HD2' ' HB1' ' A' ' 765' ' ' ALA . 43.9 Cg_endo -71.13 113.04 3.46 Favored 'Trans proline' 0 C--N 1.304 -1.787 0 O-C-N 123.961 1.506 . . . . 0.0 110.4 179.958 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 767' ' ' GLY . . . . . . . . . . . . . . . 110.07 -24.82 17.82 Favored Glycine 0 N--CA 1.488 2.16 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 -179.942 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 768' ' ' GLN . . . . . 0.775 ' HG3' ' HB3' ' A' ' 765' ' ' ALA . 3.1 mt-30 -87.77 99.84 12.4 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.238 -1.154 . . . . 0.0 110.117 -179.99 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 769' ' ' THR . . . . . 0.844 HG22 ' HG3' ' A' ' 810' ' ' GLU . 64.1 p -94.78 154.14 17.42 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.257 -0.902 . . . . 0.0 110.375 -179.988 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 770' ' ' ILE . . . . . 0.419 ' HA ' ' O ' ' A' ' 838' ' ' VAL . 11.3 mt -78.11 144.89 10.65 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.356 -0.84 . . . . 0.0 110.005 -179.999 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 771' ' ' SER . . . . . . . . . . . . . 1.8 t -137.02 -5.3 1.89 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.147 -0.971 . . . . 0.0 111.158 -179.915 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 772' ' ' ALA . . . . . . . . . . . . . . . -162.18 123.38 2.65 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.859 -1.151 . . . . 0.0 111.014 -179.906 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 773' ' ' ILE . . . . . . . . . . . . . 32.9 mm -85.67 124.48 40.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.286 -0.884 . . . . 0.0 109.551 179.889 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 774' ' ' LYS . . . . . . . . . . . . . 18.9 mmtt -80.44 -42.26 22.98 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.246 -0.909 . . . . 0.0 110.757 -179.904 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 775' ' ' PHE . . . . . 0.694 ' O ' ' HB2' ' A' ' 776' ' ' ALA . 59.3 t80 -154.04 173.0 16.61 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.027 -1.045 . . . . 0.0 111.078 -179.974 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 776' ' ' ALA . . . . . 0.694 ' HB2' ' O ' ' A' ' 775' ' ' PHE . . . 168.39 89.08 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.588 -0.695 . . . . 0.0 109.548 179.959 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 777' ' ' SER . . . . . 0.581 ' HA ' ' CB ' ' A' ' 798' ' ' SER . 59.5 p -122.66 137.7 54.82 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.231 -0.918 . . . . 0.0 110.504 -179.906 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 778' ' ' PHE . . . . . . . . . . . . . 15.7 t80 -104.18 104.32 14.22 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.245 -0.909 . . . . 0.0 110.066 179.963 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 779' ' ' GLY . . . . . . . . . . . . . . . 161.64 -113.55 0.57 Allowed Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.457 -1.457 . . . . 0.0 109.457 -179.998 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 780' ' ' THR . . . . . . . . . . . . . 12.0 p -118.56 72.86 10.75 Favored Pre-proline 0 N--CA 1.492 1.67 0 O-C-N 121.203 -1.175 . . . . 0.0 110.127 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 781' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -73.27 161.16 43.55 Favored 'Trans proline' 0 C--N 1.307 -1.629 0 O-C-N 123.952 1.501 . . . . 0.0 110.296 179.976 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 782' ' ' LEU . . . . . 0.547 ' CD1' ' CA ' ' A' ' 791' ' ' GLY . 1.2 mp -132.61 169.36 16.73 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.233 -0.917 . . . . 0.0 110.159 179.984 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 783' ' ' GLY . . . . . . . . . . . . . . . 95.61 -167.67 26.0 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.354 -1.498 . . . . 0.0 109.354 -179.994 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 784' ' ' THR . . . . . 0.574 ' O ' ' CZ ' ' A' ' 788' ' ' PHE . 1.2 p -133.62 -65.69 0.67 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.187 -1.184 . . . . 0.0 110.337 -179.981 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 785' ' ' CYS . . . . . . . . . . . . . 7.8 t -156.19 128.49 7.6 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.166 -0.959 . . . . 0.0 110.445 179.988 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 786' ' ' GLY . . . . . . . . . . . . . . . 92.25 -13.18 67.77 Favored Glycine 0 N--CA 1.492 2.384 0 N-CA-C 109.7 -1.36 . . . . 0.0 109.7 -179.973 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 787' ' ' THR . . . . . 0.435 ' O ' HG23 ' A' ' 787' ' ' THR . 7.5 t -141.21 31.99 1.73 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.206 -1.173 . . . . 0.0 110.612 -179.991 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 788' ' ' PHE . . . . . 0.574 ' CZ ' ' O ' ' A' ' 784' ' ' THR . 0.7 OUTLIER -61.02 129.23 40.37 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.094 -1.004 . . . . 0.0 109.671 179.982 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 789' ' ' GLN . . . . . . . . . . . . . 5.2 pt20 -133.23 161.06 35.46 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.075 -1.016 . . . . 0.0 110.258 -179.967 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 790' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -75.27 144.36 42.57 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.233 -0.917 . . . . 0.0 110.406 -179.931 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 791' ' ' GLY . . . . . 0.547 ' CA ' ' CD1' ' A' ' 782' ' ' LEU . . . -96.56 -46.1 2.59 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 -179.98 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 792' ' ' GLU . . . . . 0.449 ' HB3' ' O ' ' A' ' 791' ' ' GLY . 15.8 pt-20 179.17 -27.63 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.158 -1.201 . . . . 0.0 110.93 -179.921 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 793' ' ' CYS . . . . . 0.461 ' O ' ' HB2' ' A' ' 794' ' ' HIS . 1.7 m -102.72 164.1 11.83 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.058 -1.026 . . . . 0.0 110.979 -179.92 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 794' ' ' HIS . . . . . 0.53 ' CD2' ' HG ' ' A' ' 798' ' ' SER . 12.3 t-80 179.56 135.52 0.1 Allowed 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.466 -0.771 . . . . 0.0 109.727 179.941 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 795' ' ' SER . . . . . 0.419 ' O ' ' N ' ' A' ' 797' ' ' ASN . 0.2 OUTLIER -90.87 23.78 3.01 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.19 -0.944 . . . . 0.0 110.884 -179.909 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 796' ' ' ILE . . . . . 0.491 HG22 ' O ' ' A' ' 796' ' ' ILE . 40.9 mt 42.65 27.29 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 O-C-N 121.125 -0.984 . . . . 0.0 110.018 179.958 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 797' ' ' ASN . . . . . 0.419 ' N ' ' O ' ' A' ' 795' ' ' SER . 1.2 t-20 -157.25 26.88 0.3 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.246 -0.909 . . . . 0.0 109.611 179.972 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 798' ' ' SER . . . . . 0.581 ' CB ' ' HA ' ' A' ' 777' ' ' SER . 2.8 m -84.28 -19.65 33.46 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.396 -0.815 . . . . 0.0 110.515 -179.96 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 799' ' ' ASN . . . . . 0.539 ' OD1' ' HB3' ' A' ' 776' ' ' ALA . 63.9 m-80 -108.87 -1.06 19.43 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.276 -0.89 . . . . 0.0 110.751 -179.996 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 800' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -91.83 -31.34 15.76 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.21 -0.931 . . . . 0.0 110.434 -179.962 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 801' ' ' VAL . . . . . . . . . . . . . 95.7 t -79.93 -17.93 12.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.359 -0.838 . . . . 0.0 110.089 -179.949 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 802' ' ' LEU . . . . . 0.488 ' N ' ' CD2' ' A' ' 802' ' ' LEU . 4.5 mm? -87.71 -60.43 1.97 Allowed 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.317 -0.864 . . . . 0.0 110.838 -179.955 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 803' ' ' GLU . . . . . 0.603 ' CG ' HD12 ' A' ' 807' ' ' ILE . 1.1 tt0 -57.3 -20.23 27.14 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.113 -0.992 . . . . 0.0 110.527 -179.988 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 804' ' ' ARG . . . . . . . . . . . . . 48.2 ttt85 -93.8 -20.21 20.3 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.268 -0.895 . . . . 0.0 111.757 -179.896 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 805' ' ' LYS . . . . . 0.448 ' O ' ' SG ' ' A' ' 806' ' ' CYS . 8.8 tttm -126.29 40.13 3.79 Favored 'General case' 0 N--CA 1.501 2.108 0 O-C-N 120.765 -1.21 . . . . 0.0 111.502 -179.887 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 806' ' ' CYS . . . . . 0.448 ' SG ' ' O ' ' A' ' 805' ' ' LYS . 1.3 m -163.55 -55.06 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.038 -1.039 . . . . 0.0 110.235 179.892 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 807' ' ' ILE . . . . . 0.603 HD12 ' CG ' ' A' ' 803' ' ' GLU . 5.6 mt -51.09 119.15 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.315 -0.866 . . . . 0.0 110.432 -179.965 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 808' ' ' GLY . . . . . 0.43 ' C ' ' HG ' ' A' ' 809' ' ' LEU . . . 111.14 6.93 25.51 Favored Glycine 0 N--CA 1.492 2.415 0 N-CA-C 109.803 -1.319 . . . . 0.0 109.803 179.923 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 809' ' ' LEU . . . . . 0.43 ' HG ' ' C ' ' A' ' 808' ' ' GLY . 15.9 mt -136.25 148.88 48.25 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.203 -1.175 . . . . 0.0 110.311 -179.971 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 810' ' ' GLU . . . . . 0.844 ' HG3' HG22 ' A' ' 769' ' ' THR . 5.1 mt-10 -76.38 -19.09 58.49 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.253 -0.904 . . . . 0.0 109.558 179.881 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 811' ' ' ARG . . . . . 0.489 ' HG3' ' HB3' ' A' ' 763' ' ' LYS . 1.0 OUTLIER -152.78 133.74 14.07 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.527 -0.733 . . . . 0.0 109.665 179.923 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 812' ' ' CYS . . . . . . . . . . . . . 27.6 p -152.02 141.48 21.62 Favored 'General case' 0 C--N 1.296 -1.759 0 O-C-N 121.334 -0.854 . . . . 0.0 110.64 -179.927 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 813' ' ' VAL . . . . . . . . . . . . . 24.2 t -110.21 152.97 12.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.277 -0.89 . . . . 0.0 109.843 -179.983 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 814' ' ' VAL . . . . . . . . . . . . . 22.0 t -131.79 106.46 11.56 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 O-C-N 121.042 -1.036 . . . . 0.0 110.458 -179.936 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 815' ' ' ALA . . . . . . . . . . . . . . . -67.13 143.32 56.7 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.254 -0.904 . . . . 0.0 109.964 179.939 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 816' ' ' ILE . . . . . 1.058 HD13 HG21 ' A' ' 833' ' ' VAL . 20.8 mt -100.02 104.48 16.17 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.211 -0.931 . . . . 0.0 110.156 -179.928 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 817' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -144.61 153.73 55.26 Favored Pre-proline 0 N--CA 1.496 1.835 0 O-C-N 121.322 -0.861 . . . . 0.0 110.279 179.958 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 818' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -76.65 -25.73 9.08 Favored 'Trans proline' 0 C--N 1.309 -1.508 0 O-C-N 123.897 1.472 . . . . 0.0 110.391 -179.999 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 819' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -90.97 18.32 6.81 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.228 -0.92 . . . . 0.0 109.873 179.958 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 820' ' ' ASN . . . . . . . . . . . . . 31.0 t30 -116.16 -32.11 5.45 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.338 -0.851 . . . . 0.0 110.396 -179.998 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 821' ' ' PHE . . . . . . . . . . . . . 54.3 m-85 -86.07 -79.62 0.25 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.16 -0.963 . . . . 0.0 110.008 179.999 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 822' ' ' GLY . . . . . . . . . . . . . . . -177.76 56.5 0.1 OUTLIER Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.213 -1.555 . . . . 0.0 109.213 -179.97 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 823' ' ' GLY . . . . . . . . . . . . . . . 99.01 -149.65 19.12 Favored Glycine 0 N--CA 1.487 2.041 0 N-CA-C 109.353 -1.499 . . . . 0.0 109.353 179.972 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 824' ' ' ASP . . . . . 0.488 ' OD2' ' N ' ' A' ' 824' ' ' ASP . 0.8 OUTLIER -121.59 142.02 34.83 Favored Pre-proline 0 N--CA 1.492 1.649 0 O-C-N 121.23 -1.159 . . . . 0.0 110.332 179.943 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 825' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -75.61 -89.63 0.0 OUTLIER 'Trans proline' 0 C--N 1.306 -1.675 0 O-C-N 124.105 1.581 . . . . 0.0 110.888 -179.947 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 826' ' ' CYS . . . . . 0.405 ' HB3' HG21 ' A' ' 829' ' ' VAL . 79.0 m -113.62 120.72 38.88 Favored Pre-proline 0 N--CA 1.494 1.748 0 O-C-N 121.196 -0.94 . . . . 0.0 110.475 -179.953 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 827' ' ' PRO . . . . . 0.476 ' O ' ' CB ' ' A' ' 828' ' ' GLU . 49.1 Cg_endo -75.58 142.47 26.19 Favored 'Trans proline' 0 C--N 1.306 -1.66 0 O-C-N 123.839 1.442 . . . . 0.0 110.33 179.938 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 828' ' ' GLU . . . . . 0.476 ' CB ' ' O ' ' A' ' 827' ' ' PRO . 0.8 OUTLIER 67.36 38.65 3.18 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.256 -0.903 . . . . 0.0 110.35 -179.991 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 829' ' ' VAL . . . . . 0.475 ' O ' ' HD3' ' A' ' 831' ' ' LYS . 24.0 t -136.05 132.92 50.46 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.174 -0.954 . . . . 0.0 110.291 -179.945 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 830' ' ' MET . . . . . 0.414 ' C ' ' O ' ' A' ' 829' ' ' VAL . 17.4 mtt -43.96 127.88 5.46 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.289 -0.882 . . . . 0.0 110.012 179.95 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 831' ' ' LYS . . . . . 0.476 ' HB3' ' HB2' ' A' ' 737' ' ' GLU . 0.0 OUTLIER -94.08 112.99 24.87 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.144 -0.973 . . . . 0.0 110.511 -179.983 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 832' ' ' ARG . . . . . . . . . . . . . 33.4 mtp85 -125.12 139.83 53.42 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.317 -0.864 . . . . 0.0 109.823 179.914 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 833' ' ' VAL . . . . . 1.058 HG21 HD13 ' A' ' 816' ' ' ILE . 42.8 t -112.32 105.1 18.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.15 -0.969 . . . . 0.0 110.567 -179.914 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 834' ' ' ALA . . . . . . . . . . . . . . . -113.5 116.43 29.57 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.377 -0.827 . . . . 0.0 109.786 179.976 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 835' ' ' VAL . . . . . . . . . . . . . 29.4 t -130.51 156.75 42.72 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.176 -0.953 . . . . 0.0 110.544 -179.93 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 836' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -149.21 113.14 5.13 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.489 -0.757 . . . . 0.0 109.652 179.954 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 837' ' ' ALA . . . . . . . . . . . . . . . -110.22 163.42 13.64 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.098 -1.001 . . . . 0.0 110.465 -179.983 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 838' ' ' VAL . . . . . 0.419 ' O ' ' HA ' ' A' ' 770' ' ' ILE . 74.5 t -114.09 156.72 14.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.339 -0.851 . . . . 0.0 110.203 -179.968 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 839' ' ' CYS . . . . . . . . . . . . . 1.2 m -136.59 148.0 47.27 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.322 -0.861 . . . . 0.0 110.194 179.978 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 840' ' ' SER . . . . . 0.586 ' O ' HG23 ' A' ' 841' ' ' THR . 9.6 t -119.09 -99.36 0.44 Allowed 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.272 -0.892 . . . . 0.0 110.678 -179.953 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 841' ' ' THR . . . . . 0.586 HG23 ' O ' ' A' ' 840' ' ' SER . 19.5 p . . . . . 0 N--CA 1.493 1.688 0 O-C-N 121.008 -1.057 . . . . 0.0 110.191 -179.975 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 728' ' ' VAL . . . . . 0.479 ' O ' ' HB2' ' A' ' 729' ' ' SER . 68.2 t . . . . . 0 N--CA 1.493 1.676 0 CA-C-O 120.968 0.413 . . . . 0.0 110.178 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 729' ' ' SER . . . . . 0.479 ' HB2' ' O ' ' A' ' 728' ' ' VAL . 14.8 t -178.98 125.37 0.09 Allowed 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.147 -0.971 . . . . 0.0 110.891 179.947 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 730' ' ' GLY . . . . . . . . . . . . . . . 103.45 116.53 4.21 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 110.194 -1.162 . . . . 0.0 110.194 179.947 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 731' ' ' VAL . . . . . 0.521 ' CG2' ' O ' ' A' ' 837' ' ' ALA . 3.5 m -147.87 161.81 7.04 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.367 -1.078 . . . . 0.0 109.27 179.92 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 732' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -148.51 161.29 41.94 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.001 -1.062 . . . . 0.0 110.955 -179.978 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 733' ' ' ALA . . . . . . . . . . . . . . . -163.51 104.35 0.95 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.536 -0.728 . . . . 0.0 109.416 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 734' ' ' ASP . . . . . 0.589 ' C ' HG23 ' A' ' 735' ' ' VAL . 1.8 t70 -117.25 121.51 41.37 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.235 -0.916 . . . . 0.0 110.79 -179.959 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 735' ' ' VAL . . . . . 0.589 HG23 ' C ' ' A' ' 734' ' ' ASP . 49.0 t -156.09 148.61 11.67 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 O-C-N 121.326 -0.859 . . . . 0.0 109.796 179.926 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 736' ' ' SER . . . . . . . . . . . . . 90.7 p -98.77 -167.61 1.51 Allowed 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.114 -0.991 . . . . 0.0 110.588 -179.909 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 737' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.493 1.724 0 O-C-N 121.272 -0.892 . . . . 0.0 110.027 179.983 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 757' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.489 1.498 0 CA-C-O 121.39 0.614 . . . . 0.0 110.522 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 758' ' ' ALA . . . . . 0.472 ' O ' ' HG2' ' A' ' 759' ' ' LYS . . . -88.97 172.33 9.22 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.257 -0.902 . . . . 0.0 109.866 179.96 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 759' ' ' LYS . . . . . 0.472 ' HG2' ' O ' ' A' ' 758' ' ' ALA . 3.1 mtmt -142.91 162.95 34.12 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.069 -1.02 . . . . 0.0 110.644 -179.962 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 760' ' ' VAL . . . . . 0.948 ' O ' HG23 ' A' ' 813' ' ' VAL . 95.2 t -109.22 157.12 9.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.417 -0.802 . . . . 0.0 109.124 179.874 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 761' ' ' HIS . . . . . . . . . . . . . 35.2 m80 -128.53 113.91 16.08 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.937 -1.102 . . . . 0.0 111.369 -179.89 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 762' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -122.38 106.45 11.08 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 179.892 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 763' ' ' LYS . . . . . . . . . . . . . 5.4 ttmt -131.2 135.45 47.41 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.977 -1.077 . . . . 0.0 111.199 -179.833 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 764' ' ' CYS . . . . . . . . . . . . . 59.5 m -106.58 175.58 5.45 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.566 -0.709 . . . . 0.0 109.801 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 765' ' ' ALA . . . . . 0.622 ' HB1' ' HD2' ' A' ' 766' ' ' PRO . . . -55.21 167.96 0.62 Allowed Pre-proline 0 N--CA 1.494 1.771 0 O-C-N 121.216 -0.927 . . . . 0.0 110.497 179.999 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 766' ' ' PRO . . . . . 0.622 ' HD2' ' HB1' ' A' ' 765' ' ' ALA . 48.1 Cg_endo -73.43 110.17 3.0 Favored 'Trans proline' 0 C--N 1.304 -1.778 0 O-C-N 124.211 1.638 . . . . 0.0 110.309 179.975 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 767' ' ' GLY . . . . . . . . . . . . . . . 117.32 -30.69 6.13 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.711 -1.356 . . . . 0.0 109.711 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 768' ' ' GLN . . . . . 0.47 ' OE1' HG22 ' A' ' 841' ' ' THR . 44.5 mm-40 -85.88 162.01 18.8 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.183 -1.187 . . . . 0.0 110.245 -179.926 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 769' ' ' THR . . . . . 0.448 HG22 ' OE1' ' A' ' 810' ' ' GLU . 64.9 p -146.43 146.99 30.79 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.248 -0.907 . . . . 0.0 110.214 -179.986 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 770' ' ' ILE . . . . . 0.475 HG13 ' SG ' ' A' ' 839' ' ' CYS . 1.8 mp -69.06 147.79 11.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.35 -0.843 . . . . 0.0 109.13 179.942 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 771' ' ' SER . . . . . . . . . . . . . 34.8 m -130.75 -11.85 3.84 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 120.882 -1.136 . . . . 0.0 111.794 -179.891 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 772' ' ' ALA . . . . . . . . . . . . . . . -161.75 153.5 19.01 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 120.743 -1.223 . . . . 0.0 111.492 -179.927 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 773' ' ' ILE . . . . . . . . . . . . . 15.1 mm -113.97 125.17 71.2 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.534 -0.729 . . . . 0.0 109.372 179.901 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 774' ' ' LYS . . . . . 0.552 ' HG3' ' N ' ' A' ' 775' ' ' PHE . 0.5 OUTLIER -89.69 -36.13 15.4 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.089 -1.007 . . . . 0.0 110.815 -179.892 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 775' ' ' PHE . . . . . 0.552 ' N ' ' HG3' ' A' ' 774' ' ' LYS . 65.2 t80 -137.47 149.78 47.09 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.982 -1.074 . . . . 0.0 110.746 -179.924 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 776' ' ' ALA . . . . . 0.487 ' HB3' ' HB3' ' A' ' 799' ' ' ASN . . . -179.03 106.74 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.548 -0.72 . . . . 0.0 109.531 179.954 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 777' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -139.69 136.67 34.49 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.13 -0.981 . . . . 0.0 110.55 -179.877 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 778' ' ' PHE . . . . . 0.753 ' HD2' HG22 ' A' ' 833' ' ' VAL . 86.4 t80 -104.27 76.38 1.32 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.427 -0.796 . . . . 0.0 109.915 179.988 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 779' ' ' GLY . . . . . . . . . . . . . . . -171.34 -109.77 0.23 Allowed Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.755 -1.338 . . . . 0.0 109.755 -179.989 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 780' ' ' THR . . . . . . . . . . . . . 2.9 p -112.54 92.42 19.71 Favored Pre-proline 0 N--CA 1.494 1.732 0 O-C-N 121.259 -1.142 . . . . 0.0 110.662 -179.992 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 781' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -79.04 127.63 7.8 Favored 'Trans proline' 0 C--N 1.305 -1.73 0 O-C-N 124.064 1.56 . . . . 0.0 110.19 -179.999 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 782' ' ' LEU . . . . . 0.434 ' O ' ' HA ' ' A' ' 788' ' ' PHE . 2.6 mt -96.68 108.3 20.9 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.137 -0.977 . . . . 0.0 110.356 179.989 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 783' ' ' GLY . . . . . . . . . . . . . . . 120.99 -154.31 16.45 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.643 -1.383 . . . . 0.0 109.643 -179.995 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 784' ' ' THR . . . . . 0.574 ' O ' ' CZ ' ' A' ' 788' ' ' PHE . 9.9 t -151.09 -40.54 0.12 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.279 -1.13 . . . . 0.0 110.137 -179.959 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 785' ' ' CYS . . . . . 0.555 ' N ' HG23 ' A' ' 784' ' ' THR . 16.2 t -166.95 118.97 0.94 Allowed 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.306 -0.871 . . . . 0.0 109.692 -179.982 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 786' ' ' GLY . . . . . . . . . . . . . . . 85.84 -9.18 69.65 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.335 -1.506 . . . . 0.0 109.335 -179.96 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 787' ' ' THR . . . . . . . . . . . . . 18.7 p -139.56 33.94 2.04 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.23 -1.159 . . . . 0.0 110.174 -179.965 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 788' ' ' PHE . . . . . 0.676 ' CE1' ' HB1' ' A' ' 834' ' ' ALA . 7.2 m-85 -71.18 174.69 6.05 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.228 -0.92 . . . . 0.0 110.337 179.98 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 789' ' ' GLN . . . . . 0.485 ' CG ' ' O ' ' A' ' 788' ' ' PHE . 0.0 OUTLIER 179.44 167.14 1.09 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.185 -0.947 . . . . 0.0 110.327 -179.971 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 790' ' ' GLN . . . . . . . . . . . . . 31.5 mt-30 -99.05 143.84 28.87 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.258 -0.901 . . . . 0.0 110.181 179.952 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 791' ' ' GLY . . . . . . . . . . . . . . . -101.89 -109.41 3.26 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.577 -1.409 . . . . 0.0 109.577 179.993 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 792' ' ' GLU . . . . . . . . . . . . . 8.5 mt-10 -129.65 15.4 5.94 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.322 -1.105 . . . . 0.0 110.068 -179.993 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 793' ' ' CYS . . . . . . . . . . . . . 1.7 m -147.53 122.78 10.24 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.279 -0.888 . . . . 0.0 110.224 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 794' ' ' HIS . . . . . 0.633 ' CE1' ' O ' ' A' ' 795' ' ' SER . 32.9 t-80 -147.91 144.3 27.97 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.188 -0.945 . . . . 0.0 110.798 -179.97 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 795' ' ' SER . . . . . 0.633 ' O ' ' CE1' ' A' ' 794' ' ' HIS . 27.2 t -88.42 167.86 13.12 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 179.853 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 796' ' ' ILE . . . . . . . . . . . . . 3.1 mt -90.19 -22.76 6.27 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.837 0 O-C-N 120.47 -1.394 . . . . 0.0 110.286 -179.859 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 797' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -102.43 51.54 0.81 Allowed 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.167 -0.958 . . . . 0.0 109.407 179.943 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 798' ' ' SER . . . . . 0.514 ' OG ' ' CE1' ' A' ' 794' ' ' HIS . 0.3 OUTLIER -83.64 -45.08 13.86 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.407 -0.808 . . . . 0.0 111.339 -179.858 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 799' ' ' ASN . . . . . 0.495 ' HA ' HD23 ' A' ' 802' ' ' LEU . 2.0 p-10 -105.63 -14.2 15.34 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 120.889 -1.132 . . . . 0.0 111.012 -179.838 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 800' ' ' SER . . . . . . . . . . . . . 22.4 t -65.69 -19.1 65.77 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.069 -1.019 . . . . 0.0 110.37 -179.989 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 801' ' ' VAL . . . . . . . . . . . . . 96.2 t -83.86 -23.21 8.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.122 -0.986 . . . . 0.0 110.104 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 802' ' ' LEU . . . . . 0.737 HD22 ' N ' ' A' ' 802' ' ' LEU . 3.4 mm? -80.48 -62.32 1.71 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.346 -0.846 . . . . 0.0 110.337 179.969 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 803' ' ' GLU . . . . . 0.805 ' HA ' HD12 ' A' ' 807' ' ' ILE . 1.2 tm-20 -52.03 -17.88 1.2 Allowed 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.128 -0.983 . . . . 0.0 110.887 -179.983 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 804' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.29 -31.21 17.04 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 120.97 -1.082 . . . . 0.0 111.471 -179.92 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 805' ' ' LYS . . . . . . . . . . . . . 7.3 mttm -137.1 51.8 1.95 Allowed 'General case' 0 N--CA 1.498 1.961 0 O-C-N 120.756 -1.215 . . . . 0.0 111.313 -179.935 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 806' ' ' CYS . . . . . 0.52 ' HA ' ' CB ' ' A' ' 812' ' ' CYS . 1.1 m -162.75 -54.93 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.101 -0.999 . . . . 0.0 110.204 179.902 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 807' ' ' ILE . . . . . 0.805 HD12 ' HA ' ' A' ' 803' ' ' GLU . 61.6 mt -65.26 103.21 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.239 -0.913 . . . . 0.0 110.077 179.973 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 808' ' ' GLY . . . . . 0.446 ' C ' ' HG ' ' A' ' 809' ' ' LEU . . . 127.0 11.37 3.52 Favored Glycine 0 N--CA 1.492 2.377 0 N-CA-C 110.009 -1.236 . . . . 0.0 110.009 179.972 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 809' ' ' LEU . . . . . 0.446 ' HG ' ' C ' ' A' ' 808' ' ' GLY . 1.5 mt -133.23 150.13 51.96 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.111 -1.229 . . . . 0.0 110.245 179.972 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 810' ' ' GLU . . . . . 0.448 ' OE1' HG22 ' A' ' 769' ' ' THR . 0.2 OUTLIER -65.74 -26.74 67.87 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.192 -0.943 . . . . 0.0 109.255 179.914 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 811' ' ' ARG . . . . . 0.454 ' O ' ' HG3' ' A' ' 811' ' ' ARG . 4.1 ppt_? -161.23 120.58 2.56 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.629 -0.67 . . . . 0.0 109.198 179.89 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 812' ' ' CYS . . . . . 0.52 ' CB ' ' HA ' ' A' ' 806' ' ' CYS . 24.0 p -121.55 156.87 31.95 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 120.996 -1.065 . . . . 0.0 111.428 -179.856 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 813' ' ' VAL . . . . . 0.948 HG23 ' O ' ' A' ' 760' ' ' VAL . 9.9 p -139.4 126.46 24.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 179.966 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 814' ' ' VAL . . . . . . . . . . . . . 44.3 t -110.18 130.13 63.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.077 -1.015 . . . . 0.0 110.779 -179.936 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 815' ' ' ALA . . . . . . . . . . . . . . . -78.37 125.02 28.76 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.347 -0.846 . . . . 0.0 109.806 179.959 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 816' ' ' ILE . . . . . 0.401 ' CG2' HG21 ' A' ' 833' ' ' VAL . 96.4 mt -79.17 111.74 16.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.274 -0.891 . . . . 0.0 110.359 -179.949 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 817' ' ' SER . . . . . 0.44 ' OG ' ' HB2' ' A' ' 820' ' ' ASN . 0.0 OUTLIER -152.03 166.71 14.66 Favored Pre-proline 0 N--CA 1.493 1.692 0 O-C-N 121.348 -0.845 . . . . 0.0 110.016 179.961 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 818' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -76.35 -57.28 0.05 OUTLIER 'Trans proline' 0 C--N 1.307 -1.651 0 O-C-N 123.931 1.49 . . . . 0.0 110.665 -179.94 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 819' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -66.06 -9.85 34.69 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.184 -0.947 . . . . 0.0 110.524 -179.981 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 820' ' ' ASN . . . . . 0.44 ' HB2' ' OG ' ' A' ' 817' ' ' SER . 17.2 t30 -92.92 -16.4 25.22 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.117 -0.989 . . . . 0.0 110.317 -179.997 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 821' ' ' PHE . . . . . . . . . . . . . 1.9 m-85 -109.53 -79.04 0.58 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.241 -0.912 . . . . 0.0 110.211 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 822' ' ' GLY . . . . . . . . . . . . . . . 176.41 42.19 0.06 OUTLIER Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.493 -1.443 . . . . 0.0 109.493 179.956 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 823' ' ' GLY . . . . . . . . . . . . . . . 79.05 -162.6 48.54 Favored Glycine 0 N--CA 1.492 2.431 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 -179.979 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 824' ' ' ASP . . . . . . . . . . . . . 4.2 p30 -121.86 152.84 59.94 Favored Pre-proline 0 N--CA 1.493 1.723 0 O-C-N 121.254 -1.145 . . . . 0.0 110.149 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 825' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -78.76 -84.68 0.0 OUTLIER 'Trans proline' 0 C--N 1.304 -1.787 0 O-C-N 124.0 1.526 . . . . 0.0 110.751 -179.896 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 826' ' ' CYS . . . . . 0.524 ' SG ' HG21 ' A' ' 829' ' ' VAL . 28.5 p -105.85 142.75 25.46 Favored Pre-proline 0 N--CA 1.492 1.674 0 O-C-N 121.125 -0.985 . . . . 0.0 110.656 -179.913 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 827' ' ' PRO . . . . . 0.666 ' O ' HG23 ' A' ' 829' ' ' VAL . 50.3 Cg_endo -85.15 -179.14 3.43 Favored 'Trans proline' 0 C--N 1.303 -1.817 0 O-C-N 124.209 1.636 . . . . 0.0 109.983 179.895 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 828' ' ' GLU . . . . . 0.468 ' HB2' ' O ' ' A' ' 827' ' ' PRO . 7.5 mt-10 58.55 14.94 3.29 Favored 'General case' 0 C--N 1.297 -1.697 0 O-C-N 121.331 -0.856 . . . . 0.0 109.894 -179.978 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 829' ' ' VAL . . . . . 0.666 HG23 ' O ' ' A' ' 827' ' ' PRO . 60.8 t -128.85 122.5 57.01 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.405 0 O-C-N 121.333 -0.855 . . . . 0.0 110.205 -179.965 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 830' ' ' MET . . . . . 0.466 ' O ' ' O ' ' A' ' 829' ' ' VAL . 0.0 OUTLIER -48.79 176.9 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.022 -1.049 . . . . 0.0 109.531 -179.986 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 831' ' ' LYS . . . . . . . . . . . . . 6.2 mptt -138.82 110.1 6.92 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.977 -1.077 . . . . 0.0 110.873 -179.898 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 832' ' ' ARG . . . . . . . . . . . . . 73.9 mtp85 -115.84 157.59 24.21 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.382 -0.824 . . . . 0.0 109.43 179.904 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 833' ' ' VAL . . . . . 0.753 HG22 ' HD2' ' A' ' 778' ' ' PHE . 65.0 t -122.82 104.4 14.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.042 -1.036 . . . . 0.0 110.855 -179.997 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 834' ' ' ALA . . . . . 0.676 ' HB1' ' CE1' ' A' ' 788' ' ' PHE . . . -109.16 124.25 50.53 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.34 -0.85 . . . . 0.0 109.171 179.944 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 835' ' ' VAL . . . . . . . . . . . . . 11.8 t -138.9 142.81 33.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.059 -1.026 . . . . 0.0 111.346 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 836' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 -126.62 135.61 51.44 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 179.93 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 837' ' ' ALA . . . . . 0.521 ' O ' ' CG2' ' A' ' 731' ' ' VAL . . . -118.72 164.49 15.29 Favored 'General case' 0 C--N 1.298 -1.632 0 O-C-N 120.966 -1.084 . . . . 0.0 111.087 -179.85 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 838' ' ' VAL . . . . . . . . . . . . . 24.9 t -116.96 105.32 18.02 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 179.96 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 839' ' ' CYS . . . . . 0.475 ' SG ' HG13 ' A' ' 770' ' ' ILE . 0.1 OUTLIER -106.51 152.83 23.15 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.204 -0.935 . . . . 0.0 110.865 -179.82 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 840' ' ' SER . . . . . 0.489 ' O ' HG23 ' A' ' 841' ' ' THR . 2.7 p -164.08 -91.89 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.402 -0.811 . . . . 0.0 109.813 179.861 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 841' ' ' THR . . . . . 0.489 HG23 ' O ' ' A' ' 840' ' ' SER . 8.8 p . . . . . 0 N--CA 1.49 1.533 0 O-C-N 121.38 -0.825 . . . . 0.0 109.736 -179.996 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 728' ' ' VAL . . . . . . . . . . . . . 34.2 m . . . . . 0 N--CA 1.493 1.706 0 CA-C-O 121.312 0.577 . . . . 0.0 110.415 . . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 729' ' ' SER . . . . . 0.766 ' O ' HG23 ' A' ' 731' ' ' VAL . 12.1 t -127.39 74.41 1.51 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.275 -0.891 . . . . 0.0 110.217 179.965 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 730' ' ' GLY . . . . . . . . . . . . . . . -62.38 114.69 7.07 Favored Glycine 0 N--CA 1.493 2.436 0 N-CA-C 109.222 -1.551 . . . . 0.0 109.222 179.989 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 731' ' ' VAL . . . . . 0.766 HG23 ' O ' ' A' ' 729' ' ' SER . 21.8 t -129.39 137.22 57.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.189 -1.183 . . . . 0.0 110.592 -179.986 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 732' ' ' CYS . . . . . . . . . . . . . 4.9 p -129.32 146.06 51.27 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.434 -0.791 . . . . 0.0 109.366 179.967 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 733' ' ' ALA . . . . . 0.505 ' CB ' HG13 ' A' ' 760' ' ' VAL . . . -110.45 104.22 12.95 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 120.952 -1.093 . . . . 0.0 111.351 -179.978 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 734' ' ' ASP . . . . . 0.45 ' OD1' ' O ' ' A' ' 734' ' ' ASP . 0.6 OUTLIER -110.07 100.9 9.76 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.339 -0.851 . . . . 0.0 108.865 179.895 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 735' ' ' VAL . . . . . . . . . . . . . 14.4 m -140.08 152.82 22.14 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 121.229 -0.92 . . . . 0.0 110.941 -179.885 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 736' ' ' SER . . . . . 0.542 ' O ' ' CB ' ' A' ' 758' ' ' ALA . 3.3 m -82.33 177.05 8.97 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 179.839 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 737' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 . . . . . 0 N--CA 1.493 1.709 0 O-C-N 120.738 -1.226 . . . . 0.0 110.213 -179.993 . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 757' ' ' THR . . . . . 0.455 ' HB ' ' O ' ' A' ' 816' ' ' ILE . 32.1 p . . . . . 0 N--CA 1.489 1.515 0 CA-C-O 121.151 0.501 . . . . 0.0 110.205 . . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 758' ' ' ALA . . . . . 0.542 ' CB ' ' O ' ' A' ' 736' ' ' SER . . . -102.83 -179.18 3.89 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.181 -0.949 . . . . 0.0 110.153 179.99 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 759' ' ' LYS . . . . . . . . . . . . . 9.6 mtpp -133.81 161.99 33.21 Favored 'General case' 0 C--N 1.297 -1.686 0 O-C-N 121.452 -0.78 . . . . 0.0 110.233 179.997 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 760' ' ' VAL . . . . . 0.983 HG23 HD11 ' A' ' 816' ' ' ILE . 39.8 t -125.55 114.85 41.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.344 -0.847 . . . . 0.0 109.191 179.927 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 761' ' ' HIS . . . . . . . . . . . . . 1.5 t-160 -110.64 114.44 27.84 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 120.914 -1.117 . . . . 0.0 111.185 -179.964 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 762' ' ' LEU . . . . . . . . . . . . . 17.8 mt -111.2 103.66 12.1 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.508 -0.745 . . . . 0.0 109.327 179.825 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 763' ' ' LYS . . . . . . . . . . . . . 5.3 pttp -117.81 136.87 53.12 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.098 -1.001 . . . . 0.0 110.925 -179.889 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 764' ' ' CYS . . . . . . . . . . . . . 86.2 m -105.32 173.46 6.3 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.372 -0.83 . . . . 0.0 109.673 179.927 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 765' ' ' ALA . . . . . 0.417 ' HB3' ' OE1' ' A' ' 768' ' ' GLN . . . -67.88 160.91 71.25 Favored Pre-proline 0 N--CA 1.494 1.745 0 O-C-N 121.18 -0.95 . . . . 0.0 110.44 179.969 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 766' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -72.02 96.1 0.77 Allowed 'Trans proline' 0 C--N 1.308 -1.584 0 O-C-N 124.006 1.53 . . . . 0.0 110.117 179.959 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 767' ' ' GLY . . . . . . . . . . . . . . . 140.21 -31.95 2.22 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 108.762 -1.735 . . . . 0.0 108.762 -179.999 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 768' ' ' GLN . . . . . 0.477 ' HG3' ' HB ' ' A' ' 841' ' ' THR . 12.8 mp0 -93.64 152.34 19.06 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.559 -0.965 . . . . 0.0 109.421 179.956 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 769' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -129.91 151.62 50.28 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.046 -1.034 . . . . 0.0 110.741 -179.976 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 770' ' ' ILE . . . . . 0.451 HD12 ' O ' ' A' ' 809' ' ' LEU . 30.9 mt -76.48 152.78 5.87 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.433 -0.792 . . . . 0.0 109.537 179.85 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 771' ' ' SER . . . . . 0.441 ' HA ' HG23 ' A' ' 807' ' ' ILE . 3.3 m -146.57 -15.88 0.43 Allowed 'General case' 0 N--CA 1.494 1.749 0 O-C-N 120.845 -1.159 . . . . 0.0 112.597 -179.903 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 772' ' ' ALA . . . . . . . . . . . . . . . -158.34 150.05 21.35 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 120.235 -1.54 . . . . 0.0 112.438 -179.912 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 773' ' ' ILE . . . . . . . . . . . . . 14.5 mm -116.21 118.39 58.62 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 179.863 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 774' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -84.13 -38.31 20.87 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 120.957 -1.09 . . . . 0.0 111.895 -179.826 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 775' ' ' PHE . . . . . 0.622 ' O ' ' HB2' ' A' ' 776' ' ' ALA . 58.4 t80 -129.52 166.64 19.25 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 120.712 -1.243 . . . . 0.0 111.468 -179.942 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 776' ' ' ALA . . . . . 0.926 ' HB3' ' HB2' ' A' ' 799' ' ' ASN . . . 171.76 101.48 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.736 -0.603 . . . . 0.0 109.382 179.962 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 777' ' ' SER . . . . . . . . . . . . . 29.1 t -134.55 125.63 27.67 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.37 -0.831 . . . . 0.0 110.204 -179.882 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 778' ' ' PHE . . . . . 0.543 ' CZ ' ' O ' ' A' ' 817' ' ' SER . 2.2 t80 -111.12 81.35 1.42 Allowed 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.421 -0.799 . . . . 0.0 109.887 179.934 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 779' ' ' GLY . . . . . . . . . . . . . . . -179.49 -89.97 0.08 OUTLIER Glycine 0 N--CA 1.493 2.449 0 N-CA-C 109.526 -1.429 . . . . 0.0 109.526 -179.946 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 780' ' ' THR . . . . . 0.492 ' O ' ' HA3' ' A' ' 791' ' ' GLY . 38.8 p -123.17 83.0 51.52 Favored Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.048 -1.266 . . . . 0.0 110.675 179.992 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 781' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -74.45 123.54 8.23 Favored 'Trans proline' 0 C--N 1.304 -1.809 0 O-C-N 124.077 1.567 . . . . 0.0 109.952 179.989 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 782' ' ' LEU . . . . . 0.754 HD12 ' HA2' ' A' ' 791' ' ' GLY . 10.8 mt -111.1 83.83 1.83 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.237 -0.914 . . . . 0.0 110.412 -179.959 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 783' ' ' GLY . . . . . . . . . . . . . . . 148.45 -173.63 28.38 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.549 -1.42 . . . . 0.0 109.549 -179.944 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 784' ' ' THR . . . . . 0.546 ' O ' ' CD2' ' A' ' 788' ' ' PHE . 80.3 p -132.41 -148.41 0.34 Allowed 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.275 -1.132 . . . . 0.0 110.375 -179.97 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 785' ' ' CYS . . . . . . . . . . . . . 4.2 t -70.87 106.88 3.77 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.227 -0.92 . . . . 0.0 109.889 179.984 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 786' ' ' GLY . . . . . . . . . . . . . . . 114.31 -26.25 9.87 Favored Glycine 0 N--CA 1.488 2.135 0 N-CA-C 109.246 -1.542 . . . . 0.0 109.246 -179.965 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 787' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -124.46 25.95 7.46 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.326 -1.103 . . . . 0.0 110.581 -179.958 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 788' ' ' PHE . . . . . 0.808 ' CE1' ' HB1' ' A' ' 834' ' ' ALA . 2.4 m-85 -71.46 112.43 7.58 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.225 -0.922 . . . . 0.0 109.616 -179.95 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 789' ' ' GLN . . . . . . . . . . . . . 14.4 tp60 -125.71 137.19 53.82 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.143 -0.973 . . . . 0.0 110.593 -179.962 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 790' ' ' GLN . . . . . 0.426 ' O ' ' HG3' ' A' ' 790' ' ' GLN . 19.3 pt20 -41.32 139.4 1.03 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.477 -0.764 . . . . 0.0 110.316 179.928 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 791' ' ' GLY . . . . . 0.754 ' HA2' HD12 ' A' ' 782' ' ' LEU . . . -89.59 -153.92 28.64 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.356 -1.498 . . . . 0.0 109.356 -179.999 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 792' ' ' GLU . . . . . . . . . . . . . 26.6 pt-20 -87.55 -35.18 18.29 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.22 -1.165 . . . . 0.0 109.744 179.951 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 793' ' ' CYS . . . . . 0.449 ' SG ' ' HB2' ' A' ' 825' ' ' PRO . 0.5 OUTLIER -109.87 100.72 9.65 Favored 'General case' 0 C--N 1.307 -1.255 0 O-C-N 121.271 -0.893 . . . . 0.0 110.604 179.997 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 794' ' ' HIS . . . . . 0.416 ' CD2' ' N ' ' A' ' 795' ' ' SER . 16.2 t-160 -108.69 143.08 38.26 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.091 -1.006 . . . . 0.0 109.826 -179.998 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 795' ' ' SER . . . . . 0.416 ' N ' ' CD2' ' A' ' 794' ' ' HIS . 0.4 OUTLIER -80.19 5.88 13.3 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.321 -0.862 . . . . 0.0 110.021 -179.964 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 796' ' ' ILE . . . . . 0.634 HG22 ' O ' ' A' ' 796' ' ' ILE . 31.4 mt 46.37 24.23 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.162 -0.961 . . . . 0.0 109.86 -179.988 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 797' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -159.6 22.53 0.18 Allowed 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.485 -0.759 . . . . 0.0 109.542 -179.976 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 798' ' ' SER . . . . . 0.72 ' O ' ' HB1' ' A' ' 776' ' ' ALA . 1.1 m -88.31 0.09 56.55 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.414 -0.804 . . . . 0.0 110.19 -179.982 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 799' ' ' ASN . . . . . 0.926 ' HB2' ' HB3' ' A' ' 776' ' ' ALA . 60.6 t-20 -124.66 1.34 8.2 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.254 -0.903 . . . . 0.0 109.954 179.973 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 800' ' ' SER . . . . . . . . . . . . . 1.5 t -91.64 -40.17 11.46 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.371 -0.831 . . . . 0.0 110.452 -179.869 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 801' ' ' VAL . . . . . 0.468 ' HB ' ' CE1' ' A' ' 821' ' ' PHE . 93.2 t -67.55 -19.54 25.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.3 -0.875 . . . . 0.0 110.799 -179.945 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 802' ' ' LEU . . . . . . . . . . . . . 78.7 mt -87.72 -49.74 6.93 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.011 -1.056 . . . . 0.0 110.979 -179.882 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 803' ' ' GLU . . . . . 0.418 ' HG2' HD11 ' A' ' 807' ' ' ILE . 18.6 mt-10 -54.23 -27.21 33.09 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.157 -0.964 . . . . 0.0 111.045 -179.909 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 804' ' ' ARG . . . . . . . . . . . . . 1.6 mpt_? -91.62 -18.32 24.21 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.017 -1.052 . . . . 0.0 111.264 -179.905 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 805' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.66 12.89 19.83 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 120.91 -1.119 . . . . 0.0 111.331 -179.926 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 806' ' ' CYS . . . . . 0.414 ' O ' ' C ' ' A' ' 807' ' ' ILE . 21.0 m -141.38 -67.99 0.4 Allowed 'General case' 0 N--CA 1.496 1.855 0 O-C-N 120.851 -1.156 . . . . 0.0 110.58 -179.971 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 807' ' ' ILE . . . . . 0.441 HG23 ' HA ' ' A' ' 771' ' ' SER . 42.9 mt -41.24 103.68 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 O-C-N 121.258 -0.901 . . . . 0.0 110.477 -179.986 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 808' ' ' GLY . . . . . 0.71 ' O ' HD23 ' A' ' 809' ' ' LEU . . . 127.06 4.84 5.88 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.613 -1.395 . . . . 0.0 109.613 -179.984 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 809' ' ' LEU . . . . . 0.71 HD23 ' O ' ' A' ' 808' ' ' GLY . 81.4 mt -139.77 149.2 43.28 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.252 -1.146 . . . . 0.0 109.982 179.997 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 810' ' ' GLU . . . . . . . . . . . . . 2.1 pt-20 -78.93 1.47 23.57 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.173 -0.954 . . . . 0.0 109.593 179.981 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 811' ' ' ARG . . . . . . . . . . . . . 21.8 ttp180 -170.13 135.7 1.36 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.41 -0.806 . . . . 0.0 110.014 179.986 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 812' ' ' CYS . . . . . . . . . . . . . 21.9 p -155.12 150.22 26.92 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.401 -0.812 . . . . 0.0 110.292 -179.979 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 813' ' ' VAL . . . . . 0.521 ' C ' HG23 ' A' ' 814' ' ' VAL . 11.9 p -131.78 153.99 39.58 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 O-C-N 121.29 -0.881 . . . . 0.0 110.335 -179.991 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 814' ' ' VAL . . . . . 0.521 HG23 ' C ' ' A' ' 813' ' ' VAL . 11.1 t -151.59 106.58 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 O-C-N 121.314 -0.866 . . . . 0.0 110.241 179.982 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 815' ' ' ALA . . . . . . . . . . . . . . . -54.02 170.92 0.11 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.234 -0.917 . . . . 0.0 110.384 179.942 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 816' ' ' ILE . . . . . 0.983 HD11 HG23 ' A' ' 760' ' ' VAL . 80.5 mt -121.73 141.73 40.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.351 -0.843 . . . . 0.0 109.887 -179.995 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 817' ' ' SER . . . . . 0.547 ' CB ' ' HD2' ' A' ' 818' ' ' PRO . 0.3 OUTLIER -173.91 -178.06 0.37 Allowed Pre-proline 0 N--CA 1.494 1.762 0 O-C-N 121.12 -0.988 . . . . 0.0 110.64 -179.899 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 818' ' ' PRO . . . . . 0.547 ' HD2' ' CB ' ' A' ' 817' ' ' SER . 42.8 Cg_endo -72.9 -76.12 0.01 OUTLIER 'Trans proline' 0 C--N 1.313 -1.329 0 O-C-N 124.043 1.549 . . . . 0.0 111.302 -179.93 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 819' ' ' SER . . . . . . . . . . . . . 40.8 t -84.33 51.93 2.22 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.055 -1.028 . . . . 0.0 110.351 -179.972 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 820' ' ' ASN . . . . . 0.465 ' HB2' ' OG ' ' A' ' 817' ' ' SER . 2.1 t30 -101.92 -49.25 4.01 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.256 -0.903 . . . . 0.0 109.777 179.961 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 821' ' ' PHE . . . . . 0.468 ' CE1' ' HB ' ' A' ' 801' ' ' VAL . 27.4 m-85 -77.26 -23.83 51.17 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.204 -0.935 . . . . 0.0 109.764 179.981 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 822' ' ' GLY . . . . . . . . . . . . . . . 93.95 55.69 1.48 Allowed Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 -179.972 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 823' ' ' GLY . . . . . . . . . . . . . . . 168.31 144.82 4.32 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.654 -1.378 . . . . 0.0 109.654 -179.987 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 824' ' ' ASP . . . . . 0.433 ' OD1' ' O ' ' A' ' 824' ' ' ASP . 11.1 p-10 -144.07 122.3 6.91 Favored Pre-proline 0 N--CA 1.493 1.712 0 O-C-N 121.325 -1.103 . . . . 0.0 110.041 179.999 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 825' ' ' PRO . . . . . 0.449 ' HB2' ' SG ' ' A' ' 793' ' ' CYS . 43.9 Cg_endo -75.59 -78.28 0.01 OUTLIER 'Trans proline' 0 C--N 1.307 -1.632 0 O-C-N 123.88 1.463 . . . . 0.0 110.583 -179.952 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 826' ' ' CYS . . . . . 0.435 ' HA ' ' HD3' ' A' ' 827' ' ' PRO . 5.8 p -125.18 128.46 24.77 Favored Pre-proline 0 N--CA 1.494 1.772 0 O-C-N 121.111 -0.993 . . . . 0.0 110.101 -179.971 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 827' ' ' PRO . . . . . 0.506 ' O ' HG23 ' A' ' 829' ' ' VAL . 48.7 Cg_endo -85.7 177.0 5.11 Favored 'Trans proline' 0 C--N 1.305 -1.726 0 O-C-N 123.883 1.465 . . . . 0.0 110.513 -179.995 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 828' ' ' GLU . . . . . 0.454 ' HB2' ' O ' ' A' ' 827' ' ' PRO . 34.9 mt-10 56.72 23.59 8.06 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.457 -0.777 . . . . 0.0 110.338 -179.958 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 829' ' ' VAL . . . . . 0.506 HG23 ' O ' ' A' ' 827' ' ' PRO . 53.3 t -125.44 135.46 63.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.437 -0.79 . . . . 0.0 109.734 179.929 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 830' ' ' MET . . . . . 0.435 ' C ' ' O ' ' A' ' 829' ' ' VAL . 33.5 ttm -41.26 146.14 0.21 Allowed 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.269 -0.895 . . . . 0.0 109.83 -179.997 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 831' ' ' LYS . . . . . . . . . . . . . 27.6 mttp -134.46 106.47 7.06 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.042 -1.036 . . . . 0.0 111.165 -179.941 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 832' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -108.36 166.13 10.99 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.463 -0.773 . . . . 0.0 109.005 179.805 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 833' ' ' VAL . . . . . 0.9 HG21 HD13 ' A' ' 816' ' ' ILE . 69.4 t -116.19 145.44 21.93 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.602 0 O-C-N 120.879 -1.138 . . . . 0.0 110.967 -179.94 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 834' ' ' ALA . . . . . 0.808 ' HB1' ' CE1' ' A' ' 788' ' ' PHE . . . -155.5 128.15 7.93 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.635 -0.666 . . . . 0.0 109.449 179.954 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 835' ' ' VAL . . . . . 0.445 ' CG1' ' N ' ' A' ' 836' ' ' GLU . 21.7 t -148.14 163.94 5.77 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.026 0 O-C-N 120.973 -1.079 . . . . 0.0 111.439 -179.887 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 836' ' ' GLU . . . . . 0.445 ' N ' ' CG1' ' A' ' 835' ' ' VAL . 6.1 tt0 -145.89 141.38 27.77 Favored 'General case' 0 N--CA 1.496 1.864 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 179.96 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 837' ' ' ALA . . . . . . . . . . . . . . . -134.56 156.71 48.19 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 120.929 -1.107 . . . . 0.0 111.061 -179.966 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 838' ' ' VAL . . . . . . . . . . . . . 69.7 t -114.3 102.96 14.61 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.725 0 O-C-N 121.428 -0.795 . . . . 0.0 109.734 179.97 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 839' ' ' CYS . . . . . 0.438 ' SG ' HG12 ' A' ' 770' ' ' ILE . 0.1 OUTLIER -108.88 139.73 43.32 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.071 -1.018 . . . . 0.0 110.822 -179.97 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 840' ' ' SER . . . . . . . . . . . . . 17.8 m -150.22 -168.52 3.13 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.365 -0.835 . . . . 0.0 110.02 179.944 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 841' ' ' THR . . . . . 0.477 ' HB ' ' HG3' ' A' ' 768' ' ' GLN . 8.9 t . . . . . 0 N--CA 1.494 1.775 0 O-C-N 121.221 -0.925 . . . . 0.0 110.288 -179.986 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 728' ' ' VAL . . . . . 0.462 ' O ' ' HB3' ' A' ' 729' ' ' SER . 11.0 p . . . . . 0 N--CA 1.493 1.704 0 CA-C-O 121.343 0.592 . . . . 0.0 110.65 . . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 729' ' ' SER . . . . . 0.462 ' HB3' ' O ' ' A' ' 728' ' ' VAL . 10.6 t 57.92 142.67 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.47 -0.769 . . . . 0.0 111.193 179.959 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 730' ' ' GLY . . . . . . . . . . . . . . . -132.4 159.73 23.48 Favored Glycine 0 N--CA 1.492 2.424 0 N-CA-C 109.012 -1.635 . . . . 0.0 109.012 179.915 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 731' ' ' VAL . . . . . 0.421 ' CG2' ' HB3' ' A' ' 837' ' ' ALA . 35.7 m -133.37 150.78 32.64 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 O-C-N 121.125 -1.221 . . . . 0.0 110.79 -179.992 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 732' ' ' CYS . . . . . . . . . . . . . 2.4 m -128.82 135.02 48.57 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.489 -0.757 . . . . 0.0 109.647 -179.968 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 733' ' ' ALA . . . . . 0.495 ' CB ' HD21 ' A' ' 762' ' ' LEU . . . -131.87 105.3 7.37 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.922 -1.111 . . . . 0.0 110.946 -179.913 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 734' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -113.66 107.76 16.21 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.339 -0.851 . . . . 0.0 109.088 179.911 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 735' ' ' VAL . . . . . . . . . . . . . 47.9 t -139.73 120.58 14.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.047 -1.033 . . . . 0.0 111.274 -179.926 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 736' ' ' SER . . . . . 0.417 ' O ' ' C ' ' A' ' 737' ' ' GLU . 54.4 p -100.72 -176.38 3.17 Favored 'General case' 0 C--N 1.297 -1.68 0 O-C-N 121.454 -0.779 . . . . 0.0 108.898 179.848 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 737' ' ' GLU . . . . . 0.417 ' C ' ' O ' ' A' ' 736' ' ' SER . 0.7 OUTLIER . . . . . 0 N--CA 1.493 1.716 0 O-C-N 121.113 -0.992 . . . . 0.0 109.604 179.962 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 757' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.498 1.928 0 CA-C-O 121.318 0.58 . . . . 0.0 110.24 . . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 758' ' ' ALA . . . . . . . . . . . . . . . -90.8 165.0 13.88 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.169 -0.957 . . . . 0.0 110.516 -179.906 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 759' ' ' LYS . . . . . 0.444 ' HG2' ' HA ' ' A' ' 815' ' ' ALA . 3.2 mttp -130.39 165.01 23.47 Favored 'General case' 0 C--N 1.302 -1.5 0 O-C-N 121.424 -0.797 . . . . 0.0 109.839 -179.95 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 760' ' ' VAL . . . . . 0.686 HG23 HD11 ' A' ' 816' ' ' ILE . 41.6 t -106.37 153.74 7.62 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.518 0 O-C-N 121.25 -0.906 . . . . 0.0 109.459 179.953 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 761' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -147.87 116.83 6.79 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.051 -1.031 . . . . 0.0 111.219 -179.953 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 762' ' ' LEU . . . . . 0.495 HD21 ' CB ' ' A' ' 733' ' ' ALA . 32.0 mt -110.5 164.48 12.66 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.423 -0.798 . . . . 0.0 108.849 179.888 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 763' ' ' LYS . . . . . . . . . . . . . 14.9 mttt -154.04 128.98 9.5 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.78 -1.2 . . . . 0.0 110.944 -179.928 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 764' ' ' CYS . . . . . 0.433 ' O ' ' C ' ' A' ' 765' ' ' ALA . 10.4 t -103.83 143.78 32.37 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.489 -0.757 . . . . 0.0 109.601 179.996 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 765' ' ' ALA . . . . . 0.433 ' C ' ' O ' ' A' ' 764' ' ' CYS . . . -42.08 150.39 0.38 Allowed Pre-proline 0 N--CA 1.492 1.664 0 O-C-N 121.196 -0.94 . . . . 0.0 110.25 -179.945 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 766' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -70.11 95.95 0.6 Allowed 'Trans proline' 0 C--N 1.306 -1.683 0 O-C-N 124.016 1.535 . . . . 0.0 110.035 -179.923 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 767' ' ' GLY . . . . . . . . . . . . . . . 139.47 -17.76 3.08 Favored Glycine 0 N--CA 1.486 1.972 0 N-CA-C 109.029 -1.628 . . . . 0.0 109.029 -179.936 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 768' ' ' GLN . . . . . . . . . . . . . 20.7 mt-30 -108.61 174.74 5.74 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.362 -1.081 . . . . 0.0 110.133 179.981 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 769' ' ' THR . . . . . . . . . . . . . 8.9 p -144.85 147.97 33.44 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.207 -0.933 . . . . 0.0 110.454 -179.913 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 770' ' ' ILE . . . . . . . . . . . . . 72.1 mt -68.18 145.88 13.28 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.264 -0.898 . . . . 0.0 109.563 179.944 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 771' ' ' SER . . . . . . . . . . . . . 13.5 p -143.47 -3.0 0.94 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.955 -1.09 . . . . 0.0 111.951 -179.956 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 772' ' ' ALA . . . . . . . . . . . . . . . -165.98 143.25 5.41 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 120.559 -1.338 . . . . 0.0 111.648 -179.955 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 773' ' ' ILE . . . . . . . . . . . . . 34.9 mm -105.36 120.41 56.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 179.755 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 774' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.59 -43.55 22.72 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.045 -1.035 . . . . 0.0 111.077 -179.812 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 775' ' ' PHE . . . . . 0.588 ' CZ ' ' HB3' ' A' ' 788' ' ' PHE . 79.3 t80 -149.81 166.42 29.54 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 120.893 -1.129 . . . . 0.0 111.367 -179.925 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 776' ' ' ALA . . . . . 0.551 ' HB2' ' O ' ' A' ' 775' ' ' PHE . . . 174.21 126.2 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 -179.967 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 777' ' ' SER . . . . . . . . . . . . . 2.1 t -148.31 135.02 19.9 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.968 -1.083 . . . . 0.0 111.342 -179.956 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 778' ' ' PHE . . . . . . . . . . . . . 90.1 t80 -103.4 109.46 21.1 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.616 -0.677 . . . . 0.0 109.667 179.95 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 779' ' ' GLY . . . . . . . . . . . . . . . 148.52 -98.87 0.19 Allowed Glycine 0 N--CA 1.492 2.37 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 -179.907 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 780' ' ' THR . . . . . 0.477 ' O ' ' HA3' ' A' ' 791' ' ' GLY . 1.5 p -144.03 91.46 6.53 Favored Pre-proline 0 N--CA 1.494 1.743 0 O-C-N 121.153 -1.204 . . . . 0.0 110.608 179.928 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 781' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -82.57 154.36 15.78 Favored 'Trans proline' 0 C--N 1.304 -1.794 0 O-C-N 123.89 1.468 . . . . 0.0 110.269 179.931 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 782' ' ' LEU . . . . . 0.618 HD13 ' HA2' ' A' ' 791' ' ' GLY . 0.1 OUTLIER -127.76 125.33 39.7 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.082 -1.011 . . . . 0.0 110.508 -179.906 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 783' ' ' GLY . . . . . . . . . . . . . . . 128.24 -168.62 20.07 Favored Glycine 0 N--CA 1.488 2.166 0 N-CA-C 109.779 -1.328 . . . . 0.0 109.779 179.973 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 784' ' ' THR . . . . . 0.474 ' O ' ' HB2' ' A' ' 785' ' ' CYS . 24.1 p -142.93 72.19 1.36 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.323 -1.104 . . . . 0.0 109.834 179.969 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 785' ' ' CYS . . . . . 0.474 ' HB2' ' O ' ' A' ' 784' ' ' THR . 2.2 m 58.88 118.05 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.362 -0.836 . . . . 0.0 109.989 -179.973 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 786' ' ' GLY . . . . . . . . . . . . . . . 102.7 -37.33 3.75 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.061 -1.616 . . . . 0.0 109.061 -179.899 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 787' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -126.12 23.38 7.1 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.347 -1.09 . . . . 0.0 109.801 179.974 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 788' ' ' PHE . . . . . 0.588 ' HB3' ' CZ ' ' A' ' 775' ' ' PHE . 0.3 OUTLIER -56.4 149.76 16.2 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.511 -0.743 . . . . 0.0 110.009 179.987 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 789' ' ' GLN . . . . . 0.404 ' HG2' ' C ' ' A' ' 788' ' ' PHE . 2.3 mm-40 -134.65 173.69 11.39 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.255 -0.903 . . . . 0.0 110.126 -179.991 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 790' ' ' GLN . . . . . 0.408 ' O ' ' C ' ' A' ' 791' ' ' GLY . 0.0 OUTLIER -86.45 16.04 4.91 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.318 -0.864 . . . . 0.0 109.993 179.961 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 791' ' ' GLY . . . . . 0.618 ' HA2' HD13 ' A' ' 782' ' ' LEU . . . 42.45 -120.1 2.28 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.744 -1.343 . . . . 0.0 109.744 -179.963 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 792' ' ' GLU . . . . . . . . . . . . . 12.8 mt-10 -117.26 -30.64 5.54 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.272 -1.134 . . . . 0.0 110.562 179.991 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 793' ' ' CYS . . . . . . . . . . . . . 2.5 t -126.65 156.77 40.48 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.255 -0.903 . . . . 0.0 110.232 -179.979 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 794' ' ' HIS . . . . . 0.723 ' CE1' ' O ' ' A' ' 795' ' ' SER . 15.0 t-80 -170.08 150.49 3.76 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.374 -0.829 . . . . 0.0 110.229 -179.994 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 795' ' ' SER . . . . . 0.723 ' O ' ' CE1' ' A' ' 794' ' ' HIS . 3.1 t -99.68 158.07 16.03 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.394 -0.816 . . . . 0.0 109.466 179.948 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 796' ' ' ILE . . . . . 0.414 HG21 HD13 ' A' ' 796' ' ' ILE . 0.6 OUTLIER -92.07 37.24 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.087 0 O-C-N 121.005 -1.059 . . . . 0.0 109.847 -179.926 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 797' ' ' ASN . . . . . . . . . . . . . 18.9 m120 -148.06 22.92 1.08 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.383 -0.823 . . . . 0.0 109.93 179.997 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 798' ' ' SER . . . . . 0.486 ' HB3' ' O ' ' A' ' 776' ' ' ALA . 13.9 m -69.54 -50.35 45.76 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.306 -0.871 . . . . 0.0 110.637 179.991 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 799' ' ' ASN . . . . . 0.49 ' OD1' ' HB3' ' A' ' 776' ' ' ALA . 53.6 m-20 -76.33 -31.96 58.42 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.302 -0.874 . . . . 0.0 110.619 -179.944 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 800' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -56.63 -25.78 54.14 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.246 -0.909 . . . . 0.0 110.999 -179.93 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 801' ' ' VAL . . . . . 0.433 HG21 ' CD2' ' A' ' 821' ' ' PHE . 40.7 t -87.36 -21.66 7.13 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 O-C-N 121.067 -1.02 . . . . 0.0 110.769 -179.944 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 802' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -93.07 -20.91 20.07 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.092 -1.005 . . . . 0.0 111.18 -179.942 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 803' ' ' GLU . . . . . 0.449 ' HA ' HD12 ' A' ' 807' ' ' ILE . 4.4 mt-10 -83.51 -37.92 22.44 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.314 -0.866 . . . . 0.0 111.292 -179.858 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 804' ' ' ARG . . . . . . . . . . . . . 2.1 mtm180 -91.61 -25.61 19.09 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 120.997 -1.064 . . . . 0.0 111.62 -179.915 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 805' ' ' LYS . . . . . . . . . . . . . 2.0 tttp -110.53 44.53 1.24 Allowed 'General case' 0 N--CA 1.497 1.88 0 O-C-N 120.859 -1.15 . . . . 0.0 110.814 -179.939 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 806' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -160.52 -66.97 0.07 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.129 -0.982 . . . . 0.0 110.342 179.945 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 807' ' ' ILE . . . . . 0.449 HD12 ' HA ' ' A' ' 803' ' ' GLU . 30.1 mt -52.18 128.81 11.36 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.078 -1.014 . . . . 0.0 110.467 -179.998 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 808' ' ' GLY . . . . . 0.44 ' C ' ' HG ' ' A' ' 809' ' ' LEU . . . 105.24 9.48 33.82 Favored Glycine 0 N--CA 1.491 2.34 0 C-N-CA 119.918 -1.134 . . . . 0.0 110.284 179.915 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 809' ' ' LEU . . . . . 0.44 ' HG ' ' C ' ' A' ' 808' ' ' GLY . 43.7 mt -138.72 142.6 38.9 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.015 -1.285 . . . . 0.0 110.511 179.979 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 810' ' ' GLU . . . . . . . . . . . . . 5.0 mp0 -67.93 -20.88 65.12 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.182 -0.949 . . . . 0.0 109.418 179.998 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 811' ' ' ARG . . . . . . . . . . . . . 24.6 mtm180 -136.52 157.21 47.32 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.605 -0.684 . . . . 0.0 109.643 179.965 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 812' ' ' CYS . . . . . . . . . . . . . 3.2 t -131.12 146.71 52.45 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.198 -0.939 . . . . 0.0 110.193 -179.971 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 813' ' ' VAL . . . . . 0.633 HG13 ' O ' ' A' ' 813' ' ' VAL . 4.6 p -148.69 116.92 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.151 -0.968 . . . . 0.0 110.024 179.926 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 814' ' ' VAL . . . . . . . . . . . . . 6.7 t -131.39 111.73 19.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.193 -0.942 . . . . 0.0 110.077 179.959 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 815' ' ' ALA . . . . . 0.444 ' HA ' ' HG2' ' A' ' 759' ' ' LYS . . . -61.74 166.79 4.05 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.335 -0.853 . . . . 0.0 110.556 -179.955 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 816' ' ' ILE . . . . . 0.825 HG23 HG21 ' A' ' 833' ' ' VAL . 70.7 mt -119.7 112.89 38.97 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 121.378 -0.826 . . . . 0.0 110.102 179.953 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 817' ' ' SER . . . . . 0.532 ' CB ' ' HD2' ' A' ' 818' ' ' PRO . 0.7 OUTLIER -161.89 -177.36 0.7 Allowed Pre-proline 0 N--CA 1.494 1.744 0 O-C-N 121.101 -1.0 . . . . 0.0 110.313 179.97 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 818' ' ' PRO . . . . . 0.532 ' HD2' ' CB ' ' A' ' 817' ' ' SER . 48.3 Cg_endo -75.34 -48.84 0.15 Allowed 'Trans proline' 0 C--N 1.309 -1.546 0 O-C-N 123.991 1.522 . . . . 0.0 110.77 -179.971 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 819' ' ' SER . . . . . . . . . . . . . 2.8 t -92.76 71.06 4.84 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.334 -0.854 . . . . 0.0 110.411 -179.944 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 820' ' ' ASN . . . . . . . . . . . . . 5.4 t-20 -143.58 -43.23 0.28 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.137 -0.977 . . . . 0.0 110.129 -179.973 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 821' ' ' PHE . . . . . 0.433 ' CD2' HG21 ' A' ' 801' ' ' VAL . 33.3 m-85 -83.08 -57.29 3.34 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.428 -0.795 . . . . 0.0 110.501 -179.949 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 822' ' ' GLY . . . . . . . . . . . . . . . 147.21 66.76 0.01 OUTLIER Glycine 0 N--CA 1.491 2.349 0 C-N-CA 119.512 -1.328 . . . . 0.0 110.111 179.953 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 823' ' ' GLY . . . . . . . . . . . . . . . 120.4 170.5 14.26 Favored Glycine 0 N--CA 1.493 2.497 0 O-C-N 121.12 -1.224 . . . . 0.0 110.267 179.917 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 824' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -132.05 65.82 76.17 Favored Pre-proline 0 N--CA 1.494 1.733 0 O-C-N 121.583 -0.951 . . . . 0.0 109.814 179.986 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 825' ' ' PRO . . . . . 0.459 ' C ' ' HD3' ' A' ' 827' ' ' PRO . 48.7 Cg_endo -74.43 -3.42 13.82 Favored 'Trans proline' 0 C--N 1.305 -1.732 0 O-C-N 124.195 1.629 . . . . 0.0 111.122 -179.915 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 826' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER -126.44 64.83 57.25 Favored Pre-proline 0 N--CA 1.499 2.016 0 O-C-N 120.984 -1.072 . . . . 0.0 110.184 -179.944 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 827' ' ' PRO . . . . . 0.459 ' HD3' ' C ' ' A' ' 825' ' ' PRO . 50.0 Cg_endo -82.36 153.53 16.08 Favored 'Trans proline' 0 C--N 1.311 -1.416 0 O-C-N 123.897 1.472 . . . . 0.0 110.886 179.989 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 828' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 57.71 39.77 27.0 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.448 -0.782 . . . . 0.0 110.781 -179.993 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 829' ' ' VAL . . . . . 0.417 ' O ' ' C ' ' A' ' 830' ' ' MET . 54.3 t -137.45 139.76 42.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.176 -0.953 . . . . 0.0 110.116 179.974 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 830' ' ' MET . . . . . 0.417 ' C ' ' O ' ' A' ' 829' ' ' VAL . 0.2 OUTLIER -44.33 144.61 0.97 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.238 -0.913 . . . . 0.0 109.816 -179.911 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 831' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.2 105.79 18.05 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.233 -0.917 . . . . 0.0 110.689 -179.972 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 832' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -128.2 116.68 20.27 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.493 -0.754 . . . . 0.0 109.404 179.945 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 833' ' ' VAL . . . . . 0.825 HG21 HG23 ' A' ' 816' ' ' ILE . 3.3 t -109.86 116.87 53.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.165 -0.959 . . . . 0.0 110.876 -179.931 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 834' ' ' ALA . . . . . 0.572 ' O ' HG23 ' A' ' 835' ' ' VAL . . . -118.25 148.87 41.99 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.478 -0.764 . . . . 0.0 109.229 179.949 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 835' ' ' VAL . . . . . 0.572 HG23 ' O ' ' A' ' 834' ' ' ALA . 46.7 t -155.06 162.84 1.72 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.519 0 O-C-N 120.904 -1.123 . . . . 0.0 111.051 -179.914 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 836' ' ' GLU . . . . . 0.439 ' N ' HG12 ' A' ' 835' ' ' VAL . 2.6 tt0 -145.76 118.12 8.45 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.629 -0.669 . . . . 0.0 109.587 179.934 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 837' ' ' ALA . . . . . 0.421 ' HB3' ' CG2' ' A' ' 731' ' ' VAL . . . -108.12 161.17 15.22 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.152 -0.968 . . . . 0.0 110.372 -179.947 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 838' ' ' VAL . . . . . . . . . . . . . 38.8 t -128.28 130.7 69.47 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.394 -0.816 . . . . 0.0 110.0 179.926 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 839' ' ' CYS . . . . . . . . . . . . . 2.5 m -109.82 146.47 34.99 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.179 -0.95 . . . . 0.0 110.343 -179.961 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 840' ' ' SER . . . . . . . . . . . . . 67.2 p -131.01 -169.83 2.24 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.351 -0.843 . . . . 0.0 109.861 179.938 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 841' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.617 0 O-C-N 121.221 -0.925 . . . . 0.0 110.143 -179.96 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 728' ' ' VAL . . . . . 0.439 ' O ' ' O ' ' A' ' 839' ' ' CYS . 32.5 t . . . . . 0 N--CA 1.492 1.637 0 CA-C-O 121.096 0.474 . . . . 0.0 110.07 . . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 729' ' ' SER . . . . . 0.425 ' OG ' ' O ' ' A' ' 728' ' ' VAL . 0.9 OUTLIER 178.1 120.88 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.127 -0.983 . . . . 0.0 110.432 -179.95 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 730' ' ' GLY . . . . . . . . . . . . . . . 149.34 99.32 0.2 Allowed Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.767 -1.333 . . . . 0.0 109.767 -179.979 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 731' ' ' VAL . . . . . . . . . . . . . 73.1 t -142.15 148.98 19.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.282 -1.128 . . . . 0.0 109.869 179.979 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 732' ' ' CYS . . . . . . . . . . . . . 92.5 m -122.62 166.3 15.08 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.256 -0.902 . . . . 0.0 110.922 -179.971 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 733' ' ' ALA . . . . . 0.439 ' HB3' ' O ' ' A' ' 835' ' ' VAL . . . -160.96 102.09 1.28 Allowed 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 179.883 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 734' ' ' ASP . . . . . 0.565 ' C ' HG23 ' A' ' 735' ' ' VAL . 3.2 t70 -131.28 122.64 26.81 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.174 -0.954 . . . . 0.0 110.366 -179.944 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 735' ' ' VAL . . . . . 0.565 HG23 ' C ' ' A' ' 734' ' ' ASP . 40.6 t -153.25 153.06 9.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.35 -0.844 . . . . 0.0 110.152 179.979 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 736' ' ' SER . . . . . . . . . . . . . 12.3 t -110.31 152.25 26.41 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.159 -0.963 . . . . 0.0 110.207 -179.962 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 737' ' ' GLU . . . . . 0.471 ' HG3' ' HG3' ' A' ' 831' ' ' LYS . 2.1 tm-20 . . . . . 0 N--CA 1.493 1.703 0 O-C-N 121.226 -0.921 . . . . 0.0 110.225 179.981 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 757' ' ' THR . . . . . . . . . . . . . 39.0 p . . . . . 0 N--CA 1.491 1.582 0 CA-C-O 121.368 0.604 . . . . 0.0 110.098 . . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 758' ' ' ALA . . . . . . . . . . . . . . . -114.13 176.14 5.17 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.218 -0.926 . . . . 0.0 110.007 179.974 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 759' ' ' LYS . . . . . . . . . . . . . 32.2 mtmt -144.44 161.99 37.64 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.213 -0.929 . . . . 0.0 110.345 -179.963 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 760' ' ' VAL . . . . . . . . . . . . . 59.6 t -109.28 158.61 9.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.435 -0.791 . . . . 0.0 109.276 179.971 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 761' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -122.47 122.61 39.36 Favored 'General case' 0 C--N 1.298 -1.641 0 O-C-N 121.051 -1.03 . . . . 0.0 110.912 179.978 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 762' ' ' LEU . . . . . 0.495 ' HB2' ' O ' ' A' ' 812' ' ' CYS . 5.6 mt -141.4 135.97 30.92 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.462 -0.774 . . . . 0.0 109.323 179.918 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 763' ' ' LYS . . . . . . . . . . . . . 3.8 mtmt -150.38 151.17 32.42 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.009 -1.057 . . . . 0.0 110.944 -179.938 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 764' ' ' CYS . . . . . . . . . . . . . 9.2 m -127.54 172.88 10.32 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.538 -0.726 . . . . 0.0 109.622 179.963 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 765' ' ' ALA . . . . . 0.451 ' HB3' ' OE1' ' A' ' 768' ' ' GLN . . . -68.11 158.49 83.9 Favored Pre-proline 0 N--CA 1.493 1.681 0 O-C-N 121.109 -0.994 . . . . 0.0 109.947 179.947 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 766' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -72.33 119.02 5.88 Favored 'Trans proline' 0 C--N 1.306 -1.703 0 O-C-N 123.932 1.491 . . . . 0.0 110.338 179.987 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 767' ' ' GLY . . . . . . . . . . . . . . . 112.98 -6.67 25.52 Favored Glycine 0 N--CA 1.489 2.201 0 N-CA-C 109.485 -1.446 . . . . 0.0 109.485 -179.911 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 768' ' ' GLN . . . . . 0.511 ' C ' HG23 ' A' ' 769' ' ' THR . 33.6 mt-30 -114.27 169.75 8.8 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.145 -1.209 . . . . 0.0 110.463 179.969 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 769' ' ' THR . . . . . 0.511 HG23 ' C ' ' A' ' 768' ' ' GLN . 70.5 p -152.2 149.47 28.77 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.358 -0.839 . . . . 0.0 109.866 -179.97 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 770' ' ' ILE . . . . . 0.478 HD12 ' O ' ' A' ' 806' ' ' CYS . 26.9 mt -70.27 141.38 17.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.088 -1.008 . . . . 0.0 109.722 -179.985 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 771' ' ' SER . . . . . . . . . . . . . 1.6 p -126.44 -13.18 6.08 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.168 -0.958 . . . . 0.0 110.587 -179.943 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 772' ' ' ALA . . . . . . . . . . . . . . . -158.08 159.66 36.52 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 120.97 -1.081 . . . . 0.0 111.426 -179.906 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 773' ' ' ILE . . . . . . . . . . . . . 34.8 mm -124.15 123.31 66.32 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 O-C-N 121.644 -0.66 . . . . 0.0 109.296 179.936 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 774' ' ' LYS . . . . . 0.551 ' HG3' ' CG2' ' A' ' 838' ' ' VAL . 0.3 OUTLIER -80.82 -41.4 23.35 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.125 -0.984 . . . . 0.0 110.933 -179.869 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 775' ' ' PHE . . . . . 0.71 ' O ' ' HB2' ' A' ' 776' ' ' ALA . 48.7 t80 -135.5 173.59 11.55 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.069 -1.019 . . . . 0.0 111.088 -179.892 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 776' ' ' ALA . . . . . 0.71 ' HB2' ' O ' ' A' ' 775' ' ' PHE . . . 166.47 87.03 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.644 -0.66 . . . . 0.0 109.314 179.999 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 777' ' ' SER . . . . . 0.473 ' OG ' ' CZ ' ' A' ' 775' ' ' PHE . 16.1 p -119.61 129.84 54.81 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.236 -0.915 . . . . 0.0 110.709 -179.892 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 778' ' ' PHE . . . . . 0.603 ' CD2' HG22 ' A' ' 833' ' ' VAL . 39.4 t80 -104.72 78.54 1.45 Allowed 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.294 -0.879 . . . . 0.0 110.024 179.944 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 779' ' ' GLY . . . . . 0.461 ' C ' ' HD3' ' A' ' 781' ' ' PRO . . . -168.79 -105.42 0.18 Allowed Glycine 0 N--CA 1.492 2.408 0 N-CA-C 109.686 -1.366 . . . . 0.0 109.686 179.997 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 780' ' ' THR . . . . . . . . . . . . . 2.4 p -121.17 63.24 12.16 Favored Pre-proline 0 N--CA 1.493 1.686 0 O-C-N 121.229 -1.159 . . . . 0.0 110.548 -179.973 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 781' ' ' PRO . . . . . 0.496 ' HD2' ' HB3' ' A' ' 832' ' ' ARG . 46.1 Cg_endo -75.98 146.66 29.51 Favored 'Trans proline' 0 C--N 1.305 -1.726 0 O-C-N 124.068 1.562 . . . . 0.0 111.142 179.983 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 782' ' ' LEU . . . . . 0.76 HD21 ' O ' ' A' ' 790' ' ' GLN . 1.8 pt? -149.54 159.56 44.21 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.452 -0.78 . . . . 0.0 109.64 179.928 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 783' ' ' GLY . . . . . 0.416 ' O ' HG23 ' A' ' 784' ' ' THR . . . 140.48 -131.22 4.91 Favored Glycine 0 N--CA 1.496 2.66 0 N-CA-C 109.591 -1.404 . . . . 0.0 109.591 -179.96 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 784' ' ' THR . . . . . 0.416 HG23 ' O ' ' A' ' 783' ' ' GLY . 0.0 OUTLIER -162.14 -158.02 0.51 Allowed 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.121 -1.223 . . . . 0.0 110.68 -179.969 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 785' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -72.95 119.32 17.03 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.366 -0.834 . . . . 0.0 110.54 -179.989 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 786' ' ' GLY . . . . . . . . . . . . . . . 82.63 -10.63 55.5 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.895 -1.282 . . . . 0.0 109.895 -179.98 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 787' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -124.25 30.0 6.2 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.13 -1.218 . . . . 0.0 110.133 -179.989 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 788' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -58.62 91.82 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.276 -0.89 . . . . 0.0 110.387 -180.0 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 789' ' ' GLN . . . . . . . . . . . . . 4.1 tt0 -75.5 -177.24 3.53 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.405 -0.809 . . . . 0.0 110.162 -179.957 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 790' ' ' GLN . . . . . 0.76 ' O ' HD21 ' A' ' 782' ' ' LEU . 0.0 OUTLIER -108.05 174.01 6.07 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.443 -0.786 . . . . 0.0 110.307 179.992 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 791' ' ' GLY . . . . . . . . . . . . . . . -106.87 -140.82 9.87 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.519 -1.432 . . . . 0.0 109.519 179.945 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 792' ' ' GLU . . . . . 0.4 ' HG2' ' N ' ' A' ' 793' ' ' CYS . 1.5 pt-20 -105.17 -24.03 12.81 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.174 -1.192 . . . . 0.0 110.144 -179.967 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 793' ' ' CYS . . . . . 0.4 ' N ' ' HG2' ' A' ' 792' ' ' GLU . 5.7 t -126.22 145.66 50.3 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.281 -0.887 . . . . 0.0 109.974 -179.887 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 794' ' ' HIS . . . . . . . . . . . . . 23.6 t-80 -139.46 156.11 47.15 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.18 -0.95 . . . . 0.0 110.146 -179.943 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 795' ' ' SER . . . . . . . . . . . . . 1.3 t -81.56 -141.62 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.322 -0.861 . . . . 0.0 110.165 179.995 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 796' ' ' ILE . . . . . . . . . . . . . 1.5 pt -145.53 12.71 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.241 -0.912 . . . . 0.0 110.038 -179.971 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 797' ' ' ASN . . . . . . . . . . . . . 78.7 m-20 -148.99 29.16 0.82 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.328 -0.857 . . . . 0.0 110.08 179.999 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 798' ' ' SER . . . . . 0.514 ' CB ' ' O ' ' A' ' 776' ' ' ALA . 7.6 m -71.41 -30.47 66.13 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.218 -0.926 . . . . 0.0 110.625 -179.995 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 799' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -102.33 -7.89 21.67 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.244 -0.91 . . . . 0.0 110.349 179.967 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 800' ' ' SER . . . . . . . . . . . . . 5.8 p -90.46 -22.3 21.46 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.174 -0.954 . . . . 0.0 110.477 179.987 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 801' ' ' VAL . . . . . 0.502 ' O ' ' HG2' ' A' ' 805' ' ' LYS . 55.6 t -81.59 -39.05 16.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.104 -0.997 . . . . 0.0 109.949 179.977 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 802' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -70.6 -56.29 6.84 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.33 -0.856 . . . . 0.0 110.536 -179.95 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 803' ' ' GLU . . . . . 0.531 ' HG2' HD12 ' A' ' 807' ' ' ILE . 2.3 tt0 -48.97 -19.8 0.44 Allowed 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.158 -0.964 . . . . 0.0 110.946 -179.921 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 804' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.71 -46.8 8.03 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.993 -1.067 . . . . 0.0 111.328 -179.893 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 805' ' ' LYS . . . . . 0.961 ' HE2' HG22 ' A' ' 814' ' ' VAL . 0.0 OUTLIER -115.93 47.53 1.36 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.952 -1.092 . . . . 0.0 111.329 -179.829 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 806' ' ' CYS . . . . . 0.478 ' O ' HD12 ' A' ' 770' ' ' ILE . 2.4 t -150.22 -44.52 0.13 Allowed 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.056 -1.028 . . . . 0.0 110.225 179.937 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 807' ' ' ILE . . . . . 0.531 HD12 ' HG2' ' A' ' 803' ' ' GLU . 36.7 mt -80.89 129.17 37.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.188 -0.945 . . . . 0.0 110.151 -179.95 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 808' ' ' GLY . . . . . . . . . . . . . . . 110.86 -9.27 29.74 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 109.897 -1.281 . . . . 0.0 109.897 179.988 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 809' ' ' LEU . . . . . . . . . . . . . 7.8 mt -113.64 154.51 27.1 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.05 -1.265 . . . . 0.0 110.77 -179.979 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 810' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -69.93 -29.74 66.97 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.321 -0.862 . . . . 0.0 109.237 179.869 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 811' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -132.42 165.03 25.21 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.606 -0.684 . . . . 0.0 109.527 -179.993 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 812' ' ' CYS . . . . . 0.495 ' O ' ' HB2' ' A' ' 762' ' ' LEU . 22.8 t -143.12 135.12 26.93 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.079 -1.013 . . . . 0.0 110.839 179.986 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 813' ' ' VAL . . . . . 0.442 ' O ' ' CG1' ' A' ' 813' ' ' VAL . 3.0 p -144.16 129.45 14.82 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 O-C-N 121.464 -0.772 . . . . 0.0 109.192 179.856 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 814' ' ' VAL . . . . . 0.961 HG22 ' HE2' ' A' ' 805' ' ' LYS . 30.2 t -134.59 145.59 32.35 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.068 -1.02 . . . . 0.0 110.849 -179.895 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 815' ' ' ALA . . . . . . . . . . . . . . . -87.28 165.3 15.75 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.404 -0.81 . . . . 0.0 109.965 179.934 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 816' ' ' ILE . . . . . 0.494 HG12 HG21 ' A' ' 833' ' ' VAL . 71.9 mt -111.05 101.15 12.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.121 -0.987 . . . . 0.0 110.28 -179.94 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 817' ' ' SER . . . . . 0.462 ' HB2' ' HD2' ' A' ' 818' ' ' PRO . 1.4 p -155.25 176.34 2.59 Favored Pre-proline 0 N--CA 1.494 1.774 0 O-C-N 121.395 -0.815 . . . . 0.0 110.179 179.955 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 818' ' ' PRO . . . . . 0.462 ' HD2' ' HB2' ' A' ' 817' ' ' SER . 48.4 Cg_endo -76.18 -59.95 0.04 OUTLIER 'Trans proline' 0 C--N 1.309 -1.548 0 O-C-N 123.998 1.525 . . . . 0.0 111.19 -179.888 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 819' ' ' SER . . . . . . . . . . . . . 36.8 t -58.55 -42.45 87.9 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.19 -0.944 . . . . 0.0 110.59 -179.968 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 820' ' ' ASN . . . . . . . . . . . . . 18.3 t-20 -47.19 -23.83 0.59 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.218 -0.926 . . . . 0.0 110.322 -179.954 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 821' ' ' PHE . . . . . 0.423 ' CD2' HG21 ' A' ' 801' ' ' VAL . 15.6 m-85 -107.07 -96.08 0.37 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.146 -0.971 . . . . 0.0 110.715 -179.928 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 822' ' ' GLY . . . . . . . . . . . . . . . -141.8 8.18 2.49 Favored Glycine 0 N--CA 1.491 2.339 0 C-N-CA 119.648 -1.263 . . . . 0.0 110.163 -179.971 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 823' ' ' GLY . . . . . . . . . . . . . . . 124.59 -123.08 4.97 Favored Glycine 0 N--CA 1.492 2.376 0 O-C-N 120.999 -1.295 . . . . 0.0 109.966 179.972 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 824' ' ' ASP . . . . . 0.421 ' HA ' ' HD3' ' A' ' 825' ' ' PRO . 69.8 m-20 -80.42 134.99 53.98 Favored Pre-proline 0 N--CA 1.496 1.826 0 O-C-N 121.286 -1.126 . . . . 0.0 110.476 -179.943 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 825' ' ' PRO . . . . . 0.421 ' HD3' ' HA ' ' A' ' 824' ' ' ASP . 50.6 Cg_endo -83.83 -64.05 0.02 OUTLIER 'Trans proline' 0 C--N 1.308 -1.586 0 O-C-N 123.963 1.507 . . . . 0.0 110.425 179.905 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 826' ' ' CYS . . . . . 0.454 ' HB3' ' HB ' ' A' ' 829' ' ' VAL . 0.7 OUTLIER -147.42 149.71 35.25 Favored Pre-proline 0 N--CA 1.494 1.76 0 O-C-N 121.325 -0.859 . . . . 0.0 110.319 179.96 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 827' ' ' PRO . . . . . 0.441 ' O ' ' HB2' ' A' ' 828' ' ' GLU . 46.8 Cg_endo -74.3 134.57 19.26 Favored 'Trans proline' 0 C--N 1.305 -1.713 0 O-C-N 123.977 1.514 . . . . 0.0 110.694 -179.961 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 828' ' ' GLU . . . . . 0.441 ' HB2' ' O ' ' A' ' 827' ' ' PRO . 64.8 mm-40 55.77 39.7 30.76 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.315 -0.866 . . . . 0.0 110.43 179.984 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 829' ' ' VAL . . . . . 0.454 ' HB ' ' HB3' ' A' ' 826' ' ' CYS . 18.1 t -142.48 136.61 28.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.177 -0.952 . . . . 0.0 110.373 179.987 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 830' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -63.26 -149.66 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.245 -0.909 . . . . 0.0 109.856 -179.993 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 831' ' ' LYS . . . . . 0.471 ' HG3' ' HG3' ' A' ' 737' ' ' GLU . 0.0 OUTLIER -145.34 94.92 2.58 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 120.962 -1.086 . . . . 0.0 110.834 179.962 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 832' ' ' ARG . . . . . 0.496 ' HB3' ' HD2' ' A' ' 781' ' ' PRO . 0.0 OUTLIER -109.56 166.75 10.65 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.305 -0.872 . . . . 0.0 109.408 179.911 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 833' ' ' VAL . . . . . 0.603 HG22 ' CD2' ' A' ' 778' ' ' PHE . 37.0 t -142.93 120.7 6.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 120.928 -1.108 . . . . 0.0 111.763 -179.914 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 834' ' ' ALA . . . . . . . . . . . . . . . -125.31 104.1 8.3 Favored 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 107.87 -1.159 . . . . 0.0 107.87 179.769 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 835' ' ' VAL . . . . . 0.439 ' O ' ' HB3' ' A' ' 733' ' ' ALA . 67.1 t -109.5 153.56 11.23 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.579 0 O-C-N 121.153 -0.967 . . . . 0.0 112.453 -179.674 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 836' ' ' GLU . . . . . 0.448 ' OE1' ' HB2' ' A' ' 774' ' ' LYS . 31.2 tt0 -135.11 122.41 21.69 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 107.185 -1.413 . . . . 0.0 107.185 179.694 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 837' ' ' ALA . . . . . . . . . . . . . . . -113.62 161.81 16.99 Favored 'General case' 0 N--CA 1.501 2.087 0 O-C-N 120.719 -1.238 . . . . 0.0 112.722 -179.669 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 838' ' ' VAL . . . . . 0.551 ' CG2' ' HG3' ' A' ' 774' ' ' LYS . 23.9 t -118.75 105.56 17.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 179.852 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 839' ' ' CYS . . . . . 0.439 ' O ' ' O ' ' A' ' 728' ' ' VAL . 0.0 OUTLIER -107.98 140.71 40.72 Favored 'General case' 0 C--N 1.3 -1.585 0 O-C-N 120.975 -1.078 . . . . 0.0 110.462 -179.867 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 840' ' ' SER . . . . . . . . . . . . . 71.2 p -163.76 177.7 8.45 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.474 -0.766 . . . . 0.0 110.047 179.962 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 841' ' ' THR . . . . . . . . . . . . . 11.6 p . . . . . 0 N--CA 1.492 1.659 0 O-C-N 121.101 -0.999 . . . . 0.0 110.199 -179.956 . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 728' ' ' VAL . . . . . 0.703 ' O ' HG13 ' A' ' 728' ' ' VAL . 9.5 p . . . . . 0 N--CA 1.491 1.618 0 CA-C-O 121.263 0.554 . . . . 0.0 110.403 . . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 729' ' ' SER . . . . . . . . . . . . . 36.2 t -63.88 159.45 19.68 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.146 -0.971 . . . . 0.0 110.068 -179.997 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 730' ' ' GLY . . . . . . . . . . . . . . . -113.95 155.67 16.16 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.494 -1.443 . . . . 0.0 109.494 -179.995 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 731' ' ' VAL . . . . . . . . . . . . . 73.4 t -119.73 158.91 21.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.142 -1.21 . . . . 0.0 110.086 -179.932 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 732' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -131.09 125.14 32.38 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.177 -0.952 . . . . 0.0 110.02 179.996 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 733' ' ' ALA . . . . . . . . . . . . . . . -115.25 109.57 18.16 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.236 -0.915 . . . . 0.0 110.377 179.973 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 734' ' ' ASP . . . . . 0.525 ' C ' HG23 ' A' ' 735' ' ' VAL . 5.0 t0 -118.11 108.93 15.8 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.19 -0.944 . . . . 0.0 110.159 -179.987 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 735' ' ' VAL . . . . . 0.525 HG23 ' C ' ' A' ' 734' ' ' ASP . 96.3 t -152.1 145.39 15.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.287 -0.883 . . . . 0.0 110.182 179.998 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 736' ' ' SER . . . . . . . . . . . . . 66.6 p -93.18 -161.99 0.89 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.175 -0.953 . . . . 0.0 110.386 179.898 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 737' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 . . . . . 0 N--CA 1.494 1.763 0 O-C-N 121.292 -0.88 . . . . 0.0 110.26 179.955 . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 757' ' ' THR . . . . . . . . . . . . . 29.4 p . . . . . 0 N--CA 1.491 1.59 0 CA-C-O 121.289 0.566 . . . . 0.0 110.38 . . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 758' ' ' ALA . . . . . . . . . . . . . . . -140.85 166.14 25.59 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.393 -0.817 . . . . 0.0 109.758 -179.987 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 759' ' ' LYS . . . . . . . . . . . . . 8.2 mttt -113.38 166.31 11.61 Favored 'General case' 0 C--N 1.299 -1.618 0 O-C-N 121.232 -0.918 . . . . 0.0 110.3 179.993 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 760' ' ' VAL . . . . . 0.666 ' O ' HG13 ' A' ' 813' ' ' VAL . 80.3 t -105.56 150.11 8.51 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.463 0 O-C-N 121.311 -0.868 . . . . 0.0 108.873 179.91 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 761' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -125.73 103.95 8.09 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 120.916 -1.115 . . . . 0.0 111.607 -179.812 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 762' ' ' LEU . . . . . 0.501 HD23 ' HA ' ' A' ' 762' ' ' LEU . 17.8 mt -118.04 100.46 7.56 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 179.829 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 763' ' ' LYS . . . . . 0.418 ' HG2' ' HB2' ' A' ' 811' ' ' ARG . 0.0 OUTLIER -124.12 139.88 53.51 Favored 'General case' 0 C--N 1.3 -1.562 0 O-C-N 121.085 -1.009 . . . . 0.0 111.298 -179.829 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 764' ' ' CYS . . . . . 0.437 ' O ' ' C ' ' A' ' 765' ' ' ALA . 3.0 t -125.76 145.12 50.34 Favored 'General case' 0 C--N 1.299 -1.603 0 O-C-N 121.623 -0.673 . . . . 0.0 109.409 179.881 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 765' ' ' ALA . . . . . 0.437 ' C ' ' O ' ' A' ' 764' ' ' CYS . . . -41.1 161.78 0.12 Allowed Pre-proline 0 N--CA 1.495 1.782 0 O-C-N 121.164 -0.96 . . . . 0.0 110.494 179.983 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 766' ' ' PRO . . . . . 0.428 ' HD2' ' HB1' ' A' ' 765' ' ' ALA . 43.9 Cg_endo -70.55 102.47 1.16 Allowed 'Trans proline' 0 C--N 1.305 -1.726 0 O-C-N 123.94 1.495 . . . . 0.0 110.28 -179.963 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 767' ' ' GLY . . . . . . . . . . . . . . . 133.18 -21.71 4.08 Favored Glycine 0 N--CA 1.488 2.102 0 N-CA-C 109.025 -1.63 . . . . 0.0 109.025 -179.978 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 768' ' ' GLN . . . . . 0.533 ' HG2' ' CG2' ' A' ' 841' ' ' THR . 46.0 mt-30 -101.64 131.8 47.67 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.48 -1.012 . . . . 0.0 110.076 -179.999 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 769' ' ' THR . . . . . . . . . . . . . 16.9 p -125.57 147.37 49.31 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.113 -0.992 . . . . 0.0 110.232 179.965 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 770' ' ' ILE . . . . . 0.461 HG22 ' N ' ' A' ' 771' ' ' SER . 22.4 mt -59.92 166.88 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.205 -0.934 . . . . 0.0 109.639 179.964 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 771' ' ' SER . . . . . 0.461 ' N ' HG22 ' A' ' 770' ' ' ILE . 0.1 OUTLIER -160.33 -30.92 0.06 Allowed 'General case' 0 C--N 1.299 -1.621 0 O-C-N 121.094 -1.004 . . . . 0.0 111.152 -179.948 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 772' ' ' ALA . . . . . . . . . . . . . . . -135.78 122.67 21.25 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.852 -1.155 . . . . 0.0 111.402 -179.858 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 773' ' ' ILE . . . . . . . . . . . . . 38.2 mm -95.74 100.95 11.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.448 -0.783 . . . . 0.0 109.021 179.918 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 774' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.94 -37.89 28.71 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.163 -0.961 . . . . 0.0 111.284 -179.928 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 775' ' ' PHE . . . . . 0.724 ' O ' ' HB2' ' A' ' 776' ' ' ALA . 44.1 t80 -122.65 160.66 25.34 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 120.957 -1.089 . . . . 0.0 111.305 -179.843 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 776' ' ' ALA . . . . . 0.724 ' HB2' ' O ' ' A' ' 775' ' ' PHE . . . 166.28 100.64 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.607 -0.683 . . . . 0.0 109.616 179.989 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 777' ' ' SER . . . . . 0.49 ' HA ' ' HB3' ' A' ' 798' ' ' SER . 1.6 p -136.08 142.03 44.28 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.347 -0.846 . . . . 0.0 110.369 -179.909 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 778' ' ' PHE . . . . . 0.496 ' O ' ' CD2' ' A' ' 778' ' ' PHE . 68.8 t80 -120.87 73.74 1.03 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.44 -0.787 . . . . 0.0 110.298 -179.996 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 779' ' ' GLY . . . . . . . . . . . . . . . -161.57 -108.01 0.22 Allowed Glycine 0 N--CA 1.492 2.39 0 N-CA-C 109.544 -1.422 . . . . 0.0 109.544 -179.983 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 780' ' ' THR . . . . . . . . . . . . . 81.8 p -121.07 81.97 36.54 Favored Pre-proline 0 N--CA 1.489 1.506 0 O-C-N 121.187 -1.184 . . . . 0.0 110.161 -179.982 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 781' ' ' PRO . . . . . 0.476 ' CG ' ' HB3' ' A' ' 832' ' ' ARG . 47.5 Cg_endo -75.7 166.8 27.65 Favored 'Trans proline' 0 C--N 1.305 -1.733 0 O-C-N 124.103 1.581 . . . . 0.0 110.36 -179.974 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 782' ' ' LEU . . . . . . . . . . . . . 6.7 mt -140.74 131.81 26.27 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.252 -0.905 . . . . 0.0 110.134 179.999 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 783' ' ' GLY . . . . . . . . . . . . . . . 114.93 -165.86 12.11 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.638 -1.385 . . . . 0.0 109.638 -179.948 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 784' ' ' THR . . . . . 0.4 ' HA ' ' OD2' ' A' ' 734' ' ' ASP . 12.3 p -135.78 -50.1 0.71 Allowed 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.292 -1.123 . . . . 0.0 110.114 179.941 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 785' ' ' CYS . . . . . . . . . . . . . 22.5 t -173.26 87.84 0.07 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.291 -0.881 . . . . 0.0 109.854 -180.0 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 786' ' ' GLY . . . . . . . . . . . . . . . 142.34 -26.74 2.28 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 108.902 -1.679 . . . . 0.0 108.902 -179.897 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 787' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -127.17 30.19 5.46 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.487 -1.008 . . . . 0.0 109.82 179.989 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 788' ' ' PHE . . . . . 0.691 ' CE2' ' HB1' ' A' ' 834' ' ' ALA . 2.2 m-85 -51.93 121.08 6.07 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.307 -0.871 . . . . 0.0 110.245 179.993 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 789' ' ' GLN . . . . . . . . . . . . . 13.2 tt0 -133.74 120.76 20.97 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.302 -0.874 . . . . 0.0 110.274 -179.978 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 790' ' ' GLN . . . . . 0.468 ' CG ' ' O ' ' A' ' 790' ' ' GLN . 9.3 pt20 -64.96 126.21 27.31 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.251 -0.906 . . . . 0.0 110.549 -179.949 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 791' ' ' GLY . . . . . . . . . . . . . . . -69.43 -122.47 0.03 OUTLIER Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.311 -1.516 . . . . 0.0 109.311 179.948 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 792' ' ' GLU . . . . . . . . . . . . . 11.9 mt-10 -126.26 8.72 7.24 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.149 -1.207 . . . . 0.0 110.279 179.963 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 793' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -129.46 96.36 4.26 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.239 -0.913 . . . . 0.0 109.771 179.874 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 794' ' ' HIS . . . . . 0.514 ' CE1' ' O ' ' A' ' 795' ' ' SER . 34.1 t-80 -124.78 139.62 53.68 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.179 -0.95 . . . . 0.0 110.488 -179.934 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 795' ' ' SER . . . . . 0.514 ' O ' ' CE1' ' A' ' 794' ' ' HIS . 4.1 t -82.75 168.87 16.78 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.318 -0.864 . . . . 0.0 109.078 179.99 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 796' ' ' ILE . . . . . . . . . . . . . 1.7 mt -94.97 -7.88 9.79 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 O-C-N 120.857 -1.152 . . . . 0.0 110.095 -179.971 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 797' ' ' ASN . . . . . . . . . . . . . 4.8 m120 -107.38 38.65 2.08 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.288 -0.883 . . . . 0.0 109.387 179.877 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 798' ' ' SER . . . . . 0.49 ' HB3' ' HA ' ' A' ' 777' ' ' SER . 70.6 m -82.08 -52.54 6.91 Favored 'General case' 0 N--CA 1.485 1.317 0 O-C-N 121.51 -0.743 . . . . 0.0 111.184 -179.983 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 799' ' ' ASN . . . . . . . . . . . . . 47.2 t-20 -98.37 12.04 36.17 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.074 -1.017 . . . . 0.0 111.134 -179.923 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 800' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -89.29 -45.06 9.8 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.075 -1.015 . . . . 0.0 110.355 179.959 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 801' ' ' VAL . . . . . . . . . . . . . 8.7 t -74.96 -19.32 16.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.171 -0.956 . . . . 0.0 110.342 -179.974 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 802' ' ' LEU . . . . . 0.471 HD22 ' HA ' ' A' ' 802' ' ' LEU . 0.3 OUTLIER -74.2 -57.23 4.09 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.284 -0.885 . . . . 0.0 110.721 179.976 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 803' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -63.43 -18.33 63.61 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.213 -0.929 . . . . 0.0 110.543 -179.935 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 804' ' ' ARG . . . . . . . . . . . . . 3.2 mtm-85 -92.41 -16.74 25.52 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.237 -0.914 . . . . 0.0 112.066 -179.805 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 805' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.59 39.28 1.69 Allowed 'General case' 0 N--CA 1.502 2.143 0 O-C-N 120.466 -1.396 . . . . 0.0 112.594 -179.809 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 806' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -164.39 22.95 0.06 Allowed 'General case' 0 N--CA 1.501 2.112 0 O-C-N 120.58 -1.325 . . . . 0.0 111.024 179.921 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 807' ' ' ILE . . . . . . . . . . . . . 4.4 mt -125.32 119.33 55.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.093 -1.004 . . . . 0.0 109.939 179.914 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 808' ' ' GLY . . . . . . . . . . . . . . . 110.93 7.91 24.69 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.059 -1.616 . . . . 0.0 109.059 -179.889 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 809' ' ' LEU . . . . . . . . . . . . . 29.7 mt -123.65 138.34 54.55 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.287 -1.125 . . . . 0.0 109.876 179.968 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 810' ' ' GLU . . . . . . . . . . . . . 15.0 mp0 -63.04 -22.36 66.8 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.067 -1.021 . . . . 0.0 109.329 -179.992 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 811' ' ' ARG . . . . . 0.418 ' HB2' ' HG2' ' A' ' 763' ' ' LYS . 0.0 OUTLIER -154.56 122.88 6.03 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.519 -0.738 . . . . 0.0 109.881 179.94 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 812' ' ' CYS . . . . . 0.472 ' O ' ' HB2' ' A' ' 762' ' ' LEU . 6.0 p -129.47 139.07 51.71 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.126 -0.984 . . . . 0.0 110.241 -179.94 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 813' ' ' VAL . . . . . 0.666 HG13 ' O ' ' A' ' 760' ' ' VAL . 53.4 t -121.79 139.79 47.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.204 -0.935 . . . . 0.0 110.308 -179.952 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 814' ' ' VAL . . . . . . . . . . . . . 58.0 t -124.71 134.52 66.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.253 -0.905 . . . . 0.0 110.279 179.989 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 815' ' ' ALA . . . . . . . . . . . . . . . -82.32 149.56 27.7 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.288 -0.883 . . . . 0.0 109.927 -179.99 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 816' ' ' ILE . . . . . 0.548 ' CG2' HG21 ' A' ' 833' ' ' VAL . 22.0 mt -109.96 125.04 67.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.172 -0.955 . . . . 0.0 110.285 179.954 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 817' ' ' SER . . . . . 0.454 ' HB2' ' HD2' ' A' ' 818' ' ' PRO . 2.9 p -172.96 170.74 2.0 Favored Pre-proline 0 N--CA 1.492 1.659 0 O-C-N 121.148 -0.97 . . . . 0.0 110.314 179.993 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 818' ' ' PRO . . . . . 0.46 ' O ' ' HB3' ' A' ' 819' ' ' SER . 47.6 Cg_endo -74.84 158.39 42.82 Favored 'Trans proline' 0 C--N 1.305 -1.737 0 O-C-N 124.144 1.602 . . . . 0.0 110.743 -179.875 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 819' ' ' SER . . . . . 0.46 ' HB3' ' O ' ' A' ' 818' ' ' PRO . 7.5 t 63.01 9.85 4.05 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.361 -0.837 . . . . 0.0 110.842 179.983 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 820' ' ' ASN . . . . . . . . . . . . . 2.4 t30 -96.72 -44.18 7.21 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.097 -1.002 . . . . 0.0 110.208 179.988 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 821' ' ' PHE . . . . . . . . . . . . . 4.0 m-85 -89.94 -45.31 9.3 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.19 -0.944 . . . . 0.0 110.184 179.985 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 822' ' ' GLY . . . . . . . . . . . . . . . -167.43 -35.98 0.02 OUTLIER Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.61 -1.396 . . . . 0.0 109.61 -179.966 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 823' ' ' GLY . . . . . . . . . . . . . . . 159.82 -119.21 0.87 Allowed Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.648 -1.381 . . . . 0.0 109.648 -179.96 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 824' ' ' ASP . . . . . 0.463 ' OD1' ' O ' ' A' ' 824' ' ' ASP . 43.8 p-10 -148.19 101.76 3.58 Favored Pre-proline 0 N--CA 1.498 1.938 0 O-C-N 121.308 -1.113 . . . . 0.0 109.952 -179.997 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 825' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_endo -83.74 -53.22 0.03 OUTLIER 'Trans proline' 0 C--N 1.307 -1.631 0 O-C-N 123.907 1.477 . . . . 0.0 111.037 -179.968 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 826' ' ' CYS . . . . . 0.65 ' SG ' HG21 ' A' ' 829' ' ' VAL . 0.1 OUTLIER -77.56 129.1 78.09 Favored Pre-proline 0 N--CA 1.497 1.885 0 O-C-N 121.077 -1.014 . . . . 0.0 110.737 -179.876 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 827' ' ' PRO . . . . . 0.863 ' O ' HG23 ' A' ' 829' ' ' VAL . 51.2 Cg_endo -87.86 135.07 3.32 Favored 'Trans proline' 0 C--N 1.31 -1.461 0 O-C-N 123.911 1.479 . . . . 0.0 111.086 -179.97 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 828' ' ' GLU . . . . . 0.421 ' C ' ' O ' ' A' ' 827' ' ' PRO . 0.3 OUTLIER 39.29 47.57 1.48 Allowed 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.428 -0.795 . . . . 0.0 110.937 179.863 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 829' ' ' VAL . . . . . 0.863 HG23 ' O ' ' A' ' 827' ' ' PRO . 56.1 t -123.06 132.03 72.16 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.925 0 O-C-N 121.13 -0.981 . . . . 0.0 110.56 179.929 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 830' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -53.63 108.51 0.35 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.246 -0.909 . . . . 0.0 109.743 179.981 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 831' ' ' LYS . . . . . . . . . . . . . 5.0 mmtp -79.72 143.6 34.4 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.161 -0.962 . . . . 0.0 110.314 -179.944 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 832' ' ' ARG . . . . . 0.476 ' HB3' ' CG ' ' A' ' 781' ' ' PRO . 2.7 ttm180 -146.24 161.19 40.81 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.378 -0.826 . . . . 0.0 109.638 -179.979 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 833' ' ' VAL . . . . . 0.548 HG21 ' CG2' ' A' ' 816' ' ' ILE . 59.7 t -124.64 109.21 21.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.125 -0.984 . . . . 0.0 110.89 -179.967 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 834' ' ' ALA . . . . . 0.691 ' HB1' ' CE2' ' A' ' 788' ' ' PHE . . . -111.35 129.87 55.86 Favored 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 179.831 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 835' ' ' VAL . . . . . 0.412 HG12 ' N ' ' A' ' 836' ' ' GLU . 68.3 t -140.35 160.2 25.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 120.817 -1.177 . . . . 0.0 111.718 -179.888 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 836' ' ' GLU . . . . . 0.456 ' HB2' ' HB3' ' A' ' 775' ' ' PHE . 0.2 OUTLIER -151.92 103.9 2.95 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 179.851 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 837' ' ' ALA . . . . . . . . . . . . . . . -111.23 164.07 13.27 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.008 -1.058 . . . . 0.0 111.798 -179.851 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 838' ' ' VAL . . . . . . . . . . . . . 93.4 t -112.6 131.3 64.51 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.327 0 N-CA-C 109.427 -0.582 . . . . 0.0 109.427 179.882 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 839' ' ' CYS . . . . . 0.496 ' O ' ' HA ' ' A' ' 728' ' ' VAL . 2.0 t -108.76 120.26 41.97 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.002 -1.061 . . . . 0.0 110.571 -179.965 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 840' ' ' SER . . . . . . . . . . . . . 10.1 t -123.97 159.12 30.47 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.418 -0.802 . . . . 0.0 110.065 179.977 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 841' ' ' THR . . . . . 0.533 ' CG2' ' HG2' ' A' ' 768' ' ' GLN . 22.2 p . . . . . 0 N--CA 1.494 1.738 0 O-C-N 121.154 -0.967 . . . . 0.0 110.295 179.99 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 728' ' ' VAL . . . . . 0.663 ' O ' HG13 ' A' ' 728' ' ' VAL . 7.7 p . . . . . 0 N--CA 1.491 1.618 0 CA-C-O 121.228 0.537 . . . . 0.0 110.253 . . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 729' ' ' SER . . . . . . . . . . . . . 1.9 t -66.93 166.67 13.07 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.179 -0.951 . . . . 0.0 109.981 179.98 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 730' ' ' GLY . . . . . 0.465 ' C ' HG13 ' A' ' 731' ' ' VAL . . . -144.32 132.38 4.79 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.114 -1.594 . . . . 0.0 109.114 179.939 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 731' ' ' VAL . . . . . 0.523 ' O ' HG23 ' A' ' 731' ' ' VAL . 21.0 m -150.9 117.49 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.425 0 O-C-N 121.018 -1.284 . . . . 0.0 110.845 -179.935 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 732' ' ' CYS . . . . . 0.425 ' O ' ' SG ' ' A' ' 732' ' ' CYS . 15.5 p -109.22 133.85 52.51 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.31 -0.869 . . . . 0.0 109.322 179.841 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 733' ' ' ALA . . . . . . . . . . . . . . . -109.24 123.44 49.27 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.091 -1.006 . . . . 0.0 110.669 -179.862 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 734' ' ' ASP . . . . . . . . . . . . . 12.2 t0 -111.71 114.47 27.51 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.378 -0.826 . . . . 0.0 110.124 179.941 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 735' ' ' VAL . . . . . . . . . . . . . 16.6 t -122.99 155.34 28.6 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.222 -0.924 . . . . 0.0 110.338 -179.993 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 736' ' ' SER . . . . . 0.433 ' O ' ' C ' ' A' ' 737' ' ' GLU . 0.1 OUTLIER -106.15 105.5 15.56 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.263 -0.898 . . . . 0.0 109.807 -179.98 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 737' ' ' GLU . . . . . 0.542 ' CB ' ' HA ' ' A' ' 831' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.496 1.856 0 O-C-N 121.457 -0.777 . . . . 0.0 110.851 -179.963 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 757' ' ' THR . . . . . . . . . . . . . 3.7 p . . . . . 0 N--CA 1.492 1.666 0 CA-C-O 121.279 0.561 . . . . 0.0 110.391 . . . . . . . . . 0 0 . 1 . 025 nuclear build core ' A' A ' 758' ' ' ALA . . . . . . . . . . . . . . . -87.62 169.92 11.73 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.329 -0.857 . . . . 0.0 109.979 179.981 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 759' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.46 155.69 47.42 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.1 -1.0 . . . . 0.0 110.584 -179.983 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 760' ' ' VAL . . . . . 0.816 HG23 HD11 ' A' ' 816' ' ' ILE . 47.3 t -109.54 139.14 33.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.42 -0.8 . . . . 0.0 109.523 179.939 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 761' ' ' HIS . . . . . . . . . . . . . 1.7 m170 -114.3 111.27 21.23 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.142 -0.973 . . . . 0.0 111.083 -179.978 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 762' ' ' LEU . . . . . 0.451 HD22 ' HB2' ' A' ' 837' ' ' ALA . 1.8 mt -129.6 117.45 20.42 Favored 'General case' 0 N--CA 1.493 1.69 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 -179.99 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 763' ' ' LYS . . . . . 0.428 ' N ' ' CD ' ' A' ' 763' ' ' LYS . 0.0 OUTLIER -142.56 166.44 24.65 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.009 -1.057 . . . . 0.0 111.324 -179.912 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 764' ' ' CYS . . . . . 0.407 ' O ' ' C ' ' A' ' 765' ' ' ALA . 1.4 m -141.37 140.74 33.77 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.677 -0.639 . . . . 0.0 109.458 179.943 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 765' ' ' ALA . . . . . 0.407 ' C ' ' O ' ' A' ' 764' ' ' CYS . . . -44.49 160.98 0.23 Allowed Pre-proline 0 N--CA 1.495 1.806 0 O-C-N 121.109 -0.994 . . . . 0.0 110.341 -179.986 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 766' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -71.34 103.39 1.4 Allowed 'Trans proline' 0 C--N 1.309 -1.5 0 O-C-N 124.004 1.528 . . . . 0.0 110.079 180.0 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 767' ' ' GLY . . . . . . . . . . . . . . . 143.61 -29.21 2.01 Favored Glycine 0 N--CA 1.488 2.118 0 N-CA-C 108.864 -1.694 . . . . 0.0 108.864 179.971 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 768' ' ' GLN . . . . . 0.503 ' OE1' HG23 ' A' ' 841' ' ' THR . 1.5 mt-30 -113.59 115.26 27.65 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.311 -1.111 . . . . 0.0 109.599 179.975 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 769' ' ' THR . . . . . . . . . . . . . 67.2 p -99.75 145.94 27.11 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.187 -0.946 . . . . 0.0 110.576 -179.937 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 770' ' ' ILE . . . . . . . . . . . . . 35.8 mt -60.6 113.45 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 O-C-N 121.32 -0.863 . . . . 0.0 109.197 179.983 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 771' ' ' SER . . . . . 0.518 ' O ' ' HB2' ' A' ' 772' ' ' ALA . 39.2 t -91.61 -7.58 49.69 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.231 -0.918 . . . . 0.0 111.485 -179.835 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 772' ' ' ALA . . . . . 0.518 ' HB2' ' O ' ' A' ' 771' ' ' SER . . . 179.75 146.14 0.21 Allowed 'General case' 0 N--CA 1.496 1.839 0 O-C-N 120.765 -1.209 . . . . 0.0 111.475 -179.924 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 773' ' ' ILE . . . . . 0.522 HD11 ' HB3' ' A' ' 806' ' ' CYS . 31.9 mm -87.93 135.4 25.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.495 -0.753 . . . . 0.0 109.135 179.892 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 774' ' ' LYS . . . . . 0.573 ' HB3' ' CB ' ' A' ' 836' ' ' GLU . 0.4 OUTLIER -78.14 -35.53 48.88 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.119 -0.988 . . . . 0.0 110.768 -179.897 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 775' ' ' PHE . . . . . 0.521 ' CZ ' ' HB3' ' A' ' 777' ' ' SER . 44.9 t80 176.16 150.86 0.14 Allowed 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.173 -0.955 . . . . 0.0 110.897 -179.988 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 776' ' ' ALA . . . . . 0.472 ' O ' ' HB3' ' A' ' 798' ' ' SER . . . -143.65 145.78 32.73 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.472 -0.767 . . . . 0.0 108.959 179.872 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 777' ' ' SER . . . . . 0.55 ' HA ' ' OG ' ' A' ' 798' ' ' SER . 67.6 p -154.09 119.03 4.99 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.877 -1.14 . . . . 0.0 111.575 -179.949 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 778' ' ' PHE . . . . . 0.48 ' CZ ' ' HG2' ' A' ' 830' ' ' MET . 40.8 t80 -105.39 120.15 40.87 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.466 -0.771 . . . . 0.0 109.496 179.918 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 779' ' ' GLY . . . . . 0.577 ' HA2' ' HA ' ' A' ' 830' ' ' MET . . . 133.49 -100.0 0.38 Allowed Glycine 0 N--CA 1.487 2.075 0 C-N-CA 119.604 -1.284 . . . . 0.0 109.912 179.991 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 780' ' ' THR . . . . . . . . . . . . . 43.5 p -136.62 93.92 13.75 Favored Pre-proline 0 N--CA 1.495 1.781 0 O-C-N 121.133 -1.216 . . . . 0.0 110.593 -179.924 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 781' ' ' PRO . . . . . 0.511 ' CD ' ' HB3' ' A' ' 832' ' ' ARG . 51.6 Cg_endo -81.77 157.91 18.63 Favored 'Trans proline' 0 C--N 1.307 -1.643 0 O-C-N 124.004 1.528 . . . . 0.0 110.605 179.921 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 782' ' ' LEU . . . . . 0.477 HD12 ' HA2' ' A' ' 791' ' ' GLY . 0.8 OUTLIER -112.78 133.89 54.56 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.278 -0.889 . . . . 0.0 110.081 179.989 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 783' ' ' GLY . . . . . . . . . . . . . . . 84.03 -170.37 47.34 Favored Glycine 0 N--CA 1.493 2.487 0 N-CA-C 109.784 -1.326 . . . . 0.0 109.784 179.987 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 784' ' ' THR . . . . . 0.435 ' O ' ' CE1' ' A' ' 788' ' ' PHE . 44.0 p -127.68 -141.82 0.27 Allowed 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.264 -1.139 . . . . 0.0 110.529 -179.99 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 785' ' ' CYS . . . . . . . . . . . . . 38.4 m -78.52 100.56 6.95 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.278 -0.889 . . . . 0.0 110.379 -179.942 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 786' ' ' GLY . . . . . . . . . . . . . . . 140.46 -13.52 2.98 Favored Glycine 0 N--CA 1.493 2.452 0 N-CA-C 110.012 -1.235 . . . . 0.0 110.012 -179.988 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 787' ' ' THR . . . . . . . . . . . . . 9.0 t -159.52 36.62 0.19 Allowed 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.036 -1.273 . . . . 0.0 110.809 -179.978 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 788' ' ' PHE . . . . . 0.459 ' O ' ' HB2' ' A' ' 789' ' ' GLN . 14.4 m-85 -61.29 158.66 13.8 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.07 -1.019 . . . . 0.0 109.909 179.972 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 789' ' ' GLN . . . . . 0.459 ' HB2' ' O ' ' A' ' 788' ' ' PHE . 24.4 tt0 179.25 157.46 0.56 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.175 -0.953 . . . . 0.0 110.218 -179.994 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 790' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -52.17 137.81 27.26 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.252 -0.905 . . . . 0.0 110.362 -179.999 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 791' ' ' GLY . . . . . 0.477 ' HA2' HD12 ' A' ' 782' ' ' LEU . . . -111.75 -107.9 2.97 Favored Glycine 0 N--CA 1.493 2.466 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 -179.986 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 792' ' ' GLU . . . . . . . . . . . . . 39.1 tp10 -90.49 -53.02 4.61 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.194 -1.18 . . . . 0.0 110.277 179.944 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 793' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -136.08 117.69 14.91 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.263 -0.898 . . . . 0.0 110.081 179.983 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 794' ' ' HIS . . . . . . . . . . . . . 10.7 t-80 -120.2 150.51 40.54 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.252 -0.905 . . . . 0.0 110.381 -179.975 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 795' ' ' SER . . . . . 0.489 ' OG ' ' HG3' ' A' ' 825' ' ' PRO . 2.6 m -94.94 117.44 30.15 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.425 -0.797 . . . . 0.0 109.483 179.896 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 796' ' ' ILE . . . . . . . . . . . . . 6.7 mt -58.3 -13.57 3.08 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.875 0 O-C-N 121.158 -0.964 . . . . 0.0 110.775 -179.947 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 797' ' ' ASN . . . . . 0.405 ' O ' ' OG ' ' A' ' 800' ' ' SER . 3.6 m-20 -89.96 21.48 3.63 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.062 -1.024 . . . . 0.0 110.414 179.906 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 798' ' ' SER . . . . . 0.55 ' OG ' ' HA ' ' A' ' 777' ' ' SER . 0.5 OUTLIER -70.0 -33.72 72.4 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.176 -0.953 . . . . 0.0 110.806 -179.995 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 799' ' ' ASN . . . . . . . . . . . . . 7.5 m-20 -97.94 6.21 47.99 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.26 -0.9 . . . . 0.0 111.024 -179.856 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 800' ' ' SER . . . . . 0.405 ' OG ' ' O ' ' A' ' 797' ' ' ASN . 6.1 p -90.69 -29.41 17.72 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.97 -1.081 . . . . 0.0 110.396 -179.979 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 801' ' ' VAL . . . . . . . . . . . . . 15.6 t -88.03 -19.66 7.69 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.293 -0.879 . . . . 0.0 110.588 179.957 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 802' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -90.64 -48.44 7.06 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.107 -0.996 . . . . 0.0 110.572 -179.896 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 803' ' ' GLU . . . . . . . . . . . . . 20.8 mt-10 -58.61 -26.78 64.05 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.185 -0.947 . . . . 0.0 110.987 -179.895 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 804' ' ' ARG . . . . . . . . . . . . . 16.7 ttt-85 -86.63 -28.3 23.29 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 120.988 -1.07 . . . . 0.0 110.849 -179.892 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 805' ' ' LYS . . . . . 0.434 ' O ' ' SG ' ' A' ' 812' ' ' CYS . 2.1 mttm -122.28 31.81 6.02 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.055 -1.028 . . . . 0.0 110.615 179.985 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 806' ' ' CYS . . . . . 0.522 ' HB3' HD11 ' A' ' 773' ' ' ILE . 0.1 OUTLIER -162.2 41.44 0.13 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.151 -0.968 . . . . 0.0 110.4 -179.969 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 807' ' ' ILE . . . . . 0.659 HG22 ' O ' ' A' ' 807' ' ' ILE . 9.8 mm -140.59 84.23 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.248 -0.908 . . . . 0.0 110.428 -179.994 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 808' ' ' GLY . . . . . 0.448 ' C ' ' HG ' ' A' ' 809' ' ' LEU . . . 117.84 32.41 1.43 Allowed Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.751 -1.34 . . . . 0.0 109.751 -179.998 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 809' ' ' LEU . . . . . 0.448 ' HG ' ' C ' ' A' ' 808' ' ' GLY . 14.9 mt -137.61 138.12 39.2 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.195 -1.179 . . . . 0.0 110.318 -179.96 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 810' ' ' GLU . . . . . . . . . . . . . 11.5 mp0 -61.01 -33.09 72.72 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.058 -1.026 . . . . 0.0 108.684 179.937 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 811' ' ' ARG . . . . . . . . . . . . . 18.1 ttm180 -125.69 167.69 14.78 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 179.835 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 812' ' ' CYS . . . . . 0.434 ' SG ' ' O ' ' A' ' 805' ' ' LYS . 9.3 t -166.04 116.27 1.0 Allowed 'General case' 0 C--N 1.3 -1.569 0 O-C-N 120.803 -1.185 . . . . 0.0 111.046 -179.903 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 813' ' ' VAL . . . . . . . . . . . . . 75.2 t -117.63 138.45 48.27 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.472 -0.768 . . . . 0.0 109.384 179.951 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 814' ' ' VAL . . . . . . . . . . . . . 4.4 t -125.56 158.04 34.49 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.077 -1.015 . . . . 0.0 110.561 -179.917 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 815' ' ' ALA . . . . . . . . . . . . . . . -117.65 135.01 54.29 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.26 -0.9 . . . . 0.0 110.117 -179.983 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 816' ' ' ILE . . . . . 0.816 HD11 HG23 ' A' ' 760' ' ' VAL . 9.7 mt -107.52 137.22 39.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.263 -0.898 . . . . 0.0 110.276 -179.946 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 817' ' ' SER . . . . . 0.504 ' CB ' ' HD2' ' A' ' 818' ' ' PRO . 0.0 OUTLIER -161.85 -179.81 1.13 Allowed Pre-proline 0 N--CA 1.495 1.781 0 O-C-N 121.232 -0.917 . . . . 0.0 110.031 179.985 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 818' ' ' PRO . . . . . 0.504 ' HD2' ' CB ' ' A' ' 817' ' ' SER . 48.0 Cg_endo -75.45 -38.27 1.48 Allowed 'Trans proline' 0 C--N 1.305 -1.724 0 O-C-N 124.055 1.555 . . . . 0.0 110.525 -179.975 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 819' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -116.51 47.36 1.45 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.23 -0.919 . . . . 0.0 110.296 -179.909 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 820' ' ' ASN . . . . . . . . . . . . . 2.0 m120 -129.71 0.78 4.91 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.178 -0.951 . . . . 0.0 110.206 179.97 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 821' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -125.32 -39.19 2.22 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.269 -0.894 . . . . 0.0 110.258 -179.941 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 822' ' ' GLY . . . . . . . . . . . . . . . -164.52 -52.37 0.02 OUTLIER Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.684 -1.367 . . . . 0.0 109.684 -179.997 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 823' ' ' GLY . . . . . . . . . . . . . . . 158.51 -68.54 0.27 Allowed Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.717 -1.353 . . . . 0.0 109.717 -179.934 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 824' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -171.22 88.91 0.46 Allowed Pre-proline 0 N--CA 1.493 1.684 0 O-C-N 121.262 -1.14 . . . . 0.0 110.431 -179.994 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 825' ' ' PRO . . . . . 0.489 ' HG3' ' OG ' ' A' ' 795' ' ' SER . 44.8 Cg_endo -75.08 -62.79 0.03 OUTLIER 'Trans proline' 0 C--N 1.304 -1.806 0 O-C-N 123.947 1.498 . . . . 0.0 110.317 179.971 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 826' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -116.93 118.92 35.83 Favored Pre-proline 0 N--CA 1.493 1.688 0 O-C-N 121.305 -0.872 . . . . 0.0 109.632 -179.996 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 827' ' ' PRO . . . . . 0.428 ' O ' ' HB2' ' A' ' 828' ' ' GLU . 48.2 Cg_endo -75.24 141.01 25.45 Favored 'Trans proline' 0 C--N 1.308 -1.58 0 O-C-N 123.885 1.466 . . . . 0.0 110.866 -179.887 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 828' ' ' GLU . . . . . 0.428 ' HB2' ' O ' ' A' ' 827' ' ' PRO . 0.6 OUTLIER 58.41 14.16 2.81 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.486 -0.759 . . . . 0.0 110.508 179.99 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 829' ' ' VAL . . . . . 0.56 ' O ' HG12 ' A' ' 829' ' ' VAL . 54.0 t -137.59 82.03 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.165 -0.96 . . . . 0.0 110.217 -179.959 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 830' ' ' MET . . . . . 0.577 ' HA ' ' HA2' ' A' ' 779' ' ' GLY . 0.2 OUTLIER -176.26 107.65 0.08 Allowed 'General case' 0 N--CA 1.487 1.398 0 O-C-N 120.929 -1.107 . . . . 0.0 111.348 179.991 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 831' ' ' LYS . . . . . 0.542 ' HA ' ' CB ' ' A' ' 737' ' ' GLU . 20.6 ttpp -170.93 53.1 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.235 -0.915 . . . . 0.0 110.736 179.95 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 832' ' ' ARG . . . . . 0.511 ' HB3' ' CD ' ' A' ' 781' ' ' PRO . 1.7 mtt180 -172.97 107.16 0.16 Allowed 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.274 -0.891 . . . . 0.0 109.846 179.957 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 833' ' ' VAL . . . . . 0.782 HG21 HD13 ' A' ' 816' ' ' ILE . 3.8 t -107.35 109.25 27.5 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 O-C-N 121.111 -0.993 . . . . 0.0 110.836 -179.96 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 834' ' ' ALA . . . . . . . . . . . . . . . -109.62 136.47 48.94 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.371 -0.831 . . . . 0.0 109.34 179.934 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 835' ' ' VAL . . . . . . . . . . . . . 38.1 t -147.05 156.94 10.51 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.069 -1.02 . . . . 0.0 110.946 -179.95 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 836' ' ' GLU . . . . . 0.573 ' CB ' ' HB3' ' A' ' 774' ' ' LYS . 1.7 mp0 -135.2 158.89 43.21 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 179.845 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 837' ' ' ALA . . . . . 0.451 ' HB2' HD22 ' A' ' 762' ' ' LEU . . . -138.44 154.59 48.86 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 120.802 -1.186 . . . . 0.0 111.54 -179.772 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 838' ' ' VAL . . . . . . . . . . . . . 21.3 t -121.85 109.57 24.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.692 -0.63 . . . . 0.0 109.376 179.88 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 839' ' ' CYS . . . . . 0.41 ' O ' ' HA ' ' A' ' 728' ' ' VAL . 0.6 OUTLIER -108.1 129.42 55.15 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.115 -0.991 . . . . 0.0 110.522 -179.96 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 840' ' ' SER . . . . . . . . . . . . . 54.1 p -125.53 -161.03 1.0 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.282 -0.886 . . . . 0.0 110.221 179.989 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 841' ' ' THR . . . . . 0.503 HG23 ' OE1' ' A' ' 768' ' ' GLN . 0.6 OUTLIER . . . . . 0 N--CA 1.491 1.611 0 O-C-N 121.285 -0.884 . . . . 0.0 110.493 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 726' ' ' ARG . . . . . . . . . . . . . 1.9 mmm180 . . . . . 0 N--CA 1.493 1.676 0 CA-C-O 121.233 0.54 . . . . 0.0 110.142 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 727' ' ' THR . . . . . 0.435 ' HA ' ' HB2' ' A' ' 840' ' ' SER . 97.5 m -52.77 117.33 2.85 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.355 -0.841 . . . . 0.0 110.318 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 728' ' ' VAL . . . . . 0.747 ' O ' HG13 ' A' ' 728' ' ' VAL . 9.0 p -158.37 55.48 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.302 -0.874 . . . . 0.0 110.008 179.918 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 729' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -179.93 -177.96 0.41 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.264 -0.897 . . . . 0.0 110.407 -179.952 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 730' ' ' GLY . . . . . . . . . . . . . . . 172.21 113.73 0.31 Allowed Glycine 0 N--CA 1.492 2.373 0 N-CA-C 109.074 -1.61 . . . . 0.0 109.074 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 731' ' ' VAL . . . . . . . . . . . . . 31.3 m -130.02 148.41 33.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.227 -1.161 . . . . 0.0 110.872 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 732' ' ' CYS . . . . . 0.42 ' O ' ' SG ' ' A' ' 732' ' ' CYS . 16.5 p -142.18 133.89 26.95 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.521 -0.737 . . . . 0.0 109.272 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 733' ' ' ALA . . . . . 0.522 ' HB2' HD21 ' A' ' 762' ' ' LEU . . . -111.69 132.32 54.7 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.049 -1.032 . . . . 0.0 110.746 -179.911 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 734' ' ' ASP . . . . . 0.442 ' CG ' ' O ' ' A' ' 734' ' ' ASP . 8.6 p-10 -116.54 116.34 27.44 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.295 -0.878 . . . . 0.0 109.777 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 735' ' ' VAL . . . . . . . . . . . . . 5.7 t -139.62 166.9 20.36 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.154 -0.966 . . . . 0.0 110.187 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 736' ' ' SER . . . . . 0.448 ' O ' ' C ' ' A' ' 737' ' ' GLU . 1.2 m -135.78 136.27 40.58 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.265 -0.897 . . . . 0.0 109.937 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 737' ' ' GLU . . . . . 0.535 ' HB2' ' HB3' ' A' ' 831' ' ' LYS . 1.2 tm-20 -42.26 149.62 0.16 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.32 -0.863 . . . . 0.0 109.86 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 738' ' ' TYR . . . . . . . . . . . . . 45.7 t80 -165.56 123.2 1.52 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.257 -0.902 . . . . 0.0 110.047 -179.938 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 739' ' ' HIS . . . . . 0.66 ' O ' ' CG ' ' A' ' 739' ' ' HIS . 1.7 p-80 -173.67 48.44 0.07 OUTLIER Pre-proline 0 N--CA 1.489 1.523 0 O-C-N 121.269 -0.895 . . . . 0.0 110.364 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 740' ' ' PRO . . . . . 0.923 ' HG2' HD11 ' A' ' 742' ' ' ILE . 37.9 Cg_endo -62.0 151.56 80.76 Favored 'Trans proline' 0 C--N 1.299 -2.046 0 O-C-N 123.204 1.108 . . . . 0.0 109.64 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 741' ' ' ASN . . . . . 0.487 ' CG ' ' O ' ' A' ' 741' ' ' ASN . 7.4 p30 -65.02 99.77 0.38 Allowed 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.069 -1.019 . . . . 0.0 109.852 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 742' ' ' ILE . . . . . 0.923 HD11 ' HG2' ' A' ' 740' ' ' PRO . 1.4 mt -124.33 102.16 10.36 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 120.819 -1.176 . . . . 0.0 110.226 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 743' ' ' LYS . . . . . 0.408 ' O ' ' CB ' ' A' ' 744' ' ' ASN . 31.6 mmmt -98.11 63.23 1.58 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.103 -0.998 . . . . 0.0 109.577 179.85 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 744' ' ' ASN . . . . . 0.408 ' CB ' ' O ' ' A' ' 743' ' ' LYS . 1.1 t-20 172.81 101.46 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.634 -0.666 . . . . 0.0 109.562 -179.937 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 745' ' ' TRP . . . . . 0.587 ' CG ' ' O ' ' A' ' 745' ' ' TRP . 69.5 t-105 -160.72 43.98 0.18 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.071 -1.018 . . . . 0.0 110.627 -179.953 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 746' ' ' GLN . . . . . 0.453 ' HB3' ' O ' ' A' ' 745' ' ' TRP . 1.5 pt20 176.96 113.32 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.169 -0.957 . . . . 0.0 110.156 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 747' ' ' ILE . . . . . 0.406 HD12 ' N ' ' A' ' 747' ' ' ILE . 3.5 mp -115.71 46.8 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.155 -0.966 . . . . 0.0 110.293 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 748' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -136.25 -166.4 1.87 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.277 -0.889 . . . . 0.0 109.949 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 749' ' ' SER . . . . . . . . . . . . . 67.0 m -88.17 28.81 1.02 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.145 -0.972 . . . . 0.0 110.181 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 750' ' ' TYR . . . . . . . . . . . . . 12.1 t80 -118.12 169.73 9.45 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.346 -0.846 . . . . 0.0 109.837 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 751' ' ' GLY . . . . . . . . . . . . . . . -165.09 147.4 12.45 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.664 -1.374 . . . . 0.0 109.664 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 752' ' ' GLU . . . . . 0.475 ' HG2' ' OE1' ' A' ' 754' ' ' GLU . 1.2 tt0 -169.14 73.3 0.73 Allowed Pre-proline 0 C--N 1.301 -1.534 0 O-C-N 121.343 -1.092 . . . . 0.0 110.036 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 753' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_endo -79.07 45.06 1.82 Allowed 'Trans proline' 0 C--N 1.309 -1.509 0 O-C-N 124.296 1.682 . . . . 0.0 110.863 179.874 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 754' ' ' GLU . . . . . 0.475 ' OE1' ' HG2' ' A' ' 752' ' ' GLU . 6.2 pt-20 -127.07 50.55 1.97 Allowed 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.064 -1.023 . . . . 0.0 110.026 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 755' ' ' PHE . . . . . . . . . . . . . 16.3 t80 -151.98 76.0 1.16 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.212 -0.93 . . . . 0.0 110.638 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 756' ' ' HIS . . . . . 0.452 ' O ' HG23 ' A' ' 757' ' ' THR . 0.0 OUTLIER -107.98 39.32 1.97 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.22 -0.925 . . . . 0.0 109.625 179.897 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 757' ' ' THR . . . . . 0.539 HG21 ' O ' ' A' ' 816' ' ' ILE . 0.0 OUTLIER -170.97 167.12 7.4 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.417 -0.802 . . . . 0.0 109.853 179.935 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 758' ' ' ALA . . . . . . . . . . . . . . . -88.69 153.26 21.25 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.113 -0.992 . . . . 0.0 109.938 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 759' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -113.28 161.07 17.66 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.187 -0.946 . . . . 0.0 110.365 -179.942 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 760' ' ' VAL . . . . . . . . . . . . . 42.2 t -107.76 133.73 51.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.359 -0.838 . . . . 0.0 109.328 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 761' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -109.97 115.67 30.2 Favored 'General case' 0 C--N 1.302 -1.5 0 O-C-N 121.133 -0.98 . . . . 0.0 111.043 -179.925 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 762' ' ' LEU . . . . . 0.522 HD21 ' HB2' ' A' ' 733' ' ' ALA . 93.1 mt -132.36 138.78 47.87 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.543 -0.723 . . . . 0.0 109.119 179.842 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 763' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -167.7 136.72 2.57 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.834 -1.166 . . . . 0.0 110.891 -179.893 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 764' ' ' CYS . . . . . . . . . . . . . 92.7 m -106.59 172.77 6.64 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.427 -0.796 . . . . 0.0 109.849 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 765' ' ' ALA . . . . . 0.724 ' HB3' ' OE1' ' A' ' 768' ' ' GLN . . . -67.89 166.27 24.82 Favored Pre-proline 0 N--CA 1.495 1.795 0 O-C-N 121.156 -0.965 . . . . 0.0 110.277 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 766' ' ' PRO . . . . . 0.543 ' HD2' ' HB1' ' A' ' 765' ' ' ALA . 45.6 Cg_endo -72.84 107.11 2.26 Favored 'Trans proline' 0 C--N 1.307 -1.61 0 O-C-N 123.964 1.507 . . . . 0.0 110.026 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 767' ' ' GLY . . . . . . . . . . . . . . . 132.86 -3.42 4.94 Favored Glycine 0 N--CA 1.489 2.174 0 N-CA-C 109.334 -1.506 . . . . 0.0 109.334 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 768' ' ' GLN . . . . . 0.724 ' OE1' ' HB3' ' A' ' 765' ' ' ALA . 44.5 mt-30 -124.52 152.99 42.74 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.183 -1.187 . . . . 0.0 109.968 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 769' ' ' THR . . . . . . . . . . . . . 62.2 p -134.74 147.09 49.96 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.139 -0.975 . . . . 0.0 110.598 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 770' ' ' ILE . . . . . . . . . . . . . 59.1 mt -73.33 139.75 18.95 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.394 -0.816 . . . . 0.0 109.453 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 771' ' ' SER . . . . . . . . . . . . . 2.3 t -134.97 -8.17 2.35 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.974 -1.079 . . . . 0.0 111.422 -179.888 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 772' ' ' ALA . . . . . . . . . . . . . . . -162.96 155.97 19.32 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 120.684 -1.26 . . . . 0.0 111.734 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 773' ' ' ILE . . . . . . . . . . . . . 19.9 mm -110.69 125.65 68.0 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.687 -0.633 . . . . 0.0 109.48 179.861 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 774' ' ' LYS . . . . . 0.569 ' HG2' ' CG2' ' A' ' 838' ' ' VAL . 3.2 mmmp? -80.71 -33.47 35.28 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.078 -1.013 . . . . 0.0 110.928 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 775' ' ' PHE . . . . . . . . . . . . . 88.7 t80 -160.46 154.73 23.32 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.022 -1.049 . . . . 0.0 110.282 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 776' ' ' ALA . . . . . 0.456 ' O ' ' HB2' ' A' ' 798' ' ' SER . . . -169.21 113.55 0.55 Allowed 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.41 -0.806 . . . . 0.0 109.47 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 777' ' ' SER . . . . . 0.589 ' HA ' ' CB ' ' A' ' 798' ' ' SER . 0.6 OUTLIER -140.68 137.35 33.47 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.04 -1.038 . . . . 0.0 111.327 179.977 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 778' ' ' PHE . . . . . 0.545 ' CG ' ' O ' ' A' ' 778' ' ' PHE . 24.0 t80 -116.19 72.98 0.83 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.497 -0.752 . . . . 0.0 109.344 179.869 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 779' ' ' GLY . . . . . . . . . . . . . . . -164.46 -102.63 0.17 Allowed Glycine 0 N--CA 1.495 2.601 0 N-CA-C 109.696 -1.362 . . . . 0.0 109.696 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 780' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -133.15 77.0 68.31 Favored Pre-proline 0 N--CA 1.495 1.789 0 O-C-N 120.74 -1.447 . . . . 0.0 110.369 179.929 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 781' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -80.37 138.95 12.72 Favored 'Trans proline' 0 C--N 1.304 -1.78 0 O-C-N 124.162 1.612 . . . . 0.0 110.442 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 782' ' ' LEU . . . . . 0.564 HD12 ' HA2' ' A' ' 791' ' ' GLY . 1.3 mt -103.62 168.89 8.86 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.308 -0.87 . . . . 0.0 109.914 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 783' ' ' GLY . . . . . . . . . . . . . . . 91.16 -154.17 22.74 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.628 -1.389 . . . . 0.0 109.628 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 784' ' ' THR . . . . . . . . . . . . . 7.8 t -154.59 179.54 8.95 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.334 -1.098 . . . . 0.0 110.231 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 785' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -52.99 108.33 0.31 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.274 -0.892 . . . . 0.0 110.323 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 786' ' ' GLY . . . . . . . . . . . . . . . 143.89 -36.97 1.47 Allowed Glycine 0 N--CA 1.488 2.125 0 N-CA-C 109.724 -1.35 . . . . 0.0 109.724 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 787' ' ' THR . . . . . 0.508 HG22 ' O ' ' A' ' 787' ' ' THR . 30.8 m -157.81 47.27 0.38 Allowed 'General case' 0 C--N 1.306 -1.302 0 O-C-N 121.253 -1.145 . . . . 0.0 110.497 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 788' ' ' PHE . . . . . 0.423 ' O ' ' O ' ' A' ' 787' ' ' THR . 10.8 m-85 -46.02 170.89 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.154 -0.966 . . . . 0.0 110.201 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 789' ' ' GLN . . . . . . . . . . . . . 24.0 tt0 -166.56 142.9 4.73 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.278 -0.889 . . . . 0.0 110.034 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 790' ' ' GLN . . . . . . . . . . . . . 19.3 pt20 -56.84 152.47 12.56 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 120.975 -1.078 . . . . 0.0 110.329 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 791' ' ' GLY . . . . . 0.564 ' HA2' HD12 ' A' ' 782' ' ' LEU . . . -109.44 -86.33 1.75 Allowed Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.544 -1.422 . . . . 0.0 109.544 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 792' ' ' GLU . . . . . 0.403 ' HG2' ' C ' ' A' ' 791' ' ' GLY . 68.4 mm-40 -142.64 -37.97 0.37 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.207 -1.172 . . . . 0.0 110.169 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 793' ' ' CYS . . . . . . . . . . . . . 1.3 m -107.14 131.78 53.75 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.262 -0.898 . . . . 0.0 110.331 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 794' ' ' HIS . . . . . 0.628 ' CE1' ' HA ' ' A' ' 796' ' ' ILE . 8.7 t-160 -145.48 144.29 30.5 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.175 -0.953 . . . . 0.0 110.079 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 795' ' ' SER . . . . . 0.47 ' N ' ' CD2' ' A' ' 794' ' ' HIS . 1.1 m -83.01 8.8 11.72 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.231 -0.918 . . . . 0.0 110.604 -179.91 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 796' ' ' ILE . . . . . 0.764 HG22 ' O ' ' A' ' 796' ' ' ILE . 90.4 mt 42.41 26.67 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 O-C-N 121.242 -0.911 . . . . 0.0 110.269 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 797' ' ' ASN . . . . . 0.437 ' OD1' ' O ' ' A' ' 796' ' ' ILE . 5.5 m120 -152.49 22.66 0.62 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.204 -0.935 . . . . 0.0 109.797 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 798' ' ' SER . . . . . 0.589 ' CB ' ' HA ' ' A' ' 777' ' ' SER . 13.2 m -84.62 2.59 40.85 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.435 -0.791 . . . . 0.0 110.452 -179.901 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 799' ' ' ASN . . . . . . . . . . . . . 6.9 t-20 -115.41 -14.84 11.58 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.196 -0.94 . . . . 0.0 110.908 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 800' ' ' SER . . . . . . . . . . . . . 16.4 m -82.09 -18.87 41.55 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 120.903 -1.123 . . . . 0.0 109.881 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 801' ' ' VAL . . . . . 0.435 ' O ' ' HD2' ' A' ' 805' ' ' LYS . 45.0 t -86.44 -21.41 7.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.464 -0.772 . . . . 0.0 110.117 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 802' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -79.42 -57.39 3.72 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.137 -0.977 . . . . 0.0 110.313 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 803' ' ' GLU . . . . . 0.879 ' HG2' HD12 ' A' ' 807' ' ' ILE . 0.4 OUTLIER -53.82 -22.71 10.22 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.295 -0.878 . . . . 0.0 110.339 179.942 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 804' ' ' ARG . . . . . . . . . . . . . 1.9 mtm180 -91.08 -23.92 20.18 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.188 -0.945 . . . . 0.0 110.998 -180.0 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 805' ' ' LYS . . . . . 0.435 ' HD2' ' O ' ' A' ' 801' ' ' VAL . 9.6 mttt -127.06 49.83 2.04 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.07 -1.019 . . . . 0.0 111.034 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 806' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -163.23 -71.51 0.04 OUTLIER 'General case' 0 N--CA 1.497 1.909 0 O-C-N 120.952 -1.092 . . . . 0.0 110.905 179.937 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 807' ' ' ILE . . . . . 0.879 HD12 ' HG2' ' A' ' 803' ' ' GLU . 90.6 mt -50.86 128.32 8.07 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 O-C-N 121.223 -0.923 . . . . 0.0 110.988 -179.918 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 808' ' ' GLY . . . . . 0.66 ' O ' HD23 ' A' ' 809' ' ' LEU . . . 103.89 10.84 33.92 Favored Glycine 0 N--CA 1.493 2.456 0 N-CA-C 110.127 -1.189 . . . . 0.0 110.127 179.912 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 809' ' ' LEU . . . . . 0.66 HD23 ' O ' ' A' ' 808' ' ' GLY . 33.1 mt -142.67 137.11 29.7 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.108 -1.231 . . . . 0.0 110.138 -179.913 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 810' ' ' GLU . . . . . 0.444 ' HG2' ' O ' ' A' ' 768' ' ' GLN . 0.7 OUTLIER -65.16 -21.92 66.85 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.224 -0.923 . . . . 0.0 109.289 179.972 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 811' ' ' ARG . . . . . 0.471 ' HG3' ' O ' ' A' ' 762' ' ' LEU . 1.1 ttp85 -128.76 151.52 49.47 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.538 -0.726 . . . . 0.0 109.747 179.866 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 812' ' ' CYS . . . . . 0.465 ' HB3' ' HB2' ' A' ' 762' ' ' LEU . 7.8 t -129.73 139.87 51.22 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.121 -0.987 . . . . 0.0 110.602 -179.944 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 813' ' ' VAL . . . . . . . . . . . . . 84.1 t -145.63 123.11 4.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.348 -0.845 . . . . 0.0 109.663 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 814' ' ' VAL . . . . . . . . . . . . . 88.7 t -133.0 129.01 57.25 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 O-C-N 121.129 -0.982 . . . . 0.0 110.73 -179.916 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 815' ' ' ALA . . . . . . . . . . . . . . . -88.75 127.8 35.61 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.339 -0.851 . . . . 0.0 109.755 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 816' ' ' ILE . . . . . 1.014 HD13 HG21 ' A' ' 833' ' ' VAL . 46.2 mt -84.3 114.01 24.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.181 -0.949 . . . . 0.0 110.436 -179.905 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 817' ' ' SER . . . . . . . . . . . . . 5.0 p -158.84 158.57 29.27 Favored Pre-proline 0 N--CA 1.495 1.777 0 O-C-N 121.356 -0.84 . . . . 0.0 109.91 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 818' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -75.29 2.65 6.54 Favored 'Trans proline' 0 C--N 1.306 -1.692 0 O-C-N 123.926 1.487 . . . . 0.0 110.772 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 819' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -111.77 7.67 20.32 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.103 -0.998 . . . . 0.0 110.253 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 820' ' ' ASN . . . . . . . . . . . . . 6.8 m-20 -121.19 -7.2 9.38 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.248 -0.907 . . . . 0.0 110.262 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 821' ' ' PHE . . . . . . . . . . . . . 4.8 m-85 -110.66 -65.96 1.12 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.261 -0.9 . . . . 0.0 110.19 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 822' ' ' GLY . . . . . . . . . . . . . . . 161.27 63.86 0.02 OUTLIER Glycine 0 N--CA 1.492 2.41 0 N-CA-C 110.006 -1.238 . . . . 0.0 110.006 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 823' ' ' GLY . . . . . . . . . . . . . . . 78.7 -150.41 34.51 Favored Glycine 0 N--CA 1.493 2.47 0 N-CA-C 110.036 -1.226 . . . . 0.0 110.036 179.907 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 824' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -109.17 141.88 24.39 Favored Pre-proline 0 N--CA 1.493 1.709 0 O-C-N 121.26 -1.141 . . . . 0.0 110.407 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 825' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -80.53 -91.2 0.0 OUTLIER 'Trans proline' 0 C--N 1.306 -1.699 0 O-C-N 124.11 1.584 . . . . 0.0 110.693 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 826' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -101.5 132.95 21.17 Favored Pre-proline 0 N--CA 1.496 1.872 0 O-C-N 121.189 -0.944 . . . . 0.0 110.372 -179.924 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 827' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -82.52 157.51 16.63 Favored 'Trans proline' 0 C--N 1.309 -1.525 0 O-C-N 123.958 1.504 . . . . 0.0 110.629 180.0 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 828' ' ' GLU . . . . . 0.452 ' O ' ' OE1' ' A' ' 828' ' ' GLU . 7.2 tm-20 54.47 39.13 30.83 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.243 -0.91 . . . . 0.0 110.622 179.906 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 829' ' ' VAL . . . . . 0.413 ' O ' ' C ' ' A' ' 830' ' ' MET . 20.2 t -142.81 118.3 4.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.071 -1.018 . . . . 0.0 110.369 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 830' ' ' MET . . . . . 0.413 ' C ' ' O ' ' A' ' 829' ' ' VAL . 4.7 mtt -42.71 158.32 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.246 -0.909 . . . . 0.0 109.878 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 831' ' ' LYS . . . . . 0.535 ' HB3' ' HB2' ' A' ' 737' ' ' GLU . 4.9 mtmt -115.04 110.57 19.77 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.118 -0.989 . . . . 0.0 110.877 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 832' ' ' ARG . . . . . . . . . . . . . 10.6 mtm-85 -116.38 135.31 53.97 Favored 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 179.927 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 833' ' ' VAL . . . . . 1.014 HG21 HD13 ' A' ' 816' ' ' ILE . 7.7 t -111.5 130.09 65.68 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.631 0 O-C-N 120.986 -1.071 . . . . 0.0 111.334 -179.94 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 834' ' ' ALA . . . . . . . . . . . . . . . -134.81 129.43 34.52 Favored 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 835' ' ' VAL . . . . . 0.403 ' CG1' ' N ' ' A' ' 836' ' ' GLU . 18.3 t -137.95 160.82 33.13 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 O-C-N 120.932 -1.105 . . . . 0.0 111.334 -179.869 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 836' ' ' GLU . . . . . 0.403 ' N ' ' CG1' ' A' ' 835' ' ' VAL . 0.0 OUTLIER -148.39 121.41 8.83 Favored 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 179.988 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 837' ' ' ALA . . . . . . . . . . . . . . . -109.55 155.32 21.54 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.006 -1.059 . . . . 0.0 111.016 -179.893 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 838' ' ' VAL . . . . . 0.569 ' CG2' ' HG2' ' A' ' 774' ' ' LYS . 6.0 t -111.97 114.59 47.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.422 -0.799 . . . . 0.0 109.804 179.926 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 839' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -109.42 136.76 48.31 Favored 'General case' 0 C--N 1.299 -1.611 0 O-C-N 121.128 -0.982 . . . . 0.0 110.245 -179.881 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 840' ' ' SER . . . . . 0.718 ' O ' HG23 ' A' ' 841' ' ' THR . 0.4 OUTLIER -136.43 -82.02 0.38 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.284 -0.885 . . . . 0.0 109.942 179.955 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 841' ' ' THR . . . . . 0.718 HG23 ' O ' ' A' ' 840' ' ' SER . 13.5 p -159.98 -176.91 5.96 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.294 -0.878 . . . . 0.0 110.006 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 842' ' ' ALA . . . . . . . . . . . . . . . -72.88 151.12 42.1 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.228 -0.92 . . . . 0.0 110.229 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 843' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.685 0 CA-C-O 118.026 -0.988 . . . . 0.0 110.221 -179.996 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 726' ' ' ARG . . . . . 0.462 ' NE ' ' HA ' ' A' ' 726' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.682 0 CA-C-O 121.274 0.559 . . . . 0.0 110.23 . . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 727' ' ' THR . . . . . . . . . . . . . 11.8 t -124.49 160.7 27.69 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.23 -0.919 . . . . 0.0 110.183 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 728' ' ' VAL . . . . . 0.456 ' O ' ' O ' ' A' ' 839' ' ' CYS . 3.4 p -151.29 147.31 15.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.221 -0.924 . . . . 0.0 110.354 -179.981 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 729' ' ' SER . . . . . . . . . . . . . 75.3 p -55.01 178.58 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.243 -0.911 . . . . 0.0 110.3 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 730' ' ' GLY . . . . . 0.447 ' HA2' ' HB2' ' A' ' 839' ' ' CYS . . . -113.7 -139.11 7.15 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.658 -1.377 . . . . 0.0 109.658 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 731' ' ' VAL . . . . . . . . . . . . . 30.0 t -128.44 155.5 40.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.288 -1.125 . . . . 0.0 110.254 -179.89 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 732' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -108.22 145.92 33.56 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.361 -0.837 . . . . 0.0 109.431 179.892 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 733' ' ' ALA . . . . . . . . . . . . . . . -147.11 128.56 14.96 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.021 -1.049 . . . . 0.0 110.781 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 734' ' ' ASP . . . . . 0.459 ' OD1' ' O ' ' A' ' 734' ' ' ASP . 1.5 p30 -131.72 109.23 10.02 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.454 -0.779 . . . . 0.0 109.673 179.93 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 735' ' ' VAL . . . . . 0.972 HG21 HG22 ' A' ' 760' ' ' VAL . 7.0 m -129.58 157.13 42.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.115 -0.991 . . . . 0.0 110.586 -179.916 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 736' ' ' SER . . . . . 0.427 ' O ' ' C ' ' A' ' 737' ' ' GLU . 70.9 m -119.43 140.15 50.89 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.436 -0.79 . . . . 0.0 109.714 179.918 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 737' ' ' GLU . . . . . 0.427 ' C ' ' O ' ' A' ' 736' ' ' SER . 11.2 tp10 -41.9 110.74 0.18 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.215 -0.928 . . . . 0.0 109.979 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 738' ' ' TYR . . . . . 0.486 ' HB2' ' HB2' ' A' ' 758' ' ' ALA . 57.2 t80 -67.15 125.12 25.05 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.307 -0.87 . . . . 0.0 110.034 -179.926 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 739' ' ' HIS . . . . . . . . . . . . . 20.8 t-80 -175.27 97.77 0.27 Allowed Pre-proline 0 N--CA 1.489 1.478 0 O-C-N 121.246 -0.909 . . . . 0.0 110.379 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 740' ' ' PRO . . . . . 0.588 ' O ' ' CB ' ' A' ' 741' ' ' ASN . 50.1 Cg_endo -78.05 7.29 4.09 Favored 'Trans proline' 0 C--N 1.307 -1.612 0 O-C-N 124.008 1.531 . . . . 0.0 110.602 179.966 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 741' ' ' ASN . . . . . 0.588 ' CB ' ' O ' ' A' ' 740' ' ' PRO . 1.8 t-20 82.23 -52.93 0.22 Allowed 'General case' 0 N--CA 1.511 2.621 0 O-C-N 121.822 -0.549 . . . . 0.0 110.399 -179.987 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 742' ' ' ILE . . . . . 0.463 ' O ' ' O ' ' A' ' 741' ' ' ASN . 15.7 mt 59.93 133.81 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.109 -0.994 . . . . 0.0 110.28 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 743' ' ' LYS . . . . . 0.462 ' O ' ' HB3' ' A' ' 744' ' ' ASN . 30.3 pttt -125.11 145.25 50.02 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.151 -0.968 . . . . 0.0 109.952 179.934 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 744' ' ' ASN . . . . . 0.462 ' HB3' ' O ' ' A' ' 743' ' ' LYS . 10.5 t-20 59.99 62.07 1.74 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.242 -0.911 . . . . 0.0 109.944 -179.965 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 745' ' ' TRP . . . . . 0.774 ' HE1' HD11 ' A' ' 747' ' ' ILE . 40.1 p90 -80.01 3.26 20.7 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.439 -0.788 . . . . 0.0 110.098 -179.956 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 746' ' ' GLN . . . . . 0.477 ' O ' HG13 ' A' ' 747' ' ' ILE . 0.0 OUTLIER 66.73 152.69 0.07 Allowed 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.343 -0.848 . . . . 0.0 111.834 179.831 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 747' ' ' ILE . . . . . 0.807 HG22 ' O ' ' A' ' 747' ' ' ILE . 25.4 mt -157.13 36.65 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.94 0 CA-C-O 121.619 0.723 . . . . 0.0 109.078 179.942 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 748' ' ' GLU . . . . . 0.485 ' HG2' ' N ' ' A' ' 749' ' ' SER . 29.5 tt0 -101.17 -99.25 0.26 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.925 -1.109 . . . . 0.0 111.014 -179.888 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 749' ' ' SER . . . . . 0.485 ' N ' ' HG2' ' A' ' 748' ' ' GLU . 8.4 t -111.55 13.95 21.34 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.012 -1.055 . . . . 0.0 110.691 -179.955 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 750' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -92.2 -79.31 0.39 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.142 -0.974 . . . . 0.0 110.207 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 751' ' ' GLY . . . . . . . . . . . . . . . 85.55 -72.72 2.69 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.598 -1.401 . . . . 0.0 109.598 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 752' ' ' GLU . . . . . 0.483 ' HG2' ' HD2' ' A' ' 753' ' ' PRO . 0.8 OUTLIER 58.47 172.17 0.05 OUTLIER Pre-proline 0 N--CA 1.493 1.69 0 O-C-N 121.215 -1.168 . . . . 0.0 110.182 -179.944 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 753' ' ' PRO . . . . . 0.483 ' HD2' ' HG2' ' A' ' 752' ' ' GLU . 46.9 Cg_endo -74.19 138.68 25.54 Favored 'Trans proline' 0 C--N 1.305 -1.739 0 O-C-N 123.966 1.509 . . . . 0.0 110.418 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 754' ' ' GLU . . . . . . . . . . . . . 21.9 tt0 -120.65 67.62 0.85 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.281 -0.887 . . . . 0.0 110.121 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 755' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -128.48 47.66 2.41 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.238 -0.914 . . . . 0.0 110.465 -179.945 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 756' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -77.67 98.16 5.36 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.161 -0.962 . . . . 0.0 110.065 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 757' ' ' THR . . . . . . . . . . . . . 20.6 p -144.78 -178.33 5.96 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.254 -0.903 . . . . 0.0 110.421 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 758' ' ' ALA . . . . . 0.486 ' HB2' ' HB2' ' A' ' 738' ' ' TYR . . . -107.92 178.96 4.36 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.328 -0.857 . . . . 0.0 110.141 180.0 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 759' ' ' LYS . . . . . . . . . . . . . 29.7 mttm -140.42 138.82 35.03 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.224 -0.923 . . . . 0.0 110.592 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 760' ' ' VAL . . . . . 0.972 HG22 HG21 ' A' ' 735' ' ' VAL . 41.9 t -115.67 108.71 25.96 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 O-C-N 121.427 -0.796 . . . . 0.0 109.552 179.927 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 761' ' ' HIS . . . . . 0.503 ' CB ' HG22 ' A' ' 813' ' ' VAL . 42.2 p-80 -124.96 139.63 53.65 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 120.945 -1.097 . . . . 0.0 111.468 -179.82 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 762' ' ' LEU . . . . . 0.514 HD13 ' HB2' ' A' ' 837' ' ' ALA . 12.4 mt -119.33 110.87 17.48 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 109.057 -0.719 . . . . 0.0 109.057 179.892 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 763' ' ' LYS . . . . . 0.405 ' HA ' ' HA ' ' A' ' 811' ' ' ARG . 0.0 OUTLIER -110.31 133.46 53.23 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.151 -0.968 . . . . 0.0 111.001 -179.865 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 764' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -111.14 164.27 13.03 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.436 -0.79 . . . . 0.0 109.856 179.925 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 765' ' ' ALA . . . . . 0.539 ' HB3' ' OE1' ' A' ' 768' ' ' GLN . . . -56.04 164.0 2.0 Allowed Pre-proline 0 N--CA 1.493 1.68 0 O-C-N 121.118 -0.989 . . . . 0.0 110.177 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 766' ' ' PRO . . . . . 0.486 ' HD2' ' HB1' ' A' ' 765' ' ' ALA . 45.2 Cg_endo -71.71 114.2 3.88 Favored 'Trans proline' 0 C--N 1.305 -1.747 0 O-C-N 123.962 1.506 . . . . 0.0 110.394 179.984 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 767' ' ' GLY . . . . . . . . . . . . . . . 123.13 -18.48 7.88 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.436 -1.466 . . . . 0.0 109.436 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 768' ' ' GLN . . . . . 0.554 ' HG3' ' CA ' ' A' ' 841' ' ' THR . 0.5 OUTLIER -110.38 130.75 55.49 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.224 -1.162 . . . . 0.0 110.176 179.975 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 769' ' ' THR . . . . . . . . . . . . . 45.7 p -118.25 148.59 42.27 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.226 -0.921 . . . . 0.0 110.364 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 770' ' ' ILE . . . . . 0.563 HG22 HG13 ' A' ' 807' ' ' ILE . 2.6 mp -66.28 141.3 18.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.297 -0.877 . . . . 0.0 110.014 179.971 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 771' ' ' SER . . . . . . . . . . . . . 11.8 p -120.6 -15.92 8.38 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.109 -0.995 . . . . 0.0 110.565 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 772' ' ' ALA . . . . . 0.506 ' O ' HD13 ' A' ' 773' ' ' ILE . . . -169.64 171.85 7.24 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.063 -1.023 . . . . 0.0 111.029 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 773' ' ' ILE . . . . . 0.506 HD13 ' O ' ' A' ' 772' ' ' ALA . 25.8 mm -116.6 134.27 60.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.505 -0.747 . . . . 0.0 109.603 179.912 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 774' ' ' LYS . . . . . 0.515 ' HB2' ' HB3' ' A' ' 836' ' ' GLU . 0.9 OUTLIER -83.89 -34.74 24.49 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.122 -0.986 . . . . 0.0 110.718 -179.96 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 775' ' ' PHE . . . . . 0.586 ' CZ ' ' HB2' ' A' ' 777' ' ' SER . 44.7 t80 -162.31 164.1 27.67 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.091 -1.006 . . . . 0.0 110.691 -179.956 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 776' ' ' ALA . . . . . 0.671 ' HB1' ' O ' ' A' ' 798' ' ' SER . . . -176.52 121.49 0.15 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.458 -0.776 . . . . 0.0 109.922 -179.964 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 777' ' ' SER . . . . . 0.586 ' HB2' ' CZ ' ' A' ' 775' ' ' PHE . 0.2 OUTLIER -140.3 137.28 34.05 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.145 -0.972 . . . . 0.0 110.69 -179.972 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 778' ' ' PHE . . . . . 0.509 ' CG ' ' O ' ' A' ' 778' ' ' PHE . 29.3 t80 -116.82 74.19 0.9 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.276 -0.89 . . . . 0.0 109.933 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 779' ' ' GLY . . . . . . . . . . . . . . . -175.53 -86.97 0.07 OUTLIER Glycine 0 N--CA 1.495 2.619 0 C-N-CA 119.486 -1.34 . . . . 0.0 110.456 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 780' ' ' THR . . . . . . . . . . . . . 13.0 p -136.86 92.59 14.33 Favored Pre-proline 0 N--CA 1.494 1.761 0 O-C-N 121.078 -1.248 . . . . 0.0 110.825 -179.928 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 781' ' ' PRO . . . . . 0.47 ' O ' ' HG ' ' A' ' 782' ' ' LEU . 50.9 Cg_endo -85.41 155.56 10.73 Favored 'Trans proline' 0 C--N 1.306 -1.697 0 O-C-N 124.066 1.561 . . . . 0.0 110.271 179.942 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 782' ' ' LEU . . . . . 0.527 ' HB2' ' HB2' ' A' ' 789' ' ' GLN . 1.6 mt -143.81 129.38 19.13 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.115 -0.991 . . . . 0.0 110.263 179.978 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 783' ' ' GLY . . . . . . . . . . . . . . . 121.64 -168.75 14.49 Favored Glycine 0 N--CA 1.492 2.374 0 N-CA-C 109.71 -1.356 . . . . 0.0 109.71 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 784' ' ' THR . . . . . 0.497 ' O ' ' CE1' ' A' ' 788' ' ' PHE . 0.3 OUTLIER -115.33 -146.74 0.41 Allowed 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.258 -1.142 . . . . 0.0 110.163 179.997 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 785' ' ' CYS . . . . . . . . . . . . . 54.1 t -82.07 123.12 28.65 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.225 -0.922 . . . . 0.0 110.1 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 786' ' ' GLY . . . . . . . . . . . . . . . 86.34 -1.61 87.45 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.609 -1.396 . . . . 0.0 109.609 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 787' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -140.86 36.98 1.78 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.205 -1.174 . . . . 0.0 110.062 -179.957 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 788' ' ' PHE . . . . . 0.497 ' CE1' ' O ' ' A' ' 784' ' ' THR . 28.8 m-85 -74.15 171.37 13.69 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.248 -0.908 . . . . 0.0 110.369 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 789' ' ' GLN . . . . . 0.527 ' HB2' ' HB2' ' A' ' 782' ' ' LEU . 5.8 mt-30 -143.17 97.7 3.13 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.371 -0.831 . . . . 0.0 109.961 179.971 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 790' ' ' GLN . . . . . 0.49 ' O ' ' HG3' ' A' ' 790' ' ' GLN . 14.1 pt20 -46.32 108.15 0.13 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.256 -0.903 . . . . 0.0 110.306 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 791' ' ' GLY . . . . . . . . . . . . . . . -58.38 177.15 1.86 Allowed Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.326 -1.51 . . . . 0.0 109.326 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 792' ' ' GLU . . . . . 0.499 ' CG ' ' O ' ' A' ' 792' ' ' GLU . 0.6 OUTLIER -80.4 5.38 15.16 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.205 -1.174 . . . . 0.0 110.231 179.997 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 793' ' ' CYS . . . . . . . . . . . . . 22.8 t -102.8 16.69 25.82 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.238 -0.914 . . . . 0.0 111.062 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 794' ' ' HIS . . . . . 0.466 ' CD2' ' HG ' ' A' ' 798' ' ' SER . 31.8 t-80 -62.28 125.3 23.42 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.938 -1.101 . . . . 0.0 110.258 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 795' ' ' SER . . . . . . . . . . . . . 1.4 m -72.89 -130.59 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.165 -0.96 . . . . 0.0 109.605 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 796' ' ' ILE . . . . . . . . . . . . . 1.6 pt -137.94 22.9 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 120.854 -1.153 . . . . 0.0 110.363 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 797' ' ' ASN . . . . . . . . . . . . . 36.1 p30 -154.75 22.12 0.45 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.296 -0.878 . . . . 0.0 110.232 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 798' ' ' SER . . . . . 0.671 ' O ' ' HB1' ' A' ' 776' ' ' ALA . 0.8 OUTLIER -72.44 -19.68 61.53 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.115 -0.99 . . . . 0.0 109.936 179.966 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 799' ' ' ASN . . . . . 0.451 ' CG ' ' HB3' ' A' ' 776' ' ' ALA . 2.3 t-20 -114.09 -10.36 12.83 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.32 -0.863 . . . . 0.0 110.009 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 800' ' ' SER . . . . . 0.512 ' O ' ' HB2' ' A' ' 804' ' ' ARG . 0.9 OUTLIER -89.86 -28.56 19.17 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.359 -0.838 . . . . 0.0 110.13 179.954 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 801' ' ' VAL . . . . . 0.496 HG12 HD22 ' A' ' 802' ' ' LEU . 24.6 t -66.59 -30.48 49.9 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.143 -0.973 . . . . 0.0 110.472 -179.964 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 802' ' ' LEU . . . . . 0.497 ' O ' ' HB2' ' A' ' 806' ' ' CYS . 4.4 mm? -90.11 -44.84 9.53 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.231 -0.918 . . . . 0.0 110.792 -179.945 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 803' ' ' GLU . . . . . 0.571 ' HA ' ' CD1' ' A' ' 807' ' ' ILE . 32.1 tt0 -62.67 -21.94 66.09 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.125 -0.985 . . . . 0.0 110.927 -179.89 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 804' ' ' ARG . . . . . 0.512 ' HB2' ' O ' ' A' ' 800' ' ' SER . 0.0 OUTLIER -91.96 -19.4 22.47 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 120.981 -1.075 . . . . 0.0 111.055 -179.971 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 805' ' ' LYS . . . . . . . . . . . . . 12.9 ttpp -132.47 51.3 2.16 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.004 -1.06 . . . . 0.0 111.05 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 806' ' ' CYS . . . . . 0.497 ' HB2' ' O ' ' A' ' 802' ' ' LEU . 1.2 t -156.96 -33.0 0.08 Allowed 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.015 -1.053 . . . . 0.0 111.067 179.925 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 807' ' ' ILE . . . . . 0.571 ' CD1' ' HA ' ' A' ' 803' ' ' GLU . 2.5 mp -77.17 121.89 30.58 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 O-C-N 120.979 -1.076 . . . . 0.0 110.78 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 808' ' ' GLY . . . . . 0.444 ' C ' ' HG ' ' A' ' 809' ' ' LEU . . . 107.78 13.86 19.02 Favored Glycine 0 N--CA 1.494 2.521 0 N-CA-C 110.082 -1.207 . . . . 0.0 110.082 179.935 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 809' ' ' LEU . . . . . 0.444 ' HG ' ' C ' ' A' ' 808' ' ' GLY . 4.2 mt -134.5 134.84 41.92 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.076 -1.25 . . . . 0.0 110.443 179.961 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 810' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -65.82 -13.62 59.85 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.236 -0.915 . . . . 0.0 109.245 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 811' ' ' ARG . . . . . 0.405 ' HA ' ' HA ' ' A' ' 763' ' ' LYS . 0.4 OUTLIER -141.7 164.18 30.91 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.578 -0.701 . . . . 0.0 109.627 179.968 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 812' ' ' CYS . . . . . 0.439 ' O ' ' HB2' ' A' ' 761' ' ' HIS . 1.7 t -145.37 132.0 19.9 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.19 -0.944 . . . . 0.0 110.241 -179.952 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 813' ' ' VAL . . . . . 0.503 HG22 ' CB ' ' A' ' 761' ' ' HIS . 54.3 t -143.43 110.83 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.156 -0.965 . . . . 0.0 110.328 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 814' ' ' VAL . . . . . . . . . . . . . 61.4 t -119.06 149.61 21.53 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.452 0 O-C-N 121.456 -0.778 . . . . 0.0 109.629 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 815' ' ' ALA . . . . . . . . . . . . . . . -102.34 132.08 48.55 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.142 -0.974 . . . . 0.0 110.263 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 816' ' ' ILE . . . . . 0.947 HD11 HG23 ' A' ' 760' ' ' VAL . 26.6 mt -89.62 151.72 3.44 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 121.346 -0.846 . . . . 0.0 110.384 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 817' ' ' SER . . . . . 0.402 ' CB ' ' O ' ' A' ' 816' ' ' ILE . 0.0 OUTLIER 174.74 171.93 0.27 Allowed Pre-proline 0 N--CA 1.494 1.748 0 O-C-N 121.265 -0.897 . . . . 0.0 110.129 -179.99 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 818' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -73.92 -45.11 0.4 Allowed 'Trans proline' 0 C--N 1.305 -1.748 0 O-C-N 124.017 1.535 . . . . 0.0 110.468 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 819' ' ' SER . . . . . . . . . . . . . 59.5 p -95.81 46.53 1.09 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.258 -0.901 . . . . 0.0 110.088 179.92 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 820' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -126.9 -28.68 2.9 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.274 -0.891 . . . . 0.0 110.477 -179.946 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 821' ' ' PHE . . . . . 0.435 ' CD2' HG21 ' A' ' 801' ' ' VAL . 11.9 m-85 -103.73 -72.22 0.71 Allowed 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.15 -0.969 . . . . 0.0 110.302 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 822' ' ' GLY . . . . . . . . . . . . . . . -179.83 56.94 0.08 OUTLIER Glycine 0 N--CA 1.492 2.43 0 N-CA-C 109.823 -1.311 . . . . 0.0 109.823 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 823' ' ' GLY . . . . . . . . . . . . . . . 60.33 -172.57 5.86 Favored Glycine 0 N--CA 1.494 2.507 0 N-CA-C 109.87 -1.292 . . . . 0.0 109.87 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 824' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -112.76 138.43 22.11 Favored Pre-proline 0 N--CA 1.495 1.79 0 O-C-N 121.345 -1.091 . . . . 0.0 110.168 -179.976 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 825' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_endo -84.54 -36.82 0.15 Allowed 'Trans proline' 0 C--N 1.304 -1.77 0 O-C-N 124.075 1.566 . . . . 0.0 111.08 -179.89 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 826' ' ' CYS . . . . . 0.432 ' HA ' ' HD3' ' A' ' 827' ' ' PRO . 0.8 OUTLIER -110.28 133.16 21.15 Favored Pre-proline 0 N--CA 1.504 2.256 0 O-C-N 120.971 -1.081 . . . . 0.0 110.714 -179.903 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 827' ' ' PRO . . . . . 0.799 ' O ' HG23 ' A' ' 829' ' ' VAL . 51.0 Cg_endo -87.27 167.63 7.76 Favored 'Trans proline' 0 C--N 1.309 -1.517 0 O-C-N 123.997 1.525 . . . . 0.0 110.348 179.907 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 828' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER 47.36 25.2 0.55 Allowed 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.216 -0.928 . . . . 0.0 110.897 179.978 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 829' ' ' VAL . . . . . 0.799 HG23 ' O ' ' A' ' 827' ' ' PRO . 81.9 t -127.67 125.0 64.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.0 -1.063 . . . . 0.0 110.317 -179.96 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 830' ' ' MET . . . . . . . . . . . . . 29.2 mtt -56.89 -173.13 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.179 -0.951 . . . . 0.0 109.837 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 831' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.73 127.54 8.83 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.12 -0.987 . . . . 0.0 110.878 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 832' ' ' ARG . . . . . . . . . . . . . 2.8 mtt180 -123.4 167.55 13.69 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.542 -0.724 . . . . 0.0 109.094 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 833' ' ' VAL . . . . . 0.615 HG21 ' CG2' ' A' ' 816' ' ' ILE . 88.9 t -124.27 109.06 21.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 120.795 -1.191 . . . . 0.0 111.399 -179.909 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 834' ' ' ALA . . . . . 0.587 ' O ' HG23 ' A' ' 835' ' ' VAL . . . -109.49 141.02 42.54 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 179.808 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 835' ' ' VAL . . . . . 0.587 HG23 ' O ' ' A' ' 834' ' ' ALA . 23.6 t -154.85 163.52 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 120.634 -1.291 . . . . 0.0 112.095 -179.872 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 836' ' ' GLU . . . . . 0.515 ' HB3' ' HB2' ' A' ' 774' ' ' LYS . 0.6 OUTLIER -148.27 149.19 31.43 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 107.972 -1.122 . . . . 0.0 107.972 179.974 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 837' ' ' ALA . . . . . 0.514 ' HB2' HD13 ' A' ' 762' ' ' LEU . . . -135.66 154.18 51.38 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 120.633 -1.292 . . . . 0.0 111.899 -179.862 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 838' ' ' VAL . . . . . 0.451 ' O ' ' HA ' ' A' ' 770' ' ' ILE . 41.1 t -109.12 125.5 66.21 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 179.882 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 839' ' ' CYS . . . . . 0.456 ' O ' ' O ' ' A' ' 728' ' ' VAL . 0.5 OUTLIER -116.5 161.25 19.41 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.962 -1.086 . . . . 0.0 111.199 -179.928 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 840' ' ' SER . . . . . 0.412 ' OG ' ' C ' ' A' ' 839' ' ' CYS . 0.2 OUTLIER -168.27 140.39 2.9 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.665 -0.647 . . . . 0.0 109.501 -179.981 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 841' ' ' THR . . . . . 0.554 ' CA ' ' HG3' ' A' ' 768' ' ' GLN . 11.8 t -78.03 173.98 11.61 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.084 -1.01 . . . . 0.0 110.482 -179.972 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 842' ' ' ALA . . . . . . . . . . . . . . . -45.16 118.36 1.66 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.302 -0.874 . . . . 0.0 110.192 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 843' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.696 0 CA-C-O 118.013 -0.994 . . . . 0.0 110.262 179.995 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 726' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.492 1.648 0 CA-C-O 121.269 0.557 . . . . 0.0 110.14 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 727' ' ' THR . . . . . . . . . . . . . 1.7 m 62.64 152.18 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.265 -0.897 . . . . 0.0 110.15 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 728' ' ' VAL . . . . . . . . . . . . . 75.2 t -97.64 -67.88 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.224 -0.922 . . . . 0.0 110.221 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 729' ' ' SER . . . . . . . . . . . . . 16.1 p -167.26 167.11 14.38 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.164 -0.96 . . . . 0.0 110.501 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 730' ' ' GLY . . . . . . . . . . . . . . . -129.84 176.75 18.52 Favored Glycine 0 N--CA 1.489 2.202 0 N-CA-C 109.414 -1.475 . . . . 0.0 109.414 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 731' ' ' VAL . . . . . . . . . . . . . 2.6 m -131.7 137.88 54.1 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.283 -1.128 . . . . 0.0 110.462 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 732' ' ' CYS . . . . . . . . . . . . . 48.7 m -109.87 154.65 22.74 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.386 -0.821 . . . . 0.0 109.658 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 733' ' ' ALA . . . . . . . . . . . . . . . -167.59 114.27 0.74 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.111 -0.993 . . . . 0.0 111.001 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 734' ' ' ASP . . . . . 0.442 ' OD1' HG22 ' A' ' 784' ' ' THR . 1.6 m-20 -111.22 120.53 42.59 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.385 -0.822 . . . . 0.0 109.444 179.894 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 735' ' ' VAL . . . . . . . . . . . . . 79.3 t -129.44 144.69 37.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.155 -0.966 . . . . 0.0 110.591 -179.919 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 736' ' ' SER . . . . . . . . . . . . . 2.3 m -89.97 -170.46 2.8 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.39 -0.819 . . . . 0.0 109.895 179.913 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 737' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -108.08 158.19 17.62 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.203 -0.936 . . . . 0.0 110.488 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 738' ' ' TYR . . . . . 0.468 ' CD2' ' CD1' ' A' ' 755' ' ' PHE . 51.6 t80 -122.52 -57.23 1.75 Allowed 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.361 -0.837 . . . . 0.0 109.785 179.967 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 739' ' ' HIS . . . . . 0.445 ' O ' ' O ' ' A' ' 738' ' ' TYR . 0.9 OUTLIER 52.94 104.28 0.03 OUTLIER Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 121.322 -0.861 . . . . 0.0 110.752 179.981 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 740' ' ' PRO . . . . . 0.477 ' HD3' ' O ' ' A' ' 756' ' ' HIS . 50.9 Cg_endo -79.31 77.01 4.25 Favored 'Trans proline' 0 C--N 1.306 -1.697 0 O-C-N 124.094 1.576 . . . . 0.0 110.38 179.945 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 741' ' ' ASN . . . . . 0.461 ' O ' ' O ' ' A' ' 742' ' ' ILE . 42.3 t30 -134.0 -38.53 0.88 Allowed 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.021 -1.05 . . . . 0.0 110.406 -179.955 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 742' ' ' ILE . . . . . 0.616 HG22 ' N ' ' A' ' 743' ' ' LYS . 18.5 mt -50.62 -102.48 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 121.285 -0.884 . . . . 0.0 110.329 -179.944 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 743' ' ' LYS . . . . . 0.616 ' N ' HG22 ' A' ' 742' ' ' ILE . 5.9 pttp 170.96 -39.28 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.074 0 O-C-N 121.111 -0.993 . . . . 0.0 109.914 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 744' ' ' ASN . . . . . 0.415 ' O ' ' C ' ' A' ' 745' ' ' TRP . 0.8 OUTLIER -164.19 90.29 0.58 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.378 -0.826 . . . . 0.0 109.63 179.973 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 745' ' ' TRP . . . . . 0.459 ' HE1' HD12 ' A' ' 742' ' ' ILE . 4.9 m0 -42.02 156.72 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.308 -0.87 . . . . 0.0 110.642 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 746' ' ' GLN . . . . . . . . . . . . . 4.1 mt-30 -120.17 107.88 13.55 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.458 -0.776 . . . . 0.0 110.09 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 747' ' ' ILE . . . . . 0.794 HD12 ' OG ' ' A' ' 749' ' ' SER . 6.1 pt -139.48 -176.24 1.19 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.267 -0.895 . . . . 0.0 110.091 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 748' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -96.71 34.08 1.74 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.213 -0.93 . . . . 0.0 110.469 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 749' ' ' SER . . . . . 0.794 ' OG ' HD12 ' A' ' 747' ' ' ILE . 80.9 p -146.92 -43.29 0.18 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.195 -0.941 . . . . 0.0 110.211 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 750' ' ' TYR . . . . . 0.477 ' O ' ' O ' ' A' ' 749' ' ' SER . 27.6 m-85 57.72 124.32 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.413 -0.805 . . . . 0.0 110.61 179.96 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 751' ' ' GLY . . . . . . . . . . . . . . . 135.91 91.78 0.34 Allowed Glycine 0 N--CA 1.489 2.178 0 C-N-CA 119.62 -1.276 . . . . 0.0 110.329 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 752' ' ' GLU . . . . . 0.517 ' CG ' ' O ' ' A' ' 752' ' ' GLU . 16.2 pt-20 -105.92 117.24 58.17 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.349 -1.089 . . . . 0.0 109.208 179.856 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 753' ' ' PRO . . . . . 0.476 ' O ' ' O ' ' A' ' 754' ' ' GLU . 47.6 Cg_endo -75.23 71.86 4.99 Favored 'Trans proline' 0 C--N 1.309 -1.551 0 O-C-N 123.99 1.521 . . . . 0.0 111.547 -179.927 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 754' ' ' GLU . . . . . 0.476 ' O ' ' O ' ' A' ' 753' ' ' PRO . 2.2 tm-20 56.78 134.23 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.361 -0.837 . . . . 0.0 111.528 179.903 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 755' ' ' PHE . . . . . 0.468 ' CD1' ' CD2' ' A' ' 738' ' ' TYR . 4.3 t80 178.23 137.1 0.08 Allowed 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.386 -0.821 . . . . 0.0 110.144 179.91 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 756' ' ' HIS . . . . . 0.477 ' O ' ' HD3' ' A' ' 740' ' ' PRO . 83.7 m-70 -135.32 -53.71 0.78 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.244 -0.91 . . . . 0.0 110.339 -179.904 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 757' ' ' THR . . . . . 0.428 ' O ' ' C ' ' A' ' 758' ' ' ALA . 0.0 OUTLIER -130.49 117.1 19.12 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.207 -0.933 . . . . 0.0 110.332 -179.974 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 758' ' ' ALA . . . . . 0.464 ' O ' ' HG3' ' A' ' 759' ' ' LYS . . . -42.85 156.31 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.291 -0.881 . . . . 0.0 109.763 -179.997 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 759' ' ' LYS . . . . . 0.464 ' HG3' ' O ' ' A' ' 758' ' ' ALA . 18.3 mtpt -144.73 157.52 44.15 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.108 -0.995 . . . . 0.0 110.827 -179.892 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 760' ' ' VAL . . . . . 0.416 ' O ' ' HA ' ' A' ' 813' ' ' VAL . 77.9 t -107.67 132.92 53.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.395 -0.816 . . . . 0.0 108.92 179.947 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 761' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -108.87 104.82 14.15 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.065 -1.022 . . . . 0.0 111.328 -179.737 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 762' ' ' LEU . . . . . . . . . . . . . 25.8 mt -114.74 137.45 51.91 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 179.784 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 763' ' ' LYS . . . . . . . . . . . . . 18.7 ttpp -133.64 146.78 51.22 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.923 -1.111 . . . . 0.0 111.419 -179.894 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 764' ' ' CYS . . . . . 0.425 ' HB2' ' O ' ' A' ' 810' ' ' GLU . 20.7 m -141.55 155.15 45.8 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.597 -0.689 . . . . 0.0 109.434 179.86 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 765' ' ' ALA . . . . . 0.948 ' HB1' ' HD2' ' A' ' 766' ' ' PRO . . . -83.15 178.53 2.38 Favored Pre-proline 0 N--CA 1.494 1.727 0 O-C-N 121.059 -1.025 . . . . 0.0 110.354 -179.924 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 766' ' ' PRO . . . . . 0.948 ' HD2' ' HB1' ' A' ' 765' ' ' ALA . 44.0 Cg_endo -70.31 151.42 65.95 Favored 'Trans proline' 0 C--N 1.307 -1.642 0 O-C-N 123.968 1.509 . . . . 0.0 110.181 179.966 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 767' ' ' GLY . . . . . . . . . . . . . . . 70.87 3.81 52.2 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.143 -1.583 . . . . 0.0 109.143 -179.94 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 768' ' ' GLN . . . . . 0.488 ' HG2' ' O ' ' A' ' 840' ' ' SER . 28.4 mt-30 -123.66 117.45 25.02 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.346 -1.09 . . . . 0.0 109.838 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 769' ' ' THR . . . . . . . . . . . . . 60.5 p -127.17 148.32 50.18 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.061 -1.024 . . . . 0.0 110.295 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 770' ' ' ILE . . . . . . . . . . . . . 87.3 mt -60.76 117.25 2.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.256 -0.902 . . . . 0.0 109.777 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 771' ' ' SER . . . . . . . . . . . . . 13.9 t -107.27 -2.92 20.27 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.163 -0.961 . . . . 0.0 110.862 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 772' ' ' ALA . . . . . . . . . . . . . . . -170.81 135.19 1.07 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 120.806 -1.184 . . . . 0.0 111.313 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 773' ' ' ILE . . . . . 0.552 HD12 ' HB3' ' A' ' 802' ' ' LEU . 16.6 mm -85.38 128.16 39.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.441 -0.787 . . . . 0.0 108.93 179.815 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 774' ' ' LYS . . . . . 0.457 ' HB3' ' HB3' ' A' ' 836' ' ' GLU . 0.0 OUTLIER -79.29 -37.28 38.14 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.108 -0.995 . . . . 0.0 110.897 -179.827 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 775' ' ' PHE . . . . . . . . . . . . . 90.2 t80 -169.62 150.4 4.07 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.016 -1.052 . . . . 0.0 110.691 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 776' ' ' ALA . . . . . 0.479 ' O ' ' HB2' ' A' ' 798' ' ' SER . . . -163.93 126.28 2.45 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.469 -0.769 . . . . 0.0 109.483 179.94 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 777' ' ' SER . . . . . 0.532 ' HA ' ' CB ' ' A' ' 798' ' ' SER . 6.0 t -153.94 123.45 6.63 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.19 -0.944 . . . . 0.0 110.676 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 778' ' ' PHE . . . . . . . . . . . . . 42.6 t80 -97.15 82.8 3.23 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.395 -0.816 . . . . 0.0 109.712 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 779' ' ' GLY . . . . . . . . . . . . . . . 179.02 -121.42 0.75 Allowed Glycine 0 N--CA 1.492 2.392 0 N-CA-C 109.719 -1.352 . . . . 0.0 109.719 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 780' ' ' THR . . . . . 0.454 ' O ' ' HA3' ' A' ' 791' ' ' GLY . 44.9 p -114.61 97.2 46.15 Favored Pre-proline 0 N--CA 1.493 1.705 0 O-C-N 121.242 -1.152 . . . . 0.0 110.407 -179.949 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 781' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -79.35 175.94 10.21 Favored 'Trans proline' 0 C--N 1.304 -1.798 0 O-C-N 123.98 1.516 . . . . 0.0 110.514 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 782' ' ' LEU . . . . . 0.767 HD12 ' HA2' ' A' ' 791' ' ' GLY . 6.8 mt -139.05 105.4 5.27 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.344 -0.848 . . . . 0.0 110.144 -179.976 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 783' ' ' GLY . . . . . . . . . . . . . . . 102.37 -176.76 25.66 Favored Glycine 0 N--CA 1.492 2.367 0 N-CA-C 109.629 -1.389 . . . . 0.0 109.629 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 784' ' ' THR . . . . . 0.442 HG22 ' OD1' ' A' ' 734' ' ' ASP . 0.6 OUTLIER -130.05 -163.08 1.27 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.205 -1.173 . . . . 0.0 110.052 179.913 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 785' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -59.86 116.69 4.29 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.059 -1.026 . . . . 0.0 109.901 -179.958 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 786' ' ' GLY . . . . . . . . . . . . . . . 137.07 -43.94 1.18 Allowed Glycine 0 N--CA 1.489 2.209 0 N-CA-C 108.575 -1.81 . . . . 0.0 108.575 -179.913 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 787' ' ' THR . . . . . 0.471 HG22 ' O ' ' A' ' 787' ' ' THR . 25.5 m -148.39 38.43 0.87 Allowed 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.554 -0.968 . . . . 0.0 109.34 179.867 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 788' ' ' PHE . . . . . 0.421 ' CE2' ' HA ' ' A' ' 784' ' ' THR . 0.2 OUTLIER -50.4 176.31 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.814 0 CA-C-O 121.717 0.77 . . . . 0.0 111.065 -179.95 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 789' ' ' GLN . . . . . . . . . . . . . 2.2 mt-30 -161.87 170.6 19.18 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.563 -0.71 . . . . 0.0 109.508 179.951 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 790' ' ' GLN . . . . . 0.435 ' O ' ' C ' ' A' ' 791' ' ' GLY . 1.1 tp60 -88.81 21.05 3.2 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.985 -1.072 . . . . 0.0 110.283 -179.945 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 791' ' ' GLY . . . . . 0.767 ' HA2' HD12 ' A' ' 782' ' ' LEU . . . 42.34 -124.34 3.74 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.764 -1.335 . . . . 0.0 109.764 -179.953 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 792' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -133.02 -30.73 1.33 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.347 -1.09 . . . . 0.0 110.392 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 793' ' ' CYS . . . . . . . . . . . . . 5.1 t -112.07 139.44 47.59 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.187 -0.946 . . . . 0.0 110.239 -179.913 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 794' ' ' HIS . . . . . 0.594 ' CE1' ' HA ' ' A' ' 796' ' ' ILE . 10.3 t-80 -148.81 141.57 24.58 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.3 -0.875 . . . . 0.0 109.952 179.876 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 795' ' ' SER . . . . . 0.431 ' HB3' ' HG3' ' A' ' 825' ' ' PRO . 3.7 p -81.99 10.13 7.1 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.294 -0.879 . . . . 0.0 110.382 -179.967 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 796' ' ' ILE . . . . . 0.694 HG22 ' O ' ' A' ' 796' ' ' ILE . 50.2 mt 45.98 23.24 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 O-C-N 121.2 -0.937 . . . . 0.0 110.405 -179.933 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 797' ' ' ASN . . . . . 0.594 ' O ' HG23 ' A' ' 801' ' ' VAL . 2.8 t30 -150.46 17.14 0.82 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.339 -0.851 . . . . 0.0 109.815 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 798' ' ' SER . . . . . 0.532 ' CB ' ' HA ' ' A' ' 777' ' ' SER . 2.0 m -81.45 -29.72 33.7 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.47 -0.769 . . . . 0.0 110.324 -179.934 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 799' ' ' ASN . . . . . . . . . . . . . 11.9 t30 -86.78 -11.38 51.16 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.276 -0.89 . . . . 0.0 110.525 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 800' ' ' SER . . . . . 0.466 ' O ' ' HB3' ' A' ' 804' ' ' ARG . 30.5 m -87.54 -20.92 25.79 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.182 -0.949 . . . . 0.0 110.166 179.955 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 801' ' ' VAL . . . . . 0.711 HG11 ' CE2' ' A' ' 821' ' ' PHE . 42.0 t -73.75 -41.75 54.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.235 -0.916 . . . . 0.0 110.188 -179.959 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 802' ' ' LEU . . . . . 0.654 HD22 ' N ' ' A' ' 802' ' ' LEU . 4.0 mm? -75.62 -41.04 55.36 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.217 -0.927 . . . . 0.0 110.185 179.933 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 803' ' ' GLU . . . . . 0.585 ' HA ' ' CG1' ' A' ' 807' ' ' ILE . 5.5 tt0 -73.64 -18.04 61.08 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.147 -0.971 . . . . 0.0 110.663 179.948 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 804' ' ' ARG . . . . . 0.466 ' HB3' ' O ' ' A' ' 800' ' ' SER . 0.1 OUTLIER -89.2 -29.21 19.45 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.126 -0.984 . . . . 0.0 110.948 -179.979 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 805' ' ' LYS . . . . . . . . . . . . . 8.3 ttmt -122.11 -41.7 2.42 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 120.979 -1.075 . . . . 0.0 110.937 -179.944 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 806' ' ' CYS . . . . . 0.434 ' O ' HG12 ' A' ' 807' ' ' ILE . 0.9 OUTLIER -86.14 69.89 10.52 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.224 -0.923 . . . . 0.0 110.714 -179.994 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 807' ' ' ILE . . . . . 0.585 ' CG1' ' HA ' ' A' ' 803' ' ' GLU . 16.0 mm -149.72 121.63 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.411 0 O-C-N 121.287 -0.883 . . . . 0.0 110.512 179.934 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 808' ' ' GLY . . . . . . . . . . . . . . . 84.56 23.57 50.0 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.887 -1.285 . . . . 0.0 109.887 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 809' ' ' LEU . . . . . . . . . . . . . 72.5 mt -123.12 148.22 45.93 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.106 -1.232 . . . . 0.0 110.592 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 810' ' ' GLU . . . . . 0.425 ' O ' ' HB2' ' A' ' 764' ' ' CYS . 1.1 mp0 -83.45 1.25 42.55 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.256 -0.903 . . . . 0.0 110.032 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 811' ' ' ARG . . . . . . . . . . . . . 46.5 ttt180 -153.86 160.38 42.15 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.463 -0.773 . . . . 0.0 109.127 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 812' ' ' CYS . . . . . 0.574 ' C ' HG23 ' A' ' 813' ' ' VAL . 0.1 OUTLIER -155.5 143.93 20.28 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.794 -1.191 . . . . 0.0 111.735 -179.981 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 813' ' ' VAL . . . . . 0.574 HG23 ' C ' ' A' ' 812' ' ' CYS . 32.0 t -155.54 110.28 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 179.934 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 814' ' ' VAL . . . . . . . . . . . . . 76.0 t -108.43 120.36 59.67 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 121.198 -0.939 . . . . 0.0 110.746 -179.922 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 815' ' ' ALA . . . . . 0.441 ' O ' ' C ' ' A' ' 816' ' ' ILE . . . -78.01 84.69 4.27 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.425 -0.797 . . . . 0.0 110.102 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 816' ' ' ILE . . . . . 0.618 HD11 HG11 ' A' ' 833' ' ' VAL . 21.3 mt -39.39 143.11 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 O-C-N 121.476 -0.765 . . . . 0.0 110.602 179.97 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 817' ' ' SER . . . . . 0.44 ' OG ' ' HD2' ' A' ' 818' ' ' PRO . 0.0 OUTLIER -157.94 175.18 3.4 Favored Pre-proline 0 C--N 1.302 -1.481 0 O-C-N 121.328 -0.858 . . . . 0.0 109.958 179.944 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 818' ' ' PRO . . . . . 0.44 ' HD2' ' OG ' ' A' ' 817' ' ' SER . 42.7 Cg_endo -71.66 -71.42 0.02 OUTLIER 'Trans proline' 0 C--N 1.302 -1.871 0 O-C-N 123.941 1.495 . . . . 0.0 111.556 -179.933 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 819' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -86.85 39.09 0.83 Allowed 'General case' 0 N--CA 1.496 1.838 0 O-C-N 120.981 -1.074 . . . . 0.0 110.798 -179.895 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 820' ' ' ASN . . . . . 0.426 ' HB2' ' OG ' ' A' ' 817' ' ' SER . 0.7 OUTLIER -99.38 -34.07 10.45 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.135 -0.978 . . . . 0.0 109.888 179.987 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 821' ' ' PHE . . . . . 0.711 ' CE2' HG11 ' A' ' 801' ' ' VAL . 3.2 m-85 -99.7 -44.32 6.15 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.294 -0.879 . . . . 0.0 110.051 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 822' ' ' GLY . . . . . . . . . . . . . . . -165.01 -36.59 0.02 OUTLIER Glycine 0 N--CA 1.492 2.388 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 823' ' ' GLY . . . . . . . . . . . . . . . 134.4 -96.6 0.28 Allowed Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.698 -1.361 . . . . 0.0 109.698 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 824' ' ' ASP . . . . . . . . . . . . . 31.7 t0 -149.07 87.0 5.48 Favored Pre-proline 0 N--CA 1.492 1.658 0 O-C-N 121.3 -1.117 . . . . 0.0 110.359 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 825' ' ' PRO . . . . . 0.431 ' HG3' ' HB3' ' A' ' 795' ' ' SER . 43.8 Cg_endo -72.07 -49.54 0.3 Allowed 'Trans proline' 0 C--N 1.306 -1.682 0 O-C-N 123.945 1.497 . . . . 0.0 110.255 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 826' ' ' CYS . . . . . 0.72 ' SG ' HG21 ' A' ' 829' ' ' VAL . 0.0 OUTLIER -78.24 144.87 67.58 Favored Pre-proline 0 N--CA 1.489 1.478 0 O-C-N 121.241 -0.912 . . . . 0.0 109.832 179.898 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 827' ' ' PRO . . . . . 0.57 ' O ' HG23 ' A' ' 829' ' ' VAL . 46.6 Cg_endo -74.93 115.74 4.38 Favored 'Trans proline' 0 C--N 1.302 -1.888 0 O-C-N 124.007 1.53 . . . . 0.0 111.953 -179.938 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 828' ' ' GLU . . . . . 0.434 ' C ' ' O ' ' A' ' 827' ' ' PRO . 18.3 mm-40 35.8 36.99 0.04 OUTLIER 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.735 -0.603 . . . . 0.0 111.69 179.867 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 829' ' ' VAL . . . . . 0.72 HG21 ' SG ' ' A' ' 826' ' ' CYS . 17.3 t -91.07 165.27 1.98 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 O-C-N 121.114 -0.991 . . . . 0.0 109.703 179.861 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 830' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -63.67 -168.9 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.118 -0.989 . . . . 0.0 110.041 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 831' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -143.44 158.33 43.73 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.229 -0.919 . . . . 0.0 110.539 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 832' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -169.34 161.26 9.89 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.383 -0.823 . . . . 0.0 109.515 -179.958 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 833' ' ' VAL . . . . . 0.618 HG11 HD11 ' A' ' 816' ' ' ILE . 93.4 t -135.21 106.96 7.22 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 O-C-N 120.912 -1.117 . . . . 0.0 111.242 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 834' ' ' ALA . . . . . . . . . . . . . . . -115.87 114.53 24.82 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.444 -0.785 . . . . 0.0 108.894 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 835' ' ' VAL . . . . . . . . . . . . . 15.6 t -125.11 158.98 32.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.001 -1.062 . . . . 0.0 111.546 -179.847 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 836' ' ' GLU . . . . . 0.457 ' HB3' ' HB3' ' A' ' 774' ' ' LYS . 30.5 tt0 -147.63 143.29 27.59 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 108.056 -1.09 . . . . 0.0 108.056 179.847 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 837' ' ' ALA . . . . . . . . . . . . . . . -140.58 155.25 46.64 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 120.488 -1.383 . . . . 0.0 112.116 -179.877 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 838' ' ' VAL . . . . . . . . . . . . . 96.2 t -113.33 111.82 37.72 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 179.849 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 839' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -107.45 121.24 44.22 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.063 -1.023 . . . . 0.0 110.911 -179.848 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 840' ' ' SER . . . . . 0.716 ' C ' HG22 ' A' ' 841' ' ' THR . 4.6 p -140.82 -66.42 0.43 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.523 -0.736 . . . . 0.0 109.764 179.965 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 841' ' ' THR . . . . . 0.716 HG22 ' C ' ' A' ' 840' ' ' SER . 0.0 OUTLIER 165.54 164.02 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.482 -0.761 . . . . 0.0 109.918 179.933 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 842' ' ' ALA . . . . . . . . . . . . . . . -68.08 85.76 0.25 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.238 -0.914 . . . . 0.0 110.163 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 843' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.719 0 CA-C-O 118.012 -0.994 . . . . 0.0 110.292 179.949 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 726' ' ' ARG . . . . . 0.485 ' O ' ' HD2' ' A' ' 726' ' ' ARG . 1.6 tmt_? . . . . . 0 N--CA 1.493 1.681 0 CA-C-O 121.267 0.556 . . . . 0.0 110.151 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 727' ' ' THR . . . . . . . . . . . . . 1.6 m -131.15 145.72 52.08 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.246 -0.909 . . . . 0.0 110.162 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 728' ' ' VAL . . . . . 0.466 HG12 ' HA ' ' A' ' 840' ' ' SER . 0.4 OUTLIER -138.47 160.21 31.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.244 -0.91 . . . . 0.0 110.036 179.97 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 729' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER 176.59 46.82 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.254 -0.904 . . . . 0.0 109.947 -179.95 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 730' ' ' GLY . . . . . . . . . . . . . . . -143.68 89.09 0.17 Allowed Glycine 0 N--CA 1.488 2.116 0 N-CA-C 109.986 -1.246 . . . . 0.0 109.986 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 731' ' ' VAL . . . . . . . . . . . . . 18.0 t -108.27 162.94 6.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.259 -1.142 . . . . 0.0 109.158 179.912 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 732' ' ' CYS . . . . . 0.442 ' SG ' ' OE1' ' A' ' 836' ' ' GLU . 0.8 OUTLIER -156.55 157.68 35.81 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 120.907 -1.12 . . . . 0.0 111.139 -179.95 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 733' ' ' ALA . . . . . . . . . . . . . . . -170.31 103.52 0.28 Allowed 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 734' ' ' ASP . . . . . 0.578 ' C ' HG23 ' A' ' 735' ' ' VAL . 1.8 p-10 -113.09 136.04 53.14 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.226 -0.921 . . . . 0.0 110.619 -179.872 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 735' ' ' VAL . . . . . 0.65 HG11 ' O ' ' A' ' 759' ' ' LYS . 89.9 t -156.13 117.34 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.361 -0.837 . . . . 0.0 110.042 179.978 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 736' ' ' SER . . . . . . . . . . . . . 80.8 p -59.18 166.55 2.1 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.136 -0.977 . . . . 0.0 110.115 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 737' ' ' GLU . . . . . 0.723 ' HA ' ' HB3' ' A' ' 758' ' ' ALA . 35.2 tt0 -111.87 149.81 31.3 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.238 -0.914 . . . . 0.0 110.164 179.981 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 738' ' ' TYR . . . . . 0.427 ' O ' ' HB3' ' A' ' 739' ' ' HIS . 7.3 t80 -111.85 -128.22 0.29 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.269 -0.895 . . . . 0.0 110.253 -179.982 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 739' ' ' HIS . . . . . 0.725 ' HB2' HG22 ' A' ' 757' ' ' THR . 13.2 t-160 55.37 60.94 8.96 Favored Pre-proline 0 N--CA 1.494 1.739 0 O-C-N 120.997 -1.064 . . . . 0.0 110.1 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 740' ' ' PRO . . . . . 0.466 ' O ' HG13 ' A' ' 742' ' ' ILE . 47.8 Cg_endo -75.11 109.99 3.03 Favored 'Trans proline' 0 C--N 1.301 -1.937 0 O-C-N 124.075 1.566 . . . . 0.0 110.272 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 741' ' ' ASN . . . . . 0.437 ' C ' ' O ' ' A' ' 740' ' ' PRO . 4.1 m120 -42.88 129.81 4.3 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.158 -0.964 . . . . 0.0 109.865 179.929 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 742' ' ' ILE . . . . . 0.476 HD12 ' N ' ' A' ' 742' ' ' ILE . 3.5 mp -113.45 146.4 18.11 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 O-C-N 121.171 -0.956 . . . . 0.0 110.973 -179.911 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 743' ' ' LYS . . . . . 0.428 ' O ' ' HB2' ' A' ' 744' ' ' ASN . 0.1 OUTLIER -103.81 117.0 33.32 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.296 -0.877 . . . . 0.0 109.016 179.955 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 744' ' ' ASN . . . . . 0.469 ' O ' ' C ' ' A' ' 745' ' ' TRP . 0.7 OUTLIER 61.77 77.26 0.34 Allowed 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.006 -1.059 . . . . 0.0 108.892 -179.884 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 745' ' ' TRP . . . . . 0.469 ' C ' ' O ' ' A' ' 744' ' ' ASN . 3.8 m-90 -31.87 -61.88 0.22 Allowed 'General case' 0 N--CA 1.501 2.091 0 O-C-N 121.857 -0.527 . . . . 0.0 111.41 -179.926 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 746' ' ' GLN . . . . . 0.46 ' HB2' ' O ' ' A' ' 745' ' ' TRP . 43.3 mt-30 56.44 57.83 4.63 Favored 'General case' 0 C--N 1.298 -1.649 0 O-C-N 121.295 -0.878 . . . . 0.0 110.226 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 747' ' ' ILE . . . . . 0.453 HG23 ' O ' ' A' ' 749' ' ' SER . 4.1 tp -125.25 149.36 29.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.154 -0.966 . . . . 0.0 110.205 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 748' ' ' GLU . . . . . . . . . . . . . 14.5 mm-40 -63.07 -68.18 0.36 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.234 -0.916 . . . . 0.0 110.238 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 749' ' ' SER . . . . . 0.453 ' O ' HG23 ' A' ' 747' ' ' ILE . 12.8 m -69.92 141.77 53.04 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.23 -0.919 . . . . 0.0 110.039 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 750' ' ' TYR . . . . . . . . . . . . . 52.6 m-85 -106.57 144.38 33.33 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.327 -0.858 . . . . 0.0 110.297 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 751' ' ' GLY . . . . . . . . . . . . . . . 73.57 140.13 0.48 Allowed Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.602 -1.399 . . . . 0.0 109.602 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 752' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -164.57 67.86 1.39 Allowed Pre-proline 0 N--CA 1.492 1.651 0 O-C-N 121.312 -1.111 . . . . 0.0 110.029 179.988 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 753' ' ' PRO . . . . . 0.459 ' O ' ' HB2' ' A' ' 754' ' ' GLU . 45.6 Cg_endo -73.45 110.75 3.13 Favored 'Trans proline' 0 C--N 1.305 -1.723 0 O-C-N 124.059 1.557 . . . . 0.0 110.462 -179.894 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 754' ' ' GLU . . . . . 0.487 ' HA ' ' OE1' ' A' ' 754' ' ' GLU . 5.2 tp10 178.42 -81.78 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.381 -0.824 . . . . 0.0 109.997 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 755' ' ' PHE . . . . . . . . . . . . . 50.2 t80 -111.44 116.92 31.73 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.253 -0.904 . . . . 0.0 109.97 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 756' ' ' HIS . . . . . . . . . . . . . 2.3 t-160 -129.1 -69.58 0.7 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.112 -0.993 . . . . 0.0 110.396 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 757' ' ' THR . . . . . 0.725 HG22 ' HB2' ' A' ' 739' ' ' HIS . 24.2 p -101.3 -169.82 1.75 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.27 -0.894 . . . . 0.0 110.452 -179.958 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 758' ' ' ALA . . . . . 0.723 ' HB3' ' HA ' ' A' ' 737' ' ' GLU . . . -111.93 161.72 16.11 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.35 -0.844 . . . . 0.0 109.796 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 759' ' ' LYS . . . . . 0.677 ' HE3' ' HB2' ' A' ' 815' ' ' ALA . 6.1 mttt -131.34 162.11 30.83 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.203 -0.936 . . . . 0.0 110.418 179.951 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 760' ' ' VAL . . . . . . . . . . . . . 99.2 t -107.61 143.01 18.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.385 -0.822 . . . . 0.0 109.31 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 761' ' ' HIS . . . . . . . . . . . . . 6.1 m170 -112.53 120.71 42.53 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.08 -1.012 . . . . 0.0 111.069 -179.921 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 762' ' ' LEU . . . . . 0.482 ' HB2' ' O ' ' A' ' 812' ' ' CYS . 12.3 mt -127.11 141.02 51.86 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.541 -0.724 . . . . 0.0 109.081 179.955 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 763' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -158.7 147.88 18.95 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 120.905 -1.122 . . . . 0.0 111.067 -179.903 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 764' ' ' CYS . . . . . . . . . . . . . 4.2 m -124.03 171.54 9.67 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.425 -0.797 . . . . 0.0 109.674 179.907 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 765' ' ' ALA . . . . . . . . . . . . . . . -70.1 158.52 87.2 Favored Pre-proline 0 N--CA 1.493 1.724 0 O-C-N 121.038 -1.039 . . . . 0.0 109.983 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 766' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -72.04 130.17 16.23 Favored 'Trans proline' 0 C--N 1.306 -1.7 0 O-C-N 123.925 1.487 . . . . 0.0 110.067 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 767' ' ' GLY . . . . . . . . . . . . . . . 112.47 -26.63 10.8 Favored Glycine 0 N--CA 1.488 2.143 0 N-CA-C 108.974 -1.65 . . . . 0.0 108.974 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 768' ' ' GLN . . . . . 0.493 ' C ' HG23 ' A' ' 769' ' ' THR . 2.0 mt-30 -106.79 172.29 6.9 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.362 -1.081 . . . . 0.0 109.992 179.934 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 769' ' ' THR . . . . . 0.493 HG23 ' C ' ' A' ' 768' ' ' GLN . 37.4 p -153.47 147.96 26.08 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.123 -0.985 . . . . 0.0 110.384 -179.937 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 770' ' ' ILE . . . . . . . . . . . . . 12.9 mt -64.29 146.29 13.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.274 -0.891 . . . . 0.0 109.475 179.936 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 771' ' ' SER . . . . . 0.523 ' O ' ' HB2' ' A' ' 772' ' ' ALA . 0.1 OUTLIER -135.52 -0.15 2.68 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.023 -1.048 . . . . 0.0 111.053 -179.942 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 772' ' ' ALA . . . . . 0.523 ' HB2' ' O ' ' A' ' 771' ' ' SER . . . -179.14 147.34 0.33 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.795 -1.191 . . . . 0.0 111.534 179.959 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 773' ' ' ILE . . . . . 0.423 HG13 ' HB3' ' A' ' 802' ' ' LEU . 22.7 mm -107.15 135.37 45.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 179.819 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 774' ' ' LYS . . . . . . . . . . . . . 2.3 ptpt -107.36 -6.85 16.91 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.026 -1.046 . . . . 0.0 111.712 -179.806 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 775' ' ' PHE . . . . . 0.661 ' O ' ' HB2' ' A' ' 776' ' ' ALA . 39.3 t80 -157.65 162.16 38.65 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.731 -1.231 . . . . 0.0 111.337 -179.973 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 776' ' ' ALA . . . . . 0.661 ' HB2' ' O ' ' A' ' 775' ' ' PHE . . . 170.04 112.66 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 109.295 -0.632 . . . . 0.0 109.295 179.933 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 777' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -140.36 120.53 13.82 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.147 -0.971 . . . . 0.0 110.78 -179.954 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 778' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -94.39 96.43 9.52 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.416 -0.803 . . . . 0.0 109.271 179.879 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 779' ' ' GLY . . . . . . . . . . . . . . . 166.82 -111.04 0.43 Allowed Glycine 0 N--CA 1.492 2.372 0 N-CA-C 110.013 -1.235 . . . . 0.0 110.013 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 780' ' ' THR . . . . . 0.622 HG22 ' HG3' ' A' ' 830' ' ' MET . 2.1 p -118.13 102.03 51.06 Favored Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 120.958 -1.319 . . . . 0.0 110.627 -179.927 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 781' ' ' PRO . . . . . 0.529 ' CG ' ' HB3' ' A' ' 832' ' ' ARG . 49.0 Cg_endo -84.58 173.09 8.73 Favored 'Trans proline' 0 C--N 1.306 -1.692 0 O-C-N 124.126 1.592 . . . . 0.0 110.221 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 782' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -145.02 113.37 6.59 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.192 -0.942 . . . . 0.0 110.165 179.903 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 783' ' ' GLY . . . . . . . . . . . . . . . 114.21 -157.5 14.93 Favored Glycine 0 N--CA 1.492 2.409 0 N-CA-C 109.451 -1.46 . . . . 0.0 109.451 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 784' ' ' THR . . . . . 0.481 ' O ' ' CE1' ' A' ' 788' ' ' PHE . 0.0 OUTLIER -136.3 -55.1 0.75 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.101 -1.235 . . . . 0.0 110.519 179.985 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 785' ' ' CYS . . . . . . . . . . . . . 11.0 t -156.97 108.27 2.38 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.215 -0.928 . . . . 0.0 110.507 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 786' ' ' GLY . . . . . . . . . . . . . . . 112.5 -14.27 25.15 Favored Glycine 0 N--CA 1.492 2.401 0 N-CA-C 109.801 -1.319 . . . . 0.0 109.801 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 787' ' ' THR . . . . . . . . . . . . . 3.7 m -136.74 29.76 2.87 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.197 -1.178 . . . . 0.0 110.556 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 788' ' ' PHE . . . . . 0.514 ' HB3' ' CZ ' ' A' ' 775' ' ' PHE . 0.7 OUTLIER -67.75 124.54 23.57 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.174 -0.954 . . . . 0.0 109.87 179.974 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 789' ' ' GLN . . . . . . . . . . . . . 9.7 tm0? -130.22 130.22 44.35 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.234 -0.916 . . . . 0.0 110.321 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 790' ' ' GLN . . . . . 0.502 ' CG ' ' O ' ' A' ' 790' ' ' GLN . 13.1 pt20 -59.73 104.14 0.26 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.292 -0.88 . . . . 0.0 110.025 -179.965 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 791' ' ' GLY . . . . . 0.446 ' O ' ' HG2' ' A' ' 792' ' ' GLU . . . -44.7 -61.96 3.11 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.661 -1.375 . . . . 0.0 109.661 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 792' ' ' GLU . . . . . 0.446 ' HG2' ' O ' ' A' ' 791' ' ' GLY . 2.2 mm-40 -171.48 -33.33 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.18 -1.188 . . . . 0.0 110.388 -179.989 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 793' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -96.46 155.27 16.84 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.163 -0.96 . . . . 0.0 110.499 -179.958 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 794' ' ' HIS . . . . . 0.535 ' CD2' ' H ' ' A' ' 795' ' ' SER . 11.3 t-160 -165.33 164.75 19.78 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.245 -0.91 . . . . 0.0 110.039 -179.966 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 795' ' ' SER . . . . . 0.753 ' C ' HG23 ' A' ' 796' ' ' ILE . 51.1 p -100.79 -7.93 23.18 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.245 -0.909 . . . . 0.0 110.36 179.978 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 796' ' ' ILE . . . . . 0.753 HG23 ' C ' ' A' ' 795' ' ' SER . 0.6 OUTLIER 64.61 11.83 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.506 2.375 0 O-C-N 121.559 -0.713 . . . . 0.0 110.258 -179.972 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 797' ' ' ASN . . . . . 0.461 ' OD1' ' O ' ' A' ' 797' ' ' ASN . 11.0 p30 -152.18 30.91 0.55 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.374 -0.829 . . . . 0.0 109.607 179.968 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 798' ' ' SER . . . . . 0.532 ' CB ' ' O ' ' A' ' 776' ' ' ALA . 3.9 m -67.36 -51.2 55.09 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.573 -0.704 . . . . 0.0 111.707 -179.874 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 799' ' ' ASN . . . . . 0.437 ' OD1' ' N ' ' A' ' 800' ' ' SER . 36.3 p30 -74.9 -17.55 60.56 Favored 'General case' 0 N--CA 1.5 2.039 0 O-C-N 121.243 -0.911 . . . . 0.0 111.803 -179.823 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 800' ' ' SER . . . . . 0.437 ' N ' ' OD1' ' A' ' 799' ' ' ASN . 29.5 t -58.88 -22.24 58.93 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 120.853 -1.154 . . . . 0.0 110.851 -179.96 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 801' ' ' VAL . . . . . . . . . . . . . 42.6 t -93.72 -18.8 6.85 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.006 0 O-C-N 121.096 -1.002 . . . . 0.0 111.051 -179.921 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 802' ' ' LEU . . . . . 0.484 HD11 HG21 ' A' ' 814' ' ' VAL . 4.0 mm? -87.61 -21.54 25.28 Favored 'General case' 0 N--CA 1.5 2.052 0 O-C-N 121.089 -1.007 . . . . 0.0 111.176 -179.868 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 803' ' ' GLU . . . . . . . . . . . . . 24.5 mt-10 -79.31 -29.11 42.22 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.019 -1.051 . . . . 0.0 111.117 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 804' ' ' ARG . . . . . . . . . . . . . 6.8 mpt_? -92.43 -18.6 23.03 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.082 -1.011 . . . . 0.0 111.545 -179.924 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 805' ' ' LYS . . . . . . . . . . . . . 7.9 ttmt -129.4 52.03 2.01 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 120.84 -1.163 . . . . 0.0 111.625 -179.87 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 806' ' ' CYS . . . . . 0.436 ' HB2' ' O ' ' A' ' 802' ' ' LEU . 0.5 OUTLIER -162.63 -44.61 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.981 -1.074 . . . . 0.0 110.621 179.901 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 807' ' ' ILE . . . . . . . . . . . . . 30.6 mt -71.92 107.56 2.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.231 -0.918 . . . . 0.0 110.444 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 808' ' ' GLY . . . . . . . . . . . . . . . 122.11 8.79 7.05 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.756 -1.338 . . . . 0.0 109.756 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 809' ' ' LEU . . . . . . . . . . . . . 83.4 mt -135.39 144.91 46.84 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.232 -1.158 . . . . 0.0 110.517 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 810' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -70.88 -28.97 64.95 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.341 -0.85 . . . . 0.0 109.952 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 811' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -123.7 160.26 27.61 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.475 -0.765 . . . . 0.0 109.987 179.908 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 812' ' ' CYS . . . . . 0.482 ' O ' ' HB2' ' A' ' 762' ' ' LEU . 1.3 t -145.69 128.69 16.5 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.267 -0.896 . . . . 0.0 110.313 179.988 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 813' ' ' VAL . . . . . . . . . . . . . 4.8 t -127.13 108.88 19.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.17 -0.956 . . . . 0.0 109.934 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 814' ' ' VAL . . . . . 0.484 HG21 HD11 ' A' ' 802' ' ' LEU . 63.7 t -110.57 108.99 26.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.258 -0.901 . . . . 0.0 110.147 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 815' ' ' ALA . . . . . 0.677 ' HB2' ' HE3' ' A' ' 759' ' ' LYS . . . -74.32 168.15 20.22 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.285 -0.884 . . . . 0.0 110.085 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 816' ' ' ILE . . . . . 0.822 HD13 HG21 ' A' ' 833' ' ' VAL . 39.3 mt -121.82 131.67 72.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.253 -0.905 . . . . 0.0 110.322 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 817' ' ' SER . . . . . 0.475 ' HB2' ' HD2' ' A' ' 818' ' ' PRO . 9.1 p -178.71 173.63 0.58 Allowed Pre-proline 0 C--N 1.301 -1.54 0 O-C-N 121.43 -0.794 . . . . 0.0 109.695 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 818' ' ' PRO . . . . . 0.475 ' HD2' ' HB2' ' A' ' 817' ' ' SER . 51.3 Cg_endo -79.54 12.41 2.38 Favored 'Trans proline' 0 C--N 1.304 -1.78 0 O-C-N 123.847 1.446 . . . . 0.0 111.048 179.957 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 819' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -128.81 2.53 5.4 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.971 -1.081 . . . . 0.0 110.586 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 820' ' ' ASN . . . . . . . . . . . . . 5.7 m120 -96.36 -35.3 11.25 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.073 -1.017 . . . . 0.0 110.365 -179.932 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 821' ' ' PHE . . . . . . . . . . . . . 46.8 m-85 -104.04 -69.03 0.82 Allowed 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.277 -0.889 . . . . 0.0 110.352 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 822' ' ' GLY . . . . . . . . . . . . . . . 167.6 51.92 0.03 OUTLIER Glycine 0 N--CA 1.492 2.381 0 N-CA-C 109.617 -1.393 . . . . 0.0 109.617 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 823' ' ' GLY . . . . . . . . . . . . . . . 91.58 178.07 42.61 Favored Glycine 0 N--CA 1.493 2.453 0 N-CA-C 109.693 -1.363 . . . . 0.0 109.693 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 824' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -112.68 129.31 24.55 Favored Pre-proline 0 N--CA 1.495 1.797 0 O-C-N 121.338 -1.095 . . . . 0.0 110.236 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 825' ' ' PRO . . . . . 0.436 ' O ' ' HD3' ' A' ' 827' ' ' PRO . 49.4 Cg_endo -82.6 -47.28 0.06 OUTLIER 'Trans proline' 0 C--N 1.307 -1.621 0 O-C-N 123.857 1.451 . . . . 0.0 111.201 -179.958 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 826' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -114.7 93.36 32.97 Favored Pre-proline 0 N--CA 1.498 1.929 0 O-C-N 120.987 -1.07 . . . . 0.0 111.137 -179.892 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 827' ' ' PRO . . . . . 0.472 ' O ' ' CB ' ' A' ' 828' ' ' GLU . 50.6 Cg_endo -89.04 162.01 5.87 Favored 'Trans proline' 0 C--N 1.307 -1.623 0 O-C-N 123.903 1.475 . . . . 0.0 110.396 179.948 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 828' ' ' GLU . . . . . 0.472 ' CB ' ' O ' ' A' ' 827' ' ' PRO . 0.7 OUTLIER 67.35 16.29 10.05 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.206 -0.934 . . . . 0.0 110.806 179.971 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 829' ' ' VAL . . . . . 0.42 ' O ' ' C ' ' A' ' 830' ' ' MET . 59.1 t -127.3 148.27 32.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.061 -1.025 . . . . 0.0 110.129 -179.985 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 830' ' ' MET . . . . . 0.622 ' HG3' HG22 ' A' ' 780' ' ' THR . 3.1 ptt? -41.89 106.54 0.06 Allowed 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.233 -0.917 . . . . 0.0 109.885 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 831' ' ' LYS . . . . . . . . . . . . . 11.5 mttm -82.03 115.43 21.17 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.164 -0.96 . . . . 0.0 111.001 -179.882 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 832' ' ' ARG . . . . . 0.529 ' HB3' ' CG ' ' A' ' 781' ' ' PRO . 2.4 mmm-85 -135.33 132.79 38.09 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 179.889 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 833' ' ' VAL . . . . . 0.822 HG21 HD13 ' A' ' 816' ' ' ILE . 39.3 t -108.96 130.86 61.13 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.584 0 O-C-N 121.02 -1.05 . . . . 0.0 111.034 -179.889 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 834' ' ' ALA . . . . . 0.506 ' O ' HG23 ' A' ' 835' ' ' VAL . . . -128.83 135.59 49.33 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.508 -0.745 . . . . 0.0 109.411 -179.985 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 835' ' ' VAL . . . . . 0.506 HG23 ' O ' ' A' ' 834' ' ' ALA . 13.3 t -152.78 127.64 1.49 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.051 -1.031 . . . . 0.0 110.776 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 836' ' ' GLU . . . . . 0.442 ' OE1' ' SG ' ' A' ' 732' ' ' CYS . 3.4 mt-10 -110.58 133.38 53.36 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.452 -0.78 . . . . 0.0 109.587 179.922 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 837' ' ' ALA . . . . . . . . . . . . . . . -110.8 154.54 23.82 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.082 -1.011 . . . . 0.0 110.701 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 838' ' ' VAL . . . . . 0.422 ' HB ' ' O ' ' A' ' 772' ' ' ALA . 99.2 t -107.85 108.86 26.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.366 -0.834 . . . . 0.0 109.807 179.967 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 839' ' ' CYS . . . . . 0.415 ' O ' ' O ' ' A' ' 728' ' ' VAL . 0.0 OUTLIER -108.66 146.56 33.23 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.238 -0.914 . . . . 0.0 110.353 -179.934 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 840' ' ' SER . . . . . 0.466 ' HA ' HG12 ' A' ' 728' ' ' VAL . 0.6 OUTLIER -157.04 168.57 27.08 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.299 -0.875 . . . . 0.0 110.097 179.985 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 841' ' ' THR . . . . . 0.476 ' CG2' ' NH1' ' A' ' 726' ' ' ARG . 1.2 p -67.32 157.08 34.84 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.309 -0.869 . . . . 0.0 110.567 -179.979 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 842' ' ' ALA . . . . . . . . . . . . . . . -138.76 90.27 2.43 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.441 -0.787 . . . . 0.0 109.988 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 843' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.676 0 CA-C-O 118.011 -0.995 . . . . 0.0 110.171 180.0 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 726' ' ' ARG . . . . . . . . . . . . . 8.5 tpp85 . . . . . 0 N--CA 1.492 1.667 0 CA-C-O 121.234 0.54 . . . . 0.0 110.193 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 727' ' ' THR . . . . . . . . . . . . . 5.8 m -123.71 146.51 48.21 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.313 -0.867 . . . . 0.0 110.276 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 728' ' ' VAL . . . . . 0.789 ' O ' HG12 ' A' ' 728' ' ' VAL . 9.9 t -94.97 76.35 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.21 -0.931 . . . . 0.0 110.036 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 729' ' ' SER . . . . . 0.444 ' HB3' ' HB3' ' A' ' 840' ' ' SER . 69.5 p -136.06 128.85 30.99 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.162 -0.961 . . . . 0.0 110.447 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 730' ' ' GLY . . . . . . . . . . . . . . . 132.82 74.74 0.1 Allowed Glycine 0 N--CA 1.492 2.414 0 N-CA-C 109.819 -1.312 . . . . 0.0 109.819 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 731' ' ' VAL . . . . . . . . . . . . . 48.0 t -109.66 147.43 14.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.217 -1.166 . . . . 0.0 110.039 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 732' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -120.51 151.63 39.11 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.159 -0.963 . . . . 0.0 110.568 -179.963 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 733' ' ' ALA . . . . . . . . . . . . . . . -141.26 103.09 4.36 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.413 -0.804 . . . . 0.0 109.69 179.923 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 734' ' ' ASP . . . . . 0.41 ' C ' HG23 ' A' ' 735' ' ' VAL . 39.0 t70 -127.61 128.19 45.12 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.261 -0.899 . . . . 0.0 109.889 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 735' ' ' VAL . . . . . 0.41 HG23 ' C ' ' A' ' 734' ' ' ASP . 76.7 t -146.74 134.19 14.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.031 -1.043 . . . . 0.0 110.61 179.933 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 736' ' ' SER . . . . . . . . . . . . . 2.7 m -68.26 140.9 56.02 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.359 -0.838 . . . . 0.0 109.852 179.931 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 737' ' ' GLU . . . . . . . . . . . . . 9.2 tm-20 -89.76 139.46 30.55 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.199 -0.938 . . . . 0.0 110.527 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 738' ' ' TYR . . . . . 0.622 ' CZ ' ' NE2' ' A' ' 739' ' ' HIS . 49.8 t80 -98.1 125.62 43.17 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.358 -0.839 . . . . 0.0 109.601 179.926 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 739' ' ' HIS . . . . . 0.622 ' NE2' ' CZ ' ' A' ' 738' ' ' TYR . 0.7 OUTLIER -44.27 167.34 0.1 OUTLIER Pre-proline 0 N--CA 1.493 1.72 0 O-C-N 121.09 -1.006 . . . . 0.0 110.429 -179.931 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 740' ' ' PRO . . . . . 0.452 ' HD2' ' HB2' ' A' ' 739' ' ' HIS . 48.6 Cg_endo -82.3 -50.5 0.05 OUTLIER 'Trans proline' 0 C--N 1.307 -1.649 0 O-C-N 123.926 1.487 . . . . 0.0 111.516 -179.901 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 741' ' ' ASN . . . . . 0.492 ' O ' HG12 ' A' ' 742' ' ' ILE . 6.8 m-20 -157.43 115.89 3.2 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 120.781 -1.199 . . . . 0.0 111.508 -179.896 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 742' ' ' ILE . . . . . 0.633 HG22 ' O ' ' A' ' 742' ' ' ILE . 11.2 mt -155.13 17.14 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 O-C-N 121.133 -0.979 . . . . 0.0 110.222 179.813 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 743' ' ' LYS . . . . . . . . . . . . . 1.3 mmtt 45.47 -97.71 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.187 -0.945 . . . . 0.0 110.476 179.928 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 744' ' ' ASN . . . . . 0.408 ' N ' ' O ' ' A' ' 742' ' ' ILE . 2.0 m-80 -112.01 143.06 43.64 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.017 -1.052 . . . . 0.0 110.383 -179.925 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 745' ' ' TRP . . . . . 0.492 ' CD1' ' N ' ' A' ' 745' ' ' TRP . 11.1 m0 -74.82 -158.53 0.08 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.264 -0.898 . . . . 0.0 109.875 -179.961 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 746' ' ' GLN . . . . . . . . . . . . . 3.7 mt-30 -62.94 129.92 42.51 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.189 -0.944 . . . . 0.0 110.094 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 747' ' ' ILE . . . . . . . . . . . . . 15.0 mm -85.66 97.51 5.8 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 O-C-N 121.276 -0.89 . . . . 0.0 110.258 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 748' ' ' GLU . . . . . 0.51 ' HG3' ' N ' ' A' ' 749' ' ' SER . 11.6 pt-20 -171.61 -35.64 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.12 -0.988 . . . . 0.0 110.373 -179.955 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 749' ' ' SER . . . . . 0.51 ' N ' ' HG3' ' A' ' 748' ' ' GLU . 89.1 p -170.98 54.21 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.134 -0.979 . . . . 0.0 110.257 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 750' ' ' TYR . . . . . . . . . . . . . 1.4 m-85 -121.52 177.23 5.3 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.207 -0.933 . . . . 0.0 110.291 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 751' ' ' GLY . . . . . . . . . . . . . . . 169.76 58.11 0.04 OUTLIER Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 -179.882 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 752' ' ' GLU . . . . . . . . . . . . . 19.0 tt0 -143.08 68.17 17.66 Favored Pre-proline 0 N--CA 1.493 1.683 0 O-C-N 121.218 -1.166 . . . . 0.0 110.186 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 753' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -77.95 72.46 6.15 Favored 'Trans proline' 0 C--N 1.305 -1.711 0 O-C-N 124.058 1.557 . . . . 0.0 110.544 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 754' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -60.9 -156.72 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.112 -0.993 . . . . 0.0 109.864 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 755' ' ' PHE . . . . . 0.484 ' CD1' ' N ' ' A' ' 756' ' ' HIS . 48.3 p90 -121.96 -154.27 0.59 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.989 -1.069 . . . . 0.0 110.942 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 756' ' ' HIS . . . . . 0.497 ' O ' ' O ' ' A' ' 757' ' ' THR . 5.1 t-80 -64.71 116.79 6.61 Favored 'General case' 0 N--CA 1.501 2.102 0 O-C-N 121.293 -0.879 . . . . 0.0 112.073 -179.825 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 757' ' ' THR . . . . . 0.497 ' O ' ' O ' ' A' ' 756' ' ' HIS . 0.8 OUTLIER 35.58 -162.02 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.134 0 CA-C-O 121.746 0.784 . . . . 0.0 111.573 179.866 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 758' ' ' ALA . . . . . . . . . . . . . . . -142.91 176.91 8.71 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.492 -0.755 . . . . 0.0 109.424 179.895 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 759' ' ' LYS . . . . . . . . . . . . . 8.3 mtpp -136.77 165.62 25.5 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.155 -0.966 . . . . 0.0 110.926 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 760' ' ' VAL . . . . . 0.433 HG23 HG13 ' A' ' 816' ' ' ILE . 46.8 t -108.38 146.65 13.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 179.91 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 761' ' ' HIS . . . . . . . . . . . . . 31.8 m80 -122.38 105.19 9.96 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.978 -1.076 . . . . 0.0 111.618 -179.879 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 762' ' ' LEU . . . . . 0.535 ' CB ' ' HB3' ' A' ' 812' ' ' CYS . 9.1 mt -118.14 131.21 56.43 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 179.823 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 763' ' ' LYS . . . . . . . . . . . . . 4.3 pttt -159.8 156.13 26.99 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.859 -1.151 . . . . 0.0 111.276 -179.932 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 764' ' ' CYS . . . . . . . . . . . . . 66.0 m -140.02 -178.14 5.32 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.577 -0.702 . . . . 0.0 109.755 179.88 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 765' ' ' ALA . . . . . 0.475 ' HB3' ' CD ' ' A' ' 768' ' ' GLN . . . -68.49 161.21 71.83 Favored Pre-proline 0 C--N 1.293 -1.883 0 O-C-N 121.233 -0.917 . . . . 0.0 110.895 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 766' ' ' PRO . . . . . 0.403 ' HD2' ' HB1' ' A' ' 765' ' ' ALA . 47.2 Cg_endo -72.53 83.68 1.27 Allowed 'Trans proline' 0 C--N 1.309 -1.528 0 O-C-N 124.174 1.618 . . . . 0.0 109.951 179.926 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 767' ' ' GLY . . . . . . . . . . . . . . . 150.42 -26.14 1.09 Allowed Glycine 0 N--CA 1.488 2.13 0 N-CA-C 108.293 -1.923 . . . . 0.0 108.293 -179.918 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 768' ' ' GLN . . . . . 0.502 ' HA ' ' O ' ' A' ' 840' ' ' SER . 11.9 mt-30 -101.33 102.4 13.24 Favored 'General case' 0 N--CA 1.486 1.357 0 O-C-N 121.647 -0.914 . . . . 0.0 109.458 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 769' ' ' THR . . . . . . . . . . . . . 9.1 p -101.11 149.26 24.15 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.234 -0.916 . . . . 0.0 110.566 -179.857 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 770' ' ' ILE . . . . . 0.563 HG13 ' HB3' ' A' ' 839' ' ' CYS . 2.6 mp -63.06 148.16 11.47 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 O-C-N 121.287 -0.883 . . . . 0.0 109.97 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 771' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -137.49 -15.76 1.4 Allowed 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.1 -1.0 . . . . 0.0 111.847 -179.963 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 772' ' ' ALA . . . . . . . . . . . . . . . -144.3 136.59 26.49 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 120.698 -1.251 . . . . 0.0 111.689 -179.888 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 773' ' ' ILE . . . . . 0.41 HD12 HG23 ' A' ' 773' ' ' ILE . 23.1 mm -105.4 113.65 42.88 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 179.827 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 774' ' ' LYS . . . . . . . . . . . . . 27.6 ttpp -82.08 -44.96 15.88 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.077 -1.014 . . . . 0.0 111.072 -179.925 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 775' ' ' PHE . . . . . 0.531 ' CD2' ' HB3' ' A' ' 788' ' ' PHE . 73.2 t80 -138.88 163.53 32.06 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.013 -1.054 . . . . 0.0 111.194 -179.911 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 776' ' ' ALA . . . . . 0.502 ' HB1' ' O ' ' A' ' 798' ' ' SER . . . -179.68 93.63 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 109.392 -0.596 . . . . 0.0 109.392 179.989 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 777' ' ' SER . . . . . 0.493 ' HA ' ' CB ' ' A' ' 798' ' ' SER . 11.9 t -127.53 133.33 49.82 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.17 -0.956 . . . . 0.0 110.47 -179.871 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 778' ' ' PHE . . . . . 0.76 ' HE2' HG23 ' A' ' 816' ' ' ILE . 55.1 t80 -110.05 95.84 5.85 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.419 -0.8 . . . . 0.0 110.157 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 779' ' ' GLY . . . . . 0.49 ' HA2' ' HB2' ' A' ' 831' ' ' LYS . . . 163.12 -97.14 0.15 Allowed Glycine 0 N--CA 1.493 2.438 0 N-CA-C 109.655 -1.378 . . . . 0.0 109.655 -179.921 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 780' ' ' THR . . . . . 0.468 ' O ' ' HA3' ' A' ' 791' ' ' GLY . 6.3 p -132.52 89.23 36.73 Favored Pre-proline 0 N--CA 1.495 1.783 0 O-C-N 121.12 -1.223 . . . . 0.0 110.063 -179.954 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 781' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -76.36 169.21 22.39 Favored 'Trans proline' 0 C--N 1.303 -1.847 0 O-C-N 124.072 1.564 . . . . 0.0 110.607 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 782' ' ' LEU . . . . . 0.781 HD13 ' C ' ' A' ' 782' ' ' LEU . 1.9 tm? -131.11 115.11 15.98 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.25 -0.906 . . . . 0.0 110.209 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 783' ' ' GLY . . . . . 0.433 ' N ' HD22 ' A' ' 782' ' ' LEU . . . 126.46 -173.92 18.03 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.827 -1.309 . . . . 0.0 109.827 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 784' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -119.08 -169.04 1.67 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.322 -1.105 . . . . 0.0 110.32 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 785' ' ' CYS . . . . . . . . . . . . . 3.6 t -65.1 90.66 0.09 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.369 -0.832 . . . . 0.0 110.309 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 786' ' ' GLY . . . . . . . . . . . . . . . 153.04 -22.53 0.78 Allowed Glycine 0 N--CA 1.489 2.202 0 N-CA-C 110.036 -1.226 . . . . 0.0 110.036 179.914 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 787' ' ' THR . . . . . 0.784 HG22 ' O ' ' A' ' 787' ' ' THR . 60.0 m -146.7 36.28 0.96 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.121 -1.223 . . . . 0.0 110.839 -179.965 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 788' ' ' PHE . . . . . 0.531 ' HB3' ' CD2' ' A' ' 775' ' ' PHE . 7.9 m-85 -54.06 112.44 0.96 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.028 -1.045 . . . . 0.0 109.769 179.995 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 789' ' ' GLN . . . . . . . . . . . . . 3.3 mt-30 -119.36 157.95 27.12 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.255 -0.903 . . . . 0.0 110.116 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 790' ' ' GLN . . . . . . . . . . . . . 16.7 mp0 -49.38 122.01 5.66 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.257 -0.902 . . . . 0.0 110.3 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 791' ' ' GLY . . . . . 0.468 ' HA3' ' O ' ' A' ' 780' ' ' THR . . . -81.05 -103.65 0.32 Allowed Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.404 -1.478 . . . . 0.0 109.404 179.938 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 792' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -130.17 -36.17 1.54 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.294 -1.121 . . . . 0.0 110.218 179.939 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 793' ' ' CYS . . . . . 0.434 ' HB2' ' OG1' ' A' ' 780' ' ' THR . 4.6 m -107.76 146.32 32.32 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.246 -0.909 . . . . 0.0 110.418 -179.975 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 794' ' ' HIS . . . . . . . . . . . . . 17.3 t-160 -149.06 143.92 26.36 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.372 -0.83 . . . . 0.0 110.172 179.901 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 795' ' ' SER . . . . . 0.533 ' O ' ' CG1' ' A' ' 796' ' ' ILE . 9.0 t -92.93 22.92 4.52 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.25 -0.906 . . . . 0.0 110.227 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 796' ' ' ILE . . . . . 0.533 ' CG1' ' O ' ' A' ' 795' ' ' SER . 36.8 pt 37.32 29.67 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.105 0 O-C-N 121.621 -0.675 . . . . 0.0 110.861 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 797' ' ' ASN . . . . . 0.488 ' N ' ' O ' ' A' ' 795' ' ' SER . 2.0 t-20 -157.66 19.32 0.27 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.085 -1.009 . . . . 0.0 110.269 179.946 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 798' ' ' SER . . . . . 0.502 ' O ' ' HB1' ' A' ' 776' ' ' ALA . 1.2 m -90.33 18.22 6.34 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.263 -0.898 . . . . 0.0 110.395 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 799' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -131.16 -16.88 3.11 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.073 -1.017 . . . . 0.0 111.327 -179.961 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 800' ' ' SER . . . . . . . . . . . . . 5.7 p -78.79 -53.08 7.48 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.0 -1.062 . . . . 0.0 110.544 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 801' ' ' VAL . . . . . 0.547 ' O ' ' CB ' ' A' ' 805' ' ' LYS . 55.1 t -58.63 -19.77 15.14 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.31 -0.869 . . . . 0.0 110.723 -179.948 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 802' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -81.84 -62.2 1.7 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.992 -1.067 . . . . 0.0 111.165 -179.899 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 803' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -56.54 -32.78 65.46 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.192 -0.943 . . . . 0.0 111.417 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 804' ' ' ARG . . . . . . . . . . . . . 62.6 mtm-85 -92.52 -18.88 22.58 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.045 -1.034 . . . . 0.0 111.84 -179.868 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 805' ' ' LYS . . . . . 0.547 ' CB ' ' O ' ' A' ' 801' ' ' VAL . 0.2 OUTLIER -116.83 43.0 2.35 Favored 'General case' 0 N--CA 1.501 2.095 0 O-C-N 120.815 -1.178 . . . . 0.0 111.061 -179.962 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 806' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -159.5 -55.15 0.06 Allowed 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.103 -0.998 . . . . 0.0 110.259 179.833 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 807' ' ' ILE . . . . . . . . . . . . . 61.5 mt -61.21 123.82 14.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.218 -0.926 . . . . 0.0 110.314 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 808' ' ' GLY . . . . . 0.43 ' C ' ' HG ' ' A' ' 809' ' ' LEU . . . 101.31 11.8 37.91 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.603 -1.399 . . . . 0.0 109.603 -179.941 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 809' ' ' LEU . . . . . 0.43 ' HG ' ' C ' ' A' ' 808' ' ' GLY . 59.5 mt -137.28 129.83 29.95 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.228 -1.16 . . . . 0.0 110.199 179.976 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 810' ' ' GLU . . . . . . . . . . . . . 24.1 tt0 -67.56 -19.73 65.31 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.325 -0.859 . . . . 0.0 110.188 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 811' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -133.65 128.7 35.63 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.386 -0.821 . . . . 0.0 110.211 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 812' ' ' CYS . . . . . 0.535 ' HB3' ' CB ' ' A' ' 762' ' ' LEU . 1.3 t -110.65 122.38 47.63 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.329 -0.857 . . . . 0.0 110.135 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 813' ' ' VAL . . . . . . . . . . . . . 25.2 t -130.45 118.62 43.65 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.14 -0.975 . . . . 0.0 110.153 -180.0 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 814' ' ' VAL . . . . . . . . . . . . . 91.6 t -134.67 120.01 30.54 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.286 -0.884 . . . . 0.0 110.156 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 815' ' ' ALA . . . . . . . . . . . . . . . -75.71 146.47 40.11 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.227 -0.921 . . . . 0.0 110.278 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 816' ' ' ILE . . . . . 0.76 HG23 ' HE2' ' A' ' 778' ' ' PHE . 84.6 mt -96.53 123.28 48.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.319 -0.863 . . . . 0.0 110.178 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 817' ' ' SER . . . . . 0.477 ' HB2' ' HD2' ' A' ' 818' ' ' PRO . 4.5 p -159.5 170.55 8.61 Favored Pre-proline 0 N--CA 1.494 1.766 0 O-C-N 121.009 -1.057 . . . . 0.0 110.561 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 818' ' ' PRO . . . . . 0.477 ' HD2' ' HB2' ' A' ' 817' ' ' SER . 47.0 Cg_endo -73.77 -2.08 11.7 Favored 'Trans proline' 0 C--N 1.308 -1.555 0 O-C-N 124.047 1.551 . . . . 0.0 110.606 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 819' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -134.65 59.91 1.72 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.206 -0.934 . . . . 0.0 110.229 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 820' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -132.48 -41.9 0.96 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.365 -0.834 . . . . 0.0 110.278 -179.967 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 821' ' ' PHE . . . . . . . . . . . . . 79.8 m-85 -100.98 -68.79 0.8 Allowed 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.215 -0.928 . . . . 0.0 110.72 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 822' ' ' GLY . . . . . . . . . . . . . . . -149.05 20.76 1.24 Allowed Glycine 0 N--CA 1.492 2.422 0 C-N-CA 119.638 -1.268 . . . . 0.0 109.945 -179.904 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 823' ' ' GLY . . . . . 0.47 ' HA2' ' O ' ' A' ' 818' ' ' PRO . . . 102.94 -132.96 11.22 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.719 -1.352 . . . . 0.0 109.719 179.912 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 824' ' ' ASP . . . . . 0.471 ' OD1' ' HB3' ' A' ' 818' ' ' PRO . 2.2 m-20 -140.77 106.45 6.36 Favored Pre-proline 0 N--CA 1.493 1.724 0 O-C-N 121.289 -1.124 . . . . 0.0 110.246 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 825' ' ' PRO . . . . . 0.468 ' O ' ' HD3' ' A' ' 827' ' ' PRO . 44.9 Cg_endo -72.47 -88.44 0.0 OUTLIER 'Trans proline' 0 C--N 1.304 -1.774 0 O-C-N 124.085 1.571 . . . . 0.0 111.003 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 826' ' ' CYS . . . . . . . . . . . . . 97.1 m -80.6 112.18 29.29 Favored Pre-proline 0 N--CA 1.498 1.938 0 O-C-N 121.232 -0.918 . . . . 0.0 110.924 -179.908 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 827' ' ' PRO . . . . . 0.726 ' O ' HG23 ' A' ' 829' ' ' VAL . 49.7 Cg_endo -94.12 173.92 1.51 Allowed 'Trans proline' 0 C--N 1.308 -1.563 0 O-C-N 123.993 1.523 . . . . 0.0 110.251 179.956 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 828' ' ' GLU . . . . . . . . . . . . . 14.4 mt-10 52.33 31.11 8.94 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.358 -0.839 . . . . 0.0 110.826 179.945 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 829' ' ' VAL . . . . . 0.726 HG23 ' O ' ' A' ' 827' ' ' PRO . 97.9 t -137.02 113.73 12.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.013 -1.055 . . . . 0.0 110.469 -179.944 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 830' ' ' MET . . . . . 0.434 ' C ' ' O ' ' A' ' 829' ' ' VAL . 2.2 mtt -42.52 95.86 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.333 -0.854 . . . . 0.0 109.989 179.937 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 831' ' ' LYS . . . . . 0.494 ' N ' ' O ' ' A' ' 829' ' ' VAL . 1.9 pttp -109.63 139.49 44.59 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.206 -0.934 . . . . 0.0 110.925 -179.908 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 832' ' ' ARG . . . . . . . . . . . . . 10.4 ptt180 -128.45 166.57 18.5 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.416 -0.802 . . . . 0.0 109.277 179.917 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 833' ' ' VAL . . . . . 0.503 HG22 ' CD2' ' A' ' 778' ' ' PHE . 54.7 t -107.61 128.67 62.59 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.109 -0.994 . . . . 0.0 110.831 -179.913 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 834' ' ' ALA . . . . . . . . . . . . . . . -128.57 132.45 48.22 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 179.891 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 835' ' ' VAL . . . . . . . . . . . . . 53.2 t -141.25 150.9 19.76 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 O-C-N 120.819 -1.176 . . . . 0.0 111.538 -179.893 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 836' ' ' GLU . . . . . . . . . . . . . 4.0 tp10 -131.53 108.71 9.75 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 179.9 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 837' ' ' ALA . . . . . . . . . . . . . . . -107.87 158.87 16.97 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.037 -1.039 . . . . 0.0 110.264 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 838' ' ' VAL . . . . . . . . . . . . . 37.6 t -122.19 103.07 12.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.285 -0.884 . . . . 0.0 110.418 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 839' ' ' CYS . . . . . 0.563 ' HB3' HG13 ' A' ' 770' ' ' ILE . 3.1 p -120.19 132.29 55.31 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.4 -0.812 . . . . 0.0 109.401 179.931 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 840' ' ' SER . . . . . 0.502 ' O ' ' HA ' ' A' ' 768' ' ' GLN . 16.7 p -149.66 -168.45 3.11 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.065 -1.022 . . . . 0.0 110.881 -179.919 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 841' ' ' THR . . . . . 0.487 ' N ' ' HG2' ' A' ' 768' ' ' GLN . 22.7 p -76.67 130.65 38.07 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.435 -0.791 . . . . 0.0 110.767 -179.91 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 842' ' ' ALA . . . . . 0.415 ' C ' ' O ' ' A' ' 841' ' ' THR . . . 41.92 75.76 0.08 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.389 -0.819 . . . . 0.0 110.36 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 843' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.667 0 CA-C-O 117.958 -1.02 . . . . 0.0 110.171 -179.996 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 726' ' ' ARG . . . . . . . . . . . . . 6.3 ttm180 . . . . . 0 N--CA 1.492 1.653 0 CA-C-O 121.213 0.53 . . . . 0.0 110.275 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 727' ' ' THR . . . . . . . . . . . . . 2.5 m -79.21 123.26 27.24 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.249 -0.907 . . . . 0.0 110.199 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 728' ' ' VAL . . . . . . . . . . . . . 15.5 m -147.35 172.18 2.84 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.523 0 O-C-N 121.318 -0.864 . . . . 0.0 110.08 179.935 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 729' ' ' SER . . . . . . . . . . . . . 1.5 t -173.87 168.09 4.29 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.295 -0.878 . . . . 0.0 110.278 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 730' ' ' GLY . . . . . . . . . . . . . . . -138.1 130.11 4.86 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.404 -1.478 . . . . 0.0 109.404 179.931 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 731' ' ' VAL . . . . . 0.619 ' CG2' ' HB3' ' A' ' 837' ' ' ALA . 13.6 m -110.82 124.93 68.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.237 -1.155 . . . . 0.0 110.339 -179.956 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 732' ' ' CYS . . . . . . . . . . . . . 5.1 t -109.46 112.46 24.58 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.343 -0.848 . . . . 0.0 109.582 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 733' ' ' ALA . . . . . . . . . . . . . . . -114.2 142.01 46.8 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.236 -0.915 . . . . 0.0 110.974 -179.924 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 734' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -155.54 118.58 4.31 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.465 -0.772 . . . . 0.0 109.483 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 735' ' ' VAL . . . . . . . . . . . . . 65.5 t -128.55 150.39 34.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.121 -0.987 . . . . 0.0 110.789 -179.934 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 736' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -99.88 139.73 35.13 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.323 -0.861 . . . . 0.0 109.614 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 737' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -64.29 139.91 58.81 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.082 -1.011 . . . . 0.0 110.668 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 738' ' ' TYR . . . . . 0.549 ' CD1' ' C ' ' A' ' 738' ' ' TYR . 8.4 p90 -164.22 154.81 15.09 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.267 -0.896 . . . . 0.0 110.267 179.973 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 739' ' ' HIS . . . . . 0.575 ' CD2' ' HB2' ' A' ' 741' ' ' ASN . 0.0 OUTLIER -97.55 168.28 10.4 Favored Pre-proline 0 N--CA 1.496 1.864 0 O-C-N 121.282 -0.886 . . . . 0.0 110.404 179.997 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 740' ' ' PRO . . . . . 0.521 ' HD3' ' HA ' ' A' ' 756' ' ' HIS . 49.2 Cg_endo -82.06 17.95 1.47 Allowed 'Trans proline' 0 C--N 1.309 -1.544 0 O-C-N 123.947 1.499 . . . . 0.0 110.997 -179.956 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 741' ' ' ASN . . . . . 0.785 ' C ' HD12 ' A' ' 742' ' ' ILE . 1.5 t-20 -77.1 108.56 10.27 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.115 -0.991 . . . . 0.0 110.112 179.899 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 742' ' ' ILE . . . . . 0.785 HD12 ' C ' ' A' ' 741' ' ' ASN . 2.1 mp -138.39 162.18 30.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.229 -0.92 . . . . 0.0 110.147 -179.984 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 743' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.41 -42.26 6.04 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.204 -0.935 . . . . 0.0 110.712 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 744' ' ' ASN . . . . . . . . . . . . . 9.3 m120 -60.29 -12.73 9.78 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.034 -1.041 . . . . 0.0 110.088 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 745' ' ' TRP . . . . . . . . . . . . . 26.2 t90 -73.7 97.55 2.71 Favored 'General case' 0 C--N 1.299 -1.627 0 O-C-N 121.439 -0.788 . . . . 0.0 110.079 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 746' ' ' GLN . . . . . 0.586 ' C ' HG22 ' A' ' 747' ' ' ILE . 2.1 mm-40 -130.37 45.36 2.82 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.236 -0.915 . . . . 0.0 110.442 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 747' ' ' ILE . . . . . 0.586 HG22 ' C ' ' A' ' 746' ' ' GLN . 1.2 tp 36.93 46.61 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.129 0 O-C-N 121.647 -0.658 . . . . 0.0 110.79 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 748' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -106.8 -41.37 5.24 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.182 -0.949 . . . . 0.0 110.221 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 749' ' ' SER . . . . . . . . . . . . . 20.7 p -168.06 26.55 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.251 -0.906 . . . . 0.0 110.094 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 750' ' ' TYR . . . . . . . . . . . . . 22.5 m-85 -107.83 -73.73 0.68 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.299 -0.876 . . . . 0.0 110.318 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 751' ' ' GLY . . . . . . . . . . . . . . . 153.95 -135.55 4.83 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.6 -1.4 . . . . 0.0 109.6 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 752' ' ' GLU . . . . . . . . . . . . . 16.1 tt0 -176.68 100.36 0.24 Allowed Pre-proline 0 N--CA 1.494 1.728 0 O-C-N 121.279 -1.13 . . . . 0.0 110.19 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 753' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -73.24 157.65 49.82 Favored 'Trans proline' 0 C--N 1.305 -1.756 0 O-C-N 124.035 1.545 . . . . 0.0 110.42 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 754' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -127.89 61.23 1.43 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.223 -0.923 . . . . 0.0 110.255 179.988 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 755' ' ' PHE . . . . . 0.451 ' O ' ' HG3' ' A' ' 740' ' ' PRO . 0.5 OUTLIER -164.43 -165.59 0.98 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.263 -0.898 . . . . 0.0 110.18 179.987 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 756' ' ' HIS . . . . . 0.521 ' HA ' ' HD3' ' A' ' 740' ' ' PRO . 1.8 t60 -149.74 27.21 0.81 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.287 -0.883 . . . . 0.0 110.194 179.997 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 757' ' ' THR . . . . . . . . . . . . . 25.5 p -141.73 175.02 10.03 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.222 -0.924 . . . . 0.0 110.332 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 758' ' ' ALA . . . . . 0.565 ' HB3' HD12 ' A' ' 816' ' ' ILE . . . -98.79 176.83 5.48 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.294 -0.879 . . . . 0.0 110.224 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 759' ' ' LYS . . . . . . . . . . . . . 13.4 mtmm -141.09 144.58 35.0 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.261 -0.899 . . . . 0.0 110.44 -179.934 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 760' ' ' VAL . . . . . . . . . . . . . 38.5 t -106.14 133.99 49.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.333 -0.854 . . . . 0.0 108.767 179.881 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 761' ' ' HIS . . . . . 0.69 ' NE2' HG22 ' A' ' 813' ' ' VAL . 0.3 OUTLIER -120.47 123.12 42.19 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 120.907 -1.121 . . . . 0.0 111.893 -179.87 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 762' ' ' LEU . . . . . . . . . . . . . 12.5 mt -120.45 98.61 6.12 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 179.77 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 763' ' ' LYS . . . . . 0.533 ' CB ' ' HG2' ' A' ' 811' ' ' ARG . 0.2 OUTLIER -114.48 137.51 51.76 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.005 -1.059 . . . . 0.0 111.515 -179.8 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 764' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER -118.3 161.96 19.07 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.679 -0.638 . . . . 0.0 109.555 179.901 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 765' ' ' ALA . . . . . 0.579 ' HB1' ' HD2' ' A' ' 766' ' ' PRO . . . -50.62 167.73 0.25 Allowed Pre-proline 0 N--CA 1.495 1.775 0 O-C-N 120.978 -1.076 . . . . 0.0 110.133 -179.959 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 766' ' ' PRO . . . . . 0.579 ' HD2' ' HB1' ' A' ' 765' ' ' ALA . 45.5 Cg_endo -72.22 124.34 9.91 Favored 'Trans proline' 0 C--N 1.305 -1.734 0 O-C-N 123.972 1.512 . . . . 0.0 110.155 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 767' ' ' GLY . . . . . . . . . . . . . . . 109.67 -36.37 4.35 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.223 -1.551 . . . . 0.0 109.223 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 768' ' ' GLN . . . . . . . . . . . . . 28.8 mt-30 -87.89 115.27 25.23 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.281 -1.129 . . . . 0.0 109.894 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 769' ' ' THR . . . . . . . . . . . . . 29.4 p -109.28 167.64 9.97 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.215 -0.928 . . . . 0.0 110.292 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 770' ' ' ILE . . . . . . . . . . . . . 7.8 mt -85.61 101.25 9.75 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 121.236 -0.915 . . . . 0.0 109.807 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 771' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -89.55 -6.9 55.91 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.162 -0.961 . . . . 0.0 110.818 -179.923 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 772' ' ' ALA . . . . . 0.464 ' O ' ' HB ' ' A' ' 838' ' ' VAL . . . -165.84 142.46 5.28 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.008 -1.058 . . . . 0.0 111.278 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 773' ' ' ILE . . . . . 0.409 HG13 ' HG2' ' A' ' 803' ' ' GLU . 47.3 mm -94.61 125.87 47.15 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 O-C-N 121.392 -0.817 . . . . 0.0 109.134 179.944 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 774' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -80.17 -37.94 32.33 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.085 -1.01 . . . . 0.0 111.244 -179.895 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 775' ' ' PHE . . . . . 0.642 ' O ' ' HB2' ' A' ' 776' ' ' ALA . 65.0 t80 -150.96 170.18 19.96 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.82 -1.175 . . . . 0.0 111.124 -179.984 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 776' ' ' ALA . . . . . 0.642 ' HB2' ' O ' ' A' ' 775' ' ' PHE . . . 170.82 116.4 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.703 -0.623 . . . . 0.0 109.346 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 777' ' ' SER . . . . . . . . . . . . . 14.5 t -151.69 131.77 13.49 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.114 -0.991 . . . . 0.0 110.724 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 778' ' ' PHE . . . . . . . . . . . . . 2.4 t80 -99.3 124.98 44.84 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.56 -0.713 . . . . 0.0 109.756 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 779' ' ' GLY . . . . . . . . . . . . . . . 130.3 -110.5 1.03 Allowed Glycine 0 N--CA 1.493 2.482 0 N-CA-C 109.85 -1.3 . . . . 0.0 109.85 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 780' ' ' THR . . . . . . . . . . . . . 11.8 p -135.37 83.57 37.49 Favored Pre-proline 0 N--CA 1.496 1.841 0 O-C-N 121.16 -1.2 . . . . 0.0 110.636 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 781' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -76.92 158.23 34.65 Favored 'Trans proline' 0 C--N 1.307 -1.639 0 O-C-N 123.856 1.45 . . . . 0.0 110.087 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 782' ' ' LEU . . . . . 0.496 ' O ' ' HA ' ' A' ' 788' ' ' PHE . 0.3 OUTLIER -96.24 123.86 40.03 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.158 -0.964 . . . . 0.0 110.241 179.958 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 783' ' ' GLY . . . . . . . . . . . . . . . 138.37 -169.33 24.33 Favored Glycine 0 N--CA 1.492 2.404 0 N-CA-C 109.688 -1.365 . . . . 0.0 109.688 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 784' ' ' THR . . . . . . . . . . . . . 3.3 m -138.31 -52.17 0.6 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.281 -1.129 . . . . 0.0 109.961 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 785' ' ' CYS . . . . . 0.558 ' HA ' ' CZ ' ' A' ' 788' ' ' PHE . 40.3 t -166.95 74.51 0.15 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.281 -0.887 . . . . 0.0 109.793 179.948 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 786' ' ' GLY . . . . . . . . . . . . . . . 130.68 -16.07 5.39 Favored Glycine 0 N--CA 1.489 2.171 0 N-CA-C 108.949 -1.66 . . . . 0.0 108.949 -179.932 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 787' ' ' THR . . . . . 0.451 HG22 ' O ' ' A' ' 787' ' ' THR . 18.2 m -121.78 27.36 8.19 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.477 -1.014 . . . . 0.0 109.878 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 788' ' ' PHE . . . . . 0.558 ' CZ ' ' HA ' ' A' ' 785' ' ' CYS . 35.4 m-85 -55.14 172.71 0.12 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.342 -0.849 . . . . 0.0 110.349 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 789' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER 179.23 172.48 0.86 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.362 -0.836 . . . . 0.0 109.93 -179.982 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 790' ' ' GLN . . . . . . . . . . . . . 6.2 tm0? -57.12 161.42 3.14 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.124 -0.985 . . . . 0.0 110.305 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 791' ' ' GLY . . . . . . . . . . . . . . . -136.89 -131.88 3.02 Favored Glycine 0 N--CA 1.494 2.507 0 N-CA-C 109.687 -1.365 . . . . 0.0 109.687 -179.919 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 792' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -107.76 -66.32 1.04 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.216 -1.167 . . . . 0.0 109.964 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 793' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -92.54 88.66 6.42 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.266 -0.896 . . . . 0.0 109.891 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 794' ' ' HIS . . . . . 0.435 ' HE1' ' CB ' ' A' ' 798' ' ' SER . 19.2 t60 -105.54 155.49 19.14 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.174 -0.954 . . . . 0.0 110.674 -179.921 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 795' ' ' SER . . . . . 0.535 ' HB2' ' HB3' ' A' ' 825' ' ' PRO . 1.3 t -115.63 111.21 20.3 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.466 -0.771 . . . . 0.0 109.942 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 796' ' ' ILE . . . . . . . . . . . . . 3.5 pt -44.3 -23.05 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 O-C-N 121.315 -0.866 . . . . 0.0 110.816 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 797' ' ' ASN . . . . . 0.409 ' N ' ' O ' ' A' ' 795' ' ' SER . 1.6 t30 -84.19 26.93 0.71 Allowed 'General case' 0 N--CA 1.499 1.991 0 O-C-N 120.988 -1.07 . . . . 0.0 111.005 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 798' ' ' SER . . . . . 0.487 ' HB3' ' O ' ' A' ' 776' ' ' ALA . 9.0 m -82.13 -31.57 30.53 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.0 -1.063 . . . . 0.0 111.11 179.942 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 799' ' ' ASN . . . . . 0.479 ' OD1' ' HB3' ' A' ' 776' ' ' ALA . 4.8 m120 -107.36 8.08 29.47 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.017 -1.052 . . . . 0.0 111.288 -179.893 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 800' ' ' SER . . . . . 0.448 ' O ' ' HB3' ' A' ' 804' ' ' ARG . 0.7 OUTLIER -90.33 -40.68 11.97 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.953 -1.092 . . . . 0.0 110.245 179.967 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 801' ' ' VAL . . . . . 0.63 HG21 ' CD2' ' A' ' 821' ' ' PHE . 55.5 t -74.65 -35.5 37.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.256 -0.902 . . . . 0.0 110.104 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 802' ' ' LEU . . . . . 0.492 HD13 ' HA ' ' A' ' 802' ' ' LEU . 4.0 mm? -69.31 -57.09 5.76 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.207 -0.933 . . . . 0.0 110.051 179.947 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 803' ' ' GLU . . . . . 0.409 ' HG2' HG13 ' A' ' 773' ' ' ILE . 0.7 OUTLIER -62.93 -18.29 62.94 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.235 -0.916 . . . . 0.0 110.011 179.943 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 804' ' ' ARG . . . . . 0.448 ' HB3' ' O ' ' A' ' 800' ' ' SER . 12.4 ttp180 -89.55 -20.42 23.81 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.265 -0.897 . . . . 0.0 111.07 -179.968 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 805' ' ' LYS . . . . . . . . . . . . . 9.2 ttmt -141.06 53.14 1.57 Allowed 'General case' 0 N--CA 1.495 1.818 0 O-C-N 120.878 -1.139 . . . . 0.0 110.873 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 806' ' ' CYS . . . . . 0.413 ' HB2' ' O ' ' A' ' 802' ' ' LEU . 1.4 t -158.94 -36.18 0.06 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.128 -0.983 . . . . 0.0 110.317 179.942 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 807' ' ' ILE . . . . . . . . . . . . . 9.5 mt -71.12 130.76 34.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.22 -0.925 . . . . 0.0 110.058 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 808' ' ' GLY . . . . . . . . . . . . . . . 91.8 16.03 52.85 Favored Glycine 0 N--CA 1.492 2.407 0 N-CA-C 109.776 -1.329 . . . . 0.0 109.776 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 809' ' ' LEU . . . . . . . . . . . . . 58.4 mt -129.22 138.97 52.01 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.188 -1.184 . . . . 0.0 110.411 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 810' ' ' GLU . . . . . 0.434 ' OE1' ' HA ' ' A' ' 766' ' ' PRO . 43.1 tt0 -69.14 -32.2 71.39 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.333 -0.854 . . . . 0.0 109.468 179.857 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 811' ' ' ARG . . . . . 0.533 ' HG2' ' CB ' ' A' ' 763' ' ' LYS . 3.3 mtm-85 -131.63 156.34 45.99 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.46 -0.775 . . . . 0.0 109.587 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 812' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -133.03 142.4 48.78 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.13 -0.981 . . . . 0.0 110.825 -179.976 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 813' ' ' VAL . . . . . 0.69 HG22 ' NE2' ' A' ' 761' ' ' HIS . 51.2 t -140.45 115.51 6.9 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.337 -0.852 . . . . 0.0 109.841 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 814' ' ' VAL . . . . . . . . . . . . . 52.4 t -128.89 121.76 55.24 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 O-C-N 121.253 -0.904 . . . . 0.0 110.464 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 815' ' ' ALA . . . . . . . . . . . . . . . -80.41 142.57 34.22 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.212 -0.93 . . . . 0.0 109.918 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 816' ' ' ILE . . . . . 0.565 HD12 ' HB3' ' A' ' 758' ' ' ALA . 14.1 mt -88.03 112.65 23.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.212 -0.93 . . . . 0.0 110.376 -179.955 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 817' ' ' SER . . . . . 0.458 ' OG ' ' OD1' ' A' ' 820' ' ' ASN . 78.7 p -168.34 163.39 8.57 Favored Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 121.448 -0.782 . . . . 0.0 109.993 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 818' ' ' PRO . . . . . 0.47 ' HB3' ' OD1' ' A' ' 824' ' ' ASP . 44.4 Cg_endo -72.37 -19.38 25.4 Favored 'Trans proline' 0 C--N 1.305 -1.747 0 O-C-N 124.021 1.537 . . . . 0.0 110.372 -179.979 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 819' ' ' SER . . . . . . . . . . . . . 9.1 m -94.97 48.13 1.17 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.187 -0.945 . . . . 0.0 110.017 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 820' ' ' ASN . . . . . 0.458 ' OD1' ' OG ' ' A' ' 817' ' ' SER . 1.2 m120 -139.75 -53.8 0.54 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.266 -0.897 . . . . 0.0 110.195 -179.955 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 821' ' ' PHE . . . . . 0.63 ' CD2' HG21 ' A' ' 801' ' ' VAL . 87.6 m-85 -79.54 -33.05 42.26 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.345 -0.847 . . . . 0.0 110.316 -179.958 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 822' ' ' GLY . . . . . . . . . . . . . . . 128.09 66.93 0.13 Allowed Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.656 -1.378 . . . . 0.0 109.656 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 823' ' ' GLY . . . . . . . . . . . . . . . 98.86 -175.57 28.89 Favored Glycine 0 N--CA 1.492 2.411 0 N-CA-C 109.716 -1.354 . . . . 0.0 109.716 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 824' ' ' ASP . . . . . 0.47 ' OD1' ' HB3' ' A' ' 818' ' ' PRO . 0.2 OUTLIER -102.18 133.15 20.79 Favored Pre-proline 0 N--CA 1.493 1.692 0 O-C-N 121.24 -1.153 . . . . 0.0 110.115 179.919 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 825' ' ' PRO . . . . . 0.535 ' HB3' ' HB2' ' A' ' 795' ' ' SER . 51.7 Cg_endo -75.07 -89.7 0.01 OUTLIER 'Trans proline' 0 C--N 1.307 -1.637 0 O-C-N 123.964 1.508 . . . . 0.0 110.477 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 826' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -113.41 103.1 55.48 Favored Pre-proline 0 N--CA 1.492 1.645 0 O-C-N 121.136 -0.978 . . . . 0.0 110.177 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 827' ' ' PRO . . . . . 0.411 ' O ' ' HB3' ' A' ' 828' ' ' GLU . 45.3 Cg_endo -74.08 165.4 32.09 Favored 'Trans proline' 0 C--N 1.304 -1.808 0 O-C-N 123.994 1.523 . . . . 0.0 110.655 179.933 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 828' ' ' GLU . . . . . 0.411 ' HB3' ' O ' ' A' ' 827' ' ' PRO . 1.6 tt0 55.78 44.7 25.71 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.304 -0.873 . . . . 0.0 110.578 179.959 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 829' ' ' VAL . . . . . 0.408 ' O ' ' C ' ' A' ' 830' ' ' MET . 25.4 t -141.33 151.57 19.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.222 -0.924 . . . . 0.0 110.122 179.92 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 830' ' ' MET . . . . . 0.408 ' C ' ' O ' ' A' ' 829' ' ' VAL . 0.0 OUTLIER -43.15 121.34 2.12 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.301 -0.874 . . . . 0.0 109.944 -179.986 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 831' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.71 86.64 7.31 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.287 -0.883 . . . . 0.0 110.595 -179.953 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 832' ' ' ARG . . . . . . . . . . . . . 6.8 mpt_? -129.58 125.89 37.24 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.408 -0.808 . . . . 0.0 109.421 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 833' ' ' VAL . . . . . 0.509 HG21 ' CG2' ' A' ' 816' ' ' ILE . 54.7 t -109.73 140.59 27.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.098 -1.001 . . . . 0.0 110.829 -179.887 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 834' ' ' ALA . . . . . 0.599 ' O ' HG23 ' A' ' 835' ' ' VAL . . . -141.26 138.16 33.03 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.398 -0.814 . . . . 0.0 109.68 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 835' ' ' VAL . . . . . 0.599 HG23 ' O ' ' A' ' 834' ' ' ALA . 35.3 t -156.0 127.99 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 O-C-N 121.036 -1.04 . . . . 0.0 111.187 -179.93 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 836' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -114.25 128.67 56.47 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.439 -0.788 . . . . 0.0 109.248 179.884 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 837' ' ' ALA . . . . . 0.619 ' HB3' ' CG2' ' A' ' 731' ' ' VAL . . . -110.98 157.89 19.39 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.075 -1.016 . . . . 0.0 110.914 -179.853 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 838' ' ' VAL . . . . . 0.464 ' HB ' ' O ' ' A' ' 772' ' ' ALA . 98.9 t -109.28 132.39 57.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.477 -0.765 . . . . 0.0 109.662 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 839' ' ' CYS . . . . . . . . . . . . . 1.3 m -115.8 134.64 54.8 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.071 -1.018 . . . . 0.0 110.721 -179.93 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 840' ' ' SER . . . . . . . . . . . . . 4.5 t -139.95 -133.84 0.11 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.44 -0.787 . . . . 0.0 109.743 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 841' ' ' THR . . . . . . . . . . . . . 30.4 p -121.99 166.59 14.24 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.89 -1.131 . . . . 0.0 110.213 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 842' ' ' ALA . . . . . . . . . . . . . . . -121.65 138.19 54.44 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.252 -0.905 . . . . 0.0 109.977 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 843' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.624 0 CA-C-O 118.07 -0.967 . . . . 0.0 110.256 -179.949 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 726' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.644 0 CA-C-O 121.213 0.53 . . . . 0.0 110.281 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 727' ' ' THR . . . . . 0.473 HG23 HG23 ' A' ' 841' ' ' THR . 2.0 t -122.07 75.56 1.23 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.229 -0.919 . . . . 0.0 110.289 -179.982 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 728' ' ' VAL . . . . . . . . . . . . . 56.4 t -123.29 96.84 4.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.311 -0.868 . . . . 0.0 110.039 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 729' ' ' SER . . . . . . . . . . . . . 1.3 t -84.68 -149.36 0.11 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.22 -0.925 . . . . 0.0 110.482 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 730' ' ' GLY . . . . . . . . . . . . . . . 170.58 131.7 1.37 Allowed Glycine 0 N--CA 1.489 2.175 0 N-CA-C 109.216 -1.554 . . . . 0.0 109.216 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 731' ' ' VAL . . . . . . . . . . . . . 7.0 t -120.14 141.25 41.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.174 -1.192 . . . . 0.0 110.411 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 732' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -109.64 163.86 13.08 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.354 -0.841 . . . . 0.0 109.864 -179.977 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 733' ' ' ALA . . . . . . . . . . . . . . . -155.37 104.48 2.4 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.146 -0.971 . . . . 0.0 110.656 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 734' ' ' ASP . . . . . . . . . . . . . 35.3 t0 -117.7 103.69 10.26 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.376 -0.828 . . . . 0.0 109.455 179.88 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 735' ' ' VAL . . . . . . . . . . . . . 68.4 t -129.86 154.02 39.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.209 -0.932 . . . . 0.0 110.482 -179.895 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 736' ' ' SER . . . . . 0.433 ' HA ' ' HD2' ' A' ' 832' ' ' ARG . 57.8 m -66.26 -173.29 0.19 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.316 -0.865 . . . . 0.0 110.474 -179.957 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 737' ' ' GLU . . . . . 0.522 ' HG3' ' N ' ' A' ' 738' ' ' TYR . 28.8 tp10 -105.89 166.84 10.2 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.373 -0.83 . . . . 0.0 110.18 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 738' ' ' TYR . . . . . 0.575 ' CB ' HG22 ' A' ' 757' ' ' THR . 0.0 OUTLIER -65.33 165.53 11.59 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.224 -0.922 . . . . 0.0 109.133 -179.996 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 739' ' ' HIS . . . . . 0.661 ' CD2' ' HB2' ' A' ' 741' ' ' ASN . 0.1 OUTLIER -164.74 148.1 7.47 Favored Pre-proline 0 C--N 1.301 -1.521 0 O-C-N 121.114 -0.991 . . . . 0.0 110.794 -179.878 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 740' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_endo -84.65 14.06 2.57 Favored 'Trans proline' 0 C--N 1.304 -1.791 0 O-C-N 124.105 1.581 . . . . 0.0 109.891 179.864 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 741' ' ' ASN . . . . . 0.661 ' HB2' ' CD2' ' A' ' 739' ' ' HIS . 1.5 m120 -79.19 75.42 5.73 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.343 -0.848 . . . . 0.0 110.467 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 742' ' ' ILE . . . . . 0.454 HG13 ' C ' ' A' ' 741' ' ' ASN . 24.9 mt -149.98 96.18 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.333 -0.854 . . . . 0.0 109.772 179.9 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 743' ' ' LYS . . . . . 0.418 ' O ' ' HB3' ' A' ' 744' ' ' ASN . 0.0 OUTLIER -113.01 159.17 19.41 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.174 -0.954 . . . . 0.0 110.652 -179.859 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 744' ' ' ASN . . . . . 0.418 ' HB3' ' O ' ' A' ' 743' ' ' LYS . 26.8 t-20 63.05 39.86 9.69 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.368 -0.832 . . . . 0.0 110.65 179.921 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 745' ' ' TRP . . . . . 0.449 ' O ' ' O ' ' A' ' 746' ' ' GLN . 22.0 p90 -88.73 -18.89 26.87 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.163 -0.96 . . . . 0.0 109.862 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 746' ' ' GLN . . . . . 0.449 ' O ' ' O ' ' A' ' 745' ' ' TRP . 0.0 OUTLIER 60.0 139.48 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.341 -0.849 . . . . 0.0 110.631 179.916 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 747' ' ' ILE . . . . . 0.455 ' O ' HG13 ' A' ' 747' ' ' ILE . 9.9 tp -101.95 22.03 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.306 -0.871 . . . . 0.0 109.884 179.948 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 748' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -116.22 -41.54 3.13 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.491 -0.755 . . . . 0.0 109.787 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 749' ' ' SER . . . . . 0.432 ' O ' ' OG ' ' A' ' 749' ' ' SER . 0.1 OUTLIER -125.68 92.59 3.64 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.438 -0.789 . . . . 0.0 109.853 179.954 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 750' ' ' TYR . . . . . 0.407 ' C ' ' O ' ' A' ' 749' ' ' SER . 55.6 m-85 -41.16 101.62 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.352 -0.842 . . . . 0.0 110.269 -179.991 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 751' ' ' GLY . . . . . . . . . . . . . . . -131.11 -174.72 13.75 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.48 -1.448 . . . . 0.0 109.48 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 752' ' ' GLU . . . . . 0.462 ' OE2' ' HD2' ' A' ' 753' ' ' PRO . 1.1 mt-10 54.62 176.08 0.03 OUTLIER Pre-proline 0 N--CA 1.493 1.675 0 O-C-N 121.169 -1.195 . . . . 0.0 109.966 -179.942 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 753' ' ' PRO . . . . . 0.462 ' HD2' ' OE2' ' A' ' 752' ' ' GLU . 45.1 Cg_endo -70.95 103.72 1.4 Allowed 'Trans proline' 0 C--N 1.306 -1.668 0 O-C-N 123.942 1.496 . . . . 0.0 110.516 179.936 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 754' ' ' GLU . . . . . . . . . . . . . 2.5 tm-20 -151.13 82.27 1.32 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.289 -0.882 . . . . 0.0 110.139 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 755' ' ' PHE . . . . . 0.52 ' CD2' ' O ' ' A' ' 757' ' ' THR . 9.2 p90 -117.46 25.4 10.46 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.233 -0.917 . . . . 0.0 110.034 179.972 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 756' ' ' HIS . . . . . 0.482 ' HB2' ' O ' ' A' ' 755' ' ' PHE . 11.1 m170 59.8 105.58 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.407 -0.808 . . . . 0.0 110.987 179.923 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 757' ' ' THR . . . . . 0.575 HG22 ' CB ' ' A' ' 738' ' ' TYR . 0.0 OUTLIER 45.29 -176.49 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.044 0 O-C-N 121.495 -0.753 . . . . 0.0 111.258 179.938 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 758' ' ' ALA . . . . . . . . . . . . . . . -91.45 174.99 7.08 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.437 -0.789 . . . . 0.0 110.333 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 759' ' ' LYS . . . . . . . . . . . . . 10.2 mttt -147.86 145.75 28.82 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.242 -0.912 . . . . 0.0 110.525 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 760' ' ' VAL . . . . . 0.43 ' CG2' HD11 ' A' ' 816' ' ' ILE . 97.9 t -136.97 131.13 46.2 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 O-C-N 121.471 -0.768 . . . . 0.0 109.493 179.932 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 761' ' ' HIS . . . . . 0.665 ' HB2' HG22 ' A' ' 813' ' ' VAL . 25.4 p-80 -142.69 135.18 27.77 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 120.936 -1.103 . . . . 0.0 111.002 -179.974 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 762' ' ' LEU . . . . . . . . . . . . . 3.3 mp -115.17 148.06 39.52 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.437 -0.789 . . . . 0.0 109.494 179.953 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 763' ' ' LYS . . . . . 0.426 ' O ' ' CG ' ' A' ' 763' ' ' LYS . 0.0 OUTLIER -133.61 105.04 6.64 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.04 -1.038 . . . . 0.0 110.616 -179.896 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 764' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -84.09 176.59 8.71 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.18 -0.95 . . . . 0.0 110.013 179.943 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 765' ' ' ALA . . . . . . . . . . . . . . . -69.6 160.55 79.14 Favored Pre-proline 0 N--CA 1.492 1.625 0 O-C-N 121.243 -0.91 . . . . 0.0 109.975 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 766' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -71.35 132.01 20.04 Favored 'Trans proline' 0 C--N 1.303 -1.847 0 O-C-N 124.053 1.554 . . . . 0.0 110.525 -179.951 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 767' ' ' GLY . . . . . . . . . . . . . . . 108.57 -44.95 1.39 Allowed Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 179.953 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 768' ' ' GLN . . . . . 0.414 ' HB3' ' HB3' ' A' ' 839' ' ' CYS . 2.4 mp0 -85.62 119.35 25.86 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.182 -1.187 . . . . 0.0 110.053 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 769' ' ' THR . . . . . . . . . . . . . 68.4 p -102.59 146.79 27.64 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.265 -0.897 . . . . 0.0 110.463 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 770' ' ' ILE . . . . . . . . . . . . . 48.3 mt -70.23 123.82 24.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.335 -0.853 . . . . 0.0 109.728 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 771' ' ' SER . . . . . . . . . . . . . 6.7 t -119.61 -12.83 9.23 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.148 -0.97 . . . . 0.0 110.696 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 772' ' ' ALA . . . . . 0.408 ' O ' ' HB ' ' A' ' 838' ' ' VAL . . . -148.78 130.35 14.91 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.022 -1.049 . . . . 0.0 110.735 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 773' ' ' ILE . . . . . 0.531 HG13 ' HG2' ' A' ' 803' ' ' GLU . 46.8 mm -84.33 129.87 36.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.241 -0.912 . . . . 0.0 109.715 179.949 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 774' ' ' LYS . . . . . 0.509 ' HB3' ' HB3' ' A' ' 836' ' ' GLU . 1.8 tppp? -80.12 -37.69 33.09 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.121 -0.987 . . . . 0.0 110.365 -179.924 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 775' ' ' PHE . . . . . 0.704 ' O ' ' HB2' ' A' ' 776' ' ' ALA . 88.3 t80 -159.74 171.17 20.01 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.049 -1.032 . . . . 0.0 110.73 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 776' ' ' ALA . . . . . 0.704 ' HB2' ' O ' ' A' ' 775' ' ' PHE . . . 166.92 90.79 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.423 -0.798 . . . . 0.0 109.801 -179.986 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 777' ' ' SER . . . . . 0.451 ' HB3' ' CZ ' ' A' ' 775' ' ' PHE . 12.6 t -128.68 132.26 48.04 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.307 -0.871 . . . . 0.0 110.419 -179.928 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 778' ' ' PHE . . . . . 0.566 ' O ' ' CD1' ' A' ' 778' ' ' PHE . 72.0 t80 -100.33 82.73 2.54 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.232 -0.918 . . . . 0.0 110.383 179.943 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 779' ' ' GLY . . . . . . . . . . . . . . . 174.31 -108.91 0.28 Allowed Glycine 0 N--CA 1.491 2.348 0 C-N-CA 119.687 -1.244 . . . . 0.0 110.039 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 780' ' ' THR . . . . . . . . . . . . . 29.5 p -113.26 99.46 49.17 Favored Pre-proline 0 N--CA 1.494 1.736 0 O-C-N 121.255 -1.144 . . . . 0.0 110.431 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 781' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -79.89 125.26 5.94 Favored 'Trans proline' 0 C--N 1.305 -1.734 0 O-C-N 123.915 1.482 . . . . 0.0 110.432 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 782' ' ' LEU . . . . . 0.457 ' HB2' ' CD ' ' A' ' 789' ' ' GLN . 61.9 mt -101.9 118.77 37.61 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.278 -0.888 . . . . 0.0 109.85 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 783' ' ' GLY . . . . . . . . . . . . . . . 114.19 -179.49 18.65 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.315 -1.514 . . . . 0.0 109.315 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 784' ' ' THR . . . . . . . . . . . . . 40.9 p -112.65 -162.39 0.8 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.176 -1.191 . . . . 0.0 110.363 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 785' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -71.93 115.72 11.47 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.263 -0.898 . . . . 0.0 110.258 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 786' ' ' GLY . . . . . . . . . . . . . . . 124.24 -30.33 4.8 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.496 -1.442 . . . . 0.0 109.496 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 787' ' ' THR . . . . . . . . . . . . . 1.2 p -131.92 27.4 4.58 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.342 -1.093 . . . . 0.0 110.094 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 788' ' ' PHE . . . . . 0.583 ' HB3' ' CG ' ' A' ' 775' ' ' PHE . 3.4 m-85 -51.23 164.39 0.18 Allowed 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.38 -0.825 . . . . 0.0 109.986 -179.97 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 789' ' ' GLN . . . . . 0.457 ' CD ' ' HB2' ' A' ' 782' ' ' LEU . 0.9 OUTLIER -175.43 127.84 0.26 Allowed 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.121 -0.987 . . . . 0.0 110.341 179.979 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 790' ' ' GLN . . . . . . . . . . . . . 1.8 pt20 -62.95 134.78 56.73 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.258 -0.901 . . . . 0.0 110.195 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 791' ' ' GLY . . . . . . . . . . . . . . . -95.28 -105.89 2.07 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.213 -1.555 . . . . 0.0 109.213 179.953 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 792' ' ' GLU . . . . . . . . . . . . . 29.5 tt0 -119.11 -24.99 6.3 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.258 -1.142 . . . . 0.0 109.744 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 793' ' ' CYS . . . . . 0.482 ' SG ' ' HG2' ' A' ' 825' ' ' PRO . 8.3 t -84.44 95.29 8.74 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.402 -0.811 . . . . 0.0 110.161 179.995 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 794' ' ' HIS . . . . . 0.449 ' CD2' ' HG ' ' A' ' 798' ' ' SER . 8.4 t-160 -120.64 140.5 51.49 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.205 -0.934 . . . . 0.0 110.189 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 795' ' ' SER . . . . . 0.544 ' C ' HD12 ' A' ' 796' ' ' ILE . 28.0 t -81.16 9.22 7.16 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.173 -0.954 . . . . 0.0 110.355 -179.982 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 796' ' ' ILE . . . . . 0.544 HD12 ' C ' ' A' ' 795' ' ' SER . 1.4 mp 66.2 7.06 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.537 -0.727 . . . . 0.0 110.699 -179.993 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 797' ' ' ASN . . . . . 0.44 ' O ' HG23 ' A' ' 801' ' ' VAL . 38.8 t-20 -161.05 39.25 0.15 Allowed 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.06 -1.025 . . . . 0.0 110.804 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 798' ' ' SER . . . . . 0.455 ' O ' ' O ' ' A' ' 776' ' ' ALA . 0.7 OUTLIER -97.02 2.35 51.33 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.144 -0.973 . . . . 0.0 110.38 -179.967 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 799' ' ' ASN . . . . . . . . . . . . . 7.1 m120 -117.17 -22.77 8.19 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.083 -1.011 . . . . 0.0 110.707 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 800' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -89.86 -31.41 17.34 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.131 -0.981 . . . . 0.0 110.536 -179.937 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 801' ' ' VAL . . . . . 0.44 HG23 ' O ' ' A' ' 797' ' ' ASN . 97.7 t -61.85 -27.97 43.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.199 -0.938 . . . . 0.0 110.755 179.965 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 802' ' ' LEU . . . . . 0.456 HD22 ' N ' ' A' ' 802' ' ' LEU . 4.5 mm? -80.1 -56.56 4.14 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.164 -0.96 . . . . 0.0 110.686 -179.927 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 803' ' ' GLU . . . . . 0.592 ' HA ' ' CG1' ' A' ' 807' ' ' ILE . 3.7 mm-40 -55.51 -21.74 18.06 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.247 -0.908 . . . . 0.0 111.011 -179.962 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 804' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -93.0 -18.92 22.11 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.014 -1.054 . . . . 0.0 111.724 -179.827 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 805' ' ' LYS . . . . . 0.454 ' O ' ' SG ' ' A' ' 806' ' ' CYS . 0.0 OUTLIER -128.66 23.24 5.84 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 120.641 -1.287 . . . . 0.0 111.894 -179.939 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 806' ' ' CYS . . . . . 0.454 ' SG ' ' O ' ' A' ' 805' ' ' LYS . 1.6 m -160.93 32.17 0.15 Allowed 'General case' 0 N--CA 1.499 1.992 0 O-C-N 120.763 -1.211 . . . . 0.0 110.791 179.91 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 807' ' ' ILE . . . . . 0.592 ' CG1' ' HA ' ' A' ' 803' ' ' GLU . 14.4 mm -124.91 108.12 19.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.137 -0.977 . . . . 0.0 110.267 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 808' ' ' GLY . . . . . 0.433 ' C ' ' HG ' ' A' ' 809' ' ' LEU . . . 114.56 9.66 14.25 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.524 -1.431 . . . . 0.0 109.524 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 809' ' ' LEU . . . . . 0.433 ' HG ' ' C ' ' A' ' 808' ' ' GLY . 5.1 mt -131.56 134.47 46.1 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.319 -1.107 . . . . 0.0 110.137 179.943 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 810' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -65.42 -11.79 46.11 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.168 -0.957 . . . . 0.0 109.289 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 811' ' ' ARG . . . . . . . . . . . . . 2.3 ttt180 -158.28 129.65 6.56 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.515 -0.741 . . . . 0.0 109.661 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 812' ' ' CYS . . . . . . . . . . . . . 27.6 p -141.85 152.56 43.75 Favored 'General case' 0 C--N 1.294 -1.809 0 O-C-N 121.435 -0.79 . . . . 0.0 110.361 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 813' ' ' VAL . . . . . 0.665 HG22 ' HB2' ' A' ' 761' ' ' HIS . 94.6 t -123.27 156.99 29.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.309 -0.869 . . . . 0.0 110.192 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 814' ' ' VAL . . . . . 0.421 HG23 ' C ' ' A' ' 813' ' ' VAL . 30.4 t -144.55 141.95 23.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.263 -0.898 . . . . 0.0 110.255 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 815' ' ' ALA . . . . . . . . . . . . . . . -102.29 128.7 48.72 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.307 -0.87 . . . . 0.0 109.957 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 816' ' ' ILE . . . . . 1.018 HD13 HG21 ' A' ' 833' ' ' VAL . 66.8 mt -83.38 132.83 30.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.153 -0.967 . . . . 0.0 110.25 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 817' ' ' SER . . . . . . . . . . . . . 20.3 p -163.17 164.96 15.26 Favored Pre-proline 0 N--CA 1.492 1.66 0 O-C-N 121.26 -0.9 . . . . 0.0 110.054 179.936 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 818' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -80.8 18.31 1.29 Allowed 'Trans proline' 0 C--N 1.307 -1.623 0 O-C-N 123.979 1.515 . . . . 0.0 111.123 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 819' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -127.18 -30.95 2.62 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 120.929 -1.107 . . . . 0.0 110.261 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 820' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 -63.5 -43.72 96.4 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.285 -0.885 . . . . 0.0 110.377 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 821' ' ' PHE . . . . . 0.494 ' HB3' ' OG ' ' A' ' 795' ' ' SER . 91.1 m-85 -88.85 -78.81 0.33 Allowed 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.236 -0.915 . . . . 0.0 110.295 179.961 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 822' ' ' GLY . . . . . . . . . . . . . . . 176.66 38.05 0.05 OUTLIER Glycine 0 N--CA 1.492 2.383 0 N-CA-C 109.827 -1.309 . . . . 0.0 109.827 -179.908 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 823' ' ' GLY . . . . . . . . . . . . . . . 90.14 -160.49 28.39 Favored Glycine 0 N--CA 1.492 2.401 0 N-CA-C 109.885 -1.286 . . . . 0.0 109.885 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 824' ' ' ASP . . . . . 0.457 ' OD1' ' O ' ' A' ' 824' ' ' ASP . 7.4 p30 -108.73 139.41 20.84 Favored Pre-proline 0 N--CA 1.497 1.899 0 O-C-N 121.301 -1.117 . . . . 0.0 110.359 -179.967 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 825' ' ' PRO . . . . . 0.482 ' HG2' ' SG ' ' A' ' 793' ' ' CYS . 49.3 Cg_endo -81.53 -54.63 0.04 OUTLIER 'Trans proline' 0 C--N 1.306 -1.67 0 O-C-N 124.044 1.549 . . . . 0.0 110.865 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 826' ' ' CYS . . . . . . . . . . . . . 1.8 m -123.67 110.45 29.95 Favored Pre-proline 0 N--CA 1.503 2.217 0 O-C-N 121.141 -0.974 . . . . 0.0 110.298 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 827' ' ' PRO . . . . . 0.458 ' O ' ' HB3' ' A' ' 828' ' ' GLU . 49.7 Cg_endo -86.86 163.0 9.03 Favored 'Trans proline' 0 C--N 1.304 -1.766 0 O-C-N 123.995 1.524 . . . . 0.0 110.46 179.953 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 828' ' ' GLU . . . . . 0.458 ' HB3' ' O ' ' A' ' 827' ' ' PRO . 1.5 tt0 65.9 8.73 5.55 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.225 -0.922 . . . . 0.0 110.776 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 829' ' ' VAL . . . . . . . . . . . . . 93.1 t -121.76 133.76 67.18 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 O-C-N 121.08 -1.012 . . . . 0.0 110.403 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 830' ' ' MET . . . . . 0.44 ' HA ' ' CE ' ' A' ' 830' ' ' MET . 0.5 OUTLIER -48.05 130.66 15.65 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.204 -0.935 . . . . 0.0 110.057 179.998 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 831' ' ' LYS . . . . . 0.435 ' HE2' ' HG2' ' A' ' 737' ' ' GLU . 7.8 ptmt -132.49 171.83 13.27 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.226 -0.922 . . . . 0.0 110.254 -179.934 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 832' ' ' ARG . . . . . 0.433 ' HD2' ' HA ' ' A' ' 736' ' ' SER . 0.0 OUTLIER -168.3 165.53 12.88 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.399 -0.813 . . . . 0.0 109.966 -179.985 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 833' ' ' VAL . . . . . 1.018 HG21 HD13 ' A' ' 816' ' ' ILE . 87.3 t -109.8 106.58 21.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.215 -0.928 . . . . 0.0 110.474 -179.932 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 834' ' ' ALA . . . . . . . . . . . . . . . -109.5 129.05 55.58 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.342 -0.849 . . . . 0.0 109.705 179.932 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 835' ' ' VAL . . . . . . . . . . . . . 29.8 t -142.25 152.89 18.2 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 121.138 -0.976 . . . . 0.0 110.779 -179.932 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 836' ' ' GLU . . . . . 0.509 ' HB3' ' HB3' ' A' ' 774' ' ' LYS . 1.7 tt0 -149.21 140.8 23.43 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.54 -0.725 . . . . 0.0 109.153 179.885 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 837' ' ' ALA . . . . . . . . . . . . . . . -119.6 166.36 13.25 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.051 -1.031 . . . . 0.0 111.38 -179.813 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 838' ' ' VAL . . . . . 0.408 ' HB ' ' O ' ' A' ' 772' ' ' ALA . 60.2 t -127.54 124.32 63.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.66 -0.65 . . . . 0.0 109.78 179.952 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 839' ' ' CYS . . . . . 0.414 ' HB3' ' HB3' ' A' ' 768' ' ' GLN . 53.3 m -109.12 131.54 54.97 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.11 -0.994 . . . . 0.0 110.518 -179.925 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 840' ' ' SER . . . . . 0.411 ' O ' ' C ' ' A' ' 841' ' ' THR . 60.7 p -158.14 75.51 0.75 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.344 -0.847 . . . . 0.0 109.996 -179.988 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 841' ' ' THR . . . . . 0.473 HG23 HG23 ' A' ' 727' ' ' THR . 79.9 p 42.39 -160.71 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.271 -0.893 . . . . 0.0 110.167 -179.993 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 842' ' ' ALA . . . . . . . . . . . . . . . -81.03 149.59 29.21 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.279 -0.888 . . . . 0.0 110.379 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 843' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.674 0 CA-C-O 117.981 -1.009 . . . . 0.0 110.232 179.986 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 726' ' ' ARG . . . . . . . . . . . . . 42.3 mtm-85 . . . . . 0 N--CA 1.493 1.677 0 CA-C-O 121.186 0.517 . . . . 0.0 110.159 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 727' ' ' THR . . . . . . . . . . . . . 37.7 m 52.9 84.86 0.05 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.288 -0.882 . . . . 0.0 110.321 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 728' ' ' VAL . . . . . 0.405 HG13 ' O ' ' A' ' 728' ' ' VAL . 6.2 p -161.03 132.15 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 121.173 -0.955 . . . . 0.0 110.555 -179.928 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 729' ' ' SER . . . . . . . . . . . . . 67.3 m -126.6 -167.89 1.79 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.261 -0.899 . . . . 0.0 109.928 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 730' ' ' GLY . . . . . . . . . . . . . . . -139.9 134.66 6.7 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.672 -1.371 . . . . 0.0 109.672 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 731' ' ' VAL . . . . . 0.573 HG22 ' O ' ' A' ' 837' ' ' ALA . 15.4 m -121.77 133.33 68.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.376 -1.073 . . . . 0.0 110.002 179.955 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 732' ' ' CYS . . . . . 0.486 ' CB ' ' CD ' ' A' ' 836' ' ' GLU . 23.3 p -123.95 153.6 40.98 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.215 -0.928 . . . . 0.0 110.376 179.987 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 733' ' ' ALA . . . . . . . . . . . . . . . -143.15 120.17 11.38 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.314 -0.866 . . . . 0.0 109.827 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 734' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -110.86 121.18 44.7 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.159 -0.963 . . . . 0.0 110.5 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 735' ' ' VAL . . . . . . . . . . . . . 21.9 t -143.66 141.9 25.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.372 -0.83 . . . . 0.0 110.001 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 736' ' ' SER . . . . . . . . . . . . . 10.9 p -95.99 159.01 15.19 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.257 -0.902 . . . . 0.0 110.377 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 737' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -67.42 146.95 53.51 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.315 -0.866 . . . . 0.0 110.28 179.955 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 738' ' ' TYR . . . . . 0.503 ' HB2' ' HB2' ' A' ' 758' ' ' ALA . 2.2 t80 -94.03 121.07 35.14 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.135 -0.978 . . . . 0.0 110.362 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 739' ' ' HIS . . . . . 0.453 ' HB2' ' O ' ' A' ' 738' ' ' TYR . 46.1 t-80 -178.3 88.71 0.23 Allowed Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 121.381 -0.825 . . . . 0.0 109.981 179.962 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 740' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -69.46 -91.75 0.0 OUTLIER 'Trans proline' 0 C--N 1.301 -1.922 0 O-C-N 123.991 1.522 . . . . 0.0 110.352 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 741' ' ' ASN . . . . . . . . . . . . . 8.3 t30 -164.5 109.65 0.97 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.307 -0.871 . . . . 0.0 109.801 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 742' ' ' ILE . . . . . . . . . . . . . 52.9 mt -132.31 154.38 39.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.167 -0.958 . . . . 0.0 110.589 -179.918 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 743' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -153.69 -39.17 0.1 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.413 -0.804 . . . . 0.0 109.791 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 744' ' ' ASN . . . . . . . . . . . . . 63.9 t30 -68.57 89.32 0.36 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.336 -0.852 . . . . 0.0 109.828 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 745' ' ' TRP . . . . . . . . . . . . . 16.6 t90 -165.82 -33.04 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.249 -0.907 . . . . 0.0 110.49 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 746' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -84.6 50.89 1.99 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.172 -0.955 . . . . 0.0 110.353 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 747' ' ' ILE . . . . . 0.789 HG22 ' O ' ' A' ' 747' ' ' ILE . 3.4 mp -85.52 48.96 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.229 -0.919 . . . . 0.0 109.886 179.878 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 748' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 56.56 39.73 29.75 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.297 -0.877 . . . . 0.0 109.941 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 749' ' ' SER . . . . . 0.554 ' C ' ' CG ' ' A' ' 750' ' ' TYR . 10.5 p -160.27 -42.74 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.318 -0.864 . . . . 0.0 110.192 179.943 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 750' ' ' TYR . . . . . 0.554 ' CG ' ' C ' ' A' ' 749' ' ' SER . 9.6 p90 33.94 96.0 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.44 0 O-C-N 121.69 -0.631 . . . . 0.0 110.942 -179.976 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 751' ' ' GLY . . . . . 0.477 ' O ' ' HB3' ' A' ' 752' ' ' GLU . . . -134.89 -152.35 6.53 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.846 -1.302 . . . . 0.0 109.846 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 752' ' ' GLU . . . . . 0.477 ' HB3' ' O ' ' A' ' 751' ' ' GLY . 4.4 tp10 64.86 96.16 0.05 OUTLIER Pre-proline 0 N--CA 1.495 1.789 0 O-C-N 121.336 -1.096 . . . . 0.0 110.337 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 753' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -77.37 118.17 4.56 Favored 'Trans proline' 0 C--N 1.305 -1.735 0 O-C-N 124.108 1.583 . . . . 0.0 110.247 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 754' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -164.11 166.85 20.89 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.179 -0.951 . . . . 0.0 110.322 -179.954 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 755' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -101.81 156.26 17.62 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.236 -0.915 . . . . 0.0 110.235 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 756' ' ' HIS . . . . . 0.527 ' ND1' ' O ' ' A' ' 756' ' ' HIS . 18.8 p80 -149.72 51.98 0.93 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.221 -0.925 . . . . 0.0 110.319 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 757' ' ' THR . . . . . 0.434 HG21 ' HB3' ' A' ' 817' ' ' SER . 0.8 OUTLIER -136.96 168.01 20.4 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.086 -1.009 . . . . 0.0 110.553 -179.931 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 758' ' ' ALA . . . . . 0.503 ' HB2' ' HB2' ' A' ' 738' ' ' TYR . . . -90.79 178.43 6.05 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.402 -0.811 . . . . 0.0 109.619 179.947 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 759' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -135.97 159.78 40.65 Favored 'General case' 0 C--N 1.298 -1.673 0 O-C-N 121.064 -1.023 . . . . 0.0 110.858 -179.94 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 760' ' ' VAL . . . . . 0.494 HG12 ' N ' ' A' ' 761' ' ' HIS . 97.5 t -105.87 167.88 3.0 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 179.842 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 761' ' ' HIS . . . . . 0.494 ' N ' HG12 ' A' ' 760' ' ' VAL . 29.3 m80 -137.6 104.76 5.42 Favored 'General case' 0 C--N 1.299 -1.588 0 C-N-CA 118.501 -1.28 . . . . 0.0 112.263 -179.765 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 762' ' ' LEU . . . . . 0.6 HD12 ' HB3' ' A' ' 812' ' ' CYS . 32.1 mt -116.24 126.25 53.35 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 179.787 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 763' ' ' LYS . . . . . . . . . . . . . 6.7 tttt -134.59 137.51 43.79 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.67 -1.269 . . . . 0.0 112.147 -179.75 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 764' ' ' CYS . . . . . 0.495 ' HB3' ' O ' ' A' ' 810' ' ' GLU . 22.4 t -136.39 143.63 44.1 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.561 -0.712 . . . . 0.0 109.554 179.824 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 765' ' ' ALA . . . . . . . . . . . . . . . -49.79 155.41 1.48 Allowed Pre-proline 0 N--CA 1.492 1.667 0 O-C-N 121.048 -1.033 . . . . 0.0 110.104 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 766' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -71.74 91.68 0.7 Allowed 'Trans proline' 0 C--N 1.306 -1.684 0 O-C-N 123.974 1.512 . . . . 0.0 110.303 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 767' ' ' GLY . . . . . . . . . . . . . . . 152.8 -27.01 0.83 Allowed Glycine 0 N--CA 1.489 2.196 0 N-CA-C 108.81 -1.716 . . . . 0.0 108.81 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 768' ' ' GLN . . . . . 0.492 ' HB2' ' SG ' ' A' ' 764' ' ' CYS . 30.0 mt-30 -104.51 128.09 52.38 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.513 -0.992 . . . . 0.0 109.682 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 769' ' ' THR . . . . . 0.409 ' OG1' ' HB2' ' A' ' 842' ' ' ALA . 9.6 p -113.8 152.78 30.15 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.178 -0.951 . . . . 0.0 110.556 -179.936 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 770' ' ' ILE . . . . . 0.872 HD12 ' O ' ' A' ' 809' ' ' LEU . 2.8 mp -64.6 119.58 9.28 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.341 -0.849 . . . . 0.0 109.765 179.959 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 771' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -111.53 -1.74 15.72 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.277 -0.889 . . . . 0.0 110.493 -179.926 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 772' ' ' ALA . . . . . 0.495 ' O ' ' HB ' ' A' ' 838' ' ' VAL . . . -168.0 131.9 1.67 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.148 -0.97 . . . . 0.0 111.039 -179.936 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 773' ' ' ILE . . . . . 0.464 HG13 ' HG3' ' A' ' 803' ' ' GLU . 16.6 mm -91.16 125.64 43.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.244 -0.91 . . . . 0.0 109.163 179.871 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 774' ' ' LYS . . . . . 0.497 ' HB3' ' HB3' ' A' ' 836' ' ' GLU . 6.5 ttmt -79.77 -37.85 34.45 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.158 -0.964 . . . . 0.0 111.116 -179.894 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 775' ' ' PHE . . . . . . . . . . . . . 52.5 t80 -152.76 152.99 32.28 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.953 -1.092 . . . . 0.0 110.75 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 776' ' ' ALA . . . . . 0.494 ' O ' ' HB2' ' A' ' 798' ' ' SER . . . -174.13 112.35 0.17 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.552 -0.718 . . . . 0.0 109.624 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 777' ' ' SER . . . . . 0.712 ' HB3' ' CD2' ' A' ' 794' ' ' HIS . 6.7 m -162.04 98.34 1.06 Allowed 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.177 -0.952 . . . . 0.0 110.727 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 778' ' ' PHE . . . . . 0.514 ' CD1' ' C ' ' A' ' 778' ' ' PHE . 0.9 OUTLIER -72.75 103.86 3.78 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.293 -0.88 . . . . 0.0 109.969 179.936 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 779' ' ' GLY . . . . . . . . . . . . . . . 174.88 -109.52 0.29 Allowed Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.663 -1.375 . . . . 0.0 109.663 -179.903 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 780' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -124.94 70.0 58.99 Favored Pre-proline 0 N--CA 1.492 1.647 0 O-C-N 121.292 -1.122 . . . . 0.0 110.22 -179.898 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 781' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -74.4 153.21 44.79 Favored 'Trans proline' 0 C--N 1.305 -1.721 0 O-C-N 124.039 1.547 . . . . 0.0 110.542 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 782' ' ' LEU . . . . . 0.487 ' O ' ' N ' ' A' ' 789' ' ' GLN . 1.1 mt -138.76 151.0 46.72 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.288 -0.883 . . . . 0.0 110.126 -179.954 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 783' ' ' GLY . . . . . . . . . . . . . . . 118.25 -170.77 13.8 Favored Glycine 0 N--CA 1.492 2.404 0 N-CA-C 109.643 -1.383 . . . . 0.0 109.643 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 784' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -125.41 -162.71 1.13 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.274 -1.133 . . . . 0.0 110.088 -179.988 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 785' ' ' CYS . . . . . . . . . . . . . 21.2 m -79.77 94.55 5.79 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.184 -0.947 . . . . 0.0 110.476 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 786' ' ' GLY . . . . . . . . . . . . . . . 137.58 -23.29 3.12 Favored Glycine 0 N--CA 1.489 2.198 0 N-CA-C 109.577 -1.409 . . . . 0.0 109.577 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 787' ' ' THR . . . . . 0.46 ' O ' ' O ' ' A' ' 788' ' ' PHE . 20.4 p -142.73 37.9 1.47 Allowed 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.305 -1.114 . . . . 0.0 110.24 -179.952 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 788' ' ' PHE . . . . . 0.46 ' O ' ' O ' ' A' ' 787' ' ' THR . 0.9 OUTLIER -46.56 175.83 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.301 -0.875 . . . . 0.0 110.501 179.963 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 789' ' ' GLN . . . . . 0.487 ' N ' ' O ' ' A' ' 782' ' ' LEU . 0.0 OUTLIER -153.91 148.42 26.19 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.45 -0.781 . . . . 0.0 110.289 -179.976 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 790' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -78.94 151.22 31.79 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.151 -0.968 . . . . 0.0 110.132 -179.995 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 791' ' ' GLY . . . . . . . . . . . . . . . -108.83 -153.54 15.94 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.529 -1.428 . . . . 0.0 109.529 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 792' ' ' GLU . . . . . . . . . . . . . 6.0 pm0 -109.83 -19.57 13.09 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.308 -1.113 . . . . 0.0 110.358 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 793' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -98.62 24.8 7.07 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.247 -0.908 . . . . 0.0 110.307 179.903 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 794' ' ' HIS . . . . . 0.712 ' CD2' ' HB3' ' A' ' 777' ' ' SER . 8.8 t-160 -68.98 149.12 49.17 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.176 -0.953 . . . . 0.0 109.899 -179.964 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 795' ' ' SER . . . . . 0.521 ' O ' ' N ' ' A' ' 797' ' ' ASN . 1.7 p -87.9 14.16 9.4 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.191 -0.943 . . . . 0.0 110.499 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 796' ' ' ILE . . . . . 0.617 ' HA ' ' CE1' ' A' ' 794' ' ' HIS . 3.6 pt 34.56 32.27 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.505 2.31 0 CA-C-O 121.503 0.668 . . . . 0.0 110.247 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 797' ' ' ASN . . . . . 0.521 ' N ' ' O ' ' A' ' 795' ' ' SER . 60.9 t30 -157.68 21.14 0.27 Allowed 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.486 -0.759 . . . . 0.0 109.646 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 798' ' ' SER . . . . . 0.573 ' CB ' ' HA ' ' A' ' 777' ' ' SER . 17.7 m -84.51 -33.57 23.5 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.526 -0.734 . . . . 0.0 110.636 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 799' ' ' ASN . . . . . 0.465 ' O ' ' OE1' ' A' ' 803' ' ' GLU . 11.8 t-20 -74.17 -6.66 49.03 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.282 -0.886 . . . . 0.0 110.729 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 800' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -86.52 -44.03 12.26 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.052 -1.03 . . . . 0.0 110.39 179.961 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 801' ' ' VAL . . . . . . . . . . . . . 69.5 t -72.57 -21.67 20.01 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 121.29 -0.881 . . . . 0.0 110.808 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 802' ' ' LEU . . . . . 0.475 ' O ' ' HB2' ' A' ' 806' ' ' CYS . 1.8 mm? -84.08 -43.89 14.61 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.043 -1.035 . . . . 0.0 110.612 -179.946 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 803' ' ' GLU . . . . . 0.569 ' O ' HD12 ' A' ' 807' ' ' ILE . 40.6 mt-10 -67.45 -24.67 65.65 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.118 -0.989 . . . . 0.0 110.416 -179.988 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 804' ' ' ARG . . . . . . . . . . . . . 13.6 mmt-85 -90.59 -24.71 20.48 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.194 -0.942 . . . . 0.0 110.827 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 805' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.95 46.86 1.85 Allowed 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.014 -1.054 . . . . 0.0 110.701 179.977 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 806' ' ' CYS . . . . . 0.475 ' HB2' ' O ' ' A' ' 802' ' ' LEU . 1.8 t -160.59 -40.27 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.216 -0.927 . . . . 0.0 110.532 179.958 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 807' ' ' ILE . . . . . 0.569 HD12 ' O ' ' A' ' 803' ' ' GLU . 45.2 mt -67.58 123.27 20.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.242 -0.911 . . . . 0.0 110.765 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 808' ' ' GLY . . . . . . . . . . . . . . . 111.1 -8.48 29.16 Favored Glycine 0 N--CA 1.494 2.508 0 N-CA-C 110.024 -1.23 . . . . 0.0 110.024 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 809' ' ' LEU . . . . . 0.872 ' O ' HD12 ' A' ' 770' ' ' ILE . 36.0 mt -120.28 139.33 52.88 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.079 -1.247 . . . . 0.0 110.614 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 810' ' ' GLU . . . . . 0.495 ' O ' ' HB3' ' A' ' 764' ' ' CYS . 5.4 pt-20 -69.03 -33.89 74.34 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.213 -0.929 . . . . 0.0 109.356 179.942 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 811' ' ' ARG . . . . . . . . . . . . . 15.3 ttp180 -112.21 157.33 21.01 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.517 -0.739 . . . . 0.0 109.443 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 812' ' ' CYS . . . . . 0.6 ' HB3' HD12 ' A' ' 762' ' ' LEU . 1.3 t -149.44 108.21 3.85 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.099 -1.001 . . . . 0.0 111.085 -179.928 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 813' ' ' VAL . . . . . 0.576 HG13 ' O ' ' A' ' 813' ' ' VAL . 4.5 p -118.4 122.92 70.71 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 121.333 -0.854 . . . . 0.0 109.268 179.946 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 814' ' ' VAL . . . . . . . . . . . . . 45.1 t -135.89 121.97 30.91 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.987 0 O-C-N 121.117 -0.989 . . . . 0.0 111.001 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 815' ' ' ALA . . . . . . . . . . . . . . . -80.33 130.17 35.0 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.358 -0.839 . . . . 0.0 109.744 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 816' ' ' ILE . . . . . 0.842 HG21 HG21 ' A' ' 833' ' ' VAL . 2.6 mt -80.61 113.65 20.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.122 -0.986 . . . . 0.0 110.564 -179.866 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 817' ' ' SER . . . . . 0.453 ' O ' ' OD1' ' A' ' 820' ' ' ASN . 8.8 p -143.44 162.83 40.27 Favored Pre-proline 0 N--CA 1.494 1.774 0 O-C-N 121.352 -0.842 . . . . 0.0 110.074 -179.946 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 818' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -82.4 21.05 1.02 Allowed 'Trans proline' 0 C--N 1.307 -1.656 0 O-C-N 123.978 1.515 . . . . 0.0 110.931 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 819' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -135.7 9.23 3.35 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.972 -1.08 . . . . 0.0 110.327 179.94 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 820' ' ' ASN . . . . . 0.453 ' OD1' ' O ' ' A' ' 817' ' ' SER . 8.1 p-10 -117.42 -10.16 10.75 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.224 -0.922 . . . . 0.0 110.283 -179.969 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 821' ' ' PHE . . . . . . . . . . . . . 9.2 m-85 -105.14 -22.28 13.11 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.19 -0.944 . . . . 0.0 110.237 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 822' ' ' GLY . . . . . . . . . . . . . . . 104.95 47.77 1.14 Allowed Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.739 -1.344 . . . . 0.0 109.739 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 823' ' ' GLY . . . . . . . . . . . . . . . 116.58 -134.3 11.26 Favored Glycine 0 N--CA 1.492 2.41 0 N-CA-C 109.661 -1.376 . . . . 0.0 109.661 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 824' ' ' ASP . . . . . 0.452 ' CG ' ' HD2' ' A' ' 825' ' ' PRO . 0.4 OUTLIER -172.01 157.19 4.07 Favored Pre-proline 0 N--CA 1.494 1.76 0 O-C-N 121.226 -1.161 . . . . 0.0 110.395 -179.963 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 825' ' ' PRO . . . . . 0.452 ' HD2' ' CG ' ' A' ' 824' ' ' ASP . 46.8 Cg_endo -75.2 -88.33 0.0 OUTLIER 'Trans proline' 0 C--N 1.307 -1.63 0 O-C-N 124.066 1.561 . . . . 0.0 110.544 -179.931 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 826' ' ' CYS . . . . . . . . . . . . . 3.3 p -120.66 105.11 41.48 Favored Pre-proline 0 N--CA 1.498 1.933 0 O-C-N 121.201 -0.937 . . . . 0.0 110.193 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 827' ' ' PRO . . . . . 0.523 ' O ' ' CB ' ' A' ' 828' ' ' GLU . 50.3 Cg_endo -78.12 82.48 2.43 Favored 'Trans proline' 0 C--N 1.31 -1.493 0 O-C-N 124.093 1.575 . . . . 0.0 110.73 179.959 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 828' ' ' GLU . . . . . 0.523 ' CB ' ' O ' ' A' ' 827' ' ' PRO . 0.2 OUTLIER 165.12 -23.03 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.392 -0.818 . . . . 0.0 109.987 -179.984 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 829' ' ' VAL . . . . . 0.463 ' O ' ' HG3' ' A' ' 831' ' ' LYS . 42.4 t -100.0 167.06 2.07 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.505 0 O-C-N 121.266 -0.896 . . . . 0.0 110.351 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 830' ' ' MET . . . . . 0.45 ' N ' HG12 ' A' ' 829' ' ' VAL . 31.4 mtm -42.29 146.97 0.28 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.352 -0.842 . . . . 0.0 110.293 179.957 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 831' ' ' LYS . . . . . 0.463 ' HG3' ' O ' ' A' ' 829' ' ' VAL . 15.6 mtmm -127.61 83.0 2.12 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.262 -0.899 . . . . 0.0 110.054 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 832' ' ' ARG . . . . . . . . . . . . . 37.1 mtt180 -111.07 150.69 29.0 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.323 -0.861 . . . . 0.0 110.046 -179.895 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 833' ' ' VAL . . . . . 0.842 HG21 HG21 ' A' ' 816' ' ' ILE . 98.6 t -116.32 159.62 16.18 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.522 0 O-C-N 121.244 -0.91 . . . . 0.0 110.677 -179.982 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 834' ' ' ALA . . . . . 0.435 ' HB1' ' CZ ' ' A' ' 788' ' ' PHE . . . -160.11 104.2 1.49 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.508 -0.745 . . . . 0.0 109.26 179.965 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 835' ' ' VAL . . . . . . . . . . . . . 39.8 t -115.35 159.66 15.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.112 -0.993 . . . . 0.0 111.114 -179.863 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 836' ' ' GLU . . . . . 0.497 ' HB3' ' HB3' ' A' ' 774' ' ' LYS . 0.0 OUTLIER -144.34 123.96 13.27 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.574 -0.704 . . . . 0.0 109.28 179.917 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 837' ' ' ALA . . . . . 0.573 ' O ' HG22 ' A' ' 731' ' ' VAL . . . -111.66 144.9 40.17 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.15 -0.969 . . . . 0.0 110.704 -179.953 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 838' ' ' VAL . . . . . 0.495 ' HB ' ' O ' ' A' ' 772' ' ' ALA . 76.3 t -111.22 124.99 68.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.398 -0.814 . . . . 0.0 109.534 179.945 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 839' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -108.46 119.56 39.88 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.23 -0.919 . . . . 0.0 110.039 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 840' ' ' SER . . . . . 0.455 ' O ' ' O ' ' A' ' 841' ' ' THR . 0.9 OUTLIER -133.66 69.06 1.48 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.34 -0.85 . . . . 0.0 109.845 179.992 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 841' ' ' THR . . . . . 0.455 ' O ' ' O ' ' A' ' 840' ' ' SER . 30.7 p 47.03 -175.25 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.443 -0.786 . . . . 0.0 110.313 179.921 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 842' ' ' ALA . . . . . 0.668 ' O ' ' HB2' ' A' ' 843' ' ' ALA . . . -149.93 71.13 1.07 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.317 -0.864 . . . . 0.0 109.873 -180.0 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 843' ' ' ALA . . . . . 0.668 ' HB2' ' O ' ' A' ' 842' ' ' ALA . . . . . . . . 0 N--CA 1.491 1.595 0 CA-C-O 118.028 -0.987 . . . . 0.0 110.069 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 726' ' ' ARG . . . . . . . . . . . . . 6.7 mtm180 . . . . . 0 N--CA 1.492 1.666 0 CA-C-O 121.265 0.555 . . . . 0.0 110.08 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 727' ' ' THR . . . . . . . . . . . . . 87.6 m -92.96 108.7 20.2 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.473 -0.767 . . . . 0.0 110.489 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 728' ' ' VAL . . . . . 0.687 ' O ' HG12 ' A' ' 728' ' ' VAL . 72.8 t -140.61 61.83 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 O-C-N 121.197 -0.939 . . . . 0.0 109.999 179.949 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 729' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -77.12 -147.95 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.373 -0.83 . . . . 0.0 110.185 -179.971 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 730' ' ' GLY . . . . . . . . . . . . . . . -149.96 150.02 22.01 Favored Glycine 0 N--CA 1.488 2.108 0 N-CA-C 109.697 -1.361 . . . . 0.0 109.697 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 731' ' ' VAL . . . . . . . . . . . . . 86.4 t -111.12 157.28 12.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.334 -1.098 . . . . 0.0 109.836 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 732' ' ' CYS . . . . . . . . . . . . . 10.9 t -117.75 146.34 43.85 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.176 -0.953 . . . . 0.0 110.341 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 733' ' ' ALA . . . . . 0.651 ' HB2' HD21 ' A' ' 762' ' ' LEU . . . -142.13 116.25 9.42 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.268 -0.895 . . . . 0.0 110.356 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 734' ' ' ASP . . . . . 0.458 ' C ' HG23 ' A' ' 735' ' ' VAL . 0.8 OUTLIER -114.12 139.09 49.61 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.177 -0.952 . . . . 0.0 110.001 179.937 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 735' ' ' VAL . . . . . 0.458 HG23 ' C ' ' A' ' 734' ' ' ASP . 44.9 t -147.89 124.05 2.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.214 -0.929 . . . . 0.0 110.039 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 736' ' ' SER . . . . . 0.42 ' O ' ' C ' ' A' ' 737' ' ' GLU . 0.7 OUTLIER -90.87 134.89 34.1 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.23 -0.919 . . . . 0.0 110.199 179.951 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 737' ' ' GLU . . . . . 0.42 ' C ' ' O ' ' A' ' 736' ' ' SER . 29.5 tp10 -41.74 115.8 0.7 Allowed 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.275 -0.891 . . . . 0.0 110.004 179.96 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 738' ' ' TYR . . . . . 0.477 ' O ' ' CG ' ' A' ' 738' ' ' TYR . 2.7 t80 -114.36 95.87 5.49 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.225 -0.922 . . . . 0.0 110.409 -179.947 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 739' ' ' HIS . . . . . . . . . . . . . 81.5 t60 -103.0 131.89 21.69 Favored Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.343 -0.848 . . . . 0.0 109.733 179.907 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 740' ' ' PRO . . . . . 0.672 ' O ' HD13 ' A' ' 742' ' ' ILE . 42.0 Cg_endo -67.63 87.55 0.35 Allowed 'Trans proline' 0 C--N 1.302 -1.885 0 O-C-N 123.853 1.449 . . . . 0.0 110.149 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 741' ' ' ASN . . . . . 0.433 ' C ' ' O ' ' A' ' 740' ' ' PRO . 46.5 m-20 -40.84 128.13 2.62 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.376 -0.828 . . . . 0.0 110.34 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 742' ' ' ILE . . . . . 0.672 HD13 ' O ' ' A' ' 740' ' ' PRO . 6.6 mm -85.82 -9.16 11.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.298 -0.876 . . . . 0.0 109.999 179.962 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 743' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -68.94 -21.8 64.17 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.338 -0.851 . . . . 0.0 109.969 -179.981 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 744' ' ' ASN . . . . . 0.478 ' N ' ' OD1' ' A' ' 744' ' ' ASN . 20.1 p-10 -162.87 70.67 0.27 Allowed 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.368 -0.832 . . . . 0.0 110.061 179.953 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 745' ' ' TRP . . . . . 0.479 ' CD1' ' N ' ' A' ' 745' ' ' TRP . 0.3 OUTLIER -82.21 31.44 0.39 Allowed 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.382 -0.824 . . . . 0.0 111.527 179.997 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 746' ' ' GLN . . . . . 0.51 ' O ' ' HG3' ' A' ' 746' ' ' GLN . 15.3 pt20 -158.86 89.54 0.95 Allowed 'General case' 0 N--CA 1.497 1.877 0 O-C-N 120.963 -1.085 . . . . 0.0 110.163 179.87 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 747' ' ' ILE . . . . . 0.634 ' H ' HD12 ' A' ' 747' ' ' ILE . 0.1 OUTLIER -104.26 -151.66 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 2.025 0 O-C-N 120.989 -1.069 . . . . 0.0 110.046 -179.983 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 748' ' ' GLU . . . . . 0.497 ' HG2' ' N ' ' A' ' 749' ' ' SER . 0.6 OUTLIER -63.02 -18.77 63.69 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.309 -0.869 . . . . 0.0 110.093 179.972 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 749' ' ' SER . . . . . 0.497 ' N ' ' HG2' ' A' ' 748' ' ' GLU . 16.4 m -99.05 124.88 44.36 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.384 -0.822 . . . . 0.0 110.281 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 750' ' ' TYR . . . . . . . . . . . . . 28.7 m-85 -69.39 172.97 6.33 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.22 -0.925 . . . . 0.0 110.387 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 751' ' ' GLY . . . . . . . . . . . . . . . 123.74 158.75 10.24 Favored Glycine 0 N--CA 1.492 2.389 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 752' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -141.76 127.6 10.93 Favored Pre-proline 0 N--CA 1.493 1.689 0 O-C-N 121.163 -1.198 . . . . 0.0 110.368 -179.967 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 753' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -71.08 101.24 1.07 Allowed 'Trans proline' 0 C--N 1.309 -1.531 0 O-C-N 123.819 1.431 . . . . 0.0 110.324 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 754' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -83.73 -37.4 22.73 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.285 -0.884 . . . . 0.0 110.364 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 755' ' ' PHE . . . . . 0.483 ' C ' ' CG ' ' A' ' 756' ' ' HIS . 0.2 OUTLIER -73.7 -157.24 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.177 -0.952 . . . . 0.0 110.187 -179.973 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 756' ' ' HIS . . . . . 0.757 ' O ' HG23 ' A' ' 757' ' ' THR . 2.2 m-70 -150.54 16.54 0.8 Allowed 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.241 -0.912 . . . . 0.0 110.108 -179.944 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 757' ' ' THR . . . . . 0.757 HG23 ' O ' ' A' ' 756' ' ' HIS . 1.8 p -161.2 -177.71 6.23 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.003 -1.061 . . . . 0.0 110.934 -179.952 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 758' ' ' ALA . . . . . . . . . . . . . . . -101.03 173.73 6.34 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.479 -0.763 . . . . 0.0 110.169 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 759' ' ' LYS . . . . . . . . . . . . . 36.2 mtpt -137.94 165.27 26.95 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.203 -0.935 . . . . 0.0 110.63 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 760' ' ' VAL . . . . . . . . . . . . . 38.4 t -109.7 139.64 31.94 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.442 -0.786 . . . . 0.0 109.642 179.938 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 761' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -109.97 104.2 13.07 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.068 -1.02 . . . . 0.0 110.886 -179.981 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 762' ' ' LEU . . . . . 0.651 HD21 ' HB2' ' A' ' 733' ' ' ALA . 21.2 mt -121.46 124.32 44.18 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.298 -0.876 . . . . 0.0 109.414 179.879 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 763' ' ' LYS . . . . . 0.563 ' HB3' ' CD ' ' A' ' 811' ' ' ARG . 0.0 OUTLIER -156.05 123.17 5.35 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.919 -1.113 . . . . 0.0 111.243 -179.928 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 764' ' ' CYS . . . . . 0.41 ' O ' ' C ' ' A' ' 765' ' ' ALA . 19.1 m -99.04 157.34 16.41 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.342 -0.849 . . . . 0.0 109.263 179.839 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 765' ' ' ALA . . . . . 0.41 ' C ' ' O ' ' A' ' 764' ' ' CYS . . . -42.64 159.56 0.2 Allowed Pre-proline 0 N--CA 1.495 1.818 0 O-C-N 121.076 -1.015 . . . . 0.0 109.982 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 766' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -71.23 97.3 0.75 Allowed 'Trans proline' 0 C--N 1.306 -1.667 0 O-C-N 123.913 1.48 . . . . 0.0 110.524 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 767' ' ' GLY . . . . . . . . . . . . . . . 147.53 -31.69 1.38 Allowed Glycine 0 N--CA 1.489 2.198 0 N-CA-C 109.044 -1.623 . . . . 0.0 109.044 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 768' ' ' GLN . . . . . 0.434 ' HB3' ' HB3' ' A' ' 839' ' ' CYS . 20.1 mt-30 -99.0 101.61 13.05 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.369 -1.077 . . . . 0.0 109.982 179.953 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 769' ' ' THR . . . . . . . . . . . . . 11.2 p -85.28 146.95 26.79 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.112 -0.992 . . . . 0.0 110.128 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 770' ' ' ILE . . . . . . . . . . . . . 35.7 mt -66.7 144.16 14.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.306 -0.871 . . . . 0.0 109.252 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 771' ' ' SER . . . . . . . . . . . . . 47.8 t -135.28 -4.69 2.35 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.873 -1.142 . . . . 0.0 111.432 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 772' ' ' ALA . . . . . . . . . . . . . . . -172.71 151.68 2.37 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 120.781 -1.199 . . . . 0.0 111.418 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 773' ' ' ILE . . . . . . . . . . . . . 20.1 mm -110.75 120.28 61.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 179.888 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 774' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -80.09 -42.89 22.75 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 120.986 -1.071 . . . . 0.0 110.951 -179.835 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 775' ' ' PHE . . . . . 0.499 ' O ' ' HB2' ' A' ' 776' ' ' ALA . 67.2 t80 -134.0 152.25 51.77 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.098 -1.001 . . . . 0.0 110.668 -179.913 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 776' ' ' ALA . . . . . 0.499 ' HB2' ' O ' ' A' ' 775' ' ' PHE . . . 179.1 113.41 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.567 -0.708 . . . . 0.0 109.803 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 777' ' ' SER . . . . . 0.523 ' HB2' ' CD2' ' A' ' 794' ' ' HIS . 94.5 p -148.73 126.86 12.07 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.338 -0.851 . . . . 0.0 110.475 -179.958 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 778' ' ' PHE . . . . . 0.583 ' HE1' HG23 ' A' ' 816' ' ' ILE . 12.2 t80 -94.21 116.48 28.88 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.359 -0.838 . . . . 0.0 109.949 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 779' ' ' GLY . . . . . 0.505 ' HA3' ' O ' ' A' ' 793' ' ' CYS . . . 163.97 -136.15 4.11 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.932 -1.267 . . . . 0.0 109.932 -179.958 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 780' ' ' THR . . . . . . . . . . . . . 45.7 p -123.49 64.77 30.22 Favored Pre-proline 0 N--CA 1.494 1.766 0 O-C-N 121.212 -1.17 . . . . 0.0 110.595 -179.93 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 781' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -74.47 170.79 19.45 Favored 'Trans proline' 0 C--N 1.304 -1.792 0 O-C-N 124.044 1.55 . . . . 0.0 110.392 179.927 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 782' ' ' LEU . . . . . . . . . . . . . 3.7 mt -129.86 173.91 10.23 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.198 -0.939 . . . . 0.0 110.261 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 783' ' ' GLY . . . . . . . . . . . . . . . 110.93 -169.54 13.38 Favored Glycine 0 N--CA 1.494 2.561 0 N-CA-C 109.595 -1.402 . . . . 0.0 109.595 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 784' ' ' THR . . . . . 0.52 HG22 ' N ' ' A' ' 785' ' ' CYS . 54.3 m -115.62 -92.92 0.5 Allowed 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.229 -1.159 . . . . 0.0 110.336 -179.96 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 785' ' ' CYS . . . . . 0.52 ' N ' HG22 ' A' ' 784' ' ' THR . 0.3 OUTLIER -139.5 120.05 14.1 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.175 -0.953 . . . . 0.0 110.162 -179.938 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 786' ' ' GLY . . . . . . . . . . . . . . . 95.3 -4.62 67.3 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.658 -1.377 . . . . 0.0 109.658 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 787' ' ' THR . . . . . . . . . . . . . 9.0 t -145.41 34.8 1.07 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.209 -1.171 . . . . 0.0 110.109 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 788' ' ' PHE . . . . . 0.412 ' CZ ' ' O ' ' A' ' 784' ' ' THR . 39.4 m-85 -53.41 176.22 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.342 -0.849 . . . . 0.0 110.385 179.996 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 789' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -139.66 145.28 38.24 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.335 -0.853 . . . . 0.0 110.164 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 790' ' ' GLN . . . . . . . . . . . . . 2.1 mt-30 -64.21 131.05 46.25 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.121 -0.987 . . . . 0.0 109.882 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 791' ' ' GLY . . . . . . . . . . . . . . . -92.49 -163.26 37.58 Favored Glycine 0 N--CA 1.492 2.413 0 N-CA-C 109.698 -1.361 . . . . 0.0 109.698 180.0 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 792' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -98.41 -14.0 20.33 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.337 -1.096 . . . . 0.0 110.226 -179.972 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 793' ' ' CYS . . . . . 0.505 ' O ' ' HA3' ' A' ' 779' ' ' GLY . 0.5 OUTLIER -116.86 68.59 0.74 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.352 -0.842 . . . . 0.0 110.275 179.972 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 794' ' ' HIS . . . . . 0.532 ' CE1' ' O ' ' A' ' 795' ' ' SER . 38.2 t-80 -102.59 145.64 29.34 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.171 -0.956 . . . . 0.0 110.866 -179.919 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 795' ' ' SER . . . . . 0.532 ' O ' ' CE1' ' A' ' 794' ' ' HIS . 8.5 t -91.31 174.48 7.36 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.244 -0.91 . . . . 0.0 109.275 179.874 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 796' ' ' ILE . . . . . . . . . . . . . 1.5 mt -105.52 20.48 4.11 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.912 0 O-C-N 120.859 -1.151 . . . . 0.0 110.256 -179.929 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 797' ' ' ASN . . . . . 0.505 ' N ' ' OD1' ' A' ' 797' ' ' ASN . 1.6 m120 -132.5 36.22 3.58 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.427 -0.796 . . . . 0.0 109.083 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 798' ' ' SER . . . . . 0.596 ' O ' HD23 ' A' ' 802' ' ' LEU . 0.9 OUTLIER -65.6 -56.31 12.89 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.724 -0.61 . . . . 0.0 111.285 -179.92 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 799' ' ' ASN . . . . . . . . . . . . . 4.5 m120 -86.41 14.27 6.95 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.135 -0.978 . . . . 0.0 111.368 -179.782 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 800' ' ' SER . . . . . . . . . . . . . 7.8 t -91.28 -62.64 1.4 Allowed 'General case' 0 C--N 1.299 -1.616 0 O-C-N 120.874 -1.141 . . . . 0.0 110.269 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 801' ' ' VAL . . . . . 1.003 HG11 ' OD1' ' A' ' 820' ' ' ASN . 49.3 t -68.11 -19.55 24.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.274 -0.891 . . . . 0.0 110.534 -179.918 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 802' ' ' LEU . . . . . 0.596 HD23 ' O ' ' A' ' 798' ' ' SER . 4.2 mm? -69.05 -51.99 33.22 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.137 -0.977 . . . . 0.0 110.739 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 803' ' ' GLU . . . . . 0.757 ' HA ' HD13 ' A' ' 807' ' ' ILE . 4.1 tt0 -68.84 -17.76 64.05 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.034 -1.041 . . . . 0.0 110.721 -179.955 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 804' ' ' ARG . . . . . . . . . . . . . 17.9 mtp180 -91.45 -18.53 24.05 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.225 -0.922 . . . . 0.0 111.519 -179.884 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 805' ' ' LYS . . . . . 0.454 ' O ' ' SG ' ' A' ' 806' ' ' CYS . 19.8 mttt -124.49 26.96 7.11 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 120.857 -1.152 . . . . 0.0 111.882 -179.856 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 806' ' ' CYS . . . . . 0.831 ' C ' HD12 ' A' ' 807' ' ' ILE . 1.7 m -160.87 18.69 0.13 Allowed 'General case' 0 N--CA 1.501 2.111 0 O-C-N 120.737 -1.227 . . . . 0.0 111.035 179.942 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 807' ' ' ILE . . . . . 0.831 HD12 ' C ' ' A' ' 806' ' ' CYS . 1.7 mp -123.27 112.51 33.86 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.902 0 O-C-N 121.001 -1.062 . . . . 0.0 110.204 179.972 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 808' ' ' GLY . . . . . . . . . . . . . . . 116.73 -4.24 19.28 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 809' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -125.99 137.81 53.7 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.275 -1.132 . . . . 0.0 110.265 -179.944 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 810' ' ' GLU . . . . . 0.473 ' HG3' ' N ' ' A' ' 811' ' ' ARG . 0.4 OUTLIER -64.87 -17.82 64.62 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.219 -0.925 . . . . 0.0 108.965 179.886 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 811' ' ' ARG . . . . . 0.563 ' CD ' ' HB3' ' A' ' 763' ' ' LYS . 13.5 ttp85 -142.48 132.86 24.94 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.674 -0.641 . . . . 0.0 109.36 179.926 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 812' ' ' CYS . . . . . 0.497 ' CB ' ' HA ' ' A' ' 806' ' ' CYS . 15.4 p -142.02 146.86 36.01 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.171 -0.956 . . . . 0.0 110.764 -179.965 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 813' ' ' VAL . . . . . . . . . . . . . 67.0 t -120.67 135.62 60.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.44 -0.788 . . . . 0.0 110.014 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 814' ' ' VAL . . . . . . . . . . . . . 9.3 t -112.2 109.79 29.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.114 -0.991 . . . . 0.0 110.477 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 815' ' ' ALA . . . . . . . . . . . . . . . -70.77 121.26 17.67 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.259 -0.901 . . . . 0.0 110.097 179.89 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 816' ' ' ILE . . . . . 0.583 HG23 ' HE1' ' A' ' 778' ' ' PHE . 36.1 mt -81.66 104.42 10.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.185 -0.947 . . . . 0.0 110.273 -179.966 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 817' ' ' SER . . . . . 0.466 ' HB2' ' HD2' ' A' ' 818' ' ' PRO . 77.7 p -161.71 164.2 18.33 Favored Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.268 -0.895 . . . . 0.0 110.101 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 818' ' ' PRO . . . . . 0.466 ' HD2' ' HB2' ' A' ' 817' ' ' SER . 43.6 Cg_endo -71.92 -23.65 21.83 Favored 'Trans proline' 0 C--N 1.305 -1.751 0 O-C-N 124.04 1.548 . . . . 0.0 110.13 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 819' ' ' SER . . . . . . . . . . . . . 95.1 p -85.52 42.85 0.98 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.259 -0.901 . . . . 0.0 109.872 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 820' ' ' ASN . . . . . 1.003 ' OD1' HG11 ' A' ' 801' ' ' VAL . 28.6 t-20 -143.32 -46.37 0.29 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.283 -0.885 . . . . 0.0 110.13 -179.94 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 821' ' ' PHE . . . . . . . . . . . . . 80.5 m-85 -89.25 8.36 30.73 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.334 -0.854 . . . . 0.0 110.349 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 822' ' ' GLY . . . . . . . . . . . . . . . 87.09 52.72 3.01 Favored Glycine 0 N--CA 1.492 2.409 0 N-CA-C 109.901 -1.28 . . . . 0.0 109.901 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 823' ' ' GLY . . . . . . . . . . . . . . . 90.85 -174.96 39.75 Favored Glycine 0 N--CA 1.494 2.518 0 N-CA-C 109.779 -1.328 . . . . 0.0 109.779 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 824' ' ' ASP . . . . . . . . . . . . . 11.0 p-10 -125.34 150.56 67.81 Favored Pre-proline 0 N--CA 1.495 1.78 0 O-C-N 121.258 -1.142 . . . . 0.0 110.154 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 825' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -77.18 -62.94 0.03 OUTLIER 'Trans proline' 0 C--N 1.306 -1.703 0 O-C-N 124.042 1.549 . . . . 0.0 110.801 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 826' ' ' CYS . . . . . . . . . . . . . 6.0 p -122.98 117.69 28.41 Favored Pre-proline 0 N--CA 1.5 2.074 0 O-C-N 121.141 -0.975 . . . . 0.0 110.785 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 827' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_endo -88.48 168.34 6.1 Favored 'Trans proline' 0 C--N 1.311 -1.427 0 O-C-N 123.952 1.501 . . . . 0.0 110.739 179.941 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 828' ' ' GLU . . . . . . . . . . . . . 2.2 tp10 61.37 27.58 17.18 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.393 -0.817 . . . . 0.0 110.737 179.903 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 829' ' ' VAL . . . . . 0.44 ' O ' ' HD3' ' A' ' 831' ' ' LYS . 50.3 t -131.49 115.09 27.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.088 -1.008 . . . . 0.0 110.417 179.92 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 830' ' ' MET . . . . . 0.425 ' C ' ' O ' ' A' ' 829' ' ' VAL . 19.0 ptp -43.1 123.8 2.99 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.26 -0.9 . . . . 0.0 109.382 179.918 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 831' ' ' LYS . . . . . 0.44 ' HD3' ' O ' ' A' ' 829' ' ' VAL . 0.0 OUTLIER -109.23 179.16 4.24 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.105 -0.997 . . . . 0.0 111.545 -179.876 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 832' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -159.59 141.02 12.88 Favored 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 108.053 -1.092 . . . . 0.0 108.053 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 833' ' ' VAL . . . . . 0.484 HG21 HG12 ' A' ' 816' ' ' ILE . 60.6 t -110.48 139.87 32.09 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 120.741 -1.224 . . . . 0.0 112.05 -179.836 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 834' ' ' ALA . . . . . . . . . . . . . . . -139.02 111.96 7.88 Favored 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 179.862 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 835' ' ' VAL . . . . . 0.448 HG12 ' N ' ' A' ' 836' ' ' GLU . 40.8 t -129.28 163.55 34.14 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 120.923 -1.11 . . . . 0.0 111.848 -179.871 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 836' ' ' GLU . . . . . 0.466 ' HB2' ' HB3' ' A' ' 775' ' ' PHE . 0.1 OUTLIER -140.25 147.15 39.57 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 179.849 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 837' ' ' ALA . . . . . . . . . . . . . . . -128.01 165.52 20.15 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 120.856 -1.152 . . . . 0.0 111.349 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 838' ' ' VAL . . . . . . . . . . . . . 75.0 t -130.4 110.62 19.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.512 -0.743 . . . . 0.0 109.287 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 839' ' ' CYS . . . . . 0.434 ' HB3' ' HB3' ' A' ' 768' ' ' GLN . 68.4 m -107.51 133.51 51.89 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.147 -0.97 . . . . 0.0 110.777 -179.89 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 840' ' ' SER . . . . . . . . . . . . . 35.6 p -125.33 -139.64 0.28 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.482 -0.761 . . . . 0.0 109.857 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 841' ' ' THR . . . . . . . . . . . . . 32.6 p -131.94 144.17 50.64 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.117 -0.99 . . . . 0.0 110.177 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 842' ' ' ALA . . . . . 0.416 ' O ' ' OXT' ' A' ' 843' ' ' ALA . . . -115.52 73.67 0.85 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.38 -0.825 . . . . 0.0 110.174 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 843' ' ' ALA . . . . . 0.416 ' OXT' ' O ' ' A' ' 842' ' ' ALA . . . . . . . . 0 N--CA 1.491 1.62 0 CA-C-O 118.029 -0.986 . . . . 0.0 110.205 -179.947 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 726' ' ' ARG . . . . . 0.407 ' O ' ' HG3' ' A' ' 726' ' ' ARG . 11.3 ptp85 . . . . . 0 N--CA 1.492 1.634 0 CA-C-O 121.279 0.561 . . . . 0.0 110.266 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 727' ' ' THR . . . . . . . . . . . . . 3.0 m -110.46 119.87 40.6 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.325 -0.859 . . . . 0.0 110.158 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 728' ' ' VAL . . . . . 0.441 ' O ' ' O ' ' A' ' 839' ' ' CYS . 13.5 p -128.25 155.72 40.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.264 -0.898 . . . . 0.0 110.394 -179.956 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 729' ' ' SER . . . . . 0.408 ' HB2' ' HA ' ' A' ' 838' ' ' VAL . 89.0 p -172.57 -175.73 1.39 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.369 -0.832 . . . . 0.0 109.764 179.903 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 730' ' ' GLY . . . . . . . . . . . . . . . 155.28 65.69 0.01 OUTLIER Glycine 0 N--CA 1.489 2.203 0 C-N-CA 119.56 -1.305 . . . . 0.0 109.843 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 731' ' ' VAL . . . . . 1.007 HG21 ' SG ' ' A' ' 764' ' ' CYS . 6.5 t -122.65 152.02 26.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.325 -1.103 . . . . 0.0 109.983 179.966 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 732' ' ' CYS . . . . . . . . . . . . . 5.8 t -146.72 144.11 29.19 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.094 -1.004 . . . . 0.0 110.439 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 733' ' ' ALA . . . . . . . . . . . . . . . -135.89 107.73 7.08 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.344 -0.847 . . . . 0.0 109.907 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 734' ' ' ASP . . . . . . . . . . . . . 7.9 t0 -118.11 122.64 43.61 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.18 -0.95 . . . . 0.0 110.551 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 735' ' ' VAL . . . . . . . . . . . . . 45.8 t -129.15 162.45 36.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.287 -0.883 . . . . 0.0 109.856 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 736' ' ' SER . . . . . . . . . . . . . 9.7 t -110.36 139.87 45.13 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.108 -0.995 . . . . 0.0 110.441 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 737' ' ' GLU . . . . . 0.437 ' OE2' ' N ' ' A' ' 738' ' ' TYR . 0.0 OUTLIER -70.26 179.01 2.57 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.343 -0.848 . . . . 0.0 110.042 -179.994 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 738' ' ' TYR . . . . . 0.437 ' N ' ' OE2' ' A' ' 737' ' ' GLU . 22.0 t80 -164.55 115.73 1.23 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.203 -0.936 . . . . 0.0 110.197 179.987 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 739' ' ' HIS . . . . . . . . . . . . . 24.8 t-80 -170.54 101.31 0.43 Allowed Pre-proline 0 N--CA 1.492 1.648 0 O-C-N 121.292 -0.88 . . . . 0.0 110.221 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 740' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -74.97 154.4 42.6 Favored 'Trans proline' 0 C--N 1.304 -1.765 0 O-C-N 124.02 1.537 . . . . 0.0 110.323 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 741' ' ' ASN . . . . . . . . . . . . . 24.8 t-20 -70.16 119.37 14.25 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.2 -0.938 . . . . 0.0 110.028 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 742' ' ' ILE . . . . . 0.469 ' O ' ' HB2' ' A' ' 743' ' ' LYS . 11.8 pt -146.38 179.93 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.209 -0.932 . . . . 0.0 110.493 -179.913 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 743' ' ' LYS . . . . . 0.469 ' HB2' ' O ' ' A' ' 742' ' ' ILE . 44.1 tptt 174.15 -29.56 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.489 -0.757 . . . . 0.0 109.691 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 744' ' ' ASN . . . . . . . . . . . . . 3.6 t30 -143.28 119.08 10.52 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.39 -0.818 . . . . 0.0 109.519 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 745' ' ' TRP . . . . . . . . . . . . . 8.2 m95 -121.07 -59.8 1.7 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.104 -0.997 . . . . 0.0 110.848 -179.929 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 746' ' ' GLN . . . . . 0.417 ' O ' HG13 ' A' ' 747' ' ' ILE . 0.1 OUTLIER -116.81 168.72 9.96 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.041 -1.037 . . . . 0.0 110.72 -179.962 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 747' ' ' ILE . . . . . 0.652 HG22 ' O ' ' A' ' 747' ' ' ILE . 4.2 mp -142.72 56.18 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.356 -0.84 . . . . 0.0 110.198 179.972 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 748' ' ' GLU . . . . . . . . . . . . . 69.1 tt0 -140.86 -75.39 0.32 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.255 -0.903 . . . . 0.0 110.061 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 749' ' ' SER . . . . . . . . . . . . . 21.8 t -171.9 36.08 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.246 -0.909 . . . . 0.0 110.305 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 750' ' ' TYR . . . . . . . . . . . . . 49.1 m-85 -133.57 147.32 51.54 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.166 -0.958 . . . . 0.0 110.397 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 751' ' ' GLY . . . . . . . . . . . . . . . -110.68 -163.12 18.5 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 752' ' ' GLU . . . . . . . . . . . . . 3.5 tp10 -114.7 97.39 46.9 Favored Pre-proline 0 N--CA 1.494 1.769 0 O-C-N 121.316 -1.108 . . . . 0.0 110.159 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 753' ' ' PRO . . . . . 0.448 ' O ' ' HB3' ' A' ' 754' ' ' GLU . 50.5 Cg_endo -79.82 102.98 1.52 Allowed 'Trans proline' 0 C--N 1.307 -1.645 0 O-C-N 124.048 1.552 . . . . 0.0 110.7 -179.936 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 754' ' ' GLU . . . . . 0.537 ' HG3' ' CE1' ' A' ' 756' ' ' HIS . 6.7 pt-20 -177.81 -177.43 0.64 Allowed 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.24 -0.913 . . . . 0.0 110.336 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 755' ' ' PHE . . . . . 0.446 ' O ' ' CD2' ' A' ' 756' ' ' HIS . 0.2 OUTLIER -95.61 164.56 12.73 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.279 -0.888 . . . . 0.0 110.17 -179.965 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 756' ' ' HIS . . . . . 0.537 ' CE1' ' HG3' ' A' ' 754' ' ' GLU . 41.9 m80 -148.18 13.08 0.97 Allowed 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.176 -0.952 . . . . 0.0 110.547 -179.989 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 757' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -146.88 168.31 21.75 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.129 -0.982 . . . . 0.0 110.585 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 758' ' ' ALA . . . . . . . . . . . . . . . -106.27 177.94 4.71 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.41 -0.806 . . . . 0.0 109.856 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 759' ' ' LYS . . . . . . . . . . . . . 3.9 mttp -132.41 147.79 52.39 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.202 -0.936 . . . . 0.0 110.499 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 760' ' ' VAL . . . . . 0.886 ' CG2' HD11 ' A' ' 816' ' ' ILE . 13.3 t -110.27 132.36 58.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.322 -0.861 . . . . 0.0 109.595 179.942 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 761' ' ' HIS . . . . . . . . . . . . . 29.5 m80 -120.78 119.56 33.09 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.108 -0.995 . . . . 0.0 110.923 -179.902 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 762' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -115.0 117.37 30.42 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.372 -0.83 . . . . 0.0 109.011 179.829 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 763' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -136.27 120.43 17.79 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.012 -1.055 . . . . 0.0 111.315 -179.895 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 764' ' ' CYS . . . . . 1.007 ' SG ' HG21 ' A' ' 731' ' ' VAL . 1.2 m -99.4 177.54 5.15 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.491 -0.755 . . . . 0.0 109.81 179.86 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 765' ' ' ALA . . . . . 0.798 ' HB3' ' OE1' ' A' ' 768' ' ' GLN . . . -60.39 161.41 13.88 Favored Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.193 -0.942 . . . . 0.0 109.856 179.969 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 766' ' ' PRO . . . . . 0.402 ' HD2' ' HB1' ' A' ' 765' ' ' ALA . 44.1 Cg_endo -69.89 136.45 32.69 Favored 'Trans proline' 0 C--N 1.306 -1.691 0 O-C-N 123.897 1.472 . . . . 0.0 110.296 179.976 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 767' ' ' GLY . . . . . . . . . . . . . . . 93.54 -30.85 6.9 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.04 -1.624 . . . . 0.0 109.04 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 768' ' ' GLN . . . . . 0.798 ' OE1' ' HB3' ' A' ' 765' ' ' ALA . 10.5 mt-30 -82.75 105.85 14.1 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.331 -1.099 . . . . 0.0 110.076 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 769' ' ' THR . . . . . . . . . . . . . 26.6 p -95.81 146.59 24.43 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.176 -0.953 . . . . 0.0 110.367 179.916 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 770' ' ' ILE . . . . . . . . . . . . . 47.8 mt -76.62 139.47 18.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.356 -0.84 . . . . 0.0 109.675 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 771' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -137.55 -2.67 1.95 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.982 -1.074 . . . . 0.0 111.272 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 772' ' ' ALA . . . . . . . . . . . . . . . -155.99 119.42 4.33 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.763 -1.21 . . . . 0.0 111.075 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 773' ' ' ILE . . . . . . . . . . . . . 33.3 mm -83.26 126.2 40.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.322 -0.862 . . . . 0.0 109.324 179.916 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 774' ' ' LYS . . . . . 0.49 ' CB ' ' OE1' ' A' ' 836' ' ' GLU . 0.1 OUTLIER -82.54 -38.62 23.48 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.111 -0.993 . . . . 0.0 110.766 -179.909 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 775' ' ' PHE . . . . . 0.474 ' HB2' ' O ' ' A' ' 774' ' ' LYS . 11.7 t80 -179.41 133.64 0.11 Allowed 'General case' 0 N--CA 1.496 1.859 0 O-C-N 120.858 -1.151 . . . . 0.0 111.374 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 776' ' ' ALA . . . . . 0.502 ' O ' ' HB3' ' A' ' 798' ' ' SER . . . -151.14 88.91 1.48 Allowed 'General case' 0 N--CA 1.495 1.785 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 179.904 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 777' ' ' SER . . . . . 0.526 ' HA ' ' OG ' ' A' ' 798' ' ' SER . 8.7 p -102.52 165.59 11.01 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.218 -0.926 . . . . 0.0 111.425 -179.77 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 778' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -126.53 101.11 6.53 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.593 -0.692 . . . . 0.0 109.74 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 779' ' ' GLY . . . . . 0.482 ' O ' ' HG2' ' A' ' 832' ' ' ARG . . . 156.66 -109.55 0.41 Allowed Glycine 0 N--CA 1.493 2.454 0 N-CA-C 109.381 -1.488 . . . . 0.0 109.381 179.903 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 780' ' ' THR . . . . . 0.459 ' O ' ' HA3' ' A' ' 791' ' ' GLY . 76.3 p -127.78 101.19 23.8 Favored Pre-proline 0 N--CA 1.493 1.719 0 O-C-N 121.231 -1.158 . . . . 0.0 110.086 179.965 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 781' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -77.34 173.04 14.92 Favored 'Trans proline' 0 C--N 1.305 -1.751 0 O-C-N 124.082 1.569 . . . . 0.0 110.549 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 782' ' ' LEU . . . . . . . . . . . . . 1.1 mt -130.81 98.41 4.61 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.311 -0.868 . . . . 0.0 110.165 179.944 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 783' ' ' GLY . . . . . . . . . . . . . . . 139.49 -164.3 25.99 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 -180.0 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 784' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -119.94 -169.05 1.71 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.157 -1.202 . . . . 0.0 110.173 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 785' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -62.47 93.87 0.06 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.246 -0.909 . . . . 0.0 110.22 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 786' ' ' GLY . . . . . . . . . . . . . . . 146.3 -28.35 1.67 Allowed Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.468 -1.453 . . . . 0.0 109.468 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 787' ' ' THR . . . . . . . . . . . . . 66.3 p -127.2 27.32 5.92 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.24 -1.153 . . . . 0.0 110.207 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 788' ' ' PHE . . . . . 0.454 ' HB3' ' CD1' ' A' ' 775' ' ' PHE . 2.9 m-85 -52.41 110.62 0.52 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.371 -0.831 . . . . 0.0 110.196 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 789' ' ' GLN . . . . . 0.466 ' HA ' ' CE2' ' A' ' 775' ' ' PHE . 7.2 tp60 -127.53 153.36 46.44 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.298 -0.876 . . . . 0.0 110.058 179.965 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 790' ' ' GLN . . . . . 0.498 ' CG ' ' O ' ' A' ' 790' ' ' GLN . 7.5 pt20 -52.27 114.71 1.43 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.249 -0.907 . . . . 0.0 110.28 179.997 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 791' ' ' GLY . . . . . 0.459 ' HA3' ' O ' ' A' ' 780' ' ' THR . . . -66.47 -105.87 0.01 OUTLIER Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.384 -1.486 . . . . 0.0 109.384 -179.978 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 792' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -113.61 -31.67 6.42 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.282 -1.128 . . . . 0.0 110.128 -179.956 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 793' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -121.55 98.22 5.87 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.278 -0.889 . . . . 0.0 110.393 -179.935 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 794' ' ' HIS . . . . . 0.471 ' CE1' ' HB2' ' A' ' 798' ' ' SER . 30.8 t-80 -107.29 131.17 54.5 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.122 -0.986 . . . . 0.0 109.966 179.948 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 795' ' ' SER . . . . . 0.46 ' O ' ' O ' ' A' ' 794' ' ' HIS . 6.3 t -61.59 -141.14 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.172 -0.955 . . . . 0.0 109.453 179.893 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 796' ' ' ILE . . . . . . . . . . . . . 3.4 mt -136.5 -43.69 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 O-C-N 121.11 -0.994 . . . . 0.0 109.707 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 797' ' ' ASN . . . . . 0.414 ' O ' ' C ' ' A' ' 798' ' ' SER . 44.8 m-20 -82.36 10.76 6.44 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.36 -0.838 . . . . 0.0 109.46 179.864 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 798' ' ' SER . . . . . 0.526 ' OG ' ' HA ' ' A' ' 777' ' ' SER . 1.6 m -35.75 -68.69 0.12 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.747 -0.596 . . . . 0.0 111.612 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 799' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -93.95 -26.21 16.94 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.066 -1.021 . . . . 0.0 110.883 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 800' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -50.78 -22.39 2.11 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 120.973 -1.079 . . . . 0.0 110.181 179.965 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 801' ' ' VAL . . . . . 0.548 HG21 ' CD2' ' A' ' 821' ' ' PHE . 25.1 t -84.77 -41.47 15.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.275 -0.891 . . . . 0.0 110.427 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 802' ' ' LEU . . . . . 0.57 ' N ' ' CD2' ' A' ' 802' ' ' LEU . 4.0 mm? -66.2 -41.17 90.57 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.329 -0.857 . . . . 0.0 110.94 -179.933 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 803' ' ' GLU . . . . . 0.421 ' C ' ' O ' ' A' ' 802' ' ' LEU . 8.9 mt-10 -41.88 -47.63 4.28 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.216 -0.927 . . . . 0.0 110.681 -179.935 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 804' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -92.92 -28.21 16.61 Favored 'General case' 0 N--CA 1.503 2.177 0 O-C-N 121.135 -0.978 . . . . 0.0 111.987 -179.834 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 805' ' ' LYS . . . . . 0.478 ' O ' ' SG ' ' A' ' 806' ' ' CYS . 1.0 OUTLIER -89.66 26.98 1.6 Allowed 'General case' 0 N--CA 1.498 1.942 0 O-C-N 120.967 -1.083 . . . . 0.0 111.492 -179.807 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 806' ' ' CYS . . . . . 0.529 ' HA ' ' CB ' ' A' ' 812' ' ' CYS . 13.2 m -158.44 -66.64 0.09 Allowed 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.043 -1.035 . . . . 0.0 110.745 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 807' ' ' ILE . . . . . 0.419 ' C ' ' O ' ' A' ' 806' ' ' CYS . 17.5 mt -41.56 123.51 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.978 0 O-C-N 121.186 -0.947 . . . . 0.0 110.973 -179.933 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 808' ' ' GLY . . . . . 0.461 ' C ' ' HG ' ' A' ' 809' ' ' LEU . . . 115.68 -9.92 19.08 Favored Glycine 0 N--CA 1.494 2.528 0 N-CA-C 110.167 -1.173 . . . . 0.0 110.167 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 809' ' ' LEU . . . . . 0.461 ' HG ' ' C ' ' A' ' 808' ' ' GLY . 1.7 mt -132.94 151.45 52.05 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.061 -1.258 . . . . 0.0 110.306 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 810' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -73.79 -14.95 61.19 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.152 -0.968 . . . . 0.0 109.777 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 811' ' ' ARG . . . . . 0.492 ' CG ' ' O ' ' A' ' 811' ' ' ARG . 10.2 ptm180 -155.72 122.43 5.28 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.343 -0.848 . . . . 0.0 110.068 179.9 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 812' ' ' CYS . . . . . 0.529 ' CB ' ' HA ' ' A' ' 806' ' ' CYS . 31.9 p -122.73 151.71 41.31 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.227 -0.921 . . . . 0.0 110.608 -179.966 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 813' ' ' VAL . . . . . 0.52 HG13 ' O ' ' A' ' 760' ' ' VAL . 5.8 t -121.69 152.53 25.44 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.32 -0.862 . . . . 0.0 110.329 -179.963 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 814' ' ' VAL . . . . . 0.481 HG23 ' C ' ' A' ' 813' ' ' VAL . 88.9 t -148.93 104.19 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.272 -0.892 . . . . 0.0 110.357 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 815' ' ' ALA . . . . . . . . . . . . . . . -62.21 153.64 29.82 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.19 -0.944 . . . . 0.0 110.127 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 816' ' ' ILE . . . . . 0.886 HD11 ' CG2' ' A' ' 760' ' ' VAL . 11.3 mt -107.5 130.77 59.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.163 -0.96 . . . . 0.0 110.109 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 817' ' ' SER . . . . . 0.443 ' OG ' ' HB2' ' A' ' 820' ' ' ASN . 1.4 p -164.11 163.64 15.17 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.259 -0.901 . . . . 0.0 110.037 179.944 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 818' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -74.48 -7.61 19.75 Favored 'Trans proline' 0 C--N 1.303 -1.857 0 O-C-N 124.08 1.568 . . . . 0.0 110.36 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 819' ' ' SER . . . . . . . . . . . . . 3.2 t -128.4 53.14 1.84 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.311 -0.868 . . . . 0.0 110.04 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 820' ' ' ASN . . . . . 0.443 ' HB2' ' OG ' ' A' ' 817' ' ' SER . 0.4 OUTLIER -129.46 -40.0 1.45 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.199 -0.938 . . . . 0.0 110.281 -179.942 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 821' ' ' PHE . . . . . 0.548 ' CD2' HG21 ' A' ' 801' ' ' VAL . 60.1 m-85 -85.93 -60.03 2.13 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.307 -0.87 . . . . 0.0 110.254 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 822' ' ' GLY . . . . . . . . . . . . . . . 155.72 37.88 0.02 OUTLIER Glycine 0 N--CA 1.492 2.422 0 N-CA-C 109.67 -1.372 . . . . 0.0 109.67 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 823' ' ' GLY . . . . . . . . . . . . . . . 137.72 -151.92 21.46 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.819 -1.313 . . . . 0.0 109.819 180.0 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 824' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -141.62 153.68 65.43 Favored Pre-proline 0 N--CA 1.494 1.731 0 O-C-N 121.332 -1.099 . . . . 0.0 110.157 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 825' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -73.33 -94.41 0.01 OUTLIER 'Trans proline' 0 C--N 1.305 -1.724 0 O-C-N 124.073 1.565 . . . . 0.0 110.505 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 826' ' ' CYS . . . . . . . . . . . . . 61.0 m -128.06 134.13 25.89 Favored Pre-proline 0 N--CA 1.494 1.741 0 O-C-N 121.136 -0.977 . . . . 0.0 110.032 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 827' ' ' PRO . . . . . 0.534 ' O ' ' CG ' ' A' ' 828' ' ' GLU . 50.8 Cg_endo -82.87 -171.58 1.18 Allowed 'Trans proline' 0 C--N 1.306 -1.683 0 O-C-N 124.156 1.608 . . . . 0.0 111.133 -179.941 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 828' ' ' GLU . . . . . 0.534 ' CG ' ' O ' ' A' ' 827' ' ' PRO . 15.5 pt-20 39.28 34.76 0.13 Allowed 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.678 -0.639 . . . . 0.0 110.65 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 829' ' ' VAL . . . . . 0.497 ' O ' ' HD2' ' A' ' 831' ' ' LYS . 23.4 t -144.1 161.34 15.48 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.309 -0.869 . . . . 0.0 109.757 179.904 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 830' ' ' MET . . . . . 0.425 ' O ' ' HD2' ' A' ' 831' ' ' LYS . 3.2 mtp -59.12 171.17 0.76 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.031 -1.043 . . . . 0.0 109.626 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 831' ' ' LYS . . . . . 0.497 ' HD2' ' O ' ' A' ' 829' ' ' VAL . 0.6 OUTLIER -147.99 128.63 14.17 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.015 -1.053 . . . . 0.0 110.967 -179.951 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 832' ' ' ARG . . . . . 0.482 ' HG2' ' O ' ' A' ' 779' ' ' GLY . 0.0 OUTLIER -156.49 152.14 27.01 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.443 -0.786 . . . . 0.0 109.65 179.926 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 833' ' ' VAL . . . . . 0.424 HG21 ' CG2' ' A' ' 816' ' ' ILE . 28.6 t -111.16 144.09 19.75 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 O-C-N 121.116 -0.99 . . . . 0.0 110.882 -179.928 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 834' ' ' ALA . . . . . 0.442 ' C ' HG23 ' A' ' 835' ' ' VAL . . . -147.9 136.67 21.85 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.325 -0.859 . . . . 0.0 109.291 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 835' ' ' VAL . . . . . 0.442 HG23 ' C ' ' A' ' 834' ' ' ALA . 75.5 t -148.47 154.4 10.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 120.912 -1.118 . . . . 0.0 111.204 -179.931 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 836' ' ' GLU . . . . . 0.49 ' OE1' ' CB ' ' A' ' 774' ' ' LYS . 16.3 tt0 -141.28 117.48 10.67 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 179.944 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 837' ' ' ALA . . . . . . . . . . . . . . . -107.34 162.97 13.43 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.022 -1.049 . . . . 0.0 111.377 -179.836 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 838' ' ' VAL . . . . . 0.408 ' HA ' ' HB2' ' A' ' 729' ' ' SER . 90.9 t -121.58 107.66 20.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.647 -0.658 . . . . 0.0 109.841 179.98 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 839' ' ' CYS . . . . . 0.441 ' O ' ' O ' ' A' ' 728' ' ' VAL . 15.5 p -115.74 122.29 45.04 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.065 -1.022 . . . . 0.0 110.785 -179.986 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 840' ' ' SER . . . . . 0.447 ' O ' ' HA ' ' A' ' 768' ' ' GLN . 1.2 p -106.46 150.19 26.32 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.558 -0.713 . . . . 0.0 109.579 179.907 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 841' ' ' THR . . . . . 0.431 ' HA ' ' HA ' ' A' ' 768' ' ' GLN . 5.4 t -71.64 165.02 24.83 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.121 -0.987 . . . . 0.0 110.549 -179.931 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 842' ' ' ALA . . . . . . . . . . . . . . . -138.6 73.79 1.45 Allowed 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.476 -0.765 . . . . 0.0 110.007 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 843' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 1.761 0 CA-C-O 118.034 -0.984 . . . . 0.0 110.222 179.966 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 726' ' ' ARG . . . . . . . . . . . . . 12.1 ttm180 . . . . . 0 N--CA 1.492 1.626 0 CA-C-O 121.227 0.537 . . . . 0.0 110.233 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 727' ' ' THR . . . . . . . . . . . . . 40.3 m -153.27 105.6 2.89 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.282 -0.886 . . . . 0.0 110.327 -179.967 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 728' ' ' VAL . . . . . 0.405 ' O ' ' O ' ' A' ' 839' ' ' CYS . 12.0 t -94.73 138.85 19.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.252 -0.905 . . . . 0.0 110.083 -179.945 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 729' ' ' SER . . . . . 0.483 ' HA ' ' O ' ' A' ' 839' ' ' CYS . 39.0 t -160.05 41.11 0.19 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.241 -0.912 . . . . 0.0 110.625 -179.949 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 730' ' ' GLY . . . . . . . . . . . . . . . 178.25 108.44 0.23 Allowed Glycine 0 N--CA 1.49 2.297 0 C-N-CA 119.575 -1.298 . . . . 0.0 110.154 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 731' ' ' VAL . . . . . . . . . . . . . 39.0 t -112.33 164.65 8.0 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 121.361 -1.082 . . . . 0.0 109.455 179.841 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 732' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -134.24 158.72 43.0 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.036 -1.04 . . . . 0.0 110.881 -179.876 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 733' ' ' ALA . . . . . 0.672 ' CB ' HD21 ' A' ' 762' ' ' LEU . . . -161.7 133.38 5.51 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.335 -0.853 . . . . 0.0 109.925 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 734' ' ' ASP . . . . . . . . . . . . . 30.2 m-20 -150.15 111.14 4.34 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.119 -0.988 . . . . 0.0 110.464 179.901 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 735' ' ' VAL . . . . . . . . . . . . . 40.4 t -139.99 163.45 24.27 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.326 -0.859 . . . . 0.0 109.816 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 736' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -75.87 -175.1 2.87 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.164 -0.96 . . . . 0.0 110.108 -179.973 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 737' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -98.9 -160.21 0.79 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.204 -0.935 . . . . 0.0 110.336 179.965 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 738' ' ' TYR . . . . . 0.915 ' CD2' HG22 ' A' ' 757' ' ' THR . 9.1 t80 -80.18 167.04 20.83 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.418 -0.801 . . . . 0.0 110.525 -179.948 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 739' ' ' HIS . . . . . 0.709 ' CD2' ' O ' ' A' ' 741' ' ' ASN . 0.3 OUTLIER -156.88 136.78 8.61 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.397 -0.814 . . . . 0.0 110.088 179.938 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 740' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -78.13 -18.33 12.87 Favored 'Trans proline' 0 C--N 1.307 -1.62 0 O-C-N 123.983 1.518 . . . . 0.0 111.063 -179.87 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 741' ' ' ASN . . . . . 0.709 ' O ' ' CD2' ' A' ' 739' ' ' HIS . 10.4 t-20 -100.1 145.58 27.8 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.108 -0.995 . . . . 0.0 110.325 -179.94 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 742' ' ' ILE . . . . . 0.406 HD12 HG23 ' A' ' 742' ' ' ILE . 32.4 mm -98.69 123.65 51.4 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 O-C-N 121.243 -0.911 . . . . 0.0 110.344 179.956 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 743' ' ' LYS . . . . . 0.475 ' HE2' ' HA ' ' A' ' 743' ' ' LYS . 0.1 OUTLIER -145.02 11.02 1.35 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.194 -0.941 . . . . 0.0 110.28 179.991 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 744' ' ' ASN . . . . . . . . . . . . . 31.3 p30 -104.14 7.72 36.27 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.235 -0.916 . . . . 0.0 110.073 -179.976 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 745' ' ' TRP . . . . . 0.557 ' CZ3' ' HG2' ' A' ' 748' ' ' GLU . 0.0 OUTLIER -133.72 124.74 27.21 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.293 -0.879 . . . . 0.0 110.013 179.961 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 746' ' ' GLN . . . . . . . . . . . . . 2.3 tp60 -140.38 30.95 1.92 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.22 -0.925 . . . . 0.0 110.309 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 747' ' ' ILE . . . . . 0.72 HG22 ' O ' ' A' ' 747' ' ' ILE . 28.5 mt -134.4 15.54 1.23 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.109 -0.995 . . . . 0.0 110.077 179.967 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 748' ' ' GLU . . . . . 0.557 ' HG2' ' CZ3' ' A' ' 745' ' ' TRP . 18.7 mp0 -120.22 -155.48 0.62 Allowed 'General case' 0 C--N 1.295 -1.792 0 O-C-N 121.369 -0.832 . . . . 0.0 109.626 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 749' ' ' SER . . . . . 0.466 ' O ' ' HB2' ' A' ' 750' ' ' TYR . 40.0 t -83.43 17.83 2.02 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.013 -1.055 . . . . 0.0 110.518 179.982 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 750' ' ' TYR . . . . . 0.466 ' HB2' ' O ' ' A' ' 749' ' ' SER . 28.6 m-85 59.17 110.67 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.262 -0.899 . . . . 0.0 110.858 179.903 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 751' ' ' GLY . . . . . . . . . . . . . . . 99.57 86.82 1.91 Allowed Glycine 0 N--CA 1.491 2.326 0 N-CA-C 110.069 -1.213 . . . . 0.0 110.069 179.939 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 752' ' ' GLU . . . . . . . . . . . . . 5.9 tm-20 -96.7 127.22 40.23 Favored Pre-proline 0 N--CA 1.493 1.71 0 O-C-N 121.203 -1.175 . . . . 0.0 109.844 179.897 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 753' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo -78.49 144.61 20.24 Favored 'Trans proline' 0 C--N 1.308 -1.582 0 O-C-N 123.938 1.494 . . . . 0.0 111.213 -179.943 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 754' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER 59.61 50.65 7.08 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.483 -0.761 . . . . 0.0 111.218 179.951 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 755' ' ' PHE . . . . . . . . . . . . . 45.9 p90 -78.18 -167.59 1.07 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.083 -1.011 . . . . 0.0 109.296 179.917 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 756' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -128.04 172.1 11.25 Favored 'General case' 0 N--CA 1.503 2.178 0 O-C-N 120.808 -1.183 . . . . 0.0 111.433 -179.921 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 757' ' ' THR . . . . . 0.915 HG22 ' CD2' ' A' ' 738' ' ' TYR . 66.2 p -97.4 159.05 15.15 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.617 -0.677 . . . . 0.0 110.155 179.984 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 758' ' ' ALA . . . . . 0.719 ' O ' HD12 ' A' ' 816' ' ' ILE . . . -58.95 121.77 12.01 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.211 -0.931 . . . . 0.0 109.713 179.902 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 759' ' ' LYS . . . . . 0.472 ' CG ' ' HA ' ' A' ' 815' ' ' ALA . 13.6 mttt -109.16 163.34 13.44 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.145 -0.972 . . . . 0.0 110.847 -179.928 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 760' ' ' VAL . . . . . 0.617 ' CG2' HD11 ' A' ' 816' ' ' ILE . 52.1 t -106.55 131.05 57.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 179.895 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 761' ' ' HIS . . . . . . . . . . . . . 10.8 m80 -112.57 110.35 20.46 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 120.923 -1.111 . . . . 0.0 112.365 -179.736 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 762' ' ' LEU . . . . . 0.672 HD21 ' CB ' ' A' ' 733' ' ' ALA . 1.0 OUTLIER -121.79 105.0 9.98 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 107.477 -1.305 . . . . 0.0 107.477 179.788 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 763' ' ' LYS . . . . . 0.468 ' HB3' ' HG3' ' A' ' 811' ' ' ARG . 0.0 OUTLIER -129.44 150.96 50.57 Favored 'General case' 0 C--N 1.297 -1.696 0 O-C-N 120.87 -1.144 . . . . 0.0 112.168 -179.7 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 764' ' ' CYS . . . . . 0.431 ' O ' ' C ' ' A' ' 765' ' ' ALA . 18.4 m -125.08 164.11 20.92 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 109.19 -0.671 . . . . 0.0 109.19 179.875 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 765' ' ' ALA . . . . . 0.431 ' C ' ' O ' ' A' ' 764' ' ' CYS . . . -43.88 154.54 0.36 Allowed Pre-proline 0 N--CA 1.491 1.609 0 O-C-N 120.994 -1.067 . . . . 0.0 110.055 179.982 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 766' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -69.72 99.26 0.73 Allowed 'Trans proline' 0 C--N 1.304 -1.786 0 O-C-N 123.989 1.521 . . . . 0.0 110.089 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 767' ' ' GLY . . . . . . . . . . . . . . . 144.69 -30.77 1.81 Allowed Glycine 0 N--CA 1.488 2.139 0 N-CA-C 108.998 -1.641 . . . . 0.0 108.998 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 768' ' ' GLN . . . . . 0.557 ' HG2' ' N ' ' A' ' 841' ' ' THR . 2.8 mt-30 -85.76 156.74 20.49 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.433 -1.039 . . . . 0.0 109.875 179.908 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 769' ' ' THR . . . . . 0.512 HG22 ' HG3' ' A' ' 810' ' ' GLU . 23.0 p -138.04 145.76 42.2 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.202 -0.936 . . . . 0.0 110.296 -179.969 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 770' ' ' ILE . . . . . . . . . . . . . 70.3 mt -68.46 127.1 29.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.312 -0.868 . . . . 0.0 109.202 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 771' ' ' SER . . . . . 0.485 ' O ' ' HB2' ' A' ' 772' ' ' ALA . 8.5 p -103.6 -8.71 19.78 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.216 -0.928 . . . . 0.0 111.419 -179.893 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 772' ' ' ALA . . . . . 0.485 ' HB2' ' O ' ' A' ' 771' ' ' SER . . . -177.92 151.03 0.66 Allowed 'General case' 0 N--CA 1.495 1.796 0 O-C-N 120.73 -1.231 . . . . 0.0 111.805 -179.959 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 773' ' ' ILE . . . . . 0.402 HG23 HD12 ' A' ' 773' ' ' ILE . 33.6 mm -100.15 141.91 16.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 179.784 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 774' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -108.88 -24.13 11.4 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.826 -1.171 . . . . 0.0 111.733 -179.804 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 775' ' ' PHE . . . . . 0.486 ' O ' ' HB2' ' A' ' 776' ' ' ALA . 80.8 t80 -154.76 161.44 41.51 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 120.726 -1.234 . . . . 0.0 111.505 -179.854 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 776' ' ' ALA . . . . . 0.486 ' HB2' ' O ' ' A' ' 775' ' ' PHE . . . 178.58 111.24 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.626 -0.671 . . . . 0.0 109.485 179.964 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 777' ' ' SER . . . . . 0.424 ' HA ' ' OG ' ' A' ' 798' ' ' SER . 48.3 p -144.66 113.71 6.89 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.077 -1.014 . . . . 0.0 110.681 -179.966 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 778' ' ' PHE . . . . . 0.467 ' CG ' ' O ' ' A' ' 778' ' ' PHE . 8.6 t80 -91.26 78.46 5.78 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.292 -0.88 . . . . 0.0 110.046 179.943 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 779' ' ' GLY . . . . . . . . . . . . . . . -165.12 -123.26 0.64 Allowed Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.829 -1.309 . . . . 0.0 109.829 -179.946 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 780' ' ' THR . . . . . . . . . . . . . 27.9 p -120.46 78.75 28.37 Favored Pre-proline 0 N--CA 1.493 1.688 0 O-C-N 121.344 -1.092 . . . . 0.0 110.396 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 781' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -79.44 175.72 10.4 Favored 'Trans proline' 0 C--N 1.304 -1.78 0 O-C-N 123.95 1.5 . . . . 0.0 110.556 -179.961 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 782' ' ' LEU . . . . . . . . . . . . . 3.9 mt -143.47 134.98 26.22 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.296 -0.878 . . . . 0.0 110.032 179.954 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 783' ' ' GLY . . . . . . . . . . . . . . . 144.1 -174.52 24.39 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 -179.937 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 784' ' ' THR . . . . . 0.463 ' O ' ' O ' ' A' ' 785' ' ' CYS . 0.0 OUTLIER -145.64 66.82 1.21 Allowed 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.213 -1.169 . . . . 0.0 110.257 179.993 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 785' ' ' CYS . . . . . 0.463 ' O ' ' O ' ' A' ' 784' ' ' THR . 44.6 t 57.44 114.76 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.303 -0.873 . . . . 0.0 110.351 179.974 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 786' ' ' GLY . . . . . . . . . . . . . . . 109.47 -17.78 30.7 Favored Glycine 0 N--CA 1.489 2.197 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 -179.932 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 787' ' ' THR . . . . . 0.481 ' O ' HG23 ' A' ' 787' ' ' THR . 12.2 t -158.63 48.23 0.35 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.162 -1.199 . . . . 0.0 110.485 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 788' ' ' PHE . . . . . 0.443 ' CE2' ' HA ' ' A' ' 785' ' ' CYS . 41.5 m-85 -58.34 149.69 24.0 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.109 -0.994 . . . . 0.0 109.984 -179.987 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 789' ' ' GLN . . . . . . . . . . . . . 2.0 tt0 -136.04 162.22 33.51 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.158 -0.964 . . . . 0.0 110.408 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 790' ' ' GLN . . . . . 0.428 ' HG2' ' N ' ' A' ' 791' ' ' GLY . 1.8 tt0 -93.81 144.67 25.21 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.177 -0.952 . . . . 0.0 110.202 -179.993 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 791' ' ' GLY . . . . . 0.428 ' N ' ' HG2' ' A' ' 790' ' ' GLN . . . -96.95 -142.0 12.83 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.361 -1.496 . . . . 0.0 109.361 -179.955 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 792' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -93.63 -36.91 12.13 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.253 -1.145 . . . . 0.0 109.74 179.944 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 793' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -100.64 153.62 19.26 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.42 -0.8 . . . . 0.0 110.264 179.975 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 794' ' ' HIS . . . . . 0.671 ' CE1' ' O ' ' A' ' 795' ' ' SER . 7.3 t-80 -176.82 143.17 0.43 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.154 -0.966 . . . . 0.0 110.266 179.956 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 795' ' ' SER . . . . . 0.671 ' O ' ' CE1' ' A' ' 794' ' ' HIS . 58.4 p -73.69 143.62 46.13 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.311 -0.868 . . . . 0.0 109.382 179.934 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 796' ' ' ILE . . . . . . . . . . . . . 9.6 mt -90.99 42.15 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.199 -0.938 . . . . 0.0 109.768 -179.916 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 797' ' ' ASN . . . . . . . . . . . . . 10.6 t30 -159.61 23.02 0.18 Allowed 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.519 -0.738 . . . . 0.0 109.597 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 798' ' ' SER . . . . . 0.456 ' HB3' ' O ' ' A' ' 776' ' ' ALA . 0.6 OUTLIER -57.75 -71.63 0.1 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.571 -0.706 . . . . 0.0 111.563 -179.878 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 799' ' ' ASN . . . . . 0.464 ' OD1' ' HB3' ' A' ' 776' ' ' ALA . 1.4 m120 -61.92 -7.25 3.53 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.305 -0.872 . . . . 0.0 111.861 -179.801 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 800' ' ' SER . . . . . . . . . . . . . 1.3 t -74.03 -33.41 63.74 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.775 -1.203 . . . . 0.0 110.311 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 801' ' ' VAL . . . . . . . . . . . . . 59.1 t -90.83 -18.59 7.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.244 -0.91 . . . . 0.0 110.315 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 802' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -81.43 -45.89 15.38 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.247 -0.908 . . . . 0.0 111.182 -179.831 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 803' ' ' GLU . . . . . 0.647 ' HG2' HD12 ' A' ' 807' ' ' ILE . 4.8 tm-20 -74.4 -21.66 59.54 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.024 -1.048 . . . . 0.0 111.232 -179.993 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 804' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -94.44 -17.35 22.57 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.06 -1.025 . . . . 0.0 112.266 -179.853 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 805' ' ' LYS . . . . . . . . . . . . . 6.4 tttt -138.49 45.04 2.07 Favored 'General case' 0 N--CA 1.503 2.187 0 O-C-N 120.466 -1.396 . . . . 0.0 112.603 -179.879 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 806' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -163.17 -37.38 0.04 OUTLIER 'General case' 0 N--CA 1.498 1.96 0 O-C-N 120.686 -1.259 . . . . 0.0 110.613 179.918 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 807' ' ' ILE . . . . . 0.647 HD12 ' HG2' ' A' ' 803' ' ' GLU . 18.3 mt -70.7 113.5 6.95 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.636 0 O-C-N 121.299 -0.875 . . . . 0.0 110.998 -179.883 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 808' ' ' GLY . . . . . 0.491 ' C ' ' HG ' ' A' ' 809' ' ' LEU . . . 119.35 19.03 4.34 Favored Glycine 0 N--CA 1.494 2.506 0 C-N-CA 119.856 -1.164 . . . . 0.0 110.506 179.88 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 809' ' ' LEU . . . . . 0.491 ' HG ' ' C ' ' A' ' 808' ' ' GLY . 40.5 mt -142.19 142.77 32.71 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 120.883 -1.363 . . . . 0.0 110.629 -179.991 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 810' ' ' GLU . . . . . 0.512 ' HG3' HG22 ' A' ' 769' ' ' THR . 2.2 mt-10 -66.8 -27.6 67.71 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.275 -0.891 . . . . 0.0 109.24 179.959 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 811' ' ' ARG . . . . . 0.468 ' HG3' ' HB3' ' A' ' 763' ' ' LYS . 6.8 ttt85 -125.35 154.49 41.75 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.508 -0.745 . . . . 0.0 109.927 179.972 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 812' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -137.34 124.03 21.09 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.211 -0.93 . . . . 0.0 110.535 -179.982 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 813' ' ' VAL . . . . . . . . . . . . . 70.8 t -130.92 103.43 7.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.226 -0.921 . . . . 0.0 110.015 179.953 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 814' ' ' VAL . . . . . . . . . . . . . 86.0 t -124.84 121.14 60.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.191 -0.943 . . . . 0.0 110.155 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 815' ' ' ALA . . . . . 0.472 ' HA ' ' CG ' ' A' ' 759' ' ' LYS . . . -72.21 160.91 31.63 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.283 -0.886 . . . . 0.0 110.246 179.923 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 816' ' ' ILE . . . . . 0.78 HG21 HG21 ' A' ' 833' ' ' VAL . 8.2 mt -112.91 81.59 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.267 -0.896 . . . . 0.0 109.649 179.989 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 817' ' ' SER . . . . . . . . . . . . . 5.7 p -110.48 158.36 35.62 Favored Pre-proline 0 C--N 1.297 -1.71 0 O-C-N 121.318 -0.864 . . . . 0.0 110.213 -179.921 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 818' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -77.61 12.85 1.78 Allowed 'Trans proline' 0 C--N 1.306 -1.672 0 O-C-N 124.107 1.583 . . . . 0.0 111.058 179.962 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 819' ' ' SER . . . . . . . . . . . . . 10.3 p -133.84 16.49 3.9 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.107 -0.995 . . . . 0.0 110.371 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 820' ' ' ASN . . . . . . . . . . . . . 19.3 t-20 -117.81 -16.82 9.94 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.138 -0.976 . . . . 0.0 110.058 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 821' ' ' PHE . . . . . . . . . . . . . 7.4 m-85 -97.21 -39.29 9.34 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.348 -0.845 . . . . 0.0 110.257 179.896 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 822' ' ' GLY . . . . . . . . . . . . . . . 174.88 -29.49 0.08 OUTLIER Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.596 -1.402 . . . . 0.0 109.596 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 823' ' ' GLY . . . . . 0.465 ' O ' ' OD2' ' A' ' 824' ' ' ASP . . . 147.78 -82.75 0.19 Allowed Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 179.983 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 824' ' ' ASP . . . . . 0.465 ' OD2' ' O ' ' A' ' 823' ' ' GLY . 1.0 OUTLIER -148.02 121.11 4.7 Favored Pre-proline 0 N--CA 1.494 1.771 0 O-C-N 121.234 -1.157 . . . . 0.0 110.385 -179.919 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 825' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -75.51 -89.91 0.01 OUTLIER 'Trans proline' 0 C--N 1.31 -1.497 0 O-C-N 123.923 1.486 . . . . 0.0 110.478 179.932 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 826' ' ' CYS . . . . . 0.606 ' HB3' HG21 ' A' ' 829' ' ' VAL . 2.1 m -97.17 130.74 28.99 Favored Pre-proline 0 N--CA 1.492 1.646 0 O-C-N 121.201 -0.937 . . . . 0.0 109.971 179.996 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 827' ' ' PRO . . . . . 0.418 ' O ' ' HB2' ' A' ' 828' ' ' GLU . 46.4 Cg_endo -73.41 129.31 13.7 Favored 'Trans proline' 0 C--N 1.308 -1.579 0 O-C-N 124.002 1.527 . . . . 0.0 110.927 -179.991 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 828' ' ' GLU . . . . . 0.418 ' HB2' ' O ' ' A' ' 827' ' ' PRO . 8.3 mt-10 57.24 46.3 18.93 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.392 -0.818 . . . . 0.0 110.504 179.928 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 829' ' ' VAL . . . . . 0.606 HG21 ' HB3' ' A' ' 826' ' ' CYS . 39.2 t -133.95 124.88 47.76 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 O-C-N 121.209 -0.932 . . . . 0.0 110.017 179.898 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 830' ' ' MET . . . . . 0.432 ' O ' ' O ' ' A' ' 829' ' ' VAL . 13.0 mmt -41.72 162.75 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.349 -0.844 . . . . 0.0 110.03 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 831' ' ' LYS . . . . . . . . . . . . . 6.4 mttt -139.71 142.47 36.86 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.063 -1.023 . . . . 0.0 111.011 -179.872 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 832' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -144.87 158.15 43.9 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.526 -0.733 . . . . 0.0 109.325 179.976 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 833' ' ' VAL . . . . . 0.78 HG21 HG21 ' A' ' 816' ' ' ILE . 62.1 t -123.13 117.19 50.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 120.846 -1.159 . . . . 0.0 111.47 -179.784 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 834' ' ' ALA . . . . . . . . . . . . . . . -125.9 117.62 23.71 Favored 'General case' 0 N--CA 1.494 1.728 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 179.799 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 835' ' ' VAL . . . . . 0.494 HG12 ' N ' ' A' ' 836' ' ' GLU . 44.4 t -127.82 165.24 27.35 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 120.9 -1.125 . . . . 0.0 111.997 -179.792 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 836' ' ' GLU . . . . . 0.494 ' N ' HG12 ' A' ' 835' ' ' VAL . 0.9 OUTLIER -152.23 123.38 7.62 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 179.952 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 837' ' ' ALA . . . . . . . . . . . . . . . -121.83 165.98 15.06 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 120.893 -1.13 . . . . 0.0 111.809 -179.757 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 838' ' ' VAL . . . . . . . . . . . . . 17.2 t -109.84 107.23 22.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.662 -0.649 . . . . 0.0 109.275 179.928 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 839' ' ' CYS . . . . . 0.483 ' O ' ' HA ' ' A' ' 729' ' ' SER . 0.0 OUTLIER -108.21 145.26 34.52 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.13 -0.981 . . . . 0.0 110.818 -179.896 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 840' ' ' SER . . . . . . . . . . . . . 1.4 p -164.35 147.51 9.21 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.37 -0.831 . . . . 0.0 110.094 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 841' ' ' THR . . . . . 0.557 ' N ' ' HG2' ' A' ' 768' ' ' GLN . 5.2 t -77.58 173.51 11.94 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.244 -0.91 . . . . 0.0 110.208 -179.948 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 842' ' ' ALA . . . . . . . . . . . . . . . -94.76 168.8 10.59 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.195 -0.941 . . . . 0.0 110.173 179.953 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 843' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.69 0 CA-C-O 117.982 -1.009 . . . . 0.0 110.071 -179.985 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 726' ' ' ARG . . . . . . . . . . . . . 17.8 mmm180 . . . . . 0 N--CA 1.493 1.708 0 CA-C-O 121.478 0.656 . . . . 0.0 110.022 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 727' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -151.33 147.17 26.61 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.427 -0.795 . . . . 0.0 109.795 179.99 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 728' ' ' VAL . . . . . 0.713 ' O ' HG13 ' A' ' 728' ' ' VAL . 12.0 p -133.3 78.43 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.199 -0.938 . . . . 0.0 110.363 179.963 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 729' ' ' SER . . . . . . . . . . . . . 5.9 m 52.3 -177.99 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.41 -0.807 . . . . 0.0 110.731 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 730' ' ' GLY . . . . . 0.523 ' C ' HG23 ' A' ' 731' ' ' VAL . . . -152.25 -140.93 3.21 Favored Glycine 0 N--CA 1.489 2.193 0 N-CA-C 109.041 -1.624 . . . . 0.0 109.041 179.987 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 731' ' ' VAL . . . . . 0.523 HG23 ' C ' ' A' ' 730' ' ' GLY . 11.9 t -153.17 165.81 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 O-C-N 121.065 -1.256 . . . . 0.0 110.26 179.968 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 732' ' ' CYS . . . . . . . . . . . . . 6.6 t -150.92 133.98 15.98 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.343 -0.848 . . . . 0.0 109.967 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 733' ' ' ALA . . . . . . . . . . . . . . . -153.19 162.32 41.44 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.18 -0.95 . . . . 0.0 110.551 -179.969 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 734' ' ' ASP . . . . . 0.458 ' O ' ' OD2' ' A' ' 734' ' ' ASP . 4.3 p30 -162.13 118.26 2.01 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.423 -0.798 . . . . 0.0 109.9 179.995 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 735' ' ' VAL . . . . . . . . . . . . . 16.6 t -139.11 164.82 24.6 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.157 -0.964 . . . . 0.0 110.674 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 736' ' ' SER . . . . . . . . . . . . . 8.3 p -109.83 172.9 6.59 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.36 -0.837 . . . . 0.0 109.818 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 737' ' ' GLU . . . . . 0.467 ' OE1' ' HG3' ' A' ' 831' ' ' LYS . 9.5 pt-20 -69.06 -168.7 0.15 Allowed 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.124 -0.985 . . . . 0.0 110.348 179.985 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 738' ' ' TYR . . . . . 0.441 ' N ' ' HG3' ' A' ' 737' ' ' GLU . 84.3 t80 -147.05 -74.7 0.2 Allowed 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.327 -0.858 . . . . 0.0 109.869 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 739' ' ' HIS . . . . . 0.505 ' NE2' ' OD1' ' A' ' 741' ' ' ASN . 3.0 t60 58.52 107.38 0.03 OUTLIER Pre-proline 0 N--CA 1.492 1.67 0 O-C-N 121.2 -0.937 . . . . 0.0 110.551 179.921 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 740' ' ' PRO . . . . . 0.539 ' HD3' ' O ' ' A' ' 756' ' ' HIS . 49.3 Cg_endo -81.29 71.15 7.1 Favored 'Trans proline' 0 C--N 1.307 -1.642 0 O-C-N 124.006 1.53 . . . . 0.0 110.127 -179.963 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 741' ' ' ASN . . . . . 0.505 ' OD1' ' NE2' ' A' ' 739' ' ' HIS . 0.1 OUTLIER -104.39 69.45 0.91 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.205 -0.935 . . . . 0.0 110.445 179.973 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 742' ' ' ILE . . . . . 0.541 HD13 ' N ' ' A' ' 742' ' ' ILE . 0.1 OUTLIER -139.23 141.13 36.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.25 -0.906 . . . . 0.0 110.022 179.936 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 743' ' ' LYS . . . . . . . . . . . . . 27.3 tttt -122.45 -28.13 4.32 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.169 -0.957 . . . . 0.0 110.492 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 744' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -88.33 34.08 0.75 Allowed 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.168 -0.957 . . . . 0.0 110.344 179.965 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 745' ' ' TRP . . . . . 0.596 ' CD1' ' HB2' ' A' ' 746' ' ' GLN . 47.4 t-105 -85.18 -56.63 3.45 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.323 -0.861 . . . . 0.0 110.054 -179.992 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 746' ' ' GLN . . . . . 0.596 ' HB2' ' CD1' ' A' ' 745' ' ' TRP . 4.3 tp60 -151.86 102.03 2.8 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.237 -0.914 . . . . 0.0 110.194 179.983 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 747' ' ' ILE . . . . . 0.622 HG22 ' O ' ' A' ' 747' ' ' ILE . 57.1 mt -105.55 58.28 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.223 -0.923 . . . . 0.0 110.013 179.957 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 748' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -124.84 -73.23 0.64 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.246 -0.909 . . . . 0.0 110.282 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 749' ' ' SER . . . . . . . . . . . . . 1.9 p -170.82 33.91 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.182 -0.949 . . . . 0.0 110.317 -179.935 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 750' ' ' TYR . . . . . . . . . . . . . 25.0 m-85 -106.45 -94.77 0.37 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.198 -0.939 . . . . 0.0 110.34 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 751' ' ' GLY . . . . . . . . . . . . . . . 80.69 135.16 1.54 Allowed Glycine 0 N--CA 1.492 2.417 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 752' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -153.81 60.0 2.83 Favored Pre-proline 0 N--CA 1.493 1.677 0 O-C-N 121.282 -1.128 . . . . 0.0 110.272 179.977 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 753' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -73.15 78.17 2.28 Favored 'Trans proline' 0 C--N 1.305 -1.713 0 O-C-N 124.07 1.563 . . . . 0.0 110.442 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 754' ' ' GLU . . . . . . . . . . . . . 23.5 tt0 -130.96 25.2 4.97 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.174 -0.954 . . . . 0.0 110.19 179.931 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 755' ' ' PHE . . . . . 0.444 ' CD1' ' N ' ' A' ' 756' ' ' HIS . 21.1 t80 -154.13 164.69 38.1 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.314 -0.866 . . . . 0.0 109.999 179.964 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 756' ' ' HIS . . . . . 0.539 ' O ' ' HD3' ' A' ' 740' ' ' PRO . 1.1 t-160 -148.24 -71.58 0.21 Allowed 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.144 -0.973 . . . . 0.0 110.731 -179.947 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 757' ' ' THR . . . . . . . . . . . . . 47.0 p -115.77 151.93 34.25 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.825 -1.172 . . . . 0.0 110.707 -179.915 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 758' ' ' ALA . . . . . 0.431 ' C ' ' HG3' ' A' ' 759' ' ' LYS . . . -64.38 168.02 6.21 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.32 -0.862 . . . . 0.0 110.009 179.96 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 759' ' ' LYS . . . . . 0.431 ' HG3' ' C ' ' A' ' 758' ' ' ALA . 17.1 mttp -146.55 146.47 30.49 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.203 -0.935 . . . . 0.0 110.596 -179.928 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 760' ' ' VAL . . . . . . . . . . . . . 43.8 t -108.72 138.37 36.06 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.291 -0.881 . . . . 0.0 109.62 179.819 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 761' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -109.12 125.65 52.38 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.133 -0.979 . . . . 0.0 111.19 -179.917 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 762' ' ' LEU . . . . . 0.513 ' HB2' ' HB2' ' A' ' 812' ' ' CYS . 20.6 mt -123.39 112.16 17.22 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.464 -0.772 . . . . 0.0 109.296 179.849 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 763' ' ' LYS . . . . . . . . . . . . . 9.7 mttt -107.93 122.1 46.12 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.091 -1.006 . . . . 0.0 110.869 -179.827 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 764' ' ' CYS . . . . . 0.423 ' O ' ' C ' ' A' ' 765' ' ' ALA . 48.7 t -92.91 163.18 13.78 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.46 -0.775 . . . . 0.0 109.618 179.904 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 765' ' ' ALA . . . . . 0.583 ' HB3' ' HB2' ' A' ' 768' ' ' GLN . . . -44.08 154.81 0.36 Allowed Pre-proline 0 N--CA 1.493 1.685 0 O-C-N 121.041 -1.037 . . . . 0.0 109.992 -179.884 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 766' ' ' PRO . . . . . 0.436 ' C ' ' OE1' ' A' ' 768' ' ' GLN . 45.1 Cg_endo -70.95 112.14 3.22 Favored 'Trans proline' 0 C--N 1.306 -1.684 0 O-C-N 123.98 1.516 . . . . 0.0 110.657 -179.96 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 767' ' ' GLY . . . . . . . . . . . . . . . 98.29 -2.96 59.61 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.651 -1.379 . . . . 0.0 109.651 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 768' ' ' GLN . . . . . 0.583 ' HB2' ' HB3' ' A' ' 765' ' ' ALA . 27.6 mp0 -106.59 176.3 5.22 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.23 -1.159 . . . . 0.0 110.078 -179.913 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 769' ' ' THR . . . . . . . . . . . . . 40.6 p -145.12 159.18 43.37 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.225 -0.922 . . . . 0.0 110.502 -179.952 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 770' ' ' ILE . . . . . . . . . . . . . 5.6 mt -71.02 151.47 9.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.302 -0.874 . . . . 0.0 109.831 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 771' ' ' SER . . . . . . . . . . . . . 15.0 m -135.5 -9.97 2.17 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.119 -0.988 . . . . 0.0 111.152 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 772' ' ' ALA . . . . . . . . . . . . . . . -172.38 133.62 0.65 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.823 -1.173 . . . . 0.0 111.124 -179.892 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 773' ' ' ILE . . . . . . . . . . . . . 34.1 mm -86.84 120.4 36.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.367 -0.833 . . . . 0.0 109.232 179.91 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 774' ' ' LYS . . . . . . . . . . . . . 1.2 ttmp? -81.21 -38.58 26.77 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.13 -0.981 . . . . 0.0 111.024 -179.861 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 775' ' ' PHE . . . . . 0.735 ' O ' ' HB2' ' A' ' 776' ' ' ALA . 43.5 t80 -149.29 167.41 26.14 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.008 -1.057 . . . . 0.0 111.182 -179.904 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 776' ' ' ALA . . . . . 0.735 ' HB2' ' O ' ' A' ' 775' ' ' PHE . . . 163.88 59.25 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.843 0 CA-C-O 121.449 0.642 . . . . 0.0 109.328 179.975 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 777' ' ' SER . . . . . 0.545 ' HB3' ' CZ ' ' A' ' 775' ' ' PHE . 0.3 OUTLIER -89.88 154.33 19.95 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.513 -0.742 . . . . 0.0 110.776 -179.933 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 778' ' ' PHE . . . . . 0.409 ' CD2' HG22 ' A' ' 833' ' ' VAL . 7.5 t80 -121.84 89.16 3.07 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.377 -0.827 . . . . 0.0 110.137 -179.994 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 779' ' ' GLY . . . . . . . . . . . . . . . 179.94 -127.72 1.15 Allowed Glycine 0 N--CA 1.493 2.464 0 N-CA-C 109.723 -1.351 . . . . 0.0 109.723 -179.952 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 780' ' ' THR . . . . . 0.491 ' O ' ' HA3' ' A' ' 791' ' ' GLY . 9.0 p -116.03 76.17 6.22 Favored Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.209 -1.171 . . . . 0.0 110.341 179.994 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 781' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -71.18 162.47 42.45 Favored 'Trans proline' 0 C--N 1.304 -1.812 0 O-C-N 124.013 1.533 . . . . 0.0 110.369 179.982 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 782' ' ' LEU . . . . . . . . . . . . . 4.5 mt -123.32 145.52 48.66 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.263 -0.898 . . . . 0.0 110.229 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 783' ' ' GLY . . . . . . . . . . . . . . . 99.86 -175.85 27.91 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.925 -1.27 . . . . 0.0 109.925 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 784' ' ' THR . . . . . 0.471 ' O ' HG23 ' A' ' 784' ' ' THR . 1.7 t -147.41 89.48 1.78 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.313 -1.11 . . . . 0.0 109.855 179.97 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 785' ' ' CYS . . . . . 0.467 ' O ' ' O ' ' A' ' 784' ' ' THR . 4.1 t 54.48 107.89 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.297 -0.877 . . . . 0.0 110.011 -179.966 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 786' ' ' GLY . . . . . . . . . . . . . . . 115.22 -31.1 6.39 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 108.957 -1.657 . . . . 0.0 108.957 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 787' ' ' THR . . . . . . . . . . . . . 8.9 p -141.02 38.74 1.78 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.463 -1.022 . . . . 0.0 109.831 179.908 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 788' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -63.32 165.12 7.95 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.364 -0.835 . . . . 0.0 110.479 -179.992 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 789' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -159.36 165.67 32.79 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.374 -0.829 . . . . 0.0 109.443 179.95 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 790' ' ' GLN . . . . . 0.43 ' O ' ' C ' ' A' ' 791' ' ' GLY . 5.8 pt20 -90.25 20.57 4.31 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.014 -1.054 . . . . 0.0 110.487 -179.973 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 791' ' ' GLY . . . . . 0.491 ' HA3' ' O ' ' A' ' 780' ' ' THR . . . 41.77 -143.24 1.03 Allowed Glycine 0 N--CA 1.491 2.313 0 N-CA-C 110.067 -1.213 . . . . 0.0 110.067 -179.989 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 792' ' ' GLU . . . . . . . . . . . . . 27.8 mm-40 -95.15 -43.21 8.2 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.448 -1.031 . . . . 0.0 110.354 -179.957 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 793' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -108.44 134.06 51.75 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.039 -1.038 . . . . 0.0 110.075 -179.988 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 794' ' ' HIS . . . . . 0.559 ' CG ' ' N ' ' A' ' 795' ' ' SER . 68.3 t60 -139.28 169.55 17.55 Favored 'General case' 0 C--N 1.299 -1.591 0 O-C-N 121.32 -0.862 . . . . 0.0 110.176 -179.981 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 795' ' ' SER . . . . . 0.559 ' N ' ' CG ' ' A' ' 794' ' ' HIS . 0.1 OUTLIER -110.69 129.79 55.74 Favored 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 179.904 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 796' ' ' ILE . . . . . . . . . . . . . 35.9 mt -69.7 -5.62 5.33 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.619 0 O-C-N 120.915 -1.115 . . . . 0.0 109.875 -179.913 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 797' ' ' ASN . . . . . . . . . . . . . 16.1 t30 -102.85 14.83 31.0 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.334 -0.853 . . . . 0.0 109.799 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 798' ' ' SER . . . . . 0.512 ' HB2' ' O ' ' A' ' 776' ' ' ALA . 10.8 p -58.79 -62.75 1.63 Allowed 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.463 -0.773 . . . . 0.0 111.278 179.997 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 799' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -82.54 1.43 37.94 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.261 -0.9 . . . . 0.0 110.951 -179.882 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 800' ' ' SER . . . . . 0.485 ' O ' ' HG2' ' A' ' 804' ' ' ARG . 23.3 t -84.21 -25.99 29.08 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.057 -1.027 . . . . 0.0 110.478 -179.926 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 801' ' ' VAL . . . . . 0.407 ' C ' HD22 ' A' ' 802' ' ' LEU . 59.9 t -93.61 -27.99 4.41 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.282 -0.886 . . . . 0.0 111.445 -179.922 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 802' ' ' LEU . . . . . 0.643 ' CD1' HG21 ' A' ' 814' ' ' VAL . 4.0 mm? -89.96 -29.67 18.32 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 120.964 -1.085 . . . . 0.0 111.152 -179.88 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 803' ' ' GLU . . . . . . . . . . . . . 11.3 tt0 -68.93 -28.12 66.37 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 120.818 -1.176 . . . . 0.0 110.942 -179.915 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 804' ' ' ARG . . . . . 0.485 ' HG2' ' O ' ' A' ' 800' ' ' SER . 0.0 OUTLIER -95.0 -17.82 21.59 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.092 -1.005 . . . . 0.0 111.804 -179.969 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 805' ' ' LYS . . . . . 0.433 ' N ' ' HG3' ' A' ' 804' ' ' ARG . 2.3 tptp -115.58 41.33 2.53 Favored 'General case' 0 N--CA 1.501 2.125 0 O-C-N 120.872 -1.143 . . . . 0.0 112.172 -179.824 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 806' ' ' CYS . . . . . 0.524 ' HB2' ' O ' ' A' ' 802' ' ' LEU . 0.5 OUTLIER -160.31 -19.25 0.06 Allowed 'General case' 0 N--CA 1.504 2.236 0 O-C-N 120.577 -1.327 . . . . 0.0 112.306 -179.981 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 807' ' ' ILE . . . . . . . . . . . . . 52.9 mt -85.66 120.49 35.85 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 O-C-N 120.665 -1.272 . . . . 0.0 111.145 -179.962 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 808' ' ' GLY . . . . . 0.434 ' C ' ' HG ' ' A' ' 809' ' ' LEU . . . 112.92 12.63 12.15 Favored Glycine 0 N--CA 1.494 2.531 0 N-CA-C 110.363 -1.095 . . . . 0.0 110.363 179.897 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 809' ' ' LEU . . . . . 0.434 ' HG ' ' C ' ' A' ' 808' ' ' GLY . 12.1 mt -136.29 155.31 50.27 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.033 -1.275 . . . . 0.0 110.799 -179.968 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 810' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -89.99 8.72 31.01 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.433 -0.792 . . . . 0.0 109.389 179.916 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 811' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -155.89 160.94 40.58 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 -179.976 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 812' ' ' CYS . . . . . 0.513 ' HB2' ' HB2' ' A' ' 762' ' ' LEU . 1.0 OUTLIER -143.59 132.76 23.09 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.844 -1.16 . . . . 0.0 111.233 -179.936 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 813' ' ' VAL . . . . . . . . . . . . . 89.7 t -136.2 104.63 4.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.488 -0.757 . . . . 0.0 109.554 179.935 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 814' ' ' VAL . . . . . 0.643 HG21 ' CD1' ' A' ' 802' ' ' LEU . 96.8 t -113.56 129.99 68.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.137 -0.977 . . . . 0.0 110.819 -179.966 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 815' ' ' ALA . . . . . . . . . . . . . . . -85.52 141.8 29.63 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.32 -0.863 . . . . 0.0 109.387 179.933 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 816' ' ' ILE . . . . . 0.522 ' CG2' HG21 ' A' ' 833' ' ' VAL . 21.0 mt -104.5 124.12 58.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.133 -0.979 . . . . 0.0 110.651 -179.903 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 817' ' ' SER . . . . . 0.46 ' OG ' ' HD2' ' A' ' 818' ' ' PRO . 29.2 t -148.05 153.54 41.87 Favored Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 121.348 -0.845 . . . . 0.0 110.025 179.957 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 818' ' ' PRO . . . . . 0.46 ' HD2' ' OG ' ' A' ' 817' ' ' SER . 43.5 Cg_endo -70.71 -10.11 27.14 Favored 'Trans proline' 0 C--N 1.304 -1.768 0 O-C-N 123.984 1.518 . . . . 0.0 110.315 -179.954 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 819' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -125.42 59.73 1.26 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.317 -0.864 . . . . 0.0 110.014 -179.96 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 820' ' ' ASN . . . . . . . . . . . . . 1.3 m120 -148.34 -35.83 0.2 Allowed 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.361 -0.837 . . . . 0.0 110.285 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 821' ' ' PHE . . . . . . . . . . . . . 13.9 m-85 -80.16 0.76 30.92 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.145 -0.972 . . . . 0.0 110.485 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 822' ' ' GLY . . . . . . . . . . . . . . . 110.7 12.29 16.98 Favored Glycine 0 N--CA 1.493 2.448 0 N-CA-C 109.767 -1.333 . . . . 0.0 109.767 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 823' ' ' GLY . . . . . . . . . . . . . . . 108.73 -159.53 14.11 Favored Glycine 0 N--CA 1.492 2.374 0 N-CA-C 109.629 -1.388 . . . . 0.0 109.629 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 824' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -117.91 136.11 23.64 Favored Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 121.221 -1.164 . . . . 0.0 110.391 -179.997 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 825' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -72.47 -80.12 0.01 OUTLIER 'Trans proline' 0 C--N 1.307 -1.638 0 O-C-N 123.959 1.505 . . . . 0.0 110.161 179.961 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 826' ' ' CYS . . . . . 0.696 ' SG ' HG21 ' A' ' 829' ' ' VAL . 5.8 p -106.58 121.4 45.28 Favored Pre-proline 0 N--CA 1.498 1.957 0 O-C-N 121.11 -0.994 . . . . 0.0 109.921 179.93 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 827' ' ' PRO . . . . . 0.47 ' O ' ' CB ' ' A' ' 828' ' ' GLU . 43.7 Cg_endo -70.38 171.43 15.17 Favored 'Trans proline' 0 C--N 1.309 -1.523 0 O-C-N 123.942 1.496 . . . . 0.0 110.054 -179.975 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 828' ' ' GLU . . . . . 0.47 ' CB ' ' O ' ' A' ' 827' ' ' PRO . 0.0 OUTLIER 66.54 15.74 10.2 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.21 -0.931 . . . . 0.0 109.64 -179.951 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 829' ' ' VAL . . . . . 0.696 HG21 ' SG ' ' A' ' 826' ' ' CYS . 95.4 t -119.8 132.26 70.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.425 -0.797 . . . . 0.0 110.02 179.934 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 830' ' ' MET . . . . . . . . . . . . . 2.2 tpp -53.55 144.71 16.63 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.219 -0.926 . . . . 0.0 110.279 179.961 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 831' ' ' LYS . . . . . 0.467 ' HG3' ' OE1' ' A' ' 737' ' ' GLU . 0.0 OUTLIER -115.07 97.81 6.43 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.123 -0.986 . . . . 0.0 110.675 -179.938 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 832' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -122.17 167.94 12.59 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.419 -0.8 . . . . 0.0 109.434 179.989 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 833' ' ' VAL . . . . . 0.522 HG21 ' CG2' ' A' ' 816' ' ' ILE . 38.3 t -124.26 148.23 28.54 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 O-C-N 120.908 -1.12 . . . . 0.0 111.537 -179.915 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 834' ' ' ALA . . . . . 0.488 ' O ' ' HA ' ' A' ' 776' ' ' ALA . . . -150.69 111.65 4.32 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 179.919 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 835' ' ' VAL . . . . . 0.554 HG22 ' CB ' ' A' ' 776' ' ' ALA . 41.0 t -126.7 164.67 26.59 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 O-C-N 120.977 -1.077 . . . . 0.0 112.342 -179.773 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 836' ' ' GLU . . . . . 0.47 ' N ' ' CG1' ' A' ' 835' ' ' VAL . 64.0 tt0 -153.87 137.57 16.09 Favored 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 179.855 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 837' ' ' ALA . . . . . . . . . . . . . . . -124.19 162.83 22.83 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 120.769 -1.207 . . . . 0.0 111.808 -179.814 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 838' ' ' VAL . . . . . . . . . . . . . 60.7 t -115.46 128.54 72.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.702 -0.624 . . . . 0.0 109.509 179.889 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 839' ' ' CYS . . . . . . . . . . . . . 5.2 m -108.25 156.36 19.45 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.998 -1.064 . . . . 0.0 110.908 -179.957 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 840' ' ' SER . . . . . 0.625 ' HA ' HG12 ' A' ' 728' ' ' VAL . 6.0 p -157.97 136.37 11.05 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.43 -0.794 . . . . 0.0 109.84 179.917 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 841' ' ' THR . . . . . 0.429 ' HA ' ' HG3' ' A' ' 768' ' ' GLN . 65.7 p -64.64 102.86 0.61 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.32 -0.862 . . . . 0.0 110.41 -179.954 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 842' ' ' ALA . . . . . . . . . . . . . . . -89.85 75.04 7.33 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.29 -0.881 . . . . 0.0 110.116 179.938 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 843' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 1.753 0 CA-C-O 118.013 -0.994 . . . . 0.0 110.211 -179.97 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 726' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.492 1.666 0 CA-C-O 121.177 0.513 . . . . 0.0 110.321 . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 727' ' ' THR . . . . . . . . . . . . . 90.3 m -100.3 151.26 21.69 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.177 -0.952 . . . . 0.0 110.173 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 728' ' ' VAL . . . . . . . . . . . . . 66.4 t -135.18 125.22 43.89 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 O-C-N 121.257 -0.902 . . . . 0.0 110.236 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 729' ' ' SER . . . . . 0.445 ' O ' ' O ' ' A' ' 730' ' ' GLY . 15.1 p -139.7 71.08 1.37 Allowed 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.258 -0.901 . . . . 0.0 110.472 -179.943 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 730' ' ' GLY . . . . . 0.517 ' HA3' ' HA ' ' A' ' 838' ' ' VAL . . . -52.1 -175.77 0.04 OUTLIER Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 179.958 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 731' ' ' VAL . . . . . . . . . . . . . 3.6 t -132.26 135.93 57.26 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.286 -1.126 . . . . 0.0 110.036 179.994 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 732' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -110.55 126.96 54.97 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.239 -0.913 . . . . 0.0 110.081 179.936 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 733' ' ' ALA . . . . . . . . . . . . . . . -138.92 123.0 17.95 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.211 -0.931 . . . . 0.0 110.717 -179.898 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 734' ' ' ASP . . . . . . . . . . . . . 2.2 p-10 -113.0 108.8 17.85 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.401 -0.812 . . . . 0.0 109.698 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 735' ' ' VAL . . . . . 0.428 HG12 ' N ' ' A' ' 736' ' ' SER . 45.7 t -111.12 164.11 7.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.226 -0.921 . . . . 0.0 110.315 -179.937 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 736' ' ' SER . . . . . 0.428 ' N ' HG12 ' A' ' 735' ' ' VAL . 44.5 p -101.53 -178.48 3.74 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.178 -0.951 . . . . 0.0 110.264 -179.96 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 737' ' ' GLU . . . . . 0.505 ' HB2' HG21 ' A' ' 816' ' ' ILE . 25.6 tt0 -127.08 106.15 9.07 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.341 -0.849 . . . . 0.0 110.351 179.963 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 738' ' ' TYR . . . . . 0.603 ' CG ' ' N ' ' A' ' 739' ' ' HIS . 29.8 p90 -171.13 -42.67 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.216 -0.928 . . . . 0.0 110.577 -179.962 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 739' ' ' HIS . . . . . 0.603 ' N ' ' CG ' ' A' ' 738' ' ' TYR . 2.7 t60 -176.12 134.26 0.43 Allowed Pre-proline 0 N--CA 1.494 1.73 0 O-C-N 121.204 -0.935 . . . . 0.0 110.505 -179.923 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 740' ' ' PRO . . . . . 0.499 ' O ' ' CB ' ' A' ' 741' ' ' ASN . 48.3 Cg_endo -75.94 -13.96 19.32 Favored 'Trans proline' 0 C--N 1.307 -1.656 0 O-C-N 123.973 1.512 . . . . 0.0 110.432 179.94 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 741' ' ' ASN . . . . . 0.499 ' CB ' ' O ' ' A' ' 740' ' ' PRO . 4.8 m-20 70.91 75.94 0.19 Allowed 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.355 -0.84 . . . . 0.0 110.132 179.995 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 742' ' ' ILE . . . . . 0.704 ' H ' HD12 ' A' ' 742' ' ' ILE . 3.8 mp -55.52 -72.58 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.262 -0.899 . . . . 0.0 110.224 -179.976 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 743' ' ' LYS . . . . . 0.454 ' HG2' ' O ' ' A' ' 742' ' ' ILE . 1.2 mmpt? -141.38 -161.51 1.23 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.276 -0.89 . . . . 0.0 110.307 -179.899 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 744' ' ' ASN . . . . . 0.423 ' O ' ' CG ' ' A' ' 744' ' ' ASN . 8.6 p-10 -94.16 59.07 2.61 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.245 -0.91 . . . . 0.0 110.16 179.986 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 745' ' ' TRP . . . . . 0.502 ' CZ2' ' O ' ' A' ' 748' ' ' GLU . 1.0 OUTLIER -101.98 -165.09 1.15 Allowed 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.251 -0.906 . . . . 0.0 110.263 179.959 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 746' ' ' GLN . . . . . 0.421 ' C ' ' O ' ' A' ' 745' ' ' TRP . 0.7 OUTLIER -43.06 150.74 0.16 Allowed 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.301 -0.875 . . . . 0.0 109.965 -179.936 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 747' ' ' ILE . . . . . 0.675 HG22 ' O ' ' A' ' 747' ' ' ILE . 9.6 mm -85.17 13.04 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.258 -0.901 . . . . 0.0 110.21 179.953 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 748' ' ' GLU . . . . . 0.502 ' O ' ' CZ2' ' A' ' 745' ' ' TRP . 8.5 mm-40 -118.19 -168.35 1.51 Allowed 'General case' 0 C--N 1.291 -1.969 0 O-C-N 121.14 -0.975 . . . . 0.0 110.108 -179.883 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 749' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -144.4 60.2 1.34 Allowed 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.242 -0.911 . . . . 0.0 110.406 179.966 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 750' ' ' TYR . . . . . 0.429 ' CD1' ' N ' ' A' ' 750' ' ' TYR . 29.7 p90 -129.63 -3.67 4.76 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.112 -0.993 . . . . 0.0 110.519 179.991 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 751' ' ' GLY . . . . . 0.418 ' O ' ' OE2' ' A' ' 752' ' ' GLU . . . -103.02 -23.24 8.7 Favored Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.365 -1.494 . . . . 0.0 109.365 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 752' ' ' GLU . . . . . 0.418 ' OE2' ' O ' ' A' ' 751' ' ' GLY . 0.3 OUTLIER -167.33 60.45 0.53 Allowed Pre-proline 0 N--CA 1.492 1.645 0 O-C-N 121.323 -1.104 . . . . 0.0 109.744 179.951 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 753' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -73.74 80.88 1.96 Allowed 'Trans proline' 0 C--N 1.304 -1.771 0 O-C-N 124.12 1.59 . . . . 0.0 110.804 -179.916 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 754' ' ' GLU . . . . . . . . . . . . . 9.9 mt-10 -95.25 -26.16 16.06 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.132 -0.98 . . . . 0.0 109.8 179.948 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 755' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -135.08 145.8 48.28 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.332 -0.855 . . . . 0.0 109.967 179.965 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 756' ' ' HIS . . . . . 0.585 ' CG ' ' O ' ' A' ' 756' ' ' HIS . 26.5 t-80 -152.19 31.03 0.54 Allowed 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.091 -1.005 . . . . 0.0 110.703 179.994 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 757' ' ' THR . . . . . 0.464 HG23 ' C ' ' A' ' 756' ' ' HIS . 71.5 p -149.77 125.46 10.39 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.002 -1.061 . . . . 0.0 110.543 179.918 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 758' ' ' ALA . . . . . . . . . . . . . . . -60.25 170.02 1.43 Allowed 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.257 -0.902 . . . . 0.0 109.525 179.958 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 759' ' ' LYS . . . . . . . . . . . . . 21.2 mttt -129.25 161.89 29.15 Favored 'General case' 0 C--N 1.299 -1.612 0 O-C-N 121.087 -1.008 . . . . 0.0 110.382 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 760' ' ' VAL . . . . . . . . . . . . . 28.0 t -107.24 131.79 56.38 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.343 -0.848 . . . . 0.0 108.769 179.958 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 761' ' ' HIS . . . . . . . . . . . . . 27.0 m170 -112.29 104.41 12.58 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.035 -1.04 . . . . 0.0 111.545 -179.872 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 762' ' ' LEU . . . . . . . . . . . . . 19.4 mt -110.32 113.42 26.06 Favored 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 179.864 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 763' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -140.03 116.98 11.04 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.712 -1.242 . . . . 0.0 111.331 -179.858 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 764' ' ' CYS . . . . . 0.463 ' O ' ' O ' ' A' ' 765' ' ' ALA . 1.5 m -95.89 146.03 24.9 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.511 -0.743 . . . . 0.0 109.05 179.938 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 765' ' ' ALA . . . . . 0.626 ' HB3' ' OE1' ' A' ' 768' ' ' GLN . . . -39.61 160.74 0.1 OUTLIER Pre-proline 0 N--CA 1.498 1.933 0 O-C-N 121.215 -0.928 . . . . 0.0 110.413 -179.992 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 766' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -69.99 102.07 1.02 Allowed 'Trans proline' 0 C--N 1.305 -1.757 0 O-C-N 123.941 1.495 . . . . 0.0 110.213 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 767' ' ' GLY . . . . . . . . . . . . . . . 132.3 -17.92 4.75 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 108.966 -1.654 . . . . 0.0 108.966 -179.951 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 768' ' ' GLN . . . . . 0.626 ' OE1' ' HB3' ' A' ' 765' ' ' ALA . 13.2 mt-30 -102.58 114.77 29.26 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.423 -1.045 . . . . 0.0 109.77 179.895 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 769' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -106.82 149.39 27.44 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.202 -0.936 . . . . 0.0 110.616 -179.954 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 770' ' ' ILE . . . . . . . . . . . . . 49.8 mt -72.92 150.26 8.22 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.314 -0.866 . . . . 0.0 109.545 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 771' ' ' SER . . . . . . . . . . . . . 1.3 p -140.84 3.64 1.85 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 120.995 -1.066 . . . . 0.0 111.008 179.973 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 772' ' ' ALA . . . . . . . . . . . . . . . -173.65 145.96 1.25 Allowed 'General case' 0 N--CA 1.495 1.783 0 O-C-N 120.902 -1.124 . . . . 0.0 111.551 -179.946 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 773' ' ' ILE . . . . . 0.401 HD12 HG23 ' A' ' 773' ' ' ILE . 38.1 mm -107.01 147.92 11.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 179.907 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 774' ' ' LYS . . . . . . . . . . . . . 9.8 tptp -113.44 -25.0 8.99 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.998 -1.064 . . . . 0.0 110.808 -179.93 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 775' ' ' PHE . . . . . 0.588 ' O ' ' HB2' ' A' ' 776' ' ' ALA . 68.5 t80 -170.43 163.98 8.59 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.057 -1.027 . . . . 0.0 110.751 179.994 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 776' ' ' ALA . . . . . 0.588 ' HB2' ' O ' ' A' ' 775' ' ' PHE . . . 175.07 72.31 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.692 -0.63 . . . . 0.0 109.406 -179.945 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 777' ' ' SER . . . . . 0.449 ' HA ' ' HB3' ' A' ' 798' ' ' SER . 1.5 t -92.66 154.23 18.49 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.328 -0.857 . . . . 0.0 110.968 -179.891 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 778' ' ' PHE . . . . . 0.578 ' O ' ' CD2' ' A' ' 778' ' ' PHE . 33.9 t80 -124.95 94.96 4.33 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.467 -0.771 . . . . 0.0 109.899 179.958 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 779' ' ' GLY . . . . . . . . . . . . . . . 159.18 -97.12 0.16 Allowed Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 179.99 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 780' ' ' THR . . . . . 0.466 HG21 HG11 ' A' ' 829' ' ' VAL . 52.1 p -132.8 92.58 26.12 Favored Pre-proline 0 N--CA 1.493 1.716 0 O-C-N 121.271 -1.134 . . . . 0.0 110.285 -179.94 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 781' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -75.26 173.19 14.93 Favored 'Trans proline' 0 C--N 1.305 -1.744 0 O-C-N 124.098 1.578 . . . . 0.0 110.523 179.916 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 782' ' ' LEU . . . . . . . . . . . . . 2.2 tt -137.65 118.32 14.02 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.307 -0.871 . . . . 0.0 110.167 179.935 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 783' ' ' GLY . . . . . 0.409 ' HA3' HG23 ' A' ' 787' ' ' THR . . . 95.28 -176.84 34.52 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.331 -1.507 . . . . 0.0 109.331 179.98 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 784' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -117.91 -160.81 0.8 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.208 -1.172 . . . . 0.0 110.188 -179.979 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 785' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -60.56 119.16 7.54 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.306 -0.871 . . . . 0.0 110.252 -179.932 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 786' ' ' GLY . . . . . . . . . . . . . . . 114.85 -28.93 7.77 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 787' ' ' THR . . . . . 0.409 HG23 ' HA3' ' A' ' 783' ' ' GLY . 8.9 t -134.78 34.4 3.16 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.237 -1.155 . . . . 0.0 110.309 179.967 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 788' ' ' PHE . . . . . 0.493 ' CZ ' ' HB1' ' A' ' 834' ' ' ALA . 1.0 OUTLIER -65.85 132.12 47.91 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.278 -0.889 . . . . 0.0 109.943 179.989 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 789' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -139.9 154.02 47.14 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.229 -0.919 . . . . 0.0 110.33 179.925 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 790' ' ' GLN . . . . . 0.419 ' OE1' ' ND1' ' A' ' 794' ' ' HIS . 1.6 mp0 -65.84 116.3 6.86 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.351 -0.843 . . . . 0.0 110.482 -179.987 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 791' ' ' GLY . . . . . . . . . . . . . . . -64.68 -105.86 0.01 OUTLIER Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.623 -1.391 . . . . 0.0 109.623 -179.945 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 792' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -127.18 -26.12 3.15 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.302 -1.117 . . . . 0.0 110.509 -179.956 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 793' ' ' CYS . . . . . 0.474 ' O ' ' HB3' ' A' ' 794' ' ' HIS . 85.7 m -100.2 -83.91 0.43 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.206 -0.933 . . . . 0.0 109.89 -179.997 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 794' ' ' HIS . . . . . 0.637 ' CE1' ' OG ' ' A' ' 798' ' ' SER . 84.9 t60 58.4 113.77 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.506 -0.746 . . . . 0.0 110.728 179.981 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 795' ' ' SER . . . . . 0.468 ' O ' ' O ' ' A' ' 794' ' ' HIS . 100.0 p -60.66 -126.6 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.301 -0.874 . . . . 0.0 109.295 179.871 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 796' ' ' ILE . . . . . 0.424 ' CG1' ' C ' ' A' ' 795' ' ' SER . 1.0 OUTLIER -148.02 -31.06 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 2.02 0 O-C-N 120.798 -1.189 . . . . 0.0 110.68 179.856 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 797' ' ' ASN . . . . . 0.667 ' O ' HG23 ' A' ' 801' ' ' VAL . 4.3 m120 -86.26 16.28 4.54 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 120.906 -1.121 . . . . 0.0 110.04 179.914 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 798' ' ' SER . . . . . 0.637 ' OG ' ' CE1' ' A' ' 794' ' ' HIS . 0.9 OUTLIER -33.56 -70.76 0.07 Allowed 'General case' 0 N--CA 1.503 2.178 0 O-C-N 121.775 -0.578 . . . . 0.0 111.8 -179.999 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 799' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -84.99 -30.02 24.55 Favored 'General case' 0 N--CA 1.501 2.086 0 O-C-N 121.155 -0.966 . . . . 0.0 111.094 -179.876 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 800' ' ' SER . . . . . . . . . . . . . 37.2 t -54.47 -16.91 2.61 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.059 -1.026 . . . . 0.0 110.743 -179.955 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 801' ' ' VAL . . . . . 0.667 HG23 ' O ' ' A' ' 797' ' ' ASN . 85.3 t -90.97 -48.69 13.9 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.919 0 O-C-N 121.046 -1.034 . . . . 0.0 111.588 -179.851 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 802' ' ' LEU . . . . . 0.516 HD22 ' N ' ' A' ' 802' ' ' LEU . 4.6 mm? -75.08 -16.33 60.57 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.112 -0.993 . . . . 0.0 111.522 -179.801 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 803' ' ' GLU . . . . . 0.906 ' O ' HD12 ' A' ' 807' ' ' ILE . 0.5 OUTLIER -81.94 -27.53 33.24 Favored 'General case' 0 C--N 1.295 -1.77 0 O-C-N 120.73 -1.232 . . . . 0.0 110.778 -179.947 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 804' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -95.4 -18.39 20.77 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.109 -0.994 . . . . 0.0 112.28 -179.918 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 805' ' ' LYS . . . . . 0.458 ' O ' ' SG ' ' A' ' 806' ' ' CYS . 4.0 ttpt -122.17 20.25 10.63 Favored 'General case' 0 N--CA 1.501 2.078 0 O-C-N 120.452 -1.405 . . . . 0.0 112.477 -179.868 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 806' ' ' CYS . . . . . 0.512 ' HB2' ' O ' ' A' ' 802' ' ' LEU . 50.0 m -152.66 51.17 0.76 Allowed 'General case' 0 N--CA 1.496 1.832 0 O-C-N 120.665 -1.272 . . . . 0.0 110.406 179.905 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 807' ' ' ILE . . . . . 0.906 HD12 ' O ' ' A' ' 803' ' ' GLU . 9.1 mt -140.42 95.04 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.484 0 O-C-N 121.524 -0.735 . . . . 0.0 109.324 179.956 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 808' ' ' GLY . . . . . . . . . . . . . . . 118.95 10.07 8.51 Favored Glycine 0 N--CA 1.489 2.199 0 N-CA-C 109.264 -1.534 . . . . 0.0 109.264 -179.946 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 809' ' ' LEU . . . . . . . . . . . . . 9.1 mt -117.61 157.05 27.08 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.255 -1.144 . . . . 0.0 110.191 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 810' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -86.28 -18.61 31.59 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.202 -0.936 . . . . 0.0 110.088 179.987 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 811' ' ' ARG . . . . . . . . . . . . . 26.2 ttp180 -149.79 136.09 19.0 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.323 -0.861 . . . . 0.0 110.087 179.942 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 812' ' ' CYS . . . . . 0.45 ' SG ' ' O ' ' A' ' 805' ' ' LYS . 0.1 OUTLIER -123.98 144.21 49.95 Favored 'General case' 0 C--N 1.298 -1.655 0 O-C-N 121.303 -0.873 . . . . 0.0 110.256 -179.906 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 813' ' ' VAL . . . . . 0.598 HG13 ' O ' ' A' ' 813' ' ' VAL . 7.0 p -137.87 123.15 24.44 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.509 0 O-C-N 121.309 -0.87 . . . . 0.0 109.622 179.888 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 814' ' ' VAL . . . . . . . . . . . . . 36.5 t -131.38 135.81 58.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.135 -0.978 . . . . 0.0 110.393 -179.946 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 815' ' ' ALA . . . . . 0.617 ' O ' ' ND2' ' A' ' 820' ' ' ASN . . . -82.8 146.32 29.02 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.341 -0.849 . . . . 0.0 110.024 179.972 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 816' ' ' ILE . . . . . 0.863 HG23 HG21 ' A' ' 833' ' ' VAL . 18.0 mt -95.58 111.83 26.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.213 -0.93 . . . . 0.0 110.194 -179.995 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 817' ' ' SER . . . . . 0.527 ' CB ' ' HD2' ' A' ' 818' ' ' PRO . 1.0 OUTLIER -161.73 -175.83 0.53 Allowed Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.226 -0.922 . . . . 0.0 110.219 179.937 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 818' ' ' PRO . . . . . 0.527 ' HD2' ' CB ' ' A' ' 817' ' ' SER . 50.2 Cg_endo -78.32 -37.02 0.82 Allowed 'Trans proline' 0 C--N 1.305 -1.711 0 O-C-N 124.02 1.537 . . . . 0.0 110.893 -179.853 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 819' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -83.49 22.93 0.99 Allowed 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.113 -0.992 . . . . 0.0 110.826 -179.991 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 820' ' ' ASN . . . . . 0.617 ' ND2' ' O ' ' A' ' 815' ' ' ALA . 2.1 m-20 -117.0 -15.01 10.61 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.11 -0.994 . . . . 0.0 110.169 179.939 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 821' ' ' PHE . . . . . . . . . . . . . 39.4 m-85 -128.01 -74.19 0.58 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.154 -0.966 . . . . 0.0 110.621 179.987 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 822' ' ' GLY . . . . . . . . . . . . . . . -163.17 50.84 0.31 Allowed Glycine 0 N--CA 1.493 2.477 0 N-CA-C 109.778 -1.329 . . . . 0.0 109.778 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 823' ' ' GLY . . . . . . . . . . . . . . . 72.76 -126.82 11.02 Favored Glycine 0 N--CA 1.492 2.393 0 N-CA-C 109.661 -1.376 . . . . 0.0 109.661 179.944 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 824' ' ' ASP . . . . . 0.41 ' O ' ' OD2' ' A' ' 824' ' ' ASP . 1.5 p30 -127.17 134.97 26.72 Favored Pre-proline 0 N--CA 1.494 1.742 0 O-C-N 121.241 -1.152 . . . . 0.0 110.32 179.986 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 825' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -78.95 -90.76 0.0 OUTLIER 'Trans proline' 0 C--N 1.307 -1.64 0 O-C-N 124.053 1.554 . . . . 0.0 110.616 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 826' ' ' CYS . . . . . 0.452 ' HA ' ' HD3' ' A' ' 827' ' ' PRO . 24.3 p -115.39 138.26 23.58 Favored Pre-proline 0 N--CA 1.496 1.851 0 O-C-N 121.21 -0.931 . . . . 0.0 111.067 -179.897 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 827' ' ' PRO . . . . . 0.469 ' O ' ' HB2' ' A' ' 828' ' ' GLU . 54.9 Cg_endo -85.16 -178.91 3.32 Favored 'Trans proline' 0 C--N 1.306 -1.687 0 O-C-N 124.121 1.59 . . . . 0.0 110.057 179.915 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 828' ' ' GLU . . . . . 0.469 ' HB2' ' O ' ' A' ' 827' ' ' PRO . 50.6 mt-10 57.88 17.38 4.24 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.566 -0.709 . . . . 0.0 111.042 179.937 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 829' ' ' VAL . . . . . 0.466 HG11 HG21 ' A' ' 780' ' ' THR . 72.4 t -130.4 141.42 46.33 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 O-C-N 121.079 -1.013 . . . . 0.0 110.023 179.844 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 830' ' ' MET . . . . . 0.463 ' O ' ' O ' ' A' ' 829' ' ' VAL . 0.0 OUTLIER -51.21 -175.75 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.195 -0.94 . . . . 0.0 110.126 -179.975 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 831' ' ' LYS . . . . . . . . . . . . . 9.7 mttp -142.29 108.23 5.17 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.025 -1.047 . . . . 0.0 110.896 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 832' ' ' ARG . . . . . . . . . . . . . 5.9 mtp180 -129.88 147.42 51.65 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.444 -0.785 . . . . 0.0 109.483 179.957 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 833' ' ' VAL . . . . . 0.863 HG21 HG23 ' A' ' 816' ' ' ILE . 92.6 t -120.15 117.57 53.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.024 -1.047 . . . . 0.0 110.731 -179.942 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 834' ' ' ALA . . . . . 0.493 ' HB1' ' CZ ' ' A' ' 788' ' ' PHE . . . -112.99 127.92 56.36 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.284 -0.885 . . . . 0.0 109.847 179.917 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 835' ' ' VAL . . . . . 0.467 ' CG1' ' N ' ' A' ' 836' ' ' GLU . 14.9 t -126.11 165.69 23.61 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 121.11 -0.994 . . . . 0.0 110.577 -179.916 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 836' ' ' GLU . . . . . 0.467 ' N ' ' CG1' ' A' ' 835' ' ' VAL . 0.1 OUTLIER -152.88 109.69 3.46 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.377 -0.827 . . . . 0.0 109.657 -179.939 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 837' ' ' ALA . . . . . . . . . . . . . . . -111.18 162.01 15.38 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.171 -0.956 . . . . 0.0 110.532 -179.979 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 838' ' ' VAL . . . . . 0.517 ' HA ' ' HA3' ' A' ' 730' ' ' GLY . 39.1 t -120.02 132.87 68.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.321 -0.862 . . . . 0.0 110.07 -179.96 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 839' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -118.18 136.89 53.35 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.222 -0.924 . . . . 0.0 110.149 -179.976 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 840' ' ' SER . . . . . 0.44 ' O ' ' HG2' ' A' ' 768' ' ' GLN . 91.4 p -106.23 -145.01 0.38 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.161 -0.962 . . . . 0.0 110.031 179.975 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 841' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -145.86 152.26 39.2 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.062 -1.024 . . . . 0.0 110.299 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 842' ' ' ALA . . . . . . . . . . . . . . . 44.2 68.14 0.58 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.254 -0.904 . . . . 0.0 110.162 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 843' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.621 0 CA-C-O 117.985 -1.007 . . . . 0.0 110.22 -179.995 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 726' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.678 0 CA-C-O 121.312 0.577 . . . . 0.0 110.213 . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 727' ' ' THR . . . . . 0.533 ' CG2' ' HB2' ' A' ' 840' ' ' SER . 3.4 m -53.64 164.31 0.55 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.188 -0.945 . . . . 0.0 110.214 -179.994 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 728' ' ' VAL . . . . . 0.512 ' O ' ' CB ' ' A' ' 729' ' ' SER . 74.6 t -106.98 165.03 4.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.28 -0.888 . . . . 0.0 110.075 179.988 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 729' ' ' SER . . . . . 0.512 ' CB ' ' O ' ' A' ' 728' ' ' VAL . 0.3 OUTLIER 166.65 126.52 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.104 0 O-C-N 121.326 -0.859 . . . . 0.0 110.304 -179.987 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 730' ' ' GLY . . . . . 0.437 ' C ' ' CG2' ' A' ' 731' ' ' VAL . . . 142.78 76.57 0.04 OUTLIER Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.741 -1.344 . . . . 0.0 109.741 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 731' ' ' VAL . . . . . 0.437 ' CG2' ' C ' ' A' ' 730' ' ' GLY . 3.1 t -147.6 135.58 14.74 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 121.178 -1.189 . . . . 0.0 110.14 179.994 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 732' ' ' CYS . . . . . . . . . . . . . 30.4 p -153.3 138.27 17.22 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.235 -0.915 . . . . 0.0 110.094 -179.961 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 733' ' ' ALA . . . . . . . . . . . . . . . -111.92 131.21 55.52 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.266 -0.896 . . . . 0.0 110.397 179.992 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 734' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -119.7 105.37 11.1 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.296 -0.878 . . . . 0.0 110.037 179.941 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 735' ' ' VAL . . . . . 0.423 HG12 ' N ' ' A' ' 736' ' ' SER . 61.1 t -128.42 162.83 34.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.151 -0.968 . . . . 0.0 110.298 -179.942 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 736' ' ' SER . . . . . 0.423 ' N ' HG12 ' A' ' 735' ' ' VAL . 6.6 p -109.17 -165.75 1.05 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.206 -0.934 . . . . 0.0 110.007 -179.962 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 737' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -86.1 176.38 8.03 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.266 -0.896 . . . . 0.0 110.731 -179.975 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 738' ' ' TYR . . . . . 0.403 ' HB2' ' HB2' ' A' ' 758' ' ' ALA . 45.8 t80 -154.62 149.28 26.45 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.382 -0.824 . . . . 0.0 110.124 179.946 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 739' ' ' HIS . . . . . 0.515 ' HB2' ' HD2' ' A' ' 740' ' ' PRO . 4.9 p-80 -164.65 166.8 10.9 Favored Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 121.344 -0.847 . . . . 0.0 109.604 -179.985 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 740' ' ' PRO . . . . . 0.515 ' HD2' ' HB2' ' A' ' 739' ' ' HIS . 40.6 Cg_endo -66.42 83.04 0.29 Allowed 'Trans proline' 0 C--N 1.31 -1.496 0 O-C-N 123.864 1.455 . . . . 0.0 110.166 179.975 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 741' ' ' ASN . . . . . 0.724 ' O ' HD13 ' A' ' 742' ' ' ILE . 0.9 OUTLIER -167.64 24.05 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.428 -0.795 . . . . 0.0 109.918 179.958 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 742' ' ' ILE . . . . . 0.724 HD13 ' O ' ' A' ' 741' ' ' ASN . 12.2 mm -133.63 39.61 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.233 -0.917 . . . . 0.0 110.06 179.945 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 743' ' ' LYS . . . . . 0.425 ' C ' ' O ' ' A' ' 742' ' ' ILE . 0.0 OUTLIER -42.9 164.63 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.3 -0.875 . . . . 0.0 110.411 -179.962 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 744' ' ' ASN . . . . . . . . . . . . . 21.5 t-20 48.6 47.04 20.96 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.419 -0.801 . . . . 0.0 110.669 179.909 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 745' ' ' TRP . . . . . 0.513 ' CG ' ' O ' ' A' ' 745' ' ' TRP . 26.5 t-105 -98.28 1.36 47.08 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.238 -0.914 . . . . 0.0 109.824 179.878 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 746' ' ' GLN . . . . . . . . . . . . . 15.4 mm100 -119.67 131.08 55.34 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.27 -0.894 . . . . 0.0 110.088 -179.995 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 747' ' ' ILE . . . . . 0.735 HG22 ' O ' ' A' ' 747' ' ' ILE . 3.6 mp -92.8 19.64 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 121.164 -0.96 . . . . 0.0 110.471 -179.997 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 748' ' ' GLU . . . . . . . . . . . . . 19.4 tp10 -124.7 -29.55 3.41 Favored 'General case' 0 C--N 1.295 -1.769 0 O-C-N 121.31 -0.869 . . . . 0.0 109.905 179.96 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 749' ' ' SER . . . . . 0.489 ' CB ' ' OE2' ' A' ' 752' ' ' GLU . 3.3 m -126.12 167.26 15.63 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.245 -0.91 . . . . 0.0 109.826 179.986 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 750' ' ' TYR . . . . . 0.496 ' CD1' ' N ' ' A' ' 750' ' ' TYR . 20.7 m-85 -126.17 74.21 1.42 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.202 -0.937 . . . . 0.0 110.302 180.0 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 751' ' ' GLY . . . . . 0.434 ' O ' ' C ' ' A' ' 752' ' ' GLU . . . 137.09 -4.48 3.5 Favored Glycine 0 N--CA 1.492 2.426 0 N-CA-C 109.781 -1.328 . . . . 0.0 109.781 179.942 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 752' ' ' GLU . . . . . 0.489 ' OE2' ' CB ' ' A' ' 749' ' ' SER . 0.8 OUTLIER -39.92 121.03 1.51 Allowed Pre-proline 0 N--CA 1.497 1.924 0 O-C-N 121.359 -1.083 . . . . 0.0 110.233 -179.978 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 753' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -77.02 125.94 8.33 Favored 'Trans proline' 0 C--N 1.308 -1.561 0 O-C-N 123.89 1.468 . . . . 0.0 111.157 -179.953 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 754' ' ' GLU . . . . . . . . . . . . . 41.9 mp0 -94.88 -150.08 0.3 Allowed 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.305 -0.872 . . . . 0.0 109.387 179.908 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 755' ' ' PHE . . . . . 0.647 ' CZ ' ' HA ' ' A' ' 758' ' ' ALA . 16.0 p90 -139.57 94.68 2.81 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 120.823 -1.173 . . . . 0.0 111.059 179.903 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 756' ' ' HIS . . . . . 0.474 ' C ' ' O ' ' A' ' 755' ' ' PHE . 1.8 t60 12.27 -81.91 0.0 OUTLIER 'General case' 0 N--CA 1.514 2.771 0 N-CA-C 114.08 1.141 . . . . 0.0 114.08 179.922 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 757' ' ' THR . . . . . 0.563 ' O ' ' CE1' ' A' ' 755' ' ' PHE . 37.2 p -81.94 -175.01 5.38 Favored 'General case' 0 N--CA 1.505 2.306 0 O-C-N 120.702 -1.249 . . . . 0.0 112.285 -179.683 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 758' ' ' ALA . . . . . 0.647 ' HA ' ' CZ ' ' A' ' 755' ' ' PHE . . . -109.75 179.04 4.24 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.753 -0.592 . . . . 0.0 109.703 179.97 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 759' ' ' LYS . . . . . . . . . . . . . 18.0 mtpt -141.77 150.72 42.11 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.062 -1.024 . . . . 0.0 110.946 179.979 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 760' ' ' VAL . . . . . . . . . . . . . 5.4 t -108.06 131.42 58.5 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 179.884 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 761' ' ' HIS . . . . . . . . . . . . . 3.7 m170 -117.35 103.77 10.47 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.998 -1.064 . . . . 0.0 111.575 -179.878 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 762' ' ' LEU . . . . . 0.538 ' HB2' ' HB3' ' A' ' 812' ' ' CYS . 0.2 OUTLIER -109.43 103.11 11.96 Favored 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 179.818 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 763' ' ' LYS . . . . . . . . . . . . . 9.5 ttmt -109.95 165.53 11.65 Favored 'General case' 0 N--CA 1.5 2.073 0 O-C-N 121.096 -1.002 . . . . 0.0 111.766 -179.729 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 764' ' ' CYS . . . . . . . . . . . . . 7.9 m -132.18 175.58 9.13 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.705 -0.622 . . . . 0.0 109.837 179.893 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 765' ' ' ALA . . . . . 0.704 ' HB1' ' HD2' ' A' ' 766' ' ' PRO . . . -71.25 171.66 8.26 Favored Pre-proline 0 N--CA 1.495 1.789 0 O-C-N 121.181 -0.95 . . . . 0.0 109.946 179.937 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 766' ' ' PRO . . . . . 0.704 ' HD2' ' HB1' ' A' ' 765' ' ' ALA . 46.1 Cg_endo -72.47 129.03 14.22 Favored 'Trans proline' 0 C--N 1.306 -1.66 0 O-C-N 123.849 1.447 . . . . 0.0 110.159 179.99 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 767' ' ' GLY . . . . . . . . . . . . . . . 89.53 11.38 64.25 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.349 -1.5 . . . . 0.0 109.349 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 768' ' ' GLN . . . . . . . . . . . . . 2.7 mt-30 -129.1 135.07 48.4 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.304 -1.115 . . . . 0.0 110.216 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 769' ' ' THR . . . . . 0.53 ' CG2' ' HG3' ' A' ' 810' ' ' GLU . 7.7 p -133.31 147.56 51.88 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.204 -0.935 . . . . 0.0 110.32 179.958 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 770' ' ' ILE . . . . . 0.467 HD13 ' SG ' ' A' ' 806' ' ' CYS . 4.3 mt -64.35 149.46 11.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.253 -0.904 . . . . 0.0 109.454 179.997 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 771' ' ' SER . . . . . 0.466 ' O ' ' HB2' ' A' ' 772' ' ' ALA . 24.4 p -134.34 1.05 3.14 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 120.955 -1.09 . . . . 0.0 110.717 -179.88 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 772' ' ' ALA . . . . . 0.466 ' HB2' ' O ' ' A' ' 771' ' ' SER . . . -177.49 132.1 0.16 Allowed 'General case' 0 N--CA 1.495 1.779 0 O-C-N 120.998 -1.064 . . . . 0.0 111.111 -179.964 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 773' ' ' ILE . . . . . . . . . . . . . 32.5 mm -87.65 124.24 40.8 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 O-C-N 121.327 -0.858 . . . . 0.0 109.673 179.919 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 774' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.32 -40.19 18.24 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.186 -0.946 . . . . 0.0 110.725 -179.978 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 775' ' ' PHE . . . . . 0.728 ' O ' ' HB2' ' A' ' 776' ' ' ALA . 75.5 t80 -145.58 162.97 36.22 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.031 -1.043 . . . . 0.0 110.942 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 776' ' ' ALA . . . . . 0.728 ' HB2' ' O ' ' A' ' 775' ' ' PHE . . . 167.13 117.79 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.425 -0.797 . . . . 0.0 109.715 179.98 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 777' ' ' SER . . . . . 0.493 ' HA ' ' OG ' ' A' ' 798' ' ' SER . 17.2 m -151.29 136.33 17.43 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.992 -1.068 . . . . 0.0 110.775 -179.953 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 778' ' ' PHE . . . . . . . . . . . . . 46.7 t80 -103.61 107.17 17.91 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.387 -0.821 . . . . 0.0 110.101 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 779' ' ' GLY . . . . . . . . . . . . . . . 162.82 -101.45 0.19 Allowed Glycine 0 N--CA 1.492 2.43 0 N-CA-C 109.514 -1.434 . . . . 0.0 109.514 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 780' ' ' THR . . . . . . . . . . . . . 53.8 p -134.52 101.54 11.97 Favored Pre-proline 0 N--CA 1.495 1.79 0 O-C-N 121.243 -1.151 . . . . 0.0 110.201 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 781' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -77.8 148.07 25.07 Favored 'Trans proline' 0 C--N 1.306 -1.69 0 O-C-N 123.935 1.492 . . . . 0.0 110.593 -179.97 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 782' ' ' LEU . . . . . 0.494 ' HA ' HD23 ' A' ' 782' ' ' LEU . 7.3 mt -108.02 79.42 1.27 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.308 -0.87 . . . . 0.0 109.75 179.973 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 783' ' ' GLY . . . . . . . . . . . . . . . 123.38 -174.52 16.58 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 108.911 -1.675 . . . . 0.0 108.911 -179.929 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 784' ' ' THR . . . . . . . . . . . . . 37.9 p -122.61 -161.35 0.94 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.1 -1.235 . . . . 0.0 110.287 179.933 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 785' ' ' CYS . . . . . 0.52 ' HA ' ' CE1' ' A' ' 788' ' ' PHE . 6.8 t -57.32 92.94 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.186 -0.946 . . . . 0.0 110.263 179.955 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 786' ' ' GLY . . . . . . . . . . . . . . . 151.48 -28.22 0.96 Allowed Glycine 0 N--CA 1.492 2.388 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 -179.995 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 787' ' ' THR . . . . . 0.757 HG22 ' O ' ' A' ' 787' ' ' THR . 51.5 m -143.61 30.29 1.36 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.297 -1.12 . . . . 0.0 110.141 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 788' ' ' PHE . . . . . 0.52 ' CE1' ' HA ' ' A' ' 785' ' ' CYS . 6.2 m-85 -51.16 155.03 1.41 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.238 -0.914 . . . . 0.0 110.285 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 789' ' ' GLN . . . . . 0.458 ' HB2' ' O ' ' A' ' 788' ' ' PHE . 1.8 tp-100 -177.82 124.84 0.12 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.392 -0.817 . . . . 0.0 110.234 179.977 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 790' ' ' GLN . . . . . 0.438 ' C ' ' O ' ' A' ' 789' ' ' GLN . 1.4 mt-30 -40.16 123.54 1.71 Allowed 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.451 -0.78 . . . . 0.0 110.383 -179.969 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 791' ' ' GLY . . . . . . . . . . . . . . . -74.95 -132.03 0.27 Allowed Glycine 0 N--CA 1.491 2.362 0 N-CA-C 109.332 -1.507 . . . . 0.0 109.332 179.905 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 792' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -106.92 3.47 26.23 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.165 -1.197 . . . . 0.0 110.197 179.971 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 793' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -141.08 118.91 11.76 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.326 -0.859 . . . . 0.0 110.008 -179.991 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 794' ' ' HIS . . . . . 0.428 ' CE1' ' HB2' ' A' ' 798' ' ' SER . 29.7 t-80 -138.07 148.13 44.74 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.294 -0.879 . . . . 0.0 110.148 -179.987 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 795' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -76.8 -136.53 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.296 -0.878 . . . . 0.0 109.66 179.996 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 796' ' ' ILE . . . . . . . . . . . . . 3.8 pt -146.1 12.04 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 O-C-N 121.09 -1.006 . . . . 0.0 110.044 179.905 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 797' ' ' ASN . . . . . . . . . . . . . 7.5 p30 -150.6 30.0 0.67 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.383 -0.823 . . . . 0.0 109.722 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 798' ' ' SER . . . . . 0.496 ' HB3' ' O ' ' A' ' 776' ' ' ALA . 0.7 OUTLIER -57.61 -27.43 62.75 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.522 -0.736 . . . . 0.0 111.102 -179.943 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 799' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -100.83 -22.27 14.89 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 120.924 -1.11 . . . . 0.0 110.501 -179.898 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 800' ' ' SER . . . . . . . . . . . . . 47.4 t -69.45 -18.69 63.75 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.121 -0.987 . . . . 0.0 110.324 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 801' ' ' VAL . . . . . . . . . . . . . 94.2 t -84.45 -46.56 17.75 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 121.23 -0.919 . . . . 0.0 110.863 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 802' ' ' LEU . . . . . 0.527 HD22 ' N ' ' A' ' 802' ' ' LEU . 4.1 mm? -72.6 -42.98 63.94 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.18 -0.95 . . . . 0.0 111.019 -179.946 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 803' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -51.61 -31.12 23.78 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.046 -1.034 . . . . 0.0 110.648 -179.955 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 804' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -92.34 -21.38 20.29 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.105 -0.997 . . . . 0.0 111.279 -179.949 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 805' ' ' LYS . . . . . 0.471 ' O ' ' SG ' ' A' ' 812' ' ' CYS . 0.9 OUTLIER -111.92 28.75 8.47 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 120.912 -1.118 . . . . 0.0 111.216 -179.864 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 806' ' ' CYS . . . . . 0.467 ' SG ' HD13 ' A' ' 770' ' ' ILE . 0.1 OUTLIER -152.92 -74.46 0.13 Allowed 'General case' 0 N--CA 1.497 1.895 0 O-C-N 120.914 -1.116 . . . . 0.0 111.055 179.984 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 807' ' ' ILE . . . . . 0.418 ' C ' ' O ' ' A' ' 806' ' ' CYS . 29.3 mt -41.65 121.36 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.192 -0.943 . . . . 0.0 110.901 -179.883 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 808' ' ' GLY . . . . . 0.439 ' C ' ' HG ' ' A' ' 809' ' ' LEU . . . 99.0 13.45 39.71 Favored Glycine 0 N--CA 1.492 2.432 0 N-CA-C 110.369 -1.092 . . . . 0.0 110.369 179.94 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 809' ' ' LEU . . . . . 0.439 ' HG ' ' C ' ' A' ' 808' ' ' GLY . 91.9 mt -143.3 132.82 23.57 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 120.992 -1.299 . . . . 0.0 110.496 179.982 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 810' ' ' GLU . . . . . 0.53 ' HG3' ' CG2' ' A' ' 769' ' ' THR . 1.0 OUTLIER -63.46 -30.61 71.71 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.271 -0.893 . . . . 0.0 109.383 -179.969 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 811' ' ' ARG . . . . . 0.528 ' HB3' ' NH2' ' A' ' 811' ' ' ARG . 0.5 OUTLIER -117.85 156.6 28.11 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.618 -0.676 . . . . 0.0 109.886 179.958 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 812' ' ' CYS . . . . . 0.538 ' HB3' ' HB2' ' A' ' 762' ' ' LEU . 3.4 t -131.37 137.25 48.64 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.238 -0.914 . . . . 0.0 110.646 -179.925 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 813' ' ' VAL . . . . . 0.672 HG13 ' O ' ' A' ' 813' ' ' VAL . 8.6 p -139.17 119.28 14.38 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.326 -0.859 . . . . 0.0 109.687 179.932 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 814' ' ' VAL . . . . . 0.441 HG21 HD11 ' A' ' 802' ' ' LEU . 38.6 t -128.52 165.58 27.77 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.233 -0.917 . . . . 0.0 110.537 -179.974 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 815' ' ' ALA . . . . . 0.438 ' N ' HG12 ' A' ' 814' ' ' VAL . . . -122.76 147.16 46.83 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.356 -0.84 . . . . 0.0 109.504 179.97 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 816' ' ' ILE . . . . . . . . . . . . . 88.2 mt -105.2 116.2 48.54 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 O-C-N 121.067 -1.02 . . . . 0.0 110.558 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 817' ' ' SER . . . . . 0.425 ' HB2' ' HD2' ' A' ' 818' ' ' PRO . 1.4 p -164.13 169.4 8.16 Favored Pre-proline 0 N--CA 1.492 1.66 0 O-C-N 121.334 -0.854 . . . . 0.0 110.123 179.95 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 818' ' ' PRO . . . . . 0.425 ' HD2' ' HB2' ' A' ' 817' ' ' SER . 43.4 Cg_endo -69.12 -16.54 40.34 Favored 'Trans proline' 0 C--N 1.304 -1.802 0 O-C-N 123.976 1.514 . . . . 0.0 110.504 179.993 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 819' ' ' SER . . . . . . . . . . . . . 14.5 p -106.54 31.7 5.04 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.151 -0.968 . . . . 0.0 110.345 -179.974 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 820' ' ' ASN . . . . . . . . . . . . . 7.8 t-20 -113.53 -28.13 7.63 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.26 -0.9 . . . . 0.0 110.283 -179.974 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 821' ' ' PHE . . . . . . . . . . . . . 94.6 m-85 -116.19 -77.82 0.57 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.25 -0.906 . . . . 0.0 110.471 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 822' ' ' GLY . . . . . . . . . . . . . . . -152.72 42.69 0.67 Allowed Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.643 -1.383 . . . . 0.0 109.643 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 823' ' ' GLY . . . . . 0.414 ' HA2' ' O ' ' A' ' 818' ' ' PRO . . . 85.95 -117.81 4.68 Favored Glycine 0 N--CA 1.492 2.408 0 N-CA-C 109.464 -1.455 . . . . 0.0 109.464 179.993 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 824' ' ' ASP . . . . . . . . . . . . . 6.6 t0 -137.92 105.88 8.14 Favored Pre-proline 0 N--CA 1.493 1.721 0 O-C-N 121.199 -1.177 . . . . 0.0 110.282 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 825' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -74.83 -60.72 0.04 OUTLIER 'Trans proline' 0 C--N 1.307 -1.623 0 O-C-N 124.086 1.571 . . . . 0.0 110.687 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 826' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -109.83 100.44 42.89 Favored Pre-proline 0 N--CA 1.499 2.007 0 O-C-N 121.109 -0.994 . . . . 0.0 110.65 -179.949 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 827' ' ' PRO . . . . . 0.622 ' O ' HG23 ' A' ' 829' ' ' VAL . 48.9 Cg_endo -83.33 166.89 13.98 Favored 'Trans proline' 0 C--N 1.305 -1.718 0 O-C-N 124.039 1.547 . . . . 0.0 110.459 179.925 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 828' ' ' GLU . . . . . . . . . . . . . 10.2 mm-40 48.53 42.4 18.78 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.227 -0.921 . . . . 0.0 110.355 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 829' ' ' VAL . . . . . 0.622 HG23 ' O ' ' A' ' 827' ' ' PRO . 44.2 t -139.83 145.46 26.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.222 -0.924 . . . . 0.0 110.205 -179.996 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 830' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -51.15 99.49 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.175 -0.953 . . . . 0.0 110.215 179.962 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 831' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -71.69 132.69 44.91 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.223 -0.923 . . . . 0.0 110.711 -179.941 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 832' ' ' ARG . . . . . . . . . . . . . 2.5 ttt180 -150.64 149.7 30.19 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.536 -0.727 . . . . 0.0 109.397 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 833' ' ' VAL . . . . . . . . . . . . . 71.9 t -118.68 140.95 40.58 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 120.994 -1.067 . . . . 0.0 111.113 -179.899 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 834' ' ' ALA . . . . . 0.648 ' O ' HG23 ' A' ' 835' ' ' VAL . . . -143.61 136.88 27.9 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.551 -0.718 . . . . 0.0 109.384 179.911 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 835' ' ' VAL . . . . . 0.648 HG23 ' O ' ' A' ' 834' ' ' ALA . 23.6 t -156.36 145.53 11.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 120.937 -1.102 . . . . 0.0 111.484 -179.9 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 836' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -135.18 128.11 31.41 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 179.864 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 837' ' ' ALA . . . . . . . . . . . . . . . -116.6 161.76 18.66 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.96 -1.087 . . . . 0.0 111.32 -179.892 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 838' ' ' VAL . . . . . . . . . . . . . 66.2 t -109.78 114.57 47.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.663 -0.648 . . . . 0.0 109.539 179.942 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 839' ' ' CYS . . . . . 0.478 ' O ' ' O ' ' A' ' 728' ' ' VAL . 0.1 OUTLIER -108.96 144.22 37.2 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.019 -1.051 . . . . 0.0 110.88 -179.968 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 840' ' ' SER . . . . . 0.533 ' HB2' ' CG2' ' A' ' 727' ' ' THR . 79.8 p -171.52 178.67 3.1 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.42 -0.8 . . . . 0.0 110.037 -179.999 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 841' ' ' THR . . . . . . . . . . . . . 11.1 p -66.6 115.7 6.74 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.159 -0.963 . . . . 0.0 110.178 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 842' ' ' ALA . . . . . . . . . . . . . . . -161.2 119.46 2.42 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.276 -0.89 . . . . 0.0 110.252 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 843' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.652 0 CA-C-O 118.019 -0.991 . . . . 0.0 110.262 179.978 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 726' ' ' ARG . . . . . 0.449 ' HA ' ' CG2' ' A' ' 841' ' ' THR . 2.0 tpt85 . . . . . 0 N--CA 1.492 1.662 0 CA-C-O 121.203 0.525 . . . . 0.0 110.309 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 727' ' ' THR . . . . . . . . . . . . . 20.8 m -150.66 162.2 41.14 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.286 -0.884 . . . . 0.0 110.187 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 728' ' ' VAL . . . . . . . . . . . . . 35.8 m -136.99 134.56 48.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.252 -0.905 . . . . 0.0 110.057 179.933 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 729' ' ' SER . . . . . . . . . . . . . 24.4 m -128.48 -154.17 0.62 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.26 -0.9 . . . . 0.0 110.269 -179.949 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 730' ' ' GLY . . . . . . . . . . . . . . . -148.27 111.01 0.52 Allowed Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 179.967 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 731' ' ' VAL . . . . . . . . . . . . . 41.3 t -114.22 151.96 15.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.196 -1.179 . . . . 0.0 110.457 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 732' ' ' CYS . . . . . 0.404 ' HA ' ' O ' ' A' ' 835' ' ' VAL . 14.1 p -159.91 143.91 14.49 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.431 -0.793 . . . . 0.0 109.536 -179.968 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 733' ' ' ALA . . . . . . . . . . . . . . . -121.52 136.37 54.96 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.121 -0.987 . . . . 0.0 110.434 -179.953 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 734' ' ' ASP . . . . . 0.424 ' CG ' ' O ' ' A' ' 734' ' ' ASP . 5.2 p-10 -123.73 106.15 10.28 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.273 -0.892 . . . . 0.0 109.94 179.953 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 735' ' ' VAL . . . . . . . . . . . . . 5.7 t -132.12 128.86 59.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.181 -0.949 . . . . 0.0 110.277 -179.967 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 736' ' ' SER . . . . . . . . . . . . . 4.8 p -69.65 158.98 34.29 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.308 -0.87 . . . . 0.0 110.128 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 737' ' ' GLU . . . . . . . . . . . . . 7.7 tm-20 -89.75 148.95 22.95 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.269 -0.894 . . . . 0.0 110.187 -179.984 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 738' ' ' TYR . . . . . 0.441 ' O ' ' HB2' ' A' ' 739' ' ' HIS . 43.2 t80 -101.17 117.81 35.73 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.206 -0.933 . . . . 0.0 110.313 179.971 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 739' ' ' HIS . . . . . 0.441 ' HB2' ' O ' ' A' ' 738' ' ' TYR . 20.6 t-80 -177.49 86.26 0.24 Allowed Pre-proline 0 N--CA 1.494 1.742 0 O-C-N 121.213 -0.929 . . . . 0.0 110.2 -179.996 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 740' ' ' PRO . . . . . 0.474 ' O ' ' HB2' ' A' ' 741' ' ' ASN . 52.1 Cg_endo -82.33 17.34 1.6 Allowed 'Trans proline' 0 C--N 1.305 -1.717 0 O-C-N 124.075 1.566 . . . . 0.0 110.769 179.915 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 741' ' ' ASN . . . . . 0.854 ' C ' HD12 ' A' ' 742' ' ' ILE . 14.1 m120 56.91 159.37 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.125 -0.984 . . . . 0.0 110.055 -179.979 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 742' ' ' ILE . . . . . 0.854 HD12 ' C ' ' A' ' 741' ' ' ASN . 1.8 mp -130.52 76.17 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.079 -1.013 . . . . 0.0 110.479 179.942 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 743' ' ' LYS . . . . . . . . . . . . . 48.1 mttt -112.5 -18.38 12.43 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.33 -0.856 . . . . 0.0 109.202 179.881 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 744' ' ' ASN . . . . . 0.529 ' O ' ' N ' ' A' ' 746' ' ' GLN . 8.4 t-20 -166.66 31.29 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 179.983 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 745' ' ' TRP . . . . . 0.578 ' CG ' ' O ' ' A' ' 745' ' ' TRP . 1.8 p-90 -43.25 87.11 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.697 0 CA-C-O 121.308 0.575 . . . . 0.0 111.817 -179.888 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 746' ' ' GLN . . . . . 0.529 ' N ' ' O ' ' A' ' 744' ' ' ASN . 14.3 mm100 56.05 134.12 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.474 -0.766 . . . . 0.0 111.511 179.874 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 747' ' ' ILE . . . . . . . . . . . . . 6.1 tt -144.94 20.39 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.131 -0.981 . . . . 0.0 109.846 179.945 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 748' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -124.53 -59.84 1.43 Allowed 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.52 -0.738 . . . . 0.0 109.985 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 749' ' ' SER . . . . . 0.586 ' O ' ' CG ' ' A' ' 750' ' ' TYR . 0.9 OUTLIER -107.26 111.09 23.31 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.238 -0.914 . . . . 0.0 109.438 -179.999 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 750' ' ' TYR . . . . . 0.586 ' CG ' ' O ' ' A' ' 749' ' ' SER . 27.4 p90 36.44 -156.56 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.172 0 O-C-N 121.591 -0.693 . . . . 0.0 110.185 -179.902 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 751' ' ' GLY . . . . . . . . . . . . . . . -154.67 -163.87 12.4 Favored Glycine 0 N--CA 1.489 2.21 0 N-CA-C 109.457 -1.457 . . . . 0.0 109.457 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 752' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -131.96 94.82 23.56 Favored Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.235 -1.156 . . . . 0.0 109.946 -179.966 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 753' ' ' PRO . . . . . 0.463 ' O ' ' HB2' ' A' ' 754' ' ' GLU . 48.3 Cg_endo -77.97 171.3 17.45 Favored 'Trans proline' 0 C--N 1.303 -1.849 0 O-C-N 124.02 1.537 . . . . 0.0 110.457 -179.897 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 754' ' ' GLU . . . . . 0.463 ' HB2' ' O ' ' A' ' 753' ' ' PRO . 5.1 mm-40 58.4 148.16 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.418 -0.801 . . . . 0.0 110.669 -179.99 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 755' ' ' PHE . . . . . 0.599 ' CD2' ' N ' ' A' ' 756' ' ' HIS . 47.9 p90 -178.72 -38.15 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.376 -0.828 . . . . 0.0 109.6 179.975 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 756' ' ' HIS . . . . . 0.599 ' N ' ' CD2' ' A' ' 755' ' ' PHE . 0.1 OUTLIER 41.08 -163.76 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.545 -0.722 . . . . 0.0 110.639 179.955 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 757' ' ' THR . . . . . . . . . . . . . 1.2 p -103.83 -161.98 0.87 Allowed 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.444 -0.785 . . . . 0.0 110.219 -179.977 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 758' ' ' ALA . . . . . . . . . . . . . . . -119.97 171.71 8.25 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.327 -0.858 . . . . 0.0 109.856 179.952 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 759' ' ' LYS . . . . . 0.469 ' HG2' ' HA ' ' A' ' 815' ' ' ALA . 18.2 mttm -142.87 161.07 39.07 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.195 -0.941 . . . . 0.0 110.571 179.989 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 760' ' ' VAL . . . . . 1.001 ' CG2' HD11 ' A' ' 816' ' ' ILE . 11.5 t -112.52 155.57 13.74 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.408 -0.808 . . . . 0.0 109.388 179.93 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 761' ' ' HIS . . . . . 0.456 ' CD2' HG22 ' A' ' 813' ' ' VAL . 0.9 OUTLIER -133.34 119.74 20.11 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.957 -1.089 . . . . 0.0 111.024 179.995 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 762' ' ' LEU . . . . . . . . . . . . . 8.1 mt -114.54 134.78 54.77 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.484 -0.76 . . . . 0.0 109.561 179.935 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 763' ' ' LYS . . . . . . . . . . . . . 6.7 tttm -142.35 125.43 16.3 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.023 -1.048 . . . . 0.0 110.588 179.915 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 764' ' ' CYS . . . . . 0.471 ' O ' ' OE2' ' A' ' 810' ' ' GLU . 0.1 OUTLIER -104.41 -173.25 2.26 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.467 -0.77 . . . . 0.0 109.765 179.949 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 765' ' ' ALA . . . . . . . . . . . . . . . -66.05 148.93 98.16 Favored Pre-proline 0 C--N 1.296 -1.754 0 O-C-N 121.27 -0.894 . . . . 0.0 110.298 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 766' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -72.34 96.39 0.81 Allowed 'Trans proline' 0 C--N 1.307 -1.622 0 O-C-N 123.991 1.521 . . . . 0.0 110.293 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 767' ' ' GLY . . . . . . . . . . . . . . . 141.65 -21.55 2.53 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 108.907 -1.677 . . . . 0.0 108.907 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 768' ' ' GLN . . . . . 0.41 ' O ' ' HG2' ' A' ' 810' ' ' GLU . 73.2 mt-30 -110.86 145.84 37.54 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.472 -1.016 . . . . 0.0 109.688 179.905 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 769' ' ' THR . . . . . . . . . . . . . 82.3 p -121.95 146.61 46.97 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.234 -0.916 . . . . 0.0 110.669 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 770' ' ' ILE . . . . . . . . . . . . . 21.3 mt -49.62 142.82 2.13 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 121.395 -0.816 . . . . 0.0 109.669 179.898 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 771' ' ' SER . . . . . 0.655 ' O ' ' HB2' ' A' ' 772' ' ' ALA . 22.0 p -124.56 -5.45 7.62 Favored 'General case' 0 C--N 1.299 -1.597 0 O-C-N 121.092 -1.005 . . . . 0.0 110.724 -179.903 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 772' ' ' ALA . . . . . 0.655 ' HB2' ' O ' ' A' ' 771' ' ' SER . . . 174.62 146.62 0.07 Allowed 'General case' 0 N--CA 1.492 1.653 0 C-N-CA 118.879 -1.128 . . . . 0.0 111.949 -179.986 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 773' ' ' ILE . . . . . . . . . . . . . 11.7 mm -108.16 149.0 11.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 179.819 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 774' ' ' LYS . . . . . . . . . . . . . 66.8 mttt -132.35 -18.45 2.54 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.509 -1.369 . . . . 0.0 112.206 -179.801 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 775' ' ' PHE . . . . . 0.739 ' O ' ' HB2' ' A' ' 776' ' ' ALA . 43.2 t80 -140.09 168.69 19.23 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.58 -1.325 . . . . 0.0 110.999 -179.904 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 776' ' ' ALA . . . . . 0.739 ' HB2' ' O ' ' A' ' 775' ' ' PHE . . . 164.15 125.87 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.818 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 -179.991 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 777' ' ' SER . . . . . 0.572 ' HA ' ' CE1' ' A' ' 794' ' ' HIS . 0.5 OUTLIER -148.94 106.21 3.62 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.956 -1.09 . . . . 0.0 111.522 -179.906 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 778' ' ' PHE . . . . . 0.411 ' CE2' ' SD ' ' A' ' 830' ' ' MET . 89.6 t80 -85.76 123.94 31.71 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.125 -0.984 . . . . 0.0 109.539 179.908 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 779' ' ' GLY . . . . . 0.523 ' O ' ' HB2' ' A' ' 832' ' ' ARG . . . 138.15 -107.07 0.55 Allowed Glycine 0 N--CA 1.493 2.473 0 C-N-CA 119.496 -1.335 . . . . 0.0 109.99 179.998 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 780' ' ' THR . . . . . . . . . . . . . 35.1 p -133.19 88.16 36.79 Favored Pre-proline 0 N--CA 1.494 1.768 0 O-C-N 120.85 -1.382 . . . . 0.0 111.028 -179.893 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 781' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_endo -83.35 177.72 6.26 Favored 'Trans proline' 0 C--N 1.308 -1.565 0 O-C-N 123.938 1.494 . . . . 0.0 110.534 179.878 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 782' ' ' LEU . . . . . 0.545 ' CD1' ' HA2' ' A' ' 791' ' ' GLY . 1.0 OUTLIER -135.93 174.74 10.28 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.202 -0.936 . . . . 0.0 110.257 179.951 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 783' ' ' GLY . . . . . . . . . . . . . . . 59.34 -166.07 9.08 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.864 -1.295 . . . . 0.0 109.864 179.935 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 784' ' ' THR . . . . . 0.564 HG23 ' N ' ' A' ' 785' ' ' CYS . 9.3 t -133.3 -128.02 0.17 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.373 -1.075 . . . . 0.0 109.904 179.934 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 785' ' ' CYS . . . . . 0.564 ' N ' HG23 ' A' ' 784' ' ' THR . 1.9 t -92.84 96.58 10.22 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 120.752 -1.218 . . . . 0.0 110.206 -179.967 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 786' ' ' GLY . . . . . . . . . . . . . . . 139.72 -24.68 2.74 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.383 -1.487 . . . . 0.0 109.383 179.982 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 787' ' ' THR . . . . . 0.732 HG22 ' O ' ' A' ' 787' ' ' THR . 99.8 m -139.72 37.95 2.01 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.18 -1.188 . . . . 0.0 110.142 179.964 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 788' ' ' PHE . . . . . 0.572 ' HB3' ' CE2' ' A' ' 775' ' ' PHE . 0.3 OUTLIER -65.75 116.97 7.5 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.304 -0.873 . . . . 0.0 109.899 179.92 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 789' ' ' GLN . . . . . . . . . . . . . 5.3 tm0? -119.11 153.04 35.45 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.252 -0.905 . . . . 0.0 110.261 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 790' ' ' GLN . . . . . . . . . . . . . 4.1 tt0 -73.05 120.74 19.1 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.293 -0.879 . . . . 0.0 110.12 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 791' ' ' GLY . . . . . 0.545 ' HA2' ' CD1' ' A' ' 782' ' ' LEU . . . -74.21 -116.0 0.08 OUTLIER Glycine 0 N--CA 1.494 2.509 0 N-CA-C 109.867 -1.293 . . . . 0.0 109.867 -179.942 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 792' ' ' GLU . . . . . . . . . . . . . 19.8 mt-10 -118.99 -23.82 6.75 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.225 -1.162 . . . . 0.0 110.35 -179.989 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 793' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -122.88 121.85 37.19 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.165 -0.96 . . . . 0.0 110.507 -179.936 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 794' ' ' HIS . . . . . 0.572 ' CE1' ' HA ' ' A' ' 777' ' ' SER . 24.2 t60 -149.06 149.35 30.95 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.292 -0.88 . . . . 0.0 109.789 -180.0 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 795' ' ' SER . . . . . 0.473 ' O ' ' NE2' ' A' ' 794' ' ' HIS . 17.1 t -91.94 149.2 21.67 Favored 'General case' 0 C--N 1.299 -1.626 0 O-C-N 121.276 -0.89 . . . . 0.0 109.618 179.889 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 796' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -87.89 15.42 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 O-C-N 121.174 -0.953 . . . . 0.0 110.017 -179.918 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 797' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 -125.59 27.02 6.59 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.387 -0.82 . . . . 0.0 109.714 179.927 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 798' ' ' SER . . . . . 0.567 ' HB3' ' HB3' ' A' ' 776' ' ' ALA . 0.5 OUTLIER -68.25 -35.03 77.28 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.479 -0.763 . . . . 0.0 111.005 179.933 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 799' ' ' ASN . . . . . 0.511 ' N ' ' OD1' ' A' ' 799' ' ' ASN . 1.3 m120 -100.62 11.78 38.77 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.104 -0.997 . . . . 0.0 111.175 -179.859 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 800' ' ' SER . . . . . . . . . . . . . 75.0 p -93.12 -27.38 16.97 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 120.997 -1.065 . . . . 0.0 110.609 -179.925 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 801' ' ' VAL . . . . . . . . . . . . . 40.2 t -88.99 -19.67 7.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.278 -0.889 . . . . 0.0 110.467 -179.925 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 802' ' ' LEU . . . . . 0.504 ' O ' ' HB2' ' A' ' 806' ' ' CYS . 4.1 mm? -79.48 -48.8 13.28 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.187 -0.945 . . . . 0.0 110.837 179.986 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 803' ' ' GLU . . . . . . . . . . . . . 17.5 mt-10 -64.0 -18.71 64.57 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.001 -1.062 . . . . 0.0 111.036 -179.918 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 804' ' ' ARG . . . . . . . . . . . . . 51.9 ttp180 -92.46 -22.14 19.78 Favored 'General case' 0 C--N 1.297 -1.692 0 O-C-N 121.073 -1.017 . . . . 0.0 112.25 -179.844 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 805' ' ' LYS . . . . . 0.445 ' O ' ' SG ' ' A' ' 806' ' ' CYS . 5.8 tttm -140.12 54.96 1.63 Allowed 'General case' 0 N--CA 1.501 2.115 0 O-C-N 120.444 -1.41 . . . . 0.0 112.537 -179.856 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 806' ' ' CYS . . . . . 0.534 ' HA ' ' CB ' ' A' ' 812' ' ' CYS . 1.2 m -163.73 -50.68 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.801 0 O-C-N 120.842 -1.161 . . . . 0.0 110.319 179.722 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 807' ' ' ILE . . . . . . . . . . . . . 55.5 mt -61.62 129.47 24.6 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 O-C-N 121.112 -0.992 . . . . 0.0 110.156 179.905 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 808' ' ' GLY . . . . . 0.417 ' C ' ' HG ' ' A' ' 809' ' ' LEU . . . 104.76 1.86 42.89 Favored Glycine 0 N--CA 1.492 2.431 0 N-CA-C 109.616 -1.394 . . . . 0.0 109.616 179.957 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 809' ' ' LEU . . . . . 0.417 ' HG ' ' C ' ' A' ' 808' ' ' GLY . 4.2 mt -133.03 144.33 49.98 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.157 -1.202 . . . . 0.0 110.308 179.906 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 810' ' ' GLU . . . . . 0.471 ' OE2' ' O ' ' A' ' 764' ' ' CYS . 3.4 tm-20 -70.43 -20.56 62.9 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.219 -0.926 . . . . 0.0 109.653 180.0 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 811' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -156.47 121.59 4.69 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 179.907 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 812' ' ' CYS . . . . . 0.534 ' CB ' ' HA ' ' A' ' 806' ' ' CYS . 26.1 p -123.1 156.7 34.42 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 120.996 -1.065 . . . . 0.0 111.388 -179.972 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 813' ' ' VAL . . . . . 0.456 HG22 ' CD2' ' A' ' 761' ' ' HIS . 38.8 t -120.43 135.24 61.32 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.624 -0.672 . . . . 0.0 109.632 179.925 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 814' ' ' VAL . . . . . . . . . . . . . 48.2 t -112.41 153.09 14.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.095 -1.003 . . . . 0.0 110.551 -179.927 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 815' ' ' ALA . . . . . 0.584 ' HB3' ' OD1' ' A' ' 820' ' ' ASN . . . -104.49 118.37 36.43 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.27 -0.893 . . . . 0.0 109.893 179.985 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 816' ' ' ILE . . . . . 1.096 HD13 HG21 ' A' ' 833' ' ' VAL . 25.1 mt -85.25 108.41 17.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.18 -0.95 . . . . 0.0 110.489 -179.945 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 817' ' ' SER . . . . . . . . . . . . . 44.5 p -157.59 165.87 17.79 Favored Pre-proline 0 N--CA 1.494 1.75 0 O-C-N 121.366 -0.834 . . . . 0.0 109.978 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 818' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_endo -79.44 9.9 3.25 Favored 'Trans proline' 0 C--N 1.305 -1.728 0 O-C-N 123.885 1.466 . . . . 0.0 111.037 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 819' ' ' SER . . . . . . . . . . . . . 27.5 t -131.89 12.18 4.77 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.061 -1.025 . . . . 0.0 110.305 -179.932 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 820' ' ' ASN . . . . . 0.584 ' OD1' ' HB3' ' A' ' 815' ' ' ALA . 0.2 OUTLIER -114.12 -2.7 13.38 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.266 -0.897 . . . . 0.0 110.052 179.945 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 821' ' ' PHE . . . . . . . . . . . . . 8.1 m-85 -112.38 -79.46 0.58 Allowed 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.324 -0.86 . . . . 0.0 110.238 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 822' ' ' GLY . . . . . . . . . . . . . . . -171.22 54.2 0.18 Allowed Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.619 -1.392 . . . . 0.0 109.619 -179.949 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 823' ' ' GLY . . . . . . . . . . . . . . . 78.38 176.61 47.22 Favored Glycine 0 N--CA 1.492 2.399 0 N-CA-C 109.727 -1.349 . . . . 0.0 109.727 179.936 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 824' ' ' ASP . . . . . . . . . . . . . 15.7 p-10 -70.89 117.47 56.31 Favored Pre-proline 0 N--CA 1.494 1.728 0 O-C-N 121.243 -1.151 . . . . 0.0 110.216 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 825' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -79.59 -65.24 0.02 OUTLIER 'Trans proline' 0 C--N 1.308 -1.565 0 O-C-N 123.97 1.511 . . . . 0.0 110.946 -179.922 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 826' ' ' CYS . . . . . 0.462 ' HB3' ' HB ' ' A' ' 829' ' ' VAL . 22.8 m -97.44 153.64 38.29 Favored Pre-proline 0 N--CA 1.498 1.951 0 O-C-N 121.11 -0.993 . . . . 0.0 110.952 -179.937 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 827' ' ' PRO . . . . . 0.891 ' O ' HG23 ' A' ' 829' ' ' VAL . 50.1 Cg_endo -78.99 95.96 1.08 Allowed 'Trans proline' 0 C--N 1.313 -1.303 0 O-C-N 124.07 1.563 . . . . 0.0 110.673 179.963 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 828' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER 52.41 18.67 0.97 Allowed 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.152 -0.968 . . . . 0.0 110.404 179.923 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 829' ' ' VAL . . . . . 0.891 HG23 ' O ' ' A' ' 827' ' ' PRO . 66.7 t -119.41 80.86 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.198 -0.939 . . . . 0.0 110.223 179.953 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 830' ' ' MET . . . . . 0.464 ' CB ' ' HA2' ' A' ' 779' ' ' GLY . 0.0 OUTLIER -178.43 128.65 0.12 Allowed 'General case' 0 C--N 1.304 -1.381 0 O-C-N 121.131 -0.981 . . . . 0.0 110.777 -179.902 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 831' ' ' LYS . . . . . 0.46 ' O ' ' CG ' ' A' ' 832' ' ' ARG . 2.9 tttm -170.58 57.05 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.391 -0.818 . . . . 0.0 110.093 179.906 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 832' ' ' ARG . . . . . 0.523 ' HB2' ' O ' ' A' ' 779' ' ' GLY . 0.5 OUTLIER -167.62 125.32 1.21 Allowed 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.466 -0.771 . . . . 0.0 109.392 -179.996 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 833' ' ' VAL . . . . . 1.096 HG21 HD13 ' A' ' 816' ' ' ILE . 58.8 t -112.47 103.26 15.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.045 -1.035 . . . . 0.0 111.055 -179.959 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 834' ' ' ALA . . . . . 0.572 ' HB1' ' CZ ' ' A' ' 788' ' ' PHE . . . -111.16 122.02 46.79 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.471 -0.768 . . . . 0.0 109.099 179.928 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 835' ' ' VAL . . . . . 0.404 ' O ' ' HA ' ' A' ' 732' ' ' CYS . 34.7 t -139.3 143.24 31.6 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 O-C-N 120.828 -1.17 . . . . 0.0 111.648 -179.934 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 836' ' ' GLU . . . . . 0.481 ' HB2' ' HB3' ' A' ' 775' ' ' PHE . 1.3 mt-10 -115.5 160.24 20.18 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 179.807 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 837' ' ' ALA . . . . . . . . . . . . . . . -154.64 156.8 37.13 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 120.612 -1.305 . . . . 0.0 111.258 -179.944 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 838' ' ' VAL . . . . . . . . . . . . . 22.0 t -109.24 137.2 42.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.505 -0.747 . . . . 0.0 109.965 179.926 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 839' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -128.32 133.2 48.66 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.142 -0.974 . . . . 0.0 110.132 179.988 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 840' ' ' SER . . . . . . . . . . . . . 24.8 t -159.83 -177.37 6.29 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.281 -0.887 . . . . 0.0 109.939 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 841' ' ' THR . . . . . 0.546 ' O ' ' HB3' ' A' ' 842' ' ' ALA . 67.1 p -73.86 163.27 28.15 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.149 -0.97 . . . . 0.0 109.926 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 842' ' ' ALA . . . . . 0.546 ' HB3' ' O ' ' A' ' 841' ' ' THR . . . 60.43 147.7 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.193 -0.942 . . . . 0.0 110.298 -179.95 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 843' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 1.735 0 CA-C-O 118.028 -0.987 . . . . 0.0 110.28 -179.981 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 726' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.631 0 CA-C-O 121.26 0.552 . . . . 0.0 110.255 . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 727' ' ' THR . . . . . . . . . . . . . 94.5 m -109.59 153.88 23.55 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.188 -0.945 . . . . 0.0 110.176 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 728' ' ' VAL . . . . . 1.002 HG23 ' O ' ' A' ' 839' ' ' CYS . 7.6 p -159.12 139.23 3.8 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.2 -0.938 . . . . 0.0 110.141 -179.963 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 729' ' ' SER . . . . . 0.454 ' O ' HG13 ' A' ' 731' ' ' VAL . 0.5 OUTLIER -107.47 90.5 3.32 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.263 -0.898 . . . . 0.0 110.343 179.928 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 730' ' ' GLY . . . . . 0.688 ' O ' HG13 ' A' ' 731' ' ' VAL . . . -44.4 153.25 0.46 Allowed Glycine 0 N--CA 1.492 2.417 0 N-CA-C 109.298 -1.521 . . . . 0.0 109.298 179.996 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 731' ' ' VAL . . . . . 0.688 HG13 ' O ' ' A' ' 730' ' ' GLY . 2.4 m -158.48 120.42 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 121.105 -1.233 . . . . 0.0 110.767 179.937 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 732' ' ' CYS . . . . . . . . . . . . . 26.8 p -116.04 130.86 57.0 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.448 -0.783 . . . . 0.0 109.297 179.902 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 733' ' ' ALA . . . . . . . . . . . . . . . -107.77 160.55 15.64 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.106 -0.996 . . . . 0.0 110.609 -179.878 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 734' ' ' ASP . . . . . 0.526 ' OD2' ' CZ ' ' A' ' 832' ' ' ARG . 0.9 OUTLIER -164.36 105.36 0.86 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.414 -0.804 . . . . 0.0 109.444 179.941 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 735' ' ' VAL . . . . . 0.442 ' O ' ' CG ' ' A' ' 832' ' ' ARG . 37.4 t -116.04 163.39 13.31 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 121.089 -1.007 . . . . 0.0 110.715 -179.939 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 736' ' ' SER . . . . . 0.411 ' N ' HG12 ' A' ' 735' ' ' VAL . 22.5 p -99.16 158.78 15.45 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.425 -0.797 . . . . 0.0 110.029 179.954 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 737' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -77.04 170.06 17.21 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.216 -0.927 . . . . 0.0 110.457 179.944 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 738' ' ' TYR . . . . . 0.577 ' CZ ' ' HG3' ' A' ' 740' ' ' PRO . 2.8 t80 -143.88 117.37 9.14 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.412 -0.805 . . . . 0.0 109.354 179.97 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 739' ' ' HIS . . . . . 0.519 ' NE2' ' CD1' ' A' ' 742' ' ' ILE . 19.7 t-80 -151.15 92.6 3.76 Favored Pre-proline 0 N--CA 1.496 1.854 0 O-C-N 121.099 -1.0 . . . . 0.0 110.859 -179.904 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 740' ' ' PRO . . . . . 0.577 ' HG3' ' CZ ' ' A' ' 738' ' ' TYR . 50.4 Cg_endo -88.42 46.56 1.13 Allowed 'Trans proline' 0 C--N 1.307 -1.626 0 O-C-N 123.945 1.497 . . . . 0.0 110.084 179.871 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 741' ' ' ASN . . . . . 0.487 ' CB ' ' O ' ' A' ' 740' ' ' PRO . 0.2 OUTLIER 68.0 115.92 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.175 -0.953 . . . . 0.0 109.889 -179.929 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 742' ' ' ILE . . . . . 0.561 ' HA ' ' CE1' ' A' ' 755' ' ' PHE . 96.9 mt -91.59 167.62 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 O-C-N 121.149 -0.969 . . . . 0.0 110.895 179.997 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 743' ' ' LYS . . . . . 0.561 ' N ' HG22 ' A' ' 742' ' ' ILE . 29.8 tttt -167.41 160.09 12.99 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.604 -0.685 . . . . 0.0 109.521 -179.978 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 744' ' ' ASN . . . . . 0.455 ' N ' ' HG2' ' A' ' 743' ' ' LYS . 6.2 m-20 45.09 76.05 0.1 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.106 -0.996 . . . . 0.0 109.945 -179.977 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 745' ' ' TRP . . . . . 0.467 ' C ' ' CD1' ' A' ' 745' ' ' TRP . 8.5 t90 -84.27 -70.65 0.56 Allowed 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.201 -0.937 . . . . 0.0 110.175 -179.987 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 746' ' ' GLN . . . . . . . . . . . . . 7.1 tp60 -125.54 78.39 1.73 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.344 -0.847 . . . . 0.0 110.377 -179.956 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 747' ' ' ILE . . . . . 0.438 ' O ' ' CB ' ' A' ' 748' ' ' GLU . 38.1 mm -104.49 150.26 7.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.18 -0.95 . . . . 0.0 109.827 179.922 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 748' ' ' GLU . . . . . 0.549 ' HB3' ' CD1' ' A' ' 750' ' ' TYR . 0.3 OUTLIER 66.09 -142.15 0.18 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.188 -0.945 . . . . 0.0 110.032 179.995 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 749' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -112.23 -36.11 5.42 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.07 -1.019 . . . . 0.0 110.71 -179.986 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 750' ' ' TYR . . . . . 0.569 ' CG ' ' N ' ' A' ' 751' ' ' GLY . 32.0 p90 -59.26 -44.68 92.4 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.177 -0.952 . . . . 0.0 110.787 179.999 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 751' ' ' GLY . . . . . 0.569 ' N ' ' CG ' ' A' ' 750' ' ' TYR . . . 77.75 -78.99 1.45 Allowed Glycine 0 N--CA 1.497 2.756 0 N-CA-C 109.665 -1.374 . . . . 0.0 109.665 -179.97 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 752' ' ' GLU . . . . . 0.558 ' HB2' ' CD2' ' A' ' 750' ' ' TYR . 2.6 tt0 74.59 72.91 0.22 Allowed Pre-proline 0 N--CA 1.505 2.28 0 O-C-N 121.406 -1.055 . . . . 0.0 111.055 179.905 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 753' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_endo -83.71 58.01 5.78 Favored 'Trans proline' 0 C--N 1.308 -1.555 0 O-C-N 124.025 1.539 . . . . 0.0 109.622 179.923 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 754' ' ' GLU . . . . . 0.461 ' HA ' ' OE1' ' A' ' 754' ' ' GLU . 0.0 OUTLIER -83.92 -22.66 31.47 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.305 -0.872 . . . . 0.0 111.02 -179.893 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 755' ' ' PHE . . . . . 0.561 ' CE1' ' HA ' ' A' ' 742' ' ' ILE . 0.2 OUTLIER -54.5 121.0 7.44 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.136 -0.977 . . . . 0.0 110.741 -179.886 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 756' ' ' HIS . . . . . . . . . . . . . 1.2 t-160 -135.97 -166.96 1.95 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.35 -0.844 . . . . 0.0 109.858 179.966 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 757' ' ' THR . . . . . 0.47 ' OG1' ' O ' ' A' ' 816' ' ' ILE . 66.9 p -136.25 -169.04 2.35 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.174 -0.954 . . . . 0.0 110.593 -179.924 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 758' ' ' ALA . . . . . . . . . . . . . . . -55.85 176.45 0.07 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.412 -0.805 . . . . 0.0 110.052 179.944 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 759' ' ' LYS . . . . . 0.414 ' HG2' ' HA ' ' A' ' 815' ' ' ALA . 9.1 mttp -139.14 167.47 21.98 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.231 -0.918 . . . . 0.0 110.357 179.978 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 760' ' ' VAL . . . . . 0.409 ' HA ' HG21 ' A' ' 735' ' ' VAL . 5.5 t -105.52 162.49 4.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.372 -0.83 . . . . 0.0 109.392 179.919 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 761' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -140.35 105.93 5.11 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 120.846 -1.159 . . . . 0.0 111.261 -179.867 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 762' ' ' LEU . . . . . 0.529 ' HB2' ' HB3' ' A' ' 812' ' ' CYS . 0.5 OUTLIER -110.64 103.23 11.78 Favored 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 179.827 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 763' ' ' LYS . . . . . . . . . . . . . 4.4 ttpt -110.6 135.49 51.15 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.202 -0.936 . . . . 0.0 111.46 -179.812 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 764' ' ' CYS . . . . . 0.483 ' HB2' ' O ' ' A' ' 810' ' ' GLU . 1.3 m -126.63 139.89 52.83 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.533 -0.73 . . . . 0.0 109.568 179.856 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 765' ' ' ALA . . . . . 0.445 ' O ' ' O ' ' A' ' 764' ' ' CYS . . . -39.72 161.16 0.09 OUTLIER Pre-proline 0 N--CA 1.496 1.843 0 O-C-N 121.359 -0.838 . . . . 0.0 110.604 -179.98 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 766' ' ' PRO . . . . . 0.404 ' HD2' ' HB1' ' A' ' 765' ' ' ALA . 43.4 Cg_endo -70.78 113.72 3.63 Favored 'Trans proline' 0 C--N 1.306 -1.706 0 O-C-N 124.121 1.59 . . . . 0.0 110.082 -179.93 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 767' ' ' GLY . . . . . . . . . . . . . . . 118.04 -26.01 8.09 Favored Glycine 0 N--CA 1.488 2.162 0 N-CA-C 108.904 -1.679 . . . . 0.0 108.904 -179.896 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 768' ' ' GLN . . . . . 0.461 ' HA ' ' HA ' ' A' ' 841' ' ' THR . 1.3 tt0 -90.55 119.65 30.99 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.428 -1.042 . . . . 0.0 109.838 179.93 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 769' ' ' THR . . . . . . . . . . . . . 9.4 p -112.22 147.21 36.71 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.227 -0.921 . . . . 0.0 110.474 -179.964 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 770' ' ' ILE . . . . . 0.565 HD12 ' O ' ' A' ' 809' ' ' LEU . 3.5 mp -65.88 145.37 13.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.252 -0.905 . . . . 0.0 109.292 179.946 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 771' ' ' SER . . . . . . . . . . . . . 36.8 p -136.33 -5.45 2.06 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 120.955 -1.091 . . . . 0.0 111.6 -179.923 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 772' ' ' ALA . . . . . . . . . . . . . . . -171.24 148.02 2.59 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 120.608 -1.307 . . . . 0.0 111.941 -179.999 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 773' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -120.48 132.27 70.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 N-CA-C 108.482 -0.932 . . . . 0.0 108.482 179.829 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 774' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -103.4 -34.75 8.62 Favored 'General case' 0 N--CA 1.504 2.239 0 O-C-N 120.995 -1.066 . . . . 0.0 110.342 -179.918 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 775' ' ' PHE . . . . . 0.585 ' O ' ' HB2' ' A' ' 776' ' ' ALA . 52.2 t80 -126.15 152.7 45.61 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 120.925 -1.11 . . . . 0.0 110.15 179.92 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 776' ' ' ALA . . . . . 0.939 ' HB3' ' HB3' ' A' ' 799' ' ' ASN . . . 175.69 105.9 0.02 OUTLIER 'General case' 0 C--N 1.3 -1.564 0 O-C-N 121.425 -0.797 . . . . 0.0 109.664 -179.969 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 777' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -137.6 137.84 38.91 Favored 'General case' 0 C--N 1.299 -1.623 0 O-C-N 121.387 -0.82 . . . . 0.0 109.885 -179.975 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 778' ' ' PHE . . . . . 0.432 ' CD2' HG22 ' A' ' 833' ' ' VAL . 65.3 t80 -112.0 98.58 7.45 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.222 -0.924 . . . . 0.0 110.241 -179.964 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 779' ' ' GLY . . . . . 0.455 ' O ' ' HA ' ' A' ' 831' ' ' LYS . . . 167.85 -93.5 0.11 Allowed Glycine 0 N--CA 1.489 2.197 0 N-CA-C 109.419 -1.472 . . . . 0.0 109.419 179.979 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 780' ' ' THR . . . . . . . . . . . . . 60.6 p -141.11 81.67 15.65 Favored Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 121.273 -1.134 . . . . 0.0 110.253 179.945 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 781' ' ' PRO . . . . . 0.446 ' O ' HD23 ' A' ' 782' ' ' LEU . 44.7 Cg_endo -72.06 154.63 57.57 Favored 'Trans proline' 0 C--N 1.303 -1.818 0 O-C-N 124.02 1.537 . . . . 0.0 110.287 -179.966 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 782' ' ' LEU . . . . . 0.446 HD23 ' O ' ' A' ' 781' ' ' PRO . 21.4 mt -119.59 116.61 26.38 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.285 -0.884 . . . . 0.0 109.966 179.952 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 783' ' ' GLY . . . . . . . . . . . . . . . 111.5 168.21 18.52 Favored Glycine 0 N--CA 1.488 2.114 0 N-CA-C 109.345 -1.502 . . . . 0.0 109.345 -179.903 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 784' ' ' THR . . . . . 0.748 ' O ' HG23 ' A' ' 784' ' ' THR . 14.1 t -152.79 109.22 3.41 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.213 -1.169 . . . . 0.0 110.24 -179.995 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 785' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER 46.88 80.84 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.362 -0.836 . . . . 0.0 110.736 179.964 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 786' ' ' GLY . . . . . . . . . . . . . . . 135.62 -20.58 3.67 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.745 -1.342 . . . . 0.0 109.745 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 787' ' ' THR . . . . . . . . . . . . . 1.9 m -154.86 44.93 0.51 Allowed 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.059 -1.259 . . . . 0.0 110.591 -179.867 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 788' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -69.25 138.99 54.42 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.088 -1.008 . . . . 0.0 109.919 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 789' ' ' GLN . . . . . . . . . . . . . 37.2 tt0 -163.37 134.0 4.55 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.24 -0.913 . . . . 0.0 110.116 179.999 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 790' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -46.35 157.47 0.13 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.386 -0.821 . . . . 0.0 110.236 179.954 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 791' ' ' GLY . . . . . . . . . . . . . . . -113.87 -139.6 7.26 Favored Glycine 0 N--CA 1.489 2.184 0 N-CA-C 109.516 -1.434 . . . . 0.0 109.516 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 792' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -106.62 -30.86 8.75 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.203 -1.175 . . . . 0.0 110.199 179.946 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 793' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -104.3 107.45 18.38 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.271 -0.893 . . . . 0.0 110.191 -179.956 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 794' ' ' HIS . . . . . 0.45 ' CG ' ' N ' ' A' ' 795' ' ' SER . 46.1 t-80 -134.01 171.69 13.85 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.223 -0.923 . . . . 0.0 110.489 -179.988 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 795' ' ' SER . . . . . 0.45 ' N ' ' CG ' ' A' ' 794' ' ' HIS . 93.3 p -120.52 -137.37 0.33 Allowed 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.336 -0.852 . . . . 0.0 110.183 179.98 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 796' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -134.81 -29.72 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.96 0 O-C-N 121.108 -0.995 . . . . 0.0 110.806 179.996 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 797' ' ' ASN . . . . . 0.495 ' HA ' ' HB3' ' A' ' 800' ' ' SER . 1.4 m-20 -96.56 26.46 4.43 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.078 -1.014 . . . . 0.0 110.104 -179.973 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 798' ' ' SER . . . . . 0.511 ' HB2' ' O ' ' A' ' 776' ' ' ALA . 0.8 OUTLIER -51.71 -71.32 0.07 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.329 -0.857 . . . . 0.0 110.955 -179.968 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 799' ' ' ASN . . . . . 0.939 ' HB3' ' HB3' ' A' ' 776' ' ' ALA . 51.6 p30 -85.78 -15.59 41.57 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.293 -0.879 . . . . 0.0 111.101 -179.956 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 800' ' ' SER . . . . . 0.514 ' N ' ' OD1' ' A' ' 799' ' ' ASN . 12.9 t -59.18 -41.58 88.8 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.083 -1.01 . . . . 0.0 110.62 -179.966 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 801' ' ' VAL . . . . . . . . . . . . . 34.9 t -72.2 -26.46 24.89 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.14 -0.975 . . . . 0.0 110.505 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 802' ' ' LEU . . . . . 0.496 ' O ' ' HB2' ' A' ' 806' ' ' CYS . 3.4 mm? -74.2 -59.83 2.55 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.257 -0.902 . . . . 0.0 110.641 -179.944 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 803' ' ' GLU . . . . . 0.579 ' HG3' HD12 ' A' ' 807' ' ' ILE . 20.2 tt0 -54.06 -18.45 3.65 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.115 -0.991 . . . . 0.0 110.683 179.887 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 804' ' ' ARG . . . . . . . . . . . . . 56.3 ttt180 -90.08 -27.22 19.81 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.126 -0.984 . . . . 0.0 111.026 -179.914 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 805' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.76 43.97 2.83 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 120.968 -1.083 . . . . 0.0 110.968 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 806' ' ' CYS . . . . . 0.496 ' HB2' ' O ' ' A' ' 802' ' ' LEU . 0.2 OUTLIER -147.51 -72.3 0.21 Allowed 'General case' 0 N--CA 1.494 1.743 0 O-C-N 120.952 -1.092 . . . . 0.0 110.485 179.993 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 807' ' ' ILE . . . . . 0.579 HD12 ' HG3' ' A' ' 803' ' ' GLU . 31.9 mt -47.14 136.58 2.96 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 O-C-N 121.052 -1.03 . . . . 0.0 110.472 -179.955 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 808' ' ' GLY . . . . . 0.401 ' C ' ' HG ' ' A' ' 809' ' ' LEU . . . 93.23 5.52 63.7 Favored Glycine 0 N--CA 1.492 2.387 0 N-CA-C 110.229 -1.148 . . . . 0.0 110.229 179.967 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 809' ' ' LEU . . . . . 0.565 ' O ' HD12 ' A' ' 770' ' ' ILE . 41.5 mt -137.62 135.26 36.42 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.039 -1.271 . . . . 0.0 110.612 -179.987 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 810' ' ' GLU . . . . . 0.483 ' O ' ' HB2' ' A' ' 764' ' ' CYS . 57.3 mm-40 -64.45 -34.16 77.56 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.27 -0.894 . . . . 0.0 108.792 179.94 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 811' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -111.37 165.48 11.93 Favored 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 179.934 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 812' ' ' CYS . . . . . 0.529 ' HB3' ' HB2' ' A' ' 762' ' ' LEU . 49.5 t -159.66 102.28 1.51 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.861 -1.149 . . . . 0.0 110.608 -179.883 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 813' ' ' VAL . . . . . . . . . . . . . 11.9 p -115.8 136.82 51.44 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.178 -0.951 . . . . 0.0 109.981 179.964 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 814' ' ' VAL . . . . . . . . . . . . . 17.7 t -134.4 164.72 33.47 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 O-C-N 121.171 -0.956 . . . . 0.0 110.435 -179.939 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 815' ' ' ALA . . . . . 0.414 ' HA ' ' HG2' ' A' ' 759' ' ' LYS . . . -97.27 157.14 16.11 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.26 -0.9 . . . . 0.0 109.928 179.971 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 816' ' ' ILE . . . . . 0.791 HG23 ' CG2' ' A' ' 833' ' ' VAL . 20.3 mt -117.12 63.62 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.168 -0.957 . . . . 0.0 109.846 179.984 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 817' ' ' SER . . . . . 0.447 ' OG ' ' HB2' ' A' ' 820' ' ' ASN . 0.0 OUTLIER -116.15 165.98 13.56 Favored Pre-proline 0 N--CA 1.494 1.728 0 O-C-N 121.432 -0.792 . . . . 0.0 110.716 -179.875 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 818' ' ' PRO . . . . . 0.473 ' HB2' ' OD1' ' A' ' 824' ' ' ASP . 49.0 Cg_endo -76.92 -44.94 0.19 Allowed 'Trans proline' 0 C--N 1.307 -1.657 0 O-C-N 124.181 1.622 . . . . 0.0 110.573 -179.954 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 819' ' ' SER . . . . . . . . . . . . . 66.3 m -88.46 15.33 8.04 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.271 -0.893 . . . . 0.0 110.238 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 820' ' ' ASN . . . . . 0.447 ' HB2' ' OG ' ' A' ' 817' ' ' SER . 2.1 m120 -101.47 -16.51 16.8 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.225 -0.922 . . . . 0.0 110.449 179.985 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 821' ' ' PHE . . . . . . . . . . . . . 5.2 m-85 -93.32 -91.9 0.18 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.051 -1.031 . . . . 0.0 110.44 179.968 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 822' ' ' GLY . . . . . . . . . . . . . . . -152.97 14.93 0.68 Allowed Glycine 0 N--CA 1.492 2.39 0 C-N-CA 119.551 -1.309 . . . . 0.0 110.266 -179.991 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 823' ' ' GLY . . . . . . . . . . . . . . . 154.74 -170.66 33.07 Favored Glycine 0 N--CA 1.493 2.486 0 O-C-N 121.008 -1.289 . . . . 0.0 110.068 179.941 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 824' ' ' ASP . . . . . 0.473 ' OD1' ' HB2' ' A' ' 818' ' ' PRO . 0.2 OUTLIER -113.33 105.44 55.26 Favored Pre-proline 0 N--CA 1.494 1.73 0 O-C-N 121.379 -1.071 . . . . 0.0 110.14 -179.972 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 825' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -76.31 -64.9 0.02 OUTLIER 'Trans proline' 0 C--N 1.304 -1.775 0 O-C-N 123.994 1.523 . . . . 0.0 110.789 -179.963 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 826' ' ' CYS . . . . . . . . . . . . . 98.3 m -125.19 98.62 35.37 Favored Pre-proline 0 N--CA 1.495 1.794 0 O-C-N 121.119 -0.988 . . . . 0.0 110.414 179.953 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 827' ' ' PRO . . . . . 0.563 ' O ' HG23 ' A' ' 829' ' ' VAL . 50.7 Cg_endo -82.77 153.38 15.09 Favored 'Trans proline' 0 C--N 1.303 -1.847 0 O-C-N 124.062 1.559 . . . . 0.0 110.612 -179.983 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 828' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 62.26 17.85 9.66 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.304 -0.872 . . . . 0.0 110.521 179.995 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 829' ' ' VAL . . . . . 0.563 HG23 ' O ' ' A' ' 827' ' ' PRO . 66.4 t -127.5 111.21 24.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.225 -0.922 . . . . 0.0 110.283 179.981 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 830' ' ' MET . . . . . 0.431 ' C ' ' O ' ' A' ' 829' ' ' VAL . 2.9 mmt -42.41 125.49 3.21 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.278 -0.889 . . . . 0.0 109.672 -179.992 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 831' ' ' LYS . . . . . 0.455 ' HA ' ' O ' ' A' ' 779' ' ' GLY . 1.2 ptpt -128.85 133.62 48.03 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.047 -1.033 . . . . 0.0 111.151 -179.938 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 832' ' ' ARG . . . . . 0.526 ' CZ ' ' OD2' ' A' ' 734' ' ' ASP . 20.2 ttt180 -108.55 158.89 17.16 Favored 'General case' 0 N--CA 1.489 1.475 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 179.946 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 833' ' ' VAL . . . . . 0.791 ' CG2' HG23 ' A' ' 816' ' ' ILE . 8.3 t -111.85 126.68 69.26 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 120.976 -1.078 . . . . 0.0 111.133 -179.877 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 834' ' ' ALA . . . . . . . . . . . . . . . -131.08 134.15 46.34 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 179.924 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 835' ' ' VAL . . . . . . . . . . . . . 5.9 t -145.02 150.91 15.59 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 O-C-N 120.933 -1.105 . . . . 0.0 111.275 -179.919 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 836' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -127.13 110.82 13.31 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 179.9 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 837' ' ' ALA . . . . . . . . . . . . . . . -110.26 159.33 17.5 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.066 -1.021 . . . . 0.0 111.106 -179.848 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 838' ' ' VAL . . . . . . . . . . . . . 92.1 t -115.29 122.15 68.65 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.475 0 O-C-N 121.498 -0.751 . . . . 0.0 109.731 179.961 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 839' ' ' CYS . . . . . 1.002 ' O ' HG23 ' A' ' 728' ' ' VAL . 0.0 OUTLIER -108.95 122.56 47.48 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.247 -0.908 . . . . 0.0 110.532 -179.925 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 840' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -121.08 119.39 32.3 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.268 -0.895 . . . . 0.0 109.799 179.963 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 841' ' ' THR . . . . . 0.461 ' HA ' ' HA ' ' A' ' 768' ' ' GLN . 14.6 t -53.34 155.89 2.61 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.103 -0.998 . . . . 0.0 110.569 -179.927 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 842' ' ' ALA . . . . . . . . . . . . . . . -145.8 121.52 10.51 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.385 -0.822 . . . . 0.0 110.158 179.94 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 843' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.582 0 CA-C-O 117.954 -1.022 . . . . 0.0 110.262 179.964 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 726' ' ' ARG . . . . . . . . . . . . . 3.2 mmt85 . . . . . 0 N--CA 1.492 1.639 0 CA-C-O 121.23 0.538 . . . . 0.0 110.06 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 727' ' ' THR . . . . . . . . . . . . . 1.8 m -96.86 112.89 24.45 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.16 -0.962 . . . . 0.0 110.664 -179.961 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 728' ' ' VAL . . . . . 0.816 HG12 ' N ' ' A' ' 729' ' ' SER . 1.0 OUTLIER -96.36 -75.04 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.177 -0.952 . . . . 0.0 109.757 -179.969 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 729' ' ' SER . . . . . 0.816 ' N ' HG12 ' A' ' 728' ' ' VAL . 2.4 m -178.53 -163.59 0.07 Allowed 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.102 -0.999 . . . . 0.0 110.601 -179.984 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 730' ' ' GLY . . . . . . . . . . . . . . . -152.67 -166.27 14.14 Favored Glycine 0 N--CA 1.496 2.698 0 N-CA-C 109.381 -1.488 . . . . 0.0 109.381 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 731' ' ' VAL . . . . . 0.507 HG12 ' N ' ' A' ' 732' ' ' CYS . 73.7 t -140.33 165.95 20.34 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 O-C-N 121.064 -1.256 . . . . 0.0 110.508 179.978 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 732' ' ' CYS . . . . . 0.507 ' N ' HG12 ' A' ' 731' ' ' VAL . 82.1 m -111.8 156.99 21.1 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.32 -0.863 . . . . 0.0 110.094 179.999 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 733' ' ' ALA . . . . . 0.458 ' O ' ' HA ' ' A' ' 834' ' ' ALA . . . -141.68 106.72 4.95 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.144 -0.973 . . . . 0.0 110.439 -179.997 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 734' ' ' ASP . . . . . 0.449 ' N ' ' OD1' ' A' ' 734' ' ' ASP . 5.2 m-20 -118.16 124.52 48.18 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.372 -0.83 . . . . 0.0 109.944 -180.0 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 735' ' ' VAL . . . . . 0.981 HG21 HG22 ' A' ' 760' ' ' VAL . 51.5 t -125.79 166.91 20.99 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 O-C-N 121.197 -0.94 . . . . 0.0 110.181 179.985 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 736' ' ' SER . . . . . 0.507 ' N ' HG12 ' A' ' 735' ' ' VAL . 10.2 p -113.36 45.18 1.43 Allowed 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.248 -0.907 . . . . 0.0 110.573 -179.984 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 737' ' ' GLU . . . . . 0.472 ' OE1' ' HB3' ' A' ' 831' ' ' LYS . 2.1 tt0 36.03 -152.38 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.127 0 O-C-N 121.469 -0.77 . . . . 0.0 111.273 179.911 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 738' ' ' TYR . . . . . 0.641 ' HB3' ' HB2' ' A' ' 758' ' ' ALA . 56.7 t80 -168.77 -96.76 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.413 -0.804 . . . . 0.0 109.907 -179.898 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 739' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER 44.65 88.28 0.1 Allowed Pre-proline 0 N--CA 1.502 2.134 0 O-C-N 121.053 -1.029 . . . . 0.0 110.983 179.996 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 740' ' ' PRO . . . . . 0.61 ' HG3' ' CZ ' ' A' ' 738' ' ' TYR . 55.8 Cg_endo -92.23 55.48 0.68 Allowed 'Trans proline' 0 C--N 1.308 -1.596 0 O-C-N 124.021 1.538 . . . . 0.0 111.062 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 741' ' ' ASN . . . . . 0.48 ' O ' ' HB ' ' A' ' 742' ' ' ILE . 4.2 p-10 -162.34 -41.87 0.04 OUTLIER 'General case' 0 N--CA 1.497 1.884 0 O-C-N 120.636 -1.29 . . . . 0.0 111.411 -179.994 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 742' ' ' ILE . . . . . 0.582 HG22 ' N ' ' A' ' 743' ' ' LYS . 3.6 mp 55.49 173.37 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.009 -1.057 . . . . 0.0 109.443 -179.909 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 743' ' ' LYS . . . . . 0.582 ' N ' HG22 ' A' ' 742' ' ' ILE . 11.9 ttmm -87.75 149.75 24.01 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 120.961 -1.087 . . . . 0.0 110.821 -179.942 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 744' ' ' ASN . . . . . 0.454 ' HB2' ' O ' ' A' ' 743' ' ' LYS . 56.6 m-20 59.13 124.36 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.482 -0.761 . . . . 0.0 110.811 179.943 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 745' ' ' TRP . . . . . 0.418 ' CD1' ' O ' ' A' ' 744' ' ' ASN . 0.0 OUTLIER -173.23 -175.6 1.21 Allowed 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.456 -0.778 . . . . 0.0 110.203 179.978 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 746' ' ' GLN . . . . . 0.451 ' O ' ' HB ' ' A' ' 747' ' ' ILE . 7.3 mm100 -137.29 -162.56 1.31 Allowed 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.264 -0.898 . . . . 0.0 110.236 179.974 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 747' ' ' ILE . . . . . 0.451 ' HB ' ' O ' ' A' ' 746' ' ' GLN . 65.4 mt 57.38 92.7 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 121.146 -0.971 . . . . 0.0 110.339 -179.976 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 748' ' ' GLU . . . . . 0.444 ' C ' ' O ' ' A' ' 747' ' ' ILE . 0.2 OUTLIER 40.09 76.7 0.06 Allowed 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.443 -0.785 . . . . 0.0 110.262 -179.999 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 749' ' ' SER . . . . . . . . . . . . . 3.3 t -156.62 -77.03 0.09 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.208 -0.933 . . . . 0.0 110.275 -179.926 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 750' ' ' TYR . . . . . . . . . . . . . 17.8 m-85 45.51 90.78 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.216 -0.928 . . . . 0.0 110.223 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 751' ' ' GLY . . . . . 0.472 ' O ' ' HG3' ' A' ' 752' ' ' GLU . . . 82.48 133.98 1.95 Allowed Glycine 0 N--CA 1.492 2.406 0 N-CA-C 109.786 -1.326 . . . . 0.0 109.786 179.954 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 752' ' ' GLU . . . . . 0.472 ' HG3' ' O ' ' A' ' 751' ' ' GLY . 6.5 mt-10 -144.69 97.13 5.03 Favored Pre-proline 0 N--CA 1.495 1.785 0 O-C-N 121.32 -1.106 . . . . 0.0 110.028 179.952 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 753' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -74.89 -175.56 2.4 Favored 'Trans proline' 0 C--N 1.305 -1.742 0 O-C-N 124.05 1.553 . . . . 0.0 110.768 179.965 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 754' ' ' GLU . . . . . . . . . . . . . 2.4 tp10 -91.92 126.78 37.14 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.312 -0.868 . . . . 0.0 109.924 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 755' ' ' PHE . . . . . 0.59 ' O ' HG23 ' A' ' 757' ' ' THR . 18.2 p90 -143.29 -135.28 0.09 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.295 -0.878 . . . . 0.0 110.102 -179.979 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 756' ' ' HIS . . . . . 0.416 ' C ' ' O ' ' A' ' 755' ' ' PHE . 3.1 t-160 -42.68 124.78 3.14 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 120.86 -1.15 . . . . 0.0 110.505 179.978 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 757' ' ' THR . . . . . 0.59 HG23 ' O ' ' A' ' 755' ' ' PHE . 61.9 p -112.47 -148.93 0.44 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.399 -0.813 . . . . 0.0 109.858 179.925 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 758' ' ' ALA . . . . . 0.641 ' HB2' ' HB3' ' A' ' 738' ' ' TYR . . . -112.69 175.59 5.37 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.08 -1.012 . . . . 0.0 110.244 179.97 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 759' ' ' LYS . . . . . . . . . . . . . 11.4 mtmt -146.71 150.69 35.87 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.257 -0.902 . . . . 0.0 110.968 -179.899 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 760' ' ' VAL . . . . . 0.981 HG22 HG21 ' A' ' 735' ' ' VAL . 3.6 t -110.38 144.84 17.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.514 -0.741 . . . . 0.0 109.316 179.865 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 761' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -118.76 114.16 22.25 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.076 -1.015 . . . . 0.0 110.564 179.949 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 762' ' ' LEU . . . . . 0.489 ' HB2' ' HB3' ' A' ' 812' ' ' CYS . 0.4 OUTLIER -108.54 157.19 18.69 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.426 -0.796 . . . . 0.0 109.653 179.955 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 763' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -158.84 106.97 1.87 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.158 -0.964 . . . . 0.0 110.6 -179.976 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 764' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -88.21 166.54 14.29 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.364 -0.835 . . . . 0.0 109.915 -179.998 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 765' ' ' ALA . . . . . . . . . . . . . . . -63.55 154.24 80.32 Favored Pre-proline 0 N--CA 1.493 1.676 0 O-C-N 121.147 -0.971 . . . . 0.0 110.157 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 766' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -69.06 125.14 12.13 Favored 'Trans proline' 0 C--N 1.305 -1.735 0 O-C-N 124.016 1.535 . . . . 0.0 110.348 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 767' ' ' GLY . . . . . . . . . . . . . . . 108.69 -15.21 34.79 Favored Glycine 0 N--CA 1.489 2.21 0 N-CA-C 109.366 -1.493 . . . . 0.0 109.366 -179.963 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 768' ' ' GLN . . . . . 0.459 ' HB3' ' HB3' ' A' ' 839' ' ' CYS . 0.9 OUTLIER -114.32 140.72 48.39 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.338 -1.095 . . . . 0.0 110.236 179.96 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 769' ' ' THR . . . . . . . . . . . . . 69.7 p -121.48 150.4 41.63 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.295 -0.878 . . . . 0.0 110.393 -179.906 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 770' ' ' ILE . . . . . . . . . . . . . 16.9 mt -66.26 131.18 32.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.262 -0.899 . . . . 0.0 109.689 179.958 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 771' ' ' SER . . . . . 0.584 ' O ' ' HB2' ' A' ' 772' ' ' ALA . 80.2 p -129.1 -0.3 5.2 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.101 -0.999 . . . . 0.0 110.836 -179.993 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 772' ' ' ALA . . . . . 0.584 ' HB2' ' O ' ' A' ' 771' ' ' SER . . . 177.95 127.4 0.05 Allowed 'General case' 0 N--CA 1.495 1.792 0 O-C-N 120.824 -1.173 . . . . 0.0 111.576 179.998 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 773' ' ' ILE . . . . . . . . . . . . . 1.4 mp -87.17 123.44 39.98 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 N-CA-C 108.644 -0.873 . . . . 0.0 108.644 179.804 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 774' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -85.43 -31.56 22.8 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.027 -1.046 . . . . 0.0 111.88 -179.816 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 775' ' ' PHE . . . . . 0.644 ' CE2' ' CB ' ' A' ' 788' ' ' PHE . 90.6 t80 -147.61 171.82 14.99 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 120.645 -1.284 . . . . 0.0 111.325 -179.988 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 776' ' ' ALA . . . . . 0.512 ' HB1' ' O ' ' A' ' 798' ' ' SER . . . -179.52 136.7 0.12 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.544 -0.723 . . . . 0.0 109.546 -179.989 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 777' ' ' SER . . . . . 0.467 ' HB3' ' HB3' ' A' ' 781' ' ' PRO . 0.3 OUTLIER -148.44 127.04 12.43 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.119 -0.988 . . . . 0.0 110.373 -179.966 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 778' ' ' PHE . . . . . 0.614 ' CG ' ' O ' ' A' ' 778' ' ' PHE . 4.5 t80 -109.66 63.01 0.6 Allowed 'General case' 0 C--N 1.3 -1.555 0 CA-C-O 122.0 0.905 . . . . 0.0 108.957 179.935 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 779' ' ' GLY . . . . . . . . . . . . . . . -172.73 -111.02 0.25 Allowed Glycine 0 N--CA 1.488 2.152 0 N-CA-C 109.449 -1.461 . . . . 0.0 109.449 -179.945 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 780' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -115.14 81.39 7.91 Favored Pre-proline 0 N--CA 1.494 1.733 0 O-C-N 121.218 -1.166 . . . . 0.0 110.443 179.961 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 781' ' ' PRO . . . . . 0.467 ' HB3' ' HB3' ' A' ' 777' ' ' SER . 48.7 Cg_endo -77.93 143.87 21.04 Favored 'Trans proline' 0 C--N 1.304 -1.768 0 O-C-N 124.027 1.54 . . . . 0.0 109.872 179.961 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 782' ' ' LEU . . . . . 0.592 HD12 ' HA3' ' A' ' 791' ' ' GLY . 4.6 mt -137.22 148.39 46.45 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.109 -0.994 . . . . 0.0 110.373 -179.963 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 783' ' ' GLY . . . . . . . . . . . . . . . 138.26 -124.54 2.95 Favored Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.468 -1.453 . . . . 0.0 109.468 -179.984 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 784' ' ' THR . . . . . 0.425 HG22 ' N ' ' A' ' 785' ' ' CYS . 15.5 m -154.82 -75.42 0.11 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.217 -1.166 . . . . 0.0 110.393 -179.999 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 785' ' ' CYS . . . . . 0.425 ' N ' HG22 ' A' ' 784' ' ' THR . 1.0 OUTLIER -153.46 99.53 2.34 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.307 -0.87 . . . . 0.0 110.254 179.971 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 786' ' ' GLY . . . . . . . . . . . . . . . 98.04 -17.19 59.08 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.716 -1.354 . . . . 0.0 109.716 -179.95 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 787' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -113.5 23.76 12.86 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.213 -1.169 . . . . 0.0 110.275 179.958 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 788' ' ' PHE . . . . . 0.644 ' CB ' ' CE2' ' A' ' 775' ' ' PHE . 10.8 m-85 -50.66 170.79 0.03 OUTLIER 'General case' 0 C--N 1.299 -1.599 0 O-C-N 121.192 -0.942 . . . . 0.0 109.588 -179.967 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 789' ' ' GLN . . . . . 0.532 ' O ' ' N ' ' A' ' 791' ' ' GLY . 5.0 tp60 -164.8 118.52 1.3 Allowed 'General case' 0 C--N 1.298 -1.663 0 O-C-N 121.257 -0.902 . . . . 0.0 109.957 179.99 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 790' ' ' GLN . . . . . . . . . . . . . 1.8 pt20 -49.08 89.79 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.376 -0.828 . . . . 0.0 110.039 179.97 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 791' ' ' GLY . . . . . 0.592 ' HA3' HD12 ' A' ' 782' ' ' LEU . . . -43.4 -59.54 3.53 Favored Glycine 0 N--CA 1.488 2.152 0 N-CA-C 109.519 -1.433 . . . . 0.0 109.519 -179.987 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 792' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -152.56 -24.49 0.17 Allowed 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.273 -1.133 . . . . 0.0 111.419 179.973 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 793' ' ' CYS . . . . . . . . . . . . . 1.2 m -118.59 148.52 42.6 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 120.744 -1.222 . . . . 0.0 110.876 179.967 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 794' ' ' HIS . . . . . 0.492 ' NE2' ' HA ' ' A' ' 796' ' ' ILE . 5.4 t60 -169.41 146.76 3.51 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.488 -0.758 . . . . 0.0 109.808 179.917 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 795' ' ' SER . . . . . 0.474 ' O ' ' HB ' ' A' ' 796' ' ' ILE . 1.0 OUTLIER -90.06 1.2 56.6 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.194 -0.941 . . . . 0.0 111.338 -179.886 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 796' ' ' ILE . . . . . 0.715 HG22 ' O ' ' A' ' 796' ' ' ILE . 21.2 mm 55.95 16.85 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 O-C-N 120.985 -1.072 . . . . 0.0 110.068 -179.975 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 797' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -151.08 26.5 0.71 Allowed 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.277 -0.889 . . . . 0.0 109.859 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 798' ' ' SER . . . . . 0.512 ' O ' ' HB1' ' A' ' 776' ' ' ALA . 21.0 m -71.26 -14.91 62.39 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.323 -0.861 . . . . 0.0 111.395 -179.966 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 799' ' ' ASN . . . . . . . . . . . . . 24.4 p30 -105.0 -5.32 21.07 Favored 'General case' 0 N--CA 1.5 2.06 0 O-C-N 121.004 -1.06 . . . . 0.0 111.184 -179.928 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 800' ' ' SER . . . . . . . . . . . . . 49.7 m -82.83 -16.82 46.25 Favored 'General case' 0 C--N 1.293 -1.874 0 O-C-N 121.167 -0.958 . . . . 0.0 110.771 -179.972 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 801' ' ' VAL . . . . . . . . . . . . . 40.6 t -91.27 -19.67 7.02 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 O-C-N 121.15 -0.968 . . . . 0.0 111.178 -179.911 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 802' ' ' LEU . . . . . 0.591 HD11 HG21 ' A' ' 814' ' ' VAL . 3.9 mm? -88.55 -48.09 7.83 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.005 -1.059 . . . . 0.0 111.247 -179.837 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 803' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -56.85 -16.96 7.68 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.946 -1.096 . . . . 0.0 110.38 179.949 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 804' ' ' ARG . . . . . . . . . . . . . 2.9 ttt180 -91.16 -26.31 19.14 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.202 -0.936 . . . . 0.0 111.81 -179.908 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 805' ' ' LYS . . . . . . . . . . . . . 1.1 ttpt -140.84 60.57 1.52 Allowed 'General case' 0 N--CA 1.497 1.89 0 O-C-N 120.756 -1.215 . . . . 0.0 111.196 -179.87 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 806' ' ' CYS . . . . . . . . . . . . . 3.4 t -162.46 -25.68 0.04 OUTLIER 'General case' 0 N--CA 1.501 2.108 0 O-C-N 121.069 -1.019 . . . . 0.0 111.649 179.898 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 807' ' ' ILE . . . . . . . . . . . . . 30.1 mt -83.4 135.85 23.98 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 O-C-N 120.741 -1.224 . . . . 0.0 111.381 -179.97 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 808' ' ' GLY . . . . . 0.479 ' C ' ' HG ' ' A' ' 809' ' ' LEU . . . 109.92 -5.2 30.62 Favored Glycine 0 N--CA 1.492 2.394 0 C-N-CA 120.094 -1.05 . . . . 0.0 110.792 179.875 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 809' ' ' LEU . . . . . 0.479 ' HG ' ' C ' ' A' ' 808' ' ' GLY . 1.3 mp -136.17 143.46 44.45 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 120.792 -1.417 . . . . 0.0 110.688 -179.92 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 810' ' ' GLU . . . . . 0.522 ' HG3' ' N ' ' A' ' 811' ' ' ARG . 0.0 OUTLIER -70.27 -21.56 62.95 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.246 -0.909 . . . . 0.0 108.709 179.866 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 811' ' ' ARG . . . . . 0.522 ' N ' ' HG3' ' A' ' 810' ' ' GLU . 1.6 ttt180 -115.65 149.73 37.86 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.625 -0.672 . . . . 0.0 109.22 179.89 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 812' ' ' CYS . . . . . 0.489 ' HB3' ' HB2' ' A' ' 762' ' ' LEU . 9.7 t -134.54 146.56 49.78 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.954 -1.091 . . . . 0.0 110.921 -179.887 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 813' ' ' VAL . . . . . . . . . . . . . 46.0 t -135.63 104.56 4.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.536 -0.727 . . . . 0.0 109.172 179.955 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 814' ' ' VAL . . . . . 0.591 HG21 HD11 ' A' ' 802' ' ' LEU . 41.0 t -110.73 115.5 50.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.269 -0.894 . . . . 0.0 111.304 -179.881 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 815' ' ' ALA . . . . . . . . . . . . . . . -79.96 131.81 35.9 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.262 -0.899 . . . . 0.0 109.0 179.901 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 816' ' ' ILE . . . . . 0.861 ' CD1' HG21 ' A' ' 833' ' ' VAL . 59.5 mt -87.0 134.13 28.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.105 -0.997 . . . . 0.0 111.045 -179.887 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 817' ' ' SER . . . . . 0.469 ' OG ' ' HB2' ' A' ' 820' ' ' ASN . 2.9 p -164.9 171.22 5.65 Favored Pre-proline 0 N--CA 1.494 1.732 0 O-C-N 121.416 -0.802 . . . . 0.0 109.699 179.934 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 818' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -78.87 -29.9 3.16 Favored 'Trans proline' 0 C--N 1.306 -1.674 0 O-C-N 123.797 1.42 . . . . 0.0 110.374 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 819' ' ' SER . . . . . . . . . . . . . 46.5 m -87.24 7.71 27.27 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.273 -0.892 . . . . 0.0 110.338 -179.963 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 820' ' ' ASN . . . . . 0.469 ' HB2' ' OG ' ' A' ' 817' ' ' SER . 0.4 OUTLIER -105.64 -8.43 17.92 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.154 -0.966 . . . . 0.0 110.007 -179.97 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 821' ' ' PHE . . . . . . . . . . . . . 31.8 m-85 -125.61 -74.49 0.6 Allowed 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.237 -0.914 . . . . 0.0 110.334 179.961 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 822' ' ' GLY . . . . . . . . . . . . . . . -178.16 57.75 0.09 OUTLIER Glycine 0 N--CA 1.492 2.375 0 N-CA-C 109.454 -1.458 . . . . 0.0 109.454 -179.98 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 823' ' ' GLY . . . . . . . . . . . . . . . 64.05 -122.85 26.8 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 -179.983 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 824' ' ' ASP . . . . . . . . . . . . . 89.4 m-20 -132.31 130.77 22.04 Favored Pre-proline 0 N--CA 1.495 1.806 0 O-C-N 121.327 -1.102 . . . . 0.0 109.985 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 825' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -82.05 -89.95 0.0 OUTLIER 'Trans proline' 0 C--N 1.308 -1.592 0 O-C-N 123.903 1.475 . . . . 0.0 111.062 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 826' ' ' CYS . . . . . . . . . . . . . 17.7 p -111.21 124.88 31.7 Favored Pre-proline 0 N--CA 1.497 1.879 0 O-C-N 121.256 -0.902 . . . . 0.0 111.12 -179.901 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 827' ' ' PRO . . . . . 0.489 ' O ' ' HB2' ' A' ' 828' ' ' GLU . 49.6 Cg_endo -81.16 -174.03 2.06 Favored 'Trans proline' 0 C--N 1.305 -1.719 0 O-C-N 123.962 1.506 . . . . 0.0 109.562 179.777 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 828' ' ' GLU . . . . . 0.489 ' HB2' ' O ' ' A' ' 827' ' ' PRO . 3.7 mm-40 58.79 14.48 3.24 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.475 -0.765 . . . . 0.0 109.611 -179.941 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 829' ' ' VAL . . . . . 0.459 ' O ' ' O ' ' A' ' 830' ' ' MET . 74.9 t -130.58 129.99 64.65 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.332 0 O-C-N 121.575 -0.703 . . . . 0.0 109.388 -179.983 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 830' ' ' MET . . . . . 0.459 ' O ' ' O ' ' A' ' 829' ' ' VAL . 33.8 mmt -52.82 -170.19 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.271 -0.893 . . . . 0.0 110.202 -179.964 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 831' ' ' LYS . . . . . 0.472 ' HB3' ' OE1' ' A' ' 737' ' ' GLU . 9.4 mttp -147.43 149.58 32.99 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 120.94 -1.1 . . . . 0.0 110.702 -179.913 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 832' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -161.86 149.18 14.31 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.602 -0.686 . . . . 0.0 109.151 179.924 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 833' ' ' VAL . . . . . 0.861 HG21 ' CD1' ' A' ' 816' ' ' ILE . 70.2 t -111.87 107.47 23.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 120.911 -1.118 . . . . 0.0 111.375 -179.973 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 834' ' ' ALA . . . . . 0.458 ' HA ' ' O ' ' A' ' 733' ' ' ALA . . . -109.97 128.71 55.55 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.375 -0.828 . . . . 0.0 109.172 179.857 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 835' ' ' VAL . . . . . . . . . . . . . 3.0 t -138.08 145.56 28.46 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 O-C-N 120.808 -1.183 . . . . 0.0 111.232 -179.855 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 836' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -124.48 117.93 25.49 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 179.873 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 837' ' ' ALA . . . . . . . . . . . . . . . -107.94 155.57 20.17 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.156 -0.965 . . . . 0.0 111.233 -179.807 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 838' ' ' VAL . . . . . 0.483 ' HB ' ' O ' ' A' ' 772' ' ' ALA . 71.9 t -112.33 110.99 34.23 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.375 0 O-C-N 121.545 -0.722 . . . . 0.0 109.361 179.938 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 839' ' ' CYS . . . . . 0.459 ' HB3' ' HB3' ' A' ' 768' ' ' GLN . 1.2 m -105.44 108.93 20.71 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.123 -0.986 . . . . 0.0 110.216 -179.915 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 840' ' ' SER . . . . . 0.575 ' C ' HG23 ' A' ' 841' ' ' THR . 14.8 t -99.17 -89.21 0.32 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.315 -0.865 . . . . 0.0 110.25 179.994 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 841' ' ' THR . . . . . 0.575 HG23 ' C ' ' A' ' 840' ' ' SER . 62.9 p -154.29 -157.98 0.82 Allowed 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.194 -0.942 . . . . 0.0 110.578 -179.977 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 842' ' ' ALA . . . . . 0.429 ' C ' ' O ' ' A' ' 841' ' ' THR . . . -41.27 147.33 0.16 Allowed 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.407 -0.808 . . . . 0.0 110.549 -179.967 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 843' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.642 0 CA-C-O 118.018 -0.992 . . . . 0.0 110.138 -179.936 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 726' ' ' ARG . . . . . 0.442 ' HD2' ' HB ' ' A' ' 727' ' ' THR . 0.0 OUTLIER . . . . . 0 N--CA 1.496 1.854 0 CA-C-O 121.057 0.456 . . . . 0.0 110.495 . . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 727' ' ' THR . . . . . 0.442 ' HB ' ' HD2' ' A' ' 726' ' ' ARG . 27.7 m -132.65 103.16 5.99 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.142 -0.974 . . . . 0.0 109.441 -179.993 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 728' ' ' VAL . . . . . 0.693 ' O ' HG12 ' A' ' 728' ' ' VAL . 1.3 t -77.87 99.77 2.81 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.781 0 O-C-N 121.292 -0.88 . . . . 0.0 109.959 -179.951 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 729' ' ' SER . . . . . 0.478 ' HB2' ' O ' ' A' ' 728' ' ' VAL . 2.2 m 58.16 168.62 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.484 -0.76 . . . . 0.0 110.788 179.827 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 730' ' ' GLY . . . . . 0.486 ' C ' HG23 ' A' ' 731' ' ' VAL . . . -131.32 -161.35 10.18 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.065 -1.614 . . . . 0.0 109.065 179.938 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 731' ' ' VAL . . . . . 0.486 HG23 ' C ' ' A' ' 730' ' ' GLY . 4.8 t -150.58 137.39 13.0 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 121.149 -1.207 . . . . 0.0 110.324 179.989 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 732' ' ' CYS . . . . . . . . . . . . . 20.3 m -128.25 143.71 51.06 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.309 -0.869 . . . . 0.0 109.868 179.964 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 733' ' ' ALA . . . . . . . . . . . . . . . -148.38 105.06 3.57 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.989 -1.069 . . . . 0.0 110.735 -179.948 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 734' ' ' ASP . . . . . 0.47 ' OD1' ' O ' ' A' ' 734' ' ' ASP . 1.0 OUTLIER -110.39 104.01 12.73 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.352 -0.843 . . . . 0.0 109.979 179.924 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 735' ' ' VAL . . . . . 0.493 ' O ' ' HB ' ' A' ' 833' ' ' VAL . 77.0 t -129.68 123.33 56.95 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 121.125 -0.984 . . . . 0.0 110.243 -179.967 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 736' ' ' SER . . . . . 0.499 ' HA ' ' HA ' ' A' ' 832' ' ' ARG . 5.4 p -84.24 158.74 21.16 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.088 -1.007 . . . . 0.0 110.362 -179.959 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 737' ' ' GLU . . . . . 0.584 ' HB2' HG21 ' A' ' 816' ' ' ILE . 24.5 tt0 -86.74 143.55 27.49 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.271 -0.893 . . . . 0.0 109.992 179.981 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 738' ' ' TYR . . . . . 0.565 ' CE1' ' HD3' ' A' ' 740' ' ' PRO . 52.4 p90 -171.2 -158.32 0.14 Allowed 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.056 -1.028 . . . . 0.0 110.78 -179.943 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 739' ' ' HIS . . . . . . . . . . . . . 4.0 t-80 -145.89 101.36 4.23 Favored Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.595 -0.691 . . . . 0.0 109.155 179.933 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 740' ' ' PRO . . . . . 0.565 ' HD3' ' CE1' ' A' ' 738' ' ' TYR . 49.6 Cg_endo -78.96 25.22 0.57 Allowed 'Trans proline' 0 C--N 1.306 -1.7 0 O-C-N 124.024 1.539 . . . . 0.0 111.947 -179.887 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 741' ' ' ASN . . . . . 0.461 ' O ' ' O ' ' A' ' 740' ' ' PRO . 57.7 t-20 42.74 92.28 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.798 0 O-C-N 120.889 -1.132 . . . . 0.0 110.088 179.959 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 742' ' ' ILE . . . . . . . . . . . . . 3.8 mt -75.27 94.08 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.237 -0.914 . . . . 0.0 110.644 -179.922 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 743' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.08 -60.91 2.8 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.029 -1.045 . . . . 0.0 108.979 179.898 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 744' ' ' ASN . . . . . . . . . . . . . 45.1 m-80 -51.38 133.89 28.9 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.342 -0.849 . . . . 0.0 108.836 179.928 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 745' ' ' TRP . . . . . 0.534 ' CZ2' ' O ' ' A' ' 750' ' ' TYR . 0.1 OUTLIER -169.37 22.0 0.02 OUTLIER 'General case' 0 C--N 1.3 -1.585 0 O-C-N 120.91 -1.119 . . . . 0.0 111.228 -179.922 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 746' ' ' GLN . . . . . 0.477 ' O ' ' HB ' ' A' ' 747' ' ' ILE . 5.1 mm-40 -92.26 -148.28 0.23 Allowed 'General case' 0 C--N 1.298 -1.639 0 O-C-N 121.038 -1.039 . . . . 0.0 109.653 -179.95 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 747' ' ' ILE . . . . . 0.517 ' O ' ' CB ' ' A' ' 748' ' ' GLU . 2.6 mt 55.13 105.57 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.067 -1.021 . . . . 0.0 109.538 -179.957 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 748' ' ' GLU . . . . . 0.517 ' CB ' ' O ' ' A' ' 747' ' ' ILE . 0.1 OUTLIER 70.53 -140.76 0.06 Allowed 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.067 -1.021 . . . . 0.0 109.325 -179.873 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 749' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -145.44 120.63 10.16 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 120.8 -1.187 . . . . 0.0 110.463 179.974 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 750' ' ' TYR . . . . . 0.534 ' O ' ' CZ2' ' A' ' 745' ' ' TRP . 3.5 m-85 -117.84 97.56 5.9 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.297 -0.877 . . . . 0.0 109.996 179.968 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 751' ' ' GLY . . . . . . . . . . . . . . . -92.69 94.58 1.91 Allowed Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 -179.949 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 752' ' ' GLU . . . . . . . . . . . . . 6.7 tt0 -136.78 118.17 11.23 Favored Pre-proline 0 N--CA 1.493 1.706 0 O-C-N 121.298 -1.119 . . . . 0.0 109.878 179.98 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 753' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -72.61 -163.06 0.14 Allowed 'Trans proline' 0 C--N 1.308 -1.602 0 O-C-N 123.908 1.478 . . . . 0.0 110.659 -179.964 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 754' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -68.85 101.41 1.35 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.318 -0.864 . . . . 0.0 110.388 -179.936 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 755' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -128.86 86.68 2.47 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.238 -0.914 . . . . 0.0 110.271 -179.996 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 756' ' ' HIS . . . . . 0.517 ' CD2' ' O ' ' A' ' 756' ' ' HIS . 9.7 p-80 -59.32 104.47 0.26 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.223 -0.923 . . . . 0.0 110.173 179.97 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 757' ' ' THR . . . . . 0.442 ' N ' ' O ' ' A' ' 738' ' ' TYR . 60.9 p -147.96 121.65 9.24 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.153 -0.967 . . . . 0.0 110.246 -179.979 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 758' ' ' ALA . . . . . 0.407 ' HB2' ' CE2' ' A' ' 738' ' ' TYR . . . -111.9 157.93 20.06 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.295 -0.878 . . . . 0.0 110.238 179.955 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 759' ' ' LYS . . . . . . . . . . . . . 1.3 ttmt -113.51 155.0 26.15 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.338 -0.851 . . . . 0.0 109.928 -179.974 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 760' ' ' VAL . . . . . . . . . . . . . 16.8 t -109.06 136.87 43.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.246 -0.909 . . . . 0.0 109.729 179.926 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 761' ' ' HIS . . . . . . . . . . . . . 3.5 m80 -109.52 107.34 17.42 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.147 -0.97 . . . . 0.0 110.467 -179.984 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 762' ' ' LEU . . . . . . . . . . . . . 2.0 mt -109.54 148.13 31.77 Favored 'General case' 0 C--N 1.299 -1.607 0 O-C-N 121.65 -0.656 . . . . 0.0 109.502 179.944 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 763' ' ' LYS . . . . . . . . . . . . . 3.3 ttpt -158.39 121.46 3.83 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.131 -0.98 . . . . 0.0 110.091 179.997 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 764' ' ' CYS . . . . . 0.442 ' O ' ' C ' ' A' ' 765' ' ' ALA . 12.7 t -82.06 157.77 24.02 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.262 -0.899 . . . . 0.0 110.001 179.958 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 765' ' ' ALA . . . . . 0.442 ' C ' ' O ' ' A' ' 764' ' ' CYS . . . -41.29 162.36 0.12 Allowed Pre-proline 0 N--CA 1.495 1.799 0 O-C-N 121.263 -0.898 . . . . 0.0 110.325 -179.966 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 766' ' ' PRO . . . . . 0.412 ' HD2' ' HB1' ' A' ' 765' ' ' ALA . 45.8 Cg_endo -73.16 99.75 1.14 Allowed 'Trans proline' 0 C--N 1.304 -1.799 0 O-C-N 124.025 1.54 . . . . 0.0 110.185 -179.979 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 767' ' ' GLY . . . . . . . . . . . . . . . 117.76 1.0 17.58 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.486 -1.446 . . . . 0.0 109.486 -179.962 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 768' ' ' GLN . . . . . 0.501 ' CG ' ' O ' ' A' ' 840' ' ' SER . 10.7 mp0 -116.47 154.47 30.29 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.219 -1.165 . . . . 0.0 110.273 179.938 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 769' ' ' THR . . . . . . . . . . . . . 43.1 p -129.02 147.54 50.9 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.184 -0.948 . . . . 0.0 110.359 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 770' ' ' ILE . . . . . . . . . . . . . 37.0 mt -58.99 133.17 24.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.308 -0.87 . . . . 0.0 109.751 179.952 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 771' ' ' SER . . . . . 0.476 ' O ' ' HB2' ' A' ' 772' ' ' ALA . 51.7 p -108.47 -17.0 14.09 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.236 -0.915 . . . . 0.0 110.861 -179.889 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 772' ' ' ALA . . . . . 0.476 ' HB2' ' O ' ' A' ' 771' ' ' SER . . . -177.77 171.84 1.79 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.875 -1.141 . . . . 0.0 111.271 -179.999 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 773' ' ' ILE . . . . . . . . . . . . . 42.6 mm -123.72 129.49 74.45 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 179.858 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 774' ' ' LYS . . . . . . . . . . . . . 5.9 mtpt -95.03 -35.47 11.93 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 121.033 -1.042 . . . . 0.0 111.537 -179.848 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 775' ' ' PHE . . . . . 0.674 ' O ' ' HB2' ' A' ' 776' ' ' ALA . 60.1 t80 -149.06 172.34 14.92 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 120.686 -1.259 . . . . 0.0 111.465 -179.948 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 776' ' ' ALA . . . . . 0.674 ' HB2' ' O ' ' A' ' 775' ' ' PHE . . . 169.3 119.93 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 109.187 -0.672 . . . . 0.0 109.187 -179.971 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 777' ' ' SER . . . . . 0.554 ' HA ' ' HB3' ' A' ' 798' ' ' SER . 44.4 t -143.69 137.2 28.02 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 120.978 -1.076 . . . . 0.0 111.172 -179.891 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 778' ' ' PHE . . . . . 0.57 ' CG ' ' O ' ' A' ' 778' ' ' PHE . 1.4 t80 -107.34 72.37 0.87 Allowed 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.422 -0.799 . . . . 0.0 109.73 179.925 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 779' ' ' GLY . . . . . . . . . . . . . . . -174.24 -120.6 0.59 Allowed Glycine 0 N--CA 1.492 2.405 0 N-CA-C 109.961 -1.255 . . . . 0.0 109.961 179.989 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 780' ' ' THR . . . . . 0.644 HG22 ' O ' ' A' ' 830' ' ' MET . 24.8 p -117.11 81.46 12.79 Favored Pre-proline 0 N--CA 1.494 1.775 0 O-C-N 121.197 -1.178 . . . . 0.0 110.553 179.984 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 781' ' ' PRO . . . . . 0.427 ' HA ' ' O ' ' A' ' 789' ' ' GLN . 46.8 Cg_endo -80.48 144.43 15.97 Favored 'Trans proline' 0 C--N 1.304 -1.805 0 O-C-N 124.054 1.555 . . . . 0.0 110.229 -179.983 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 782' ' ' LEU . . . . . . . . . . . . . 36.8 mt -120.32 148.91 43.12 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.176 -0.953 . . . . 0.0 110.331 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 783' ' ' GLY . . . . . . . . . . . . . . . 112.2 -139.29 15.54 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.546 -1.422 . . . . 0.0 109.546 -179.962 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 784' ' ' THR . . . . . . . . . . . . . 10.8 t -161.12 -173.26 3.78 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.254 -1.144 . . . . 0.0 110.138 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 785' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -64.37 107.15 1.27 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.191 -0.943 . . . . 0.0 110.204 -179.975 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 786' ' ' GLY . . . . . . . . . . . . . . . 131.36 -31.65 3.09 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.2 -1.56 . . . . 0.0 109.2 179.981 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 787' ' ' THR . . . . . . . . . . . . . 25.2 p -144.38 39.81 1.31 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.32 -1.106 . . . . 0.0 110.088 -179.942 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 788' ' ' PHE . . . . . 0.583 ' HB3' ' CZ ' ' A' ' 775' ' ' PHE . 1.9 m-85 -50.97 171.55 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.328 -0.858 . . . . 0.0 110.229 179.935 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 789' ' ' GLN . . . . . 0.427 ' O ' ' HA ' ' A' ' 781' ' ' PRO . 26.4 tt0 -161.05 169.57 22.22 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.114 -0.991 . . . . 0.0 110.424 -179.989 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 790' ' ' GLN . . . . . 0.454 ' O ' ' HG3' ' A' ' 790' ' ' GLN . 0.0 OUTLIER -94.89 147.96 22.82 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.23 -0.919 . . . . 0.0 110.041 -179.992 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 791' ' ' GLY . . . . . 0.443 ' HA3' ' OG1' ' A' ' 780' ' ' THR . . . -97.4 -150.67 26.88 Favored Glycine 0 N--CA 1.492 2.393 0 N-CA-C 109.516 -1.434 . . . . 0.0 109.516 179.943 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 792' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -70.08 -19.66 63.25 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.255 -1.144 . . . . 0.0 109.973 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 793' ' ' CYS . . . . . 0.475 ' SG ' ' N ' ' A' ' 794' ' ' HIS . 1.8 t -136.72 164.86 27.26 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.337 -0.852 . . . . 0.0 110.051 -179.963 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 794' ' ' HIS . . . . . 0.644 ' CD2' ' N ' ' A' ' 795' ' ' SER . 0.7 OUTLIER 179.5 154.65 0.5 Allowed 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.285 -0.884 . . . . 0.0 109.861 179.976 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 795' ' ' SER . . . . . 0.644 ' N ' ' CD2' ' A' ' 794' ' ' HIS . 1.8 t -91.78 107.61 19.33 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.324 -0.86 . . . . 0.0 110.15 179.993 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 796' ' ' ILE . . . . . 0.436 ' C ' ' O ' ' A' ' 795' ' ' SER . 6.5 pt -38.63 -25.05 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.939 0 O-C-N 121.372 -0.83 . . . . 0.0 111.23 179.981 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 797' ' ' ASN . . . . . 0.532 ' N ' ' O ' ' A' ' 795' ' ' SER . 19.3 p30 -107.85 51.74 0.73 Allowed 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.003 -1.06 . . . . 0.0 111.313 -179.894 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 798' ' ' SER . . . . . 0.554 ' HB3' ' HA ' ' A' ' 777' ' ' SER . 4.3 m -102.8 26.42 8.08 Favored 'General case' 0 N--CA 1.497 1.925 0 O-C-N 120.697 -1.252 . . . . 0.0 110.403 179.939 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 799' ' ' ASN . . . . . . . . . . . . . 38.4 m-80 -138.07 -46.97 0.53 Allowed 'General case' 0 N--CA 1.496 1.831 0 O-C-N 120.998 -1.064 . . . . 0.0 110.874 -179.905 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 800' ' ' SER . . . . . . . . . . . . . 8.7 t -62.78 -33.12 74.52 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.118 -0.989 . . . . 0.0 110.385 -179.93 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 801' ' ' VAL . . . . . . . . . . . . . 97.8 t -51.92 -52.06 25.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.285 -0.884 . . . . 0.0 110.582 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 802' ' ' LEU . . . . . 0.464 ' O ' ' HB2' ' A' ' 806' ' ' CYS . 1.1 mm? -63.15 -43.48 98.2 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.206 -0.934 . . . . 0.0 110.861 179.996 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 803' ' ' GLU . . . . . . . . . . . . . 24.7 tt0 -55.33 -21.1 13.62 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.232 -0.918 . . . . 0.0 110.646 -179.959 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 804' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -92.14 -23.22 19.49 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.234 -0.916 . . . . 0.0 110.98 -179.969 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 805' ' ' LYS . . . . . 0.4 ' O ' ' SG ' ' A' ' 812' ' ' CYS . 5.0 mmmt -130.77 52.57 2.03 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.017 -1.052 . . . . 0.0 110.892 -179.904 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 806' ' ' CYS . . . . . 0.546 ' O ' HD12 ' A' ' 809' ' ' LEU . 0.3 OUTLIER -160.95 -72.19 0.06 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.035 -1.041 . . . . 0.0 110.903 179.986 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 807' ' ' ILE . . . . . . . . . . . . . 94.4 mt -55.28 128.74 15.85 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 121.223 -0.923 . . . . 0.0 110.776 -179.921 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 808' ' ' GLY . . . . . 0.475 ' C ' ' HG ' ' A' ' 809' ' ' LEU . . . 106.83 1.16 36.58 Favored Glycine 0 N--CA 1.495 2.576 0 N-CA-C 110.385 -1.086 . . . . 0.0 110.385 179.906 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 809' ' ' LEU . . . . . 0.546 HD12 ' O ' ' A' ' 806' ' ' CYS . 1.0 OUTLIER -131.83 160.61 35.15 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 120.831 -1.393 . . . . 0.0 110.534 -179.958 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 810' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -83.78 -9.49 58.76 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.329 -0.857 . . . . 0.0 109.583 179.91 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 811' ' ' ARG . . . . . 0.533 ' NH1' HD22 ' A' ' 809' ' ' LEU . 0.1 OUTLIER -143.62 164.93 29.03 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.39 -0.819 . . . . 0.0 109.193 -179.987 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 812' ' ' CYS . . . . . 0.4 ' SG ' ' O ' ' A' ' 805' ' ' LYS . 7.9 t -143.77 126.99 16.62 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.922 -1.111 . . . . 0.0 111.268 -179.852 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 813' ' ' VAL . . . . . . . . . . . . . 98.3 t -128.45 115.11 36.54 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.298 -0.877 . . . . 0.0 109.225 179.809 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 814' ' ' VAL . . . . . . . . . . . . . 97.9 t -123.28 129.21 74.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.134 -0.978 . . . . 0.0 110.772 -179.876 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 815' ' ' ALA . . . . . . . . . . . . . . . -86.69 158.82 19.35 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.323 -0.861 . . . . 0.0 109.623 179.909 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 816' ' ' ILE . . . . . 0.78 HD13 HG21 ' A' ' 833' ' ' VAL . 75.9 mt -109.65 133.02 56.24 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.577 0 O-C-N 121.218 -0.926 . . . . 0.0 110.575 -179.985 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 817' ' ' SER . . . . . 0.502 ' OG ' ' CB ' ' A' ' 820' ' ' ASN . 0.1 OUTLIER -165.98 170.45 5.8 Favored Pre-proline 0 N--CA 1.488 1.447 0 O-C-N 121.267 -0.896 . . . . 0.0 109.888 179.978 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 818' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -78.16 -63.63 0.02 OUTLIER 'Trans proline' 0 C--N 1.303 -1.834 0 O-C-N 123.982 1.517 . . . . 0.0 111.497 -179.886 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 819' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -70.24 -1.1 9.31 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 120.986 -1.071 . . . . 0.0 111.215 -179.849 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 820' ' ' ASN . . . . . 0.502 ' CB ' ' OG ' ' A' ' 817' ' ' SER . 27.9 t-20 -84.49 -20.79 31.1 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 120.952 -1.093 . . . . 0.0 109.999 179.977 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 821' ' ' PHE . . . . . . . . . . . . . 5.5 m-85 -108.45 -59.3 1.88 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.232 -0.918 . . . . 0.0 110.562 -179.903 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 822' ' ' GLY . . . . . . . . . . . . . . . -144.13 -55.65 0.03 OUTLIER Glycine 0 N--CA 1.491 2.366 0 N-CA-C 109.773 -1.331 . . . . 0.0 109.773 179.965 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 823' ' ' GLY . . . . . . . . . . . . . . . 137.77 108.32 0.85 Allowed Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.661 -1.376 . . . . 0.0 109.661 -179.958 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 824' ' ' ASP . . . . . 0.521 ' N ' ' HD3' ' A' ' 825' ' ' PRO . 4.2 m-20 43.11 59.93 10.99 Favored Pre-proline 0 N--CA 1.494 1.736 0 O-C-N 121.343 -1.092 . . . . 0.0 110.73 -179.976 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 825' ' ' PRO . . . . . 0.521 ' HD3' ' N ' ' A' ' 824' ' ' ASP . 47.8 Cg_endo -84.29 -54.91 0.03 OUTLIER 'Trans proline' 0 C--N 1.304 -1.784 0 O-C-N 123.926 1.487 . . . . 0.0 110.261 179.998 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 826' ' ' CYS . . . . . 0.4 ' SG ' HG11 ' A' ' 829' ' ' VAL . 0.5 OUTLIER -131.56 85.24 53.02 Favored Pre-proline 0 N--CA 1.496 1.838 0 O-C-N 121.267 -0.896 . . . . 0.0 110.375 -179.993 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 827' ' ' PRO . . . . . 0.448 ' O ' HG23 ' A' ' 829' ' ' VAL . 50.5 Cg_endo -86.64 151.11 8.81 Favored 'Trans proline' 0 C--N 1.306 -1.671 0 O-C-N 123.919 1.484 . . . . 0.0 111.287 -179.969 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 828' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 45.28 48.99 10.28 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.426 -0.796 . . . . 0.0 111.111 179.968 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 829' ' ' VAL . . . . . 0.515 ' O ' ' N ' ' A' ' 831' ' ' LYS . 20.4 t -147.44 137.95 17.34 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.583 0 O-C-N 121.164 -0.96 . . . . 0.0 110.173 179.899 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 830' ' ' MET . . . . . 0.644 ' O ' HG22 ' A' ' 780' ' ' THR . 0.2 OUTLIER -42.31 95.11 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.419 -0.8 . . . . 0.0 109.618 179.976 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 831' ' ' LYS . . . . . 0.515 ' N ' ' O ' ' A' ' 829' ' ' VAL . 0.0 OUTLIER -94.61 150.22 20.46 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.186 -0.946 . . . . 0.0 110.565 -179.938 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 832' ' ' ARG . . . . . 0.499 ' HA ' ' HA ' ' A' ' 736' ' ' SER . 0.0 OUTLIER -156.94 151.76 25.84 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.404 -0.81 . . . . 0.0 109.662 179.97 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 833' ' ' VAL . . . . . 0.78 HG21 HD13 ' A' ' 816' ' ' ILE . 66.6 t -115.79 106.1 19.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 120.979 -1.075 . . . . 0.0 110.955 179.978 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 834' ' ' ALA . . . . . 0.447 ' HB1' ' CZ ' ' A' ' 788' ' ' PHE . . . -108.87 132.95 53.53 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.307 -0.87 . . . . 0.0 109.092 179.922 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 835' ' ' VAL . . . . . . . . . . . . . 73.1 t -141.16 133.03 28.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.012 -1.055 . . . . 0.0 111.323 -179.94 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 836' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -125.53 112.64 16.45 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 179.897 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 837' ' ' ALA . . . . . . . . . . . . . . . -108.91 162.67 13.99 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.146 -0.971 . . . . 0.0 111.089 -179.926 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 838' ' ' VAL . . . . . . . . . . . . . 38.6 t -111.84 119.15 59.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.524 -0.735 . . . . 0.0 109.727 -179.946 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 839' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -105.71 146.18 30.11 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.9 -1.125 . . . . 0.0 110.94 179.946 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 840' ' ' SER . . . . . 0.501 ' O ' ' CG ' ' A' ' 768' ' ' GLN . 79.1 p -138.94 -152.22 0.41 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.498 -0.752 . . . . 0.0 109.775 -179.991 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 841' ' ' THR . . . . . . . . . . . . . 69.6 p -121.63 -175.94 3.2 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.186 -0.946 . . . . 0.0 109.993 179.977 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 842' ' ' ALA . . . . . . . . . . . . . . . -108.49 99.3 8.7 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.157 -0.964 . . . . 0.0 110.331 -179.991 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 843' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.679 0 CA-C-O 118.052 -0.975 . . . . 0.0 110.198 179.962 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 726' ' ' ARG . . . . . 0.709 ' O ' HG22 ' A' ' 727' ' ' THR . 1.9 ttt180 . . . . . 0 N--CA 1.492 1.66 0 CA-C-O 121.027 0.442 . . . . 0.0 110.183 . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 727' ' ' THR . . . . . 0.709 HG22 ' O ' ' A' ' 726' ' ' ARG . 0.4 OUTLIER 73.73 179.08 0.22 Allowed 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.2 -0.937 . . . . 0.0 110.116 179.987 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 728' ' ' VAL . . . . . 0.515 ' N ' HG23 ' A' ' 727' ' ' THR . 43.0 t -124.6 117.47 50.55 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.654 0 O-C-N 121.43 -0.794 . . . . 0.0 110.177 179.969 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 729' ' ' SER . . . . . 0.401 ' O ' ' O ' ' A' ' 728' ' ' VAL . 40.5 m 51.78 179.21 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.18 -0.95 . . . . 0.0 110.034 -179.972 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 730' ' ' GLY . . . . . . . . . . . . . . . -152.8 -158.8 8.69 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.622 -1.391 . . . . 0.0 109.622 -179.938 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 731' ' ' VAL . . . . . 0.511 ' CG2' ' SG ' ' A' ' 764' ' ' CYS . 18.0 t -140.1 144.65 27.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.21 -1.171 . . . . 0.0 110.506 179.99 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 732' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -135.96 143.15 44.71 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.432 -0.793 . . . . 0.0 109.729 179.952 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 733' ' ' ALA . . . . . . . . . . . . . . . -148.44 122.74 9.61 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.123 -0.986 . . . . 0.0 110.726 179.997 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 734' ' ' ASP . . . . . 0.461 ' O ' ' OD2' ' A' ' 734' ' ' ASP . 19.3 p-10 -129.92 106.06 8.41 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.326 -0.859 . . . . 0.0 109.877 179.953 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 735' ' ' VAL . . . . . . . . . . . . . 61.3 t -126.8 159.32 36.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.107 -0.996 . . . . 0.0 110.428 -179.951 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 736' ' ' SER . . . . . 0.428 ' O ' ' C ' ' A' ' 737' ' ' GLU . 24.6 m -109.51 127.29 54.34 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.321 -0.862 . . . . 0.0 109.932 179.992 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 737' ' ' GLU . . . . . 0.476 ' HB2' ' HB3' ' A' ' 831' ' ' LYS . 14.9 tp10 -41.8 149.59 0.13 Allowed 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.296 -0.878 . . . . 0.0 110.433 179.992 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 738' ' ' TYR . . . . . 0.417 ' O ' ' O ' ' A' ' 739' ' ' HIS . 21.0 t80 -109.46 -73.22 0.69 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.286 -0.884 . . . . 0.0 110.111 179.952 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 739' ' ' HIS . . . . . 0.417 ' O ' ' O ' ' A' ' 738' ' ' TYR . 26.5 t-80 59.87 116.12 0.02 OUTLIER Pre-proline 0 N--CA 1.494 1.751 0 O-C-N 121.252 -0.905 . . . . 0.0 110.488 179.936 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 740' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_endo -80.32 69.37 7.98 Favored 'Trans proline' 0 C--N 1.309 -1.51 0 O-C-N 124.008 1.531 . . . . 0.0 110.118 179.832 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 741' ' ' ASN . . . . . 0.43 ' N ' HD12 ' A' ' 742' ' ' ILE . 28.2 p30 -104.22 63.96 0.76 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.204 -0.935 . . . . 0.0 110.321 -179.951 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 742' ' ' ILE . . . . . 0.592 HD12 ' N ' ' A' ' 742' ' ' ILE . 5.1 mp -113.9 158.66 14.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.26 -0.9 . . . . 0.0 109.951 -179.981 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 743' ' ' LYS . . . . . . . . . . . . . 30.9 ttmt -85.23 -71.63 0.52 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.11 -0.994 . . . . 0.0 109.878 179.949 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 744' ' ' ASN . . . . . 0.605 ' ND2' ' O ' ' A' ' 744' ' ' ASN . 0.5 OUTLIER -91.27 127.98 36.91 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.09 -1.006 . . . . 0.0 109.458 179.935 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 745' ' ' TRP . . . . . 0.5 ' HA ' ' CE3' ' A' ' 745' ' ' TRP . 0.1 OUTLIER -154.42 15.12 0.45 Allowed 'General case' 0 C--N 1.296 -1.719 0 O-C-N 121.441 -0.787 . . . . 0.0 110.723 -179.894 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 746' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -94.17 134.54 36.51 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.085 -1.009 . . . . 0.0 109.868 179.951 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 747' ' ' ILE . . . . . . . . . . . . . 14.8 pt -139.33 -160.56 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.243 -0.911 . . . . 0.0 110.408 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 748' ' ' GLU . . . . . . . . . . . . . 13.4 mt-10 -81.87 -10.6 59.26 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.39 -0.819 . . . . 0.0 110.064 -179.982 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 749' ' ' SER . . . . . 0.454 ' O ' ' HB2' ' A' ' 750' ' ' TYR . 3.1 t -90.55 -19.43 23.77 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.207 -0.933 . . . . 0.0 110.127 179.998 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 750' ' ' TYR . . . . . 0.454 ' HB2' ' O ' ' A' ' 749' ' ' SER . 80.2 m-85 55.8 163.33 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.199 -0.938 . . . . 0.0 110.237 179.99 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 751' ' ' GLY . . . . . 0.438 ' C ' ' HD2' ' A' ' 753' ' ' PRO . . . 44.0 44.94 7.54 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 -179.992 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 752' ' ' GLU . . . . . 0.609 ' N ' ' CD ' ' A' ' 753' ' ' PRO . 4.6 tp10 -59.72 -41.01 83.65 Favored Pre-proline 0 N--CA 1.489 1.501 0 O-C-N 121.309 -1.112 . . . . 0.0 111.317 -179.955 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 753' ' ' PRO . . . . . 0.609 ' CD ' ' N ' ' A' ' 752' ' ' GLU . 47.0 Cg_endo -77.59 100.86 1.43 Allowed 'Trans proline' 0 C--N 1.312 -1.356 0 O-C-N 123.491 1.258 . . . . 0.0 110.435 -179.971 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 754' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -80.72 -15.9 55.31 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.304 -0.873 . . . . 0.0 110.311 -179.975 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 755' ' ' PHE . . . . . 0.402 ' CZ ' ' HD2' ' A' ' 759' ' ' LYS . 0.8 OUTLIER -143.66 139.78 29.74 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.203 -0.936 . . . . 0.0 110.203 179.931 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 756' ' ' HIS . . . . . 0.433 ' C ' ' OG1' ' A' ' 757' ' ' THR . 27.5 p80 -117.3 48.02 1.41 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.31 -0.869 . . . . 0.0 110.212 179.947 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 757' ' ' THR . . . . . 0.433 ' OG1' ' C ' ' A' ' 756' ' ' HIS . 0.0 OUTLIER -175.78 172.5 2.5 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.231 -0.918 . . . . 0.0 110.217 179.96 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 758' ' ' ALA . . . . . 0.89 ' HB3' ' HB ' ' A' ' 816' ' ' ILE . . . -98.9 172.26 7.54 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.32 -0.862 . . . . 0.0 109.855 179.939 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 759' ' ' LYS . . . . . 0.402 ' HD2' ' CZ ' ' A' ' 755' ' ' PHE . 6.4 mttm -150.74 136.58 18.22 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.115 -0.991 . . . . 0.0 110.41 179.959 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 760' ' ' VAL . . . . . . . . . . . . . 42.1 t -106.6 136.65 40.58 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.305 -0.872 . . . . 0.0 109.263 179.941 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 761' ' ' HIS . . . . . . . . . . . . . 68.1 m80 -109.71 104.15 13.1 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.198 -0.939 . . . . 0.0 110.981 -179.947 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 762' ' ' LEU . . . . . . . . . . . . . 39.4 mt -119.13 101.77 8.25 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.33 -0.857 . . . . 0.0 108.951 179.905 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 763' ' ' LYS . . . . . 0.489 ' HB3' ' HG3' ' A' ' 811' ' ' ARG . 6.6 pttm -135.66 140.86 44.82 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.077 -1.015 . . . . 0.0 110.803 -179.956 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 764' ' ' CYS . . . . . 0.511 ' SG ' ' CG2' ' A' ' 731' ' ' VAL . 0.5 OUTLIER -113.47 157.77 21.55 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.407 -0.808 . . . . 0.0 109.891 179.983 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 765' ' ' ALA . . . . . 0.775 ' HB3' ' HG3' ' A' ' 768' ' ' GLN . . . -44.73 169.71 0.06 OUTLIER Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 121.197 -0.939 . . . . 0.0 110.218 179.963 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 766' ' ' PRO . . . . . 0.659 ' HD2' ' HB1' ' A' ' 765' ' ' ALA . 43.9 Cg_endo -71.13 113.04 3.46 Favored 'Trans proline' 0 C--N 1.304 -1.787 0 O-C-N 123.961 1.506 . . . . 0.0 110.4 179.958 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 767' ' ' GLY . . . . . 0.81 ' O ' ' HB3' ' A' ' 842' ' ' ALA . . . 110.07 -24.82 17.82 Favored Glycine 0 N--CA 1.488 2.16 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 -179.942 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 768' ' ' GLN . . . . . 0.775 ' HG3' ' HB3' ' A' ' 765' ' ' ALA . 3.1 mt-30 -87.77 99.84 12.4 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.238 -1.154 . . . . 0.0 110.117 -179.99 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 769' ' ' THR . . . . . 0.844 HG22 ' HG3' ' A' ' 810' ' ' GLU . 64.1 p -94.78 154.14 17.42 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.257 -0.902 . . . . 0.0 110.375 -179.988 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 770' ' ' ILE . . . . . 0.419 ' HA ' ' O ' ' A' ' 838' ' ' VAL . 11.3 mt -78.11 144.89 10.65 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.356 -0.84 . . . . 0.0 110.005 -179.999 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 771' ' ' SER . . . . . . . . . . . . . 1.8 t -137.02 -5.3 1.89 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.147 -0.971 . . . . 0.0 111.158 -179.915 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 772' ' ' ALA . . . . . . . . . . . . . . . -162.18 123.38 2.65 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.859 -1.151 . . . . 0.0 111.014 -179.906 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 773' ' ' ILE . . . . . . . . . . . . . 32.9 mm -85.67 124.48 40.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.286 -0.884 . . . . 0.0 109.551 179.889 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 774' ' ' LYS . . . . . . . . . . . . . 18.9 mmtt -80.44 -42.26 22.98 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.246 -0.909 . . . . 0.0 110.757 -179.904 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 775' ' ' PHE . . . . . 0.694 ' O ' ' HB2' ' A' ' 776' ' ' ALA . 59.3 t80 -154.04 173.0 16.61 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.027 -1.045 . . . . 0.0 111.078 -179.974 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 776' ' ' ALA . . . . . 0.694 ' HB2' ' O ' ' A' ' 775' ' ' PHE . . . 168.39 89.08 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.588 -0.695 . . . . 0.0 109.548 179.959 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 777' ' ' SER . . . . . 0.581 ' HA ' ' CB ' ' A' ' 798' ' ' SER . 59.5 p -122.66 137.7 54.82 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.231 -0.918 . . . . 0.0 110.504 -179.906 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 778' ' ' PHE . . . . . . . . . . . . . 15.7 t80 -104.18 104.32 14.22 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.245 -0.909 . . . . 0.0 110.066 179.963 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 779' ' ' GLY . . . . . . . . . . . . . . . 161.64 -113.55 0.57 Allowed Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.457 -1.457 . . . . 0.0 109.457 -179.998 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 780' ' ' THR . . . . . . . . . . . . . 12.0 p -118.56 72.86 10.75 Favored Pre-proline 0 N--CA 1.492 1.67 0 O-C-N 121.203 -1.175 . . . . 0.0 110.127 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 781' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -73.27 161.16 43.55 Favored 'Trans proline' 0 C--N 1.307 -1.629 0 O-C-N 123.952 1.501 . . . . 0.0 110.296 179.976 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 782' ' ' LEU . . . . . 0.547 ' CD1' ' CA ' ' A' ' 791' ' ' GLY . 1.2 mp -132.61 169.36 16.73 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.233 -0.917 . . . . 0.0 110.159 179.984 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 783' ' ' GLY . . . . . . . . . . . . . . . 95.61 -167.67 26.0 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.354 -1.498 . . . . 0.0 109.354 -179.994 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 784' ' ' THR . . . . . 0.574 ' O ' ' CZ ' ' A' ' 788' ' ' PHE . 1.2 p -133.62 -65.69 0.67 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.187 -1.184 . . . . 0.0 110.337 -179.981 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 785' ' ' CYS . . . . . . . . . . . . . 7.8 t -156.19 128.49 7.6 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.166 -0.959 . . . . 0.0 110.445 179.988 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 786' ' ' GLY . . . . . . . . . . . . . . . 92.25 -13.18 67.77 Favored Glycine 0 N--CA 1.492 2.384 0 N-CA-C 109.7 -1.36 . . . . 0.0 109.7 -179.973 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 787' ' ' THR . . . . . 0.435 ' O ' HG23 ' A' ' 787' ' ' THR . 7.5 t -141.21 31.99 1.73 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.206 -1.173 . . . . 0.0 110.612 -179.991 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 788' ' ' PHE . . . . . 0.574 ' CZ ' ' O ' ' A' ' 784' ' ' THR . 0.7 OUTLIER -61.02 129.23 40.37 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.094 -1.004 . . . . 0.0 109.671 179.982 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 789' ' ' GLN . . . . . . . . . . . . . 5.2 pt20 -133.23 161.06 35.46 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.075 -1.016 . . . . 0.0 110.258 -179.967 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 790' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -75.27 144.36 42.57 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.233 -0.917 . . . . 0.0 110.406 -179.931 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 791' ' ' GLY . . . . . 0.547 ' CA ' ' CD1' ' A' ' 782' ' ' LEU . . . -96.56 -46.1 2.59 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 -179.98 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 792' ' ' GLU . . . . . 0.449 ' HB3' ' O ' ' A' ' 791' ' ' GLY . 15.8 pt-20 179.17 -27.63 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.158 -1.201 . . . . 0.0 110.93 -179.921 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 793' ' ' CYS . . . . . 0.461 ' O ' ' HB2' ' A' ' 794' ' ' HIS . 1.7 m -102.72 164.1 11.83 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.058 -1.026 . . . . 0.0 110.979 -179.92 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 794' ' ' HIS . . . . . 0.53 ' CD2' ' HG ' ' A' ' 798' ' ' SER . 12.3 t-80 179.56 135.52 0.1 Allowed 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.466 -0.771 . . . . 0.0 109.727 179.941 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 795' ' ' SER . . . . . 0.419 ' O ' ' N ' ' A' ' 797' ' ' ASN . 0.2 OUTLIER -90.87 23.78 3.01 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.19 -0.944 . . . . 0.0 110.884 -179.909 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 796' ' ' ILE . . . . . 0.491 HG22 ' O ' ' A' ' 796' ' ' ILE . 40.9 mt 42.65 27.29 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 O-C-N 121.125 -0.984 . . . . 0.0 110.018 179.958 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 797' ' ' ASN . . . . . 0.419 ' N ' ' O ' ' A' ' 795' ' ' SER . 1.2 t-20 -157.25 26.88 0.3 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.246 -0.909 . . . . 0.0 109.611 179.972 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 798' ' ' SER . . . . . 0.581 ' CB ' ' HA ' ' A' ' 777' ' ' SER . 2.8 m -84.28 -19.65 33.46 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.396 -0.815 . . . . 0.0 110.515 -179.96 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 799' ' ' ASN . . . . . 0.539 ' OD1' ' HB3' ' A' ' 776' ' ' ALA . 63.9 m-80 -108.87 -1.06 19.43 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.276 -0.89 . . . . 0.0 110.751 -179.996 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 800' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -91.83 -31.34 15.76 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.21 -0.931 . . . . 0.0 110.434 -179.962 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 801' ' ' VAL . . . . . . . . . . . . . 95.7 t -79.93 -17.93 12.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.359 -0.838 . . . . 0.0 110.089 -179.949 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 802' ' ' LEU . . . . . 0.488 ' N ' ' CD2' ' A' ' 802' ' ' LEU . 4.5 mm? -87.71 -60.43 1.97 Allowed 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.317 -0.864 . . . . 0.0 110.838 -179.955 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 803' ' ' GLU . . . . . 0.603 ' CG ' HD12 ' A' ' 807' ' ' ILE . 1.1 tt0 -57.3 -20.23 27.14 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.113 -0.992 . . . . 0.0 110.527 -179.988 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 804' ' ' ARG . . . . . . . . . . . . . 48.2 ttt85 -93.8 -20.21 20.3 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.268 -0.895 . . . . 0.0 111.757 -179.896 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 805' ' ' LYS . . . . . 0.448 ' O ' ' SG ' ' A' ' 806' ' ' CYS . 8.8 tttm -126.29 40.13 3.79 Favored 'General case' 0 N--CA 1.501 2.108 0 O-C-N 120.765 -1.21 . . . . 0.0 111.502 -179.887 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 806' ' ' CYS . . . . . 0.448 ' SG ' ' O ' ' A' ' 805' ' ' LYS . 1.3 m -163.55 -55.06 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.038 -1.039 . . . . 0.0 110.235 179.892 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 807' ' ' ILE . . . . . 0.603 HD12 ' CG ' ' A' ' 803' ' ' GLU . 5.6 mt -51.09 119.15 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.315 -0.866 . . . . 0.0 110.432 -179.965 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 808' ' ' GLY . . . . . 0.43 ' C ' ' HG ' ' A' ' 809' ' ' LEU . . . 111.14 6.93 25.51 Favored Glycine 0 N--CA 1.492 2.415 0 N-CA-C 109.803 -1.319 . . . . 0.0 109.803 179.923 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 809' ' ' LEU . . . . . 0.43 ' HG ' ' C ' ' A' ' 808' ' ' GLY . 15.9 mt -136.25 148.88 48.25 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.203 -1.175 . . . . 0.0 110.311 -179.971 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 810' ' ' GLU . . . . . 0.844 ' HG3' HG22 ' A' ' 769' ' ' THR . 5.1 mt-10 -76.38 -19.09 58.49 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.253 -0.904 . . . . 0.0 109.558 179.881 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 811' ' ' ARG . . . . . 0.489 ' HG3' ' HB3' ' A' ' 763' ' ' LYS . 1.0 OUTLIER -152.78 133.74 14.07 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.527 -0.733 . . . . 0.0 109.665 179.923 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 812' ' ' CYS . . . . . . . . . . . . . 27.6 p -152.02 141.48 21.62 Favored 'General case' 0 C--N 1.296 -1.759 0 O-C-N 121.334 -0.854 . . . . 0.0 110.64 -179.927 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 813' ' ' VAL . . . . . . . . . . . . . 24.2 t -110.21 152.97 12.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.277 -0.89 . . . . 0.0 109.843 -179.983 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 814' ' ' VAL . . . . . . . . . . . . . 22.0 t -131.79 106.46 11.56 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 O-C-N 121.042 -1.036 . . . . 0.0 110.458 -179.936 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 815' ' ' ALA . . . . . . . . . . . . . . . -67.13 143.32 56.7 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.254 -0.904 . . . . 0.0 109.964 179.939 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 816' ' ' ILE . . . . . 1.058 HD13 HG21 ' A' ' 833' ' ' VAL . 20.8 mt -100.02 104.48 16.17 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.211 -0.931 . . . . 0.0 110.156 -179.928 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 817' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -144.61 153.73 55.26 Favored Pre-proline 0 N--CA 1.496 1.835 0 O-C-N 121.322 -0.861 . . . . 0.0 110.279 179.958 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 818' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -76.65 -25.73 9.08 Favored 'Trans proline' 0 C--N 1.309 -1.508 0 O-C-N 123.897 1.472 . . . . 0.0 110.391 -179.999 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 819' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -90.97 18.32 6.81 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.228 -0.92 . . . . 0.0 109.873 179.958 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 820' ' ' ASN . . . . . . . . . . . . . 31.0 t30 -116.16 -32.11 5.45 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.338 -0.851 . . . . 0.0 110.396 -179.998 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 821' ' ' PHE . . . . . . . . . . . . . 54.3 m-85 -86.07 -79.62 0.25 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.16 -0.963 . . . . 0.0 110.008 179.999 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 822' ' ' GLY . . . . . . . . . . . . . . . -177.76 56.5 0.1 OUTLIER Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.213 -1.555 . . . . 0.0 109.213 -179.97 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 823' ' ' GLY . . . . . . . . . . . . . . . 99.01 -149.65 19.12 Favored Glycine 0 N--CA 1.487 2.041 0 N-CA-C 109.353 -1.499 . . . . 0.0 109.353 179.972 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 824' ' ' ASP . . . . . 0.488 ' OD2' ' N ' ' A' ' 824' ' ' ASP . 0.8 OUTLIER -121.59 142.02 34.83 Favored Pre-proline 0 N--CA 1.492 1.649 0 O-C-N 121.23 -1.159 . . . . 0.0 110.332 179.943 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 825' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -75.61 -89.63 0.0 OUTLIER 'Trans proline' 0 C--N 1.306 -1.675 0 O-C-N 124.105 1.581 . . . . 0.0 110.888 -179.947 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 826' ' ' CYS . . . . . 0.405 ' HB3' HG21 ' A' ' 829' ' ' VAL . 79.0 m -113.62 120.72 38.88 Favored Pre-proline 0 N--CA 1.494 1.748 0 O-C-N 121.196 -0.94 . . . . 0.0 110.475 -179.953 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 827' ' ' PRO . . . . . 0.476 ' O ' ' CB ' ' A' ' 828' ' ' GLU . 49.1 Cg_endo -75.58 142.47 26.19 Favored 'Trans proline' 0 C--N 1.306 -1.66 0 O-C-N 123.839 1.442 . . . . 0.0 110.33 179.938 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 828' ' ' GLU . . . . . 0.476 ' CB ' ' O ' ' A' ' 827' ' ' PRO . 0.8 OUTLIER 67.36 38.65 3.18 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.256 -0.903 . . . . 0.0 110.35 -179.991 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 829' ' ' VAL . . . . . 0.475 ' O ' ' HD3' ' A' ' 831' ' ' LYS . 24.0 t -136.05 132.92 50.46 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.174 -0.954 . . . . 0.0 110.291 -179.945 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 830' ' ' MET . . . . . 0.414 ' C ' ' O ' ' A' ' 829' ' ' VAL . 17.4 mtt -43.96 127.88 5.46 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.289 -0.882 . . . . 0.0 110.012 179.95 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 831' ' ' LYS . . . . . 0.476 ' HB3' ' HB2' ' A' ' 737' ' ' GLU . 0.0 OUTLIER -94.08 112.99 24.87 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.144 -0.973 . . . . 0.0 110.511 -179.983 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 832' ' ' ARG . . . . . . . . . . . . . 33.4 mtp85 -125.12 139.83 53.42 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.317 -0.864 . . . . 0.0 109.823 179.914 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 833' ' ' VAL . . . . . 1.058 HG21 HD13 ' A' ' 816' ' ' ILE . 42.8 t -112.32 105.1 18.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.15 -0.969 . . . . 0.0 110.567 -179.914 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 834' ' ' ALA . . . . . . . . . . . . . . . -113.5 116.43 29.57 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.377 -0.827 . . . . 0.0 109.786 179.976 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 835' ' ' VAL . . . . . . . . . . . . . 29.4 t -130.51 156.75 42.72 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.176 -0.953 . . . . 0.0 110.544 -179.93 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 836' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -149.21 113.14 5.13 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.489 -0.757 . . . . 0.0 109.652 179.954 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 837' ' ' ALA . . . . . . . . . . . . . . . -110.22 163.42 13.64 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.098 -1.001 . . . . 0.0 110.465 -179.983 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 838' ' ' VAL . . . . . 0.529 HG13 HG21 ' A' ' 727' ' ' THR . 74.5 t -114.09 156.72 14.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.339 -0.851 . . . . 0.0 110.203 -179.968 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 839' ' ' CYS . . . . . . . . . . . . . 1.2 m -136.59 148.0 47.27 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.322 -0.861 . . . . 0.0 110.194 179.978 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 840' ' ' SER . . . . . 0.586 ' O ' HG23 ' A' ' 841' ' ' THR . 9.6 t -119.09 -99.36 0.44 Allowed 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.272 -0.892 . . . . 0.0 110.678 -179.953 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 841' ' ' THR . . . . . 0.586 HG23 ' O ' ' A' ' 840' ' ' SER . 19.5 p -156.58 153.43 28.63 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.008 -1.057 . . . . 0.0 110.191 -179.975 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 842' ' ' ALA . . . . . 0.81 ' HB3' ' O ' ' A' ' 767' ' ' GLY . . . 176.84 171.69 0.48 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.264 -0.897 . . . . 0.0 110.243 179.941 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 843' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.684 0 CA-C-O 117.961 -1.019 . . . . 0.0 110.159 -179.976 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 726' ' ' ARG . . . . . 0.453 ' O ' ' HB ' ' A' ' 727' ' ' THR . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.688 0 CA-C-O 121.197 0.523 . . . . 0.0 110.111 . . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 727' ' ' THR . . . . . 0.453 ' HB ' ' O ' ' A' ' 726' ' ' ARG . 31.4 m 58.31 114.21 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.157 -0.965 . . . . 0.0 110.023 -179.995 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 728' ' ' VAL . . . . . 0.479 ' O ' ' HB2' ' A' ' 729' ' ' SER . 68.2 t -138.48 120.87 18.29 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.199 -0.938 . . . . 0.0 110.178 -179.997 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 729' ' ' SER . . . . . 0.479 ' HB2' ' O ' ' A' ' 728' ' ' VAL . 14.8 t -178.98 125.37 0.09 Allowed 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.147 -0.971 . . . . 0.0 110.891 179.947 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 730' ' ' GLY . . . . . . . . . . . . . . . 103.45 116.53 4.21 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 110.194 -1.162 . . . . 0.0 110.194 179.947 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 731' ' ' VAL . . . . . 0.521 ' CG2' ' O ' ' A' ' 837' ' ' ALA . 3.5 m -147.87 161.81 7.04 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.367 -1.078 . . . . 0.0 109.27 179.92 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 732' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -148.51 161.29 41.94 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.001 -1.062 . . . . 0.0 110.955 -179.978 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 733' ' ' ALA . . . . . . . . . . . . . . . -163.51 104.35 0.95 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.536 -0.728 . . . . 0.0 109.416 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 734' ' ' ASP . . . . . 0.589 ' C ' HG23 ' A' ' 735' ' ' VAL . 1.8 t70 -117.25 121.51 41.37 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.235 -0.916 . . . . 0.0 110.79 -179.959 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 735' ' ' VAL . . . . . 0.589 HG23 ' C ' ' A' ' 734' ' ' ASP . 49.0 t -156.09 148.61 11.67 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 O-C-N 121.326 -0.859 . . . . 0.0 109.796 179.926 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 736' ' ' SER . . . . . . . . . . . . . 90.7 p -98.77 -167.61 1.51 Allowed 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.114 -0.991 . . . . 0.0 110.588 -179.909 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 737' ' ' GLU . . . . . 0.485 ' OE1' ' HB3' ' A' ' 739' ' ' HIS . 0.8 OUTLIER -93.28 171.93 8.61 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.272 -0.892 . . . . 0.0 110.027 179.983 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 738' ' ' TYR . . . . . 0.452 ' O ' ' OE1' ' A' ' 737' ' ' GLU . 30.0 t80 -116.12 -90.82 0.54 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.129 -0.982 . . . . 0.0 110.427 179.972 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 739' ' ' HIS . . . . . 0.485 ' HB3' ' OE1' ' A' ' 737' ' ' GLU . 4.6 t-80 55.82 105.94 0.03 OUTLIER Pre-proline 0 N--CA 1.49 1.546 0 O-C-N 121.099 -1.0 . . . . 0.0 110.451 179.982 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 740' ' ' PRO . . . . . 0.798 ' HG2' HD11 ' A' ' 742' ' ' ILE . 47.2 Cg_endo -85.73 -160.38 0.11 Allowed 'Trans proline' 0 C--N 1.303 -1.816 0 O-C-N 123.914 1.481 . . . . 0.0 110.002 179.923 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 741' ' ' ASN . . . . . 0.449 ' O ' HG13 ' A' ' 742' ' ' ILE . 9.2 p30 -127.93 112.35 14.59 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.141 -0.974 . . . . 0.0 110.075 179.945 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 742' ' ' ILE . . . . . 0.82 HG23 ' CD1' ' A' ' 745' ' ' TRP . 1.5 mp -144.26 57.23 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 O-C-N 121.007 -1.058 . . . . 0.0 110.106 -179.983 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 743' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.4 3.83 50.85 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.276 -0.89 . . . . 0.0 110.264 -179.94 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 744' ' ' ASN . . . . . . . . . . . . . 51.3 p-10 -153.58 43.11 0.58 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.362 -0.836 . . . . 0.0 109.955 179.969 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 745' ' ' TRP . . . . . 0.82 ' CD1' HG23 ' A' ' 742' ' ' ILE . 1.9 m95 -82.56 -41.18 19.91 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.394 -0.816 . . . . 0.0 110.383 -179.981 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 746' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -137.97 131.72 31.24 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.113 -0.992 . . . . 0.0 110.395 -179.997 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 747' ' ' ILE . . . . . 0.462 ' O ' ' HG2' ' A' ' 748' ' ' GLU . 14.6 mm -123.47 122.54 65.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.404 -0.81 . . . . 0.0 110.334 179.975 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 748' ' ' GLU . . . . . 0.462 ' HG2' ' O ' ' A' ' 747' ' ' ILE . 1.4 mm-40 -150.75 -58.31 0.17 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.342 -0.848 . . . . 0.0 109.562 -179.999 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 749' ' ' SER . . . . . 0.459 ' O ' ' HB3' ' A' ' 750' ' ' TYR . 1.1 p -154.41 18.29 0.48 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.558 -0.714 . . . . 0.0 109.685 179.922 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 750' ' ' TYR . . . . . 0.536 ' CD2' ' O ' ' A' ' 751' ' ' GLY . 2.7 p90 -178.5 -149.59 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.376 -0.827 . . . . 0.0 110.048 -179.879 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 751' ' ' GLY . . . . . 0.536 ' O ' ' CD2' ' A' ' 750' ' ' TYR . . . -137.08 167.19 24.74 Favored Glycine 0 N--CA 1.492 2.382 0 N-CA-C 109.017 -1.633 . . . . 0.0 109.017 179.981 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 752' ' ' GLU . . . . . 0.537 ' N ' ' CD ' ' A' ' 753' ' ' PRO . 11.3 tt0 -149.7 49.61 0.68 Allowed Pre-proline 0 N--CA 1.491 1.601 0 O-C-N 121.022 -1.281 . . . . 0.0 110.634 -179.958 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 753' ' ' PRO . . . . . 0.537 ' CD ' ' N ' ' A' ' 752' ' ' GLU . 44.5 Cg_endo -72.28 135.63 25.08 Favored 'Trans proline' 0 C--N 1.305 -1.744 0 O-C-N 123.86 1.452 . . . . 0.0 110.007 179.942 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 754' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -91.54 174.46 7.36 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.175 -0.953 . . . . 0.0 110.334 -179.966 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 755' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -138.97 62.68 1.53 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.348 -0.845 . . . . 0.0 110.136 179.991 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 756' ' ' HIS . . . . . 0.807 ' O ' HG23 ' A' ' 757' ' ' THR . 2.0 t-80 -68.91 177.33 2.65 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.214 -0.929 . . . . 0.0 110.277 -179.983 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 757' ' ' THR . . . . . 0.807 HG23 ' O ' ' A' ' 756' ' ' HIS . 0.6 OUTLIER -166.06 157.53 13.69 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.338 -0.851 . . . . 0.0 110.522 179.995 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 758' ' ' ALA . . . . . 0.472 ' O ' ' HG2' ' A' ' 759' ' ' LYS . . . -88.97 172.33 9.22 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.257 -0.902 . . . . 0.0 109.866 179.96 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 759' ' ' LYS . . . . . 0.472 ' HG2' ' O ' ' A' ' 758' ' ' ALA . 3.1 mtmt -142.91 162.95 34.12 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.069 -1.02 . . . . 0.0 110.644 -179.962 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 760' ' ' VAL . . . . . 0.948 ' O ' HG23 ' A' ' 813' ' ' VAL . 95.2 t -109.22 157.12 9.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.417 -0.802 . . . . 0.0 109.124 179.874 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 761' ' ' HIS . . . . . . . . . . . . . 35.2 m80 -128.53 113.91 16.08 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.937 -1.102 . . . . 0.0 111.369 -179.89 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 762' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -122.38 106.45 11.08 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 179.892 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 763' ' ' LYS . . . . . . . . . . . . . 5.4 ttmt -131.2 135.45 47.41 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.977 -1.077 . . . . 0.0 111.199 -179.833 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 764' ' ' CYS . . . . . . . . . . . . . 59.5 m -106.58 175.58 5.45 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.566 -0.709 . . . . 0.0 109.801 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 765' ' ' ALA . . . . . 0.622 ' HB1' ' HD2' ' A' ' 766' ' ' PRO . . . -55.21 167.96 0.62 Allowed Pre-proline 0 N--CA 1.494 1.771 0 O-C-N 121.216 -0.927 . . . . 0.0 110.497 179.999 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 766' ' ' PRO . . . . . 0.622 ' HD2' ' HB1' ' A' ' 765' ' ' ALA . 48.1 Cg_endo -73.43 110.17 3.0 Favored 'Trans proline' 0 C--N 1.304 -1.778 0 O-C-N 124.211 1.638 . . . . 0.0 110.309 179.975 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 767' ' ' GLY . . . . . . . . . . . . . . . 117.32 -30.69 6.13 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.711 -1.356 . . . . 0.0 109.711 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 768' ' ' GLN . . . . . 0.47 ' OE1' HG22 ' A' ' 841' ' ' THR . 44.5 mm-40 -85.88 162.01 18.8 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.183 -1.187 . . . . 0.0 110.245 -179.926 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 769' ' ' THR . . . . . 0.448 HG22 ' OE1' ' A' ' 810' ' ' GLU . 64.9 p -146.43 146.99 30.79 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.248 -0.907 . . . . 0.0 110.214 -179.986 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 770' ' ' ILE . . . . . 0.475 HG13 ' SG ' ' A' ' 839' ' ' CYS . 1.8 mp -69.06 147.79 11.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.35 -0.843 . . . . 0.0 109.13 179.942 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 771' ' ' SER . . . . . 0.475 ' OG ' ' HB2' ' A' ' 843' ' ' ALA . 34.8 m -130.75 -11.85 3.84 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 120.882 -1.136 . . . . 0.0 111.794 -179.891 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 772' ' ' ALA . . . . . . . . . . . . . . . -161.75 153.5 19.01 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 120.743 -1.223 . . . . 0.0 111.492 -179.927 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 773' ' ' ILE . . . . . . . . . . . . . 15.1 mm -113.97 125.17 71.2 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.534 -0.729 . . . . 0.0 109.372 179.901 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 774' ' ' LYS . . . . . 0.552 ' HG3' ' N ' ' A' ' 775' ' ' PHE . 0.5 OUTLIER -89.69 -36.13 15.4 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.089 -1.007 . . . . 0.0 110.815 -179.892 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 775' ' ' PHE . . . . . 0.552 ' N ' ' HG3' ' A' ' 774' ' ' LYS . 65.2 t80 -137.47 149.78 47.09 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.982 -1.074 . . . . 0.0 110.746 -179.924 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 776' ' ' ALA . . . . . 0.487 ' HB3' ' HB3' ' A' ' 799' ' ' ASN . . . -179.03 106.74 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.548 -0.72 . . . . 0.0 109.531 179.954 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 777' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -139.69 136.67 34.49 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.13 -0.981 . . . . 0.0 110.55 -179.877 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 778' ' ' PHE . . . . . 0.753 ' HD2' HG22 ' A' ' 833' ' ' VAL . 86.4 t80 -104.27 76.38 1.32 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.427 -0.796 . . . . 0.0 109.915 179.988 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 779' ' ' GLY . . . . . . . . . . . . . . . -171.34 -109.77 0.23 Allowed Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.755 -1.338 . . . . 0.0 109.755 -179.989 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 780' ' ' THR . . . . . . . . . . . . . 2.9 p -112.54 92.42 19.71 Favored Pre-proline 0 N--CA 1.494 1.732 0 O-C-N 121.259 -1.142 . . . . 0.0 110.662 -179.992 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 781' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -79.04 127.63 7.8 Favored 'Trans proline' 0 C--N 1.305 -1.73 0 O-C-N 124.064 1.56 . . . . 0.0 110.19 -179.999 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 782' ' ' LEU . . . . . 0.434 ' O ' ' HA ' ' A' ' 788' ' ' PHE . 2.6 mt -96.68 108.3 20.9 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.137 -0.977 . . . . 0.0 110.356 179.989 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 783' ' ' GLY . . . . . . . . . . . . . . . 120.99 -154.31 16.45 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.643 -1.383 . . . . 0.0 109.643 -179.995 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 784' ' ' THR . . . . . 0.574 ' O ' ' CZ ' ' A' ' 788' ' ' PHE . 9.9 t -151.09 -40.54 0.12 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.279 -1.13 . . . . 0.0 110.137 -179.959 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 785' ' ' CYS . . . . . 0.555 ' N ' HG23 ' A' ' 784' ' ' THR . 16.2 t -166.95 118.97 0.94 Allowed 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.306 -0.871 . . . . 0.0 109.692 -179.982 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 786' ' ' GLY . . . . . . . . . . . . . . . 85.84 -9.18 69.65 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.335 -1.506 . . . . 0.0 109.335 -179.96 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 787' ' ' THR . . . . . . . . . . . . . 18.7 p -139.56 33.94 2.04 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.23 -1.159 . . . . 0.0 110.174 -179.965 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 788' ' ' PHE . . . . . 0.676 ' CE1' ' HB1' ' A' ' 834' ' ' ALA . 7.2 m-85 -71.18 174.69 6.05 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.228 -0.92 . . . . 0.0 110.337 179.98 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 789' ' ' GLN . . . . . 0.485 ' CG ' ' O ' ' A' ' 788' ' ' PHE . 0.0 OUTLIER 179.44 167.14 1.09 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.185 -0.947 . . . . 0.0 110.327 -179.971 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 790' ' ' GLN . . . . . . . . . . . . . 31.5 mt-30 -99.05 143.84 28.87 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.258 -0.901 . . . . 0.0 110.181 179.952 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 791' ' ' GLY . . . . . . . . . . . . . . . -101.89 -109.41 3.26 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.577 -1.409 . . . . 0.0 109.577 179.993 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 792' ' ' GLU . . . . . . . . . . . . . 8.5 mt-10 -129.65 15.4 5.94 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.322 -1.105 . . . . 0.0 110.068 -179.993 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 793' ' ' CYS . . . . . . . . . . . . . 1.7 m -147.53 122.78 10.24 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.279 -0.888 . . . . 0.0 110.224 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 794' ' ' HIS . . . . . 0.633 ' CE1' ' O ' ' A' ' 795' ' ' SER . 32.9 t-80 -147.91 144.3 27.97 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.188 -0.945 . . . . 0.0 110.798 -179.97 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 795' ' ' SER . . . . . 0.633 ' O ' ' CE1' ' A' ' 794' ' ' HIS . 27.2 t -88.42 167.86 13.12 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 179.853 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 796' ' ' ILE . . . . . . . . . . . . . 3.1 mt -90.19 -22.76 6.27 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.837 0 O-C-N 120.47 -1.394 . . . . 0.0 110.286 -179.859 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 797' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -102.43 51.54 0.81 Allowed 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.167 -0.958 . . . . 0.0 109.407 179.943 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 798' ' ' SER . . . . . 0.514 ' OG ' ' CE1' ' A' ' 794' ' ' HIS . 0.3 OUTLIER -83.64 -45.08 13.86 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.407 -0.808 . . . . 0.0 111.339 -179.858 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 799' ' ' ASN . . . . . 0.495 ' HA ' HD23 ' A' ' 802' ' ' LEU . 2.0 p-10 -105.63 -14.2 15.34 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 120.889 -1.132 . . . . 0.0 111.012 -179.838 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 800' ' ' SER . . . . . . . . . . . . . 22.4 t -65.69 -19.1 65.77 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.069 -1.019 . . . . 0.0 110.37 -179.989 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 801' ' ' VAL . . . . . . . . . . . . . 96.2 t -83.86 -23.21 8.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.122 -0.986 . . . . 0.0 110.104 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 802' ' ' LEU . . . . . 0.737 HD22 ' N ' ' A' ' 802' ' ' LEU . 3.4 mm? -80.48 -62.32 1.71 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.346 -0.846 . . . . 0.0 110.337 179.969 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 803' ' ' GLU . . . . . 0.805 ' HA ' HD12 ' A' ' 807' ' ' ILE . 1.2 tm-20 -52.03 -17.88 1.2 Allowed 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.128 -0.983 . . . . 0.0 110.887 -179.983 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 804' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.29 -31.21 17.04 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 120.97 -1.082 . . . . 0.0 111.471 -179.92 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 805' ' ' LYS . . . . . . . . . . . . . 7.3 mttm -137.1 51.8 1.95 Allowed 'General case' 0 N--CA 1.498 1.961 0 O-C-N 120.756 -1.215 . . . . 0.0 111.313 -179.935 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 806' ' ' CYS . . . . . 0.52 ' HA ' ' CB ' ' A' ' 812' ' ' CYS . 1.1 m -162.75 -54.93 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.101 -0.999 . . . . 0.0 110.204 179.902 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 807' ' ' ILE . . . . . 0.805 HD12 ' HA ' ' A' ' 803' ' ' GLU . 61.6 mt -65.26 103.21 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.239 -0.913 . . . . 0.0 110.077 179.973 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 808' ' ' GLY . . . . . 0.446 ' C ' ' HG ' ' A' ' 809' ' ' LEU . . . 127.0 11.37 3.52 Favored Glycine 0 N--CA 1.492 2.377 0 N-CA-C 110.009 -1.236 . . . . 0.0 110.009 179.972 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 809' ' ' LEU . . . . . 0.446 ' HG ' ' C ' ' A' ' 808' ' ' GLY . 1.5 mt -133.23 150.13 51.96 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.111 -1.229 . . . . 0.0 110.245 179.972 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 810' ' ' GLU . . . . . 0.448 ' OE1' HG22 ' A' ' 769' ' ' THR . 0.2 OUTLIER -65.74 -26.74 67.87 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.192 -0.943 . . . . 0.0 109.255 179.914 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 811' ' ' ARG . . . . . 0.454 ' O ' ' HG3' ' A' ' 811' ' ' ARG . 4.1 ppt_? -161.23 120.58 2.56 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.629 -0.67 . . . . 0.0 109.198 179.89 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 812' ' ' CYS . . . . . 0.52 ' CB ' ' HA ' ' A' ' 806' ' ' CYS . 24.0 p -121.55 156.87 31.95 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 120.996 -1.065 . . . . 0.0 111.428 -179.856 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 813' ' ' VAL . . . . . 0.948 HG23 ' O ' ' A' ' 760' ' ' VAL . 9.9 p -139.4 126.46 24.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 179.966 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 814' ' ' VAL . . . . . . . . . . . . . 44.3 t -110.18 130.13 63.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.077 -1.015 . . . . 0.0 110.779 -179.936 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 815' ' ' ALA . . . . . . . . . . . . . . . -78.37 125.02 28.76 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.347 -0.846 . . . . 0.0 109.806 179.959 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 816' ' ' ILE . . . . . 0.401 ' CG2' HG21 ' A' ' 833' ' ' VAL . 96.4 mt -79.17 111.74 16.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.274 -0.891 . . . . 0.0 110.359 -179.949 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 817' ' ' SER . . . . . 0.44 ' OG ' ' HB2' ' A' ' 820' ' ' ASN . 0.0 OUTLIER -152.03 166.71 14.66 Favored Pre-proline 0 N--CA 1.493 1.692 0 O-C-N 121.348 -0.845 . . . . 0.0 110.016 179.961 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 818' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -76.35 -57.28 0.05 OUTLIER 'Trans proline' 0 C--N 1.307 -1.651 0 O-C-N 123.931 1.49 . . . . 0.0 110.665 -179.94 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 819' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -66.06 -9.85 34.69 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.184 -0.947 . . . . 0.0 110.524 -179.981 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 820' ' ' ASN . . . . . 0.44 ' HB2' ' OG ' ' A' ' 817' ' ' SER . 17.2 t30 -92.92 -16.4 25.22 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.117 -0.989 . . . . 0.0 110.317 -179.997 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 821' ' ' PHE . . . . . . . . . . . . . 1.9 m-85 -109.53 -79.04 0.58 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.241 -0.912 . . . . 0.0 110.211 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 822' ' ' GLY . . . . . . . . . . . . . . . 176.41 42.19 0.06 OUTLIER Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.493 -1.443 . . . . 0.0 109.493 179.956 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 823' ' ' GLY . . . . . . . . . . . . . . . 79.05 -162.6 48.54 Favored Glycine 0 N--CA 1.492 2.431 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 -179.979 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 824' ' ' ASP . . . . . . . . . . . . . 4.2 p30 -121.86 152.84 59.94 Favored Pre-proline 0 N--CA 1.493 1.723 0 O-C-N 121.254 -1.145 . . . . 0.0 110.149 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 825' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -78.76 -84.68 0.0 OUTLIER 'Trans proline' 0 C--N 1.304 -1.787 0 O-C-N 124.0 1.526 . . . . 0.0 110.751 -179.896 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 826' ' ' CYS . . . . . 0.524 ' SG ' HG21 ' A' ' 829' ' ' VAL . 28.5 p -105.85 142.75 25.46 Favored Pre-proline 0 N--CA 1.492 1.674 0 O-C-N 121.125 -0.985 . . . . 0.0 110.656 -179.913 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 827' ' ' PRO . . . . . 0.666 ' O ' HG23 ' A' ' 829' ' ' VAL . 50.3 Cg_endo -85.15 -179.14 3.43 Favored 'Trans proline' 0 C--N 1.303 -1.817 0 O-C-N 124.209 1.636 . . . . 0.0 109.983 179.895 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 828' ' ' GLU . . . . . 0.468 ' HB2' ' O ' ' A' ' 827' ' ' PRO . 7.5 mt-10 58.55 14.94 3.29 Favored 'General case' 0 C--N 1.297 -1.697 0 O-C-N 121.331 -0.856 . . . . 0.0 109.894 -179.978 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 829' ' ' VAL . . . . . 0.666 HG23 ' O ' ' A' ' 827' ' ' PRO . 60.8 t -128.85 122.5 57.01 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.405 0 O-C-N 121.333 -0.855 . . . . 0.0 110.205 -179.965 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 830' ' ' MET . . . . . 0.466 ' O ' ' O ' ' A' ' 829' ' ' VAL . 0.0 OUTLIER -48.79 176.9 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.022 -1.049 . . . . 0.0 109.531 -179.986 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 831' ' ' LYS . . . . . . . . . . . . . 6.2 mptt -138.82 110.1 6.92 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.977 -1.077 . . . . 0.0 110.873 -179.898 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 832' ' ' ARG . . . . . . . . . . . . . 73.9 mtp85 -115.84 157.59 24.21 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.382 -0.824 . . . . 0.0 109.43 179.904 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 833' ' ' VAL . . . . . 0.753 HG22 ' HD2' ' A' ' 778' ' ' PHE . 65.0 t -122.82 104.4 14.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.042 -1.036 . . . . 0.0 110.855 -179.997 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 834' ' ' ALA . . . . . 0.676 ' HB1' ' CE1' ' A' ' 788' ' ' PHE . . . -109.16 124.25 50.53 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.34 -0.85 . . . . 0.0 109.171 179.944 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 835' ' ' VAL . . . . . . . . . . . . . 11.8 t -138.9 142.81 33.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.059 -1.026 . . . . 0.0 111.346 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 836' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 -126.62 135.61 51.44 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 179.93 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 837' ' ' ALA . . . . . 0.521 ' O ' ' CG2' ' A' ' 731' ' ' VAL . . . -118.72 164.49 15.29 Favored 'General case' 0 C--N 1.298 -1.632 0 O-C-N 120.966 -1.084 . . . . 0.0 111.087 -179.85 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 838' ' ' VAL . . . . . . . . . . . . . 24.9 t -116.96 105.32 18.02 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 179.96 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 839' ' ' CYS . . . . . 0.475 ' SG ' HG13 ' A' ' 770' ' ' ILE . 0.1 OUTLIER -106.51 152.83 23.15 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.204 -0.935 . . . . 0.0 110.865 -179.82 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 840' ' ' SER . . . . . 0.489 ' O ' HG23 ' A' ' 841' ' ' THR . 2.7 p -164.08 -91.89 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.402 -0.811 . . . . 0.0 109.813 179.861 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 841' ' ' THR . . . . . 0.489 HG23 ' O ' ' A' ' 840' ' ' SER . 8.8 p -154.42 75.51 1.0 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.38 -0.825 . . . . 0.0 109.736 -179.996 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 842' ' ' ALA . . . . . 0.482 ' HB3' ' O ' ' A' ' 841' ' ' THR . . . 57.49 152.69 0.01 OUTLIER 'General case' 0 C--N 1.293 -1.878 0 O-C-N 121.582 -0.699 . . . . 0.0 110.341 -179.914 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 843' ' ' ALA . . . . . 0.475 ' HB2' ' OG ' ' A' ' 771' ' ' SER . . . . . . . . 0 N--CA 1.494 1.725 0 O-C-N 121.062 -1.024 . . . . 0.0 110.079 179.985 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 726' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.492 1.639 0 CA-C-O 121.285 0.564 . . . . 0.0 110.272 . . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 727' ' ' THR . . . . . . . . . . . . . 38.7 m -138.85 139.32 38.11 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.219 -0.926 . . . . 0.0 110.071 -179.963 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 728' ' ' VAL . . . . . . . . . . . . . 34.2 m -130.0 145.99 34.8 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.231 -0.918 . . . . 0.0 110.415 -179.963 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 729' ' ' SER . . . . . 0.766 ' O ' HG23 ' A' ' 731' ' ' VAL . 12.1 t -127.39 74.41 1.51 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.275 -0.891 . . . . 0.0 110.217 179.965 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 730' ' ' GLY . . . . . . . . . . . . . . . -62.38 114.69 7.07 Favored Glycine 0 N--CA 1.493 2.436 0 N-CA-C 109.222 -1.551 . . . . 0.0 109.222 179.989 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 731' ' ' VAL . . . . . 0.766 HG23 ' O ' ' A' ' 729' ' ' SER . 21.8 t -129.39 137.22 57.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.189 -1.183 . . . . 0.0 110.592 -179.986 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 732' ' ' CYS . . . . . . . . . . . . . 4.9 p -129.32 146.06 51.27 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.434 -0.791 . . . . 0.0 109.366 179.967 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 733' ' ' ALA . . . . . 0.505 ' CB ' HG13 ' A' ' 760' ' ' VAL . . . -110.45 104.22 12.95 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 120.952 -1.093 . . . . 0.0 111.351 -179.978 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 734' ' ' ASP . . . . . 0.45 ' OD1' ' O ' ' A' ' 734' ' ' ASP . 0.6 OUTLIER -110.07 100.9 9.76 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.339 -0.851 . . . . 0.0 108.865 179.895 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 735' ' ' VAL . . . . . . . . . . . . . 14.4 m -140.08 152.82 22.14 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 121.229 -0.92 . . . . 0.0 110.941 -179.885 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 736' ' ' SER . . . . . 0.542 ' O ' ' CB ' ' A' ' 758' ' ' ALA . 3.3 m -82.33 177.05 8.97 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 179.839 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 737' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -96.72 76.84 2.83 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 120.738 -1.226 . . . . 0.0 110.213 -179.993 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 738' ' ' TYR . . . . . 0.62 ' H ' ' HB2' ' A' ' 758' ' ' ALA . 13.1 t80 -161.42 145.91 13.27 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.37 -0.831 . . . . 0.0 110.194 179.986 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 739' ' ' HIS . . . . . 0.663 ' CE1' HD12 ' A' ' 742' ' ' ILE . 4.6 t-80 -90.11 149.56 41.73 Favored Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.289 -0.882 . . . . 0.0 110.247 179.985 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 740' ' ' PRO . . . . . 0.614 ' HD2' ' CG ' ' A' ' 739' ' ' HIS . 48.5 Cg_endo -71.79 -96.64 0.01 OUTLIER 'Trans proline' 0 C--N 1.313 -1.327 0 O-C-N 123.829 1.436 . . . . 0.0 110.361 -179.951 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 741' ' ' ASN . . . . . 0.452 ' CG ' ' O ' ' A' ' 740' ' ' PRO . 21.3 m120 -159.15 140.98 13.45 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.156 -0.965 . . . . 0.0 110.518 -179.981 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 742' ' ' ILE . . . . . 0.663 HD12 ' CE1' ' A' ' 739' ' ' HIS . 0.1 OUTLIER -149.52 85.83 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.267 -0.895 . . . . 0.0 109.997 179.973 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 743' ' ' LYS . . . . . 0.405 ' O ' ' HB2' ' A' ' 744' ' ' ASN . 0.6 OUTLIER -82.93 42.21 0.78 Allowed 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.292 -0.88 . . . . 0.0 109.868 179.908 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 744' ' ' ASN . . . . . 0.405 ' HB2' ' O ' ' A' ' 743' ' ' LYS . 1.6 t-20 -179.95 35.28 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.303 -0.873 . . . . 0.0 109.784 -179.989 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 745' ' ' TRP . . . . . 0.444 ' HB2' ' HB ' ' A' ' 742' ' ' ILE . 51.9 t-105 -96.29 -20.22 18.68 Favored 'General case' 0 C--N 1.299 -1.617 0 O-C-N 121.431 -0.793 . . . . 0.0 109.708 -179.975 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 746' ' ' GLN . . . . . 0.426 ' C ' ' O ' ' A' ' 745' ' ' TRP . 2.8 mt-30 -39.89 130.51 2.0 Favored 'General case' 0 C--N 1.298 -1.661 0 O-C-N 121.667 -0.645 . . . . 0.0 110.997 179.944 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 747' ' ' ILE . . . . . 0.763 ' O ' HG23 ' A' ' 747' ' ' ILE . 10.5 tt -80.25 102.06 5.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.15 -0.969 . . . . 0.0 109.041 179.864 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 748' ' ' GLU . . . . . 0.476 ' HB2' ' O ' ' A' ' 747' ' ' ILE . 0.6 OUTLIER 66.95 -84.65 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.357 -0.839 . . . . 0.0 109.646 -179.898 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 749' ' ' SER . . . . . 0.565 ' O ' ' CD2' ' A' ' 750' ' ' TYR . 74.9 m -145.37 79.71 1.58 Allowed 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.054 -1.029 . . . . 0.0 110.55 179.983 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 750' ' ' TYR . . . . . 0.565 ' CD2' ' O ' ' A' ' 749' ' ' SER . 36.7 m-85 -148.4 -160.65 1.2 Allowed 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.204 -0.935 . . . . 0.0 110.16 179.954 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 751' ' ' GLY . . . . . . . . . . . . . . . -134.5 178.53 18.37 Favored Glycine 0 N--CA 1.493 2.489 0 C-N-CA 119.697 -1.239 . . . . 0.0 110.335 -179.999 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 752' ' ' GLU . . . . . 0.493 ' OE2' HG13 ' A' ' 742' ' ' ILE . 10.0 mt-10 -103.73 137.37 19.22 Favored Pre-proline 0 N--CA 1.495 1.781 0 O-C-N 121.529 -0.983 . . . . 0.0 110.327 -179.982 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 753' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -71.65 179.65 4.51 Favored 'Trans proline' 0 C--N 1.306 -1.658 0 O-C-N 123.874 1.46 . . . . 0.0 110.324 179.945 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 754' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -92.56 58.09 3.06 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.168 -0.957 . . . . 0.0 110.668 -179.909 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 755' ' ' PHE . . . . . 0.576 ' CZ ' ' HD2' ' A' ' 818' ' ' PRO . 0.1 OUTLIER -125.93 66.62 1.19 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.236 -0.915 . . . . 0.0 110.012 179.958 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 756' ' ' HIS . . . . . 0.42 ' O ' ' HA ' ' A' ' 738' ' ' TYR . 3.4 m80 -75.3 80.52 2.39 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.354 -0.841 . . . . 0.0 109.958 -179.971 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 757' ' ' THR . . . . . 0.455 ' HB ' ' O ' ' A' ' 816' ' ' ILE . 32.1 p -115.74 174.82 5.82 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.325 -0.859 . . . . 0.0 110.205 179.957 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 758' ' ' ALA . . . . . 0.62 ' HB2' ' H ' ' A' ' 738' ' ' TYR . . . -102.83 -179.18 3.89 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.181 -0.949 . . . . 0.0 110.153 179.99 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 759' ' ' LYS . . . . . . . . . . . . . 9.6 mtpp -133.81 161.99 33.21 Favored 'General case' 0 C--N 1.297 -1.686 0 O-C-N 121.452 -0.78 . . . . 0.0 110.233 179.997 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 760' ' ' VAL . . . . . 0.983 HG23 HD11 ' A' ' 816' ' ' ILE . 39.8 t -125.55 114.85 41.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.344 -0.847 . . . . 0.0 109.191 179.927 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 761' ' ' HIS . . . . . . . . . . . . . 1.5 t-160 -110.64 114.44 27.84 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 120.914 -1.117 . . . . 0.0 111.185 -179.964 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 762' ' ' LEU . . . . . . . . . . . . . 17.8 mt -111.2 103.66 12.1 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.508 -0.745 . . . . 0.0 109.327 179.825 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 763' ' ' LYS . . . . . . . . . . . . . 5.3 pttp -117.81 136.87 53.12 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.098 -1.001 . . . . 0.0 110.925 -179.889 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 764' ' ' CYS . . . . . . . . . . . . . 86.2 m -105.32 173.46 6.3 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.372 -0.83 . . . . 0.0 109.673 179.927 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 765' ' ' ALA . . . . . 0.417 ' HB3' ' OE1' ' A' ' 768' ' ' GLN . . . -67.88 160.91 71.25 Favored Pre-proline 0 N--CA 1.494 1.745 0 O-C-N 121.18 -0.95 . . . . 0.0 110.44 179.969 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 766' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -72.02 96.1 0.77 Allowed 'Trans proline' 0 C--N 1.308 -1.584 0 O-C-N 124.006 1.53 . . . . 0.0 110.117 179.959 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 767' ' ' GLY . . . . . . . . . . . . . . . 140.21 -31.95 2.22 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 108.762 -1.735 . . . . 0.0 108.762 -179.999 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 768' ' ' GLN . . . . . 0.477 ' HG3' ' HB ' ' A' ' 841' ' ' THR . 12.8 mp0 -93.64 152.34 19.06 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.559 -0.965 . . . . 0.0 109.421 179.956 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 769' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -129.91 151.62 50.28 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.046 -1.034 . . . . 0.0 110.741 -179.976 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 770' ' ' ILE . . . . . 0.451 HD12 ' O ' ' A' ' 809' ' ' LEU . 30.9 mt -76.48 152.78 5.87 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.433 -0.792 . . . . 0.0 109.537 179.85 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 771' ' ' SER . . . . . 0.441 ' HA ' HG23 ' A' ' 807' ' ' ILE . 3.3 m -146.57 -15.88 0.43 Allowed 'General case' 0 N--CA 1.494 1.749 0 O-C-N 120.845 -1.159 . . . . 0.0 112.597 -179.903 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 772' ' ' ALA . . . . . . . . . . . . . . . -158.34 150.05 21.35 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 120.235 -1.54 . . . . 0.0 112.438 -179.912 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 773' ' ' ILE . . . . . . . . . . . . . 14.5 mm -116.21 118.39 58.62 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 179.863 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 774' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -84.13 -38.31 20.87 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 120.957 -1.09 . . . . 0.0 111.895 -179.826 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 775' ' ' PHE . . . . . 0.622 ' O ' ' HB2' ' A' ' 776' ' ' ALA . 58.4 t80 -129.52 166.64 19.25 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 120.712 -1.243 . . . . 0.0 111.468 -179.942 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 776' ' ' ALA . . . . . 0.926 ' HB3' ' HB2' ' A' ' 799' ' ' ASN . . . 171.76 101.48 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.736 -0.603 . . . . 0.0 109.382 179.962 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 777' ' ' SER . . . . . . . . . . . . . 29.1 t -134.55 125.63 27.67 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.37 -0.831 . . . . 0.0 110.204 -179.882 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 778' ' ' PHE . . . . . 0.543 ' CZ ' ' O ' ' A' ' 817' ' ' SER . 2.2 t80 -111.12 81.35 1.42 Allowed 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.421 -0.799 . . . . 0.0 109.887 179.934 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 779' ' ' GLY . . . . . . . . . . . . . . . -179.49 -89.97 0.08 OUTLIER Glycine 0 N--CA 1.493 2.449 0 N-CA-C 109.526 -1.429 . . . . 0.0 109.526 -179.946 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 780' ' ' THR . . . . . 0.492 ' O ' ' HA3' ' A' ' 791' ' ' GLY . 38.8 p -123.17 83.0 51.52 Favored Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.048 -1.266 . . . . 0.0 110.675 179.992 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 781' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -74.45 123.54 8.23 Favored 'Trans proline' 0 C--N 1.304 -1.809 0 O-C-N 124.077 1.567 . . . . 0.0 109.952 179.989 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 782' ' ' LEU . . . . . 0.754 HD12 ' HA2' ' A' ' 791' ' ' GLY . 10.8 mt -111.1 83.83 1.83 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.237 -0.914 . . . . 0.0 110.412 -179.959 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 783' ' ' GLY . . . . . . . . . . . . . . . 148.45 -173.63 28.38 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.549 -1.42 . . . . 0.0 109.549 -179.944 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 784' ' ' THR . . . . . 0.546 ' O ' ' CD2' ' A' ' 788' ' ' PHE . 80.3 p -132.41 -148.41 0.34 Allowed 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.275 -1.132 . . . . 0.0 110.375 -179.97 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 785' ' ' CYS . . . . . . . . . . . . . 4.2 t -70.87 106.88 3.77 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.227 -0.92 . . . . 0.0 109.889 179.984 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 786' ' ' GLY . . . . . . . . . . . . . . . 114.31 -26.25 9.87 Favored Glycine 0 N--CA 1.488 2.135 0 N-CA-C 109.246 -1.542 . . . . 0.0 109.246 -179.965 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 787' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -124.46 25.95 7.46 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.326 -1.103 . . . . 0.0 110.581 -179.958 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 788' ' ' PHE . . . . . 0.808 ' CE1' ' HB1' ' A' ' 834' ' ' ALA . 2.4 m-85 -71.46 112.43 7.58 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.225 -0.922 . . . . 0.0 109.616 -179.95 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 789' ' ' GLN . . . . . . . . . . . . . 14.4 tp60 -125.71 137.19 53.82 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.143 -0.973 . . . . 0.0 110.593 -179.962 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 790' ' ' GLN . . . . . 0.426 ' O ' ' HG3' ' A' ' 790' ' ' GLN . 19.3 pt20 -41.32 139.4 1.03 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.477 -0.764 . . . . 0.0 110.316 179.928 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 791' ' ' GLY . . . . . 0.754 ' HA2' HD12 ' A' ' 782' ' ' LEU . . . -89.59 -153.92 28.64 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.356 -1.498 . . . . 0.0 109.356 -179.999 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 792' ' ' GLU . . . . . . . . . . . . . 26.6 pt-20 -87.55 -35.18 18.29 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.22 -1.165 . . . . 0.0 109.744 179.951 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 793' ' ' CYS . . . . . 0.449 ' SG ' ' HB2' ' A' ' 825' ' ' PRO . 0.5 OUTLIER -109.87 100.72 9.65 Favored 'General case' 0 C--N 1.307 -1.255 0 O-C-N 121.271 -0.893 . . . . 0.0 110.604 179.997 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 794' ' ' HIS . . . . . 0.416 ' CD2' ' N ' ' A' ' 795' ' ' SER . 16.2 t-160 -108.69 143.08 38.26 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.091 -1.006 . . . . 0.0 109.826 -179.998 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 795' ' ' SER . . . . . 0.416 ' N ' ' CD2' ' A' ' 794' ' ' HIS . 0.4 OUTLIER -80.19 5.88 13.3 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.321 -0.862 . . . . 0.0 110.021 -179.964 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 796' ' ' ILE . . . . . 0.634 HG22 ' O ' ' A' ' 796' ' ' ILE . 31.4 mt 46.37 24.23 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.162 -0.961 . . . . 0.0 109.86 -179.988 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 797' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -159.6 22.53 0.18 Allowed 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.485 -0.759 . . . . 0.0 109.542 -179.976 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 798' ' ' SER . . . . . 0.72 ' O ' ' HB1' ' A' ' 776' ' ' ALA . 1.1 m -88.31 0.09 56.55 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.414 -0.804 . . . . 0.0 110.19 -179.982 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 799' ' ' ASN . . . . . 0.926 ' HB2' ' HB3' ' A' ' 776' ' ' ALA . 60.6 t-20 -124.66 1.34 8.2 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.254 -0.903 . . . . 0.0 109.954 179.973 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 800' ' ' SER . . . . . . . . . . . . . 1.5 t -91.64 -40.17 11.46 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.371 -0.831 . . . . 0.0 110.452 -179.869 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 801' ' ' VAL . . . . . 0.468 ' HB ' ' CE1' ' A' ' 821' ' ' PHE . 93.2 t -67.55 -19.54 25.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.3 -0.875 . . . . 0.0 110.799 -179.945 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 802' ' ' LEU . . . . . . . . . . . . . 78.7 mt -87.72 -49.74 6.93 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.011 -1.056 . . . . 0.0 110.979 -179.882 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 803' ' ' GLU . . . . . 0.418 ' HG2' HD11 ' A' ' 807' ' ' ILE . 18.6 mt-10 -54.23 -27.21 33.09 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.157 -0.964 . . . . 0.0 111.045 -179.909 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 804' ' ' ARG . . . . . . . . . . . . . 1.6 mpt_? -91.62 -18.32 24.21 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.017 -1.052 . . . . 0.0 111.264 -179.905 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 805' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.66 12.89 19.83 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 120.91 -1.119 . . . . 0.0 111.331 -179.926 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 806' ' ' CYS . . . . . 0.414 ' O ' ' C ' ' A' ' 807' ' ' ILE . 21.0 m -141.38 -67.99 0.4 Allowed 'General case' 0 N--CA 1.496 1.855 0 O-C-N 120.851 -1.156 . . . . 0.0 110.58 -179.971 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 807' ' ' ILE . . . . . 0.441 HG23 ' HA ' ' A' ' 771' ' ' SER . 42.9 mt -41.24 103.68 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 O-C-N 121.258 -0.901 . . . . 0.0 110.477 -179.986 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 808' ' ' GLY . . . . . 0.71 ' O ' HD23 ' A' ' 809' ' ' LEU . . . 127.06 4.84 5.88 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.613 -1.395 . . . . 0.0 109.613 -179.984 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 809' ' ' LEU . . . . . 0.71 HD23 ' O ' ' A' ' 808' ' ' GLY . 81.4 mt -139.77 149.2 43.28 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.252 -1.146 . . . . 0.0 109.982 179.997 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 810' ' ' GLU . . . . . . . . . . . . . 2.1 pt-20 -78.93 1.47 23.57 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.173 -0.954 . . . . 0.0 109.593 179.981 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 811' ' ' ARG . . . . . . . . . . . . . 21.8 ttp180 -170.13 135.7 1.36 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.41 -0.806 . . . . 0.0 110.014 179.986 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 812' ' ' CYS . . . . . . . . . . . . . 21.9 p -155.12 150.22 26.92 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.401 -0.812 . . . . 0.0 110.292 -179.979 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 813' ' ' VAL . . . . . 0.521 ' C ' HG23 ' A' ' 814' ' ' VAL . 11.9 p -131.78 153.99 39.58 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 O-C-N 121.29 -0.881 . . . . 0.0 110.335 -179.991 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 814' ' ' VAL . . . . . 0.521 HG23 ' C ' ' A' ' 813' ' ' VAL . 11.1 t -151.59 106.58 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 O-C-N 121.314 -0.866 . . . . 0.0 110.241 179.982 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 815' ' ' ALA . . . . . . . . . . . . . . . -54.02 170.92 0.11 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.234 -0.917 . . . . 0.0 110.384 179.942 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 816' ' ' ILE . . . . . 0.983 HD11 HG23 ' A' ' 760' ' ' VAL . 80.5 mt -121.73 141.73 40.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.351 -0.843 . . . . 0.0 109.887 -179.995 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 817' ' ' SER . . . . . 0.547 ' CB ' ' HD2' ' A' ' 818' ' ' PRO . 0.3 OUTLIER -173.91 -178.06 0.37 Allowed Pre-proline 0 N--CA 1.494 1.762 0 O-C-N 121.12 -0.988 . . . . 0.0 110.64 -179.899 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 818' ' ' PRO . . . . . 0.576 ' HD2' ' CZ ' ' A' ' 755' ' ' PHE . 42.8 Cg_endo -72.9 -76.12 0.01 OUTLIER 'Trans proline' 0 C--N 1.313 -1.329 0 O-C-N 124.043 1.549 . . . . 0.0 111.302 -179.93 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 819' ' ' SER . . . . . . . . . . . . . 40.8 t -84.33 51.93 2.22 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.055 -1.028 . . . . 0.0 110.351 -179.972 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 820' ' ' ASN . . . . . 0.465 ' HB2' ' OG ' ' A' ' 817' ' ' SER . 2.1 t30 -101.92 -49.25 4.01 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.256 -0.903 . . . . 0.0 109.777 179.961 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 821' ' ' PHE . . . . . 0.468 ' CE1' ' HB ' ' A' ' 801' ' ' VAL . 27.4 m-85 -77.26 -23.83 51.17 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.204 -0.935 . . . . 0.0 109.764 179.981 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 822' ' ' GLY . . . . . . . . . . . . . . . 93.95 55.69 1.48 Allowed Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 -179.972 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 823' ' ' GLY . . . . . . . . . . . . . . . 168.31 144.82 4.32 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.654 -1.378 . . . . 0.0 109.654 -179.987 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 824' ' ' ASP . . . . . 0.433 ' OD1' ' O ' ' A' ' 824' ' ' ASP . 11.1 p-10 -144.07 122.3 6.91 Favored Pre-proline 0 N--CA 1.493 1.712 0 O-C-N 121.325 -1.103 . . . . 0.0 110.041 179.999 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 825' ' ' PRO . . . . . 0.449 ' HB2' ' SG ' ' A' ' 793' ' ' CYS . 43.9 Cg_endo -75.59 -78.28 0.01 OUTLIER 'Trans proline' 0 C--N 1.307 -1.632 0 O-C-N 123.88 1.463 . . . . 0.0 110.583 -179.952 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 826' ' ' CYS . . . . . 0.435 ' HA ' ' HD3' ' A' ' 827' ' ' PRO . 5.8 p -125.18 128.46 24.77 Favored Pre-proline 0 N--CA 1.494 1.772 0 O-C-N 121.111 -0.993 . . . . 0.0 110.101 -179.971 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 827' ' ' PRO . . . . . 0.506 ' O ' HG23 ' A' ' 829' ' ' VAL . 48.7 Cg_endo -85.7 177.0 5.11 Favored 'Trans proline' 0 C--N 1.305 -1.726 0 O-C-N 123.883 1.465 . . . . 0.0 110.513 -179.995 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 828' ' ' GLU . . . . . 0.454 ' HB2' ' O ' ' A' ' 827' ' ' PRO . 34.9 mt-10 56.72 23.59 8.06 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.457 -0.777 . . . . 0.0 110.338 -179.958 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 829' ' ' VAL . . . . . 0.506 HG23 ' O ' ' A' ' 827' ' ' PRO . 53.3 t -125.44 135.46 63.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.437 -0.79 . . . . 0.0 109.734 179.929 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 830' ' ' MET . . . . . 0.435 ' C ' ' O ' ' A' ' 829' ' ' VAL . 33.5 ttm -41.26 146.14 0.21 Allowed 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.269 -0.895 . . . . 0.0 109.83 -179.997 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 831' ' ' LYS . . . . . . . . . . . . . 27.6 mttp -134.46 106.47 7.06 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.042 -1.036 . . . . 0.0 111.165 -179.941 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 832' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -108.36 166.13 10.99 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.463 -0.773 . . . . 0.0 109.005 179.805 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 833' ' ' VAL . . . . . 0.9 HG21 HD13 ' A' ' 816' ' ' ILE . 69.4 t -116.19 145.44 21.93 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.602 0 O-C-N 120.879 -1.138 . . . . 0.0 110.967 -179.94 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 834' ' ' ALA . . . . . 0.808 ' HB1' ' CE1' ' A' ' 788' ' ' PHE . . . -155.5 128.15 7.93 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.635 -0.666 . . . . 0.0 109.449 179.954 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 835' ' ' VAL . . . . . 0.445 ' CG1' ' N ' ' A' ' 836' ' ' GLU . 21.7 t -148.14 163.94 5.77 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.026 0 O-C-N 120.973 -1.079 . . . . 0.0 111.439 -179.887 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 836' ' ' GLU . . . . . 0.445 ' N ' ' CG1' ' A' ' 835' ' ' VAL . 6.1 tt0 -145.89 141.38 27.77 Favored 'General case' 0 N--CA 1.496 1.864 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 179.96 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 837' ' ' ALA . . . . . . . . . . . . . . . -134.56 156.71 48.19 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 120.929 -1.107 . . . . 0.0 111.061 -179.966 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 838' ' ' VAL . . . . . . . . . . . . . 69.7 t -114.3 102.96 14.61 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.725 0 O-C-N 121.428 -0.795 . . . . 0.0 109.734 179.97 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 839' ' ' CYS . . . . . 0.438 ' SG ' HG12 ' A' ' 770' ' ' ILE . 0.1 OUTLIER -108.88 139.73 43.32 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.071 -1.018 . . . . 0.0 110.822 -179.97 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 840' ' ' SER . . . . . . . . . . . . . 17.8 m -150.22 -168.52 3.13 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.365 -0.835 . . . . 0.0 110.02 179.944 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 841' ' ' THR . . . . . 0.477 ' HB ' ' HG3' ' A' ' 768' ' ' GLN . 8.9 t -115.0 167.19 11.02 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.221 -0.925 . . . . 0.0 110.288 -179.986 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 842' ' ' ALA . . . . . . . . . . . . . . . -53.24 110.83 0.59 Allowed 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.246 -0.909 . . . . 0.0 110.352 179.999 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 843' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.641 0 CA-C-O 118.014 -0.993 . . . . 0.0 110.175 179.993 . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 726' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.493 1.681 0 CA-C-O 121.247 0.546 . . . . 0.0 110.198 . . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 727' ' ' THR . . . . . . . . . . . . . 9.3 t -162.93 151.96 14.89 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.354 -0.841 . . . . 0.0 110.02 -179.992 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 728' ' ' VAL . . . . . 0.462 ' O ' ' HB3' ' A' ' 729' ' ' SER . 11.0 p -160.51 154.91 3.88 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.215 -0.928 . . . . 0.0 110.65 -179.995 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 729' ' ' SER . . . . . 0.462 ' HB3' ' O ' ' A' ' 728' ' ' VAL . 10.6 t 57.92 142.67 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.47 -0.769 . . . . 0.0 111.193 179.959 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 730' ' ' GLY . . . . . . . . . . . . . . . -132.4 159.73 23.48 Favored Glycine 0 N--CA 1.492 2.424 0 N-CA-C 109.012 -1.635 . . . . 0.0 109.012 179.915 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 731' ' ' VAL . . . . . 0.421 ' CG2' ' HB3' ' A' ' 837' ' ' ALA . 35.7 m -133.37 150.78 32.64 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 O-C-N 121.125 -1.221 . . . . 0.0 110.79 -179.992 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 732' ' ' CYS . . . . . . . . . . . . . 2.4 m -128.82 135.02 48.57 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.489 -0.757 . . . . 0.0 109.647 -179.968 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 733' ' ' ALA . . . . . 0.495 ' CB ' HD21 ' A' ' 762' ' ' LEU . . . -131.87 105.3 7.37 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.922 -1.111 . . . . 0.0 110.946 -179.913 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 734' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -113.66 107.76 16.21 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.339 -0.851 . . . . 0.0 109.088 179.911 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 735' ' ' VAL . . . . . . . . . . . . . 47.9 t -139.73 120.58 14.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.047 -1.033 . . . . 0.0 111.274 -179.926 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 736' ' ' SER . . . . . 0.417 ' O ' ' C ' ' A' ' 737' ' ' GLU . 54.4 p -100.72 -176.38 3.17 Favored 'General case' 0 C--N 1.297 -1.68 0 O-C-N 121.454 -0.779 . . . . 0.0 108.898 179.848 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 737' ' ' GLU . . . . . 0.417 ' C ' ' O ' ' A' ' 736' ' ' SER . 0.7 OUTLIER -44.12 160.94 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.113 -0.992 . . . . 0.0 109.604 179.962 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 738' ' ' TYR . . . . . 0.663 ' CG ' ' N ' ' A' ' 739' ' ' HIS . 0.4 OUTLIER -129.83 -52.8 1.14 Allowed 'General case' 0 N--CA 1.497 1.878 0 O-C-N 120.821 -1.174 . . . . 0.0 110.988 179.986 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 739' ' ' HIS . . . . . 0.663 ' N ' ' CG ' ' A' ' 738' ' ' TYR . 10.2 t-80 57.39 129.1 0.01 OUTLIER Pre-proline 0 N--CA 1.499 1.998 0 O-C-N 121.375 -0.828 . . . . 0.0 110.216 -179.898 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 740' ' ' PRO . . . . . 0.416 ' HD2' ' CD2' ' A' ' 739' ' ' HIS . 45.7 Cg_endo -71.12 151.54 61.4 Favored 'Trans proline' 0 C--N 1.307 -1.614 0 O-C-N 123.495 1.26 . . . . 0.0 110.542 179.953 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 741' ' ' ASN . . . . . 0.408 ' O ' ' HB ' ' A' ' 742' ' ' ILE . 0.2 OUTLIER -71.3 -31.85 67.94 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.302 -0.874 . . . . 0.0 110.441 -179.992 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 742' ' ' ILE . . . . . 0.439 HG22 ' N ' ' A' ' 743' ' ' LYS . 43.7 mt 56.4 164.88 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 O-C-N 121.211 -0.93 . . . . 0.0 110.688 -179.971 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 743' ' ' LYS . . . . . 0.518 ' O ' ' CZ3' ' A' ' 745' ' ' TRP . 1.0 OUTLIER -157.53 -53.91 0.07 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.396 -0.815 . . . . 0.0 109.807 179.954 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 744' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -104.74 118.91 37.75 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.198 -0.939 . . . . 0.0 109.678 179.926 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 745' ' ' TRP . . . . . 0.583 ' CG ' ' O ' ' A' ' 745' ' ' TRP . 1.2 p90 -169.39 116.57 0.6 Allowed 'General case' 0 C--N 1.304 -1.386 0 O-C-N 121.237 -0.914 . . . . 0.0 110.614 -179.965 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 746' ' ' GLN . . . . . 0.413 ' N ' ' OE2' ' A' ' 752' ' ' GLU . 4.3 mt-30 -52.97 158.43 1.43 Allowed 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.29 -0.881 . . . . 0.0 110.44 -179.963 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 747' ' ' ILE . . . . . 0.729 ' O ' HG23 ' A' ' 747' ' ' ILE . 3.6 tt -176.81 100.96 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.327 -0.858 . . . . 0.0 110.286 -179.989 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 748' ' ' GLU . . . . . . . . . . . . . 14.0 mt-10 -121.09 -58.84 1.77 Allowed 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.298 -0.876 . . . . 0.0 109.941 179.968 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 749' ' ' SER . . . . . 0.449 ' C ' ' CD2' ' A' ' 750' ' ' TYR . 0.1 OUTLIER -138.77 9.06 2.6 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.231 -0.918 . . . . 0.0 110.165 -179.968 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 750' ' ' TYR . . . . . 0.625 ' N ' ' CD2' ' A' ' 750' ' ' TYR . 0.1 OUTLIER -143.55 -77.24 0.23 Allowed 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.248 -0.908 . . . . 0.0 110.069 -179.976 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 751' ' ' GLY . . . . . . . . . . . . . . . 116.5 -174.39 15.21 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.564 -1.415 . . . . 0.0 109.564 179.964 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 752' ' ' GLU . . . . . 0.413 ' OE2' ' N ' ' A' ' 746' ' ' GLN . 7.9 mt-10 -114.72 137.37 22.73 Favored Pre-proline 0 N--CA 1.494 1.734 0 O-C-N 121.241 -1.152 . . . . 0.0 110.187 -179.964 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 753' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -75.07 131.74 14.55 Favored 'Trans proline' 0 C--N 1.305 -1.715 0 O-C-N 124.02 1.537 . . . . 0.0 110.67 179.969 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 754' ' ' GLU . . . . . . . . . . . . . 6.1 tt0 -162.09 166.24 26.06 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.349 -0.844 . . . . 0.0 110.12 -179.997 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 755' ' ' PHE . . . . . . . . . . . . . 4.9 m-85 -103.69 163.67 12.17 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.27 -0.894 . . . . 0.0 110.27 179.968 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 756' ' ' HIS . . . . . 0.407 ' HB2' ' HA ' ' A' ' 739' ' ' HIS . 0.2 OUTLIER -160.75 35.36 0.15 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.304 -0.872 . . . . 0.0 110.299 -179.975 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 757' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -89.2 141.03 28.87 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.295 -0.878 . . . . 0.0 110.24 -179.975 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 758' ' ' ALA . . . . . 0.555 ' HB2' ' HB3' ' A' ' 738' ' ' TYR . . . -90.8 165.0 13.88 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.169 -0.957 . . . . 0.0 110.516 -179.906 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 759' ' ' LYS . . . . . 0.444 ' HG2' ' HA ' ' A' ' 815' ' ' ALA . 3.2 mttp -130.39 165.01 23.47 Favored 'General case' 0 C--N 1.302 -1.5 0 O-C-N 121.424 -0.797 . . . . 0.0 109.839 -179.95 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 760' ' ' VAL . . . . . 0.686 HG23 HD11 ' A' ' 816' ' ' ILE . 41.6 t -106.37 153.74 7.62 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.518 0 O-C-N 121.25 -0.906 . . . . 0.0 109.459 179.953 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 761' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -147.87 116.83 6.79 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.051 -1.031 . . . . 0.0 111.219 -179.953 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 762' ' ' LEU . . . . . 0.495 HD21 ' CB ' ' A' ' 733' ' ' ALA . 32.0 mt -110.5 164.48 12.66 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.423 -0.798 . . . . 0.0 108.849 179.888 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 763' ' ' LYS . . . . . . . . . . . . . 14.9 mttt -154.04 128.98 9.5 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.78 -1.2 . . . . 0.0 110.944 -179.928 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 764' ' ' CYS . . . . . 0.433 ' O ' ' C ' ' A' ' 765' ' ' ALA . 10.4 t -103.83 143.78 32.37 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.489 -0.757 . . . . 0.0 109.601 179.996 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 765' ' ' ALA . . . . . 0.433 ' C ' ' O ' ' A' ' 764' ' ' CYS . . . -42.08 150.39 0.38 Allowed Pre-proline 0 N--CA 1.492 1.664 0 O-C-N 121.196 -0.94 . . . . 0.0 110.25 -179.945 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 766' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -70.11 95.95 0.6 Allowed 'Trans proline' 0 C--N 1.306 -1.683 0 O-C-N 124.016 1.535 . . . . 0.0 110.035 -179.923 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 767' ' ' GLY . . . . . . . . . . . . . . . 139.47 -17.76 3.08 Favored Glycine 0 N--CA 1.486 1.972 0 N-CA-C 109.029 -1.628 . . . . 0.0 109.029 -179.936 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 768' ' ' GLN . . . . . . . . . . . . . 20.7 mt-30 -108.61 174.74 5.74 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.362 -1.081 . . . . 0.0 110.133 179.981 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 769' ' ' THR . . . . . . . . . . . . . 8.9 p -144.85 147.97 33.44 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.207 -0.933 . . . . 0.0 110.454 -179.913 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 770' ' ' ILE . . . . . . . . . . . . . 72.1 mt -68.18 145.88 13.28 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.264 -0.898 . . . . 0.0 109.563 179.944 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 771' ' ' SER . . . . . . . . . . . . . 13.5 p -143.47 -3.0 0.94 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.955 -1.09 . . . . 0.0 111.951 -179.956 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 772' ' ' ALA . . . . . . . . . . . . . . . -165.98 143.25 5.41 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 120.559 -1.338 . . . . 0.0 111.648 -179.955 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 773' ' ' ILE . . . . . . . . . . . . . 34.9 mm -105.36 120.41 56.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 179.755 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 774' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.59 -43.55 22.72 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.045 -1.035 . . . . 0.0 111.077 -179.812 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 775' ' ' PHE . . . . . 0.588 ' CZ ' ' HB3' ' A' ' 788' ' ' PHE . 79.3 t80 -149.81 166.42 29.54 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 120.893 -1.129 . . . . 0.0 111.367 -179.925 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 776' ' ' ALA . . . . . 0.551 ' HB2' ' O ' ' A' ' 775' ' ' PHE . . . 174.21 126.2 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 -179.967 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 777' ' ' SER . . . . . . . . . . . . . 2.1 t -148.31 135.02 19.9 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.968 -1.083 . . . . 0.0 111.342 -179.956 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 778' ' ' PHE . . . . . . . . . . . . . 90.1 t80 -103.4 109.46 21.1 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.616 -0.677 . . . . 0.0 109.667 179.95 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 779' ' ' GLY . . . . . . . . . . . . . . . 148.52 -98.87 0.19 Allowed Glycine 0 N--CA 1.492 2.37 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 -179.907 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 780' ' ' THR . . . . . 0.477 ' O ' ' HA3' ' A' ' 791' ' ' GLY . 1.5 p -144.03 91.46 6.53 Favored Pre-proline 0 N--CA 1.494 1.743 0 O-C-N 121.153 -1.204 . . . . 0.0 110.608 179.928 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 781' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -82.57 154.36 15.78 Favored 'Trans proline' 0 C--N 1.304 -1.794 0 O-C-N 123.89 1.468 . . . . 0.0 110.269 179.931 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 782' ' ' LEU . . . . . 0.618 HD13 ' HA2' ' A' ' 791' ' ' GLY . 0.1 OUTLIER -127.76 125.33 39.7 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.082 -1.011 . . . . 0.0 110.508 -179.906 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 783' ' ' GLY . . . . . . . . . . . . . . . 128.24 -168.62 20.07 Favored Glycine 0 N--CA 1.488 2.166 0 N-CA-C 109.779 -1.328 . . . . 0.0 109.779 179.973 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 784' ' ' THR . . . . . 0.474 ' O ' ' HB2' ' A' ' 785' ' ' CYS . 24.1 p -142.93 72.19 1.36 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.323 -1.104 . . . . 0.0 109.834 179.969 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 785' ' ' CYS . . . . . 0.474 ' HB2' ' O ' ' A' ' 784' ' ' THR . 2.2 m 58.88 118.05 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.362 -0.836 . . . . 0.0 109.989 -179.973 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 786' ' ' GLY . . . . . . . . . . . . . . . 102.7 -37.33 3.75 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.061 -1.616 . . . . 0.0 109.061 -179.899 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 787' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -126.12 23.38 7.1 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.347 -1.09 . . . . 0.0 109.801 179.974 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 788' ' ' PHE . . . . . 0.588 ' HB3' ' CZ ' ' A' ' 775' ' ' PHE . 0.3 OUTLIER -56.4 149.76 16.2 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.511 -0.743 . . . . 0.0 110.009 179.987 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 789' ' ' GLN . . . . . 0.404 ' HG2' ' C ' ' A' ' 788' ' ' PHE . 2.3 mm-40 -134.65 173.69 11.39 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.255 -0.903 . . . . 0.0 110.126 -179.991 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 790' ' ' GLN . . . . . 0.408 ' O ' ' C ' ' A' ' 791' ' ' GLY . 0.0 OUTLIER -86.45 16.04 4.91 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.318 -0.864 . . . . 0.0 109.993 179.961 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 791' ' ' GLY . . . . . 0.618 ' HA2' HD13 ' A' ' 782' ' ' LEU . . . 42.45 -120.1 2.28 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.744 -1.343 . . . . 0.0 109.744 -179.963 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 792' ' ' GLU . . . . . . . . . . . . . 12.8 mt-10 -117.26 -30.64 5.54 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.272 -1.134 . . . . 0.0 110.562 179.991 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 793' ' ' CYS . . . . . . . . . . . . . 2.5 t -126.65 156.77 40.48 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.255 -0.903 . . . . 0.0 110.232 -179.979 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 794' ' ' HIS . . . . . 0.723 ' CE1' ' O ' ' A' ' 795' ' ' SER . 15.0 t-80 -170.08 150.49 3.76 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.374 -0.829 . . . . 0.0 110.229 -179.994 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 795' ' ' SER . . . . . 0.723 ' O ' ' CE1' ' A' ' 794' ' ' HIS . 3.1 t -99.68 158.07 16.03 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.394 -0.816 . . . . 0.0 109.466 179.948 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 796' ' ' ILE . . . . . 0.414 HG21 HD13 ' A' ' 796' ' ' ILE . 0.6 OUTLIER -92.07 37.24 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.087 0 O-C-N 121.005 -1.059 . . . . 0.0 109.847 -179.926 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 797' ' ' ASN . . . . . . . . . . . . . 18.9 m120 -148.06 22.92 1.08 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.383 -0.823 . . . . 0.0 109.93 179.997 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 798' ' ' SER . . . . . 0.486 ' HB3' ' O ' ' A' ' 776' ' ' ALA . 13.9 m -69.54 -50.35 45.76 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.306 -0.871 . . . . 0.0 110.637 179.991 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 799' ' ' ASN . . . . . 0.49 ' OD1' ' HB3' ' A' ' 776' ' ' ALA . 53.6 m-20 -76.33 -31.96 58.42 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.302 -0.874 . . . . 0.0 110.619 -179.944 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 800' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -56.63 -25.78 54.14 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.246 -0.909 . . . . 0.0 110.999 -179.93 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 801' ' ' VAL . . . . . 0.433 HG21 ' CD2' ' A' ' 821' ' ' PHE . 40.7 t -87.36 -21.66 7.13 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 O-C-N 121.067 -1.02 . . . . 0.0 110.769 -179.944 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 802' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -93.07 -20.91 20.07 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.092 -1.005 . . . . 0.0 111.18 -179.942 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 803' ' ' GLU . . . . . 0.449 ' HA ' HD12 ' A' ' 807' ' ' ILE . 4.4 mt-10 -83.51 -37.92 22.44 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.314 -0.866 . . . . 0.0 111.292 -179.858 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 804' ' ' ARG . . . . . . . . . . . . . 2.1 mtm180 -91.61 -25.61 19.09 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 120.997 -1.064 . . . . 0.0 111.62 -179.915 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 805' ' ' LYS . . . . . . . . . . . . . 2.0 tttp -110.53 44.53 1.24 Allowed 'General case' 0 N--CA 1.497 1.88 0 O-C-N 120.859 -1.15 . . . . 0.0 110.814 -179.939 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 806' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -160.52 -66.97 0.07 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.129 -0.982 . . . . 0.0 110.342 179.945 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 807' ' ' ILE . . . . . 0.449 HD12 ' HA ' ' A' ' 803' ' ' GLU . 30.1 mt -52.18 128.81 11.36 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.078 -1.014 . . . . 0.0 110.467 -179.998 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 808' ' ' GLY . . . . . 0.44 ' C ' ' HG ' ' A' ' 809' ' ' LEU . . . 105.24 9.48 33.82 Favored Glycine 0 N--CA 1.491 2.34 0 C-N-CA 119.918 -1.134 . . . . 0.0 110.284 179.915 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 809' ' ' LEU . . . . . 0.44 ' HG ' ' C ' ' A' ' 808' ' ' GLY . 43.7 mt -138.72 142.6 38.9 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.015 -1.285 . . . . 0.0 110.511 179.979 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 810' ' ' GLU . . . . . . . . . . . . . 5.0 mp0 -67.93 -20.88 65.12 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.182 -0.949 . . . . 0.0 109.418 179.998 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 811' ' ' ARG . . . . . . . . . . . . . 24.6 mtm180 -136.52 157.21 47.32 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.605 -0.684 . . . . 0.0 109.643 179.965 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 812' ' ' CYS . . . . . . . . . . . . . 3.2 t -131.12 146.71 52.45 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.198 -0.939 . . . . 0.0 110.193 -179.971 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 813' ' ' VAL . . . . . 0.633 HG13 ' O ' ' A' ' 813' ' ' VAL . 4.6 p -148.69 116.92 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.151 -0.968 . . . . 0.0 110.024 179.926 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 814' ' ' VAL . . . . . . . . . . . . . 6.7 t -131.39 111.73 19.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.193 -0.942 . . . . 0.0 110.077 179.959 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 815' ' ' ALA . . . . . 0.444 ' HA ' ' HG2' ' A' ' 759' ' ' LYS . . . -61.74 166.79 4.05 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.335 -0.853 . . . . 0.0 110.556 -179.955 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 816' ' ' ILE . . . . . 0.825 HG23 HG21 ' A' ' 833' ' ' VAL . 70.7 mt -119.7 112.89 38.97 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 121.378 -0.826 . . . . 0.0 110.102 179.953 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 817' ' ' SER . . . . . 0.532 ' CB ' ' HD2' ' A' ' 818' ' ' PRO . 0.7 OUTLIER -161.89 -177.36 0.7 Allowed Pre-proline 0 N--CA 1.494 1.744 0 O-C-N 121.101 -1.0 . . . . 0.0 110.313 179.97 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 818' ' ' PRO . . . . . 0.532 ' HD2' ' CB ' ' A' ' 817' ' ' SER . 48.3 Cg_endo -75.34 -48.84 0.15 Allowed 'Trans proline' 0 C--N 1.309 -1.546 0 O-C-N 123.991 1.522 . . . . 0.0 110.77 -179.971 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 819' ' ' SER . . . . . . . . . . . . . 2.8 t -92.76 71.06 4.84 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.334 -0.854 . . . . 0.0 110.411 -179.944 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 820' ' ' ASN . . . . . . . . . . . . . 5.4 t-20 -143.58 -43.23 0.28 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.137 -0.977 . . . . 0.0 110.129 -179.973 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 821' ' ' PHE . . . . . 0.433 ' CD2' HG21 ' A' ' 801' ' ' VAL . 33.3 m-85 -83.08 -57.29 3.34 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.428 -0.795 . . . . 0.0 110.501 -179.949 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 822' ' ' GLY . . . . . . . . . . . . . . . 147.21 66.76 0.01 OUTLIER Glycine 0 N--CA 1.491 2.349 0 C-N-CA 119.512 -1.328 . . . . 0.0 110.111 179.953 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 823' ' ' GLY . . . . . . . . . . . . . . . 120.4 170.5 14.26 Favored Glycine 0 N--CA 1.493 2.497 0 O-C-N 121.12 -1.224 . . . . 0.0 110.267 179.917 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 824' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -132.05 65.82 76.17 Favored Pre-proline 0 N--CA 1.494 1.733 0 O-C-N 121.583 -0.951 . . . . 0.0 109.814 179.986 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 825' ' ' PRO . . . . . 0.459 ' C ' ' HD3' ' A' ' 827' ' ' PRO . 48.7 Cg_endo -74.43 -3.42 13.82 Favored 'Trans proline' 0 C--N 1.305 -1.732 0 O-C-N 124.195 1.629 . . . . 0.0 111.122 -179.915 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 826' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER -126.44 64.83 57.25 Favored Pre-proline 0 N--CA 1.499 2.016 0 O-C-N 120.984 -1.072 . . . . 0.0 110.184 -179.944 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 827' ' ' PRO . . . . . 0.459 ' HD3' ' C ' ' A' ' 825' ' ' PRO . 50.0 Cg_endo -82.36 153.53 16.08 Favored 'Trans proline' 0 C--N 1.311 -1.416 0 O-C-N 123.897 1.472 . . . . 0.0 110.886 179.989 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 828' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 57.71 39.77 27.0 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.448 -0.782 . . . . 0.0 110.781 -179.993 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 829' ' ' VAL . . . . . 0.417 ' O ' ' C ' ' A' ' 830' ' ' MET . 54.3 t -137.45 139.76 42.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.176 -0.953 . . . . 0.0 110.116 179.974 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 830' ' ' MET . . . . . 0.417 ' C ' ' O ' ' A' ' 829' ' ' VAL . 0.2 OUTLIER -44.33 144.61 0.97 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.238 -0.913 . . . . 0.0 109.816 -179.911 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 831' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.2 105.79 18.05 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.233 -0.917 . . . . 0.0 110.689 -179.972 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 832' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -128.2 116.68 20.27 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.493 -0.754 . . . . 0.0 109.404 179.945 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 833' ' ' VAL . . . . . 0.825 HG21 HG23 ' A' ' 816' ' ' ILE . 3.3 t -109.86 116.87 53.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.165 -0.959 . . . . 0.0 110.876 -179.931 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 834' ' ' ALA . . . . . 0.572 ' O ' HG23 ' A' ' 835' ' ' VAL . . . -118.25 148.87 41.99 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.478 -0.764 . . . . 0.0 109.229 179.949 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 835' ' ' VAL . . . . . 0.572 HG23 ' O ' ' A' ' 834' ' ' ALA . 46.7 t -155.06 162.84 1.72 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.519 0 O-C-N 120.904 -1.123 . . . . 0.0 111.051 -179.914 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 836' ' ' GLU . . . . . 0.439 ' N ' HG12 ' A' ' 835' ' ' VAL . 2.6 tt0 -145.76 118.12 8.45 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.629 -0.669 . . . . 0.0 109.587 179.934 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 837' ' ' ALA . . . . . 0.421 ' HB3' ' CG2' ' A' ' 731' ' ' VAL . . . -108.12 161.17 15.22 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.152 -0.968 . . . . 0.0 110.372 -179.947 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 838' ' ' VAL . . . . . . . . . . . . . 38.8 t -128.28 130.7 69.47 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.394 -0.816 . . . . 0.0 110.0 179.926 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 839' ' ' CYS . . . . . . . . . . . . . 2.5 m -109.82 146.47 34.99 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.179 -0.95 . . . . 0.0 110.343 -179.961 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 840' ' ' SER . . . . . . . . . . . . . 67.2 p -131.01 -169.83 2.24 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.351 -0.843 . . . . 0.0 109.861 179.938 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 841' ' ' THR . . . . . 0.677 ' O ' ' HB3' ' A' ' 842' ' ' ALA . 0.2 OUTLIER -111.23 20.03 17.76 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.221 -0.925 . . . . 0.0 110.143 -179.96 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 842' ' ' ALA . . . . . 0.677 ' HB3' ' O ' ' A' ' 841' ' ' THR . . . 66.91 166.34 0.22 Allowed 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.536 -0.727 . . . . 0.0 110.435 179.914 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 843' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.577 0 CA-C-O 117.973 -1.013 . . . . 0.0 110.158 -179.98 . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 726' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.699 0 CA-C-O 121.265 0.555 . . . . 0.0 110.263 . . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 727' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -127.97 171.49 11.78 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.324 -0.86 . . . . 0.0 110.268 179.992 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 728' ' ' VAL . . . . . 0.439 ' O ' ' O ' ' A' ' 839' ' ' CYS . 32.5 t -149.77 159.78 5.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.254 -0.904 . . . . 0.0 110.07 -179.962 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 729' ' ' SER . . . . . 0.425 ' OG ' ' O ' ' A' ' 728' ' ' VAL . 0.9 OUTLIER 178.1 120.88 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.127 -0.983 . . . . 0.0 110.432 -179.95 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 730' ' ' GLY . . . . . . . . . . . . . . . 149.34 99.32 0.2 Allowed Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.767 -1.333 . . . . 0.0 109.767 -179.979 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 731' ' ' VAL . . . . . . . . . . . . . 73.1 t -142.15 148.98 19.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.282 -1.128 . . . . 0.0 109.869 179.979 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 732' ' ' CYS . . . . . . . . . . . . . 92.5 m -122.62 166.3 15.08 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.256 -0.902 . . . . 0.0 110.922 -179.971 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 733' ' ' ALA . . . . . 0.439 ' HB3' ' O ' ' A' ' 835' ' ' VAL . . . -160.96 102.09 1.28 Allowed 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 179.883 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 734' ' ' ASP . . . . . 0.565 ' C ' HG23 ' A' ' 735' ' ' VAL . 3.2 t70 -131.28 122.64 26.81 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.174 -0.954 . . . . 0.0 110.366 -179.944 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 735' ' ' VAL . . . . . 0.565 HG23 ' C ' ' A' ' 734' ' ' ASP . 40.6 t -153.25 153.06 9.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.35 -0.844 . . . . 0.0 110.152 179.979 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 736' ' ' SER . . . . . . . . . . . . . 12.3 t -110.31 152.25 26.41 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.159 -0.963 . . . . 0.0 110.207 -179.962 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 737' ' ' GLU . . . . . 0.472 ' OE2' ' HB2' ' A' ' 739' ' ' HIS . 2.1 tm-20 -52.59 -176.59 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.226 -0.921 . . . . 0.0 110.225 179.981 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 738' ' ' TYR . . . . . 0.469 ' O ' ' HB3' ' A' ' 739' ' ' HIS . 7.5 t80 -126.61 -47.91 1.55 Allowed 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.21 -0.931 . . . . 0.0 110.437 179.998 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 739' ' ' HIS . . . . . 0.524 ' O ' ' CD1' ' A' ' 742' ' ' ILE . 19.6 t-160 62.77 103.47 0.03 OUTLIER Pre-proline 0 N--CA 1.493 1.709 0 O-C-N 121.292 -0.88 . . . . 0.0 110.424 179.941 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 740' ' ' PRO . . . . . 0.449 ' HD3' ' O ' ' A' ' 756' ' ' HIS . 48.7 Cg_endo -86.54 51.42 2.54 Favored 'Trans proline' 0 C--N 1.303 -1.842 0 O-C-N 123.954 1.502 . . . . 0.0 110.152 179.977 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 741' ' ' ASN . . . . . 0.662 ' H ' HD12 ' A' ' 742' ' ' ILE . 15.3 t30 -160.63 80.01 0.65 Allowed 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.143 -0.973 . . . . 0.0 110.682 -179.976 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 742' ' ' ILE . . . . . 0.662 HD12 ' H ' ' A' ' 741' ' ' ASN . 4.3 mp -144.26 -97.28 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.233 -0.917 . . . . 0.0 110.024 179.933 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 743' ' ' LYS . . . . . 0.495 ' N ' HG22 ' A' ' 742' ' ' ILE . 0.0 OUTLIER 174.6 -71.92 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.134 -0.978 . . . . 0.0 109.656 179.984 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 744' ' ' ASN . . . . . 0.466 ' O ' ' O ' ' A' ' 745' ' ' TRP . 9.9 p30 -86.3 3.9 41.34 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.322 -0.861 . . . . 0.0 109.938 179.951 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 745' ' ' TRP . . . . . 0.466 ' O ' ' O ' ' A' ' 744' ' ' ASN . 28.1 m95 41.19 -165.53 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.348 -0.845 . . . . 0.0 110.635 179.944 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 746' ' ' GLN . . . . . 0.721 ' C ' HD12 ' A' ' 747' ' ' ILE . 17.6 mt-30 -152.83 34.08 0.49 Allowed 'General case' 0 C--N 1.3 -1.576 0 O-C-N 121.247 -0.908 . . . . 0.0 110.133 -179.932 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 747' ' ' ILE . . . . . 0.721 HD12 ' C ' ' A' ' 746' ' ' GLN . 2.1 mp -116.14 170.79 5.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.237 -0.914 . . . . 0.0 110.331 179.987 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 748' ' ' GLU . . . . . 0.536 ' N ' HG22 ' A' ' 747' ' ' ILE . 2.2 mp0 -87.61 31.53 0.75 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.253 -0.904 . . . . 0.0 110.352 -179.939 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 749' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -156.58 93.85 1.42 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.224 -0.922 . . . . 0.0 110.226 -179.977 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 750' ' ' TYR . . . . . . . . . . . . . 76.6 m-85 -55.45 147.53 17.34 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.264 -0.897 . . . . 0.0 110.146 179.994 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 751' ' ' GLY . . . . . 0.421 ' O ' ' C ' ' A' ' 752' ' ' GLU . . . 101.9 124.67 5.45 Favored Glycine 0 N--CA 1.488 2.155 0 N-CA-C 109.08 -1.608 . . . . 0.0 109.08 -179.979 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 752' ' ' GLU . . . . . 0.421 ' C ' ' O ' ' A' ' 751' ' ' GLY . 3.0 pt-20 -42.89 108.78 0.68 Allowed Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.278 -1.131 . . . . 0.0 110.285 -179.995 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 753' ' ' PRO . . . . . 0.561 ' O ' ' CG ' ' A' ' 754' ' ' GLU . 49.2 Cg_endo -78.79 70.84 7.23 Favored 'Trans proline' 0 C--N 1.309 -1.548 0 O-C-N 124.055 1.555 . . . . 0.0 110.702 -179.952 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 754' ' ' GLU . . . . . 0.561 ' CG ' ' O ' ' A' ' 753' ' ' PRO . 4.5 pt-20 42.56 -177.56 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.309 0 CA-C-O 121.663 0.744 . . . . 0.0 111.579 179.967 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 755' ' ' PHE . . . . . 0.471 ' O ' ' O ' ' A' ' 754' ' ' GLU . 0.2 OUTLIER 50.8 171.24 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.446 -0.784 . . . . 0.0 110.955 179.979 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 756' ' ' HIS . . . . . 0.449 ' O ' ' HD3' ' A' ' 740' ' ' PRO . 57.5 m80 -126.98 -32.72 2.51 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.36 -0.838 . . . . 0.0 109.772 179.968 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 757' ' ' THR . . . . . . . . . . . . . 39.0 p -108.77 -159.33 0.68 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.368 -0.833 . . . . 0.0 110.098 179.972 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 758' ' ' ALA . . . . . . . . . . . . . . . -114.13 176.14 5.17 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.218 -0.926 . . . . 0.0 110.007 179.974 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 759' ' ' LYS . . . . . 0.466 ' HD3' ' CZ ' ' A' ' 755' ' ' PHE . 32.2 mtmt -144.44 161.99 37.64 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.213 -0.929 . . . . 0.0 110.345 -179.963 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 760' ' ' VAL . . . . . . . . . . . . . 59.6 t -109.28 158.61 9.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.435 -0.791 . . . . 0.0 109.276 179.971 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 761' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -122.47 122.61 39.36 Favored 'General case' 0 C--N 1.298 -1.641 0 O-C-N 121.051 -1.03 . . . . 0.0 110.912 179.978 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 762' ' ' LEU . . . . . 0.495 ' HB2' ' O ' ' A' ' 812' ' ' CYS . 5.6 mt -141.4 135.97 30.92 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.462 -0.774 . . . . 0.0 109.323 179.918 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 763' ' ' LYS . . . . . . . . . . . . . 3.8 mtmt -150.38 151.17 32.42 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.009 -1.057 . . . . 0.0 110.944 -179.938 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 764' ' ' CYS . . . . . . . . . . . . . 9.2 m -127.54 172.88 10.32 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.538 -0.726 . . . . 0.0 109.622 179.963 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 765' ' ' ALA . . . . . 0.451 ' HB3' ' OE1' ' A' ' 768' ' ' GLN . . . -68.11 158.49 83.9 Favored Pre-proline 0 N--CA 1.493 1.681 0 O-C-N 121.109 -0.994 . . . . 0.0 109.947 179.947 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 766' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -72.33 119.02 5.88 Favored 'Trans proline' 0 C--N 1.306 -1.703 0 O-C-N 123.932 1.491 . . . . 0.0 110.338 179.987 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 767' ' ' GLY . . . . . . . . . . . . . . . 112.98 -6.67 25.52 Favored Glycine 0 N--CA 1.489 2.201 0 N-CA-C 109.485 -1.446 . . . . 0.0 109.485 -179.911 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 768' ' ' GLN . . . . . 0.511 ' C ' HG23 ' A' ' 769' ' ' THR . 33.6 mt-30 -114.27 169.75 8.8 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.145 -1.209 . . . . 0.0 110.463 179.969 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 769' ' ' THR . . . . . 0.511 HG23 ' C ' ' A' ' 768' ' ' GLN . 70.5 p -152.2 149.47 28.77 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.358 -0.839 . . . . 0.0 109.866 -179.97 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 770' ' ' ILE . . . . . 0.478 HD12 ' O ' ' A' ' 806' ' ' CYS . 26.9 mt -70.27 141.38 17.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.088 -1.008 . . . . 0.0 109.722 -179.985 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 771' ' ' SER . . . . . . . . . . . . . 1.6 p -126.44 -13.18 6.08 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.168 -0.958 . . . . 0.0 110.587 -179.943 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 772' ' ' ALA . . . . . . . . . . . . . . . -158.08 159.66 36.52 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 120.97 -1.081 . . . . 0.0 111.426 -179.906 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 773' ' ' ILE . . . . . . . . . . . . . 34.8 mm -124.15 123.31 66.32 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 O-C-N 121.644 -0.66 . . . . 0.0 109.296 179.936 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 774' ' ' LYS . . . . . 0.551 ' HG3' ' CG2' ' A' ' 838' ' ' VAL . 0.3 OUTLIER -80.82 -41.4 23.35 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.125 -0.984 . . . . 0.0 110.933 -179.869 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 775' ' ' PHE . . . . . 0.71 ' O ' ' HB2' ' A' ' 776' ' ' ALA . 48.7 t80 -135.5 173.59 11.55 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.069 -1.019 . . . . 0.0 111.088 -179.892 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 776' ' ' ALA . . . . . 0.71 ' HB2' ' O ' ' A' ' 775' ' ' PHE . . . 166.47 87.03 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.644 -0.66 . . . . 0.0 109.314 179.999 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 777' ' ' SER . . . . . 0.473 ' OG ' ' CZ ' ' A' ' 775' ' ' PHE . 16.1 p -119.61 129.84 54.81 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.236 -0.915 . . . . 0.0 110.709 -179.892 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 778' ' ' PHE . . . . . 0.603 ' CD2' HG22 ' A' ' 833' ' ' VAL . 39.4 t80 -104.72 78.54 1.45 Allowed 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.294 -0.879 . . . . 0.0 110.024 179.944 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 779' ' ' GLY . . . . . 0.461 ' C ' ' HD3' ' A' ' 781' ' ' PRO . . . -168.79 -105.42 0.18 Allowed Glycine 0 N--CA 1.492 2.408 0 N-CA-C 109.686 -1.366 . . . . 0.0 109.686 179.997 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 780' ' ' THR . . . . . . . . . . . . . 2.4 p -121.17 63.24 12.16 Favored Pre-proline 0 N--CA 1.493 1.686 0 O-C-N 121.229 -1.159 . . . . 0.0 110.548 -179.973 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 781' ' ' PRO . . . . . 0.496 ' HD2' ' HB3' ' A' ' 832' ' ' ARG . 46.1 Cg_endo -75.98 146.66 29.51 Favored 'Trans proline' 0 C--N 1.305 -1.726 0 O-C-N 124.068 1.562 . . . . 0.0 111.142 179.983 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 782' ' ' LEU . . . . . 0.76 HD21 ' O ' ' A' ' 790' ' ' GLN . 1.8 pt? -149.54 159.56 44.21 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.452 -0.78 . . . . 0.0 109.64 179.928 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 783' ' ' GLY . . . . . 0.416 ' O ' HG23 ' A' ' 784' ' ' THR . . . 140.48 -131.22 4.91 Favored Glycine 0 N--CA 1.496 2.66 0 N-CA-C 109.591 -1.404 . . . . 0.0 109.591 -179.96 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 784' ' ' THR . . . . . 0.416 HG23 ' O ' ' A' ' 783' ' ' GLY . 0.0 OUTLIER -162.14 -158.02 0.51 Allowed 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.121 -1.223 . . . . 0.0 110.68 -179.969 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 785' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -72.95 119.32 17.03 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.366 -0.834 . . . . 0.0 110.54 -179.989 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 786' ' ' GLY . . . . . . . . . . . . . . . 82.63 -10.63 55.5 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.895 -1.282 . . . . 0.0 109.895 -179.98 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 787' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -124.25 30.0 6.2 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.13 -1.218 . . . . 0.0 110.133 -179.989 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 788' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -58.62 91.82 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.276 -0.89 . . . . 0.0 110.387 -180.0 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 789' ' ' GLN . . . . . . . . . . . . . 4.1 tt0 -75.5 -177.24 3.53 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.405 -0.809 . . . . 0.0 110.162 -179.957 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 790' ' ' GLN . . . . . 0.76 ' O ' HD21 ' A' ' 782' ' ' LEU . 0.0 OUTLIER -108.05 174.01 6.07 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.443 -0.786 . . . . 0.0 110.307 179.992 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 791' ' ' GLY . . . . . . . . . . . . . . . -106.87 -140.82 9.87 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.519 -1.432 . . . . 0.0 109.519 179.945 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 792' ' ' GLU . . . . . 0.4 ' HG2' ' N ' ' A' ' 793' ' ' CYS . 1.5 pt-20 -105.17 -24.03 12.81 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.174 -1.192 . . . . 0.0 110.144 -179.967 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 793' ' ' CYS . . . . . 0.4 ' N ' ' HG2' ' A' ' 792' ' ' GLU . 5.7 t -126.22 145.66 50.3 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.281 -0.887 . . . . 0.0 109.974 -179.887 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 794' ' ' HIS . . . . . . . . . . . . . 23.6 t-80 -139.46 156.11 47.15 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.18 -0.95 . . . . 0.0 110.146 -179.943 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 795' ' ' SER . . . . . . . . . . . . . 1.3 t -81.56 -141.62 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.322 -0.861 . . . . 0.0 110.165 179.995 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 796' ' ' ILE . . . . . . . . . . . . . 1.5 pt -145.53 12.71 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.241 -0.912 . . . . 0.0 110.038 -179.971 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 797' ' ' ASN . . . . . . . . . . . . . 78.7 m-20 -148.99 29.16 0.82 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.328 -0.857 . . . . 0.0 110.08 179.999 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 798' ' ' SER . . . . . 0.514 ' CB ' ' O ' ' A' ' 776' ' ' ALA . 7.6 m -71.41 -30.47 66.13 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.218 -0.926 . . . . 0.0 110.625 -179.995 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 799' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -102.33 -7.89 21.67 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.244 -0.91 . . . . 0.0 110.349 179.967 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 800' ' ' SER . . . . . . . . . . . . . 5.8 p -90.46 -22.3 21.46 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.174 -0.954 . . . . 0.0 110.477 179.987 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 801' ' ' VAL . . . . . 0.502 ' O ' ' HG2' ' A' ' 805' ' ' LYS . 55.6 t -81.59 -39.05 16.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.104 -0.997 . . . . 0.0 109.949 179.977 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 802' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -70.6 -56.29 6.84 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.33 -0.856 . . . . 0.0 110.536 -179.95 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 803' ' ' GLU . . . . . 0.531 ' HG2' HD12 ' A' ' 807' ' ' ILE . 2.3 tt0 -48.97 -19.8 0.44 Allowed 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.158 -0.964 . . . . 0.0 110.946 -179.921 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 804' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.71 -46.8 8.03 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.993 -1.067 . . . . 0.0 111.328 -179.893 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 805' ' ' LYS . . . . . 0.961 ' HE2' HG22 ' A' ' 814' ' ' VAL . 0.0 OUTLIER -115.93 47.53 1.36 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.952 -1.092 . . . . 0.0 111.329 -179.829 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 806' ' ' CYS . . . . . 0.478 ' O ' HD12 ' A' ' 770' ' ' ILE . 2.4 t -150.22 -44.52 0.13 Allowed 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.056 -1.028 . . . . 0.0 110.225 179.937 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 807' ' ' ILE . . . . . 0.531 HD12 ' HG2' ' A' ' 803' ' ' GLU . 36.7 mt -80.89 129.17 37.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.188 -0.945 . . . . 0.0 110.151 -179.95 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 808' ' ' GLY . . . . . . . . . . . . . . . 110.86 -9.27 29.74 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 109.897 -1.281 . . . . 0.0 109.897 179.988 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 809' ' ' LEU . . . . . . . . . . . . . 7.8 mt -113.64 154.51 27.1 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.05 -1.265 . . . . 0.0 110.77 -179.979 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 810' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -69.93 -29.74 66.97 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.321 -0.862 . . . . 0.0 109.237 179.869 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 811' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -132.42 165.03 25.21 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.606 -0.684 . . . . 0.0 109.527 -179.993 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 812' ' ' CYS . . . . . 0.495 ' O ' ' HB2' ' A' ' 762' ' ' LEU . 22.8 t -143.12 135.12 26.93 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.079 -1.013 . . . . 0.0 110.839 179.986 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 813' ' ' VAL . . . . . 0.442 ' O ' ' CG1' ' A' ' 813' ' ' VAL . 3.0 p -144.16 129.45 14.82 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 O-C-N 121.464 -0.772 . . . . 0.0 109.192 179.856 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 814' ' ' VAL . . . . . 0.961 HG22 ' HE2' ' A' ' 805' ' ' LYS . 30.2 t -134.59 145.59 32.35 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.068 -1.02 . . . . 0.0 110.849 -179.895 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 815' ' ' ALA . . . . . . . . . . . . . . . -87.28 165.3 15.75 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.404 -0.81 . . . . 0.0 109.965 179.934 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 816' ' ' ILE . . . . . 0.494 HG12 HG21 ' A' ' 833' ' ' VAL . 71.9 mt -111.05 101.15 12.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.121 -0.987 . . . . 0.0 110.28 -179.94 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 817' ' ' SER . . . . . 0.462 ' HB2' ' HD2' ' A' ' 818' ' ' PRO . 1.4 p -155.25 176.34 2.59 Favored Pre-proline 0 N--CA 1.494 1.774 0 O-C-N 121.395 -0.815 . . . . 0.0 110.179 179.955 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 818' ' ' PRO . . . . . 0.462 ' HD2' ' HB2' ' A' ' 817' ' ' SER . 48.4 Cg_endo -76.18 -59.95 0.04 OUTLIER 'Trans proline' 0 C--N 1.309 -1.548 0 O-C-N 123.998 1.525 . . . . 0.0 111.19 -179.888 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 819' ' ' SER . . . . . . . . . . . . . 36.8 t -58.55 -42.45 87.9 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.19 -0.944 . . . . 0.0 110.59 -179.968 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 820' ' ' ASN . . . . . . . . . . . . . 18.3 t-20 -47.19 -23.83 0.59 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.218 -0.926 . . . . 0.0 110.322 -179.954 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 821' ' ' PHE . . . . . 0.423 ' CD2' HG21 ' A' ' 801' ' ' VAL . 15.6 m-85 -107.07 -96.08 0.37 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.146 -0.971 . . . . 0.0 110.715 -179.928 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 822' ' ' GLY . . . . . . . . . . . . . . . -141.8 8.18 2.49 Favored Glycine 0 N--CA 1.491 2.339 0 C-N-CA 119.648 -1.263 . . . . 0.0 110.163 -179.971 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 823' ' ' GLY . . . . . . . . . . . . . . . 124.59 -123.08 4.97 Favored Glycine 0 N--CA 1.492 2.376 0 O-C-N 120.999 -1.295 . . . . 0.0 109.966 179.972 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 824' ' ' ASP . . . . . 0.421 ' HA ' ' HD3' ' A' ' 825' ' ' PRO . 69.8 m-20 -80.42 134.99 53.98 Favored Pre-proline 0 N--CA 1.496 1.826 0 O-C-N 121.286 -1.126 . . . . 0.0 110.476 -179.943 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 825' ' ' PRO . . . . . 0.421 ' HD3' ' HA ' ' A' ' 824' ' ' ASP . 50.6 Cg_endo -83.83 -64.05 0.02 OUTLIER 'Trans proline' 0 C--N 1.308 -1.586 0 O-C-N 123.963 1.507 . . . . 0.0 110.425 179.905 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 826' ' ' CYS . . . . . 0.454 ' HB3' ' HB ' ' A' ' 829' ' ' VAL . 0.7 OUTLIER -147.42 149.71 35.25 Favored Pre-proline 0 N--CA 1.494 1.76 0 O-C-N 121.325 -0.859 . . . . 0.0 110.319 179.96 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 827' ' ' PRO . . . . . 0.441 ' O ' ' HB2' ' A' ' 828' ' ' GLU . 46.8 Cg_endo -74.3 134.57 19.26 Favored 'Trans proline' 0 C--N 1.305 -1.713 0 O-C-N 123.977 1.514 . . . . 0.0 110.694 -179.961 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 828' ' ' GLU . . . . . 0.441 ' HB2' ' O ' ' A' ' 827' ' ' PRO . 64.8 mm-40 55.77 39.7 30.76 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.315 -0.866 . . . . 0.0 110.43 179.984 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 829' ' ' VAL . . . . . 0.454 ' HB ' ' HB3' ' A' ' 826' ' ' CYS . 18.1 t -142.48 136.61 28.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.177 -0.952 . . . . 0.0 110.373 179.987 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 830' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -63.26 -149.66 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.245 -0.909 . . . . 0.0 109.856 -179.993 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 831' ' ' LYS . . . . . 0.471 ' HG3' ' HG3' ' A' ' 737' ' ' GLU . 0.0 OUTLIER -145.34 94.92 2.58 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 120.962 -1.086 . . . . 0.0 110.834 179.962 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 832' ' ' ARG . . . . . 0.496 ' HB3' ' HD2' ' A' ' 781' ' ' PRO . 0.0 OUTLIER -109.56 166.75 10.65 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.305 -0.872 . . . . 0.0 109.408 179.911 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 833' ' ' VAL . . . . . 0.603 HG22 ' CD2' ' A' ' 778' ' ' PHE . 37.0 t -142.93 120.7 6.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 120.928 -1.108 . . . . 0.0 111.763 -179.914 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 834' ' ' ALA . . . . . . . . . . . . . . . -125.31 104.1 8.3 Favored 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 107.87 -1.159 . . . . 0.0 107.87 179.769 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 835' ' ' VAL . . . . . 0.439 ' O ' ' HB3' ' A' ' 733' ' ' ALA . 67.1 t -109.5 153.56 11.23 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.579 0 O-C-N 121.153 -0.967 . . . . 0.0 112.453 -179.674 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 836' ' ' GLU . . . . . 0.448 ' OE1' ' HB2' ' A' ' 774' ' ' LYS . 31.2 tt0 -135.11 122.41 21.69 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 107.185 -1.413 . . . . 0.0 107.185 179.694 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 837' ' ' ALA . . . . . . . . . . . . . . . -113.62 161.81 16.99 Favored 'General case' 0 N--CA 1.501 2.087 0 O-C-N 120.719 -1.238 . . . . 0.0 112.722 -179.669 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 838' ' ' VAL . . . . . 0.551 ' CG2' ' HG3' ' A' ' 774' ' ' LYS . 23.9 t -118.75 105.56 17.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 179.852 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 839' ' ' CYS . . . . . 0.439 ' O ' ' O ' ' A' ' 728' ' ' VAL . 0.0 OUTLIER -107.98 140.71 40.72 Favored 'General case' 0 C--N 1.3 -1.585 0 O-C-N 120.975 -1.078 . . . . 0.0 110.462 -179.867 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 840' ' ' SER . . . . . . . . . . . . . 71.2 p -163.76 177.7 8.45 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.474 -0.766 . . . . 0.0 110.047 179.962 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 841' ' ' THR . . . . . 0.455 ' O ' ' O ' ' A' ' 842' ' ' ALA . 11.6 p -87.58 108.0 18.86 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.101 -0.999 . . . . 0.0 110.199 -179.956 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 842' ' ' ALA . . . . . 0.455 ' O ' ' O ' ' A' ' 841' ' ' THR . . . 53.66 169.28 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.232 -0.917 . . . . 0.0 110.134 179.985 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 843' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.674 0 CA-C-O 117.978 -1.011 . . . . 0.0 110.283 179.976 . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A ' 726' ' ' ARG . . . . . . . . . . . . . 35.8 mtm180 . . . . . 0 N--CA 1.492 1.662 0 CA-C-O 121.215 0.531 . . . . 0.0 110.224 . . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A ' 727' ' ' THR . . . . . 0.569 HG22 ' OE1' ' A' ' 768' ' ' GLN . 7.0 m -75.2 88.15 2.48 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.224 -0.922 . . . . 0.0 110.099 179.988 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 728' ' ' VAL . . . . . 0.703 ' O ' HG13 ' A' ' 728' ' ' VAL . 9.5 p -121.68 61.58 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.223 -0.923 . . . . 0.0 110.403 180.0 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 729' ' ' SER . . . . . . . . . . . . . 36.2 t -63.88 159.45 19.68 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.146 -0.971 . . . . 0.0 110.068 -179.997 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 730' ' ' GLY . . . . . . . . . . . . . . . -113.95 155.67 16.16 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.494 -1.443 . . . . 0.0 109.494 -179.995 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 731' ' ' VAL . . . . . . . . . . . . . 73.4 t -119.73 158.91 21.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.142 -1.21 . . . . 0.0 110.086 -179.932 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 732' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -131.09 125.14 32.38 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.177 -0.952 . . . . 0.0 110.02 179.996 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 733' ' ' ALA . . . . . . . . . . . . . . . -115.25 109.57 18.16 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.236 -0.915 . . . . 0.0 110.377 179.973 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 734' ' ' ASP . . . . . 0.525 ' C ' HG23 ' A' ' 735' ' ' VAL . 5.0 t0 -118.11 108.93 15.8 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.19 -0.944 . . . . 0.0 110.159 -179.987 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 735' ' ' VAL . . . . . 0.525 HG23 ' C ' ' A' ' 734' ' ' ASP . 96.3 t -152.1 145.39 15.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.287 -0.883 . . . . 0.0 110.182 179.998 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 736' ' ' SER . . . . . . . . . . . . . 66.6 p -93.18 -161.99 0.89 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.175 -0.953 . . . . 0.0 110.386 179.898 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 737' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 -115.25 72.26 0.79 Allowed 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.292 -0.88 . . . . 0.0 110.26 179.955 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 738' ' ' TYR . . . . . . . . . . . . . 70.9 t80 -171.36 141.63 1.59 Allowed 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.275 -0.891 . . . . 0.0 110.122 179.99 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 739' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -92.97 118.91 68.02 Favored Pre-proline 0 N--CA 1.493 1.693 0 O-C-N 121.118 -0.989 . . . . 0.0 110.234 179.993 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 740' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -78.23 -17.9 12.97 Favored 'Trans proline' 0 C--N 1.308 -1.59 0 O-C-N 123.892 1.47 . . . . 0.0 111.103 -179.954 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 741' ' ' ASN . . . . . . . . . . . . . 8.9 p-10 -172.92 130.07 0.5 Allowed 'General case' 0 N--CA 1.497 1.92 0 O-C-N 120.863 -1.148 . . . . 0.0 110.95 -179.965 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 742' ' ' ILE . . . . . 0.429 ' O ' ' N ' ' A' ' 744' ' ' ASN . 1.8 pt -130.42 -16.57 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.013 0 O-C-N 121.335 -0.853 . . . . 0.0 110.45 179.963 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 743' ' ' LYS . . . . . 0.472 ' HG2' ' N ' ' A' ' 744' ' ' ASN . 0.9 OUTLIER 52.52 -92.13 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.035 -1.041 . . . . 0.0 110.346 -179.962 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 744' ' ' ASN . . . . . 0.472 ' N ' ' HG2' ' A' ' 743' ' ' LYS . 87.5 m-20 -133.23 119.11 19.41 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.25 -0.906 . . . . 0.0 110.114 -179.984 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 745' ' ' TRP . . . . . . . . . . . . . 7.8 m95 -56.79 150.81 15.43 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.213 -0.929 . . . . 0.0 110.405 179.971 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 746' ' ' GLN . . . . . . . . . . . . . 28.2 tp60 -127.87 85.75 2.39 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.263 -0.898 . . . . 0.0 110.045 179.937 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 747' ' ' ILE . . . . . . . . . . . . . 43.9 pt -136.07 -171.63 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.319 -0.863 . . . . 0.0 110.376 -179.972 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 748' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -83.8 -41.46 17.54 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.256 -0.903 . . . . 0.0 110.189 179.876 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 749' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -80.06 176.82 9.4 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.324 -0.86 . . . . 0.0 110.224 179.958 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 750' ' ' TYR . . . . . . . . . . . . . 28.1 m-85 -131.49 175.34 9.23 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.208 -0.932 . . . . 0.0 110.223 -179.97 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 751' ' ' GLY . . . . . . . . . . . . . . . 122.0 174.04 14.54 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.625 -1.39 . . . . 0.0 109.625 -179.991 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 752' ' ' GLU . . . . . . . . . . . . . 6.2 tt0 -122.24 115.92 29.95 Favored Pre-proline 0 N--CA 1.492 1.656 0 O-C-N 121.3 -1.117 . . . . 0.0 110.02 -179.998 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 753' ' ' PRO . . . . . 0.474 ' HB2' ' CD1' ' A' ' 755' ' ' PHE . 46.7 Cg_endo -73.5 159.56 46.07 Favored 'Trans proline' 0 C--N 1.308 -1.567 0 O-C-N 123.955 1.502 . . . . 0.0 110.525 -179.928 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 754' ' ' GLU . . . . . . . . . . . . . 7.2 mt-10 -119.46 29.69 7.49 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.276 -0.89 . . . . 0.0 110.289 179.992 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 755' ' ' PHE . . . . . 0.474 ' CD1' ' HB2' ' A' ' 753' ' ' PRO . 18.8 p90 -128.43 136.68 51.2 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.189 -0.944 . . . . 0.0 110.48 -179.984 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 756' ' ' HIS . . . . . 0.495 ' C ' HG23 ' A' ' 757' ' ' THR . 70.7 m80 -112.73 130.33 56.1 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.296 -0.878 . . . . 0.0 109.826 179.938 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 757' ' ' THR . . . . . 0.495 HG23 ' C ' ' A' ' 756' ' ' HIS . 29.4 p -153.13 -170.39 3.61 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.199 -0.938 . . . . 0.0 110.38 -179.957 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 758' ' ' ALA . . . . . . . . . . . . . . . -140.85 166.14 25.59 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.393 -0.817 . . . . 0.0 109.758 -179.987 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 759' ' ' LYS . . . . . . . . . . . . . 8.2 mttt -113.38 166.31 11.61 Favored 'General case' 0 C--N 1.299 -1.618 0 O-C-N 121.232 -0.918 . . . . 0.0 110.3 179.993 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 760' ' ' VAL . . . . . 0.666 ' O ' HG13 ' A' ' 813' ' ' VAL . 80.3 t -105.56 150.11 8.51 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.463 0 O-C-N 121.311 -0.868 . . . . 0.0 108.873 179.91 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 761' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -125.73 103.95 8.09 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 120.916 -1.115 . . . . 0.0 111.607 -179.812 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 762' ' ' LEU . . . . . 0.501 HD23 ' HA ' ' A' ' 762' ' ' LEU . 17.8 mt -118.04 100.46 7.56 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 179.829 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 763' ' ' LYS . . . . . 0.418 ' HG2' ' HB2' ' A' ' 811' ' ' ARG . 0.0 OUTLIER -124.12 139.88 53.51 Favored 'General case' 0 C--N 1.3 -1.562 0 O-C-N 121.085 -1.009 . . . . 0.0 111.298 -179.829 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 764' ' ' CYS . . . . . 0.437 ' O ' ' C ' ' A' ' 765' ' ' ALA . 3.0 t -125.76 145.12 50.34 Favored 'General case' 0 C--N 1.299 -1.603 0 O-C-N 121.623 -0.673 . . . . 0.0 109.409 179.881 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 765' ' ' ALA . . . . . 0.437 ' C ' ' O ' ' A' ' 764' ' ' CYS . . . -41.1 161.78 0.12 Allowed Pre-proline 0 N--CA 1.495 1.782 0 O-C-N 121.164 -0.96 . . . . 0.0 110.494 179.983 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 766' ' ' PRO . . . . . 0.428 ' HD2' ' HB1' ' A' ' 765' ' ' ALA . 43.9 Cg_endo -70.55 102.47 1.16 Allowed 'Trans proline' 0 C--N 1.305 -1.726 0 O-C-N 123.94 1.495 . . . . 0.0 110.28 -179.963 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 767' ' ' GLY . . . . . . . . . . . . . . . 133.18 -21.71 4.08 Favored Glycine 0 N--CA 1.488 2.102 0 N-CA-C 109.025 -1.63 . . . . 0.0 109.025 -179.978 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 768' ' ' GLN . . . . . 0.569 ' OE1' HG22 ' A' ' 727' ' ' THR . 22.6 mt-30 -101.64 131.8 47.67 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.48 -1.012 . . . . 0.0 110.076 -179.999 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 769' ' ' THR . . . . . . . . . . . . . 16.9 p -125.57 147.37 49.31 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.113 -0.992 . . . . 0.0 110.232 179.965 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 770' ' ' ILE . . . . . 0.461 HG22 ' N ' ' A' ' 771' ' ' SER . 22.4 mt -59.92 166.88 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.205 -0.934 . . . . 0.0 109.639 179.964 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 771' ' ' SER . . . . . 0.461 ' N ' HG22 ' A' ' 770' ' ' ILE . 0.1 OUTLIER -160.33 -30.92 0.06 Allowed 'General case' 0 C--N 1.299 -1.621 0 O-C-N 121.094 -1.004 . . . . 0.0 111.152 -179.948 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 772' ' ' ALA . . . . . . . . . . . . . . . -135.78 122.67 21.25 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.852 -1.155 . . . . 0.0 111.402 -179.858 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 773' ' ' ILE . . . . . . . . . . . . . 38.2 mm -95.74 100.95 11.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.448 -0.783 . . . . 0.0 109.021 179.918 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 774' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.94 -37.89 28.71 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.163 -0.961 . . . . 0.0 111.284 -179.928 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 775' ' ' PHE . . . . . 0.724 ' O ' ' HB2' ' A' ' 776' ' ' ALA . 44.1 t80 -122.65 160.66 25.34 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 120.957 -1.089 . . . . 0.0 111.305 -179.843 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 776' ' ' ALA . . . . . 0.724 ' HB2' ' O ' ' A' ' 775' ' ' PHE . . . 166.28 100.64 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.607 -0.683 . . . . 0.0 109.616 179.989 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 777' ' ' SER . . . . . 0.49 ' HA ' ' HB3' ' A' ' 798' ' ' SER . 1.6 p -136.08 142.03 44.28 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.347 -0.846 . . . . 0.0 110.369 -179.909 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 778' ' ' PHE . . . . . 0.496 ' O ' ' CD2' ' A' ' 778' ' ' PHE . 68.8 t80 -120.87 73.74 1.03 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.44 -0.787 . . . . 0.0 110.298 -179.996 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 779' ' ' GLY . . . . . . . . . . . . . . . -161.57 -108.01 0.22 Allowed Glycine 0 N--CA 1.492 2.39 0 N-CA-C 109.544 -1.422 . . . . 0.0 109.544 -179.983 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 780' ' ' THR . . . . . . . . . . . . . 81.8 p -121.07 81.97 36.54 Favored Pre-proline 0 N--CA 1.489 1.506 0 O-C-N 121.187 -1.184 . . . . 0.0 110.161 -179.982 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 781' ' ' PRO . . . . . 0.476 ' CG ' ' HB3' ' A' ' 832' ' ' ARG . 47.5 Cg_endo -75.7 166.8 27.65 Favored 'Trans proline' 0 C--N 1.305 -1.733 0 O-C-N 124.103 1.581 . . . . 0.0 110.36 -179.974 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 782' ' ' LEU . . . . . . . . . . . . . 6.7 mt -140.74 131.81 26.27 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.252 -0.905 . . . . 0.0 110.134 179.999 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 783' ' ' GLY . . . . . . . . . . . . . . . 114.93 -165.86 12.11 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.638 -1.385 . . . . 0.0 109.638 -179.948 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 784' ' ' THR . . . . . 0.4 ' HA ' ' OD2' ' A' ' 734' ' ' ASP . 12.3 p -135.78 -50.1 0.71 Allowed 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.292 -1.123 . . . . 0.0 110.114 179.941 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 785' ' ' CYS . . . . . . . . . . . . . 22.5 t -173.26 87.84 0.07 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.291 -0.881 . . . . 0.0 109.854 -180.0 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 786' ' ' GLY . . . . . . . . . . . . . . . 142.34 -26.74 2.28 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 108.902 -1.679 . . . . 0.0 108.902 -179.897 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 787' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -127.17 30.19 5.46 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.487 -1.008 . . . . 0.0 109.82 179.989 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 788' ' ' PHE . . . . . 0.691 ' CE2' ' HB1' ' A' ' 834' ' ' ALA . 2.2 m-85 -51.93 121.08 6.07 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.307 -0.871 . . . . 0.0 110.245 179.993 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 789' ' ' GLN . . . . . . . . . . . . . 13.2 tt0 -133.74 120.76 20.97 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.302 -0.874 . . . . 0.0 110.274 -179.978 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 790' ' ' GLN . . . . . 0.468 ' CG ' ' O ' ' A' ' 790' ' ' GLN . 9.3 pt20 -64.96 126.21 27.31 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.251 -0.906 . . . . 0.0 110.549 -179.949 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 791' ' ' GLY . . . . . . . . . . . . . . . -69.43 -122.47 0.03 OUTLIER Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.311 -1.516 . . . . 0.0 109.311 179.948 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 792' ' ' GLU . . . . . . . . . . . . . 11.9 mt-10 -126.26 8.72 7.24 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.149 -1.207 . . . . 0.0 110.279 179.963 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 793' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -129.46 96.36 4.26 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.239 -0.913 . . . . 0.0 109.771 179.874 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 794' ' ' HIS . . . . . 0.514 ' CE1' ' O ' ' A' ' 795' ' ' SER . 34.1 t-80 -124.78 139.62 53.68 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.179 -0.95 . . . . 0.0 110.488 -179.934 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 795' ' ' SER . . . . . 0.514 ' O ' ' CE1' ' A' ' 794' ' ' HIS . 4.1 t -82.75 168.87 16.78 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.318 -0.864 . . . . 0.0 109.078 179.99 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 796' ' ' ILE . . . . . . . . . . . . . 1.7 mt -94.97 -7.88 9.79 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 O-C-N 120.857 -1.152 . . . . 0.0 110.095 -179.971 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 797' ' ' ASN . . . . . . . . . . . . . 4.8 m120 -107.38 38.65 2.08 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.288 -0.883 . . . . 0.0 109.387 179.877 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 798' ' ' SER . . . . . 0.49 ' HB3' ' HA ' ' A' ' 777' ' ' SER . 70.6 m -82.08 -52.54 6.91 Favored 'General case' 0 N--CA 1.485 1.317 0 O-C-N 121.51 -0.743 . . . . 0.0 111.184 -179.983 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 799' ' ' ASN . . . . . . . . . . . . . 47.2 t-20 -98.37 12.04 36.17 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.074 -1.017 . . . . 0.0 111.134 -179.923 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 800' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -89.29 -45.06 9.8 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.075 -1.015 . . . . 0.0 110.355 179.959 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 801' ' ' VAL . . . . . . . . . . . . . 8.7 t -74.96 -19.32 16.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.171 -0.956 . . . . 0.0 110.342 -179.974 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 802' ' ' LEU . . . . . 0.471 HD22 ' HA ' ' A' ' 802' ' ' LEU . 0.3 OUTLIER -74.2 -57.23 4.09 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.284 -0.885 . . . . 0.0 110.721 179.976 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 803' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -63.43 -18.33 63.61 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.213 -0.929 . . . . 0.0 110.543 -179.935 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 804' ' ' ARG . . . . . . . . . . . . . 3.2 mtm-85 -92.41 -16.74 25.52 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.237 -0.914 . . . . 0.0 112.066 -179.805 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 805' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.59 39.28 1.69 Allowed 'General case' 0 N--CA 1.502 2.143 0 O-C-N 120.466 -1.396 . . . . 0.0 112.594 -179.809 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 806' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -164.39 22.95 0.06 Allowed 'General case' 0 N--CA 1.501 2.112 0 O-C-N 120.58 -1.325 . . . . 0.0 111.024 179.921 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 807' ' ' ILE . . . . . . . . . . . . . 4.4 mt -125.32 119.33 55.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.093 -1.004 . . . . 0.0 109.939 179.914 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 808' ' ' GLY . . . . . . . . . . . . . . . 110.93 7.91 24.69 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.059 -1.616 . . . . 0.0 109.059 -179.889 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 809' ' ' LEU . . . . . . . . . . . . . 29.7 mt -123.65 138.34 54.55 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.287 -1.125 . . . . 0.0 109.876 179.968 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 810' ' ' GLU . . . . . . . . . . . . . 15.0 mp0 -63.04 -22.36 66.8 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.067 -1.021 . . . . 0.0 109.329 -179.992 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 811' ' ' ARG . . . . . 0.418 ' HB2' ' HG2' ' A' ' 763' ' ' LYS . 0.0 OUTLIER -154.56 122.88 6.03 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.519 -0.738 . . . . 0.0 109.881 179.94 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 812' ' ' CYS . . . . . 0.472 ' O ' ' HB2' ' A' ' 762' ' ' LEU . 6.0 p -129.47 139.07 51.71 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.126 -0.984 . . . . 0.0 110.241 -179.94 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 813' ' ' VAL . . . . . 0.666 HG13 ' O ' ' A' ' 760' ' ' VAL . 53.4 t -121.79 139.79 47.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.204 -0.935 . . . . 0.0 110.308 -179.952 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 814' ' ' VAL . . . . . . . . . . . . . 58.0 t -124.71 134.52 66.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.253 -0.905 . . . . 0.0 110.279 179.989 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 815' ' ' ALA . . . . . . . . . . . . . . . -82.32 149.56 27.7 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.288 -0.883 . . . . 0.0 109.927 -179.99 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 816' ' ' ILE . . . . . 0.548 ' CG2' HG21 ' A' ' 833' ' ' VAL . 22.0 mt -109.96 125.04 67.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.172 -0.955 . . . . 0.0 110.285 179.954 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 817' ' ' SER . . . . . 0.454 ' HB2' ' HD2' ' A' ' 818' ' ' PRO . 2.9 p -172.96 170.74 2.0 Favored Pre-proline 0 N--CA 1.492 1.659 0 O-C-N 121.148 -0.97 . . . . 0.0 110.314 179.993 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 818' ' ' PRO . . . . . 0.46 ' O ' ' HB3' ' A' ' 819' ' ' SER . 47.6 Cg_endo -74.84 158.39 42.82 Favored 'Trans proline' 0 C--N 1.305 -1.737 0 O-C-N 124.144 1.602 . . . . 0.0 110.743 -179.875 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 819' ' ' SER . . . . . 0.46 ' HB3' ' O ' ' A' ' 818' ' ' PRO . 7.5 t 63.01 9.85 4.05 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.361 -0.837 . . . . 0.0 110.842 179.983 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 820' ' ' ASN . . . . . . . . . . . . . 2.4 t30 -96.72 -44.18 7.21 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.097 -1.002 . . . . 0.0 110.208 179.988 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 821' ' ' PHE . . . . . . . . . . . . . 4.0 m-85 -89.94 -45.31 9.3 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.19 -0.944 . . . . 0.0 110.184 179.985 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 822' ' ' GLY . . . . . . . . . . . . . . . -167.43 -35.98 0.02 OUTLIER Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.61 -1.396 . . . . 0.0 109.61 -179.966 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 823' ' ' GLY . . . . . . . . . . . . . . . 159.82 -119.21 0.87 Allowed Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.648 -1.381 . . . . 0.0 109.648 -179.96 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 824' ' ' ASP . . . . . 0.463 ' OD1' ' O ' ' A' ' 824' ' ' ASP . 43.8 p-10 -148.19 101.76 3.58 Favored Pre-proline 0 N--CA 1.498 1.938 0 O-C-N 121.308 -1.113 . . . . 0.0 109.952 -179.997 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 825' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_endo -83.74 -53.22 0.03 OUTLIER 'Trans proline' 0 C--N 1.307 -1.631 0 O-C-N 123.907 1.477 . . . . 0.0 111.037 -179.968 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 826' ' ' CYS . . . . . 0.65 ' SG ' HG21 ' A' ' 829' ' ' VAL . 0.1 OUTLIER -77.56 129.1 78.09 Favored Pre-proline 0 N--CA 1.497 1.885 0 O-C-N 121.077 -1.014 . . . . 0.0 110.737 -179.876 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 827' ' ' PRO . . . . . 0.863 ' O ' HG23 ' A' ' 829' ' ' VAL . 51.2 Cg_endo -87.86 135.07 3.32 Favored 'Trans proline' 0 C--N 1.31 -1.461 0 O-C-N 123.911 1.479 . . . . 0.0 111.086 -179.97 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 828' ' ' GLU . . . . . 0.421 ' C ' ' O ' ' A' ' 827' ' ' PRO . 0.3 OUTLIER 39.29 47.57 1.48 Allowed 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.428 -0.795 . . . . 0.0 110.937 179.863 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 829' ' ' VAL . . . . . 0.863 HG23 ' O ' ' A' ' 827' ' ' PRO . 56.1 t -123.06 132.03 72.16 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.925 0 O-C-N 121.13 -0.981 . . . . 0.0 110.56 179.929 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 830' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -53.63 108.51 0.35 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.246 -0.909 . . . . 0.0 109.743 179.981 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 831' ' ' LYS . . . . . . . . . . . . . 5.0 mmtp -79.72 143.6 34.4 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.161 -0.962 . . . . 0.0 110.314 -179.944 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 832' ' ' ARG . . . . . 0.476 ' HB3' ' CG ' ' A' ' 781' ' ' PRO . 2.7 ttm180 -146.24 161.19 40.81 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.378 -0.826 . . . . 0.0 109.638 -179.979 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 833' ' ' VAL . . . . . 0.548 HG21 ' CG2' ' A' ' 816' ' ' ILE . 59.7 t -124.64 109.21 21.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.125 -0.984 . . . . 0.0 110.89 -179.967 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 834' ' ' ALA . . . . . 0.691 ' HB1' ' CE2' ' A' ' 788' ' ' PHE . . . -111.35 129.87 55.86 Favored 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 179.831 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 835' ' ' VAL . . . . . 0.412 HG12 ' N ' ' A' ' 836' ' ' GLU . 68.3 t -140.35 160.2 25.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 120.817 -1.177 . . . . 0.0 111.718 -179.888 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 836' ' ' GLU . . . . . 0.456 ' HB2' ' HB3' ' A' ' 775' ' ' PHE . 0.2 OUTLIER -151.92 103.9 2.95 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 179.851 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 837' ' ' ALA . . . . . . . . . . . . . . . -111.23 164.07 13.27 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.008 -1.058 . . . . 0.0 111.798 -179.851 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 838' ' ' VAL . . . . . . . . . . . . . 93.4 t -112.6 131.3 64.51 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.327 0 N-CA-C 109.427 -0.582 . . . . 0.0 109.427 179.882 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 839' ' ' CYS . . . . . 0.496 ' O ' ' HA ' ' A' ' 728' ' ' VAL . 2.0 t -108.76 120.26 41.97 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.002 -1.061 . . . . 0.0 110.571 -179.965 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 840' ' ' SER . . . . . . . . . . . . . 10.1 t -123.97 159.12 30.47 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.418 -0.802 . . . . 0.0 110.065 179.977 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 841' ' ' THR . . . . . 0.533 ' CG2' ' HG2' ' A' ' 768' ' ' GLN . 22.2 p -90.13 156.49 18.31 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.154 -0.967 . . . . 0.0 110.295 179.99 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 842' ' ' ALA . . . . . 0.433 ' O ' ' C ' ' A' ' 843' ' ' ALA . . . -53.17 175.22 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.296 -0.877 . . . . 0.0 110.229 -179.993 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 843' ' ' ALA . . . . . 0.433 ' C ' ' O ' ' A' ' 842' ' ' ALA . . . . . . . . 0 N--CA 1.492 1.658 0 CA-C-O 118.067 -0.968 . . . . 0.0 110.338 179.95 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 726' ' ' ARG . . . . . 0.429 ' O ' ' C ' ' A' ' 727' ' ' THR . 13.5 ptt180 . . . . . 0 N--CA 1.493 1.721 0 CA-C-O 121.117 0.484 . . . . 0.0 110.328 . . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 727' ' ' THR . . . . . 0.429 ' C ' ' O ' ' A' ' 726' ' ' ARG . 32.6 p 42.05 58.62 2.85 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.373 -0.829 . . . . 0.0 110.286 179.931 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 728' ' ' VAL . . . . . 0.663 ' O ' HG13 ' A' ' 728' ' ' VAL . 7.7 p -163.05 103.22 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.298 -1.666 0 O-C-N 121.461 -0.774 . . . . 0.0 110.253 -179.961 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 729' ' ' SER . . . . . . . . . . . . . 1.9 t -66.93 166.67 13.07 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.179 -0.951 . . . . 0.0 109.981 179.98 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 730' ' ' GLY . . . . . 0.465 ' C ' HG13 ' A' ' 731' ' ' VAL . . . -144.32 132.38 4.79 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.114 -1.594 . . . . 0.0 109.114 179.939 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 731' ' ' VAL . . . . . 0.523 ' O ' HG23 ' A' ' 731' ' ' VAL . 21.0 m -150.9 117.49 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.425 0 O-C-N 121.018 -1.284 . . . . 0.0 110.845 -179.935 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 732' ' ' CYS . . . . . 0.425 ' O ' ' SG ' ' A' ' 732' ' ' CYS . 15.5 p -109.22 133.85 52.51 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.31 -0.869 . . . . 0.0 109.322 179.841 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 733' ' ' ALA . . . . . . . . . . . . . . . -109.24 123.44 49.27 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.091 -1.006 . . . . 0.0 110.669 -179.862 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 734' ' ' ASP . . . . . . . . . . . . . 12.2 t0 -111.71 114.47 27.51 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.378 -0.826 . . . . 0.0 110.124 179.941 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 735' ' ' VAL . . . . . . . . . . . . . 16.6 t -122.99 155.34 28.6 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.222 -0.924 . . . . 0.0 110.338 -179.993 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 736' ' ' SER . . . . . 0.433 ' O ' ' C ' ' A' ' 737' ' ' GLU . 0.1 OUTLIER -106.15 105.5 15.56 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.263 -0.898 . . . . 0.0 109.807 -179.98 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 737' ' ' GLU . . . . . 0.542 ' CB ' ' HA ' ' A' ' 831' ' ' LYS . 0.0 OUTLIER -39.05 138.92 0.52 Allowed 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.457 -0.777 . . . . 0.0 110.851 -179.963 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 738' ' ' TYR . . . . . 0.48 ' CD1' ' HD3' ' A' ' 740' ' ' PRO . 14.9 t80 -98.81 -115.64 0.15 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.44 -0.787 . . . . 0.0 109.62 179.954 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 739' ' ' HIS . . . . . 0.459 ' C ' ' O ' ' A' ' 738' ' ' TYR . 0.5 OUTLIER 37.85 54.23 3.72 Favored Pre-proline 0 N--CA 1.498 1.945 0 O-C-N 121.129 -0.982 . . . . 0.0 110.921 -179.994 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 740' ' ' PRO . . . . . 0.48 ' HD3' ' CD1' ' A' ' 738' ' ' TYR . 42.9 Cg_endo -70.8 -19.84 30.67 Favored 'Trans proline' 0 C--N 1.306 -1.675 0 O-C-N 123.858 1.452 . . . . 0.0 109.41 179.904 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 741' ' ' ASN . . . . . 0.481 ' O ' ' O ' ' A' ' 742' ' ' ILE . 10.1 m-20 -164.06 -73.69 0.04 OUTLIER 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 109.176 -0.675 . . . . 0.0 109.176 179.877 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 742' ' ' ILE . . . . . 0.481 ' O ' ' O ' ' A' ' 741' ' ' ASN . 31.9 mm 50.08 109.9 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 O-C-N 121.541 -0.724 . . . . 0.0 111.221 179.897 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 743' ' ' LYS . . . . . 0.448 ' HD3' ' O ' ' A' ' 742' ' ' ILE . 0.0 OUTLIER -176.51 -36.71 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.221 -0.925 . . . . 0.0 109.672 179.993 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 744' ' ' ASN . . . . . 0.433 ' O ' ' C ' ' A' ' 745' ' ' TRP . 55.7 t30 -117.78 26.27 9.8 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.513 -0.742 . . . . 0.0 109.487 179.896 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 745' ' ' TRP . . . . . 0.622 ' CD1' ' N ' ' A' ' 746' ' ' GLN . 44.1 p90 -40.45 -45.51 2.24 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.621 -0.675 . . . . 0.0 110.277 -179.932 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 746' ' ' GLN . . . . . 0.622 ' N ' ' CD1' ' A' ' 745' ' ' TRP . 27.8 pt20 -95.82 120.75 36.63 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.102 -0.999 . . . . 0.0 109.273 179.863 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 747' ' ' ILE . . . . . 0.731 HG21 ' OH ' ' A' ' 750' ' ' TYR . 13.1 mt -86.1 75.75 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.614 0 O-C-N 121.214 -0.929 . . . . 0.0 110.642 -179.914 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 748' ' ' GLU . . . . . 0.566 ' CB ' ' O ' ' A' ' 747' ' ' ILE . 1.1 tt0 79.91 -47.01 0.33 Allowed 'General case' 0 N--CA 1.505 2.29 0 O-C-N 121.908 -0.495 . . . . 0.0 111.97 179.879 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 749' ' ' SER . . . . . . . . . . . . . 73.6 m -152.56 -22.98 0.17 Allowed 'General case' 0 N--CA 1.5 2.03 0 O-C-N 120.431 -1.418 . . . . 0.0 112.747 -179.919 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 750' ' ' TYR . . . . . 0.731 ' OH ' HG21 ' A' ' 747' ' ' ILE . 45.8 p90 -110.58 134.89 52.0 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 120.367 -1.458 . . . . 0.0 111.471 -179.898 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 751' ' ' GLY . . . . . . . . . . . . . . . 152.65 104.38 0.26 Allowed Glycine 0 N--CA 1.495 2.624 0 N-CA-C 108.84 -1.704 . . . . 0.0 108.84 -179.948 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 752' ' ' GLU . . . . . 0.456 ' O ' ' HG2' ' A' ' 752' ' ' GLU . 45.1 tt0 -123.44 77.25 54.28 Favored Pre-proline 0 N--CA 1.498 1.971 0 O-C-N 121.084 -1.245 . . . . 0.0 111.147 -179.909 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 753' ' ' PRO . . . . . 0.561 ' HG3' ' HB2' ' A' ' 745' ' ' TRP . 49.2 Cg_endo -89.94 122.53 1.06 Allowed 'Trans proline' 0 C--N 1.302 -1.879 0 O-C-N 123.813 1.428 . . . . 0.0 110.307 179.972 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 754' ' ' GLU . . . . . . . . . . . . . 6.1 tt0 -95.67 5.84 50.43 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.189 -0.944 . . . . 0.0 110.074 179.969 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 755' ' ' PHE . . . . . . . . . . . . . 11.4 t80 -118.12 109.53 16.53 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.355 -0.841 . . . . 0.0 109.92 179.956 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 756' ' ' HIS . . . . . . . . . . . . . 29.8 m170 -118.07 -13.71 9.97 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.189 -0.944 . . . . 0.0 110.423 -179.977 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 757' ' ' THR . . . . . . . . . . . . . 3.7 p -150.11 161.55 42.15 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.181 -0.95 . . . . 0.0 110.391 -179.989 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 758' ' ' ALA . . . . . . . . . . . . . . . -87.62 169.92 11.73 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.329 -0.857 . . . . 0.0 109.979 179.981 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 759' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.46 155.69 47.42 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.1 -1.0 . . . . 0.0 110.584 -179.983 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 760' ' ' VAL . . . . . 0.816 HG23 HD11 ' A' ' 816' ' ' ILE . 47.3 t -109.54 139.14 33.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.42 -0.8 . . . . 0.0 109.523 179.939 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 761' ' ' HIS . . . . . . . . . . . . . 1.7 m170 -114.3 111.27 21.23 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.142 -0.973 . . . . 0.0 111.083 -179.978 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 762' ' ' LEU . . . . . 0.451 HD22 ' HB2' ' A' ' 837' ' ' ALA . 1.8 mt -129.6 117.45 20.42 Favored 'General case' 0 N--CA 1.493 1.69 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 -179.99 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 763' ' ' LYS . . . . . 0.428 ' N ' ' CD ' ' A' ' 763' ' ' LYS . 0.0 OUTLIER -142.56 166.44 24.65 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.009 -1.057 . . . . 0.0 111.324 -179.912 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 764' ' ' CYS . . . . . 0.407 ' O ' ' C ' ' A' ' 765' ' ' ALA . 1.4 m -141.37 140.74 33.77 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.677 -0.639 . . . . 0.0 109.458 179.943 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 765' ' ' ALA . . . . . 0.407 ' C ' ' O ' ' A' ' 764' ' ' CYS . . . -44.49 160.98 0.23 Allowed Pre-proline 0 N--CA 1.495 1.806 0 O-C-N 121.109 -0.994 . . . . 0.0 110.341 -179.986 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 766' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -71.34 103.39 1.4 Allowed 'Trans proline' 0 C--N 1.309 -1.5 0 O-C-N 124.004 1.528 . . . . 0.0 110.079 180.0 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 767' ' ' GLY . . . . . . . . . . . . . . . 143.61 -29.21 2.01 Favored Glycine 0 N--CA 1.488 2.118 0 N-CA-C 108.864 -1.694 . . . . 0.0 108.864 179.971 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 768' ' ' GLN . . . . . 0.503 ' OE1' HG23 ' A' ' 841' ' ' THR . 1.5 mt-30 -113.59 115.26 27.65 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.311 -1.111 . . . . 0.0 109.599 179.975 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 769' ' ' THR . . . . . . . . . . . . . 67.2 p -99.75 145.94 27.11 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.187 -0.946 . . . . 0.0 110.576 -179.937 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 770' ' ' ILE . . . . . . . . . . . . . 35.8 mt -60.6 113.45 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 O-C-N 121.32 -0.863 . . . . 0.0 109.197 179.983 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 771' ' ' SER . . . . . 0.518 ' O ' ' HB2' ' A' ' 772' ' ' ALA . 39.2 t -91.61 -7.58 49.69 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.231 -0.918 . . . . 0.0 111.485 -179.835 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 772' ' ' ALA . . . . . 0.518 ' HB2' ' O ' ' A' ' 771' ' ' SER . . . 179.75 146.14 0.21 Allowed 'General case' 0 N--CA 1.496 1.839 0 O-C-N 120.765 -1.209 . . . . 0.0 111.475 -179.924 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 773' ' ' ILE . . . . . 0.522 HD11 ' HB3' ' A' ' 806' ' ' CYS . 31.9 mm -87.93 135.4 25.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.495 -0.753 . . . . 0.0 109.135 179.892 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 774' ' ' LYS . . . . . 0.573 ' HB3' ' CB ' ' A' ' 836' ' ' GLU . 0.4 OUTLIER -78.14 -35.53 48.88 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.119 -0.988 . . . . 0.0 110.768 -179.897 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 775' ' ' PHE . . . . . 0.521 ' CZ ' ' HB3' ' A' ' 777' ' ' SER . 44.9 t80 176.16 150.86 0.14 Allowed 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.173 -0.955 . . . . 0.0 110.897 -179.988 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 776' ' ' ALA . . . . . 0.472 ' O ' ' HB3' ' A' ' 798' ' ' SER . . . -143.65 145.78 32.73 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.472 -0.767 . . . . 0.0 108.959 179.872 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 777' ' ' SER . . . . . 0.55 ' HA ' ' OG ' ' A' ' 798' ' ' SER . 67.6 p -154.09 119.03 4.99 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.877 -1.14 . . . . 0.0 111.575 -179.949 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 778' ' ' PHE . . . . . 0.48 ' CZ ' ' HG2' ' A' ' 830' ' ' MET . 40.8 t80 -105.39 120.15 40.87 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.466 -0.771 . . . . 0.0 109.496 179.918 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 779' ' ' GLY . . . . . 0.577 ' HA2' ' HA ' ' A' ' 830' ' ' MET . . . 133.49 -100.0 0.38 Allowed Glycine 0 N--CA 1.487 2.075 0 C-N-CA 119.604 -1.284 . . . . 0.0 109.912 179.991 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 780' ' ' THR . . . . . . . . . . . . . 43.5 p -136.62 93.92 13.75 Favored Pre-proline 0 N--CA 1.495 1.781 0 O-C-N 121.133 -1.216 . . . . 0.0 110.593 -179.924 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 781' ' ' PRO . . . . . 0.511 ' CD ' ' HB3' ' A' ' 832' ' ' ARG . 51.6 Cg_endo -81.77 157.91 18.63 Favored 'Trans proline' 0 C--N 1.307 -1.643 0 O-C-N 124.004 1.528 . . . . 0.0 110.605 179.921 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 782' ' ' LEU . . . . . 0.477 HD12 ' HA2' ' A' ' 791' ' ' GLY . 0.8 OUTLIER -112.78 133.89 54.56 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.278 -0.889 . . . . 0.0 110.081 179.989 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 783' ' ' GLY . . . . . . . . . . . . . . . 84.03 -170.37 47.34 Favored Glycine 0 N--CA 1.493 2.487 0 N-CA-C 109.784 -1.326 . . . . 0.0 109.784 179.987 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 784' ' ' THR . . . . . 0.435 ' O ' ' CE1' ' A' ' 788' ' ' PHE . 44.0 p -127.68 -141.82 0.27 Allowed 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.264 -1.139 . . . . 0.0 110.529 -179.99 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 785' ' ' CYS . . . . . . . . . . . . . 38.4 m -78.52 100.56 6.95 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.278 -0.889 . . . . 0.0 110.379 -179.942 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 786' ' ' GLY . . . . . . . . . . . . . . . 140.46 -13.52 2.98 Favored Glycine 0 N--CA 1.493 2.452 0 N-CA-C 110.012 -1.235 . . . . 0.0 110.012 -179.988 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 787' ' ' THR . . . . . . . . . . . . . 9.0 t -159.52 36.62 0.19 Allowed 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.036 -1.273 . . . . 0.0 110.809 -179.978 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 788' ' ' PHE . . . . . 0.459 ' O ' ' HB2' ' A' ' 789' ' ' GLN . 14.4 m-85 -61.29 158.66 13.8 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.07 -1.019 . . . . 0.0 109.909 179.972 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 789' ' ' GLN . . . . . 0.459 ' HB2' ' O ' ' A' ' 788' ' ' PHE . 24.4 tt0 179.25 157.46 0.56 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.175 -0.953 . . . . 0.0 110.218 -179.994 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 790' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -52.17 137.81 27.26 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.252 -0.905 . . . . 0.0 110.362 -179.999 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 791' ' ' GLY . . . . . 0.477 ' HA2' HD12 ' A' ' 782' ' ' LEU . . . -111.75 -107.9 2.97 Favored Glycine 0 N--CA 1.493 2.466 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 -179.986 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 792' ' ' GLU . . . . . . . . . . . . . 39.1 tp10 -90.49 -53.02 4.61 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.194 -1.18 . . . . 0.0 110.277 179.944 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 793' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -136.08 117.69 14.91 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.263 -0.898 . . . . 0.0 110.081 179.983 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 794' ' ' HIS . . . . . . . . . . . . . 10.7 t-80 -120.2 150.51 40.54 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.252 -0.905 . . . . 0.0 110.381 -179.975 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 795' ' ' SER . . . . . 0.489 ' OG ' ' HG3' ' A' ' 825' ' ' PRO . 2.6 m -94.94 117.44 30.15 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.425 -0.797 . . . . 0.0 109.483 179.896 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 796' ' ' ILE . . . . . . . . . . . . . 6.7 mt -58.3 -13.57 3.08 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.875 0 O-C-N 121.158 -0.964 . . . . 0.0 110.775 -179.947 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 797' ' ' ASN . . . . . 0.405 ' O ' ' OG ' ' A' ' 800' ' ' SER . 3.6 m-20 -89.96 21.48 3.63 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.062 -1.024 . . . . 0.0 110.414 179.906 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 798' ' ' SER . . . . . 0.55 ' OG ' ' HA ' ' A' ' 777' ' ' SER . 0.5 OUTLIER -70.0 -33.72 72.4 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.176 -0.953 . . . . 0.0 110.806 -179.995 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 799' ' ' ASN . . . . . . . . . . . . . 7.5 m-20 -97.94 6.21 47.99 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.26 -0.9 . . . . 0.0 111.024 -179.856 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 800' ' ' SER . . . . . 0.405 ' OG ' ' O ' ' A' ' 797' ' ' ASN . 6.1 p -90.69 -29.41 17.72 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.97 -1.081 . . . . 0.0 110.396 -179.979 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 801' ' ' VAL . . . . . . . . . . . . . 15.6 t -88.03 -19.66 7.69 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.293 -0.879 . . . . 0.0 110.588 179.957 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 802' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -90.64 -48.44 7.06 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.107 -0.996 . . . . 0.0 110.572 -179.896 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 803' ' ' GLU . . . . . . . . . . . . . 20.8 mt-10 -58.61 -26.78 64.05 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.185 -0.947 . . . . 0.0 110.987 -179.895 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 804' ' ' ARG . . . . . . . . . . . . . 16.7 ttt-85 -86.63 -28.3 23.29 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 120.988 -1.07 . . . . 0.0 110.849 -179.892 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 805' ' ' LYS . . . . . 0.434 ' O ' ' SG ' ' A' ' 812' ' ' CYS . 2.1 mttm -122.28 31.81 6.02 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.055 -1.028 . . . . 0.0 110.615 179.985 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 806' ' ' CYS . . . . . 0.522 ' HB3' HD11 ' A' ' 773' ' ' ILE . 0.1 OUTLIER -162.2 41.44 0.13 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.151 -0.968 . . . . 0.0 110.4 -179.969 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 807' ' ' ILE . . . . . 0.659 HG22 ' O ' ' A' ' 807' ' ' ILE . 9.8 mm -140.59 84.23 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.248 -0.908 . . . . 0.0 110.428 -179.994 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 808' ' ' GLY . . . . . 0.448 ' C ' ' HG ' ' A' ' 809' ' ' LEU . . . 117.84 32.41 1.43 Allowed Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.751 -1.34 . . . . 0.0 109.751 -179.998 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 809' ' ' LEU . . . . . 0.448 ' HG ' ' C ' ' A' ' 808' ' ' GLY . 14.9 mt -137.61 138.12 39.2 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.195 -1.179 . . . . 0.0 110.318 -179.96 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 810' ' ' GLU . . . . . . . . . . . . . 11.5 mp0 -61.01 -33.09 72.72 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.058 -1.026 . . . . 0.0 108.684 179.937 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 811' ' ' ARG . . . . . . . . . . . . . 18.1 ttm180 -125.69 167.69 14.78 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 179.835 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 812' ' ' CYS . . . . . 0.434 ' SG ' ' O ' ' A' ' 805' ' ' LYS . 9.3 t -166.04 116.27 1.0 Allowed 'General case' 0 C--N 1.3 -1.569 0 O-C-N 120.803 -1.185 . . . . 0.0 111.046 -179.903 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 813' ' ' VAL . . . . . . . . . . . . . 75.2 t -117.63 138.45 48.27 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.472 -0.768 . . . . 0.0 109.384 179.951 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 814' ' ' VAL . . . . . . . . . . . . . 4.4 t -125.56 158.04 34.49 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.077 -1.015 . . . . 0.0 110.561 -179.917 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 815' ' ' ALA . . . . . . . . . . . . . . . -117.65 135.01 54.29 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.26 -0.9 . . . . 0.0 110.117 -179.983 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 816' ' ' ILE . . . . . 0.816 HD11 HG23 ' A' ' 760' ' ' VAL . 9.7 mt -107.52 137.22 39.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.263 -0.898 . . . . 0.0 110.276 -179.946 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 817' ' ' SER . . . . . 0.504 ' CB ' ' HD2' ' A' ' 818' ' ' PRO . 0.0 OUTLIER -161.85 -179.81 1.13 Allowed Pre-proline 0 N--CA 1.495 1.781 0 O-C-N 121.232 -0.917 . . . . 0.0 110.031 179.985 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 818' ' ' PRO . . . . . 0.504 ' HD2' ' CB ' ' A' ' 817' ' ' SER . 48.0 Cg_endo -75.45 -38.27 1.48 Allowed 'Trans proline' 0 C--N 1.305 -1.724 0 O-C-N 124.055 1.555 . . . . 0.0 110.525 -179.975 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 819' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -116.51 47.36 1.45 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.23 -0.919 . . . . 0.0 110.296 -179.909 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 820' ' ' ASN . . . . . . . . . . . . . 2.0 m120 -129.71 0.78 4.91 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.178 -0.951 . . . . 0.0 110.206 179.97 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 821' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -125.32 -39.19 2.22 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.269 -0.894 . . . . 0.0 110.258 -179.941 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 822' ' ' GLY . . . . . . . . . . . . . . . -164.52 -52.37 0.02 OUTLIER Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.684 -1.367 . . . . 0.0 109.684 -179.997 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 823' ' ' GLY . . . . . . . . . . . . . . . 158.51 -68.54 0.27 Allowed Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.717 -1.353 . . . . 0.0 109.717 -179.934 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 824' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -171.22 88.91 0.46 Allowed Pre-proline 0 N--CA 1.493 1.684 0 O-C-N 121.262 -1.14 . . . . 0.0 110.431 -179.994 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 825' ' ' PRO . . . . . 0.489 ' HG3' ' OG ' ' A' ' 795' ' ' SER . 44.8 Cg_endo -75.08 -62.79 0.03 OUTLIER 'Trans proline' 0 C--N 1.304 -1.806 0 O-C-N 123.947 1.498 . . . . 0.0 110.317 179.971 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 826' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -116.93 118.92 35.83 Favored Pre-proline 0 N--CA 1.493 1.688 0 O-C-N 121.305 -0.872 . . . . 0.0 109.632 -179.996 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 827' ' ' PRO . . . . . 0.428 ' O ' ' HB2' ' A' ' 828' ' ' GLU . 48.2 Cg_endo -75.24 141.01 25.45 Favored 'Trans proline' 0 C--N 1.308 -1.58 0 O-C-N 123.885 1.466 . . . . 0.0 110.866 -179.887 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 828' ' ' GLU . . . . . 0.428 ' HB2' ' O ' ' A' ' 827' ' ' PRO . 0.6 OUTLIER 58.41 14.16 2.81 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.486 -0.759 . . . . 0.0 110.508 179.99 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 829' ' ' VAL . . . . . 0.56 ' O ' HG12 ' A' ' 829' ' ' VAL . 54.0 t -137.59 82.03 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.165 -0.96 . . . . 0.0 110.217 -179.959 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 830' ' ' MET . . . . . 0.577 ' HA ' ' HA2' ' A' ' 779' ' ' GLY . 0.2 OUTLIER -176.26 107.65 0.08 Allowed 'General case' 0 N--CA 1.487 1.398 0 O-C-N 120.929 -1.107 . . . . 0.0 111.348 179.991 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 831' ' ' LYS . . . . . 0.542 ' HA ' ' CB ' ' A' ' 737' ' ' GLU . 20.6 ttpp -170.93 53.1 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.235 -0.915 . . . . 0.0 110.736 179.95 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 832' ' ' ARG . . . . . 0.511 ' HB3' ' CD ' ' A' ' 781' ' ' PRO . 1.7 mtt180 -172.97 107.16 0.16 Allowed 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.274 -0.891 . . . . 0.0 109.846 179.957 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 833' ' ' VAL . . . . . 0.782 HG21 HD13 ' A' ' 816' ' ' ILE . 3.8 t -107.35 109.25 27.5 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 O-C-N 121.111 -0.993 . . . . 0.0 110.836 -179.96 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 834' ' ' ALA . . . . . . . . . . . . . . . -109.62 136.47 48.94 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.371 -0.831 . . . . 0.0 109.34 179.934 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 835' ' ' VAL . . . . . . . . . . . . . 38.1 t -147.05 156.94 10.51 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.069 -1.02 . . . . 0.0 110.946 -179.95 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 836' ' ' GLU . . . . . 0.573 ' CB ' ' HB3' ' A' ' 774' ' ' LYS . 1.7 mp0 -135.2 158.89 43.21 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 179.845 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 837' ' ' ALA . . . . . 0.451 ' HB2' HD22 ' A' ' 762' ' ' LEU . . . -138.44 154.59 48.86 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 120.802 -1.186 . . . . 0.0 111.54 -179.772 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 838' ' ' VAL . . . . . . . . . . . . . 21.3 t -121.85 109.57 24.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.692 -0.63 . . . . 0.0 109.376 179.88 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 839' ' ' CYS . . . . . 0.41 ' O ' ' HA ' ' A' ' 728' ' ' VAL . 0.6 OUTLIER -108.1 129.42 55.15 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.115 -0.991 . . . . 0.0 110.522 -179.96 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 840' ' ' SER . . . . . . . . . . . . . 54.1 p -125.53 -161.03 1.0 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.282 -0.886 . . . . 0.0 110.221 179.989 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 841' ' ' THR . . . . . 0.503 HG23 ' OE1' ' A' ' 768' ' ' GLN . 0.6 OUTLIER -102.64 9.33 39.36 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.285 -0.884 . . . . 0.0 110.493 -179.985 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 842' ' ' ALA . . . . . . . . . . . . . . . -161.06 157.03 25.44 Favored 'General case' 0 C--N 1.293 -1.851 0 O-C-N 121.426 -0.796 . . . . 0.0 110.325 179.98 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 843' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.711 0 CA-C-O 118.052 -0.975 . . . . 0.0 110.235 -179.988 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 728' ' ' VAL . . . . . 0.747 ' O ' HG13 ' A' ' 728' ' ' VAL . 9.0 p . . . . . 0 N--CA 1.491 1.594 0 CA-C-O 121.256 0.551 . . . . 0.0 110.008 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 729' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -179.93 -177.96 0.41 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.264 -0.897 . . . . 0.0 110.407 -179.952 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 730' ' ' GLY . . . . . . . . . . . . . . . 172.21 113.73 0.31 Allowed Glycine 0 N--CA 1.492 2.373 0 N-CA-C 109.074 -1.61 . . . . 0.0 109.074 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 731' ' ' VAL . . . . . . . . . . . . . 31.3 m -130.02 148.41 33.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.227 -1.161 . . . . 0.0 110.872 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 732' ' ' CYS . . . . . 0.42 ' O ' ' SG ' ' A' ' 732' ' ' CYS . 16.5 p -142.18 133.89 26.95 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.521 -0.737 . . . . 0.0 109.272 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 733' ' ' ALA . . . . . 0.522 ' HB2' HD21 ' A' ' 762' ' ' LEU . . . -111.69 132.32 54.7 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.049 -1.032 . . . . 0.0 110.746 -179.911 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 734' ' ' ASP . . . . . 0.442 ' CG ' ' O ' ' A' ' 734' ' ' ASP . 8.6 p-10 -116.54 116.34 27.44 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.295 -0.878 . . . . 0.0 109.777 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 735' ' ' VAL . . . . . . . . . . . . . 5.7 t -139.62 166.9 20.36 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.154 -0.966 . . . . 0.0 110.187 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 736' ' ' SER . . . . . 0.448 ' O ' ' C ' ' A' ' 737' ' ' GLU . 1.2 m -135.78 136.27 40.58 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.265 -0.897 . . . . 0.0 109.937 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 737' ' ' GLU . . . . . 0.535 ' HB2' ' HB3' ' A' ' 831' ' ' LYS . 1.2 tm-20 . . . . . 0 N--CA 1.492 1.64 0 O-C-N 121.32 -0.863 . . . . 0.0 109.86 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 757' ' ' THR . . . . . 0.539 HG21 ' O ' ' A' ' 816' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.575 0 CA-C-O 121.141 0.496 . . . . 0.0 109.853 . . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 758' ' ' ALA . . . . . . . . . . . . . . . -88.69 153.26 21.25 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.113 -0.992 . . . . 0.0 109.938 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 759' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -113.28 161.07 17.66 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.187 -0.946 . . . . 0.0 110.365 -179.942 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 760' ' ' VAL . . . . . . . . . . . . . 42.2 t -107.76 133.73 51.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.359 -0.838 . . . . 0.0 109.328 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 761' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -109.97 115.67 30.2 Favored 'General case' 0 C--N 1.302 -1.5 0 O-C-N 121.133 -0.98 . . . . 0.0 111.043 -179.925 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 762' ' ' LEU . . . . . 0.522 HD21 ' HB2' ' A' ' 733' ' ' ALA . 93.1 mt -132.36 138.78 47.87 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.543 -0.723 . . . . 0.0 109.119 179.842 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 763' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -167.7 136.72 2.57 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.834 -1.166 . . . . 0.0 110.891 -179.893 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 764' ' ' CYS . . . . . . . . . . . . . 92.7 m -106.59 172.77 6.64 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.427 -0.796 . . . . 0.0 109.849 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 765' ' ' ALA . . . . . 0.724 ' HB3' ' OE1' ' A' ' 768' ' ' GLN . . . -67.89 166.27 24.82 Favored Pre-proline 0 N--CA 1.495 1.795 0 O-C-N 121.156 -0.965 . . . . 0.0 110.277 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 766' ' ' PRO . . . . . 0.543 ' HD2' ' HB1' ' A' ' 765' ' ' ALA . 45.6 Cg_endo -72.84 107.11 2.26 Favored 'Trans proline' 0 C--N 1.307 -1.61 0 O-C-N 123.964 1.507 . . . . 0.0 110.026 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 767' ' ' GLY . . . . . . . . . . . . . . . 132.86 -3.42 4.94 Favored Glycine 0 N--CA 1.489 2.174 0 N-CA-C 109.334 -1.506 . . . . 0.0 109.334 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 768' ' ' GLN . . . . . 0.724 ' OE1' ' HB3' ' A' ' 765' ' ' ALA . 44.5 mt-30 -124.52 152.99 42.74 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.183 -1.187 . . . . 0.0 109.968 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 769' ' ' THR . . . . . . . . . . . . . 62.2 p -134.74 147.09 49.96 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.139 -0.975 . . . . 0.0 110.598 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 770' ' ' ILE . . . . . . . . . . . . . 59.1 mt -73.33 139.75 18.95 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.394 -0.816 . . . . 0.0 109.453 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 771' ' ' SER . . . . . . . . . . . . . 2.3 t -134.97 -8.17 2.35 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.974 -1.079 . . . . 0.0 111.422 -179.888 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 772' ' ' ALA . . . . . . . . . . . . . . . -162.96 155.97 19.32 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 120.684 -1.26 . . . . 0.0 111.734 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 773' ' ' ILE . . . . . . . . . . . . . 19.9 mm -110.69 125.65 68.0 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.687 -0.633 . . . . 0.0 109.48 179.861 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 774' ' ' LYS . . . . . 0.569 ' HG2' ' CG2' ' A' ' 838' ' ' VAL . 3.2 mmmp? -80.71 -33.47 35.28 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.078 -1.013 . . . . 0.0 110.928 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 775' ' ' PHE . . . . . . . . . . . . . 88.7 t80 -160.46 154.73 23.32 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.022 -1.049 . . . . 0.0 110.282 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 776' ' ' ALA . . . . . 0.456 ' O ' ' HB2' ' A' ' 798' ' ' SER . . . -169.21 113.55 0.55 Allowed 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.41 -0.806 . . . . 0.0 109.47 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 777' ' ' SER . . . . . 0.589 ' HA ' ' CB ' ' A' ' 798' ' ' SER . 0.6 OUTLIER -140.68 137.35 33.47 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.04 -1.038 . . . . 0.0 111.327 179.977 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 778' ' ' PHE . . . . . 0.545 ' CG ' ' O ' ' A' ' 778' ' ' PHE . 24.0 t80 -116.19 72.98 0.83 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.497 -0.752 . . . . 0.0 109.344 179.869 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 779' ' ' GLY . . . . . . . . . . . . . . . -164.46 -102.63 0.17 Allowed Glycine 0 N--CA 1.495 2.601 0 N-CA-C 109.696 -1.362 . . . . 0.0 109.696 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 780' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -133.15 77.0 68.31 Favored Pre-proline 0 N--CA 1.495 1.789 0 O-C-N 120.74 -1.447 . . . . 0.0 110.369 179.929 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 781' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -80.37 138.95 12.72 Favored 'Trans proline' 0 C--N 1.304 -1.78 0 O-C-N 124.162 1.612 . . . . 0.0 110.442 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 782' ' ' LEU . . . . . 0.564 HD12 ' HA2' ' A' ' 791' ' ' GLY . 1.3 mt -103.62 168.89 8.86 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.308 -0.87 . . . . 0.0 109.914 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 783' ' ' GLY . . . . . . . . . . . . . . . 91.16 -154.17 22.74 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.628 -1.389 . . . . 0.0 109.628 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 784' ' ' THR . . . . . . . . . . . . . 7.8 t -154.59 179.54 8.95 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.334 -1.098 . . . . 0.0 110.231 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 785' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -52.99 108.33 0.31 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.274 -0.892 . . . . 0.0 110.323 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 786' ' ' GLY . . . . . . . . . . . . . . . 143.89 -36.97 1.47 Allowed Glycine 0 N--CA 1.488 2.125 0 N-CA-C 109.724 -1.35 . . . . 0.0 109.724 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 787' ' ' THR . . . . . 0.508 HG22 ' O ' ' A' ' 787' ' ' THR . 30.8 m -157.81 47.27 0.38 Allowed 'General case' 0 C--N 1.306 -1.302 0 O-C-N 121.253 -1.145 . . . . 0.0 110.497 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 788' ' ' PHE . . . . . 0.423 ' O ' ' O ' ' A' ' 787' ' ' THR . 10.8 m-85 -46.02 170.89 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.154 -0.966 . . . . 0.0 110.201 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 789' ' ' GLN . . . . . . . . . . . . . 24.0 tt0 -166.56 142.9 4.73 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.278 -0.889 . . . . 0.0 110.034 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 790' ' ' GLN . . . . . . . . . . . . . 19.3 pt20 -56.84 152.47 12.56 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 120.975 -1.078 . . . . 0.0 110.329 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 791' ' ' GLY . . . . . 0.564 ' HA2' HD12 ' A' ' 782' ' ' LEU . . . -109.44 -86.33 1.75 Allowed Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.544 -1.422 . . . . 0.0 109.544 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 792' ' ' GLU . . . . . 0.403 ' HG2' ' C ' ' A' ' 791' ' ' GLY . 68.4 mm-40 -142.64 -37.97 0.37 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.207 -1.172 . . . . 0.0 110.169 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 793' ' ' CYS . . . . . . . . . . . . . 1.3 m -107.14 131.78 53.75 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.262 -0.898 . . . . 0.0 110.331 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 794' ' ' HIS . . . . . 0.48 ' CG ' ' H ' ' A' ' 796' ' ' ILE . 5.0 t60 -145.48 144.29 30.5 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.175 -0.953 . . . . 0.0 110.079 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 795' ' ' SER . . . . . 0.423 ' O ' ' N ' ' A' ' 797' ' ' ASN . 1.1 m -83.01 8.8 11.72 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.231 -0.918 . . . . 0.0 110.604 -179.91 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 796' ' ' ILE . . . . . 0.764 HG22 ' O ' ' A' ' 796' ' ' ILE . 90.4 mt 42.41 26.67 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 O-C-N 121.242 -0.911 . . . . 0.0 110.269 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 797' ' ' ASN . . . . . 0.437 ' OD1' ' O ' ' A' ' 796' ' ' ILE . 5.5 m120 -152.49 22.66 0.62 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.204 -0.935 . . . . 0.0 109.797 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 798' ' ' SER . . . . . 0.589 ' CB ' ' HA ' ' A' ' 777' ' ' SER . 13.2 m -84.62 2.59 40.85 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.435 -0.791 . . . . 0.0 110.452 -179.901 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 799' ' ' ASN . . . . . . . . . . . . . 6.9 t-20 -115.41 -14.84 11.58 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.196 -0.94 . . . . 0.0 110.908 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 800' ' ' SER . . . . . . . . . . . . . 16.4 m -82.09 -18.87 41.55 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 120.903 -1.123 . . . . 0.0 109.881 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 801' ' ' VAL . . . . . 0.435 ' O ' ' HD2' ' A' ' 805' ' ' LYS . 45.0 t -86.44 -21.41 7.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.464 -0.772 . . . . 0.0 110.117 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 802' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -79.42 -57.39 3.72 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.137 -0.977 . . . . 0.0 110.313 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 803' ' ' GLU . . . . . 0.879 ' HG2' HD12 ' A' ' 807' ' ' ILE . 0.4 OUTLIER -53.82 -22.71 10.22 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.295 -0.878 . . . . 0.0 110.339 179.942 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 804' ' ' ARG . . . . . . . . . . . . . 1.9 mtm180 -91.08 -23.92 20.18 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.188 -0.945 . . . . 0.0 110.998 -180.0 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 805' ' ' LYS . . . . . 0.435 ' HD2' ' O ' ' A' ' 801' ' ' VAL . 9.6 mttt -127.06 49.83 2.04 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.07 -1.019 . . . . 0.0 111.034 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 806' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -163.23 -71.51 0.04 OUTLIER 'General case' 0 N--CA 1.497 1.909 0 O-C-N 120.952 -1.092 . . . . 0.0 110.905 179.937 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 807' ' ' ILE . . . . . 0.879 HD12 ' HG2' ' A' ' 803' ' ' GLU . 90.6 mt -50.86 128.32 8.07 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 O-C-N 121.223 -0.923 . . . . 0.0 110.988 -179.918 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 808' ' ' GLY . . . . . 0.66 ' O ' HD23 ' A' ' 809' ' ' LEU . . . 103.89 10.84 33.92 Favored Glycine 0 N--CA 1.493 2.456 0 N-CA-C 110.127 -1.189 . . . . 0.0 110.127 179.912 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 809' ' ' LEU . . . . . 0.66 HD23 ' O ' ' A' ' 808' ' ' GLY . 33.1 mt -142.67 137.11 29.7 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.108 -1.231 . . . . 0.0 110.138 -179.913 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 810' ' ' GLU . . . . . 0.444 ' HG2' ' O ' ' A' ' 768' ' ' GLN . 0.7 OUTLIER -65.16 -21.92 66.85 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.224 -0.923 . . . . 0.0 109.289 179.972 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 811' ' ' ARG . . . . . 0.471 ' HG3' ' O ' ' A' ' 762' ' ' LEU . 1.1 ttp85 -128.76 151.52 49.47 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.538 -0.726 . . . . 0.0 109.747 179.866 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 812' ' ' CYS . . . . . 0.465 ' HB3' ' HB2' ' A' ' 762' ' ' LEU . 7.8 t -129.73 139.87 51.22 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.121 -0.987 . . . . 0.0 110.602 -179.944 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 813' ' ' VAL . . . . . . . . . . . . . 84.1 t -145.63 123.11 4.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.348 -0.845 . . . . 0.0 109.663 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 814' ' ' VAL . . . . . . . . . . . . . 88.7 t -133.0 129.01 57.25 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 O-C-N 121.129 -0.982 . . . . 0.0 110.73 -179.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 815' ' ' ALA . . . . . . . . . . . . . . . -88.75 127.8 35.61 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.339 -0.851 . . . . 0.0 109.755 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 816' ' ' ILE . . . . . 1.014 HD13 HG21 ' A' ' 833' ' ' VAL . 46.2 mt -84.3 114.01 24.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.181 -0.949 . . . . 0.0 110.436 -179.905 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 817' ' ' SER . . . . . . . . . . . . . 5.0 p -158.84 158.57 29.27 Favored Pre-proline 0 N--CA 1.495 1.777 0 O-C-N 121.356 -0.84 . . . . 0.0 109.91 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 818' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -75.29 2.65 6.54 Favored 'Trans proline' 0 C--N 1.306 -1.692 0 O-C-N 123.926 1.487 . . . . 0.0 110.772 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 819' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -111.77 7.67 20.32 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.103 -0.998 . . . . 0.0 110.253 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 820' ' ' ASN . . . . . . . . . . . . . 6.8 m-20 -121.19 -7.2 9.38 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.248 -0.907 . . . . 0.0 110.262 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 821' ' ' PHE . . . . . . . . . . . . . 4.8 m-85 -110.66 -65.96 1.12 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.261 -0.9 . . . . 0.0 110.19 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 822' ' ' GLY . . . . . . . . . . . . . . . 161.27 63.86 0.02 OUTLIER Glycine 0 N--CA 1.492 2.41 0 N-CA-C 110.006 -1.238 . . . . 0.0 110.006 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 823' ' ' GLY . . . . . . . . . . . . . . . 78.7 -150.41 34.51 Favored Glycine 0 N--CA 1.493 2.47 0 N-CA-C 110.036 -1.226 . . . . 0.0 110.036 179.907 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 824' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -109.17 141.88 24.39 Favored Pre-proline 0 N--CA 1.493 1.709 0 O-C-N 121.26 -1.141 . . . . 0.0 110.407 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 825' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -80.53 -91.2 0.0 OUTLIER 'Trans proline' 0 C--N 1.306 -1.699 0 O-C-N 124.11 1.584 . . . . 0.0 110.693 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 826' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -101.5 132.95 21.17 Favored Pre-proline 0 N--CA 1.496 1.872 0 O-C-N 121.189 -0.944 . . . . 0.0 110.372 -179.924 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 827' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -82.52 157.51 16.63 Favored 'Trans proline' 0 C--N 1.309 -1.525 0 O-C-N 123.958 1.504 . . . . 0.0 110.629 180.0 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 828' ' ' GLU . . . . . 0.452 ' O ' ' OE1' ' A' ' 828' ' ' GLU . 7.2 tm-20 54.47 39.13 30.83 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.243 -0.91 . . . . 0.0 110.622 179.906 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 829' ' ' VAL . . . . . 0.413 ' O ' ' C ' ' A' ' 830' ' ' MET . 20.2 t -142.81 118.3 4.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.071 -1.018 . . . . 0.0 110.369 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 830' ' ' MET . . . . . 0.413 ' C ' ' O ' ' A' ' 829' ' ' VAL . 4.7 mtt -42.71 158.32 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.246 -0.909 . . . . 0.0 109.878 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 831' ' ' LYS . . . . . 0.535 ' HB3' ' HB2' ' A' ' 737' ' ' GLU . 4.9 mtmt -115.04 110.57 19.77 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.118 -0.989 . . . . 0.0 110.877 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 832' ' ' ARG . . . . . . . . . . . . . 10.6 mtm-85 -116.38 135.31 53.97 Favored 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 179.927 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 833' ' ' VAL . . . . . 1.014 HG21 HD13 ' A' ' 816' ' ' ILE . 7.7 t -111.5 130.09 65.68 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.631 0 O-C-N 120.986 -1.071 . . . . 0.0 111.334 -179.94 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 834' ' ' ALA . . . . . . . . . . . . . . . -134.81 129.43 34.52 Favored 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 835' ' ' VAL . . . . . 0.403 ' CG1' ' N ' ' A' ' 836' ' ' GLU . 18.3 t -137.95 160.82 33.13 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 O-C-N 120.932 -1.105 . . . . 0.0 111.334 -179.869 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 836' ' ' GLU . . . . . 0.403 ' N ' ' CG1' ' A' ' 835' ' ' VAL . 0.0 OUTLIER -148.39 121.41 8.83 Favored 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 179.988 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 837' ' ' ALA . . . . . . . . . . . . . . . -109.55 155.32 21.54 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.006 -1.059 . . . . 0.0 111.016 -179.893 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 838' ' ' VAL . . . . . 0.569 ' CG2' ' HG2' ' A' ' 774' ' ' LYS . 6.0 t -111.97 114.59 47.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.422 -0.799 . . . . 0.0 109.804 179.926 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 839' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -109.42 136.76 48.31 Favored 'General case' 0 C--N 1.299 -1.611 0 O-C-N 121.128 -0.982 . . . . 0.0 110.245 -179.881 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 840' ' ' SER . . . . . 0.718 ' O ' HG23 ' A' ' 841' ' ' THR . 0.4 OUTLIER -136.43 -82.02 0.38 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.284 -0.885 . . . . 0.0 109.942 179.955 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 841' ' ' THR . . . . . 0.718 HG23 ' O ' ' A' ' 840' ' ' SER . 13.5 p . . . . . 0 N--CA 1.492 1.672 0 O-C-N 121.294 -0.878 . . . . 0.0 110.006 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 728' ' ' VAL . . . . . 0.456 ' O ' ' O ' ' A' ' 839' ' ' CYS . 3.4 p . . . . . 0 N--CA 1.492 1.652 0 CA-C-O 121.199 0.523 . . . . 0.0 110.354 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 729' ' ' SER . . . . . . . . . . . . . 75.3 p -55.01 178.58 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.243 -0.911 . . . . 0.0 110.3 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 730' ' ' GLY . . . . . 0.447 ' HA2' ' HB2' ' A' ' 839' ' ' CYS . . . -113.7 -139.11 7.15 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.658 -1.377 . . . . 0.0 109.658 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 731' ' ' VAL . . . . . . . . . . . . . 30.0 t -128.44 155.5 40.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.288 -1.125 . . . . 0.0 110.254 -179.89 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 732' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -108.22 145.92 33.56 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.361 -0.837 . . . . 0.0 109.431 179.892 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 733' ' ' ALA . . . . . . . . . . . . . . . -147.11 128.56 14.96 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.021 -1.049 . . . . 0.0 110.781 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 734' ' ' ASP . . . . . 0.459 ' OD1' ' O ' ' A' ' 734' ' ' ASP . 1.5 p30 -131.72 109.23 10.02 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.454 -0.779 . . . . 0.0 109.673 179.93 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 735' ' ' VAL . . . . . 0.972 HG21 HG22 ' A' ' 760' ' ' VAL . 7.0 m -129.58 157.13 42.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.115 -0.991 . . . . 0.0 110.586 -179.916 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 736' ' ' SER . . . . . 0.427 ' O ' ' C ' ' A' ' 737' ' ' GLU . 70.9 m -119.43 140.15 50.89 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.436 -0.79 . . . . 0.0 109.714 179.918 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 737' ' ' GLU . . . . . 0.427 ' C ' ' O ' ' A' ' 736' ' ' SER . 11.2 tp10 . . . . . 0 N--CA 1.491 1.605 0 O-C-N 121.215 -0.928 . . . . 0.0 109.979 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 757' ' ' THR . . . . . . . . . . . . . 20.6 p . . . . . 0 N--CA 1.492 1.663 0 CA-C-O 121.364 0.602 . . . . 0.0 110.421 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 758' ' ' ALA . . . . . . . . . . . . . . . -107.92 178.96 4.36 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.328 -0.857 . . . . 0.0 110.141 180.0 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 759' ' ' LYS . . . . . . . . . . . . . 29.7 mttm -140.42 138.82 35.03 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.224 -0.923 . . . . 0.0 110.592 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 760' ' ' VAL . . . . . 0.972 HG22 HG21 ' A' ' 735' ' ' VAL . 41.9 t -115.67 108.71 25.96 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 O-C-N 121.427 -0.796 . . . . 0.0 109.552 179.927 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 761' ' ' HIS . . . . . 0.503 ' CB ' HG22 ' A' ' 813' ' ' VAL . 42.2 p-80 -124.96 139.63 53.65 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 120.945 -1.097 . . . . 0.0 111.468 -179.82 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 762' ' ' LEU . . . . . 0.514 HD13 ' HB2' ' A' ' 837' ' ' ALA . 12.4 mt -119.33 110.87 17.48 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 109.057 -0.719 . . . . 0.0 109.057 179.892 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 763' ' ' LYS . . . . . 0.405 ' HA ' ' HA ' ' A' ' 811' ' ' ARG . 0.0 OUTLIER -110.31 133.46 53.23 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.151 -0.968 . . . . 0.0 111.001 -179.865 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 764' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -111.14 164.27 13.03 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.436 -0.79 . . . . 0.0 109.856 179.925 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 765' ' ' ALA . . . . . 0.539 ' HB3' ' OE1' ' A' ' 768' ' ' GLN . . . -56.04 164.0 2.0 Allowed Pre-proline 0 N--CA 1.493 1.68 0 O-C-N 121.118 -0.989 . . . . 0.0 110.177 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 766' ' ' PRO . . . . . 0.486 ' HD2' ' HB1' ' A' ' 765' ' ' ALA . 45.2 Cg_endo -71.71 114.2 3.88 Favored 'Trans proline' 0 C--N 1.305 -1.747 0 O-C-N 123.962 1.506 . . . . 0.0 110.394 179.984 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 767' ' ' GLY . . . . . . . . . . . . . . . 123.13 -18.48 7.88 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.436 -1.466 . . . . 0.0 109.436 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 768' ' ' GLN . . . . . 0.554 ' HG3' ' CA ' ' A' ' 841' ' ' THR . 0.5 OUTLIER -110.38 130.75 55.49 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.224 -1.162 . . . . 0.0 110.176 179.975 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 769' ' ' THR . . . . . . . . . . . . . 45.7 p -118.25 148.59 42.27 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.226 -0.921 . . . . 0.0 110.364 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 770' ' ' ILE . . . . . 0.563 HG22 HG13 ' A' ' 807' ' ' ILE . 2.6 mp -66.28 141.3 18.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.297 -0.877 . . . . 0.0 110.014 179.971 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 771' ' ' SER . . . . . . . . . . . . . 11.8 p -120.6 -15.92 8.38 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.109 -0.995 . . . . 0.0 110.565 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 772' ' ' ALA . . . . . 0.506 ' O ' HD13 ' A' ' 773' ' ' ILE . . . -169.64 171.85 7.24 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.063 -1.023 . . . . 0.0 111.029 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 773' ' ' ILE . . . . . 0.506 HD13 ' O ' ' A' ' 772' ' ' ALA . 25.8 mm -116.6 134.27 60.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.505 -0.747 . . . . 0.0 109.603 179.912 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 774' ' ' LYS . . . . . 0.515 ' HB2' ' HB3' ' A' ' 836' ' ' GLU . 0.9 OUTLIER -83.89 -34.74 24.49 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.122 -0.986 . . . . 0.0 110.718 -179.96 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 775' ' ' PHE . . . . . 0.586 ' CZ ' ' HB2' ' A' ' 777' ' ' SER . 44.7 t80 -162.31 164.1 27.67 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.091 -1.006 . . . . 0.0 110.691 -179.956 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 776' ' ' ALA . . . . . 0.671 ' HB1' ' O ' ' A' ' 798' ' ' SER . . . -176.52 121.49 0.15 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.458 -0.776 . . . . 0.0 109.922 -179.964 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 777' ' ' SER . . . . . 0.586 ' HB2' ' CZ ' ' A' ' 775' ' ' PHE . 0.2 OUTLIER -140.3 137.28 34.05 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.145 -0.972 . . . . 0.0 110.69 -179.972 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 778' ' ' PHE . . . . . 0.509 ' CG ' ' O ' ' A' ' 778' ' ' PHE . 29.3 t80 -116.82 74.19 0.9 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.276 -0.89 . . . . 0.0 109.933 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 779' ' ' GLY . . . . . . . . . . . . . . . -175.53 -86.97 0.07 OUTLIER Glycine 0 N--CA 1.495 2.619 0 C-N-CA 119.486 -1.34 . . . . 0.0 110.456 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 780' ' ' THR . . . . . . . . . . . . . 13.0 p -136.86 92.59 14.33 Favored Pre-proline 0 N--CA 1.494 1.761 0 O-C-N 121.078 -1.248 . . . . 0.0 110.825 -179.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 781' ' ' PRO . . . . . 0.47 ' O ' ' HG ' ' A' ' 782' ' ' LEU . 50.9 Cg_endo -85.41 155.56 10.73 Favored 'Trans proline' 0 C--N 1.306 -1.697 0 O-C-N 124.066 1.561 . . . . 0.0 110.271 179.942 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 782' ' ' LEU . . . . . 0.527 ' HB2' ' HB2' ' A' ' 789' ' ' GLN . 1.6 mt -143.81 129.38 19.13 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.115 -0.991 . . . . 0.0 110.263 179.978 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 783' ' ' GLY . . . . . . . . . . . . . . . 121.64 -168.75 14.49 Favored Glycine 0 N--CA 1.492 2.374 0 N-CA-C 109.71 -1.356 . . . . 0.0 109.71 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 784' ' ' THR . . . . . 0.497 ' O ' ' CE1' ' A' ' 788' ' ' PHE . 0.3 OUTLIER -115.33 -146.74 0.41 Allowed 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.258 -1.142 . . . . 0.0 110.163 179.997 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 785' ' ' CYS . . . . . . . . . . . . . 54.1 t -82.07 123.12 28.65 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.225 -0.922 . . . . 0.0 110.1 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 786' ' ' GLY . . . . . . . . . . . . . . . 86.34 -1.61 87.45 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.609 -1.396 . . . . 0.0 109.609 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 787' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -140.86 36.98 1.78 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.205 -1.174 . . . . 0.0 110.062 -179.957 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 788' ' ' PHE . . . . . 0.497 ' CE1' ' O ' ' A' ' 784' ' ' THR . 28.8 m-85 -74.15 171.37 13.69 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.248 -0.908 . . . . 0.0 110.369 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 789' ' ' GLN . . . . . 0.527 ' HB2' ' HB2' ' A' ' 782' ' ' LEU . 5.8 mt-30 -143.17 97.7 3.13 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.371 -0.831 . . . . 0.0 109.961 179.971 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 790' ' ' GLN . . . . . 0.49 ' O ' ' HG3' ' A' ' 790' ' ' GLN . 14.1 pt20 -46.32 108.15 0.13 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.256 -0.903 . . . . 0.0 110.306 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 791' ' ' GLY . . . . . . . . . . . . . . . -58.38 177.15 1.86 Allowed Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.326 -1.51 . . . . 0.0 109.326 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 792' ' ' GLU . . . . . 0.499 ' CG ' ' O ' ' A' ' 792' ' ' GLU . 0.6 OUTLIER -80.4 5.38 15.16 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.205 -1.174 . . . . 0.0 110.231 179.997 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 793' ' ' CYS . . . . . . . . . . . . . 22.8 t -102.8 16.69 25.82 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.238 -0.914 . . . . 0.0 111.062 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 794' ' ' HIS . . . . . 0.601 ' CE1' ' OG ' ' A' ' 798' ' ' SER . 75.9 t60 -62.28 125.3 23.42 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.938 -1.101 . . . . 0.0 110.258 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 795' ' ' SER . . . . . . . . . . . . . 1.4 m -72.89 -130.59 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.165 -0.96 . . . . 0.0 109.605 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 796' ' ' ILE . . . . . . . . . . . . . 1.6 pt -137.94 22.9 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 120.854 -1.153 . . . . 0.0 110.363 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 797' ' ' ASN . . . . . . . . . . . . . 36.1 p30 -154.75 22.12 0.45 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.296 -0.878 . . . . 0.0 110.232 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 798' ' ' SER . . . . . 0.671 ' O ' ' HB1' ' A' ' 776' ' ' ALA . 0.8 OUTLIER -72.44 -19.68 61.53 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.115 -0.99 . . . . 0.0 109.936 179.966 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 799' ' ' ASN . . . . . 0.451 ' CG ' ' HB3' ' A' ' 776' ' ' ALA . 2.3 t-20 -114.09 -10.36 12.83 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.32 -0.863 . . . . 0.0 110.009 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 800' ' ' SER . . . . . 0.512 ' O ' ' HB2' ' A' ' 804' ' ' ARG . 0.9 OUTLIER -89.86 -28.56 19.17 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.359 -0.838 . . . . 0.0 110.13 179.954 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 801' ' ' VAL . . . . . 0.496 HG12 HD22 ' A' ' 802' ' ' LEU . 24.6 t -66.59 -30.48 49.9 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.143 -0.973 . . . . 0.0 110.472 -179.964 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 802' ' ' LEU . . . . . 0.497 ' O ' ' HB2' ' A' ' 806' ' ' CYS . 4.4 mm? -90.11 -44.84 9.53 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.231 -0.918 . . . . 0.0 110.792 -179.945 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 803' ' ' GLU . . . . . 0.571 ' HA ' ' CD1' ' A' ' 807' ' ' ILE . 32.1 tt0 -62.67 -21.94 66.09 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.125 -0.985 . . . . 0.0 110.927 -179.89 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 804' ' ' ARG . . . . . 0.512 ' HB2' ' O ' ' A' ' 800' ' ' SER . 0.0 OUTLIER -91.96 -19.4 22.47 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 120.981 -1.075 . . . . 0.0 111.055 -179.971 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 805' ' ' LYS . . . . . . . . . . . . . 12.9 ttpp -132.47 51.3 2.16 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.004 -1.06 . . . . 0.0 111.05 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 806' ' ' CYS . . . . . 0.497 ' HB2' ' O ' ' A' ' 802' ' ' LEU . 1.2 t -156.96 -33.0 0.08 Allowed 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.015 -1.053 . . . . 0.0 111.067 179.925 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 807' ' ' ILE . . . . . 0.571 ' CD1' ' HA ' ' A' ' 803' ' ' GLU . 2.5 mp -77.17 121.89 30.58 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 O-C-N 120.979 -1.076 . . . . 0.0 110.78 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 808' ' ' GLY . . . . . 0.444 ' C ' ' HG ' ' A' ' 809' ' ' LEU . . . 107.78 13.86 19.02 Favored Glycine 0 N--CA 1.494 2.521 0 N-CA-C 110.082 -1.207 . . . . 0.0 110.082 179.935 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 809' ' ' LEU . . . . . 0.444 ' HG ' ' C ' ' A' ' 808' ' ' GLY . 4.2 mt -134.5 134.84 41.92 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.076 -1.25 . . . . 0.0 110.443 179.961 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 810' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -65.82 -13.62 59.85 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.236 -0.915 . . . . 0.0 109.245 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 811' ' ' ARG . . . . . 0.405 ' HA ' ' HA ' ' A' ' 763' ' ' LYS . 0.4 OUTLIER -141.7 164.18 30.91 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.578 -0.701 . . . . 0.0 109.627 179.968 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 812' ' ' CYS . . . . . 0.439 ' O ' ' HB2' ' A' ' 761' ' ' HIS . 1.7 t -145.37 132.0 19.9 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.19 -0.944 . . . . 0.0 110.241 -179.952 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 813' ' ' VAL . . . . . 0.503 HG22 ' CB ' ' A' ' 761' ' ' HIS . 54.3 t -143.43 110.83 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.156 -0.965 . . . . 0.0 110.328 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 814' ' ' VAL . . . . . . . . . . . . . 61.4 t -119.06 149.61 21.53 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.452 0 O-C-N 121.456 -0.778 . . . . 0.0 109.629 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 815' ' ' ALA . . . . . . . . . . . . . . . -102.34 132.08 48.55 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.142 -0.974 . . . . 0.0 110.263 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 816' ' ' ILE . . . . . 0.947 HD11 HG23 ' A' ' 760' ' ' VAL . 26.6 mt -89.62 151.72 3.44 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 121.346 -0.846 . . . . 0.0 110.384 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 817' ' ' SER . . . . . 0.402 ' CB ' ' O ' ' A' ' 816' ' ' ILE . 0.0 OUTLIER 174.74 171.93 0.27 Allowed Pre-proline 0 N--CA 1.494 1.748 0 O-C-N 121.265 -0.897 . . . . 0.0 110.129 -179.99 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 818' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -73.92 -45.11 0.4 Allowed 'Trans proline' 0 C--N 1.305 -1.748 0 O-C-N 124.017 1.535 . . . . 0.0 110.468 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 819' ' ' SER . . . . . . . . . . . . . 59.5 p -95.81 46.53 1.09 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.258 -0.901 . . . . 0.0 110.088 179.92 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 820' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -126.9 -28.68 2.9 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.274 -0.891 . . . . 0.0 110.477 -179.946 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 821' ' ' PHE . . . . . 0.435 ' CD2' HG21 ' A' ' 801' ' ' VAL . 11.9 m-85 -103.73 -72.22 0.71 Allowed 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.15 -0.969 . . . . 0.0 110.302 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 822' ' ' GLY . . . . . . . . . . . . . . . -179.83 56.94 0.08 OUTLIER Glycine 0 N--CA 1.492 2.43 0 N-CA-C 109.823 -1.311 . . . . 0.0 109.823 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 823' ' ' GLY . . . . . . . . . . . . . . . 60.33 -172.57 5.86 Favored Glycine 0 N--CA 1.494 2.507 0 N-CA-C 109.87 -1.292 . . . . 0.0 109.87 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 824' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -112.76 138.43 22.11 Favored Pre-proline 0 N--CA 1.495 1.79 0 O-C-N 121.345 -1.091 . . . . 0.0 110.168 -179.976 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 825' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_endo -84.54 -36.82 0.15 Allowed 'Trans proline' 0 C--N 1.304 -1.77 0 O-C-N 124.075 1.566 . . . . 0.0 111.08 -179.89 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 826' ' ' CYS . . . . . 0.432 ' HA ' ' HD3' ' A' ' 827' ' ' PRO . 0.8 OUTLIER -110.28 133.16 21.15 Favored Pre-proline 0 N--CA 1.504 2.256 0 O-C-N 120.971 -1.081 . . . . 0.0 110.714 -179.903 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 827' ' ' PRO . . . . . 0.799 ' O ' HG23 ' A' ' 829' ' ' VAL . 51.0 Cg_endo -87.27 167.63 7.76 Favored 'Trans proline' 0 C--N 1.309 -1.517 0 O-C-N 123.997 1.525 . . . . 0.0 110.348 179.907 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 828' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER 47.36 25.2 0.55 Allowed 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.216 -0.928 . . . . 0.0 110.897 179.978 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 829' ' ' VAL . . . . . 0.799 HG23 ' O ' ' A' ' 827' ' ' PRO . 81.9 t -127.67 125.0 64.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.0 -1.063 . . . . 0.0 110.317 -179.96 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 830' ' ' MET . . . . . . . . . . . . . 29.2 mtt -56.89 -173.13 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.179 -0.951 . . . . 0.0 109.837 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 831' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.73 127.54 8.83 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.12 -0.987 . . . . 0.0 110.878 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 832' ' ' ARG . . . . . . . . . . . . . 2.8 mtt180 -123.4 167.55 13.69 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.542 -0.724 . . . . 0.0 109.094 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 833' ' ' VAL . . . . . 0.615 HG21 ' CG2' ' A' ' 816' ' ' ILE . 88.9 t -124.27 109.06 21.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 120.795 -1.191 . . . . 0.0 111.399 -179.909 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 834' ' ' ALA . . . . . 0.587 ' O ' HG23 ' A' ' 835' ' ' VAL . . . -109.49 141.02 42.54 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 179.808 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 835' ' ' VAL . . . . . 0.587 HG23 ' O ' ' A' ' 834' ' ' ALA . 23.6 t -154.85 163.52 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 120.634 -1.291 . . . . 0.0 112.095 -179.872 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 836' ' ' GLU . . . . . 0.515 ' HB3' ' HB2' ' A' ' 774' ' ' LYS . 0.6 OUTLIER -148.27 149.19 31.43 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 107.972 -1.122 . . . . 0.0 107.972 179.974 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 837' ' ' ALA . . . . . 0.514 ' HB2' HD13 ' A' ' 762' ' ' LEU . . . -135.66 154.18 51.38 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 120.633 -1.292 . . . . 0.0 111.899 -179.862 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 838' ' ' VAL . . . . . 0.451 ' O ' ' HA ' ' A' ' 770' ' ' ILE . 41.1 t -109.12 125.5 66.21 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 179.882 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 839' ' ' CYS . . . . . 0.456 ' O ' ' O ' ' A' ' 728' ' ' VAL . 0.5 OUTLIER -116.5 161.25 19.41 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.962 -1.086 . . . . 0.0 111.199 -179.928 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 840' ' ' SER . . . . . 0.412 ' OG ' ' C ' ' A' ' 839' ' ' CYS . 0.2 OUTLIER -168.27 140.39 2.9 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.665 -0.647 . . . . 0.0 109.501 -179.981 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 841' ' ' THR . . . . . 0.554 ' CA ' ' HG3' ' A' ' 768' ' ' GLN . 11.8 t . . . . . 0 N--CA 1.493 1.723 0 O-C-N 121.084 -1.01 . . . . 0.0 110.482 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 728' ' ' VAL . . . . . . . . . . . . . 75.2 t . . . . . 0 N--CA 1.491 1.623 0 CA-C-O 121.192 0.52 . . . . 0.0 110.221 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 729' ' ' SER . . . . . . . . . . . . . 16.1 p -167.26 167.11 14.38 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.164 -0.96 . . . . 0.0 110.501 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 730' ' ' GLY . . . . . . . . . . . . . . . -129.84 176.75 18.52 Favored Glycine 0 N--CA 1.489 2.202 0 N-CA-C 109.414 -1.475 . . . . 0.0 109.414 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 731' ' ' VAL . . . . . . . . . . . . . 2.6 m -131.7 137.88 54.1 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.283 -1.128 . . . . 0.0 110.462 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 732' ' ' CYS . . . . . . . . . . . . . 48.7 m -109.87 154.65 22.74 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.386 -0.821 . . . . 0.0 109.658 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 733' ' ' ALA . . . . . . . . . . . . . . . -167.59 114.27 0.74 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.111 -0.993 . . . . 0.0 111.001 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 734' ' ' ASP . . . . . 0.442 ' OD1' HG22 ' A' ' 784' ' ' THR . 1.6 m-20 -111.22 120.53 42.59 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.385 -0.822 . . . . 0.0 109.444 179.894 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 735' ' ' VAL . . . . . . . . . . . . . 79.3 t -129.44 144.69 37.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.155 -0.966 . . . . 0.0 110.591 -179.919 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 736' ' ' SER . . . . . . . . . . . . . 2.3 m -89.97 -170.46 2.8 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.39 -0.819 . . . . 0.0 109.895 179.913 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 737' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 . . . . . 0 N--CA 1.494 1.74 0 O-C-N 121.203 -0.936 . . . . 0.0 110.488 179.974 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 757' ' ' THR . . . . . 0.428 ' O ' ' C ' ' A' ' 758' ' ' ALA . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.67 0 CA-C-O 121.083 0.468 . . . . 0.0 110.332 . . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 758' ' ' ALA . . . . . 0.464 ' O ' ' HG3' ' A' ' 759' ' ' LYS . . . -42.85 156.31 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.291 -0.881 . . . . 0.0 109.763 -179.997 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 759' ' ' LYS . . . . . 0.464 ' HG3' ' O ' ' A' ' 758' ' ' ALA . 18.3 mtpt -144.73 157.52 44.15 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.108 -0.995 . . . . 0.0 110.827 -179.892 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 760' ' ' VAL . . . . . 0.416 ' O ' ' HA ' ' A' ' 813' ' ' VAL . 77.9 t -107.67 132.92 53.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.395 -0.816 . . . . 0.0 108.92 179.947 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 761' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -108.87 104.82 14.15 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.065 -1.022 . . . . 0.0 111.328 -179.737 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 762' ' ' LEU . . . . . . . . . . . . . 25.8 mt -114.74 137.45 51.91 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 179.784 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 763' ' ' LYS . . . . . . . . . . . . . 18.7 ttpp -133.64 146.78 51.22 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.923 -1.111 . . . . 0.0 111.419 -179.894 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 764' ' ' CYS . . . . . 0.425 ' HB2' ' O ' ' A' ' 810' ' ' GLU . 20.7 m -141.55 155.15 45.8 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.597 -0.689 . . . . 0.0 109.434 179.86 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 765' ' ' ALA . . . . . 0.948 ' HB1' ' HD2' ' A' ' 766' ' ' PRO . . . -83.15 178.53 2.38 Favored Pre-proline 0 N--CA 1.494 1.727 0 O-C-N 121.059 -1.025 . . . . 0.0 110.354 -179.924 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 766' ' ' PRO . . . . . 0.948 ' HD2' ' HB1' ' A' ' 765' ' ' ALA . 44.0 Cg_endo -70.31 151.42 65.95 Favored 'Trans proline' 0 C--N 1.307 -1.642 0 O-C-N 123.968 1.509 . . . . 0.0 110.181 179.966 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 767' ' ' GLY . . . . . . . . . . . . . . . 70.87 3.81 52.2 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.143 -1.583 . . . . 0.0 109.143 -179.94 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 768' ' ' GLN . . . . . 0.488 ' HG2' ' O ' ' A' ' 840' ' ' SER . 28.4 mt-30 -123.66 117.45 25.02 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.346 -1.09 . . . . 0.0 109.838 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 769' ' ' THR . . . . . . . . . . . . . 60.5 p -127.17 148.32 50.18 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.061 -1.024 . . . . 0.0 110.295 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 770' ' ' ILE . . . . . . . . . . . . . 87.3 mt -60.76 117.25 2.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.256 -0.902 . . . . 0.0 109.777 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 771' ' ' SER . . . . . . . . . . . . . 13.9 t -107.27 -2.92 20.27 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.163 -0.961 . . . . 0.0 110.862 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 772' ' ' ALA . . . . . . . . . . . . . . . -170.81 135.19 1.07 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 120.806 -1.184 . . . . 0.0 111.313 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 773' ' ' ILE . . . . . 0.552 HD12 ' HB3' ' A' ' 802' ' ' LEU . 16.6 mm -85.38 128.16 39.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.441 -0.787 . . . . 0.0 108.93 179.815 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 774' ' ' LYS . . . . . 0.457 ' HB3' ' HB3' ' A' ' 836' ' ' GLU . 0.0 OUTLIER -79.29 -37.28 38.14 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.108 -0.995 . . . . 0.0 110.897 -179.827 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 775' ' ' PHE . . . . . . . . . . . . . 90.2 t80 -169.62 150.4 4.07 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.016 -1.052 . . . . 0.0 110.691 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 776' ' ' ALA . . . . . 0.479 ' O ' ' HB2' ' A' ' 798' ' ' SER . . . -163.93 126.28 2.45 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.469 -0.769 . . . . 0.0 109.483 179.94 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 777' ' ' SER . . . . . 0.532 ' HA ' ' CB ' ' A' ' 798' ' ' SER . 6.0 t -153.94 123.45 6.63 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.19 -0.944 . . . . 0.0 110.676 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 778' ' ' PHE . . . . . . . . . . . . . 42.6 t80 -97.15 82.8 3.23 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.395 -0.816 . . . . 0.0 109.712 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 779' ' ' GLY . . . . . . . . . . . . . . . 179.02 -121.42 0.75 Allowed Glycine 0 N--CA 1.492 2.392 0 N-CA-C 109.719 -1.352 . . . . 0.0 109.719 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 780' ' ' THR . . . . . 0.454 ' O ' ' HA3' ' A' ' 791' ' ' GLY . 44.9 p -114.61 97.2 46.15 Favored Pre-proline 0 N--CA 1.493 1.705 0 O-C-N 121.242 -1.152 . . . . 0.0 110.407 -179.949 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 781' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -79.35 175.94 10.21 Favored 'Trans proline' 0 C--N 1.304 -1.798 0 O-C-N 123.98 1.516 . . . . 0.0 110.514 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 782' ' ' LEU . . . . . 0.767 HD12 ' HA2' ' A' ' 791' ' ' GLY . 6.8 mt -139.05 105.4 5.27 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.344 -0.848 . . . . 0.0 110.144 -179.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 783' ' ' GLY . . . . . . . . . . . . . . . 102.37 -176.76 25.66 Favored Glycine 0 N--CA 1.492 2.367 0 N-CA-C 109.629 -1.389 . . . . 0.0 109.629 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 784' ' ' THR . . . . . 0.442 HG22 ' OD1' ' A' ' 734' ' ' ASP . 0.6 OUTLIER -130.05 -163.08 1.27 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.205 -1.173 . . . . 0.0 110.052 179.913 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 785' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -59.86 116.69 4.29 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.059 -1.026 . . . . 0.0 109.901 -179.958 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 786' ' ' GLY . . . . . . . . . . . . . . . 137.07 -43.94 1.18 Allowed Glycine 0 N--CA 1.489 2.209 0 N-CA-C 108.575 -1.81 . . . . 0.0 108.575 -179.913 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 787' ' ' THR . . . . . 0.471 HG22 ' O ' ' A' ' 787' ' ' THR . 25.5 m -148.39 38.43 0.87 Allowed 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.554 -0.968 . . . . 0.0 109.34 179.867 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 788' ' ' PHE . . . . . 0.421 ' CE2' ' HA ' ' A' ' 784' ' ' THR . 0.2 OUTLIER -50.4 176.31 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.814 0 CA-C-O 121.717 0.77 . . . . 0.0 111.065 -179.95 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 789' ' ' GLN . . . . . . . . . . . . . 2.2 mt-30 -161.87 170.6 19.18 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.563 -0.71 . . . . 0.0 109.508 179.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 790' ' ' GLN . . . . . 0.435 ' O ' ' C ' ' A' ' 791' ' ' GLY . 1.1 tp60 -88.81 21.05 3.2 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.985 -1.072 . . . . 0.0 110.283 -179.945 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 791' ' ' GLY . . . . . 0.767 ' HA2' HD12 ' A' ' 782' ' ' LEU . . . 42.34 -124.34 3.74 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.764 -1.335 . . . . 0.0 109.764 -179.953 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 792' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -133.02 -30.73 1.33 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.347 -1.09 . . . . 0.0 110.392 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 793' ' ' CYS . . . . . . . . . . . . . 5.1 t -112.07 139.44 47.59 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.187 -0.946 . . . . 0.0 110.239 -179.913 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 794' ' ' HIS . . . . . 0.471 ' CD2' ' H ' ' A' ' 796' ' ' ILE . 19.0 t60 -148.81 141.57 24.58 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.3 -0.875 . . . . 0.0 109.952 179.876 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 795' ' ' SER . . . . . 0.431 ' HB3' ' HG3' ' A' ' 825' ' ' PRO . 3.7 p -81.99 10.13 7.1 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.294 -0.879 . . . . 0.0 110.382 -179.967 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 796' ' ' ILE . . . . . 0.694 HG22 ' O ' ' A' ' 796' ' ' ILE . 50.2 mt 45.98 23.24 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 O-C-N 121.2 -0.937 . . . . 0.0 110.405 -179.933 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 797' ' ' ASN . . . . . 0.594 ' O ' HG23 ' A' ' 801' ' ' VAL . 2.8 t30 -150.46 17.14 0.82 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.339 -0.851 . . . . 0.0 109.815 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 798' ' ' SER . . . . . 0.532 ' CB ' ' HA ' ' A' ' 777' ' ' SER . 2.0 m -81.45 -29.72 33.7 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.47 -0.769 . . . . 0.0 110.324 -179.934 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 799' ' ' ASN . . . . . . . . . . . . . 11.9 t30 -86.78 -11.38 51.16 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.276 -0.89 . . . . 0.0 110.525 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 800' ' ' SER . . . . . 0.466 ' O ' ' HB3' ' A' ' 804' ' ' ARG . 30.5 m -87.54 -20.92 25.79 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.182 -0.949 . . . . 0.0 110.166 179.955 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 801' ' ' VAL . . . . . 0.711 HG11 ' CE2' ' A' ' 821' ' ' PHE . 42.0 t -73.75 -41.75 54.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.235 -0.916 . . . . 0.0 110.188 -179.959 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 802' ' ' LEU . . . . . 0.654 HD22 ' N ' ' A' ' 802' ' ' LEU . 4.0 mm? -75.62 -41.04 55.36 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.217 -0.927 . . . . 0.0 110.185 179.933 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 803' ' ' GLU . . . . . 0.585 ' HA ' ' CG1' ' A' ' 807' ' ' ILE . 5.5 tt0 -73.64 -18.04 61.08 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.147 -0.971 . . . . 0.0 110.663 179.948 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 804' ' ' ARG . . . . . 0.466 ' HB3' ' O ' ' A' ' 800' ' ' SER . 0.1 OUTLIER -89.2 -29.21 19.45 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.126 -0.984 . . . . 0.0 110.948 -179.979 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 805' ' ' LYS . . . . . . . . . . . . . 8.3 ttmt -122.11 -41.7 2.42 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 120.979 -1.075 . . . . 0.0 110.937 -179.944 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 806' ' ' CYS . . . . . 0.434 ' O ' HG12 ' A' ' 807' ' ' ILE . 0.9 OUTLIER -86.14 69.89 10.52 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.224 -0.923 . . . . 0.0 110.714 -179.994 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 807' ' ' ILE . . . . . 0.585 ' CG1' ' HA ' ' A' ' 803' ' ' GLU . 16.0 mm -149.72 121.63 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.411 0 O-C-N 121.287 -0.883 . . . . 0.0 110.512 179.934 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 808' ' ' GLY . . . . . . . . . . . . . . . 84.56 23.57 50.0 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.887 -1.285 . . . . 0.0 109.887 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 809' ' ' LEU . . . . . . . . . . . . . 72.5 mt -123.12 148.22 45.93 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.106 -1.232 . . . . 0.0 110.592 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 810' ' ' GLU . . . . . 0.425 ' O ' ' HB2' ' A' ' 764' ' ' CYS . 1.1 mp0 -83.45 1.25 42.55 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.256 -0.903 . . . . 0.0 110.032 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 811' ' ' ARG . . . . . . . . . . . . . 46.5 ttt180 -153.86 160.38 42.15 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.463 -0.773 . . . . 0.0 109.127 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 812' ' ' CYS . . . . . 0.574 ' C ' HG23 ' A' ' 813' ' ' VAL . 0.1 OUTLIER -155.5 143.93 20.28 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.794 -1.191 . . . . 0.0 111.735 -179.981 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 813' ' ' VAL . . . . . 0.574 HG23 ' C ' ' A' ' 812' ' ' CYS . 32.0 t -155.54 110.28 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 179.934 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 814' ' ' VAL . . . . . . . . . . . . . 76.0 t -108.43 120.36 59.67 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 121.198 -0.939 . . . . 0.0 110.746 -179.922 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 815' ' ' ALA . . . . . 0.441 ' O ' ' C ' ' A' ' 816' ' ' ILE . . . -78.01 84.69 4.27 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.425 -0.797 . . . . 0.0 110.102 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 816' ' ' ILE . . . . . 0.618 HD11 HG11 ' A' ' 833' ' ' VAL . 21.3 mt -39.39 143.11 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 O-C-N 121.476 -0.765 . . . . 0.0 110.602 179.97 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 817' ' ' SER . . . . . 0.44 ' OG ' ' HD2' ' A' ' 818' ' ' PRO . 0.0 OUTLIER -157.94 175.18 3.4 Favored Pre-proline 0 C--N 1.302 -1.481 0 O-C-N 121.328 -0.858 . . . . 0.0 109.958 179.944 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 818' ' ' PRO . . . . . 0.44 ' HD2' ' OG ' ' A' ' 817' ' ' SER . 42.7 Cg_endo -71.66 -71.42 0.02 OUTLIER 'Trans proline' 0 C--N 1.302 -1.871 0 O-C-N 123.941 1.495 . . . . 0.0 111.556 -179.933 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 819' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -86.85 39.09 0.83 Allowed 'General case' 0 N--CA 1.496 1.838 0 O-C-N 120.981 -1.074 . . . . 0.0 110.798 -179.895 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 820' ' ' ASN . . . . . 0.426 ' HB2' ' OG ' ' A' ' 817' ' ' SER . 0.7 OUTLIER -99.38 -34.07 10.45 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.135 -0.978 . . . . 0.0 109.888 179.987 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 821' ' ' PHE . . . . . 0.711 ' CE2' HG11 ' A' ' 801' ' ' VAL . 3.2 m-85 -99.7 -44.32 6.15 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.294 -0.879 . . . . 0.0 110.051 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 822' ' ' GLY . . . . . . . . . . . . . . . -165.01 -36.59 0.02 OUTLIER Glycine 0 N--CA 1.492 2.388 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 823' ' ' GLY . . . . . . . . . . . . . . . 134.4 -96.6 0.28 Allowed Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.698 -1.361 . . . . 0.0 109.698 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 824' ' ' ASP . . . . . . . . . . . . . 31.7 t0 -149.07 87.0 5.48 Favored Pre-proline 0 N--CA 1.492 1.658 0 O-C-N 121.3 -1.117 . . . . 0.0 110.359 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 825' ' ' PRO . . . . . 0.431 ' HG3' ' HB3' ' A' ' 795' ' ' SER . 43.8 Cg_endo -72.07 -49.54 0.3 Allowed 'Trans proline' 0 C--N 1.306 -1.682 0 O-C-N 123.945 1.497 . . . . 0.0 110.255 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 826' ' ' CYS . . . . . 0.72 ' SG ' HG21 ' A' ' 829' ' ' VAL . 0.0 OUTLIER -78.24 144.87 67.58 Favored Pre-proline 0 N--CA 1.489 1.478 0 O-C-N 121.241 -0.912 . . . . 0.0 109.832 179.898 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 827' ' ' PRO . . . . . 0.57 ' O ' HG23 ' A' ' 829' ' ' VAL . 46.6 Cg_endo -74.93 115.74 4.38 Favored 'Trans proline' 0 C--N 1.302 -1.888 0 O-C-N 124.007 1.53 . . . . 0.0 111.953 -179.938 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 828' ' ' GLU . . . . . 0.434 ' C ' ' O ' ' A' ' 827' ' ' PRO . 18.3 mm-40 35.8 36.99 0.04 OUTLIER 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.735 -0.603 . . . . 0.0 111.69 179.867 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 829' ' ' VAL . . . . . 0.72 HG21 ' SG ' ' A' ' 826' ' ' CYS . 17.3 t -91.07 165.27 1.98 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 O-C-N 121.114 -0.991 . . . . 0.0 109.703 179.861 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 830' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -63.67 -168.9 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.118 -0.989 . . . . 0.0 110.041 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 831' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -143.44 158.33 43.73 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.229 -0.919 . . . . 0.0 110.539 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 832' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -169.34 161.26 9.89 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.383 -0.823 . . . . 0.0 109.515 -179.958 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 833' ' ' VAL . . . . . 0.618 HG11 HD11 ' A' ' 816' ' ' ILE . 93.4 t -135.21 106.96 7.22 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 O-C-N 120.912 -1.117 . . . . 0.0 111.242 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 834' ' ' ALA . . . . . . . . . . . . . . . -115.87 114.53 24.82 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.444 -0.785 . . . . 0.0 108.894 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 835' ' ' VAL . . . . . . . . . . . . . 15.6 t -125.11 158.98 32.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.001 -1.062 . . . . 0.0 111.546 -179.847 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 836' ' ' GLU . . . . . 0.457 ' HB3' ' HB3' ' A' ' 774' ' ' LYS . 30.5 tt0 -147.63 143.29 27.59 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 108.056 -1.09 . . . . 0.0 108.056 179.847 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 837' ' ' ALA . . . . . . . . . . . . . . . -140.58 155.25 46.64 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 120.488 -1.383 . . . . 0.0 112.116 -179.877 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 838' ' ' VAL . . . . . . . . . . . . . 96.2 t -113.33 111.82 37.72 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 179.849 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 839' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -107.45 121.24 44.22 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.063 -1.023 . . . . 0.0 110.911 -179.848 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 840' ' ' SER . . . . . 0.716 ' C ' HG22 ' A' ' 841' ' ' THR . 4.6 p -140.82 -66.42 0.43 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.523 -0.736 . . . . 0.0 109.764 179.965 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 841' ' ' THR . . . . . 0.716 HG22 ' C ' ' A' ' 840' ' ' SER . 0.0 OUTLIER . . . . . 0 N--CA 1.5 2.057 0 O-C-N 121.482 -0.761 . . . . 0.0 109.918 179.933 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 728' ' ' VAL . . . . . 0.466 HG12 ' HA ' ' A' ' 840' ' ' SER . 0.4 OUTLIER . . . . . 0 N--CA 1.489 1.483 0 CA-C-O 121.353 0.596 . . . . 0.0 110.036 . . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 729' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER 176.59 46.82 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.254 -0.904 . . . . 0.0 109.947 -179.95 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 730' ' ' GLY . . . . . . . . . . . . . . . -143.68 89.09 0.17 Allowed Glycine 0 N--CA 1.488 2.116 0 N-CA-C 109.986 -1.246 . . . . 0.0 109.986 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 731' ' ' VAL . . . . . . . . . . . . . 18.0 t -108.27 162.94 6.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.259 -1.142 . . . . 0.0 109.158 179.912 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 732' ' ' CYS . . . . . 0.442 ' SG ' ' OE1' ' A' ' 836' ' ' GLU . 0.8 OUTLIER -156.55 157.68 35.81 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 120.907 -1.12 . . . . 0.0 111.139 -179.95 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 733' ' ' ALA . . . . . . . . . . . . . . . -170.31 103.52 0.28 Allowed 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 734' ' ' ASP . . . . . 0.578 ' C ' HG23 ' A' ' 735' ' ' VAL . 1.8 p-10 -113.09 136.04 53.14 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.226 -0.921 . . . . 0.0 110.619 -179.872 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 735' ' ' VAL . . . . . 0.65 HG11 ' O ' ' A' ' 759' ' ' LYS . 89.9 t -156.13 117.34 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.361 -0.837 . . . . 0.0 110.042 179.978 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 736' ' ' SER . . . . . . . . . . . . . 80.8 p -59.18 166.55 2.1 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.136 -0.977 . . . . 0.0 110.115 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 737' ' ' GLU . . . . . 0.723 ' HA ' ' HB3' ' A' ' 758' ' ' ALA . 35.2 tt0 . . . . . 0 N--CA 1.494 1.73 0 O-C-N 121.238 -0.914 . . . . 0.0 110.164 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 757' ' ' THR . . . . . . . . . . . . . 24.2 p . . . . . 0 N--CA 1.492 1.67 0 CA-C-O 121.273 0.559 . . . . 0.0 110.452 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 758' ' ' ALA . . . . . 0.723 ' HB3' ' HA ' ' A' ' 737' ' ' GLU . . . -111.93 161.72 16.11 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.35 -0.844 . . . . 0.0 109.796 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 759' ' ' LYS . . . . . 0.677 ' HE3' ' HB2' ' A' ' 815' ' ' ALA . 6.1 mttt -131.34 162.11 30.83 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.203 -0.936 . . . . 0.0 110.418 179.951 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 760' ' ' VAL . . . . . . . . . . . . . 99.2 t -107.61 143.01 18.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.385 -0.822 . . . . 0.0 109.31 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 761' ' ' HIS . . . . . . . . . . . . . 6.1 m170 -112.53 120.71 42.53 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.08 -1.012 . . . . 0.0 111.069 -179.921 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 762' ' ' LEU . . . . . 0.482 ' HB2' ' O ' ' A' ' 812' ' ' CYS . 12.3 mt -127.11 141.02 51.86 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.541 -0.724 . . . . 0.0 109.081 179.955 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 763' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -158.7 147.88 18.95 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 120.905 -1.122 . . . . 0.0 111.067 -179.903 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 764' ' ' CYS . . . . . . . . . . . . . 4.2 m -124.03 171.54 9.67 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.425 -0.797 . . . . 0.0 109.674 179.907 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 765' ' ' ALA . . . . . . . . . . . . . . . -70.1 158.52 87.2 Favored Pre-proline 0 N--CA 1.493 1.724 0 O-C-N 121.038 -1.039 . . . . 0.0 109.983 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 766' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -72.04 130.17 16.23 Favored 'Trans proline' 0 C--N 1.306 -1.7 0 O-C-N 123.925 1.487 . . . . 0.0 110.067 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 767' ' ' GLY . . . . . . . . . . . . . . . 112.47 -26.63 10.8 Favored Glycine 0 N--CA 1.488 2.143 0 N-CA-C 108.974 -1.65 . . . . 0.0 108.974 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 768' ' ' GLN . . . . . 0.493 ' C ' HG23 ' A' ' 769' ' ' THR . 2.0 mt-30 -106.79 172.29 6.9 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.362 -1.081 . . . . 0.0 109.992 179.934 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 769' ' ' THR . . . . . 0.493 HG23 ' C ' ' A' ' 768' ' ' GLN . 37.4 p -153.47 147.96 26.08 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.123 -0.985 . . . . 0.0 110.384 -179.937 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 770' ' ' ILE . . . . . . . . . . . . . 12.9 mt -64.29 146.29 13.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.274 -0.891 . . . . 0.0 109.475 179.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 771' ' ' SER . . . . . 0.523 ' O ' ' HB2' ' A' ' 772' ' ' ALA . 0.1 OUTLIER -135.52 -0.15 2.68 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.023 -1.048 . . . . 0.0 111.053 -179.942 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 772' ' ' ALA . . . . . 0.523 ' HB2' ' O ' ' A' ' 771' ' ' SER . . . -179.14 147.34 0.33 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.795 -1.191 . . . . 0.0 111.534 179.959 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 773' ' ' ILE . . . . . 0.423 HG13 ' HB3' ' A' ' 802' ' ' LEU . 22.7 mm -107.15 135.37 45.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 179.819 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 774' ' ' LYS . . . . . . . . . . . . . 2.3 ptpt -107.36 -6.85 16.91 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.026 -1.046 . . . . 0.0 111.712 -179.806 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 775' ' ' PHE . . . . . 0.661 ' O ' ' HB2' ' A' ' 776' ' ' ALA . 39.3 t80 -157.65 162.16 38.65 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.731 -1.231 . . . . 0.0 111.337 -179.973 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 776' ' ' ALA . . . . . 0.661 ' HB2' ' O ' ' A' ' 775' ' ' PHE . . . 170.04 112.66 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 109.295 -0.632 . . . . 0.0 109.295 179.933 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 777' ' ' SER . . . . . 0.434 ' HA ' ' CE1' ' A' ' 794' ' ' HIS . 0.2 OUTLIER -140.36 120.53 13.82 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.147 -0.971 . . . . 0.0 110.78 -179.954 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 778' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -94.39 96.43 9.52 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.416 -0.803 . . . . 0.0 109.271 179.879 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 779' ' ' GLY . . . . . . . . . . . . . . . 166.82 -111.04 0.43 Allowed Glycine 0 N--CA 1.492 2.372 0 N-CA-C 110.013 -1.235 . . . . 0.0 110.013 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 780' ' ' THR . . . . . 0.622 HG22 ' HG3' ' A' ' 830' ' ' MET . 2.1 p -118.13 102.03 51.06 Favored Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 120.958 -1.319 . . . . 0.0 110.627 -179.927 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 781' ' ' PRO . . . . . 0.529 ' CG ' ' HB3' ' A' ' 832' ' ' ARG . 49.0 Cg_endo -84.58 173.09 8.73 Favored 'Trans proline' 0 C--N 1.306 -1.692 0 O-C-N 124.126 1.592 . . . . 0.0 110.221 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 782' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -145.02 113.37 6.59 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.192 -0.942 . . . . 0.0 110.165 179.903 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 783' ' ' GLY . . . . . . . . . . . . . . . 114.21 -157.5 14.93 Favored Glycine 0 N--CA 1.492 2.409 0 N-CA-C 109.451 -1.46 . . . . 0.0 109.451 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 784' ' ' THR . . . . . 0.481 ' O ' ' CE1' ' A' ' 788' ' ' PHE . 0.0 OUTLIER -136.3 -55.1 0.75 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.101 -1.235 . . . . 0.0 110.519 179.985 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 785' ' ' CYS . . . . . . . . . . . . . 11.0 t -156.97 108.27 2.38 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.215 -0.928 . . . . 0.0 110.507 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 786' ' ' GLY . . . . . . . . . . . . . . . 112.5 -14.27 25.15 Favored Glycine 0 N--CA 1.492 2.401 0 N-CA-C 109.801 -1.319 . . . . 0.0 109.801 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 787' ' ' THR . . . . . . . . . . . . . 3.7 m -136.74 29.76 2.87 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.197 -1.178 . . . . 0.0 110.556 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 788' ' ' PHE . . . . . 0.514 ' HB3' ' CZ ' ' A' ' 775' ' ' PHE . 0.7 OUTLIER -67.75 124.54 23.57 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.174 -0.954 . . . . 0.0 109.87 179.974 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 789' ' ' GLN . . . . . . . . . . . . . 9.7 tm0? -130.22 130.22 44.35 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.234 -0.916 . . . . 0.0 110.321 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 790' ' ' GLN . . . . . 0.502 ' CG ' ' O ' ' A' ' 790' ' ' GLN . 2.3 pt20 -59.73 104.14 0.26 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.292 -0.88 . . . . 0.0 110.025 -179.965 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 791' ' ' GLY . . . . . 0.446 ' O ' ' HG2' ' A' ' 792' ' ' GLU . . . -44.7 -61.96 3.11 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.661 -1.375 . . . . 0.0 109.661 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 792' ' ' GLU . . . . . 0.446 ' HG2' ' O ' ' A' ' 791' ' ' GLY . 2.2 mm-40 -171.48 -33.33 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.18 -1.188 . . . . 0.0 110.388 -179.989 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 793' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -96.46 155.27 16.84 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.163 -0.96 . . . . 0.0 110.499 -179.958 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 794' ' ' HIS . . . . . 0.477 ' CD2' ' H ' ' A' ' 796' ' ' ILE . 13.4 t60 -165.33 164.75 19.78 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.245 -0.91 . . . . 0.0 110.039 -179.966 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 795' ' ' SER . . . . . 0.753 ' C ' HG23 ' A' ' 796' ' ' ILE . 51.1 p -100.79 -7.93 23.18 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.245 -0.909 . . . . 0.0 110.36 179.978 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 796' ' ' ILE . . . . . 0.753 HG23 ' C ' ' A' ' 795' ' ' SER . 0.6 OUTLIER 64.61 11.83 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.506 2.375 0 O-C-N 121.559 -0.713 . . . . 0.0 110.258 -179.972 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 797' ' ' ASN . . . . . 0.461 ' OD1' ' O ' ' A' ' 797' ' ' ASN . 11.0 p30 -152.18 30.91 0.55 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.374 -0.829 . . . . 0.0 109.607 179.968 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 798' ' ' SER . . . . . 0.532 ' CB ' ' O ' ' A' ' 776' ' ' ALA . 3.9 m -67.36 -51.2 55.09 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.573 -0.704 . . . . 0.0 111.707 -179.874 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 799' ' ' ASN . . . . . 0.437 ' OD1' ' N ' ' A' ' 800' ' ' SER . 36.3 p30 -74.9 -17.55 60.56 Favored 'General case' 0 N--CA 1.5 2.039 0 O-C-N 121.243 -0.911 . . . . 0.0 111.803 -179.823 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 800' ' ' SER . . . . . 0.437 ' N ' ' OD1' ' A' ' 799' ' ' ASN . 29.5 t -58.88 -22.24 58.93 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 120.853 -1.154 . . . . 0.0 110.851 -179.96 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 801' ' ' VAL . . . . . . . . . . . . . 42.6 t -93.72 -18.8 6.85 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.006 0 O-C-N 121.096 -1.002 . . . . 0.0 111.051 -179.921 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 802' ' ' LEU . . . . . 0.484 HD11 HG21 ' A' ' 814' ' ' VAL . 4.0 mm? -87.61 -21.54 25.28 Favored 'General case' 0 N--CA 1.5 2.052 0 O-C-N 121.089 -1.007 . . . . 0.0 111.176 -179.868 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 803' ' ' GLU . . . . . . . . . . . . . 24.5 mt-10 -79.31 -29.11 42.22 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.019 -1.051 . . . . 0.0 111.117 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 804' ' ' ARG . . . . . . . . . . . . . 6.8 mpt_? -92.43 -18.6 23.03 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.082 -1.011 . . . . 0.0 111.545 -179.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 805' ' ' LYS . . . . . . . . . . . . . 7.9 ttmt -129.4 52.03 2.01 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 120.84 -1.163 . . . . 0.0 111.625 -179.87 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 806' ' ' CYS . . . . . 0.436 ' HB2' ' O ' ' A' ' 802' ' ' LEU . 0.5 OUTLIER -162.63 -44.61 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.981 -1.074 . . . . 0.0 110.621 179.901 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 807' ' ' ILE . . . . . . . . . . . . . 30.6 mt -71.92 107.56 2.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.231 -0.918 . . . . 0.0 110.444 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 808' ' ' GLY . . . . . . . . . . . . . . . 122.11 8.79 7.05 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.756 -1.338 . . . . 0.0 109.756 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 809' ' ' LEU . . . . . . . . . . . . . 83.4 mt -135.39 144.91 46.84 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.232 -1.158 . . . . 0.0 110.517 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 810' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -70.88 -28.97 64.95 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.341 -0.85 . . . . 0.0 109.952 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 811' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -123.7 160.26 27.61 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.475 -0.765 . . . . 0.0 109.987 179.908 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 812' ' ' CYS . . . . . 0.482 ' O ' ' HB2' ' A' ' 762' ' ' LEU . 1.3 t -145.69 128.69 16.5 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.267 -0.896 . . . . 0.0 110.313 179.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 813' ' ' VAL . . . . . . . . . . . . . 4.8 t -127.13 108.88 19.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.17 -0.956 . . . . 0.0 109.934 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 814' ' ' VAL . . . . . 0.484 HG21 HD11 ' A' ' 802' ' ' LEU . 63.7 t -110.57 108.99 26.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.258 -0.901 . . . . 0.0 110.147 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 815' ' ' ALA . . . . . 0.677 ' HB2' ' HE3' ' A' ' 759' ' ' LYS . . . -74.32 168.15 20.22 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.285 -0.884 . . . . 0.0 110.085 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 816' ' ' ILE . . . . . 0.822 HD13 HG21 ' A' ' 833' ' ' VAL . 39.3 mt -121.82 131.67 72.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.253 -0.905 . . . . 0.0 110.322 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 817' ' ' SER . . . . . 0.475 ' HB2' ' HD2' ' A' ' 818' ' ' PRO . 9.1 p -178.71 173.63 0.58 Allowed Pre-proline 0 C--N 1.301 -1.54 0 O-C-N 121.43 -0.794 . . . . 0.0 109.695 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 818' ' ' PRO . . . . . 0.475 ' HD2' ' HB2' ' A' ' 817' ' ' SER . 51.3 Cg_endo -79.54 12.41 2.38 Favored 'Trans proline' 0 C--N 1.304 -1.78 0 O-C-N 123.847 1.446 . . . . 0.0 111.048 179.957 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 819' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -128.81 2.53 5.4 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.971 -1.081 . . . . 0.0 110.586 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 820' ' ' ASN . . . . . . . . . . . . . 5.7 m120 -96.36 -35.3 11.25 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.073 -1.017 . . . . 0.0 110.365 -179.932 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 821' ' ' PHE . . . . . . . . . . . . . 46.8 m-85 -104.04 -69.03 0.82 Allowed 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.277 -0.889 . . . . 0.0 110.352 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 822' ' ' GLY . . . . . . . . . . . . . . . 167.6 51.92 0.03 OUTLIER Glycine 0 N--CA 1.492 2.381 0 N-CA-C 109.617 -1.393 . . . . 0.0 109.617 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 823' ' ' GLY . . . . . . . . . . . . . . . 91.58 178.07 42.61 Favored Glycine 0 N--CA 1.493 2.453 0 N-CA-C 109.693 -1.363 . . . . 0.0 109.693 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 824' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -112.68 129.31 24.55 Favored Pre-proline 0 N--CA 1.495 1.797 0 O-C-N 121.338 -1.095 . . . . 0.0 110.236 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 825' ' ' PRO . . . . . 0.436 ' O ' ' HD3' ' A' ' 827' ' ' PRO . 49.4 Cg_endo -82.6 -47.28 0.06 OUTLIER 'Trans proline' 0 C--N 1.307 -1.621 0 O-C-N 123.857 1.451 . . . . 0.0 111.201 -179.958 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 826' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -114.7 93.36 32.97 Favored Pre-proline 0 N--CA 1.498 1.929 0 O-C-N 120.987 -1.07 . . . . 0.0 111.137 -179.892 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 827' ' ' PRO . . . . . 0.472 ' O ' ' CB ' ' A' ' 828' ' ' GLU . 50.6 Cg_endo -89.04 162.01 5.87 Favored 'Trans proline' 0 C--N 1.307 -1.623 0 O-C-N 123.903 1.475 . . . . 0.0 110.396 179.948 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 828' ' ' GLU . . . . . 0.472 ' CB ' ' O ' ' A' ' 827' ' ' PRO . 0.7 OUTLIER 67.35 16.29 10.05 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.206 -0.934 . . . . 0.0 110.806 179.971 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 829' ' ' VAL . . . . . 0.42 ' O ' ' C ' ' A' ' 830' ' ' MET . 59.1 t -127.3 148.27 32.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.061 -1.025 . . . . 0.0 110.129 -179.985 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 830' ' ' MET . . . . . 0.622 ' HG3' HG22 ' A' ' 780' ' ' THR . 3.1 ptt? -41.89 106.54 0.06 Allowed 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.233 -0.917 . . . . 0.0 109.885 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 831' ' ' LYS . . . . . . . . . . . . . 11.5 mttm -82.03 115.43 21.17 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.164 -0.96 . . . . 0.0 111.001 -179.882 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 832' ' ' ARG . . . . . 0.529 ' HB3' ' CG ' ' A' ' 781' ' ' PRO . 2.4 mmm-85 -135.33 132.79 38.09 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 179.889 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 833' ' ' VAL . . . . . 0.822 HG21 HD13 ' A' ' 816' ' ' ILE . 39.3 t -108.96 130.86 61.13 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.584 0 O-C-N 121.02 -1.05 . . . . 0.0 111.034 -179.889 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 834' ' ' ALA . . . . . 0.506 ' O ' HG23 ' A' ' 835' ' ' VAL . . . -128.83 135.59 49.33 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.508 -0.745 . . . . 0.0 109.411 -179.985 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 835' ' ' VAL . . . . . 0.506 HG23 ' O ' ' A' ' 834' ' ' ALA . 13.3 t -152.78 127.64 1.49 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.051 -1.031 . . . . 0.0 110.776 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 836' ' ' GLU . . . . . 0.442 ' OE1' ' SG ' ' A' ' 732' ' ' CYS . 3.4 mt-10 -110.58 133.38 53.36 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.452 -0.78 . . . . 0.0 109.587 179.922 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 837' ' ' ALA . . . . . . . . . . . . . . . -110.8 154.54 23.82 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.082 -1.011 . . . . 0.0 110.701 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 838' ' ' VAL . . . . . 0.422 ' HB ' ' O ' ' A' ' 772' ' ' ALA . 99.2 t -107.85 108.86 26.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.366 -0.834 . . . . 0.0 109.807 179.967 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 839' ' ' CYS . . . . . 0.415 ' O ' ' O ' ' A' ' 728' ' ' VAL . 0.0 OUTLIER -108.66 146.56 33.23 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.238 -0.914 . . . . 0.0 110.353 -179.934 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 840' ' ' SER . . . . . 0.466 ' HA ' HG12 ' A' ' 728' ' ' VAL . 0.6 OUTLIER -157.04 168.57 27.08 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.299 -0.875 . . . . 0.0 110.097 179.985 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 841' ' ' THR . . . . . . . . . . . . . 1.2 p . . . . . 0 N--CA 1.494 1.769 0 O-C-N 121.309 -0.869 . . . . 0.0 110.567 -179.979 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 728' ' ' VAL . . . . . 0.789 ' O ' HG12 ' A' ' 728' ' ' VAL . 9.9 t . . . . . 0 N--CA 1.492 1.643 0 CA-C-O 121.135 0.493 . . . . 0.0 110.036 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 729' ' ' SER . . . . . 0.444 ' HB3' ' HB3' ' A' ' 840' ' ' SER . 69.5 p -136.06 128.85 30.99 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.162 -0.961 . . . . 0.0 110.447 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 730' ' ' GLY . . . . . . . . . . . . . . . 132.82 74.74 0.1 Allowed Glycine 0 N--CA 1.492 2.414 0 N-CA-C 109.819 -1.312 . . . . 0.0 109.819 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 731' ' ' VAL . . . . . . . . . . . . . 48.0 t -109.66 147.43 14.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.217 -1.166 . . . . 0.0 110.039 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 732' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -120.51 151.63 39.11 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.159 -0.963 . . . . 0.0 110.568 -179.963 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 733' ' ' ALA . . . . . . . . . . . . . . . -141.26 103.09 4.36 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.413 -0.804 . . . . 0.0 109.69 179.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 734' ' ' ASP . . . . . 0.41 ' C ' HG23 ' A' ' 735' ' ' VAL . 39.0 t70 -127.61 128.19 45.12 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.261 -0.899 . . . . 0.0 109.889 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 735' ' ' VAL . . . . . 0.41 HG23 ' C ' ' A' ' 734' ' ' ASP . 76.7 t -146.74 134.19 14.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.031 -1.043 . . . . 0.0 110.61 179.933 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 736' ' ' SER . . . . . . . . . . . . . 2.7 m -68.26 140.9 56.02 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.359 -0.838 . . . . 0.0 109.852 179.931 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 737' ' ' GLU . . . . . . . . . . . . . 9.2 tm-20 . . . . . 0 N--CA 1.49 1.537 0 O-C-N 121.199 -0.938 . . . . 0.0 110.527 -179.976 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 757' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.502 2.134 0 CA-C-O 121.746 0.784 . . . . 0.0 111.573 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 758' ' ' ALA . . . . . . . . . . . . . . . -142.91 176.91 8.71 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.492 -0.755 . . . . 0.0 109.424 179.895 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 759' ' ' LYS . . . . . . . . . . . . . 8.3 mtpp -136.77 165.62 25.5 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.155 -0.966 . . . . 0.0 110.926 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 760' ' ' VAL . . . . . 0.433 HG23 HG13 ' A' ' 816' ' ' ILE . 46.8 t -108.38 146.65 13.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 179.91 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 761' ' ' HIS . . . . . . . . . . . . . 31.8 m80 -122.38 105.19 9.96 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.978 -1.076 . . . . 0.0 111.618 -179.879 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 762' ' ' LEU . . . . . 0.535 ' CB ' ' HB3' ' A' ' 812' ' ' CYS . 9.1 mt -118.14 131.21 56.43 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 179.823 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 763' ' ' LYS . . . . . . . . . . . . . 4.3 pttt -159.8 156.13 26.99 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.859 -1.151 . . . . 0.0 111.276 -179.932 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 764' ' ' CYS . . . . . . . . . . . . . 66.0 m -140.02 -178.14 5.32 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.577 -0.702 . . . . 0.0 109.755 179.88 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 765' ' ' ALA . . . . . 0.475 ' HB3' ' CD ' ' A' ' 768' ' ' GLN . . . -68.49 161.21 71.83 Favored Pre-proline 0 C--N 1.293 -1.883 0 O-C-N 121.233 -0.917 . . . . 0.0 110.895 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 766' ' ' PRO . . . . . 0.403 ' HD2' ' HB1' ' A' ' 765' ' ' ALA . 47.2 Cg_endo -72.53 83.68 1.27 Allowed 'Trans proline' 0 C--N 1.309 -1.528 0 O-C-N 124.174 1.618 . . . . 0.0 109.951 179.926 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 767' ' ' GLY . . . . . . . . . . . . . . . 150.42 -26.14 1.09 Allowed Glycine 0 N--CA 1.488 2.13 0 N-CA-C 108.293 -1.923 . . . . 0.0 108.293 -179.918 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 768' ' ' GLN . . . . . 0.645 ' NE2' HG11 ' A' ' 728' ' ' VAL . 6.4 mt-30 -101.33 102.4 13.24 Favored 'General case' 0 N--CA 1.486 1.357 0 O-C-N 121.647 -0.914 . . . . 0.0 109.458 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 769' ' ' THR . . . . . . . . . . . . . 9.1 p -101.11 149.26 24.15 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.234 -0.916 . . . . 0.0 110.566 -179.857 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 770' ' ' ILE . . . . . 0.563 HG13 ' HB3' ' A' ' 839' ' ' CYS . 2.6 mp -63.06 148.16 11.47 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 O-C-N 121.287 -0.883 . . . . 0.0 109.97 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 771' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -137.49 -15.76 1.4 Allowed 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.1 -1.0 . . . . 0.0 111.847 -179.963 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 772' ' ' ALA . . . . . . . . . . . . . . . -144.3 136.59 26.49 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 120.698 -1.251 . . . . 0.0 111.689 -179.888 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 773' ' ' ILE . . . . . 0.41 HD12 HG23 ' A' ' 773' ' ' ILE . 23.1 mm -105.4 113.65 42.88 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 179.827 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 774' ' ' LYS . . . . . . . . . . . . . 27.6 ttpp -82.08 -44.96 15.88 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.077 -1.014 . . . . 0.0 111.072 -179.925 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 775' ' ' PHE . . . . . 0.531 ' CD2' ' HB3' ' A' ' 788' ' ' PHE . 73.2 t80 -138.88 163.53 32.06 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.013 -1.054 . . . . 0.0 111.194 -179.911 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 776' ' ' ALA . . . . . 0.502 ' HB1' ' O ' ' A' ' 798' ' ' SER . . . -179.68 93.63 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 109.392 -0.596 . . . . 0.0 109.392 179.989 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 777' ' ' SER . . . . . 0.493 ' HA ' ' CB ' ' A' ' 798' ' ' SER . 11.9 t -127.53 133.33 49.82 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.17 -0.956 . . . . 0.0 110.47 -179.871 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 778' ' ' PHE . . . . . 0.76 ' HE2' HG23 ' A' ' 816' ' ' ILE . 55.1 t80 -110.05 95.84 5.85 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.419 -0.8 . . . . 0.0 110.157 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 779' ' ' GLY . . . . . 0.49 ' HA2' ' HB2' ' A' ' 831' ' ' LYS . . . 163.12 -97.14 0.15 Allowed Glycine 0 N--CA 1.493 2.438 0 N-CA-C 109.655 -1.378 . . . . 0.0 109.655 -179.921 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 780' ' ' THR . . . . . 0.468 ' O ' ' HA3' ' A' ' 791' ' ' GLY . 6.3 p -132.52 89.23 36.73 Favored Pre-proline 0 N--CA 1.495 1.783 0 O-C-N 121.12 -1.223 . . . . 0.0 110.063 -179.954 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 781' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -76.36 169.21 22.39 Favored 'Trans proline' 0 C--N 1.303 -1.847 0 O-C-N 124.072 1.564 . . . . 0.0 110.607 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 782' ' ' LEU . . . . . 0.781 HD13 ' C ' ' A' ' 782' ' ' LEU . 1.9 tm? -131.11 115.11 15.98 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.25 -0.906 . . . . 0.0 110.209 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 783' ' ' GLY . . . . . 0.433 ' N ' HD22 ' A' ' 782' ' ' LEU . . . 126.46 -173.92 18.03 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.827 -1.309 . . . . 0.0 109.827 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 784' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -119.08 -169.04 1.67 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.322 -1.105 . . . . 0.0 110.32 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 785' ' ' CYS . . . . . . . . . . . . . 3.6 t -65.1 90.66 0.09 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.369 -0.832 . . . . 0.0 110.309 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 786' ' ' GLY . . . . . . . . . . . . . . . 153.04 -22.53 0.78 Allowed Glycine 0 N--CA 1.489 2.202 0 N-CA-C 110.036 -1.226 . . . . 0.0 110.036 179.914 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 787' ' ' THR . . . . . 0.784 HG22 ' O ' ' A' ' 787' ' ' THR . 60.0 m -146.7 36.28 0.96 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.121 -1.223 . . . . 0.0 110.839 -179.965 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 788' ' ' PHE . . . . . 0.531 ' HB3' ' CD2' ' A' ' 775' ' ' PHE . 7.9 m-85 -54.06 112.44 0.96 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.028 -1.045 . . . . 0.0 109.769 179.995 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 789' ' ' GLN . . . . . . . . . . . . . 3.3 mt-30 -119.36 157.95 27.12 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.255 -0.903 . . . . 0.0 110.116 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 790' ' ' GLN . . . . . . . . . . . . . 16.7 mp0 -49.38 122.01 5.66 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.257 -0.902 . . . . 0.0 110.3 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 791' ' ' GLY . . . . . 0.468 ' HA3' ' O ' ' A' ' 780' ' ' THR . . . -81.05 -103.65 0.32 Allowed Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.404 -1.478 . . . . 0.0 109.404 179.938 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 792' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -130.17 -36.17 1.54 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.294 -1.121 . . . . 0.0 110.218 179.939 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 793' ' ' CYS . . . . . 0.434 ' HB2' ' OG1' ' A' ' 780' ' ' THR . 4.6 m -107.76 146.32 32.32 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.246 -0.909 . . . . 0.0 110.418 -179.975 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 794' ' ' HIS . . . . . . . . . . . . . 4.4 t60 -149.06 143.92 26.36 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.372 -0.83 . . . . 0.0 110.172 179.901 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 795' ' ' SER . . . . . 0.533 ' O ' ' CG1' ' A' ' 796' ' ' ILE . 9.0 t -92.93 22.92 4.52 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.25 -0.906 . . . . 0.0 110.227 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 796' ' ' ILE . . . . . 0.533 ' CG1' ' O ' ' A' ' 795' ' ' SER . 36.8 pt 37.32 29.67 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.105 0 O-C-N 121.621 -0.675 . . . . 0.0 110.861 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 797' ' ' ASN . . . . . 0.488 ' N ' ' O ' ' A' ' 795' ' ' SER . 2.0 t-20 -157.66 19.32 0.27 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.085 -1.009 . . . . 0.0 110.269 179.946 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 798' ' ' SER . . . . . 0.502 ' O ' ' HB1' ' A' ' 776' ' ' ALA . 1.2 m -90.33 18.22 6.34 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.263 -0.898 . . . . 0.0 110.395 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 799' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -131.16 -16.88 3.11 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.073 -1.017 . . . . 0.0 111.327 -179.961 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 800' ' ' SER . . . . . . . . . . . . . 5.7 p -78.79 -53.08 7.48 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.0 -1.062 . . . . 0.0 110.544 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 801' ' ' VAL . . . . . 0.547 ' O ' ' CB ' ' A' ' 805' ' ' LYS . 55.1 t -58.63 -19.77 15.14 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.31 -0.869 . . . . 0.0 110.723 -179.948 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 802' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -81.84 -62.2 1.7 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.992 -1.067 . . . . 0.0 111.165 -179.899 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 803' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -56.54 -32.78 65.46 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.192 -0.943 . . . . 0.0 111.417 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 804' ' ' ARG . . . . . . . . . . . . . 62.6 mtm-85 -92.52 -18.88 22.58 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.045 -1.034 . . . . 0.0 111.84 -179.868 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 805' ' ' LYS . . . . . 0.547 ' CB ' ' O ' ' A' ' 801' ' ' VAL . 0.2 OUTLIER -116.83 43.0 2.35 Favored 'General case' 0 N--CA 1.501 2.095 0 O-C-N 120.815 -1.178 . . . . 0.0 111.061 -179.962 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 806' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -159.5 -55.15 0.06 Allowed 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.103 -0.998 . . . . 0.0 110.259 179.833 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 807' ' ' ILE . . . . . . . . . . . . . 61.5 mt -61.21 123.82 14.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.218 -0.926 . . . . 0.0 110.314 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 808' ' ' GLY . . . . . 0.43 ' C ' ' HG ' ' A' ' 809' ' ' LEU . . . 101.31 11.8 37.91 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.603 -1.399 . . . . 0.0 109.603 -179.941 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 809' ' ' LEU . . . . . 0.43 ' HG ' ' C ' ' A' ' 808' ' ' GLY . 59.5 mt -137.28 129.83 29.95 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.228 -1.16 . . . . 0.0 110.199 179.976 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 810' ' ' GLU . . . . . . . . . . . . . 24.1 tt0 -67.56 -19.73 65.31 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.325 -0.859 . . . . 0.0 110.188 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 811' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -133.65 128.7 35.63 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.386 -0.821 . . . . 0.0 110.211 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 812' ' ' CYS . . . . . 0.535 ' HB3' ' CB ' ' A' ' 762' ' ' LEU . 1.3 t -110.65 122.38 47.63 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.329 -0.857 . . . . 0.0 110.135 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 813' ' ' VAL . . . . . . . . . . . . . 25.2 t -130.45 118.62 43.65 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.14 -0.975 . . . . 0.0 110.153 -180.0 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 814' ' ' VAL . . . . . . . . . . . . . 91.6 t -134.67 120.01 30.54 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.286 -0.884 . . . . 0.0 110.156 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 815' ' ' ALA . . . . . . . . . . . . . . . -75.71 146.47 40.11 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.227 -0.921 . . . . 0.0 110.278 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 816' ' ' ILE . . . . . 0.76 HG23 ' HE2' ' A' ' 778' ' ' PHE . 84.6 mt -96.53 123.28 48.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.319 -0.863 . . . . 0.0 110.178 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 817' ' ' SER . . . . . 0.477 ' HB2' ' HD2' ' A' ' 818' ' ' PRO . 4.5 p -159.5 170.55 8.61 Favored Pre-proline 0 N--CA 1.494 1.766 0 O-C-N 121.009 -1.057 . . . . 0.0 110.561 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 818' ' ' PRO . . . . . 0.477 ' HD2' ' HB2' ' A' ' 817' ' ' SER . 47.0 Cg_endo -73.77 -2.08 11.7 Favored 'Trans proline' 0 C--N 1.308 -1.555 0 O-C-N 124.047 1.551 . . . . 0.0 110.606 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 819' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -134.65 59.91 1.72 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.206 -0.934 . . . . 0.0 110.229 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 820' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -132.48 -41.9 0.96 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.365 -0.834 . . . . 0.0 110.278 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 821' ' ' PHE . . . . . . . . . . . . . 79.8 m-85 -100.98 -68.79 0.8 Allowed 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.215 -0.928 . . . . 0.0 110.72 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 822' ' ' GLY . . . . . . . . . . . . . . . -149.05 20.76 1.24 Allowed Glycine 0 N--CA 1.492 2.422 0 C-N-CA 119.638 -1.268 . . . . 0.0 109.945 -179.904 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 823' ' ' GLY . . . . . 0.47 ' HA2' ' O ' ' A' ' 818' ' ' PRO . . . 102.94 -132.96 11.22 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.719 -1.352 . . . . 0.0 109.719 179.912 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 824' ' ' ASP . . . . . 0.471 ' OD1' ' HB3' ' A' ' 818' ' ' PRO . 2.2 m-20 -140.77 106.45 6.36 Favored Pre-proline 0 N--CA 1.493 1.724 0 O-C-N 121.289 -1.124 . . . . 0.0 110.246 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 825' ' ' PRO . . . . . 0.468 ' O ' ' HD3' ' A' ' 827' ' ' PRO . 44.9 Cg_endo -72.47 -88.44 0.0 OUTLIER 'Trans proline' 0 C--N 1.304 -1.774 0 O-C-N 124.085 1.571 . . . . 0.0 111.003 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 826' ' ' CYS . . . . . . . . . . . . . 97.1 m -80.6 112.18 29.29 Favored Pre-proline 0 N--CA 1.498 1.938 0 O-C-N 121.232 -0.918 . . . . 0.0 110.924 -179.908 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 827' ' ' PRO . . . . . 0.726 ' O ' HG23 ' A' ' 829' ' ' VAL . 49.7 Cg_endo -94.12 173.92 1.51 Allowed 'Trans proline' 0 C--N 1.308 -1.563 0 O-C-N 123.993 1.523 . . . . 0.0 110.251 179.956 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 828' ' ' GLU . . . . . . . . . . . . . 14.4 mt-10 52.33 31.11 8.94 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.358 -0.839 . . . . 0.0 110.826 179.945 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 829' ' ' VAL . . . . . 0.726 HG23 ' O ' ' A' ' 827' ' ' PRO . 97.9 t -137.02 113.73 12.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.013 -1.055 . . . . 0.0 110.469 -179.944 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 830' ' ' MET . . . . . 0.434 ' C ' ' O ' ' A' ' 829' ' ' VAL . 2.2 mtt -42.52 95.86 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.333 -0.854 . . . . 0.0 109.989 179.937 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 831' ' ' LYS . . . . . 0.494 ' N ' ' O ' ' A' ' 829' ' ' VAL . 1.9 pttp -109.63 139.49 44.59 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.206 -0.934 . . . . 0.0 110.925 -179.908 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 832' ' ' ARG . . . . . . . . . . . . . 10.4 ptt180 -128.45 166.57 18.5 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.416 -0.802 . . . . 0.0 109.277 179.917 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 833' ' ' VAL . . . . . 0.503 HG22 ' CD2' ' A' ' 778' ' ' PHE . 54.7 t -107.61 128.67 62.59 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.109 -0.994 . . . . 0.0 110.831 -179.913 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 834' ' ' ALA . . . . . . . . . . . . . . . -128.57 132.45 48.22 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 179.891 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 835' ' ' VAL . . . . . . . . . . . . . 53.2 t -141.25 150.9 19.76 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 O-C-N 120.819 -1.176 . . . . 0.0 111.538 -179.893 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 836' ' ' GLU . . . . . . . . . . . . . 4.0 tp10 -131.53 108.71 9.75 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 179.9 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 837' ' ' ALA . . . . . . . . . . . . . . . -107.87 158.87 16.97 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.037 -1.039 . . . . 0.0 110.264 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 838' ' ' VAL . . . . . . . . . . . . . 37.6 t -122.19 103.07 12.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.285 -0.884 . . . . 0.0 110.418 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 839' ' ' CYS . . . . . 0.563 ' HB3' HG13 ' A' ' 770' ' ' ILE . 3.1 p -120.19 132.29 55.31 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.4 -0.812 . . . . 0.0 109.401 179.931 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 840' ' ' SER . . . . . 0.502 ' O ' ' HA ' ' A' ' 768' ' ' GLN . 16.7 p -149.66 -168.45 3.11 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.065 -1.022 . . . . 0.0 110.881 -179.919 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 841' ' ' THR . . . . . 0.487 ' N ' ' HG2' ' A' ' 768' ' ' GLN . 22.7 p . . . . . 0 N--CA 1.497 1.884 0 O-C-N 121.435 -0.791 . . . . 0.0 110.767 -179.91 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 728' ' ' VAL . . . . . . . . . . . . . 15.5 m . . . . . 0 N--CA 1.489 1.487 0 CA-C-O 121.196 0.522 . . . . 0.0 110.08 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 729' ' ' SER . . . . . . . . . . . . . 1.5 t -173.87 168.09 4.29 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.295 -0.878 . . . . 0.0 110.278 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 730' ' ' GLY . . . . . . . . . . . . . . . -138.1 130.11 4.86 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.404 -1.478 . . . . 0.0 109.404 179.931 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 731' ' ' VAL . . . . . 0.619 ' CG2' ' HB3' ' A' ' 837' ' ' ALA . 13.6 m -110.82 124.93 68.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.237 -1.155 . . . . 0.0 110.339 -179.956 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 732' ' ' CYS . . . . . . . . . . . . . 5.1 t -109.46 112.46 24.58 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.343 -0.848 . . . . 0.0 109.582 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 733' ' ' ALA . . . . . . . . . . . . . . . -114.2 142.01 46.8 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.236 -0.915 . . . . 0.0 110.974 -179.924 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 734' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -155.54 118.58 4.31 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.465 -0.772 . . . . 0.0 109.483 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 735' ' ' VAL . . . . . . . . . . . . . 65.5 t -128.55 150.39 34.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.121 -0.987 . . . . 0.0 110.789 -179.934 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 736' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -99.88 139.73 35.13 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.323 -0.861 . . . . 0.0 109.614 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 737' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 . . . . . 0 N--CA 1.495 1.811 0 O-C-N 121.082 -1.011 . . . . 0.0 110.668 179.991 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 757' ' ' THR . . . . . . . . . . . . . 25.5 p . . . . . 0 N--CA 1.493 1.702 0 CA-C-O 121.326 0.584 . . . . 0.0 110.332 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 758' ' ' ALA . . . . . 0.565 ' HB3' HD12 ' A' ' 816' ' ' ILE . . . -98.79 176.83 5.48 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.294 -0.879 . . . . 0.0 110.224 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 759' ' ' LYS . . . . . . . . . . . . . 13.4 mtmm -141.09 144.58 35.0 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.261 -0.899 . . . . 0.0 110.44 -179.934 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 760' ' ' VAL . . . . . . . . . . . . . 38.5 t -106.14 133.99 49.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.333 -0.854 . . . . 0.0 108.767 179.881 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 761' ' ' HIS . . . . . 0.89 ' CE1' HG22 ' A' ' 813' ' ' VAL . 0.3 OUTLIER -120.47 123.12 42.19 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 120.907 -1.121 . . . . 0.0 111.893 -179.87 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 762' ' ' LEU . . . . . . . . . . . . . 12.5 mt -120.45 98.61 6.12 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 179.77 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 763' ' ' LYS . . . . . 0.533 ' CB ' ' HG2' ' A' ' 811' ' ' ARG . 0.2 OUTLIER -114.48 137.51 51.76 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.005 -1.059 . . . . 0.0 111.515 -179.8 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 764' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER -118.3 161.96 19.07 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.679 -0.638 . . . . 0.0 109.555 179.901 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 765' ' ' ALA . . . . . 0.579 ' HB1' ' HD2' ' A' ' 766' ' ' PRO . . . -50.62 167.73 0.25 Allowed Pre-proline 0 N--CA 1.495 1.775 0 O-C-N 120.978 -1.076 . . . . 0.0 110.133 -179.959 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 766' ' ' PRO . . . . . 0.579 ' HD2' ' HB1' ' A' ' 765' ' ' ALA . 45.5 Cg_endo -72.22 124.34 9.91 Favored 'Trans proline' 0 C--N 1.305 -1.734 0 O-C-N 123.972 1.512 . . . . 0.0 110.155 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 767' ' ' GLY . . . . . . . . . . . . . . . 109.67 -36.37 4.35 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.223 -1.551 . . . . 0.0 109.223 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 768' ' ' GLN . . . . . . . . . . . . . 28.8 mt-30 -87.89 115.27 25.23 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.281 -1.129 . . . . 0.0 109.894 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 769' ' ' THR . . . . . . . . . . . . . 29.4 p -109.28 167.64 9.97 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.215 -0.928 . . . . 0.0 110.292 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 770' ' ' ILE . . . . . . . . . . . . . 7.8 mt -85.61 101.25 9.75 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 121.236 -0.915 . . . . 0.0 109.807 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 771' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -89.55 -6.9 55.91 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.162 -0.961 . . . . 0.0 110.818 -179.923 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 772' ' ' ALA . . . . . 0.464 ' O ' ' HB ' ' A' ' 838' ' ' VAL . . . -165.84 142.46 5.28 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.008 -1.058 . . . . 0.0 111.278 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 773' ' ' ILE . . . . . 0.409 HG13 ' HG2' ' A' ' 803' ' ' GLU . 47.3 mm -94.61 125.87 47.15 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 O-C-N 121.392 -0.817 . . . . 0.0 109.134 179.944 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 774' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -80.17 -37.94 32.33 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.085 -1.01 . . . . 0.0 111.244 -179.895 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 775' ' ' PHE . . . . . 0.642 ' O ' ' HB2' ' A' ' 776' ' ' ALA . 65.0 t80 -150.96 170.18 19.96 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.82 -1.175 . . . . 0.0 111.124 -179.984 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 776' ' ' ALA . . . . . 0.642 ' HB2' ' O ' ' A' ' 775' ' ' PHE . . . 170.82 116.4 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.703 -0.623 . . . . 0.0 109.346 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 777' ' ' SER . . . . . . . . . . . . . 14.5 t -151.69 131.77 13.49 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.114 -0.991 . . . . 0.0 110.724 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 778' ' ' PHE . . . . . . . . . . . . . 2.4 t80 -99.3 124.98 44.84 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.56 -0.713 . . . . 0.0 109.756 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 779' ' ' GLY . . . . . . . . . . . . . . . 130.3 -110.5 1.03 Allowed Glycine 0 N--CA 1.493 2.482 0 N-CA-C 109.85 -1.3 . . . . 0.0 109.85 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 780' ' ' THR . . . . . . . . . . . . . 11.8 p -135.37 83.57 37.49 Favored Pre-proline 0 N--CA 1.496 1.841 0 O-C-N 121.16 -1.2 . . . . 0.0 110.636 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 781' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -76.92 158.23 34.65 Favored 'Trans proline' 0 C--N 1.307 -1.639 0 O-C-N 123.856 1.45 . . . . 0.0 110.087 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 782' ' ' LEU . . . . . 0.496 ' O ' ' HA ' ' A' ' 788' ' ' PHE . 0.3 OUTLIER -96.24 123.86 40.03 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.158 -0.964 . . . . 0.0 110.241 179.958 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 783' ' ' GLY . . . . . . . . . . . . . . . 138.37 -169.33 24.33 Favored Glycine 0 N--CA 1.492 2.404 0 N-CA-C 109.688 -1.365 . . . . 0.0 109.688 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 784' ' ' THR . . . . . . . . . . . . . 3.3 m -138.31 -52.17 0.6 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.281 -1.129 . . . . 0.0 109.961 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 785' ' ' CYS . . . . . 0.558 ' HA ' ' CZ ' ' A' ' 788' ' ' PHE . 40.3 t -166.95 74.51 0.15 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.281 -0.887 . . . . 0.0 109.793 179.948 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 786' ' ' GLY . . . . . . . . . . . . . . . 130.68 -16.07 5.39 Favored Glycine 0 N--CA 1.489 2.171 0 N-CA-C 108.949 -1.66 . . . . 0.0 108.949 -179.932 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 787' ' ' THR . . . . . 0.451 HG22 ' O ' ' A' ' 787' ' ' THR . 18.2 m -121.78 27.36 8.19 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.477 -1.014 . . . . 0.0 109.878 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 788' ' ' PHE . . . . . 0.558 ' CZ ' ' HA ' ' A' ' 785' ' ' CYS . 35.4 m-85 -55.14 172.71 0.12 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.342 -0.849 . . . . 0.0 110.349 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 789' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER 179.23 172.48 0.86 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.362 -0.836 . . . . 0.0 109.93 -179.982 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 790' ' ' GLN . . . . . . . . . . . . . 6.2 tm0? -57.12 161.42 3.14 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.124 -0.985 . . . . 0.0 110.305 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 791' ' ' GLY . . . . . . . . . . . . . . . -136.89 -131.88 3.02 Favored Glycine 0 N--CA 1.494 2.507 0 N-CA-C 109.687 -1.365 . . . . 0.0 109.687 -179.919 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 792' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -107.76 -66.32 1.04 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.216 -1.167 . . . . 0.0 109.964 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 793' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -92.54 88.66 6.42 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.266 -0.896 . . . . 0.0 109.891 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 794' ' ' HIS . . . . . 0.435 ' HE1' ' CB ' ' A' ' 798' ' ' SER . 19.2 t60 -105.54 155.49 19.14 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.174 -0.954 . . . . 0.0 110.674 -179.921 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 795' ' ' SER . . . . . 0.535 ' HB2' ' HB3' ' A' ' 825' ' ' PRO . 1.3 t -115.63 111.21 20.3 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.466 -0.771 . . . . 0.0 109.942 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 796' ' ' ILE . . . . . . . . . . . . . 3.5 pt -44.3 -23.05 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 O-C-N 121.315 -0.866 . . . . 0.0 110.816 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 797' ' ' ASN . . . . . 0.409 ' N ' ' O ' ' A' ' 795' ' ' SER . 1.6 t30 -84.19 26.93 0.71 Allowed 'General case' 0 N--CA 1.499 1.991 0 O-C-N 120.988 -1.07 . . . . 0.0 111.005 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 798' ' ' SER . . . . . 0.487 ' HB3' ' O ' ' A' ' 776' ' ' ALA . 9.0 m -82.13 -31.57 30.53 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.0 -1.063 . . . . 0.0 111.11 179.942 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 799' ' ' ASN . . . . . 0.479 ' OD1' ' HB3' ' A' ' 776' ' ' ALA . 4.8 m120 -107.36 8.08 29.47 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.017 -1.052 . . . . 0.0 111.288 -179.893 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 800' ' ' SER . . . . . 0.448 ' O ' ' HB3' ' A' ' 804' ' ' ARG . 0.7 OUTLIER -90.33 -40.68 11.97 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.953 -1.092 . . . . 0.0 110.245 179.967 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 801' ' ' VAL . . . . . 0.63 HG21 ' CD2' ' A' ' 821' ' ' PHE . 55.5 t -74.65 -35.5 37.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.256 -0.902 . . . . 0.0 110.104 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 802' ' ' LEU . . . . . 0.492 HD13 ' HA ' ' A' ' 802' ' ' LEU . 4.0 mm? -69.31 -57.09 5.76 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.207 -0.933 . . . . 0.0 110.051 179.947 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 803' ' ' GLU . . . . . 0.409 ' HG2' HG13 ' A' ' 773' ' ' ILE . 0.7 OUTLIER -62.93 -18.29 62.94 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.235 -0.916 . . . . 0.0 110.011 179.943 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 804' ' ' ARG . . . . . 0.448 ' HB3' ' O ' ' A' ' 800' ' ' SER . 12.4 ttp180 -89.55 -20.42 23.81 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.265 -0.897 . . . . 0.0 111.07 -179.968 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 805' ' ' LYS . . . . . . . . . . . . . 9.2 ttmt -141.06 53.14 1.57 Allowed 'General case' 0 N--CA 1.495 1.818 0 O-C-N 120.878 -1.139 . . . . 0.0 110.873 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 806' ' ' CYS . . . . . 0.413 ' HB2' ' O ' ' A' ' 802' ' ' LEU . 1.4 t -158.94 -36.18 0.06 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.128 -0.983 . . . . 0.0 110.317 179.942 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 807' ' ' ILE . . . . . . . . . . . . . 9.5 mt -71.12 130.76 34.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.22 -0.925 . . . . 0.0 110.058 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 808' ' ' GLY . . . . . . . . . . . . . . . 91.8 16.03 52.85 Favored Glycine 0 N--CA 1.492 2.407 0 N-CA-C 109.776 -1.329 . . . . 0.0 109.776 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 809' ' ' LEU . . . . . . . . . . . . . 58.4 mt -129.22 138.97 52.01 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.188 -1.184 . . . . 0.0 110.411 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 810' ' ' GLU . . . . . 0.434 ' OE1' ' HA ' ' A' ' 766' ' ' PRO . 43.1 tt0 -69.14 -32.2 71.39 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.333 -0.854 . . . . 0.0 109.468 179.857 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 811' ' ' ARG . . . . . 0.533 ' HG2' ' CB ' ' A' ' 763' ' ' LYS . 3.3 mtm-85 -131.63 156.34 45.99 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.46 -0.775 . . . . 0.0 109.587 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 812' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -133.03 142.4 48.78 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.13 -0.981 . . . . 0.0 110.825 -179.976 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 813' ' ' VAL . . . . . 0.89 HG22 ' CE1' ' A' ' 761' ' ' HIS . 51.2 t -140.45 115.51 6.9 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.337 -0.852 . . . . 0.0 109.841 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 814' ' ' VAL . . . . . . . . . . . . . 52.4 t -128.89 121.76 55.24 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 O-C-N 121.253 -0.904 . . . . 0.0 110.464 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 815' ' ' ALA . . . . . . . . . . . . . . . -80.41 142.57 34.22 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.212 -0.93 . . . . 0.0 109.918 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 816' ' ' ILE . . . . . 0.565 HD12 ' HB3' ' A' ' 758' ' ' ALA . 14.1 mt -88.03 112.65 23.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.212 -0.93 . . . . 0.0 110.376 -179.955 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 817' ' ' SER . . . . . 0.458 ' OG ' ' OD1' ' A' ' 820' ' ' ASN . 78.7 p -168.34 163.39 8.57 Favored Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 121.448 -0.782 . . . . 0.0 109.993 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 818' ' ' PRO . . . . . 0.47 ' HB3' ' OD1' ' A' ' 824' ' ' ASP . 44.4 Cg_endo -72.37 -19.38 25.4 Favored 'Trans proline' 0 C--N 1.305 -1.747 0 O-C-N 124.021 1.537 . . . . 0.0 110.372 -179.979 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 819' ' ' SER . . . . . . . . . . . . . 9.1 m -94.97 48.13 1.17 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.187 -0.945 . . . . 0.0 110.017 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 820' ' ' ASN . . . . . 0.458 ' OD1' ' OG ' ' A' ' 817' ' ' SER . 1.2 m120 -139.75 -53.8 0.54 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.266 -0.897 . . . . 0.0 110.195 -179.955 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 821' ' ' PHE . . . . . 0.63 ' CD2' HG21 ' A' ' 801' ' ' VAL . 87.6 m-85 -79.54 -33.05 42.26 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.345 -0.847 . . . . 0.0 110.316 -179.958 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 822' ' ' GLY . . . . . . . . . . . . . . . 128.09 66.93 0.13 Allowed Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.656 -1.378 . . . . 0.0 109.656 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 823' ' ' GLY . . . . . . . . . . . . . . . 98.86 -175.57 28.89 Favored Glycine 0 N--CA 1.492 2.411 0 N-CA-C 109.716 -1.354 . . . . 0.0 109.716 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 824' ' ' ASP . . . . . 0.47 ' OD1' ' HB3' ' A' ' 818' ' ' PRO . 0.2 OUTLIER -102.18 133.15 20.79 Favored Pre-proline 0 N--CA 1.493 1.692 0 O-C-N 121.24 -1.153 . . . . 0.0 110.115 179.919 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 825' ' ' PRO . . . . . 0.535 ' HB3' ' HB2' ' A' ' 795' ' ' SER . 51.7 Cg_endo -75.07 -89.7 0.01 OUTLIER 'Trans proline' 0 C--N 1.307 -1.637 0 O-C-N 123.964 1.508 . . . . 0.0 110.477 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 826' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -113.41 103.1 55.48 Favored Pre-proline 0 N--CA 1.492 1.645 0 O-C-N 121.136 -0.978 . . . . 0.0 110.177 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 827' ' ' PRO . . . . . 0.411 ' O ' ' HB3' ' A' ' 828' ' ' GLU . 45.3 Cg_endo -74.08 165.4 32.09 Favored 'Trans proline' 0 C--N 1.304 -1.808 0 O-C-N 123.994 1.523 . . . . 0.0 110.655 179.933 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 828' ' ' GLU . . . . . 0.411 ' HB3' ' O ' ' A' ' 827' ' ' PRO . 1.6 tt0 55.78 44.7 25.71 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.304 -0.873 . . . . 0.0 110.578 179.959 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 829' ' ' VAL . . . . . 0.408 ' O ' ' C ' ' A' ' 830' ' ' MET . 25.4 t -141.33 151.57 19.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.222 -0.924 . . . . 0.0 110.122 179.92 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 830' ' ' MET . . . . . 0.408 ' C ' ' O ' ' A' ' 829' ' ' VAL . 0.0 OUTLIER -43.15 121.34 2.12 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.301 -0.874 . . . . 0.0 109.944 -179.986 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 831' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.71 86.64 7.31 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.287 -0.883 . . . . 0.0 110.595 -179.953 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 832' ' ' ARG . . . . . . . . . . . . . 6.8 mpt_? -129.58 125.89 37.24 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.408 -0.808 . . . . 0.0 109.421 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 833' ' ' VAL . . . . . 0.509 HG21 ' CG2' ' A' ' 816' ' ' ILE . 54.7 t -109.73 140.59 27.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.098 -1.001 . . . . 0.0 110.829 -179.887 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 834' ' ' ALA . . . . . 0.599 ' O ' HG23 ' A' ' 835' ' ' VAL . . . -141.26 138.16 33.03 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.398 -0.814 . . . . 0.0 109.68 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 835' ' ' VAL . . . . . 0.599 HG23 ' O ' ' A' ' 834' ' ' ALA . 35.3 t -156.0 127.99 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 O-C-N 121.036 -1.04 . . . . 0.0 111.187 -179.93 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 836' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -114.25 128.67 56.47 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.439 -0.788 . . . . 0.0 109.248 179.884 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 837' ' ' ALA . . . . . 0.619 ' HB3' ' CG2' ' A' ' 731' ' ' VAL . . . -110.98 157.89 19.39 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.075 -1.016 . . . . 0.0 110.914 -179.853 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 838' ' ' VAL . . . . . 0.464 ' HB ' ' O ' ' A' ' 772' ' ' ALA . 98.9 t -109.28 132.39 57.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.477 -0.765 . . . . 0.0 109.662 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 839' ' ' CYS . . . . . . . . . . . . . 1.3 m -115.8 134.64 54.8 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.071 -1.018 . . . . 0.0 110.721 -179.93 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 840' ' ' SER . . . . . . . . . . . . . 4.5 t -139.95 -133.84 0.11 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.44 -0.787 . . . . 0.0 109.743 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 841' ' ' THR . . . . . . . . . . . . . 30.4 p . . . . . 0 N--CA 1.492 1.627 0 O-C-N 120.89 -1.131 . . . . 0.0 110.213 -179.964 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 728' ' ' VAL . . . . . . . . . . . . . 56.4 t . . . . . 0 N--CA 1.492 1.662 0 CA-C-O 121.326 0.584 . . . . 0.0 110.039 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 729' ' ' SER . . . . . . . . . . . . . 1.3 t -84.68 -149.36 0.11 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.22 -0.925 . . . . 0.0 110.482 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 730' ' ' GLY . . . . . . . . . . . . . . . 170.58 131.7 1.37 Allowed Glycine 0 N--CA 1.489 2.175 0 N-CA-C 109.216 -1.554 . . . . 0.0 109.216 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 731' ' ' VAL . . . . . . . . . . . . . 7.0 t -120.14 141.25 41.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.174 -1.192 . . . . 0.0 110.411 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 732' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -109.64 163.86 13.08 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.354 -0.841 . . . . 0.0 109.864 -179.977 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 733' ' ' ALA . . . . . . . . . . . . . . . -155.37 104.48 2.4 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.146 -0.971 . . . . 0.0 110.656 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 734' ' ' ASP . . . . . . . . . . . . . 35.3 t0 -117.7 103.69 10.26 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.376 -0.828 . . . . 0.0 109.455 179.88 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 735' ' ' VAL . . . . . . . . . . . . . 68.4 t -129.86 154.02 39.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.209 -0.932 . . . . 0.0 110.482 -179.895 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 736' ' ' SER . . . . . 0.433 ' HA ' ' HD2' ' A' ' 832' ' ' ARG . 57.8 m -66.26 -173.29 0.19 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.316 -0.865 . . . . 0.0 110.474 -179.957 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 737' ' ' GLU . . . . . 0.455 ' OE1' HG21 ' A' ' 816' ' ' ILE . 28.8 tp10 . . . . . 0 N--CA 1.493 1.704 0 O-C-N 121.373 -0.83 . . . . 0.0 110.18 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 757' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.5 2.044 0 CA-C-O 121.474 0.654 . . . . 0.0 111.258 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 758' ' ' ALA . . . . . . . . . . . . . . . -91.45 174.99 7.08 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.437 -0.789 . . . . 0.0 110.333 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 759' ' ' LYS . . . . . . . . . . . . . 10.2 mttt -147.86 145.75 28.82 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.242 -0.912 . . . . 0.0 110.525 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 760' ' ' VAL . . . . . 0.43 ' CG2' HD11 ' A' ' 816' ' ' ILE . 97.9 t -136.97 131.13 46.2 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 O-C-N 121.471 -0.768 . . . . 0.0 109.493 179.932 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 761' ' ' HIS . . . . . 0.665 ' HB2' HG22 ' A' ' 813' ' ' VAL . 25.4 p-80 -142.69 135.18 27.77 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 120.936 -1.103 . . . . 0.0 111.002 -179.974 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 762' ' ' LEU . . . . . . . . . . . . . 3.3 mp -115.17 148.06 39.52 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.437 -0.789 . . . . 0.0 109.494 179.953 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 763' ' ' LYS . . . . . 0.426 ' O ' ' CG ' ' A' ' 763' ' ' LYS . 0.0 OUTLIER -133.61 105.04 6.64 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.04 -1.038 . . . . 0.0 110.616 -179.896 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 764' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -84.09 176.59 8.71 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.18 -0.95 . . . . 0.0 110.013 179.943 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 765' ' ' ALA . . . . . . . . . . . . . . . -69.6 160.55 79.14 Favored Pre-proline 0 N--CA 1.492 1.625 0 O-C-N 121.243 -0.91 . . . . 0.0 109.975 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 766' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -71.35 132.01 20.04 Favored 'Trans proline' 0 C--N 1.303 -1.847 0 O-C-N 124.053 1.554 . . . . 0.0 110.525 -179.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 767' ' ' GLY . . . . . . . . . . . . . . . 108.57 -44.95 1.39 Allowed Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 179.953 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 768' ' ' GLN . . . . . 0.414 ' HB3' ' HB3' ' A' ' 839' ' ' CYS . 2.4 mp0 -85.62 119.35 25.86 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.182 -1.187 . . . . 0.0 110.053 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 769' ' ' THR . . . . . . . . . . . . . 68.4 p -102.59 146.79 27.64 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.265 -0.897 . . . . 0.0 110.463 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 770' ' ' ILE . . . . . . . . . . . . . 48.3 mt -70.23 123.82 24.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.335 -0.853 . . . . 0.0 109.728 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 771' ' ' SER . . . . . . . . . . . . . 6.7 t -119.61 -12.83 9.23 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.148 -0.97 . . . . 0.0 110.696 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 772' ' ' ALA . . . . . 0.408 ' O ' ' HB ' ' A' ' 838' ' ' VAL . . . -148.78 130.35 14.91 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.022 -1.049 . . . . 0.0 110.735 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 773' ' ' ILE . . . . . 0.531 HG13 ' HG2' ' A' ' 803' ' ' GLU . 46.8 mm -84.33 129.87 36.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.241 -0.912 . . . . 0.0 109.715 179.949 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 774' ' ' LYS . . . . . 0.509 ' HB3' ' HB3' ' A' ' 836' ' ' GLU . 1.8 tppp? -80.12 -37.69 33.09 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.121 -0.987 . . . . 0.0 110.365 -179.924 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 775' ' ' PHE . . . . . 0.704 ' O ' ' HB2' ' A' ' 776' ' ' ALA . 88.3 t80 -159.74 171.17 20.01 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.049 -1.032 . . . . 0.0 110.73 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 776' ' ' ALA . . . . . 0.704 ' HB2' ' O ' ' A' ' 775' ' ' PHE . . . 166.92 90.79 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.423 -0.798 . . . . 0.0 109.801 -179.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 777' ' ' SER . . . . . 0.451 ' HB3' ' CZ ' ' A' ' 775' ' ' PHE . 12.6 t -128.68 132.26 48.04 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.307 -0.871 . . . . 0.0 110.419 -179.928 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 778' ' ' PHE . . . . . 0.566 ' O ' ' CD1' ' A' ' 778' ' ' PHE . 72.0 t80 -100.33 82.73 2.54 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.232 -0.918 . . . . 0.0 110.383 179.943 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 779' ' ' GLY . . . . . . . . . . . . . . . 174.31 -108.91 0.28 Allowed Glycine 0 N--CA 1.491 2.348 0 C-N-CA 119.687 -1.244 . . . . 0.0 110.039 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 780' ' ' THR . . . . . . . . . . . . . 29.5 p -113.26 99.46 49.17 Favored Pre-proline 0 N--CA 1.494 1.736 0 O-C-N 121.255 -1.144 . . . . 0.0 110.431 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 781' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -79.89 125.26 5.94 Favored 'Trans proline' 0 C--N 1.305 -1.734 0 O-C-N 123.915 1.482 . . . . 0.0 110.432 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 782' ' ' LEU . . . . . 0.457 ' HB2' ' CD ' ' A' ' 789' ' ' GLN . 61.9 mt -101.9 118.77 37.61 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.278 -0.888 . . . . 0.0 109.85 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 783' ' ' GLY . . . . . . . . . . . . . . . 114.19 -179.49 18.65 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.315 -1.514 . . . . 0.0 109.315 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 784' ' ' THR . . . . . . . . . . . . . 40.9 p -112.65 -162.39 0.8 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.176 -1.191 . . . . 0.0 110.363 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 785' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -71.93 115.72 11.47 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.263 -0.898 . . . . 0.0 110.258 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 786' ' ' GLY . . . . . . . . . . . . . . . 124.24 -30.33 4.8 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.496 -1.442 . . . . 0.0 109.496 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 787' ' ' THR . . . . . . . . . . . . . 1.2 p -131.92 27.4 4.58 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.342 -1.093 . . . . 0.0 110.094 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 788' ' ' PHE . . . . . 0.583 ' HB3' ' CG ' ' A' ' 775' ' ' PHE . 3.4 m-85 -51.23 164.39 0.18 Allowed 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.38 -0.825 . . . . 0.0 109.986 -179.97 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 789' ' ' GLN . . . . . 0.457 ' CD ' ' HB2' ' A' ' 782' ' ' LEU . 0.0 OUTLIER -175.43 127.84 0.26 Allowed 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.121 -0.987 . . . . 0.0 110.341 179.979 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 790' ' ' GLN . . . . . . . . . . . . . 1.8 pt20 -62.95 134.78 56.73 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.258 -0.901 . . . . 0.0 110.195 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 791' ' ' GLY . . . . . . . . . . . . . . . -95.28 -105.89 2.07 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.213 -1.555 . . . . 0.0 109.213 179.953 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 792' ' ' GLU . . . . . . . . . . . . . 29.5 tt0 -119.11 -24.99 6.3 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.258 -1.142 . . . . 0.0 109.744 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 793' ' ' CYS . . . . . 0.482 ' SG ' ' HG2' ' A' ' 825' ' ' PRO . 8.3 t -84.44 95.29 8.74 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.402 -0.811 . . . . 0.0 110.161 179.995 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 794' ' ' HIS . . . . . 0.583 ' CE1' ' OG ' ' A' ' 798' ' ' SER . 16.9 t60 -120.64 140.5 51.49 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.205 -0.934 . . . . 0.0 110.189 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 795' ' ' SER . . . . . 0.544 ' C ' HD12 ' A' ' 796' ' ' ILE . 28.0 t -81.16 9.22 7.16 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.173 -0.954 . . . . 0.0 110.355 -179.982 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 796' ' ' ILE . . . . . 0.544 HD12 ' C ' ' A' ' 795' ' ' SER . 1.4 mp 66.2 7.06 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.537 -0.727 . . . . 0.0 110.699 -179.993 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 797' ' ' ASN . . . . . 0.44 ' O ' HG23 ' A' ' 801' ' ' VAL . 38.8 t-20 -161.05 39.25 0.15 Allowed 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.06 -1.025 . . . . 0.0 110.804 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 798' ' ' SER . . . . . 0.583 ' OG ' ' CE1' ' A' ' 794' ' ' HIS . 0.7 OUTLIER -97.02 2.35 51.33 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.144 -0.973 . . . . 0.0 110.38 -179.967 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 799' ' ' ASN . . . . . . . . . . . . . 7.1 m120 -117.17 -22.77 8.19 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.083 -1.011 . . . . 0.0 110.707 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 800' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -89.86 -31.41 17.34 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.131 -0.981 . . . . 0.0 110.536 -179.937 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 801' ' ' VAL . . . . . 0.44 HG23 ' O ' ' A' ' 797' ' ' ASN . 97.7 t -61.85 -27.97 43.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.199 -0.938 . . . . 0.0 110.755 179.965 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 802' ' ' LEU . . . . . 0.456 HD22 ' N ' ' A' ' 802' ' ' LEU . 4.5 mm? -80.1 -56.56 4.14 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.164 -0.96 . . . . 0.0 110.686 -179.927 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 803' ' ' GLU . . . . . 0.592 ' HA ' ' CG1' ' A' ' 807' ' ' ILE . 3.7 mm-40 -55.51 -21.74 18.06 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.247 -0.908 . . . . 0.0 111.011 -179.962 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 804' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -93.0 -18.92 22.11 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.014 -1.054 . . . . 0.0 111.724 -179.827 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 805' ' ' LYS . . . . . 0.454 ' O ' ' SG ' ' A' ' 806' ' ' CYS . 0.0 OUTLIER -128.66 23.24 5.84 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 120.641 -1.287 . . . . 0.0 111.894 -179.939 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 806' ' ' CYS . . . . . 0.454 ' SG ' ' O ' ' A' ' 805' ' ' LYS . 1.6 m -160.93 32.17 0.15 Allowed 'General case' 0 N--CA 1.499 1.992 0 O-C-N 120.763 -1.211 . . . . 0.0 110.791 179.91 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 807' ' ' ILE . . . . . 0.592 ' CG1' ' HA ' ' A' ' 803' ' ' GLU . 14.4 mm -124.91 108.12 19.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.137 -0.977 . . . . 0.0 110.267 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 808' ' ' GLY . . . . . 0.433 ' C ' ' HG ' ' A' ' 809' ' ' LEU . . . 114.56 9.66 14.25 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.524 -1.431 . . . . 0.0 109.524 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 809' ' ' LEU . . . . . 0.433 ' HG ' ' C ' ' A' ' 808' ' ' GLY . 5.1 mt -131.56 134.47 46.1 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.319 -1.107 . . . . 0.0 110.137 179.943 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 810' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -65.42 -11.79 46.11 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.168 -0.957 . . . . 0.0 109.289 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 811' ' ' ARG . . . . . . . . . . . . . 2.3 ttt180 -158.28 129.65 6.56 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.515 -0.741 . . . . 0.0 109.661 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 812' ' ' CYS . . . . . . . . . . . . . 27.6 p -141.85 152.56 43.75 Favored 'General case' 0 C--N 1.294 -1.809 0 O-C-N 121.435 -0.79 . . . . 0.0 110.361 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 813' ' ' VAL . . . . . 0.665 HG22 ' HB2' ' A' ' 761' ' ' HIS . 94.6 t -123.27 156.99 29.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.309 -0.869 . . . . 0.0 110.192 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 814' ' ' VAL . . . . . 0.421 HG23 ' C ' ' A' ' 813' ' ' VAL . 30.4 t -144.55 141.95 23.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.263 -0.898 . . . . 0.0 110.255 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 815' ' ' ALA . . . . . . . . . . . . . . . -102.29 128.7 48.72 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.307 -0.87 . . . . 0.0 109.957 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 816' ' ' ILE . . . . . 1.018 HD13 HG21 ' A' ' 833' ' ' VAL . 66.8 mt -83.38 132.83 30.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.153 -0.967 . . . . 0.0 110.25 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 817' ' ' SER . . . . . . . . . . . . . 20.3 p -163.17 164.96 15.26 Favored Pre-proline 0 N--CA 1.492 1.66 0 O-C-N 121.26 -0.9 . . . . 0.0 110.054 179.936 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 818' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -80.8 18.31 1.29 Allowed 'Trans proline' 0 C--N 1.307 -1.623 0 O-C-N 123.979 1.515 . . . . 0.0 111.123 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 819' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -127.18 -30.95 2.62 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 120.929 -1.107 . . . . 0.0 110.261 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 820' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 -63.5 -43.72 96.4 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.285 -0.885 . . . . 0.0 110.377 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 821' ' ' PHE . . . . . 0.494 ' HB3' ' OG ' ' A' ' 795' ' ' SER . 91.1 m-85 -88.85 -78.81 0.33 Allowed 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.236 -0.915 . . . . 0.0 110.295 179.961 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 822' ' ' GLY . . . . . . . . . . . . . . . 176.66 38.05 0.05 OUTLIER Glycine 0 N--CA 1.492 2.383 0 N-CA-C 109.827 -1.309 . . . . 0.0 109.827 -179.908 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 823' ' ' GLY . . . . . . . . . . . . . . . 90.14 -160.49 28.39 Favored Glycine 0 N--CA 1.492 2.401 0 N-CA-C 109.885 -1.286 . . . . 0.0 109.885 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 824' ' ' ASP . . . . . 0.457 ' OD1' ' O ' ' A' ' 824' ' ' ASP . 7.4 p30 -108.73 139.41 20.84 Favored Pre-proline 0 N--CA 1.497 1.899 0 O-C-N 121.301 -1.117 . . . . 0.0 110.359 -179.967 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 825' ' ' PRO . . . . . 0.482 ' HG2' ' SG ' ' A' ' 793' ' ' CYS . 49.3 Cg_endo -81.53 -54.63 0.04 OUTLIER 'Trans proline' 0 C--N 1.306 -1.67 0 O-C-N 124.044 1.549 . . . . 0.0 110.865 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 826' ' ' CYS . . . . . . . . . . . . . 1.8 m -123.67 110.45 29.95 Favored Pre-proline 0 N--CA 1.503 2.217 0 O-C-N 121.141 -0.974 . . . . 0.0 110.298 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 827' ' ' PRO . . . . . 0.458 ' O ' ' HB3' ' A' ' 828' ' ' GLU . 49.7 Cg_endo -86.86 163.0 9.03 Favored 'Trans proline' 0 C--N 1.304 -1.766 0 O-C-N 123.995 1.524 . . . . 0.0 110.46 179.953 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 828' ' ' GLU . . . . . 0.458 ' HB3' ' O ' ' A' ' 827' ' ' PRO . 1.5 tt0 65.9 8.73 5.55 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.225 -0.922 . . . . 0.0 110.776 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 829' ' ' VAL . . . . . . . . . . . . . 93.1 t -121.76 133.76 67.18 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 O-C-N 121.08 -1.012 . . . . 0.0 110.403 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 830' ' ' MET . . . . . 0.44 ' HA ' ' CE ' ' A' ' 830' ' ' MET . 0.5 OUTLIER -48.05 130.66 15.65 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.204 -0.935 . . . . 0.0 110.057 179.998 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 831' ' ' LYS . . . . . 0.435 ' HE2' ' HG2' ' A' ' 737' ' ' GLU . 7.8 ptmt -132.49 171.83 13.27 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.226 -0.922 . . . . 0.0 110.254 -179.934 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 832' ' ' ARG . . . . . 0.433 ' HD2' ' HA ' ' A' ' 736' ' ' SER . 0.0 OUTLIER -168.3 165.53 12.88 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.399 -0.813 . . . . 0.0 109.966 -179.985 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 833' ' ' VAL . . . . . 1.018 HG21 HD13 ' A' ' 816' ' ' ILE . 87.3 t -109.8 106.58 21.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.215 -0.928 . . . . 0.0 110.474 -179.932 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 834' ' ' ALA . . . . . . . . . . . . . . . -109.5 129.05 55.58 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.342 -0.849 . . . . 0.0 109.705 179.932 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 835' ' ' VAL . . . . . . . . . . . . . 29.8 t -142.25 152.89 18.2 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 121.138 -0.976 . . . . 0.0 110.779 -179.932 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 836' ' ' GLU . . . . . 0.509 ' HB3' ' HB3' ' A' ' 774' ' ' LYS . 1.7 tt0 -149.21 140.8 23.43 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.54 -0.725 . . . . 0.0 109.153 179.885 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 837' ' ' ALA . . . . . . . . . . . . . . . -119.6 166.36 13.25 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.051 -1.031 . . . . 0.0 111.38 -179.813 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 838' ' ' VAL . . . . . 0.408 ' HB ' ' O ' ' A' ' 772' ' ' ALA . 60.2 t -127.54 124.32 63.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.66 -0.65 . . . . 0.0 109.78 179.952 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 839' ' ' CYS . . . . . 0.414 ' HB3' ' HB3' ' A' ' 768' ' ' GLN . 53.3 m -109.12 131.54 54.97 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.11 -0.994 . . . . 0.0 110.518 -179.925 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 840' ' ' SER . . . . . 0.411 ' O ' ' C ' ' A' ' 841' ' ' THR . 60.7 p -158.14 75.51 0.75 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.344 -0.847 . . . . 0.0 109.996 -179.988 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 841' ' ' THR . . . . . 0.411 ' C ' ' O ' ' A' ' 840' ' ' SER . 79.9 p . . . . . 0 N--CA 1.493 1.684 0 O-C-N 121.271 -0.893 . . . . 0.0 110.167 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 728' ' ' VAL . . . . . 0.405 HG13 ' O ' ' A' ' 728' ' ' VAL . 6.2 p . . . . . 0 N--CA 1.494 1.741 0 CA-C-O 121.213 0.53 . . . . 0.0 110.555 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 729' ' ' SER . . . . . . . . . . . . . 67.3 m -126.6 -167.89 1.79 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.261 -0.899 . . . . 0.0 109.928 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 730' ' ' GLY . . . . . . . . . . . . . . . -139.9 134.66 6.7 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.672 -1.371 . . . . 0.0 109.672 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 731' ' ' VAL . . . . . 0.573 HG22 ' O ' ' A' ' 837' ' ' ALA . 15.4 m -121.77 133.33 68.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.376 -1.073 . . . . 0.0 110.002 179.955 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 732' ' ' CYS . . . . . 0.486 ' CB ' ' CD ' ' A' ' 836' ' ' GLU . 23.3 p -123.95 153.6 40.98 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.215 -0.928 . . . . 0.0 110.376 179.987 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 733' ' ' ALA . . . . . . . . . . . . . . . -143.15 120.17 11.38 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.314 -0.866 . . . . 0.0 109.827 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 734' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -110.86 121.18 44.7 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.159 -0.963 . . . . 0.0 110.5 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 735' ' ' VAL . . . . . . . . . . . . . 21.9 t -143.66 141.9 25.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.372 -0.83 . . . . 0.0 110.001 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 736' ' ' SER . . . . . . . . . . . . . 10.9 p -95.99 159.01 15.19 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.257 -0.902 . . . . 0.0 110.377 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 737' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.493 1.701 0 O-C-N 121.315 -0.866 . . . . 0.0 110.28 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 757' ' ' THR . . . . . 0.434 HG21 ' HB3' ' A' ' 817' ' ' SER . 0.8 OUTLIER . . . . . 0 N--CA 1.492 1.636 0 CA-C-O 121.345 0.593 . . . . 0.0 110.553 . . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 758' ' ' ALA . . . . . . . . . . . . . . . -90.79 178.43 6.05 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.402 -0.811 . . . . 0.0 109.619 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 759' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -135.97 159.78 40.65 Favored 'General case' 0 C--N 1.298 -1.673 0 O-C-N 121.064 -1.023 . . . . 0.0 110.858 -179.94 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 760' ' ' VAL . . . . . 0.494 HG12 ' N ' ' A' ' 761' ' ' HIS . 97.5 t -105.87 167.88 3.0 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 179.842 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 761' ' ' HIS . . . . . 0.494 ' N ' HG12 ' A' ' 760' ' ' VAL . 29.3 m80 -137.6 104.76 5.42 Favored 'General case' 0 C--N 1.299 -1.588 0 C-N-CA 118.501 -1.28 . . . . 0.0 112.263 -179.765 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 762' ' ' LEU . . . . . 0.6 HD12 ' HB3' ' A' ' 812' ' ' CYS . 32.1 mt -116.24 126.25 53.35 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 179.787 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 763' ' ' LYS . . . . . . . . . . . . . 6.7 tttt -134.59 137.51 43.79 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.67 -1.269 . . . . 0.0 112.147 -179.75 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 764' ' ' CYS . . . . . 0.495 ' HB3' ' O ' ' A' ' 810' ' ' GLU . 22.4 t -136.39 143.63 44.1 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.561 -0.712 . . . . 0.0 109.554 179.824 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 765' ' ' ALA . . . . . . . . . . . . . . . -49.79 155.41 1.48 Allowed Pre-proline 0 N--CA 1.492 1.667 0 O-C-N 121.048 -1.033 . . . . 0.0 110.104 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 766' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -71.74 91.68 0.7 Allowed 'Trans proline' 0 C--N 1.306 -1.684 0 O-C-N 123.974 1.512 . . . . 0.0 110.303 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 767' ' ' GLY . . . . . . . . . . . . . . . 152.8 -27.01 0.83 Allowed Glycine 0 N--CA 1.489 2.196 0 N-CA-C 108.81 -1.716 . . . . 0.0 108.81 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 768' ' ' GLN . . . . . 0.492 ' HB2' ' SG ' ' A' ' 764' ' ' CYS . 30.0 mt-30 -104.51 128.09 52.38 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.513 -0.992 . . . . 0.0 109.682 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 769' ' ' THR . . . . . . . . . . . . . 9.6 p -113.8 152.78 30.15 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.178 -0.951 . . . . 0.0 110.556 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 770' ' ' ILE . . . . . 0.872 HD12 ' O ' ' A' ' 809' ' ' LEU . 2.8 mp -64.6 119.58 9.28 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.341 -0.849 . . . . 0.0 109.765 179.959 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 771' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -111.53 -1.74 15.72 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.277 -0.889 . . . . 0.0 110.493 -179.926 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 772' ' ' ALA . . . . . 0.495 ' O ' ' HB ' ' A' ' 838' ' ' VAL . . . -168.0 131.9 1.67 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.148 -0.97 . . . . 0.0 111.039 -179.936 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 773' ' ' ILE . . . . . 0.464 HG13 ' HG3' ' A' ' 803' ' ' GLU . 16.6 mm -91.16 125.64 43.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.244 -0.91 . . . . 0.0 109.163 179.871 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 774' ' ' LYS . . . . . 0.497 ' HB3' ' HB3' ' A' ' 836' ' ' GLU . 6.5 ttmt -79.77 -37.85 34.45 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.158 -0.964 . . . . 0.0 111.116 -179.894 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 775' ' ' PHE . . . . . . . . . . . . . 52.5 t80 -152.76 152.99 32.28 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.953 -1.092 . . . . 0.0 110.75 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 776' ' ' ALA . . . . . 0.494 ' O ' ' HB2' ' A' ' 798' ' ' SER . . . -174.13 112.35 0.17 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.552 -0.718 . . . . 0.0 109.624 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 777' ' ' SER . . . . . 0.573 ' HA ' ' CB ' ' A' ' 798' ' ' SER . 6.7 m -162.04 98.34 1.06 Allowed 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.177 -0.952 . . . . 0.0 110.727 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 778' ' ' PHE . . . . . 0.514 ' CD1' ' C ' ' A' ' 778' ' ' PHE . 0.9 OUTLIER -72.75 103.86 3.78 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.293 -0.88 . . . . 0.0 109.969 179.936 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 779' ' ' GLY . . . . . . . . . . . . . . . 174.88 -109.52 0.29 Allowed Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.663 -1.375 . . . . 0.0 109.663 -179.903 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 780' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -124.94 70.0 58.99 Favored Pre-proline 0 N--CA 1.492 1.647 0 O-C-N 121.292 -1.122 . . . . 0.0 110.22 -179.898 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 781' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -74.4 153.21 44.79 Favored 'Trans proline' 0 C--N 1.305 -1.721 0 O-C-N 124.039 1.547 . . . . 0.0 110.542 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 782' ' ' LEU . . . . . 0.487 ' O ' ' N ' ' A' ' 789' ' ' GLN . 1.1 mt -138.76 151.0 46.72 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.288 -0.883 . . . . 0.0 110.126 -179.954 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 783' ' ' GLY . . . . . . . . . . . . . . . 118.25 -170.77 13.8 Favored Glycine 0 N--CA 1.492 2.404 0 N-CA-C 109.643 -1.383 . . . . 0.0 109.643 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 784' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -125.41 -162.71 1.13 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.274 -1.133 . . . . 0.0 110.088 -179.988 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 785' ' ' CYS . . . . . . . . . . . . . 21.2 m -79.77 94.55 5.79 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.184 -0.947 . . . . 0.0 110.476 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 786' ' ' GLY . . . . . . . . . . . . . . . 137.58 -23.29 3.12 Favored Glycine 0 N--CA 1.489 2.198 0 N-CA-C 109.577 -1.409 . . . . 0.0 109.577 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 787' ' ' THR . . . . . 0.46 ' O ' ' O ' ' A' ' 788' ' ' PHE . 20.4 p -142.73 37.9 1.47 Allowed 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.305 -1.114 . . . . 0.0 110.24 -179.952 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 788' ' ' PHE . . . . . 0.46 ' O ' ' O ' ' A' ' 787' ' ' THR . 0.9 OUTLIER -46.56 175.83 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.301 -0.875 . . . . 0.0 110.501 179.963 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 789' ' ' GLN . . . . . 0.487 ' N ' ' O ' ' A' ' 782' ' ' LEU . 0.0 OUTLIER -153.91 148.42 26.19 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.45 -0.781 . . . . 0.0 110.289 -179.976 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 790' ' ' GLN . . . . . 0.532 ' OE1' ' CD2' ' A' ' 794' ' ' HIS . 0.0 OUTLIER -78.94 151.22 31.79 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.151 -0.968 . . . . 0.0 110.132 -179.995 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 791' ' ' GLY . . . . . . . . . . . . . . . -108.83 -153.54 15.94 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.529 -1.428 . . . . 0.0 109.529 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 792' ' ' GLU . . . . . . . . . . . . . 6.0 pm0 -109.83 -19.57 13.09 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.308 -1.113 . . . . 0.0 110.358 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 793' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -98.62 24.8 7.07 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.247 -0.908 . . . . 0.0 110.307 179.903 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 794' ' ' HIS . . . . . 0.532 ' CD2' ' OE1' ' A' ' 790' ' ' GLN . 7.5 t60 -68.98 149.12 49.17 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.176 -0.953 . . . . 0.0 109.899 -179.964 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 795' ' ' SER . . . . . 0.521 ' O ' ' N ' ' A' ' 797' ' ' ASN . 1.7 p -87.9 14.16 9.4 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.191 -0.943 . . . . 0.0 110.499 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 796' ' ' ILE . . . . . 0.508 ' CG1' ' C ' ' A' ' 795' ' ' SER . 3.6 pt 34.56 32.27 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.505 2.31 0 CA-C-O 121.503 0.668 . . . . 0.0 110.247 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 797' ' ' ASN . . . . . 0.521 ' N ' ' O ' ' A' ' 795' ' ' SER . 60.9 t30 -157.68 21.14 0.27 Allowed 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.486 -0.759 . . . . 0.0 109.646 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 798' ' ' SER . . . . . 0.573 ' CB ' ' HA ' ' A' ' 777' ' ' SER . 17.7 m -84.51 -33.57 23.5 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.526 -0.734 . . . . 0.0 110.636 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 799' ' ' ASN . . . . . 0.465 ' O ' ' OE1' ' A' ' 803' ' ' GLU . 11.8 t-20 -74.17 -6.66 49.03 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.282 -0.886 . . . . 0.0 110.729 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 800' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -86.52 -44.03 12.26 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.052 -1.03 . . . . 0.0 110.39 179.961 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 801' ' ' VAL . . . . . . . . . . . . . 69.5 t -72.57 -21.67 20.01 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 121.29 -0.881 . . . . 0.0 110.808 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 802' ' ' LEU . . . . . 0.475 ' O ' ' HB2' ' A' ' 806' ' ' CYS . 1.8 mm? -84.08 -43.89 14.61 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.043 -1.035 . . . . 0.0 110.612 -179.946 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 803' ' ' GLU . . . . . 0.569 ' O ' HD12 ' A' ' 807' ' ' ILE . 40.6 mt-10 -67.45 -24.67 65.65 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.118 -0.989 . . . . 0.0 110.416 -179.988 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 804' ' ' ARG . . . . . . . . . . . . . 13.6 mmt-85 -90.59 -24.71 20.48 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.194 -0.942 . . . . 0.0 110.827 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 805' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.95 46.86 1.85 Allowed 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.014 -1.054 . . . . 0.0 110.701 179.977 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 806' ' ' CYS . . . . . 0.475 ' HB2' ' O ' ' A' ' 802' ' ' LEU . 1.8 t -160.59 -40.27 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.216 -0.927 . . . . 0.0 110.532 179.958 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 807' ' ' ILE . . . . . 0.569 HD12 ' O ' ' A' ' 803' ' ' GLU . 45.2 mt -67.58 123.27 20.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.242 -0.911 . . . . 0.0 110.765 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 808' ' ' GLY . . . . . . . . . . . . . . . 111.1 -8.48 29.16 Favored Glycine 0 N--CA 1.494 2.508 0 N-CA-C 110.024 -1.23 . . . . 0.0 110.024 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 809' ' ' LEU . . . . . 0.872 ' O ' HD12 ' A' ' 770' ' ' ILE . 36.0 mt -120.28 139.33 52.88 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.079 -1.247 . . . . 0.0 110.614 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 810' ' ' GLU . . . . . 0.495 ' O ' ' HB3' ' A' ' 764' ' ' CYS . 5.4 pt-20 -69.03 -33.89 74.34 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.213 -0.929 . . . . 0.0 109.356 179.942 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 811' ' ' ARG . . . . . . . . . . . . . 15.3 ttp180 -112.21 157.33 21.01 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.517 -0.739 . . . . 0.0 109.443 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 812' ' ' CYS . . . . . 0.6 ' HB3' HD12 ' A' ' 762' ' ' LEU . 1.3 t -149.44 108.21 3.85 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.099 -1.001 . . . . 0.0 111.085 -179.928 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 813' ' ' VAL . . . . . 0.576 HG13 ' O ' ' A' ' 813' ' ' VAL . 4.5 p -118.4 122.92 70.71 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 121.333 -0.854 . . . . 0.0 109.268 179.946 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 814' ' ' VAL . . . . . . . . . . . . . 45.1 t -135.89 121.97 30.91 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.987 0 O-C-N 121.117 -0.989 . . . . 0.0 111.001 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 815' ' ' ALA . . . . . . . . . . . . . . . -80.33 130.17 35.0 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.358 -0.839 . . . . 0.0 109.744 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 816' ' ' ILE . . . . . 0.842 HG21 HG21 ' A' ' 833' ' ' VAL . 2.6 mt -80.61 113.65 20.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.122 -0.986 . . . . 0.0 110.564 -179.866 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 817' ' ' SER . . . . . 0.453 ' O ' ' OD1' ' A' ' 820' ' ' ASN . 8.8 p -143.44 162.83 40.27 Favored Pre-proline 0 N--CA 1.494 1.774 0 O-C-N 121.352 -0.842 . . . . 0.0 110.074 -179.946 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 818' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -82.4 21.05 1.02 Allowed 'Trans proline' 0 C--N 1.307 -1.656 0 O-C-N 123.978 1.515 . . . . 0.0 110.931 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 819' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -135.7 9.23 3.35 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.972 -1.08 . . . . 0.0 110.327 179.94 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 820' ' ' ASN . . . . . 0.453 ' OD1' ' O ' ' A' ' 817' ' ' SER . 8.1 p-10 -117.42 -10.16 10.75 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.224 -0.922 . . . . 0.0 110.283 -179.969 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 821' ' ' PHE . . . . . . . . . . . . . 9.2 m-85 -105.14 -22.28 13.11 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.19 -0.944 . . . . 0.0 110.237 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 822' ' ' GLY . . . . . . . . . . . . . . . 104.95 47.77 1.14 Allowed Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.739 -1.344 . . . . 0.0 109.739 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 823' ' ' GLY . . . . . . . . . . . . . . . 116.58 -134.3 11.26 Favored Glycine 0 N--CA 1.492 2.41 0 N-CA-C 109.661 -1.376 . . . . 0.0 109.661 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 824' ' ' ASP . . . . . 0.452 ' CG ' ' HD2' ' A' ' 825' ' ' PRO . 0.4 OUTLIER -172.01 157.19 4.07 Favored Pre-proline 0 N--CA 1.494 1.76 0 O-C-N 121.226 -1.161 . . . . 0.0 110.395 -179.963 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 825' ' ' PRO . . . . . 0.452 ' HD2' ' CG ' ' A' ' 824' ' ' ASP . 46.8 Cg_endo -75.2 -88.33 0.0 OUTLIER 'Trans proline' 0 C--N 1.307 -1.63 0 O-C-N 124.066 1.561 . . . . 0.0 110.544 -179.931 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 826' ' ' CYS . . . . . . . . . . . . . 3.3 p -120.66 105.11 41.48 Favored Pre-proline 0 N--CA 1.498 1.933 0 O-C-N 121.201 -0.937 . . . . 0.0 110.193 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 827' ' ' PRO . . . . . 0.523 ' O ' ' CB ' ' A' ' 828' ' ' GLU . 50.3 Cg_endo -78.12 82.48 2.43 Favored 'Trans proline' 0 C--N 1.31 -1.493 0 O-C-N 124.093 1.575 . . . . 0.0 110.73 179.959 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 828' ' ' GLU . . . . . 0.523 ' CB ' ' O ' ' A' ' 827' ' ' PRO . 0.2 OUTLIER 165.12 -23.03 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.392 -0.818 . . . . 0.0 109.987 -179.984 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 829' ' ' VAL . . . . . 0.463 ' O ' ' HG3' ' A' ' 831' ' ' LYS . 42.4 t -100.0 167.06 2.07 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.505 0 O-C-N 121.266 -0.896 . . . . 0.0 110.351 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 830' ' ' MET . . . . . 0.45 ' N ' HG12 ' A' ' 829' ' ' VAL . 31.4 mtm -42.29 146.97 0.28 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.352 -0.842 . . . . 0.0 110.293 179.957 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 831' ' ' LYS . . . . . 0.463 ' HG3' ' O ' ' A' ' 829' ' ' VAL . 15.6 mtmm -127.61 83.0 2.12 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.262 -0.899 . . . . 0.0 110.054 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 832' ' ' ARG . . . . . . . . . . . . . 37.1 mtt180 -111.07 150.69 29.0 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.323 -0.861 . . . . 0.0 110.046 -179.895 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 833' ' ' VAL . . . . . 0.842 HG21 HG21 ' A' ' 816' ' ' ILE . 98.6 t -116.32 159.62 16.18 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.522 0 O-C-N 121.244 -0.91 . . . . 0.0 110.677 -179.982 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 834' ' ' ALA . . . . . 0.435 ' HB1' ' CZ ' ' A' ' 788' ' ' PHE . . . -160.11 104.2 1.49 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.508 -0.745 . . . . 0.0 109.26 179.965 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 835' ' ' VAL . . . . . . . . . . . . . 39.8 t -115.35 159.66 15.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.112 -0.993 . . . . 0.0 111.114 -179.863 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 836' ' ' GLU . . . . . 0.497 ' HB3' ' HB3' ' A' ' 774' ' ' LYS . 0.0 OUTLIER -144.34 123.96 13.27 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.574 -0.704 . . . . 0.0 109.28 179.917 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 837' ' ' ALA . . . . . 0.573 ' O ' HG22 ' A' ' 731' ' ' VAL . . . -111.66 144.9 40.17 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.15 -0.969 . . . . 0.0 110.704 -179.953 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 838' ' ' VAL . . . . . 0.495 ' HB ' ' O ' ' A' ' 772' ' ' ALA . 76.3 t -111.22 124.99 68.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.398 -0.814 . . . . 0.0 109.534 179.945 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 839' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -108.46 119.56 39.88 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.23 -0.919 . . . . 0.0 110.039 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 840' ' ' SER . . . . . 0.455 ' O ' ' O ' ' A' ' 841' ' ' THR . 0.9 OUTLIER -133.66 69.06 1.48 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.34 -0.85 . . . . 0.0 109.845 179.992 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 841' ' ' THR . . . . . 0.455 ' O ' ' O ' ' A' ' 840' ' ' SER . 30.7 p . . . . . 0 N--CA 1.491 1.625 0 O-C-N 121.443 -0.786 . . . . 0.0 110.313 179.921 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 728' ' ' VAL . . . . . 0.687 ' O ' HG12 ' A' ' 728' ' ' VAL . 72.8 t . . . . . 0 N--CA 1.496 1.848 0 CA-C-O 121.348 0.594 . . . . 0.0 109.999 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 729' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -77.12 -147.95 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.373 -0.83 . . . . 0.0 110.185 -179.971 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 730' ' ' GLY . . . . . . . . . . . . . . . -149.96 150.02 22.01 Favored Glycine 0 N--CA 1.488 2.108 0 N-CA-C 109.697 -1.361 . . . . 0.0 109.697 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 731' ' ' VAL . . . . . . . . . . . . . 86.4 t -111.12 157.28 12.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.334 -1.098 . . . . 0.0 109.836 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 732' ' ' CYS . . . . . . . . . . . . . 10.9 t -117.75 146.34 43.85 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.176 -0.953 . . . . 0.0 110.341 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 733' ' ' ALA . . . . . 0.651 ' HB2' HD21 ' A' ' 762' ' ' LEU . . . -142.13 116.25 9.42 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.268 -0.895 . . . . 0.0 110.356 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 734' ' ' ASP . . . . . 0.458 ' C ' HG23 ' A' ' 735' ' ' VAL . 0.8 OUTLIER -114.12 139.09 49.61 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.177 -0.952 . . . . 0.0 110.001 179.937 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 735' ' ' VAL . . . . . 0.458 HG23 ' C ' ' A' ' 734' ' ' ASP . 44.9 t -147.89 124.05 2.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.214 -0.929 . . . . 0.0 110.039 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 736' ' ' SER . . . . . 0.42 ' O ' ' C ' ' A' ' 737' ' ' GLU . 0.7 OUTLIER -90.87 134.89 34.1 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.23 -0.919 . . . . 0.0 110.199 179.951 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 737' ' ' GLU . . . . . 0.42 ' C ' ' O ' ' A' ' 736' ' ' SER . 29.5 tp10 . . . . . 0 N--CA 1.495 1.793 0 O-C-N 121.275 -0.891 . . . . 0.0 110.004 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 757' ' ' THR . . . . . . . . . . . . . 1.8 p . . . . . 0 N--CA 1.496 1.841 0 CA-C-O 121.457 0.646 . . . . 0.0 110.934 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 758' ' ' ALA . . . . . . . . . . . . . . . -101.03 173.73 6.34 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.479 -0.763 . . . . 0.0 110.169 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 759' ' ' LYS . . . . . . . . . . . . . 36.2 mtpt -137.94 165.27 26.95 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.203 -0.935 . . . . 0.0 110.63 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 760' ' ' VAL . . . . . . . . . . . . . 38.4 t -109.7 139.64 31.94 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.442 -0.786 . . . . 0.0 109.642 179.938 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 761' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -109.97 104.2 13.07 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.068 -1.02 . . . . 0.0 110.886 -179.981 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 762' ' ' LEU . . . . . 0.651 HD21 ' HB2' ' A' ' 733' ' ' ALA . 21.2 mt -121.46 124.32 44.18 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.298 -0.876 . . . . 0.0 109.414 179.879 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 763' ' ' LYS . . . . . 0.563 ' HB3' ' CD ' ' A' ' 811' ' ' ARG . 0.0 OUTLIER -156.05 123.17 5.35 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.919 -1.113 . . . . 0.0 111.243 -179.928 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 764' ' ' CYS . . . . . 0.41 ' O ' ' C ' ' A' ' 765' ' ' ALA . 19.1 m -99.04 157.34 16.41 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.342 -0.849 . . . . 0.0 109.263 179.839 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 765' ' ' ALA . . . . . 0.41 ' C ' ' O ' ' A' ' 764' ' ' CYS . . . -42.64 159.56 0.2 Allowed Pre-proline 0 N--CA 1.495 1.818 0 O-C-N 121.076 -1.015 . . . . 0.0 109.982 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 766' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -71.23 97.3 0.75 Allowed 'Trans proline' 0 C--N 1.306 -1.667 0 O-C-N 123.913 1.48 . . . . 0.0 110.524 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 767' ' ' GLY . . . . . . . . . . . . . . . 147.53 -31.69 1.38 Allowed Glycine 0 N--CA 1.489 2.198 0 N-CA-C 109.044 -1.623 . . . . 0.0 109.044 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 768' ' ' GLN . . . . . 0.434 ' HB3' ' HB3' ' A' ' 839' ' ' CYS . 20.1 mt-30 -99.0 101.61 13.05 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.369 -1.077 . . . . 0.0 109.982 179.953 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 769' ' ' THR . . . . . . . . . . . . . 11.2 p -85.28 146.95 26.79 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.112 -0.992 . . . . 0.0 110.128 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 770' ' ' ILE . . . . . . . . . . . . . 35.7 mt -66.7 144.16 14.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.306 -0.871 . . . . 0.0 109.252 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 771' ' ' SER . . . . . . . . . . . . . 47.8 t -135.28 -4.69 2.35 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.873 -1.142 . . . . 0.0 111.432 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 772' ' ' ALA . . . . . . . . . . . . . . . -172.71 151.68 2.37 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 120.781 -1.199 . . . . 0.0 111.418 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 773' ' ' ILE . . . . . . . . . . . . . 20.1 mm -110.75 120.28 61.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 179.888 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 774' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -80.09 -42.89 22.75 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 120.986 -1.071 . . . . 0.0 110.951 -179.835 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 775' ' ' PHE . . . . . 0.499 ' O ' ' HB2' ' A' ' 776' ' ' ALA . 67.2 t80 -134.0 152.25 51.77 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.098 -1.001 . . . . 0.0 110.668 -179.913 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 776' ' ' ALA . . . . . 0.499 ' HB2' ' O ' ' A' ' 775' ' ' PHE . . . 179.1 113.41 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.567 -0.708 . . . . 0.0 109.803 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 777' ' ' SER . . . . . 0.491 ' HA ' ' HB3' ' A' ' 798' ' ' SER . 94.5 p -148.73 126.86 12.07 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.338 -0.851 . . . . 0.0 110.475 -179.958 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 778' ' ' PHE . . . . . 0.583 ' HE1' HG23 ' A' ' 816' ' ' ILE . 12.2 t80 -94.21 116.48 28.88 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.359 -0.838 . . . . 0.0 109.949 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 779' ' ' GLY . . . . . 0.505 ' HA3' ' O ' ' A' ' 793' ' ' CYS . . . 163.97 -136.15 4.11 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.932 -1.267 . . . . 0.0 109.932 -179.958 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 780' ' ' THR . . . . . . . . . . . . . 45.7 p -123.49 64.77 30.22 Favored Pre-proline 0 N--CA 1.494 1.766 0 O-C-N 121.212 -1.17 . . . . 0.0 110.595 -179.93 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 781' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -74.47 170.79 19.45 Favored 'Trans proline' 0 C--N 1.304 -1.792 0 O-C-N 124.044 1.55 . . . . 0.0 110.392 179.927 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 782' ' ' LEU . . . . . . . . . . . . . 3.7 mt -129.86 173.91 10.23 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.198 -0.939 . . . . 0.0 110.261 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 783' ' ' GLY . . . . . . . . . . . . . . . 110.93 -169.54 13.38 Favored Glycine 0 N--CA 1.494 2.561 0 N-CA-C 109.595 -1.402 . . . . 0.0 109.595 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 784' ' ' THR . . . . . 0.52 HG22 ' N ' ' A' ' 785' ' ' CYS . 54.3 m -115.62 -92.92 0.5 Allowed 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.229 -1.159 . . . . 0.0 110.336 -179.96 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 785' ' ' CYS . . . . . 0.52 ' N ' HG22 ' A' ' 784' ' ' THR . 0.3 OUTLIER -139.5 120.05 14.1 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.175 -0.953 . . . . 0.0 110.162 -179.938 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 786' ' ' GLY . . . . . . . . . . . . . . . 95.3 -4.62 67.3 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.658 -1.377 . . . . 0.0 109.658 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 787' ' ' THR . . . . . . . . . . . . . 9.0 t -145.41 34.8 1.07 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.209 -1.171 . . . . 0.0 110.109 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 788' ' ' PHE . . . . . 0.412 ' CZ ' ' O ' ' A' ' 784' ' ' THR . 39.4 m-85 -53.41 176.22 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.342 -0.849 . . . . 0.0 110.385 179.996 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 789' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -139.66 145.28 38.24 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.335 -0.853 . . . . 0.0 110.164 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 790' ' ' GLN . . . . . . . . . . . . . 2.1 mt-30 -64.21 131.05 46.25 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.121 -0.987 . . . . 0.0 109.882 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 791' ' ' GLY . . . . . . . . . . . . . . . -92.49 -163.26 37.58 Favored Glycine 0 N--CA 1.492 2.413 0 N-CA-C 109.698 -1.361 . . . . 0.0 109.698 180.0 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 792' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -98.41 -14.0 20.33 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.337 -1.096 . . . . 0.0 110.226 -179.972 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 793' ' ' CYS . . . . . 0.505 ' O ' ' HA3' ' A' ' 779' ' ' GLY . 0.5 OUTLIER -116.86 68.59 0.74 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.352 -0.842 . . . . 0.0 110.275 179.972 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 794' ' ' HIS . . . . . 0.61 ' CE1' ' OG ' ' A' ' 798' ' ' SER . 81.6 t60 -102.59 145.64 29.34 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.171 -0.956 . . . . 0.0 110.866 -179.919 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 795' ' ' SER . . . . . 0.576 ' O ' ' CD2' ' A' ' 794' ' ' HIS . 8.5 t -91.31 174.48 7.36 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.244 -0.91 . . . . 0.0 109.275 179.874 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 796' ' ' ILE . . . . . . . . . . . . . 1.5 mt -105.52 20.48 4.11 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.912 0 O-C-N 120.859 -1.151 . . . . 0.0 110.256 -179.929 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 797' ' ' ASN . . . . . 0.505 ' N ' ' OD1' ' A' ' 797' ' ' ASN . 1.6 m120 -132.5 36.22 3.58 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.427 -0.796 . . . . 0.0 109.083 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 798' ' ' SER . . . . . 0.61 ' OG ' ' CE1' ' A' ' 794' ' ' HIS . 0.9 OUTLIER -65.6 -56.31 12.89 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.724 -0.61 . . . . 0.0 111.285 -179.92 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 799' ' ' ASN . . . . . . . . . . . . . 4.5 m120 -86.41 14.27 6.95 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.135 -0.978 . . . . 0.0 111.368 -179.782 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 800' ' ' SER . . . . . . . . . . . . . 7.8 t -91.28 -62.64 1.4 Allowed 'General case' 0 C--N 1.299 -1.616 0 O-C-N 120.874 -1.141 . . . . 0.0 110.269 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 801' ' ' VAL . . . . . 1.003 HG11 ' OD1' ' A' ' 820' ' ' ASN . 49.3 t -68.11 -19.55 24.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.274 -0.891 . . . . 0.0 110.534 -179.918 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 802' ' ' LEU . . . . . 0.596 HD23 ' O ' ' A' ' 798' ' ' SER . 4.2 mm? -69.05 -51.99 33.22 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.137 -0.977 . . . . 0.0 110.739 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 803' ' ' GLU . . . . . 0.757 ' HA ' HD13 ' A' ' 807' ' ' ILE . 4.1 tt0 -68.84 -17.76 64.05 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.034 -1.041 . . . . 0.0 110.721 -179.955 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 804' ' ' ARG . . . . . . . . . . . . . 17.9 mtp180 -91.45 -18.53 24.05 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.225 -0.922 . . . . 0.0 111.519 -179.884 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 805' ' ' LYS . . . . . 0.454 ' O ' ' SG ' ' A' ' 806' ' ' CYS . 19.8 mttt -124.49 26.96 7.11 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 120.857 -1.152 . . . . 0.0 111.882 -179.856 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 806' ' ' CYS . . . . . 0.831 ' C ' HD12 ' A' ' 807' ' ' ILE . 1.7 m -160.87 18.69 0.13 Allowed 'General case' 0 N--CA 1.501 2.111 0 O-C-N 120.737 -1.227 . . . . 0.0 111.035 179.942 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 807' ' ' ILE . . . . . 0.831 HD12 ' C ' ' A' ' 806' ' ' CYS . 1.7 mp -123.27 112.51 33.86 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.902 0 O-C-N 121.001 -1.062 . . . . 0.0 110.204 179.972 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 808' ' ' GLY . . . . . . . . . . . . . . . 116.73 -4.24 19.28 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 809' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -125.99 137.81 53.7 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.275 -1.132 . . . . 0.0 110.265 -179.944 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 810' ' ' GLU . . . . . 0.473 ' HG3' ' N ' ' A' ' 811' ' ' ARG . 0.4 OUTLIER -64.87 -17.82 64.62 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.219 -0.925 . . . . 0.0 108.965 179.886 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 811' ' ' ARG . . . . . 0.563 ' CD ' ' HB3' ' A' ' 763' ' ' LYS . 13.5 ttp85 -142.48 132.86 24.94 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.674 -0.641 . . . . 0.0 109.36 179.926 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 812' ' ' CYS . . . . . 0.497 ' CB ' ' HA ' ' A' ' 806' ' ' CYS . 15.4 p -142.02 146.86 36.01 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.171 -0.956 . . . . 0.0 110.764 -179.965 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 813' ' ' VAL . . . . . . . . . . . . . 67.0 t -120.67 135.62 60.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.44 -0.788 . . . . 0.0 110.014 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 814' ' ' VAL . . . . . . . . . . . . . 9.3 t -112.2 109.79 29.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.114 -0.991 . . . . 0.0 110.477 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 815' ' ' ALA . . . . . . . . . . . . . . . -70.77 121.26 17.67 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.259 -0.901 . . . . 0.0 110.097 179.89 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 816' ' ' ILE . . . . . 0.583 HG23 ' HE1' ' A' ' 778' ' ' PHE . 36.1 mt -81.66 104.42 10.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.185 -0.947 . . . . 0.0 110.273 -179.966 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 817' ' ' SER . . . . . 0.466 ' HB2' ' HD2' ' A' ' 818' ' ' PRO . 77.7 p -161.71 164.2 18.33 Favored Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.268 -0.895 . . . . 0.0 110.101 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 818' ' ' PRO . . . . . 0.466 ' HD2' ' HB2' ' A' ' 817' ' ' SER . 43.6 Cg_endo -71.92 -23.65 21.83 Favored 'Trans proline' 0 C--N 1.305 -1.751 0 O-C-N 124.04 1.548 . . . . 0.0 110.13 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 819' ' ' SER . . . . . . . . . . . . . 95.1 p -85.52 42.85 0.98 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.259 -0.901 . . . . 0.0 109.872 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 820' ' ' ASN . . . . . 1.003 ' OD1' HG11 ' A' ' 801' ' ' VAL . 28.6 t-20 -143.32 -46.37 0.29 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.283 -0.885 . . . . 0.0 110.13 -179.94 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 821' ' ' PHE . . . . . . . . . . . . . 80.5 m-85 -89.25 8.36 30.73 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.334 -0.854 . . . . 0.0 110.349 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 822' ' ' GLY . . . . . . . . . . . . . . . 87.09 52.72 3.01 Favored Glycine 0 N--CA 1.492 2.409 0 N-CA-C 109.901 -1.28 . . . . 0.0 109.901 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 823' ' ' GLY . . . . . . . . . . . . . . . 90.85 -174.96 39.75 Favored Glycine 0 N--CA 1.494 2.518 0 N-CA-C 109.779 -1.328 . . . . 0.0 109.779 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 824' ' ' ASP . . . . . . . . . . . . . 11.0 p-10 -125.34 150.56 67.81 Favored Pre-proline 0 N--CA 1.495 1.78 0 O-C-N 121.258 -1.142 . . . . 0.0 110.154 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 825' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -77.18 -62.94 0.03 OUTLIER 'Trans proline' 0 C--N 1.306 -1.703 0 O-C-N 124.042 1.549 . . . . 0.0 110.801 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 826' ' ' CYS . . . . . . . . . . . . . 6.0 p -122.98 117.69 28.41 Favored Pre-proline 0 N--CA 1.5 2.074 0 O-C-N 121.141 -0.975 . . . . 0.0 110.785 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 827' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_endo -88.48 168.34 6.1 Favored 'Trans proline' 0 C--N 1.311 -1.427 0 O-C-N 123.952 1.501 . . . . 0.0 110.739 179.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 828' ' ' GLU . . . . . . . . . . . . . 2.2 tp10 61.37 27.58 17.18 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.393 -0.817 . . . . 0.0 110.737 179.903 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 829' ' ' VAL . . . . . 0.44 ' O ' ' HD3' ' A' ' 831' ' ' LYS . 50.3 t -131.49 115.09 27.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.088 -1.008 . . . . 0.0 110.417 179.92 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 830' ' ' MET . . . . . 0.425 ' C ' ' O ' ' A' ' 829' ' ' VAL . 19.0 ptp -43.1 123.8 2.99 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.26 -0.9 . . . . 0.0 109.382 179.918 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 831' ' ' LYS . . . . . 0.44 ' HD3' ' O ' ' A' ' 829' ' ' VAL . 0.0 OUTLIER -109.23 179.16 4.24 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.105 -0.997 . . . . 0.0 111.545 -179.876 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 832' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -159.59 141.02 12.88 Favored 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 108.053 -1.092 . . . . 0.0 108.053 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 833' ' ' VAL . . . . . 0.484 HG21 HG12 ' A' ' 816' ' ' ILE . 60.6 t -110.48 139.87 32.09 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 120.741 -1.224 . . . . 0.0 112.05 -179.836 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 834' ' ' ALA . . . . . . . . . . . . . . . -139.02 111.96 7.88 Favored 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 179.862 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 835' ' ' VAL . . . . . 0.448 HG12 ' N ' ' A' ' 836' ' ' GLU . 40.8 t -129.28 163.55 34.14 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 120.923 -1.11 . . . . 0.0 111.848 -179.871 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 836' ' ' GLU . . . . . 0.466 ' HB2' ' HB3' ' A' ' 775' ' ' PHE . 0.1 OUTLIER -140.25 147.15 39.57 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 179.849 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 837' ' ' ALA . . . . . . . . . . . . . . . -128.01 165.52 20.15 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 120.856 -1.152 . . . . 0.0 111.349 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 838' ' ' VAL . . . . . . . . . . . . . 75.0 t -130.4 110.62 19.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.512 -0.743 . . . . 0.0 109.287 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 839' ' ' CYS . . . . . 0.434 ' HB3' ' HB3' ' A' ' 768' ' ' GLN . 68.4 m -107.51 133.51 51.89 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.147 -0.97 . . . . 0.0 110.777 -179.89 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 840' ' ' SER . . . . . . . . . . . . . 35.6 p -125.33 -139.64 0.28 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.482 -0.761 . . . . 0.0 109.857 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 841' ' ' THR . . . . . . . . . . . . . 32.6 p . . . . . 0 N--CA 1.496 1.851 0 O-C-N 121.117 -0.99 . . . . 0.0 110.177 -179.966 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 728' ' ' VAL . . . . . 0.441 ' O ' ' O ' ' A' ' 839' ' ' CYS . 13.5 p . . . . . 0 N--CA 1.491 1.6 0 CA-C-O 121.332 0.587 . . . . 0.0 110.394 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 729' ' ' SER . . . . . 0.408 ' HB2' ' HA ' ' A' ' 838' ' ' VAL . 89.0 p -172.57 -175.73 1.39 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.369 -0.832 . . . . 0.0 109.764 179.903 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 730' ' ' GLY . . . . . . . . . . . . . . . 155.28 65.69 0.01 OUTLIER Glycine 0 N--CA 1.489 2.203 0 C-N-CA 119.56 -1.305 . . . . 0.0 109.843 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 731' ' ' VAL . . . . . 1.007 HG21 ' SG ' ' A' ' 764' ' ' CYS . 6.5 t -122.65 152.02 26.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.325 -1.103 . . . . 0.0 109.983 179.966 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 732' ' ' CYS . . . . . . . . . . . . . 5.8 t -146.72 144.11 29.19 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.094 -1.004 . . . . 0.0 110.439 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 733' ' ' ALA . . . . . . . . . . . . . . . -135.89 107.73 7.08 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.344 -0.847 . . . . 0.0 109.907 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 734' ' ' ASP . . . . . . . . . . . . . 7.9 t0 -118.11 122.64 43.61 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.18 -0.95 . . . . 0.0 110.551 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 735' ' ' VAL . . . . . . . . . . . . . 45.8 t -129.15 162.45 36.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.287 -0.883 . . . . 0.0 109.856 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 736' ' ' SER . . . . . . . . . . . . . 9.7 t -110.36 139.87 45.13 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.108 -0.995 . . . . 0.0 110.441 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 737' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.629 0 O-C-N 121.343 -0.848 . . . . 0.0 110.042 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 757' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.492 1.64 0 CA-C-O 121.39 0.614 . . . . 0.0 110.585 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 758' ' ' ALA . . . . . . . . . . . . . . . -106.27 177.94 4.71 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.41 -0.806 . . . . 0.0 109.856 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 759' ' ' LYS . . . . . . . . . . . . . 3.9 mttp -132.41 147.79 52.39 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.202 -0.936 . . . . 0.0 110.499 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 760' ' ' VAL . . . . . 0.886 ' CG2' HD11 ' A' ' 816' ' ' ILE . 13.3 t -110.27 132.36 58.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.322 -0.861 . . . . 0.0 109.595 179.942 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 761' ' ' HIS . . . . . . . . . . . . . 29.5 m80 -120.78 119.56 33.09 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.108 -0.995 . . . . 0.0 110.923 -179.902 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 762' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -115.0 117.37 30.42 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.372 -0.83 . . . . 0.0 109.011 179.829 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 763' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -136.27 120.43 17.79 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.012 -1.055 . . . . 0.0 111.315 -179.895 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 764' ' ' CYS . . . . . 1.007 ' SG ' HG21 ' A' ' 731' ' ' VAL . 1.2 m -99.4 177.54 5.15 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.491 -0.755 . . . . 0.0 109.81 179.86 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 765' ' ' ALA . . . . . 0.798 ' HB3' ' OE1' ' A' ' 768' ' ' GLN . . . -60.39 161.41 13.88 Favored Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.193 -0.942 . . . . 0.0 109.856 179.969 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 766' ' ' PRO . . . . . 0.402 ' HD2' ' HB1' ' A' ' 765' ' ' ALA . 44.1 Cg_endo -69.89 136.45 32.69 Favored 'Trans proline' 0 C--N 1.306 -1.691 0 O-C-N 123.897 1.472 . . . . 0.0 110.296 179.976 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 767' ' ' GLY . . . . . . . . . . . . . . . 93.54 -30.85 6.9 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.04 -1.624 . . . . 0.0 109.04 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 768' ' ' GLN . . . . . 0.798 ' OE1' ' HB3' ' A' ' 765' ' ' ALA . 10.5 mt-30 -82.75 105.85 14.1 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.331 -1.099 . . . . 0.0 110.076 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 769' ' ' THR . . . . . . . . . . . . . 26.6 p -95.81 146.59 24.43 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.176 -0.953 . . . . 0.0 110.367 179.916 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 770' ' ' ILE . . . . . . . . . . . . . 47.8 mt -76.62 139.47 18.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.356 -0.84 . . . . 0.0 109.675 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 771' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -137.55 -2.67 1.95 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.982 -1.074 . . . . 0.0 111.272 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 772' ' ' ALA . . . . . . . . . . . . . . . -155.99 119.42 4.33 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.763 -1.21 . . . . 0.0 111.075 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 773' ' ' ILE . . . . . . . . . . . . . 33.3 mm -83.26 126.2 40.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.322 -0.862 . . . . 0.0 109.324 179.916 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 774' ' ' LYS . . . . . 0.49 ' CB ' ' OE1' ' A' ' 836' ' ' GLU . 0.1 OUTLIER -82.54 -38.62 23.48 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.111 -0.993 . . . . 0.0 110.766 -179.909 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 775' ' ' PHE . . . . . 0.474 ' HB2' ' O ' ' A' ' 774' ' ' LYS . 11.7 t80 -179.41 133.64 0.11 Allowed 'General case' 0 N--CA 1.496 1.859 0 O-C-N 120.858 -1.151 . . . . 0.0 111.374 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 776' ' ' ALA . . . . . 0.502 ' O ' ' HB3' ' A' ' 798' ' ' SER . . . -151.14 88.91 1.48 Allowed 'General case' 0 N--CA 1.495 1.785 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 179.904 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 777' ' ' SER . . . . . 0.526 ' HA ' ' OG ' ' A' ' 798' ' ' SER . 8.7 p -102.52 165.59 11.01 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.218 -0.926 . . . . 0.0 111.425 -179.77 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 778' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -126.53 101.11 6.53 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.593 -0.692 . . . . 0.0 109.74 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 779' ' ' GLY . . . . . 0.482 ' O ' ' HG2' ' A' ' 832' ' ' ARG . . . 156.66 -109.55 0.41 Allowed Glycine 0 N--CA 1.493 2.454 0 N-CA-C 109.381 -1.488 . . . . 0.0 109.381 179.903 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 780' ' ' THR . . . . . 0.459 ' O ' ' HA3' ' A' ' 791' ' ' GLY . 76.3 p -127.78 101.19 23.8 Favored Pre-proline 0 N--CA 1.493 1.719 0 O-C-N 121.231 -1.158 . . . . 0.0 110.086 179.965 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 781' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -77.34 173.04 14.92 Favored 'Trans proline' 0 C--N 1.305 -1.751 0 O-C-N 124.082 1.569 . . . . 0.0 110.549 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 782' ' ' LEU . . . . . . . . . . . . . 1.1 mt -130.81 98.41 4.61 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.311 -0.868 . . . . 0.0 110.165 179.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 783' ' ' GLY . . . . . . . . . . . . . . . 139.49 -164.3 25.99 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 -180.0 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 784' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -119.94 -169.05 1.71 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.157 -1.202 . . . . 0.0 110.173 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 785' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -62.47 93.87 0.06 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.246 -0.909 . . . . 0.0 110.22 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 786' ' ' GLY . . . . . . . . . . . . . . . 146.3 -28.35 1.67 Allowed Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.468 -1.453 . . . . 0.0 109.468 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 787' ' ' THR . . . . . . . . . . . . . 66.3 p -127.2 27.32 5.92 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.24 -1.153 . . . . 0.0 110.207 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 788' ' ' PHE . . . . . 0.454 ' HB3' ' CD1' ' A' ' 775' ' ' PHE . 2.9 m-85 -52.41 110.62 0.52 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.371 -0.831 . . . . 0.0 110.196 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 789' ' ' GLN . . . . . 0.466 ' HA ' ' CE2' ' A' ' 775' ' ' PHE . 7.2 tp60 -127.53 153.36 46.44 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.298 -0.876 . . . . 0.0 110.058 179.965 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 790' ' ' GLN . . . . . 0.498 ' CG ' ' O ' ' A' ' 790' ' ' GLN . 7.5 pt20 -52.27 114.71 1.43 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.249 -0.907 . . . . 0.0 110.28 179.997 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 791' ' ' GLY . . . . . 0.459 ' HA3' ' O ' ' A' ' 780' ' ' THR . . . -66.47 -105.87 0.01 OUTLIER Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.384 -1.486 . . . . 0.0 109.384 -179.978 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 792' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -113.61 -31.67 6.42 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.282 -1.128 . . . . 0.0 110.128 -179.956 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 793' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -121.55 98.22 5.87 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.278 -0.889 . . . . 0.0 110.393 -179.935 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 794' ' ' HIS . . . . . 0.606 ' CE1' ' CB ' ' A' ' 798' ' ' SER . 66.3 t60 -107.29 131.17 54.5 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.122 -0.986 . . . . 0.0 109.966 179.948 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 795' ' ' SER . . . . . 0.46 ' O ' ' O ' ' A' ' 794' ' ' HIS . 6.3 t -61.59 -141.14 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.172 -0.955 . . . . 0.0 109.453 179.893 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 796' ' ' ILE . . . . . . . . . . . . . 3.4 mt -136.5 -43.69 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 O-C-N 121.11 -0.994 . . . . 0.0 109.707 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 797' ' ' ASN . . . . . 0.414 ' O ' ' C ' ' A' ' 798' ' ' SER . 44.8 m-20 -82.36 10.76 6.44 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.36 -0.838 . . . . 0.0 109.46 179.864 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 798' ' ' SER . . . . . 0.606 ' CB ' ' CE1' ' A' ' 794' ' ' HIS . 1.6 m -35.75 -68.69 0.12 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.747 -0.596 . . . . 0.0 111.612 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 799' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -93.95 -26.21 16.94 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.066 -1.021 . . . . 0.0 110.883 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 800' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -50.78 -22.39 2.11 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 120.973 -1.079 . . . . 0.0 110.181 179.965 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 801' ' ' VAL . . . . . 0.548 HG21 ' CD2' ' A' ' 821' ' ' PHE . 25.1 t -84.77 -41.47 15.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.275 -0.891 . . . . 0.0 110.427 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 802' ' ' LEU . . . . . 0.57 ' N ' ' CD2' ' A' ' 802' ' ' LEU . 4.0 mm? -66.2 -41.17 90.57 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.329 -0.857 . . . . 0.0 110.94 -179.933 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 803' ' ' GLU . . . . . 0.421 ' C ' ' O ' ' A' ' 802' ' ' LEU . 8.9 mt-10 -41.88 -47.63 4.28 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.216 -0.927 . . . . 0.0 110.681 -179.935 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 804' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -92.92 -28.21 16.61 Favored 'General case' 0 N--CA 1.503 2.177 0 O-C-N 121.135 -0.978 . . . . 0.0 111.987 -179.834 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 805' ' ' LYS . . . . . 0.478 ' O ' ' SG ' ' A' ' 806' ' ' CYS . 1.0 OUTLIER -89.66 26.98 1.6 Allowed 'General case' 0 N--CA 1.498 1.942 0 O-C-N 120.967 -1.083 . . . . 0.0 111.492 -179.807 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 806' ' ' CYS . . . . . 0.529 ' HA ' ' CB ' ' A' ' 812' ' ' CYS . 13.2 m -158.44 -66.64 0.09 Allowed 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.043 -1.035 . . . . 0.0 110.745 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 807' ' ' ILE . . . . . 0.419 ' C ' ' O ' ' A' ' 806' ' ' CYS . 17.5 mt -41.56 123.51 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.978 0 O-C-N 121.186 -0.947 . . . . 0.0 110.973 -179.933 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 808' ' ' GLY . . . . . 0.461 ' C ' ' HG ' ' A' ' 809' ' ' LEU . . . 115.68 -9.92 19.08 Favored Glycine 0 N--CA 1.494 2.528 0 N-CA-C 110.167 -1.173 . . . . 0.0 110.167 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 809' ' ' LEU . . . . . 0.461 ' HG ' ' C ' ' A' ' 808' ' ' GLY . 1.7 mt -132.94 151.45 52.05 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.061 -1.258 . . . . 0.0 110.306 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 810' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -73.79 -14.95 61.19 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.152 -0.968 . . . . 0.0 109.777 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 811' ' ' ARG . . . . . 0.492 ' CG ' ' O ' ' A' ' 811' ' ' ARG . 10.2 ptm180 -155.72 122.43 5.28 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.343 -0.848 . . . . 0.0 110.068 179.9 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 812' ' ' CYS . . . . . 0.529 ' CB ' ' HA ' ' A' ' 806' ' ' CYS . 31.9 p -122.73 151.71 41.31 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.227 -0.921 . . . . 0.0 110.608 -179.966 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 813' ' ' VAL . . . . . 0.52 HG13 ' O ' ' A' ' 760' ' ' VAL . 5.8 t -121.69 152.53 25.44 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.32 -0.862 . . . . 0.0 110.329 -179.963 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 814' ' ' VAL . . . . . 0.481 HG23 ' C ' ' A' ' 813' ' ' VAL . 88.9 t -148.93 104.19 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.272 -0.892 . . . . 0.0 110.357 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 815' ' ' ALA . . . . . . . . . . . . . . . -62.21 153.64 29.82 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.19 -0.944 . . . . 0.0 110.127 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 816' ' ' ILE . . . . . 0.886 HD11 ' CG2' ' A' ' 760' ' ' VAL . 11.3 mt -107.5 130.77 59.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.163 -0.96 . . . . 0.0 110.109 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 817' ' ' SER . . . . . 0.443 ' OG ' ' HB2' ' A' ' 820' ' ' ASN . 1.4 p -164.11 163.64 15.17 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.259 -0.901 . . . . 0.0 110.037 179.944 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 818' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -74.48 -7.61 19.75 Favored 'Trans proline' 0 C--N 1.303 -1.857 0 O-C-N 124.08 1.568 . . . . 0.0 110.36 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 819' ' ' SER . . . . . . . . . . . . . 3.2 t -128.4 53.14 1.84 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.311 -0.868 . . . . 0.0 110.04 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 820' ' ' ASN . . . . . 0.443 ' HB2' ' OG ' ' A' ' 817' ' ' SER . 0.4 OUTLIER -129.46 -40.0 1.45 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.199 -0.938 . . . . 0.0 110.281 -179.942 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 821' ' ' PHE . . . . . 0.548 ' CD2' HG21 ' A' ' 801' ' ' VAL . 60.1 m-85 -85.93 -60.03 2.13 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.307 -0.87 . . . . 0.0 110.254 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 822' ' ' GLY . . . . . . . . . . . . . . . 155.72 37.88 0.02 OUTLIER Glycine 0 N--CA 1.492 2.422 0 N-CA-C 109.67 -1.372 . . . . 0.0 109.67 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 823' ' ' GLY . . . . . . . . . . . . . . . 137.72 -151.92 21.46 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.819 -1.313 . . . . 0.0 109.819 180.0 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 824' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -141.62 153.68 65.43 Favored Pre-proline 0 N--CA 1.494 1.731 0 O-C-N 121.332 -1.099 . . . . 0.0 110.157 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 825' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -73.33 -94.41 0.01 OUTLIER 'Trans proline' 0 C--N 1.305 -1.724 0 O-C-N 124.073 1.565 . . . . 0.0 110.505 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 826' ' ' CYS . . . . . . . . . . . . . 61.0 m -128.06 134.13 25.89 Favored Pre-proline 0 N--CA 1.494 1.741 0 O-C-N 121.136 -0.977 . . . . 0.0 110.032 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 827' ' ' PRO . . . . . 0.534 ' O ' ' CG ' ' A' ' 828' ' ' GLU . 50.8 Cg_endo -82.87 -171.58 1.18 Allowed 'Trans proline' 0 C--N 1.306 -1.683 0 O-C-N 124.156 1.608 . . . . 0.0 111.133 -179.941 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 828' ' ' GLU . . . . . 0.534 ' CG ' ' O ' ' A' ' 827' ' ' PRO . 15.5 pt-20 39.28 34.76 0.13 Allowed 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.678 -0.639 . . . . 0.0 110.65 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 829' ' ' VAL . . . . . 0.497 ' O ' ' HD2' ' A' ' 831' ' ' LYS . 23.4 t -144.1 161.34 15.48 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.309 -0.869 . . . . 0.0 109.757 179.904 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 830' ' ' MET . . . . . 0.425 ' O ' ' HD2' ' A' ' 831' ' ' LYS . 3.2 mtp -59.12 171.17 0.76 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.031 -1.043 . . . . 0.0 109.626 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 831' ' ' LYS . . . . . 0.497 ' HD2' ' O ' ' A' ' 829' ' ' VAL . 0.6 OUTLIER -147.99 128.63 14.17 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.015 -1.053 . . . . 0.0 110.967 -179.951 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 832' ' ' ARG . . . . . 0.482 ' HG2' ' O ' ' A' ' 779' ' ' GLY . 0.0 OUTLIER -156.49 152.14 27.01 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.443 -0.786 . . . . 0.0 109.65 179.926 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 833' ' ' VAL . . . . . 0.424 HG21 ' CG2' ' A' ' 816' ' ' ILE . 28.6 t -111.16 144.09 19.75 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 O-C-N 121.116 -0.99 . . . . 0.0 110.882 -179.928 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 834' ' ' ALA . . . . . 0.442 ' C ' HG23 ' A' ' 835' ' ' VAL . . . -147.9 136.67 21.85 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.325 -0.859 . . . . 0.0 109.291 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 835' ' ' VAL . . . . . 0.442 HG23 ' C ' ' A' ' 834' ' ' ALA . 75.5 t -148.47 154.4 10.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 120.912 -1.118 . . . . 0.0 111.204 -179.931 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 836' ' ' GLU . . . . . 0.49 ' OE1' ' CB ' ' A' ' 774' ' ' LYS . 16.3 tt0 -141.28 117.48 10.67 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 179.944 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 837' ' ' ALA . . . . . . . . . . . . . . . -107.34 162.97 13.43 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.022 -1.049 . . . . 0.0 111.377 -179.836 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 838' ' ' VAL . . . . . 0.408 ' HA ' ' HB2' ' A' ' 729' ' ' SER . 90.9 t -121.58 107.66 20.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.647 -0.658 . . . . 0.0 109.841 179.98 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 839' ' ' CYS . . . . . 0.441 ' O ' ' O ' ' A' ' 728' ' ' VAL . 15.5 p -115.74 122.29 45.04 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.065 -1.022 . . . . 0.0 110.785 -179.986 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 840' ' ' SER . . . . . 0.447 ' O ' ' HA ' ' A' ' 768' ' ' GLN . 1.2 p -106.46 150.19 26.32 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.558 -0.713 . . . . 0.0 109.579 179.907 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 841' ' ' THR . . . . . 0.431 ' HA ' ' HA ' ' A' ' 768' ' ' GLN . 5.4 t . . . . . 0 N--CA 1.492 1.63 0 O-C-N 121.121 -0.987 . . . . 0.0 110.549 -179.931 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 728' ' ' VAL . . . . . 0.405 ' O ' ' O ' ' A' ' 839' ' ' CYS . 12.0 t . . . . . 0 N--CA 1.493 1.685 0 CA-C-O 121.116 0.484 . . . . 0.0 110.083 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 729' ' ' SER . . . . . 0.483 ' HA ' ' O ' ' A' ' 839' ' ' CYS . 39.0 t -160.05 41.11 0.19 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.241 -0.912 . . . . 0.0 110.625 -179.949 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 730' ' ' GLY . . . . . . . . . . . . . . . 178.25 108.44 0.23 Allowed Glycine 0 N--CA 1.49 2.297 0 C-N-CA 119.575 -1.298 . . . . 0.0 110.154 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 731' ' ' VAL . . . . . . . . . . . . . 39.0 t -112.33 164.65 8.0 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 121.361 -1.082 . . . . 0.0 109.455 179.841 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 732' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -134.24 158.72 43.0 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.036 -1.04 . . . . 0.0 110.881 -179.876 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 733' ' ' ALA . . . . . 0.672 ' CB ' HD21 ' A' ' 762' ' ' LEU . . . -161.7 133.38 5.51 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.335 -0.853 . . . . 0.0 109.925 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 734' ' ' ASP . . . . . . . . . . . . . 30.2 m-20 -150.15 111.14 4.34 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.119 -0.988 . . . . 0.0 110.464 179.901 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 735' ' ' VAL . . . . . . . . . . . . . 40.4 t -139.99 163.45 24.27 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.326 -0.859 . . . . 0.0 109.816 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 736' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -75.87 -175.1 2.87 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.164 -0.96 . . . . 0.0 110.108 -179.973 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 737' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.556 0 O-C-N 121.204 -0.935 . . . . 0.0 110.336 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 757' ' ' THR . . . . . . . . . . . . . 66.2 p . . . . . 0 N--CA 1.496 1.844 0 CA-C-O 121.096 0.474 . . . . 0.0 110.155 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 758' ' ' ALA . . . . . 0.719 ' O ' HD12 ' A' ' 816' ' ' ILE . . . -58.95 121.77 12.01 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.211 -0.931 . . . . 0.0 109.713 179.902 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 759' ' ' LYS . . . . . 0.472 ' CG ' ' HA ' ' A' ' 815' ' ' ALA . 13.6 mttt -109.16 163.34 13.44 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.145 -0.972 . . . . 0.0 110.847 -179.928 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 760' ' ' VAL . . . . . 0.617 ' CG2' HD11 ' A' ' 816' ' ' ILE . 52.1 t -106.55 131.05 57.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 179.895 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 761' ' ' HIS . . . . . . . . . . . . . 10.8 m80 -112.57 110.35 20.46 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 120.923 -1.111 . . . . 0.0 112.365 -179.736 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 762' ' ' LEU . . . . . 0.672 HD21 ' CB ' ' A' ' 733' ' ' ALA . 1.0 OUTLIER -121.79 105.0 9.98 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 107.477 -1.305 . . . . 0.0 107.477 179.788 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 763' ' ' LYS . . . . . 0.468 ' HB3' ' HG3' ' A' ' 811' ' ' ARG . 0.0 OUTLIER -129.44 150.96 50.57 Favored 'General case' 0 C--N 1.297 -1.696 0 O-C-N 120.87 -1.144 . . . . 0.0 112.168 -179.7 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 764' ' ' CYS . . . . . 0.431 ' O ' ' C ' ' A' ' 765' ' ' ALA . 18.4 m -125.08 164.11 20.92 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 109.19 -0.671 . . . . 0.0 109.19 179.875 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 765' ' ' ALA . . . . . 0.554 ' HB3' ' NE2' ' A' ' 768' ' ' GLN . . . -43.88 154.54 0.36 Allowed Pre-proline 0 N--CA 1.491 1.609 0 O-C-N 120.994 -1.067 . . . . 0.0 110.055 179.982 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 766' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -69.72 99.26 0.73 Allowed 'Trans proline' 0 C--N 1.304 -1.786 0 O-C-N 123.989 1.521 . . . . 0.0 110.089 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 767' ' ' GLY . . . . . . . . . . . . . . . 144.69 -30.77 1.81 Allowed Glycine 0 N--CA 1.488 2.139 0 N-CA-C 108.998 -1.641 . . . . 0.0 108.998 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 768' ' ' GLN . . . . . 0.557 ' HG2' ' N ' ' A' ' 841' ' ' THR . 4.1 mt-30 -85.76 156.74 20.49 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.433 -1.039 . . . . 0.0 109.875 179.908 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 769' ' ' THR . . . . . 0.512 HG22 ' HG3' ' A' ' 810' ' ' GLU . 23.0 p -138.04 145.76 42.2 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.202 -0.936 . . . . 0.0 110.296 -179.969 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 770' ' ' ILE . . . . . . . . . . . . . 70.3 mt -68.46 127.1 29.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.312 -0.868 . . . . 0.0 109.202 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 771' ' ' SER . . . . . 0.485 ' O ' ' HB2' ' A' ' 772' ' ' ALA . 8.5 p -103.6 -8.71 19.78 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.216 -0.928 . . . . 0.0 111.419 -179.893 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 772' ' ' ALA . . . . . 0.485 ' HB2' ' O ' ' A' ' 771' ' ' SER . . . -177.92 151.03 0.66 Allowed 'General case' 0 N--CA 1.495 1.796 0 O-C-N 120.73 -1.231 . . . . 0.0 111.805 -179.959 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 773' ' ' ILE . . . . . 0.402 HG23 HD12 ' A' ' 773' ' ' ILE . 33.6 mm -100.15 141.91 16.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 179.784 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 774' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -108.88 -24.13 11.4 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.826 -1.171 . . . . 0.0 111.733 -179.804 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 775' ' ' PHE . . . . . 0.486 ' O ' ' HB2' ' A' ' 776' ' ' ALA . 80.8 t80 -154.76 161.44 41.51 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 120.726 -1.234 . . . . 0.0 111.505 -179.854 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 776' ' ' ALA . . . . . 0.486 ' HB2' ' O ' ' A' ' 775' ' ' PHE . . . 178.58 111.24 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.626 -0.671 . . . . 0.0 109.485 179.964 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 777' ' ' SER . . . . . 0.424 ' HA ' ' OG ' ' A' ' 798' ' ' SER . 48.3 p -144.66 113.71 6.89 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.077 -1.014 . . . . 0.0 110.681 -179.966 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 778' ' ' PHE . . . . . 0.467 ' CG ' ' O ' ' A' ' 778' ' ' PHE . 8.6 t80 -91.26 78.46 5.78 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.292 -0.88 . . . . 0.0 110.046 179.943 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 779' ' ' GLY . . . . . . . . . . . . . . . -165.12 -123.26 0.64 Allowed Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.829 -1.309 . . . . 0.0 109.829 -179.946 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 780' ' ' THR . . . . . . . . . . . . . 27.9 p -120.46 78.75 28.37 Favored Pre-proline 0 N--CA 1.493 1.688 0 O-C-N 121.344 -1.092 . . . . 0.0 110.396 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 781' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -79.44 175.72 10.4 Favored 'Trans proline' 0 C--N 1.304 -1.78 0 O-C-N 123.95 1.5 . . . . 0.0 110.556 -179.961 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 782' ' ' LEU . . . . . . . . . . . . . 3.9 mt -143.47 134.98 26.22 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.296 -0.878 . . . . 0.0 110.032 179.954 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 783' ' ' GLY . . . . . . . . . . . . . . . 144.1 -174.52 24.39 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 -179.937 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 784' ' ' THR . . . . . 0.463 ' O ' ' O ' ' A' ' 785' ' ' CYS . 0.0 OUTLIER -145.64 66.82 1.21 Allowed 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.213 -1.169 . . . . 0.0 110.257 179.993 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 785' ' ' CYS . . . . . 0.463 ' O ' ' O ' ' A' ' 784' ' ' THR . 44.6 t 57.44 114.76 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.303 -0.873 . . . . 0.0 110.351 179.974 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 786' ' ' GLY . . . . . . . . . . . . . . . 109.47 -17.78 30.7 Favored Glycine 0 N--CA 1.489 2.197 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 -179.932 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 787' ' ' THR . . . . . 0.481 ' O ' HG23 ' A' ' 787' ' ' THR . 12.2 t -158.63 48.23 0.35 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.162 -1.199 . . . . 0.0 110.485 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 788' ' ' PHE . . . . . 0.443 ' CE2' ' HA ' ' A' ' 785' ' ' CYS . 41.5 m-85 -58.34 149.69 24.0 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.109 -0.994 . . . . 0.0 109.984 -179.987 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 789' ' ' GLN . . . . . . . . . . . . . 2.0 tt0 -136.04 162.22 33.51 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.158 -0.964 . . . . 0.0 110.408 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 790' ' ' GLN . . . . . 0.428 ' HG2' ' N ' ' A' ' 791' ' ' GLY . 1.8 tt0 -93.81 144.67 25.21 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.177 -0.952 . . . . 0.0 110.202 -179.993 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 791' ' ' GLY . . . . . 0.428 ' N ' ' HG2' ' A' ' 790' ' ' GLN . . . -96.95 -142.0 12.83 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.361 -1.496 . . . . 0.0 109.361 -179.955 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 792' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -93.63 -36.91 12.13 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.253 -1.145 . . . . 0.0 109.74 179.944 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 793' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -100.64 153.62 19.26 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.42 -0.8 . . . . 0.0 110.264 179.975 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 794' ' ' HIS . . . . . 0.471 ' NE2' ' O ' ' A' ' 795' ' ' SER . 26.4 t60 -176.82 143.17 0.43 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.154 -0.966 . . . . 0.0 110.266 179.956 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 795' ' ' SER . . . . . 0.471 ' O ' ' NE2' ' A' ' 794' ' ' HIS . 58.4 p -73.69 143.62 46.13 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.311 -0.868 . . . . 0.0 109.382 179.934 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 796' ' ' ILE . . . . . . . . . . . . . 9.6 mt -90.99 42.15 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.199 -0.938 . . . . 0.0 109.768 -179.916 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 797' ' ' ASN . . . . . . . . . . . . . 10.6 t30 -159.61 23.02 0.18 Allowed 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.519 -0.738 . . . . 0.0 109.597 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 798' ' ' SER . . . . . 0.456 ' HB3' ' O ' ' A' ' 776' ' ' ALA . 0.6 OUTLIER -57.75 -71.63 0.1 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.571 -0.706 . . . . 0.0 111.563 -179.878 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 799' ' ' ASN . . . . . 0.464 ' OD1' ' HB3' ' A' ' 776' ' ' ALA . 1.4 m120 -61.92 -7.25 3.53 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.305 -0.872 . . . . 0.0 111.861 -179.801 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 800' ' ' SER . . . . . . . . . . . . . 1.3 t -74.03 -33.41 63.74 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.775 -1.203 . . . . 0.0 110.311 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 801' ' ' VAL . . . . . . . . . . . . . 59.1 t -90.83 -18.59 7.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.244 -0.91 . . . . 0.0 110.315 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 802' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -81.43 -45.89 15.38 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.247 -0.908 . . . . 0.0 111.182 -179.831 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 803' ' ' GLU . . . . . 0.647 ' HG2' HD12 ' A' ' 807' ' ' ILE . 4.8 tm-20 -74.4 -21.66 59.54 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.024 -1.048 . . . . 0.0 111.232 -179.993 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 804' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -94.44 -17.35 22.57 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.06 -1.025 . . . . 0.0 112.266 -179.853 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 805' ' ' LYS . . . . . . . . . . . . . 6.4 tttt -138.49 45.04 2.07 Favored 'General case' 0 N--CA 1.503 2.187 0 O-C-N 120.466 -1.396 . . . . 0.0 112.603 -179.879 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 806' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -163.17 -37.38 0.04 OUTLIER 'General case' 0 N--CA 1.498 1.96 0 O-C-N 120.686 -1.259 . . . . 0.0 110.613 179.918 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 807' ' ' ILE . . . . . 0.647 HD12 ' HG2' ' A' ' 803' ' ' GLU . 18.3 mt -70.7 113.5 6.95 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.636 0 O-C-N 121.299 -0.875 . . . . 0.0 110.998 -179.883 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 808' ' ' GLY . . . . . 0.491 ' C ' ' HG ' ' A' ' 809' ' ' LEU . . . 119.35 19.03 4.34 Favored Glycine 0 N--CA 1.494 2.506 0 C-N-CA 119.856 -1.164 . . . . 0.0 110.506 179.88 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 809' ' ' LEU . . . . . 0.491 ' HG ' ' C ' ' A' ' 808' ' ' GLY . 40.5 mt -142.19 142.77 32.71 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 120.883 -1.363 . . . . 0.0 110.629 -179.991 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 810' ' ' GLU . . . . . 0.512 ' HG3' HG22 ' A' ' 769' ' ' THR . 2.2 mt-10 -66.8 -27.6 67.71 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.275 -0.891 . . . . 0.0 109.24 179.959 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 811' ' ' ARG . . . . . 0.468 ' HG3' ' HB3' ' A' ' 763' ' ' LYS . 6.8 ttt85 -125.35 154.49 41.75 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.508 -0.745 . . . . 0.0 109.927 179.972 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 812' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -137.34 124.03 21.09 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.211 -0.93 . . . . 0.0 110.535 -179.982 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 813' ' ' VAL . . . . . . . . . . . . . 70.8 t -130.92 103.43 7.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.226 -0.921 . . . . 0.0 110.015 179.953 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 814' ' ' VAL . . . . . . . . . . . . . 86.0 t -124.84 121.14 60.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.191 -0.943 . . . . 0.0 110.155 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 815' ' ' ALA . . . . . 0.472 ' HA ' ' CG ' ' A' ' 759' ' ' LYS . . . -72.21 160.91 31.63 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.283 -0.886 . . . . 0.0 110.246 179.923 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 816' ' ' ILE . . . . . 0.78 HG21 HG21 ' A' ' 833' ' ' VAL . 8.2 mt -112.91 81.59 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.267 -0.896 . . . . 0.0 109.649 179.989 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 817' ' ' SER . . . . . . . . . . . . . 5.7 p -110.48 158.36 35.62 Favored Pre-proline 0 C--N 1.297 -1.71 0 O-C-N 121.318 -0.864 . . . . 0.0 110.213 -179.921 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 818' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -77.61 12.85 1.78 Allowed 'Trans proline' 0 C--N 1.306 -1.672 0 O-C-N 124.107 1.583 . . . . 0.0 111.058 179.962 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 819' ' ' SER . . . . . . . . . . . . . 10.3 p -133.84 16.49 3.9 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.107 -0.995 . . . . 0.0 110.371 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 820' ' ' ASN . . . . . . . . . . . . . 19.3 t-20 -117.81 -16.82 9.94 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.138 -0.976 . . . . 0.0 110.058 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 821' ' ' PHE . . . . . . . . . . . . . 7.4 m-85 -97.21 -39.29 9.34 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.348 -0.845 . . . . 0.0 110.257 179.896 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 822' ' ' GLY . . . . . . . . . . . . . . . 174.88 -29.49 0.08 OUTLIER Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.596 -1.402 . . . . 0.0 109.596 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 823' ' ' GLY . . . . . 0.465 ' O ' ' OD2' ' A' ' 824' ' ' ASP . . . 147.78 -82.75 0.19 Allowed Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 179.983 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 824' ' ' ASP . . . . . 0.465 ' OD2' ' O ' ' A' ' 823' ' ' GLY . 1.0 OUTLIER -148.02 121.11 4.7 Favored Pre-proline 0 N--CA 1.494 1.771 0 O-C-N 121.234 -1.157 . . . . 0.0 110.385 -179.919 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 825' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -75.51 -89.91 0.01 OUTLIER 'Trans proline' 0 C--N 1.31 -1.497 0 O-C-N 123.923 1.486 . . . . 0.0 110.478 179.932 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 826' ' ' CYS . . . . . 0.606 ' HB3' HG21 ' A' ' 829' ' ' VAL . 2.1 m -97.17 130.74 28.99 Favored Pre-proline 0 N--CA 1.492 1.646 0 O-C-N 121.201 -0.937 . . . . 0.0 109.971 179.996 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 827' ' ' PRO . . . . . 0.418 ' O ' ' HB2' ' A' ' 828' ' ' GLU . 46.4 Cg_endo -73.41 129.31 13.7 Favored 'Trans proline' 0 C--N 1.308 -1.579 0 O-C-N 124.002 1.527 . . . . 0.0 110.927 -179.991 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 828' ' ' GLU . . . . . 0.418 ' HB2' ' O ' ' A' ' 827' ' ' PRO . 8.3 mt-10 57.24 46.3 18.93 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.392 -0.818 . . . . 0.0 110.504 179.928 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 829' ' ' VAL . . . . . 0.606 HG21 ' HB3' ' A' ' 826' ' ' CYS . 39.2 t -133.95 124.88 47.76 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 O-C-N 121.209 -0.932 . . . . 0.0 110.017 179.898 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 830' ' ' MET . . . . . 0.432 ' O ' ' O ' ' A' ' 829' ' ' VAL . 13.0 mmt -41.72 162.75 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.349 -0.844 . . . . 0.0 110.03 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 831' ' ' LYS . . . . . . . . . . . . . 6.4 mttt -139.71 142.47 36.86 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.063 -1.023 . . . . 0.0 111.011 -179.872 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 832' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -144.87 158.15 43.9 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.526 -0.733 . . . . 0.0 109.325 179.976 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 833' ' ' VAL . . . . . 0.78 HG21 HG21 ' A' ' 816' ' ' ILE . 62.1 t -123.13 117.19 50.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 120.846 -1.159 . . . . 0.0 111.47 -179.784 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 834' ' ' ALA . . . . . . . . . . . . . . . -125.9 117.62 23.71 Favored 'General case' 0 N--CA 1.494 1.728 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 179.799 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 835' ' ' VAL . . . . . 0.494 HG12 ' N ' ' A' ' 836' ' ' GLU . 44.4 t -127.82 165.24 27.35 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 120.9 -1.125 . . . . 0.0 111.997 -179.792 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 836' ' ' GLU . . . . . 0.494 ' N ' HG12 ' A' ' 835' ' ' VAL . 0.9 OUTLIER -152.23 123.38 7.62 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 179.952 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 837' ' ' ALA . . . . . . . . . . . . . . . -121.83 165.98 15.06 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 120.893 -1.13 . . . . 0.0 111.809 -179.757 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 838' ' ' VAL . . . . . . . . . . . . . 17.2 t -109.84 107.23 22.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.662 -0.649 . . . . 0.0 109.275 179.928 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 839' ' ' CYS . . . . . 0.483 ' O ' ' HA ' ' A' ' 729' ' ' SER . 0.0 OUTLIER -108.21 145.26 34.52 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.13 -0.981 . . . . 0.0 110.818 -179.896 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 840' ' ' SER . . . . . . . . . . . . . 1.4 p -164.35 147.51 9.21 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.37 -0.831 . . . . 0.0 110.094 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 841' ' ' THR . . . . . 0.557 ' N ' ' HG2' ' A' ' 768' ' ' GLN . 5.2 t . . . . . 0 N--CA 1.494 1.736 0 O-C-N 121.244 -0.91 . . . . 0.0 110.208 -179.948 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 728' ' ' VAL . . . . . 0.713 ' O ' HG13 ' A' ' 728' ' ' VAL . 12.0 p . . . . . 0 N--CA 1.489 1.519 0 CA-C-O 121.351 0.596 . . . . 0.0 110.363 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 729' ' ' SER . . . . . . . . . . . . . 5.9 m 52.3 -177.99 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.41 -0.807 . . . . 0.0 110.731 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 730' ' ' GLY . . . . . 0.523 ' C ' HG23 ' A' ' 731' ' ' VAL . . . -152.25 -140.93 3.21 Favored Glycine 0 N--CA 1.489 2.193 0 N-CA-C 109.041 -1.624 . . . . 0.0 109.041 179.987 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 731' ' ' VAL . . . . . 0.523 HG23 ' C ' ' A' ' 730' ' ' GLY . 11.9 t -153.17 165.81 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 O-C-N 121.065 -1.256 . . . . 0.0 110.26 179.968 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 732' ' ' CYS . . . . . . . . . . . . . 6.6 t -150.92 133.98 15.98 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.343 -0.848 . . . . 0.0 109.967 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 733' ' ' ALA . . . . . . . . . . . . . . . -153.19 162.32 41.44 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.18 -0.95 . . . . 0.0 110.551 -179.969 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 734' ' ' ASP . . . . . 0.458 ' O ' ' OD2' ' A' ' 734' ' ' ASP . 4.3 p30 -162.13 118.26 2.01 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.423 -0.798 . . . . 0.0 109.9 179.995 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 735' ' ' VAL . . . . . . . . . . . . . 16.6 t -139.11 164.82 24.6 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.157 -0.964 . . . . 0.0 110.674 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 736' ' ' SER . . . . . . . . . . . . . 8.3 p -109.83 172.9 6.59 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.36 -0.837 . . . . 0.0 109.818 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 737' ' ' GLU . . . . . 0.467 ' OE1' ' HG3' ' A' ' 831' ' ' LYS . 9.5 pt-20 . . . . . 0 N--CA 1.496 1.852 0 O-C-N 121.124 -0.985 . . . . 0.0 110.348 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 757' ' ' THR . . . . . . . . . . . . . 47.0 p . . . . . 0 N--CA 1.492 1.672 0 CA-C-O 121.368 0.604 . . . . 0.0 110.707 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 758' ' ' ALA . . . . . 0.431 ' C ' ' HG3' ' A' ' 759' ' ' LYS . . . -64.38 168.02 6.21 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.32 -0.862 . . . . 0.0 110.009 179.96 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 759' ' ' LYS . . . . . 0.431 ' HG3' ' C ' ' A' ' 758' ' ' ALA . 17.1 mttp -146.55 146.47 30.49 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.203 -0.935 . . . . 0.0 110.596 -179.928 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 760' ' ' VAL . . . . . . . . . . . . . 43.8 t -108.72 138.37 36.06 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.291 -0.881 . . . . 0.0 109.62 179.819 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 761' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -109.12 125.65 52.38 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.133 -0.979 . . . . 0.0 111.19 -179.917 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 762' ' ' LEU . . . . . 0.513 ' HB2' ' HB2' ' A' ' 812' ' ' CYS . 20.6 mt -123.39 112.16 17.22 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.464 -0.772 . . . . 0.0 109.296 179.849 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 763' ' ' LYS . . . . . . . . . . . . . 9.7 mttt -107.93 122.1 46.12 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.091 -1.006 . . . . 0.0 110.869 -179.827 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 764' ' ' CYS . . . . . 0.423 ' O ' ' C ' ' A' ' 765' ' ' ALA . 48.7 t -92.91 163.18 13.78 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.46 -0.775 . . . . 0.0 109.618 179.904 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 765' ' ' ALA . . . . . 0.583 ' HB3' ' HB2' ' A' ' 768' ' ' GLN . . . -44.08 154.81 0.36 Allowed Pre-proline 0 N--CA 1.493 1.685 0 O-C-N 121.041 -1.037 . . . . 0.0 109.992 -179.884 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 766' ' ' PRO . . . . . 0.436 ' C ' ' OE1' ' A' ' 768' ' ' GLN . 45.1 Cg_endo -70.95 112.14 3.22 Favored 'Trans proline' 0 C--N 1.306 -1.684 0 O-C-N 123.98 1.516 . . . . 0.0 110.657 -179.96 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 767' ' ' GLY . . . . . . . . . . . . . . . 98.29 -2.96 59.61 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.651 -1.379 . . . . 0.0 109.651 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 768' ' ' GLN . . . . . 0.583 ' HB2' ' HB3' ' A' ' 765' ' ' ALA . 27.6 mp0 -106.59 176.3 5.22 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.23 -1.159 . . . . 0.0 110.078 -179.913 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 769' ' ' THR . . . . . . . . . . . . . 40.6 p -145.12 159.18 43.37 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.225 -0.922 . . . . 0.0 110.502 -179.952 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 770' ' ' ILE . . . . . . . . . . . . . 5.6 mt -71.02 151.47 9.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.302 -0.874 . . . . 0.0 109.831 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 771' ' ' SER . . . . . . . . . . . . . 15.0 m -135.5 -9.97 2.17 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.119 -0.988 . . . . 0.0 111.152 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 772' ' ' ALA . . . . . . . . . . . . . . . -172.38 133.62 0.65 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.823 -1.173 . . . . 0.0 111.124 -179.892 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 773' ' ' ILE . . . . . . . . . . . . . 34.1 mm -86.84 120.4 36.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.367 -0.833 . . . . 0.0 109.232 179.91 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 774' ' ' LYS . . . . . . . . . . . . . 1.2 ttmp? -81.21 -38.58 26.77 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.13 -0.981 . . . . 0.0 111.024 -179.861 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 775' ' ' PHE . . . . . 0.735 ' O ' ' HB2' ' A' ' 776' ' ' ALA . 43.5 t80 -149.29 167.41 26.14 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.008 -1.057 . . . . 0.0 111.182 -179.904 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 776' ' ' ALA . . . . . 0.735 ' HB2' ' O ' ' A' ' 775' ' ' PHE . . . 163.88 59.25 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.843 0 CA-C-O 121.449 0.642 . . . . 0.0 109.328 179.975 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 777' ' ' SER . . . . . 0.545 ' HB3' ' CZ ' ' A' ' 775' ' ' PHE . 0.3 OUTLIER -89.88 154.33 19.95 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.513 -0.742 . . . . 0.0 110.776 -179.933 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 778' ' ' PHE . . . . . 0.409 ' CD2' HG22 ' A' ' 833' ' ' VAL . 7.5 t80 -121.84 89.16 3.07 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.377 -0.827 . . . . 0.0 110.137 -179.994 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 779' ' ' GLY . . . . . . . . . . . . . . . 179.94 -127.72 1.15 Allowed Glycine 0 N--CA 1.493 2.464 0 N-CA-C 109.723 -1.351 . . . . 0.0 109.723 -179.952 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 780' ' ' THR . . . . . 0.491 ' O ' ' HA3' ' A' ' 791' ' ' GLY . 9.0 p -116.03 76.17 6.22 Favored Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.209 -1.171 . . . . 0.0 110.341 179.994 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 781' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -71.18 162.47 42.45 Favored 'Trans proline' 0 C--N 1.304 -1.812 0 O-C-N 124.013 1.533 . . . . 0.0 110.369 179.982 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 782' ' ' LEU . . . . . . . . . . . . . 4.5 mt -123.32 145.52 48.66 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.263 -0.898 . . . . 0.0 110.229 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 783' ' ' GLY . . . . . . . . . . . . . . . 99.86 -175.85 27.91 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.925 -1.27 . . . . 0.0 109.925 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 784' ' ' THR . . . . . 0.471 ' O ' HG23 ' A' ' 784' ' ' THR . 1.7 t -147.41 89.48 1.78 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.313 -1.11 . . . . 0.0 109.855 179.97 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 785' ' ' CYS . . . . . 0.467 ' O ' ' O ' ' A' ' 784' ' ' THR . 4.1 t 54.48 107.89 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.297 -0.877 . . . . 0.0 110.011 -179.966 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 786' ' ' GLY . . . . . . . . . . . . . . . 115.22 -31.1 6.39 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 108.957 -1.657 . . . . 0.0 108.957 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 787' ' ' THR . . . . . . . . . . . . . 8.9 p -141.02 38.74 1.78 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.463 -1.022 . . . . 0.0 109.831 179.908 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 788' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -63.32 165.12 7.95 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.364 -0.835 . . . . 0.0 110.479 -179.992 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 789' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -159.36 165.67 32.79 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.374 -0.829 . . . . 0.0 109.443 179.95 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 790' ' ' GLN . . . . . 0.43 ' O ' ' C ' ' A' ' 791' ' ' GLY . 5.8 pt20 -90.25 20.57 4.31 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.014 -1.054 . . . . 0.0 110.487 -179.973 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 791' ' ' GLY . . . . . 0.491 ' HA3' ' O ' ' A' ' 780' ' ' THR . . . 41.77 -143.24 1.03 Allowed Glycine 0 N--CA 1.491 2.313 0 N-CA-C 110.067 -1.213 . . . . 0.0 110.067 -179.989 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 792' ' ' GLU . . . . . . . . . . . . . 27.8 mm-40 -95.15 -43.21 8.2 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.448 -1.031 . . . . 0.0 110.354 -179.957 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 793' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -108.44 134.06 51.75 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.039 -1.038 . . . . 0.0 110.075 -179.988 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 794' ' ' HIS . . . . . 0.559 ' CG ' ' N ' ' A' ' 795' ' ' SER . 68.3 t60 -139.28 169.55 17.55 Favored 'General case' 0 C--N 1.299 -1.591 0 O-C-N 121.32 -0.862 . . . . 0.0 110.176 -179.981 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 795' ' ' SER . . . . . 0.559 ' N ' ' CG ' ' A' ' 794' ' ' HIS . 0.1 OUTLIER -110.69 129.79 55.74 Favored 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 179.904 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 796' ' ' ILE . . . . . . . . . . . . . 35.9 mt -69.7 -5.62 5.33 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.619 0 O-C-N 120.915 -1.115 . . . . 0.0 109.875 -179.913 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 797' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -102.85 14.83 31.0 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.334 -0.853 . . . . 0.0 109.799 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 798' ' ' SER . . . . . 0.512 ' HB2' ' O ' ' A' ' 776' ' ' ALA . 10.8 p -58.79 -62.75 1.63 Allowed 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.463 -0.773 . . . . 0.0 111.278 179.997 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 799' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -82.54 1.43 37.94 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.261 -0.9 . . . . 0.0 110.951 -179.882 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 800' ' ' SER . . . . . 0.485 ' O ' ' HG2' ' A' ' 804' ' ' ARG . 23.3 t -84.21 -25.99 29.08 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.057 -1.027 . . . . 0.0 110.478 -179.926 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 801' ' ' VAL . . . . . 0.407 ' C ' HD22 ' A' ' 802' ' ' LEU . 59.9 t -93.61 -27.99 4.41 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.282 -0.886 . . . . 0.0 111.445 -179.922 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 802' ' ' LEU . . . . . 0.643 ' CD1' HG21 ' A' ' 814' ' ' VAL . 4.0 mm? -89.96 -29.67 18.32 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 120.964 -1.085 . . . . 0.0 111.152 -179.88 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 803' ' ' GLU . . . . . . . . . . . . . 11.3 tt0 -68.93 -28.12 66.37 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 120.818 -1.176 . . . . 0.0 110.942 -179.915 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 804' ' ' ARG . . . . . 0.485 ' HG2' ' O ' ' A' ' 800' ' ' SER . 0.0 OUTLIER -95.0 -17.82 21.59 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.092 -1.005 . . . . 0.0 111.804 -179.969 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 805' ' ' LYS . . . . . 0.433 ' N ' ' HG3' ' A' ' 804' ' ' ARG . 2.3 tptp -115.58 41.33 2.53 Favored 'General case' 0 N--CA 1.501 2.125 0 O-C-N 120.872 -1.143 . . . . 0.0 112.172 -179.824 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 806' ' ' CYS . . . . . 0.524 ' HB2' ' O ' ' A' ' 802' ' ' LEU . 0.5 OUTLIER -160.31 -19.25 0.06 Allowed 'General case' 0 N--CA 1.504 2.236 0 O-C-N 120.577 -1.327 . . . . 0.0 112.306 -179.981 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 807' ' ' ILE . . . . . . . . . . . . . 52.9 mt -85.66 120.49 35.85 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 O-C-N 120.665 -1.272 . . . . 0.0 111.145 -179.962 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 808' ' ' GLY . . . . . 0.434 ' C ' ' HG ' ' A' ' 809' ' ' LEU . . . 112.92 12.63 12.15 Favored Glycine 0 N--CA 1.494 2.531 0 N-CA-C 110.363 -1.095 . . . . 0.0 110.363 179.897 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 809' ' ' LEU . . . . . 0.434 ' HG ' ' C ' ' A' ' 808' ' ' GLY . 12.1 mt -136.29 155.31 50.27 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.033 -1.275 . . . . 0.0 110.799 -179.968 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 810' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -89.99 8.72 31.01 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.433 -0.792 . . . . 0.0 109.389 179.916 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 811' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -155.89 160.94 40.58 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 -179.976 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 812' ' ' CYS . . . . . 0.513 ' HB2' ' HB2' ' A' ' 762' ' ' LEU . 1.0 OUTLIER -143.59 132.76 23.09 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.844 -1.16 . . . . 0.0 111.233 -179.936 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 813' ' ' VAL . . . . . . . . . . . . . 89.7 t -136.2 104.63 4.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.488 -0.757 . . . . 0.0 109.554 179.935 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 814' ' ' VAL . . . . . 0.643 HG21 ' CD1' ' A' ' 802' ' ' LEU . 96.8 t -113.56 129.99 68.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.137 -0.977 . . . . 0.0 110.819 -179.966 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 815' ' ' ALA . . . . . . . . . . . . . . . -85.52 141.8 29.63 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.32 -0.863 . . . . 0.0 109.387 179.933 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 816' ' ' ILE . . . . . 0.522 ' CG2' HG21 ' A' ' 833' ' ' VAL . 21.0 mt -104.5 124.12 58.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.133 -0.979 . . . . 0.0 110.651 -179.903 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 817' ' ' SER . . . . . 0.46 ' OG ' ' HD2' ' A' ' 818' ' ' PRO . 29.2 t -148.05 153.54 41.87 Favored Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 121.348 -0.845 . . . . 0.0 110.025 179.957 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 818' ' ' PRO . . . . . 0.46 ' HD2' ' OG ' ' A' ' 817' ' ' SER . 43.5 Cg_endo -70.71 -10.11 27.14 Favored 'Trans proline' 0 C--N 1.304 -1.768 0 O-C-N 123.984 1.518 . . . . 0.0 110.315 -179.954 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 819' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -125.42 59.73 1.26 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.317 -0.864 . . . . 0.0 110.014 -179.96 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 820' ' ' ASN . . . . . . . . . . . . . 1.3 m120 -148.34 -35.83 0.2 Allowed 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.361 -0.837 . . . . 0.0 110.285 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 821' ' ' PHE . . . . . . . . . . . . . 13.9 m-85 -80.16 0.76 30.92 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.145 -0.972 . . . . 0.0 110.485 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 822' ' ' GLY . . . . . . . . . . . . . . . 110.7 12.29 16.98 Favored Glycine 0 N--CA 1.493 2.448 0 N-CA-C 109.767 -1.333 . . . . 0.0 109.767 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 823' ' ' GLY . . . . . . . . . . . . . . . 108.73 -159.53 14.11 Favored Glycine 0 N--CA 1.492 2.374 0 N-CA-C 109.629 -1.388 . . . . 0.0 109.629 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 824' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -117.91 136.11 23.64 Favored Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 121.221 -1.164 . . . . 0.0 110.391 -179.997 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 825' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -72.47 -80.12 0.01 OUTLIER 'Trans proline' 0 C--N 1.307 -1.638 0 O-C-N 123.959 1.505 . . . . 0.0 110.161 179.961 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 826' ' ' CYS . . . . . 0.696 ' SG ' HG21 ' A' ' 829' ' ' VAL . 5.8 p -106.58 121.4 45.28 Favored Pre-proline 0 N--CA 1.498 1.957 0 O-C-N 121.11 -0.994 . . . . 0.0 109.921 179.93 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 827' ' ' PRO . . . . . 0.47 ' O ' ' CB ' ' A' ' 828' ' ' GLU . 43.7 Cg_endo -70.38 171.43 15.17 Favored 'Trans proline' 0 C--N 1.309 -1.523 0 O-C-N 123.942 1.496 . . . . 0.0 110.054 -179.975 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 828' ' ' GLU . . . . . 0.47 ' CB ' ' O ' ' A' ' 827' ' ' PRO . 0.0 OUTLIER 66.54 15.74 10.2 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.21 -0.931 . . . . 0.0 109.64 -179.951 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 829' ' ' VAL . . . . . 0.696 HG21 ' SG ' ' A' ' 826' ' ' CYS . 95.4 t -119.8 132.26 70.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.425 -0.797 . . . . 0.0 110.02 179.934 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 830' ' ' MET . . . . . . . . . . . . . 2.2 tpp -53.55 144.71 16.63 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.219 -0.926 . . . . 0.0 110.279 179.961 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 831' ' ' LYS . . . . . 0.467 ' HG3' ' OE1' ' A' ' 737' ' ' GLU . 0.0 OUTLIER -115.07 97.81 6.43 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.123 -0.986 . . . . 0.0 110.675 -179.938 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 832' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -122.17 167.94 12.59 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.419 -0.8 . . . . 0.0 109.434 179.989 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 833' ' ' VAL . . . . . 0.522 HG21 ' CG2' ' A' ' 816' ' ' ILE . 38.3 t -124.26 148.23 28.54 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 O-C-N 120.908 -1.12 . . . . 0.0 111.537 -179.915 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 834' ' ' ALA . . . . . 0.488 ' O ' ' HA ' ' A' ' 776' ' ' ALA . . . -150.69 111.65 4.32 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 179.919 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 835' ' ' VAL . . . . . 0.554 HG22 ' CB ' ' A' ' 776' ' ' ALA . 41.0 t -126.7 164.67 26.59 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 O-C-N 120.977 -1.077 . . . . 0.0 112.342 -179.773 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 836' ' ' GLU . . . . . 0.47 ' N ' ' CG1' ' A' ' 835' ' ' VAL . 64.0 tt0 -153.87 137.57 16.09 Favored 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 179.855 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 837' ' ' ALA . . . . . . . . . . . . . . . -124.19 162.83 22.83 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 120.769 -1.207 . . . . 0.0 111.808 -179.814 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 838' ' ' VAL . . . . . . . . . . . . . 60.7 t -115.46 128.54 72.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.702 -0.624 . . . . 0.0 109.509 179.889 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 839' ' ' CYS . . . . . . . . . . . . . 5.2 m -108.25 156.36 19.45 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.998 -1.064 . . . . 0.0 110.908 -179.957 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 840' ' ' SER . . . . . 0.625 ' HA ' HG12 ' A' ' 728' ' ' VAL . 6.0 p -157.97 136.37 11.05 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.43 -0.794 . . . . 0.0 109.84 179.917 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 841' ' ' THR . . . . . 0.429 ' HA ' ' HG3' ' A' ' 768' ' ' GLN . 65.7 p . . . . . 0 N--CA 1.493 1.693 0 O-C-N 121.32 -0.862 . . . . 0.0 110.41 -179.954 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 728' ' ' VAL . . . . . . . . . . . . . 66.4 t . . . . . 0 N--CA 1.494 1.749 0 CA-C-O 121.175 0.512 . . . . 0.0 110.236 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 729' ' ' SER . . . . . 0.445 ' O ' ' O ' ' A' ' 730' ' ' GLY . 15.1 p -139.7 71.08 1.37 Allowed 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.258 -0.901 . . . . 0.0 110.472 -179.943 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 730' ' ' GLY . . . . . 0.517 ' HA3' ' HA ' ' A' ' 838' ' ' VAL . . . -52.1 -175.77 0.04 OUTLIER Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 179.958 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 731' ' ' VAL . . . . . . . . . . . . . 3.6 t -132.26 135.93 57.26 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.286 -1.126 . . . . 0.0 110.036 179.994 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 732' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -110.55 126.96 54.97 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.239 -0.913 . . . . 0.0 110.081 179.936 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 733' ' ' ALA . . . . . . . . . . . . . . . -138.92 123.0 17.95 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.211 -0.931 . . . . 0.0 110.717 -179.898 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 734' ' ' ASP . . . . . . . . . . . . . 2.2 p-10 -113.0 108.8 17.85 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.401 -0.812 . . . . 0.0 109.698 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 735' ' ' VAL . . . . . 0.428 HG12 ' N ' ' A' ' 736' ' ' SER . 45.7 t -111.12 164.11 7.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.226 -0.921 . . . . 0.0 110.315 -179.937 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 736' ' ' SER . . . . . 0.428 ' N ' HG12 ' A' ' 735' ' ' VAL . 44.5 p -101.53 -178.48 3.74 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.178 -0.951 . . . . 0.0 110.264 -179.96 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 737' ' ' GLU . . . . . 0.505 ' HB2' HG21 ' A' ' 816' ' ' ILE . 25.6 tt0 . . . . . 0 N--CA 1.494 1.737 0 O-C-N 121.341 -0.849 . . . . 0.0 110.351 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 757' ' ' THR . . . . . . . . . . . . . 71.5 p . . . . . 0 N--CA 1.496 1.868 0 CA-C-O 121.321 0.581 . . . . 0.0 110.543 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 758' ' ' ALA . . . . . . . . . . . . . . . -60.25 170.02 1.43 Allowed 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.257 -0.902 . . . . 0.0 109.525 179.958 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 759' ' ' LYS . . . . . . . . . . . . . 21.2 mttt -129.25 161.89 29.15 Favored 'General case' 0 C--N 1.299 -1.612 0 O-C-N 121.087 -1.008 . . . . 0.0 110.382 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 760' ' ' VAL . . . . . . . . . . . . . 28.0 t -107.24 131.79 56.38 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.343 -0.848 . . . . 0.0 108.769 179.958 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 761' ' ' HIS . . . . . . . . . . . . . 27.0 m170 -112.29 104.41 12.58 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.035 -1.04 . . . . 0.0 111.545 -179.872 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 762' ' ' LEU . . . . . . . . . . . . . 19.4 mt -110.32 113.42 26.06 Favored 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 179.864 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 763' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -140.03 116.98 11.04 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.712 -1.242 . . . . 0.0 111.331 -179.858 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 764' ' ' CYS . . . . . 0.463 ' O ' ' O ' ' A' ' 765' ' ' ALA . 1.5 m -95.89 146.03 24.9 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.511 -0.743 . . . . 0.0 109.05 179.938 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 765' ' ' ALA . . . . . 0.626 ' HB3' ' OE1' ' A' ' 768' ' ' GLN . . . -39.61 160.74 0.1 OUTLIER Pre-proline 0 N--CA 1.498 1.933 0 O-C-N 121.215 -0.928 . . . . 0.0 110.413 -179.992 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 766' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -69.99 102.07 1.02 Allowed 'Trans proline' 0 C--N 1.305 -1.757 0 O-C-N 123.941 1.495 . . . . 0.0 110.213 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 767' ' ' GLY . . . . . . . . . . . . . . . 132.3 -17.92 4.75 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 108.966 -1.654 . . . . 0.0 108.966 -179.951 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 768' ' ' GLN . . . . . 0.626 ' OE1' ' HB3' ' A' ' 765' ' ' ALA . 13.2 mt-30 -102.58 114.77 29.26 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.423 -1.045 . . . . 0.0 109.77 179.895 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 769' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -106.82 149.39 27.44 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.202 -0.936 . . . . 0.0 110.616 -179.954 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 770' ' ' ILE . . . . . . . . . . . . . 49.8 mt -72.92 150.26 8.22 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.314 -0.866 . . . . 0.0 109.545 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 771' ' ' SER . . . . . . . . . . . . . 1.3 p -140.84 3.64 1.85 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 120.995 -1.066 . . . . 0.0 111.008 179.973 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 772' ' ' ALA . . . . . . . . . . . . . . . -173.65 145.96 1.25 Allowed 'General case' 0 N--CA 1.495 1.783 0 O-C-N 120.902 -1.124 . . . . 0.0 111.551 -179.946 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 773' ' ' ILE . . . . . 0.401 HD12 HG23 ' A' ' 773' ' ' ILE . 38.1 mm -107.01 147.92 11.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 179.907 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 774' ' ' LYS . . . . . . . . . . . . . 9.8 tptp -113.44 -25.0 8.99 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.998 -1.064 . . . . 0.0 110.808 -179.93 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 775' ' ' PHE . . . . . 0.588 ' O ' ' HB2' ' A' ' 776' ' ' ALA . 68.5 t80 -170.43 163.98 8.59 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.057 -1.027 . . . . 0.0 110.751 179.994 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 776' ' ' ALA . . . . . 0.588 ' HB2' ' O ' ' A' ' 775' ' ' PHE . . . 175.07 72.31 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.692 -0.63 . . . . 0.0 109.406 -179.945 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 777' ' ' SER . . . . . 0.449 ' HA ' ' HB3' ' A' ' 798' ' ' SER . 1.5 t -92.66 154.23 18.49 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.328 -0.857 . . . . 0.0 110.968 -179.891 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 778' ' ' PHE . . . . . 0.578 ' O ' ' CD2' ' A' ' 778' ' ' PHE . 33.9 t80 -124.95 94.96 4.33 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.467 -0.771 . . . . 0.0 109.899 179.958 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 779' ' ' GLY . . . . . . . . . . . . . . . 159.18 -97.12 0.16 Allowed Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 179.99 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 780' ' ' THR . . . . . 0.466 HG21 HG11 ' A' ' 829' ' ' VAL . 52.1 p -132.8 92.58 26.12 Favored Pre-proline 0 N--CA 1.493 1.716 0 O-C-N 121.271 -1.134 . . . . 0.0 110.285 -179.94 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 781' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -75.26 173.19 14.93 Favored 'Trans proline' 0 C--N 1.305 -1.744 0 O-C-N 124.098 1.578 . . . . 0.0 110.523 179.916 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 782' ' ' LEU . . . . . . . . . . . . . 2.2 tt -137.65 118.32 14.02 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.307 -0.871 . . . . 0.0 110.167 179.935 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 783' ' ' GLY . . . . . 0.409 ' HA3' HG23 ' A' ' 787' ' ' THR . . . 95.28 -176.84 34.52 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.331 -1.507 . . . . 0.0 109.331 179.98 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 784' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -117.91 -160.81 0.8 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.208 -1.172 . . . . 0.0 110.188 -179.979 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 785' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -60.56 119.16 7.54 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.306 -0.871 . . . . 0.0 110.252 -179.932 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 786' ' ' GLY . . . . . . . . . . . . . . . 114.85 -28.93 7.77 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 787' ' ' THR . . . . . 0.409 HG23 ' HA3' ' A' ' 783' ' ' GLY . 8.9 t -134.78 34.4 3.16 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.237 -1.155 . . . . 0.0 110.309 179.967 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 788' ' ' PHE . . . . . 0.493 ' CZ ' ' HB1' ' A' ' 834' ' ' ALA . 1.0 OUTLIER -65.85 132.12 47.91 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.278 -0.889 . . . . 0.0 109.943 179.989 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 789' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -139.9 154.02 47.14 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.229 -0.919 . . . . 0.0 110.33 179.925 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 790' ' ' GLN . . . . . 0.419 ' OE1' ' ND1' ' A' ' 794' ' ' HIS . 1.6 mp0 -65.84 116.3 6.86 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.351 -0.843 . . . . 0.0 110.482 -179.987 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 791' ' ' GLY . . . . . . . . . . . . . . . -64.68 -105.86 0.01 OUTLIER Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.623 -1.391 . . . . 0.0 109.623 -179.945 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 792' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -127.18 -26.12 3.15 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.302 -1.117 . . . . 0.0 110.509 -179.956 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 793' ' ' CYS . . . . . 0.474 ' O ' ' HB3' ' A' ' 794' ' ' HIS . 85.7 m -100.2 -83.91 0.43 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.206 -0.933 . . . . 0.0 109.89 -179.997 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 794' ' ' HIS . . . . . 0.637 ' CE1' ' OG ' ' A' ' 798' ' ' SER . 84.9 t60 58.4 113.77 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.506 -0.746 . . . . 0.0 110.728 179.981 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 795' ' ' SER . . . . . 0.468 ' O ' ' O ' ' A' ' 794' ' ' HIS . 100.0 p -60.66 -126.6 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.301 -0.874 . . . . 0.0 109.295 179.871 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 796' ' ' ILE . . . . . 0.424 ' CG1' ' C ' ' A' ' 795' ' ' SER . 1.0 OUTLIER -148.02 -31.06 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 2.02 0 O-C-N 120.798 -1.189 . . . . 0.0 110.68 179.856 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 797' ' ' ASN . . . . . 0.667 ' O ' HG23 ' A' ' 801' ' ' VAL . 4.3 m120 -86.26 16.28 4.54 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 120.906 -1.121 . . . . 0.0 110.04 179.914 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 798' ' ' SER . . . . . 0.637 ' OG ' ' CE1' ' A' ' 794' ' ' HIS . 0.9 OUTLIER -33.56 -70.76 0.07 Allowed 'General case' 0 N--CA 1.503 2.178 0 O-C-N 121.775 -0.578 . . . . 0.0 111.8 -179.999 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 799' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -84.99 -30.02 24.55 Favored 'General case' 0 N--CA 1.501 2.086 0 O-C-N 121.155 -0.966 . . . . 0.0 111.094 -179.876 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 800' ' ' SER . . . . . . . . . . . . . 37.2 t -54.47 -16.91 2.61 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.059 -1.026 . . . . 0.0 110.743 -179.955 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 801' ' ' VAL . . . . . 0.667 HG23 ' O ' ' A' ' 797' ' ' ASN . 85.3 t -90.97 -48.69 13.9 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.919 0 O-C-N 121.046 -1.034 . . . . 0.0 111.588 -179.851 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 802' ' ' LEU . . . . . 0.516 HD22 ' N ' ' A' ' 802' ' ' LEU . 4.6 mm? -75.08 -16.33 60.57 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.112 -0.993 . . . . 0.0 111.522 -179.801 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 803' ' ' GLU . . . . . 0.906 ' O ' HD12 ' A' ' 807' ' ' ILE . 0.5 OUTLIER -81.94 -27.53 33.24 Favored 'General case' 0 C--N 1.295 -1.77 0 O-C-N 120.73 -1.232 . . . . 0.0 110.778 -179.947 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 804' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -95.4 -18.39 20.77 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.109 -0.994 . . . . 0.0 112.28 -179.918 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 805' ' ' LYS . . . . . 0.458 ' O ' ' SG ' ' A' ' 806' ' ' CYS . 4.0 ttpt -122.17 20.25 10.63 Favored 'General case' 0 N--CA 1.501 2.078 0 O-C-N 120.452 -1.405 . . . . 0.0 112.477 -179.868 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 806' ' ' CYS . . . . . 0.512 ' HB2' ' O ' ' A' ' 802' ' ' LEU . 50.0 m -152.66 51.17 0.76 Allowed 'General case' 0 N--CA 1.496 1.832 0 O-C-N 120.665 -1.272 . . . . 0.0 110.406 179.905 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 807' ' ' ILE . . . . . 0.906 HD12 ' O ' ' A' ' 803' ' ' GLU . 9.1 mt -140.42 95.04 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.484 0 O-C-N 121.524 -0.735 . . . . 0.0 109.324 179.956 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 808' ' ' GLY . . . . . . . . . . . . . . . 118.95 10.07 8.51 Favored Glycine 0 N--CA 1.489 2.199 0 N-CA-C 109.264 -1.534 . . . . 0.0 109.264 -179.946 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 809' ' ' LEU . . . . . . . . . . . . . 9.1 mt -117.61 157.05 27.08 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.255 -1.144 . . . . 0.0 110.191 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 810' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -86.28 -18.61 31.59 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.202 -0.936 . . . . 0.0 110.088 179.987 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 811' ' ' ARG . . . . . . . . . . . . . 26.2 ttp180 -149.79 136.09 19.0 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.323 -0.861 . . . . 0.0 110.087 179.942 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 812' ' ' CYS . . . . . 0.45 ' SG ' ' O ' ' A' ' 805' ' ' LYS . 0.1 OUTLIER -123.98 144.21 49.95 Favored 'General case' 0 C--N 1.298 -1.655 0 O-C-N 121.303 -0.873 . . . . 0.0 110.256 -179.906 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 813' ' ' VAL . . . . . 0.598 HG13 ' O ' ' A' ' 813' ' ' VAL . 7.0 p -137.87 123.15 24.44 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.509 0 O-C-N 121.309 -0.87 . . . . 0.0 109.622 179.888 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 814' ' ' VAL . . . . . . . . . . . . . 36.5 t -131.38 135.81 58.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.135 -0.978 . . . . 0.0 110.393 -179.946 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 815' ' ' ALA . . . . . 0.467 ' O ' ' OD1' ' A' ' 820' ' ' ASN . . . -82.8 146.32 29.02 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.341 -0.849 . . . . 0.0 110.024 179.972 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 816' ' ' ILE . . . . . 0.863 HG23 HG21 ' A' ' 833' ' ' VAL . 18.0 mt -95.58 111.83 26.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.213 -0.93 . . . . 0.0 110.194 -179.995 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 817' ' ' SER . . . . . 0.527 ' CB ' ' HD2' ' A' ' 818' ' ' PRO . 1.0 OUTLIER -161.73 -175.83 0.53 Allowed Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.226 -0.922 . . . . 0.0 110.219 179.937 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 818' ' ' PRO . . . . . 0.527 ' HD2' ' CB ' ' A' ' 817' ' ' SER . 50.2 Cg_endo -78.32 -37.02 0.82 Allowed 'Trans proline' 0 C--N 1.305 -1.711 0 O-C-N 124.02 1.537 . . . . 0.0 110.893 -179.853 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 819' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -83.49 22.93 0.99 Allowed 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.113 -0.992 . . . . 0.0 110.826 -179.991 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 820' ' ' ASN . . . . . 0.467 ' OD1' ' O ' ' A' ' 815' ' ' ALA . 0.7 OUTLIER -117.0 -15.01 10.61 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.11 -0.994 . . . . 0.0 110.169 179.939 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 821' ' ' PHE . . . . . . . . . . . . . 39.4 m-85 -128.01 -74.19 0.58 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.154 -0.966 . . . . 0.0 110.621 179.987 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 822' ' ' GLY . . . . . . . . . . . . . . . -163.17 50.84 0.31 Allowed Glycine 0 N--CA 1.493 2.477 0 N-CA-C 109.778 -1.329 . . . . 0.0 109.778 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 823' ' ' GLY . . . . . . . . . . . . . . . 72.76 -126.82 11.02 Favored Glycine 0 N--CA 1.492 2.393 0 N-CA-C 109.661 -1.376 . . . . 0.0 109.661 179.944 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 824' ' ' ASP . . . . . 0.41 ' O ' ' OD2' ' A' ' 824' ' ' ASP . 1.5 p30 -127.17 134.97 26.72 Favored Pre-proline 0 N--CA 1.494 1.742 0 O-C-N 121.241 -1.152 . . . . 0.0 110.32 179.986 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 825' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -78.95 -90.76 0.0 OUTLIER 'Trans proline' 0 C--N 1.307 -1.64 0 O-C-N 124.053 1.554 . . . . 0.0 110.616 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 826' ' ' CYS . . . . . 0.452 ' HA ' ' HD3' ' A' ' 827' ' ' PRO . 24.3 p -115.39 138.26 23.58 Favored Pre-proline 0 N--CA 1.496 1.851 0 O-C-N 121.21 -0.931 . . . . 0.0 111.067 -179.897 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 827' ' ' PRO . . . . . 0.469 ' O ' ' HB2' ' A' ' 828' ' ' GLU . 54.9 Cg_endo -85.16 -178.91 3.32 Favored 'Trans proline' 0 C--N 1.306 -1.687 0 O-C-N 124.121 1.59 . . . . 0.0 110.057 179.915 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 828' ' ' GLU . . . . . 0.469 ' HB2' ' O ' ' A' ' 827' ' ' PRO . 50.6 mt-10 57.88 17.38 4.24 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.566 -0.709 . . . . 0.0 111.042 179.937 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 829' ' ' VAL . . . . . 0.466 HG11 HG21 ' A' ' 780' ' ' THR . 72.4 t -130.4 141.42 46.33 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 O-C-N 121.079 -1.013 . . . . 0.0 110.023 179.844 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 830' ' ' MET . . . . . 0.463 ' O ' ' O ' ' A' ' 829' ' ' VAL . 0.0 OUTLIER -51.21 -175.75 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.195 -0.94 . . . . 0.0 110.126 -179.975 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 831' ' ' LYS . . . . . . . . . . . . . 9.7 mttp -142.29 108.23 5.17 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.025 -1.047 . . . . 0.0 110.896 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 832' ' ' ARG . . . . . . . . . . . . . 5.9 mtp180 -129.88 147.42 51.65 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.444 -0.785 . . . . 0.0 109.483 179.957 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 833' ' ' VAL . . . . . 0.863 HG21 HG23 ' A' ' 816' ' ' ILE . 92.6 t -120.15 117.57 53.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.024 -1.047 . . . . 0.0 110.731 -179.942 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 834' ' ' ALA . . . . . 0.493 ' HB1' ' CZ ' ' A' ' 788' ' ' PHE . . . -112.99 127.92 56.36 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.284 -0.885 . . . . 0.0 109.847 179.917 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 835' ' ' VAL . . . . . 0.467 ' CG1' ' N ' ' A' ' 836' ' ' GLU . 14.9 t -126.11 165.69 23.61 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 121.11 -0.994 . . . . 0.0 110.577 -179.916 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 836' ' ' GLU . . . . . 0.467 ' N ' ' CG1' ' A' ' 835' ' ' VAL . 0.1 OUTLIER -152.88 109.69 3.46 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.377 -0.827 . . . . 0.0 109.657 -179.939 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 837' ' ' ALA . . . . . . . . . . . . . . . -111.18 162.01 15.38 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.171 -0.956 . . . . 0.0 110.532 -179.979 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 838' ' ' VAL . . . . . 0.517 ' HA ' ' HA3' ' A' ' 730' ' ' GLY . 39.1 t -120.02 132.87 68.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.321 -0.862 . . . . 0.0 110.07 -179.96 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 839' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -118.18 136.89 53.35 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.222 -0.924 . . . . 0.0 110.149 -179.976 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 840' ' ' SER . . . . . 0.44 ' O ' ' HG2' ' A' ' 768' ' ' GLN . 91.4 p -106.23 -145.01 0.38 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.161 -0.962 . . . . 0.0 110.031 179.975 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 841' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.494 1.727 0 O-C-N 121.062 -1.024 . . . . 0.0 110.299 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 728' ' ' VAL . . . . . 0.512 ' O ' ' CB ' ' A' ' 729' ' ' SER . 74.6 t . . . . . 0 N--CA 1.492 1.627 0 CA-C-O 121.026 0.441 . . . . 0.0 110.075 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 729' ' ' SER . . . . . 0.512 ' CB ' ' O ' ' A' ' 728' ' ' VAL . 0.3 OUTLIER 166.65 126.52 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.104 0 O-C-N 121.326 -0.859 . . . . 0.0 110.304 -179.987 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 730' ' ' GLY . . . . . 0.437 ' C ' ' CG2' ' A' ' 731' ' ' VAL . . . 142.78 76.57 0.04 OUTLIER Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.741 -1.344 . . . . 0.0 109.741 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 731' ' ' VAL . . . . . 0.437 ' CG2' ' C ' ' A' ' 730' ' ' GLY . 3.1 t -147.6 135.58 14.74 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 121.178 -1.189 . . . . 0.0 110.14 179.994 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 732' ' ' CYS . . . . . . . . . . . . . 30.4 p -153.3 138.27 17.22 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.235 -0.915 . . . . 0.0 110.094 -179.961 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 733' ' ' ALA . . . . . . . . . . . . . . . -111.92 131.21 55.52 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.266 -0.896 . . . . 0.0 110.397 179.992 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 734' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -119.7 105.37 11.1 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.296 -0.878 . . . . 0.0 110.037 179.941 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 735' ' ' VAL . . . . . 0.423 HG12 ' N ' ' A' ' 736' ' ' SER . 61.1 t -128.42 162.83 34.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.151 -0.968 . . . . 0.0 110.298 -179.942 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 736' ' ' SER . . . . . 0.423 ' N ' HG12 ' A' ' 735' ' ' VAL . 6.6 p -109.17 -165.75 1.05 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.206 -0.934 . . . . 0.0 110.007 -179.962 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 737' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.495 1.813 0 O-C-N 121.266 -0.896 . . . . 0.0 110.731 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 757' ' ' THR . . . . . . . . . . . . . 37.2 p . . . . . 0 N--CA 1.505 2.306 0 CA-C-O 121.872 0.844 . . . . 0.0 112.285 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 758' ' ' ALA . . . . . . . . . . . . . . . -109.75 179.04 4.24 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.753 -0.592 . . . . 0.0 109.703 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 759' ' ' LYS . . . . . . . . . . . . . 18.0 mtpt -141.77 150.72 42.11 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.062 -1.024 . . . . 0.0 110.946 179.979 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 760' ' ' VAL . . . . . . . . . . . . . 5.4 t -108.06 131.42 58.5 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 179.884 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 761' ' ' HIS . . . . . . . . . . . . . 3.7 m170 -117.35 103.77 10.47 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.998 -1.064 . . . . 0.0 111.575 -179.878 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 762' ' ' LEU . . . . . 0.538 ' HB2' ' HB3' ' A' ' 812' ' ' CYS . 0.2 OUTLIER -109.43 103.11 11.96 Favored 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 179.818 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 763' ' ' LYS . . . . . . . . . . . . . 9.5 ttmt -109.95 165.53 11.65 Favored 'General case' 0 N--CA 1.5 2.073 0 O-C-N 121.096 -1.002 . . . . 0.0 111.766 -179.729 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 764' ' ' CYS . . . . . . . . . . . . . 7.9 m -132.18 175.58 9.13 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.705 -0.622 . . . . 0.0 109.837 179.893 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 765' ' ' ALA . . . . . 0.704 ' HB1' ' HD2' ' A' ' 766' ' ' PRO . . . -71.25 171.66 8.26 Favored Pre-proline 0 N--CA 1.495 1.789 0 O-C-N 121.181 -0.95 . . . . 0.0 109.946 179.937 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 766' ' ' PRO . . . . . 0.704 ' HD2' ' HB1' ' A' ' 765' ' ' ALA . 46.1 Cg_endo -72.47 129.03 14.22 Favored 'Trans proline' 0 C--N 1.306 -1.66 0 O-C-N 123.849 1.447 . . . . 0.0 110.159 179.99 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 767' ' ' GLY . . . . . . . . . . . . . . . 89.53 11.38 64.25 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.349 -1.5 . . . . 0.0 109.349 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 768' ' ' GLN . . . . . . . . . . . . . 2.7 mt-30 -129.1 135.07 48.4 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.304 -1.115 . . . . 0.0 110.216 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 769' ' ' THR . . . . . 0.53 ' CG2' ' HG3' ' A' ' 810' ' ' GLU . 7.7 p -133.31 147.56 51.88 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.204 -0.935 . . . . 0.0 110.32 179.958 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 770' ' ' ILE . . . . . 0.467 HD13 ' SG ' ' A' ' 806' ' ' CYS . 4.3 mt -64.35 149.46 11.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.253 -0.904 . . . . 0.0 109.454 179.997 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 771' ' ' SER . . . . . 0.466 ' O ' ' HB2' ' A' ' 772' ' ' ALA . 24.4 p -134.34 1.05 3.14 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 120.955 -1.09 . . . . 0.0 110.717 -179.88 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 772' ' ' ALA . . . . . 0.466 ' HB2' ' O ' ' A' ' 771' ' ' SER . . . -177.49 132.1 0.16 Allowed 'General case' 0 N--CA 1.495 1.779 0 O-C-N 120.998 -1.064 . . . . 0.0 111.111 -179.964 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 773' ' ' ILE . . . . . . . . . . . . . 32.5 mm -87.65 124.24 40.8 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 O-C-N 121.327 -0.858 . . . . 0.0 109.673 179.919 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 774' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.32 -40.19 18.24 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.186 -0.946 . . . . 0.0 110.725 -179.978 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 775' ' ' PHE . . . . . 0.728 ' O ' ' HB2' ' A' ' 776' ' ' ALA . 75.5 t80 -145.58 162.97 36.22 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.031 -1.043 . . . . 0.0 110.942 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 776' ' ' ALA . . . . . 0.728 ' HB2' ' O ' ' A' ' 775' ' ' PHE . . . 167.13 117.79 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.425 -0.797 . . . . 0.0 109.715 179.98 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 777' ' ' SER . . . . . 0.493 ' HA ' ' OG ' ' A' ' 798' ' ' SER . 17.2 m -151.29 136.33 17.43 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.992 -1.068 . . . . 0.0 110.775 -179.953 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 778' ' ' PHE . . . . . . . . . . . . . 46.7 t80 -103.61 107.17 17.91 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.387 -0.821 . . . . 0.0 110.101 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 779' ' ' GLY . . . . . . . . . . . . . . . 162.82 -101.45 0.19 Allowed Glycine 0 N--CA 1.492 2.43 0 N-CA-C 109.514 -1.434 . . . . 0.0 109.514 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 780' ' ' THR . . . . . . . . . . . . . 53.8 p -134.52 101.54 11.97 Favored Pre-proline 0 N--CA 1.495 1.79 0 O-C-N 121.243 -1.151 . . . . 0.0 110.201 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 781' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -77.8 148.07 25.07 Favored 'Trans proline' 0 C--N 1.306 -1.69 0 O-C-N 123.935 1.492 . . . . 0.0 110.593 -179.97 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 782' ' ' LEU . . . . . 0.494 ' HA ' HD23 ' A' ' 782' ' ' LEU . 7.3 mt -108.02 79.42 1.27 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.308 -0.87 . . . . 0.0 109.75 179.973 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 783' ' ' GLY . . . . . . . . . . . . . . . 123.38 -174.52 16.58 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 108.911 -1.675 . . . . 0.0 108.911 -179.929 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 784' ' ' THR . . . . . . . . . . . . . 37.9 p -122.61 -161.35 0.94 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.1 -1.235 . . . . 0.0 110.287 179.933 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 785' ' ' CYS . . . . . 0.52 ' HA ' ' CE1' ' A' ' 788' ' ' PHE . 6.8 t -57.32 92.94 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.186 -0.946 . . . . 0.0 110.263 179.955 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 786' ' ' GLY . . . . . . . . . . . . . . . 151.48 -28.22 0.96 Allowed Glycine 0 N--CA 1.492 2.388 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 -179.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 787' ' ' THR . . . . . 0.757 HG22 ' O ' ' A' ' 787' ' ' THR . 51.5 m -143.61 30.29 1.36 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.297 -1.12 . . . . 0.0 110.141 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 788' ' ' PHE . . . . . 0.52 ' CE1' ' HA ' ' A' ' 785' ' ' CYS . 6.2 m-85 -51.16 155.03 1.41 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.238 -0.914 . . . . 0.0 110.285 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 789' ' ' GLN . . . . . 0.458 ' HB2' ' O ' ' A' ' 788' ' ' PHE . 1.1 tp60 -177.82 124.84 0.12 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.392 -0.817 . . . . 0.0 110.234 179.977 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 790' ' ' GLN . . . . . 0.438 ' C ' ' O ' ' A' ' 789' ' ' GLN . 1.4 mt-30 -40.16 123.54 1.71 Allowed 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.451 -0.78 . . . . 0.0 110.383 -179.969 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 791' ' ' GLY . . . . . . . . . . . . . . . -74.95 -132.03 0.27 Allowed Glycine 0 N--CA 1.491 2.362 0 N-CA-C 109.332 -1.507 . . . . 0.0 109.332 179.905 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 792' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -106.92 3.47 26.23 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.165 -1.197 . . . . 0.0 110.197 179.971 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 793' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -141.08 118.91 11.76 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.326 -0.859 . . . . 0.0 110.008 -179.991 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 794' ' ' HIS . . . . . 0.457 ' CE1' ' OG ' ' A' ' 798' ' ' SER . 81.8 t60 -138.07 148.13 44.74 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.294 -0.879 . . . . 0.0 110.148 -179.987 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 795' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -76.8 -136.53 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.296 -0.878 . . . . 0.0 109.66 179.996 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 796' ' ' ILE . . . . . . . . . . . . . 3.8 pt -146.1 12.04 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 O-C-N 121.09 -1.006 . . . . 0.0 110.044 179.905 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 797' ' ' ASN . . . . . . . . . . . . . 7.5 p30 -150.6 30.0 0.67 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.383 -0.823 . . . . 0.0 109.722 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 798' ' ' SER . . . . . 0.496 ' HB3' ' O ' ' A' ' 776' ' ' ALA . 0.7 OUTLIER -57.61 -27.43 62.75 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.522 -0.736 . . . . 0.0 111.102 -179.943 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 799' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -100.83 -22.27 14.89 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 120.924 -1.11 . . . . 0.0 110.501 -179.898 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 800' ' ' SER . . . . . . . . . . . . . 47.4 t -69.45 -18.69 63.75 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.121 -0.987 . . . . 0.0 110.324 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 801' ' ' VAL . . . . . . . . . . . . . 94.2 t -84.45 -46.56 17.75 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 121.23 -0.919 . . . . 0.0 110.863 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 802' ' ' LEU . . . . . 0.527 HD22 ' N ' ' A' ' 802' ' ' LEU . 4.1 mm? -72.6 -42.98 63.94 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.18 -0.95 . . . . 0.0 111.019 -179.946 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 803' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -51.61 -31.12 23.78 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.046 -1.034 . . . . 0.0 110.648 -179.955 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 804' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -92.34 -21.38 20.29 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.105 -0.997 . . . . 0.0 111.279 -179.949 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 805' ' ' LYS . . . . . 0.471 ' O ' ' SG ' ' A' ' 812' ' ' CYS . 0.9 OUTLIER -111.92 28.75 8.47 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 120.912 -1.118 . . . . 0.0 111.216 -179.864 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 806' ' ' CYS . . . . . 0.467 ' SG ' HD13 ' A' ' 770' ' ' ILE . 0.1 OUTLIER -152.92 -74.46 0.13 Allowed 'General case' 0 N--CA 1.497 1.895 0 O-C-N 120.914 -1.116 . . . . 0.0 111.055 179.984 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 807' ' ' ILE . . . . . 0.418 ' C ' ' O ' ' A' ' 806' ' ' CYS . 29.3 mt -41.65 121.36 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.192 -0.943 . . . . 0.0 110.901 -179.883 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 808' ' ' GLY . . . . . 0.439 ' C ' ' HG ' ' A' ' 809' ' ' LEU . . . 99.0 13.45 39.71 Favored Glycine 0 N--CA 1.492 2.432 0 N-CA-C 110.369 -1.092 . . . . 0.0 110.369 179.94 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 809' ' ' LEU . . . . . 0.439 ' HG ' ' C ' ' A' ' 808' ' ' GLY . 91.9 mt -143.3 132.82 23.57 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 120.992 -1.299 . . . . 0.0 110.496 179.982 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 810' ' ' GLU . . . . . 0.53 ' HG3' ' CG2' ' A' ' 769' ' ' THR . 1.0 OUTLIER -63.46 -30.61 71.71 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.271 -0.893 . . . . 0.0 109.383 -179.969 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 811' ' ' ARG . . . . . 0.528 ' HB3' ' NH2' ' A' ' 811' ' ' ARG . 0.5 OUTLIER -117.85 156.6 28.11 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.618 -0.676 . . . . 0.0 109.886 179.958 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 812' ' ' CYS . . . . . 0.538 ' HB3' ' HB2' ' A' ' 762' ' ' LEU . 3.4 t -131.37 137.25 48.64 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.238 -0.914 . . . . 0.0 110.646 -179.925 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 813' ' ' VAL . . . . . 0.672 HG13 ' O ' ' A' ' 813' ' ' VAL . 8.6 p -139.17 119.28 14.38 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.326 -0.859 . . . . 0.0 109.687 179.932 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 814' ' ' VAL . . . . . 0.441 HG21 HD11 ' A' ' 802' ' ' LEU . 38.6 t -128.52 165.58 27.77 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.233 -0.917 . . . . 0.0 110.537 -179.974 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 815' ' ' ALA . . . . . 0.438 ' N ' HG12 ' A' ' 814' ' ' VAL . . . -122.76 147.16 46.83 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.356 -0.84 . . . . 0.0 109.504 179.97 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 816' ' ' ILE . . . . . . . . . . . . . 88.2 mt -105.2 116.2 48.54 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 O-C-N 121.067 -1.02 . . . . 0.0 110.558 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 817' ' ' SER . . . . . 0.425 ' HB2' ' HD2' ' A' ' 818' ' ' PRO . 1.4 p -164.13 169.4 8.16 Favored Pre-proline 0 N--CA 1.492 1.66 0 O-C-N 121.334 -0.854 . . . . 0.0 110.123 179.95 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 818' ' ' PRO . . . . . 0.425 ' HD2' ' HB2' ' A' ' 817' ' ' SER . 43.4 Cg_endo -69.12 -16.54 40.34 Favored 'Trans proline' 0 C--N 1.304 -1.802 0 O-C-N 123.976 1.514 . . . . 0.0 110.504 179.993 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 819' ' ' SER . . . . . . . . . . . . . 14.5 p -106.54 31.7 5.04 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.151 -0.968 . . . . 0.0 110.345 -179.974 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 820' ' ' ASN . . . . . . . . . . . . . 7.8 t-20 -113.53 -28.13 7.63 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.26 -0.9 . . . . 0.0 110.283 -179.974 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 821' ' ' PHE . . . . . . . . . . . . . 94.6 m-85 -116.19 -77.82 0.57 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.25 -0.906 . . . . 0.0 110.471 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 822' ' ' GLY . . . . . . . . . . . . . . . -152.72 42.69 0.67 Allowed Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.643 -1.383 . . . . 0.0 109.643 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 823' ' ' GLY . . . . . 0.414 ' HA2' ' O ' ' A' ' 818' ' ' PRO . . . 85.95 -117.81 4.68 Favored Glycine 0 N--CA 1.492 2.408 0 N-CA-C 109.464 -1.455 . . . . 0.0 109.464 179.993 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 824' ' ' ASP . . . . . . . . . . . . . 6.6 t0 -137.92 105.88 8.14 Favored Pre-proline 0 N--CA 1.493 1.721 0 O-C-N 121.199 -1.177 . . . . 0.0 110.282 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 825' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -74.83 -60.72 0.04 OUTLIER 'Trans proline' 0 C--N 1.307 -1.623 0 O-C-N 124.086 1.571 . . . . 0.0 110.687 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 826' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -109.83 100.44 42.89 Favored Pre-proline 0 N--CA 1.499 2.007 0 O-C-N 121.109 -0.994 . . . . 0.0 110.65 -179.949 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 827' ' ' PRO . . . . . 0.622 ' O ' HG23 ' A' ' 829' ' ' VAL . 48.9 Cg_endo -83.33 166.89 13.98 Favored 'Trans proline' 0 C--N 1.305 -1.718 0 O-C-N 124.039 1.547 . . . . 0.0 110.459 179.925 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 828' ' ' GLU . . . . . . . . . . . . . 10.2 mm-40 48.53 42.4 18.78 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.227 -0.921 . . . . 0.0 110.355 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 829' ' ' VAL . . . . . 0.622 HG23 ' O ' ' A' ' 827' ' ' PRO . 44.2 t -139.83 145.46 26.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.222 -0.924 . . . . 0.0 110.205 -179.996 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 830' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -51.15 99.49 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.175 -0.953 . . . . 0.0 110.215 179.962 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 831' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -71.69 132.69 44.91 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.223 -0.923 . . . . 0.0 110.711 -179.941 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 832' ' ' ARG . . . . . . . . . . . . . 2.5 ttt180 -150.64 149.7 30.19 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.536 -0.727 . . . . 0.0 109.397 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 833' ' ' VAL . . . . . . . . . . . . . 71.9 t -118.68 140.95 40.58 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 120.994 -1.067 . . . . 0.0 111.113 -179.899 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 834' ' ' ALA . . . . . 0.648 ' O ' HG23 ' A' ' 835' ' ' VAL . . . -143.61 136.88 27.9 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.551 -0.718 . . . . 0.0 109.384 179.911 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 835' ' ' VAL . . . . . 0.648 HG23 ' O ' ' A' ' 834' ' ' ALA . 23.6 t -156.36 145.53 11.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 120.937 -1.102 . . . . 0.0 111.484 -179.9 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 836' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -135.18 128.11 31.41 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 179.864 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 837' ' ' ALA . . . . . . . . . . . . . . . -116.6 161.76 18.66 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.96 -1.087 . . . . 0.0 111.32 -179.892 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 838' ' ' VAL . . . . . . . . . . . . . 66.2 t -109.78 114.57 47.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.663 -0.648 . . . . 0.0 109.539 179.942 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 839' ' ' CYS . . . . . 0.478 ' O ' ' O ' ' A' ' 728' ' ' VAL . 0.1 OUTLIER -108.96 144.22 37.2 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.019 -1.051 . . . . 0.0 110.88 -179.968 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 840' ' ' SER . . . . . . . . . . . . . 79.8 p -171.52 178.67 3.1 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.42 -0.8 . . . . 0.0 110.037 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 841' ' ' THR . . . . . . . . . . . . . 11.1 p . . . . . 0 N--CA 1.495 1.78 0 O-C-N 121.159 -0.963 . . . . 0.0 110.178 -179.975 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 728' ' ' VAL . . . . . . . . . . . . . 35.8 m . . . . . 0 N--CA 1.492 1.645 0 CA-C-O 121.216 0.532 . . . . 0.0 110.057 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 729' ' ' SER . . . . . . . . . . . . . 24.4 m -128.48 -154.17 0.62 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.26 -0.9 . . . . 0.0 110.269 -179.949 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 730' ' ' GLY . . . . . . . . . . . . . . . -148.27 111.01 0.52 Allowed Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 179.967 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 731' ' ' VAL . . . . . . . . . . . . . 41.3 t -114.22 151.96 15.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.196 -1.179 . . . . 0.0 110.457 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 732' ' ' CYS . . . . . 0.404 ' HA ' ' O ' ' A' ' 835' ' ' VAL . 14.1 p -159.91 143.91 14.49 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.431 -0.793 . . . . 0.0 109.536 -179.968 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 733' ' ' ALA . . . . . . . . . . . . . . . -121.52 136.37 54.96 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.121 -0.987 . . . . 0.0 110.434 -179.953 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 734' ' ' ASP . . . . . 0.424 ' CG ' ' O ' ' A' ' 734' ' ' ASP . 5.2 p-10 -123.73 106.15 10.28 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.273 -0.892 . . . . 0.0 109.94 179.953 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 735' ' ' VAL . . . . . . . . . . . . . 5.7 t -132.12 128.86 59.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.181 -0.949 . . . . 0.0 110.277 -179.967 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 736' ' ' SER . . . . . . . . . . . . . 4.8 p -69.65 158.98 34.29 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.308 -0.87 . . . . 0.0 110.128 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 737' ' ' GLU . . . . . . . . . . . . . 7.7 tm-20 . . . . . 0 N--CA 1.493 1.705 0 O-C-N 121.269 -0.894 . . . . 0.0 110.187 -179.984 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 757' ' ' THR . . . . . . . . . . . . . 1.2 p . . . . . 0 N--CA 1.494 1.761 0 CA-C-O 121.279 0.562 . . . . 0.0 110.219 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 758' ' ' ALA . . . . . . . . . . . . . . . -119.97 171.71 8.25 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.327 -0.858 . . . . 0.0 109.856 179.952 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 759' ' ' LYS . . . . . 0.469 ' HG2' ' HA ' ' A' ' 815' ' ' ALA . 18.2 mttm -142.87 161.07 39.07 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.195 -0.941 . . . . 0.0 110.571 179.989 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 760' ' ' VAL . . . . . 1.001 ' CG2' HD11 ' A' ' 816' ' ' ILE . 11.5 t -112.52 155.57 13.74 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.408 -0.808 . . . . 0.0 109.388 179.93 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 761' ' ' HIS . . . . . 0.456 ' CD2' HG22 ' A' ' 813' ' ' VAL . 0.9 OUTLIER -133.34 119.74 20.11 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.957 -1.089 . . . . 0.0 111.024 179.995 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 762' ' ' LEU . . . . . . . . . . . . . 8.1 mt -114.54 134.78 54.77 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.484 -0.76 . . . . 0.0 109.561 179.935 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 763' ' ' LYS . . . . . . . . . . . . . 6.7 tttm -142.35 125.43 16.3 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.023 -1.048 . . . . 0.0 110.588 179.915 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 764' ' ' CYS . . . . . 0.471 ' O ' ' OE2' ' A' ' 810' ' ' GLU . 0.1 OUTLIER -104.41 -173.25 2.26 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.467 -0.77 . . . . 0.0 109.765 179.949 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 765' ' ' ALA . . . . . . . . . . . . . . . -66.05 148.93 98.16 Favored Pre-proline 0 C--N 1.296 -1.754 0 O-C-N 121.27 -0.894 . . . . 0.0 110.298 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 766' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -72.34 96.39 0.81 Allowed 'Trans proline' 0 C--N 1.307 -1.622 0 O-C-N 123.991 1.521 . . . . 0.0 110.293 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 767' ' ' GLY . . . . . . . . . . . . . . . 141.65 -21.55 2.53 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 108.907 -1.677 . . . . 0.0 108.907 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 768' ' ' GLN . . . . . 0.41 ' O ' ' HG2' ' A' ' 810' ' ' GLU . 23.5 mt-30 -110.86 145.84 37.54 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.472 -1.016 . . . . 0.0 109.688 179.905 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 769' ' ' THR . . . . . . . . . . . . . 82.3 p -121.95 146.61 46.97 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.234 -0.916 . . . . 0.0 110.669 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 770' ' ' ILE . . . . . . . . . . . . . 21.3 mt -49.62 142.82 2.13 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 121.395 -0.816 . . . . 0.0 109.669 179.898 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 771' ' ' SER . . . . . 0.655 ' O ' ' HB2' ' A' ' 772' ' ' ALA . 22.0 p -124.56 -5.45 7.62 Favored 'General case' 0 C--N 1.299 -1.597 0 O-C-N 121.092 -1.005 . . . . 0.0 110.724 -179.903 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 772' ' ' ALA . . . . . 0.655 ' HB2' ' O ' ' A' ' 771' ' ' SER . . . 174.62 146.62 0.07 Allowed 'General case' 0 N--CA 1.492 1.653 0 C-N-CA 118.879 -1.128 . . . . 0.0 111.949 -179.986 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 773' ' ' ILE . . . . . . . . . . . . . 11.7 mm -108.16 149.0 11.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 179.819 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 774' ' ' LYS . . . . . . . . . . . . . 66.8 mttt -132.35 -18.45 2.54 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.509 -1.369 . . . . 0.0 112.206 -179.801 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 775' ' ' PHE . . . . . 0.739 ' O ' ' HB2' ' A' ' 776' ' ' ALA . 43.2 t80 -140.09 168.69 19.23 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.58 -1.325 . . . . 0.0 110.999 -179.904 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 776' ' ' ALA . . . . . 0.739 ' HB2' ' O ' ' A' ' 775' ' ' PHE . . . 164.15 125.87 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.818 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 -179.991 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 777' ' ' SER . . . . . 0.572 ' HA ' ' CE1' ' A' ' 794' ' ' HIS . 0.5 OUTLIER -148.94 106.21 3.62 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.956 -1.09 . . . . 0.0 111.522 -179.906 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 778' ' ' PHE . . . . . 0.411 ' CE2' ' SD ' ' A' ' 830' ' ' MET . 89.6 t80 -85.76 123.94 31.71 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.125 -0.984 . . . . 0.0 109.539 179.908 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 779' ' ' GLY . . . . . 0.523 ' O ' ' HB2' ' A' ' 832' ' ' ARG . . . 138.15 -107.07 0.55 Allowed Glycine 0 N--CA 1.493 2.473 0 C-N-CA 119.496 -1.335 . . . . 0.0 109.99 179.998 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 780' ' ' THR . . . . . . . . . . . . . 35.1 p -133.19 88.16 36.79 Favored Pre-proline 0 N--CA 1.494 1.768 0 O-C-N 120.85 -1.382 . . . . 0.0 111.028 -179.893 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 781' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_endo -83.35 177.72 6.26 Favored 'Trans proline' 0 C--N 1.308 -1.565 0 O-C-N 123.938 1.494 . . . . 0.0 110.534 179.878 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 782' ' ' LEU . . . . . 0.545 ' CD1' ' HA2' ' A' ' 791' ' ' GLY . 1.0 OUTLIER -135.93 174.74 10.28 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.202 -0.936 . . . . 0.0 110.257 179.951 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 783' ' ' GLY . . . . . . . . . . . . . . . 59.34 -166.07 9.08 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.864 -1.295 . . . . 0.0 109.864 179.935 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 784' ' ' THR . . . . . 0.564 HG23 ' N ' ' A' ' 785' ' ' CYS . 9.3 t -133.3 -128.02 0.17 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.373 -1.075 . . . . 0.0 109.904 179.934 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 785' ' ' CYS . . . . . 0.564 ' N ' HG23 ' A' ' 784' ' ' THR . 1.9 t -92.84 96.58 10.22 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 120.752 -1.218 . . . . 0.0 110.206 -179.967 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 786' ' ' GLY . . . . . . . . . . . . . . . 139.72 -24.68 2.74 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.383 -1.487 . . . . 0.0 109.383 179.982 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 787' ' ' THR . . . . . 0.732 HG22 ' O ' ' A' ' 787' ' ' THR . 99.8 m -139.72 37.95 2.01 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.18 -1.188 . . . . 0.0 110.142 179.964 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 788' ' ' PHE . . . . . 0.572 ' HB3' ' CE2' ' A' ' 775' ' ' PHE . 0.3 OUTLIER -65.75 116.97 7.5 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.304 -0.873 . . . . 0.0 109.899 179.92 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 789' ' ' GLN . . . . . . . . . . . . . 5.3 tm0? -119.11 153.04 35.45 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.252 -0.905 . . . . 0.0 110.261 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 790' ' ' GLN . . . . . . . . . . . . . 4.1 tt0 -73.05 120.74 19.1 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.293 -0.879 . . . . 0.0 110.12 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 791' ' ' GLY . . . . . 0.545 ' HA2' ' CD1' ' A' ' 782' ' ' LEU . . . -74.21 -116.0 0.08 OUTLIER Glycine 0 N--CA 1.494 2.509 0 N-CA-C 109.867 -1.293 . . . . 0.0 109.867 -179.942 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 792' ' ' GLU . . . . . . . . . . . . . 19.8 mt-10 -118.99 -23.82 6.75 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.225 -1.162 . . . . 0.0 110.35 -179.989 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 793' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -122.88 121.85 37.19 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.165 -0.96 . . . . 0.0 110.507 -179.936 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 794' ' ' HIS . . . . . 0.572 ' CE1' ' HA ' ' A' ' 777' ' ' SER . 24.2 t60 -149.06 149.35 30.95 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.292 -0.88 . . . . 0.0 109.789 -180.0 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 795' ' ' SER . . . . . 0.473 ' O ' ' NE2' ' A' ' 794' ' ' HIS . 17.1 t -91.94 149.2 21.67 Favored 'General case' 0 C--N 1.299 -1.626 0 O-C-N 121.276 -0.89 . . . . 0.0 109.618 179.889 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 796' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -87.89 15.42 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 O-C-N 121.174 -0.953 . . . . 0.0 110.017 -179.918 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 797' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 -125.59 27.02 6.59 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.387 -0.82 . . . . 0.0 109.714 179.927 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 798' ' ' SER . . . . . 0.567 ' HB3' ' HB3' ' A' ' 776' ' ' ALA . 0.5 OUTLIER -68.25 -35.03 77.28 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.479 -0.763 . . . . 0.0 111.005 179.933 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 799' ' ' ASN . . . . . 0.511 ' N ' ' OD1' ' A' ' 799' ' ' ASN . 1.3 m120 -100.62 11.78 38.77 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.104 -0.997 . . . . 0.0 111.175 -179.859 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 800' ' ' SER . . . . . . . . . . . . . 75.0 p -93.12 -27.38 16.97 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 120.997 -1.065 . . . . 0.0 110.609 -179.925 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 801' ' ' VAL . . . . . . . . . . . . . 40.2 t -88.99 -19.67 7.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.278 -0.889 . . . . 0.0 110.467 -179.925 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 802' ' ' LEU . . . . . 0.504 ' O ' ' HB2' ' A' ' 806' ' ' CYS . 4.1 mm? -79.48 -48.8 13.28 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.187 -0.945 . . . . 0.0 110.837 179.986 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 803' ' ' GLU . . . . . . . . . . . . . 17.5 mt-10 -64.0 -18.71 64.57 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.001 -1.062 . . . . 0.0 111.036 -179.918 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 804' ' ' ARG . . . . . . . . . . . . . 51.9 ttp180 -92.46 -22.14 19.78 Favored 'General case' 0 C--N 1.297 -1.692 0 O-C-N 121.073 -1.017 . . . . 0.0 112.25 -179.844 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 805' ' ' LYS . . . . . 0.445 ' O ' ' SG ' ' A' ' 806' ' ' CYS . 5.8 tttm -140.12 54.96 1.63 Allowed 'General case' 0 N--CA 1.501 2.115 0 O-C-N 120.444 -1.41 . . . . 0.0 112.537 -179.856 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 806' ' ' CYS . . . . . 0.534 ' HA ' ' CB ' ' A' ' 812' ' ' CYS . 1.2 m -163.73 -50.68 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.801 0 O-C-N 120.842 -1.161 . . . . 0.0 110.319 179.722 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 807' ' ' ILE . . . . . . . . . . . . . 55.5 mt -61.62 129.47 24.6 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 O-C-N 121.112 -0.992 . . . . 0.0 110.156 179.905 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 808' ' ' GLY . . . . . 0.417 ' C ' ' HG ' ' A' ' 809' ' ' LEU . . . 104.76 1.86 42.89 Favored Glycine 0 N--CA 1.492 2.431 0 N-CA-C 109.616 -1.394 . . . . 0.0 109.616 179.957 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 809' ' ' LEU . . . . . 0.417 ' HG ' ' C ' ' A' ' 808' ' ' GLY . 4.2 mt -133.03 144.33 49.98 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.157 -1.202 . . . . 0.0 110.308 179.906 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 810' ' ' GLU . . . . . 0.471 ' OE2' ' O ' ' A' ' 764' ' ' CYS . 3.4 tm-20 -70.43 -20.56 62.9 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.219 -0.926 . . . . 0.0 109.653 180.0 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 811' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -156.47 121.59 4.69 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 179.907 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 812' ' ' CYS . . . . . 0.534 ' CB ' ' HA ' ' A' ' 806' ' ' CYS . 26.1 p -123.1 156.7 34.42 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 120.996 -1.065 . . . . 0.0 111.388 -179.972 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 813' ' ' VAL . . . . . 0.456 HG22 ' CD2' ' A' ' 761' ' ' HIS . 38.8 t -120.43 135.24 61.32 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.624 -0.672 . . . . 0.0 109.632 179.925 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 814' ' ' VAL . . . . . . . . . . . . . 48.2 t -112.41 153.09 14.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.095 -1.003 . . . . 0.0 110.551 -179.927 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 815' ' ' ALA . . . . . 0.821 ' HB3' HD22 ' A' ' 820' ' ' ASN . . . -104.49 118.37 36.43 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.27 -0.893 . . . . 0.0 109.893 179.985 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 816' ' ' ILE . . . . . 1.096 HD13 HG21 ' A' ' 833' ' ' VAL . 25.1 mt -85.25 108.41 17.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.18 -0.95 . . . . 0.0 110.489 -179.945 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 817' ' ' SER . . . . . . . . . . . . . 44.5 p -157.59 165.87 17.79 Favored Pre-proline 0 N--CA 1.494 1.75 0 O-C-N 121.366 -0.834 . . . . 0.0 109.978 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 818' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_endo -79.44 9.9 3.25 Favored 'Trans proline' 0 C--N 1.305 -1.728 0 O-C-N 123.885 1.466 . . . . 0.0 111.037 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 819' ' ' SER . . . . . . . . . . . . . 27.5 t -131.89 12.18 4.77 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.061 -1.025 . . . . 0.0 110.305 -179.932 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 820' ' ' ASN . . . . . 0.821 HD22 ' HB3' ' A' ' 815' ' ' ALA . 45.8 t-20 -114.12 -2.7 13.38 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.266 -0.897 . . . . 0.0 110.052 179.945 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 821' ' ' PHE . . . . . . . . . . . . . 8.1 m-85 -112.38 -79.46 0.58 Allowed 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.324 -0.86 . . . . 0.0 110.238 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 822' ' ' GLY . . . . . . . . . . . . . . . -171.22 54.2 0.18 Allowed Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.619 -1.392 . . . . 0.0 109.619 -179.949 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 823' ' ' GLY . . . . . . . . . . . . . . . 78.38 176.61 47.22 Favored Glycine 0 N--CA 1.492 2.399 0 N-CA-C 109.727 -1.349 . . . . 0.0 109.727 179.936 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 824' ' ' ASP . . . . . . . . . . . . . 15.7 p-10 -70.89 117.47 56.31 Favored Pre-proline 0 N--CA 1.494 1.728 0 O-C-N 121.243 -1.151 . . . . 0.0 110.216 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 825' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -79.59 -65.24 0.02 OUTLIER 'Trans proline' 0 C--N 1.308 -1.565 0 O-C-N 123.97 1.511 . . . . 0.0 110.946 -179.922 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 826' ' ' CYS . . . . . 0.462 ' HB3' ' HB ' ' A' ' 829' ' ' VAL . 22.8 m -97.44 153.64 38.29 Favored Pre-proline 0 N--CA 1.498 1.951 0 O-C-N 121.11 -0.993 . . . . 0.0 110.952 -179.937 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 827' ' ' PRO . . . . . 0.891 ' O ' HG23 ' A' ' 829' ' ' VAL . 50.1 Cg_endo -78.99 95.96 1.08 Allowed 'Trans proline' 0 C--N 1.313 -1.303 0 O-C-N 124.07 1.563 . . . . 0.0 110.673 179.963 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 828' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER 52.41 18.67 0.97 Allowed 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.152 -0.968 . . . . 0.0 110.404 179.923 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 829' ' ' VAL . . . . . 0.891 HG23 ' O ' ' A' ' 827' ' ' PRO . 66.7 t -119.41 80.86 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.198 -0.939 . . . . 0.0 110.223 179.953 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 830' ' ' MET . . . . . 0.464 ' CB ' ' HA2' ' A' ' 779' ' ' GLY . 0.0 OUTLIER -178.43 128.65 0.12 Allowed 'General case' 0 C--N 1.304 -1.381 0 O-C-N 121.131 -0.981 . . . . 0.0 110.777 -179.902 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 831' ' ' LYS . . . . . 0.46 ' O ' ' CG ' ' A' ' 832' ' ' ARG . 2.9 tttm -170.58 57.05 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.391 -0.818 . . . . 0.0 110.093 179.906 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 832' ' ' ARG . . . . . 0.523 ' HB2' ' O ' ' A' ' 779' ' ' GLY . 0.5 OUTLIER -167.62 125.32 1.21 Allowed 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.466 -0.771 . . . . 0.0 109.392 -179.996 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 833' ' ' VAL . . . . . 1.096 HG21 HD13 ' A' ' 816' ' ' ILE . 58.8 t -112.47 103.26 15.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.045 -1.035 . . . . 0.0 111.055 -179.959 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 834' ' ' ALA . . . . . 0.572 ' HB1' ' CZ ' ' A' ' 788' ' ' PHE . . . -111.16 122.02 46.79 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.471 -0.768 . . . . 0.0 109.099 179.928 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 835' ' ' VAL . . . . . 0.404 ' O ' ' HA ' ' A' ' 732' ' ' CYS . 34.7 t -139.3 143.24 31.6 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 O-C-N 120.828 -1.17 . . . . 0.0 111.648 -179.934 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 836' ' ' GLU . . . . . 0.481 ' HB2' ' HB3' ' A' ' 775' ' ' PHE . 1.3 mt-10 -115.5 160.24 20.18 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 179.807 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 837' ' ' ALA . . . . . . . . . . . . . . . -154.64 156.8 37.13 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 120.612 -1.305 . . . . 0.0 111.258 -179.944 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 838' ' ' VAL . . . . . . . . . . . . . 22.0 t -109.24 137.2 42.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.505 -0.747 . . . . 0.0 109.965 179.926 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 839' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -128.32 133.2 48.66 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.142 -0.974 . . . . 0.0 110.132 179.988 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 840' ' ' SER . . . . . . . . . . . . . 24.8 t -159.83 -177.37 6.29 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.281 -0.887 . . . . 0.0 109.939 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 841' ' ' THR . . . . . . . . . . . . . 67.1 p . . . . . 0 N--CA 1.49 1.567 0 O-C-N 121.149 -0.97 . . . . 0.0 109.926 179.981 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 728' ' ' VAL . . . . . 1.002 HG23 ' O ' ' A' ' 839' ' ' CYS . 7.6 p . . . . . 0 N--CA 1.493 1.685 0 CA-C-O 121.288 0.566 . . . . 0.0 110.141 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 729' ' ' SER . . . . . 0.454 ' O ' HG13 ' A' ' 731' ' ' VAL . 0.5 OUTLIER -107.47 90.5 3.32 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.263 -0.898 . . . . 0.0 110.343 179.928 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 730' ' ' GLY . . . . . 0.688 ' O ' HG13 ' A' ' 731' ' ' VAL . . . -44.4 153.25 0.46 Allowed Glycine 0 N--CA 1.492 2.417 0 N-CA-C 109.298 -1.521 . . . . 0.0 109.298 179.996 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 731' ' ' VAL . . . . . 0.688 HG13 ' O ' ' A' ' 730' ' ' GLY . 2.4 m -158.48 120.42 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 121.105 -1.233 . . . . 0.0 110.767 179.937 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 732' ' ' CYS . . . . . . . . . . . . . 26.8 p -116.04 130.86 57.0 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.448 -0.783 . . . . 0.0 109.297 179.902 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 733' ' ' ALA . . . . . . . . . . . . . . . -107.77 160.55 15.64 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.106 -0.996 . . . . 0.0 110.609 -179.878 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 734' ' ' ASP . . . . . 0.526 ' OD2' ' CZ ' ' A' ' 832' ' ' ARG . 0.9 OUTLIER -164.36 105.36 0.86 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.414 -0.804 . . . . 0.0 109.444 179.941 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 735' ' ' VAL . . . . . 0.442 ' O ' ' CG ' ' A' ' 832' ' ' ARG . 37.4 t -116.04 163.39 13.31 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 121.089 -1.007 . . . . 0.0 110.715 -179.939 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 736' ' ' SER . . . . . 0.411 ' N ' HG12 ' A' ' 735' ' ' VAL . 22.5 p -99.16 158.78 15.45 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.425 -0.797 . . . . 0.0 110.029 179.954 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 737' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.493 1.702 0 O-C-N 121.216 -0.927 . . . . 0.0 110.457 179.944 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 757' ' ' THR . . . . . 0.47 ' OG1' ' O ' ' A' ' 816' ' ' ILE . 66.9 p . . . . . 0 N--CA 1.495 1.779 0 CA-C-O 121.364 0.602 . . . . 0.0 110.593 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 758' ' ' ALA . . . . . . . . . . . . . . . -55.85 176.45 0.07 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.412 -0.805 . . . . 0.0 110.052 179.944 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 759' ' ' LYS . . . . . 0.414 ' HG2' ' HA ' ' A' ' 815' ' ' ALA . 9.1 mttp -139.14 167.47 21.98 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.231 -0.918 . . . . 0.0 110.357 179.978 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 760' ' ' VAL . . . . . 0.409 ' HA ' HG21 ' A' ' 735' ' ' VAL . 5.5 t -105.52 162.49 4.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.372 -0.83 . . . . 0.0 109.392 179.919 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 761' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -140.35 105.93 5.11 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 120.846 -1.159 . . . . 0.0 111.261 -179.867 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 762' ' ' LEU . . . . . 0.529 ' HB2' ' HB3' ' A' ' 812' ' ' CYS . 0.5 OUTLIER -110.64 103.23 11.78 Favored 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 179.827 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 763' ' ' LYS . . . . . . . . . . . . . 4.4 ttpt -110.6 135.49 51.15 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.202 -0.936 . . . . 0.0 111.46 -179.812 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 764' ' ' CYS . . . . . 0.483 ' HB2' ' O ' ' A' ' 810' ' ' GLU . 1.3 m -126.63 139.89 52.83 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.533 -0.73 . . . . 0.0 109.568 179.856 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 765' ' ' ALA . . . . . 0.445 ' O ' ' O ' ' A' ' 764' ' ' CYS . . . -39.72 161.16 0.09 OUTLIER Pre-proline 0 N--CA 1.496 1.843 0 O-C-N 121.359 -0.838 . . . . 0.0 110.604 -179.98 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 766' ' ' PRO . . . . . 0.404 ' HD2' ' HB1' ' A' ' 765' ' ' ALA . 43.4 Cg_endo -70.78 113.72 3.63 Favored 'Trans proline' 0 C--N 1.306 -1.706 0 O-C-N 124.121 1.59 . . . . 0.0 110.082 -179.93 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 767' ' ' GLY . . . . . . . . . . . . . . . 118.04 -26.01 8.09 Favored Glycine 0 N--CA 1.488 2.162 0 N-CA-C 108.904 -1.679 . . . . 0.0 108.904 -179.896 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 768' ' ' GLN . . . . . 0.461 ' HA ' ' HA ' ' A' ' 841' ' ' THR . 1.3 tt0 -90.55 119.65 30.99 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.428 -1.042 . . . . 0.0 109.838 179.93 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 769' ' ' THR . . . . . . . . . . . . . 9.4 p -112.22 147.21 36.71 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.227 -0.921 . . . . 0.0 110.474 -179.964 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 770' ' ' ILE . . . . . 0.565 HD12 ' O ' ' A' ' 809' ' ' LEU . 3.5 mp -65.88 145.37 13.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.252 -0.905 . . . . 0.0 109.292 179.946 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 771' ' ' SER . . . . . . . . . . . . . 36.8 p -136.33 -5.45 2.06 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 120.955 -1.091 . . . . 0.0 111.6 -179.923 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 772' ' ' ALA . . . . . . . . . . . . . . . -171.24 148.02 2.59 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 120.608 -1.307 . . . . 0.0 111.941 -179.999 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 773' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -120.48 132.27 70.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 N-CA-C 108.482 -0.932 . . . . 0.0 108.482 179.829 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 774' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -103.4 -34.75 8.62 Favored 'General case' 0 N--CA 1.504 2.239 0 O-C-N 120.995 -1.066 . . . . 0.0 110.342 -179.918 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 775' ' ' PHE . . . . . 0.585 ' O ' ' HB2' ' A' ' 776' ' ' ALA . 52.2 t80 -126.15 152.7 45.61 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 120.925 -1.11 . . . . 0.0 110.15 179.92 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 776' ' ' ALA . . . . . 0.939 ' HB3' ' HB3' ' A' ' 799' ' ' ASN . . . 175.69 105.9 0.02 OUTLIER 'General case' 0 C--N 1.3 -1.564 0 O-C-N 121.425 -0.797 . . . . 0.0 109.664 -179.969 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 777' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -137.6 137.84 38.91 Favored 'General case' 0 C--N 1.299 -1.623 0 O-C-N 121.387 -0.82 . . . . 0.0 109.885 -179.975 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 778' ' ' PHE . . . . . 0.432 ' CD2' HG22 ' A' ' 833' ' ' VAL . 65.3 t80 -112.0 98.58 7.45 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.222 -0.924 . . . . 0.0 110.241 -179.964 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 779' ' ' GLY . . . . . 0.455 ' O ' ' HA ' ' A' ' 831' ' ' LYS . . . 167.85 -93.5 0.11 Allowed Glycine 0 N--CA 1.489 2.197 0 N-CA-C 109.419 -1.472 . . . . 0.0 109.419 179.979 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 780' ' ' THR . . . . . . . . . . . . . 60.6 p -141.11 81.67 15.65 Favored Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 121.273 -1.134 . . . . 0.0 110.253 179.945 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 781' ' ' PRO . . . . . 0.446 ' O ' HD23 ' A' ' 782' ' ' LEU . 44.7 Cg_endo -72.06 154.63 57.57 Favored 'Trans proline' 0 C--N 1.303 -1.818 0 O-C-N 124.02 1.537 . . . . 0.0 110.287 -179.966 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 782' ' ' LEU . . . . . 0.446 HD23 ' O ' ' A' ' 781' ' ' PRO . 21.4 mt -119.59 116.61 26.38 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.285 -0.884 . . . . 0.0 109.966 179.952 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 783' ' ' GLY . . . . . . . . . . . . . . . 111.5 168.21 18.52 Favored Glycine 0 N--CA 1.488 2.114 0 N-CA-C 109.345 -1.502 . . . . 0.0 109.345 -179.903 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 784' ' ' THR . . . . . 0.748 ' O ' HG23 ' A' ' 784' ' ' THR . 14.1 t -152.79 109.22 3.41 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.213 -1.169 . . . . 0.0 110.24 -179.995 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 785' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER 46.88 80.84 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.362 -0.836 . . . . 0.0 110.736 179.964 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 786' ' ' GLY . . . . . . . . . . . . . . . 135.62 -20.58 3.67 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.745 -1.342 . . . . 0.0 109.745 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 787' ' ' THR . . . . . . . . . . . . . 1.9 m -154.86 44.93 0.51 Allowed 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.059 -1.259 . . . . 0.0 110.591 -179.867 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 788' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -69.25 138.99 54.42 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.088 -1.008 . . . . 0.0 109.919 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 789' ' ' GLN . . . . . . . . . . . . . 37.2 tt0 -163.37 134.0 4.55 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.24 -0.913 . . . . 0.0 110.116 179.999 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 790' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -46.35 157.47 0.13 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.386 -0.821 . . . . 0.0 110.236 179.954 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 791' ' ' GLY . . . . . . . . . . . . . . . -113.87 -139.6 7.26 Favored Glycine 0 N--CA 1.489 2.184 0 N-CA-C 109.516 -1.434 . . . . 0.0 109.516 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 792' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -106.62 -30.86 8.75 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.203 -1.175 . . . . 0.0 110.199 179.946 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 793' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -104.3 107.45 18.38 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.271 -0.893 . . . . 0.0 110.191 -179.956 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 794' ' ' HIS . . . . . 0.45 ' CG ' ' N ' ' A' ' 795' ' ' SER . 86.3 t60 -134.01 171.69 13.85 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.223 -0.923 . . . . 0.0 110.489 -179.988 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 795' ' ' SER . . . . . 0.45 ' N ' ' CG ' ' A' ' 794' ' ' HIS . 93.3 p -120.52 -137.37 0.33 Allowed 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.336 -0.852 . . . . 0.0 110.183 179.98 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 796' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -134.81 -29.72 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.96 0 O-C-N 121.108 -0.995 . . . . 0.0 110.806 179.996 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 797' ' ' ASN . . . . . 0.495 ' HA ' ' HB3' ' A' ' 800' ' ' SER . 1.4 m-20 -96.56 26.46 4.43 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.078 -1.014 . . . . 0.0 110.104 -179.973 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 798' ' ' SER . . . . . 0.511 ' HB2' ' O ' ' A' ' 776' ' ' ALA . 0.8 OUTLIER -51.71 -71.32 0.07 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.329 -0.857 . . . . 0.0 110.955 -179.968 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 799' ' ' ASN . . . . . 0.939 ' HB3' ' HB3' ' A' ' 776' ' ' ALA . 51.6 p30 -85.78 -15.59 41.57 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.293 -0.879 . . . . 0.0 111.101 -179.956 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 800' ' ' SER . . . . . 0.514 ' N ' ' OD1' ' A' ' 799' ' ' ASN . 12.9 t -59.18 -41.58 88.8 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.083 -1.01 . . . . 0.0 110.62 -179.966 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 801' ' ' VAL . . . . . . . . . . . . . 34.9 t -72.2 -26.46 24.89 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.14 -0.975 . . . . 0.0 110.505 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 802' ' ' LEU . . . . . 0.496 ' O ' ' HB2' ' A' ' 806' ' ' CYS . 3.4 mm? -74.2 -59.83 2.55 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.257 -0.902 . . . . 0.0 110.641 -179.944 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 803' ' ' GLU . . . . . 0.579 ' HG3' HD12 ' A' ' 807' ' ' ILE . 20.2 tt0 -54.06 -18.45 3.65 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.115 -0.991 . . . . 0.0 110.683 179.887 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 804' ' ' ARG . . . . . . . . . . . . . 56.3 ttt180 -90.08 -27.22 19.81 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.126 -0.984 . . . . 0.0 111.026 -179.914 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 805' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.76 43.97 2.83 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 120.968 -1.083 . . . . 0.0 110.968 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 806' ' ' CYS . . . . . 0.496 ' HB2' ' O ' ' A' ' 802' ' ' LEU . 0.2 OUTLIER -147.51 -72.3 0.21 Allowed 'General case' 0 N--CA 1.494 1.743 0 O-C-N 120.952 -1.092 . . . . 0.0 110.485 179.993 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 807' ' ' ILE . . . . . 0.579 HD12 ' HG3' ' A' ' 803' ' ' GLU . 31.9 mt -47.14 136.58 2.96 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 O-C-N 121.052 -1.03 . . . . 0.0 110.472 -179.955 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 808' ' ' GLY . . . . . 0.401 ' C ' ' HG ' ' A' ' 809' ' ' LEU . . . 93.23 5.52 63.7 Favored Glycine 0 N--CA 1.492 2.387 0 N-CA-C 110.229 -1.148 . . . . 0.0 110.229 179.967 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 809' ' ' LEU . . . . . 0.565 ' O ' HD12 ' A' ' 770' ' ' ILE . 41.5 mt -137.62 135.26 36.42 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.039 -1.271 . . . . 0.0 110.612 -179.987 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 810' ' ' GLU . . . . . 0.483 ' O ' ' HB2' ' A' ' 764' ' ' CYS . 57.3 mm-40 -64.45 -34.16 77.56 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.27 -0.894 . . . . 0.0 108.792 179.94 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 811' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -111.37 165.48 11.93 Favored 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 179.934 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 812' ' ' CYS . . . . . 0.529 ' HB3' ' HB2' ' A' ' 762' ' ' LEU . 49.5 t -159.66 102.28 1.51 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.861 -1.149 . . . . 0.0 110.608 -179.883 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 813' ' ' VAL . . . . . . . . . . . . . 11.9 p -115.8 136.82 51.44 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.178 -0.951 . . . . 0.0 109.981 179.964 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 814' ' ' VAL . . . . . . . . . . . . . 17.7 t -134.4 164.72 33.47 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 O-C-N 121.171 -0.956 . . . . 0.0 110.435 -179.939 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 815' ' ' ALA . . . . . 0.414 ' HA ' ' HG2' ' A' ' 759' ' ' LYS . . . -97.27 157.14 16.11 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.26 -0.9 . . . . 0.0 109.928 179.971 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 816' ' ' ILE . . . . . 0.791 HG23 ' CG2' ' A' ' 833' ' ' VAL . 20.3 mt -117.12 63.62 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.168 -0.957 . . . . 0.0 109.846 179.984 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 817' ' ' SER . . . . . 0.447 ' OG ' ' HB2' ' A' ' 820' ' ' ASN . 0.0 OUTLIER -116.15 165.98 13.56 Favored Pre-proline 0 N--CA 1.494 1.728 0 O-C-N 121.432 -0.792 . . . . 0.0 110.716 -179.875 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 818' ' ' PRO . . . . . 0.473 ' HB2' ' OD1' ' A' ' 824' ' ' ASP . 49.0 Cg_endo -76.92 -44.94 0.19 Allowed 'Trans proline' 0 C--N 1.307 -1.657 0 O-C-N 124.181 1.622 . . . . 0.0 110.573 -179.954 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 819' ' ' SER . . . . . . . . . . . . . 66.3 m -88.46 15.33 8.04 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.271 -0.893 . . . . 0.0 110.238 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 820' ' ' ASN . . . . . 0.447 ' HB2' ' OG ' ' A' ' 817' ' ' SER . 2.1 m120 -101.47 -16.51 16.8 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.225 -0.922 . . . . 0.0 110.449 179.985 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 821' ' ' PHE . . . . . . . . . . . . . 5.2 m-85 -93.32 -91.9 0.18 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.051 -1.031 . . . . 0.0 110.44 179.968 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 822' ' ' GLY . . . . . . . . . . . . . . . -152.97 14.93 0.68 Allowed Glycine 0 N--CA 1.492 2.39 0 C-N-CA 119.551 -1.309 . . . . 0.0 110.266 -179.991 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 823' ' ' GLY . . . . . . . . . . . . . . . 154.74 -170.66 33.07 Favored Glycine 0 N--CA 1.493 2.486 0 O-C-N 121.008 -1.289 . . . . 0.0 110.068 179.941 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 824' ' ' ASP . . . . . 0.473 ' OD1' ' HB2' ' A' ' 818' ' ' PRO . 0.2 OUTLIER -113.33 105.44 55.26 Favored Pre-proline 0 N--CA 1.494 1.73 0 O-C-N 121.379 -1.071 . . . . 0.0 110.14 -179.972 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 825' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -76.31 -64.9 0.02 OUTLIER 'Trans proline' 0 C--N 1.304 -1.775 0 O-C-N 123.994 1.523 . . . . 0.0 110.789 -179.963 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 826' ' ' CYS . . . . . . . . . . . . . 98.3 m -125.19 98.62 35.37 Favored Pre-proline 0 N--CA 1.495 1.794 0 O-C-N 121.119 -0.988 . . . . 0.0 110.414 179.953 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 827' ' ' PRO . . . . . 0.563 ' O ' HG23 ' A' ' 829' ' ' VAL . 50.7 Cg_endo -82.77 153.38 15.09 Favored 'Trans proline' 0 C--N 1.303 -1.847 0 O-C-N 124.062 1.559 . . . . 0.0 110.612 -179.983 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 828' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 62.26 17.85 9.66 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.304 -0.872 . . . . 0.0 110.521 179.995 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 829' ' ' VAL . . . . . 0.563 HG23 ' O ' ' A' ' 827' ' ' PRO . 66.4 t -127.5 111.21 24.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.225 -0.922 . . . . 0.0 110.283 179.981 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 830' ' ' MET . . . . . 0.431 ' C ' ' O ' ' A' ' 829' ' ' VAL . 2.9 mmt -42.41 125.49 3.21 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.278 -0.889 . . . . 0.0 109.672 -179.992 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 831' ' ' LYS . . . . . 0.455 ' HA ' ' O ' ' A' ' 779' ' ' GLY . 1.2 ptpt -128.85 133.62 48.03 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.047 -1.033 . . . . 0.0 111.151 -179.938 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 832' ' ' ARG . . . . . 0.526 ' CZ ' ' OD2' ' A' ' 734' ' ' ASP . 20.2 ttt180 -108.55 158.89 17.16 Favored 'General case' 0 N--CA 1.489 1.475 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 179.946 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 833' ' ' VAL . . . . . 0.791 ' CG2' HG23 ' A' ' 816' ' ' ILE . 8.3 t -111.85 126.68 69.26 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 120.976 -1.078 . . . . 0.0 111.133 -179.877 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 834' ' ' ALA . . . . . . . . . . . . . . . -131.08 134.15 46.34 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 179.924 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 835' ' ' VAL . . . . . . . . . . . . . 5.9 t -145.02 150.91 15.59 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 O-C-N 120.933 -1.105 . . . . 0.0 111.275 -179.919 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 836' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -127.13 110.82 13.31 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 179.9 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 837' ' ' ALA . . . . . . . . . . . . . . . -110.26 159.33 17.5 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.066 -1.021 . . . . 0.0 111.106 -179.848 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 838' ' ' VAL . . . . . . . . . . . . . 92.1 t -115.29 122.15 68.65 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.475 0 O-C-N 121.498 -0.751 . . . . 0.0 109.731 179.961 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 839' ' ' CYS . . . . . 1.002 ' O ' HG23 ' A' ' 728' ' ' VAL . 0.0 OUTLIER -108.95 122.56 47.48 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.247 -0.908 . . . . 0.0 110.532 -179.925 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 840' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -121.08 119.39 32.3 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.268 -0.895 . . . . 0.0 109.799 179.963 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 841' ' ' THR . . . . . 0.461 ' HA ' ' HA ' ' A' ' 768' ' ' GLN . 14.6 t . . . . . 0 N--CA 1.492 1.654 0 O-C-N 121.103 -0.998 . . . . 0.0 110.569 -179.927 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 728' ' ' VAL . . . . . 0.816 HG12 ' N ' ' A' ' 729' ' ' SER . 1.0 OUTLIER . . . . . 0 N--CA 1.49 1.548 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 . . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 729' ' ' SER . . . . . 0.816 ' N ' HG12 ' A' ' 728' ' ' VAL . 2.4 m -178.53 -163.59 0.07 Allowed 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.102 -0.999 . . . . 0.0 110.601 -179.984 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 730' ' ' GLY . . . . . . . . . . . . . . . -152.67 -166.27 14.14 Favored Glycine 0 N--CA 1.496 2.698 0 N-CA-C 109.381 -1.488 . . . . 0.0 109.381 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 731' ' ' VAL . . . . . 0.507 HG12 ' N ' ' A' ' 732' ' ' CYS . 73.7 t -140.33 165.95 20.34 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 O-C-N 121.064 -1.256 . . . . 0.0 110.508 179.978 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 732' ' ' CYS . . . . . 0.507 ' N ' HG12 ' A' ' 731' ' ' VAL . 82.1 m -111.8 156.99 21.1 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.32 -0.863 . . . . 0.0 110.094 179.999 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 733' ' ' ALA . . . . . 0.458 ' O ' ' HA ' ' A' ' 834' ' ' ALA . . . -141.68 106.72 4.95 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.144 -0.973 . . . . 0.0 110.439 -179.997 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 734' ' ' ASP . . . . . 0.449 ' N ' ' OD1' ' A' ' 734' ' ' ASP . 5.2 m-20 -118.16 124.52 48.18 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.372 -0.83 . . . . 0.0 109.944 -180.0 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 735' ' ' VAL . . . . . 0.981 HG21 HG22 ' A' ' 760' ' ' VAL . 51.5 t -125.79 166.91 20.99 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 O-C-N 121.197 -0.94 . . . . 0.0 110.181 179.985 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 736' ' ' SER . . . . . 0.507 ' N ' HG12 ' A' ' 735' ' ' VAL . 10.2 p -113.36 45.18 1.43 Allowed 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.248 -0.907 . . . . 0.0 110.573 -179.984 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 737' ' ' GLU . . . . . 0.472 ' OE1' ' HB3' ' A' ' 831' ' ' LYS . 2.1 tt0 . . . . . 0 N--CA 1.502 2.127 0 O-C-N 121.469 -0.77 . . . . 0.0 111.273 179.911 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 757' ' ' THR . . . . . . . . . . . . . 61.9 p . . . . . 0 N--CA 1.492 1.632 0 CA-C-O 121.091 0.472 . . . . 0.0 109.858 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 758' ' ' ALA . . . . . . . . . . . . . . . -112.69 175.59 5.37 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.08 -1.012 . . . . 0.0 110.244 179.97 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 759' ' ' LYS . . . . . . . . . . . . . 11.4 mtmt -146.71 150.69 35.87 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.257 -0.902 . . . . 0.0 110.968 -179.899 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 760' ' ' VAL . . . . . 0.981 HG22 HG21 ' A' ' 735' ' ' VAL . 3.6 t -110.38 144.84 17.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.514 -0.741 . . . . 0.0 109.316 179.865 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 761' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -118.76 114.16 22.25 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.076 -1.015 . . . . 0.0 110.564 179.949 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 762' ' ' LEU . . . . . 0.489 ' HB2' ' HB3' ' A' ' 812' ' ' CYS . 0.4 OUTLIER -108.54 157.19 18.69 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.426 -0.796 . . . . 0.0 109.653 179.955 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 763' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -158.84 106.97 1.87 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.158 -0.964 . . . . 0.0 110.6 -179.976 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 764' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -88.21 166.54 14.29 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.364 -0.835 . . . . 0.0 109.915 -179.998 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 765' ' ' ALA . . . . . . . . . . . . . . . -63.55 154.24 80.32 Favored Pre-proline 0 N--CA 1.493 1.676 0 O-C-N 121.147 -0.971 . . . . 0.0 110.157 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 766' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -69.06 125.14 12.13 Favored 'Trans proline' 0 C--N 1.305 -1.735 0 O-C-N 124.016 1.535 . . . . 0.0 110.348 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 767' ' ' GLY . . . . . . . . . . . . . . . 108.69 -15.21 34.79 Favored Glycine 0 N--CA 1.489 2.21 0 N-CA-C 109.366 -1.493 . . . . 0.0 109.366 -179.963 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 768' ' ' GLN . . . . . 0.459 ' HB3' ' HB3' ' A' ' 839' ' ' CYS . 0.9 OUTLIER -114.32 140.72 48.39 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.338 -1.095 . . . . 0.0 110.236 179.96 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 769' ' ' THR . . . . . . . . . . . . . 69.7 p -121.48 150.4 41.63 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.295 -0.878 . . . . 0.0 110.393 -179.906 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 770' ' ' ILE . . . . . . . . . . . . . 16.9 mt -66.26 131.18 32.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.262 -0.899 . . . . 0.0 109.689 179.958 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 771' ' ' SER . . . . . 0.584 ' O ' ' HB2' ' A' ' 772' ' ' ALA . 80.2 p -129.1 -0.3 5.2 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.101 -0.999 . . . . 0.0 110.836 -179.993 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 772' ' ' ALA . . . . . 0.584 ' HB2' ' O ' ' A' ' 771' ' ' SER . . . 177.95 127.4 0.05 Allowed 'General case' 0 N--CA 1.495 1.792 0 O-C-N 120.824 -1.173 . . . . 0.0 111.576 179.998 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 773' ' ' ILE . . . . . . . . . . . . . 1.4 mp -87.17 123.44 39.98 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 N-CA-C 108.644 -0.873 . . . . 0.0 108.644 179.804 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 774' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -85.43 -31.56 22.8 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.027 -1.046 . . . . 0.0 111.88 -179.816 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 775' ' ' PHE . . . . . 0.644 ' CE2' ' CB ' ' A' ' 788' ' ' PHE . 90.6 t80 -147.61 171.82 14.99 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 120.645 -1.284 . . . . 0.0 111.325 -179.988 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 776' ' ' ALA . . . . . 0.512 ' HB1' ' O ' ' A' ' 798' ' ' SER . . . -179.52 136.7 0.12 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.544 -0.723 . . . . 0.0 109.546 -179.989 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 777' ' ' SER . . . . . 0.467 ' HB3' ' HB3' ' A' ' 781' ' ' PRO . 0.3 OUTLIER -148.44 127.04 12.43 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.119 -0.988 . . . . 0.0 110.373 -179.966 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 778' ' ' PHE . . . . . 0.614 ' CG ' ' O ' ' A' ' 778' ' ' PHE . 4.5 t80 -109.66 63.01 0.6 Allowed 'General case' 0 C--N 1.3 -1.555 0 CA-C-O 122.0 0.905 . . . . 0.0 108.957 179.935 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 779' ' ' GLY . . . . . . . . . . . . . . . -172.73 -111.02 0.25 Allowed Glycine 0 N--CA 1.488 2.152 0 N-CA-C 109.449 -1.461 . . . . 0.0 109.449 -179.945 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 780' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -115.14 81.39 7.91 Favored Pre-proline 0 N--CA 1.494 1.733 0 O-C-N 121.218 -1.166 . . . . 0.0 110.443 179.961 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 781' ' ' PRO . . . . . 0.467 ' HB3' ' HB3' ' A' ' 777' ' ' SER . 48.7 Cg_endo -77.93 143.87 21.04 Favored 'Trans proline' 0 C--N 1.304 -1.768 0 O-C-N 124.027 1.54 . . . . 0.0 109.872 179.961 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 782' ' ' LEU . . . . . 0.592 HD12 ' HA3' ' A' ' 791' ' ' GLY . 4.6 mt -137.22 148.39 46.45 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.109 -0.994 . . . . 0.0 110.373 -179.963 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 783' ' ' GLY . . . . . . . . . . . . . . . 138.26 -124.54 2.95 Favored Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.468 -1.453 . . . . 0.0 109.468 -179.984 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 784' ' ' THR . . . . . 0.425 HG22 ' N ' ' A' ' 785' ' ' CYS . 15.5 m -154.82 -75.42 0.11 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.217 -1.166 . . . . 0.0 110.393 -179.999 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 785' ' ' CYS . . . . . 0.425 ' N ' HG22 ' A' ' 784' ' ' THR . 1.0 OUTLIER -153.46 99.53 2.34 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.307 -0.87 . . . . 0.0 110.254 179.971 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 786' ' ' GLY . . . . . . . . . . . . . . . 98.04 -17.19 59.08 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.716 -1.354 . . . . 0.0 109.716 -179.95 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 787' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -113.5 23.76 12.86 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.213 -1.169 . . . . 0.0 110.275 179.958 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 788' ' ' PHE . . . . . 0.644 ' CB ' ' CE2' ' A' ' 775' ' ' PHE . 10.8 m-85 -50.66 170.79 0.03 OUTLIER 'General case' 0 C--N 1.299 -1.599 0 O-C-N 121.192 -0.942 . . . . 0.0 109.588 -179.967 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 789' ' ' GLN . . . . . 0.532 ' O ' ' N ' ' A' ' 791' ' ' GLY . 5.0 tp60 -164.8 118.52 1.3 Allowed 'General case' 0 C--N 1.298 -1.663 0 O-C-N 121.257 -0.902 . . . . 0.0 109.957 179.99 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 790' ' ' GLN . . . . . . . . . . . . . 1.8 pt20 -49.08 89.79 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.376 -0.828 . . . . 0.0 110.039 179.97 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 791' ' ' GLY . . . . . 0.592 ' HA3' HD12 ' A' ' 782' ' ' LEU . . . -43.4 -59.54 3.53 Favored Glycine 0 N--CA 1.488 2.152 0 N-CA-C 109.519 -1.433 . . . . 0.0 109.519 -179.987 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 792' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -152.56 -24.49 0.17 Allowed 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.273 -1.133 . . . . 0.0 111.419 179.973 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 793' ' ' CYS . . . . . . . . . . . . . 1.2 m -118.59 148.52 42.6 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 120.744 -1.222 . . . . 0.0 110.876 179.967 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 794' ' ' HIS . . . . . 0.492 ' NE2' ' HA ' ' A' ' 796' ' ' ILE . 5.4 t60 -169.41 146.76 3.51 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.488 -0.758 . . . . 0.0 109.808 179.917 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 795' ' ' SER . . . . . 0.474 ' O ' ' HB ' ' A' ' 796' ' ' ILE . 1.0 OUTLIER -90.06 1.2 56.6 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.194 -0.941 . . . . 0.0 111.338 -179.886 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 796' ' ' ILE . . . . . 0.715 HG22 ' O ' ' A' ' 796' ' ' ILE . 21.2 mm 55.95 16.85 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 O-C-N 120.985 -1.072 . . . . 0.0 110.068 -179.975 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 797' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -151.08 26.5 0.71 Allowed 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.277 -0.889 . . . . 0.0 109.859 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 798' ' ' SER . . . . . 0.512 ' O ' ' HB1' ' A' ' 776' ' ' ALA . 21.0 m -71.26 -14.91 62.39 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.323 -0.861 . . . . 0.0 111.395 -179.966 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 799' ' ' ASN . . . . . . . . . . . . . 24.4 p30 -105.0 -5.32 21.07 Favored 'General case' 0 N--CA 1.5 2.06 0 O-C-N 121.004 -1.06 . . . . 0.0 111.184 -179.928 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 800' ' ' SER . . . . . . . . . . . . . 49.7 m -82.83 -16.82 46.25 Favored 'General case' 0 C--N 1.293 -1.874 0 O-C-N 121.167 -0.958 . . . . 0.0 110.771 -179.972 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 801' ' ' VAL . . . . . . . . . . . . . 40.6 t -91.27 -19.67 7.02 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 O-C-N 121.15 -0.968 . . . . 0.0 111.178 -179.911 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 802' ' ' LEU . . . . . 0.591 HD11 HG21 ' A' ' 814' ' ' VAL . 3.9 mm? -88.55 -48.09 7.83 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.005 -1.059 . . . . 0.0 111.247 -179.837 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 803' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -56.85 -16.96 7.68 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.946 -1.096 . . . . 0.0 110.38 179.949 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 804' ' ' ARG . . . . . . . . . . . . . 2.9 ttt180 -91.16 -26.31 19.14 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.202 -0.936 . . . . 0.0 111.81 -179.908 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 805' ' ' LYS . . . . . . . . . . . . . 1.1 ttpt -140.84 60.57 1.52 Allowed 'General case' 0 N--CA 1.497 1.89 0 O-C-N 120.756 -1.215 . . . . 0.0 111.196 -179.87 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 806' ' ' CYS . . . . . . . . . . . . . 3.4 t -162.46 -25.68 0.04 OUTLIER 'General case' 0 N--CA 1.501 2.108 0 O-C-N 121.069 -1.019 . . . . 0.0 111.649 179.898 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 807' ' ' ILE . . . . . . . . . . . . . 30.1 mt -83.4 135.85 23.98 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 O-C-N 120.741 -1.224 . . . . 0.0 111.381 -179.97 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 808' ' ' GLY . . . . . 0.479 ' C ' ' HG ' ' A' ' 809' ' ' LEU . . . 109.92 -5.2 30.62 Favored Glycine 0 N--CA 1.492 2.394 0 C-N-CA 120.094 -1.05 . . . . 0.0 110.792 179.875 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 809' ' ' LEU . . . . . 0.479 ' HG ' ' C ' ' A' ' 808' ' ' GLY . 1.3 mp -136.17 143.46 44.45 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 120.792 -1.417 . . . . 0.0 110.688 -179.92 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 810' ' ' GLU . . . . . 0.522 ' HG3' ' N ' ' A' ' 811' ' ' ARG . 0.0 OUTLIER -70.27 -21.56 62.95 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.246 -0.909 . . . . 0.0 108.709 179.866 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 811' ' ' ARG . . . . . 0.522 ' N ' ' HG3' ' A' ' 810' ' ' GLU . 1.6 ttt180 -115.65 149.73 37.86 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.625 -0.672 . . . . 0.0 109.22 179.89 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 812' ' ' CYS . . . . . 0.489 ' HB3' ' HB2' ' A' ' 762' ' ' LEU . 9.7 t -134.54 146.56 49.78 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.954 -1.091 . . . . 0.0 110.921 -179.887 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 813' ' ' VAL . . . . . . . . . . . . . 46.0 t -135.63 104.56 4.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.536 -0.727 . . . . 0.0 109.172 179.955 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 814' ' ' VAL . . . . . 0.591 HG21 HD11 ' A' ' 802' ' ' LEU . 41.0 t -110.73 115.5 50.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.269 -0.894 . . . . 0.0 111.304 -179.881 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 815' ' ' ALA . . . . . . . . . . . . . . . -79.96 131.81 35.9 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.262 -0.899 . . . . 0.0 109.0 179.901 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 816' ' ' ILE . . . . . 0.861 ' CD1' HG21 ' A' ' 833' ' ' VAL . 59.5 mt -87.0 134.13 28.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.105 -0.997 . . . . 0.0 111.045 -179.887 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 817' ' ' SER . . . . . 0.469 ' OG ' ' HB2' ' A' ' 820' ' ' ASN . 2.9 p -164.9 171.22 5.65 Favored Pre-proline 0 N--CA 1.494 1.732 0 O-C-N 121.416 -0.802 . . . . 0.0 109.699 179.934 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 818' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -78.87 -29.9 3.16 Favored 'Trans proline' 0 C--N 1.306 -1.674 0 O-C-N 123.797 1.42 . . . . 0.0 110.374 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 819' ' ' SER . . . . . . . . . . . . . 46.5 m -87.24 7.71 27.27 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.273 -0.892 . . . . 0.0 110.338 -179.963 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 820' ' ' ASN . . . . . 0.469 ' HB2' ' OG ' ' A' ' 817' ' ' SER . 0.4 OUTLIER -105.64 -8.43 17.92 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.154 -0.966 . . . . 0.0 110.007 -179.97 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 821' ' ' PHE . . . . . . . . . . . . . 31.8 m-85 -125.61 -74.49 0.6 Allowed 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.237 -0.914 . . . . 0.0 110.334 179.961 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 822' ' ' GLY . . . . . . . . . . . . . . . -178.16 57.75 0.09 OUTLIER Glycine 0 N--CA 1.492 2.375 0 N-CA-C 109.454 -1.458 . . . . 0.0 109.454 -179.98 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 823' ' ' GLY . . . . . . . . . . . . . . . 64.05 -122.85 26.8 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 -179.983 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 824' ' ' ASP . . . . . . . . . . . . . 89.4 m-20 -132.31 130.77 22.04 Favored Pre-proline 0 N--CA 1.495 1.806 0 O-C-N 121.327 -1.102 . . . . 0.0 109.985 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 825' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -82.05 -89.95 0.0 OUTLIER 'Trans proline' 0 C--N 1.308 -1.592 0 O-C-N 123.903 1.475 . . . . 0.0 111.062 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 826' ' ' CYS . . . . . . . . . . . . . 17.7 p -111.21 124.88 31.7 Favored Pre-proline 0 N--CA 1.497 1.879 0 O-C-N 121.256 -0.902 . . . . 0.0 111.12 -179.901 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 827' ' ' PRO . . . . . 0.489 ' O ' ' HB2' ' A' ' 828' ' ' GLU . 49.6 Cg_endo -81.16 -174.03 2.06 Favored 'Trans proline' 0 C--N 1.305 -1.719 0 O-C-N 123.962 1.506 . . . . 0.0 109.562 179.777 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 828' ' ' GLU . . . . . 0.489 ' HB2' ' O ' ' A' ' 827' ' ' PRO . 3.7 mm-40 58.79 14.48 3.24 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.475 -0.765 . . . . 0.0 109.611 -179.941 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 829' ' ' VAL . . . . . 0.459 ' O ' ' O ' ' A' ' 830' ' ' MET . 74.9 t -130.58 129.99 64.65 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.332 0 O-C-N 121.575 -0.703 . . . . 0.0 109.388 -179.983 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 830' ' ' MET . . . . . 0.459 ' O ' ' O ' ' A' ' 829' ' ' VAL . 33.8 mmt -52.82 -170.19 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.271 -0.893 . . . . 0.0 110.202 -179.964 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 831' ' ' LYS . . . . . 0.472 ' HB3' ' OE1' ' A' ' 737' ' ' GLU . 9.4 mttp -147.43 149.58 32.99 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 120.94 -1.1 . . . . 0.0 110.702 -179.913 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 832' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -161.86 149.18 14.31 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.602 -0.686 . . . . 0.0 109.151 179.924 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 833' ' ' VAL . . . . . 0.861 HG21 ' CD1' ' A' ' 816' ' ' ILE . 70.2 t -111.87 107.47 23.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 120.911 -1.118 . . . . 0.0 111.375 -179.973 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 834' ' ' ALA . . . . . 0.458 ' HA ' ' O ' ' A' ' 733' ' ' ALA . . . -109.97 128.71 55.55 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.375 -0.828 . . . . 0.0 109.172 179.857 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 835' ' ' VAL . . . . . . . . . . . . . 3.0 t -138.08 145.56 28.46 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 O-C-N 120.808 -1.183 . . . . 0.0 111.232 -179.855 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 836' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -124.48 117.93 25.49 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 179.873 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 837' ' ' ALA . . . . . . . . . . . . . . . -107.94 155.57 20.17 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.156 -0.965 . . . . 0.0 111.233 -179.807 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 838' ' ' VAL . . . . . 0.483 ' HB ' ' O ' ' A' ' 772' ' ' ALA . 71.9 t -112.33 110.99 34.23 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.375 0 O-C-N 121.545 -0.722 . . . . 0.0 109.361 179.938 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 839' ' ' CYS . . . . . 0.459 ' HB3' ' HB3' ' A' ' 768' ' ' GLN . 1.2 m -105.44 108.93 20.71 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.123 -0.986 . . . . 0.0 110.216 -179.915 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 840' ' ' SER . . . . . 0.575 ' C ' HG23 ' A' ' 841' ' ' THR . 14.8 t -99.17 -89.21 0.32 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.315 -0.865 . . . . 0.0 110.25 179.994 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 841' ' ' THR . . . . . 0.575 HG23 ' C ' ' A' ' 840' ' ' SER . 62.9 p . . . . . 0 N--CA 1.495 1.805 0 O-C-N 121.194 -0.942 . . . . 0.0 110.578 -179.977 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 728' ' ' VAL . . . . . 0.693 ' O ' HG12 ' A' ' 728' ' ' VAL . 1.3 t . . . . . 0 N--CA 1.485 1.283 0 CA-C-O 121.355 0.598 . . . . 0.0 109.959 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 729' ' ' SER . . . . . 0.478 ' HB2' ' O ' ' A' ' 728' ' ' VAL . 2.2 m 58.16 168.62 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.484 -0.76 . . . . 0.0 110.788 179.827 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 730' ' ' GLY . . . . . 0.486 ' C ' HG23 ' A' ' 731' ' ' VAL . . . -131.32 -161.35 10.18 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.065 -1.614 . . . . 0.0 109.065 179.938 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 731' ' ' VAL . . . . . 0.486 HG23 ' C ' ' A' ' 730' ' ' GLY . 4.8 t -150.58 137.39 13.0 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 121.149 -1.207 . . . . 0.0 110.324 179.989 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 732' ' ' CYS . . . . . . . . . . . . . 20.3 m -128.25 143.71 51.06 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.309 -0.869 . . . . 0.0 109.868 179.964 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 733' ' ' ALA . . . . . . . . . . . . . . . -148.38 105.06 3.57 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.989 -1.069 . . . . 0.0 110.735 -179.948 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 734' ' ' ASP . . . . . 0.47 ' OD1' ' O ' ' A' ' 734' ' ' ASP . 1.0 OUTLIER -110.39 104.01 12.73 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.352 -0.843 . . . . 0.0 109.979 179.924 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 735' ' ' VAL . . . . . 0.493 ' O ' ' HB ' ' A' ' 833' ' ' VAL . 77.0 t -129.68 123.33 56.95 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 121.125 -0.984 . . . . 0.0 110.243 -179.967 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 736' ' ' SER . . . . . 0.499 ' HA ' ' HA ' ' A' ' 832' ' ' ARG . 5.4 p -84.24 158.74 21.16 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.088 -1.007 . . . . 0.0 110.362 -179.959 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 737' ' ' GLU . . . . . 0.584 ' HB2' HG21 ' A' ' 816' ' ' ILE . 24.5 tt0 . . . . . 0 N--CA 1.494 1.769 0 O-C-N 121.271 -0.893 . . . . 0.0 109.992 179.981 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 757' ' ' THR . . . . . . . . . . . . . 60.9 p . . . . . 0 N--CA 1.494 1.755 0 CA-C-O 121.386 0.613 . . . . 0.0 110.246 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 758' ' ' ALA . . . . . . . . . . . . . . . -111.9 157.93 20.06 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.295 -0.878 . . . . 0.0 110.238 179.955 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 759' ' ' LYS . . . . . . . . . . . . . 1.3 ttmt -113.51 155.0 26.15 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.338 -0.851 . . . . 0.0 109.928 -179.974 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 760' ' ' VAL . . . . . . . . . . . . . 16.8 t -109.06 136.87 43.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.246 -0.909 . . . . 0.0 109.729 179.926 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 761' ' ' HIS . . . . . . . . . . . . . 3.5 m80 -109.52 107.34 17.42 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.147 -0.97 . . . . 0.0 110.467 -179.984 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 762' ' ' LEU . . . . . . . . . . . . . 2.0 mt -109.54 148.13 31.77 Favored 'General case' 0 C--N 1.299 -1.607 0 O-C-N 121.65 -0.656 . . . . 0.0 109.502 179.944 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 763' ' ' LYS . . . . . . . . . . . . . 3.3 ttpt -158.39 121.46 3.83 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.131 -0.98 . . . . 0.0 110.091 179.997 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 764' ' ' CYS . . . . . 0.442 ' O ' ' C ' ' A' ' 765' ' ' ALA . 12.7 t -82.06 157.77 24.02 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.262 -0.899 . . . . 0.0 110.001 179.958 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 765' ' ' ALA . . . . . 0.442 ' C ' ' O ' ' A' ' 764' ' ' CYS . . . -41.29 162.36 0.12 Allowed Pre-proline 0 N--CA 1.495 1.799 0 O-C-N 121.263 -0.898 . . . . 0.0 110.325 -179.966 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 766' ' ' PRO . . . . . 0.412 ' HD2' ' HB1' ' A' ' 765' ' ' ALA . 45.8 Cg_endo -73.16 99.75 1.14 Allowed 'Trans proline' 0 C--N 1.304 -1.799 0 O-C-N 124.025 1.54 . . . . 0.0 110.185 -179.979 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 767' ' ' GLY . . . . . . . . . . . . . . . 117.76 1.0 17.58 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.486 -1.446 . . . . 0.0 109.486 -179.962 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 768' ' ' GLN . . . . . 0.501 ' CG ' ' O ' ' A' ' 840' ' ' SER . 10.7 mp0 -116.47 154.47 30.29 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.219 -1.165 . . . . 0.0 110.273 179.938 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 769' ' ' THR . . . . . . . . . . . . . 43.1 p -129.02 147.54 50.9 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.184 -0.948 . . . . 0.0 110.359 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 770' ' ' ILE . . . . . . . . . . . . . 37.0 mt -58.99 133.17 24.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.308 -0.87 . . . . 0.0 109.751 179.952 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 771' ' ' SER . . . . . 0.476 ' O ' ' HB2' ' A' ' 772' ' ' ALA . 51.7 p -108.47 -17.0 14.09 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.236 -0.915 . . . . 0.0 110.861 -179.889 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 772' ' ' ALA . . . . . 0.476 ' HB2' ' O ' ' A' ' 771' ' ' SER . . . -177.77 171.84 1.79 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.875 -1.141 . . . . 0.0 111.271 -179.999 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 773' ' ' ILE . . . . . . . . . . . . . 42.6 mm -123.72 129.49 74.45 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 179.858 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 774' ' ' LYS . . . . . . . . . . . . . 5.9 mtpt -95.03 -35.47 11.93 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 121.033 -1.042 . . . . 0.0 111.537 -179.848 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 775' ' ' PHE . . . . . 0.674 ' O ' ' HB2' ' A' ' 776' ' ' ALA . 60.1 t80 -149.06 172.34 14.92 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 120.686 -1.259 . . . . 0.0 111.465 -179.948 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 776' ' ' ALA . . . . . 0.674 ' HB2' ' O ' ' A' ' 775' ' ' PHE . . . 169.3 119.93 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 109.187 -0.672 . . . . 0.0 109.187 -179.971 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 777' ' ' SER . . . . . 0.554 ' HA ' ' HB3' ' A' ' 798' ' ' SER . 44.4 t -143.69 137.2 28.02 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 120.978 -1.076 . . . . 0.0 111.172 -179.891 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 778' ' ' PHE . . . . . 0.57 ' CG ' ' O ' ' A' ' 778' ' ' PHE . 1.4 t80 -107.34 72.37 0.87 Allowed 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.422 -0.799 . . . . 0.0 109.73 179.925 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 779' ' ' GLY . . . . . . . . . . . . . . . -174.24 -120.6 0.59 Allowed Glycine 0 N--CA 1.492 2.405 0 N-CA-C 109.961 -1.255 . . . . 0.0 109.961 179.989 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 780' ' ' THR . . . . . 0.644 HG22 ' O ' ' A' ' 830' ' ' MET . 24.8 p -117.11 81.46 12.79 Favored Pre-proline 0 N--CA 1.494 1.775 0 O-C-N 121.197 -1.178 . . . . 0.0 110.553 179.984 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 781' ' ' PRO . . . . . 0.427 ' HA ' ' O ' ' A' ' 789' ' ' GLN . 46.8 Cg_endo -80.48 144.43 15.97 Favored 'Trans proline' 0 C--N 1.304 -1.805 0 O-C-N 124.054 1.555 . . . . 0.0 110.229 -179.983 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 782' ' ' LEU . . . . . . . . . . . . . 36.8 mt -120.32 148.91 43.12 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.176 -0.953 . . . . 0.0 110.331 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 783' ' ' GLY . . . . . . . . . . . . . . . 112.2 -139.29 15.54 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.546 -1.422 . . . . 0.0 109.546 -179.962 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 784' ' ' THR . . . . . . . . . . . . . 10.8 t -161.12 -173.26 3.78 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.254 -1.144 . . . . 0.0 110.138 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 785' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -64.37 107.15 1.27 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.191 -0.943 . . . . 0.0 110.204 -179.975 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 786' ' ' GLY . . . . . . . . . . . . . . . 131.36 -31.65 3.09 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.2 -1.56 . . . . 0.0 109.2 179.981 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 787' ' ' THR . . . . . . . . . . . . . 25.2 p -144.38 39.81 1.31 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.32 -1.106 . . . . 0.0 110.088 -179.942 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 788' ' ' PHE . . . . . 0.583 ' HB3' ' CZ ' ' A' ' 775' ' ' PHE . 1.9 m-85 -50.97 171.55 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.328 -0.858 . . . . 0.0 110.229 179.935 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 789' ' ' GLN . . . . . 0.427 ' O ' ' HA ' ' A' ' 781' ' ' PRO . 26.4 tt0 -161.05 169.57 22.22 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.114 -0.991 . . . . 0.0 110.424 -179.989 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 790' ' ' GLN . . . . . 0.454 ' O ' ' HG3' ' A' ' 790' ' ' GLN . 0.0 OUTLIER -94.89 147.96 22.82 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.23 -0.919 . . . . 0.0 110.041 -179.992 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 791' ' ' GLY . . . . . 0.443 ' HA3' ' OG1' ' A' ' 780' ' ' THR . . . -97.4 -150.67 26.88 Favored Glycine 0 N--CA 1.492 2.393 0 N-CA-C 109.516 -1.434 . . . . 0.0 109.516 179.943 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 792' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -70.08 -19.66 63.25 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.255 -1.144 . . . . 0.0 109.973 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 793' ' ' CYS . . . . . 0.475 ' SG ' ' N ' ' A' ' 794' ' ' HIS . 1.8 t -136.72 164.86 27.26 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.337 -0.852 . . . . 0.0 110.051 -179.963 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 794' ' ' HIS . . . . . 0.596 ' CE1' ' O ' ' A' ' 795' ' ' SER . 0.2 OUTLIER 179.5 154.65 0.5 Allowed 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.285 -0.884 . . . . 0.0 109.861 179.976 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 795' ' ' SER . . . . . 0.596 ' O ' ' CE1' ' A' ' 794' ' ' HIS . 1.8 t -91.78 107.61 19.33 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.324 -0.86 . . . . 0.0 110.15 179.993 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 796' ' ' ILE . . . . . 0.436 ' C ' ' O ' ' A' ' 795' ' ' SER . 6.5 pt -38.63 -25.05 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.939 0 O-C-N 121.372 -0.83 . . . . 0.0 111.23 179.981 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 797' ' ' ASN . . . . . 0.532 ' N ' ' O ' ' A' ' 795' ' ' SER . 19.3 p30 -107.85 51.74 0.73 Allowed 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.003 -1.06 . . . . 0.0 111.313 -179.894 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 798' ' ' SER . . . . . 0.554 ' HB3' ' HA ' ' A' ' 777' ' ' SER . 4.3 m -102.8 26.42 8.08 Favored 'General case' 0 N--CA 1.497 1.925 0 O-C-N 120.697 -1.252 . . . . 0.0 110.403 179.939 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 799' ' ' ASN . . . . . . . . . . . . . 38.4 m-80 -138.07 -46.97 0.53 Allowed 'General case' 0 N--CA 1.496 1.831 0 O-C-N 120.998 -1.064 . . . . 0.0 110.874 -179.905 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 800' ' ' SER . . . . . . . . . . . . . 8.7 t -62.78 -33.12 74.52 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.118 -0.989 . . . . 0.0 110.385 -179.93 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 801' ' ' VAL . . . . . . . . . . . . . 97.8 t -51.92 -52.06 25.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.285 -0.884 . . . . 0.0 110.582 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 802' ' ' LEU . . . . . 0.464 ' O ' ' HB2' ' A' ' 806' ' ' CYS . 1.1 mm? -63.15 -43.48 98.2 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.206 -0.934 . . . . 0.0 110.861 179.996 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 803' ' ' GLU . . . . . . . . . . . . . 24.7 tt0 -55.33 -21.1 13.62 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.232 -0.918 . . . . 0.0 110.646 -179.959 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 804' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -92.14 -23.22 19.49 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.234 -0.916 . . . . 0.0 110.98 -179.969 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 805' ' ' LYS . . . . . 0.4 ' O ' ' SG ' ' A' ' 812' ' ' CYS . 5.0 mmmt -130.77 52.57 2.03 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.017 -1.052 . . . . 0.0 110.892 -179.904 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 806' ' ' CYS . . . . . 0.546 ' O ' HD12 ' A' ' 809' ' ' LEU . 0.3 OUTLIER -160.95 -72.19 0.06 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.035 -1.041 . . . . 0.0 110.903 179.986 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 807' ' ' ILE . . . . . . . . . . . . . 94.4 mt -55.28 128.74 15.85 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 121.223 -0.923 . . . . 0.0 110.776 -179.921 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 808' ' ' GLY . . . . . 0.475 ' C ' ' HG ' ' A' ' 809' ' ' LEU . . . 106.83 1.16 36.58 Favored Glycine 0 N--CA 1.495 2.576 0 N-CA-C 110.385 -1.086 . . . . 0.0 110.385 179.906 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 809' ' ' LEU . . . . . 0.546 HD12 ' O ' ' A' ' 806' ' ' CYS . 1.0 OUTLIER -131.83 160.61 35.15 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 120.831 -1.393 . . . . 0.0 110.534 -179.958 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 810' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -83.78 -9.49 58.76 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.329 -0.857 . . . . 0.0 109.583 179.91 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 811' ' ' ARG . . . . . 0.533 ' NH1' HD22 ' A' ' 809' ' ' LEU . 0.1 OUTLIER -143.62 164.93 29.03 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.39 -0.819 . . . . 0.0 109.193 -179.987 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 812' ' ' CYS . . . . . 0.4 ' SG ' ' O ' ' A' ' 805' ' ' LYS . 7.9 t -143.77 126.99 16.62 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.922 -1.111 . . . . 0.0 111.268 -179.852 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 813' ' ' VAL . . . . . . . . . . . . . 98.3 t -128.45 115.11 36.54 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.298 -0.877 . . . . 0.0 109.225 179.809 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 814' ' ' VAL . . . . . . . . . . . . . 97.9 t -123.28 129.21 74.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.134 -0.978 . . . . 0.0 110.772 -179.876 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 815' ' ' ALA . . . . . . . . . . . . . . . -86.69 158.82 19.35 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.323 -0.861 . . . . 0.0 109.623 179.909 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 816' ' ' ILE . . . . . 0.78 HD13 HG21 ' A' ' 833' ' ' VAL . 75.9 mt -109.65 133.02 56.24 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.577 0 O-C-N 121.218 -0.926 . . . . 0.0 110.575 -179.985 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 817' ' ' SER . . . . . 0.502 ' OG ' ' CB ' ' A' ' 820' ' ' ASN . 0.1 OUTLIER -165.98 170.45 5.8 Favored Pre-proline 0 N--CA 1.488 1.447 0 O-C-N 121.267 -0.896 . . . . 0.0 109.888 179.978 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 818' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -78.16 -63.63 0.02 OUTLIER 'Trans proline' 0 C--N 1.303 -1.834 0 O-C-N 123.982 1.517 . . . . 0.0 111.497 -179.886 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 819' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -70.24 -1.1 9.31 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 120.986 -1.071 . . . . 0.0 111.215 -179.849 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 820' ' ' ASN . . . . . 0.502 ' CB ' ' OG ' ' A' ' 817' ' ' SER . 27.9 t-20 -84.49 -20.79 31.1 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 120.952 -1.093 . . . . 0.0 109.999 179.977 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 821' ' ' PHE . . . . . . . . . . . . . 5.5 m-85 -108.45 -59.3 1.88 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.232 -0.918 . . . . 0.0 110.562 -179.903 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 822' ' ' GLY . . . . . . . . . . . . . . . -144.13 -55.65 0.03 OUTLIER Glycine 0 N--CA 1.491 2.366 0 N-CA-C 109.773 -1.331 . . . . 0.0 109.773 179.965 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 823' ' ' GLY . . . . . . . . . . . . . . . 137.77 108.32 0.85 Allowed Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.661 -1.376 . . . . 0.0 109.661 -179.958 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 824' ' ' ASP . . . . . 0.521 ' N ' ' HD3' ' A' ' 825' ' ' PRO . 4.2 m-20 43.11 59.93 10.99 Favored Pre-proline 0 N--CA 1.494 1.736 0 O-C-N 121.343 -1.092 . . . . 0.0 110.73 -179.976 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 825' ' ' PRO . . . . . 0.521 ' HD3' ' N ' ' A' ' 824' ' ' ASP . 47.8 Cg_endo -84.29 -54.91 0.03 OUTLIER 'Trans proline' 0 C--N 1.304 -1.784 0 O-C-N 123.926 1.487 . . . . 0.0 110.261 179.998 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 826' ' ' CYS . . . . . 0.4 ' SG ' HG11 ' A' ' 829' ' ' VAL . 0.5 OUTLIER -131.56 85.24 53.02 Favored Pre-proline 0 N--CA 1.496 1.838 0 O-C-N 121.267 -0.896 . . . . 0.0 110.375 -179.993 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 827' ' ' PRO . . . . . 0.448 ' O ' HG23 ' A' ' 829' ' ' VAL . 50.5 Cg_endo -86.64 151.11 8.81 Favored 'Trans proline' 0 C--N 1.306 -1.671 0 O-C-N 123.919 1.484 . . . . 0.0 111.287 -179.969 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 828' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 45.28 48.99 10.28 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.426 -0.796 . . . . 0.0 111.111 179.968 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 829' ' ' VAL . . . . . 0.515 ' O ' ' N ' ' A' ' 831' ' ' LYS . 20.4 t -147.44 137.95 17.34 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.583 0 O-C-N 121.164 -0.96 . . . . 0.0 110.173 179.899 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 830' ' ' MET . . . . . 0.644 ' O ' HG22 ' A' ' 780' ' ' THR . 0.2 OUTLIER -42.31 95.11 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.419 -0.8 . . . . 0.0 109.618 179.976 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 831' ' ' LYS . . . . . 0.515 ' N ' ' O ' ' A' ' 829' ' ' VAL . 0.0 OUTLIER -94.61 150.22 20.46 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.186 -0.946 . . . . 0.0 110.565 -179.938 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 832' ' ' ARG . . . . . 0.499 ' HA ' ' HA ' ' A' ' 736' ' ' SER . 0.0 OUTLIER -156.94 151.76 25.84 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.404 -0.81 . . . . 0.0 109.662 179.97 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 833' ' ' VAL . . . . . 0.78 HG21 HD13 ' A' ' 816' ' ' ILE . 66.6 t -115.79 106.1 19.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 120.979 -1.075 . . . . 0.0 110.955 179.978 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 834' ' ' ALA . . . . . 0.447 ' HB1' ' CZ ' ' A' ' 788' ' ' PHE . . . -108.87 132.95 53.53 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.307 -0.87 . . . . 0.0 109.092 179.922 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 835' ' ' VAL . . . . . . . . . . . . . 73.1 t -141.16 133.03 28.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.012 -1.055 . . . . 0.0 111.323 -179.94 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 836' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -125.53 112.64 16.45 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 179.897 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 837' ' ' ALA . . . . . . . . . . . . . . . -108.91 162.67 13.99 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.146 -0.971 . . . . 0.0 111.089 -179.926 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 838' ' ' VAL . . . . . . . . . . . . . 38.6 t -111.84 119.15 59.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.524 -0.735 . . . . 0.0 109.727 -179.946 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 839' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -105.71 146.18 30.11 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.9 -1.125 . . . . 0.0 110.94 179.946 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 840' ' ' SER . . . . . 0.501 ' O ' ' CG ' ' A' ' 768' ' ' GLN . 79.1 p -138.94 -152.22 0.41 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.498 -0.752 . . . . 0.0 109.775 -179.991 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 841' ' ' THR . . . . . . . . . . . . . 69.6 p . . . . . 0 N--CA 1.492 1.648 0 O-C-N 121.186 -0.946 . . . . 0.0 109.993 179.977 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 728' ' ' VAL . . . . . 0.401 ' O ' ' O ' ' A' ' 729' ' ' SER . 43.0 t . . . . . 0 N--CA 1.489 1.505 0 CA-C-O 121.264 0.554 . . . . 0.0 110.177 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 729' ' ' SER . . . . . 0.401 ' O ' ' O ' ' A' ' 728' ' ' VAL . 40.5 m 51.78 179.21 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.18 -0.95 . . . . 0.0 110.034 -179.972 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 730' ' ' GLY . . . . . . . . . . . . . . . -152.8 -158.8 8.69 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.622 -1.391 . . . . 0.0 109.622 -179.938 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 731' ' ' VAL . . . . . 0.511 ' CG2' ' SG ' ' A' ' 764' ' ' CYS . 18.0 t -140.1 144.65 27.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.21 -1.171 . . . . 0.0 110.506 179.99 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 732' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -135.96 143.15 44.71 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.432 -0.793 . . . . 0.0 109.729 179.952 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 733' ' ' ALA . . . . . . . . . . . . . . . -148.44 122.74 9.61 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.123 -0.986 . . . . 0.0 110.726 179.997 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 734' ' ' ASP . . . . . 0.461 ' O ' ' OD2' ' A' ' 734' ' ' ASP . 19.3 p-10 -129.92 106.06 8.41 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.326 -0.859 . . . . 0.0 109.877 179.953 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 735' ' ' VAL . . . . . . . . . . . . . 61.3 t -126.8 159.32 36.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.107 -0.996 . . . . 0.0 110.428 -179.951 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 736' ' ' SER . . . . . 0.428 ' O ' ' C ' ' A' ' 737' ' ' GLU . 24.6 m -109.51 127.29 54.34 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.321 -0.862 . . . . 0.0 109.932 179.992 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 737' ' ' GLU . . . . . 0.476 ' HB2' ' HB3' ' A' ' 831' ' ' LYS . 14.9 tp10 . . . . . 0 N--CA 1.495 1.787 0 O-C-N 121.296 -0.878 . . . . 0.0 110.433 179.992 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 757' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.751 0 CA-C-O 121.337 0.589 . . . . 0.0 110.217 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 758' ' ' ALA . . . . . 0.89 ' HB3' ' HB ' ' A' ' 816' ' ' ILE . . . -98.9 172.26 7.54 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.32 -0.862 . . . . 0.0 109.855 179.939 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 759' ' ' LYS . . . . . . . . . . . . . 6.4 mttm -150.74 136.58 18.22 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.115 -0.991 . . . . 0.0 110.41 179.959 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 760' ' ' VAL . . . . . . . . . . . . . 42.1 t -106.6 136.65 40.58 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.305 -0.872 . . . . 0.0 109.263 179.941 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 761' ' ' HIS . . . . . . . . . . . . . 68.1 m80 -109.71 104.15 13.1 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.198 -0.939 . . . . 0.0 110.981 -179.947 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 762' ' ' LEU . . . . . . . . . . . . . 39.4 mt -119.13 101.77 8.25 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.33 -0.857 . . . . 0.0 108.951 179.905 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 763' ' ' LYS . . . . . 0.489 ' HB3' ' HG3' ' A' ' 811' ' ' ARG . 6.6 pttm -135.66 140.86 44.82 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.077 -1.015 . . . . 0.0 110.803 -179.956 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 764' ' ' CYS . . . . . 0.511 ' SG ' ' CG2' ' A' ' 731' ' ' VAL . 0.5 OUTLIER -113.47 157.77 21.55 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.407 -0.808 . . . . 0.0 109.891 179.983 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 765' ' ' ALA . . . . . 0.775 ' HB3' ' HG3' ' A' ' 768' ' ' GLN . . . -44.73 169.71 0.06 OUTLIER Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 121.197 -0.939 . . . . 0.0 110.218 179.963 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 766' ' ' PRO . . . . . 0.659 ' HD2' ' HB1' ' A' ' 765' ' ' ALA . 43.9 Cg_endo -71.13 113.04 3.46 Favored 'Trans proline' 0 C--N 1.304 -1.787 0 O-C-N 123.961 1.506 . . . . 0.0 110.4 179.958 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 767' ' ' GLY . . . . . . . . . . . . . . . 110.07 -24.82 17.82 Favored Glycine 0 N--CA 1.488 2.16 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 -179.942 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 768' ' ' GLN . . . . . 0.775 ' HG3' ' HB3' ' A' ' 765' ' ' ALA . 3.1 mt-30 -87.77 99.84 12.4 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.238 -1.154 . . . . 0.0 110.117 -179.99 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 769' ' ' THR . . . . . 0.844 HG22 ' HG3' ' A' ' 810' ' ' GLU . 64.1 p -94.78 154.14 17.42 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.257 -0.902 . . . . 0.0 110.375 -179.988 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 770' ' ' ILE . . . . . 0.419 ' HA ' ' O ' ' A' ' 838' ' ' VAL . 11.3 mt -78.11 144.89 10.65 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.356 -0.84 . . . . 0.0 110.005 -179.999 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 771' ' ' SER . . . . . . . . . . . . . 1.8 t -137.02 -5.3 1.89 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.147 -0.971 . . . . 0.0 111.158 -179.915 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 772' ' ' ALA . . . . . . . . . . . . . . . -162.18 123.38 2.65 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.859 -1.151 . . . . 0.0 111.014 -179.906 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 773' ' ' ILE . . . . . . . . . . . . . 32.9 mm -85.67 124.48 40.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.286 -0.884 . . . . 0.0 109.551 179.889 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 774' ' ' LYS . . . . . . . . . . . . . 18.9 mmtt -80.44 -42.26 22.98 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.246 -0.909 . . . . 0.0 110.757 -179.904 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 775' ' ' PHE . . . . . 0.694 ' O ' ' HB2' ' A' ' 776' ' ' ALA . 59.3 t80 -154.04 173.0 16.61 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.027 -1.045 . . . . 0.0 111.078 -179.974 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 776' ' ' ALA . . . . . 0.694 ' HB2' ' O ' ' A' ' 775' ' ' PHE . . . 168.39 89.08 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.588 -0.695 . . . . 0.0 109.548 179.959 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 777' ' ' SER . . . . . 0.581 ' HA ' ' CB ' ' A' ' 798' ' ' SER . 59.5 p -122.66 137.7 54.82 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.231 -0.918 . . . . 0.0 110.504 -179.906 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 778' ' ' PHE . . . . . . . . . . . . . 15.7 t80 -104.18 104.32 14.22 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.245 -0.909 . . . . 0.0 110.066 179.963 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 779' ' ' GLY . . . . . . . . . . . . . . . 161.64 -113.55 0.57 Allowed Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.457 -1.457 . . . . 0.0 109.457 -179.998 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 780' ' ' THR . . . . . . . . . . . . . 12.0 p -118.56 72.86 10.75 Favored Pre-proline 0 N--CA 1.492 1.67 0 O-C-N 121.203 -1.175 . . . . 0.0 110.127 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 781' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -73.27 161.16 43.55 Favored 'Trans proline' 0 C--N 1.307 -1.629 0 O-C-N 123.952 1.501 . . . . 0.0 110.296 179.976 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 782' ' ' LEU . . . . . 0.547 ' CD1' ' CA ' ' A' ' 791' ' ' GLY . 1.2 mp -132.61 169.36 16.73 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.233 -0.917 . . . . 0.0 110.159 179.984 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 783' ' ' GLY . . . . . . . . . . . . . . . 95.61 -167.67 26.0 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.354 -1.498 . . . . 0.0 109.354 -179.994 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 784' ' ' THR . . . . . 0.574 ' O ' ' CZ ' ' A' ' 788' ' ' PHE . 1.2 p -133.62 -65.69 0.67 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.187 -1.184 . . . . 0.0 110.337 -179.981 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 785' ' ' CYS . . . . . . . . . . . . . 7.8 t -156.19 128.49 7.6 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.166 -0.959 . . . . 0.0 110.445 179.988 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 786' ' ' GLY . . . . . . . . . . . . . . . 92.25 -13.18 67.77 Favored Glycine 0 N--CA 1.492 2.384 0 N-CA-C 109.7 -1.36 . . . . 0.0 109.7 -179.973 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 787' ' ' THR . . . . . 0.435 ' O ' HG23 ' A' ' 787' ' ' THR . 7.5 t -141.21 31.99 1.73 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.206 -1.173 . . . . 0.0 110.612 -179.991 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 788' ' ' PHE . . . . . 0.574 ' CZ ' ' O ' ' A' ' 784' ' ' THR . 0.7 OUTLIER -61.02 129.23 40.37 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.094 -1.004 . . . . 0.0 109.671 179.982 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 789' ' ' GLN . . . . . . . . . . . . . 5.2 pt20 -133.23 161.06 35.46 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.075 -1.016 . . . . 0.0 110.258 -179.967 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 790' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -75.27 144.36 42.57 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.233 -0.917 . . . . 0.0 110.406 -179.931 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 791' ' ' GLY . . . . . 0.547 ' CA ' ' CD1' ' A' ' 782' ' ' LEU . . . -96.56 -46.1 2.59 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 -179.98 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 792' ' ' GLU . . . . . 0.449 ' HB3' ' O ' ' A' ' 791' ' ' GLY . 15.8 pt-20 179.17 -27.63 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.158 -1.201 . . . . 0.0 110.93 -179.921 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 793' ' ' CYS . . . . . 0.461 ' O ' ' HB2' ' A' ' 794' ' ' HIS . 1.7 m -102.72 164.1 11.83 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.058 -1.026 . . . . 0.0 110.979 -179.92 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 794' ' ' HIS . . . . . 0.498 ' CE1' ' OG ' ' A' ' 798' ' ' SER . 32.3 t60 179.56 135.52 0.1 Allowed 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.466 -0.771 . . . . 0.0 109.727 179.941 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 795' ' ' SER . . . . . 0.419 ' O ' ' N ' ' A' ' 797' ' ' ASN . 0.2 OUTLIER -90.87 23.78 3.01 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.19 -0.944 . . . . 0.0 110.884 -179.909 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 796' ' ' ILE . . . . . 0.491 HG22 ' O ' ' A' ' 796' ' ' ILE . 40.9 mt 42.65 27.29 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 O-C-N 121.125 -0.984 . . . . 0.0 110.018 179.958 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 797' ' ' ASN . . . . . 0.419 ' N ' ' O ' ' A' ' 795' ' ' SER . 1.2 t-20 -157.25 26.88 0.3 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.246 -0.909 . . . . 0.0 109.611 179.972 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 798' ' ' SER . . . . . 0.581 ' CB ' ' HA ' ' A' ' 777' ' ' SER . 2.8 m -84.28 -19.65 33.46 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.396 -0.815 . . . . 0.0 110.515 -179.96 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 799' ' ' ASN . . . . . 0.539 ' OD1' ' HB3' ' A' ' 776' ' ' ALA . 63.9 m-80 -108.87 -1.06 19.43 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.276 -0.89 . . . . 0.0 110.751 -179.996 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 800' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -91.83 -31.34 15.76 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.21 -0.931 . . . . 0.0 110.434 -179.962 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 801' ' ' VAL . . . . . . . . . . . . . 95.7 t -79.93 -17.93 12.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.359 -0.838 . . . . 0.0 110.089 -179.949 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 802' ' ' LEU . . . . . 0.488 ' N ' ' CD2' ' A' ' 802' ' ' LEU . 4.5 mm? -87.71 -60.43 1.97 Allowed 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.317 -0.864 . . . . 0.0 110.838 -179.955 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 803' ' ' GLU . . . . . 0.603 ' CG ' HD12 ' A' ' 807' ' ' ILE . 1.1 tt0 -57.3 -20.23 27.14 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.113 -0.992 . . . . 0.0 110.527 -179.988 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 804' ' ' ARG . . . . . . . . . . . . . 48.2 ttt85 -93.8 -20.21 20.3 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.268 -0.895 . . . . 0.0 111.757 -179.896 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 805' ' ' LYS . . . . . 0.448 ' O ' ' SG ' ' A' ' 806' ' ' CYS . 8.8 tttm -126.29 40.13 3.79 Favored 'General case' 0 N--CA 1.501 2.108 0 O-C-N 120.765 -1.21 . . . . 0.0 111.502 -179.887 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 806' ' ' CYS . . . . . 0.448 ' SG ' ' O ' ' A' ' 805' ' ' LYS . 1.3 m -163.55 -55.06 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.038 -1.039 . . . . 0.0 110.235 179.892 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 807' ' ' ILE . . . . . 0.603 HD12 ' CG ' ' A' ' 803' ' ' GLU . 5.6 mt -51.09 119.15 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.315 -0.866 . . . . 0.0 110.432 -179.965 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 808' ' ' GLY . . . . . 0.43 ' C ' ' HG ' ' A' ' 809' ' ' LEU . . . 111.14 6.93 25.51 Favored Glycine 0 N--CA 1.492 2.415 0 N-CA-C 109.803 -1.319 . . . . 0.0 109.803 179.923 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 809' ' ' LEU . . . . . 0.43 ' HG ' ' C ' ' A' ' 808' ' ' GLY . 15.9 mt -136.25 148.88 48.25 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.203 -1.175 . . . . 0.0 110.311 -179.971 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 810' ' ' GLU . . . . . 0.844 ' HG3' HG22 ' A' ' 769' ' ' THR . 5.1 mt-10 -76.38 -19.09 58.49 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.253 -0.904 . . . . 0.0 109.558 179.881 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 811' ' ' ARG . . . . . 0.489 ' HG3' ' HB3' ' A' ' 763' ' ' LYS . 1.0 OUTLIER -152.78 133.74 14.07 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.527 -0.733 . . . . 0.0 109.665 179.923 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 812' ' ' CYS . . . . . . . . . . . . . 27.6 p -152.02 141.48 21.62 Favored 'General case' 0 C--N 1.296 -1.759 0 O-C-N 121.334 -0.854 . . . . 0.0 110.64 -179.927 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 813' ' ' VAL . . . . . . . . . . . . . 24.2 t -110.21 152.97 12.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.277 -0.89 . . . . 0.0 109.843 -179.983 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 814' ' ' VAL . . . . . . . . . . . . . 22.0 t -131.79 106.46 11.56 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 O-C-N 121.042 -1.036 . . . . 0.0 110.458 -179.936 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 815' ' ' ALA . . . . . . . . . . . . . . . -67.13 143.32 56.7 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.254 -0.904 . . . . 0.0 109.964 179.939 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 816' ' ' ILE . . . . . 1.058 HD13 HG21 ' A' ' 833' ' ' VAL . 20.8 mt -100.02 104.48 16.17 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.211 -0.931 . . . . 0.0 110.156 -179.928 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 817' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -144.61 153.73 55.26 Favored Pre-proline 0 N--CA 1.496 1.835 0 O-C-N 121.322 -0.861 . . . . 0.0 110.279 179.958 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 818' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -76.65 -25.73 9.08 Favored 'Trans proline' 0 C--N 1.309 -1.508 0 O-C-N 123.897 1.472 . . . . 0.0 110.391 -179.999 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 819' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -90.97 18.32 6.81 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.228 -0.92 . . . . 0.0 109.873 179.958 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 820' ' ' ASN . . . . . . . . . . . . . 31.0 t30 -116.16 -32.11 5.45 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.338 -0.851 . . . . 0.0 110.396 -179.998 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 821' ' ' PHE . . . . . . . . . . . . . 54.3 m-85 -86.07 -79.62 0.25 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.16 -0.963 . . . . 0.0 110.008 179.999 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 822' ' ' GLY . . . . . . . . . . . . . . . -177.76 56.5 0.1 OUTLIER Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.213 -1.555 . . . . 0.0 109.213 -179.97 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 823' ' ' GLY . . . . . . . . . . . . . . . 99.01 -149.65 19.12 Favored Glycine 0 N--CA 1.487 2.041 0 N-CA-C 109.353 -1.499 . . . . 0.0 109.353 179.972 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 824' ' ' ASP . . . . . 0.488 ' OD2' ' N ' ' A' ' 824' ' ' ASP . 0.8 OUTLIER -121.59 142.02 34.83 Favored Pre-proline 0 N--CA 1.492 1.649 0 O-C-N 121.23 -1.159 . . . . 0.0 110.332 179.943 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 825' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -75.61 -89.63 0.0 OUTLIER 'Trans proline' 0 C--N 1.306 -1.675 0 O-C-N 124.105 1.581 . . . . 0.0 110.888 -179.947 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 826' ' ' CYS . . . . . 0.405 ' HB3' HG21 ' A' ' 829' ' ' VAL . 79.0 m -113.62 120.72 38.88 Favored Pre-proline 0 N--CA 1.494 1.748 0 O-C-N 121.196 -0.94 . . . . 0.0 110.475 -179.953 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 827' ' ' PRO . . . . . 0.476 ' O ' ' CB ' ' A' ' 828' ' ' GLU . 49.1 Cg_endo -75.58 142.47 26.19 Favored 'Trans proline' 0 C--N 1.306 -1.66 0 O-C-N 123.839 1.442 . . . . 0.0 110.33 179.938 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 828' ' ' GLU . . . . . 0.476 ' CB ' ' O ' ' A' ' 827' ' ' PRO . 0.8 OUTLIER 67.36 38.65 3.18 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.256 -0.903 . . . . 0.0 110.35 -179.991 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 829' ' ' VAL . . . . . 0.475 ' O ' ' HD3' ' A' ' 831' ' ' LYS . 24.0 t -136.05 132.92 50.46 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.174 -0.954 . . . . 0.0 110.291 -179.945 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 830' ' ' MET . . . . . 0.414 ' C ' ' O ' ' A' ' 829' ' ' VAL . 17.4 mtt -43.96 127.88 5.46 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.289 -0.882 . . . . 0.0 110.012 179.95 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 831' ' ' LYS . . . . . 0.476 ' HB3' ' HB2' ' A' ' 737' ' ' GLU . 0.0 OUTLIER -94.08 112.99 24.87 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.144 -0.973 . . . . 0.0 110.511 -179.983 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 832' ' ' ARG . . . . . . . . . . . . . 33.4 mtp85 -125.12 139.83 53.42 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.317 -0.864 . . . . 0.0 109.823 179.914 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 833' ' ' VAL . . . . . 1.058 HG21 HD13 ' A' ' 816' ' ' ILE . 42.8 t -112.32 105.1 18.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.15 -0.969 . . . . 0.0 110.567 -179.914 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 834' ' ' ALA . . . . . . . . . . . . . . . -113.5 116.43 29.57 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.377 -0.827 . . . . 0.0 109.786 179.976 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 835' ' ' VAL . . . . . . . . . . . . . 29.4 t -130.51 156.75 42.72 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.176 -0.953 . . . . 0.0 110.544 -179.93 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 836' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -149.21 113.14 5.13 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.489 -0.757 . . . . 0.0 109.652 179.954 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 837' ' ' ALA . . . . . . . . . . . . . . . -110.22 163.42 13.64 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.098 -1.001 . . . . 0.0 110.465 -179.983 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 838' ' ' VAL . . . . . 0.419 ' O ' ' HA ' ' A' ' 770' ' ' ILE . 74.5 t -114.09 156.72 14.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.339 -0.851 . . . . 0.0 110.203 -179.968 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 839' ' ' CYS . . . . . . . . . . . . . 1.2 m -136.59 148.0 47.27 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.322 -0.861 . . . . 0.0 110.194 179.978 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 840' ' ' SER . . . . . 0.586 ' O ' HG23 ' A' ' 841' ' ' THR . 9.6 t -119.09 -99.36 0.44 Allowed 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.272 -0.892 . . . . 0.0 110.678 -179.953 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 841' ' ' THR . . . . . 0.586 HG23 ' O ' ' A' ' 840' ' ' SER . 19.5 p . . . . . 0 N--CA 1.493 1.688 0 O-C-N 121.008 -1.057 . . . . 0.0 110.191 -179.975 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 728' ' ' VAL . . . . . 0.479 ' O ' ' HB2' ' A' ' 729' ' ' SER . 68.2 t . . . . . 0 N--CA 1.493 1.676 0 CA-C-O 120.968 0.413 . . . . 0.0 110.178 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 729' ' ' SER . . . . . 0.479 ' HB2' ' O ' ' A' ' 728' ' ' VAL . 14.8 t -178.98 125.37 0.09 Allowed 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.147 -0.971 . . . . 0.0 110.891 179.947 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 730' ' ' GLY . . . . . . . . . . . . . . . 103.45 116.53 4.21 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 110.194 -1.162 . . . . 0.0 110.194 179.947 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 731' ' ' VAL . . . . . 0.521 ' CG2' ' O ' ' A' ' 837' ' ' ALA . 3.5 m -147.87 161.81 7.04 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.367 -1.078 . . . . 0.0 109.27 179.92 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 732' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -148.51 161.29 41.94 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.001 -1.062 . . . . 0.0 110.955 -179.978 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 733' ' ' ALA . . . . . . . . . . . . . . . -163.51 104.35 0.95 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.536 -0.728 . . . . 0.0 109.416 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 734' ' ' ASP . . . . . 0.589 ' C ' HG23 ' A' ' 735' ' ' VAL . 1.8 t70 -117.25 121.51 41.37 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.235 -0.916 . . . . 0.0 110.79 -179.959 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 735' ' ' VAL . . . . . 0.589 HG23 ' C ' ' A' ' 734' ' ' ASP . 49.0 t -156.09 148.61 11.67 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 O-C-N 121.326 -0.859 . . . . 0.0 109.796 179.926 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 736' ' ' SER . . . . . . . . . . . . . 90.7 p -98.77 -167.61 1.51 Allowed 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.114 -0.991 . . . . 0.0 110.588 -179.909 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 737' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.493 1.724 0 O-C-N 121.272 -0.892 . . . . 0.0 110.027 179.983 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 757' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.489 1.498 0 CA-C-O 121.39 0.614 . . . . 0.0 110.522 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 758' ' ' ALA . . . . . 0.472 ' O ' ' HG2' ' A' ' 759' ' ' LYS . . . -88.97 172.33 9.22 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.257 -0.902 . . . . 0.0 109.866 179.96 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 759' ' ' LYS . . . . . 0.472 ' HG2' ' O ' ' A' ' 758' ' ' ALA . 3.1 mtmt -142.91 162.95 34.12 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.069 -1.02 . . . . 0.0 110.644 -179.962 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 760' ' ' VAL . . . . . 0.948 ' O ' HG23 ' A' ' 813' ' ' VAL . 95.2 t -109.22 157.12 9.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.417 -0.802 . . . . 0.0 109.124 179.874 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 761' ' ' HIS . . . . . . . . . . . . . 35.2 m80 -128.53 113.91 16.08 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.937 -1.102 . . . . 0.0 111.369 -179.89 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 762' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -122.38 106.45 11.08 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 179.892 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 763' ' ' LYS . . . . . . . . . . . . . 5.4 ttmt -131.2 135.45 47.41 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.977 -1.077 . . . . 0.0 111.199 -179.833 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 764' ' ' CYS . . . . . . . . . . . . . 59.5 m -106.58 175.58 5.45 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.566 -0.709 . . . . 0.0 109.801 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 765' ' ' ALA . . . . . 0.622 ' HB1' ' HD2' ' A' ' 766' ' ' PRO . . . -55.21 167.96 0.62 Allowed Pre-proline 0 N--CA 1.494 1.771 0 O-C-N 121.216 -0.927 . . . . 0.0 110.497 179.999 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 766' ' ' PRO . . . . . 0.622 ' HD2' ' HB1' ' A' ' 765' ' ' ALA . 48.1 Cg_endo -73.43 110.17 3.0 Favored 'Trans proline' 0 C--N 1.304 -1.778 0 O-C-N 124.211 1.638 . . . . 0.0 110.309 179.975 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 767' ' ' GLY . . . . . . . . . . . . . . . 117.32 -30.69 6.13 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.711 -1.356 . . . . 0.0 109.711 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 768' ' ' GLN . . . . . 0.47 ' OE1' HG22 ' A' ' 841' ' ' THR . 44.5 mm-40 -85.88 162.01 18.8 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.183 -1.187 . . . . 0.0 110.245 -179.926 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 769' ' ' THR . . . . . 0.448 HG22 ' OE1' ' A' ' 810' ' ' GLU . 64.9 p -146.43 146.99 30.79 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.248 -0.907 . . . . 0.0 110.214 -179.986 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 770' ' ' ILE . . . . . 0.475 HG13 ' SG ' ' A' ' 839' ' ' CYS . 1.8 mp -69.06 147.79 11.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.35 -0.843 . . . . 0.0 109.13 179.942 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 771' ' ' SER . . . . . . . . . . . . . 34.8 m -130.75 -11.85 3.84 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 120.882 -1.136 . . . . 0.0 111.794 -179.891 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 772' ' ' ALA . . . . . . . . . . . . . . . -161.75 153.5 19.01 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 120.743 -1.223 . . . . 0.0 111.492 -179.927 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 773' ' ' ILE . . . . . . . . . . . . . 15.1 mm -113.97 125.17 71.2 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.534 -0.729 . . . . 0.0 109.372 179.901 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 774' ' ' LYS . . . . . 0.552 ' HG3' ' N ' ' A' ' 775' ' ' PHE . 0.5 OUTLIER -89.69 -36.13 15.4 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.089 -1.007 . . . . 0.0 110.815 -179.892 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 775' ' ' PHE . . . . . 0.552 ' N ' ' HG3' ' A' ' 774' ' ' LYS . 65.2 t80 -137.47 149.78 47.09 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.982 -1.074 . . . . 0.0 110.746 -179.924 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 776' ' ' ALA . . . . . 0.487 ' HB3' ' HB3' ' A' ' 799' ' ' ASN . . . -179.03 106.74 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.548 -0.72 . . . . 0.0 109.531 179.954 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 777' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -139.69 136.67 34.49 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.13 -0.981 . . . . 0.0 110.55 -179.877 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 778' ' ' PHE . . . . . 0.753 ' HD2' HG22 ' A' ' 833' ' ' VAL . 86.4 t80 -104.27 76.38 1.32 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.427 -0.796 . . . . 0.0 109.915 179.988 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 779' ' ' GLY . . . . . . . . . . . . . . . -171.34 -109.77 0.23 Allowed Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.755 -1.338 . . . . 0.0 109.755 -179.989 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 780' ' ' THR . . . . . . . . . . . . . 2.9 p -112.54 92.42 19.71 Favored Pre-proline 0 N--CA 1.494 1.732 0 O-C-N 121.259 -1.142 . . . . 0.0 110.662 -179.992 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 781' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -79.04 127.63 7.8 Favored 'Trans proline' 0 C--N 1.305 -1.73 0 O-C-N 124.064 1.56 . . . . 0.0 110.19 -179.999 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 782' ' ' LEU . . . . . 0.434 ' O ' ' HA ' ' A' ' 788' ' ' PHE . 2.6 mt -96.68 108.3 20.9 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.137 -0.977 . . . . 0.0 110.356 179.989 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 783' ' ' GLY . . . . . . . . . . . . . . . 120.99 -154.31 16.45 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.643 -1.383 . . . . 0.0 109.643 -179.995 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 784' ' ' THR . . . . . 0.574 ' O ' ' CZ ' ' A' ' 788' ' ' PHE . 9.9 t -151.09 -40.54 0.12 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.279 -1.13 . . . . 0.0 110.137 -179.959 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 785' ' ' CYS . . . . . 0.555 ' N ' HG23 ' A' ' 784' ' ' THR . 16.2 t -166.95 118.97 0.94 Allowed 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.306 -0.871 . . . . 0.0 109.692 -179.982 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 786' ' ' GLY . . . . . . . . . . . . . . . 85.84 -9.18 69.65 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.335 -1.506 . . . . 0.0 109.335 -179.96 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 787' ' ' THR . . . . . . . . . . . . . 18.7 p -139.56 33.94 2.04 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.23 -1.159 . . . . 0.0 110.174 -179.965 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 788' ' ' PHE . . . . . 0.676 ' CE1' ' HB1' ' A' ' 834' ' ' ALA . 7.2 m-85 -71.18 174.69 6.05 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.228 -0.92 . . . . 0.0 110.337 179.98 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 789' ' ' GLN . . . . . 0.485 ' CG ' ' O ' ' A' ' 788' ' ' PHE . 0.0 OUTLIER 179.44 167.14 1.09 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.185 -0.947 . . . . 0.0 110.327 -179.971 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 790' ' ' GLN . . . . . . . . . . . . . 31.5 mt-30 -99.05 143.84 28.87 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.258 -0.901 . . . . 0.0 110.181 179.952 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 791' ' ' GLY . . . . . . . . . . . . . . . -101.89 -109.41 3.26 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.577 -1.409 . . . . 0.0 109.577 179.993 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 792' ' ' GLU . . . . . . . . . . . . . 8.5 mt-10 -129.65 15.4 5.94 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.322 -1.105 . . . . 0.0 110.068 -179.993 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 793' ' ' CYS . . . . . . . . . . . . . 1.7 m -147.53 122.78 10.24 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.279 -0.888 . . . . 0.0 110.224 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 794' ' ' HIS . . . . . 0.609 ' CD2' ' O ' ' A' ' 795' ' ' SER . 77.4 t60 -147.91 144.3 27.97 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.188 -0.945 . . . . 0.0 110.798 -179.97 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 795' ' ' SER . . . . . 0.609 ' O ' ' CD2' ' A' ' 794' ' ' HIS . 27.2 t -88.42 167.86 13.12 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 179.853 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 796' ' ' ILE . . . . . . . . . . . . . 3.1 mt -90.19 -22.76 6.27 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.837 0 O-C-N 120.47 -1.394 . . . . 0.0 110.286 -179.859 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 797' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -102.43 51.54 0.81 Allowed 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.167 -0.958 . . . . 0.0 109.407 179.943 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 798' ' ' SER . . . . . 0.572 ' OG ' ' CE1' ' A' ' 794' ' ' HIS . 0.3 OUTLIER -83.64 -45.08 13.86 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.407 -0.808 . . . . 0.0 111.339 -179.858 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 799' ' ' ASN . . . . . 0.495 ' HA ' HD23 ' A' ' 802' ' ' LEU . 7.3 p30 -105.63 -14.2 15.34 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 120.889 -1.132 . . . . 0.0 111.012 -179.838 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 800' ' ' SER . . . . . . . . . . . . . 22.4 t -65.69 -19.1 65.77 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.069 -1.019 . . . . 0.0 110.37 -179.989 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 801' ' ' VAL . . . . . . . . . . . . . 96.2 t -83.86 -23.21 8.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.122 -0.986 . . . . 0.0 110.104 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 802' ' ' LEU . . . . . 0.737 HD22 ' N ' ' A' ' 802' ' ' LEU . 3.4 mm? -80.48 -62.32 1.71 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.346 -0.846 . . . . 0.0 110.337 179.969 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 803' ' ' GLU . . . . . 0.805 ' HA ' HD12 ' A' ' 807' ' ' ILE . 1.2 tm-20 -52.03 -17.88 1.2 Allowed 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.128 -0.983 . . . . 0.0 110.887 -179.983 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 804' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.29 -31.21 17.04 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 120.97 -1.082 . . . . 0.0 111.471 -179.92 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 805' ' ' LYS . . . . . . . . . . . . . 7.3 mttm -137.1 51.8 1.95 Allowed 'General case' 0 N--CA 1.498 1.961 0 O-C-N 120.756 -1.215 . . . . 0.0 111.313 -179.935 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 806' ' ' CYS . . . . . 0.52 ' HA ' ' CB ' ' A' ' 812' ' ' CYS . 1.1 m -162.75 -54.93 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.101 -0.999 . . . . 0.0 110.204 179.902 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 807' ' ' ILE . . . . . 0.805 HD12 ' HA ' ' A' ' 803' ' ' GLU . 61.6 mt -65.26 103.21 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.239 -0.913 . . . . 0.0 110.077 179.973 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 808' ' ' GLY . . . . . 0.446 ' C ' ' HG ' ' A' ' 809' ' ' LEU . . . 127.0 11.37 3.52 Favored Glycine 0 N--CA 1.492 2.377 0 N-CA-C 110.009 -1.236 . . . . 0.0 110.009 179.972 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 809' ' ' LEU . . . . . 0.446 ' HG ' ' C ' ' A' ' 808' ' ' GLY . 1.5 mt -133.23 150.13 51.96 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.111 -1.229 . . . . 0.0 110.245 179.972 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 810' ' ' GLU . . . . . 0.448 ' OE1' HG22 ' A' ' 769' ' ' THR . 0.2 OUTLIER -65.74 -26.74 67.87 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.192 -0.943 . . . . 0.0 109.255 179.914 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 811' ' ' ARG . . . . . 0.454 ' O ' ' HG3' ' A' ' 811' ' ' ARG . 4.1 ppt_? -161.23 120.58 2.56 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.629 -0.67 . . . . 0.0 109.198 179.89 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 812' ' ' CYS . . . . . 0.52 ' CB ' ' HA ' ' A' ' 806' ' ' CYS . 24.0 p -121.55 156.87 31.95 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 120.996 -1.065 . . . . 0.0 111.428 -179.856 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 813' ' ' VAL . . . . . 0.948 HG23 ' O ' ' A' ' 760' ' ' VAL . 9.9 p -139.4 126.46 24.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 179.966 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 814' ' ' VAL . . . . . . . . . . . . . 44.3 t -110.18 130.13 63.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.077 -1.015 . . . . 0.0 110.779 -179.936 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 815' ' ' ALA . . . . . . . . . . . . . . . -78.37 125.02 28.76 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.347 -0.846 . . . . 0.0 109.806 179.959 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 816' ' ' ILE . . . . . 0.401 ' CG2' HG21 ' A' ' 833' ' ' VAL . 96.4 mt -79.17 111.74 16.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.274 -0.891 . . . . 0.0 110.359 -179.949 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 817' ' ' SER . . . . . 0.44 ' OG ' ' HB2' ' A' ' 820' ' ' ASN . 0.0 OUTLIER -152.03 166.71 14.66 Favored Pre-proline 0 N--CA 1.493 1.692 0 O-C-N 121.348 -0.845 . . . . 0.0 110.016 179.961 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 818' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -76.35 -57.28 0.05 OUTLIER 'Trans proline' 0 C--N 1.307 -1.651 0 O-C-N 123.931 1.49 . . . . 0.0 110.665 -179.94 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 819' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -66.06 -9.85 34.69 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.184 -0.947 . . . . 0.0 110.524 -179.981 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 820' ' ' ASN . . . . . 0.44 ' HB2' ' OG ' ' A' ' 817' ' ' SER . 17.2 t30 -92.92 -16.4 25.22 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.117 -0.989 . . . . 0.0 110.317 -179.997 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 821' ' ' PHE . . . . . . . . . . . . . 1.9 m-85 -109.53 -79.04 0.58 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.241 -0.912 . . . . 0.0 110.211 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 822' ' ' GLY . . . . . . . . . . . . . . . 176.41 42.19 0.06 OUTLIER Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.493 -1.443 . . . . 0.0 109.493 179.956 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 823' ' ' GLY . . . . . . . . . . . . . . . 79.05 -162.6 48.54 Favored Glycine 0 N--CA 1.492 2.431 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 -179.979 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 824' ' ' ASP . . . . . . . . . . . . . 4.2 p30 -121.86 152.84 59.94 Favored Pre-proline 0 N--CA 1.493 1.723 0 O-C-N 121.254 -1.145 . . . . 0.0 110.149 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 825' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -78.76 -84.68 0.0 OUTLIER 'Trans proline' 0 C--N 1.304 -1.787 0 O-C-N 124.0 1.526 . . . . 0.0 110.751 -179.896 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 826' ' ' CYS . . . . . 0.524 ' SG ' HG21 ' A' ' 829' ' ' VAL . 28.5 p -105.85 142.75 25.46 Favored Pre-proline 0 N--CA 1.492 1.674 0 O-C-N 121.125 -0.985 . . . . 0.0 110.656 -179.913 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 827' ' ' PRO . . . . . 0.666 ' O ' HG23 ' A' ' 829' ' ' VAL . 50.3 Cg_endo -85.15 -179.14 3.43 Favored 'Trans proline' 0 C--N 1.303 -1.817 0 O-C-N 124.209 1.636 . . . . 0.0 109.983 179.895 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 828' ' ' GLU . . . . . 0.468 ' HB2' ' O ' ' A' ' 827' ' ' PRO . 7.5 mt-10 58.55 14.94 3.29 Favored 'General case' 0 C--N 1.297 -1.697 0 O-C-N 121.331 -0.856 . . . . 0.0 109.894 -179.978 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 829' ' ' VAL . . . . . 0.666 HG23 ' O ' ' A' ' 827' ' ' PRO . 60.8 t -128.85 122.5 57.01 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.405 0 O-C-N 121.333 -0.855 . . . . 0.0 110.205 -179.965 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 830' ' ' MET . . . . . 0.466 ' O ' ' O ' ' A' ' 829' ' ' VAL . 0.0 OUTLIER -48.79 176.9 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.022 -1.049 . . . . 0.0 109.531 -179.986 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 831' ' ' LYS . . . . . . . . . . . . . 6.2 mptt -138.82 110.1 6.92 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.977 -1.077 . . . . 0.0 110.873 -179.898 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 832' ' ' ARG . . . . . . . . . . . . . 73.9 mtp85 -115.84 157.59 24.21 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.382 -0.824 . . . . 0.0 109.43 179.904 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 833' ' ' VAL . . . . . 0.753 HG22 ' HD2' ' A' ' 778' ' ' PHE . 65.0 t -122.82 104.4 14.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.042 -1.036 . . . . 0.0 110.855 -179.997 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 834' ' ' ALA . . . . . 0.676 ' HB1' ' CE1' ' A' ' 788' ' ' PHE . . . -109.16 124.25 50.53 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.34 -0.85 . . . . 0.0 109.171 179.944 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 835' ' ' VAL . . . . . . . . . . . . . 11.8 t -138.9 142.81 33.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.059 -1.026 . . . . 0.0 111.346 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 836' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 -126.62 135.61 51.44 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 179.93 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 837' ' ' ALA . . . . . 0.521 ' O ' ' CG2' ' A' ' 731' ' ' VAL . . . -118.72 164.49 15.29 Favored 'General case' 0 C--N 1.298 -1.632 0 O-C-N 120.966 -1.084 . . . . 0.0 111.087 -179.85 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 838' ' ' VAL . . . . . . . . . . . . . 24.9 t -116.96 105.32 18.02 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 179.96 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 839' ' ' CYS . . . . . 0.475 ' SG ' HG13 ' A' ' 770' ' ' ILE . 0.1 OUTLIER -106.51 152.83 23.15 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.204 -0.935 . . . . 0.0 110.865 -179.82 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 840' ' ' SER . . . . . 0.489 ' O ' HG23 ' A' ' 841' ' ' THR . 2.7 p -164.08 -91.89 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.402 -0.811 . . . . 0.0 109.813 179.861 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 841' ' ' THR . . . . . 0.489 HG23 ' O ' ' A' ' 840' ' ' SER . 8.8 p . . . . . 0 N--CA 1.49 1.533 0 O-C-N 121.38 -0.825 . . . . 0.0 109.736 -179.996 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 728' ' ' VAL . . . . . . . . . . . . . 34.2 m . . . . . 0 N--CA 1.493 1.706 0 CA-C-O 121.312 0.577 . . . . 0.0 110.415 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 729' ' ' SER . . . . . 0.766 ' O ' HG23 ' A' ' 731' ' ' VAL . 12.1 t -127.39 74.41 1.51 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.275 -0.891 . . . . 0.0 110.217 179.965 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 730' ' ' GLY . . . . . . . . . . . . . . . -62.38 114.69 7.07 Favored Glycine 0 N--CA 1.493 2.436 0 N-CA-C 109.222 -1.551 . . . . 0.0 109.222 179.989 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 731' ' ' VAL . . . . . 0.766 HG23 ' O ' ' A' ' 729' ' ' SER . 21.8 t -129.39 137.22 57.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.189 -1.183 . . . . 0.0 110.592 -179.986 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 732' ' ' CYS . . . . . . . . . . . . . 4.9 p -129.32 146.06 51.27 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.434 -0.791 . . . . 0.0 109.366 179.967 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 733' ' ' ALA . . . . . 0.505 ' CB ' HG13 ' A' ' 760' ' ' VAL . . . -110.45 104.22 12.95 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 120.952 -1.093 . . . . 0.0 111.351 -179.978 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 734' ' ' ASP . . . . . 0.45 ' OD1' ' O ' ' A' ' 734' ' ' ASP . 0.6 OUTLIER -110.07 100.9 9.76 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.339 -0.851 . . . . 0.0 108.865 179.895 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 735' ' ' VAL . . . . . . . . . . . . . 14.4 m -140.08 152.82 22.14 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 121.229 -0.92 . . . . 0.0 110.941 -179.885 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 736' ' ' SER . . . . . 0.542 ' O ' ' CB ' ' A' ' 758' ' ' ALA . 3.3 m -82.33 177.05 8.97 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 179.839 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 737' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 . . . . . 0 N--CA 1.493 1.709 0 O-C-N 120.738 -1.226 . . . . 0.0 110.213 -179.993 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 757' ' ' THR . . . . . 0.455 ' HB ' ' O ' ' A' ' 816' ' ' ILE . 32.1 p . . . . . 0 N--CA 1.489 1.515 0 CA-C-O 121.151 0.501 . . . . 0.0 110.205 . . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 758' ' ' ALA . . . . . 0.542 ' CB ' ' O ' ' A' ' 736' ' ' SER . . . -102.83 -179.18 3.89 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.181 -0.949 . . . . 0.0 110.153 179.99 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 759' ' ' LYS . . . . . . . . . . . . . 9.6 mtpp -133.81 161.99 33.21 Favored 'General case' 0 C--N 1.297 -1.686 0 O-C-N 121.452 -0.78 . . . . 0.0 110.233 179.997 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 760' ' ' VAL . . . . . 0.983 HG23 HD11 ' A' ' 816' ' ' ILE . 39.8 t -125.55 114.85 41.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.344 -0.847 . . . . 0.0 109.191 179.927 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 761' ' ' HIS . . . . . . . . . . . . . 1.5 t-160 -110.64 114.44 27.84 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 120.914 -1.117 . . . . 0.0 111.185 -179.964 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 762' ' ' LEU . . . . . . . . . . . . . 17.8 mt -111.2 103.66 12.1 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.508 -0.745 . . . . 0.0 109.327 179.825 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 763' ' ' LYS . . . . . . . . . . . . . 5.3 pttp -117.81 136.87 53.12 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.098 -1.001 . . . . 0.0 110.925 -179.889 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 764' ' ' CYS . . . . . . . . . . . . . 86.2 m -105.32 173.46 6.3 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.372 -0.83 . . . . 0.0 109.673 179.927 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 765' ' ' ALA . . . . . 0.417 ' HB3' ' OE1' ' A' ' 768' ' ' GLN . . . -67.88 160.91 71.25 Favored Pre-proline 0 N--CA 1.494 1.745 0 O-C-N 121.18 -0.95 . . . . 0.0 110.44 179.969 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 766' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -72.02 96.1 0.77 Allowed 'Trans proline' 0 C--N 1.308 -1.584 0 O-C-N 124.006 1.53 . . . . 0.0 110.117 179.959 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 767' ' ' GLY . . . . . . . . . . . . . . . 140.21 -31.95 2.22 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 108.762 -1.735 . . . . 0.0 108.762 -179.999 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 768' ' ' GLN . . . . . 0.477 ' HG3' ' HB ' ' A' ' 841' ' ' THR . 12.8 mp0 -93.64 152.34 19.06 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.559 -0.965 . . . . 0.0 109.421 179.956 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 769' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -129.91 151.62 50.28 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.046 -1.034 . . . . 0.0 110.741 -179.976 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 770' ' ' ILE . . . . . 0.451 HD12 ' O ' ' A' ' 809' ' ' LEU . 30.9 mt -76.48 152.78 5.87 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.433 -0.792 . . . . 0.0 109.537 179.85 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 771' ' ' SER . . . . . 0.441 ' HA ' HG23 ' A' ' 807' ' ' ILE . 3.3 m -146.57 -15.88 0.43 Allowed 'General case' 0 N--CA 1.494 1.749 0 O-C-N 120.845 -1.159 . . . . 0.0 112.597 -179.903 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 772' ' ' ALA . . . . . . . . . . . . . . . -158.34 150.05 21.35 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 120.235 -1.54 . . . . 0.0 112.438 -179.912 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 773' ' ' ILE . . . . . . . . . . . . . 14.5 mm -116.21 118.39 58.62 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 179.863 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 774' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -84.13 -38.31 20.87 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 120.957 -1.09 . . . . 0.0 111.895 -179.826 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 775' ' ' PHE . . . . . 0.622 ' O ' ' HB2' ' A' ' 776' ' ' ALA . 58.4 t80 -129.52 166.64 19.25 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 120.712 -1.243 . . . . 0.0 111.468 -179.942 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 776' ' ' ALA . . . . . 0.926 ' HB3' ' HB2' ' A' ' 799' ' ' ASN . . . 171.76 101.48 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.736 -0.603 . . . . 0.0 109.382 179.962 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 777' ' ' SER . . . . . . . . . . . . . 29.1 t -134.55 125.63 27.67 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.37 -0.831 . . . . 0.0 110.204 -179.882 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 778' ' ' PHE . . . . . 0.543 ' CZ ' ' O ' ' A' ' 817' ' ' SER . 2.2 t80 -111.12 81.35 1.42 Allowed 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.421 -0.799 . . . . 0.0 109.887 179.934 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 779' ' ' GLY . . . . . . . . . . . . . . . -179.49 -89.97 0.08 OUTLIER Glycine 0 N--CA 1.493 2.449 0 N-CA-C 109.526 -1.429 . . . . 0.0 109.526 -179.946 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 780' ' ' THR . . . . . 0.492 ' O ' ' HA3' ' A' ' 791' ' ' GLY . 38.8 p -123.17 83.0 51.52 Favored Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.048 -1.266 . . . . 0.0 110.675 179.992 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 781' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -74.45 123.54 8.23 Favored 'Trans proline' 0 C--N 1.304 -1.809 0 O-C-N 124.077 1.567 . . . . 0.0 109.952 179.989 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 782' ' ' LEU . . . . . 0.754 HD12 ' HA2' ' A' ' 791' ' ' GLY . 10.8 mt -111.1 83.83 1.83 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.237 -0.914 . . . . 0.0 110.412 -179.959 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 783' ' ' GLY . . . . . . . . . . . . . . . 148.45 -173.63 28.38 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.549 -1.42 . . . . 0.0 109.549 -179.944 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 784' ' ' THR . . . . . 0.546 ' O ' ' CD2' ' A' ' 788' ' ' PHE . 80.3 p -132.41 -148.41 0.34 Allowed 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.275 -1.132 . . . . 0.0 110.375 -179.97 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 785' ' ' CYS . . . . . . . . . . . . . 4.2 t -70.87 106.88 3.77 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.227 -0.92 . . . . 0.0 109.889 179.984 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 786' ' ' GLY . . . . . . . . . . . . . . . 114.31 -26.25 9.87 Favored Glycine 0 N--CA 1.488 2.135 0 N-CA-C 109.246 -1.542 . . . . 0.0 109.246 -179.965 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 787' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -124.46 25.95 7.46 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.326 -1.103 . . . . 0.0 110.581 -179.958 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 788' ' ' PHE . . . . . 0.808 ' CE1' ' HB1' ' A' ' 834' ' ' ALA . 2.4 m-85 -71.46 112.43 7.58 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.225 -0.922 . . . . 0.0 109.616 -179.95 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 789' ' ' GLN . . . . . . . . . . . . . 14.4 tp60 -125.71 137.19 53.82 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.143 -0.973 . . . . 0.0 110.593 -179.962 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 790' ' ' GLN . . . . . 0.426 ' O ' ' HG3' ' A' ' 790' ' ' GLN . 19.3 pt20 -41.32 139.4 1.03 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.477 -0.764 . . . . 0.0 110.316 179.928 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 791' ' ' GLY . . . . . 0.754 ' HA2' HD12 ' A' ' 782' ' ' LEU . . . -89.59 -153.92 28.64 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.356 -1.498 . . . . 0.0 109.356 -179.999 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 792' ' ' GLU . . . . . . . . . . . . . 26.6 pt-20 -87.55 -35.18 18.29 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.22 -1.165 . . . . 0.0 109.744 179.951 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 793' ' ' CYS . . . . . 0.449 ' SG ' ' HB2' ' A' ' 825' ' ' PRO . 0.5 OUTLIER -109.87 100.72 9.65 Favored 'General case' 0 C--N 1.307 -1.255 0 O-C-N 121.271 -0.893 . . . . 0.0 110.604 179.997 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 794' ' ' HIS . . . . . . . . . . . . . 4.4 t60 -108.69 143.08 38.26 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.091 -1.006 . . . . 0.0 109.826 -179.998 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 795' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -80.19 5.88 13.3 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.321 -0.862 . . . . 0.0 110.021 -179.964 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 796' ' ' ILE . . . . . 0.634 HG22 ' O ' ' A' ' 796' ' ' ILE . 31.4 mt 46.37 24.23 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.162 -0.961 . . . . 0.0 109.86 -179.988 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 797' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -159.6 22.53 0.18 Allowed 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.485 -0.759 . . . . 0.0 109.542 -179.976 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 798' ' ' SER . . . . . 0.72 ' O ' ' HB1' ' A' ' 776' ' ' ALA . 1.1 m -88.31 0.09 56.55 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.414 -0.804 . . . . 0.0 110.19 -179.982 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 799' ' ' ASN . . . . . 0.926 ' HB2' ' HB3' ' A' ' 776' ' ' ALA . 60.6 t-20 -124.66 1.34 8.2 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.254 -0.903 . . . . 0.0 109.954 179.973 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 800' ' ' SER . . . . . . . . . . . . . 1.5 t -91.64 -40.17 11.46 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.371 -0.831 . . . . 0.0 110.452 -179.869 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 801' ' ' VAL . . . . . 0.468 ' HB ' ' CE1' ' A' ' 821' ' ' PHE . 93.2 t -67.55 -19.54 25.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.3 -0.875 . . . . 0.0 110.799 -179.945 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 802' ' ' LEU . . . . . . . . . . . . . 78.7 mt -87.72 -49.74 6.93 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.011 -1.056 . . . . 0.0 110.979 -179.882 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 803' ' ' GLU . . . . . 0.418 ' HG2' HD11 ' A' ' 807' ' ' ILE . 18.6 mt-10 -54.23 -27.21 33.09 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.157 -0.964 . . . . 0.0 111.045 -179.909 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 804' ' ' ARG . . . . . . . . . . . . . 1.6 mpt_? -91.62 -18.32 24.21 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.017 -1.052 . . . . 0.0 111.264 -179.905 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 805' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.66 12.89 19.83 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 120.91 -1.119 . . . . 0.0 111.331 -179.926 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 806' ' ' CYS . . . . . 0.414 ' O ' ' C ' ' A' ' 807' ' ' ILE . 21.0 m -141.38 -67.99 0.4 Allowed 'General case' 0 N--CA 1.496 1.855 0 O-C-N 120.851 -1.156 . . . . 0.0 110.58 -179.971 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 807' ' ' ILE . . . . . 0.441 HG23 ' HA ' ' A' ' 771' ' ' SER . 42.9 mt -41.24 103.68 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 O-C-N 121.258 -0.901 . . . . 0.0 110.477 -179.986 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 808' ' ' GLY . . . . . 0.71 ' O ' HD23 ' A' ' 809' ' ' LEU . . . 127.06 4.84 5.88 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.613 -1.395 . . . . 0.0 109.613 -179.984 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 809' ' ' LEU . . . . . 0.71 HD23 ' O ' ' A' ' 808' ' ' GLY . 81.4 mt -139.77 149.2 43.28 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.252 -1.146 . . . . 0.0 109.982 179.997 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 810' ' ' GLU . . . . . . . . . . . . . 2.1 pt-20 -78.93 1.47 23.57 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.173 -0.954 . . . . 0.0 109.593 179.981 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 811' ' ' ARG . . . . . . . . . . . . . 21.8 ttp180 -170.13 135.7 1.36 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.41 -0.806 . . . . 0.0 110.014 179.986 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 812' ' ' CYS . . . . . . . . . . . . . 21.9 p -155.12 150.22 26.92 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.401 -0.812 . . . . 0.0 110.292 -179.979 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 813' ' ' VAL . . . . . 0.521 ' C ' HG23 ' A' ' 814' ' ' VAL . 11.9 p -131.78 153.99 39.58 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 O-C-N 121.29 -0.881 . . . . 0.0 110.335 -179.991 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 814' ' ' VAL . . . . . 0.521 HG23 ' C ' ' A' ' 813' ' ' VAL . 11.1 t -151.59 106.58 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 O-C-N 121.314 -0.866 . . . . 0.0 110.241 179.982 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 815' ' ' ALA . . . . . . . . . . . . . . . -54.02 170.92 0.11 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.234 -0.917 . . . . 0.0 110.384 179.942 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 816' ' ' ILE . . . . . 0.983 HD11 HG23 ' A' ' 760' ' ' VAL . 80.5 mt -121.73 141.73 40.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.351 -0.843 . . . . 0.0 109.887 -179.995 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 817' ' ' SER . . . . . 0.547 ' CB ' ' HD2' ' A' ' 818' ' ' PRO . 0.3 OUTLIER -173.91 -178.06 0.37 Allowed Pre-proline 0 N--CA 1.494 1.762 0 O-C-N 121.12 -0.988 . . . . 0.0 110.64 -179.899 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 818' ' ' PRO . . . . . 0.547 ' HD2' ' CB ' ' A' ' 817' ' ' SER . 42.8 Cg_endo -72.9 -76.12 0.01 OUTLIER 'Trans proline' 0 C--N 1.313 -1.329 0 O-C-N 124.043 1.549 . . . . 0.0 111.302 -179.93 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 819' ' ' SER . . . . . . . . . . . . . 40.8 t -84.33 51.93 2.22 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.055 -1.028 . . . . 0.0 110.351 -179.972 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 820' ' ' ASN . . . . . 0.465 ' HB2' ' OG ' ' A' ' 817' ' ' SER . 2.1 t30 -101.92 -49.25 4.01 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.256 -0.903 . . . . 0.0 109.777 179.961 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 821' ' ' PHE . . . . . 0.468 ' CE1' ' HB ' ' A' ' 801' ' ' VAL . 27.4 m-85 -77.26 -23.83 51.17 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.204 -0.935 . . . . 0.0 109.764 179.981 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 822' ' ' GLY . . . . . . . . . . . . . . . 93.95 55.69 1.48 Allowed Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 -179.972 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 823' ' ' GLY . . . . . . . . . . . . . . . 168.31 144.82 4.32 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.654 -1.378 . . . . 0.0 109.654 -179.987 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 824' ' ' ASP . . . . . 0.433 ' OD1' ' O ' ' A' ' 824' ' ' ASP . 11.1 p-10 -144.07 122.3 6.91 Favored Pre-proline 0 N--CA 1.493 1.712 0 O-C-N 121.325 -1.103 . . . . 0.0 110.041 179.999 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 825' ' ' PRO . . . . . 0.449 ' HB2' ' SG ' ' A' ' 793' ' ' CYS . 43.9 Cg_endo -75.59 -78.28 0.01 OUTLIER 'Trans proline' 0 C--N 1.307 -1.632 0 O-C-N 123.88 1.463 . . . . 0.0 110.583 -179.952 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 826' ' ' CYS . . . . . 0.435 ' HA ' ' HD3' ' A' ' 827' ' ' PRO . 5.8 p -125.18 128.46 24.77 Favored Pre-proline 0 N--CA 1.494 1.772 0 O-C-N 121.111 -0.993 . . . . 0.0 110.101 -179.971 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 827' ' ' PRO . . . . . 0.506 ' O ' HG23 ' A' ' 829' ' ' VAL . 48.7 Cg_endo -85.7 177.0 5.11 Favored 'Trans proline' 0 C--N 1.305 -1.726 0 O-C-N 123.883 1.465 . . . . 0.0 110.513 -179.995 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 828' ' ' GLU . . . . . 0.454 ' HB2' ' O ' ' A' ' 827' ' ' PRO . 34.9 mt-10 56.72 23.59 8.06 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.457 -0.777 . . . . 0.0 110.338 -179.958 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 829' ' ' VAL . . . . . 0.506 HG23 ' O ' ' A' ' 827' ' ' PRO . 53.3 t -125.44 135.46 63.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.437 -0.79 . . . . 0.0 109.734 179.929 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 830' ' ' MET . . . . . 0.435 ' C ' ' O ' ' A' ' 829' ' ' VAL . 33.5 ttm -41.26 146.14 0.21 Allowed 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.269 -0.895 . . . . 0.0 109.83 -179.997 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 831' ' ' LYS . . . . . . . . . . . . . 27.6 mttp -134.46 106.47 7.06 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.042 -1.036 . . . . 0.0 111.165 -179.941 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 832' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -108.36 166.13 10.99 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.463 -0.773 . . . . 0.0 109.005 179.805 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 833' ' ' VAL . . . . . 0.9 HG21 HD13 ' A' ' 816' ' ' ILE . 69.4 t -116.19 145.44 21.93 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.602 0 O-C-N 120.879 -1.138 . . . . 0.0 110.967 -179.94 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 834' ' ' ALA . . . . . 0.808 ' HB1' ' CE1' ' A' ' 788' ' ' PHE . . . -155.5 128.15 7.93 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.635 -0.666 . . . . 0.0 109.449 179.954 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 835' ' ' VAL . . . . . 0.445 ' CG1' ' N ' ' A' ' 836' ' ' GLU . 21.7 t -148.14 163.94 5.77 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.026 0 O-C-N 120.973 -1.079 . . . . 0.0 111.439 -179.887 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 836' ' ' GLU . . . . . 0.445 ' N ' ' CG1' ' A' ' 835' ' ' VAL . 6.1 tt0 -145.89 141.38 27.77 Favored 'General case' 0 N--CA 1.496 1.864 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 179.96 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 837' ' ' ALA . . . . . . . . . . . . . . . -134.56 156.71 48.19 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 120.929 -1.107 . . . . 0.0 111.061 -179.966 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 838' ' ' VAL . . . . . . . . . . . . . 69.7 t -114.3 102.96 14.61 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.725 0 O-C-N 121.428 -0.795 . . . . 0.0 109.734 179.97 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 839' ' ' CYS . . . . . 0.438 ' SG ' HG12 ' A' ' 770' ' ' ILE . 0.1 OUTLIER -108.88 139.73 43.32 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.071 -1.018 . . . . 0.0 110.822 -179.97 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 840' ' ' SER . . . . . . . . . . . . . 17.8 m -150.22 -168.52 3.13 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.365 -0.835 . . . . 0.0 110.02 179.944 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 841' ' ' THR . . . . . 0.477 ' HB ' ' HG3' ' A' ' 768' ' ' GLN . 8.9 t . . . . . 0 N--CA 1.494 1.775 0 O-C-N 121.221 -0.925 . . . . 0.0 110.288 -179.986 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 728' ' ' VAL . . . . . 0.462 ' O ' ' HB3' ' A' ' 729' ' ' SER . 11.0 p . . . . . 0 N--CA 1.493 1.704 0 CA-C-O 121.343 0.592 . . . . 0.0 110.65 . . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 729' ' ' SER . . . . . 0.462 ' HB3' ' O ' ' A' ' 728' ' ' VAL . 10.6 t 57.92 142.67 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.47 -0.769 . . . . 0.0 111.193 179.959 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 730' ' ' GLY . . . . . . . . . . . . . . . -132.4 159.73 23.48 Favored Glycine 0 N--CA 1.492 2.424 0 N-CA-C 109.012 -1.635 . . . . 0.0 109.012 179.915 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 731' ' ' VAL . . . . . 0.421 ' CG2' ' HB3' ' A' ' 837' ' ' ALA . 35.7 m -133.37 150.78 32.64 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 O-C-N 121.125 -1.221 . . . . 0.0 110.79 -179.992 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 732' ' ' CYS . . . . . . . . . . . . . 2.4 m -128.82 135.02 48.57 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.489 -0.757 . . . . 0.0 109.647 -179.968 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 733' ' ' ALA . . . . . 0.495 ' CB ' HD21 ' A' ' 762' ' ' LEU . . . -131.87 105.3 7.37 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.922 -1.111 . . . . 0.0 110.946 -179.913 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 734' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -113.66 107.76 16.21 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.339 -0.851 . . . . 0.0 109.088 179.911 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 735' ' ' VAL . . . . . . . . . . . . . 47.9 t -139.73 120.58 14.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.047 -1.033 . . . . 0.0 111.274 -179.926 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 736' ' ' SER . . . . . 0.417 ' O ' ' C ' ' A' ' 737' ' ' GLU . 54.4 p -100.72 -176.38 3.17 Favored 'General case' 0 C--N 1.297 -1.68 0 O-C-N 121.454 -0.779 . . . . 0.0 108.898 179.848 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 737' ' ' GLU . . . . . 0.417 ' C ' ' O ' ' A' ' 736' ' ' SER . 0.7 OUTLIER . . . . . 0 N--CA 1.493 1.716 0 O-C-N 121.113 -0.992 . . . . 0.0 109.604 179.962 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 757' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.498 1.928 0 CA-C-O 121.318 0.58 . . . . 0.0 110.24 . . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 758' ' ' ALA . . . . . . . . . . . . . . . -90.8 165.0 13.88 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.169 -0.957 . . . . 0.0 110.516 -179.906 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 759' ' ' LYS . . . . . 0.444 ' HG2' ' HA ' ' A' ' 815' ' ' ALA . 3.2 mttp -130.39 165.01 23.47 Favored 'General case' 0 C--N 1.302 -1.5 0 O-C-N 121.424 -0.797 . . . . 0.0 109.839 -179.95 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 760' ' ' VAL . . . . . 0.686 HG23 HD11 ' A' ' 816' ' ' ILE . 41.6 t -106.37 153.74 7.62 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.518 0 O-C-N 121.25 -0.906 . . . . 0.0 109.459 179.953 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 761' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -147.87 116.83 6.79 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.051 -1.031 . . . . 0.0 111.219 -179.953 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 762' ' ' LEU . . . . . 0.495 HD21 ' CB ' ' A' ' 733' ' ' ALA . 32.0 mt -110.5 164.48 12.66 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.423 -0.798 . . . . 0.0 108.849 179.888 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 763' ' ' LYS . . . . . . . . . . . . . 14.9 mttt -154.04 128.98 9.5 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.78 -1.2 . . . . 0.0 110.944 -179.928 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 764' ' ' CYS . . . . . 0.433 ' O ' ' C ' ' A' ' 765' ' ' ALA . 10.4 t -103.83 143.78 32.37 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.489 -0.757 . . . . 0.0 109.601 179.996 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 765' ' ' ALA . . . . . 0.433 ' C ' ' O ' ' A' ' 764' ' ' CYS . . . -42.08 150.39 0.38 Allowed Pre-proline 0 N--CA 1.492 1.664 0 O-C-N 121.196 -0.94 . . . . 0.0 110.25 -179.945 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 766' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -70.11 95.95 0.6 Allowed 'Trans proline' 0 C--N 1.306 -1.683 0 O-C-N 124.016 1.535 . . . . 0.0 110.035 -179.923 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 767' ' ' GLY . . . . . . . . . . . . . . . 139.47 -17.76 3.08 Favored Glycine 0 N--CA 1.486 1.972 0 N-CA-C 109.029 -1.628 . . . . 0.0 109.029 -179.936 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 768' ' ' GLN . . . . . . . . . . . . . 20.7 mt-30 -108.61 174.74 5.74 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.362 -1.081 . . . . 0.0 110.133 179.981 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 769' ' ' THR . . . . . . . . . . . . . 8.9 p -144.85 147.97 33.44 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.207 -0.933 . . . . 0.0 110.454 -179.913 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 770' ' ' ILE . . . . . . . . . . . . . 72.1 mt -68.18 145.88 13.28 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.264 -0.898 . . . . 0.0 109.563 179.944 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 771' ' ' SER . . . . . . . . . . . . . 13.5 p -143.47 -3.0 0.94 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.955 -1.09 . . . . 0.0 111.951 -179.956 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 772' ' ' ALA . . . . . . . . . . . . . . . -165.98 143.25 5.41 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 120.559 -1.338 . . . . 0.0 111.648 -179.955 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 773' ' ' ILE . . . . . . . . . . . . . 34.9 mm -105.36 120.41 56.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 179.755 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 774' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.59 -43.55 22.72 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.045 -1.035 . . . . 0.0 111.077 -179.812 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 775' ' ' PHE . . . . . 0.588 ' CZ ' ' HB3' ' A' ' 788' ' ' PHE . 79.3 t80 -149.81 166.42 29.54 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 120.893 -1.129 . . . . 0.0 111.367 -179.925 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 776' ' ' ALA . . . . . 0.551 ' HB2' ' O ' ' A' ' 775' ' ' PHE . . . 174.21 126.2 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 -179.967 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 777' ' ' SER . . . . . . . . . . . . . 2.1 t -148.31 135.02 19.9 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.968 -1.083 . . . . 0.0 111.342 -179.956 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 778' ' ' PHE . . . . . . . . . . . . . 90.1 t80 -103.4 109.46 21.1 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.616 -0.677 . . . . 0.0 109.667 179.95 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 779' ' ' GLY . . . . . . . . . . . . . . . 148.52 -98.87 0.19 Allowed Glycine 0 N--CA 1.492 2.37 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 -179.907 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 780' ' ' THR . . . . . 0.477 ' O ' ' HA3' ' A' ' 791' ' ' GLY . 1.5 p -144.03 91.46 6.53 Favored Pre-proline 0 N--CA 1.494 1.743 0 O-C-N 121.153 -1.204 . . . . 0.0 110.608 179.928 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 781' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -82.57 154.36 15.78 Favored 'Trans proline' 0 C--N 1.304 -1.794 0 O-C-N 123.89 1.468 . . . . 0.0 110.269 179.931 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 782' ' ' LEU . . . . . 0.618 HD13 ' HA2' ' A' ' 791' ' ' GLY . 0.1 OUTLIER -127.76 125.33 39.7 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.082 -1.011 . . . . 0.0 110.508 -179.906 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 783' ' ' GLY . . . . . . . . . . . . . . . 128.24 -168.62 20.07 Favored Glycine 0 N--CA 1.488 2.166 0 N-CA-C 109.779 -1.328 . . . . 0.0 109.779 179.973 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 784' ' ' THR . . . . . 0.474 ' O ' ' HB2' ' A' ' 785' ' ' CYS . 24.1 p -142.93 72.19 1.36 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.323 -1.104 . . . . 0.0 109.834 179.969 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 785' ' ' CYS . . . . . 0.474 ' HB2' ' O ' ' A' ' 784' ' ' THR . 2.2 m 58.88 118.05 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.362 -0.836 . . . . 0.0 109.989 -179.973 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 786' ' ' GLY . . . . . . . . . . . . . . . 102.7 -37.33 3.75 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.061 -1.616 . . . . 0.0 109.061 -179.899 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 787' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -126.12 23.38 7.1 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.347 -1.09 . . . . 0.0 109.801 179.974 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 788' ' ' PHE . . . . . 0.588 ' HB3' ' CZ ' ' A' ' 775' ' ' PHE . 0.3 OUTLIER -56.4 149.76 16.2 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.511 -0.743 . . . . 0.0 110.009 179.987 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 789' ' ' GLN . . . . . 0.404 ' HG2' ' C ' ' A' ' 788' ' ' PHE . 2.3 mm-40 -134.65 173.69 11.39 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.255 -0.903 . . . . 0.0 110.126 -179.991 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 790' ' ' GLN . . . . . 0.408 ' O ' ' C ' ' A' ' 791' ' ' GLY . 0.0 OUTLIER -86.45 16.04 4.91 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.318 -0.864 . . . . 0.0 109.993 179.961 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 791' ' ' GLY . . . . . 0.618 ' HA2' HD13 ' A' ' 782' ' ' LEU . . . 42.45 -120.1 2.28 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.744 -1.343 . . . . 0.0 109.744 -179.963 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 792' ' ' GLU . . . . . . . . . . . . . 12.8 mt-10 -117.26 -30.64 5.54 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.272 -1.134 . . . . 0.0 110.562 179.991 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 793' ' ' CYS . . . . . . . . . . . . . 2.5 t -126.65 156.77 40.48 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.255 -0.903 . . . . 0.0 110.232 -179.979 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 794' ' ' HIS . . . . . 0.51 ' NE2' ' O ' ' A' ' 795' ' ' SER . 49.9 t60 -170.08 150.49 3.76 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.374 -0.829 . . . . 0.0 110.229 -179.994 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 795' ' ' SER . . . . . 0.51 ' O ' ' NE2' ' A' ' 794' ' ' HIS . 3.1 t -99.68 158.07 16.03 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.394 -0.816 . . . . 0.0 109.466 179.948 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 796' ' ' ILE . . . . . 0.414 HG21 HD13 ' A' ' 796' ' ' ILE . 0.6 OUTLIER -92.07 37.24 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.087 0 O-C-N 121.005 -1.059 . . . . 0.0 109.847 -179.926 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 797' ' ' ASN . . . . . . . . . . . . . 18.9 m120 -148.06 22.92 1.08 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.383 -0.823 . . . . 0.0 109.93 179.997 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 798' ' ' SER . . . . . 0.486 ' HB3' ' O ' ' A' ' 776' ' ' ALA . 13.9 m -69.54 -50.35 45.76 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.306 -0.871 . . . . 0.0 110.637 179.991 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 799' ' ' ASN . . . . . 0.49 ' OD1' ' HB3' ' A' ' 776' ' ' ALA . 53.6 m-20 -76.33 -31.96 58.42 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.302 -0.874 . . . . 0.0 110.619 -179.944 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 800' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -56.63 -25.78 54.14 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.246 -0.909 . . . . 0.0 110.999 -179.93 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 801' ' ' VAL . . . . . 0.433 HG21 ' CD2' ' A' ' 821' ' ' PHE . 40.7 t -87.36 -21.66 7.13 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 O-C-N 121.067 -1.02 . . . . 0.0 110.769 -179.944 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 802' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -93.07 -20.91 20.07 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.092 -1.005 . . . . 0.0 111.18 -179.942 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 803' ' ' GLU . . . . . 0.449 ' HA ' HD12 ' A' ' 807' ' ' ILE . 4.4 mt-10 -83.51 -37.92 22.44 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.314 -0.866 . . . . 0.0 111.292 -179.858 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 804' ' ' ARG . . . . . . . . . . . . . 2.1 mtm180 -91.61 -25.61 19.09 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 120.997 -1.064 . . . . 0.0 111.62 -179.915 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 805' ' ' LYS . . . . . . . . . . . . . 2.0 tttp -110.53 44.53 1.24 Allowed 'General case' 0 N--CA 1.497 1.88 0 O-C-N 120.859 -1.15 . . . . 0.0 110.814 -179.939 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 806' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -160.52 -66.97 0.07 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.129 -0.982 . . . . 0.0 110.342 179.945 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 807' ' ' ILE . . . . . 0.449 HD12 ' HA ' ' A' ' 803' ' ' GLU . 30.1 mt -52.18 128.81 11.36 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.078 -1.014 . . . . 0.0 110.467 -179.998 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 808' ' ' GLY . . . . . 0.44 ' C ' ' HG ' ' A' ' 809' ' ' LEU . . . 105.24 9.48 33.82 Favored Glycine 0 N--CA 1.491 2.34 0 C-N-CA 119.918 -1.134 . . . . 0.0 110.284 179.915 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 809' ' ' LEU . . . . . 0.44 ' HG ' ' C ' ' A' ' 808' ' ' GLY . 43.7 mt -138.72 142.6 38.9 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.015 -1.285 . . . . 0.0 110.511 179.979 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 810' ' ' GLU . . . . . . . . . . . . . 5.0 mp0 -67.93 -20.88 65.12 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.182 -0.949 . . . . 0.0 109.418 179.998 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 811' ' ' ARG . . . . . . . . . . . . . 24.6 mtm180 -136.52 157.21 47.32 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.605 -0.684 . . . . 0.0 109.643 179.965 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 812' ' ' CYS . . . . . . . . . . . . . 3.2 t -131.12 146.71 52.45 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.198 -0.939 . . . . 0.0 110.193 -179.971 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 813' ' ' VAL . . . . . 0.633 HG13 ' O ' ' A' ' 813' ' ' VAL . 4.6 p -148.69 116.92 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.151 -0.968 . . . . 0.0 110.024 179.926 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 814' ' ' VAL . . . . . . . . . . . . . 6.7 t -131.39 111.73 19.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.193 -0.942 . . . . 0.0 110.077 179.959 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 815' ' ' ALA . . . . . 0.444 ' HA ' ' HG2' ' A' ' 759' ' ' LYS . . . -61.74 166.79 4.05 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.335 -0.853 . . . . 0.0 110.556 -179.955 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 816' ' ' ILE . . . . . 0.825 HG23 HG21 ' A' ' 833' ' ' VAL . 70.7 mt -119.7 112.89 38.97 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 121.378 -0.826 . . . . 0.0 110.102 179.953 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 817' ' ' SER . . . . . 0.532 ' CB ' ' HD2' ' A' ' 818' ' ' PRO . 0.7 OUTLIER -161.89 -177.36 0.7 Allowed Pre-proline 0 N--CA 1.494 1.744 0 O-C-N 121.101 -1.0 . . . . 0.0 110.313 179.97 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 818' ' ' PRO . . . . . 0.532 ' HD2' ' CB ' ' A' ' 817' ' ' SER . 48.3 Cg_endo -75.34 -48.84 0.15 Allowed 'Trans proline' 0 C--N 1.309 -1.546 0 O-C-N 123.991 1.522 . . . . 0.0 110.77 -179.971 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 819' ' ' SER . . . . . . . . . . . . . 2.8 t -92.76 71.06 4.84 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.334 -0.854 . . . . 0.0 110.411 -179.944 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 820' ' ' ASN . . . . . . . . . . . . . 5.4 t-20 -143.58 -43.23 0.28 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.137 -0.977 . . . . 0.0 110.129 -179.973 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 821' ' ' PHE . . . . . 0.433 ' CD2' HG21 ' A' ' 801' ' ' VAL . 33.3 m-85 -83.08 -57.29 3.34 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.428 -0.795 . . . . 0.0 110.501 -179.949 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 822' ' ' GLY . . . . . . . . . . . . . . . 147.21 66.76 0.01 OUTLIER Glycine 0 N--CA 1.491 2.349 0 C-N-CA 119.512 -1.328 . . . . 0.0 110.111 179.953 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 823' ' ' GLY . . . . . . . . . . . . . . . 120.4 170.5 14.26 Favored Glycine 0 N--CA 1.493 2.497 0 O-C-N 121.12 -1.224 . . . . 0.0 110.267 179.917 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 824' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -132.05 65.82 76.17 Favored Pre-proline 0 N--CA 1.494 1.733 0 O-C-N 121.583 -0.951 . . . . 0.0 109.814 179.986 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 825' ' ' PRO . . . . . 0.459 ' C ' ' HD3' ' A' ' 827' ' ' PRO . 48.7 Cg_endo -74.43 -3.42 13.82 Favored 'Trans proline' 0 C--N 1.305 -1.732 0 O-C-N 124.195 1.629 . . . . 0.0 111.122 -179.915 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 826' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER -126.44 64.83 57.25 Favored Pre-proline 0 N--CA 1.499 2.016 0 O-C-N 120.984 -1.072 . . . . 0.0 110.184 -179.944 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 827' ' ' PRO . . . . . 0.459 ' HD3' ' C ' ' A' ' 825' ' ' PRO . 50.0 Cg_endo -82.36 153.53 16.08 Favored 'Trans proline' 0 C--N 1.311 -1.416 0 O-C-N 123.897 1.472 . . . . 0.0 110.886 179.989 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 828' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 57.71 39.77 27.0 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.448 -0.782 . . . . 0.0 110.781 -179.993 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 829' ' ' VAL . . . . . 0.417 ' O ' ' C ' ' A' ' 830' ' ' MET . 54.3 t -137.45 139.76 42.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.176 -0.953 . . . . 0.0 110.116 179.974 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 830' ' ' MET . . . . . 0.417 ' C ' ' O ' ' A' ' 829' ' ' VAL . 0.2 OUTLIER -44.33 144.61 0.97 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.238 -0.913 . . . . 0.0 109.816 -179.911 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 831' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.2 105.79 18.05 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.233 -0.917 . . . . 0.0 110.689 -179.972 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 832' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -128.2 116.68 20.27 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.493 -0.754 . . . . 0.0 109.404 179.945 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 833' ' ' VAL . . . . . 0.825 HG21 HG23 ' A' ' 816' ' ' ILE . 3.3 t -109.86 116.87 53.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.165 -0.959 . . . . 0.0 110.876 -179.931 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 834' ' ' ALA . . . . . 0.572 ' O ' HG23 ' A' ' 835' ' ' VAL . . . -118.25 148.87 41.99 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.478 -0.764 . . . . 0.0 109.229 179.949 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 835' ' ' VAL . . . . . 0.572 HG23 ' O ' ' A' ' 834' ' ' ALA . 46.7 t -155.06 162.84 1.72 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.519 0 O-C-N 120.904 -1.123 . . . . 0.0 111.051 -179.914 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 836' ' ' GLU . . . . . 0.439 ' N ' HG12 ' A' ' 835' ' ' VAL . 2.6 tt0 -145.76 118.12 8.45 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.629 -0.669 . . . . 0.0 109.587 179.934 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 837' ' ' ALA . . . . . 0.421 ' HB3' ' CG2' ' A' ' 731' ' ' VAL . . . -108.12 161.17 15.22 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.152 -0.968 . . . . 0.0 110.372 -179.947 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 838' ' ' VAL . . . . . . . . . . . . . 38.8 t -128.28 130.7 69.47 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.394 -0.816 . . . . 0.0 110.0 179.926 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 839' ' ' CYS . . . . . . . . . . . . . 2.5 m -109.82 146.47 34.99 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.179 -0.95 . . . . 0.0 110.343 -179.961 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 840' ' ' SER . . . . . . . . . . . . . 67.2 p -131.01 -169.83 2.24 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.351 -0.843 . . . . 0.0 109.861 179.938 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 841' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.617 0 O-C-N 121.221 -0.925 . . . . 0.0 110.143 -179.96 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 728' ' ' VAL . . . . . 0.439 ' O ' ' O ' ' A' ' 839' ' ' CYS . 32.5 t . . . . . 0 N--CA 1.492 1.637 0 CA-C-O 121.096 0.474 . . . . 0.0 110.07 . . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 729' ' ' SER . . . . . 0.425 ' OG ' ' O ' ' A' ' 728' ' ' VAL . 0.9 OUTLIER 178.1 120.88 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.127 -0.983 . . . . 0.0 110.432 -179.95 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 730' ' ' GLY . . . . . . . . . . . . . . . 149.34 99.32 0.2 Allowed Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.767 -1.333 . . . . 0.0 109.767 -179.979 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 731' ' ' VAL . . . . . . . . . . . . . 73.1 t -142.15 148.98 19.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.282 -1.128 . . . . 0.0 109.869 179.979 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 732' ' ' CYS . . . . . . . . . . . . . 92.5 m -122.62 166.3 15.08 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.256 -0.902 . . . . 0.0 110.922 -179.971 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 733' ' ' ALA . . . . . 0.439 ' HB3' ' O ' ' A' ' 835' ' ' VAL . . . -160.96 102.09 1.28 Allowed 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 179.883 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 734' ' ' ASP . . . . . 0.565 ' C ' HG23 ' A' ' 735' ' ' VAL . 3.2 t70 -131.28 122.64 26.81 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.174 -0.954 . . . . 0.0 110.366 -179.944 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 735' ' ' VAL . . . . . 0.565 HG23 ' C ' ' A' ' 734' ' ' ASP . 40.6 t -153.25 153.06 9.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.35 -0.844 . . . . 0.0 110.152 179.979 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 736' ' ' SER . . . . . . . . . . . . . 12.3 t -110.31 152.25 26.41 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.159 -0.963 . . . . 0.0 110.207 -179.962 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 737' ' ' GLU . . . . . 0.471 ' HG3' ' HG3' ' A' ' 831' ' ' LYS . 2.1 tm-20 . . . . . 0 N--CA 1.493 1.703 0 O-C-N 121.226 -0.921 . . . . 0.0 110.225 179.981 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 757' ' ' THR . . . . . . . . . . . . . 39.0 p . . . . . 0 N--CA 1.491 1.582 0 CA-C-O 121.368 0.604 . . . . 0.0 110.098 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 758' ' ' ALA . . . . . . . . . . . . . . . -114.13 176.14 5.17 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.218 -0.926 . . . . 0.0 110.007 179.974 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 759' ' ' LYS . . . . . . . . . . . . . 32.2 mtmt -144.44 161.99 37.64 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.213 -0.929 . . . . 0.0 110.345 -179.963 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 760' ' ' VAL . . . . . . . . . . . . . 59.6 t -109.28 158.61 9.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.435 -0.791 . . . . 0.0 109.276 179.971 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 761' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -122.47 122.61 39.36 Favored 'General case' 0 C--N 1.298 -1.641 0 O-C-N 121.051 -1.03 . . . . 0.0 110.912 179.978 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 762' ' ' LEU . . . . . 0.495 ' HB2' ' O ' ' A' ' 812' ' ' CYS . 5.6 mt -141.4 135.97 30.92 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.462 -0.774 . . . . 0.0 109.323 179.918 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 763' ' ' LYS . . . . . . . . . . . . . 3.8 mtmt -150.38 151.17 32.42 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.009 -1.057 . . . . 0.0 110.944 -179.938 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 764' ' ' CYS . . . . . . . . . . . . . 9.2 m -127.54 172.88 10.32 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.538 -0.726 . . . . 0.0 109.622 179.963 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 765' ' ' ALA . . . . . 0.451 ' HB3' ' OE1' ' A' ' 768' ' ' GLN . . . -68.11 158.49 83.9 Favored Pre-proline 0 N--CA 1.493 1.681 0 O-C-N 121.109 -0.994 . . . . 0.0 109.947 179.947 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 766' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -72.33 119.02 5.88 Favored 'Trans proline' 0 C--N 1.306 -1.703 0 O-C-N 123.932 1.491 . . . . 0.0 110.338 179.987 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 767' ' ' GLY . . . . . . . . . . . . . . . 112.98 -6.67 25.52 Favored Glycine 0 N--CA 1.489 2.201 0 N-CA-C 109.485 -1.446 . . . . 0.0 109.485 -179.911 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 768' ' ' GLN . . . . . 0.511 ' C ' HG23 ' A' ' 769' ' ' THR . 33.6 mt-30 -114.27 169.75 8.8 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.145 -1.209 . . . . 0.0 110.463 179.969 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 769' ' ' THR . . . . . 0.511 HG23 ' C ' ' A' ' 768' ' ' GLN . 70.5 p -152.2 149.47 28.77 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.358 -0.839 . . . . 0.0 109.866 -179.97 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 770' ' ' ILE . . . . . 0.478 HD12 ' O ' ' A' ' 806' ' ' CYS . 26.9 mt -70.27 141.38 17.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.088 -1.008 . . . . 0.0 109.722 -179.985 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 771' ' ' SER . . . . . . . . . . . . . 1.6 p -126.44 -13.18 6.08 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.168 -0.958 . . . . 0.0 110.587 -179.943 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 772' ' ' ALA . . . . . . . . . . . . . . . -158.08 159.66 36.52 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 120.97 -1.081 . . . . 0.0 111.426 -179.906 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 773' ' ' ILE . . . . . . . . . . . . . 34.8 mm -124.15 123.31 66.32 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 O-C-N 121.644 -0.66 . . . . 0.0 109.296 179.936 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 774' ' ' LYS . . . . . 0.551 ' HG3' ' CG2' ' A' ' 838' ' ' VAL . 0.3 OUTLIER -80.82 -41.4 23.35 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.125 -0.984 . . . . 0.0 110.933 -179.869 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 775' ' ' PHE . . . . . 0.71 ' O ' ' HB2' ' A' ' 776' ' ' ALA . 48.7 t80 -135.5 173.59 11.55 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.069 -1.019 . . . . 0.0 111.088 -179.892 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 776' ' ' ALA . . . . . 0.71 ' HB2' ' O ' ' A' ' 775' ' ' PHE . . . 166.47 87.03 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.644 -0.66 . . . . 0.0 109.314 179.999 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 777' ' ' SER . . . . . 0.473 ' OG ' ' CZ ' ' A' ' 775' ' ' PHE . 16.1 p -119.61 129.84 54.81 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.236 -0.915 . . . . 0.0 110.709 -179.892 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 778' ' ' PHE . . . . . 0.603 ' CD2' HG22 ' A' ' 833' ' ' VAL . 39.4 t80 -104.72 78.54 1.45 Allowed 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.294 -0.879 . . . . 0.0 110.024 179.944 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 779' ' ' GLY . . . . . 0.461 ' C ' ' HD3' ' A' ' 781' ' ' PRO . . . -168.79 -105.42 0.18 Allowed Glycine 0 N--CA 1.492 2.408 0 N-CA-C 109.686 -1.366 . . . . 0.0 109.686 179.997 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 780' ' ' THR . . . . . . . . . . . . . 2.4 p -121.17 63.24 12.16 Favored Pre-proline 0 N--CA 1.493 1.686 0 O-C-N 121.229 -1.159 . . . . 0.0 110.548 -179.973 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 781' ' ' PRO . . . . . 0.496 ' HD2' ' HB3' ' A' ' 832' ' ' ARG . 46.1 Cg_endo -75.98 146.66 29.51 Favored 'Trans proline' 0 C--N 1.305 -1.726 0 O-C-N 124.068 1.562 . . . . 0.0 111.142 179.983 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 782' ' ' LEU . . . . . 0.76 HD21 ' O ' ' A' ' 790' ' ' GLN . 1.8 pt? -149.54 159.56 44.21 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.452 -0.78 . . . . 0.0 109.64 179.928 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 783' ' ' GLY . . . . . 0.416 ' O ' HG23 ' A' ' 784' ' ' THR . . . 140.48 -131.22 4.91 Favored Glycine 0 N--CA 1.496 2.66 0 N-CA-C 109.591 -1.404 . . . . 0.0 109.591 -179.96 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 784' ' ' THR . . . . . 0.416 HG23 ' O ' ' A' ' 783' ' ' GLY . 0.0 OUTLIER -162.14 -158.02 0.51 Allowed 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.121 -1.223 . . . . 0.0 110.68 -179.969 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 785' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -72.95 119.32 17.03 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.366 -0.834 . . . . 0.0 110.54 -179.989 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 786' ' ' GLY . . . . . . . . . . . . . . . 82.63 -10.63 55.5 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.895 -1.282 . . . . 0.0 109.895 -179.98 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 787' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -124.25 30.0 6.2 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.13 -1.218 . . . . 0.0 110.133 -179.989 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 788' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -58.62 91.82 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.276 -0.89 . . . . 0.0 110.387 -180.0 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 789' ' ' GLN . . . . . . . . . . . . . 4.1 tt0 -75.5 -177.24 3.53 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.405 -0.809 . . . . 0.0 110.162 -179.957 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 790' ' ' GLN . . . . . 0.76 ' O ' HD21 ' A' ' 782' ' ' LEU . 0.0 OUTLIER -108.05 174.01 6.07 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.443 -0.786 . . . . 0.0 110.307 179.992 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 791' ' ' GLY . . . . . . . . . . . . . . . -106.87 -140.82 9.87 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.519 -1.432 . . . . 0.0 109.519 179.945 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 792' ' ' GLU . . . . . 0.4 ' HG2' ' N ' ' A' ' 793' ' ' CYS . 1.5 pt-20 -105.17 -24.03 12.81 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.174 -1.192 . . . . 0.0 110.144 -179.967 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 793' ' ' CYS . . . . . 0.4 ' N ' ' HG2' ' A' ' 792' ' ' GLU . 5.7 t -126.22 145.66 50.3 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.281 -0.887 . . . . 0.0 109.974 -179.887 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 794' ' ' HIS . . . . . 0.492 ' CE1' ' OG ' ' A' ' 798' ' ' SER . 73.0 t60 -139.46 156.11 47.15 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.18 -0.95 . . . . 0.0 110.146 -179.943 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 795' ' ' SER . . . . . . . . . . . . . 1.3 t -81.56 -141.62 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.322 -0.861 . . . . 0.0 110.165 179.995 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 796' ' ' ILE . . . . . . . . . . . . . 1.5 pt -145.53 12.71 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.241 -0.912 . . . . 0.0 110.038 -179.971 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 797' ' ' ASN . . . . . . . . . . . . . 31.5 m120 -148.99 29.16 0.82 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.328 -0.857 . . . . 0.0 110.08 179.999 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 798' ' ' SER . . . . . 0.514 ' CB ' ' O ' ' A' ' 776' ' ' ALA . 7.6 m -71.41 -30.47 66.13 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.218 -0.926 . . . . 0.0 110.625 -179.995 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 799' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -102.33 -7.89 21.67 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.244 -0.91 . . . . 0.0 110.349 179.967 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 800' ' ' SER . . . . . . . . . . . . . 5.8 p -90.46 -22.3 21.46 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.174 -0.954 . . . . 0.0 110.477 179.987 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 801' ' ' VAL . . . . . 0.502 ' O ' ' HG2' ' A' ' 805' ' ' LYS . 55.6 t -81.59 -39.05 16.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.104 -0.997 . . . . 0.0 109.949 179.977 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 802' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -70.6 -56.29 6.84 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.33 -0.856 . . . . 0.0 110.536 -179.95 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 803' ' ' GLU . . . . . 0.531 ' HG2' HD12 ' A' ' 807' ' ' ILE . 2.3 tt0 -48.97 -19.8 0.44 Allowed 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.158 -0.964 . . . . 0.0 110.946 -179.921 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 804' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.71 -46.8 8.03 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.993 -1.067 . . . . 0.0 111.328 -179.893 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 805' ' ' LYS . . . . . 0.961 ' HE2' HG22 ' A' ' 814' ' ' VAL . 0.0 OUTLIER -115.93 47.53 1.36 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.952 -1.092 . . . . 0.0 111.329 -179.829 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 806' ' ' CYS . . . . . 0.478 ' O ' HD12 ' A' ' 770' ' ' ILE . 2.4 t -150.22 -44.52 0.13 Allowed 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.056 -1.028 . . . . 0.0 110.225 179.937 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 807' ' ' ILE . . . . . 0.531 HD12 ' HG2' ' A' ' 803' ' ' GLU . 36.7 mt -80.89 129.17 37.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.188 -0.945 . . . . 0.0 110.151 -179.95 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 808' ' ' GLY . . . . . . . . . . . . . . . 110.86 -9.27 29.74 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 109.897 -1.281 . . . . 0.0 109.897 179.988 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 809' ' ' LEU . . . . . . . . . . . . . 7.8 mt -113.64 154.51 27.1 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.05 -1.265 . . . . 0.0 110.77 -179.979 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 810' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -69.93 -29.74 66.97 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.321 -0.862 . . . . 0.0 109.237 179.869 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 811' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -132.42 165.03 25.21 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.606 -0.684 . . . . 0.0 109.527 -179.993 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 812' ' ' CYS . . . . . 0.495 ' O ' ' HB2' ' A' ' 762' ' ' LEU . 22.8 t -143.12 135.12 26.93 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.079 -1.013 . . . . 0.0 110.839 179.986 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 813' ' ' VAL . . . . . 0.442 ' O ' ' CG1' ' A' ' 813' ' ' VAL . 3.0 p -144.16 129.45 14.82 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 O-C-N 121.464 -0.772 . . . . 0.0 109.192 179.856 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 814' ' ' VAL . . . . . 0.961 HG22 ' HE2' ' A' ' 805' ' ' LYS . 30.2 t -134.59 145.59 32.35 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.068 -1.02 . . . . 0.0 110.849 -179.895 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 815' ' ' ALA . . . . . . . . . . . . . . . -87.28 165.3 15.75 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.404 -0.81 . . . . 0.0 109.965 179.934 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 816' ' ' ILE . . . . . 0.494 HG12 HG21 ' A' ' 833' ' ' VAL . 71.9 mt -111.05 101.15 12.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.121 -0.987 . . . . 0.0 110.28 -179.94 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 817' ' ' SER . . . . . 0.462 ' HB2' ' HD2' ' A' ' 818' ' ' PRO . 1.4 p -155.25 176.34 2.59 Favored Pre-proline 0 N--CA 1.494 1.774 0 O-C-N 121.395 -0.815 . . . . 0.0 110.179 179.955 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 818' ' ' PRO . . . . . 0.462 ' HD2' ' HB2' ' A' ' 817' ' ' SER . 48.4 Cg_endo -76.18 -59.95 0.04 OUTLIER 'Trans proline' 0 C--N 1.309 -1.548 0 O-C-N 123.998 1.525 . . . . 0.0 111.19 -179.888 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 819' ' ' SER . . . . . . . . . . . . . 36.8 t -58.55 -42.45 87.9 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.19 -0.944 . . . . 0.0 110.59 -179.968 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 820' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -47.19 -23.83 0.59 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.218 -0.926 . . . . 0.0 110.322 -179.954 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 821' ' ' PHE . . . . . 0.423 ' CD2' HG21 ' A' ' 801' ' ' VAL . 15.6 m-85 -107.07 -96.08 0.37 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.146 -0.971 . . . . 0.0 110.715 -179.928 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 822' ' ' GLY . . . . . . . . . . . . . . . -141.8 8.18 2.49 Favored Glycine 0 N--CA 1.491 2.339 0 C-N-CA 119.648 -1.263 . . . . 0.0 110.163 -179.971 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 823' ' ' GLY . . . . . . . . . . . . . . . 124.59 -123.08 4.97 Favored Glycine 0 N--CA 1.492 2.376 0 O-C-N 120.999 -1.295 . . . . 0.0 109.966 179.972 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 824' ' ' ASP . . . . . 0.421 ' HA ' ' HD3' ' A' ' 825' ' ' PRO . 69.8 m-20 -80.42 134.99 53.98 Favored Pre-proline 0 N--CA 1.496 1.826 0 O-C-N 121.286 -1.126 . . . . 0.0 110.476 -179.943 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 825' ' ' PRO . . . . . 0.421 ' HD3' ' HA ' ' A' ' 824' ' ' ASP . 50.6 Cg_endo -83.83 -64.05 0.02 OUTLIER 'Trans proline' 0 C--N 1.308 -1.586 0 O-C-N 123.963 1.507 . . . . 0.0 110.425 179.905 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 826' ' ' CYS . . . . . 0.454 ' HB3' ' HB ' ' A' ' 829' ' ' VAL . 0.7 OUTLIER -147.42 149.71 35.25 Favored Pre-proline 0 N--CA 1.494 1.76 0 O-C-N 121.325 -0.859 . . . . 0.0 110.319 179.96 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 827' ' ' PRO . . . . . 0.441 ' O ' ' HB2' ' A' ' 828' ' ' GLU . 46.8 Cg_endo -74.3 134.57 19.26 Favored 'Trans proline' 0 C--N 1.305 -1.713 0 O-C-N 123.977 1.514 . . . . 0.0 110.694 -179.961 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 828' ' ' GLU . . . . . 0.441 ' HB2' ' O ' ' A' ' 827' ' ' PRO . 64.8 mm-40 55.77 39.7 30.76 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.315 -0.866 . . . . 0.0 110.43 179.984 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 829' ' ' VAL . . . . . 0.454 ' HB ' ' HB3' ' A' ' 826' ' ' CYS . 18.1 t -142.48 136.61 28.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.177 -0.952 . . . . 0.0 110.373 179.987 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 830' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -63.26 -149.66 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.245 -0.909 . . . . 0.0 109.856 -179.993 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 831' ' ' LYS . . . . . 0.471 ' HG3' ' HG3' ' A' ' 737' ' ' GLU . 0.0 OUTLIER -145.34 94.92 2.58 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 120.962 -1.086 . . . . 0.0 110.834 179.962 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 832' ' ' ARG . . . . . 0.496 ' HB3' ' HD2' ' A' ' 781' ' ' PRO . 0.0 OUTLIER -109.56 166.75 10.65 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.305 -0.872 . . . . 0.0 109.408 179.911 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 833' ' ' VAL . . . . . 0.603 HG22 ' CD2' ' A' ' 778' ' ' PHE . 37.0 t -142.93 120.7 6.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 120.928 -1.108 . . . . 0.0 111.763 -179.914 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 834' ' ' ALA . . . . . . . . . . . . . . . -125.31 104.1 8.3 Favored 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 107.87 -1.159 . . . . 0.0 107.87 179.769 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 835' ' ' VAL . . . . . 0.439 ' O ' ' HB3' ' A' ' 733' ' ' ALA . 67.1 t -109.5 153.56 11.23 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.579 0 O-C-N 121.153 -0.967 . . . . 0.0 112.453 -179.674 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 836' ' ' GLU . . . . . 0.448 ' OE1' ' HB2' ' A' ' 774' ' ' LYS . 31.2 tt0 -135.11 122.41 21.69 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 107.185 -1.413 . . . . 0.0 107.185 179.694 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 837' ' ' ALA . . . . . . . . . . . . . . . -113.62 161.81 16.99 Favored 'General case' 0 N--CA 1.501 2.087 0 O-C-N 120.719 -1.238 . . . . 0.0 112.722 -179.669 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 838' ' ' VAL . . . . . 0.551 ' CG2' ' HG3' ' A' ' 774' ' ' LYS . 23.9 t -118.75 105.56 17.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 179.852 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 839' ' ' CYS . . . . . 0.439 ' O ' ' O ' ' A' ' 728' ' ' VAL . 0.0 OUTLIER -107.98 140.71 40.72 Favored 'General case' 0 C--N 1.3 -1.585 0 O-C-N 120.975 -1.078 . . . . 0.0 110.462 -179.867 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 840' ' ' SER . . . . . . . . . . . . . 71.2 p -163.76 177.7 8.45 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.474 -0.766 . . . . 0.0 110.047 179.962 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 841' ' ' THR . . . . . . . . . . . . . 11.6 p . . . . . 0 N--CA 1.492 1.659 0 O-C-N 121.101 -0.999 . . . . 0.0 110.199 -179.956 . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 728' ' ' VAL . . . . . 0.703 ' O ' HG13 ' A' ' 728' ' ' VAL . 9.5 p . . . . . 0 N--CA 1.491 1.618 0 CA-C-O 121.263 0.554 . . . . 0.0 110.403 . . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 729' ' ' SER . . . . . . . . . . . . . 36.2 t -63.88 159.45 19.68 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.146 -0.971 . . . . 0.0 110.068 -179.997 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 730' ' ' GLY . . . . . . . . . . . . . . . -113.95 155.67 16.16 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.494 -1.443 . . . . 0.0 109.494 -179.995 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 731' ' ' VAL . . . . . . . . . . . . . 73.4 t -119.73 158.91 21.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.142 -1.21 . . . . 0.0 110.086 -179.932 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 732' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -131.09 125.14 32.38 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.177 -0.952 . . . . 0.0 110.02 179.996 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 733' ' ' ALA . . . . . . . . . . . . . . . -115.25 109.57 18.16 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.236 -0.915 . . . . 0.0 110.377 179.973 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 734' ' ' ASP . . . . . 0.525 ' C ' HG23 ' A' ' 735' ' ' VAL . 5.0 t0 -118.11 108.93 15.8 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.19 -0.944 . . . . 0.0 110.159 -179.987 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 735' ' ' VAL . . . . . 0.525 HG23 ' C ' ' A' ' 734' ' ' ASP . 96.3 t -152.1 145.39 15.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.287 -0.883 . . . . 0.0 110.182 179.998 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 736' ' ' SER . . . . . . . . . . . . . 66.6 p -93.18 -161.99 0.89 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.175 -0.953 . . . . 0.0 110.386 179.898 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 737' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 . . . . . 0 N--CA 1.494 1.763 0 O-C-N 121.292 -0.88 . . . . 0.0 110.26 179.955 . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 757' ' ' THR . . . . . . . . . . . . . 29.4 p . . . . . 0 N--CA 1.491 1.59 0 CA-C-O 121.289 0.566 . . . . 0.0 110.38 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 758' ' ' ALA . . . . . . . . . . . . . . . -140.85 166.14 25.59 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.393 -0.817 . . . . 0.0 109.758 -179.987 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 759' ' ' LYS . . . . . . . . . . . . . 8.2 mttt -113.38 166.31 11.61 Favored 'General case' 0 C--N 1.299 -1.618 0 O-C-N 121.232 -0.918 . . . . 0.0 110.3 179.993 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 760' ' ' VAL . . . . . 0.666 ' O ' HG13 ' A' ' 813' ' ' VAL . 80.3 t -105.56 150.11 8.51 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.463 0 O-C-N 121.311 -0.868 . . . . 0.0 108.873 179.91 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 761' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -125.73 103.95 8.09 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 120.916 -1.115 . . . . 0.0 111.607 -179.812 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 762' ' ' LEU . . . . . 0.501 HD23 ' HA ' ' A' ' 762' ' ' LEU . 17.8 mt -118.04 100.46 7.56 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 179.829 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 763' ' ' LYS . . . . . 0.418 ' HG2' ' HB2' ' A' ' 811' ' ' ARG . 0.0 OUTLIER -124.12 139.88 53.51 Favored 'General case' 0 C--N 1.3 -1.562 0 O-C-N 121.085 -1.009 . . . . 0.0 111.298 -179.829 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 764' ' ' CYS . . . . . 0.437 ' O ' ' C ' ' A' ' 765' ' ' ALA . 3.0 t -125.76 145.12 50.34 Favored 'General case' 0 C--N 1.299 -1.603 0 O-C-N 121.623 -0.673 . . . . 0.0 109.409 179.881 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 765' ' ' ALA . . . . . 0.437 ' C ' ' O ' ' A' ' 764' ' ' CYS . . . -41.1 161.78 0.12 Allowed Pre-proline 0 N--CA 1.495 1.782 0 O-C-N 121.164 -0.96 . . . . 0.0 110.494 179.983 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 766' ' ' PRO . . . . . 0.428 ' HD2' ' HB1' ' A' ' 765' ' ' ALA . 43.9 Cg_endo -70.55 102.47 1.16 Allowed 'Trans proline' 0 C--N 1.305 -1.726 0 O-C-N 123.94 1.495 . . . . 0.0 110.28 -179.963 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 767' ' ' GLY . . . . . . . . . . . . . . . 133.18 -21.71 4.08 Favored Glycine 0 N--CA 1.488 2.102 0 N-CA-C 109.025 -1.63 . . . . 0.0 109.025 -179.978 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 768' ' ' GLN . . . . . 0.533 ' HG2' ' CG2' ' A' ' 841' ' ' THR . 22.6 mt-30 -101.64 131.8 47.67 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.48 -1.012 . . . . 0.0 110.076 -179.999 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 769' ' ' THR . . . . . . . . . . . . . 16.9 p -125.57 147.37 49.31 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.113 -0.992 . . . . 0.0 110.232 179.965 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 770' ' ' ILE . . . . . 0.461 HG22 ' N ' ' A' ' 771' ' ' SER . 22.4 mt -59.92 166.88 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.205 -0.934 . . . . 0.0 109.639 179.964 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 771' ' ' SER . . . . . 0.461 ' N ' HG22 ' A' ' 770' ' ' ILE . 0.1 OUTLIER -160.33 -30.92 0.06 Allowed 'General case' 0 C--N 1.299 -1.621 0 O-C-N 121.094 -1.004 . . . . 0.0 111.152 -179.948 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 772' ' ' ALA . . . . . . . . . . . . . . . -135.78 122.67 21.25 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.852 -1.155 . . . . 0.0 111.402 -179.858 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 773' ' ' ILE . . . . . . . . . . . . . 38.2 mm -95.74 100.95 11.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.448 -0.783 . . . . 0.0 109.021 179.918 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 774' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.94 -37.89 28.71 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.163 -0.961 . . . . 0.0 111.284 -179.928 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 775' ' ' PHE . . . . . 0.724 ' O ' ' HB2' ' A' ' 776' ' ' ALA . 44.1 t80 -122.65 160.66 25.34 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 120.957 -1.089 . . . . 0.0 111.305 -179.843 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 776' ' ' ALA . . . . . 0.724 ' HB2' ' O ' ' A' ' 775' ' ' PHE . . . 166.28 100.64 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.607 -0.683 . . . . 0.0 109.616 179.989 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 777' ' ' SER . . . . . 0.49 ' HA ' ' HB3' ' A' ' 798' ' ' SER . 1.6 p -136.08 142.03 44.28 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.347 -0.846 . . . . 0.0 110.369 -179.909 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 778' ' ' PHE . . . . . 0.496 ' O ' ' CD2' ' A' ' 778' ' ' PHE . 68.8 t80 -120.87 73.74 1.03 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.44 -0.787 . . . . 0.0 110.298 -179.996 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 779' ' ' GLY . . . . . . . . . . . . . . . -161.57 -108.01 0.22 Allowed Glycine 0 N--CA 1.492 2.39 0 N-CA-C 109.544 -1.422 . . . . 0.0 109.544 -179.983 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 780' ' ' THR . . . . . . . . . . . . . 81.8 p -121.07 81.97 36.54 Favored Pre-proline 0 N--CA 1.489 1.506 0 O-C-N 121.187 -1.184 . . . . 0.0 110.161 -179.982 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 781' ' ' PRO . . . . . 0.476 ' CG ' ' HB3' ' A' ' 832' ' ' ARG . 47.5 Cg_endo -75.7 166.8 27.65 Favored 'Trans proline' 0 C--N 1.305 -1.733 0 O-C-N 124.103 1.581 . . . . 0.0 110.36 -179.974 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 782' ' ' LEU . . . . . . . . . . . . . 6.7 mt -140.74 131.81 26.27 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.252 -0.905 . . . . 0.0 110.134 179.999 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 783' ' ' GLY . . . . . . . . . . . . . . . 114.93 -165.86 12.11 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.638 -1.385 . . . . 0.0 109.638 -179.948 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 784' ' ' THR . . . . . 0.4 ' HA ' ' OD2' ' A' ' 734' ' ' ASP . 12.3 p -135.78 -50.1 0.71 Allowed 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.292 -1.123 . . . . 0.0 110.114 179.941 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 785' ' ' CYS . . . . . . . . . . . . . 22.5 t -173.26 87.84 0.07 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.291 -0.881 . . . . 0.0 109.854 -180.0 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 786' ' ' GLY . . . . . . . . . . . . . . . 142.34 -26.74 2.28 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 108.902 -1.679 . . . . 0.0 108.902 -179.897 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 787' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -127.17 30.19 5.46 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.487 -1.008 . . . . 0.0 109.82 179.989 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 788' ' ' PHE . . . . . 0.691 ' CE2' ' HB1' ' A' ' 834' ' ' ALA . 2.2 m-85 -51.93 121.08 6.07 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.307 -0.871 . . . . 0.0 110.245 179.993 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 789' ' ' GLN . . . . . . . . . . . . . 13.2 tt0 -133.74 120.76 20.97 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.302 -0.874 . . . . 0.0 110.274 -179.978 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 790' ' ' GLN . . . . . 0.468 ' CG ' ' O ' ' A' ' 790' ' ' GLN . 9.3 pt20 -64.96 126.21 27.31 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.251 -0.906 . . . . 0.0 110.549 -179.949 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 791' ' ' GLY . . . . . . . . . . . . . . . -69.43 -122.47 0.03 OUTLIER Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.311 -1.516 . . . . 0.0 109.311 179.948 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 792' ' ' GLU . . . . . . . . . . . . . 11.9 mt-10 -126.26 8.72 7.24 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.149 -1.207 . . . . 0.0 110.279 179.963 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 793' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -129.46 96.36 4.26 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.239 -0.913 . . . . 0.0 109.771 179.874 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 794' ' ' HIS . . . . . 0.589 ' CD2' ' O ' ' A' ' 795' ' ' SER . 77.6 t60 -124.78 139.62 53.68 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.179 -0.95 . . . . 0.0 110.488 -179.934 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 795' ' ' SER . . . . . 0.589 ' O ' ' CD2' ' A' ' 794' ' ' HIS . 4.1 t -82.75 168.87 16.78 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.318 -0.864 . . . . 0.0 109.078 179.99 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 796' ' ' ILE . . . . . . . . . . . . . 1.7 mt -94.97 -7.88 9.79 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 O-C-N 120.857 -1.152 . . . . 0.0 110.095 -179.971 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 797' ' ' ASN . . . . . . . . . . . . . 4.8 m120 -107.38 38.65 2.08 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.288 -0.883 . . . . 0.0 109.387 179.877 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 798' ' ' SER . . . . . 0.552 ' OG ' ' CE1' ' A' ' 794' ' ' HIS . 70.6 m -82.08 -52.54 6.91 Favored 'General case' 0 N--CA 1.485 1.317 0 O-C-N 121.51 -0.743 . . . . 0.0 111.184 -179.983 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 799' ' ' ASN . . . . . . . . . . . . . 47.2 t-20 -98.37 12.04 36.17 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.074 -1.017 . . . . 0.0 111.134 -179.923 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 800' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -89.29 -45.06 9.8 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.075 -1.015 . . . . 0.0 110.355 179.959 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 801' ' ' VAL . . . . . . . . . . . . . 8.7 t -74.96 -19.32 16.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.171 -0.956 . . . . 0.0 110.342 -179.974 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 802' ' ' LEU . . . . . 0.471 HD22 ' HA ' ' A' ' 802' ' ' LEU . 0.3 OUTLIER -74.2 -57.23 4.09 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.284 -0.885 . . . . 0.0 110.721 179.976 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 803' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -63.43 -18.33 63.61 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.213 -0.929 . . . . 0.0 110.543 -179.935 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 804' ' ' ARG . . . . . . . . . . . . . 3.2 mtm-85 -92.41 -16.74 25.52 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.237 -0.914 . . . . 0.0 112.066 -179.805 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 805' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.59 39.28 1.69 Allowed 'General case' 0 N--CA 1.502 2.143 0 O-C-N 120.466 -1.396 . . . . 0.0 112.594 -179.809 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 806' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -164.39 22.95 0.06 Allowed 'General case' 0 N--CA 1.501 2.112 0 O-C-N 120.58 -1.325 . . . . 0.0 111.024 179.921 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 807' ' ' ILE . . . . . . . . . . . . . 4.4 mt -125.32 119.33 55.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.093 -1.004 . . . . 0.0 109.939 179.914 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 808' ' ' GLY . . . . . . . . . . . . . . . 110.93 7.91 24.69 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.059 -1.616 . . . . 0.0 109.059 -179.889 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 809' ' ' LEU . . . . . . . . . . . . . 29.7 mt -123.65 138.34 54.55 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.287 -1.125 . . . . 0.0 109.876 179.968 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 810' ' ' GLU . . . . . . . . . . . . . 15.0 mp0 -63.04 -22.36 66.8 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.067 -1.021 . . . . 0.0 109.329 -179.992 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 811' ' ' ARG . . . . . 0.418 ' HB2' ' HG2' ' A' ' 763' ' ' LYS . 0.0 OUTLIER -154.56 122.88 6.03 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.519 -0.738 . . . . 0.0 109.881 179.94 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 812' ' ' CYS . . . . . 0.472 ' O ' ' HB2' ' A' ' 762' ' ' LEU . 6.0 p -129.47 139.07 51.71 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.126 -0.984 . . . . 0.0 110.241 -179.94 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 813' ' ' VAL . . . . . 0.666 HG13 ' O ' ' A' ' 760' ' ' VAL . 53.4 t -121.79 139.79 47.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.204 -0.935 . . . . 0.0 110.308 -179.952 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 814' ' ' VAL . . . . . . . . . . . . . 58.0 t -124.71 134.52 66.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.253 -0.905 . . . . 0.0 110.279 179.989 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 815' ' ' ALA . . . . . . . . . . . . . . . -82.32 149.56 27.7 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.288 -0.883 . . . . 0.0 109.927 -179.99 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 816' ' ' ILE . . . . . 0.548 ' CG2' HG21 ' A' ' 833' ' ' VAL . 22.0 mt -109.96 125.04 67.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.172 -0.955 . . . . 0.0 110.285 179.954 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 817' ' ' SER . . . . . 0.454 ' HB2' ' HD2' ' A' ' 818' ' ' PRO . 2.9 p -172.96 170.74 2.0 Favored Pre-proline 0 N--CA 1.492 1.659 0 O-C-N 121.148 -0.97 . . . . 0.0 110.314 179.993 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 818' ' ' PRO . . . . . 0.46 ' O ' ' HB3' ' A' ' 819' ' ' SER . 47.6 Cg_endo -74.84 158.39 42.82 Favored 'Trans proline' 0 C--N 1.305 -1.737 0 O-C-N 124.144 1.602 . . . . 0.0 110.743 -179.875 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 819' ' ' SER . . . . . 0.46 ' HB3' ' O ' ' A' ' 818' ' ' PRO . 7.5 t 63.01 9.85 4.05 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.361 -0.837 . . . . 0.0 110.842 179.983 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 820' ' ' ASN . . . . . . . . . . . . . 2.4 t30 -96.72 -44.18 7.21 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.097 -1.002 . . . . 0.0 110.208 179.988 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 821' ' ' PHE . . . . . . . . . . . . . 4.0 m-85 -89.94 -45.31 9.3 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.19 -0.944 . . . . 0.0 110.184 179.985 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 822' ' ' GLY . . . . . . . . . . . . . . . -167.43 -35.98 0.02 OUTLIER Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.61 -1.396 . . . . 0.0 109.61 -179.966 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 823' ' ' GLY . . . . . . . . . . . . . . . 159.82 -119.21 0.87 Allowed Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.648 -1.381 . . . . 0.0 109.648 -179.96 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 824' ' ' ASP . . . . . 0.463 ' OD1' ' O ' ' A' ' 824' ' ' ASP . 43.8 p-10 -148.19 101.76 3.58 Favored Pre-proline 0 N--CA 1.498 1.938 0 O-C-N 121.308 -1.113 . . . . 0.0 109.952 -179.997 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 825' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_endo -83.74 -53.22 0.03 OUTLIER 'Trans proline' 0 C--N 1.307 -1.631 0 O-C-N 123.907 1.477 . . . . 0.0 111.037 -179.968 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 826' ' ' CYS . . . . . 0.65 ' SG ' HG21 ' A' ' 829' ' ' VAL . 0.1 OUTLIER -77.56 129.1 78.09 Favored Pre-proline 0 N--CA 1.497 1.885 0 O-C-N 121.077 -1.014 . . . . 0.0 110.737 -179.876 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 827' ' ' PRO . . . . . 0.863 ' O ' HG23 ' A' ' 829' ' ' VAL . 51.2 Cg_endo -87.86 135.07 3.32 Favored 'Trans proline' 0 C--N 1.31 -1.461 0 O-C-N 123.911 1.479 . . . . 0.0 111.086 -179.97 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 828' ' ' GLU . . . . . 0.421 ' C ' ' O ' ' A' ' 827' ' ' PRO . 0.3 OUTLIER 39.29 47.57 1.48 Allowed 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.428 -0.795 . . . . 0.0 110.937 179.863 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 829' ' ' VAL . . . . . 0.863 HG23 ' O ' ' A' ' 827' ' ' PRO . 56.1 t -123.06 132.03 72.16 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.925 0 O-C-N 121.13 -0.981 . . . . 0.0 110.56 179.929 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 830' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -53.63 108.51 0.35 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.246 -0.909 . . . . 0.0 109.743 179.981 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 831' ' ' LYS . . . . . . . . . . . . . 5.0 mmtp -79.72 143.6 34.4 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.161 -0.962 . . . . 0.0 110.314 -179.944 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 832' ' ' ARG . . . . . 0.476 ' HB3' ' CG ' ' A' ' 781' ' ' PRO . 2.7 ttm180 -146.24 161.19 40.81 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.378 -0.826 . . . . 0.0 109.638 -179.979 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 833' ' ' VAL . . . . . 0.548 HG21 ' CG2' ' A' ' 816' ' ' ILE . 59.7 t -124.64 109.21 21.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.125 -0.984 . . . . 0.0 110.89 -179.967 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 834' ' ' ALA . . . . . 0.691 ' HB1' ' CE2' ' A' ' 788' ' ' PHE . . . -111.35 129.87 55.86 Favored 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 179.831 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 835' ' ' VAL . . . . . 0.412 HG12 ' N ' ' A' ' 836' ' ' GLU . 68.3 t -140.35 160.2 25.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 120.817 -1.177 . . . . 0.0 111.718 -179.888 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 836' ' ' GLU . . . . . 0.456 ' HB2' ' HB3' ' A' ' 775' ' ' PHE . 0.2 OUTLIER -151.92 103.9 2.95 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 179.851 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 837' ' ' ALA . . . . . . . . . . . . . . . -111.23 164.07 13.27 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.008 -1.058 . . . . 0.0 111.798 -179.851 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 838' ' ' VAL . . . . . . . . . . . . . 93.4 t -112.6 131.3 64.51 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.327 0 N-CA-C 109.427 -0.582 . . . . 0.0 109.427 179.882 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 839' ' ' CYS . . . . . 0.496 ' O ' ' HA ' ' A' ' 728' ' ' VAL . 2.0 t -108.76 120.26 41.97 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.002 -1.061 . . . . 0.0 110.571 -179.965 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 840' ' ' SER . . . . . . . . . . . . . 10.1 t -123.97 159.12 30.47 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.418 -0.802 . . . . 0.0 110.065 179.977 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 841' ' ' THR . . . . . 0.533 ' CG2' ' HG2' ' A' ' 768' ' ' GLN . 22.2 p . . . . . 0 N--CA 1.494 1.738 0 O-C-N 121.154 -0.967 . . . . 0.0 110.295 179.99 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 728' ' ' VAL . . . . . 0.663 ' O ' HG13 ' A' ' 728' ' ' VAL . 7.7 p . . . . . 0 N--CA 1.491 1.618 0 CA-C-O 121.228 0.537 . . . . 0.0 110.253 . . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 729' ' ' SER . . . . . . . . . . . . . 1.9 t -66.93 166.67 13.07 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.179 -0.951 . . . . 0.0 109.981 179.98 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 730' ' ' GLY . . . . . 0.465 ' C ' HG13 ' A' ' 731' ' ' VAL . . . -144.32 132.38 4.79 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.114 -1.594 . . . . 0.0 109.114 179.939 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 731' ' ' VAL . . . . . 0.523 ' O ' HG23 ' A' ' 731' ' ' VAL . 21.0 m -150.9 117.49 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.425 0 O-C-N 121.018 -1.284 . . . . 0.0 110.845 -179.935 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 732' ' ' CYS . . . . . 0.425 ' O ' ' SG ' ' A' ' 732' ' ' CYS . 15.5 p -109.22 133.85 52.51 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.31 -0.869 . . . . 0.0 109.322 179.841 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 733' ' ' ALA . . . . . . . . . . . . . . . -109.24 123.44 49.27 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.091 -1.006 . . . . 0.0 110.669 -179.862 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 734' ' ' ASP . . . . . . . . . . . . . 12.2 t0 -111.71 114.47 27.51 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.378 -0.826 . . . . 0.0 110.124 179.941 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 735' ' ' VAL . . . . . . . . . . . . . 16.6 t -122.99 155.34 28.6 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.222 -0.924 . . . . 0.0 110.338 -179.993 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 736' ' ' SER . . . . . 0.433 ' O ' ' C ' ' A' ' 737' ' ' GLU . 0.1 OUTLIER -106.15 105.5 15.56 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.263 -0.898 . . . . 0.0 109.807 -179.98 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 737' ' ' GLU . . . . . 0.542 ' CB ' ' HA ' ' A' ' 831' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.496 1.856 0 O-C-N 121.457 -0.777 . . . . 0.0 110.851 -179.963 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 757' ' ' THR . . . . . . . . . . . . . 3.7 p . . . . . 0 N--CA 1.492 1.666 0 CA-C-O 121.279 0.561 . . . . 0.0 110.391 . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild core ' A' A ' 758' ' ' ALA . . . . . . . . . . . . . . . -87.62 169.92 11.73 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.329 -0.857 . . . . 0.0 109.979 179.981 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 759' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.46 155.69 47.42 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.1 -1.0 . . . . 0.0 110.584 -179.983 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 760' ' ' VAL . . . . . 0.816 HG23 HD11 ' A' ' 816' ' ' ILE . 47.3 t -109.54 139.14 33.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.42 -0.8 . . . . 0.0 109.523 179.939 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 761' ' ' HIS . . . . . . . . . . . . . 1.7 m170 -114.3 111.27 21.23 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.142 -0.973 . . . . 0.0 111.083 -179.978 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 762' ' ' LEU . . . . . 0.451 HD22 ' HB2' ' A' ' 837' ' ' ALA . 1.8 mt -129.6 117.45 20.42 Favored 'General case' 0 N--CA 1.493 1.69 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 -179.99 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 763' ' ' LYS . . . . . 0.428 ' N ' ' CD ' ' A' ' 763' ' ' LYS . 0.0 OUTLIER -142.56 166.44 24.65 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.009 -1.057 . . . . 0.0 111.324 -179.912 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 764' ' ' CYS . . . . . 0.407 ' O ' ' C ' ' A' ' 765' ' ' ALA . 1.4 m -141.37 140.74 33.77 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.677 -0.639 . . . . 0.0 109.458 179.943 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 765' ' ' ALA . . . . . 0.407 ' C ' ' O ' ' A' ' 764' ' ' CYS . . . -44.49 160.98 0.23 Allowed Pre-proline 0 N--CA 1.495 1.806 0 O-C-N 121.109 -0.994 . . . . 0.0 110.341 -179.986 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 766' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -71.34 103.39 1.4 Allowed 'Trans proline' 0 C--N 1.309 -1.5 0 O-C-N 124.004 1.528 . . . . 0.0 110.079 180.0 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 767' ' ' GLY . . . . . . . . . . . . . . . 143.61 -29.21 2.01 Favored Glycine 0 N--CA 1.488 2.118 0 N-CA-C 108.864 -1.694 . . . . 0.0 108.864 179.971 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 768' ' ' GLN . . . . . 0.503 ' OE1' HG23 ' A' ' 841' ' ' THR . 1.5 mt-30 -113.59 115.26 27.65 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.311 -1.111 . . . . 0.0 109.599 179.975 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 769' ' ' THR . . . . . . . . . . . . . 67.2 p -99.75 145.94 27.11 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.187 -0.946 . . . . 0.0 110.576 -179.937 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 770' ' ' ILE . . . . . . . . . . . . . 35.8 mt -60.6 113.45 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 O-C-N 121.32 -0.863 . . . . 0.0 109.197 179.983 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 771' ' ' SER . . . . . 0.518 ' O ' ' HB2' ' A' ' 772' ' ' ALA . 39.2 t -91.61 -7.58 49.69 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.231 -0.918 . . . . 0.0 111.485 -179.835 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 772' ' ' ALA . . . . . 0.518 ' HB2' ' O ' ' A' ' 771' ' ' SER . . . 179.75 146.14 0.21 Allowed 'General case' 0 N--CA 1.496 1.839 0 O-C-N 120.765 -1.209 . . . . 0.0 111.475 -179.924 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 773' ' ' ILE . . . . . 0.522 HD11 ' HB3' ' A' ' 806' ' ' CYS . 31.9 mm -87.93 135.4 25.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.495 -0.753 . . . . 0.0 109.135 179.892 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 774' ' ' LYS . . . . . 0.573 ' HB3' ' CB ' ' A' ' 836' ' ' GLU . 0.4 OUTLIER -78.14 -35.53 48.88 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.119 -0.988 . . . . 0.0 110.768 -179.897 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 775' ' ' PHE . . . . . 0.521 ' CZ ' ' HB3' ' A' ' 777' ' ' SER . 44.9 t80 176.16 150.86 0.14 Allowed 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.173 -0.955 . . . . 0.0 110.897 -179.988 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 776' ' ' ALA . . . . . 0.472 ' O ' ' HB3' ' A' ' 798' ' ' SER . . . -143.65 145.78 32.73 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.472 -0.767 . . . . 0.0 108.959 179.872 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 777' ' ' SER . . . . . 0.55 ' HA ' ' OG ' ' A' ' 798' ' ' SER . 67.6 p -154.09 119.03 4.99 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.877 -1.14 . . . . 0.0 111.575 -179.949 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 778' ' ' PHE . . . . . 0.48 ' CZ ' ' HG2' ' A' ' 830' ' ' MET . 40.8 t80 -105.39 120.15 40.87 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.466 -0.771 . . . . 0.0 109.496 179.918 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 779' ' ' GLY . . . . . 0.577 ' HA2' ' HA ' ' A' ' 830' ' ' MET . . . 133.49 -100.0 0.38 Allowed Glycine 0 N--CA 1.487 2.075 0 C-N-CA 119.604 -1.284 . . . . 0.0 109.912 179.991 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 780' ' ' THR . . . . . . . . . . . . . 43.5 p -136.62 93.92 13.75 Favored Pre-proline 0 N--CA 1.495 1.781 0 O-C-N 121.133 -1.216 . . . . 0.0 110.593 -179.924 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 781' ' ' PRO . . . . . 0.511 ' CD ' ' HB3' ' A' ' 832' ' ' ARG . 51.6 Cg_endo -81.77 157.91 18.63 Favored 'Trans proline' 0 C--N 1.307 -1.643 0 O-C-N 124.004 1.528 . . . . 0.0 110.605 179.921 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 782' ' ' LEU . . . . . 0.477 HD12 ' HA2' ' A' ' 791' ' ' GLY . 0.8 OUTLIER -112.78 133.89 54.56 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.278 -0.889 . . . . 0.0 110.081 179.989 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 783' ' ' GLY . . . . . . . . . . . . . . . 84.03 -170.37 47.34 Favored Glycine 0 N--CA 1.493 2.487 0 N-CA-C 109.784 -1.326 . . . . 0.0 109.784 179.987 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 784' ' ' THR . . . . . 0.435 ' O ' ' CE1' ' A' ' 788' ' ' PHE . 44.0 p -127.68 -141.82 0.27 Allowed 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.264 -1.139 . . . . 0.0 110.529 -179.99 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 785' ' ' CYS . . . . . . . . . . . . . 38.4 m -78.52 100.56 6.95 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.278 -0.889 . . . . 0.0 110.379 -179.942 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 786' ' ' GLY . . . . . . . . . . . . . . . 140.46 -13.52 2.98 Favored Glycine 0 N--CA 1.493 2.452 0 N-CA-C 110.012 -1.235 . . . . 0.0 110.012 -179.988 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 787' ' ' THR . . . . . . . . . . . . . 9.0 t -159.52 36.62 0.19 Allowed 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.036 -1.273 . . . . 0.0 110.809 -179.978 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 788' ' ' PHE . . . . . 0.459 ' O ' ' HB2' ' A' ' 789' ' ' GLN . 14.4 m-85 -61.29 158.66 13.8 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.07 -1.019 . . . . 0.0 109.909 179.972 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 789' ' ' GLN . . . . . 0.459 ' HB2' ' O ' ' A' ' 788' ' ' PHE . 24.4 tt0 179.25 157.46 0.56 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.175 -0.953 . . . . 0.0 110.218 -179.994 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 790' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -52.17 137.81 27.26 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.252 -0.905 . . . . 0.0 110.362 -179.999 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 791' ' ' GLY . . . . . 0.477 ' HA2' HD12 ' A' ' 782' ' ' LEU . . . -111.75 -107.9 2.97 Favored Glycine 0 N--CA 1.493 2.466 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 -179.986 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 792' ' ' GLU . . . . . . . . . . . . . 39.1 tp10 -90.49 -53.02 4.61 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.194 -1.18 . . . . 0.0 110.277 179.944 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 793' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -136.08 117.69 14.91 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.263 -0.898 . . . . 0.0 110.081 179.983 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 794' ' ' HIS . . . . . . . . . . . . . 40.5 t60 -120.2 150.51 40.54 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.252 -0.905 . . . . 0.0 110.381 -179.975 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 795' ' ' SER . . . . . 0.489 ' OG ' ' HG3' ' A' ' 825' ' ' PRO . 2.6 m -94.94 117.44 30.15 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.425 -0.797 . . . . 0.0 109.483 179.896 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 796' ' ' ILE . . . . . . . . . . . . . 6.7 mt -58.3 -13.57 3.08 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.875 0 O-C-N 121.158 -0.964 . . . . 0.0 110.775 -179.947 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 797' ' ' ASN . . . . . 0.405 ' O ' ' OG ' ' A' ' 800' ' ' SER . 3.6 m-20 -89.96 21.48 3.63 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.062 -1.024 . . . . 0.0 110.414 179.906 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 798' ' ' SER . . . . . 0.55 ' OG ' ' HA ' ' A' ' 777' ' ' SER . 0.5 OUTLIER -70.0 -33.72 72.4 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.176 -0.953 . . . . 0.0 110.806 -179.995 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 799' ' ' ASN . . . . . . . . . . . . . 7.5 m-20 -97.94 6.21 47.99 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.26 -0.9 . . . . 0.0 111.024 -179.856 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 800' ' ' SER . . . . . 0.405 ' OG ' ' O ' ' A' ' 797' ' ' ASN . 6.1 p -90.69 -29.41 17.72 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.97 -1.081 . . . . 0.0 110.396 -179.979 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 801' ' ' VAL . . . . . . . . . . . . . 15.6 t -88.03 -19.66 7.69 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.293 -0.879 . . . . 0.0 110.588 179.957 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 802' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -90.64 -48.44 7.06 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.107 -0.996 . . . . 0.0 110.572 -179.896 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 803' ' ' GLU . . . . . . . . . . . . . 20.8 mt-10 -58.61 -26.78 64.05 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.185 -0.947 . . . . 0.0 110.987 -179.895 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 804' ' ' ARG . . . . . . . . . . . . . 16.7 ttt-85 -86.63 -28.3 23.29 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 120.988 -1.07 . . . . 0.0 110.849 -179.892 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 805' ' ' LYS . . . . . 0.434 ' O ' ' SG ' ' A' ' 812' ' ' CYS . 2.1 mttm -122.28 31.81 6.02 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.055 -1.028 . . . . 0.0 110.615 179.985 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 806' ' ' CYS . . . . . 0.522 ' HB3' HD11 ' A' ' 773' ' ' ILE . 0.1 OUTLIER -162.2 41.44 0.13 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.151 -0.968 . . . . 0.0 110.4 -179.969 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 807' ' ' ILE . . . . . 0.659 HG22 ' O ' ' A' ' 807' ' ' ILE . 9.8 mm -140.59 84.23 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.248 -0.908 . . . . 0.0 110.428 -179.994 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 808' ' ' GLY . . . . . 0.448 ' C ' ' HG ' ' A' ' 809' ' ' LEU . . . 117.84 32.41 1.43 Allowed Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.751 -1.34 . . . . 0.0 109.751 -179.998 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 809' ' ' LEU . . . . . 0.448 ' HG ' ' C ' ' A' ' 808' ' ' GLY . 14.9 mt -137.61 138.12 39.2 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.195 -1.179 . . . . 0.0 110.318 -179.96 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 810' ' ' GLU . . . . . . . . . . . . . 11.5 mp0 -61.01 -33.09 72.72 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.058 -1.026 . . . . 0.0 108.684 179.937 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 811' ' ' ARG . . . . . . . . . . . . . 18.1 ttm180 -125.69 167.69 14.78 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 179.835 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 812' ' ' CYS . . . . . 0.434 ' SG ' ' O ' ' A' ' 805' ' ' LYS . 9.3 t -166.04 116.27 1.0 Allowed 'General case' 0 C--N 1.3 -1.569 0 O-C-N 120.803 -1.185 . . . . 0.0 111.046 -179.903 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 813' ' ' VAL . . . . . . . . . . . . . 75.2 t -117.63 138.45 48.27 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.472 -0.768 . . . . 0.0 109.384 179.951 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 814' ' ' VAL . . . . . . . . . . . . . 4.4 t -125.56 158.04 34.49 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.077 -1.015 . . . . 0.0 110.561 -179.917 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 815' ' ' ALA . . . . . . . . . . . . . . . -117.65 135.01 54.29 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.26 -0.9 . . . . 0.0 110.117 -179.983 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 816' ' ' ILE . . . . . 0.816 HD11 HG23 ' A' ' 760' ' ' VAL . 9.7 mt -107.52 137.22 39.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.263 -0.898 . . . . 0.0 110.276 -179.946 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 817' ' ' SER . . . . . 0.504 ' CB ' ' HD2' ' A' ' 818' ' ' PRO . 0.0 OUTLIER -161.85 -179.81 1.13 Allowed Pre-proline 0 N--CA 1.495 1.781 0 O-C-N 121.232 -0.917 . . . . 0.0 110.031 179.985 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 818' ' ' PRO . . . . . 0.504 ' HD2' ' CB ' ' A' ' 817' ' ' SER . 48.0 Cg_endo -75.45 -38.27 1.48 Allowed 'Trans proline' 0 C--N 1.305 -1.724 0 O-C-N 124.055 1.555 . . . . 0.0 110.525 -179.975 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 819' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -116.51 47.36 1.45 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.23 -0.919 . . . . 0.0 110.296 -179.909 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 820' ' ' ASN . . . . . . . . . . . . . 2.0 m120 -129.71 0.78 4.91 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.178 -0.951 . . . . 0.0 110.206 179.97 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 821' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -125.32 -39.19 2.22 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.269 -0.894 . . . . 0.0 110.258 -179.941 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 822' ' ' GLY . . . . . . . . . . . . . . . -164.52 -52.37 0.02 OUTLIER Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.684 -1.367 . . . . 0.0 109.684 -179.997 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 823' ' ' GLY . . . . . . . . . . . . . . . 158.51 -68.54 0.27 Allowed Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.717 -1.353 . . . . 0.0 109.717 -179.934 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 824' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -171.22 88.91 0.46 Allowed Pre-proline 0 N--CA 1.493 1.684 0 O-C-N 121.262 -1.14 . . . . 0.0 110.431 -179.994 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 825' ' ' PRO . . . . . 0.489 ' HG3' ' OG ' ' A' ' 795' ' ' SER . 44.8 Cg_endo -75.08 -62.79 0.03 OUTLIER 'Trans proline' 0 C--N 1.304 -1.806 0 O-C-N 123.947 1.498 . . . . 0.0 110.317 179.971 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 826' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -116.93 118.92 35.83 Favored Pre-proline 0 N--CA 1.493 1.688 0 O-C-N 121.305 -0.872 . . . . 0.0 109.632 -179.996 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 827' ' ' PRO . . . . . 0.428 ' O ' ' HB2' ' A' ' 828' ' ' GLU . 48.2 Cg_endo -75.24 141.01 25.45 Favored 'Trans proline' 0 C--N 1.308 -1.58 0 O-C-N 123.885 1.466 . . . . 0.0 110.866 -179.887 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 828' ' ' GLU . . . . . 0.428 ' HB2' ' O ' ' A' ' 827' ' ' PRO . 0.6 OUTLIER 58.41 14.16 2.81 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.486 -0.759 . . . . 0.0 110.508 179.99 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 829' ' ' VAL . . . . . 0.56 ' O ' HG12 ' A' ' 829' ' ' VAL . 54.0 t -137.59 82.03 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.165 -0.96 . . . . 0.0 110.217 -179.959 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 830' ' ' MET . . . . . 0.577 ' HA ' ' HA2' ' A' ' 779' ' ' GLY . 0.2 OUTLIER -176.26 107.65 0.08 Allowed 'General case' 0 N--CA 1.487 1.398 0 O-C-N 120.929 -1.107 . . . . 0.0 111.348 179.991 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 831' ' ' LYS . . . . . 0.542 ' HA ' ' CB ' ' A' ' 737' ' ' GLU . 20.6 ttpp -170.93 53.1 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.235 -0.915 . . . . 0.0 110.736 179.95 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 832' ' ' ARG . . . . . 0.511 ' HB3' ' CD ' ' A' ' 781' ' ' PRO . 1.7 mtt180 -172.97 107.16 0.16 Allowed 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.274 -0.891 . . . . 0.0 109.846 179.957 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 833' ' ' VAL . . . . . 0.782 HG21 HD13 ' A' ' 816' ' ' ILE . 3.8 t -107.35 109.25 27.5 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 O-C-N 121.111 -0.993 . . . . 0.0 110.836 -179.96 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 834' ' ' ALA . . . . . . . . . . . . . . . -109.62 136.47 48.94 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.371 -0.831 . . . . 0.0 109.34 179.934 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 835' ' ' VAL . . . . . . . . . . . . . 38.1 t -147.05 156.94 10.51 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.069 -1.02 . . . . 0.0 110.946 -179.95 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 836' ' ' GLU . . . . . 0.573 ' CB ' ' HB3' ' A' ' 774' ' ' LYS . 1.7 mp0 -135.2 158.89 43.21 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 179.845 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 837' ' ' ALA . . . . . 0.451 ' HB2' HD22 ' A' ' 762' ' ' LEU . . . -138.44 154.59 48.86 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 120.802 -1.186 . . . . 0.0 111.54 -179.772 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 838' ' ' VAL . . . . . . . . . . . . . 21.3 t -121.85 109.57 24.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.692 -0.63 . . . . 0.0 109.376 179.88 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 839' ' ' CYS . . . . . 0.41 ' O ' ' HA ' ' A' ' 728' ' ' VAL . 0.6 OUTLIER -108.1 129.42 55.15 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.115 -0.991 . . . . 0.0 110.522 -179.96 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 840' ' ' SER . . . . . . . . . . . . . 54.1 p -125.53 -161.03 1.0 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.282 -0.886 . . . . 0.0 110.221 179.989 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 841' ' ' THR . . . . . 0.503 HG23 ' OE1' ' A' ' 768' ' ' GLN . 0.6 OUTLIER . . . . . 0 N--CA 1.491 1.611 0 O-C-N 121.285 -0.884 . . . . 0.0 110.493 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 726' ' ' ARG . . . . . . . . . . . . . 1.9 mmm180 . . . . . 0 N--CA 1.493 1.676 0 CA-C-O 121.233 0.54 . . . . 0.0 110.142 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 727' ' ' THR . . . . . 0.435 ' HA ' ' HB2' ' A' ' 840' ' ' SER . 97.5 m -52.77 117.33 2.85 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.355 -0.841 . . . . 0.0 110.318 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 728' ' ' VAL . . . . . 0.747 ' O ' HG13 ' A' ' 728' ' ' VAL . 9.0 p -158.37 55.48 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.302 -0.874 . . . . 0.0 110.008 179.918 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 729' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -179.93 -177.96 0.41 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.264 -0.897 . . . . 0.0 110.407 -179.952 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 730' ' ' GLY . . . . . . . . . . . . . . . 172.21 113.73 0.31 Allowed Glycine 0 N--CA 1.492 2.373 0 N-CA-C 109.074 -1.61 . . . . 0.0 109.074 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 731' ' ' VAL . . . . . . . . . . . . . 31.3 m -130.02 148.41 33.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.227 -1.161 . . . . 0.0 110.872 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 732' ' ' CYS . . . . . 0.42 ' O ' ' SG ' ' A' ' 732' ' ' CYS . 16.5 p -142.18 133.89 26.95 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.521 -0.737 . . . . 0.0 109.272 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 733' ' ' ALA . . . . . 0.522 ' HB2' HD21 ' A' ' 762' ' ' LEU . . . -111.69 132.32 54.7 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.049 -1.032 . . . . 0.0 110.746 -179.911 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 734' ' ' ASP . . . . . 0.442 ' CG ' ' O ' ' A' ' 734' ' ' ASP . 8.6 p-10 -116.54 116.34 27.44 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.295 -0.878 . . . . 0.0 109.777 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 735' ' ' VAL . . . . . . . . . . . . . 5.7 t -139.62 166.9 20.36 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.154 -0.966 . . . . 0.0 110.187 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 736' ' ' SER . . . . . 0.448 ' O ' ' C ' ' A' ' 737' ' ' GLU . 1.2 m -135.78 136.27 40.58 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.265 -0.897 . . . . 0.0 109.937 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 737' ' ' GLU . . . . . 0.535 ' HB2' ' HB3' ' A' ' 831' ' ' LYS . 1.2 tm-20 -42.26 149.62 0.16 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.32 -0.863 . . . . 0.0 109.86 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 738' ' ' TYR . . . . . . . . . . . . . 45.7 t80 -165.56 123.2 1.52 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.257 -0.902 . . . . 0.0 110.047 -179.938 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 739' ' ' HIS . . . . . 0.66 ' O ' ' CG ' ' A' ' 739' ' ' HIS . 0.2 OUTLIER -173.67 48.44 0.07 OUTLIER Pre-proline 0 N--CA 1.489 1.523 0 O-C-N 121.269 -0.895 . . . . 0.0 110.364 179.977 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 740' ' ' PRO . . . . . 0.923 ' HG2' HD11 ' A' ' 742' ' ' ILE . 37.9 Cg_endo -62.0 151.56 80.76 Favored 'Trans proline' 0 C--N 1.299 -2.046 0 O-C-N 123.204 1.108 . . . . 0.0 109.64 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 741' ' ' ASN . . . . . 0.487 ' CG ' ' O ' ' A' ' 741' ' ' ASN . 7.4 p30 -65.02 99.77 0.38 Allowed 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.069 -1.019 . . . . 0.0 109.852 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 742' ' ' ILE . . . . . 0.923 HD11 ' HG2' ' A' ' 740' ' ' PRO . 1.4 mt -124.33 102.16 10.36 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 120.819 -1.176 . . . . 0.0 110.226 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 743' ' ' LYS . . . . . 0.408 ' O ' ' CB ' ' A' ' 744' ' ' ASN . 31.6 mmmt -98.11 63.23 1.58 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.103 -0.998 . . . . 0.0 109.577 179.85 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 744' ' ' ASN . . . . . 0.408 ' CB ' ' O ' ' A' ' 743' ' ' LYS . 0.0 OUTLIER 172.81 101.46 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.634 -0.666 . . . . 0.0 109.562 -179.937 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 745' ' ' TRP . . . . . 0.587 ' CG ' ' O ' ' A' ' 745' ' ' TRP . 69.5 t-105 -160.72 43.98 0.18 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.071 -1.018 . . . . 0.0 110.627 -179.953 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 746' ' ' GLN . . . . . 0.453 ' HB3' ' O ' ' A' ' 745' ' ' TRP . 1.5 pt20 176.96 113.32 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.169 -0.957 . . . . 0.0 110.156 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 747' ' ' ILE . . . . . 0.406 HD12 ' N ' ' A' ' 747' ' ' ILE . 3.5 mp -115.71 46.8 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.155 -0.966 . . . . 0.0 110.293 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 748' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -136.25 -166.4 1.87 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.277 -0.889 . . . . 0.0 109.949 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 749' ' ' SER . . . . . . . . . . . . . 67.0 m -88.17 28.81 1.02 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.145 -0.972 . . . . 0.0 110.181 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 750' ' ' TYR . . . . . . . . . . . . . 12.1 t80 -118.12 169.73 9.45 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.346 -0.846 . . . . 0.0 109.837 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 751' ' ' GLY . . . . . . . . . . . . . . . -165.09 147.4 12.45 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.664 -1.374 . . . . 0.0 109.664 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 752' ' ' GLU . . . . . 0.475 ' HG2' ' OE1' ' A' ' 754' ' ' GLU . 1.2 tt0 -169.14 73.3 0.73 Allowed Pre-proline 0 C--N 1.301 -1.534 0 O-C-N 121.343 -1.092 . . . . 0.0 110.036 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 753' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_endo -79.07 45.06 1.82 Allowed 'Trans proline' 0 C--N 1.309 -1.509 0 O-C-N 124.296 1.682 . . . . 0.0 110.863 179.874 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 754' ' ' GLU . . . . . 0.475 ' OE1' ' HG2' ' A' ' 752' ' ' GLU . 6.2 pt-20 -127.07 50.55 1.97 Allowed 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.064 -1.023 . . . . 0.0 110.026 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 755' ' ' PHE . . . . . . . . . . . . . 16.3 t80 -151.98 76.0 1.16 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.212 -0.93 . . . . 0.0 110.638 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 756' ' ' HIS . . . . . 0.452 ' O ' HG23 ' A' ' 757' ' ' THR . 0.0 OUTLIER -107.98 39.32 1.97 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.22 -0.925 . . . . 0.0 109.625 179.897 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 757' ' ' THR . . . . . 0.539 HG21 ' O ' ' A' ' 816' ' ' ILE . 0.0 OUTLIER -170.97 167.12 7.4 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.417 -0.802 . . . . 0.0 109.853 179.935 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 758' ' ' ALA . . . . . . . . . . . . . . . -88.69 153.26 21.25 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.113 -0.992 . . . . 0.0 109.938 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 759' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -113.28 161.07 17.66 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.187 -0.946 . . . . 0.0 110.365 -179.942 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 760' ' ' VAL . . . . . . . . . . . . . 42.2 t -107.76 133.73 51.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.359 -0.838 . . . . 0.0 109.328 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 761' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -109.97 115.67 30.2 Favored 'General case' 0 C--N 1.302 -1.5 0 O-C-N 121.133 -0.98 . . . . 0.0 111.043 -179.925 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 762' ' ' LEU . . . . . 0.522 HD21 ' HB2' ' A' ' 733' ' ' ALA . 93.1 mt -132.36 138.78 47.87 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.543 -0.723 . . . . 0.0 109.119 179.842 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 763' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -167.7 136.72 2.57 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.834 -1.166 . . . . 0.0 110.891 -179.893 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 764' ' ' CYS . . . . . . . . . . . . . 92.7 m -106.59 172.77 6.64 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.427 -0.796 . . . . 0.0 109.849 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 765' ' ' ALA . . . . . 0.724 ' HB3' ' OE1' ' A' ' 768' ' ' GLN . . . -67.89 166.27 24.82 Favored Pre-proline 0 N--CA 1.495 1.795 0 O-C-N 121.156 -0.965 . . . . 0.0 110.277 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 766' ' ' PRO . . . . . 0.543 ' HD2' ' HB1' ' A' ' 765' ' ' ALA . 45.6 Cg_endo -72.84 107.11 2.26 Favored 'Trans proline' 0 C--N 1.307 -1.61 0 O-C-N 123.964 1.507 . . . . 0.0 110.026 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 767' ' ' GLY . . . . . . . . . . . . . . . 132.86 -3.42 4.94 Favored Glycine 0 N--CA 1.489 2.174 0 N-CA-C 109.334 -1.506 . . . . 0.0 109.334 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 768' ' ' GLN . . . . . 0.724 ' OE1' ' HB3' ' A' ' 765' ' ' ALA . 44.5 mt-30 -124.52 152.99 42.74 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.183 -1.187 . . . . 0.0 109.968 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 769' ' ' THR . . . . . . . . . . . . . 62.2 p -134.74 147.09 49.96 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.139 -0.975 . . . . 0.0 110.598 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 770' ' ' ILE . . . . . . . . . . . . . 59.1 mt -73.33 139.75 18.95 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.394 -0.816 . . . . 0.0 109.453 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 771' ' ' SER . . . . . . . . . . . . . 2.3 t -134.97 -8.17 2.35 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.974 -1.079 . . . . 0.0 111.422 -179.888 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 772' ' ' ALA . . . . . . . . . . . . . . . -162.96 155.97 19.32 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 120.684 -1.26 . . . . 0.0 111.734 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 773' ' ' ILE . . . . . . . . . . . . . 19.9 mm -110.69 125.65 68.0 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.687 -0.633 . . . . 0.0 109.48 179.861 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 774' ' ' LYS . . . . . 0.569 ' HG2' ' CG2' ' A' ' 838' ' ' VAL . 3.2 mmmp? -80.71 -33.47 35.28 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.078 -1.013 . . . . 0.0 110.928 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 775' ' ' PHE . . . . . . . . . . . . . 88.7 t80 -160.46 154.73 23.32 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.022 -1.049 . . . . 0.0 110.282 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 776' ' ' ALA . . . . . 0.456 ' O ' ' HB2' ' A' ' 798' ' ' SER . . . -169.21 113.55 0.55 Allowed 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.41 -0.806 . . . . 0.0 109.47 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 777' ' ' SER . . . . . 0.589 ' HA ' ' CB ' ' A' ' 798' ' ' SER . 0.6 OUTLIER -140.68 137.35 33.47 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.04 -1.038 . . . . 0.0 111.327 179.977 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 778' ' ' PHE . . . . . 0.545 ' CG ' ' O ' ' A' ' 778' ' ' PHE . 24.0 t80 -116.19 72.98 0.83 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.497 -0.752 . . . . 0.0 109.344 179.869 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 779' ' ' GLY . . . . . . . . . . . . . . . -164.46 -102.63 0.17 Allowed Glycine 0 N--CA 1.495 2.601 0 N-CA-C 109.696 -1.362 . . . . 0.0 109.696 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 780' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -133.15 77.0 68.31 Favored Pre-proline 0 N--CA 1.495 1.789 0 O-C-N 120.74 -1.447 . . . . 0.0 110.369 179.929 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 781' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -80.37 138.95 12.72 Favored 'Trans proline' 0 C--N 1.304 -1.78 0 O-C-N 124.162 1.612 . . . . 0.0 110.442 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 782' ' ' LEU . . . . . 0.564 HD12 ' HA2' ' A' ' 791' ' ' GLY . 1.3 mt -103.62 168.89 8.86 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.308 -0.87 . . . . 0.0 109.914 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 783' ' ' GLY . . . . . . . . . . . . . . . 91.16 -154.17 22.74 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.628 -1.389 . . . . 0.0 109.628 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 784' ' ' THR . . . . . . . . . . . . . 7.8 t -154.59 179.54 8.95 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.334 -1.098 . . . . 0.0 110.231 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 785' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -52.99 108.33 0.31 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.274 -0.892 . . . . 0.0 110.323 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 786' ' ' GLY . . . . . . . . . . . . . . . 143.89 -36.97 1.47 Allowed Glycine 0 N--CA 1.488 2.125 0 N-CA-C 109.724 -1.35 . . . . 0.0 109.724 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 787' ' ' THR . . . . . 0.508 HG22 ' O ' ' A' ' 787' ' ' THR . 30.8 m -157.81 47.27 0.38 Allowed 'General case' 0 C--N 1.306 -1.302 0 O-C-N 121.253 -1.145 . . . . 0.0 110.497 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 788' ' ' PHE . . . . . 0.423 ' O ' ' O ' ' A' ' 787' ' ' THR . 10.8 m-85 -46.02 170.89 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.154 -0.966 . . . . 0.0 110.201 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 789' ' ' GLN . . . . . . . . . . . . . 24.0 tt0 -166.56 142.9 4.73 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.278 -0.889 . . . . 0.0 110.034 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 790' ' ' GLN . . . . . . . . . . . . . 19.3 pt20 -56.84 152.47 12.56 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 120.975 -1.078 . . . . 0.0 110.329 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 791' ' ' GLY . . . . . 0.564 ' HA2' HD12 ' A' ' 782' ' ' LEU . . . -109.44 -86.33 1.75 Allowed Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.544 -1.422 . . . . 0.0 109.544 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 792' ' ' GLU . . . . . 0.403 ' HG2' ' C ' ' A' ' 791' ' ' GLY . 68.4 mm-40 -142.64 -37.97 0.37 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.207 -1.172 . . . . 0.0 110.169 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 793' ' ' CYS . . . . . . . . . . . . . 1.3 m -107.14 131.78 53.75 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.262 -0.898 . . . . 0.0 110.331 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 794' ' ' HIS . . . . . 0.48 ' CG ' ' H ' ' A' ' 796' ' ' ILE . 5.0 t60 -145.48 144.29 30.5 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.175 -0.953 . . . . 0.0 110.079 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 795' ' ' SER . . . . . 0.423 ' O ' ' N ' ' A' ' 797' ' ' ASN . 1.1 m -83.01 8.8 11.72 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.231 -0.918 . . . . 0.0 110.604 -179.91 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 796' ' ' ILE . . . . . 0.764 HG22 ' O ' ' A' ' 796' ' ' ILE . 90.4 mt 42.41 26.67 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 O-C-N 121.242 -0.911 . . . . 0.0 110.269 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 797' ' ' ASN . . . . . 0.437 ' OD1' ' O ' ' A' ' 796' ' ' ILE . 5.5 m120 -152.49 22.66 0.62 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.204 -0.935 . . . . 0.0 109.797 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 798' ' ' SER . . . . . 0.589 ' CB ' ' HA ' ' A' ' 777' ' ' SER . 13.2 m -84.62 2.59 40.85 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.435 -0.791 . . . . 0.0 110.452 -179.901 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 799' ' ' ASN . . . . . . . . . . . . . 6.9 t-20 -115.41 -14.84 11.58 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.196 -0.94 . . . . 0.0 110.908 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 800' ' ' SER . . . . . . . . . . . . . 16.4 m -82.09 -18.87 41.55 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 120.903 -1.123 . . . . 0.0 109.881 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 801' ' ' VAL . . . . . 0.435 ' O ' ' HD2' ' A' ' 805' ' ' LYS . 45.0 t -86.44 -21.41 7.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.464 -0.772 . . . . 0.0 110.117 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 802' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -79.42 -57.39 3.72 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.137 -0.977 . . . . 0.0 110.313 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 803' ' ' GLU . . . . . 0.879 ' HG2' HD12 ' A' ' 807' ' ' ILE . 0.4 OUTLIER -53.82 -22.71 10.22 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.295 -0.878 . . . . 0.0 110.339 179.942 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 804' ' ' ARG . . . . . . . . . . . . . 1.9 mtm180 -91.08 -23.92 20.18 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.188 -0.945 . . . . 0.0 110.998 -180.0 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 805' ' ' LYS . . . . . 0.435 ' HD2' ' O ' ' A' ' 801' ' ' VAL . 9.6 mttt -127.06 49.83 2.04 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.07 -1.019 . . . . 0.0 111.034 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 806' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -163.23 -71.51 0.04 OUTLIER 'General case' 0 N--CA 1.497 1.909 0 O-C-N 120.952 -1.092 . . . . 0.0 110.905 179.937 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 807' ' ' ILE . . . . . 0.879 HD12 ' HG2' ' A' ' 803' ' ' GLU . 90.6 mt -50.86 128.32 8.07 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 O-C-N 121.223 -0.923 . . . . 0.0 110.988 -179.918 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 808' ' ' GLY . . . . . 0.66 ' O ' HD23 ' A' ' 809' ' ' LEU . . . 103.89 10.84 33.92 Favored Glycine 0 N--CA 1.493 2.456 0 N-CA-C 110.127 -1.189 . . . . 0.0 110.127 179.912 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 809' ' ' LEU . . . . . 0.66 HD23 ' O ' ' A' ' 808' ' ' GLY . 33.1 mt -142.67 137.11 29.7 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.108 -1.231 . . . . 0.0 110.138 -179.913 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 810' ' ' GLU . . . . . 0.444 ' HG2' ' O ' ' A' ' 768' ' ' GLN . 0.7 OUTLIER -65.16 -21.92 66.85 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.224 -0.923 . . . . 0.0 109.289 179.972 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 811' ' ' ARG . . . . . 0.471 ' HG3' ' O ' ' A' ' 762' ' ' LEU . 1.1 ttp85 -128.76 151.52 49.47 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.538 -0.726 . . . . 0.0 109.747 179.866 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 812' ' ' CYS . . . . . 0.465 ' HB3' ' HB2' ' A' ' 762' ' ' LEU . 7.8 t -129.73 139.87 51.22 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.121 -0.987 . . . . 0.0 110.602 -179.944 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 813' ' ' VAL . . . . . . . . . . . . . 84.1 t -145.63 123.11 4.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.348 -0.845 . . . . 0.0 109.663 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 814' ' ' VAL . . . . . . . . . . . . . 88.7 t -133.0 129.01 57.25 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 O-C-N 121.129 -0.982 . . . . 0.0 110.73 -179.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 815' ' ' ALA . . . . . . . . . . . . . . . -88.75 127.8 35.61 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.339 -0.851 . . . . 0.0 109.755 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 816' ' ' ILE . . . . . 1.014 HD13 HG21 ' A' ' 833' ' ' VAL . 46.2 mt -84.3 114.01 24.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.181 -0.949 . . . . 0.0 110.436 -179.905 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 817' ' ' SER . . . . . . . . . . . . . 5.0 p -158.84 158.57 29.27 Favored Pre-proline 0 N--CA 1.495 1.777 0 O-C-N 121.356 -0.84 . . . . 0.0 109.91 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 818' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -75.29 2.65 6.54 Favored 'Trans proline' 0 C--N 1.306 -1.692 0 O-C-N 123.926 1.487 . . . . 0.0 110.772 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 819' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -111.77 7.67 20.32 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.103 -0.998 . . . . 0.0 110.253 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 820' ' ' ASN . . . . . . . . . . . . . 6.8 m-20 -121.19 -7.2 9.38 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.248 -0.907 . . . . 0.0 110.262 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 821' ' ' PHE . . . . . . . . . . . . . 4.8 m-85 -110.66 -65.96 1.12 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.261 -0.9 . . . . 0.0 110.19 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 822' ' ' GLY . . . . . . . . . . . . . . . 161.27 63.86 0.02 OUTLIER Glycine 0 N--CA 1.492 2.41 0 N-CA-C 110.006 -1.238 . . . . 0.0 110.006 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 823' ' ' GLY . . . . . . . . . . . . . . . 78.7 -150.41 34.51 Favored Glycine 0 N--CA 1.493 2.47 0 N-CA-C 110.036 -1.226 . . . . 0.0 110.036 179.907 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 824' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -109.17 141.88 24.39 Favored Pre-proline 0 N--CA 1.493 1.709 0 O-C-N 121.26 -1.141 . . . . 0.0 110.407 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 825' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -80.53 -91.2 0.0 OUTLIER 'Trans proline' 0 C--N 1.306 -1.699 0 O-C-N 124.11 1.584 . . . . 0.0 110.693 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 826' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -101.5 132.95 21.17 Favored Pre-proline 0 N--CA 1.496 1.872 0 O-C-N 121.189 -0.944 . . . . 0.0 110.372 -179.924 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 827' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -82.52 157.51 16.63 Favored 'Trans proline' 0 C--N 1.309 -1.525 0 O-C-N 123.958 1.504 . . . . 0.0 110.629 180.0 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 828' ' ' GLU . . . . . 0.452 ' O ' ' OE1' ' A' ' 828' ' ' GLU . 7.2 tm-20 54.47 39.13 30.83 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.243 -0.91 . . . . 0.0 110.622 179.906 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 829' ' ' VAL . . . . . 0.413 ' O ' ' C ' ' A' ' 830' ' ' MET . 20.2 t -142.81 118.3 4.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.071 -1.018 . . . . 0.0 110.369 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 830' ' ' MET . . . . . 0.413 ' C ' ' O ' ' A' ' 829' ' ' VAL . 4.7 mtt -42.71 158.32 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.246 -0.909 . . . . 0.0 109.878 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 831' ' ' LYS . . . . . 0.535 ' HB3' ' HB2' ' A' ' 737' ' ' GLU . 4.9 mtmt -115.04 110.57 19.77 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.118 -0.989 . . . . 0.0 110.877 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 832' ' ' ARG . . . . . . . . . . . . . 10.6 mtm-85 -116.38 135.31 53.97 Favored 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 179.927 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 833' ' ' VAL . . . . . 1.014 HG21 HD13 ' A' ' 816' ' ' ILE . 7.7 t -111.5 130.09 65.68 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.631 0 O-C-N 120.986 -1.071 . . . . 0.0 111.334 -179.94 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 834' ' ' ALA . . . . . . . . . . . . . . . -134.81 129.43 34.52 Favored 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 835' ' ' VAL . . . . . 0.403 ' CG1' ' N ' ' A' ' 836' ' ' GLU . 18.3 t -137.95 160.82 33.13 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 O-C-N 120.932 -1.105 . . . . 0.0 111.334 -179.869 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 836' ' ' GLU . . . . . 0.403 ' N ' ' CG1' ' A' ' 835' ' ' VAL . 0.0 OUTLIER -148.39 121.41 8.83 Favored 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 179.988 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 837' ' ' ALA . . . . . . . . . . . . . . . -109.55 155.32 21.54 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.006 -1.059 . . . . 0.0 111.016 -179.893 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 838' ' ' VAL . . . . . 0.569 ' CG2' ' HG2' ' A' ' 774' ' ' LYS . 6.0 t -111.97 114.59 47.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.422 -0.799 . . . . 0.0 109.804 179.926 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 839' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -109.42 136.76 48.31 Favored 'General case' 0 C--N 1.299 -1.611 0 O-C-N 121.128 -0.982 . . . . 0.0 110.245 -179.881 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 840' ' ' SER . . . . . 0.718 ' O ' HG23 ' A' ' 841' ' ' THR . 0.4 OUTLIER -136.43 -82.02 0.38 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.284 -0.885 . . . . 0.0 109.942 179.955 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 841' ' ' THR . . . . . 0.718 HG23 ' O ' ' A' ' 840' ' ' SER . 13.5 p -159.98 -176.91 5.96 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.294 -0.878 . . . . 0.0 110.006 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 842' ' ' ALA . . . . . . . . . . . . . . . -72.88 151.12 42.1 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.228 -0.92 . . . . 0.0 110.229 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 843' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.685 0 CA-C-O 118.026 -0.988 . . . . 0.0 110.221 -179.996 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 726' ' ' ARG . . . . . 0.462 ' NE ' ' HA ' ' A' ' 726' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.682 0 CA-C-O 121.274 0.559 . . . . 0.0 110.23 . . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 727' ' ' THR . . . . . . . . . . . . . 11.8 t -124.49 160.7 27.69 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.23 -0.919 . . . . 0.0 110.183 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 728' ' ' VAL . . . . . 0.456 ' O ' ' O ' ' A' ' 839' ' ' CYS . 3.4 p -151.29 147.31 15.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.221 -0.924 . . . . 0.0 110.354 -179.981 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 729' ' ' SER . . . . . . . . . . . . . 75.3 p -55.01 178.58 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.243 -0.911 . . . . 0.0 110.3 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 730' ' ' GLY . . . . . 0.447 ' HA2' ' HB2' ' A' ' 839' ' ' CYS . . . -113.7 -139.11 7.15 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.658 -1.377 . . . . 0.0 109.658 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 731' ' ' VAL . . . . . . . . . . . . . 30.0 t -128.44 155.5 40.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.288 -1.125 . . . . 0.0 110.254 -179.89 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 732' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -108.22 145.92 33.56 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.361 -0.837 . . . . 0.0 109.431 179.892 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 733' ' ' ALA . . . . . . . . . . . . . . . -147.11 128.56 14.96 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.021 -1.049 . . . . 0.0 110.781 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 734' ' ' ASP . . . . . 0.459 ' OD1' ' O ' ' A' ' 734' ' ' ASP . 1.5 p30 -131.72 109.23 10.02 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.454 -0.779 . . . . 0.0 109.673 179.93 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 735' ' ' VAL . . . . . 0.972 HG21 HG22 ' A' ' 760' ' ' VAL . 7.0 m -129.58 157.13 42.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.115 -0.991 . . . . 0.0 110.586 -179.916 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 736' ' ' SER . . . . . 0.427 ' O ' ' C ' ' A' ' 737' ' ' GLU . 70.9 m -119.43 140.15 50.89 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.436 -0.79 . . . . 0.0 109.714 179.918 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 737' ' ' GLU . . . . . 0.427 ' C ' ' O ' ' A' ' 736' ' ' SER . 11.2 tp10 -41.9 110.74 0.18 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.215 -0.928 . . . . 0.0 109.979 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 738' ' ' TYR . . . . . 0.486 ' HB2' ' HB2' ' A' ' 758' ' ' ALA . 57.2 t80 -67.15 125.12 25.05 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.307 -0.87 . . . . 0.0 110.034 -179.926 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 739' ' ' HIS . . . . . . . . . . . . . 20.8 t-80 -175.27 97.77 0.27 Allowed Pre-proline 0 N--CA 1.489 1.478 0 O-C-N 121.246 -0.909 . . . . 0.0 110.379 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 740' ' ' PRO . . . . . 0.588 ' O ' ' CB ' ' A' ' 741' ' ' ASN . 50.1 Cg_endo -78.05 7.29 4.09 Favored 'Trans proline' 0 C--N 1.307 -1.612 0 O-C-N 124.008 1.531 . . . . 0.0 110.602 179.966 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 741' ' ' ASN . . . . . 0.588 ' CB ' ' O ' ' A' ' 740' ' ' PRO . 1.8 t-20 82.23 -52.93 0.22 Allowed 'General case' 0 N--CA 1.511 2.621 0 O-C-N 121.822 -0.549 . . . . 0.0 110.399 -179.987 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 742' ' ' ILE . . . . . 0.463 ' O ' ' O ' ' A' ' 741' ' ' ASN . 15.7 mt 59.93 133.81 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.109 -0.994 . . . . 0.0 110.28 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 743' ' ' LYS . . . . . 0.462 ' O ' ' HB3' ' A' ' 744' ' ' ASN . 30.3 pttt -125.11 145.25 50.02 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.151 -0.968 . . . . 0.0 109.952 179.934 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 744' ' ' ASN . . . . . 0.462 ' HB3' ' O ' ' A' ' 743' ' ' LYS . 10.5 t-20 59.99 62.07 1.74 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.242 -0.911 . . . . 0.0 109.944 -179.965 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 745' ' ' TRP . . . . . 0.774 ' HE1' HD11 ' A' ' 747' ' ' ILE . 40.1 p90 -80.01 3.26 20.7 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.439 -0.788 . . . . 0.0 110.098 -179.956 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 746' ' ' GLN . . . . . 0.477 ' O ' HG13 ' A' ' 747' ' ' ILE . 0.0 OUTLIER 66.73 152.69 0.07 Allowed 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.343 -0.848 . . . . 0.0 111.834 179.831 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 747' ' ' ILE . . . . . 0.807 HG22 ' O ' ' A' ' 747' ' ' ILE . 25.4 mt -157.13 36.65 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.94 0 CA-C-O 121.619 0.723 . . . . 0.0 109.078 179.942 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 748' ' ' GLU . . . . . 0.485 ' HG2' ' N ' ' A' ' 749' ' ' SER . 29.5 tt0 -101.17 -99.25 0.26 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.925 -1.109 . . . . 0.0 111.014 -179.888 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 749' ' ' SER . . . . . 0.485 ' N ' ' HG2' ' A' ' 748' ' ' GLU . 8.4 t -111.55 13.95 21.34 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.012 -1.055 . . . . 0.0 110.691 -179.955 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 750' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -92.2 -79.31 0.39 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.142 -0.974 . . . . 0.0 110.207 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 751' ' ' GLY . . . . . . . . . . . . . . . 85.55 -72.72 2.69 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.598 -1.401 . . . . 0.0 109.598 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 752' ' ' GLU . . . . . 0.483 ' HG2' ' HD2' ' A' ' 753' ' ' PRO . 0.8 OUTLIER 58.47 172.17 0.05 OUTLIER Pre-proline 0 N--CA 1.493 1.69 0 O-C-N 121.215 -1.168 . . . . 0.0 110.182 -179.944 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 753' ' ' PRO . . . . . 0.483 ' HD2' ' HG2' ' A' ' 752' ' ' GLU . 46.9 Cg_endo -74.19 138.68 25.54 Favored 'Trans proline' 0 C--N 1.305 -1.739 0 O-C-N 123.966 1.509 . . . . 0.0 110.418 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 754' ' ' GLU . . . . . . . . . . . . . 21.9 tt0 -120.65 67.62 0.85 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.281 -0.887 . . . . 0.0 110.121 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 755' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -128.48 47.66 2.41 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.238 -0.914 . . . . 0.0 110.465 -179.945 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 756' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -77.67 98.16 5.36 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.161 -0.962 . . . . 0.0 110.065 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 757' ' ' THR . . . . . . . . . . . . . 20.6 p -144.78 -178.33 5.96 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.254 -0.903 . . . . 0.0 110.421 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 758' ' ' ALA . . . . . 0.486 ' HB2' ' HB2' ' A' ' 738' ' ' TYR . . . -107.92 178.96 4.36 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.328 -0.857 . . . . 0.0 110.141 180.0 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 759' ' ' LYS . . . . . . . . . . . . . 29.7 mttm -140.42 138.82 35.03 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.224 -0.923 . . . . 0.0 110.592 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 760' ' ' VAL . . . . . 0.972 HG22 HG21 ' A' ' 735' ' ' VAL . 41.9 t -115.67 108.71 25.96 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 O-C-N 121.427 -0.796 . . . . 0.0 109.552 179.927 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 761' ' ' HIS . . . . . 0.503 ' CB ' HG22 ' A' ' 813' ' ' VAL . 42.2 p-80 -124.96 139.63 53.65 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 120.945 -1.097 . . . . 0.0 111.468 -179.82 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 762' ' ' LEU . . . . . 0.514 HD13 ' HB2' ' A' ' 837' ' ' ALA . 12.4 mt -119.33 110.87 17.48 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 109.057 -0.719 . . . . 0.0 109.057 179.892 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 763' ' ' LYS . . . . . 0.405 ' HA ' ' HA ' ' A' ' 811' ' ' ARG . 0.0 OUTLIER -110.31 133.46 53.23 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.151 -0.968 . . . . 0.0 111.001 -179.865 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 764' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -111.14 164.27 13.03 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.436 -0.79 . . . . 0.0 109.856 179.925 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 765' ' ' ALA . . . . . 0.539 ' HB3' ' OE1' ' A' ' 768' ' ' GLN . . . -56.04 164.0 2.0 Allowed Pre-proline 0 N--CA 1.493 1.68 0 O-C-N 121.118 -0.989 . . . . 0.0 110.177 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 766' ' ' PRO . . . . . 0.486 ' HD2' ' HB1' ' A' ' 765' ' ' ALA . 45.2 Cg_endo -71.71 114.2 3.88 Favored 'Trans proline' 0 C--N 1.305 -1.747 0 O-C-N 123.962 1.506 . . . . 0.0 110.394 179.984 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 767' ' ' GLY . . . . . . . . . . . . . . . 123.13 -18.48 7.88 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.436 -1.466 . . . . 0.0 109.436 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 768' ' ' GLN . . . . . 0.554 ' HG3' ' CA ' ' A' ' 841' ' ' THR . 0.5 OUTLIER -110.38 130.75 55.49 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.224 -1.162 . . . . 0.0 110.176 179.975 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 769' ' ' THR . . . . . . . . . . . . . 45.7 p -118.25 148.59 42.27 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.226 -0.921 . . . . 0.0 110.364 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 770' ' ' ILE . . . . . 0.563 HG22 HG13 ' A' ' 807' ' ' ILE . 2.6 mp -66.28 141.3 18.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.297 -0.877 . . . . 0.0 110.014 179.971 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 771' ' ' SER . . . . . . . . . . . . . 11.8 p -120.6 -15.92 8.38 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.109 -0.995 . . . . 0.0 110.565 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 772' ' ' ALA . . . . . 0.506 ' O ' HD13 ' A' ' 773' ' ' ILE . . . -169.64 171.85 7.24 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.063 -1.023 . . . . 0.0 111.029 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 773' ' ' ILE . . . . . 0.506 HD13 ' O ' ' A' ' 772' ' ' ALA . 25.8 mm -116.6 134.27 60.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.505 -0.747 . . . . 0.0 109.603 179.912 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 774' ' ' LYS . . . . . 0.515 ' HB2' ' HB3' ' A' ' 836' ' ' GLU . 0.9 OUTLIER -83.89 -34.74 24.49 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.122 -0.986 . . . . 0.0 110.718 -179.96 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 775' ' ' PHE . . . . . 0.586 ' CZ ' ' HB2' ' A' ' 777' ' ' SER . 44.7 t80 -162.31 164.1 27.67 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.091 -1.006 . . . . 0.0 110.691 -179.956 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 776' ' ' ALA . . . . . 0.671 ' HB1' ' O ' ' A' ' 798' ' ' SER . . . -176.52 121.49 0.15 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.458 -0.776 . . . . 0.0 109.922 -179.964 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 777' ' ' SER . . . . . 0.586 ' HB2' ' CZ ' ' A' ' 775' ' ' PHE . 0.2 OUTLIER -140.3 137.28 34.05 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.145 -0.972 . . . . 0.0 110.69 -179.972 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 778' ' ' PHE . . . . . 0.509 ' CG ' ' O ' ' A' ' 778' ' ' PHE . 29.3 t80 -116.82 74.19 0.9 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.276 -0.89 . . . . 0.0 109.933 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 779' ' ' GLY . . . . . . . . . . . . . . . -175.53 -86.97 0.07 OUTLIER Glycine 0 N--CA 1.495 2.619 0 C-N-CA 119.486 -1.34 . . . . 0.0 110.456 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 780' ' ' THR . . . . . . . . . . . . . 13.0 p -136.86 92.59 14.33 Favored Pre-proline 0 N--CA 1.494 1.761 0 O-C-N 121.078 -1.248 . . . . 0.0 110.825 -179.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 781' ' ' PRO . . . . . 0.47 ' O ' ' HG ' ' A' ' 782' ' ' LEU . 50.9 Cg_endo -85.41 155.56 10.73 Favored 'Trans proline' 0 C--N 1.306 -1.697 0 O-C-N 124.066 1.561 . . . . 0.0 110.271 179.942 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 782' ' ' LEU . . . . . 0.527 ' HB2' ' HB2' ' A' ' 789' ' ' GLN . 1.6 mt -143.81 129.38 19.13 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.115 -0.991 . . . . 0.0 110.263 179.978 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 783' ' ' GLY . . . . . . . . . . . . . . . 121.64 -168.75 14.49 Favored Glycine 0 N--CA 1.492 2.374 0 N-CA-C 109.71 -1.356 . . . . 0.0 109.71 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 784' ' ' THR . . . . . 0.497 ' O ' ' CE1' ' A' ' 788' ' ' PHE . 0.3 OUTLIER -115.33 -146.74 0.41 Allowed 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.258 -1.142 . . . . 0.0 110.163 179.997 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 785' ' ' CYS . . . . . . . . . . . . . 54.1 t -82.07 123.12 28.65 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.225 -0.922 . . . . 0.0 110.1 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 786' ' ' GLY . . . . . . . . . . . . . . . 86.34 -1.61 87.45 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.609 -1.396 . . . . 0.0 109.609 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 787' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -140.86 36.98 1.78 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.205 -1.174 . . . . 0.0 110.062 -179.957 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 788' ' ' PHE . . . . . 0.497 ' CE1' ' O ' ' A' ' 784' ' ' THR . 28.8 m-85 -74.15 171.37 13.69 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.248 -0.908 . . . . 0.0 110.369 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 789' ' ' GLN . . . . . 0.527 ' HB2' ' HB2' ' A' ' 782' ' ' LEU . 5.8 mt-30 -143.17 97.7 3.13 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.371 -0.831 . . . . 0.0 109.961 179.971 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 790' ' ' GLN . . . . . 0.49 ' O ' ' HG3' ' A' ' 790' ' ' GLN . 14.1 pt20 -46.32 108.15 0.13 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.256 -0.903 . . . . 0.0 110.306 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 791' ' ' GLY . . . . . . . . . . . . . . . -58.38 177.15 1.86 Allowed Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.326 -1.51 . . . . 0.0 109.326 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 792' ' ' GLU . . . . . 0.499 ' CG ' ' O ' ' A' ' 792' ' ' GLU . 0.6 OUTLIER -80.4 5.38 15.16 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.205 -1.174 . . . . 0.0 110.231 179.997 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 793' ' ' CYS . . . . . . . . . . . . . 22.8 t -102.8 16.69 25.82 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.238 -0.914 . . . . 0.0 111.062 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 794' ' ' HIS . . . . . 0.601 ' CE1' ' OG ' ' A' ' 798' ' ' SER . 75.9 t60 -62.28 125.3 23.42 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.938 -1.101 . . . . 0.0 110.258 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 795' ' ' SER . . . . . . . . . . . . . 1.4 m -72.89 -130.59 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.165 -0.96 . . . . 0.0 109.605 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 796' ' ' ILE . . . . . . . . . . . . . 1.6 pt -137.94 22.9 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 120.854 -1.153 . . . . 0.0 110.363 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 797' ' ' ASN . . . . . . . . . . . . . 36.1 p30 -154.75 22.12 0.45 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.296 -0.878 . . . . 0.0 110.232 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 798' ' ' SER . . . . . 0.671 ' O ' ' HB1' ' A' ' 776' ' ' ALA . 0.8 OUTLIER -72.44 -19.68 61.53 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.115 -0.99 . . . . 0.0 109.936 179.966 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 799' ' ' ASN . . . . . 0.451 ' CG ' ' HB3' ' A' ' 776' ' ' ALA . 2.3 t-20 -114.09 -10.36 12.83 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.32 -0.863 . . . . 0.0 110.009 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 800' ' ' SER . . . . . 0.512 ' O ' ' HB2' ' A' ' 804' ' ' ARG . 0.9 OUTLIER -89.86 -28.56 19.17 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.359 -0.838 . . . . 0.0 110.13 179.954 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 801' ' ' VAL . . . . . 0.496 HG12 HD22 ' A' ' 802' ' ' LEU . 24.6 t -66.59 -30.48 49.9 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.143 -0.973 . . . . 0.0 110.472 -179.964 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 802' ' ' LEU . . . . . 0.497 ' O ' ' HB2' ' A' ' 806' ' ' CYS . 4.4 mm? -90.11 -44.84 9.53 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.231 -0.918 . . . . 0.0 110.792 -179.945 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 803' ' ' GLU . . . . . 0.571 ' HA ' ' CD1' ' A' ' 807' ' ' ILE . 32.1 tt0 -62.67 -21.94 66.09 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.125 -0.985 . . . . 0.0 110.927 -179.89 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 804' ' ' ARG . . . . . 0.512 ' HB2' ' O ' ' A' ' 800' ' ' SER . 0.0 OUTLIER -91.96 -19.4 22.47 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 120.981 -1.075 . . . . 0.0 111.055 -179.971 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 805' ' ' LYS . . . . . . . . . . . . . 12.9 ttpp -132.47 51.3 2.16 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.004 -1.06 . . . . 0.0 111.05 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 806' ' ' CYS . . . . . 0.497 ' HB2' ' O ' ' A' ' 802' ' ' LEU . 1.2 t -156.96 -33.0 0.08 Allowed 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.015 -1.053 . . . . 0.0 111.067 179.925 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 807' ' ' ILE . . . . . 0.571 ' CD1' ' HA ' ' A' ' 803' ' ' GLU . 2.5 mp -77.17 121.89 30.58 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 O-C-N 120.979 -1.076 . . . . 0.0 110.78 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 808' ' ' GLY . . . . . 0.444 ' C ' ' HG ' ' A' ' 809' ' ' LEU . . . 107.78 13.86 19.02 Favored Glycine 0 N--CA 1.494 2.521 0 N-CA-C 110.082 -1.207 . . . . 0.0 110.082 179.935 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 809' ' ' LEU . . . . . 0.444 ' HG ' ' C ' ' A' ' 808' ' ' GLY . 4.2 mt -134.5 134.84 41.92 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.076 -1.25 . . . . 0.0 110.443 179.961 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 810' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -65.82 -13.62 59.85 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.236 -0.915 . . . . 0.0 109.245 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 811' ' ' ARG . . . . . 0.405 ' HA ' ' HA ' ' A' ' 763' ' ' LYS . 0.4 OUTLIER -141.7 164.18 30.91 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.578 -0.701 . . . . 0.0 109.627 179.968 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 812' ' ' CYS . . . . . 0.439 ' O ' ' HB2' ' A' ' 761' ' ' HIS . 1.7 t -145.37 132.0 19.9 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.19 -0.944 . . . . 0.0 110.241 -179.952 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 813' ' ' VAL . . . . . 0.503 HG22 ' CB ' ' A' ' 761' ' ' HIS . 54.3 t -143.43 110.83 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.156 -0.965 . . . . 0.0 110.328 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 814' ' ' VAL . . . . . . . . . . . . . 61.4 t -119.06 149.61 21.53 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.452 0 O-C-N 121.456 -0.778 . . . . 0.0 109.629 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 815' ' ' ALA . . . . . . . . . . . . . . . -102.34 132.08 48.55 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.142 -0.974 . . . . 0.0 110.263 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 816' ' ' ILE . . . . . 0.947 HD11 HG23 ' A' ' 760' ' ' VAL . 26.6 mt -89.62 151.72 3.44 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 121.346 -0.846 . . . . 0.0 110.384 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 817' ' ' SER . . . . . 0.402 ' CB ' ' O ' ' A' ' 816' ' ' ILE . 0.0 OUTLIER 174.74 171.93 0.27 Allowed Pre-proline 0 N--CA 1.494 1.748 0 O-C-N 121.265 -0.897 . . . . 0.0 110.129 -179.99 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 818' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -73.92 -45.11 0.4 Allowed 'Trans proline' 0 C--N 1.305 -1.748 0 O-C-N 124.017 1.535 . . . . 0.0 110.468 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 819' ' ' SER . . . . . . . . . . . . . 59.5 p -95.81 46.53 1.09 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.258 -0.901 . . . . 0.0 110.088 179.92 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 820' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -126.9 -28.68 2.9 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.274 -0.891 . . . . 0.0 110.477 -179.946 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 821' ' ' PHE . . . . . 0.435 ' CD2' HG21 ' A' ' 801' ' ' VAL . 11.9 m-85 -103.73 -72.22 0.71 Allowed 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.15 -0.969 . . . . 0.0 110.302 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 822' ' ' GLY . . . . . . . . . . . . . . . -179.83 56.94 0.08 OUTLIER Glycine 0 N--CA 1.492 2.43 0 N-CA-C 109.823 -1.311 . . . . 0.0 109.823 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 823' ' ' GLY . . . . . . . . . . . . . . . 60.33 -172.57 5.86 Favored Glycine 0 N--CA 1.494 2.507 0 N-CA-C 109.87 -1.292 . . . . 0.0 109.87 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 824' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -112.76 138.43 22.11 Favored Pre-proline 0 N--CA 1.495 1.79 0 O-C-N 121.345 -1.091 . . . . 0.0 110.168 -179.976 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 825' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_endo -84.54 -36.82 0.15 Allowed 'Trans proline' 0 C--N 1.304 -1.77 0 O-C-N 124.075 1.566 . . . . 0.0 111.08 -179.89 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 826' ' ' CYS . . . . . 0.432 ' HA ' ' HD3' ' A' ' 827' ' ' PRO . 0.8 OUTLIER -110.28 133.16 21.15 Favored Pre-proline 0 N--CA 1.504 2.256 0 O-C-N 120.971 -1.081 . . . . 0.0 110.714 -179.903 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 827' ' ' PRO . . . . . 0.799 ' O ' HG23 ' A' ' 829' ' ' VAL . 51.0 Cg_endo -87.27 167.63 7.76 Favored 'Trans proline' 0 C--N 1.309 -1.517 0 O-C-N 123.997 1.525 . . . . 0.0 110.348 179.907 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 828' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER 47.36 25.2 0.55 Allowed 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.216 -0.928 . . . . 0.0 110.897 179.978 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 829' ' ' VAL . . . . . 0.799 HG23 ' O ' ' A' ' 827' ' ' PRO . 81.9 t -127.67 125.0 64.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.0 -1.063 . . . . 0.0 110.317 -179.96 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 830' ' ' MET . . . . . . . . . . . . . 29.2 mtt -56.89 -173.13 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.179 -0.951 . . . . 0.0 109.837 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 831' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.73 127.54 8.83 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.12 -0.987 . . . . 0.0 110.878 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 832' ' ' ARG . . . . . . . . . . . . . 2.8 mtt180 -123.4 167.55 13.69 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.542 -0.724 . . . . 0.0 109.094 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 833' ' ' VAL . . . . . 0.615 HG21 ' CG2' ' A' ' 816' ' ' ILE . 88.9 t -124.27 109.06 21.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 120.795 -1.191 . . . . 0.0 111.399 -179.909 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 834' ' ' ALA . . . . . 0.587 ' O ' HG23 ' A' ' 835' ' ' VAL . . . -109.49 141.02 42.54 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 179.808 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 835' ' ' VAL . . . . . 0.587 HG23 ' O ' ' A' ' 834' ' ' ALA . 23.6 t -154.85 163.52 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 120.634 -1.291 . . . . 0.0 112.095 -179.872 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 836' ' ' GLU . . . . . 0.515 ' HB3' ' HB2' ' A' ' 774' ' ' LYS . 0.6 OUTLIER -148.27 149.19 31.43 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 107.972 -1.122 . . . . 0.0 107.972 179.974 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 837' ' ' ALA . . . . . 0.514 ' HB2' HD13 ' A' ' 762' ' ' LEU . . . -135.66 154.18 51.38 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 120.633 -1.292 . . . . 0.0 111.899 -179.862 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 838' ' ' VAL . . . . . 0.451 ' O ' ' HA ' ' A' ' 770' ' ' ILE . 41.1 t -109.12 125.5 66.21 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 179.882 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 839' ' ' CYS . . . . . 0.456 ' O ' ' O ' ' A' ' 728' ' ' VAL . 0.5 OUTLIER -116.5 161.25 19.41 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.962 -1.086 . . . . 0.0 111.199 -179.928 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 840' ' ' SER . . . . . 0.412 ' OG ' ' C ' ' A' ' 839' ' ' CYS . 0.2 OUTLIER -168.27 140.39 2.9 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.665 -0.647 . . . . 0.0 109.501 -179.981 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 841' ' ' THR . . . . . 0.554 ' CA ' ' HG3' ' A' ' 768' ' ' GLN . 11.8 t -78.03 173.98 11.61 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.084 -1.01 . . . . 0.0 110.482 -179.972 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 842' ' ' ALA . . . . . . . . . . . . . . . -45.16 118.36 1.66 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.302 -0.874 . . . . 0.0 110.192 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 843' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.696 0 CA-C-O 118.013 -0.994 . . . . 0.0 110.262 179.995 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 726' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.492 1.648 0 CA-C-O 121.269 0.557 . . . . 0.0 110.14 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 727' ' ' THR . . . . . . . . . . . . . 1.7 m 62.64 152.18 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.265 -0.897 . . . . 0.0 110.15 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 728' ' ' VAL . . . . . . . . . . . . . 75.2 t -97.64 -67.88 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.224 -0.922 . . . . 0.0 110.221 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 729' ' ' SER . . . . . . . . . . . . . 16.1 p -167.26 167.11 14.38 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.164 -0.96 . . . . 0.0 110.501 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 730' ' ' GLY . . . . . . . . . . . . . . . -129.84 176.75 18.52 Favored Glycine 0 N--CA 1.489 2.202 0 N-CA-C 109.414 -1.475 . . . . 0.0 109.414 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 731' ' ' VAL . . . . . . . . . . . . . 2.6 m -131.7 137.88 54.1 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.283 -1.128 . . . . 0.0 110.462 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 732' ' ' CYS . . . . . . . . . . . . . 48.7 m -109.87 154.65 22.74 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.386 -0.821 . . . . 0.0 109.658 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 733' ' ' ALA . . . . . . . . . . . . . . . -167.59 114.27 0.74 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.111 -0.993 . . . . 0.0 111.001 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 734' ' ' ASP . . . . . 0.442 ' OD1' HG22 ' A' ' 784' ' ' THR . 1.6 m-20 -111.22 120.53 42.59 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.385 -0.822 . . . . 0.0 109.444 179.894 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 735' ' ' VAL . . . . . . . . . . . . . 79.3 t -129.44 144.69 37.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.155 -0.966 . . . . 0.0 110.591 -179.919 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 736' ' ' SER . . . . . . . . . . . . . 2.3 m -89.97 -170.46 2.8 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.39 -0.819 . . . . 0.0 109.895 179.913 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 737' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -108.08 158.19 17.62 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.203 -0.936 . . . . 0.0 110.488 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 738' ' ' TYR . . . . . 0.468 ' CD2' ' CD1' ' A' ' 755' ' ' PHE . 51.6 t80 -122.52 -57.23 1.75 Allowed 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.361 -0.837 . . . . 0.0 109.785 179.967 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 739' ' ' HIS . . . . . 0.445 ' O ' ' O ' ' A' ' 738' ' ' TYR . 8.6 t-160 52.94 104.28 0.03 OUTLIER Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 121.322 -0.861 . . . . 0.0 110.752 179.981 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 740' ' ' PRO . . . . . 0.477 ' HD3' ' O ' ' A' ' 756' ' ' HIS . 50.9 Cg_endo -79.31 77.01 4.25 Favored 'Trans proline' 0 C--N 1.306 -1.697 0 O-C-N 124.094 1.576 . . . . 0.0 110.38 179.945 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 741' ' ' ASN . . . . . 0.461 ' O ' ' O ' ' A' ' 742' ' ' ILE . 42.3 t30 -134.0 -38.53 0.88 Allowed 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.021 -1.05 . . . . 0.0 110.406 -179.955 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 742' ' ' ILE . . . . . 0.616 HG22 ' N ' ' A' ' 743' ' ' LYS . 18.5 mt -50.62 -102.48 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 121.285 -0.884 . . . . 0.0 110.329 -179.944 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 743' ' ' LYS . . . . . 0.616 ' N ' HG22 ' A' ' 742' ' ' ILE . 5.9 pttp 170.96 -39.28 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.074 0 O-C-N 121.111 -0.993 . . . . 0.0 109.914 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 744' ' ' ASN . . . . . 0.415 ' O ' ' C ' ' A' ' 745' ' ' TRP . 0.8 OUTLIER -164.19 90.29 0.58 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.378 -0.826 . . . . 0.0 109.63 179.973 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 745' ' ' TRP . . . . . 0.459 ' HE1' HD12 ' A' ' 742' ' ' ILE . 4.9 m0 -42.02 156.72 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.308 -0.87 . . . . 0.0 110.642 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 746' ' ' GLN . . . . . . . . . . . . . 4.1 mt-30 -120.17 107.88 13.55 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.458 -0.776 . . . . 0.0 110.09 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 747' ' ' ILE . . . . . 0.794 HD12 ' OG ' ' A' ' 749' ' ' SER . 6.1 pt -139.48 -176.24 1.19 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.267 -0.895 . . . . 0.0 110.091 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 748' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -96.71 34.08 1.74 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.213 -0.93 . . . . 0.0 110.469 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 749' ' ' SER . . . . . 0.794 ' OG ' HD12 ' A' ' 747' ' ' ILE . 80.9 p -146.92 -43.29 0.18 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.195 -0.941 . . . . 0.0 110.211 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 750' ' ' TYR . . . . . 0.477 ' O ' ' O ' ' A' ' 749' ' ' SER . 27.6 m-85 57.72 124.32 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.413 -0.805 . . . . 0.0 110.61 179.96 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 751' ' ' GLY . . . . . . . . . . . . . . . 135.91 91.78 0.34 Allowed Glycine 0 N--CA 1.489 2.178 0 C-N-CA 119.62 -1.276 . . . . 0.0 110.329 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 752' ' ' GLU . . . . . 0.517 ' CG ' ' O ' ' A' ' 752' ' ' GLU . 16.2 pt-20 -105.92 117.24 58.17 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.349 -1.089 . . . . 0.0 109.208 179.856 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 753' ' ' PRO . . . . . 0.476 ' O ' ' O ' ' A' ' 754' ' ' GLU . 47.6 Cg_endo -75.23 71.86 4.99 Favored 'Trans proline' 0 C--N 1.309 -1.551 0 O-C-N 123.99 1.521 . . . . 0.0 111.547 -179.927 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 754' ' ' GLU . . . . . 0.476 ' O ' ' O ' ' A' ' 753' ' ' PRO . 2.2 tm-20 56.78 134.23 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.361 -0.837 . . . . 0.0 111.528 179.903 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 755' ' ' PHE . . . . . 0.468 ' CD1' ' CD2' ' A' ' 738' ' ' TYR . 4.3 t80 178.23 137.1 0.08 Allowed 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.386 -0.821 . . . . 0.0 110.144 179.91 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 756' ' ' HIS . . . . . 0.477 ' O ' ' HD3' ' A' ' 740' ' ' PRO . 38.5 m80 -135.32 -53.71 0.78 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.244 -0.91 . . . . 0.0 110.339 -179.904 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 757' ' ' THR . . . . . 0.428 ' O ' ' C ' ' A' ' 758' ' ' ALA . 0.0 OUTLIER -130.49 117.1 19.12 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.207 -0.933 . . . . 0.0 110.332 -179.974 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 758' ' ' ALA . . . . . 0.464 ' O ' ' HG3' ' A' ' 759' ' ' LYS . . . -42.85 156.31 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.291 -0.881 . . . . 0.0 109.763 -179.997 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 759' ' ' LYS . . . . . 0.464 ' HG3' ' O ' ' A' ' 758' ' ' ALA . 18.3 mtpt -144.73 157.52 44.15 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.108 -0.995 . . . . 0.0 110.827 -179.892 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 760' ' ' VAL . . . . . 0.416 ' O ' ' HA ' ' A' ' 813' ' ' VAL . 77.9 t -107.67 132.92 53.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.395 -0.816 . . . . 0.0 108.92 179.947 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 761' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -108.87 104.82 14.15 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.065 -1.022 . . . . 0.0 111.328 -179.737 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 762' ' ' LEU . . . . . . . . . . . . . 25.8 mt -114.74 137.45 51.91 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 179.784 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 763' ' ' LYS . . . . . . . . . . . . . 18.7 ttpp -133.64 146.78 51.22 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.923 -1.111 . . . . 0.0 111.419 -179.894 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 764' ' ' CYS . . . . . 0.425 ' HB2' ' O ' ' A' ' 810' ' ' GLU . 20.7 m -141.55 155.15 45.8 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.597 -0.689 . . . . 0.0 109.434 179.86 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 765' ' ' ALA . . . . . 0.948 ' HB1' ' HD2' ' A' ' 766' ' ' PRO . . . -83.15 178.53 2.38 Favored Pre-proline 0 N--CA 1.494 1.727 0 O-C-N 121.059 -1.025 . . . . 0.0 110.354 -179.924 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 766' ' ' PRO . . . . . 0.948 ' HD2' ' HB1' ' A' ' 765' ' ' ALA . 44.0 Cg_endo -70.31 151.42 65.95 Favored 'Trans proline' 0 C--N 1.307 -1.642 0 O-C-N 123.968 1.509 . . . . 0.0 110.181 179.966 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 767' ' ' GLY . . . . . . . . . . . . . . . 70.87 3.81 52.2 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.143 -1.583 . . . . 0.0 109.143 -179.94 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 768' ' ' GLN . . . . . 0.488 ' HG2' ' O ' ' A' ' 840' ' ' SER . 28.4 mt-30 -123.66 117.45 25.02 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.346 -1.09 . . . . 0.0 109.838 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 769' ' ' THR . . . . . . . . . . . . . 60.5 p -127.17 148.32 50.18 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.061 -1.024 . . . . 0.0 110.295 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 770' ' ' ILE . . . . . . . . . . . . . 87.3 mt -60.76 117.25 2.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.256 -0.902 . . . . 0.0 109.777 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 771' ' ' SER . . . . . . . . . . . . . 13.9 t -107.27 -2.92 20.27 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.163 -0.961 . . . . 0.0 110.862 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 772' ' ' ALA . . . . . . . . . . . . . . . -170.81 135.19 1.07 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 120.806 -1.184 . . . . 0.0 111.313 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 773' ' ' ILE . . . . . 0.552 HD12 ' HB3' ' A' ' 802' ' ' LEU . 16.6 mm -85.38 128.16 39.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.441 -0.787 . . . . 0.0 108.93 179.815 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 774' ' ' LYS . . . . . 0.457 ' HB3' ' HB3' ' A' ' 836' ' ' GLU . 0.0 OUTLIER -79.29 -37.28 38.14 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.108 -0.995 . . . . 0.0 110.897 -179.827 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 775' ' ' PHE . . . . . . . . . . . . . 90.2 t80 -169.62 150.4 4.07 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.016 -1.052 . . . . 0.0 110.691 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 776' ' ' ALA . . . . . 0.479 ' O ' ' HB2' ' A' ' 798' ' ' SER . . . -163.93 126.28 2.45 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.469 -0.769 . . . . 0.0 109.483 179.94 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 777' ' ' SER . . . . . 0.532 ' HA ' ' CB ' ' A' ' 798' ' ' SER . 6.0 t -153.94 123.45 6.63 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.19 -0.944 . . . . 0.0 110.676 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 778' ' ' PHE . . . . . . . . . . . . . 42.6 t80 -97.15 82.8 3.23 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.395 -0.816 . . . . 0.0 109.712 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 779' ' ' GLY . . . . . . . . . . . . . . . 179.02 -121.42 0.75 Allowed Glycine 0 N--CA 1.492 2.392 0 N-CA-C 109.719 -1.352 . . . . 0.0 109.719 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 780' ' ' THR . . . . . 0.454 ' O ' ' HA3' ' A' ' 791' ' ' GLY . 44.9 p -114.61 97.2 46.15 Favored Pre-proline 0 N--CA 1.493 1.705 0 O-C-N 121.242 -1.152 . . . . 0.0 110.407 -179.949 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 781' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -79.35 175.94 10.21 Favored 'Trans proline' 0 C--N 1.304 -1.798 0 O-C-N 123.98 1.516 . . . . 0.0 110.514 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 782' ' ' LEU . . . . . 0.767 HD12 ' HA2' ' A' ' 791' ' ' GLY . 6.8 mt -139.05 105.4 5.27 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.344 -0.848 . . . . 0.0 110.144 -179.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 783' ' ' GLY . . . . . . . . . . . . . . . 102.37 -176.76 25.66 Favored Glycine 0 N--CA 1.492 2.367 0 N-CA-C 109.629 -1.389 . . . . 0.0 109.629 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 784' ' ' THR . . . . . 0.442 HG22 ' OD1' ' A' ' 734' ' ' ASP . 0.6 OUTLIER -130.05 -163.08 1.27 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.205 -1.173 . . . . 0.0 110.052 179.913 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 785' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -59.86 116.69 4.29 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.059 -1.026 . . . . 0.0 109.901 -179.958 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 786' ' ' GLY . . . . . . . . . . . . . . . 137.07 -43.94 1.18 Allowed Glycine 0 N--CA 1.489 2.209 0 N-CA-C 108.575 -1.81 . . . . 0.0 108.575 -179.913 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 787' ' ' THR . . . . . 0.471 HG22 ' O ' ' A' ' 787' ' ' THR . 25.5 m -148.39 38.43 0.87 Allowed 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.554 -0.968 . . . . 0.0 109.34 179.867 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 788' ' ' PHE . . . . . 0.421 ' CE2' ' HA ' ' A' ' 784' ' ' THR . 0.2 OUTLIER -50.4 176.31 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.814 0 CA-C-O 121.717 0.77 . . . . 0.0 111.065 -179.95 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 789' ' ' GLN . . . . . . . . . . . . . 2.2 mt-30 -161.87 170.6 19.18 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.563 -0.71 . . . . 0.0 109.508 179.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 790' ' ' GLN . . . . . 0.435 ' O ' ' C ' ' A' ' 791' ' ' GLY . 1.1 tp60 -88.81 21.05 3.2 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.985 -1.072 . . . . 0.0 110.283 -179.945 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 791' ' ' GLY . . . . . 0.767 ' HA2' HD12 ' A' ' 782' ' ' LEU . . . 42.34 -124.34 3.74 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.764 -1.335 . . . . 0.0 109.764 -179.953 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 792' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -133.02 -30.73 1.33 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.347 -1.09 . . . . 0.0 110.392 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 793' ' ' CYS . . . . . . . . . . . . . 5.1 t -112.07 139.44 47.59 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.187 -0.946 . . . . 0.0 110.239 -179.913 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 794' ' ' HIS . . . . . 0.471 ' CD2' ' H ' ' A' ' 796' ' ' ILE . 19.0 t60 -148.81 141.57 24.58 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.3 -0.875 . . . . 0.0 109.952 179.876 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 795' ' ' SER . . . . . 0.431 ' HB3' ' HG3' ' A' ' 825' ' ' PRO . 3.7 p -81.99 10.13 7.1 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.294 -0.879 . . . . 0.0 110.382 -179.967 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 796' ' ' ILE . . . . . 0.694 HG22 ' O ' ' A' ' 796' ' ' ILE . 50.2 mt 45.98 23.24 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 O-C-N 121.2 -0.937 . . . . 0.0 110.405 -179.933 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 797' ' ' ASN . . . . . 0.594 ' O ' HG23 ' A' ' 801' ' ' VAL . 2.8 t30 -150.46 17.14 0.82 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.339 -0.851 . . . . 0.0 109.815 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 798' ' ' SER . . . . . 0.532 ' CB ' ' HA ' ' A' ' 777' ' ' SER . 2.0 m -81.45 -29.72 33.7 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.47 -0.769 . . . . 0.0 110.324 -179.934 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 799' ' ' ASN . . . . . . . . . . . . . 11.9 t30 -86.78 -11.38 51.16 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.276 -0.89 . . . . 0.0 110.525 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 800' ' ' SER . . . . . 0.466 ' O ' ' HB3' ' A' ' 804' ' ' ARG . 30.5 m -87.54 -20.92 25.79 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.182 -0.949 . . . . 0.0 110.166 179.955 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 801' ' ' VAL . . . . . 0.711 HG11 ' CE2' ' A' ' 821' ' ' PHE . 42.0 t -73.75 -41.75 54.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.235 -0.916 . . . . 0.0 110.188 -179.959 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 802' ' ' LEU . . . . . 0.654 HD22 ' N ' ' A' ' 802' ' ' LEU . 4.0 mm? -75.62 -41.04 55.36 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.217 -0.927 . . . . 0.0 110.185 179.933 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 803' ' ' GLU . . . . . 0.585 ' HA ' ' CG1' ' A' ' 807' ' ' ILE . 5.5 tt0 -73.64 -18.04 61.08 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.147 -0.971 . . . . 0.0 110.663 179.948 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 804' ' ' ARG . . . . . 0.466 ' HB3' ' O ' ' A' ' 800' ' ' SER . 0.1 OUTLIER -89.2 -29.21 19.45 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.126 -0.984 . . . . 0.0 110.948 -179.979 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 805' ' ' LYS . . . . . . . . . . . . . 8.3 ttmt -122.11 -41.7 2.42 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 120.979 -1.075 . . . . 0.0 110.937 -179.944 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 806' ' ' CYS . . . . . 0.434 ' O ' HG12 ' A' ' 807' ' ' ILE . 0.9 OUTLIER -86.14 69.89 10.52 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.224 -0.923 . . . . 0.0 110.714 -179.994 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 807' ' ' ILE . . . . . 0.585 ' CG1' ' HA ' ' A' ' 803' ' ' GLU . 16.0 mm -149.72 121.63 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.411 0 O-C-N 121.287 -0.883 . . . . 0.0 110.512 179.934 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 808' ' ' GLY . . . . . . . . . . . . . . . 84.56 23.57 50.0 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.887 -1.285 . . . . 0.0 109.887 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 809' ' ' LEU . . . . . . . . . . . . . 72.5 mt -123.12 148.22 45.93 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.106 -1.232 . . . . 0.0 110.592 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 810' ' ' GLU . . . . . 0.425 ' O ' ' HB2' ' A' ' 764' ' ' CYS . 1.1 mp0 -83.45 1.25 42.55 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.256 -0.903 . . . . 0.0 110.032 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 811' ' ' ARG . . . . . . . . . . . . . 46.5 ttt180 -153.86 160.38 42.15 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.463 -0.773 . . . . 0.0 109.127 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 812' ' ' CYS . . . . . 0.574 ' C ' HG23 ' A' ' 813' ' ' VAL . 0.1 OUTLIER -155.5 143.93 20.28 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.794 -1.191 . . . . 0.0 111.735 -179.981 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 813' ' ' VAL . . . . . 0.574 HG23 ' C ' ' A' ' 812' ' ' CYS . 32.0 t -155.54 110.28 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 179.934 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 814' ' ' VAL . . . . . . . . . . . . . 76.0 t -108.43 120.36 59.67 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 121.198 -0.939 . . . . 0.0 110.746 -179.922 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 815' ' ' ALA . . . . . 0.441 ' O ' ' C ' ' A' ' 816' ' ' ILE . . . -78.01 84.69 4.27 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.425 -0.797 . . . . 0.0 110.102 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 816' ' ' ILE . . . . . 0.618 HD11 HG11 ' A' ' 833' ' ' VAL . 21.3 mt -39.39 143.11 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 O-C-N 121.476 -0.765 . . . . 0.0 110.602 179.97 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 817' ' ' SER . . . . . 0.44 ' OG ' ' HD2' ' A' ' 818' ' ' PRO . 0.0 OUTLIER -157.94 175.18 3.4 Favored Pre-proline 0 C--N 1.302 -1.481 0 O-C-N 121.328 -0.858 . . . . 0.0 109.958 179.944 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 818' ' ' PRO . . . . . 0.44 ' HD2' ' OG ' ' A' ' 817' ' ' SER . 42.7 Cg_endo -71.66 -71.42 0.02 OUTLIER 'Trans proline' 0 C--N 1.302 -1.871 0 O-C-N 123.941 1.495 . . . . 0.0 111.556 -179.933 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 819' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -86.85 39.09 0.83 Allowed 'General case' 0 N--CA 1.496 1.838 0 O-C-N 120.981 -1.074 . . . . 0.0 110.798 -179.895 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 820' ' ' ASN . . . . . 0.426 ' HB2' ' OG ' ' A' ' 817' ' ' SER . 0.7 OUTLIER -99.38 -34.07 10.45 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.135 -0.978 . . . . 0.0 109.888 179.987 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 821' ' ' PHE . . . . . 0.711 ' CE2' HG11 ' A' ' 801' ' ' VAL . 3.2 m-85 -99.7 -44.32 6.15 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.294 -0.879 . . . . 0.0 110.051 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 822' ' ' GLY . . . . . . . . . . . . . . . -165.01 -36.59 0.02 OUTLIER Glycine 0 N--CA 1.492 2.388 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 823' ' ' GLY . . . . . . . . . . . . . . . 134.4 -96.6 0.28 Allowed Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.698 -1.361 . . . . 0.0 109.698 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 824' ' ' ASP . . . . . . . . . . . . . 31.7 t0 -149.07 87.0 5.48 Favored Pre-proline 0 N--CA 1.492 1.658 0 O-C-N 121.3 -1.117 . . . . 0.0 110.359 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 825' ' ' PRO . . . . . 0.431 ' HG3' ' HB3' ' A' ' 795' ' ' SER . 43.8 Cg_endo -72.07 -49.54 0.3 Allowed 'Trans proline' 0 C--N 1.306 -1.682 0 O-C-N 123.945 1.497 . . . . 0.0 110.255 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 826' ' ' CYS . . . . . 0.72 ' SG ' HG21 ' A' ' 829' ' ' VAL . 0.0 OUTLIER -78.24 144.87 67.58 Favored Pre-proline 0 N--CA 1.489 1.478 0 O-C-N 121.241 -0.912 . . . . 0.0 109.832 179.898 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 827' ' ' PRO . . . . . 0.57 ' O ' HG23 ' A' ' 829' ' ' VAL . 46.6 Cg_endo -74.93 115.74 4.38 Favored 'Trans proline' 0 C--N 1.302 -1.888 0 O-C-N 124.007 1.53 . . . . 0.0 111.953 -179.938 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 828' ' ' GLU . . . . . 0.434 ' C ' ' O ' ' A' ' 827' ' ' PRO . 18.3 mm-40 35.8 36.99 0.04 OUTLIER 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.735 -0.603 . . . . 0.0 111.69 179.867 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 829' ' ' VAL . . . . . 0.72 HG21 ' SG ' ' A' ' 826' ' ' CYS . 17.3 t -91.07 165.27 1.98 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 O-C-N 121.114 -0.991 . . . . 0.0 109.703 179.861 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 830' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -63.67 -168.9 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.118 -0.989 . . . . 0.0 110.041 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 831' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -143.44 158.33 43.73 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.229 -0.919 . . . . 0.0 110.539 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 832' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -169.34 161.26 9.89 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.383 -0.823 . . . . 0.0 109.515 -179.958 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 833' ' ' VAL . . . . . 0.618 HG11 HD11 ' A' ' 816' ' ' ILE . 93.4 t -135.21 106.96 7.22 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 O-C-N 120.912 -1.117 . . . . 0.0 111.242 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 834' ' ' ALA . . . . . . . . . . . . . . . -115.87 114.53 24.82 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.444 -0.785 . . . . 0.0 108.894 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 835' ' ' VAL . . . . . . . . . . . . . 15.6 t -125.11 158.98 32.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.001 -1.062 . . . . 0.0 111.546 -179.847 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 836' ' ' GLU . . . . . 0.457 ' HB3' ' HB3' ' A' ' 774' ' ' LYS . 30.5 tt0 -147.63 143.29 27.59 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 108.056 -1.09 . . . . 0.0 108.056 179.847 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 837' ' ' ALA . . . . . . . . . . . . . . . -140.58 155.25 46.64 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 120.488 -1.383 . . . . 0.0 112.116 -179.877 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 838' ' ' VAL . . . . . . . . . . . . . 96.2 t -113.33 111.82 37.72 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 179.849 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 839' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -107.45 121.24 44.22 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.063 -1.023 . . . . 0.0 110.911 -179.848 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 840' ' ' SER . . . . . 0.716 ' C ' HG22 ' A' ' 841' ' ' THR . 4.6 p -140.82 -66.42 0.43 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.523 -0.736 . . . . 0.0 109.764 179.965 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 841' ' ' THR . . . . . 0.716 HG22 ' C ' ' A' ' 840' ' ' SER . 0.0 OUTLIER 165.54 164.02 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.482 -0.761 . . . . 0.0 109.918 179.933 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 842' ' ' ALA . . . . . . . . . . . . . . . -68.08 85.76 0.25 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.238 -0.914 . . . . 0.0 110.163 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 843' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.719 0 CA-C-O 118.012 -0.994 . . . . 0.0 110.292 179.949 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 726' ' ' ARG . . . . . 0.485 ' O ' ' HD2' ' A' ' 726' ' ' ARG . 1.6 tmt_? . . . . . 0 N--CA 1.493 1.681 0 CA-C-O 121.267 0.556 . . . . 0.0 110.151 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 727' ' ' THR . . . . . . . . . . . . . 1.6 m -131.15 145.72 52.08 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.246 -0.909 . . . . 0.0 110.162 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 728' ' ' VAL . . . . . 0.466 HG12 ' HA ' ' A' ' 840' ' ' SER . 0.4 OUTLIER -138.47 160.21 31.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.244 -0.91 . . . . 0.0 110.036 179.97 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 729' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER 176.59 46.82 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.254 -0.904 . . . . 0.0 109.947 -179.95 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 730' ' ' GLY . . . . . . . . . . . . . . . -143.68 89.09 0.17 Allowed Glycine 0 N--CA 1.488 2.116 0 N-CA-C 109.986 -1.246 . . . . 0.0 109.986 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 731' ' ' VAL . . . . . . . . . . . . . 18.0 t -108.27 162.94 6.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.259 -1.142 . . . . 0.0 109.158 179.912 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 732' ' ' CYS . . . . . 0.442 ' SG ' ' OE1' ' A' ' 836' ' ' GLU . 0.8 OUTLIER -156.55 157.68 35.81 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 120.907 -1.12 . . . . 0.0 111.139 -179.95 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 733' ' ' ALA . . . . . . . . . . . . . . . -170.31 103.52 0.28 Allowed 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 734' ' ' ASP . . . . . 0.578 ' C ' HG23 ' A' ' 735' ' ' VAL . 1.8 p-10 -113.09 136.04 53.14 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.226 -0.921 . . . . 0.0 110.619 -179.872 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 735' ' ' VAL . . . . . 0.65 HG11 ' O ' ' A' ' 759' ' ' LYS . 89.9 t -156.13 117.34 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.361 -0.837 . . . . 0.0 110.042 179.978 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 736' ' ' SER . . . . . . . . . . . . . 80.8 p -59.18 166.55 2.1 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.136 -0.977 . . . . 0.0 110.115 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 737' ' ' GLU . . . . . 0.723 ' HA ' ' HB3' ' A' ' 758' ' ' ALA . 35.2 tt0 -111.87 149.81 31.3 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.238 -0.914 . . . . 0.0 110.164 179.981 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 738' ' ' TYR . . . . . 0.427 ' O ' ' HB3' ' A' ' 739' ' ' HIS . 7.3 t80 -111.85 -128.22 0.29 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.269 -0.895 . . . . 0.0 110.253 -179.982 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 739' ' ' HIS . . . . . 0.725 ' HB2' HG22 ' A' ' 757' ' ' THR . 13.2 t-160 55.37 60.94 8.96 Favored Pre-proline 0 N--CA 1.494 1.739 0 O-C-N 120.997 -1.064 . . . . 0.0 110.1 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 740' ' ' PRO . . . . . 0.466 ' O ' HG13 ' A' ' 742' ' ' ILE . 47.8 Cg_endo -75.11 109.99 3.03 Favored 'Trans proline' 0 C--N 1.301 -1.937 0 O-C-N 124.075 1.566 . . . . 0.0 110.272 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 741' ' ' ASN . . . . . 0.437 ' C ' ' O ' ' A' ' 740' ' ' PRO . 4.1 m120 -42.88 129.81 4.3 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.158 -0.964 . . . . 0.0 109.865 179.929 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 742' ' ' ILE . . . . . 0.476 HD12 ' N ' ' A' ' 742' ' ' ILE . 3.5 mp -113.45 146.4 18.11 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 O-C-N 121.171 -0.956 . . . . 0.0 110.973 -179.911 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 743' ' ' LYS . . . . . 0.428 ' O ' ' HB2' ' A' ' 744' ' ' ASN . 0.1 OUTLIER -103.81 117.0 33.32 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.296 -0.877 . . . . 0.0 109.016 179.955 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 744' ' ' ASN . . . . . 0.469 ' O ' ' C ' ' A' ' 745' ' ' TRP . 0.7 OUTLIER 61.77 77.26 0.34 Allowed 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.006 -1.059 . . . . 0.0 108.892 -179.884 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 745' ' ' TRP . . . . . 0.469 ' C ' ' O ' ' A' ' 744' ' ' ASN . 3.8 m-90 -31.87 -61.88 0.22 Allowed 'General case' 0 N--CA 1.501 2.091 0 O-C-N 121.857 -0.527 . . . . 0.0 111.41 -179.926 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 746' ' ' GLN . . . . . 0.46 ' HB2' ' O ' ' A' ' 745' ' ' TRP . 43.3 mt-30 56.44 57.83 4.63 Favored 'General case' 0 C--N 1.298 -1.649 0 O-C-N 121.295 -0.878 . . . . 0.0 110.226 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 747' ' ' ILE . . . . . 0.453 HG23 ' O ' ' A' ' 749' ' ' SER . 4.1 tp -125.25 149.36 29.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.154 -0.966 . . . . 0.0 110.205 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 748' ' ' GLU . . . . . . . . . . . . . 14.5 mm-40 -63.07 -68.18 0.36 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.234 -0.916 . . . . 0.0 110.238 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 749' ' ' SER . . . . . 0.453 ' O ' HG23 ' A' ' 747' ' ' ILE . 12.8 m -69.92 141.77 53.04 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.23 -0.919 . . . . 0.0 110.039 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 750' ' ' TYR . . . . . . . . . . . . . 52.6 m-85 -106.57 144.38 33.33 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.327 -0.858 . . . . 0.0 110.297 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 751' ' ' GLY . . . . . . . . . . . . . . . 73.57 140.13 0.48 Allowed Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.602 -1.399 . . . . 0.0 109.602 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 752' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -164.57 67.86 1.39 Allowed Pre-proline 0 N--CA 1.492 1.651 0 O-C-N 121.312 -1.111 . . . . 0.0 110.029 179.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 753' ' ' PRO . . . . . 0.459 ' O ' ' HB2' ' A' ' 754' ' ' GLU . 45.6 Cg_endo -73.45 110.75 3.13 Favored 'Trans proline' 0 C--N 1.305 -1.723 0 O-C-N 124.059 1.557 . . . . 0.0 110.462 -179.894 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 754' ' ' GLU . . . . . 0.487 ' HA ' ' OE1' ' A' ' 754' ' ' GLU . 5.2 tp10 178.42 -81.78 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.381 -0.824 . . . . 0.0 109.997 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 755' ' ' PHE . . . . . . . . . . . . . 50.2 t80 -111.44 116.92 31.73 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.253 -0.904 . . . . 0.0 109.97 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 756' ' ' HIS . . . . . . . . . . . . . 2.3 t-160 -129.1 -69.58 0.7 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.112 -0.993 . . . . 0.0 110.396 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 757' ' ' THR . . . . . 0.725 HG22 ' HB2' ' A' ' 739' ' ' HIS . 24.2 p -101.3 -169.82 1.75 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.27 -0.894 . . . . 0.0 110.452 -179.958 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 758' ' ' ALA . . . . . 0.723 ' HB3' ' HA ' ' A' ' 737' ' ' GLU . . . -111.93 161.72 16.11 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.35 -0.844 . . . . 0.0 109.796 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 759' ' ' LYS . . . . . 0.677 ' HE3' ' HB2' ' A' ' 815' ' ' ALA . 6.1 mttt -131.34 162.11 30.83 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.203 -0.936 . . . . 0.0 110.418 179.951 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 760' ' ' VAL . . . . . . . . . . . . . 99.2 t -107.61 143.01 18.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.385 -0.822 . . . . 0.0 109.31 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 761' ' ' HIS . . . . . . . . . . . . . 6.1 m170 -112.53 120.71 42.53 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.08 -1.012 . . . . 0.0 111.069 -179.921 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 762' ' ' LEU . . . . . 0.482 ' HB2' ' O ' ' A' ' 812' ' ' CYS . 12.3 mt -127.11 141.02 51.86 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.541 -0.724 . . . . 0.0 109.081 179.955 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 763' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -158.7 147.88 18.95 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 120.905 -1.122 . . . . 0.0 111.067 -179.903 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 764' ' ' CYS . . . . . . . . . . . . . 4.2 m -124.03 171.54 9.67 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.425 -0.797 . . . . 0.0 109.674 179.907 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 765' ' ' ALA . . . . . . . . . . . . . . . -70.1 158.52 87.2 Favored Pre-proline 0 N--CA 1.493 1.724 0 O-C-N 121.038 -1.039 . . . . 0.0 109.983 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 766' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -72.04 130.17 16.23 Favored 'Trans proline' 0 C--N 1.306 -1.7 0 O-C-N 123.925 1.487 . . . . 0.0 110.067 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 767' ' ' GLY . . . . . . . . . . . . . . . 112.47 -26.63 10.8 Favored Glycine 0 N--CA 1.488 2.143 0 N-CA-C 108.974 -1.65 . . . . 0.0 108.974 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 768' ' ' GLN . . . . . 0.493 ' C ' HG23 ' A' ' 769' ' ' THR . 2.0 mt-30 -106.79 172.29 6.9 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.362 -1.081 . . . . 0.0 109.992 179.934 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 769' ' ' THR . . . . . 0.493 HG23 ' C ' ' A' ' 768' ' ' GLN . 37.4 p -153.47 147.96 26.08 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.123 -0.985 . . . . 0.0 110.384 -179.937 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 770' ' ' ILE . . . . . . . . . . . . . 12.9 mt -64.29 146.29 13.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.274 -0.891 . . . . 0.0 109.475 179.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 771' ' ' SER . . . . . 0.523 ' O ' ' HB2' ' A' ' 772' ' ' ALA . 0.1 OUTLIER -135.52 -0.15 2.68 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.023 -1.048 . . . . 0.0 111.053 -179.942 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 772' ' ' ALA . . . . . 0.523 ' HB2' ' O ' ' A' ' 771' ' ' SER . . . -179.14 147.34 0.33 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.795 -1.191 . . . . 0.0 111.534 179.959 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 773' ' ' ILE . . . . . 0.423 HG13 ' HB3' ' A' ' 802' ' ' LEU . 22.7 mm -107.15 135.37 45.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 179.819 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 774' ' ' LYS . . . . . . . . . . . . . 2.3 ptpt -107.36 -6.85 16.91 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.026 -1.046 . . . . 0.0 111.712 -179.806 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 775' ' ' PHE . . . . . 0.661 ' O ' ' HB2' ' A' ' 776' ' ' ALA . 39.3 t80 -157.65 162.16 38.65 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.731 -1.231 . . . . 0.0 111.337 -179.973 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 776' ' ' ALA . . . . . 0.661 ' HB2' ' O ' ' A' ' 775' ' ' PHE . . . 170.04 112.66 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 109.295 -0.632 . . . . 0.0 109.295 179.933 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 777' ' ' SER . . . . . 0.434 ' HA ' ' CE1' ' A' ' 794' ' ' HIS . 0.2 OUTLIER -140.36 120.53 13.82 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.147 -0.971 . . . . 0.0 110.78 -179.954 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 778' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -94.39 96.43 9.52 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.416 -0.803 . . . . 0.0 109.271 179.879 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 779' ' ' GLY . . . . . . . . . . . . . . . 166.82 -111.04 0.43 Allowed Glycine 0 N--CA 1.492 2.372 0 N-CA-C 110.013 -1.235 . . . . 0.0 110.013 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 780' ' ' THR . . . . . 0.622 HG22 ' HG3' ' A' ' 830' ' ' MET . 2.1 p -118.13 102.03 51.06 Favored Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 120.958 -1.319 . . . . 0.0 110.627 -179.927 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 781' ' ' PRO . . . . . 0.529 ' CG ' ' HB3' ' A' ' 832' ' ' ARG . 49.0 Cg_endo -84.58 173.09 8.73 Favored 'Trans proline' 0 C--N 1.306 -1.692 0 O-C-N 124.126 1.592 . . . . 0.0 110.221 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 782' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -145.02 113.37 6.59 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.192 -0.942 . . . . 0.0 110.165 179.903 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 783' ' ' GLY . . . . . . . . . . . . . . . 114.21 -157.5 14.93 Favored Glycine 0 N--CA 1.492 2.409 0 N-CA-C 109.451 -1.46 . . . . 0.0 109.451 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 784' ' ' THR . . . . . 0.481 ' O ' ' CE1' ' A' ' 788' ' ' PHE . 0.0 OUTLIER -136.3 -55.1 0.75 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.101 -1.235 . . . . 0.0 110.519 179.985 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 785' ' ' CYS . . . . . . . . . . . . . 11.0 t -156.97 108.27 2.38 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.215 -0.928 . . . . 0.0 110.507 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 786' ' ' GLY . . . . . . . . . . . . . . . 112.5 -14.27 25.15 Favored Glycine 0 N--CA 1.492 2.401 0 N-CA-C 109.801 -1.319 . . . . 0.0 109.801 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 787' ' ' THR . . . . . . . . . . . . . 3.7 m -136.74 29.76 2.87 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.197 -1.178 . . . . 0.0 110.556 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 788' ' ' PHE . . . . . 0.514 ' HB3' ' CZ ' ' A' ' 775' ' ' PHE . 0.7 OUTLIER -67.75 124.54 23.57 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.174 -0.954 . . . . 0.0 109.87 179.974 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 789' ' ' GLN . . . . . . . . . . . . . 9.7 tm0? -130.22 130.22 44.35 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.234 -0.916 . . . . 0.0 110.321 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 790' ' ' GLN . . . . . 0.502 ' CG ' ' O ' ' A' ' 790' ' ' GLN . 2.3 pt20 -59.73 104.14 0.26 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.292 -0.88 . . . . 0.0 110.025 -179.965 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 791' ' ' GLY . . . . . 0.446 ' O ' ' HG2' ' A' ' 792' ' ' GLU . . . -44.7 -61.96 3.11 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.661 -1.375 . . . . 0.0 109.661 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 792' ' ' GLU . . . . . 0.446 ' HG2' ' O ' ' A' ' 791' ' ' GLY . 2.2 mm-40 -171.48 -33.33 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.18 -1.188 . . . . 0.0 110.388 -179.989 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 793' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -96.46 155.27 16.84 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.163 -0.96 . . . . 0.0 110.499 -179.958 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 794' ' ' HIS . . . . . 0.477 ' CD2' ' H ' ' A' ' 796' ' ' ILE . 13.4 t60 -165.33 164.75 19.78 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.245 -0.91 . . . . 0.0 110.039 -179.966 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 795' ' ' SER . . . . . 0.753 ' C ' HG23 ' A' ' 796' ' ' ILE . 51.1 p -100.79 -7.93 23.18 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.245 -0.909 . . . . 0.0 110.36 179.978 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 796' ' ' ILE . . . . . 0.753 HG23 ' C ' ' A' ' 795' ' ' SER . 0.6 OUTLIER 64.61 11.83 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.506 2.375 0 O-C-N 121.559 -0.713 . . . . 0.0 110.258 -179.972 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 797' ' ' ASN . . . . . 0.461 ' OD1' ' O ' ' A' ' 797' ' ' ASN . 11.0 p30 -152.18 30.91 0.55 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.374 -0.829 . . . . 0.0 109.607 179.968 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 798' ' ' SER . . . . . 0.532 ' CB ' ' O ' ' A' ' 776' ' ' ALA . 3.9 m -67.36 -51.2 55.09 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.573 -0.704 . . . . 0.0 111.707 -179.874 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 799' ' ' ASN . . . . . 0.437 ' OD1' ' N ' ' A' ' 800' ' ' SER . 36.3 p30 -74.9 -17.55 60.56 Favored 'General case' 0 N--CA 1.5 2.039 0 O-C-N 121.243 -0.911 . . . . 0.0 111.803 -179.823 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 800' ' ' SER . . . . . 0.437 ' N ' ' OD1' ' A' ' 799' ' ' ASN . 29.5 t -58.88 -22.24 58.93 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 120.853 -1.154 . . . . 0.0 110.851 -179.96 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 801' ' ' VAL . . . . . . . . . . . . . 42.6 t -93.72 -18.8 6.85 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.006 0 O-C-N 121.096 -1.002 . . . . 0.0 111.051 -179.921 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 802' ' ' LEU . . . . . 0.484 HD11 HG21 ' A' ' 814' ' ' VAL . 4.0 mm? -87.61 -21.54 25.28 Favored 'General case' 0 N--CA 1.5 2.052 0 O-C-N 121.089 -1.007 . . . . 0.0 111.176 -179.868 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 803' ' ' GLU . . . . . . . . . . . . . 24.5 mt-10 -79.31 -29.11 42.22 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.019 -1.051 . . . . 0.0 111.117 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 804' ' ' ARG . . . . . . . . . . . . . 6.8 mpt_? -92.43 -18.6 23.03 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.082 -1.011 . . . . 0.0 111.545 -179.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 805' ' ' LYS . . . . . . . . . . . . . 7.9 ttmt -129.4 52.03 2.01 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 120.84 -1.163 . . . . 0.0 111.625 -179.87 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 806' ' ' CYS . . . . . 0.436 ' HB2' ' O ' ' A' ' 802' ' ' LEU . 0.5 OUTLIER -162.63 -44.61 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.981 -1.074 . . . . 0.0 110.621 179.901 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 807' ' ' ILE . . . . . . . . . . . . . 30.6 mt -71.92 107.56 2.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.231 -0.918 . . . . 0.0 110.444 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 808' ' ' GLY . . . . . . . . . . . . . . . 122.11 8.79 7.05 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.756 -1.338 . . . . 0.0 109.756 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 809' ' ' LEU . . . . . . . . . . . . . 83.4 mt -135.39 144.91 46.84 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.232 -1.158 . . . . 0.0 110.517 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 810' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -70.88 -28.97 64.95 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.341 -0.85 . . . . 0.0 109.952 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 811' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -123.7 160.26 27.61 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.475 -0.765 . . . . 0.0 109.987 179.908 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 812' ' ' CYS . . . . . 0.482 ' O ' ' HB2' ' A' ' 762' ' ' LEU . 1.3 t -145.69 128.69 16.5 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.267 -0.896 . . . . 0.0 110.313 179.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 813' ' ' VAL . . . . . . . . . . . . . 4.8 t -127.13 108.88 19.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.17 -0.956 . . . . 0.0 109.934 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 814' ' ' VAL . . . . . 0.484 HG21 HD11 ' A' ' 802' ' ' LEU . 63.7 t -110.57 108.99 26.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.258 -0.901 . . . . 0.0 110.147 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 815' ' ' ALA . . . . . 0.677 ' HB2' ' HE3' ' A' ' 759' ' ' LYS . . . -74.32 168.15 20.22 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.285 -0.884 . . . . 0.0 110.085 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 816' ' ' ILE . . . . . 0.822 HD13 HG21 ' A' ' 833' ' ' VAL . 39.3 mt -121.82 131.67 72.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.253 -0.905 . . . . 0.0 110.322 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 817' ' ' SER . . . . . 0.475 ' HB2' ' HD2' ' A' ' 818' ' ' PRO . 9.1 p -178.71 173.63 0.58 Allowed Pre-proline 0 C--N 1.301 -1.54 0 O-C-N 121.43 -0.794 . . . . 0.0 109.695 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 818' ' ' PRO . . . . . 0.475 ' HD2' ' HB2' ' A' ' 817' ' ' SER . 51.3 Cg_endo -79.54 12.41 2.38 Favored 'Trans proline' 0 C--N 1.304 -1.78 0 O-C-N 123.847 1.446 . . . . 0.0 111.048 179.957 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 819' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -128.81 2.53 5.4 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.971 -1.081 . . . . 0.0 110.586 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 820' ' ' ASN . . . . . . . . . . . . . 5.7 m120 -96.36 -35.3 11.25 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.073 -1.017 . . . . 0.0 110.365 -179.932 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 821' ' ' PHE . . . . . . . . . . . . . 46.8 m-85 -104.04 -69.03 0.82 Allowed 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.277 -0.889 . . . . 0.0 110.352 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 822' ' ' GLY . . . . . . . . . . . . . . . 167.6 51.92 0.03 OUTLIER Glycine 0 N--CA 1.492 2.381 0 N-CA-C 109.617 -1.393 . . . . 0.0 109.617 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 823' ' ' GLY . . . . . . . . . . . . . . . 91.58 178.07 42.61 Favored Glycine 0 N--CA 1.493 2.453 0 N-CA-C 109.693 -1.363 . . . . 0.0 109.693 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 824' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -112.68 129.31 24.55 Favored Pre-proline 0 N--CA 1.495 1.797 0 O-C-N 121.338 -1.095 . . . . 0.0 110.236 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 825' ' ' PRO . . . . . 0.436 ' O ' ' HD3' ' A' ' 827' ' ' PRO . 49.4 Cg_endo -82.6 -47.28 0.06 OUTLIER 'Trans proline' 0 C--N 1.307 -1.621 0 O-C-N 123.857 1.451 . . . . 0.0 111.201 -179.958 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 826' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -114.7 93.36 32.97 Favored Pre-proline 0 N--CA 1.498 1.929 0 O-C-N 120.987 -1.07 . . . . 0.0 111.137 -179.892 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 827' ' ' PRO . . . . . 0.472 ' O ' ' CB ' ' A' ' 828' ' ' GLU . 50.6 Cg_endo -89.04 162.01 5.87 Favored 'Trans proline' 0 C--N 1.307 -1.623 0 O-C-N 123.903 1.475 . . . . 0.0 110.396 179.948 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 828' ' ' GLU . . . . . 0.472 ' CB ' ' O ' ' A' ' 827' ' ' PRO . 0.7 OUTLIER 67.35 16.29 10.05 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.206 -0.934 . . . . 0.0 110.806 179.971 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 829' ' ' VAL . . . . . 0.42 ' O ' ' C ' ' A' ' 830' ' ' MET . 59.1 t -127.3 148.27 32.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.061 -1.025 . . . . 0.0 110.129 -179.985 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 830' ' ' MET . . . . . 0.622 ' HG3' HG22 ' A' ' 780' ' ' THR . 3.1 ptt? -41.89 106.54 0.06 Allowed 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.233 -0.917 . . . . 0.0 109.885 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 831' ' ' LYS . . . . . . . . . . . . . 11.5 mttm -82.03 115.43 21.17 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.164 -0.96 . . . . 0.0 111.001 -179.882 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 832' ' ' ARG . . . . . 0.529 ' HB3' ' CG ' ' A' ' 781' ' ' PRO . 2.4 mmm-85 -135.33 132.79 38.09 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 179.889 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 833' ' ' VAL . . . . . 0.822 HG21 HD13 ' A' ' 816' ' ' ILE . 39.3 t -108.96 130.86 61.13 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.584 0 O-C-N 121.02 -1.05 . . . . 0.0 111.034 -179.889 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 834' ' ' ALA . . . . . 0.506 ' O ' HG23 ' A' ' 835' ' ' VAL . . . -128.83 135.59 49.33 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.508 -0.745 . . . . 0.0 109.411 -179.985 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 835' ' ' VAL . . . . . 0.506 HG23 ' O ' ' A' ' 834' ' ' ALA . 13.3 t -152.78 127.64 1.49 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.051 -1.031 . . . . 0.0 110.776 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 836' ' ' GLU . . . . . 0.442 ' OE1' ' SG ' ' A' ' 732' ' ' CYS . 3.4 mt-10 -110.58 133.38 53.36 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.452 -0.78 . . . . 0.0 109.587 179.922 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 837' ' ' ALA . . . . . . . . . . . . . . . -110.8 154.54 23.82 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.082 -1.011 . . . . 0.0 110.701 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 838' ' ' VAL . . . . . 0.422 ' HB ' ' O ' ' A' ' 772' ' ' ALA . 99.2 t -107.85 108.86 26.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.366 -0.834 . . . . 0.0 109.807 179.967 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 839' ' ' CYS . . . . . 0.415 ' O ' ' O ' ' A' ' 728' ' ' VAL . 0.0 OUTLIER -108.66 146.56 33.23 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.238 -0.914 . . . . 0.0 110.353 -179.934 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 840' ' ' SER . . . . . 0.466 ' HA ' HG12 ' A' ' 728' ' ' VAL . 0.6 OUTLIER -157.04 168.57 27.08 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.299 -0.875 . . . . 0.0 110.097 179.985 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 841' ' ' THR . . . . . 0.476 ' CG2' ' NH1' ' A' ' 726' ' ' ARG . 1.2 p -67.32 157.08 34.84 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.309 -0.869 . . . . 0.0 110.567 -179.979 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 842' ' ' ALA . . . . . . . . . . . . . . . -138.76 90.27 2.43 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.441 -0.787 . . . . 0.0 109.988 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 843' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.676 0 CA-C-O 118.011 -0.995 . . . . 0.0 110.171 180.0 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 726' ' ' ARG . . . . . . . . . . . . . 8.5 tpp85 . . . . . 0 N--CA 1.492 1.667 0 CA-C-O 121.234 0.54 . . . . 0.0 110.193 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 727' ' ' THR . . . . . . . . . . . . . 5.8 m -123.71 146.51 48.21 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.313 -0.867 . . . . 0.0 110.276 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 728' ' ' VAL . . . . . 0.789 ' O ' HG12 ' A' ' 728' ' ' VAL . 9.9 t -94.97 76.35 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.21 -0.931 . . . . 0.0 110.036 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 729' ' ' SER . . . . . 0.444 ' HB3' ' HB3' ' A' ' 840' ' ' SER . 69.5 p -136.06 128.85 30.99 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.162 -0.961 . . . . 0.0 110.447 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 730' ' ' GLY . . . . . . . . . . . . . . . 132.82 74.74 0.1 Allowed Glycine 0 N--CA 1.492 2.414 0 N-CA-C 109.819 -1.312 . . . . 0.0 109.819 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 731' ' ' VAL . . . . . . . . . . . . . 48.0 t -109.66 147.43 14.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.217 -1.166 . . . . 0.0 110.039 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 732' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -120.51 151.63 39.11 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.159 -0.963 . . . . 0.0 110.568 -179.963 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 733' ' ' ALA . . . . . . . . . . . . . . . -141.26 103.09 4.36 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.413 -0.804 . . . . 0.0 109.69 179.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 734' ' ' ASP . . . . . 0.41 ' C ' HG23 ' A' ' 735' ' ' VAL . 39.0 t70 -127.61 128.19 45.12 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.261 -0.899 . . . . 0.0 109.889 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 735' ' ' VAL . . . . . 0.41 HG23 ' C ' ' A' ' 734' ' ' ASP . 76.7 t -146.74 134.19 14.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.031 -1.043 . . . . 0.0 110.61 179.933 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 736' ' ' SER . . . . . . . . . . . . . 2.7 m -68.26 140.9 56.02 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.359 -0.838 . . . . 0.0 109.852 179.931 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 737' ' ' GLU . . . . . . . . . . . . . 9.2 tm-20 -89.76 139.46 30.55 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.199 -0.938 . . . . 0.0 110.527 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 738' ' ' TYR . . . . . 0.622 ' CZ ' ' NE2' ' A' ' 739' ' ' HIS . 49.8 t80 -98.1 125.62 43.17 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.358 -0.839 . . . . 0.0 109.601 179.926 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 739' ' ' HIS . . . . . 0.622 ' NE2' ' CZ ' ' A' ' 738' ' ' TYR . 0.7 OUTLIER -44.27 167.34 0.1 OUTLIER Pre-proline 0 N--CA 1.493 1.72 0 O-C-N 121.09 -1.006 . . . . 0.0 110.429 -179.931 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 740' ' ' PRO . . . . . 0.452 ' HD2' ' HB2' ' A' ' 739' ' ' HIS . 48.6 Cg_endo -82.3 -50.5 0.05 OUTLIER 'Trans proline' 0 C--N 1.307 -1.649 0 O-C-N 123.926 1.487 . . . . 0.0 111.516 -179.901 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 741' ' ' ASN . . . . . 0.492 ' O ' HG12 ' A' ' 742' ' ' ILE . 6.8 m-20 -157.43 115.89 3.2 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 120.781 -1.199 . . . . 0.0 111.508 -179.896 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 742' ' ' ILE . . . . . 0.633 HG22 ' O ' ' A' ' 742' ' ' ILE . 11.2 mt -155.13 17.14 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 O-C-N 121.133 -0.979 . . . . 0.0 110.222 179.813 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 743' ' ' LYS . . . . . . . . . . . . . 1.3 mmtt 45.47 -97.71 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.187 -0.945 . . . . 0.0 110.476 179.928 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 744' ' ' ASN . . . . . 0.408 ' N ' ' O ' ' A' ' 742' ' ' ILE . 2.0 m-80 -112.01 143.06 43.64 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.017 -1.052 . . . . 0.0 110.383 -179.925 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 745' ' ' TRP . . . . . 0.492 ' CD1' ' N ' ' A' ' 745' ' ' TRP . 11.1 m0 -74.82 -158.53 0.08 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.264 -0.898 . . . . 0.0 109.875 -179.961 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 746' ' ' GLN . . . . . . . . . . . . . 3.7 mt-30 -62.94 129.92 42.51 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.189 -0.944 . . . . 0.0 110.094 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 747' ' ' ILE . . . . . . . . . . . . . 15.0 mm -85.66 97.51 5.8 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 O-C-N 121.276 -0.89 . . . . 0.0 110.258 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 748' ' ' GLU . . . . . 0.51 ' HG3' ' N ' ' A' ' 749' ' ' SER . 11.6 pt-20 -171.61 -35.64 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.12 -0.988 . . . . 0.0 110.373 -179.955 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 749' ' ' SER . . . . . 0.51 ' N ' ' HG3' ' A' ' 748' ' ' GLU . 89.1 p -170.98 54.21 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.134 -0.979 . . . . 0.0 110.257 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 750' ' ' TYR . . . . . . . . . . . . . 1.4 m-85 -121.52 177.23 5.3 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.207 -0.933 . . . . 0.0 110.291 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 751' ' ' GLY . . . . . . . . . . . . . . . 169.76 58.11 0.04 OUTLIER Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 -179.882 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 752' ' ' GLU . . . . . . . . . . . . . 19.0 tt0 -143.08 68.17 17.66 Favored Pre-proline 0 N--CA 1.493 1.683 0 O-C-N 121.218 -1.166 . . . . 0.0 110.186 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 753' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -77.95 72.46 6.15 Favored 'Trans proline' 0 C--N 1.305 -1.711 0 O-C-N 124.058 1.557 . . . . 0.0 110.544 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 754' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -60.9 -156.72 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.112 -0.993 . . . . 0.0 109.864 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 755' ' ' PHE . . . . . 0.484 ' CD1' ' N ' ' A' ' 756' ' ' HIS . 48.3 p90 -121.96 -154.27 0.59 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.989 -1.069 . . . . 0.0 110.942 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 756' ' ' HIS . . . . . 0.497 ' O ' ' O ' ' A' ' 757' ' ' THR . 5.1 t-80 -64.71 116.79 6.61 Favored 'General case' 0 N--CA 1.501 2.102 0 O-C-N 121.293 -0.879 . . . . 0.0 112.073 -179.825 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 757' ' ' THR . . . . . 0.497 ' O ' ' O ' ' A' ' 756' ' ' HIS . 0.8 OUTLIER 35.58 -162.02 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.134 0 CA-C-O 121.746 0.784 . . . . 0.0 111.573 179.866 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 758' ' ' ALA . . . . . . . . . . . . . . . -142.91 176.91 8.71 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.492 -0.755 . . . . 0.0 109.424 179.895 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 759' ' ' LYS . . . . . . . . . . . . . 8.3 mtpp -136.77 165.62 25.5 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.155 -0.966 . . . . 0.0 110.926 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 760' ' ' VAL . . . . . 0.433 HG23 HG13 ' A' ' 816' ' ' ILE . 46.8 t -108.38 146.65 13.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 179.91 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 761' ' ' HIS . . . . . . . . . . . . . 31.8 m80 -122.38 105.19 9.96 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.978 -1.076 . . . . 0.0 111.618 -179.879 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 762' ' ' LEU . . . . . 0.535 ' CB ' ' HB3' ' A' ' 812' ' ' CYS . 9.1 mt -118.14 131.21 56.43 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 179.823 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 763' ' ' LYS . . . . . . . . . . . . . 4.3 pttt -159.8 156.13 26.99 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.859 -1.151 . . . . 0.0 111.276 -179.932 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 764' ' ' CYS . . . . . . . . . . . . . 66.0 m -140.02 -178.14 5.32 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.577 -0.702 . . . . 0.0 109.755 179.88 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 765' ' ' ALA . . . . . 0.475 ' HB3' ' CD ' ' A' ' 768' ' ' GLN . . . -68.49 161.21 71.83 Favored Pre-proline 0 C--N 1.293 -1.883 0 O-C-N 121.233 -0.917 . . . . 0.0 110.895 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 766' ' ' PRO . . . . . 0.403 ' HD2' ' HB1' ' A' ' 765' ' ' ALA . 47.2 Cg_endo -72.53 83.68 1.27 Allowed 'Trans proline' 0 C--N 1.309 -1.528 0 O-C-N 124.174 1.618 . . . . 0.0 109.951 179.926 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 767' ' ' GLY . . . . . . . . . . . . . . . 150.42 -26.14 1.09 Allowed Glycine 0 N--CA 1.488 2.13 0 N-CA-C 108.293 -1.923 . . . . 0.0 108.293 -179.918 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 768' ' ' GLN . . . . . 0.645 ' NE2' HG11 ' A' ' 728' ' ' VAL . 6.4 mt-30 -101.33 102.4 13.24 Favored 'General case' 0 N--CA 1.486 1.357 0 O-C-N 121.647 -0.914 . . . . 0.0 109.458 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 769' ' ' THR . . . . . . . . . . . . . 9.1 p -101.11 149.26 24.15 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.234 -0.916 . . . . 0.0 110.566 -179.857 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 770' ' ' ILE . . . . . 0.563 HG13 ' HB3' ' A' ' 839' ' ' CYS . 2.6 mp -63.06 148.16 11.47 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 O-C-N 121.287 -0.883 . . . . 0.0 109.97 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 771' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -137.49 -15.76 1.4 Allowed 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.1 -1.0 . . . . 0.0 111.847 -179.963 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 772' ' ' ALA . . . . . . . . . . . . . . . -144.3 136.59 26.49 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 120.698 -1.251 . . . . 0.0 111.689 -179.888 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 773' ' ' ILE . . . . . 0.41 HD12 HG23 ' A' ' 773' ' ' ILE . 23.1 mm -105.4 113.65 42.88 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 179.827 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 774' ' ' LYS . . . . . . . . . . . . . 27.6 ttpp -82.08 -44.96 15.88 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.077 -1.014 . . . . 0.0 111.072 -179.925 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 775' ' ' PHE . . . . . 0.531 ' CD2' ' HB3' ' A' ' 788' ' ' PHE . 73.2 t80 -138.88 163.53 32.06 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.013 -1.054 . . . . 0.0 111.194 -179.911 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 776' ' ' ALA . . . . . 0.502 ' HB1' ' O ' ' A' ' 798' ' ' SER . . . -179.68 93.63 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 109.392 -0.596 . . . . 0.0 109.392 179.989 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 777' ' ' SER . . . . . 0.493 ' HA ' ' CB ' ' A' ' 798' ' ' SER . 11.9 t -127.53 133.33 49.82 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.17 -0.956 . . . . 0.0 110.47 -179.871 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 778' ' ' PHE . . . . . 0.76 ' HE2' HG23 ' A' ' 816' ' ' ILE . 55.1 t80 -110.05 95.84 5.85 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.419 -0.8 . . . . 0.0 110.157 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 779' ' ' GLY . . . . . 0.49 ' HA2' ' HB2' ' A' ' 831' ' ' LYS . . . 163.12 -97.14 0.15 Allowed Glycine 0 N--CA 1.493 2.438 0 N-CA-C 109.655 -1.378 . . . . 0.0 109.655 -179.921 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 780' ' ' THR . . . . . 0.468 ' O ' ' HA3' ' A' ' 791' ' ' GLY . 6.3 p -132.52 89.23 36.73 Favored Pre-proline 0 N--CA 1.495 1.783 0 O-C-N 121.12 -1.223 . . . . 0.0 110.063 -179.954 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 781' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -76.36 169.21 22.39 Favored 'Trans proline' 0 C--N 1.303 -1.847 0 O-C-N 124.072 1.564 . . . . 0.0 110.607 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 782' ' ' LEU . . . . . 0.781 HD13 ' C ' ' A' ' 782' ' ' LEU . 1.9 tm? -131.11 115.11 15.98 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.25 -0.906 . . . . 0.0 110.209 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 783' ' ' GLY . . . . . 0.433 ' N ' HD22 ' A' ' 782' ' ' LEU . . . 126.46 -173.92 18.03 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.827 -1.309 . . . . 0.0 109.827 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 784' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -119.08 -169.04 1.67 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.322 -1.105 . . . . 0.0 110.32 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 785' ' ' CYS . . . . . . . . . . . . . 3.6 t -65.1 90.66 0.09 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.369 -0.832 . . . . 0.0 110.309 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 786' ' ' GLY . . . . . . . . . . . . . . . 153.04 -22.53 0.78 Allowed Glycine 0 N--CA 1.489 2.202 0 N-CA-C 110.036 -1.226 . . . . 0.0 110.036 179.914 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 787' ' ' THR . . . . . 0.784 HG22 ' O ' ' A' ' 787' ' ' THR . 60.0 m -146.7 36.28 0.96 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.121 -1.223 . . . . 0.0 110.839 -179.965 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 788' ' ' PHE . . . . . 0.531 ' HB3' ' CD2' ' A' ' 775' ' ' PHE . 7.9 m-85 -54.06 112.44 0.96 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.028 -1.045 . . . . 0.0 109.769 179.995 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 789' ' ' GLN . . . . . . . . . . . . . 3.3 mt-30 -119.36 157.95 27.12 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.255 -0.903 . . . . 0.0 110.116 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 790' ' ' GLN . . . . . . . . . . . . . 16.7 mp0 -49.38 122.01 5.66 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.257 -0.902 . . . . 0.0 110.3 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 791' ' ' GLY . . . . . 0.468 ' HA3' ' O ' ' A' ' 780' ' ' THR . . . -81.05 -103.65 0.32 Allowed Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.404 -1.478 . . . . 0.0 109.404 179.938 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 792' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -130.17 -36.17 1.54 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.294 -1.121 . . . . 0.0 110.218 179.939 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 793' ' ' CYS . . . . . 0.434 ' HB2' ' OG1' ' A' ' 780' ' ' THR . 4.6 m -107.76 146.32 32.32 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.246 -0.909 . . . . 0.0 110.418 -179.975 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 794' ' ' HIS . . . . . . . . . . . . . 4.4 t60 -149.06 143.92 26.36 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.372 -0.83 . . . . 0.0 110.172 179.901 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 795' ' ' SER . . . . . 0.533 ' O ' ' CG1' ' A' ' 796' ' ' ILE . 9.0 t -92.93 22.92 4.52 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.25 -0.906 . . . . 0.0 110.227 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 796' ' ' ILE . . . . . 0.533 ' CG1' ' O ' ' A' ' 795' ' ' SER . 36.8 pt 37.32 29.67 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.105 0 O-C-N 121.621 -0.675 . . . . 0.0 110.861 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 797' ' ' ASN . . . . . 0.488 ' N ' ' O ' ' A' ' 795' ' ' SER . 2.0 t-20 -157.66 19.32 0.27 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.085 -1.009 . . . . 0.0 110.269 179.946 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 798' ' ' SER . . . . . 0.502 ' O ' ' HB1' ' A' ' 776' ' ' ALA . 1.2 m -90.33 18.22 6.34 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.263 -0.898 . . . . 0.0 110.395 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 799' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -131.16 -16.88 3.11 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.073 -1.017 . . . . 0.0 111.327 -179.961 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 800' ' ' SER . . . . . . . . . . . . . 5.7 p -78.79 -53.08 7.48 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.0 -1.062 . . . . 0.0 110.544 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 801' ' ' VAL . . . . . 0.547 ' O ' ' CB ' ' A' ' 805' ' ' LYS . 55.1 t -58.63 -19.77 15.14 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.31 -0.869 . . . . 0.0 110.723 -179.948 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 802' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -81.84 -62.2 1.7 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.992 -1.067 . . . . 0.0 111.165 -179.899 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 803' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -56.54 -32.78 65.46 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.192 -0.943 . . . . 0.0 111.417 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 804' ' ' ARG . . . . . . . . . . . . . 62.6 mtm-85 -92.52 -18.88 22.58 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.045 -1.034 . . . . 0.0 111.84 -179.868 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 805' ' ' LYS . . . . . 0.547 ' CB ' ' O ' ' A' ' 801' ' ' VAL . 0.2 OUTLIER -116.83 43.0 2.35 Favored 'General case' 0 N--CA 1.501 2.095 0 O-C-N 120.815 -1.178 . . . . 0.0 111.061 -179.962 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 806' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -159.5 -55.15 0.06 Allowed 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.103 -0.998 . . . . 0.0 110.259 179.833 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 807' ' ' ILE . . . . . . . . . . . . . 61.5 mt -61.21 123.82 14.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.218 -0.926 . . . . 0.0 110.314 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 808' ' ' GLY . . . . . 0.43 ' C ' ' HG ' ' A' ' 809' ' ' LEU . . . 101.31 11.8 37.91 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.603 -1.399 . . . . 0.0 109.603 -179.941 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 809' ' ' LEU . . . . . 0.43 ' HG ' ' C ' ' A' ' 808' ' ' GLY . 59.5 mt -137.28 129.83 29.95 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.228 -1.16 . . . . 0.0 110.199 179.976 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 810' ' ' GLU . . . . . . . . . . . . . 24.1 tt0 -67.56 -19.73 65.31 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.325 -0.859 . . . . 0.0 110.188 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 811' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -133.65 128.7 35.63 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.386 -0.821 . . . . 0.0 110.211 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 812' ' ' CYS . . . . . 0.535 ' HB3' ' CB ' ' A' ' 762' ' ' LEU . 1.3 t -110.65 122.38 47.63 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.329 -0.857 . . . . 0.0 110.135 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 813' ' ' VAL . . . . . . . . . . . . . 25.2 t -130.45 118.62 43.65 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.14 -0.975 . . . . 0.0 110.153 -180.0 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 814' ' ' VAL . . . . . . . . . . . . . 91.6 t -134.67 120.01 30.54 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.286 -0.884 . . . . 0.0 110.156 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 815' ' ' ALA . . . . . . . . . . . . . . . -75.71 146.47 40.11 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.227 -0.921 . . . . 0.0 110.278 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 816' ' ' ILE . . . . . 0.76 HG23 ' HE2' ' A' ' 778' ' ' PHE . 84.6 mt -96.53 123.28 48.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.319 -0.863 . . . . 0.0 110.178 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 817' ' ' SER . . . . . 0.477 ' HB2' ' HD2' ' A' ' 818' ' ' PRO . 4.5 p -159.5 170.55 8.61 Favored Pre-proline 0 N--CA 1.494 1.766 0 O-C-N 121.009 -1.057 . . . . 0.0 110.561 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 818' ' ' PRO . . . . . 0.477 ' HD2' ' HB2' ' A' ' 817' ' ' SER . 47.0 Cg_endo -73.77 -2.08 11.7 Favored 'Trans proline' 0 C--N 1.308 -1.555 0 O-C-N 124.047 1.551 . . . . 0.0 110.606 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 819' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -134.65 59.91 1.72 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.206 -0.934 . . . . 0.0 110.229 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 820' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -132.48 -41.9 0.96 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.365 -0.834 . . . . 0.0 110.278 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 821' ' ' PHE . . . . . . . . . . . . . 79.8 m-85 -100.98 -68.79 0.8 Allowed 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.215 -0.928 . . . . 0.0 110.72 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 822' ' ' GLY . . . . . . . . . . . . . . . -149.05 20.76 1.24 Allowed Glycine 0 N--CA 1.492 2.422 0 C-N-CA 119.638 -1.268 . . . . 0.0 109.945 -179.904 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 823' ' ' GLY . . . . . 0.47 ' HA2' ' O ' ' A' ' 818' ' ' PRO . . . 102.94 -132.96 11.22 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.719 -1.352 . . . . 0.0 109.719 179.912 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 824' ' ' ASP . . . . . 0.471 ' OD1' ' HB3' ' A' ' 818' ' ' PRO . 2.2 m-20 -140.77 106.45 6.36 Favored Pre-proline 0 N--CA 1.493 1.724 0 O-C-N 121.289 -1.124 . . . . 0.0 110.246 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 825' ' ' PRO . . . . . 0.468 ' O ' ' HD3' ' A' ' 827' ' ' PRO . 44.9 Cg_endo -72.47 -88.44 0.0 OUTLIER 'Trans proline' 0 C--N 1.304 -1.774 0 O-C-N 124.085 1.571 . . . . 0.0 111.003 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 826' ' ' CYS . . . . . . . . . . . . . 97.1 m -80.6 112.18 29.29 Favored Pre-proline 0 N--CA 1.498 1.938 0 O-C-N 121.232 -0.918 . . . . 0.0 110.924 -179.908 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 827' ' ' PRO . . . . . 0.726 ' O ' HG23 ' A' ' 829' ' ' VAL . 49.7 Cg_endo -94.12 173.92 1.51 Allowed 'Trans proline' 0 C--N 1.308 -1.563 0 O-C-N 123.993 1.523 . . . . 0.0 110.251 179.956 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 828' ' ' GLU . . . . . . . . . . . . . 14.4 mt-10 52.33 31.11 8.94 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.358 -0.839 . . . . 0.0 110.826 179.945 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 829' ' ' VAL . . . . . 0.726 HG23 ' O ' ' A' ' 827' ' ' PRO . 97.9 t -137.02 113.73 12.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.013 -1.055 . . . . 0.0 110.469 -179.944 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 830' ' ' MET . . . . . 0.434 ' C ' ' O ' ' A' ' 829' ' ' VAL . 2.2 mtt -42.52 95.86 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.333 -0.854 . . . . 0.0 109.989 179.937 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 831' ' ' LYS . . . . . 0.494 ' N ' ' O ' ' A' ' 829' ' ' VAL . 1.9 pttp -109.63 139.49 44.59 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.206 -0.934 . . . . 0.0 110.925 -179.908 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 832' ' ' ARG . . . . . . . . . . . . . 10.4 ptt180 -128.45 166.57 18.5 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.416 -0.802 . . . . 0.0 109.277 179.917 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 833' ' ' VAL . . . . . 0.503 HG22 ' CD2' ' A' ' 778' ' ' PHE . 54.7 t -107.61 128.67 62.59 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.109 -0.994 . . . . 0.0 110.831 -179.913 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 834' ' ' ALA . . . . . . . . . . . . . . . -128.57 132.45 48.22 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 179.891 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 835' ' ' VAL . . . . . . . . . . . . . 53.2 t -141.25 150.9 19.76 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 O-C-N 120.819 -1.176 . . . . 0.0 111.538 -179.893 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 836' ' ' GLU . . . . . . . . . . . . . 4.0 tp10 -131.53 108.71 9.75 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 179.9 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 837' ' ' ALA . . . . . . . . . . . . . . . -107.87 158.87 16.97 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.037 -1.039 . . . . 0.0 110.264 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 838' ' ' VAL . . . . . . . . . . . . . 37.6 t -122.19 103.07 12.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.285 -0.884 . . . . 0.0 110.418 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 839' ' ' CYS . . . . . 0.563 ' HB3' HG13 ' A' ' 770' ' ' ILE . 3.1 p -120.19 132.29 55.31 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.4 -0.812 . . . . 0.0 109.401 179.931 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 840' ' ' SER . . . . . 0.502 ' O ' ' HA ' ' A' ' 768' ' ' GLN . 16.7 p -149.66 -168.45 3.11 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.065 -1.022 . . . . 0.0 110.881 -179.919 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 841' ' ' THR . . . . . 0.487 ' N ' ' HG2' ' A' ' 768' ' ' GLN . 22.7 p -76.67 130.65 38.07 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.435 -0.791 . . . . 0.0 110.767 -179.91 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 842' ' ' ALA . . . . . 0.415 ' C ' ' O ' ' A' ' 841' ' ' THR . . . 41.92 75.76 0.08 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.389 -0.819 . . . . 0.0 110.36 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 843' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.667 0 CA-C-O 117.958 -1.02 . . . . 0.0 110.171 -179.996 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 726' ' ' ARG . . . . . . . . . . . . . 6.3 ttm180 . . . . . 0 N--CA 1.492 1.653 0 CA-C-O 121.213 0.53 . . . . 0.0 110.275 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 727' ' ' THR . . . . . . . . . . . . . 2.5 m -79.21 123.26 27.24 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.249 -0.907 . . . . 0.0 110.199 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 728' ' ' VAL . . . . . . . . . . . . . 15.5 m -147.35 172.18 2.84 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.523 0 O-C-N 121.318 -0.864 . . . . 0.0 110.08 179.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 729' ' ' SER . . . . . . . . . . . . . 1.5 t -173.87 168.09 4.29 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.295 -0.878 . . . . 0.0 110.278 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 730' ' ' GLY . . . . . . . . . . . . . . . -138.1 130.11 4.86 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.404 -1.478 . . . . 0.0 109.404 179.931 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 731' ' ' VAL . . . . . 0.619 ' CG2' ' HB3' ' A' ' 837' ' ' ALA . 13.6 m -110.82 124.93 68.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.237 -1.155 . . . . 0.0 110.339 -179.956 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 732' ' ' CYS . . . . . . . . . . . . . 5.1 t -109.46 112.46 24.58 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.343 -0.848 . . . . 0.0 109.582 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 733' ' ' ALA . . . . . . . . . . . . . . . -114.2 142.01 46.8 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.236 -0.915 . . . . 0.0 110.974 -179.924 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 734' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -155.54 118.58 4.31 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.465 -0.772 . . . . 0.0 109.483 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 735' ' ' VAL . . . . . . . . . . . . . 65.5 t -128.55 150.39 34.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.121 -0.987 . . . . 0.0 110.789 -179.934 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 736' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -99.88 139.73 35.13 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.323 -0.861 . . . . 0.0 109.614 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 737' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -64.29 139.91 58.81 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.082 -1.011 . . . . 0.0 110.668 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 738' ' ' TYR . . . . . 0.549 ' CD1' ' C ' ' A' ' 738' ' ' TYR . 8.4 p90 -164.22 154.81 15.09 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.267 -0.896 . . . . 0.0 110.267 179.973 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 739' ' ' HIS . . . . . 0.599 ' CE1' ' HB3' ' A' ' 741' ' ' ASN . 0.6 OUTLIER -97.55 168.28 10.4 Favored Pre-proline 0 N--CA 1.496 1.864 0 O-C-N 121.282 -0.886 . . . . 0.0 110.404 179.997 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 740' ' ' PRO . . . . . 0.521 ' HD3' ' HA ' ' A' ' 756' ' ' HIS . 49.2 Cg_endo -82.06 17.95 1.47 Allowed 'Trans proline' 0 C--N 1.309 -1.544 0 O-C-N 123.947 1.499 . . . . 0.0 110.997 -179.956 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 741' ' ' ASN . . . . . 0.785 ' C ' HD12 ' A' ' 742' ' ' ILE . 1.5 t-20 -77.1 108.56 10.27 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.115 -0.991 . . . . 0.0 110.112 179.899 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 742' ' ' ILE . . . . . 0.785 HD12 ' C ' ' A' ' 741' ' ' ASN . 2.1 mp -138.39 162.18 30.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.229 -0.92 . . . . 0.0 110.147 -179.984 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 743' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.41 -42.26 6.04 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.204 -0.935 . . . . 0.0 110.712 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 744' ' ' ASN . . . . . 0.432 ' ND2' ' H ' ' A' ' 744' ' ' ASN . 13.3 m-80 -60.29 -12.73 9.78 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.034 -1.041 . . . . 0.0 110.088 179.949 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 745' ' ' TRP . . . . . . . . . . . . . 26.2 t90 -73.7 97.55 2.71 Favored 'General case' 0 C--N 1.299 -1.627 0 O-C-N 121.439 -0.788 . . . . 0.0 110.079 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 746' ' ' GLN . . . . . 0.586 ' C ' HG22 ' A' ' 747' ' ' ILE . 2.1 mm-40 -130.37 45.36 2.82 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.236 -0.915 . . . . 0.0 110.442 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 747' ' ' ILE . . . . . 0.586 HG22 ' C ' ' A' ' 746' ' ' GLN . 1.2 tp 36.93 46.61 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.129 0 O-C-N 121.647 -0.658 . . . . 0.0 110.79 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 748' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -106.8 -41.37 5.24 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.182 -0.949 . . . . 0.0 110.221 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 749' ' ' SER . . . . . . . . . . . . . 20.7 p -168.06 26.55 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.251 -0.906 . . . . 0.0 110.094 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 750' ' ' TYR . . . . . . . . . . . . . 22.5 m-85 -107.83 -73.73 0.68 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.299 -0.876 . . . . 0.0 110.318 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 751' ' ' GLY . . . . . . . . . . . . . . . 153.95 -135.55 4.83 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.6 -1.4 . . . . 0.0 109.6 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 752' ' ' GLU . . . . . . . . . . . . . 16.1 tt0 -176.68 100.36 0.24 Allowed Pre-proline 0 N--CA 1.494 1.728 0 O-C-N 121.279 -1.13 . . . . 0.0 110.19 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 753' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -73.24 157.65 49.82 Favored 'Trans proline' 0 C--N 1.305 -1.756 0 O-C-N 124.035 1.545 . . . . 0.0 110.42 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 754' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -127.89 61.23 1.43 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.223 -0.923 . . . . 0.0 110.255 179.988 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 755' ' ' PHE . . . . . 0.451 ' O ' ' HG3' ' A' ' 740' ' ' PRO . 0.5 OUTLIER -164.43 -165.59 0.98 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.263 -0.898 . . . . 0.0 110.18 179.987 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 756' ' ' HIS . . . . . 0.521 ' HA ' ' HD3' ' A' ' 740' ' ' PRO . 1.8 t60 -149.74 27.21 0.81 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.287 -0.883 . . . . 0.0 110.194 179.997 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 757' ' ' THR . . . . . . . . . . . . . 25.5 p -141.73 175.02 10.03 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.222 -0.924 . . . . 0.0 110.332 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 758' ' ' ALA . . . . . 0.565 ' HB3' HD12 ' A' ' 816' ' ' ILE . . . -98.79 176.83 5.48 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.294 -0.879 . . . . 0.0 110.224 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 759' ' ' LYS . . . . . . . . . . . . . 13.4 mtmm -141.09 144.58 35.0 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.261 -0.899 . . . . 0.0 110.44 -179.934 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 760' ' ' VAL . . . . . . . . . . . . . 38.5 t -106.14 133.99 49.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.333 -0.854 . . . . 0.0 108.767 179.881 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 761' ' ' HIS . . . . . 0.89 ' CE1' HG22 ' A' ' 813' ' ' VAL . 0.3 OUTLIER -120.47 123.12 42.19 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 120.907 -1.121 . . . . 0.0 111.893 -179.87 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 762' ' ' LEU . . . . . . . . . . . . . 12.5 mt -120.45 98.61 6.12 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 179.77 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 763' ' ' LYS . . . . . 0.533 ' CB ' ' HG2' ' A' ' 811' ' ' ARG . 0.2 OUTLIER -114.48 137.51 51.76 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.005 -1.059 . . . . 0.0 111.515 -179.8 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 764' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER -118.3 161.96 19.07 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.679 -0.638 . . . . 0.0 109.555 179.901 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 765' ' ' ALA . . . . . 0.579 ' HB1' ' HD2' ' A' ' 766' ' ' PRO . . . -50.62 167.73 0.25 Allowed Pre-proline 0 N--CA 1.495 1.775 0 O-C-N 120.978 -1.076 . . . . 0.0 110.133 -179.959 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 766' ' ' PRO . . . . . 0.579 ' HD2' ' HB1' ' A' ' 765' ' ' ALA . 45.5 Cg_endo -72.22 124.34 9.91 Favored 'Trans proline' 0 C--N 1.305 -1.734 0 O-C-N 123.972 1.512 . . . . 0.0 110.155 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 767' ' ' GLY . . . . . . . . . . . . . . . 109.67 -36.37 4.35 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.223 -1.551 . . . . 0.0 109.223 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 768' ' ' GLN . . . . . . . . . . . . . 28.8 mt-30 -87.89 115.27 25.23 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.281 -1.129 . . . . 0.0 109.894 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 769' ' ' THR . . . . . . . . . . . . . 29.4 p -109.28 167.64 9.97 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.215 -0.928 . . . . 0.0 110.292 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 770' ' ' ILE . . . . . . . . . . . . . 7.8 mt -85.61 101.25 9.75 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 121.236 -0.915 . . . . 0.0 109.807 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 771' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -89.55 -6.9 55.91 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.162 -0.961 . . . . 0.0 110.818 -179.923 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 772' ' ' ALA . . . . . 0.464 ' O ' ' HB ' ' A' ' 838' ' ' VAL . . . -165.84 142.46 5.28 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.008 -1.058 . . . . 0.0 111.278 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 773' ' ' ILE . . . . . 0.409 HG13 ' HG2' ' A' ' 803' ' ' GLU . 47.3 mm -94.61 125.87 47.15 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 O-C-N 121.392 -0.817 . . . . 0.0 109.134 179.944 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 774' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -80.17 -37.94 32.33 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.085 -1.01 . . . . 0.0 111.244 -179.895 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 775' ' ' PHE . . . . . 0.642 ' O ' ' HB2' ' A' ' 776' ' ' ALA . 65.0 t80 -150.96 170.18 19.96 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.82 -1.175 . . . . 0.0 111.124 -179.984 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 776' ' ' ALA . . . . . 0.642 ' HB2' ' O ' ' A' ' 775' ' ' PHE . . . 170.82 116.4 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.703 -0.623 . . . . 0.0 109.346 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 777' ' ' SER . . . . . . . . . . . . . 14.5 t -151.69 131.77 13.49 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.114 -0.991 . . . . 0.0 110.724 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 778' ' ' PHE . . . . . . . . . . . . . 2.4 t80 -99.3 124.98 44.84 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.56 -0.713 . . . . 0.0 109.756 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 779' ' ' GLY . . . . . . . . . . . . . . . 130.3 -110.5 1.03 Allowed Glycine 0 N--CA 1.493 2.482 0 N-CA-C 109.85 -1.3 . . . . 0.0 109.85 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 780' ' ' THR . . . . . . . . . . . . . 11.8 p -135.37 83.57 37.49 Favored Pre-proline 0 N--CA 1.496 1.841 0 O-C-N 121.16 -1.2 . . . . 0.0 110.636 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 781' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -76.92 158.23 34.65 Favored 'Trans proline' 0 C--N 1.307 -1.639 0 O-C-N 123.856 1.45 . . . . 0.0 110.087 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 782' ' ' LEU . . . . . 0.496 ' O ' ' HA ' ' A' ' 788' ' ' PHE . 0.3 OUTLIER -96.24 123.86 40.03 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.158 -0.964 . . . . 0.0 110.241 179.958 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 783' ' ' GLY . . . . . . . . . . . . . . . 138.37 -169.33 24.33 Favored Glycine 0 N--CA 1.492 2.404 0 N-CA-C 109.688 -1.365 . . . . 0.0 109.688 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 784' ' ' THR . . . . . . . . . . . . . 3.3 m -138.31 -52.17 0.6 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.281 -1.129 . . . . 0.0 109.961 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 785' ' ' CYS . . . . . 0.558 ' HA ' ' CZ ' ' A' ' 788' ' ' PHE . 40.3 t -166.95 74.51 0.15 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.281 -0.887 . . . . 0.0 109.793 179.948 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 786' ' ' GLY . . . . . . . . . . . . . . . 130.68 -16.07 5.39 Favored Glycine 0 N--CA 1.489 2.171 0 N-CA-C 108.949 -1.66 . . . . 0.0 108.949 -179.932 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 787' ' ' THR . . . . . 0.451 HG22 ' O ' ' A' ' 787' ' ' THR . 18.2 m -121.78 27.36 8.19 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.477 -1.014 . . . . 0.0 109.878 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 788' ' ' PHE . . . . . 0.558 ' CZ ' ' HA ' ' A' ' 785' ' ' CYS . 35.4 m-85 -55.14 172.71 0.12 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.342 -0.849 . . . . 0.0 110.349 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 789' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER 179.23 172.48 0.86 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.362 -0.836 . . . . 0.0 109.93 -179.982 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 790' ' ' GLN . . . . . . . . . . . . . 6.2 tm0? -57.12 161.42 3.14 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.124 -0.985 . . . . 0.0 110.305 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 791' ' ' GLY . . . . . . . . . . . . . . . -136.89 -131.88 3.02 Favored Glycine 0 N--CA 1.494 2.507 0 N-CA-C 109.687 -1.365 . . . . 0.0 109.687 -179.919 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 792' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -107.76 -66.32 1.04 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.216 -1.167 . . . . 0.0 109.964 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 793' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -92.54 88.66 6.42 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.266 -0.896 . . . . 0.0 109.891 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 794' ' ' HIS . . . . . 0.435 ' HE1' ' CB ' ' A' ' 798' ' ' SER . 19.2 t60 -105.54 155.49 19.14 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.174 -0.954 . . . . 0.0 110.674 -179.921 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 795' ' ' SER . . . . . 0.535 ' HB2' ' HB3' ' A' ' 825' ' ' PRO . 1.3 t -115.63 111.21 20.3 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.466 -0.771 . . . . 0.0 109.942 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 796' ' ' ILE . . . . . . . . . . . . . 3.5 pt -44.3 -23.05 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 O-C-N 121.315 -0.866 . . . . 0.0 110.816 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 797' ' ' ASN . . . . . 0.409 ' N ' ' O ' ' A' ' 795' ' ' SER . 1.6 t30 -84.19 26.93 0.71 Allowed 'General case' 0 N--CA 1.499 1.991 0 O-C-N 120.988 -1.07 . . . . 0.0 111.005 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 798' ' ' SER . . . . . 0.487 ' HB3' ' O ' ' A' ' 776' ' ' ALA . 9.0 m -82.13 -31.57 30.53 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.0 -1.063 . . . . 0.0 111.11 179.942 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 799' ' ' ASN . . . . . 0.479 ' OD1' ' HB3' ' A' ' 776' ' ' ALA . 4.8 m120 -107.36 8.08 29.47 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.017 -1.052 . . . . 0.0 111.288 -179.893 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 800' ' ' SER . . . . . 0.448 ' O ' ' HB3' ' A' ' 804' ' ' ARG . 0.7 OUTLIER -90.33 -40.68 11.97 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.953 -1.092 . . . . 0.0 110.245 179.967 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 801' ' ' VAL . . . . . 0.63 HG21 ' CD2' ' A' ' 821' ' ' PHE . 55.5 t -74.65 -35.5 37.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.256 -0.902 . . . . 0.0 110.104 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 802' ' ' LEU . . . . . 0.492 HD13 ' HA ' ' A' ' 802' ' ' LEU . 4.0 mm? -69.31 -57.09 5.76 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.207 -0.933 . . . . 0.0 110.051 179.947 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 803' ' ' GLU . . . . . 0.409 ' HG2' HG13 ' A' ' 773' ' ' ILE . 0.7 OUTLIER -62.93 -18.29 62.94 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.235 -0.916 . . . . 0.0 110.011 179.943 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 804' ' ' ARG . . . . . 0.448 ' HB3' ' O ' ' A' ' 800' ' ' SER . 12.4 ttp180 -89.55 -20.42 23.81 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.265 -0.897 . . . . 0.0 111.07 -179.968 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 805' ' ' LYS . . . . . . . . . . . . . 9.2 ttmt -141.06 53.14 1.57 Allowed 'General case' 0 N--CA 1.495 1.818 0 O-C-N 120.878 -1.139 . . . . 0.0 110.873 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 806' ' ' CYS . . . . . 0.413 ' HB2' ' O ' ' A' ' 802' ' ' LEU . 1.4 t -158.94 -36.18 0.06 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.128 -0.983 . . . . 0.0 110.317 179.942 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 807' ' ' ILE . . . . . . . . . . . . . 9.5 mt -71.12 130.76 34.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.22 -0.925 . . . . 0.0 110.058 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 808' ' ' GLY . . . . . . . . . . . . . . . 91.8 16.03 52.85 Favored Glycine 0 N--CA 1.492 2.407 0 N-CA-C 109.776 -1.329 . . . . 0.0 109.776 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 809' ' ' LEU . . . . . . . . . . . . . 58.4 mt -129.22 138.97 52.01 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.188 -1.184 . . . . 0.0 110.411 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 810' ' ' GLU . . . . . 0.434 ' OE1' ' HA ' ' A' ' 766' ' ' PRO . 43.1 tt0 -69.14 -32.2 71.39 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.333 -0.854 . . . . 0.0 109.468 179.857 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 811' ' ' ARG . . . . . 0.533 ' HG2' ' CB ' ' A' ' 763' ' ' LYS . 3.3 mtm-85 -131.63 156.34 45.99 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.46 -0.775 . . . . 0.0 109.587 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 812' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -133.03 142.4 48.78 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.13 -0.981 . . . . 0.0 110.825 -179.976 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 813' ' ' VAL . . . . . 0.89 HG22 ' CE1' ' A' ' 761' ' ' HIS . 51.2 t -140.45 115.51 6.9 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.337 -0.852 . . . . 0.0 109.841 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 814' ' ' VAL . . . . . . . . . . . . . 52.4 t -128.89 121.76 55.24 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 O-C-N 121.253 -0.904 . . . . 0.0 110.464 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 815' ' ' ALA . . . . . . . . . . . . . . . -80.41 142.57 34.22 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.212 -0.93 . . . . 0.0 109.918 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 816' ' ' ILE . . . . . 0.565 HD12 ' HB3' ' A' ' 758' ' ' ALA . 14.1 mt -88.03 112.65 23.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.212 -0.93 . . . . 0.0 110.376 -179.955 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 817' ' ' SER . . . . . 0.458 ' OG ' ' OD1' ' A' ' 820' ' ' ASN . 78.7 p -168.34 163.39 8.57 Favored Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 121.448 -0.782 . . . . 0.0 109.993 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 818' ' ' PRO . . . . . 0.47 ' HB3' ' OD1' ' A' ' 824' ' ' ASP . 44.4 Cg_endo -72.37 -19.38 25.4 Favored 'Trans proline' 0 C--N 1.305 -1.747 0 O-C-N 124.021 1.537 . . . . 0.0 110.372 -179.979 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 819' ' ' SER . . . . . . . . . . . . . 9.1 m -94.97 48.13 1.17 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.187 -0.945 . . . . 0.0 110.017 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 820' ' ' ASN . . . . . 0.458 ' OD1' ' OG ' ' A' ' 817' ' ' SER . 1.2 m120 -139.75 -53.8 0.54 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.266 -0.897 . . . . 0.0 110.195 -179.955 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 821' ' ' PHE . . . . . 0.63 ' CD2' HG21 ' A' ' 801' ' ' VAL . 87.6 m-85 -79.54 -33.05 42.26 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.345 -0.847 . . . . 0.0 110.316 -179.958 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 822' ' ' GLY . . . . . . . . . . . . . . . 128.09 66.93 0.13 Allowed Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.656 -1.378 . . . . 0.0 109.656 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 823' ' ' GLY . . . . . . . . . . . . . . . 98.86 -175.57 28.89 Favored Glycine 0 N--CA 1.492 2.411 0 N-CA-C 109.716 -1.354 . . . . 0.0 109.716 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 824' ' ' ASP . . . . . 0.47 ' OD1' ' HB3' ' A' ' 818' ' ' PRO . 0.2 OUTLIER -102.18 133.15 20.79 Favored Pre-proline 0 N--CA 1.493 1.692 0 O-C-N 121.24 -1.153 . . . . 0.0 110.115 179.919 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 825' ' ' PRO . . . . . 0.535 ' HB3' ' HB2' ' A' ' 795' ' ' SER . 51.7 Cg_endo -75.07 -89.7 0.01 OUTLIER 'Trans proline' 0 C--N 1.307 -1.637 0 O-C-N 123.964 1.508 . . . . 0.0 110.477 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 826' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -113.41 103.1 55.48 Favored Pre-proline 0 N--CA 1.492 1.645 0 O-C-N 121.136 -0.978 . . . . 0.0 110.177 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 827' ' ' PRO . . . . . 0.411 ' O ' ' HB3' ' A' ' 828' ' ' GLU . 45.3 Cg_endo -74.08 165.4 32.09 Favored 'Trans proline' 0 C--N 1.304 -1.808 0 O-C-N 123.994 1.523 . . . . 0.0 110.655 179.933 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 828' ' ' GLU . . . . . 0.411 ' HB3' ' O ' ' A' ' 827' ' ' PRO . 1.6 tt0 55.78 44.7 25.71 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.304 -0.873 . . . . 0.0 110.578 179.959 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 829' ' ' VAL . . . . . 0.408 ' O ' ' C ' ' A' ' 830' ' ' MET . 25.4 t -141.33 151.57 19.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.222 -0.924 . . . . 0.0 110.122 179.92 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 830' ' ' MET . . . . . 0.408 ' C ' ' O ' ' A' ' 829' ' ' VAL . 0.0 OUTLIER -43.15 121.34 2.12 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.301 -0.874 . . . . 0.0 109.944 -179.986 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 831' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.71 86.64 7.31 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.287 -0.883 . . . . 0.0 110.595 -179.953 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 832' ' ' ARG . . . . . . . . . . . . . 6.8 mpt_? -129.58 125.89 37.24 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.408 -0.808 . . . . 0.0 109.421 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 833' ' ' VAL . . . . . 0.509 HG21 ' CG2' ' A' ' 816' ' ' ILE . 54.7 t -109.73 140.59 27.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.098 -1.001 . . . . 0.0 110.829 -179.887 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 834' ' ' ALA . . . . . 0.599 ' O ' HG23 ' A' ' 835' ' ' VAL . . . -141.26 138.16 33.03 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.398 -0.814 . . . . 0.0 109.68 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 835' ' ' VAL . . . . . 0.599 HG23 ' O ' ' A' ' 834' ' ' ALA . 35.3 t -156.0 127.99 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 O-C-N 121.036 -1.04 . . . . 0.0 111.187 -179.93 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 836' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -114.25 128.67 56.47 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.439 -0.788 . . . . 0.0 109.248 179.884 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 837' ' ' ALA . . . . . 0.619 ' HB3' ' CG2' ' A' ' 731' ' ' VAL . . . -110.98 157.89 19.39 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.075 -1.016 . . . . 0.0 110.914 -179.853 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 838' ' ' VAL . . . . . 0.464 ' HB ' ' O ' ' A' ' 772' ' ' ALA . 98.9 t -109.28 132.39 57.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.477 -0.765 . . . . 0.0 109.662 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 839' ' ' CYS . . . . . . . . . . . . . 1.3 m -115.8 134.64 54.8 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.071 -1.018 . . . . 0.0 110.721 -179.93 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 840' ' ' SER . . . . . . . . . . . . . 4.5 t -139.95 -133.84 0.11 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.44 -0.787 . . . . 0.0 109.743 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 841' ' ' THR . . . . . . . . . . . . . 30.4 p -121.99 166.59 14.24 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.89 -1.131 . . . . 0.0 110.213 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 842' ' ' ALA . . . . . . . . . . . . . . . -121.65 138.19 54.44 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.252 -0.905 . . . . 0.0 109.977 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 843' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.624 0 CA-C-O 118.07 -0.967 . . . . 0.0 110.256 -179.949 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 726' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.644 0 CA-C-O 121.213 0.53 . . . . 0.0 110.281 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 727' ' ' THR . . . . . 0.473 HG23 HG23 ' A' ' 841' ' ' THR . 2.0 t -122.07 75.56 1.23 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.229 -0.919 . . . . 0.0 110.289 -179.982 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 728' ' ' VAL . . . . . . . . . . . . . 56.4 t -123.29 96.84 4.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.311 -0.868 . . . . 0.0 110.039 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 729' ' ' SER . . . . . . . . . . . . . 1.3 t -84.68 -149.36 0.11 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.22 -0.925 . . . . 0.0 110.482 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 730' ' ' GLY . . . . . . . . . . . . . . . 170.58 131.7 1.37 Allowed Glycine 0 N--CA 1.489 2.175 0 N-CA-C 109.216 -1.554 . . . . 0.0 109.216 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 731' ' ' VAL . . . . . . . . . . . . . 7.0 t -120.14 141.25 41.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.174 -1.192 . . . . 0.0 110.411 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 732' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -109.64 163.86 13.08 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.354 -0.841 . . . . 0.0 109.864 -179.977 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 733' ' ' ALA . . . . . . . . . . . . . . . -155.37 104.48 2.4 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.146 -0.971 . . . . 0.0 110.656 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 734' ' ' ASP . . . . . . . . . . . . . 35.3 t0 -117.7 103.69 10.26 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.376 -0.828 . . . . 0.0 109.455 179.88 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 735' ' ' VAL . . . . . . . . . . . . . 68.4 t -129.86 154.02 39.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.209 -0.932 . . . . 0.0 110.482 -179.895 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 736' ' ' SER . . . . . 0.433 ' HA ' ' HD2' ' A' ' 832' ' ' ARG . 57.8 m -66.26 -173.29 0.19 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.316 -0.865 . . . . 0.0 110.474 -179.957 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 737' ' ' GLU . . . . . 0.522 ' HG3' ' N ' ' A' ' 738' ' ' TYR . 28.8 tp10 -105.89 166.84 10.2 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.373 -0.83 . . . . 0.0 110.18 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 738' ' ' TYR . . . . . 0.575 ' CB ' HG22 ' A' ' 757' ' ' THR . 0.0 OUTLIER -65.33 165.53 11.59 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.224 -0.922 . . . . 0.0 109.133 -179.996 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 739' ' ' HIS . . . . . 0.586 ' CD2' ' O ' ' A' ' 739' ' ' HIS . 0.4 OUTLIER -164.74 148.1 7.47 Favored Pre-proline 0 C--N 1.301 -1.521 0 O-C-N 121.114 -0.991 . . . . 0.0 110.794 -179.878 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 740' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_endo -84.65 14.06 2.57 Favored 'Trans proline' 0 C--N 1.304 -1.791 0 O-C-N 124.105 1.581 . . . . 0.0 109.891 179.864 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 741' ' ' ASN . . . . . 0.466 ' HB2' ' ND1' ' A' ' 739' ' ' HIS . 1.5 m120 -79.19 75.42 5.73 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.343 -0.848 . . . . 0.0 110.467 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 742' ' ' ILE . . . . . 0.454 HG13 ' C ' ' A' ' 741' ' ' ASN . 24.9 mt -149.98 96.18 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.333 -0.854 . . . . 0.0 109.772 179.9 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 743' ' ' LYS . . . . . 0.418 ' O ' ' HB3' ' A' ' 744' ' ' ASN . 0.0 OUTLIER -113.01 159.17 19.41 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.174 -0.954 . . . . 0.0 110.652 -179.859 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 744' ' ' ASN . . . . . 0.418 ' HB3' ' O ' ' A' ' 743' ' ' LYS . 26.8 t-20 63.05 39.86 9.69 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.368 -0.832 . . . . 0.0 110.65 179.921 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 745' ' ' TRP . . . . . 0.449 ' O ' ' O ' ' A' ' 746' ' ' GLN . 22.0 p90 -88.73 -18.89 26.87 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.163 -0.96 . . . . 0.0 109.862 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 746' ' ' GLN . . . . . 0.449 ' O ' ' O ' ' A' ' 745' ' ' TRP . 0.0 OUTLIER 60.0 139.48 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.341 -0.849 . . . . 0.0 110.631 179.916 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 747' ' ' ILE . . . . . 0.455 ' O ' HG13 ' A' ' 747' ' ' ILE . 9.9 tp -101.95 22.03 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.306 -0.871 . . . . 0.0 109.884 179.948 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 748' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -116.22 -41.54 3.13 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.491 -0.755 . . . . 0.0 109.787 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 749' ' ' SER . . . . . 0.432 ' O ' ' OG ' ' A' ' 749' ' ' SER . 0.1 OUTLIER -125.68 92.59 3.64 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.438 -0.789 . . . . 0.0 109.853 179.954 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 750' ' ' TYR . . . . . 0.407 ' C ' ' O ' ' A' ' 749' ' ' SER . 55.6 m-85 -41.16 101.62 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.352 -0.842 . . . . 0.0 110.269 -179.991 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 751' ' ' GLY . . . . . . . . . . . . . . . -131.11 -174.72 13.75 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.48 -1.448 . . . . 0.0 109.48 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 752' ' ' GLU . . . . . 0.462 ' OE2' ' HD2' ' A' ' 753' ' ' PRO . 1.1 mt-10 54.62 176.08 0.03 OUTLIER Pre-proline 0 N--CA 1.493 1.675 0 O-C-N 121.169 -1.195 . . . . 0.0 109.966 -179.942 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 753' ' ' PRO . . . . . 0.462 ' HD2' ' OE2' ' A' ' 752' ' ' GLU . 45.1 Cg_endo -70.95 103.72 1.4 Allowed 'Trans proline' 0 C--N 1.306 -1.668 0 O-C-N 123.942 1.496 . . . . 0.0 110.516 179.936 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 754' ' ' GLU . . . . . . . . . . . . . 2.5 tm-20 -151.13 82.27 1.32 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.289 -0.882 . . . . 0.0 110.139 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 755' ' ' PHE . . . . . 0.52 ' CD2' ' O ' ' A' ' 757' ' ' THR . 9.2 p90 -117.46 25.4 10.46 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.233 -0.917 . . . . 0.0 110.034 179.972 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 756' ' ' HIS . . . . . 0.482 ' HB2' ' O ' ' A' ' 755' ' ' PHE . 11.1 m170 59.8 105.58 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.407 -0.808 . . . . 0.0 110.987 179.923 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 757' ' ' THR . . . . . 0.575 HG22 ' CB ' ' A' ' 738' ' ' TYR . 0.0 OUTLIER 45.29 -176.49 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.044 0 O-C-N 121.495 -0.753 . . . . 0.0 111.258 179.938 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 758' ' ' ALA . . . . . . . . . . . . . . . -91.45 174.99 7.08 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.437 -0.789 . . . . 0.0 110.333 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 759' ' ' LYS . . . . . . . . . . . . . 10.2 mttt -147.86 145.75 28.82 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.242 -0.912 . . . . 0.0 110.525 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 760' ' ' VAL . . . . . 0.43 ' CG2' HD11 ' A' ' 816' ' ' ILE . 97.9 t -136.97 131.13 46.2 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 O-C-N 121.471 -0.768 . . . . 0.0 109.493 179.932 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 761' ' ' HIS . . . . . 0.665 ' HB2' HG22 ' A' ' 813' ' ' VAL . 25.4 p-80 -142.69 135.18 27.77 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 120.936 -1.103 . . . . 0.0 111.002 -179.974 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 762' ' ' LEU . . . . . . . . . . . . . 3.3 mp -115.17 148.06 39.52 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.437 -0.789 . . . . 0.0 109.494 179.953 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 763' ' ' LYS . . . . . 0.426 ' O ' ' CG ' ' A' ' 763' ' ' LYS . 0.0 OUTLIER -133.61 105.04 6.64 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.04 -1.038 . . . . 0.0 110.616 -179.896 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 764' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -84.09 176.59 8.71 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.18 -0.95 . . . . 0.0 110.013 179.943 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 765' ' ' ALA . . . . . . . . . . . . . . . -69.6 160.55 79.14 Favored Pre-proline 0 N--CA 1.492 1.625 0 O-C-N 121.243 -0.91 . . . . 0.0 109.975 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 766' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -71.35 132.01 20.04 Favored 'Trans proline' 0 C--N 1.303 -1.847 0 O-C-N 124.053 1.554 . . . . 0.0 110.525 -179.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 767' ' ' GLY . . . . . . . . . . . . . . . 108.57 -44.95 1.39 Allowed Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 179.953 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 768' ' ' GLN . . . . . 0.414 ' HB3' ' HB3' ' A' ' 839' ' ' CYS . 2.4 mp0 -85.62 119.35 25.86 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.182 -1.187 . . . . 0.0 110.053 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 769' ' ' THR . . . . . . . . . . . . . 68.4 p -102.59 146.79 27.64 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.265 -0.897 . . . . 0.0 110.463 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 770' ' ' ILE . . . . . . . . . . . . . 48.3 mt -70.23 123.82 24.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.335 -0.853 . . . . 0.0 109.728 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 771' ' ' SER . . . . . . . . . . . . . 6.7 t -119.61 -12.83 9.23 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.148 -0.97 . . . . 0.0 110.696 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 772' ' ' ALA . . . . . 0.408 ' O ' ' HB ' ' A' ' 838' ' ' VAL . . . -148.78 130.35 14.91 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.022 -1.049 . . . . 0.0 110.735 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 773' ' ' ILE . . . . . 0.531 HG13 ' HG2' ' A' ' 803' ' ' GLU . 46.8 mm -84.33 129.87 36.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.241 -0.912 . . . . 0.0 109.715 179.949 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 774' ' ' LYS . . . . . 0.509 ' HB3' ' HB3' ' A' ' 836' ' ' GLU . 1.8 tppp? -80.12 -37.69 33.09 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.121 -0.987 . . . . 0.0 110.365 -179.924 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 775' ' ' PHE . . . . . 0.704 ' O ' ' HB2' ' A' ' 776' ' ' ALA . 88.3 t80 -159.74 171.17 20.01 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.049 -1.032 . . . . 0.0 110.73 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 776' ' ' ALA . . . . . 0.704 ' HB2' ' O ' ' A' ' 775' ' ' PHE . . . 166.92 90.79 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.423 -0.798 . . . . 0.0 109.801 -179.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 777' ' ' SER . . . . . 0.451 ' HB3' ' CZ ' ' A' ' 775' ' ' PHE . 12.6 t -128.68 132.26 48.04 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.307 -0.871 . . . . 0.0 110.419 -179.928 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 778' ' ' PHE . . . . . 0.566 ' O ' ' CD1' ' A' ' 778' ' ' PHE . 72.0 t80 -100.33 82.73 2.54 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.232 -0.918 . . . . 0.0 110.383 179.943 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 779' ' ' GLY . . . . . . . . . . . . . . . 174.31 -108.91 0.28 Allowed Glycine 0 N--CA 1.491 2.348 0 C-N-CA 119.687 -1.244 . . . . 0.0 110.039 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 780' ' ' THR . . . . . . . . . . . . . 29.5 p -113.26 99.46 49.17 Favored Pre-proline 0 N--CA 1.494 1.736 0 O-C-N 121.255 -1.144 . . . . 0.0 110.431 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 781' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -79.89 125.26 5.94 Favored 'Trans proline' 0 C--N 1.305 -1.734 0 O-C-N 123.915 1.482 . . . . 0.0 110.432 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 782' ' ' LEU . . . . . 0.457 ' HB2' ' CD ' ' A' ' 789' ' ' GLN . 61.9 mt -101.9 118.77 37.61 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.278 -0.888 . . . . 0.0 109.85 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 783' ' ' GLY . . . . . . . . . . . . . . . 114.19 -179.49 18.65 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.315 -1.514 . . . . 0.0 109.315 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 784' ' ' THR . . . . . . . . . . . . . 40.9 p -112.65 -162.39 0.8 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.176 -1.191 . . . . 0.0 110.363 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 785' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -71.93 115.72 11.47 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.263 -0.898 . . . . 0.0 110.258 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 786' ' ' GLY . . . . . . . . . . . . . . . 124.24 -30.33 4.8 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.496 -1.442 . . . . 0.0 109.496 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 787' ' ' THR . . . . . . . . . . . . . 1.2 p -131.92 27.4 4.58 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.342 -1.093 . . . . 0.0 110.094 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 788' ' ' PHE . . . . . 0.583 ' HB3' ' CG ' ' A' ' 775' ' ' PHE . 3.4 m-85 -51.23 164.39 0.18 Allowed 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.38 -0.825 . . . . 0.0 109.986 -179.97 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 789' ' ' GLN . . . . . 0.457 ' CD ' ' HB2' ' A' ' 782' ' ' LEU . 0.0 OUTLIER -175.43 127.84 0.26 Allowed 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.121 -0.987 . . . . 0.0 110.341 179.979 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 790' ' ' GLN . . . . . . . . . . . . . 1.8 pt20 -62.95 134.78 56.73 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.258 -0.901 . . . . 0.0 110.195 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 791' ' ' GLY . . . . . . . . . . . . . . . -95.28 -105.89 2.07 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.213 -1.555 . . . . 0.0 109.213 179.953 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 792' ' ' GLU . . . . . . . . . . . . . 29.5 tt0 -119.11 -24.99 6.3 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.258 -1.142 . . . . 0.0 109.744 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 793' ' ' CYS . . . . . 0.482 ' SG ' ' HG2' ' A' ' 825' ' ' PRO . 8.3 t -84.44 95.29 8.74 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.402 -0.811 . . . . 0.0 110.161 179.995 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 794' ' ' HIS . . . . . 0.583 ' CE1' ' OG ' ' A' ' 798' ' ' SER . 16.9 t60 -120.64 140.5 51.49 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.205 -0.934 . . . . 0.0 110.189 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 795' ' ' SER . . . . . 0.544 ' C ' HD12 ' A' ' 796' ' ' ILE . 28.0 t -81.16 9.22 7.16 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.173 -0.954 . . . . 0.0 110.355 -179.982 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 796' ' ' ILE . . . . . 0.544 HD12 ' C ' ' A' ' 795' ' ' SER . 1.4 mp 66.2 7.06 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.537 -0.727 . . . . 0.0 110.699 -179.993 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 797' ' ' ASN . . . . . 0.44 ' O ' HG23 ' A' ' 801' ' ' VAL . 38.8 t-20 -161.05 39.25 0.15 Allowed 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.06 -1.025 . . . . 0.0 110.804 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 798' ' ' SER . . . . . 0.583 ' OG ' ' CE1' ' A' ' 794' ' ' HIS . 0.7 OUTLIER -97.02 2.35 51.33 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.144 -0.973 . . . . 0.0 110.38 -179.967 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 799' ' ' ASN . . . . . . . . . . . . . 7.1 m120 -117.17 -22.77 8.19 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.083 -1.011 . . . . 0.0 110.707 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 800' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -89.86 -31.41 17.34 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.131 -0.981 . . . . 0.0 110.536 -179.937 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 801' ' ' VAL . . . . . 0.44 HG23 ' O ' ' A' ' 797' ' ' ASN . 97.7 t -61.85 -27.97 43.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.199 -0.938 . . . . 0.0 110.755 179.965 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 802' ' ' LEU . . . . . 0.456 HD22 ' N ' ' A' ' 802' ' ' LEU . 4.5 mm? -80.1 -56.56 4.14 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.164 -0.96 . . . . 0.0 110.686 -179.927 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 803' ' ' GLU . . . . . 0.592 ' HA ' ' CG1' ' A' ' 807' ' ' ILE . 3.7 mm-40 -55.51 -21.74 18.06 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.247 -0.908 . . . . 0.0 111.011 -179.962 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 804' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -93.0 -18.92 22.11 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.014 -1.054 . . . . 0.0 111.724 -179.827 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 805' ' ' LYS . . . . . 0.454 ' O ' ' SG ' ' A' ' 806' ' ' CYS . 0.0 OUTLIER -128.66 23.24 5.84 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 120.641 -1.287 . . . . 0.0 111.894 -179.939 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 806' ' ' CYS . . . . . 0.454 ' SG ' ' O ' ' A' ' 805' ' ' LYS . 1.6 m -160.93 32.17 0.15 Allowed 'General case' 0 N--CA 1.499 1.992 0 O-C-N 120.763 -1.211 . . . . 0.0 110.791 179.91 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 807' ' ' ILE . . . . . 0.592 ' CG1' ' HA ' ' A' ' 803' ' ' GLU . 14.4 mm -124.91 108.12 19.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.137 -0.977 . . . . 0.0 110.267 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 808' ' ' GLY . . . . . 0.433 ' C ' ' HG ' ' A' ' 809' ' ' LEU . . . 114.56 9.66 14.25 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.524 -1.431 . . . . 0.0 109.524 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 809' ' ' LEU . . . . . 0.433 ' HG ' ' C ' ' A' ' 808' ' ' GLY . 5.1 mt -131.56 134.47 46.1 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.319 -1.107 . . . . 0.0 110.137 179.943 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 810' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -65.42 -11.79 46.11 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.168 -0.957 . . . . 0.0 109.289 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 811' ' ' ARG . . . . . . . . . . . . . 2.3 ttt180 -158.28 129.65 6.56 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.515 -0.741 . . . . 0.0 109.661 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 812' ' ' CYS . . . . . . . . . . . . . 27.6 p -141.85 152.56 43.75 Favored 'General case' 0 C--N 1.294 -1.809 0 O-C-N 121.435 -0.79 . . . . 0.0 110.361 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 813' ' ' VAL . . . . . 0.665 HG22 ' HB2' ' A' ' 761' ' ' HIS . 94.6 t -123.27 156.99 29.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.309 -0.869 . . . . 0.0 110.192 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 814' ' ' VAL . . . . . 0.421 HG23 ' C ' ' A' ' 813' ' ' VAL . 30.4 t -144.55 141.95 23.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.263 -0.898 . . . . 0.0 110.255 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 815' ' ' ALA . . . . . . . . . . . . . . . -102.29 128.7 48.72 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.307 -0.87 . . . . 0.0 109.957 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 816' ' ' ILE . . . . . 1.018 HD13 HG21 ' A' ' 833' ' ' VAL . 66.8 mt -83.38 132.83 30.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.153 -0.967 . . . . 0.0 110.25 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 817' ' ' SER . . . . . . . . . . . . . 20.3 p -163.17 164.96 15.26 Favored Pre-proline 0 N--CA 1.492 1.66 0 O-C-N 121.26 -0.9 . . . . 0.0 110.054 179.936 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 818' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -80.8 18.31 1.29 Allowed 'Trans proline' 0 C--N 1.307 -1.623 0 O-C-N 123.979 1.515 . . . . 0.0 111.123 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 819' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -127.18 -30.95 2.62 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 120.929 -1.107 . . . . 0.0 110.261 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 820' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 -63.5 -43.72 96.4 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.285 -0.885 . . . . 0.0 110.377 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 821' ' ' PHE . . . . . 0.494 ' HB3' ' OG ' ' A' ' 795' ' ' SER . 91.1 m-85 -88.85 -78.81 0.33 Allowed 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.236 -0.915 . . . . 0.0 110.295 179.961 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 822' ' ' GLY . . . . . . . . . . . . . . . 176.66 38.05 0.05 OUTLIER Glycine 0 N--CA 1.492 2.383 0 N-CA-C 109.827 -1.309 . . . . 0.0 109.827 -179.908 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 823' ' ' GLY . . . . . . . . . . . . . . . 90.14 -160.49 28.39 Favored Glycine 0 N--CA 1.492 2.401 0 N-CA-C 109.885 -1.286 . . . . 0.0 109.885 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 824' ' ' ASP . . . . . 0.457 ' OD1' ' O ' ' A' ' 824' ' ' ASP . 7.4 p30 -108.73 139.41 20.84 Favored Pre-proline 0 N--CA 1.497 1.899 0 O-C-N 121.301 -1.117 . . . . 0.0 110.359 -179.967 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 825' ' ' PRO . . . . . 0.482 ' HG2' ' SG ' ' A' ' 793' ' ' CYS . 49.3 Cg_endo -81.53 -54.63 0.04 OUTLIER 'Trans proline' 0 C--N 1.306 -1.67 0 O-C-N 124.044 1.549 . . . . 0.0 110.865 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 826' ' ' CYS . . . . . . . . . . . . . 1.8 m -123.67 110.45 29.95 Favored Pre-proline 0 N--CA 1.503 2.217 0 O-C-N 121.141 -0.974 . . . . 0.0 110.298 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 827' ' ' PRO . . . . . 0.458 ' O ' ' HB3' ' A' ' 828' ' ' GLU . 49.7 Cg_endo -86.86 163.0 9.03 Favored 'Trans proline' 0 C--N 1.304 -1.766 0 O-C-N 123.995 1.524 . . . . 0.0 110.46 179.953 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 828' ' ' GLU . . . . . 0.458 ' HB3' ' O ' ' A' ' 827' ' ' PRO . 1.5 tt0 65.9 8.73 5.55 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.225 -0.922 . . . . 0.0 110.776 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 829' ' ' VAL . . . . . . . . . . . . . 93.1 t -121.76 133.76 67.18 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 O-C-N 121.08 -1.012 . . . . 0.0 110.403 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 830' ' ' MET . . . . . 0.44 ' HA ' ' CE ' ' A' ' 830' ' ' MET . 0.5 OUTLIER -48.05 130.66 15.65 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.204 -0.935 . . . . 0.0 110.057 179.998 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 831' ' ' LYS . . . . . 0.435 ' HE2' ' HG2' ' A' ' 737' ' ' GLU . 7.8 ptmt -132.49 171.83 13.27 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.226 -0.922 . . . . 0.0 110.254 -179.934 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 832' ' ' ARG . . . . . 0.433 ' HD2' ' HA ' ' A' ' 736' ' ' SER . 0.0 OUTLIER -168.3 165.53 12.88 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.399 -0.813 . . . . 0.0 109.966 -179.985 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 833' ' ' VAL . . . . . 1.018 HG21 HD13 ' A' ' 816' ' ' ILE . 87.3 t -109.8 106.58 21.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.215 -0.928 . . . . 0.0 110.474 -179.932 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 834' ' ' ALA . . . . . . . . . . . . . . . -109.5 129.05 55.58 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.342 -0.849 . . . . 0.0 109.705 179.932 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 835' ' ' VAL . . . . . . . . . . . . . 29.8 t -142.25 152.89 18.2 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 121.138 -0.976 . . . . 0.0 110.779 -179.932 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 836' ' ' GLU . . . . . 0.509 ' HB3' ' HB3' ' A' ' 774' ' ' LYS . 1.7 tt0 -149.21 140.8 23.43 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.54 -0.725 . . . . 0.0 109.153 179.885 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 837' ' ' ALA . . . . . . . . . . . . . . . -119.6 166.36 13.25 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.051 -1.031 . . . . 0.0 111.38 -179.813 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 838' ' ' VAL . . . . . 0.408 ' HB ' ' O ' ' A' ' 772' ' ' ALA . 60.2 t -127.54 124.32 63.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.66 -0.65 . . . . 0.0 109.78 179.952 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 839' ' ' CYS . . . . . 0.414 ' HB3' ' HB3' ' A' ' 768' ' ' GLN . 53.3 m -109.12 131.54 54.97 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.11 -0.994 . . . . 0.0 110.518 -179.925 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 840' ' ' SER . . . . . 0.411 ' O ' ' C ' ' A' ' 841' ' ' THR . 60.7 p -158.14 75.51 0.75 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.344 -0.847 . . . . 0.0 109.996 -179.988 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 841' ' ' THR . . . . . 0.473 HG23 HG23 ' A' ' 727' ' ' THR . 79.9 p 42.39 -160.71 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.271 -0.893 . . . . 0.0 110.167 -179.993 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 842' ' ' ALA . . . . . . . . . . . . . . . -81.03 149.59 29.21 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.279 -0.888 . . . . 0.0 110.379 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 843' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.674 0 CA-C-O 117.981 -1.009 . . . . 0.0 110.232 179.986 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 726' ' ' ARG . . . . . . . . . . . . . 42.3 mtm-85 . . . . . 0 N--CA 1.493 1.677 0 CA-C-O 121.186 0.517 . . . . 0.0 110.159 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 727' ' ' THR . . . . . . . . . . . . . 37.7 m 52.9 84.86 0.05 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.288 -0.882 . . . . 0.0 110.321 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 728' ' ' VAL . . . . . 0.405 HG13 ' O ' ' A' ' 728' ' ' VAL . 6.2 p -161.03 132.15 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 121.173 -0.955 . . . . 0.0 110.555 -179.928 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 729' ' ' SER . . . . . . . . . . . . . 67.3 m -126.6 -167.89 1.79 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.261 -0.899 . . . . 0.0 109.928 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 730' ' ' GLY . . . . . . . . . . . . . . . -139.9 134.66 6.7 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.672 -1.371 . . . . 0.0 109.672 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 731' ' ' VAL . . . . . 0.573 HG22 ' O ' ' A' ' 837' ' ' ALA . 15.4 m -121.77 133.33 68.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.376 -1.073 . . . . 0.0 110.002 179.955 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 732' ' ' CYS . . . . . 0.486 ' CB ' ' CD ' ' A' ' 836' ' ' GLU . 23.3 p -123.95 153.6 40.98 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.215 -0.928 . . . . 0.0 110.376 179.987 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 733' ' ' ALA . . . . . . . . . . . . . . . -143.15 120.17 11.38 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.314 -0.866 . . . . 0.0 109.827 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 734' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -110.86 121.18 44.7 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.159 -0.963 . . . . 0.0 110.5 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 735' ' ' VAL . . . . . . . . . . . . . 21.9 t -143.66 141.9 25.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.372 -0.83 . . . . 0.0 110.001 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 736' ' ' SER . . . . . . . . . . . . . 10.9 p -95.99 159.01 15.19 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.257 -0.902 . . . . 0.0 110.377 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 737' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -67.42 146.95 53.51 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.315 -0.866 . . . . 0.0 110.28 179.955 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 738' ' ' TYR . . . . . 0.503 ' HB2' ' HB2' ' A' ' 758' ' ' ALA . 2.2 t80 -94.03 121.07 35.14 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.135 -0.978 . . . . 0.0 110.362 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 739' ' ' HIS . . . . . 0.453 ' HB2' ' O ' ' A' ' 738' ' ' TYR . 46.1 t-80 -178.3 88.71 0.23 Allowed Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 121.381 -0.825 . . . . 0.0 109.981 179.962 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 740' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -69.46 -91.75 0.0 OUTLIER 'Trans proline' 0 C--N 1.301 -1.922 0 O-C-N 123.991 1.522 . . . . 0.0 110.352 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 741' ' ' ASN . . . . . . . . . . . . . 8.3 t30 -164.5 109.65 0.97 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.307 -0.871 . . . . 0.0 109.801 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 742' ' ' ILE . . . . . . . . . . . . . 52.9 mt -132.31 154.38 39.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.167 -0.958 . . . . 0.0 110.589 -179.918 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 743' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -153.69 -39.17 0.1 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.413 -0.804 . . . . 0.0 109.791 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 744' ' ' ASN . . . . . . . . . . . . . 63.9 t30 -68.57 89.32 0.36 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.336 -0.852 . . . . 0.0 109.828 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 745' ' ' TRP . . . . . . . . . . . . . 16.6 t90 -165.82 -33.04 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.249 -0.907 . . . . 0.0 110.49 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 746' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -84.6 50.89 1.99 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.172 -0.955 . . . . 0.0 110.353 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 747' ' ' ILE . . . . . 0.789 HG22 ' O ' ' A' ' 747' ' ' ILE . 3.4 mp -85.52 48.96 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.229 -0.919 . . . . 0.0 109.886 179.878 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 748' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 56.56 39.73 29.75 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.297 -0.877 . . . . 0.0 109.941 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 749' ' ' SER . . . . . 0.554 ' C ' ' CG ' ' A' ' 750' ' ' TYR . 10.5 p -160.27 -42.74 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.318 -0.864 . . . . 0.0 110.192 179.943 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 750' ' ' TYR . . . . . 0.554 ' CG ' ' C ' ' A' ' 749' ' ' SER . 9.6 p90 33.94 96.0 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.44 0 O-C-N 121.69 -0.631 . . . . 0.0 110.942 -179.976 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 751' ' ' GLY . . . . . 0.477 ' O ' ' HB3' ' A' ' 752' ' ' GLU . . . -134.89 -152.35 6.53 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.846 -1.302 . . . . 0.0 109.846 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 752' ' ' GLU . . . . . 0.477 ' HB3' ' O ' ' A' ' 751' ' ' GLY . 4.4 tp10 64.86 96.16 0.05 OUTLIER Pre-proline 0 N--CA 1.495 1.789 0 O-C-N 121.336 -1.096 . . . . 0.0 110.337 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 753' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -77.37 118.17 4.56 Favored 'Trans proline' 0 C--N 1.305 -1.735 0 O-C-N 124.108 1.583 . . . . 0.0 110.247 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 754' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -164.11 166.85 20.89 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.179 -0.951 . . . . 0.0 110.322 -179.954 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 755' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -101.81 156.26 17.62 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.236 -0.915 . . . . 0.0 110.235 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 756' ' ' HIS . . . . . 0.527 ' ND1' ' O ' ' A' ' 756' ' ' HIS . 18.8 p80 -149.72 51.98 0.93 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.221 -0.925 . . . . 0.0 110.319 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 757' ' ' THR . . . . . 0.434 HG21 ' HB3' ' A' ' 817' ' ' SER . 0.8 OUTLIER -136.96 168.01 20.4 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.086 -1.009 . . . . 0.0 110.553 -179.931 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 758' ' ' ALA . . . . . 0.503 ' HB2' ' HB2' ' A' ' 738' ' ' TYR . . . -90.79 178.43 6.05 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.402 -0.811 . . . . 0.0 109.619 179.947 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 759' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -135.97 159.78 40.65 Favored 'General case' 0 C--N 1.298 -1.673 0 O-C-N 121.064 -1.023 . . . . 0.0 110.858 -179.94 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 760' ' ' VAL . . . . . 0.494 HG12 ' N ' ' A' ' 761' ' ' HIS . 97.5 t -105.87 167.88 3.0 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 179.842 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 761' ' ' HIS . . . . . 0.494 ' N ' HG12 ' A' ' 760' ' ' VAL . 29.3 m80 -137.6 104.76 5.42 Favored 'General case' 0 C--N 1.299 -1.588 0 C-N-CA 118.501 -1.28 . . . . 0.0 112.263 -179.765 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 762' ' ' LEU . . . . . 0.6 HD12 ' HB3' ' A' ' 812' ' ' CYS . 32.1 mt -116.24 126.25 53.35 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 179.787 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 763' ' ' LYS . . . . . . . . . . . . . 6.7 tttt -134.59 137.51 43.79 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.67 -1.269 . . . . 0.0 112.147 -179.75 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 764' ' ' CYS . . . . . 0.495 ' HB3' ' O ' ' A' ' 810' ' ' GLU . 22.4 t -136.39 143.63 44.1 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.561 -0.712 . . . . 0.0 109.554 179.824 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 765' ' ' ALA . . . . . . . . . . . . . . . -49.79 155.41 1.48 Allowed Pre-proline 0 N--CA 1.492 1.667 0 O-C-N 121.048 -1.033 . . . . 0.0 110.104 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 766' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -71.74 91.68 0.7 Allowed 'Trans proline' 0 C--N 1.306 -1.684 0 O-C-N 123.974 1.512 . . . . 0.0 110.303 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 767' ' ' GLY . . . . . . . . . . . . . . . 152.8 -27.01 0.83 Allowed Glycine 0 N--CA 1.489 2.196 0 N-CA-C 108.81 -1.716 . . . . 0.0 108.81 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 768' ' ' GLN . . . . . 0.492 ' HB2' ' SG ' ' A' ' 764' ' ' CYS . 30.0 mt-30 -104.51 128.09 52.38 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.513 -0.992 . . . . 0.0 109.682 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 769' ' ' THR . . . . . 0.409 ' OG1' ' HB2' ' A' ' 842' ' ' ALA . 9.6 p -113.8 152.78 30.15 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.178 -0.951 . . . . 0.0 110.556 -179.936 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 770' ' ' ILE . . . . . 0.872 HD12 ' O ' ' A' ' 809' ' ' LEU . 2.8 mp -64.6 119.58 9.28 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.341 -0.849 . . . . 0.0 109.765 179.959 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 771' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -111.53 -1.74 15.72 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.277 -0.889 . . . . 0.0 110.493 -179.926 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 772' ' ' ALA . . . . . 0.495 ' O ' ' HB ' ' A' ' 838' ' ' VAL . . . -168.0 131.9 1.67 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.148 -0.97 . . . . 0.0 111.039 -179.936 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 773' ' ' ILE . . . . . 0.464 HG13 ' HG3' ' A' ' 803' ' ' GLU . 16.6 mm -91.16 125.64 43.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.244 -0.91 . . . . 0.0 109.163 179.871 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 774' ' ' LYS . . . . . 0.497 ' HB3' ' HB3' ' A' ' 836' ' ' GLU . 6.5 ttmt -79.77 -37.85 34.45 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.158 -0.964 . . . . 0.0 111.116 -179.894 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 775' ' ' PHE . . . . . . . . . . . . . 52.5 t80 -152.76 152.99 32.28 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.953 -1.092 . . . . 0.0 110.75 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 776' ' ' ALA . . . . . 0.494 ' O ' ' HB2' ' A' ' 798' ' ' SER . . . -174.13 112.35 0.17 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.552 -0.718 . . . . 0.0 109.624 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 777' ' ' SER . . . . . 0.573 ' HA ' ' CB ' ' A' ' 798' ' ' SER . 6.7 m -162.04 98.34 1.06 Allowed 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.177 -0.952 . . . . 0.0 110.727 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 778' ' ' PHE . . . . . 0.514 ' CD1' ' C ' ' A' ' 778' ' ' PHE . 0.9 OUTLIER -72.75 103.86 3.78 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.293 -0.88 . . . . 0.0 109.969 179.936 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 779' ' ' GLY . . . . . . . . . . . . . . . 174.88 -109.52 0.29 Allowed Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.663 -1.375 . . . . 0.0 109.663 -179.903 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 780' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -124.94 70.0 58.99 Favored Pre-proline 0 N--CA 1.492 1.647 0 O-C-N 121.292 -1.122 . . . . 0.0 110.22 -179.898 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 781' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -74.4 153.21 44.79 Favored 'Trans proline' 0 C--N 1.305 -1.721 0 O-C-N 124.039 1.547 . . . . 0.0 110.542 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 782' ' ' LEU . . . . . 0.487 ' O ' ' N ' ' A' ' 789' ' ' GLN . 1.1 mt -138.76 151.0 46.72 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.288 -0.883 . . . . 0.0 110.126 -179.954 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 783' ' ' GLY . . . . . . . . . . . . . . . 118.25 -170.77 13.8 Favored Glycine 0 N--CA 1.492 2.404 0 N-CA-C 109.643 -1.383 . . . . 0.0 109.643 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 784' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -125.41 -162.71 1.13 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.274 -1.133 . . . . 0.0 110.088 -179.988 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 785' ' ' CYS . . . . . . . . . . . . . 21.2 m -79.77 94.55 5.79 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.184 -0.947 . . . . 0.0 110.476 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 786' ' ' GLY . . . . . . . . . . . . . . . 137.58 -23.29 3.12 Favored Glycine 0 N--CA 1.489 2.198 0 N-CA-C 109.577 -1.409 . . . . 0.0 109.577 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 787' ' ' THR . . . . . 0.46 ' O ' ' O ' ' A' ' 788' ' ' PHE . 20.4 p -142.73 37.9 1.47 Allowed 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.305 -1.114 . . . . 0.0 110.24 -179.952 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 788' ' ' PHE . . . . . 0.46 ' O ' ' O ' ' A' ' 787' ' ' THR . 0.9 OUTLIER -46.56 175.83 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.301 -0.875 . . . . 0.0 110.501 179.963 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 789' ' ' GLN . . . . . 0.487 ' N ' ' O ' ' A' ' 782' ' ' LEU . 0.0 OUTLIER -153.91 148.42 26.19 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.45 -0.781 . . . . 0.0 110.289 -179.976 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 790' ' ' GLN . . . . . 0.532 ' OE1' ' CD2' ' A' ' 794' ' ' HIS . 0.0 OUTLIER -78.94 151.22 31.79 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.151 -0.968 . . . . 0.0 110.132 -179.995 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 791' ' ' GLY . . . . . . . . . . . . . . . -108.83 -153.54 15.94 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.529 -1.428 . . . . 0.0 109.529 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 792' ' ' GLU . . . . . . . . . . . . . 6.0 pm0 -109.83 -19.57 13.09 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.308 -1.113 . . . . 0.0 110.358 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 793' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -98.62 24.8 7.07 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.247 -0.908 . . . . 0.0 110.307 179.903 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 794' ' ' HIS . . . . . 0.532 ' CD2' ' OE1' ' A' ' 790' ' ' GLN . 7.5 t60 -68.98 149.12 49.17 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.176 -0.953 . . . . 0.0 109.899 -179.964 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 795' ' ' SER . . . . . 0.521 ' O ' ' N ' ' A' ' 797' ' ' ASN . 1.7 p -87.9 14.16 9.4 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.191 -0.943 . . . . 0.0 110.499 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 796' ' ' ILE . . . . . 0.508 ' CG1' ' C ' ' A' ' 795' ' ' SER . 3.6 pt 34.56 32.27 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.505 2.31 0 CA-C-O 121.503 0.668 . . . . 0.0 110.247 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 797' ' ' ASN . . . . . 0.521 ' N ' ' O ' ' A' ' 795' ' ' SER . 60.9 t30 -157.68 21.14 0.27 Allowed 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.486 -0.759 . . . . 0.0 109.646 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 798' ' ' SER . . . . . 0.573 ' CB ' ' HA ' ' A' ' 777' ' ' SER . 17.7 m -84.51 -33.57 23.5 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.526 -0.734 . . . . 0.0 110.636 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 799' ' ' ASN . . . . . 0.465 ' O ' ' OE1' ' A' ' 803' ' ' GLU . 11.8 t-20 -74.17 -6.66 49.03 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.282 -0.886 . . . . 0.0 110.729 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 800' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -86.52 -44.03 12.26 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.052 -1.03 . . . . 0.0 110.39 179.961 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 801' ' ' VAL . . . . . . . . . . . . . 69.5 t -72.57 -21.67 20.01 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 121.29 -0.881 . . . . 0.0 110.808 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 802' ' ' LEU . . . . . 0.475 ' O ' ' HB2' ' A' ' 806' ' ' CYS . 1.8 mm? -84.08 -43.89 14.61 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.043 -1.035 . . . . 0.0 110.612 -179.946 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 803' ' ' GLU . . . . . 0.569 ' O ' HD12 ' A' ' 807' ' ' ILE . 40.6 mt-10 -67.45 -24.67 65.65 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.118 -0.989 . . . . 0.0 110.416 -179.988 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 804' ' ' ARG . . . . . . . . . . . . . 13.6 mmt-85 -90.59 -24.71 20.48 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.194 -0.942 . . . . 0.0 110.827 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 805' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.95 46.86 1.85 Allowed 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.014 -1.054 . . . . 0.0 110.701 179.977 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 806' ' ' CYS . . . . . 0.475 ' HB2' ' O ' ' A' ' 802' ' ' LEU . 1.8 t -160.59 -40.27 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.216 -0.927 . . . . 0.0 110.532 179.958 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 807' ' ' ILE . . . . . 0.569 HD12 ' O ' ' A' ' 803' ' ' GLU . 45.2 mt -67.58 123.27 20.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.242 -0.911 . . . . 0.0 110.765 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 808' ' ' GLY . . . . . . . . . . . . . . . 111.1 -8.48 29.16 Favored Glycine 0 N--CA 1.494 2.508 0 N-CA-C 110.024 -1.23 . . . . 0.0 110.024 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 809' ' ' LEU . . . . . 0.872 ' O ' HD12 ' A' ' 770' ' ' ILE . 36.0 mt -120.28 139.33 52.88 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.079 -1.247 . . . . 0.0 110.614 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 810' ' ' GLU . . . . . 0.495 ' O ' ' HB3' ' A' ' 764' ' ' CYS . 5.4 pt-20 -69.03 -33.89 74.34 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.213 -0.929 . . . . 0.0 109.356 179.942 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 811' ' ' ARG . . . . . . . . . . . . . 15.3 ttp180 -112.21 157.33 21.01 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.517 -0.739 . . . . 0.0 109.443 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 812' ' ' CYS . . . . . 0.6 ' HB3' HD12 ' A' ' 762' ' ' LEU . 1.3 t -149.44 108.21 3.85 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.099 -1.001 . . . . 0.0 111.085 -179.928 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 813' ' ' VAL . . . . . 0.576 HG13 ' O ' ' A' ' 813' ' ' VAL . 4.5 p -118.4 122.92 70.71 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 121.333 -0.854 . . . . 0.0 109.268 179.946 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 814' ' ' VAL . . . . . . . . . . . . . 45.1 t -135.89 121.97 30.91 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.987 0 O-C-N 121.117 -0.989 . . . . 0.0 111.001 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 815' ' ' ALA . . . . . . . . . . . . . . . -80.33 130.17 35.0 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.358 -0.839 . . . . 0.0 109.744 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 816' ' ' ILE . . . . . 0.842 HG21 HG21 ' A' ' 833' ' ' VAL . 2.6 mt -80.61 113.65 20.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.122 -0.986 . . . . 0.0 110.564 -179.866 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 817' ' ' SER . . . . . 0.453 ' O ' ' OD1' ' A' ' 820' ' ' ASN . 8.8 p -143.44 162.83 40.27 Favored Pre-proline 0 N--CA 1.494 1.774 0 O-C-N 121.352 -0.842 . . . . 0.0 110.074 -179.946 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 818' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -82.4 21.05 1.02 Allowed 'Trans proline' 0 C--N 1.307 -1.656 0 O-C-N 123.978 1.515 . . . . 0.0 110.931 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 819' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -135.7 9.23 3.35 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.972 -1.08 . . . . 0.0 110.327 179.94 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 820' ' ' ASN . . . . . 0.453 ' OD1' ' O ' ' A' ' 817' ' ' SER . 8.1 p-10 -117.42 -10.16 10.75 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.224 -0.922 . . . . 0.0 110.283 -179.969 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 821' ' ' PHE . . . . . . . . . . . . . 9.2 m-85 -105.14 -22.28 13.11 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.19 -0.944 . . . . 0.0 110.237 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 822' ' ' GLY . . . . . . . . . . . . . . . 104.95 47.77 1.14 Allowed Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.739 -1.344 . . . . 0.0 109.739 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 823' ' ' GLY . . . . . . . . . . . . . . . 116.58 -134.3 11.26 Favored Glycine 0 N--CA 1.492 2.41 0 N-CA-C 109.661 -1.376 . . . . 0.0 109.661 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 824' ' ' ASP . . . . . 0.452 ' CG ' ' HD2' ' A' ' 825' ' ' PRO . 0.4 OUTLIER -172.01 157.19 4.07 Favored Pre-proline 0 N--CA 1.494 1.76 0 O-C-N 121.226 -1.161 . . . . 0.0 110.395 -179.963 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 825' ' ' PRO . . . . . 0.452 ' HD2' ' CG ' ' A' ' 824' ' ' ASP . 46.8 Cg_endo -75.2 -88.33 0.0 OUTLIER 'Trans proline' 0 C--N 1.307 -1.63 0 O-C-N 124.066 1.561 . . . . 0.0 110.544 -179.931 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 826' ' ' CYS . . . . . . . . . . . . . 3.3 p -120.66 105.11 41.48 Favored Pre-proline 0 N--CA 1.498 1.933 0 O-C-N 121.201 -0.937 . . . . 0.0 110.193 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 827' ' ' PRO . . . . . 0.523 ' O ' ' CB ' ' A' ' 828' ' ' GLU . 50.3 Cg_endo -78.12 82.48 2.43 Favored 'Trans proline' 0 C--N 1.31 -1.493 0 O-C-N 124.093 1.575 . . . . 0.0 110.73 179.959 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 828' ' ' GLU . . . . . 0.523 ' CB ' ' O ' ' A' ' 827' ' ' PRO . 0.2 OUTLIER 165.12 -23.03 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.392 -0.818 . . . . 0.0 109.987 -179.984 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 829' ' ' VAL . . . . . 0.463 ' O ' ' HG3' ' A' ' 831' ' ' LYS . 42.4 t -100.0 167.06 2.07 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.505 0 O-C-N 121.266 -0.896 . . . . 0.0 110.351 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 830' ' ' MET . . . . . 0.45 ' N ' HG12 ' A' ' 829' ' ' VAL . 31.4 mtm -42.29 146.97 0.28 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.352 -0.842 . . . . 0.0 110.293 179.957 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 831' ' ' LYS . . . . . 0.463 ' HG3' ' O ' ' A' ' 829' ' ' VAL . 15.6 mtmm -127.61 83.0 2.12 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.262 -0.899 . . . . 0.0 110.054 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 832' ' ' ARG . . . . . . . . . . . . . 37.1 mtt180 -111.07 150.69 29.0 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.323 -0.861 . . . . 0.0 110.046 -179.895 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 833' ' ' VAL . . . . . 0.842 HG21 HG21 ' A' ' 816' ' ' ILE . 98.6 t -116.32 159.62 16.18 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.522 0 O-C-N 121.244 -0.91 . . . . 0.0 110.677 -179.982 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 834' ' ' ALA . . . . . 0.435 ' HB1' ' CZ ' ' A' ' 788' ' ' PHE . . . -160.11 104.2 1.49 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.508 -0.745 . . . . 0.0 109.26 179.965 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 835' ' ' VAL . . . . . . . . . . . . . 39.8 t -115.35 159.66 15.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.112 -0.993 . . . . 0.0 111.114 -179.863 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 836' ' ' GLU . . . . . 0.497 ' HB3' ' HB3' ' A' ' 774' ' ' LYS . 0.0 OUTLIER -144.34 123.96 13.27 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.574 -0.704 . . . . 0.0 109.28 179.917 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 837' ' ' ALA . . . . . 0.573 ' O ' HG22 ' A' ' 731' ' ' VAL . . . -111.66 144.9 40.17 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.15 -0.969 . . . . 0.0 110.704 -179.953 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 838' ' ' VAL . . . . . 0.495 ' HB ' ' O ' ' A' ' 772' ' ' ALA . 76.3 t -111.22 124.99 68.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.398 -0.814 . . . . 0.0 109.534 179.945 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 839' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -108.46 119.56 39.88 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.23 -0.919 . . . . 0.0 110.039 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 840' ' ' SER . . . . . 0.455 ' O ' ' O ' ' A' ' 841' ' ' THR . 0.9 OUTLIER -133.66 69.06 1.48 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.34 -0.85 . . . . 0.0 109.845 179.992 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 841' ' ' THR . . . . . 0.455 ' O ' ' O ' ' A' ' 840' ' ' SER . 30.7 p 47.03 -175.25 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.443 -0.786 . . . . 0.0 110.313 179.921 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 842' ' ' ALA . . . . . 0.668 ' O ' ' HB2' ' A' ' 843' ' ' ALA . . . -149.93 71.13 1.07 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.317 -0.864 . . . . 0.0 109.873 -180.0 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 843' ' ' ALA . . . . . 0.668 ' HB2' ' O ' ' A' ' 842' ' ' ALA . . . . . . . . 0 N--CA 1.491 1.595 0 CA-C-O 118.028 -0.987 . . . . 0.0 110.069 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 726' ' ' ARG . . . . . . . . . . . . . 6.7 mtm180 . . . . . 0 N--CA 1.492 1.666 0 CA-C-O 121.265 0.555 . . . . 0.0 110.08 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 727' ' ' THR . . . . . . . . . . . . . 87.6 m -92.96 108.7 20.2 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.473 -0.767 . . . . 0.0 110.489 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 728' ' ' VAL . . . . . 0.687 ' O ' HG12 ' A' ' 728' ' ' VAL . 72.8 t -140.61 61.83 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 O-C-N 121.197 -0.939 . . . . 0.0 109.999 179.949 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 729' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -77.12 -147.95 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.373 -0.83 . . . . 0.0 110.185 -179.971 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 730' ' ' GLY . . . . . . . . . . . . . . . -149.96 150.02 22.01 Favored Glycine 0 N--CA 1.488 2.108 0 N-CA-C 109.697 -1.361 . . . . 0.0 109.697 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 731' ' ' VAL . . . . . . . . . . . . . 86.4 t -111.12 157.28 12.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.334 -1.098 . . . . 0.0 109.836 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 732' ' ' CYS . . . . . . . . . . . . . 10.9 t -117.75 146.34 43.85 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.176 -0.953 . . . . 0.0 110.341 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 733' ' ' ALA . . . . . 0.651 ' HB2' HD21 ' A' ' 762' ' ' LEU . . . -142.13 116.25 9.42 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.268 -0.895 . . . . 0.0 110.356 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 734' ' ' ASP . . . . . 0.458 ' C ' HG23 ' A' ' 735' ' ' VAL . 0.8 OUTLIER -114.12 139.09 49.61 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.177 -0.952 . . . . 0.0 110.001 179.937 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 735' ' ' VAL . . . . . 0.458 HG23 ' C ' ' A' ' 734' ' ' ASP . 44.9 t -147.89 124.05 2.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.214 -0.929 . . . . 0.0 110.039 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 736' ' ' SER . . . . . 0.42 ' O ' ' C ' ' A' ' 737' ' ' GLU . 0.7 OUTLIER -90.87 134.89 34.1 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.23 -0.919 . . . . 0.0 110.199 179.951 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 737' ' ' GLU . . . . . 0.42 ' C ' ' O ' ' A' ' 736' ' ' SER . 29.5 tp10 -41.74 115.8 0.7 Allowed 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.275 -0.891 . . . . 0.0 110.004 179.96 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 738' ' ' TYR . . . . . 0.477 ' O ' ' CG ' ' A' ' 738' ' ' TYR . 2.7 t80 -114.36 95.87 5.49 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.225 -0.922 . . . . 0.0 110.409 -179.947 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 739' ' ' HIS . . . . . 0.545 ' CD2' ' HD2' ' A' ' 740' ' ' PRO . 30.4 t-80 -103.0 131.89 21.69 Favored Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.343 -0.848 . . . . 0.0 109.733 179.907 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 740' ' ' PRO . . . . . 0.672 ' O ' HD13 ' A' ' 742' ' ' ILE . 42.0 Cg_endo -67.63 87.55 0.35 Allowed 'Trans proline' 0 C--N 1.302 -1.885 0 O-C-N 123.853 1.449 . . . . 0.0 110.149 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 741' ' ' ASN . . . . . 0.433 ' C ' ' O ' ' A' ' 740' ' ' PRO . 46.5 m-20 -40.84 128.13 2.62 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.376 -0.828 . . . . 0.0 110.34 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 742' ' ' ILE . . . . . 0.672 HD13 ' O ' ' A' ' 740' ' ' PRO . 6.6 mm -85.82 -9.16 11.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.298 -0.876 . . . . 0.0 109.999 179.962 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 743' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -68.94 -21.8 64.17 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.338 -0.851 . . . . 0.0 109.969 -179.981 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 744' ' ' ASN . . . . . 0.478 ' N ' ' OD1' ' A' ' 744' ' ' ASN . 20.1 p-10 -162.87 70.67 0.27 Allowed 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.368 -0.832 . . . . 0.0 110.061 179.953 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 745' ' ' TRP . . . . . 0.479 ' CD1' ' N ' ' A' ' 745' ' ' TRP . 0.3 OUTLIER -82.21 31.44 0.39 Allowed 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.382 -0.824 . . . . 0.0 111.527 179.997 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 746' ' ' GLN . . . . . 0.51 ' O ' ' HG3' ' A' ' 746' ' ' GLN . 15.3 pt20 -158.86 89.54 0.95 Allowed 'General case' 0 N--CA 1.497 1.877 0 O-C-N 120.963 -1.085 . . . . 0.0 110.163 179.87 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 747' ' ' ILE . . . . . 0.634 ' H ' HD12 ' A' ' 747' ' ' ILE . 0.1 OUTLIER -104.26 -151.66 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 2.025 0 O-C-N 120.989 -1.069 . . . . 0.0 110.046 -179.983 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 748' ' ' GLU . . . . . 0.497 ' HG2' ' N ' ' A' ' 749' ' ' SER . 0.6 OUTLIER -63.02 -18.77 63.69 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.309 -0.869 . . . . 0.0 110.093 179.972 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 749' ' ' SER . . . . . 0.497 ' N ' ' HG2' ' A' ' 748' ' ' GLU . 16.4 m -99.05 124.88 44.36 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.384 -0.822 . . . . 0.0 110.281 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 750' ' ' TYR . . . . . . . . . . . . . 28.7 m-85 -69.39 172.97 6.33 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.22 -0.925 . . . . 0.0 110.387 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 751' ' ' GLY . . . . . . . . . . . . . . . 123.74 158.75 10.24 Favored Glycine 0 N--CA 1.492 2.389 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 752' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -141.76 127.6 10.93 Favored Pre-proline 0 N--CA 1.493 1.689 0 O-C-N 121.163 -1.198 . . . . 0.0 110.368 -179.967 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 753' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -71.08 101.24 1.07 Allowed 'Trans proline' 0 C--N 1.309 -1.531 0 O-C-N 123.819 1.431 . . . . 0.0 110.324 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 754' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -83.73 -37.4 22.73 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.285 -0.884 . . . . 0.0 110.364 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 755' ' ' PHE . . . . . 0.483 ' C ' ' CG ' ' A' ' 756' ' ' HIS . 0.2 OUTLIER -73.7 -157.24 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.177 -0.952 . . . . 0.0 110.187 -179.973 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 756' ' ' HIS . . . . . 0.757 ' O ' HG23 ' A' ' 757' ' ' THR . 2.2 m-70 -150.54 16.54 0.8 Allowed 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.241 -0.912 . . . . 0.0 110.108 -179.944 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 757' ' ' THR . . . . . 0.757 HG23 ' O ' ' A' ' 756' ' ' HIS . 1.8 p -161.2 -177.71 6.23 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.003 -1.061 . . . . 0.0 110.934 -179.952 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 758' ' ' ALA . . . . . . . . . . . . . . . -101.03 173.73 6.34 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.479 -0.763 . . . . 0.0 110.169 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 759' ' ' LYS . . . . . . . . . . . . . 36.2 mtpt -137.94 165.27 26.95 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.203 -0.935 . . . . 0.0 110.63 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 760' ' ' VAL . . . . . . . . . . . . . 38.4 t -109.7 139.64 31.94 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.442 -0.786 . . . . 0.0 109.642 179.938 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 761' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -109.97 104.2 13.07 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.068 -1.02 . . . . 0.0 110.886 -179.981 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 762' ' ' LEU . . . . . 0.651 HD21 ' HB2' ' A' ' 733' ' ' ALA . 21.2 mt -121.46 124.32 44.18 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.298 -0.876 . . . . 0.0 109.414 179.879 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 763' ' ' LYS . . . . . 0.563 ' HB3' ' CD ' ' A' ' 811' ' ' ARG . 0.0 OUTLIER -156.05 123.17 5.35 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.919 -1.113 . . . . 0.0 111.243 -179.928 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 764' ' ' CYS . . . . . 0.41 ' O ' ' C ' ' A' ' 765' ' ' ALA . 19.1 m -99.04 157.34 16.41 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.342 -0.849 . . . . 0.0 109.263 179.839 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 765' ' ' ALA . . . . . 0.41 ' C ' ' O ' ' A' ' 764' ' ' CYS . . . -42.64 159.56 0.2 Allowed Pre-proline 0 N--CA 1.495 1.818 0 O-C-N 121.076 -1.015 . . . . 0.0 109.982 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 766' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -71.23 97.3 0.75 Allowed 'Trans proline' 0 C--N 1.306 -1.667 0 O-C-N 123.913 1.48 . . . . 0.0 110.524 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 767' ' ' GLY . . . . . . . . . . . . . . . 147.53 -31.69 1.38 Allowed Glycine 0 N--CA 1.489 2.198 0 N-CA-C 109.044 -1.623 . . . . 0.0 109.044 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 768' ' ' GLN . . . . . 0.434 ' HB3' ' HB3' ' A' ' 839' ' ' CYS . 20.1 mt-30 -99.0 101.61 13.05 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.369 -1.077 . . . . 0.0 109.982 179.953 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 769' ' ' THR . . . . . . . . . . . . . 11.2 p -85.28 146.95 26.79 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.112 -0.992 . . . . 0.0 110.128 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 770' ' ' ILE . . . . . . . . . . . . . 35.7 mt -66.7 144.16 14.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.306 -0.871 . . . . 0.0 109.252 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 771' ' ' SER . . . . . . . . . . . . . 47.8 t -135.28 -4.69 2.35 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.873 -1.142 . . . . 0.0 111.432 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 772' ' ' ALA . . . . . . . . . . . . . . . -172.71 151.68 2.37 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 120.781 -1.199 . . . . 0.0 111.418 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 773' ' ' ILE . . . . . . . . . . . . . 20.1 mm -110.75 120.28 61.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 179.888 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 774' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -80.09 -42.89 22.75 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 120.986 -1.071 . . . . 0.0 110.951 -179.835 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 775' ' ' PHE . . . . . 0.499 ' O ' ' HB2' ' A' ' 776' ' ' ALA . 67.2 t80 -134.0 152.25 51.77 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.098 -1.001 . . . . 0.0 110.668 -179.913 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 776' ' ' ALA . . . . . 0.499 ' HB2' ' O ' ' A' ' 775' ' ' PHE . . . 179.1 113.41 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.567 -0.708 . . . . 0.0 109.803 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 777' ' ' SER . . . . . 0.491 ' HA ' ' HB3' ' A' ' 798' ' ' SER . 94.5 p -148.73 126.86 12.07 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.338 -0.851 . . . . 0.0 110.475 -179.958 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 778' ' ' PHE . . . . . 0.583 ' HE1' HG23 ' A' ' 816' ' ' ILE . 12.2 t80 -94.21 116.48 28.88 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.359 -0.838 . . . . 0.0 109.949 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 779' ' ' GLY . . . . . 0.505 ' HA3' ' O ' ' A' ' 793' ' ' CYS . . . 163.97 -136.15 4.11 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.932 -1.267 . . . . 0.0 109.932 -179.958 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 780' ' ' THR . . . . . . . . . . . . . 45.7 p -123.49 64.77 30.22 Favored Pre-proline 0 N--CA 1.494 1.766 0 O-C-N 121.212 -1.17 . . . . 0.0 110.595 -179.93 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 781' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -74.47 170.79 19.45 Favored 'Trans proline' 0 C--N 1.304 -1.792 0 O-C-N 124.044 1.55 . . . . 0.0 110.392 179.927 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 782' ' ' LEU . . . . . . . . . . . . . 3.7 mt -129.86 173.91 10.23 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.198 -0.939 . . . . 0.0 110.261 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 783' ' ' GLY . . . . . . . . . . . . . . . 110.93 -169.54 13.38 Favored Glycine 0 N--CA 1.494 2.561 0 N-CA-C 109.595 -1.402 . . . . 0.0 109.595 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 784' ' ' THR . . . . . 0.52 HG22 ' N ' ' A' ' 785' ' ' CYS . 54.3 m -115.62 -92.92 0.5 Allowed 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.229 -1.159 . . . . 0.0 110.336 -179.96 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 785' ' ' CYS . . . . . 0.52 ' N ' HG22 ' A' ' 784' ' ' THR . 0.3 OUTLIER -139.5 120.05 14.1 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.175 -0.953 . . . . 0.0 110.162 -179.938 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 786' ' ' GLY . . . . . . . . . . . . . . . 95.3 -4.62 67.3 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.658 -1.377 . . . . 0.0 109.658 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 787' ' ' THR . . . . . . . . . . . . . 9.0 t -145.41 34.8 1.07 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.209 -1.171 . . . . 0.0 110.109 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 788' ' ' PHE . . . . . 0.412 ' CZ ' ' O ' ' A' ' 784' ' ' THR . 39.4 m-85 -53.41 176.22 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.342 -0.849 . . . . 0.0 110.385 179.996 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 789' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -139.66 145.28 38.24 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.335 -0.853 . . . . 0.0 110.164 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 790' ' ' GLN . . . . . . . . . . . . . 2.1 mt-30 -64.21 131.05 46.25 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.121 -0.987 . . . . 0.0 109.882 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 791' ' ' GLY . . . . . . . . . . . . . . . -92.49 -163.26 37.58 Favored Glycine 0 N--CA 1.492 2.413 0 N-CA-C 109.698 -1.361 . . . . 0.0 109.698 180.0 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 792' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -98.41 -14.0 20.33 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.337 -1.096 . . . . 0.0 110.226 -179.972 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 793' ' ' CYS . . . . . 0.505 ' O ' ' HA3' ' A' ' 779' ' ' GLY . 0.5 OUTLIER -116.86 68.59 0.74 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.352 -0.842 . . . . 0.0 110.275 179.972 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 794' ' ' HIS . . . . . 0.61 ' CE1' ' OG ' ' A' ' 798' ' ' SER . 81.6 t60 -102.59 145.64 29.34 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.171 -0.956 . . . . 0.0 110.866 -179.919 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 795' ' ' SER . . . . . 0.576 ' O ' ' CD2' ' A' ' 794' ' ' HIS . 8.5 t -91.31 174.48 7.36 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.244 -0.91 . . . . 0.0 109.275 179.874 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 796' ' ' ILE . . . . . . . . . . . . . 1.5 mt -105.52 20.48 4.11 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.912 0 O-C-N 120.859 -1.151 . . . . 0.0 110.256 -179.929 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 797' ' ' ASN . . . . . 0.505 ' N ' ' OD1' ' A' ' 797' ' ' ASN . 1.6 m120 -132.5 36.22 3.58 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.427 -0.796 . . . . 0.0 109.083 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 798' ' ' SER . . . . . 0.61 ' OG ' ' CE1' ' A' ' 794' ' ' HIS . 0.9 OUTLIER -65.6 -56.31 12.89 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.724 -0.61 . . . . 0.0 111.285 -179.92 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 799' ' ' ASN . . . . . . . . . . . . . 4.5 m120 -86.41 14.27 6.95 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.135 -0.978 . . . . 0.0 111.368 -179.782 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 800' ' ' SER . . . . . . . . . . . . . 7.8 t -91.28 -62.64 1.4 Allowed 'General case' 0 C--N 1.299 -1.616 0 O-C-N 120.874 -1.141 . . . . 0.0 110.269 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 801' ' ' VAL . . . . . 1.003 HG11 ' OD1' ' A' ' 820' ' ' ASN . 49.3 t -68.11 -19.55 24.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.274 -0.891 . . . . 0.0 110.534 -179.918 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 802' ' ' LEU . . . . . 0.596 HD23 ' O ' ' A' ' 798' ' ' SER . 4.2 mm? -69.05 -51.99 33.22 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.137 -0.977 . . . . 0.0 110.739 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 803' ' ' GLU . . . . . 0.757 ' HA ' HD13 ' A' ' 807' ' ' ILE . 4.1 tt0 -68.84 -17.76 64.05 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.034 -1.041 . . . . 0.0 110.721 -179.955 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 804' ' ' ARG . . . . . . . . . . . . . 17.9 mtp180 -91.45 -18.53 24.05 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.225 -0.922 . . . . 0.0 111.519 -179.884 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 805' ' ' LYS . . . . . 0.454 ' O ' ' SG ' ' A' ' 806' ' ' CYS . 19.8 mttt -124.49 26.96 7.11 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 120.857 -1.152 . . . . 0.0 111.882 -179.856 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 806' ' ' CYS . . . . . 0.831 ' C ' HD12 ' A' ' 807' ' ' ILE . 1.7 m -160.87 18.69 0.13 Allowed 'General case' 0 N--CA 1.501 2.111 0 O-C-N 120.737 -1.227 . . . . 0.0 111.035 179.942 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 807' ' ' ILE . . . . . 0.831 HD12 ' C ' ' A' ' 806' ' ' CYS . 1.7 mp -123.27 112.51 33.86 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.902 0 O-C-N 121.001 -1.062 . . . . 0.0 110.204 179.972 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 808' ' ' GLY . . . . . . . . . . . . . . . 116.73 -4.24 19.28 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 809' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -125.99 137.81 53.7 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.275 -1.132 . . . . 0.0 110.265 -179.944 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 810' ' ' GLU . . . . . 0.473 ' HG3' ' N ' ' A' ' 811' ' ' ARG . 0.4 OUTLIER -64.87 -17.82 64.62 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.219 -0.925 . . . . 0.0 108.965 179.886 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 811' ' ' ARG . . . . . 0.563 ' CD ' ' HB3' ' A' ' 763' ' ' LYS . 13.5 ttp85 -142.48 132.86 24.94 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.674 -0.641 . . . . 0.0 109.36 179.926 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 812' ' ' CYS . . . . . 0.497 ' CB ' ' HA ' ' A' ' 806' ' ' CYS . 15.4 p -142.02 146.86 36.01 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.171 -0.956 . . . . 0.0 110.764 -179.965 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 813' ' ' VAL . . . . . . . . . . . . . 67.0 t -120.67 135.62 60.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.44 -0.788 . . . . 0.0 110.014 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 814' ' ' VAL . . . . . . . . . . . . . 9.3 t -112.2 109.79 29.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.114 -0.991 . . . . 0.0 110.477 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 815' ' ' ALA . . . . . . . . . . . . . . . -70.77 121.26 17.67 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.259 -0.901 . . . . 0.0 110.097 179.89 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 816' ' ' ILE . . . . . 0.583 HG23 ' HE1' ' A' ' 778' ' ' PHE . 36.1 mt -81.66 104.42 10.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.185 -0.947 . . . . 0.0 110.273 -179.966 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 817' ' ' SER . . . . . 0.466 ' HB2' ' HD2' ' A' ' 818' ' ' PRO . 77.7 p -161.71 164.2 18.33 Favored Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.268 -0.895 . . . . 0.0 110.101 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 818' ' ' PRO . . . . . 0.466 ' HD2' ' HB2' ' A' ' 817' ' ' SER . 43.6 Cg_endo -71.92 -23.65 21.83 Favored 'Trans proline' 0 C--N 1.305 -1.751 0 O-C-N 124.04 1.548 . . . . 0.0 110.13 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 819' ' ' SER . . . . . . . . . . . . . 95.1 p -85.52 42.85 0.98 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.259 -0.901 . . . . 0.0 109.872 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 820' ' ' ASN . . . . . 1.003 ' OD1' HG11 ' A' ' 801' ' ' VAL . 28.6 t-20 -143.32 -46.37 0.29 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.283 -0.885 . . . . 0.0 110.13 -179.94 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 821' ' ' PHE . . . . . . . . . . . . . 80.5 m-85 -89.25 8.36 30.73 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.334 -0.854 . . . . 0.0 110.349 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 822' ' ' GLY . . . . . . . . . . . . . . . 87.09 52.72 3.01 Favored Glycine 0 N--CA 1.492 2.409 0 N-CA-C 109.901 -1.28 . . . . 0.0 109.901 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 823' ' ' GLY . . . . . . . . . . . . . . . 90.85 -174.96 39.75 Favored Glycine 0 N--CA 1.494 2.518 0 N-CA-C 109.779 -1.328 . . . . 0.0 109.779 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 824' ' ' ASP . . . . . . . . . . . . . 11.0 p-10 -125.34 150.56 67.81 Favored Pre-proline 0 N--CA 1.495 1.78 0 O-C-N 121.258 -1.142 . . . . 0.0 110.154 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 825' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -77.18 -62.94 0.03 OUTLIER 'Trans proline' 0 C--N 1.306 -1.703 0 O-C-N 124.042 1.549 . . . . 0.0 110.801 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 826' ' ' CYS . . . . . . . . . . . . . 6.0 p -122.98 117.69 28.41 Favored Pre-proline 0 N--CA 1.5 2.074 0 O-C-N 121.141 -0.975 . . . . 0.0 110.785 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 827' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_endo -88.48 168.34 6.1 Favored 'Trans proline' 0 C--N 1.311 -1.427 0 O-C-N 123.952 1.501 . . . . 0.0 110.739 179.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 828' ' ' GLU . . . . . . . . . . . . . 2.2 tp10 61.37 27.58 17.18 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.393 -0.817 . . . . 0.0 110.737 179.903 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 829' ' ' VAL . . . . . 0.44 ' O ' ' HD3' ' A' ' 831' ' ' LYS . 50.3 t -131.49 115.09 27.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.088 -1.008 . . . . 0.0 110.417 179.92 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 830' ' ' MET . . . . . 0.425 ' C ' ' O ' ' A' ' 829' ' ' VAL . 19.0 ptp -43.1 123.8 2.99 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.26 -0.9 . . . . 0.0 109.382 179.918 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 831' ' ' LYS . . . . . 0.44 ' HD3' ' O ' ' A' ' 829' ' ' VAL . 0.0 OUTLIER -109.23 179.16 4.24 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.105 -0.997 . . . . 0.0 111.545 -179.876 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 832' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -159.59 141.02 12.88 Favored 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 108.053 -1.092 . . . . 0.0 108.053 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 833' ' ' VAL . . . . . 0.484 HG21 HG12 ' A' ' 816' ' ' ILE . 60.6 t -110.48 139.87 32.09 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 120.741 -1.224 . . . . 0.0 112.05 -179.836 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 834' ' ' ALA . . . . . . . . . . . . . . . -139.02 111.96 7.88 Favored 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 179.862 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 835' ' ' VAL . . . . . 0.448 HG12 ' N ' ' A' ' 836' ' ' GLU . 40.8 t -129.28 163.55 34.14 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 120.923 -1.11 . . . . 0.0 111.848 -179.871 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 836' ' ' GLU . . . . . 0.466 ' HB2' ' HB3' ' A' ' 775' ' ' PHE . 0.1 OUTLIER -140.25 147.15 39.57 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 179.849 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 837' ' ' ALA . . . . . . . . . . . . . . . -128.01 165.52 20.15 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 120.856 -1.152 . . . . 0.0 111.349 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 838' ' ' VAL . . . . . . . . . . . . . 75.0 t -130.4 110.62 19.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.512 -0.743 . . . . 0.0 109.287 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 839' ' ' CYS . . . . . 0.434 ' HB3' ' HB3' ' A' ' 768' ' ' GLN . 68.4 m -107.51 133.51 51.89 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.147 -0.97 . . . . 0.0 110.777 -179.89 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 840' ' ' SER . . . . . . . . . . . . . 35.6 p -125.33 -139.64 0.28 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.482 -0.761 . . . . 0.0 109.857 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 841' ' ' THR . . . . . . . . . . . . . 32.6 p -131.94 144.17 50.64 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.117 -0.99 . . . . 0.0 110.177 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 842' ' ' ALA . . . . . 0.416 ' O ' ' OXT' ' A' ' 843' ' ' ALA . . . -115.52 73.67 0.85 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.38 -0.825 . . . . 0.0 110.174 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 843' ' ' ALA . . . . . 0.416 ' OXT' ' O ' ' A' ' 842' ' ' ALA . . . . . . . . 0 N--CA 1.491 1.62 0 CA-C-O 118.029 -0.986 . . . . 0.0 110.205 -179.947 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 726' ' ' ARG . . . . . 0.407 ' O ' ' HG3' ' A' ' 726' ' ' ARG . 11.3 ptp85 . . . . . 0 N--CA 1.492 1.634 0 CA-C-O 121.279 0.561 . . . . 0.0 110.266 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 727' ' ' THR . . . . . . . . . . . . . 3.0 m -110.46 119.87 40.6 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.325 -0.859 . . . . 0.0 110.158 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 728' ' ' VAL . . . . . 0.441 ' O ' ' O ' ' A' ' 839' ' ' CYS . 13.5 p -128.25 155.72 40.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.264 -0.898 . . . . 0.0 110.394 -179.956 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 729' ' ' SER . . . . . 0.408 ' HB2' ' HA ' ' A' ' 838' ' ' VAL . 89.0 p -172.57 -175.73 1.39 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.369 -0.832 . . . . 0.0 109.764 179.903 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 730' ' ' GLY . . . . . . . . . . . . . . . 155.28 65.69 0.01 OUTLIER Glycine 0 N--CA 1.489 2.203 0 C-N-CA 119.56 -1.305 . . . . 0.0 109.843 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 731' ' ' VAL . . . . . 1.007 HG21 ' SG ' ' A' ' 764' ' ' CYS . 6.5 t -122.65 152.02 26.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.325 -1.103 . . . . 0.0 109.983 179.966 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 732' ' ' CYS . . . . . . . . . . . . . 5.8 t -146.72 144.11 29.19 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.094 -1.004 . . . . 0.0 110.439 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 733' ' ' ALA . . . . . . . . . . . . . . . -135.89 107.73 7.08 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.344 -0.847 . . . . 0.0 109.907 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 734' ' ' ASP . . . . . . . . . . . . . 7.9 t0 -118.11 122.64 43.61 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.18 -0.95 . . . . 0.0 110.551 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 735' ' ' VAL . . . . . . . . . . . . . 45.8 t -129.15 162.45 36.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.287 -0.883 . . . . 0.0 109.856 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 736' ' ' SER . . . . . . . . . . . . . 9.7 t -110.36 139.87 45.13 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.108 -0.995 . . . . 0.0 110.441 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 737' ' ' GLU . . . . . 0.437 ' OE2' ' N ' ' A' ' 738' ' ' TYR . 0.0 OUTLIER -70.26 179.01 2.57 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.343 -0.848 . . . . 0.0 110.042 -179.994 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 738' ' ' TYR . . . . . 0.437 ' N ' ' OE2' ' A' ' 737' ' ' GLU . 22.0 t80 -164.55 115.73 1.23 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.203 -0.936 . . . . 0.0 110.197 179.987 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 739' ' ' HIS . . . . . . . . . . . . . 24.8 t-80 -170.54 101.31 0.43 Allowed Pre-proline 0 N--CA 1.492 1.648 0 O-C-N 121.292 -0.88 . . . . 0.0 110.221 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 740' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -74.97 154.4 42.6 Favored 'Trans proline' 0 C--N 1.304 -1.765 0 O-C-N 124.02 1.537 . . . . 0.0 110.323 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 741' ' ' ASN . . . . . . . . . . . . . 24.8 t-20 -70.16 119.37 14.25 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.2 -0.938 . . . . 0.0 110.028 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 742' ' ' ILE . . . . . 0.469 ' O ' ' HB2' ' A' ' 743' ' ' LYS . 11.8 pt -146.38 179.93 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.209 -0.932 . . . . 0.0 110.493 -179.913 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 743' ' ' LYS . . . . . 0.469 ' HB2' ' O ' ' A' ' 742' ' ' ILE . 44.1 tptt 174.15 -29.56 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.489 -0.757 . . . . 0.0 109.691 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 744' ' ' ASN . . . . . . . . . . . . . 3.6 t30 -143.28 119.08 10.52 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.39 -0.818 . . . . 0.0 109.519 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 745' ' ' TRP . . . . . . . . . . . . . 8.2 m95 -121.07 -59.8 1.7 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.104 -0.997 . . . . 0.0 110.848 -179.929 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 746' ' ' GLN . . . . . 0.417 ' O ' HG13 ' A' ' 747' ' ' ILE . 0.1 OUTLIER -116.81 168.72 9.96 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.041 -1.037 . . . . 0.0 110.72 -179.962 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 747' ' ' ILE . . . . . 0.652 HG22 ' O ' ' A' ' 747' ' ' ILE . 4.2 mp -142.72 56.18 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.356 -0.84 . . . . 0.0 110.198 179.972 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 748' ' ' GLU . . . . . . . . . . . . . 69.1 tt0 -140.86 -75.39 0.32 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.255 -0.903 . . . . 0.0 110.061 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 749' ' ' SER . . . . . . . . . . . . . 21.8 t -171.9 36.08 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.246 -0.909 . . . . 0.0 110.305 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 750' ' ' TYR . . . . . . . . . . . . . 49.1 m-85 -133.57 147.32 51.54 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.166 -0.958 . . . . 0.0 110.397 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 751' ' ' GLY . . . . . . . . . . . . . . . -110.68 -163.12 18.5 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 752' ' ' GLU . . . . . . . . . . . . . 3.5 tp10 -114.7 97.39 46.9 Favored Pre-proline 0 N--CA 1.494 1.769 0 O-C-N 121.316 -1.108 . . . . 0.0 110.159 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 753' ' ' PRO . . . . . 0.448 ' O ' ' HB3' ' A' ' 754' ' ' GLU . 50.5 Cg_endo -79.82 102.98 1.52 Allowed 'Trans proline' 0 C--N 1.307 -1.645 0 O-C-N 124.048 1.552 . . . . 0.0 110.7 -179.936 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 754' ' ' GLU . . . . . 0.537 ' HG3' ' CE1' ' A' ' 756' ' ' HIS . 6.7 pt-20 -177.81 -177.43 0.64 Allowed 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.24 -0.913 . . . . 0.0 110.336 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 755' ' ' PHE . . . . . 0.446 ' O ' ' CD2' ' A' ' 756' ' ' HIS . 0.2 OUTLIER -95.61 164.56 12.73 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.279 -0.888 . . . . 0.0 110.17 -179.965 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 756' ' ' HIS . . . . . 0.537 ' CE1' ' HG3' ' A' ' 754' ' ' GLU . 41.9 m80 -148.18 13.08 0.97 Allowed 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.176 -0.952 . . . . 0.0 110.547 -179.989 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 757' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -146.88 168.31 21.75 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.129 -0.982 . . . . 0.0 110.585 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 758' ' ' ALA . . . . . . . . . . . . . . . -106.27 177.94 4.71 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.41 -0.806 . . . . 0.0 109.856 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 759' ' ' LYS . . . . . . . . . . . . . 3.9 mttp -132.41 147.79 52.39 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.202 -0.936 . . . . 0.0 110.499 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 760' ' ' VAL . . . . . 0.886 ' CG2' HD11 ' A' ' 816' ' ' ILE . 13.3 t -110.27 132.36 58.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.322 -0.861 . . . . 0.0 109.595 179.942 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 761' ' ' HIS . . . . . . . . . . . . . 29.5 m80 -120.78 119.56 33.09 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.108 -0.995 . . . . 0.0 110.923 -179.902 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 762' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -115.0 117.37 30.42 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.372 -0.83 . . . . 0.0 109.011 179.829 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 763' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -136.27 120.43 17.79 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.012 -1.055 . . . . 0.0 111.315 -179.895 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 764' ' ' CYS . . . . . 1.007 ' SG ' HG21 ' A' ' 731' ' ' VAL . 1.2 m -99.4 177.54 5.15 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.491 -0.755 . . . . 0.0 109.81 179.86 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 765' ' ' ALA . . . . . 0.798 ' HB3' ' OE1' ' A' ' 768' ' ' GLN . . . -60.39 161.41 13.88 Favored Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.193 -0.942 . . . . 0.0 109.856 179.969 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 766' ' ' PRO . . . . . 0.402 ' HD2' ' HB1' ' A' ' 765' ' ' ALA . 44.1 Cg_endo -69.89 136.45 32.69 Favored 'Trans proline' 0 C--N 1.306 -1.691 0 O-C-N 123.897 1.472 . . . . 0.0 110.296 179.976 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 767' ' ' GLY . . . . . . . . . . . . . . . 93.54 -30.85 6.9 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.04 -1.624 . . . . 0.0 109.04 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 768' ' ' GLN . . . . . 0.798 ' OE1' ' HB3' ' A' ' 765' ' ' ALA . 10.5 mt-30 -82.75 105.85 14.1 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.331 -1.099 . . . . 0.0 110.076 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 769' ' ' THR . . . . . . . . . . . . . 26.6 p -95.81 146.59 24.43 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.176 -0.953 . . . . 0.0 110.367 179.916 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 770' ' ' ILE . . . . . . . . . . . . . 47.8 mt -76.62 139.47 18.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.356 -0.84 . . . . 0.0 109.675 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 771' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -137.55 -2.67 1.95 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.982 -1.074 . . . . 0.0 111.272 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 772' ' ' ALA . . . . . . . . . . . . . . . -155.99 119.42 4.33 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.763 -1.21 . . . . 0.0 111.075 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 773' ' ' ILE . . . . . . . . . . . . . 33.3 mm -83.26 126.2 40.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.322 -0.862 . . . . 0.0 109.324 179.916 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 774' ' ' LYS . . . . . 0.49 ' CB ' ' OE1' ' A' ' 836' ' ' GLU . 0.1 OUTLIER -82.54 -38.62 23.48 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.111 -0.993 . . . . 0.0 110.766 -179.909 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 775' ' ' PHE . . . . . 0.474 ' HB2' ' O ' ' A' ' 774' ' ' LYS . 11.7 t80 -179.41 133.64 0.11 Allowed 'General case' 0 N--CA 1.496 1.859 0 O-C-N 120.858 -1.151 . . . . 0.0 111.374 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 776' ' ' ALA . . . . . 0.502 ' O ' ' HB3' ' A' ' 798' ' ' SER . . . -151.14 88.91 1.48 Allowed 'General case' 0 N--CA 1.495 1.785 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 179.904 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 777' ' ' SER . . . . . 0.526 ' HA ' ' OG ' ' A' ' 798' ' ' SER . 8.7 p -102.52 165.59 11.01 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.218 -0.926 . . . . 0.0 111.425 -179.77 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 778' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -126.53 101.11 6.53 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.593 -0.692 . . . . 0.0 109.74 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 779' ' ' GLY . . . . . 0.482 ' O ' ' HG2' ' A' ' 832' ' ' ARG . . . 156.66 -109.55 0.41 Allowed Glycine 0 N--CA 1.493 2.454 0 N-CA-C 109.381 -1.488 . . . . 0.0 109.381 179.903 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 780' ' ' THR . . . . . 0.459 ' O ' ' HA3' ' A' ' 791' ' ' GLY . 76.3 p -127.78 101.19 23.8 Favored Pre-proline 0 N--CA 1.493 1.719 0 O-C-N 121.231 -1.158 . . . . 0.0 110.086 179.965 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 781' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -77.34 173.04 14.92 Favored 'Trans proline' 0 C--N 1.305 -1.751 0 O-C-N 124.082 1.569 . . . . 0.0 110.549 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 782' ' ' LEU . . . . . . . . . . . . . 1.1 mt -130.81 98.41 4.61 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.311 -0.868 . . . . 0.0 110.165 179.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 783' ' ' GLY . . . . . . . . . . . . . . . 139.49 -164.3 25.99 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 -180.0 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 784' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -119.94 -169.05 1.71 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.157 -1.202 . . . . 0.0 110.173 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 785' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -62.47 93.87 0.06 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.246 -0.909 . . . . 0.0 110.22 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 786' ' ' GLY . . . . . . . . . . . . . . . 146.3 -28.35 1.67 Allowed Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.468 -1.453 . . . . 0.0 109.468 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 787' ' ' THR . . . . . . . . . . . . . 66.3 p -127.2 27.32 5.92 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.24 -1.153 . . . . 0.0 110.207 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 788' ' ' PHE . . . . . 0.454 ' HB3' ' CD1' ' A' ' 775' ' ' PHE . 2.9 m-85 -52.41 110.62 0.52 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.371 -0.831 . . . . 0.0 110.196 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 789' ' ' GLN . . . . . 0.466 ' HA ' ' CE2' ' A' ' 775' ' ' PHE . 7.2 tp60 -127.53 153.36 46.44 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.298 -0.876 . . . . 0.0 110.058 179.965 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 790' ' ' GLN . . . . . 0.498 ' CG ' ' O ' ' A' ' 790' ' ' GLN . 7.5 pt20 -52.27 114.71 1.43 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.249 -0.907 . . . . 0.0 110.28 179.997 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 791' ' ' GLY . . . . . 0.459 ' HA3' ' O ' ' A' ' 780' ' ' THR . . . -66.47 -105.87 0.01 OUTLIER Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.384 -1.486 . . . . 0.0 109.384 -179.978 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 792' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -113.61 -31.67 6.42 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.282 -1.128 . . . . 0.0 110.128 -179.956 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 793' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -121.55 98.22 5.87 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.278 -0.889 . . . . 0.0 110.393 -179.935 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 794' ' ' HIS . . . . . 0.606 ' CE1' ' CB ' ' A' ' 798' ' ' SER . 66.3 t60 -107.29 131.17 54.5 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.122 -0.986 . . . . 0.0 109.966 179.948 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 795' ' ' SER . . . . . 0.46 ' O ' ' O ' ' A' ' 794' ' ' HIS . 6.3 t -61.59 -141.14 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.172 -0.955 . . . . 0.0 109.453 179.893 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 796' ' ' ILE . . . . . . . . . . . . . 3.4 mt -136.5 -43.69 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 O-C-N 121.11 -0.994 . . . . 0.0 109.707 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 797' ' ' ASN . . . . . 0.414 ' O ' ' C ' ' A' ' 798' ' ' SER . 44.8 m-20 -82.36 10.76 6.44 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.36 -0.838 . . . . 0.0 109.46 179.864 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 798' ' ' SER . . . . . 0.606 ' CB ' ' CE1' ' A' ' 794' ' ' HIS . 1.6 m -35.75 -68.69 0.12 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.747 -0.596 . . . . 0.0 111.612 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 799' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -93.95 -26.21 16.94 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.066 -1.021 . . . . 0.0 110.883 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 800' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -50.78 -22.39 2.11 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 120.973 -1.079 . . . . 0.0 110.181 179.965 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 801' ' ' VAL . . . . . 0.548 HG21 ' CD2' ' A' ' 821' ' ' PHE . 25.1 t -84.77 -41.47 15.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.275 -0.891 . . . . 0.0 110.427 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 802' ' ' LEU . . . . . 0.57 ' N ' ' CD2' ' A' ' 802' ' ' LEU . 4.0 mm? -66.2 -41.17 90.57 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.329 -0.857 . . . . 0.0 110.94 -179.933 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 803' ' ' GLU . . . . . 0.421 ' C ' ' O ' ' A' ' 802' ' ' LEU . 8.9 mt-10 -41.88 -47.63 4.28 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.216 -0.927 . . . . 0.0 110.681 -179.935 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 804' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -92.92 -28.21 16.61 Favored 'General case' 0 N--CA 1.503 2.177 0 O-C-N 121.135 -0.978 . . . . 0.0 111.987 -179.834 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 805' ' ' LYS . . . . . 0.478 ' O ' ' SG ' ' A' ' 806' ' ' CYS . 1.0 OUTLIER -89.66 26.98 1.6 Allowed 'General case' 0 N--CA 1.498 1.942 0 O-C-N 120.967 -1.083 . . . . 0.0 111.492 -179.807 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 806' ' ' CYS . . . . . 0.529 ' HA ' ' CB ' ' A' ' 812' ' ' CYS . 13.2 m -158.44 -66.64 0.09 Allowed 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.043 -1.035 . . . . 0.0 110.745 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 807' ' ' ILE . . . . . 0.419 ' C ' ' O ' ' A' ' 806' ' ' CYS . 17.5 mt -41.56 123.51 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.978 0 O-C-N 121.186 -0.947 . . . . 0.0 110.973 -179.933 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 808' ' ' GLY . . . . . 0.461 ' C ' ' HG ' ' A' ' 809' ' ' LEU . . . 115.68 -9.92 19.08 Favored Glycine 0 N--CA 1.494 2.528 0 N-CA-C 110.167 -1.173 . . . . 0.0 110.167 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 809' ' ' LEU . . . . . 0.461 ' HG ' ' C ' ' A' ' 808' ' ' GLY . 1.7 mt -132.94 151.45 52.05 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.061 -1.258 . . . . 0.0 110.306 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 810' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -73.79 -14.95 61.19 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.152 -0.968 . . . . 0.0 109.777 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 811' ' ' ARG . . . . . 0.492 ' CG ' ' O ' ' A' ' 811' ' ' ARG . 10.2 ptm180 -155.72 122.43 5.28 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.343 -0.848 . . . . 0.0 110.068 179.9 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 812' ' ' CYS . . . . . 0.529 ' CB ' ' HA ' ' A' ' 806' ' ' CYS . 31.9 p -122.73 151.71 41.31 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.227 -0.921 . . . . 0.0 110.608 -179.966 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 813' ' ' VAL . . . . . 0.52 HG13 ' O ' ' A' ' 760' ' ' VAL . 5.8 t -121.69 152.53 25.44 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.32 -0.862 . . . . 0.0 110.329 -179.963 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 814' ' ' VAL . . . . . 0.481 HG23 ' C ' ' A' ' 813' ' ' VAL . 88.9 t -148.93 104.19 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.272 -0.892 . . . . 0.0 110.357 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 815' ' ' ALA . . . . . . . . . . . . . . . -62.21 153.64 29.82 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.19 -0.944 . . . . 0.0 110.127 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 816' ' ' ILE . . . . . 0.886 HD11 ' CG2' ' A' ' 760' ' ' VAL . 11.3 mt -107.5 130.77 59.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.163 -0.96 . . . . 0.0 110.109 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 817' ' ' SER . . . . . 0.443 ' OG ' ' HB2' ' A' ' 820' ' ' ASN . 1.4 p -164.11 163.64 15.17 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.259 -0.901 . . . . 0.0 110.037 179.944 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 818' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -74.48 -7.61 19.75 Favored 'Trans proline' 0 C--N 1.303 -1.857 0 O-C-N 124.08 1.568 . . . . 0.0 110.36 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 819' ' ' SER . . . . . . . . . . . . . 3.2 t -128.4 53.14 1.84 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.311 -0.868 . . . . 0.0 110.04 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 820' ' ' ASN . . . . . 0.443 ' HB2' ' OG ' ' A' ' 817' ' ' SER . 0.4 OUTLIER -129.46 -40.0 1.45 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.199 -0.938 . . . . 0.0 110.281 -179.942 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 821' ' ' PHE . . . . . 0.548 ' CD2' HG21 ' A' ' 801' ' ' VAL . 60.1 m-85 -85.93 -60.03 2.13 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.307 -0.87 . . . . 0.0 110.254 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 822' ' ' GLY . . . . . . . . . . . . . . . 155.72 37.88 0.02 OUTLIER Glycine 0 N--CA 1.492 2.422 0 N-CA-C 109.67 -1.372 . . . . 0.0 109.67 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 823' ' ' GLY . . . . . . . . . . . . . . . 137.72 -151.92 21.46 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.819 -1.313 . . . . 0.0 109.819 180.0 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 824' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -141.62 153.68 65.43 Favored Pre-proline 0 N--CA 1.494 1.731 0 O-C-N 121.332 -1.099 . . . . 0.0 110.157 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 825' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -73.33 -94.41 0.01 OUTLIER 'Trans proline' 0 C--N 1.305 -1.724 0 O-C-N 124.073 1.565 . . . . 0.0 110.505 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 826' ' ' CYS . . . . . . . . . . . . . 61.0 m -128.06 134.13 25.89 Favored Pre-proline 0 N--CA 1.494 1.741 0 O-C-N 121.136 -0.977 . . . . 0.0 110.032 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 827' ' ' PRO . . . . . 0.534 ' O ' ' CG ' ' A' ' 828' ' ' GLU . 50.8 Cg_endo -82.87 -171.58 1.18 Allowed 'Trans proline' 0 C--N 1.306 -1.683 0 O-C-N 124.156 1.608 . . . . 0.0 111.133 -179.941 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 828' ' ' GLU . . . . . 0.534 ' CG ' ' O ' ' A' ' 827' ' ' PRO . 15.5 pt-20 39.28 34.76 0.13 Allowed 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.678 -0.639 . . . . 0.0 110.65 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 829' ' ' VAL . . . . . 0.497 ' O ' ' HD2' ' A' ' 831' ' ' LYS . 23.4 t -144.1 161.34 15.48 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.309 -0.869 . . . . 0.0 109.757 179.904 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 830' ' ' MET . . . . . 0.425 ' O ' ' HD2' ' A' ' 831' ' ' LYS . 3.2 mtp -59.12 171.17 0.76 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.031 -1.043 . . . . 0.0 109.626 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 831' ' ' LYS . . . . . 0.497 ' HD2' ' O ' ' A' ' 829' ' ' VAL . 0.6 OUTLIER -147.99 128.63 14.17 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.015 -1.053 . . . . 0.0 110.967 -179.951 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 832' ' ' ARG . . . . . 0.482 ' HG2' ' O ' ' A' ' 779' ' ' GLY . 0.0 OUTLIER -156.49 152.14 27.01 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.443 -0.786 . . . . 0.0 109.65 179.926 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 833' ' ' VAL . . . . . 0.424 HG21 ' CG2' ' A' ' 816' ' ' ILE . 28.6 t -111.16 144.09 19.75 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 O-C-N 121.116 -0.99 . . . . 0.0 110.882 -179.928 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 834' ' ' ALA . . . . . 0.442 ' C ' HG23 ' A' ' 835' ' ' VAL . . . -147.9 136.67 21.85 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.325 -0.859 . . . . 0.0 109.291 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 835' ' ' VAL . . . . . 0.442 HG23 ' C ' ' A' ' 834' ' ' ALA . 75.5 t -148.47 154.4 10.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 120.912 -1.118 . . . . 0.0 111.204 -179.931 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 836' ' ' GLU . . . . . 0.49 ' OE1' ' CB ' ' A' ' 774' ' ' LYS . 16.3 tt0 -141.28 117.48 10.67 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 179.944 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 837' ' ' ALA . . . . . . . . . . . . . . . -107.34 162.97 13.43 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.022 -1.049 . . . . 0.0 111.377 -179.836 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 838' ' ' VAL . . . . . 0.408 ' HA ' ' HB2' ' A' ' 729' ' ' SER . 90.9 t -121.58 107.66 20.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.647 -0.658 . . . . 0.0 109.841 179.98 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 839' ' ' CYS . . . . . 0.441 ' O ' ' O ' ' A' ' 728' ' ' VAL . 15.5 p -115.74 122.29 45.04 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.065 -1.022 . . . . 0.0 110.785 -179.986 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 840' ' ' SER . . . . . 0.447 ' O ' ' HA ' ' A' ' 768' ' ' GLN . 1.2 p -106.46 150.19 26.32 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.558 -0.713 . . . . 0.0 109.579 179.907 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 841' ' ' THR . . . . . 0.431 ' HA ' ' HA ' ' A' ' 768' ' ' GLN . 5.4 t -71.64 165.02 24.83 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.121 -0.987 . . . . 0.0 110.549 -179.931 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 842' ' ' ALA . . . . . . . . . . . . . . . -138.6 73.79 1.45 Allowed 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.476 -0.765 . . . . 0.0 110.007 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 843' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 1.761 0 CA-C-O 118.034 -0.984 . . . . 0.0 110.222 179.966 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 726' ' ' ARG . . . . . . . . . . . . . 12.1 ttm180 . . . . . 0 N--CA 1.492 1.626 0 CA-C-O 121.227 0.537 . . . . 0.0 110.233 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 727' ' ' THR . . . . . . . . . . . . . 40.3 m -153.27 105.6 2.89 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.282 -0.886 . . . . 0.0 110.327 -179.967 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 728' ' ' VAL . . . . . 0.405 ' O ' ' O ' ' A' ' 839' ' ' CYS . 12.0 t -94.73 138.85 19.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.252 -0.905 . . . . 0.0 110.083 -179.945 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 729' ' ' SER . . . . . 0.483 ' HA ' ' O ' ' A' ' 839' ' ' CYS . 39.0 t -160.05 41.11 0.19 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.241 -0.912 . . . . 0.0 110.625 -179.949 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 730' ' ' GLY . . . . . . . . . . . . . . . 178.25 108.44 0.23 Allowed Glycine 0 N--CA 1.49 2.297 0 C-N-CA 119.575 -1.298 . . . . 0.0 110.154 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 731' ' ' VAL . . . . . . . . . . . . . 39.0 t -112.33 164.65 8.0 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 121.361 -1.082 . . . . 0.0 109.455 179.841 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 732' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -134.24 158.72 43.0 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.036 -1.04 . . . . 0.0 110.881 -179.876 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 733' ' ' ALA . . . . . 0.672 ' CB ' HD21 ' A' ' 762' ' ' LEU . . . -161.7 133.38 5.51 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.335 -0.853 . . . . 0.0 109.925 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 734' ' ' ASP . . . . . . . . . . . . . 30.2 m-20 -150.15 111.14 4.34 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.119 -0.988 . . . . 0.0 110.464 179.901 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 735' ' ' VAL . . . . . . . . . . . . . 40.4 t -139.99 163.45 24.27 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.326 -0.859 . . . . 0.0 109.816 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 736' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -75.87 -175.1 2.87 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.164 -0.96 . . . . 0.0 110.108 -179.973 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 737' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -98.9 -160.21 0.79 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.204 -0.935 . . . . 0.0 110.336 179.965 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 738' ' ' TYR . . . . . 0.915 ' CD2' HG22 ' A' ' 757' ' ' THR . 9.1 t80 -80.18 167.04 20.83 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.418 -0.801 . . . . 0.0 110.525 -179.948 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 739' ' ' HIS . . . . . 0.595 ' CD2' ' O ' ' A' ' 739' ' ' HIS . 0.3 OUTLIER -156.88 136.78 8.61 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.397 -0.814 . . . . 0.0 110.088 179.938 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 740' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -78.13 -18.33 12.87 Favored 'Trans proline' 0 C--N 1.307 -1.62 0 O-C-N 123.983 1.518 . . . . 0.0 111.063 -179.87 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 741' ' ' ASN . . . . . 0.551 ' O ' ' CE1' ' A' ' 739' ' ' HIS . 10.4 t-20 -100.1 145.58 27.8 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.108 -0.995 . . . . 0.0 110.325 -179.94 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 742' ' ' ILE . . . . . 0.406 HD12 HG23 ' A' ' 742' ' ' ILE . 32.4 mm -98.69 123.65 51.4 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 O-C-N 121.243 -0.911 . . . . 0.0 110.344 179.956 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 743' ' ' LYS . . . . . 0.475 ' HE2' ' HA ' ' A' ' 743' ' ' LYS . 0.1 OUTLIER -145.02 11.02 1.35 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.194 -0.941 . . . . 0.0 110.28 179.991 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 744' ' ' ASN . . . . . . . . . . . . . 31.3 p30 -104.14 7.72 36.27 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.235 -0.916 . . . . 0.0 110.073 -179.976 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 745' ' ' TRP . . . . . 0.557 ' CZ3' ' HG2' ' A' ' 748' ' ' GLU . 0.0 OUTLIER -133.72 124.74 27.21 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.293 -0.879 . . . . 0.0 110.013 179.961 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 746' ' ' GLN . . . . . . . . . . . . . 2.3 tp60 -140.38 30.95 1.92 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.22 -0.925 . . . . 0.0 110.309 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 747' ' ' ILE . . . . . 0.72 HG22 ' O ' ' A' ' 747' ' ' ILE . 28.5 mt -134.4 15.54 1.23 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.109 -0.995 . . . . 0.0 110.077 179.967 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 748' ' ' GLU . . . . . 0.557 ' HG2' ' CZ3' ' A' ' 745' ' ' TRP . 18.7 mp0 -120.22 -155.48 0.62 Allowed 'General case' 0 C--N 1.295 -1.792 0 O-C-N 121.369 -0.832 . . . . 0.0 109.626 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 749' ' ' SER . . . . . 0.466 ' O ' ' HB2' ' A' ' 750' ' ' TYR . 40.0 t -83.43 17.83 2.02 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.013 -1.055 . . . . 0.0 110.518 179.982 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 750' ' ' TYR . . . . . 0.466 ' HB2' ' O ' ' A' ' 749' ' ' SER . 28.6 m-85 59.17 110.67 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.262 -0.899 . . . . 0.0 110.858 179.903 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 751' ' ' GLY . . . . . . . . . . . . . . . 99.57 86.82 1.91 Allowed Glycine 0 N--CA 1.491 2.326 0 N-CA-C 110.069 -1.213 . . . . 0.0 110.069 179.939 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 752' ' ' GLU . . . . . . . . . . . . . 5.9 tm-20 -96.7 127.22 40.23 Favored Pre-proline 0 N--CA 1.493 1.71 0 O-C-N 121.203 -1.175 . . . . 0.0 109.844 179.897 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 753' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo -78.49 144.61 20.24 Favored 'Trans proline' 0 C--N 1.308 -1.582 0 O-C-N 123.938 1.494 . . . . 0.0 111.213 -179.943 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 754' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER 59.61 50.65 7.08 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.483 -0.761 . . . . 0.0 111.218 179.951 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 755' ' ' PHE . . . . . . . . . . . . . 45.9 p90 -78.18 -167.59 1.07 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.083 -1.011 . . . . 0.0 109.296 179.917 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 756' ' ' HIS . . . . . 0.424 ' CD2' ' H ' ' A' ' 756' ' ' HIS . 0.4 OUTLIER -128.04 172.1 11.25 Favored 'General case' 0 N--CA 1.503 2.178 0 O-C-N 120.808 -1.183 . . . . 0.0 111.433 -179.921 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 757' ' ' THR . . . . . 0.915 HG22 ' CD2' ' A' ' 738' ' ' TYR . 66.2 p -97.4 159.05 15.15 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.617 -0.677 . . . . 0.0 110.155 179.984 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 758' ' ' ALA . . . . . 0.719 ' O ' HD12 ' A' ' 816' ' ' ILE . . . -58.95 121.77 12.01 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.211 -0.931 . . . . 0.0 109.713 179.902 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 759' ' ' LYS . . . . . 0.472 ' CG ' ' HA ' ' A' ' 815' ' ' ALA . 13.6 mttt -109.16 163.34 13.44 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.145 -0.972 . . . . 0.0 110.847 -179.928 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 760' ' ' VAL . . . . . 0.617 ' CG2' HD11 ' A' ' 816' ' ' ILE . 52.1 t -106.55 131.05 57.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 179.895 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 761' ' ' HIS . . . . . . . . . . . . . 10.8 m80 -112.57 110.35 20.46 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 120.923 -1.111 . . . . 0.0 112.365 -179.736 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 762' ' ' LEU . . . . . 0.672 HD21 ' CB ' ' A' ' 733' ' ' ALA . 1.0 OUTLIER -121.79 105.0 9.98 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 107.477 -1.305 . . . . 0.0 107.477 179.788 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 763' ' ' LYS . . . . . 0.468 ' HB3' ' HG3' ' A' ' 811' ' ' ARG . 0.0 OUTLIER -129.44 150.96 50.57 Favored 'General case' 0 C--N 1.297 -1.696 0 O-C-N 120.87 -1.144 . . . . 0.0 112.168 -179.7 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 764' ' ' CYS . . . . . 0.431 ' O ' ' C ' ' A' ' 765' ' ' ALA . 18.4 m -125.08 164.11 20.92 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 109.19 -0.671 . . . . 0.0 109.19 179.875 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 765' ' ' ALA . . . . . 0.554 ' HB3' ' NE2' ' A' ' 768' ' ' GLN . . . -43.88 154.54 0.36 Allowed Pre-proline 0 N--CA 1.491 1.609 0 O-C-N 120.994 -1.067 . . . . 0.0 110.055 179.982 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 766' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -69.72 99.26 0.73 Allowed 'Trans proline' 0 C--N 1.304 -1.786 0 O-C-N 123.989 1.521 . . . . 0.0 110.089 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 767' ' ' GLY . . . . . . . . . . . . . . . 144.69 -30.77 1.81 Allowed Glycine 0 N--CA 1.488 2.139 0 N-CA-C 108.998 -1.641 . . . . 0.0 108.998 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 768' ' ' GLN . . . . . 0.557 ' HG2' ' N ' ' A' ' 841' ' ' THR . 4.1 mt-30 -85.76 156.74 20.49 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.433 -1.039 . . . . 0.0 109.875 179.908 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 769' ' ' THR . . . . . 0.512 HG22 ' HG3' ' A' ' 810' ' ' GLU . 23.0 p -138.04 145.76 42.2 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.202 -0.936 . . . . 0.0 110.296 -179.969 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 770' ' ' ILE . . . . . . . . . . . . . 70.3 mt -68.46 127.1 29.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.312 -0.868 . . . . 0.0 109.202 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 771' ' ' SER . . . . . 0.485 ' O ' ' HB2' ' A' ' 772' ' ' ALA . 8.5 p -103.6 -8.71 19.78 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.216 -0.928 . . . . 0.0 111.419 -179.893 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 772' ' ' ALA . . . . . 0.485 ' HB2' ' O ' ' A' ' 771' ' ' SER . . . -177.92 151.03 0.66 Allowed 'General case' 0 N--CA 1.495 1.796 0 O-C-N 120.73 -1.231 . . . . 0.0 111.805 -179.959 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 773' ' ' ILE . . . . . 0.402 HG23 HD12 ' A' ' 773' ' ' ILE . 33.6 mm -100.15 141.91 16.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 179.784 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 774' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -108.88 -24.13 11.4 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.826 -1.171 . . . . 0.0 111.733 -179.804 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 775' ' ' PHE . . . . . 0.486 ' O ' ' HB2' ' A' ' 776' ' ' ALA . 80.8 t80 -154.76 161.44 41.51 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 120.726 -1.234 . . . . 0.0 111.505 -179.854 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 776' ' ' ALA . . . . . 0.486 ' HB2' ' O ' ' A' ' 775' ' ' PHE . . . 178.58 111.24 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.626 -0.671 . . . . 0.0 109.485 179.964 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 777' ' ' SER . . . . . 0.424 ' HA ' ' OG ' ' A' ' 798' ' ' SER . 48.3 p -144.66 113.71 6.89 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.077 -1.014 . . . . 0.0 110.681 -179.966 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 778' ' ' PHE . . . . . 0.467 ' CG ' ' O ' ' A' ' 778' ' ' PHE . 8.6 t80 -91.26 78.46 5.78 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.292 -0.88 . . . . 0.0 110.046 179.943 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 779' ' ' GLY . . . . . . . . . . . . . . . -165.12 -123.26 0.64 Allowed Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.829 -1.309 . . . . 0.0 109.829 -179.946 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 780' ' ' THR . . . . . . . . . . . . . 27.9 p -120.46 78.75 28.37 Favored Pre-proline 0 N--CA 1.493 1.688 0 O-C-N 121.344 -1.092 . . . . 0.0 110.396 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 781' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -79.44 175.72 10.4 Favored 'Trans proline' 0 C--N 1.304 -1.78 0 O-C-N 123.95 1.5 . . . . 0.0 110.556 -179.961 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 782' ' ' LEU . . . . . . . . . . . . . 3.9 mt -143.47 134.98 26.22 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.296 -0.878 . . . . 0.0 110.032 179.954 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 783' ' ' GLY . . . . . . . . . . . . . . . 144.1 -174.52 24.39 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 -179.937 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 784' ' ' THR . . . . . 0.463 ' O ' ' O ' ' A' ' 785' ' ' CYS . 0.0 OUTLIER -145.64 66.82 1.21 Allowed 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.213 -1.169 . . . . 0.0 110.257 179.993 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 785' ' ' CYS . . . . . 0.463 ' O ' ' O ' ' A' ' 784' ' ' THR . 44.6 t 57.44 114.76 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.303 -0.873 . . . . 0.0 110.351 179.974 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 786' ' ' GLY . . . . . . . . . . . . . . . 109.47 -17.78 30.7 Favored Glycine 0 N--CA 1.489 2.197 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 -179.932 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 787' ' ' THR . . . . . 0.481 ' O ' HG23 ' A' ' 787' ' ' THR . 12.2 t -158.63 48.23 0.35 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.162 -1.199 . . . . 0.0 110.485 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 788' ' ' PHE . . . . . 0.443 ' CE2' ' HA ' ' A' ' 785' ' ' CYS . 41.5 m-85 -58.34 149.69 24.0 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.109 -0.994 . . . . 0.0 109.984 -179.987 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 789' ' ' GLN . . . . . . . . . . . . . 2.0 tt0 -136.04 162.22 33.51 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.158 -0.964 . . . . 0.0 110.408 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 790' ' ' GLN . . . . . 0.428 ' HG2' ' N ' ' A' ' 791' ' ' GLY . 1.8 tt0 -93.81 144.67 25.21 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.177 -0.952 . . . . 0.0 110.202 -179.993 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 791' ' ' GLY . . . . . 0.428 ' N ' ' HG2' ' A' ' 790' ' ' GLN . . . -96.95 -142.0 12.83 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.361 -1.496 . . . . 0.0 109.361 -179.955 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 792' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -93.63 -36.91 12.13 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.253 -1.145 . . . . 0.0 109.74 179.944 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 793' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -100.64 153.62 19.26 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.42 -0.8 . . . . 0.0 110.264 179.975 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 794' ' ' HIS . . . . . 0.471 ' NE2' ' O ' ' A' ' 795' ' ' SER . 26.4 t60 -176.82 143.17 0.43 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.154 -0.966 . . . . 0.0 110.266 179.956 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 795' ' ' SER . . . . . 0.471 ' O ' ' NE2' ' A' ' 794' ' ' HIS . 58.4 p -73.69 143.62 46.13 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.311 -0.868 . . . . 0.0 109.382 179.934 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 796' ' ' ILE . . . . . . . . . . . . . 9.6 mt -90.99 42.15 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.199 -0.938 . . . . 0.0 109.768 -179.916 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 797' ' ' ASN . . . . . . . . . . . . . 10.6 t30 -159.61 23.02 0.18 Allowed 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.519 -0.738 . . . . 0.0 109.597 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 798' ' ' SER . . . . . 0.456 ' HB3' ' O ' ' A' ' 776' ' ' ALA . 0.6 OUTLIER -57.75 -71.63 0.1 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.571 -0.706 . . . . 0.0 111.563 -179.878 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 799' ' ' ASN . . . . . 0.464 ' OD1' ' HB3' ' A' ' 776' ' ' ALA . 1.4 m120 -61.92 -7.25 3.53 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.305 -0.872 . . . . 0.0 111.861 -179.801 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 800' ' ' SER . . . . . . . . . . . . . 1.3 t -74.03 -33.41 63.74 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.775 -1.203 . . . . 0.0 110.311 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 801' ' ' VAL . . . . . . . . . . . . . 59.1 t -90.83 -18.59 7.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.244 -0.91 . . . . 0.0 110.315 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 802' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -81.43 -45.89 15.38 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.247 -0.908 . . . . 0.0 111.182 -179.831 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 803' ' ' GLU . . . . . 0.647 ' HG2' HD12 ' A' ' 807' ' ' ILE . 4.8 tm-20 -74.4 -21.66 59.54 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.024 -1.048 . . . . 0.0 111.232 -179.993 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 804' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -94.44 -17.35 22.57 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.06 -1.025 . . . . 0.0 112.266 -179.853 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 805' ' ' LYS . . . . . . . . . . . . . 6.4 tttt -138.49 45.04 2.07 Favored 'General case' 0 N--CA 1.503 2.187 0 O-C-N 120.466 -1.396 . . . . 0.0 112.603 -179.879 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 806' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -163.17 -37.38 0.04 OUTLIER 'General case' 0 N--CA 1.498 1.96 0 O-C-N 120.686 -1.259 . . . . 0.0 110.613 179.918 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 807' ' ' ILE . . . . . 0.647 HD12 ' HG2' ' A' ' 803' ' ' GLU . 18.3 mt -70.7 113.5 6.95 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.636 0 O-C-N 121.299 -0.875 . . . . 0.0 110.998 -179.883 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 808' ' ' GLY . . . . . 0.491 ' C ' ' HG ' ' A' ' 809' ' ' LEU . . . 119.35 19.03 4.34 Favored Glycine 0 N--CA 1.494 2.506 0 C-N-CA 119.856 -1.164 . . . . 0.0 110.506 179.88 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 809' ' ' LEU . . . . . 0.491 ' HG ' ' C ' ' A' ' 808' ' ' GLY . 40.5 mt -142.19 142.77 32.71 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 120.883 -1.363 . . . . 0.0 110.629 -179.991 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 810' ' ' GLU . . . . . 0.512 ' HG3' HG22 ' A' ' 769' ' ' THR . 2.2 mt-10 -66.8 -27.6 67.71 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.275 -0.891 . . . . 0.0 109.24 179.959 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 811' ' ' ARG . . . . . 0.468 ' HG3' ' HB3' ' A' ' 763' ' ' LYS . 6.8 ttt85 -125.35 154.49 41.75 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.508 -0.745 . . . . 0.0 109.927 179.972 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 812' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -137.34 124.03 21.09 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.211 -0.93 . . . . 0.0 110.535 -179.982 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 813' ' ' VAL . . . . . . . . . . . . . 70.8 t -130.92 103.43 7.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.226 -0.921 . . . . 0.0 110.015 179.953 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 814' ' ' VAL . . . . . . . . . . . . . 86.0 t -124.84 121.14 60.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.191 -0.943 . . . . 0.0 110.155 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 815' ' ' ALA . . . . . 0.472 ' HA ' ' CG ' ' A' ' 759' ' ' LYS . . . -72.21 160.91 31.63 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.283 -0.886 . . . . 0.0 110.246 179.923 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 816' ' ' ILE . . . . . 0.78 HG21 HG21 ' A' ' 833' ' ' VAL . 8.2 mt -112.91 81.59 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.267 -0.896 . . . . 0.0 109.649 179.989 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 817' ' ' SER . . . . . . . . . . . . . 5.7 p -110.48 158.36 35.62 Favored Pre-proline 0 C--N 1.297 -1.71 0 O-C-N 121.318 -0.864 . . . . 0.0 110.213 -179.921 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 818' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -77.61 12.85 1.78 Allowed 'Trans proline' 0 C--N 1.306 -1.672 0 O-C-N 124.107 1.583 . . . . 0.0 111.058 179.962 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 819' ' ' SER . . . . . . . . . . . . . 10.3 p -133.84 16.49 3.9 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.107 -0.995 . . . . 0.0 110.371 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 820' ' ' ASN . . . . . . . . . . . . . 19.3 t-20 -117.81 -16.82 9.94 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.138 -0.976 . . . . 0.0 110.058 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 821' ' ' PHE . . . . . . . . . . . . . 7.4 m-85 -97.21 -39.29 9.34 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.348 -0.845 . . . . 0.0 110.257 179.896 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 822' ' ' GLY . . . . . . . . . . . . . . . 174.88 -29.49 0.08 OUTLIER Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.596 -1.402 . . . . 0.0 109.596 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 823' ' ' GLY . . . . . 0.465 ' O ' ' OD2' ' A' ' 824' ' ' ASP . . . 147.78 -82.75 0.19 Allowed Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 179.983 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 824' ' ' ASP . . . . . 0.465 ' OD2' ' O ' ' A' ' 823' ' ' GLY . 1.0 OUTLIER -148.02 121.11 4.7 Favored Pre-proline 0 N--CA 1.494 1.771 0 O-C-N 121.234 -1.157 . . . . 0.0 110.385 -179.919 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 825' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -75.51 -89.91 0.01 OUTLIER 'Trans proline' 0 C--N 1.31 -1.497 0 O-C-N 123.923 1.486 . . . . 0.0 110.478 179.932 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 826' ' ' CYS . . . . . 0.606 ' HB3' HG21 ' A' ' 829' ' ' VAL . 2.1 m -97.17 130.74 28.99 Favored Pre-proline 0 N--CA 1.492 1.646 0 O-C-N 121.201 -0.937 . . . . 0.0 109.971 179.996 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 827' ' ' PRO . . . . . 0.418 ' O ' ' HB2' ' A' ' 828' ' ' GLU . 46.4 Cg_endo -73.41 129.31 13.7 Favored 'Trans proline' 0 C--N 1.308 -1.579 0 O-C-N 124.002 1.527 . . . . 0.0 110.927 -179.991 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 828' ' ' GLU . . . . . 0.418 ' HB2' ' O ' ' A' ' 827' ' ' PRO . 8.3 mt-10 57.24 46.3 18.93 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.392 -0.818 . . . . 0.0 110.504 179.928 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 829' ' ' VAL . . . . . 0.606 HG21 ' HB3' ' A' ' 826' ' ' CYS . 39.2 t -133.95 124.88 47.76 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 O-C-N 121.209 -0.932 . . . . 0.0 110.017 179.898 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 830' ' ' MET . . . . . 0.432 ' O ' ' O ' ' A' ' 829' ' ' VAL . 13.0 mmt -41.72 162.75 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.349 -0.844 . . . . 0.0 110.03 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 831' ' ' LYS . . . . . . . . . . . . . 6.4 mttt -139.71 142.47 36.86 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.063 -1.023 . . . . 0.0 111.011 -179.872 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 832' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -144.87 158.15 43.9 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.526 -0.733 . . . . 0.0 109.325 179.976 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 833' ' ' VAL . . . . . 0.78 HG21 HG21 ' A' ' 816' ' ' ILE . 62.1 t -123.13 117.19 50.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 120.846 -1.159 . . . . 0.0 111.47 -179.784 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 834' ' ' ALA . . . . . . . . . . . . . . . -125.9 117.62 23.71 Favored 'General case' 0 N--CA 1.494 1.728 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 179.799 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 835' ' ' VAL . . . . . 0.494 HG12 ' N ' ' A' ' 836' ' ' GLU . 44.4 t -127.82 165.24 27.35 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 120.9 -1.125 . . . . 0.0 111.997 -179.792 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 836' ' ' GLU . . . . . 0.494 ' N ' HG12 ' A' ' 835' ' ' VAL . 0.9 OUTLIER -152.23 123.38 7.62 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 179.952 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 837' ' ' ALA . . . . . . . . . . . . . . . -121.83 165.98 15.06 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 120.893 -1.13 . . . . 0.0 111.809 -179.757 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 838' ' ' VAL . . . . . . . . . . . . . 17.2 t -109.84 107.23 22.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.662 -0.649 . . . . 0.0 109.275 179.928 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 839' ' ' CYS . . . . . 0.483 ' O ' ' HA ' ' A' ' 729' ' ' SER . 0.0 OUTLIER -108.21 145.26 34.52 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.13 -0.981 . . . . 0.0 110.818 -179.896 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 840' ' ' SER . . . . . . . . . . . . . 1.4 p -164.35 147.51 9.21 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.37 -0.831 . . . . 0.0 110.094 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 841' ' ' THR . . . . . 0.557 ' N ' ' HG2' ' A' ' 768' ' ' GLN . 5.2 t -77.58 173.51 11.94 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.244 -0.91 . . . . 0.0 110.208 -179.948 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 842' ' ' ALA . . . . . . . . . . . . . . . -94.76 168.8 10.59 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.195 -0.941 . . . . 0.0 110.173 179.953 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 843' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.69 0 CA-C-O 117.982 -1.009 . . . . 0.0 110.071 -179.985 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 726' ' ' ARG . . . . . . . . . . . . . 17.8 mmm180 . . . . . 0 N--CA 1.493 1.708 0 CA-C-O 121.478 0.656 . . . . 0.0 110.022 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 727' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -151.33 147.17 26.61 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.427 -0.795 . . . . 0.0 109.795 179.99 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 728' ' ' VAL . . . . . 0.713 ' O ' HG13 ' A' ' 728' ' ' VAL . 12.0 p -133.3 78.43 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.199 -0.938 . . . . 0.0 110.363 179.963 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 729' ' ' SER . . . . . . . . . . . . . 5.9 m 52.3 -177.99 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.41 -0.807 . . . . 0.0 110.731 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 730' ' ' GLY . . . . . 0.523 ' C ' HG23 ' A' ' 731' ' ' VAL . . . -152.25 -140.93 3.21 Favored Glycine 0 N--CA 1.489 2.193 0 N-CA-C 109.041 -1.624 . . . . 0.0 109.041 179.987 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 731' ' ' VAL . . . . . 0.523 HG23 ' C ' ' A' ' 730' ' ' GLY . 11.9 t -153.17 165.81 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 O-C-N 121.065 -1.256 . . . . 0.0 110.26 179.968 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 732' ' ' CYS . . . . . . . . . . . . . 6.6 t -150.92 133.98 15.98 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.343 -0.848 . . . . 0.0 109.967 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 733' ' ' ALA . . . . . . . . . . . . . . . -153.19 162.32 41.44 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.18 -0.95 . . . . 0.0 110.551 -179.969 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 734' ' ' ASP . . . . . 0.458 ' O ' ' OD2' ' A' ' 734' ' ' ASP . 4.3 p30 -162.13 118.26 2.01 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.423 -0.798 . . . . 0.0 109.9 179.995 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 735' ' ' VAL . . . . . . . . . . . . . 16.6 t -139.11 164.82 24.6 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.157 -0.964 . . . . 0.0 110.674 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 736' ' ' SER . . . . . . . . . . . . . 8.3 p -109.83 172.9 6.59 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.36 -0.837 . . . . 0.0 109.818 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 737' ' ' GLU . . . . . 0.467 ' OE1' ' HG3' ' A' ' 831' ' ' LYS . 9.5 pt-20 -69.06 -168.7 0.15 Allowed 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.124 -0.985 . . . . 0.0 110.348 179.985 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 738' ' ' TYR . . . . . 0.441 ' N ' ' HG3' ' A' ' 737' ' ' GLU . 84.3 t80 -147.05 -74.7 0.2 Allowed 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.327 -0.858 . . . . 0.0 109.869 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 739' ' ' HIS . . . . . 0.505 ' NE2' ' OD1' ' A' ' 741' ' ' ASN . 3.0 t60 58.52 107.38 0.03 OUTLIER Pre-proline 0 N--CA 1.492 1.67 0 O-C-N 121.2 -0.937 . . . . 0.0 110.551 179.921 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 740' ' ' PRO . . . . . 0.539 ' HD3' ' O ' ' A' ' 756' ' ' HIS . 49.3 Cg_endo -81.29 71.15 7.1 Favored 'Trans proline' 0 C--N 1.307 -1.642 0 O-C-N 124.006 1.53 . . . . 0.0 110.127 -179.963 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 741' ' ' ASN . . . . . 0.505 ' OD1' ' NE2' ' A' ' 739' ' ' HIS . 0.1 OUTLIER -104.39 69.45 0.91 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.205 -0.935 . . . . 0.0 110.445 179.973 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 742' ' ' ILE . . . . . 0.541 HD13 ' N ' ' A' ' 742' ' ' ILE . 0.1 OUTLIER -139.23 141.13 36.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.25 -0.906 . . . . 0.0 110.022 179.936 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 743' ' ' LYS . . . . . . . . . . . . . 27.3 tttt -122.45 -28.13 4.32 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.169 -0.957 . . . . 0.0 110.492 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 744' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -88.33 34.08 0.75 Allowed 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.168 -0.957 . . . . 0.0 110.344 179.965 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 745' ' ' TRP . . . . . 0.596 ' CD1' ' HB2' ' A' ' 746' ' ' GLN . 47.4 t-105 -85.18 -56.63 3.45 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.323 -0.861 . . . . 0.0 110.054 -179.992 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 746' ' ' GLN . . . . . 0.596 ' HB2' ' CD1' ' A' ' 745' ' ' TRP . 4.3 tp60 -151.86 102.03 2.8 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.237 -0.914 . . . . 0.0 110.194 179.983 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 747' ' ' ILE . . . . . 0.622 HG22 ' O ' ' A' ' 747' ' ' ILE . 57.1 mt -105.55 58.28 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.223 -0.923 . . . . 0.0 110.013 179.957 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 748' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -124.84 -73.23 0.64 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.246 -0.909 . . . . 0.0 110.282 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 749' ' ' SER . . . . . . . . . . . . . 1.9 p -170.82 33.91 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.182 -0.949 . . . . 0.0 110.317 -179.935 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 750' ' ' TYR . . . . . . . . . . . . . 25.0 m-85 -106.45 -94.77 0.37 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.198 -0.939 . . . . 0.0 110.34 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 751' ' ' GLY . . . . . . . . . . . . . . . 80.69 135.16 1.54 Allowed Glycine 0 N--CA 1.492 2.417 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 752' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -153.81 60.0 2.83 Favored Pre-proline 0 N--CA 1.493 1.677 0 O-C-N 121.282 -1.128 . . . . 0.0 110.272 179.977 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 753' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -73.15 78.17 2.28 Favored 'Trans proline' 0 C--N 1.305 -1.713 0 O-C-N 124.07 1.563 . . . . 0.0 110.442 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 754' ' ' GLU . . . . . . . . . . . . . 23.5 tt0 -130.96 25.2 4.97 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.174 -0.954 . . . . 0.0 110.19 179.931 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 755' ' ' PHE . . . . . 0.444 ' CD1' ' N ' ' A' ' 756' ' ' HIS . 21.1 t80 -154.13 164.69 38.1 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.314 -0.866 . . . . 0.0 109.999 179.964 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 756' ' ' HIS . . . . . 0.539 ' O ' ' HD3' ' A' ' 740' ' ' PRO . 1.1 t-160 -148.24 -71.58 0.21 Allowed 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.144 -0.973 . . . . 0.0 110.731 -179.947 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 757' ' ' THR . . . . . . . . . . . . . 47.0 p -115.77 151.93 34.25 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.825 -1.172 . . . . 0.0 110.707 -179.915 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 758' ' ' ALA . . . . . 0.431 ' C ' ' HG3' ' A' ' 759' ' ' LYS . . . -64.38 168.02 6.21 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.32 -0.862 . . . . 0.0 110.009 179.96 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 759' ' ' LYS . . . . . 0.431 ' HG3' ' C ' ' A' ' 758' ' ' ALA . 17.1 mttp -146.55 146.47 30.49 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.203 -0.935 . . . . 0.0 110.596 -179.928 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 760' ' ' VAL . . . . . . . . . . . . . 43.8 t -108.72 138.37 36.06 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.291 -0.881 . . . . 0.0 109.62 179.819 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 761' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -109.12 125.65 52.38 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.133 -0.979 . . . . 0.0 111.19 -179.917 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 762' ' ' LEU . . . . . 0.513 ' HB2' ' HB2' ' A' ' 812' ' ' CYS . 20.6 mt -123.39 112.16 17.22 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.464 -0.772 . . . . 0.0 109.296 179.849 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 763' ' ' LYS . . . . . . . . . . . . . 9.7 mttt -107.93 122.1 46.12 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.091 -1.006 . . . . 0.0 110.869 -179.827 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 764' ' ' CYS . . . . . 0.423 ' O ' ' C ' ' A' ' 765' ' ' ALA . 48.7 t -92.91 163.18 13.78 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.46 -0.775 . . . . 0.0 109.618 179.904 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 765' ' ' ALA . . . . . 0.583 ' HB3' ' HB2' ' A' ' 768' ' ' GLN . . . -44.08 154.81 0.36 Allowed Pre-proline 0 N--CA 1.493 1.685 0 O-C-N 121.041 -1.037 . . . . 0.0 109.992 -179.884 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 766' ' ' PRO . . . . . 0.436 ' C ' ' OE1' ' A' ' 768' ' ' GLN . 45.1 Cg_endo -70.95 112.14 3.22 Favored 'Trans proline' 0 C--N 1.306 -1.684 0 O-C-N 123.98 1.516 . . . . 0.0 110.657 -179.96 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 767' ' ' GLY . . . . . . . . . . . . . . . 98.29 -2.96 59.61 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.651 -1.379 . . . . 0.0 109.651 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 768' ' ' GLN . . . . . 0.583 ' HB2' ' HB3' ' A' ' 765' ' ' ALA . 27.6 mp0 -106.59 176.3 5.22 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.23 -1.159 . . . . 0.0 110.078 -179.913 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 769' ' ' THR . . . . . . . . . . . . . 40.6 p -145.12 159.18 43.37 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.225 -0.922 . . . . 0.0 110.502 -179.952 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 770' ' ' ILE . . . . . . . . . . . . . 5.6 mt -71.02 151.47 9.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.302 -0.874 . . . . 0.0 109.831 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 771' ' ' SER . . . . . . . . . . . . . 15.0 m -135.5 -9.97 2.17 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.119 -0.988 . . . . 0.0 111.152 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 772' ' ' ALA . . . . . . . . . . . . . . . -172.38 133.62 0.65 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.823 -1.173 . . . . 0.0 111.124 -179.892 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 773' ' ' ILE . . . . . . . . . . . . . 34.1 mm -86.84 120.4 36.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.367 -0.833 . . . . 0.0 109.232 179.91 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 774' ' ' LYS . . . . . . . . . . . . . 1.2 ttmp? -81.21 -38.58 26.77 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.13 -0.981 . . . . 0.0 111.024 -179.861 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 775' ' ' PHE . . . . . 0.735 ' O ' ' HB2' ' A' ' 776' ' ' ALA . 43.5 t80 -149.29 167.41 26.14 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.008 -1.057 . . . . 0.0 111.182 -179.904 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 776' ' ' ALA . . . . . 0.735 ' HB2' ' O ' ' A' ' 775' ' ' PHE . . . 163.88 59.25 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.843 0 CA-C-O 121.449 0.642 . . . . 0.0 109.328 179.975 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 777' ' ' SER . . . . . 0.545 ' HB3' ' CZ ' ' A' ' 775' ' ' PHE . 0.3 OUTLIER -89.88 154.33 19.95 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.513 -0.742 . . . . 0.0 110.776 -179.933 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 778' ' ' PHE . . . . . 0.409 ' CD2' HG22 ' A' ' 833' ' ' VAL . 7.5 t80 -121.84 89.16 3.07 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.377 -0.827 . . . . 0.0 110.137 -179.994 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 779' ' ' GLY . . . . . . . . . . . . . . . 179.94 -127.72 1.15 Allowed Glycine 0 N--CA 1.493 2.464 0 N-CA-C 109.723 -1.351 . . . . 0.0 109.723 -179.952 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 780' ' ' THR . . . . . 0.491 ' O ' ' HA3' ' A' ' 791' ' ' GLY . 9.0 p -116.03 76.17 6.22 Favored Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.209 -1.171 . . . . 0.0 110.341 179.994 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 781' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -71.18 162.47 42.45 Favored 'Trans proline' 0 C--N 1.304 -1.812 0 O-C-N 124.013 1.533 . . . . 0.0 110.369 179.982 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 782' ' ' LEU . . . . . . . . . . . . . 4.5 mt -123.32 145.52 48.66 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.263 -0.898 . . . . 0.0 110.229 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 783' ' ' GLY . . . . . . . . . . . . . . . 99.86 -175.85 27.91 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.925 -1.27 . . . . 0.0 109.925 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 784' ' ' THR . . . . . 0.471 ' O ' HG23 ' A' ' 784' ' ' THR . 1.7 t -147.41 89.48 1.78 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.313 -1.11 . . . . 0.0 109.855 179.97 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 785' ' ' CYS . . . . . 0.467 ' O ' ' O ' ' A' ' 784' ' ' THR . 4.1 t 54.48 107.89 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.297 -0.877 . . . . 0.0 110.011 -179.966 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 786' ' ' GLY . . . . . . . . . . . . . . . 115.22 -31.1 6.39 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 108.957 -1.657 . . . . 0.0 108.957 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 787' ' ' THR . . . . . . . . . . . . . 8.9 p -141.02 38.74 1.78 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.463 -1.022 . . . . 0.0 109.831 179.908 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 788' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -63.32 165.12 7.95 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.364 -0.835 . . . . 0.0 110.479 -179.992 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 789' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -159.36 165.67 32.79 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.374 -0.829 . . . . 0.0 109.443 179.95 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 790' ' ' GLN . . . . . 0.43 ' O ' ' C ' ' A' ' 791' ' ' GLY . 5.8 pt20 -90.25 20.57 4.31 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.014 -1.054 . . . . 0.0 110.487 -179.973 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 791' ' ' GLY . . . . . 0.491 ' HA3' ' O ' ' A' ' 780' ' ' THR . . . 41.77 -143.24 1.03 Allowed Glycine 0 N--CA 1.491 2.313 0 N-CA-C 110.067 -1.213 . . . . 0.0 110.067 -179.989 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 792' ' ' GLU . . . . . . . . . . . . . 27.8 mm-40 -95.15 -43.21 8.2 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.448 -1.031 . . . . 0.0 110.354 -179.957 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 793' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -108.44 134.06 51.75 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.039 -1.038 . . . . 0.0 110.075 -179.988 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 794' ' ' HIS . . . . . 0.559 ' CG ' ' N ' ' A' ' 795' ' ' SER . 68.3 t60 -139.28 169.55 17.55 Favored 'General case' 0 C--N 1.299 -1.591 0 O-C-N 121.32 -0.862 . . . . 0.0 110.176 -179.981 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 795' ' ' SER . . . . . 0.559 ' N ' ' CG ' ' A' ' 794' ' ' HIS . 0.1 OUTLIER -110.69 129.79 55.74 Favored 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 179.904 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 796' ' ' ILE . . . . . . . . . . . . . 35.9 mt -69.7 -5.62 5.33 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.619 0 O-C-N 120.915 -1.115 . . . . 0.0 109.875 -179.913 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 797' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -102.85 14.83 31.0 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.334 -0.853 . . . . 0.0 109.799 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 798' ' ' SER . . . . . 0.512 ' HB2' ' O ' ' A' ' 776' ' ' ALA . 10.8 p -58.79 -62.75 1.63 Allowed 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.463 -0.773 . . . . 0.0 111.278 179.997 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 799' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -82.54 1.43 37.94 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.261 -0.9 . . . . 0.0 110.951 -179.882 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 800' ' ' SER . . . . . 0.485 ' O ' ' HG2' ' A' ' 804' ' ' ARG . 23.3 t -84.21 -25.99 29.08 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.057 -1.027 . . . . 0.0 110.478 -179.926 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 801' ' ' VAL . . . . . 0.407 ' C ' HD22 ' A' ' 802' ' ' LEU . 59.9 t -93.61 -27.99 4.41 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.282 -0.886 . . . . 0.0 111.445 -179.922 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 802' ' ' LEU . . . . . 0.643 ' CD1' HG21 ' A' ' 814' ' ' VAL . 4.0 mm? -89.96 -29.67 18.32 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 120.964 -1.085 . . . . 0.0 111.152 -179.88 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 803' ' ' GLU . . . . . . . . . . . . . 11.3 tt0 -68.93 -28.12 66.37 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 120.818 -1.176 . . . . 0.0 110.942 -179.915 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 804' ' ' ARG . . . . . 0.485 ' HG2' ' O ' ' A' ' 800' ' ' SER . 0.0 OUTLIER -95.0 -17.82 21.59 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.092 -1.005 . . . . 0.0 111.804 -179.969 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 805' ' ' LYS . . . . . 0.433 ' N ' ' HG3' ' A' ' 804' ' ' ARG . 2.3 tptp -115.58 41.33 2.53 Favored 'General case' 0 N--CA 1.501 2.125 0 O-C-N 120.872 -1.143 . . . . 0.0 112.172 -179.824 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 806' ' ' CYS . . . . . 0.524 ' HB2' ' O ' ' A' ' 802' ' ' LEU . 0.5 OUTLIER -160.31 -19.25 0.06 Allowed 'General case' 0 N--CA 1.504 2.236 0 O-C-N 120.577 -1.327 . . . . 0.0 112.306 -179.981 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 807' ' ' ILE . . . . . . . . . . . . . 52.9 mt -85.66 120.49 35.85 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 O-C-N 120.665 -1.272 . . . . 0.0 111.145 -179.962 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 808' ' ' GLY . . . . . 0.434 ' C ' ' HG ' ' A' ' 809' ' ' LEU . . . 112.92 12.63 12.15 Favored Glycine 0 N--CA 1.494 2.531 0 N-CA-C 110.363 -1.095 . . . . 0.0 110.363 179.897 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 809' ' ' LEU . . . . . 0.434 ' HG ' ' C ' ' A' ' 808' ' ' GLY . 12.1 mt -136.29 155.31 50.27 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.033 -1.275 . . . . 0.0 110.799 -179.968 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 810' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -89.99 8.72 31.01 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.433 -0.792 . . . . 0.0 109.389 179.916 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 811' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -155.89 160.94 40.58 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 -179.976 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 812' ' ' CYS . . . . . 0.513 ' HB2' ' HB2' ' A' ' 762' ' ' LEU . 1.0 OUTLIER -143.59 132.76 23.09 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.844 -1.16 . . . . 0.0 111.233 -179.936 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 813' ' ' VAL . . . . . . . . . . . . . 89.7 t -136.2 104.63 4.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.488 -0.757 . . . . 0.0 109.554 179.935 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 814' ' ' VAL . . . . . 0.643 HG21 ' CD1' ' A' ' 802' ' ' LEU . 96.8 t -113.56 129.99 68.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.137 -0.977 . . . . 0.0 110.819 -179.966 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 815' ' ' ALA . . . . . . . . . . . . . . . -85.52 141.8 29.63 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.32 -0.863 . . . . 0.0 109.387 179.933 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 816' ' ' ILE . . . . . 0.522 ' CG2' HG21 ' A' ' 833' ' ' VAL . 21.0 mt -104.5 124.12 58.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.133 -0.979 . . . . 0.0 110.651 -179.903 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 817' ' ' SER . . . . . 0.46 ' OG ' ' HD2' ' A' ' 818' ' ' PRO . 29.2 t -148.05 153.54 41.87 Favored Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 121.348 -0.845 . . . . 0.0 110.025 179.957 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 818' ' ' PRO . . . . . 0.46 ' HD2' ' OG ' ' A' ' 817' ' ' SER . 43.5 Cg_endo -70.71 -10.11 27.14 Favored 'Trans proline' 0 C--N 1.304 -1.768 0 O-C-N 123.984 1.518 . . . . 0.0 110.315 -179.954 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 819' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -125.42 59.73 1.26 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.317 -0.864 . . . . 0.0 110.014 -179.96 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 820' ' ' ASN . . . . . . . . . . . . . 1.3 m120 -148.34 -35.83 0.2 Allowed 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.361 -0.837 . . . . 0.0 110.285 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 821' ' ' PHE . . . . . . . . . . . . . 13.9 m-85 -80.16 0.76 30.92 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.145 -0.972 . . . . 0.0 110.485 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 822' ' ' GLY . . . . . . . . . . . . . . . 110.7 12.29 16.98 Favored Glycine 0 N--CA 1.493 2.448 0 N-CA-C 109.767 -1.333 . . . . 0.0 109.767 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 823' ' ' GLY . . . . . . . . . . . . . . . 108.73 -159.53 14.11 Favored Glycine 0 N--CA 1.492 2.374 0 N-CA-C 109.629 -1.388 . . . . 0.0 109.629 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 824' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -117.91 136.11 23.64 Favored Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 121.221 -1.164 . . . . 0.0 110.391 -179.997 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 825' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -72.47 -80.12 0.01 OUTLIER 'Trans proline' 0 C--N 1.307 -1.638 0 O-C-N 123.959 1.505 . . . . 0.0 110.161 179.961 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 826' ' ' CYS . . . . . 0.696 ' SG ' HG21 ' A' ' 829' ' ' VAL . 5.8 p -106.58 121.4 45.28 Favored Pre-proline 0 N--CA 1.498 1.957 0 O-C-N 121.11 -0.994 . . . . 0.0 109.921 179.93 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 827' ' ' PRO . . . . . 0.47 ' O ' ' CB ' ' A' ' 828' ' ' GLU . 43.7 Cg_endo -70.38 171.43 15.17 Favored 'Trans proline' 0 C--N 1.309 -1.523 0 O-C-N 123.942 1.496 . . . . 0.0 110.054 -179.975 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 828' ' ' GLU . . . . . 0.47 ' CB ' ' O ' ' A' ' 827' ' ' PRO . 0.0 OUTLIER 66.54 15.74 10.2 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.21 -0.931 . . . . 0.0 109.64 -179.951 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 829' ' ' VAL . . . . . 0.696 HG21 ' SG ' ' A' ' 826' ' ' CYS . 95.4 t -119.8 132.26 70.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.425 -0.797 . . . . 0.0 110.02 179.934 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 830' ' ' MET . . . . . . . . . . . . . 2.2 tpp -53.55 144.71 16.63 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.219 -0.926 . . . . 0.0 110.279 179.961 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 831' ' ' LYS . . . . . 0.467 ' HG3' ' OE1' ' A' ' 737' ' ' GLU . 0.0 OUTLIER -115.07 97.81 6.43 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.123 -0.986 . . . . 0.0 110.675 -179.938 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 832' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -122.17 167.94 12.59 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.419 -0.8 . . . . 0.0 109.434 179.989 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 833' ' ' VAL . . . . . 0.522 HG21 ' CG2' ' A' ' 816' ' ' ILE . 38.3 t -124.26 148.23 28.54 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 O-C-N 120.908 -1.12 . . . . 0.0 111.537 -179.915 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 834' ' ' ALA . . . . . 0.488 ' O ' ' HA ' ' A' ' 776' ' ' ALA . . . -150.69 111.65 4.32 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 179.919 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 835' ' ' VAL . . . . . 0.554 HG22 ' CB ' ' A' ' 776' ' ' ALA . 41.0 t -126.7 164.67 26.59 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 O-C-N 120.977 -1.077 . . . . 0.0 112.342 -179.773 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 836' ' ' GLU . . . . . 0.47 ' N ' ' CG1' ' A' ' 835' ' ' VAL . 64.0 tt0 -153.87 137.57 16.09 Favored 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 179.855 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 837' ' ' ALA . . . . . . . . . . . . . . . -124.19 162.83 22.83 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 120.769 -1.207 . . . . 0.0 111.808 -179.814 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 838' ' ' VAL . . . . . . . . . . . . . 60.7 t -115.46 128.54 72.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.702 -0.624 . . . . 0.0 109.509 179.889 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 839' ' ' CYS . . . . . . . . . . . . . 5.2 m -108.25 156.36 19.45 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.998 -1.064 . . . . 0.0 110.908 -179.957 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 840' ' ' SER . . . . . 0.625 ' HA ' HG12 ' A' ' 728' ' ' VAL . 6.0 p -157.97 136.37 11.05 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.43 -0.794 . . . . 0.0 109.84 179.917 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 841' ' ' THR . . . . . 0.429 ' HA ' ' HG3' ' A' ' 768' ' ' GLN . 65.7 p -64.64 102.86 0.61 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.32 -0.862 . . . . 0.0 110.41 -179.954 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 842' ' ' ALA . . . . . . . . . . . . . . . -89.85 75.04 7.33 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.29 -0.881 . . . . 0.0 110.116 179.938 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 843' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 1.753 0 CA-C-O 118.013 -0.994 . . . . 0.0 110.211 -179.97 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 726' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.492 1.666 0 CA-C-O 121.177 0.513 . . . . 0.0 110.321 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 727' ' ' THR . . . . . . . . . . . . . 90.3 m -100.3 151.26 21.69 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.177 -0.952 . . . . 0.0 110.173 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 728' ' ' VAL . . . . . . . . . . . . . 66.4 t -135.18 125.22 43.89 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 O-C-N 121.257 -0.902 . . . . 0.0 110.236 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 729' ' ' SER . . . . . 0.445 ' O ' ' O ' ' A' ' 730' ' ' GLY . 15.1 p -139.7 71.08 1.37 Allowed 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.258 -0.901 . . . . 0.0 110.472 -179.943 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 730' ' ' GLY . . . . . 0.517 ' HA3' ' HA ' ' A' ' 838' ' ' VAL . . . -52.1 -175.77 0.04 OUTLIER Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 179.958 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 731' ' ' VAL . . . . . . . . . . . . . 3.6 t -132.26 135.93 57.26 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.286 -1.126 . . . . 0.0 110.036 179.994 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 732' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -110.55 126.96 54.97 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.239 -0.913 . . . . 0.0 110.081 179.936 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 733' ' ' ALA . . . . . . . . . . . . . . . -138.92 123.0 17.95 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.211 -0.931 . . . . 0.0 110.717 -179.898 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 734' ' ' ASP . . . . . . . . . . . . . 2.2 p-10 -113.0 108.8 17.85 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.401 -0.812 . . . . 0.0 109.698 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 735' ' ' VAL . . . . . 0.428 HG12 ' N ' ' A' ' 736' ' ' SER . 45.7 t -111.12 164.11 7.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.226 -0.921 . . . . 0.0 110.315 -179.937 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 736' ' ' SER . . . . . 0.428 ' N ' HG12 ' A' ' 735' ' ' VAL . 44.5 p -101.53 -178.48 3.74 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.178 -0.951 . . . . 0.0 110.264 -179.96 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 737' ' ' GLU . . . . . 0.505 ' HB2' HG21 ' A' ' 816' ' ' ILE . 25.6 tt0 -127.08 106.15 9.07 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.341 -0.849 . . . . 0.0 110.351 179.963 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 738' ' ' TYR . . . . . 0.603 ' CG ' ' N ' ' A' ' 739' ' ' HIS . 29.8 p90 -171.13 -42.67 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.216 -0.928 . . . . 0.0 110.577 -179.962 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 739' ' ' HIS . . . . . 0.603 ' N ' ' CG ' ' A' ' 738' ' ' TYR . 0.5 OUTLIER -176.12 134.26 0.43 Allowed Pre-proline 0 N--CA 1.494 1.73 0 O-C-N 121.204 -0.935 . . . . 0.0 110.505 -179.923 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 740' ' ' PRO . . . . . 0.499 ' O ' ' CB ' ' A' ' 741' ' ' ASN . 48.3 Cg_endo -75.94 -13.96 19.32 Favored 'Trans proline' 0 C--N 1.307 -1.656 0 O-C-N 123.973 1.512 . . . . 0.0 110.432 179.94 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 741' ' ' ASN . . . . . 0.499 ' CB ' ' O ' ' A' ' 740' ' ' PRO . 4.8 m-20 70.91 75.94 0.19 Allowed 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.355 -0.84 . . . . 0.0 110.132 179.995 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 742' ' ' ILE . . . . . 0.704 ' H ' HD12 ' A' ' 742' ' ' ILE . 3.8 mp -55.52 -72.58 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.262 -0.899 . . . . 0.0 110.224 -179.976 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 743' ' ' LYS . . . . . 0.454 ' HG2' ' O ' ' A' ' 742' ' ' ILE . 1.2 mmpt? -141.38 -161.51 1.23 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.276 -0.89 . . . . 0.0 110.307 -179.899 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 744' ' ' ASN . . . . . 0.423 ' O ' ' CG ' ' A' ' 744' ' ' ASN . 8.6 p-10 -94.16 59.07 2.61 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.245 -0.91 . . . . 0.0 110.16 179.986 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 745' ' ' TRP . . . . . 0.502 ' CZ2' ' O ' ' A' ' 748' ' ' GLU . 1.0 OUTLIER -101.98 -165.09 1.15 Allowed 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.251 -0.906 . . . . 0.0 110.263 179.959 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 746' ' ' GLN . . . . . 0.421 ' C ' ' O ' ' A' ' 745' ' ' TRP . 0.7 OUTLIER -43.06 150.74 0.16 Allowed 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.301 -0.875 . . . . 0.0 109.965 -179.936 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 747' ' ' ILE . . . . . 0.675 HG22 ' O ' ' A' ' 747' ' ' ILE . 9.6 mm -85.17 13.04 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.258 -0.901 . . . . 0.0 110.21 179.953 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 748' ' ' GLU . . . . . 0.502 ' O ' ' CZ2' ' A' ' 745' ' ' TRP . 8.5 mm-40 -118.19 -168.35 1.51 Allowed 'General case' 0 C--N 1.291 -1.969 0 O-C-N 121.14 -0.975 . . . . 0.0 110.108 -179.883 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 749' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -144.4 60.2 1.34 Allowed 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.242 -0.911 . . . . 0.0 110.406 179.966 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 750' ' ' TYR . . . . . 0.429 ' CD1' ' N ' ' A' ' 750' ' ' TYR . 29.7 p90 -129.63 -3.67 4.76 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.112 -0.993 . . . . 0.0 110.519 179.991 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 751' ' ' GLY . . . . . 0.418 ' O ' ' OE2' ' A' ' 752' ' ' GLU . . . -103.02 -23.24 8.7 Favored Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.365 -1.494 . . . . 0.0 109.365 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 752' ' ' GLU . . . . . 0.418 ' OE2' ' O ' ' A' ' 751' ' ' GLY . 0.3 OUTLIER -167.33 60.45 0.53 Allowed Pre-proline 0 N--CA 1.492 1.645 0 O-C-N 121.323 -1.104 . . . . 0.0 109.744 179.951 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 753' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -73.74 80.88 1.96 Allowed 'Trans proline' 0 C--N 1.304 -1.771 0 O-C-N 124.12 1.59 . . . . 0.0 110.804 -179.916 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 754' ' ' GLU . . . . . . . . . . . . . 9.9 mt-10 -95.25 -26.16 16.06 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.132 -0.98 . . . . 0.0 109.8 179.948 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 755' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -135.08 145.8 48.28 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.332 -0.855 . . . . 0.0 109.967 179.965 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 756' ' ' HIS . . . . . 0.585 ' CG ' ' O ' ' A' ' 756' ' ' HIS . 26.5 t-80 -152.19 31.03 0.54 Allowed 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.091 -1.005 . . . . 0.0 110.703 179.994 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 757' ' ' THR . . . . . 0.464 HG23 ' C ' ' A' ' 756' ' ' HIS . 71.5 p -149.77 125.46 10.39 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.002 -1.061 . . . . 0.0 110.543 179.918 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 758' ' ' ALA . . . . . . . . . . . . . . . -60.25 170.02 1.43 Allowed 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.257 -0.902 . . . . 0.0 109.525 179.958 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 759' ' ' LYS . . . . . . . . . . . . . 21.2 mttt -129.25 161.89 29.15 Favored 'General case' 0 C--N 1.299 -1.612 0 O-C-N 121.087 -1.008 . . . . 0.0 110.382 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 760' ' ' VAL . . . . . . . . . . . . . 28.0 t -107.24 131.79 56.38 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.343 -0.848 . . . . 0.0 108.769 179.958 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 761' ' ' HIS . . . . . . . . . . . . . 27.0 m170 -112.29 104.41 12.58 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.035 -1.04 . . . . 0.0 111.545 -179.872 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 762' ' ' LEU . . . . . . . . . . . . . 19.4 mt -110.32 113.42 26.06 Favored 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 179.864 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 763' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -140.03 116.98 11.04 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.712 -1.242 . . . . 0.0 111.331 -179.858 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 764' ' ' CYS . . . . . 0.463 ' O ' ' O ' ' A' ' 765' ' ' ALA . 1.5 m -95.89 146.03 24.9 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.511 -0.743 . . . . 0.0 109.05 179.938 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 765' ' ' ALA . . . . . 0.626 ' HB3' ' OE1' ' A' ' 768' ' ' GLN . . . -39.61 160.74 0.1 OUTLIER Pre-proline 0 N--CA 1.498 1.933 0 O-C-N 121.215 -0.928 . . . . 0.0 110.413 -179.992 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 766' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -69.99 102.07 1.02 Allowed 'Trans proline' 0 C--N 1.305 -1.757 0 O-C-N 123.941 1.495 . . . . 0.0 110.213 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 767' ' ' GLY . . . . . . . . . . . . . . . 132.3 -17.92 4.75 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 108.966 -1.654 . . . . 0.0 108.966 -179.951 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 768' ' ' GLN . . . . . 0.626 ' OE1' ' HB3' ' A' ' 765' ' ' ALA . 13.2 mt-30 -102.58 114.77 29.26 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.423 -1.045 . . . . 0.0 109.77 179.895 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 769' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -106.82 149.39 27.44 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.202 -0.936 . . . . 0.0 110.616 -179.954 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 770' ' ' ILE . . . . . . . . . . . . . 49.8 mt -72.92 150.26 8.22 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.314 -0.866 . . . . 0.0 109.545 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 771' ' ' SER . . . . . . . . . . . . . 1.3 p -140.84 3.64 1.85 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 120.995 -1.066 . . . . 0.0 111.008 179.973 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 772' ' ' ALA . . . . . . . . . . . . . . . -173.65 145.96 1.25 Allowed 'General case' 0 N--CA 1.495 1.783 0 O-C-N 120.902 -1.124 . . . . 0.0 111.551 -179.946 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 773' ' ' ILE . . . . . 0.401 HD12 HG23 ' A' ' 773' ' ' ILE . 38.1 mm -107.01 147.92 11.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 179.907 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 774' ' ' LYS . . . . . . . . . . . . . 9.8 tptp -113.44 -25.0 8.99 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.998 -1.064 . . . . 0.0 110.808 -179.93 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 775' ' ' PHE . . . . . 0.588 ' O ' ' HB2' ' A' ' 776' ' ' ALA . 68.5 t80 -170.43 163.98 8.59 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.057 -1.027 . . . . 0.0 110.751 179.994 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 776' ' ' ALA . . . . . 0.588 ' HB2' ' O ' ' A' ' 775' ' ' PHE . . . 175.07 72.31 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.692 -0.63 . . . . 0.0 109.406 -179.945 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 777' ' ' SER . . . . . 0.449 ' HA ' ' HB3' ' A' ' 798' ' ' SER . 1.5 t -92.66 154.23 18.49 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.328 -0.857 . . . . 0.0 110.968 -179.891 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 778' ' ' PHE . . . . . 0.578 ' O ' ' CD2' ' A' ' 778' ' ' PHE . 33.9 t80 -124.95 94.96 4.33 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.467 -0.771 . . . . 0.0 109.899 179.958 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 779' ' ' GLY . . . . . . . . . . . . . . . 159.18 -97.12 0.16 Allowed Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 179.99 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 780' ' ' THR . . . . . 0.466 HG21 HG11 ' A' ' 829' ' ' VAL . 52.1 p -132.8 92.58 26.12 Favored Pre-proline 0 N--CA 1.493 1.716 0 O-C-N 121.271 -1.134 . . . . 0.0 110.285 -179.94 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 781' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -75.26 173.19 14.93 Favored 'Trans proline' 0 C--N 1.305 -1.744 0 O-C-N 124.098 1.578 . . . . 0.0 110.523 179.916 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 782' ' ' LEU . . . . . . . . . . . . . 2.2 tt -137.65 118.32 14.02 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.307 -0.871 . . . . 0.0 110.167 179.935 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 783' ' ' GLY . . . . . 0.409 ' HA3' HG23 ' A' ' 787' ' ' THR . . . 95.28 -176.84 34.52 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.331 -1.507 . . . . 0.0 109.331 179.98 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 784' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -117.91 -160.81 0.8 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.208 -1.172 . . . . 0.0 110.188 -179.979 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 785' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -60.56 119.16 7.54 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.306 -0.871 . . . . 0.0 110.252 -179.932 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 786' ' ' GLY . . . . . . . . . . . . . . . 114.85 -28.93 7.77 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 787' ' ' THR . . . . . 0.409 HG23 ' HA3' ' A' ' 783' ' ' GLY . 8.9 t -134.78 34.4 3.16 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.237 -1.155 . . . . 0.0 110.309 179.967 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 788' ' ' PHE . . . . . 0.493 ' CZ ' ' HB1' ' A' ' 834' ' ' ALA . 1.0 OUTLIER -65.85 132.12 47.91 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.278 -0.889 . . . . 0.0 109.943 179.989 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 789' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -139.9 154.02 47.14 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.229 -0.919 . . . . 0.0 110.33 179.925 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 790' ' ' GLN . . . . . 0.419 ' OE1' ' ND1' ' A' ' 794' ' ' HIS . 1.6 mp0 -65.84 116.3 6.86 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.351 -0.843 . . . . 0.0 110.482 -179.987 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 791' ' ' GLY . . . . . . . . . . . . . . . -64.68 -105.86 0.01 OUTLIER Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.623 -1.391 . . . . 0.0 109.623 -179.945 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 792' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -127.18 -26.12 3.15 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.302 -1.117 . . . . 0.0 110.509 -179.956 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 793' ' ' CYS . . . . . 0.474 ' O ' ' HB3' ' A' ' 794' ' ' HIS . 85.7 m -100.2 -83.91 0.43 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.206 -0.933 . . . . 0.0 109.89 -179.997 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 794' ' ' HIS . . . . . 0.637 ' CE1' ' OG ' ' A' ' 798' ' ' SER . 84.9 t60 58.4 113.77 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.506 -0.746 . . . . 0.0 110.728 179.981 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 795' ' ' SER . . . . . 0.468 ' O ' ' O ' ' A' ' 794' ' ' HIS . 100.0 p -60.66 -126.6 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.301 -0.874 . . . . 0.0 109.295 179.871 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 796' ' ' ILE . . . . . 0.424 ' CG1' ' C ' ' A' ' 795' ' ' SER . 1.0 OUTLIER -148.02 -31.06 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 2.02 0 O-C-N 120.798 -1.189 . . . . 0.0 110.68 179.856 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 797' ' ' ASN . . . . . 0.667 ' O ' HG23 ' A' ' 801' ' ' VAL . 4.3 m120 -86.26 16.28 4.54 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 120.906 -1.121 . . . . 0.0 110.04 179.914 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 798' ' ' SER . . . . . 0.637 ' OG ' ' CE1' ' A' ' 794' ' ' HIS . 0.9 OUTLIER -33.56 -70.76 0.07 Allowed 'General case' 0 N--CA 1.503 2.178 0 O-C-N 121.775 -0.578 . . . . 0.0 111.8 -179.999 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 799' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -84.99 -30.02 24.55 Favored 'General case' 0 N--CA 1.501 2.086 0 O-C-N 121.155 -0.966 . . . . 0.0 111.094 -179.876 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 800' ' ' SER . . . . . . . . . . . . . 37.2 t -54.47 -16.91 2.61 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.059 -1.026 . . . . 0.0 110.743 -179.955 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 801' ' ' VAL . . . . . 0.667 HG23 ' O ' ' A' ' 797' ' ' ASN . 85.3 t -90.97 -48.69 13.9 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.919 0 O-C-N 121.046 -1.034 . . . . 0.0 111.588 -179.851 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 802' ' ' LEU . . . . . 0.516 HD22 ' N ' ' A' ' 802' ' ' LEU . 4.6 mm? -75.08 -16.33 60.57 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.112 -0.993 . . . . 0.0 111.522 -179.801 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 803' ' ' GLU . . . . . 0.906 ' O ' HD12 ' A' ' 807' ' ' ILE . 0.5 OUTLIER -81.94 -27.53 33.24 Favored 'General case' 0 C--N 1.295 -1.77 0 O-C-N 120.73 -1.232 . . . . 0.0 110.778 -179.947 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 804' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -95.4 -18.39 20.77 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.109 -0.994 . . . . 0.0 112.28 -179.918 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 805' ' ' LYS . . . . . 0.458 ' O ' ' SG ' ' A' ' 806' ' ' CYS . 4.0 ttpt -122.17 20.25 10.63 Favored 'General case' 0 N--CA 1.501 2.078 0 O-C-N 120.452 -1.405 . . . . 0.0 112.477 -179.868 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 806' ' ' CYS . . . . . 0.512 ' HB2' ' O ' ' A' ' 802' ' ' LEU . 50.0 m -152.66 51.17 0.76 Allowed 'General case' 0 N--CA 1.496 1.832 0 O-C-N 120.665 -1.272 . . . . 0.0 110.406 179.905 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 807' ' ' ILE . . . . . 0.906 HD12 ' O ' ' A' ' 803' ' ' GLU . 9.1 mt -140.42 95.04 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.484 0 O-C-N 121.524 -0.735 . . . . 0.0 109.324 179.956 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 808' ' ' GLY . . . . . . . . . . . . . . . 118.95 10.07 8.51 Favored Glycine 0 N--CA 1.489 2.199 0 N-CA-C 109.264 -1.534 . . . . 0.0 109.264 -179.946 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 809' ' ' LEU . . . . . . . . . . . . . 9.1 mt -117.61 157.05 27.08 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.255 -1.144 . . . . 0.0 110.191 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 810' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -86.28 -18.61 31.59 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.202 -0.936 . . . . 0.0 110.088 179.987 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 811' ' ' ARG . . . . . . . . . . . . . 26.2 ttp180 -149.79 136.09 19.0 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.323 -0.861 . . . . 0.0 110.087 179.942 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 812' ' ' CYS . . . . . 0.45 ' SG ' ' O ' ' A' ' 805' ' ' LYS . 0.1 OUTLIER -123.98 144.21 49.95 Favored 'General case' 0 C--N 1.298 -1.655 0 O-C-N 121.303 -0.873 . . . . 0.0 110.256 -179.906 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 813' ' ' VAL . . . . . 0.598 HG13 ' O ' ' A' ' 813' ' ' VAL . 7.0 p -137.87 123.15 24.44 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.509 0 O-C-N 121.309 -0.87 . . . . 0.0 109.622 179.888 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 814' ' ' VAL . . . . . . . . . . . . . 36.5 t -131.38 135.81 58.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.135 -0.978 . . . . 0.0 110.393 -179.946 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 815' ' ' ALA . . . . . 0.467 ' O ' ' OD1' ' A' ' 820' ' ' ASN . . . -82.8 146.32 29.02 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.341 -0.849 . . . . 0.0 110.024 179.972 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 816' ' ' ILE . . . . . 0.863 HG23 HG21 ' A' ' 833' ' ' VAL . 18.0 mt -95.58 111.83 26.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.213 -0.93 . . . . 0.0 110.194 -179.995 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 817' ' ' SER . . . . . 0.527 ' CB ' ' HD2' ' A' ' 818' ' ' PRO . 1.0 OUTLIER -161.73 -175.83 0.53 Allowed Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.226 -0.922 . . . . 0.0 110.219 179.937 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 818' ' ' PRO . . . . . 0.527 ' HD2' ' CB ' ' A' ' 817' ' ' SER . 50.2 Cg_endo -78.32 -37.02 0.82 Allowed 'Trans proline' 0 C--N 1.305 -1.711 0 O-C-N 124.02 1.537 . . . . 0.0 110.893 -179.853 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 819' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -83.49 22.93 0.99 Allowed 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.113 -0.992 . . . . 0.0 110.826 -179.991 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 820' ' ' ASN . . . . . 0.467 ' OD1' ' O ' ' A' ' 815' ' ' ALA . 0.7 OUTLIER -117.0 -15.01 10.61 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.11 -0.994 . . . . 0.0 110.169 179.939 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 821' ' ' PHE . . . . . . . . . . . . . 39.4 m-85 -128.01 -74.19 0.58 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.154 -0.966 . . . . 0.0 110.621 179.987 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 822' ' ' GLY . . . . . . . . . . . . . . . -163.17 50.84 0.31 Allowed Glycine 0 N--CA 1.493 2.477 0 N-CA-C 109.778 -1.329 . . . . 0.0 109.778 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 823' ' ' GLY . . . . . . . . . . . . . . . 72.76 -126.82 11.02 Favored Glycine 0 N--CA 1.492 2.393 0 N-CA-C 109.661 -1.376 . . . . 0.0 109.661 179.944 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 824' ' ' ASP . . . . . 0.41 ' O ' ' OD2' ' A' ' 824' ' ' ASP . 1.5 p30 -127.17 134.97 26.72 Favored Pre-proline 0 N--CA 1.494 1.742 0 O-C-N 121.241 -1.152 . . . . 0.0 110.32 179.986 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 825' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -78.95 -90.76 0.0 OUTLIER 'Trans proline' 0 C--N 1.307 -1.64 0 O-C-N 124.053 1.554 . . . . 0.0 110.616 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 826' ' ' CYS . . . . . 0.452 ' HA ' ' HD3' ' A' ' 827' ' ' PRO . 24.3 p -115.39 138.26 23.58 Favored Pre-proline 0 N--CA 1.496 1.851 0 O-C-N 121.21 -0.931 . . . . 0.0 111.067 -179.897 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 827' ' ' PRO . . . . . 0.469 ' O ' ' HB2' ' A' ' 828' ' ' GLU . 54.9 Cg_endo -85.16 -178.91 3.32 Favored 'Trans proline' 0 C--N 1.306 -1.687 0 O-C-N 124.121 1.59 . . . . 0.0 110.057 179.915 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 828' ' ' GLU . . . . . 0.469 ' HB2' ' O ' ' A' ' 827' ' ' PRO . 50.6 mt-10 57.88 17.38 4.24 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.566 -0.709 . . . . 0.0 111.042 179.937 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 829' ' ' VAL . . . . . 0.466 HG11 HG21 ' A' ' 780' ' ' THR . 72.4 t -130.4 141.42 46.33 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 O-C-N 121.079 -1.013 . . . . 0.0 110.023 179.844 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 830' ' ' MET . . . . . 0.463 ' O ' ' O ' ' A' ' 829' ' ' VAL . 0.0 OUTLIER -51.21 -175.75 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.195 -0.94 . . . . 0.0 110.126 -179.975 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 831' ' ' LYS . . . . . . . . . . . . . 9.7 mttp -142.29 108.23 5.17 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.025 -1.047 . . . . 0.0 110.896 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 832' ' ' ARG . . . . . . . . . . . . . 5.9 mtp180 -129.88 147.42 51.65 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.444 -0.785 . . . . 0.0 109.483 179.957 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 833' ' ' VAL . . . . . 0.863 HG21 HG23 ' A' ' 816' ' ' ILE . 92.6 t -120.15 117.57 53.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.024 -1.047 . . . . 0.0 110.731 -179.942 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 834' ' ' ALA . . . . . 0.493 ' HB1' ' CZ ' ' A' ' 788' ' ' PHE . . . -112.99 127.92 56.36 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.284 -0.885 . . . . 0.0 109.847 179.917 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 835' ' ' VAL . . . . . 0.467 ' CG1' ' N ' ' A' ' 836' ' ' GLU . 14.9 t -126.11 165.69 23.61 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 121.11 -0.994 . . . . 0.0 110.577 -179.916 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 836' ' ' GLU . . . . . 0.467 ' N ' ' CG1' ' A' ' 835' ' ' VAL . 0.1 OUTLIER -152.88 109.69 3.46 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.377 -0.827 . . . . 0.0 109.657 -179.939 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 837' ' ' ALA . . . . . . . . . . . . . . . -111.18 162.01 15.38 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.171 -0.956 . . . . 0.0 110.532 -179.979 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 838' ' ' VAL . . . . . 0.517 ' HA ' ' HA3' ' A' ' 730' ' ' GLY . 39.1 t -120.02 132.87 68.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.321 -0.862 . . . . 0.0 110.07 -179.96 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 839' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -118.18 136.89 53.35 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.222 -0.924 . . . . 0.0 110.149 -179.976 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 840' ' ' SER . . . . . 0.44 ' O ' ' HG2' ' A' ' 768' ' ' GLN . 91.4 p -106.23 -145.01 0.38 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.161 -0.962 . . . . 0.0 110.031 179.975 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 841' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -145.86 152.26 39.2 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.062 -1.024 . . . . 0.0 110.299 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 842' ' ' ALA . . . . . . . . . . . . . . . 44.2 68.14 0.58 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.254 -0.904 . . . . 0.0 110.162 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 843' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.621 0 CA-C-O 117.985 -1.007 . . . . 0.0 110.22 -179.995 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 726' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.678 0 CA-C-O 121.312 0.577 . . . . 0.0 110.213 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 727' ' ' THR . . . . . 0.533 ' CG2' ' HB2' ' A' ' 840' ' ' SER . 3.4 m -53.64 164.31 0.55 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.188 -0.945 . . . . 0.0 110.214 -179.994 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 728' ' ' VAL . . . . . 0.512 ' O ' ' CB ' ' A' ' 729' ' ' SER . 74.6 t -106.98 165.03 4.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.28 -0.888 . . . . 0.0 110.075 179.988 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 729' ' ' SER . . . . . 0.512 ' CB ' ' O ' ' A' ' 728' ' ' VAL . 0.3 OUTLIER 166.65 126.52 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.104 0 O-C-N 121.326 -0.859 . . . . 0.0 110.304 -179.987 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 730' ' ' GLY . . . . . 0.437 ' C ' ' CG2' ' A' ' 731' ' ' VAL . . . 142.78 76.57 0.04 OUTLIER Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.741 -1.344 . . . . 0.0 109.741 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 731' ' ' VAL . . . . . 0.437 ' CG2' ' C ' ' A' ' 730' ' ' GLY . 3.1 t -147.6 135.58 14.74 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 121.178 -1.189 . . . . 0.0 110.14 179.994 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 732' ' ' CYS . . . . . . . . . . . . . 30.4 p -153.3 138.27 17.22 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.235 -0.915 . . . . 0.0 110.094 -179.961 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 733' ' ' ALA . . . . . . . . . . . . . . . -111.92 131.21 55.52 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.266 -0.896 . . . . 0.0 110.397 179.992 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 734' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -119.7 105.37 11.1 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.296 -0.878 . . . . 0.0 110.037 179.941 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 735' ' ' VAL . . . . . 0.423 HG12 ' N ' ' A' ' 736' ' ' SER . 61.1 t -128.42 162.83 34.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.151 -0.968 . . . . 0.0 110.298 -179.942 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 736' ' ' SER . . . . . 0.423 ' N ' HG12 ' A' ' 735' ' ' VAL . 6.6 p -109.17 -165.75 1.05 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.206 -0.934 . . . . 0.0 110.007 -179.962 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 737' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -86.1 176.38 8.03 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.266 -0.896 . . . . 0.0 110.731 -179.975 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 738' ' ' TYR . . . . . 0.403 ' HB2' ' HB2' ' A' ' 758' ' ' ALA . 45.8 t80 -154.62 149.28 26.45 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.382 -0.824 . . . . 0.0 110.124 179.946 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 739' ' ' HIS . . . . . 0.618 ' CD2' ' N ' ' A' ' 739' ' ' HIS . 1.7 p80 -164.65 166.8 10.9 Favored Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 121.344 -0.847 . . . . 0.0 109.604 -179.985 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 740' ' ' PRO . . . . . 0.515 ' HD2' ' HB2' ' A' ' 739' ' ' HIS . 40.6 Cg_endo -66.42 83.04 0.29 Allowed 'Trans proline' 0 C--N 1.31 -1.496 0 O-C-N 123.864 1.455 . . . . 0.0 110.166 179.975 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 741' ' ' ASN . . . . . 0.724 ' O ' HD13 ' A' ' 742' ' ' ILE . 0.9 OUTLIER -167.64 24.05 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.428 -0.795 . . . . 0.0 109.918 179.958 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 742' ' ' ILE . . . . . 0.724 HD13 ' O ' ' A' ' 741' ' ' ASN . 12.2 mm -133.63 39.61 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.233 -0.917 . . . . 0.0 110.06 179.945 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 743' ' ' LYS . . . . . 0.425 ' C ' ' O ' ' A' ' 742' ' ' ILE . 0.0 OUTLIER -42.9 164.63 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.3 -0.875 . . . . 0.0 110.411 -179.962 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 744' ' ' ASN . . . . . . . . . . . . . 21.5 t-20 48.6 47.04 20.96 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.419 -0.801 . . . . 0.0 110.669 179.909 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 745' ' ' TRP . . . . . 0.513 ' CG ' ' O ' ' A' ' 745' ' ' TRP . 26.5 t-105 -98.28 1.36 47.08 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.238 -0.914 . . . . 0.0 109.824 179.878 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 746' ' ' GLN . . . . . . . . . . . . . 15.4 mm100 -119.67 131.08 55.34 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.27 -0.894 . . . . 0.0 110.088 -179.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 747' ' ' ILE . . . . . 0.735 HG22 ' O ' ' A' ' 747' ' ' ILE . 3.6 mp -92.8 19.64 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 121.164 -0.96 . . . . 0.0 110.471 -179.997 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 748' ' ' GLU . . . . . . . . . . . . . 19.4 tp10 -124.7 -29.55 3.41 Favored 'General case' 0 C--N 1.295 -1.769 0 O-C-N 121.31 -0.869 . . . . 0.0 109.905 179.96 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 749' ' ' SER . . . . . 0.489 ' CB ' ' OE2' ' A' ' 752' ' ' GLU . 3.3 m -126.12 167.26 15.63 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.245 -0.91 . . . . 0.0 109.826 179.986 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 750' ' ' TYR . . . . . 0.496 ' CD1' ' N ' ' A' ' 750' ' ' TYR . 20.7 m-85 -126.17 74.21 1.42 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.202 -0.937 . . . . 0.0 110.302 180.0 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 751' ' ' GLY . . . . . 0.434 ' O ' ' C ' ' A' ' 752' ' ' GLU . . . 137.09 -4.48 3.5 Favored Glycine 0 N--CA 1.492 2.426 0 N-CA-C 109.781 -1.328 . . . . 0.0 109.781 179.942 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 752' ' ' GLU . . . . . 0.489 ' OE2' ' CB ' ' A' ' 749' ' ' SER . 0.8 OUTLIER -39.92 121.03 1.51 Allowed Pre-proline 0 N--CA 1.497 1.924 0 O-C-N 121.359 -1.083 . . . . 0.0 110.233 -179.978 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 753' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -77.02 125.94 8.33 Favored 'Trans proline' 0 C--N 1.308 -1.561 0 O-C-N 123.89 1.468 . . . . 0.0 111.157 -179.953 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 754' ' ' GLU . . . . . . . . . . . . . 41.9 mp0 -94.88 -150.08 0.3 Allowed 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.305 -0.872 . . . . 0.0 109.387 179.908 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 755' ' ' PHE . . . . . 0.647 ' CZ ' ' HA ' ' A' ' 758' ' ' ALA . 16.0 p90 -139.57 94.68 2.81 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 120.823 -1.173 . . . . 0.0 111.059 179.903 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 756' ' ' HIS . . . . . 0.474 ' C ' ' O ' ' A' ' 755' ' ' PHE . 1.8 t60 12.27 -81.91 0.0 OUTLIER 'General case' 0 N--CA 1.514 2.771 0 N-CA-C 114.08 1.141 . . . . 0.0 114.08 179.922 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 757' ' ' THR . . . . . 0.563 ' O ' ' CE1' ' A' ' 755' ' ' PHE . 37.2 p -81.94 -175.01 5.38 Favored 'General case' 0 N--CA 1.505 2.306 0 O-C-N 120.702 -1.249 . . . . 0.0 112.285 -179.683 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 758' ' ' ALA . . . . . 0.647 ' HA ' ' CZ ' ' A' ' 755' ' ' PHE . . . -109.75 179.04 4.24 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.753 -0.592 . . . . 0.0 109.703 179.97 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 759' ' ' LYS . . . . . . . . . . . . . 18.0 mtpt -141.77 150.72 42.11 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.062 -1.024 . . . . 0.0 110.946 179.979 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 760' ' ' VAL . . . . . . . . . . . . . 5.4 t -108.06 131.42 58.5 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 179.884 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 761' ' ' HIS . . . . . . . . . . . . . 3.7 m170 -117.35 103.77 10.47 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.998 -1.064 . . . . 0.0 111.575 -179.878 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 762' ' ' LEU . . . . . 0.538 ' HB2' ' HB3' ' A' ' 812' ' ' CYS . 0.2 OUTLIER -109.43 103.11 11.96 Favored 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 179.818 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 763' ' ' LYS . . . . . . . . . . . . . 9.5 ttmt -109.95 165.53 11.65 Favored 'General case' 0 N--CA 1.5 2.073 0 O-C-N 121.096 -1.002 . . . . 0.0 111.766 -179.729 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 764' ' ' CYS . . . . . . . . . . . . . 7.9 m -132.18 175.58 9.13 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.705 -0.622 . . . . 0.0 109.837 179.893 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 765' ' ' ALA . . . . . 0.704 ' HB1' ' HD2' ' A' ' 766' ' ' PRO . . . -71.25 171.66 8.26 Favored Pre-proline 0 N--CA 1.495 1.789 0 O-C-N 121.181 -0.95 . . . . 0.0 109.946 179.937 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 766' ' ' PRO . . . . . 0.704 ' HD2' ' HB1' ' A' ' 765' ' ' ALA . 46.1 Cg_endo -72.47 129.03 14.22 Favored 'Trans proline' 0 C--N 1.306 -1.66 0 O-C-N 123.849 1.447 . . . . 0.0 110.159 179.99 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 767' ' ' GLY . . . . . . . . . . . . . . . 89.53 11.38 64.25 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.349 -1.5 . . . . 0.0 109.349 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 768' ' ' GLN . . . . . . . . . . . . . 2.7 mt-30 -129.1 135.07 48.4 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.304 -1.115 . . . . 0.0 110.216 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 769' ' ' THR . . . . . 0.53 ' CG2' ' HG3' ' A' ' 810' ' ' GLU . 7.7 p -133.31 147.56 51.88 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.204 -0.935 . . . . 0.0 110.32 179.958 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 770' ' ' ILE . . . . . 0.467 HD13 ' SG ' ' A' ' 806' ' ' CYS . 4.3 mt -64.35 149.46 11.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.253 -0.904 . . . . 0.0 109.454 179.997 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 771' ' ' SER . . . . . 0.466 ' O ' ' HB2' ' A' ' 772' ' ' ALA . 24.4 p -134.34 1.05 3.14 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 120.955 -1.09 . . . . 0.0 110.717 -179.88 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 772' ' ' ALA . . . . . 0.466 ' HB2' ' O ' ' A' ' 771' ' ' SER . . . -177.49 132.1 0.16 Allowed 'General case' 0 N--CA 1.495 1.779 0 O-C-N 120.998 -1.064 . . . . 0.0 111.111 -179.964 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 773' ' ' ILE . . . . . . . . . . . . . 32.5 mm -87.65 124.24 40.8 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 O-C-N 121.327 -0.858 . . . . 0.0 109.673 179.919 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 774' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.32 -40.19 18.24 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.186 -0.946 . . . . 0.0 110.725 -179.978 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 775' ' ' PHE . . . . . 0.728 ' O ' ' HB2' ' A' ' 776' ' ' ALA . 75.5 t80 -145.58 162.97 36.22 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.031 -1.043 . . . . 0.0 110.942 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 776' ' ' ALA . . . . . 0.728 ' HB2' ' O ' ' A' ' 775' ' ' PHE . . . 167.13 117.79 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.425 -0.797 . . . . 0.0 109.715 179.98 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 777' ' ' SER . . . . . 0.493 ' HA ' ' OG ' ' A' ' 798' ' ' SER . 17.2 m -151.29 136.33 17.43 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.992 -1.068 . . . . 0.0 110.775 -179.953 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 778' ' ' PHE . . . . . . . . . . . . . 46.7 t80 -103.61 107.17 17.91 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.387 -0.821 . . . . 0.0 110.101 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 779' ' ' GLY . . . . . . . . . . . . . . . 162.82 -101.45 0.19 Allowed Glycine 0 N--CA 1.492 2.43 0 N-CA-C 109.514 -1.434 . . . . 0.0 109.514 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 780' ' ' THR . . . . . . . . . . . . . 53.8 p -134.52 101.54 11.97 Favored Pre-proline 0 N--CA 1.495 1.79 0 O-C-N 121.243 -1.151 . . . . 0.0 110.201 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 781' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -77.8 148.07 25.07 Favored 'Trans proline' 0 C--N 1.306 -1.69 0 O-C-N 123.935 1.492 . . . . 0.0 110.593 -179.97 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 782' ' ' LEU . . . . . 0.494 ' HA ' HD23 ' A' ' 782' ' ' LEU . 7.3 mt -108.02 79.42 1.27 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.308 -0.87 . . . . 0.0 109.75 179.973 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 783' ' ' GLY . . . . . . . . . . . . . . . 123.38 -174.52 16.58 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 108.911 -1.675 . . . . 0.0 108.911 -179.929 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 784' ' ' THR . . . . . . . . . . . . . 37.9 p -122.61 -161.35 0.94 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.1 -1.235 . . . . 0.0 110.287 179.933 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 785' ' ' CYS . . . . . 0.52 ' HA ' ' CE1' ' A' ' 788' ' ' PHE . 6.8 t -57.32 92.94 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.186 -0.946 . . . . 0.0 110.263 179.955 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 786' ' ' GLY . . . . . . . . . . . . . . . 151.48 -28.22 0.96 Allowed Glycine 0 N--CA 1.492 2.388 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 -179.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 787' ' ' THR . . . . . 0.757 HG22 ' O ' ' A' ' 787' ' ' THR . 51.5 m -143.61 30.29 1.36 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.297 -1.12 . . . . 0.0 110.141 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 788' ' ' PHE . . . . . 0.52 ' CE1' ' HA ' ' A' ' 785' ' ' CYS . 6.2 m-85 -51.16 155.03 1.41 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.238 -0.914 . . . . 0.0 110.285 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 789' ' ' GLN . . . . . 0.458 ' HB2' ' O ' ' A' ' 788' ' ' PHE . 1.1 tp60 -177.82 124.84 0.12 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.392 -0.817 . . . . 0.0 110.234 179.977 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 790' ' ' GLN . . . . . 0.438 ' C ' ' O ' ' A' ' 789' ' ' GLN . 1.4 mt-30 -40.16 123.54 1.71 Allowed 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.451 -0.78 . . . . 0.0 110.383 -179.969 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 791' ' ' GLY . . . . . . . . . . . . . . . -74.95 -132.03 0.27 Allowed Glycine 0 N--CA 1.491 2.362 0 N-CA-C 109.332 -1.507 . . . . 0.0 109.332 179.905 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 792' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -106.92 3.47 26.23 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.165 -1.197 . . . . 0.0 110.197 179.971 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 793' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -141.08 118.91 11.76 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.326 -0.859 . . . . 0.0 110.008 -179.991 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 794' ' ' HIS . . . . . 0.457 ' CE1' ' OG ' ' A' ' 798' ' ' SER . 81.8 t60 -138.07 148.13 44.74 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.294 -0.879 . . . . 0.0 110.148 -179.987 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 795' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -76.8 -136.53 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.296 -0.878 . . . . 0.0 109.66 179.996 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 796' ' ' ILE . . . . . . . . . . . . . 3.8 pt -146.1 12.04 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 O-C-N 121.09 -1.006 . . . . 0.0 110.044 179.905 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 797' ' ' ASN . . . . . . . . . . . . . 7.5 p30 -150.6 30.0 0.67 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.383 -0.823 . . . . 0.0 109.722 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 798' ' ' SER . . . . . 0.496 ' HB3' ' O ' ' A' ' 776' ' ' ALA . 0.7 OUTLIER -57.61 -27.43 62.75 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.522 -0.736 . . . . 0.0 111.102 -179.943 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 799' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -100.83 -22.27 14.89 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 120.924 -1.11 . . . . 0.0 110.501 -179.898 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 800' ' ' SER . . . . . . . . . . . . . 47.4 t -69.45 -18.69 63.75 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.121 -0.987 . . . . 0.0 110.324 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 801' ' ' VAL . . . . . . . . . . . . . 94.2 t -84.45 -46.56 17.75 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 121.23 -0.919 . . . . 0.0 110.863 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 802' ' ' LEU . . . . . 0.527 HD22 ' N ' ' A' ' 802' ' ' LEU . 4.1 mm? -72.6 -42.98 63.94 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.18 -0.95 . . . . 0.0 111.019 -179.946 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 803' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -51.61 -31.12 23.78 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.046 -1.034 . . . . 0.0 110.648 -179.955 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 804' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -92.34 -21.38 20.29 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.105 -0.997 . . . . 0.0 111.279 -179.949 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 805' ' ' LYS . . . . . 0.471 ' O ' ' SG ' ' A' ' 812' ' ' CYS . 0.9 OUTLIER -111.92 28.75 8.47 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 120.912 -1.118 . . . . 0.0 111.216 -179.864 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 806' ' ' CYS . . . . . 0.467 ' SG ' HD13 ' A' ' 770' ' ' ILE . 0.1 OUTLIER -152.92 -74.46 0.13 Allowed 'General case' 0 N--CA 1.497 1.895 0 O-C-N 120.914 -1.116 . . . . 0.0 111.055 179.984 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 807' ' ' ILE . . . . . 0.418 ' C ' ' O ' ' A' ' 806' ' ' CYS . 29.3 mt -41.65 121.36 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.192 -0.943 . . . . 0.0 110.901 -179.883 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 808' ' ' GLY . . . . . 0.439 ' C ' ' HG ' ' A' ' 809' ' ' LEU . . . 99.0 13.45 39.71 Favored Glycine 0 N--CA 1.492 2.432 0 N-CA-C 110.369 -1.092 . . . . 0.0 110.369 179.94 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 809' ' ' LEU . . . . . 0.439 ' HG ' ' C ' ' A' ' 808' ' ' GLY . 91.9 mt -143.3 132.82 23.57 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 120.992 -1.299 . . . . 0.0 110.496 179.982 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 810' ' ' GLU . . . . . 0.53 ' HG3' ' CG2' ' A' ' 769' ' ' THR . 1.0 OUTLIER -63.46 -30.61 71.71 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.271 -0.893 . . . . 0.0 109.383 -179.969 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 811' ' ' ARG . . . . . 0.528 ' HB3' ' NH2' ' A' ' 811' ' ' ARG . 0.5 OUTLIER -117.85 156.6 28.11 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.618 -0.676 . . . . 0.0 109.886 179.958 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 812' ' ' CYS . . . . . 0.538 ' HB3' ' HB2' ' A' ' 762' ' ' LEU . 3.4 t -131.37 137.25 48.64 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.238 -0.914 . . . . 0.0 110.646 -179.925 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 813' ' ' VAL . . . . . 0.672 HG13 ' O ' ' A' ' 813' ' ' VAL . 8.6 p -139.17 119.28 14.38 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.326 -0.859 . . . . 0.0 109.687 179.932 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 814' ' ' VAL . . . . . 0.441 HG21 HD11 ' A' ' 802' ' ' LEU . 38.6 t -128.52 165.58 27.77 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.233 -0.917 . . . . 0.0 110.537 -179.974 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 815' ' ' ALA . . . . . 0.438 ' N ' HG12 ' A' ' 814' ' ' VAL . . . -122.76 147.16 46.83 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.356 -0.84 . . . . 0.0 109.504 179.97 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 816' ' ' ILE . . . . . . . . . . . . . 88.2 mt -105.2 116.2 48.54 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 O-C-N 121.067 -1.02 . . . . 0.0 110.558 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 817' ' ' SER . . . . . 0.425 ' HB2' ' HD2' ' A' ' 818' ' ' PRO . 1.4 p -164.13 169.4 8.16 Favored Pre-proline 0 N--CA 1.492 1.66 0 O-C-N 121.334 -0.854 . . . . 0.0 110.123 179.95 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 818' ' ' PRO . . . . . 0.425 ' HD2' ' HB2' ' A' ' 817' ' ' SER . 43.4 Cg_endo -69.12 -16.54 40.34 Favored 'Trans proline' 0 C--N 1.304 -1.802 0 O-C-N 123.976 1.514 . . . . 0.0 110.504 179.993 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 819' ' ' SER . . . . . . . . . . . . . 14.5 p -106.54 31.7 5.04 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.151 -0.968 . . . . 0.0 110.345 -179.974 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 820' ' ' ASN . . . . . . . . . . . . . 7.8 t-20 -113.53 -28.13 7.63 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.26 -0.9 . . . . 0.0 110.283 -179.974 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 821' ' ' PHE . . . . . . . . . . . . . 94.6 m-85 -116.19 -77.82 0.57 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.25 -0.906 . . . . 0.0 110.471 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 822' ' ' GLY . . . . . . . . . . . . . . . -152.72 42.69 0.67 Allowed Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.643 -1.383 . . . . 0.0 109.643 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 823' ' ' GLY . . . . . 0.414 ' HA2' ' O ' ' A' ' 818' ' ' PRO . . . 85.95 -117.81 4.68 Favored Glycine 0 N--CA 1.492 2.408 0 N-CA-C 109.464 -1.455 . . . . 0.0 109.464 179.993 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 824' ' ' ASP . . . . . . . . . . . . . 6.6 t0 -137.92 105.88 8.14 Favored Pre-proline 0 N--CA 1.493 1.721 0 O-C-N 121.199 -1.177 . . . . 0.0 110.282 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 825' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -74.83 -60.72 0.04 OUTLIER 'Trans proline' 0 C--N 1.307 -1.623 0 O-C-N 124.086 1.571 . . . . 0.0 110.687 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 826' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -109.83 100.44 42.89 Favored Pre-proline 0 N--CA 1.499 2.007 0 O-C-N 121.109 -0.994 . . . . 0.0 110.65 -179.949 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 827' ' ' PRO . . . . . 0.622 ' O ' HG23 ' A' ' 829' ' ' VAL . 48.9 Cg_endo -83.33 166.89 13.98 Favored 'Trans proline' 0 C--N 1.305 -1.718 0 O-C-N 124.039 1.547 . . . . 0.0 110.459 179.925 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 828' ' ' GLU . . . . . . . . . . . . . 10.2 mm-40 48.53 42.4 18.78 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.227 -0.921 . . . . 0.0 110.355 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 829' ' ' VAL . . . . . 0.622 HG23 ' O ' ' A' ' 827' ' ' PRO . 44.2 t -139.83 145.46 26.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.222 -0.924 . . . . 0.0 110.205 -179.996 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 830' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -51.15 99.49 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.175 -0.953 . . . . 0.0 110.215 179.962 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 831' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -71.69 132.69 44.91 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.223 -0.923 . . . . 0.0 110.711 -179.941 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 832' ' ' ARG . . . . . . . . . . . . . 2.5 ttt180 -150.64 149.7 30.19 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.536 -0.727 . . . . 0.0 109.397 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 833' ' ' VAL . . . . . . . . . . . . . 71.9 t -118.68 140.95 40.58 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 120.994 -1.067 . . . . 0.0 111.113 -179.899 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 834' ' ' ALA . . . . . 0.648 ' O ' HG23 ' A' ' 835' ' ' VAL . . . -143.61 136.88 27.9 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.551 -0.718 . . . . 0.0 109.384 179.911 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 835' ' ' VAL . . . . . 0.648 HG23 ' O ' ' A' ' 834' ' ' ALA . 23.6 t -156.36 145.53 11.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 120.937 -1.102 . . . . 0.0 111.484 -179.9 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 836' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -135.18 128.11 31.41 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 179.864 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 837' ' ' ALA . . . . . . . . . . . . . . . -116.6 161.76 18.66 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.96 -1.087 . . . . 0.0 111.32 -179.892 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 838' ' ' VAL . . . . . . . . . . . . . 66.2 t -109.78 114.57 47.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.663 -0.648 . . . . 0.0 109.539 179.942 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 839' ' ' CYS . . . . . 0.478 ' O ' ' O ' ' A' ' 728' ' ' VAL . 0.1 OUTLIER -108.96 144.22 37.2 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.019 -1.051 . . . . 0.0 110.88 -179.968 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 840' ' ' SER . . . . . 0.533 ' HB2' ' CG2' ' A' ' 727' ' ' THR . 79.8 p -171.52 178.67 3.1 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.42 -0.8 . . . . 0.0 110.037 -179.999 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 841' ' ' THR . . . . . . . . . . . . . 11.1 p -66.6 115.7 6.74 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.159 -0.963 . . . . 0.0 110.178 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 842' ' ' ALA . . . . . . . . . . . . . . . -161.2 119.46 2.42 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.276 -0.89 . . . . 0.0 110.252 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 843' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.652 0 CA-C-O 118.019 -0.991 . . . . 0.0 110.262 179.978 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 726' ' ' ARG . . . . . 0.449 ' HA ' ' CG2' ' A' ' 841' ' ' THR . 2.0 tpt85 . . . . . 0 N--CA 1.492 1.662 0 CA-C-O 121.203 0.525 . . . . 0.0 110.309 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 727' ' ' THR . . . . . . . . . . . . . 20.8 m -150.66 162.2 41.14 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.286 -0.884 . . . . 0.0 110.187 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 728' ' ' VAL . . . . . . . . . . . . . 35.8 m -136.99 134.56 48.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.252 -0.905 . . . . 0.0 110.057 179.933 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 729' ' ' SER . . . . . . . . . . . . . 24.4 m -128.48 -154.17 0.62 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.26 -0.9 . . . . 0.0 110.269 -179.949 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 730' ' ' GLY . . . . . . . . . . . . . . . -148.27 111.01 0.52 Allowed Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 179.967 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 731' ' ' VAL . . . . . . . . . . . . . 41.3 t -114.22 151.96 15.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.196 -1.179 . . . . 0.0 110.457 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 732' ' ' CYS . . . . . 0.404 ' HA ' ' O ' ' A' ' 835' ' ' VAL . 14.1 p -159.91 143.91 14.49 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.431 -0.793 . . . . 0.0 109.536 -179.968 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 733' ' ' ALA . . . . . . . . . . . . . . . -121.52 136.37 54.96 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.121 -0.987 . . . . 0.0 110.434 -179.953 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 734' ' ' ASP . . . . . 0.424 ' CG ' ' O ' ' A' ' 734' ' ' ASP . 5.2 p-10 -123.73 106.15 10.28 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.273 -0.892 . . . . 0.0 109.94 179.953 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 735' ' ' VAL . . . . . . . . . . . . . 5.7 t -132.12 128.86 59.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.181 -0.949 . . . . 0.0 110.277 -179.967 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 736' ' ' SER . . . . . . . . . . . . . 4.8 p -69.65 158.98 34.29 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.308 -0.87 . . . . 0.0 110.128 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 737' ' ' GLU . . . . . . . . . . . . . 7.7 tm-20 -89.75 148.95 22.95 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.269 -0.894 . . . . 0.0 110.187 -179.984 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 738' ' ' TYR . . . . . 0.441 ' O ' ' HB2' ' A' ' 739' ' ' HIS . 43.2 t80 -101.17 117.81 35.73 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.206 -0.933 . . . . 0.0 110.313 179.971 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 739' ' ' HIS . . . . . 0.441 ' HB2' ' O ' ' A' ' 738' ' ' TYR . 20.6 t-80 -177.49 86.26 0.24 Allowed Pre-proline 0 N--CA 1.494 1.742 0 O-C-N 121.213 -0.929 . . . . 0.0 110.2 -179.996 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 740' ' ' PRO . . . . . 0.474 ' O ' ' HB2' ' A' ' 741' ' ' ASN . 52.1 Cg_endo -82.33 17.34 1.6 Allowed 'Trans proline' 0 C--N 1.305 -1.717 0 O-C-N 124.075 1.566 . . . . 0.0 110.769 179.915 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 741' ' ' ASN . . . . . 0.854 ' C ' HD12 ' A' ' 742' ' ' ILE . 14.1 m120 56.91 159.37 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.125 -0.984 . . . . 0.0 110.055 -179.979 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 742' ' ' ILE . . . . . 0.854 HD12 ' C ' ' A' ' 741' ' ' ASN . 1.8 mp -130.52 76.17 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.079 -1.013 . . . . 0.0 110.479 179.942 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 743' ' ' LYS . . . . . . . . . . . . . 48.1 mttt -112.5 -18.38 12.43 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.33 -0.856 . . . . 0.0 109.202 179.881 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 744' ' ' ASN . . . . . 0.529 ' O ' ' N ' ' A' ' 746' ' ' GLN . 8.4 t-20 -166.66 31.29 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 179.983 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 745' ' ' TRP . . . . . 0.578 ' CG ' ' O ' ' A' ' 745' ' ' TRP . 1.8 p-90 -43.25 87.11 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.697 0 CA-C-O 121.308 0.575 . . . . 0.0 111.817 -179.888 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 746' ' ' GLN . . . . . 0.529 ' N ' ' O ' ' A' ' 744' ' ' ASN . 14.3 mm100 56.05 134.12 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.474 -0.766 . . . . 0.0 111.511 179.874 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 747' ' ' ILE . . . . . . . . . . . . . 6.1 tt -144.94 20.39 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.131 -0.981 . . . . 0.0 109.846 179.945 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 748' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -124.53 -59.84 1.43 Allowed 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.52 -0.738 . . . . 0.0 109.985 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 749' ' ' SER . . . . . 0.586 ' O ' ' CG ' ' A' ' 750' ' ' TYR . 0.9 OUTLIER -107.26 111.09 23.31 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.238 -0.914 . . . . 0.0 109.438 -179.999 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 750' ' ' TYR . . . . . 0.586 ' CG ' ' O ' ' A' ' 749' ' ' SER . 27.4 p90 36.44 -156.56 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.172 0 O-C-N 121.591 -0.693 . . . . 0.0 110.185 -179.902 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 751' ' ' GLY . . . . . . . . . . . . . . . -154.67 -163.87 12.4 Favored Glycine 0 N--CA 1.489 2.21 0 N-CA-C 109.457 -1.457 . . . . 0.0 109.457 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 752' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -131.96 94.82 23.56 Favored Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.235 -1.156 . . . . 0.0 109.946 -179.966 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 753' ' ' PRO . . . . . 0.463 ' O ' ' HB2' ' A' ' 754' ' ' GLU . 48.3 Cg_endo -77.97 171.3 17.45 Favored 'Trans proline' 0 C--N 1.303 -1.849 0 O-C-N 124.02 1.537 . . . . 0.0 110.457 -179.897 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 754' ' ' GLU . . . . . 0.463 ' HB2' ' O ' ' A' ' 753' ' ' PRO . 5.1 mm-40 58.4 148.16 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.418 -0.801 . . . . 0.0 110.669 -179.99 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 755' ' ' PHE . . . . . 0.599 ' CD2' ' N ' ' A' ' 756' ' ' HIS . 47.9 p90 -178.72 -38.15 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.376 -0.828 . . . . 0.0 109.6 179.975 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 756' ' ' HIS . . . . . 0.599 ' N ' ' CD2' ' A' ' 755' ' ' PHE . 0.1 OUTLIER 41.08 -163.76 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.545 -0.722 . . . . 0.0 110.639 179.955 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 757' ' ' THR . . . . . . . . . . . . . 1.2 p -103.83 -161.98 0.87 Allowed 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.444 -0.785 . . . . 0.0 110.219 -179.977 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 758' ' ' ALA . . . . . . . . . . . . . . . -119.97 171.71 8.25 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.327 -0.858 . . . . 0.0 109.856 179.952 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 759' ' ' LYS . . . . . 0.469 ' HG2' ' HA ' ' A' ' 815' ' ' ALA . 18.2 mttm -142.87 161.07 39.07 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.195 -0.941 . . . . 0.0 110.571 179.989 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 760' ' ' VAL . . . . . 1.001 ' CG2' HD11 ' A' ' 816' ' ' ILE . 11.5 t -112.52 155.57 13.74 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.408 -0.808 . . . . 0.0 109.388 179.93 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 761' ' ' HIS . . . . . 0.456 ' CD2' HG22 ' A' ' 813' ' ' VAL . 0.9 OUTLIER -133.34 119.74 20.11 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.957 -1.089 . . . . 0.0 111.024 179.995 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 762' ' ' LEU . . . . . . . . . . . . . 8.1 mt -114.54 134.78 54.77 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.484 -0.76 . . . . 0.0 109.561 179.935 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 763' ' ' LYS . . . . . . . . . . . . . 6.7 tttm -142.35 125.43 16.3 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.023 -1.048 . . . . 0.0 110.588 179.915 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 764' ' ' CYS . . . . . 0.471 ' O ' ' OE2' ' A' ' 810' ' ' GLU . 0.1 OUTLIER -104.41 -173.25 2.26 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.467 -0.77 . . . . 0.0 109.765 179.949 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 765' ' ' ALA . . . . . . . . . . . . . . . -66.05 148.93 98.16 Favored Pre-proline 0 C--N 1.296 -1.754 0 O-C-N 121.27 -0.894 . . . . 0.0 110.298 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 766' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -72.34 96.39 0.81 Allowed 'Trans proline' 0 C--N 1.307 -1.622 0 O-C-N 123.991 1.521 . . . . 0.0 110.293 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 767' ' ' GLY . . . . . . . . . . . . . . . 141.65 -21.55 2.53 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 108.907 -1.677 . . . . 0.0 108.907 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 768' ' ' GLN . . . . . 0.41 ' O ' ' HG2' ' A' ' 810' ' ' GLU . 23.5 mt-30 -110.86 145.84 37.54 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.472 -1.016 . . . . 0.0 109.688 179.905 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 769' ' ' THR . . . . . . . . . . . . . 82.3 p -121.95 146.61 46.97 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.234 -0.916 . . . . 0.0 110.669 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 770' ' ' ILE . . . . . . . . . . . . . 21.3 mt -49.62 142.82 2.13 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 121.395 -0.816 . . . . 0.0 109.669 179.898 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 771' ' ' SER . . . . . 0.655 ' O ' ' HB2' ' A' ' 772' ' ' ALA . 22.0 p -124.56 -5.45 7.62 Favored 'General case' 0 C--N 1.299 -1.597 0 O-C-N 121.092 -1.005 . . . . 0.0 110.724 -179.903 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 772' ' ' ALA . . . . . 0.655 ' HB2' ' O ' ' A' ' 771' ' ' SER . . . 174.62 146.62 0.07 Allowed 'General case' 0 N--CA 1.492 1.653 0 C-N-CA 118.879 -1.128 . . . . 0.0 111.949 -179.986 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 773' ' ' ILE . . . . . . . . . . . . . 11.7 mm -108.16 149.0 11.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 179.819 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 774' ' ' LYS . . . . . . . . . . . . . 66.8 mttt -132.35 -18.45 2.54 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.509 -1.369 . . . . 0.0 112.206 -179.801 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 775' ' ' PHE . . . . . 0.739 ' O ' ' HB2' ' A' ' 776' ' ' ALA . 43.2 t80 -140.09 168.69 19.23 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.58 -1.325 . . . . 0.0 110.999 -179.904 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 776' ' ' ALA . . . . . 0.739 ' HB2' ' O ' ' A' ' 775' ' ' PHE . . . 164.15 125.87 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.818 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 -179.991 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 777' ' ' SER . . . . . 0.572 ' HA ' ' CE1' ' A' ' 794' ' ' HIS . 0.5 OUTLIER -148.94 106.21 3.62 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.956 -1.09 . . . . 0.0 111.522 -179.906 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 778' ' ' PHE . . . . . 0.411 ' CE2' ' SD ' ' A' ' 830' ' ' MET . 89.6 t80 -85.76 123.94 31.71 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.125 -0.984 . . . . 0.0 109.539 179.908 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 779' ' ' GLY . . . . . 0.523 ' O ' ' HB2' ' A' ' 832' ' ' ARG . . . 138.15 -107.07 0.55 Allowed Glycine 0 N--CA 1.493 2.473 0 C-N-CA 119.496 -1.335 . . . . 0.0 109.99 179.998 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 780' ' ' THR . . . . . . . . . . . . . 35.1 p -133.19 88.16 36.79 Favored Pre-proline 0 N--CA 1.494 1.768 0 O-C-N 120.85 -1.382 . . . . 0.0 111.028 -179.893 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 781' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_endo -83.35 177.72 6.26 Favored 'Trans proline' 0 C--N 1.308 -1.565 0 O-C-N 123.938 1.494 . . . . 0.0 110.534 179.878 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 782' ' ' LEU . . . . . 0.545 ' CD1' ' HA2' ' A' ' 791' ' ' GLY . 1.0 OUTLIER -135.93 174.74 10.28 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.202 -0.936 . . . . 0.0 110.257 179.951 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 783' ' ' GLY . . . . . . . . . . . . . . . 59.34 -166.07 9.08 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.864 -1.295 . . . . 0.0 109.864 179.935 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 784' ' ' THR . . . . . 0.564 HG23 ' N ' ' A' ' 785' ' ' CYS . 9.3 t -133.3 -128.02 0.17 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.373 -1.075 . . . . 0.0 109.904 179.934 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 785' ' ' CYS . . . . . 0.564 ' N ' HG23 ' A' ' 784' ' ' THR . 1.9 t -92.84 96.58 10.22 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 120.752 -1.218 . . . . 0.0 110.206 -179.967 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 786' ' ' GLY . . . . . . . . . . . . . . . 139.72 -24.68 2.74 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.383 -1.487 . . . . 0.0 109.383 179.982 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 787' ' ' THR . . . . . 0.732 HG22 ' O ' ' A' ' 787' ' ' THR . 99.8 m -139.72 37.95 2.01 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.18 -1.188 . . . . 0.0 110.142 179.964 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 788' ' ' PHE . . . . . 0.572 ' HB3' ' CE2' ' A' ' 775' ' ' PHE . 0.3 OUTLIER -65.75 116.97 7.5 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.304 -0.873 . . . . 0.0 109.899 179.92 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 789' ' ' GLN . . . . . . . . . . . . . 5.3 tm0? -119.11 153.04 35.45 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.252 -0.905 . . . . 0.0 110.261 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 790' ' ' GLN . . . . . . . . . . . . . 4.1 tt0 -73.05 120.74 19.1 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.293 -0.879 . . . . 0.0 110.12 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 791' ' ' GLY . . . . . 0.545 ' HA2' ' CD1' ' A' ' 782' ' ' LEU . . . -74.21 -116.0 0.08 OUTLIER Glycine 0 N--CA 1.494 2.509 0 N-CA-C 109.867 -1.293 . . . . 0.0 109.867 -179.942 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 792' ' ' GLU . . . . . . . . . . . . . 19.8 mt-10 -118.99 -23.82 6.75 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.225 -1.162 . . . . 0.0 110.35 -179.989 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 793' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -122.88 121.85 37.19 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.165 -0.96 . . . . 0.0 110.507 -179.936 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 794' ' ' HIS . . . . . 0.572 ' CE1' ' HA ' ' A' ' 777' ' ' SER . 24.2 t60 -149.06 149.35 30.95 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.292 -0.88 . . . . 0.0 109.789 -180.0 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 795' ' ' SER . . . . . 0.473 ' O ' ' NE2' ' A' ' 794' ' ' HIS . 17.1 t -91.94 149.2 21.67 Favored 'General case' 0 C--N 1.299 -1.626 0 O-C-N 121.276 -0.89 . . . . 0.0 109.618 179.889 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 796' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -87.89 15.42 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 O-C-N 121.174 -0.953 . . . . 0.0 110.017 -179.918 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 797' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 -125.59 27.02 6.59 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.387 -0.82 . . . . 0.0 109.714 179.927 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 798' ' ' SER . . . . . 0.567 ' HB3' ' HB3' ' A' ' 776' ' ' ALA . 0.5 OUTLIER -68.25 -35.03 77.28 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.479 -0.763 . . . . 0.0 111.005 179.933 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 799' ' ' ASN . . . . . 0.511 ' N ' ' OD1' ' A' ' 799' ' ' ASN . 1.3 m120 -100.62 11.78 38.77 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.104 -0.997 . . . . 0.0 111.175 -179.859 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 800' ' ' SER . . . . . . . . . . . . . 75.0 p -93.12 -27.38 16.97 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 120.997 -1.065 . . . . 0.0 110.609 -179.925 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 801' ' ' VAL . . . . . . . . . . . . . 40.2 t -88.99 -19.67 7.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.278 -0.889 . . . . 0.0 110.467 -179.925 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 802' ' ' LEU . . . . . 0.504 ' O ' ' HB2' ' A' ' 806' ' ' CYS . 4.1 mm? -79.48 -48.8 13.28 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.187 -0.945 . . . . 0.0 110.837 179.986 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 803' ' ' GLU . . . . . . . . . . . . . 17.5 mt-10 -64.0 -18.71 64.57 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.001 -1.062 . . . . 0.0 111.036 -179.918 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 804' ' ' ARG . . . . . . . . . . . . . 51.9 ttp180 -92.46 -22.14 19.78 Favored 'General case' 0 C--N 1.297 -1.692 0 O-C-N 121.073 -1.017 . . . . 0.0 112.25 -179.844 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 805' ' ' LYS . . . . . 0.445 ' O ' ' SG ' ' A' ' 806' ' ' CYS . 5.8 tttm -140.12 54.96 1.63 Allowed 'General case' 0 N--CA 1.501 2.115 0 O-C-N 120.444 -1.41 . . . . 0.0 112.537 -179.856 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 806' ' ' CYS . . . . . 0.534 ' HA ' ' CB ' ' A' ' 812' ' ' CYS . 1.2 m -163.73 -50.68 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.801 0 O-C-N 120.842 -1.161 . . . . 0.0 110.319 179.722 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 807' ' ' ILE . . . . . . . . . . . . . 55.5 mt -61.62 129.47 24.6 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 O-C-N 121.112 -0.992 . . . . 0.0 110.156 179.905 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 808' ' ' GLY . . . . . 0.417 ' C ' ' HG ' ' A' ' 809' ' ' LEU . . . 104.76 1.86 42.89 Favored Glycine 0 N--CA 1.492 2.431 0 N-CA-C 109.616 -1.394 . . . . 0.0 109.616 179.957 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 809' ' ' LEU . . . . . 0.417 ' HG ' ' C ' ' A' ' 808' ' ' GLY . 4.2 mt -133.03 144.33 49.98 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.157 -1.202 . . . . 0.0 110.308 179.906 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 810' ' ' GLU . . . . . 0.471 ' OE2' ' O ' ' A' ' 764' ' ' CYS . 3.4 tm-20 -70.43 -20.56 62.9 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.219 -0.926 . . . . 0.0 109.653 180.0 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 811' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -156.47 121.59 4.69 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 179.907 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 812' ' ' CYS . . . . . 0.534 ' CB ' ' HA ' ' A' ' 806' ' ' CYS . 26.1 p -123.1 156.7 34.42 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 120.996 -1.065 . . . . 0.0 111.388 -179.972 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 813' ' ' VAL . . . . . 0.456 HG22 ' CD2' ' A' ' 761' ' ' HIS . 38.8 t -120.43 135.24 61.32 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.624 -0.672 . . . . 0.0 109.632 179.925 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 814' ' ' VAL . . . . . . . . . . . . . 48.2 t -112.41 153.09 14.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.095 -1.003 . . . . 0.0 110.551 -179.927 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 815' ' ' ALA . . . . . 0.821 ' HB3' HD22 ' A' ' 820' ' ' ASN . . . -104.49 118.37 36.43 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.27 -0.893 . . . . 0.0 109.893 179.985 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 816' ' ' ILE . . . . . 1.096 HD13 HG21 ' A' ' 833' ' ' VAL . 25.1 mt -85.25 108.41 17.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.18 -0.95 . . . . 0.0 110.489 -179.945 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 817' ' ' SER . . . . . . . . . . . . . 44.5 p -157.59 165.87 17.79 Favored Pre-proline 0 N--CA 1.494 1.75 0 O-C-N 121.366 -0.834 . . . . 0.0 109.978 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 818' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_endo -79.44 9.9 3.25 Favored 'Trans proline' 0 C--N 1.305 -1.728 0 O-C-N 123.885 1.466 . . . . 0.0 111.037 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 819' ' ' SER . . . . . . . . . . . . . 27.5 t -131.89 12.18 4.77 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.061 -1.025 . . . . 0.0 110.305 -179.932 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 820' ' ' ASN . . . . . 0.821 HD22 ' HB3' ' A' ' 815' ' ' ALA . 45.8 t-20 -114.12 -2.7 13.38 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.266 -0.897 . . . . 0.0 110.052 179.945 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 821' ' ' PHE . . . . . . . . . . . . . 8.1 m-85 -112.38 -79.46 0.58 Allowed 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.324 -0.86 . . . . 0.0 110.238 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 822' ' ' GLY . . . . . . . . . . . . . . . -171.22 54.2 0.18 Allowed Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.619 -1.392 . . . . 0.0 109.619 -179.949 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 823' ' ' GLY . . . . . . . . . . . . . . . 78.38 176.61 47.22 Favored Glycine 0 N--CA 1.492 2.399 0 N-CA-C 109.727 -1.349 . . . . 0.0 109.727 179.936 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 824' ' ' ASP . . . . . . . . . . . . . 15.7 p-10 -70.89 117.47 56.31 Favored Pre-proline 0 N--CA 1.494 1.728 0 O-C-N 121.243 -1.151 . . . . 0.0 110.216 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 825' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -79.59 -65.24 0.02 OUTLIER 'Trans proline' 0 C--N 1.308 -1.565 0 O-C-N 123.97 1.511 . . . . 0.0 110.946 -179.922 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 826' ' ' CYS . . . . . 0.462 ' HB3' ' HB ' ' A' ' 829' ' ' VAL . 22.8 m -97.44 153.64 38.29 Favored Pre-proline 0 N--CA 1.498 1.951 0 O-C-N 121.11 -0.993 . . . . 0.0 110.952 -179.937 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 827' ' ' PRO . . . . . 0.891 ' O ' HG23 ' A' ' 829' ' ' VAL . 50.1 Cg_endo -78.99 95.96 1.08 Allowed 'Trans proline' 0 C--N 1.313 -1.303 0 O-C-N 124.07 1.563 . . . . 0.0 110.673 179.963 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 828' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER 52.41 18.67 0.97 Allowed 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.152 -0.968 . . . . 0.0 110.404 179.923 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 829' ' ' VAL . . . . . 0.891 HG23 ' O ' ' A' ' 827' ' ' PRO . 66.7 t -119.41 80.86 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.198 -0.939 . . . . 0.0 110.223 179.953 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 830' ' ' MET . . . . . 0.464 ' CB ' ' HA2' ' A' ' 779' ' ' GLY . 0.0 OUTLIER -178.43 128.65 0.12 Allowed 'General case' 0 C--N 1.304 -1.381 0 O-C-N 121.131 -0.981 . . . . 0.0 110.777 -179.902 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 831' ' ' LYS . . . . . 0.46 ' O ' ' CG ' ' A' ' 832' ' ' ARG . 2.9 tttm -170.58 57.05 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.391 -0.818 . . . . 0.0 110.093 179.906 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 832' ' ' ARG . . . . . 0.523 ' HB2' ' O ' ' A' ' 779' ' ' GLY . 0.5 OUTLIER -167.62 125.32 1.21 Allowed 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.466 -0.771 . . . . 0.0 109.392 -179.996 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 833' ' ' VAL . . . . . 1.096 HG21 HD13 ' A' ' 816' ' ' ILE . 58.8 t -112.47 103.26 15.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.045 -1.035 . . . . 0.0 111.055 -179.959 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 834' ' ' ALA . . . . . 0.572 ' HB1' ' CZ ' ' A' ' 788' ' ' PHE . . . -111.16 122.02 46.79 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.471 -0.768 . . . . 0.0 109.099 179.928 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 835' ' ' VAL . . . . . 0.404 ' O ' ' HA ' ' A' ' 732' ' ' CYS . 34.7 t -139.3 143.24 31.6 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 O-C-N 120.828 -1.17 . . . . 0.0 111.648 -179.934 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 836' ' ' GLU . . . . . 0.481 ' HB2' ' HB3' ' A' ' 775' ' ' PHE . 1.3 mt-10 -115.5 160.24 20.18 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 179.807 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 837' ' ' ALA . . . . . . . . . . . . . . . -154.64 156.8 37.13 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 120.612 -1.305 . . . . 0.0 111.258 -179.944 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 838' ' ' VAL . . . . . . . . . . . . . 22.0 t -109.24 137.2 42.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.505 -0.747 . . . . 0.0 109.965 179.926 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 839' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -128.32 133.2 48.66 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.142 -0.974 . . . . 0.0 110.132 179.988 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 840' ' ' SER . . . . . . . . . . . . . 24.8 t -159.83 -177.37 6.29 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.281 -0.887 . . . . 0.0 109.939 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 841' ' ' THR . . . . . 0.546 ' O ' ' HB3' ' A' ' 842' ' ' ALA . 67.1 p -73.86 163.27 28.15 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.149 -0.97 . . . . 0.0 109.926 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 842' ' ' ALA . . . . . 0.546 ' HB3' ' O ' ' A' ' 841' ' ' THR . . . 60.43 147.7 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.193 -0.942 . . . . 0.0 110.298 -179.95 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 843' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 1.735 0 CA-C-O 118.028 -0.987 . . . . 0.0 110.28 -179.981 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 726' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.631 0 CA-C-O 121.26 0.552 . . . . 0.0 110.255 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 727' ' ' THR . . . . . . . . . . . . . 94.5 m -109.59 153.88 23.55 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.188 -0.945 . . . . 0.0 110.176 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 728' ' ' VAL . . . . . 1.002 HG23 ' O ' ' A' ' 839' ' ' CYS . 7.6 p -159.12 139.23 3.8 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.2 -0.938 . . . . 0.0 110.141 -179.963 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 729' ' ' SER . . . . . 0.454 ' O ' HG13 ' A' ' 731' ' ' VAL . 0.5 OUTLIER -107.47 90.5 3.32 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.263 -0.898 . . . . 0.0 110.343 179.928 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 730' ' ' GLY . . . . . 0.688 ' O ' HG13 ' A' ' 731' ' ' VAL . . . -44.4 153.25 0.46 Allowed Glycine 0 N--CA 1.492 2.417 0 N-CA-C 109.298 -1.521 . . . . 0.0 109.298 179.996 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 731' ' ' VAL . . . . . 0.688 HG13 ' O ' ' A' ' 730' ' ' GLY . 2.4 m -158.48 120.42 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 121.105 -1.233 . . . . 0.0 110.767 179.937 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 732' ' ' CYS . . . . . . . . . . . . . 26.8 p -116.04 130.86 57.0 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.448 -0.783 . . . . 0.0 109.297 179.902 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 733' ' ' ALA . . . . . . . . . . . . . . . -107.77 160.55 15.64 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.106 -0.996 . . . . 0.0 110.609 -179.878 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 734' ' ' ASP . . . . . 0.526 ' OD2' ' CZ ' ' A' ' 832' ' ' ARG . 0.9 OUTLIER -164.36 105.36 0.86 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.414 -0.804 . . . . 0.0 109.444 179.941 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 735' ' ' VAL . . . . . 0.442 ' O ' ' CG ' ' A' ' 832' ' ' ARG . 37.4 t -116.04 163.39 13.31 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 121.089 -1.007 . . . . 0.0 110.715 -179.939 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 736' ' ' SER . . . . . 0.411 ' N ' HG12 ' A' ' 735' ' ' VAL . 22.5 p -99.16 158.78 15.45 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.425 -0.797 . . . . 0.0 110.029 179.954 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 737' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -77.04 170.06 17.21 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.216 -0.927 . . . . 0.0 110.457 179.944 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 738' ' ' TYR . . . . . 0.577 ' CZ ' ' HG3' ' A' ' 740' ' ' PRO . 2.8 t80 -143.88 117.37 9.14 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.412 -0.805 . . . . 0.0 109.354 179.97 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 739' ' ' HIS . . . . . 0.519 ' NE2' ' CD1' ' A' ' 742' ' ' ILE . 19.7 t-80 -151.15 92.6 3.76 Favored Pre-proline 0 N--CA 1.496 1.854 0 O-C-N 121.099 -1.0 . . . . 0.0 110.859 -179.904 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 740' ' ' PRO . . . . . 0.577 ' HG3' ' CZ ' ' A' ' 738' ' ' TYR . 50.4 Cg_endo -88.42 46.56 1.13 Allowed 'Trans proline' 0 C--N 1.307 -1.626 0 O-C-N 123.945 1.497 . . . . 0.0 110.084 179.871 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 741' ' ' ASN . . . . . 0.487 ' CB ' ' O ' ' A' ' 740' ' ' PRO . 0.2 OUTLIER 68.0 115.92 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.175 -0.953 . . . . 0.0 109.889 -179.929 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 742' ' ' ILE . . . . . 0.561 ' HA ' ' CE1' ' A' ' 755' ' ' PHE . 96.9 mt -91.59 167.62 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 O-C-N 121.149 -0.969 . . . . 0.0 110.895 179.997 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 743' ' ' LYS . . . . . 0.561 ' N ' HG22 ' A' ' 742' ' ' ILE . 29.8 tttt -167.41 160.09 12.99 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.604 -0.685 . . . . 0.0 109.521 -179.978 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 744' ' ' ASN . . . . . 0.455 ' N ' ' HG2' ' A' ' 743' ' ' LYS . 6.2 m-20 45.09 76.05 0.1 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.106 -0.996 . . . . 0.0 109.945 -179.977 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 745' ' ' TRP . . . . . 0.467 ' C ' ' CD1' ' A' ' 745' ' ' TRP . 8.5 t90 -84.27 -70.65 0.56 Allowed 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.201 -0.937 . . . . 0.0 110.175 -179.987 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 746' ' ' GLN . . . . . . . . . . . . . 7.1 tp60 -125.54 78.39 1.73 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.344 -0.847 . . . . 0.0 110.377 -179.956 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 747' ' ' ILE . . . . . 0.438 ' O ' ' CB ' ' A' ' 748' ' ' GLU . 38.1 mm -104.49 150.26 7.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.18 -0.95 . . . . 0.0 109.827 179.922 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 748' ' ' GLU . . . . . 0.549 ' HB3' ' CD1' ' A' ' 750' ' ' TYR . 0.3 OUTLIER 66.09 -142.15 0.18 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.188 -0.945 . . . . 0.0 110.032 179.995 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 749' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -112.23 -36.11 5.42 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.07 -1.019 . . . . 0.0 110.71 -179.986 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 750' ' ' TYR . . . . . 0.569 ' CG ' ' N ' ' A' ' 751' ' ' GLY . 32.0 p90 -59.26 -44.68 92.4 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.177 -0.952 . . . . 0.0 110.787 179.999 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 751' ' ' GLY . . . . . 0.569 ' N ' ' CG ' ' A' ' 750' ' ' TYR . . . 77.75 -78.99 1.45 Allowed Glycine 0 N--CA 1.497 2.756 0 N-CA-C 109.665 -1.374 . . . . 0.0 109.665 -179.97 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 752' ' ' GLU . . . . . 0.558 ' HB2' ' CD2' ' A' ' 750' ' ' TYR . 2.6 tt0 74.59 72.91 0.22 Allowed Pre-proline 0 N--CA 1.505 2.28 0 O-C-N 121.406 -1.055 . . . . 0.0 111.055 179.905 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 753' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_endo -83.71 58.01 5.78 Favored 'Trans proline' 0 C--N 1.308 -1.555 0 O-C-N 124.025 1.539 . . . . 0.0 109.622 179.923 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 754' ' ' GLU . . . . . 0.461 ' HA ' ' OE1' ' A' ' 754' ' ' GLU . 0.0 OUTLIER -83.92 -22.66 31.47 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.305 -0.872 . . . . 0.0 111.02 -179.893 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 755' ' ' PHE . . . . . 0.561 ' CE1' ' HA ' ' A' ' 742' ' ' ILE . 0.2 OUTLIER -54.5 121.0 7.44 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.136 -0.977 . . . . 0.0 110.741 -179.886 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 756' ' ' HIS . . . . . . . . . . . . . 1.2 t-160 -135.97 -166.96 1.95 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.35 -0.844 . . . . 0.0 109.858 179.966 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 757' ' ' THR . . . . . 0.47 ' OG1' ' O ' ' A' ' 816' ' ' ILE . 66.9 p -136.25 -169.04 2.35 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.174 -0.954 . . . . 0.0 110.593 -179.924 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 758' ' ' ALA . . . . . . . . . . . . . . . -55.85 176.45 0.07 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.412 -0.805 . . . . 0.0 110.052 179.944 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 759' ' ' LYS . . . . . 0.414 ' HG2' ' HA ' ' A' ' 815' ' ' ALA . 9.1 mttp -139.14 167.47 21.98 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.231 -0.918 . . . . 0.0 110.357 179.978 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 760' ' ' VAL . . . . . 0.409 ' HA ' HG21 ' A' ' 735' ' ' VAL . 5.5 t -105.52 162.49 4.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.372 -0.83 . . . . 0.0 109.392 179.919 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 761' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -140.35 105.93 5.11 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 120.846 -1.159 . . . . 0.0 111.261 -179.867 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 762' ' ' LEU . . . . . 0.529 ' HB2' ' HB3' ' A' ' 812' ' ' CYS . 0.5 OUTLIER -110.64 103.23 11.78 Favored 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 179.827 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 763' ' ' LYS . . . . . . . . . . . . . 4.4 ttpt -110.6 135.49 51.15 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.202 -0.936 . . . . 0.0 111.46 -179.812 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 764' ' ' CYS . . . . . 0.483 ' HB2' ' O ' ' A' ' 810' ' ' GLU . 1.3 m -126.63 139.89 52.83 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.533 -0.73 . . . . 0.0 109.568 179.856 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 765' ' ' ALA . . . . . 0.445 ' O ' ' O ' ' A' ' 764' ' ' CYS . . . -39.72 161.16 0.09 OUTLIER Pre-proline 0 N--CA 1.496 1.843 0 O-C-N 121.359 -0.838 . . . . 0.0 110.604 -179.98 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 766' ' ' PRO . . . . . 0.404 ' HD2' ' HB1' ' A' ' 765' ' ' ALA . 43.4 Cg_endo -70.78 113.72 3.63 Favored 'Trans proline' 0 C--N 1.306 -1.706 0 O-C-N 124.121 1.59 . . . . 0.0 110.082 -179.93 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 767' ' ' GLY . . . . . . . . . . . . . . . 118.04 -26.01 8.09 Favored Glycine 0 N--CA 1.488 2.162 0 N-CA-C 108.904 -1.679 . . . . 0.0 108.904 -179.896 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 768' ' ' GLN . . . . . 0.461 ' HA ' ' HA ' ' A' ' 841' ' ' THR . 1.3 tt0 -90.55 119.65 30.99 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.428 -1.042 . . . . 0.0 109.838 179.93 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 769' ' ' THR . . . . . . . . . . . . . 9.4 p -112.22 147.21 36.71 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.227 -0.921 . . . . 0.0 110.474 -179.964 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 770' ' ' ILE . . . . . 0.565 HD12 ' O ' ' A' ' 809' ' ' LEU . 3.5 mp -65.88 145.37 13.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.252 -0.905 . . . . 0.0 109.292 179.946 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 771' ' ' SER . . . . . . . . . . . . . 36.8 p -136.33 -5.45 2.06 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 120.955 -1.091 . . . . 0.0 111.6 -179.923 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 772' ' ' ALA . . . . . . . . . . . . . . . -171.24 148.02 2.59 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 120.608 -1.307 . . . . 0.0 111.941 -179.999 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 773' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -120.48 132.27 70.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 N-CA-C 108.482 -0.932 . . . . 0.0 108.482 179.829 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 774' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -103.4 -34.75 8.62 Favored 'General case' 0 N--CA 1.504 2.239 0 O-C-N 120.995 -1.066 . . . . 0.0 110.342 -179.918 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 775' ' ' PHE . . . . . 0.585 ' O ' ' HB2' ' A' ' 776' ' ' ALA . 52.2 t80 -126.15 152.7 45.61 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 120.925 -1.11 . . . . 0.0 110.15 179.92 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 776' ' ' ALA . . . . . 0.939 ' HB3' ' HB3' ' A' ' 799' ' ' ASN . . . 175.69 105.9 0.02 OUTLIER 'General case' 0 C--N 1.3 -1.564 0 O-C-N 121.425 -0.797 . . . . 0.0 109.664 -179.969 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 777' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -137.6 137.84 38.91 Favored 'General case' 0 C--N 1.299 -1.623 0 O-C-N 121.387 -0.82 . . . . 0.0 109.885 -179.975 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 778' ' ' PHE . . . . . 0.432 ' CD2' HG22 ' A' ' 833' ' ' VAL . 65.3 t80 -112.0 98.58 7.45 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.222 -0.924 . . . . 0.0 110.241 -179.964 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 779' ' ' GLY . . . . . 0.455 ' O ' ' HA ' ' A' ' 831' ' ' LYS . . . 167.85 -93.5 0.11 Allowed Glycine 0 N--CA 1.489 2.197 0 N-CA-C 109.419 -1.472 . . . . 0.0 109.419 179.979 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 780' ' ' THR . . . . . . . . . . . . . 60.6 p -141.11 81.67 15.65 Favored Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 121.273 -1.134 . . . . 0.0 110.253 179.945 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 781' ' ' PRO . . . . . 0.446 ' O ' HD23 ' A' ' 782' ' ' LEU . 44.7 Cg_endo -72.06 154.63 57.57 Favored 'Trans proline' 0 C--N 1.303 -1.818 0 O-C-N 124.02 1.537 . . . . 0.0 110.287 -179.966 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 782' ' ' LEU . . . . . 0.446 HD23 ' O ' ' A' ' 781' ' ' PRO . 21.4 mt -119.59 116.61 26.38 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.285 -0.884 . . . . 0.0 109.966 179.952 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 783' ' ' GLY . . . . . . . . . . . . . . . 111.5 168.21 18.52 Favored Glycine 0 N--CA 1.488 2.114 0 N-CA-C 109.345 -1.502 . . . . 0.0 109.345 -179.903 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 784' ' ' THR . . . . . 0.748 ' O ' HG23 ' A' ' 784' ' ' THR . 14.1 t -152.79 109.22 3.41 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.213 -1.169 . . . . 0.0 110.24 -179.995 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 785' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER 46.88 80.84 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.362 -0.836 . . . . 0.0 110.736 179.964 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 786' ' ' GLY . . . . . . . . . . . . . . . 135.62 -20.58 3.67 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.745 -1.342 . . . . 0.0 109.745 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 787' ' ' THR . . . . . . . . . . . . . 1.9 m -154.86 44.93 0.51 Allowed 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.059 -1.259 . . . . 0.0 110.591 -179.867 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 788' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -69.25 138.99 54.42 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.088 -1.008 . . . . 0.0 109.919 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 789' ' ' GLN . . . . . . . . . . . . . 37.2 tt0 -163.37 134.0 4.55 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.24 -0.913 . . . . 0.0 110.116 179.999 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 790' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -46.35 157.47 0.13 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.386 -0.821 . . . . 0.0 110.236 179.954 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 791' ' ' GLY . . . . . . . . . . . . . . . -113.87 -139.6 7.26 Favored Glycine 0 N--CA 1.489 2.184 0 N-CA-C 109.516 -1.434 . . . . 0.0 109.516 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 792' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -106.62 -30.86 8.75 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.203 -1.175 . . . . 0.0 110.199 179.946 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 793' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -104.3 107.45 18.38 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.271 -0.893 . . . . 0.0 110.191 -179.956 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 794' ' ' HIS . . . . . 0.45 ' CG ' ' N ' ' A' ' 795' ' ' SER . 86.3 t60 -134.01 171.69 13.85 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.223 -0.923 . . . . 0.0 110.489 -179.988 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 795' ' ' SER . . . . . 0.45 ' N ' ' CG ' ' A' ' 794' ' ' HIS . 93.3 p -120.52 -137.37 0.33 Allowed 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.336 -0.852 . . . . 0.0 110.183 179.98 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 796' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -134.81 -29.72 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.96 0 O-C-N 121.108 -0.995 . . . . 0.0 110.806 179.996 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 797' ' ' ASN . . . . . 0.495 ' HA ' ' HB3' ' A' ' 800' ' ' SER . 1.4 m-20 -96.56 26.46 4.43 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.078 -1.014 . . . . 0.0 110.104 -179.973 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 798' ' ' SER . . . . . 0.511 ' HB2' ' O ' ' A' ' 776' ' ' ALA . 0.8 OUTLIER -51.71 -71.32 0.07 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.329 -0.857 . . . . 0.0 110.955 -179.968 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 799' ' ' ASN . . . . . 0.939 ' HB3' ' HB3' ' A' ' 776' ' ' ALA . 51.6 p30 -85.78 -15.59 41.57 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.293 -0.879 . . . . 0.0 111.101 -179.956 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 800' ' ' SER . . . . . 0.514 ' N ' ' OD1' ' A' ' 799' ' ' ASN . 12.9 t -59.18 -41.58 88.8 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.083 -1.01 . . . . 0.0 110.62 -179.966 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 801' ' ' VAL . . . . . . . . . . . . . 34.9 t -72.2 -26.46 24.89 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.14 -0.975 . . . . 0.0 110.505 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 802' ' ' LEU . . . . . 0.496 ' O ' ' HB2' ' A' ' 806' ' ' CYS . 3.4 mm? -74.2 -59.83 2.55 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.257 -0.902 . . . . 0.0 110.641 -179.944 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 803' ' ' GLU . . . . . 0.579 ' HG3' HD12 ' A' ' 807' ' ' ILE . 20.2 tt0 -54.06 -18.45 3.65 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.115 -0.991 . . . . 0.0 110.683 179.887 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 804' ' ' ARG . . . . . . . . . . . . . 56.3 ttt180 -90.08 -27.22 19.81 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.126 -0.984 . . . . 0.0 111.026 -179.914 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 805' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.76 43.97 2.83 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 120.968 -1.083 . . . . 0.0 110.968 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 806' ' ' CYS . . . . . 0.496 ' HB2' ' O ' ' A' ' 802' ' ' LEU . 0.2 OUTLIER -147.51 -72.3 0.21 Allowed 'General case' 0 N--CA 1.494 1.743 0 O-C-N 120.952 -1.092 . . . . 0.0 110.485 179.993 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 807' ' ' ILE . . . . . 0.579 HD12 ' HG3' ' A' ' 803' ' ' GLU . 31.9 mt -47.14 136.58 2.96 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 O-C-N 121.052 -1.03 . . . . 0.0 110.472 -179.955 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 808' ' ' GLY . . . . . 0.401 ' C ' ' HG ' ' A' ' 809' ' ' LEU . . . 93.23 5.52 63.7 Favored Glycine 0 N--CA 1.492 2.387 0 N-CA-C 110.229 -1.148 . . . . 0.0 110.229 179.967 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 809' ' ' LEU . . . . . 0.565 ' O ' HD12 ' A' ' 770' ' ' ILE . 41.5 mt -137.62 135.26 36.42 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.039 -1.271 . . . . 0.0 110.612 -179.987 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 810' ' ' GLU . . . . . 0.483 ' O ' ' HB2' ' A' ' 764' ' ' CYS . 57.3 mm-40 -64.45 -34.16 77.56 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.27 -0.894 . . . . 0.0 108.792 179.94 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 811' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -111.37 165.48 11.93 Favored 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 179.934 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 812' ' ' CYS . . . . . 0.529 ' HB3' ' HB2' ' A' ' 762' ' ' LEU . 49.5 t -159.66 102.28 1.51 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.861 -1.149 . . . . 0.0 110.608 -179.883 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 813' ' ' VAL . . . . . . . . . . . . . 11.9 p -115.8 136.82 51.44 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.178 -0.951 . . . . 0.0 109.981 179.964 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 814' ' ' VAL . . . . . . . . . . . . . 17.7 t -134.4 164.72 33.47 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 O-C-N 121.171 -0.956 . . . . 0.0 110.435 -179.939 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 815' ' ' ALA . . . . . 0.414 ' HA ' ' HG2' ' A' ' 759' ' ' LYS . . . -97.27 157.14 16.11 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.26 -0.9 . . . . 0.0 109.928 179.971 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 816' ' ' ILE . . . . . 0.791 HG23 ' CG2' ' A' ' 833' ' ' VAL . 20.3 mt -117.12 63.62 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.168 -0.957 . . . . 0.0 109.846 179.984 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 817' ' ' SER . . . . . 0.447 ' OG ' ' HB2' ' A' ' 820' ' ' ASN . 0.0 OUTLIER -116.15 165.98 13.56 Favored Pre-proline 0 N--CA 1.494 1.728 0 O-C-N 121.432 -0.792 . . . . 0.0 110.716 -179.875 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 818' ' ' PRO . . . . . 0.473 ' HB2' ' OD1' ' A' ' 824' ' ' ASP . 49.0 Cg_endo -76.92 -44.94 0.19 Allowed 'Trans proline' 0 C--N 1.307 -1.657 0 O-C-N 124.181 1.622 . . . . 0.0 110.573 -179.954 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 819' ' ' SER . . . . . . . . . . . . . 66.3 m -88.46 15.33 8.04 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.271 -0.893 . . . . 0.0 110.238 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 820' ' ' ASN . . . . . 0.447 ' HB2' ' OG ' ' A' ' 817' ' ' SER . 2.1 m120 -101.47 -16.51 16.8 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.225 -0.922 . . . . 0.0 110.449 179.985 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 821' ' ' PHE . . . . . . . . . . . . . 5.2 m-85 -93.32 -91.9 0.18 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.051 -1.031 . . . . 0.0 110.44 179.968 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 822' ' ' GLY . . . . . . . . . . . . . . . -152.97 14.93 0.68 Allowed Glycine 0 N--CA 1.492 2.39 0 C-N-CA 119.551 -1.309 . . . . 0.0 110.266 -179.991 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 823' ' ' GLY . . . . . . . . . . . . . . . 154.74 -170.66 33.07 Favored Glycine 0 N--CA 1.493 2.486 0 O-C-N 121.008 -1.289 . . . . 0.0 110.068 179.941 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 824' ' ' ASP . . . . . 0.473 ' OD1' ' HB2' ' A' ' 818' ' ' PRO . 0.2 OUTLIER -113.33 105.44 55.26 Favored Pre-proline 0 N--CA 1.494 1.73 0 O-C-N 121.379 -1.071 . . . . 0.0 110.14 -179.972 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 825' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -76.31 -64.9 0.02 OUTLIER 'Trans proline' 0 C--N 1.304 -1.775 0 O-C-N 123.994 1.523 . . . . 0.0 110.789 -179.963 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 826' ' ' CYS . . . . . . . . . . . . . 98.3 m -125.19 98.62 35.37 Favored Pre-proline 0 N--CA 1.495 1.794 0 O-C-N 121.119 -0.988 . . . . 0.0 110.414 179.953 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 827' ' ' PRO . . . . . 0.563 ' O ' HG23 ' A' ' 829' ' ' VAL . 50.7 Cg_endo -82.77 153.38 15.09 Favored 'Trans proline' 0 C--N 1.303 -1.847 0 O-C-N 124.062 1.559 . . . . 0.0 110.612 -179.983 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 828' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 62.26 17.85 9.66 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.304 -0.872 . . . . 0.0 110.521 179.995 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 829' ' ' VAL . . . . . 0.563 HG23 ' O ' ' A' ' 827' ' ' PRO . 66.4 t -127.5 111.21 24.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.225 -0.922 . . . . 0.0 110.283 179.981 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 830' ' ' MET . . . . . 0.431 ' C ' ' O ' ' A' ' 829' ' ' VAL . 2.9 mmt -42.41 125.49 3.21 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.278 -0.889 . . . . 0.0 109.672 -179.992 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 831' ' ' LYS . . . . . 0.455 ' HA ' ' O ' ' A' ' 779' ' ' GLY . 1.2 ptpt -128.85 133.62 48.03 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.047 -1.033 . . . . 0.0 111.151 -179.938 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 832' ' ' ARG . . . . . 0.526 ' CZ ' ' OD2' ' A' ' 734' ' ' ASP . 20.2 ttt180 -108.55 158.89 17.16 Favored 'General case' 0 N--CA 1.489 1.475 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 179.946 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 833' ' ' VAL . . . . . 0.791 ' CG2' HG23 ' A' ' 816' ' ' ILE . 8.3 t -111.85 126.68 69.26 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 120.976 -1.078 . . . . 0.0 111.133 -179.877 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 834' ' ' ALA . . . . . . . . . . . . . . . -131.08 134.15 46.34 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 179.924 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 835' ' ' VAL . . . . . . . . . . . . . 5.9 t -145.02 150.91 15.59 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 O-C-N 120.933 -1.105 . . . . 0.0 111.275 -179.919 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 836' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -127.13 110.82 13.31 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 179.9 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 837' ' ' ALA . . . . . . . . . . . . . . . -110.26 159.33 17.5 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.066 -1.021 . . . . 0.0 111.106 -179.848 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 838' ' ' VAL . . . . . . . . . . . . . 92.1 t -115.29 122.15 68.65 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.475 0 O-C-N 121.498 -0.751 . . . . 0.0 109.731 179.961 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 839' ' ' CYS . . . . . 1.002 ' O ' HG23 ' A' ' 728' ' ' VAL . 0.0 OUTLIER -108.95 122.56 47.48 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.247 -0.908 . . . . 0.0 110.532 -179.925 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 840' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -121.08 119.39 32.3 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.268 -0.895 . . . . 0.0 109.799 179.963 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 841' ' ' THR . . . . . 0.461 ' HA ' ' HA ' ' A' ' 768' ' ' GLN . 14.6 t -53.34 155.89 2.61 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.103 -0.998 . . . . 0.0 110.569 -179.927 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 842' ' ' ALA . . . . . . . . . . . . . . . -145.8 121.52 10.51 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.385 -0.822 . . . . 0.0 110.158 179.94 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 843' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.582 0 CA-C-O 117.954 -1.022 . . . . 0.0 110.262 179.964 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 726' ' ' ARG . . . . . . . . . . . . . 3.2 mmt85 . . . . . 0 N--CA 1.492 1.639 0 CA-C-O 121.23 0.538 . . . . 0.0 110.06 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 727' ' ' THR . . . . . . . . . . . . . 1.8 m -96.86 112.89 24.45 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.16 -0.962 . . . . 0.0 110.664 -179.961 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 728' ' ' VAL . . . . . 0.816 HG12 ' N ' ' A' ' 729' ' ' SER . 1.0 OUTLIER -96.36 -75.04 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.177 -0.952 . . . . 0.0 109.757 -179.969 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 729' ' ' SER . . . . . 0.816 ' N ' HG12 ' A' ' 728' ' ' VAL . 2.4 m -178.53 -163.59 0.07 Allowed 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.102 -0.999 . . . . 0.0 110.601 -179.984 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 730' ' ' GLY . . . . . . . . . . . . . . . -152.67 -166.27 14.14 Favored Glycine 0 N--CA 1.496 2.698 0 N-CA-C 109.381 -1.488 . . . . 0.0 109.381 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 731' ' ' VAL . . . . . 0.507 HG12 ' N ' ' A' ' 732' ' ' CYS . 73.7 t -140.33 165.95 20.34 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 O-C-N 121.064 -1.256 . . . . 0.0 110.508 179.978 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 732' ' ' CYS . . . . . 0.507 ' N ' HG12 ' A' ' 731' ' ' VAL . 82.1 m -111.8 156.99 21.1 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.32 -0.863 . . . . 0.0 110.094 179.999 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 733' ' ' ALA . . . . . 0.458 ' O ' ' HA ' ' A' ' 834' ' ' ALA . . . -141.68 106.72 4.95 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.144 -0.973 . . . . 0.0 110.439 -179.997 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 734' ' ' ASP . . . . . 0.449 ' N ' ' OD1' ' A' ' 734' ' ' ASP . 5.2 m-20 -118.16 124.52 48.18 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.372 -0.83 . . . . 0.0 109.944 -180.0 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 735' ' ' VAL . . . . . 0.981 HG21 HG22 ' A' ' 760' ' ' VAL . 51.5 t -125.79 166.91 20.99 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 O-C-N 121.197 -0.94 . . . . 0.0 110.181 179.985 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 736' ' ' SER . . . . . 0.507 ' N ' HG12 ' A' ' 735' ' ' VAL . 10.2 p -113.36 45.18 1.43 Allowed 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.248 -0.907 . . . . 0.0 110.573 -179.984 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 737' ' ' GLU . . . . . 0.472 ' OE1' ' HB3' ' A' ' 831' ' ' LYS . 2.1 tt0 36.03 -152.38 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.127 0 O-C-N 121.469 -0.77 . . . . 0.0 111.273 179.911 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 738' ' ' TYR . . . . . 0.641 ' HB3' ' HB2' ' A' ' 758' ' ' ALA . 56.7 t80 -168.77 -96.76 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.413 -0.804 . . . . 0.0 109.907 -179.898 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 739' ' ' HIS . . . . . 0.441 ' CD2' HD21 ' A' ' 741' ' ' ASN . 1.0 OUTLIER 44.65 88.28 0.1 Allowed Pre-proline 0 N--CA 1.502 2.134 0 O-C-N 121.053 -1.029 . . . . 0.0 110.983 179.996 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 740' ' ' PRO . . . . . 0.61 ' HG3' ' CZ ' ' A' ' 738' ' ' TYR . 55.8 Cg_endo -92.23 55.48 0.68 Allowed 'Trans proline' 0 C--N 1.308 -1.596 0 O-C-N 124.021 1.538 . . . . 0.0 111.062 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 741' ' ' ASN . . . . . 0.48 ' O ' ' HB ' ' A' ' 742' ' ' ILE . 7.7 p30 -162.34 -41.87 0.04 OUTLIER 'General case' 0 N--CA 1.497 1.884 0 O-C-N 120.636 -1.29 . . . . 0.0 111.411 -179.994 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 742' ' ' ILE . . . . . 0.582 HG22 ' N ' ' A' ' 743' ' ' LYS . 3.6 mp 55.49 173.37 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.009 -1.057 . . . . 0.0 109.443 -179.909 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 743' ' ' LYS . . . . . 0.582 ' N ' HG22 ' A' ' 742' ' ' ILE . 11.9 ttmm -87.75 149.75 24.01 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 120.961 -1.087 . . . . 0.0 110.821 -179.942 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 744' ' ' ASN . . . . . 0.454 ' HB2' ' O ' ' A' ' 743' ' ' LYS . 9.6 m120 59.13 124.36 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.482 -0.761 . . . . 0.0 110.811 179.943 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 745' ' ' TRP . . . . . 0.418 ' CD1' ' O ' ' A' ' 744' ' ' ASN . 0.0 OUTLIER -173.23 -175.6 1.21 Allowed 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.456 -0.778 . . . . 0.0 110.203 179.978 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 746' ' ' GLN . . . . . 0.451 ' O ' ' HB ' ' A' ' 747' ' ' ILE . 7.3 mm100 -137.29 -162.56 1.31 Allowed 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.264 -0.898 . . . . 0.0 110.236 179.974 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 747' ' ' ILE . . . . . 0.451 ' HB ' ' O ' ' A' ' 746' ' ' GLN . 65.4 mt 57.38 92.7 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 121.146 -0.971 . . . . 0.0 110.339 -179.976 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 748' ' ' GLU . . . . . 0.444 ' C ' ' O ' ' A' ' 747' ' ' ILE . 0.2 OUTLIER 40.09 76.7 0.06 Allowed 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.443 -0.785 . . . . 0.0 110.262 -179.999 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 749' ' ' SER . . . . . . . . . . . . . 3.3 t -156.62 -77.03 0.09 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.208 -0.933 . . . . 0.0 110.275 -179.926 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 750' ' ' TYR . . . . . . . . . . . . . 17.8 m-85 45.51 90.78 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.216 -0.928 . . . . 0.0 110.223 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 751' ' ' GLY . . . . . 0.472 ' O ' ' HG3' ' A' ' 752' ' ' GLU . . . 82.48 133.98 1.95 Allowed Glycine 0 N--CA 1.492 2.406 0 N-CA-C 109.786 -1.326 . . . . 0.0 109.786 179.954 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 752' ' ' GLU . . . . . 0.472 ' HG3' ' O ' ' A' ' 751' ' ' GLY . 6.5 mt-10 -144.69 97.13 5.03 Favored Pre-proline 0 N--CA 1.495 1.785 0 O-C-N 121.32 -1.106 . . . . 0.0 110.028 179.952 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 753' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -74.89 -175.56 2.4 Favored 'Trans proline' 0 C--N 1.305 -1.742 0 O-C-N 124.05 1.553 . . . . 0.0 110.768 179.965 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 754' ' ' GLU . . . . . . . . . . . . . 2.4 tp10 -91.92 126.78 37.14 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.312 -0.868 . . . . 0.0 109.924 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 755' ' ' PHE . . . . . 0.59 ' O ' HG23 ' A' ' 757' ' ' THR . 18.2 p90 -143.29 -135.28 0.09 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.295 -0.878 . . . . 0.0 110.102 -179.979 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 756' ' ' HIS . . . . . 0.416 ' C ' ' O ' ' A' ' 755' ' ' PHE . 3.1 t-160 -42.68 124.78 3.14 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 120.86 -1.15 . . . . 0.0 110.505 179.978 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 757' ' ' THR . . . . . 0.59 HG23 ' O ' ' A' ' 755' ' ' PHE . 61.9 p -112.47 -148.93 0.44 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.399 -0.813 . . . . 0.0 109.858 179.925 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 758' ' ' ALA . . . . . 0.641 ' HB2' ' HB3' ' A' ' 738' ' ' TYR . . . -112.69 175.59 5.37 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.08 -1.012 . . . . 0.0 110.244 179.97 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 759' ' ' LYS . . . . . . . . . . . . . 11.4 mtmt -146.71 150.69 35.87 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.257 -0.902 . . . . 0.0 110.968 -179.899 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 760' ' ' VAL . . . . . 0.981 HG22 HG21 ' A' ' 735' ' ' VAL . 3.6 t -110.38 144.84 17.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.514 -0.741 . . . . 0.0 109.316 179.865 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 761' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -118.76 114.16 22.25 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.076 -1.015 . . . . 0.0 110.564 179.949 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 762' ' ' LEU . . . . . 0.489 ' HB2' ' HB3' ' A' ' 812' ' ' CYS . 0.4 OUTLIER -108.54 157.19 18.69 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.426 -0.796 . . . . 0.0 109.653 179.955 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 763' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -158.84 106.97 1.87 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.158 -0.964 . . . . 0.0 110.6 -179.976 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 764' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -88.21 166.54 14.29 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.364 -0.835 . . . . 0.0 109.915 -179.998 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 765' ' ' ALA . . . . . . . . . . . . . . . -63.55 154.24 80.32 Favored Pre-proline 0 N--CA 1.493 1.676 0 O-C-N 121.147 -0.971 . . . . 0.0 110.157 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 766' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -69.06 125.14 12.13 Favored 'Trans proline' 0 C--N 1.305 -1.735 0 O-C-N 124.016 1.535 . . . . 0.0 110.348 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 767' ' ' GLY . . . . . . . . . . . . . . . 108.69 -15.21 34.79 Favored Glycine 0 N--CA 1.489 2.21 0 N-CA-C 109.366 -1.493 . . . . 0.0 109.366 -179.963 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 768' ' ' GLN . . . . . 0.459 ' HB3' ' HB3' ' A' ' 839' ' ' CYS . 0.9 OUTLIER -114.32 140.72 48.39 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.338 -1.095 . . . . 0.0 110.236 179.96 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 769' ' ' THR . . . . . . . . . . . . . 69.7 p -121.48 150.4 41.63 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.295 -0.878 . . . . 0.0 110.393 -179.906 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 770' ' ' ILE . . . . . . . . . . . . . 16.9 mt -66.26 131.18 32.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.262 -0.899 . . . . 0.0 109.689 179.958 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 771' ' ' SER . . . . . 0.584 ' O ' ' HB2' ' A' ' 772' ' ' ALA . 80.2 p -129.1 -0.3 5.2 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.101 -0.999 . . . . 0.0 110.836 -179.993 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 772' ' ' ALA . . . . . 0.584 ' HB2' ' O ' ' A' ' 771' ' ' SER . . . 177.95 127.4 0.05 Allowed 'General case' 0 N--CA 1.495 1.792 0 O-C-N 120.824 -1.173 . . . . 0.0 111.576 179.998 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 773' ' ' ILE . . . . . . . . . . . . . 1.4 mp -87.17 123.44 39.98 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 N-CA-C 108.644 -0.873 . . . . 0.0 108.644 179.804 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 774' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -85.43 -31.56 22.8 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.027 -1.046 . . . . 0.0 111.88 -179.816 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 775' ' ' PHE . . . . . 0.644 ' CE2' ' CB ' ' A' ' 788' ' ' PHE . 90.6 t80 -147.61 171.82 14.99 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 120.645 -1.284 . . . . 0.0 111.325 -179.988 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 776' ' ' ALA . . . . . 0.512 ' HB1' ' O ' ' A' ' 798' ' ' SER . . . -179.52 136.7 0.12 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.544 -0.723 . . . . 0.0 109.546 -179.989 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 777' ' ' SER . . . . . 0.467 ' HB3' ' HB3' ' A' ' 781' ' ' PRO . 0.3 OUTLIER -148.44 127.04 12.43 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.119 -0.988 . . . . 0.0 110.373 -179.966 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 778' ' ' PHE . . . . . 0.614 ' CG ' ' O ' ' A' ' 778' ' ' PHE . 4.5 t80 -109.66 63.01 0.6 Allowed 'General case' 0 C--N 1.3 -1.555 0 CA-C-O 122.0 0.905 . . . . 0.0 108.957 179.935 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 779' ' ' GLY . . . . . . . . . . . . . . . -172.73 -111.02 0.25 Allowed Glycine 0 N--CA 1.488 2.152 0 N-CA-C 109.449 -1.461 . . . . 0.0 109.449 -179.945 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 780' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -115.14 81.39 7.91 Favored Pre-proline 0 N--CA 1.494 1.733 0 O-C-N 121.218 -1.166 . . . . 0.0 110.443 179.961 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 781' ' ' PRO . . . . . 0.467 ' HB3' ' HB3' ' A' ' 777' ' ' SER . 48.7 Cg_endo -77.93 143.87 21.04 Favored 'Trans proline' 0 C--N 1.304 -1.768 0 O-C-N 124.027 1.54 . . . . 0.0 109.872 179.961 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 782' ' ' LEU . . . . . 0.592 HD12 ' HA3' ' A' ' 791' ' ' GLY . 4.6 mt -137.22 148.39 46.45 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.109 -0.994 . . . . 0.0 110.373 -179.963 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 783' ' ' GLY . . . . . . . . . . . . . . . 138.26 -124.54 2.95 Favored Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.468 -1.453 . . . . 0.0 109.468 -179.984 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 784' ' ' THR . . . . . 0.425 HG22 ' N ' ' A' ' 785' ' ' CYS . 15.5 m -154.82 -75.42 0.11 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.217 -1.166 . . . . 0.0 110.393 -179.999 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 785' ' ' CYS . . . . . 0.425 ' N ' HG22 ' A' ' 784' ' ' THR . 1.0 OUTLIER -153.46 99.53 2.34 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.307 -0.87 . . . . 0.0 110.254 179.971 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 786' ' ' GLY . . . . . . . . . . . . . . . 98.04 -17.19 59.08 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.716 -1.354 . . . . 0.0 109.716 -179.95 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 787' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -113.5 23.76 12.86 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.213 -1.169 . . . . 0.0 110.275 179.958 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 788' ' ' PHE . . . . . 0.644 ' CB ' ' CE2' ' A' ' 775' ' ' PHE . 10.8 m-85 -50.66 170.79 0.03 OUTLIER 'General case' 0 C--N 1.299 -1.599 0 O-C-N 121.192 -0.942 . . . . 0.0 109.588 -179.967 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 789' ' ' GLN . . . . . 0.532 ' O ' ' N ' ' A' ' 791' ' ' GLY . 5.0 tp60 -164.8 118.52 1.3 Allowed 'General case' 0 C--N 1.298 -1.663 0 O-C-N 121.257 -0.902 . . . . 0.0 109.957 179.99 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 790' ' ' GLN . . . . . . . . . . . . . 1.8 pt20 -49.08 89.79 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.376 -0.828 . . . . 0.0 110.039 179.97 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 791' ' ' GLY . . . . . 0.592 ' HA3' HD12 ' A' ' 782' ' ' LEU . . . -43.4 -59.54 3.53 Favored Glycine 0 N--CA 1.488 2.152 0 N-CA-C 109.519 -1.433 . . . . 0.0 109.519 -179.987 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 792' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -152.56 -24.49 0.17 Allowed 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.273 -1.133 . . . . 0.0 111.419 179.973 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 793' ' ' CYS . . . . . . . . . . . . . 1.2 m -118.59 148.52 42.6 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 120.744 -1.222 . . . . 0.0 110.876 179.967 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 794' ' ' HIS . . . . . 0.492 ' NE2' ' HA ' ' A' ' 796' ' ' ILE . 5.4 t60 -169.41 146.76 3.51 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.488 -0.758 . . . . 0.0 109.808 179.917 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 795' ' ' SER . . . . . 0.474 ' O ' ' HB ' ' A' ' 796' ' ' ILE . 1.0 OUTLIER -90.06 1.2 56.6 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.194 -0.941 . . . . 0.0 111.338 -179.886 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 796' ' ' ILE . . . . . 0.715 HG22 ' O ' ' A' ' 796' ' ' ILE . 21.2 mm 55.95 16.85 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 O-C-N 120.985 -1.072 . . . . 0.0 110.068 -179.975 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 797' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -151.08 26.5 0.71 Allowed 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.277 -0.889 . . . . 0.0 109.859 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 798' ' ' SER . . . . . 0.512 ' O ' ' HB1' ' A' ' 776' ' ' ALA . 21.0 m -71.26 -14.91 62.39 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.323 -0.861 . . . . 0.0 111.395 -179.966 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 799' ' ' ASN . . . . . . . . . . . . . 24.4 p30 -105.0 -5.32 21.07 Favored 'General case' 0 N--CA 1.5 2.06 0 O-C-N 121.004 -1.06 . . . . 0.0 111.184 -179.928 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 800' ' ' SER . . . . . . . . . . . . . 49.7 m -82.83 -16.82 46.25 Favored 'General case' 0 C--N 1.293 -1.874 0 O-C-N 121.167 -0.958 . . . . 0.0 110.771 -179.972 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 801' ' ' VAL . . . . . . . . . . . . . 40.6 t -91.27 -19.67 7.02 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 O-C-N 121.15 -0.968 . . . . 0.0 111.178 -179.911 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 802' ' ' LEU . . . . . 0.591 HD11 HG21 ' A' ' 814' ' ' VAL . 3.9 mm? -88.55 -48.09 7.83 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.005 -1.059 . . . . 0.0 111.247 -179.837 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 803' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -56.85 -16.96 7.68 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.946 -1.096 . . . . 0.0 110.38 179.949 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 804' ' ' ARG . . . . . . . . . . . . . 2.9 ttt180 -91.16 -26.31 19.14 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.202 -0.936 . . . . 0.0 111.81 -179.908 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 805' ' ' LYS . . . . . . . . . . . . . 1.1 ttpt -140.84 60.57 1.52 Allowed 'General case' 0 N--CA 1.497 1.89 0 O-C-N 120.756 -1.215 . . . . 0.0 111.196 -179.87 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 806' ' ' CYS . . . . . . . . . . . . . 3.4 t -162.46 -25.68 0.04 OUTLIER 'General case' 0 N--CA 1.501 2.108 0 O-C-N 121.069 -1.019 . . . . 0.0 111.649 179.898 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 807' ' ' ILE . . . . . . . . . . . . . 30.1 mt -83.4 135.85 23.98 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 O-C-N 120.741 -1.224 . . . . 0.0 111.381 -179.97 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 808' ' ' GLY . . . . . 0.479 ' C ' ' HG ' ' A' ' 809' ' ' LEU . . . 109.92 -5.2 30.62 Favored Glycine 0 N--CA 1.492 2.394 0 C-N-CA 120.094 -1.05 . . . . 0.0 110.792 179.875 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 809' ' ' LEU . . . . . 0.479 ' HG ' ' C ' ' A' ' 808' ' ' GLY . 1.3 mp -136.17 143.46 44.45 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 120.792 -1.417 . . . . 0.0 110.688 -179.92 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 810' ' ' GLU . . . . . 0.522 ' HG3' ' N ' ' A' ' 811' ' ' ARG . 0.0 OUTLIER -70.27 -21.56 62.95 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.246 -0.909 . . . . 0.0 108.709 179.866 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 811' ' ' ARG . . . . . 0.522 ' N ' ' HG3' ' A' ' 810' ' ' GLU . 1.6 ttt180 -115.65 149.73 37.86 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.625 -0.672 . . . . 0.0 109.22 179.89 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 812' ' ' CYS . . . . . 0.489 ' HB3' ' HB2' ' A' ' 762' ' ' LEU . 9.7 t -134.54 146.56 49.78 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.954 -1.091 . . . . 0.0 110.921 -179.887 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 813' ' ' VAL . . . . . . . . . . . . . 46.0 t -135.63 104.56 4.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.536 -0.727 . . . . 0.0 109.172 179.955 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 814' ' ' VAL . . . . . 0.591 HG21 HD11 ' A' ' 802' ' ' LEU . 41.0 t -110.73 115.5 50.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.269 -0.894 . . . . 0.0 111.304 -179.881 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 815' ' ' ALA . . . . . . . . . . . . . . . -79.96 131.81 35.9 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.262 -0.899 . . . . 0.0 109.0 179.901 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 816' ' ' ILE . . . . . 0.861 ' CD1' HG21 ' A' ' 833' ' ' VAL . 59.5 mt -87.0 134.13 28.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.105 -0.997 . . . . 0.0 111.045 -179.887 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 817' ' ' SER . . . . . 0.469 ' OG ' ' HB2' ' A' ' 820' ' ' ASN . 2.9 p -164.9 171.22 5.65 Favored Pre-proline 0 N--CA 1.494 1.732 0 O-C-N 121.416 -0.802 . . . . 0.0 109.699 179.934 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 818' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -78.87 -29.9 3.16 Favored 'Trans proline' 0 C--N 1.306 -1.674 0 O-C-N 123.797 1.42 . . . . 0.0 110.374 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 819' ' ' SER . . . . . . . . . . . . . 46.5 m -87.24 7.71 27.27 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.273 -0.892 . . . . 0.0 110.338 -179.963 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 820' ' ' ASN . . . . . 0.469 ' HB2' ' OG ' ' A' ' 817' ' ' SER . 0.4 OUTLIER -105.64 -8.43 17.92 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.154 -0.966 . . . . 0.0 110.007 -179.97 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 821' ' ' PHE . . . . . . . . . . . . . 31.8 m-85 -125.61 -74.49 0.6 Allowed 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.237 -0.914 . . . . 0.0 110.334 179.961 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 822' ' ' GLY . . . . . . . . . . . . . . . -178.16 57.75 0.09 OUTLIER Glycine 0 N--CA 1.492 2.375 0 N-CA-C 109.454 -1.458 . . . . 0.0 109.454 -179.98 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 823' ' ' GLY . . . . . . . . . . . . . . . 64.05 -122.85 26.8 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 -179.983 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 824' ' ' ASP . . . . . . . . . . . . . 89.4 m-20 -132.31 130.77 22.04 Favored Pre-proline 0 N--CA 1.495 1.806 0 O-C-N 121.327 -1.102 . . . . 0.0 109.985 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 825' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -82.05 -89.95 0.0 OUTLIER 'Trans proline' 0 C--N 1.308 -1.592 0 O-C-N 123.903 1.475 . . . . 0.0 111.062 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 826' ' ' CYS . . . . . . . . . . . . . 17.7 p -111.21 124.88 31.7 Favored Pre-proline 0 N--CA 1.497 1.879 0 O-C-N 121.256 -0.902 . . . . 0.0 111.12 -179.901 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 827' ' ' PRO . . . . . 0.489 ' O ' ' HB2' ' A' ' 828' ' ' GLU . 49.6 Cg_endo -81.16 -174.03 2.06 Favored 'Trans proline' 0 C--N 1.305 -1.719 0 O-C-N 123.962 1.506 . . . . 0.0 109.562 179.777 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 828' ' ' GLU . . . . . 0.489 ' HB2' ' O ' ' A' ' 827' ' ' PRO . 3.7 mm-40 58.79 14.48 3.24 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.475 -0.765 . . . . 0.0 109.611 -179.941 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 829' ' ' VAL . . . . . 0.459 ' O ' ' O ' ' A' ' 830' ' ' MET . 74.9 t -130.58 129.99 64.65 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.332 0 O-C-N 121.575 -0.703 . . . . 0.0 109.388 -179.983 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 830' ' ' MET . . . . . 0.459 ' O ' ' O ' ' A' ' 829' ' ' VAL . 33.8 mmt -52.82 -170.19 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.271 -0.893 . . . . 0.0 110.202 -179.964 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 831' ' ' LYS . . . . . 0.472 ' HB3' ' OE1' ' A' ' 737' ' ' GLU . 9.4 mttp -147.43 149.58 32.99 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 120.94 -1.1 . . . . 0.0 110.702 -179.913 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 832' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -161.86 149.18 14.31 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.602 -0.686 . . . . 0.0 109.151 179.924 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 833' ' ' VAL . . . . . 0.861 HG21 ' CD1' ' A' ' 816' ' ' ILE . 70.2 t -111.87 107.47 23.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 120.911 -1.118 . . . . 0.0 111.375 -179.973 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 834' ' ' ALA . . . . . 0.458 ' HA ' ' O ' ' A' ' 733' ' ' ALA . . . -109.97 128.71 55.55 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.375 -0.828 . . . . 0.0 109.172 179.857 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 835' ' ' VAL . . . . . . . . . . . . . 3.0 t -138.08 145.56 28.46 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 O-C-N 120.808 -1.183 . . . . 0.0 111.232 -179.855 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 836' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -124.48 117.93 25.49 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 179.873 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 837' ' ' ALA . . . . . . . . . . . . . . . -107.94 155.57 20.17 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.156 -0.965 . . . . 0.0 111.233 -179.807 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 838' ' ' VAL . . . . . 0.483 ' HB ' ' O ' ' A' ' 772' ' ' ALA . 71.9 t -112.33 110.99 34.23 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.375 0 O-C-N 121.545 -0.722 . . . . 0.0 109.361 179.938 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 839' ' ' CYS . . . . . 0.459 ' HB3' ' HB3' ' A' ' 768' ' ' GLN . 1.2 m -105.44 108.93 20.71 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.123 -0.986 . . . . 0.0 110.216 -179.915 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 840' ' ' SER . . . . . 0.575 ' C ' HG23 ' A' ' 841' ' ' THR . 14.8 t -99.17 -89.21 0.32 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.315 -0.865 . . . . 0.0 110.25 179.994 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 841' ' ' THR . . . . . 0.575 HG23 ' C ' ' A' ' 840' ' ' SER . 62.9 p -154.29 -157.98 0.82 Allowed 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.194 -0.942 . . . . 0.0 110.578 -179.977 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 842' ' ' ALA . . . . . 0.429 ' C ' ' O ' ' A' ' 841' ' ' THR . . . -41.27 147.33 0.16 Allowed 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.407 -0.808 . . . . 0.0 110.549 -179.967 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 843' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.642 0 CA-C-O 118.018 -0.992 . . . . 0.0 110.138 -179.936 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 726' ' ' ARG . . . . . 0.442 ' HD2' ' HB ' ' A' ' 727' ' ' THR . 0.0 OUTLIER . . . . . 0 N--CA 1.496 1.854 0 CA-C-O 121.057 0.456 . . . . 0.0 110.495 . . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 727' ' ' THR . . . . . 0.442 ' HB ' ' HD2' ' A' ' 726' ' ' ARG . 27.7 m -132.65 103.16 5.99 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.142 -0.974 . . . . 0.0 109.441 -179.993 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 728' ' ' VAL . . . . . 0.693 ' O ' HG12 ' A' ' 728' ' ' VAL . 1.3 t -77.87 99.77 2.81 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.781 0 O-C-N 121.292 -0.88 . . . . 0.0 109.959 -179.951 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 729' ' ' SER . . . . . 0.478 ' HB2' ' O ' ' A' ' 728' ' ' VAL . 2.2 m 58.16 168.62 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.484 -0.76 . . . . 0.0 110.788 179.827 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 730' ' ' GLY . . . . . 0.486 ' C ' HG23 ' A' ' 731' ' ' VAL . . . -131.32 -161.35 10.18 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.065 -1.614 . . . . 0.0 109.065 179.938 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 731' ' ' VAL . . . . . 0.486 HG23 ' C ' ' A' ' 730' ' ' GLY . 4.8 t -150.58 137.39 13.0 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 121.149 -1.207 . . . . 0.0 110.324 179.989 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 732' ' ' CYS . . . . . . . . . . . . . 20.3 m -128.25 143.71 51.06 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.309 -0.869 . . . . 0.0 109.868 179.964 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 733' ' ' ALA . . . . . . . . . . . . . . . -148.38 105.06 3.57 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.989 -1.069 . . . . 0.0 110.735 -179.948 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 734' ' ' ASP . . . . . 0.47 ' OD1' ' O ' ' A' ' 734' ' ' ASP . 1.0 OUTLIER -110.39 104.01 12.73 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.352 -0.843 . . . . 0.0 109.979 179.924 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 735' ' ' VAL . . . . . 0.493 ' O ' ' HB ' ' A' ' 833' ' ' VAL . 77.0 t -129.68 123.33 56.95 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 121.125 -0.984 . . . . 0.0 110.243 -179.967 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 736' ' ' SER . . . . . 0.499 ' HA ' ' HA ' ' A' ' 832' ' ' ARG . 5.4 p -84.24 158.74 21.16 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.088 -1.007 . . . . 0.0 110.362 -179.959 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 737' ' ' GLU . . . . . 0.584 ' HB2' HG21 ' A' ' 816' ' ' ILE . 24.5 tt0 -86.74 143.55 27.49 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.271 -0.893 . . . . 0.0 109.992 179.981 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 738' ' ' TYR . . . . . 0.565 ' CE1' ' HD3' ' A' ' 740' ' ' PRO . 52.4 p90 -171.2 -158.32 0.14 Allowed 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.056 -1.028 . . . . 0.0 110.78 -179.943 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 739' ' ' HIS . . . . . . . . . . . . . 4.0 t-80 -145.89 101.36 4.23 Favored Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.595 -0.691 . . . . 0.0 109.155 179.933 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 740' ' ' PRO . . . . . 0.565 ' HD3' ' CE1' ' A' ' 738' ' ' TYR . 49.6 Cg_endo -78.96 25.22 0.57 Allowed 'Trans proline' 0 C--N 1.306 -1.7 0 O-C-N 124.024 1.539 . . . . 0.0 111.947 -179.887 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 741' ' ' ASN . . . . . 0.461 ' O ' ' O ' ' A' ' 740' ' ' PRO . 57.7 t-20 42.74 92.28 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.798 0 O-C-N 120.889 -1.132 . . . . 0.0 110.088 179.959 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 742' ' ' ILE . . . . . . . . . . . . . 3.8 mt -75.27 94.08 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.237 -0.914 . . . . 0.0 110.644 -179.922 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 743' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.08 -60.91 2.8 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.029 -1.045 . . . . 0.0 108.979 179.898 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 744' ' ' ASN . . . . . . . . . . . . . 45.1 m-80 -51.38 133.89 28.9 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.342 -0.849 . . . . 0.0 108.836 179.928 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 745' ' ' TRP . . . . . 0.534 ' CZ2' ' O ' ' A' ' 750' ' ' TYR . 0.1 OUTLIER -169.37 22.0 0.02 OUTLIER 'General case' 0 C--N 1.3 -1.585 0 O-C-N 120.91 -1.119 . . . . 0.0 111.228 -179.922 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 746' ' ' GLN . . . . . 0.477 ' O ' ' HB ' ' A' ' 747' ' ' ILE . 5.1 mm-40 -92.26 -148.28 0.23 Allowed 'General case' 0 C--N 1.298 -1.639 0 O-C-N 121.038 -1.039 . . . . 0.0 109.653 -179.95 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 747' ' ' ILE . . . . . 0.517 ' O ' ' CB ' ' A' ' 748' ' ' GLU . 2.6 mt 55.13 105.57 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.067 -1.021 . . . . 0.0 109.538 -179.957 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 748' ' ' GLU . . . . . 0.517 ' CB ' ' O ' ' A' ' 747' ' ' ILE . 0.1 OUTLIER 70.53 -140.76 0.06 Allowed 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.067 -1.021 . . . . 0.0 109.325 -179.873 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 749' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -145.44 120.63 10.16 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 120.8 -1.187 . . . . 0.0 110.463 179.974 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 750' ' ' TYR . . . . . 0.534 ' O ' ' CZ2' ' A' ' 745' ' ' TRP . 3.5 m-85 -117.84 97.56 5.9 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.297 -0.877 . . . . 0.0 109.996 179.968 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 751' ' ' GLY . . . . . . . . . . . . . . . -92.69 94.58 1.91 Allowed Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 -179.949 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 752' ' ' GLU . . . . . . . . . . . . . 6.7 tt0 -136.78 118.17 11.23 Favored Pre-proline 0 N--CA 1.493 1.706 0 O-C-N 121.298 -1.119 . . . . 0.0 109.878 179.98 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 753' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -72.61 -163.06 0.14 Allowed 'Trans proline' 0 C--N 1.308 -1.602 0 O-C-N 123.908 1.478 . . . . 0.0 110.659 -179.964 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 754' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -68.85 101.41 1.35 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.318 -0.864 . . . . 0.0 110.388 -179.936 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 755' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -128.86 86.68 2.47 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.238 -0.914 . . . . 0.0 110.271 -179.996 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 756' ' ' HIS . . . . . 0.517 ' CD2' ' O ' ' A' ' 756' ' ' HIS . 9.7 p-80 -59.32 104.47 0.26 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.223 -0.923 . . . . 0.0 110.173 179.97 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 757' ' ' THR . . . . . 0.442 ' N ' ' O ' ' A' ' 738' ' ' TYR . 60.9 p -147.96 121.65 9.24 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.153 -0.967 . . . . 0.0 110.246 -179.979 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 758' ' ' ALA . . . . . 0.407 ' HB2' ' CE2' ' A' ' 738' ' ' TYR . . . -111.9 157.93 20.06 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.295 -0.878 . . . . 0.0 110.238 179.955 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 759' ' ' LYS . . . . . . . . . . . . . 1.3 ttmt -113.51 155.0 26.15 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.338 -0.851 . . . . 0.0 109.928 -179.974 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 760' ' ' VAL . . . . . . . . . . . . . 16.8 t -109.06 136.87 43.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.246 -0.909 . . . . 0.0 109.729 179.926 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 761' ' ' HIS . . . . . . . . . . . . . 3.5 m80 -109.52 107.34 17.42 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.147 -0.97 . . . . 0.0 110.467 -179.984 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 762' ' ' LEU . . . . . . . . . . . . . 2.0 mt -109.54 148.13 31.77 Favored 'General case' 0 C--N 1.299 -1.607 0 O-C-N 121.65 -0.656 . . . . 0.0 109.502 179.944 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 763' ' ' LYS . . . . . . . . . . . . . 3.3 ttpt -158.39 121.46 3.83 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.131 -0.98 . . . . 0.0 110.091 179.997 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 764' ' ' CYS . . . . . 0.442 ' O ' ' C ' ' A' ' 765' ' ' ALA . 12.7 t -82.06 157.77 24.02 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.262 -0.899 . . . . 0.0 110.001 179.958 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 765' ' ' ALA . . . . . 0.442 ' C ' ' O ' ' A' ' 764' ' ' CYS . . . -41.29 162.36 0.12 Allowed Pre-proline 0 N--CA 1.495 1.799 0 O-C-N 121.263 -0.898 . . . . 0.0 110.325 -179.966 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 766' ' ' PRO . . . . . 0.412 ' HD2' ' HB1' ' A' ' 765' ' ' ALA . 45.8 Cg_endo -73.16 99.75 1.14 Allowed 'Trans proline' 0 C--N 1.304 -1.799 0 O-C-N 124.025 1.54 . . . . 0.0 110.185 -179.979 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 767' ' ' GLY . . . . . . . . . . . . . . . 117.76 1.0 17.58 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.486 -1.446 . . . . 0.0 109.486 -179.962 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 768' ' ' GLN . . . . . 0.501 ' CG ' ' O ' ' A' ' 840' ' ' SER . 10.7 mp0 -116.47 154.47 30.29 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.219 -1.165 . . . . 0.0 110.273 179.938 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 769' ' ' THR . . . . . . . . . . . . . 43.1 p -129.02 147.54 50.9 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.184 -0.948 . . . . 0.0 110.359 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 770' ' ' ILE . . . . . . . . . . . . . 37.0 mt -58.99 133.17 24.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.308 -0.87 . . . . 0.0 109.751 179.952 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 771' ' ' SER . . . . . 0.476 ' O ' ' HB2' ' A' ' 772' ' ' ALA . 51.7 p -108.47 -17.0 14.09 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.236 -0.915 . . . . 0.0 110.861 -179.889 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 772' ' ' ALA . . . . . 0.476 ' HB2' ' O ' ' A' ' 771' ' ' SER . . . -177.77 171.84 1.79 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.875 -1.141 . . . . 0.0 111.271 -179.999 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 773' ' ' ILE . . . . . . . . . . . . . 42.6 mm -123.72 129.49 74.45 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 179.858 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 774' ' ' LYS . . . . . . . . . . . . . 5.9 mtpt -95.03 -35.47 11.93 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 121.033 -1.042 . . . . 0.0 111.537 -179.848 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 775' ' ' PHE . . . . . 0.674 ' O ' ' HB2' ' A' ' 776' ' ' ALA . 60.1 t80 -149.06 172.34 14.92 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 120.686 -1.259 . . . . 0.0 111.465 -179.948 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 776' ' ' ALA . . . . . 0.674 ' HB2' ' O ' ' A' ' 775' ' ' PHE . . . 169.3 119.93 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 109.187 -0.672 . . . . 0.0 109.187 -179.971 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 777' ' ' SER . . . . . 0.554 ' HA ' ' HB3' ' A' ' 798' ' ' SER . 44.4 t -143.69 137.2 28.02 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 120.978 -1.076 . . . . 0.0 111.172 -179.891 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 778' ' ' PHE . . . . . 0.57 ' CG ' ' O ' ' A' ' 778' ' ' PHE . 1.4 t80 -107.34 72.37 0.87 Allowed 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.422 -0.799 . . . . 0.0 109.73 179.925 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 779' ' ' GLY . . . . . . . . . . . . . . . -174.24 -120.6 0.59 Allowed Glycine 0 N--CA 1.492 2.405 0 N-CA-C 109.961 -1.255 . . . . 0.0 109.961 179.989 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 780' ' ' THR . . . . . 0.644 HG22 ' O ' ' A' ' 830' ' ' MET . 24.8 p -117.11 81.46 12.79 Favored Pre-proline 0 N--CA 1.494 1.775 0 O-C-N 121.197 -1.178 . . . . 0.0 110.553 179.984 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 781' ' ' PRO . . . . . 0.427 ' HA ' ' O ' ' A' ' 789' ' ' GLN . 46.8 Cg_endo -80.48 144.43 15.97 Favored 'Trans proline' 0 C--N 1.304 -1.805 0 O-C-N 124.054 1.555 . . . . 0.0 110.229 -179.983 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 782' ' ' LEU . . . . . . . . . . . . . 36.8 mt -120.32 148.91 43.12 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.176 -0.953 . . . . 0.0 110.331 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 783' ' ' GLY . . . . . . . . . . . . . . . 112.2 -139.29 15.54 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.546 -1.422 . . . . 0.0 109.546 -179.962 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 784' ' ' THR . . . . . . . . . . . . . 10.8 t -161.12 -173.26 3.78 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.254 -1.144 . . . . 0.0 110.138 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 785' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -64.37 107.15 1.27 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.191 -0.943 . . . . 0.0 110.204 -179.975 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 786' ' ' GLY . . . . . . . . . . . . . . . 131.36 -31.65 3.09 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.2 -1.56 . . . . 0.0 109.2 179.981 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 787' ' ' THR . . . . . . . . . . . . . 25.2 p -144.38 39.81 1.31 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.32 -1.106 . . . . 0.0 110.088 -179.942 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 788' ' ' PHE . . . . . 0.583 ' HB3' ' CZ ' ' A' ' 775' ' ' PHE . 1.9 m-85 -50.97 171.55 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.328 -0.858 . . . . 0.0 110.229 179.935 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 789' ' ' GLN . . . . . 0.427 ' O ' ' HA ' ' A' ' 781' ' ' PRO . 26.4 tt0 -161.05 169.57 22.22 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.114 -0.991 . . . . 0.0 110.424 -179.989 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 790' ' ' GLN . . . . . 0.454 ' O ' ' HG3' ' A' ' 790' ' ' GLN . 0.0 OUTLIER -94.89 147.96 22.82 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.23 -0.919 . . . . 0.0 110.041 -179.992 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 791' ' ' GLY . . . . . 0.443 ' HA3' ' OG1' ' A' ' 780' ' ' THR . . . -97.4 -150.67 26.88 Favored Glycine 0 N--CA 1.492 2.393 0 N-CA-C 109.516 -1.434 . . . . 0.0 109.516 179.943 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 792' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -70.08 -19.66 63.25 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.255 -1.144 . . . . 0.0 109.973 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 793' ' ' CYS . . . . . 0.475 ' SG ' ' N ' ' A' ' 794' ' ' HIS . 1.8 t -136.72 164.86 27.26 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.337 -0.852 . . . . 0.0 110.051 -179.963 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 794' ' ' HIS . . . . . 0.596 ' CE1' ' O ' ' A' ' 795' ' ' SER . 0.2 OUTLIER 179.5 154.65 0.5 Allowed 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.285 -0.884 . . . . 0.0 109.861 179.976 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 795' ' ' SER . . . . . 0.596 ' O ' ' CE1' ' A' ' 794' ' ' HIS . 1.8 t -91.78 107.61 19.33 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.324 -0.86 . . . . 0.0 110.15 179.993 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 796' ' ' ILE . . . . . 0.436 ' C ' ' O ' ' A' ' 795' ' ' SER . 6.5 pt -38.63 -25.05 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.939 0 O-C-N 121.372 -0.83 . . . . 0.0 111.23 179.981 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 797' ' ' ASN . . . . . 0.532 ' N ' ' O ' ' A' ' 795' ' ' SER . 19.3 p30 -107.85 51.74 0.73 Allowed 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.003 -1.06 . . . . 0.0 111.313 -179.894 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 798' ' ' SER . . . . . 0.554 ' HB3' ' HA ' ' A' ' 777' ' ' SER . 4.3 m -102.8 26.42 8.08 Favored 'General case' 0 N--CA 1.497 1.925 0 O-C-N 120.697 -1.252 . . . . 0.0 110.403 179.939 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 799' ' ' ASN . . . . . . . . . . . . . 38.4 m-80 -138.07 -46.97 0.53 Allowed 'General case' 0 N--CA 1.496 1.831 0 O-C-N 120.998 -1.064 . . . . 0.0 110.874 -179.905 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 800' ' ' SER . . . . . . . . . . . . . 8.7 t -62.78 -33.12 74.52 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.118 -0.989 . . . . 0.0 110.385 -179.93 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 801' ' ' VAL . . . . . . . . . . . . . 97.8 t -51.92 -52.06 25.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.285 -0.884 . . . . 0.0 110.582 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 802' ' ' LEU . . . . . 0.464 ' O ' ' HB2' ' A' ' 806' ' ' CYS . 1.1 mm? -63.15 -43.48 98.2 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.206 -0.934 . . . . 0.0 110.861 179.996 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 803' ' ' GLU . . . . . . . . . . . . . 24.7 tt0 -55.33 -21.1 13.62 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.232 -0.918 . . . . 0.0 110.646 -179.959 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 804' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -92.14 -23.22 19.49 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.234 -0.916 . . . . 0.0 110.98 -179.969 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 805' ' ' LYS . . . . . 0.4 ' O ' ' SG ' ' A' ' 812' ' ' CYS . 5.0 mmmt -130.77 52.57 2.03 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.017 -1.052 . . . . 0.0 110.892 -179.904 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 806' ' ' CYS . . . . . 0.546 ' O ' HD12 ' A' ' 809' ' ' LEU . 0.3 OUTLIER -160.95 -72.19 0.06 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.035 -1.041 . . . . 0.0 110.903 179.986 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 807' ' ' ILE . . . . . . . . . . . . . 94.4 mt -55.28 128.74 15.85 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 121.223 -0.923 . . . . 0.0 110.776 -179.921 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 808' ' ' GLY . . . . . 0.475 ' C ' ' HG ' ' A' ' 809' ' ' LEU . . . 106.83 1.16 36.58 Favored Glycine 0 N--CA 1.495 2.576 0 N-CA-C 110.385 -1.086 . . . . 0.0 110.385 179.906 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 809' ' ' LEU . . . . . 0.546 HD12 ' O ' ' A' ' 806' ' ' CYS . 1.0 OUTLIER -131.83 160.61 35.15 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 120.831 -1.393 . . . . 0.0 110.534 -179.958 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 810' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -83.78 -9.49 58.76 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.329 -0.857 . . . . 0.0 109.583 179.91 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 811' ' ' ARG . . . . . 0.533 ' NH1' HD22 ' A' ' 809' ' ' LEU . 0.1 OUTLIER -143.62 164.93 29.03 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.39 -0.819 . . . . 0.0 109.193 -179.987 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 812' ' ' CYS . . . . . 0.4 ' SG ' ' O ' ' A' ' 805' ' ' LYS . 7.9 t -143.77 126.99 16.62 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.922 -1.111 . . . . 0.0 111.268 -179.852 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 813' ' ' VAL . . . . . . . . . . . . . 98.3 t -128.45 115.11 36.54 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.298 -0.877 . . . . 0.0 109.225 179.809 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 814' ' ' VAL . . . . . . . . . . . . . 97.9 t -123.28 129.21 74.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.134 -0.978 . . . . 0.0 110.772 -179.876 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 815' ' ' ALA . . . . . . . . . . . . . . . -86.69 158.82 19.35 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.323 -0.861 . . . . 0.0 109.623 179.909 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 816' ' ' ILE . . . . . 0.78 HD13 HG21 ' A' ' 833' ' ' VAL . 75.9 mt -109.65 133.02 56.24 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.577 0 O-C-N 121.218 -0.926 . . . . 0.0 110.575 -179.985 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 817' ' ' SER . . . . . 0.502 ' OG ' ' CB ' ' A' ' 820' ' ' ASN . 0.1 OUTLIER -165.98 170.45 5.8 Favored Pre-proline 0 N--CA 1.488 1.447 0 O-C-N 121.267 -0.896 . . . . 0.0 109.888 179.978 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 818' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -78.16 -63.63 0.02 OUTLIER 'Trans proline' 0 C--N 1.303 -1.834 0 O-C-N 123.982 1.517 . . . . 0.0 111.497 -179.886 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 819' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -70.24 -1.1 9.31 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 120.986 -1.071 . . . . 0.0 111.215 -179.849 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 820' ' ' ASN . . . . . 0.502 ' CB ' ' OG ' ' A' ' 817' ' ' SER . 27.9 t-20 -84.49 -20.79 31.1 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 120.952 -1.093 . . . . 0.0 109.999 179.977 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 821' ' ' PHE . . . . . . . . . . . . . 5.5 m-85 -108.45 -59.3 1.88 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.232 -0.918 . . . . 0.0 110.562 -179.903 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 822' ' ' GLY . . . . . . . . . . . . . . . -144.13 -55.65 0.03 OUTLIER Glycine 0 N--CA 1.491 2.366 0 N-CA-C 109.773 -1.331 . . . . 0.0 109.773 179.965 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 823' ' ' GLY . . . . . . . . . . . . . . . 137.77 108.32 0.85 Allowed Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.661 -1.376 . . . . 0.0 109.661 -179.958 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 824' ' ' ASP . . . . . 0.521 ' N ' ' HD3' ' A' ' 825' ' ' PRO . 4.2 m-20 43.11 59.93 10.99 Favored Pre-proline 0 N--CA 1.494 1.736 0 O-C-N 121.343 -1.092 . . . . 0.0 110.73 -179.976 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 825' ' ' PRO . . . . . 0.521 ' HD3' ' N ' ' A' ' 824' ' ' ASP . 47.8 Cg_endo -84.29 -54.91 0.03 OUTLIER 'Trans proline' 0 C--N 1.304 -1.784 0 O-C-N 123.926 1.487 . . . . 0.0 110.261 179.998 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 826' ' ' CYS . . . . . 0.4 ' SG ' HG11 ' A' ' 829' ' ' VAL . 0.5 OUTLIER -131.56 85.24 53.02 Favored Pre-proline 0 N--CA 1.496 1.838 0 O-C-N 121.267 -0.896 . . . . 0.0 110.375 -179.993 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 827' ' ' PRO . . . . . 0.448 ' O ' HG23 ' A' ' 829' ' ' VAL . 50.5 Cg_endo -86.64 151.11 8.81 Favored 'Trans proline' 0 C--N 1.306 -1.671 0 O-C-N 123.919 1.484 . . . . 0.0 111.287 -179.969 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 828' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 45.28 48.99 10.28 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.426 -0.796 . . . . 0.0 111.111 179.968 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 829' ' ' VAL . . . . . 0.515 ' O ' ' N ' ' A' ' 831' ' ' LYS . 20.4 t -147.44 137.95 17.34 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.583 0 O-C-N 121.164 -0.96 . . . . 0.0 110.173 179.899 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 830' ' ' MET . . . . . 0.644 ' O ' HG22 ' A' ' 780' ' ' THR . 0.2 OUTLIER -42.31 95.11 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.419 -0.8 . . . . 0.0 109.618 179.976 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 831' ' ' LYS . . . . . 0.515 ' N ' ' O ' ' A' ' 829' ' ' VAL . 0.0 OUTLIER -94.61 150.22 20.46 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.186 -0.946 . . . . 0.0 110.565 -179.938 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 832' ' ' ARG . . . . . 0.499 ' HA ' ' HA ' ' A' ' 736' ' ' SER . 0.0 OUTLIER -156.94 151.76 25.84 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.404 -0.81 . . . . 0.0 109.662 179.97 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 833' ' ' VAL . . . . . 0.78 HG21 HD13 ' A' ' 816' ' ' ILE . 66.6 t -115.79 106.1 19.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 120.979 -1.075 . . . . 0.0 110.955 179.978 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 834' ' ' ALA . . . . . 0.447 ' HB1' ' CZ ' ' A' ' 788' ' ' PHE . . . -108.87 132.95 53.53 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.307 -0.87 . . . . 0.0 109.092 179.922 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 835' ' ' VAL . . . . . . . . . . . . . 73.1 t -141.16 133.03 28.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.012 -1.055 . . . . 0.0 111.323 -179.94 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 836' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -125.53 112.64 16.45 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 179.897 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 837' ' ' ALA . . . . . . . . . . . . . . . -108.91 162.67 13.99 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.146 -0.971 . . . . 0.0 111.089 -179.926 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 838' ' ' VAL . . . . . . . . . . . . . 38.6 t -111.84 119.15 59.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.524 -0.735 . . . . 0.0 109.727 -179.946 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 839' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -105.71 146.18 30.11 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.9 -1.125 . . . . 0.0 110.94 179.946 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 840' ' ' SER . . . . . 0.501 ' O ' ' CG ' ' A' ' 768' ' ' GLN . 79.1 p -138.94 -152.22 0.41 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.498 -0.752 . . . . 0.0 109.775 -179.991 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 841' ' ' THR . . . . . . . . . . . . . 69.6 p -121.63 -175.94 3.2 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.186 -0.946 . . . . 0.0 109.993 179.977 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 842' ' ' ALA . . . . . . . . . . . . . . . -108.49 99.3 8.7 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.157 -0.964 . . . . 0.0 110.331 -179.991 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 843' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.679 0 CA-C-O 118.052 -0.975 . . . . 0.0 110.198 179.962 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 726' ' ' ARG . . . . . 0.709 ' O ' HG22 ' A' ' 727' ' ' THR . 1.9 ttt180 . . . . . 0 N--CA 1.492 1.66 0 CA-C-O 121.027 0.442 . . . . 0.0 110.183 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 727' ' ' THR . . . . . 0.709 HG22 ' O ' ' A' ' 726' ' ' ARG . 0.4 OUTLIER 73.73 179.08 0.22 Allowed 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.2 -0.937 . . . . 0.0 110.116 179.987 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 728' ' ' VAL . . . . . 0.515 ' N ' HG23 ' A' ' 727' ' ' THR . 43.0 t -124.6 117.47 50.55 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.654 0 O-C-N 121.43 -0.794 . . . . 0.0 110.177 179.969 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 729' ' ' SER . . . . . 0.401 ' O ' ' O ' ' A' ' 728' ' ' VAL . 40.5 m 51.78 179.21 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.18 -0.95 . . . . 0.0 110.034 -179.972 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 730' ' ' GLY . . . . . . . . . . . . . . . -152.8 -158.8 8.69 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.622 -1.391 . . . . 0.0 109.622 -179.938 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 731' ' ' VAL . . . . . 0.511 ' CG2' ' SG ' ' A' ' 764' ' ' CYS . 18.0 t -140.1 144.65 27.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.21 -1.171 . . . . 0.0 110.506 179.99 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 732' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -135.96 143.15 44.71 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.432 -0.793 . . . . 0.0 109.729 179.952 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 733' ' ' ALA . . . . . . . . . . . . . . . -148.44 122.74 9.61 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.123 -0.986 . . . . 0.0 110.726 179.997 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 734' ' ' ASP . . . . . 0.461 ' O ' ' OD2' ' A' ' 734' ' ' ASP . 19.3 p-10 -129.92 106.06 8.41 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.326 -0.859 . . . . 0.0 109.877 179.953 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 735' ' ' VAL . . . . . . . . . . . . . 61.3 t -126.8 159.32 36.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.107 -0.996 . . . . 0.0 110.428 -179.951 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 736' ' ' SER . . . . . 0.428 ' O ' ' C ' ' A' ' 737' ' ' GLU . 24.6 m -109.51 127.29 54.34 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.321 -0.862 . . . . 0.0 109.932 179.992 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 737' ' ' GLU . . . . . 0.476 ' HB2' ' HB3' ' A' ' 831' ' ' LYS . 14.9 tp10 -41.8 149.59 0.13 Allowed 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.296 -0.878 . . . . 0.0 110.433 179.992 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 738' ' ' TYR . . . . . 0.417 ' O ' ' O ' ' A' ' 739' ' ' HIS . 21.0 t80 -109.46 -73.22 0.69 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.286 -0.884 . . . . 0.0 110.111 179.952 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 739' ' ' HIS . . . . . 0.417 ' O ' ' O ' ' A' ' 738' ' ' TYR . 2.9 t60 59.87 116.12 0.02 OUTLIER Pre-proline 0 N--CA 1.494 1.751 0 O-C-N 121.252 -0.905 . . . . 0.0 110.488 179.936 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 740' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_endo -80.32 69.37 7.98 Favored 'Trans proline' 0 C--N 1.309 -1.51 0 O-C-N 124.008 1.531 . . . . 0.0 110.118 179.832 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 741' ' ' ASN . . . . . 0.43 ' N ' HD12 ' A' ' 742' ' ' ILE . 28.2 p30 -104.22 63.96 0.76 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.204 -0.935 . . . . 0.0 110.321 -179.951 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 742' ' ' ILE . . . . . 0.592 HD12 ' N ' ' A' ' 742' ' ' ILE . 5.1 mp -113.9 158.66 14.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.26 -0.9 . . . . 0.0 109.951 -179.981 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 743' ' ' LYS . . . . . . . . . . . . . 30.9 ttmt -85.23 -71.63 0.52 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.11 -0.994 . . . . 0.0 109.878 179.949 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 744' ' ' ASN . . . . . 0.464 ' OD1' ' O ' ' A' ' 744' ' ' ASN . 14.3 p30 -91.27 127.98 36.91 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.09 -1.006 . . . . 0.0 109.458 179.935 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 745' ' ' TRP . . . . . 0.5 ' HA ' ' CE3' ' A' ' 745' ' ' TRP . 0.1 OUTLIER -154.42 15.12 0.45 Allowed 'General case' 0 C--N 1.296 -1.719 0 O-C-N 121.441 -0.787 . . . . 0.0 110.723 -179.894 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 746' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -94.17 134.54 36.51 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.085 -1.009 . . . . 0.0 109.868 179.951 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 747' ' ' ILE . . . . . . . . . . . . . 14.8 pt -139.33 -160.56 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.243 -0.911 . . . . 0.0 110.408 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 748' ' ' GLU . . . . . . . . . . . . . 13.4 mt-10 -81.87 -10.6 59.26 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.39 -0.819 . . . . 0.0 110.064 -179.982 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 749' ' ' SER . . . . . 0.454 ' O ' ' HB2' ' A' ' 750' ' ' TYR . 3.1 t -90.55 -19.43 23.77 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.207 -0.933 . . . . 0.0 110.127 179.998 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 750' ' ' TYR . . . . . 0.454 ' HB2' ' O ' ' A' ' 749' ' ' SER . 80.2 m-85 55.8 163.33 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.199 -0.938 . . . . 0.0 110.237 179.99 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 751' ' ' GLY . . . . . 0.438 ' C ' ' HD2' ' A' ' 753' ' ' PRO . . . 44.0 44.94 7.54 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 -179.992 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 752' ' ' GLU . . . . . 0.609 ' N ' ' CD ' ' A' ' 753' ' ' PRO . 4.6 tp10 -59.72 -41.01 83.65 Favored Pre-proline 0 N--CA 1.489 1.501 0 O-C-N 121.309 -1.112 . . . . 0.0 111.317 -179.955 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 753' ' ' PRO . . . . . 0.609 ' CD ' ' N ' ' A' ' 752' ' ' GLU . 47.0 Cg_endo -77.59 100.86 1.43 Allowed 'Trans proline' 0 C--N 1.312 -1.356 0 O-C-N 123.491 1.258 . . . . 0.0 110.435 -179.971 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 754' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -80.72 -15.9 55.31 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.304 -0.873 . . . . 0.0 110.311 -179.975 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 755' ' ' PHE . . . . . 0.402 ' CZ ' ' HD2' ' A' ' 759' ' ' LYS . 0.8 OUTLIER -143.66 139.78 29.74 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.203 -0.936 . . . . 0.0 110.203 179.931 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 756' ' ' HIS . . . . . 0.433 ' C ' ' OG1' ' A' ' 757' ' ' THR . 14.9 p-80 -117.3 48.02 1.41 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.31 -0.869 . . . . 0.0 110.212 179.947 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 757' ' ' THR . . . . . 0.433 ' OG1' ' C ' ' A' ' 756' ' ' HIS . 0.0 OUTLIER -175.78 172.5 2.5 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.231 -0.918 . . . . 0.0 110.217 179.96 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 758' ' ' ALA . . . . . 0.89 ' HB3' ' HB ' ' A' ' 816' ' ' ILE . . . -98.9 172.26 7.54 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.32 -0.862 . . . . 0.0 109.855 179.939 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 759' ' ' LYS . . . . . 0.402 ' HD2' ' CZ ' ' A' ' 755' ' ' PHE . 6.4 mttm -150.74 136.58 18.22 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.115 -0.991 . . . . 0.0 110.41 179.959 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 760' ' ' VAL . . . . . . . . . . . . . 42.1 t -106.6 136.65 40.58 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.305 -0.872 . . . . 0.0 109.263 179.941 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 761' ' ' HIS . . . . . . . . . . . . . 68.1 m80 -109.71 104.15 13.1 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.198 -0.939 . . . . 0.0 110.981 -179.947 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 762' ' ' LEU . . . . . . . . . . . . . 39.4 mt -119.13 101.77 8.25 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.33 -0.857 . . . . 0.0 108.951 179.905 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 763' ' ' LYS . . . . . 0.489 ' HB3' ' HG3' ' A' ' 811' ' ' ARG . 6.6 pttm -135.66 140.86 44.82 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.077 -1.015 . . . . 0.0 110.803 -179.956 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 764' ' ' CYS . . . . . 0.511 ' SG ' ' CG2' ' A' ' 731' ' ' VAL . 0.5 OUTLIER -113.47 157.77 21.55 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.407 -0.808 . . . . 0.0 109.891 179.983 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 765' ' ' ALA . . . . . 0.775 ' HB3' ' HG3' ' A' ' 768' ' ' GLN . . . -44.73 169.71 0.06 OUTLIER Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 121.197 -0.939 . . . . 0.0 110.218 179.963 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 766' ' ' PRO . . . . . 0.659 ' HD2' ' HB1' ' A' ' 765' ' ' ALA . 43.9 Cg_endo -71.13 113.04 3.46 Favored 'Trans proline' 0 C--N 1.304 -1.787 0 O-C-N 123.961 1.506 . . . . 0.0 110.4 179.958 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 767' ' ' GLY . . . . . 0.81 ' O ' ' HB3' ' A' ' 842' ' ' ALA . . . 110.07 -24.82 17.82 Favored Glycine 0 N--CA 1.488 2.16 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 -179.942 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 768' ' ' GLN . . . . . 0.775 ' HG3' ' HB3' ' A' ' 765' ' ' ALA . 3.1 mt-30 -87.77 99.84 12.4 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.238 -1.154 . . . . 0.0 110.117 -179.99 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 769' ' ' THR . . . . . 0.844 HG22 ' HG3' ' A' ' 810' ' ' GLU . 64.1 p -94.78 154.14 17.42 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.257 -0.902 . . . . 0.0 110.375 -179.988 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 770' ' ' ILE . . . . . 0.419 ' HA ' ' O ' ' A' ' 838' ' ' VAL . 11.3 mt -78.11 144.89 10.65 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.356 -0.84 . . . . 0.0 110.005 -179.999 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 771' ' ' SER . . . . . . . . . . . . . 1.8 t -137.02 -5.3 1.89 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.147 -0.971 . . . . 0.0 111.158 -179.915 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 772' ' ' ALA . . . . . . . . . . . . . . . -162.18 123.38 2.65 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.859 -1.151 . . . . 0.0 111.014 -179.906 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 773' ' ' ILE . . . . . . . . . . . . . 32.9 mm -85.67 124.48 40.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.286 -0.884 . . . . 0.0 109.551 179.889 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 774' ' ' LYS . . . . . . . . . . . . . 18.9 mmtt -80.44 -42.26 22.98 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.246 -0.909 . . . . 0.0 110.757 -179.904 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 775' ' ' PHE . . . . . 0.694 ' O ' ' HB2' ' A' ' 776' ' ' ALA . 59.3 t80 -154.04 173.0 16.61 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.027 -1.045 . . . . 0.0 111.078 -179.974 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 776' ' ' ALA . . . . . 0.694 ' HB2' ' O ' ' A' ' 775' ' ' PHE . . . 168.39 89.08 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.588 -0.695 . . . . 0.0 109.548 179.959 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 777' ' ' SER . . . . . 0.581 ' HA ' ' CB ' ' A' ' 798' ' ' SER . 59.5 p -122.66 137.7 54.82 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.231 -0.918 . . . . 0.0 110.504 -179.906 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 778' ' ' PHE . . . . . . . . . . . . . 15.7 t80 -104.18 104.32 14.22 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.245 -0.909 . . . . 0.0 110.066 179.963 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 779' ' ' GLY . . . . . . . . . . . . . . . 161.64 -113.55 0.57 Allowed Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.457 -1.457 . . . . 0.0 109.457 -179.998 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 780' ' ' THR . . . . . . . . . . . . . 12.0 p -118.56 72.86 10.75 Favored Pre-proline 0 N--CA 1.492 1.67 0 O-C-N 121.203 -1.175 . . . . 0.0 110.127 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 781' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -73.27 161.16 43.55 Favored 'Trans proline' 0 C--N 1.307 -1.629 0 O-C-N 123.952 1.501 . . . . 0.0 110.296 179.976 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 782' ' ' LEU . . . . . 0.547 ' CD1' ' CA ' ' A' ' 791' ' ' GLY . 1.2 mp -132.61 169.36 16.73 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.233 -0.917 . . . . 0.0 110.159 179.984 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 783' ' ' GLY . . . . . . . . . . . . . . . 95.61 -167.67 26.0 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.354 -1.498 . . . . 0.0 109.354 -179.994 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 784' ' ' THR . . . . . 0.574 ' O ' ' CZ ' ' A' ' 788' ' ' PHE . 1.2 p -133.62 -65.69 0.67 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.187 -1.184 . . . . 0.0 110.337 -179.981 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 785' ' ' CYS . . . . . . . . . . . . . 7.8 t -156.19 128.49 7.6 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.166 -0.959 . . . . 0.0 110.445 179.988 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 786' ' ' GLY . . . . . . . . . . . . . . . 92.25 -13.18 67.77 Favored Glycine 0 N--CA 1.492 2.384 0 N-CA-C 109.7 -1.36 . . . . 0.0 109.7 -179.973 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 787' ' ' THR . . . . . 0.435 ' O ' HG23 ' A' ' 787' ' ' THR . 7.5 t -141.21 31.99 1.73 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.206 -1.173 . . . . 0.0 110.612 -179.991 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 788' ' ' PHE . . . . . 0.574 ' CZ ' ' O ' ' A' ' 784' ' ' THR . 0.7 OUTLIER -61.02 129.23 40.37 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.094 -1.004 . . . . 0.0 109.671 179.982 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 789' ' ' GLN . . . . . . . . . . . . . 5.2 pt20 -133.23 161.06 35.46 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.075 -1.016 . . . . 0.0 110.258 -179.967 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 790' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -75.27 144.36 42.57 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.233 -0.917 . . . . 0.0 110.406 -179.931 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 791' ' ' GLY . . . . . 0.547 ' CA ' ' CD1' ' A' ' 782' ' ' LEU . . . -96.56 -46.1 2.59 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 -179.98 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 792' ' ' GLU . . . . . 0.449 ' HB3' ' O ' ' A' ' 791' ' ' GLY . 15.8 pt-20 179.17 -27.63 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.158 -1.201 . . . . 0.0 110.93 -179.921 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 793' ' ' CYS . . . . . 0.461 ' O ' ' HB2' ' A' ' 794' ' ' HIS . 1.7 m -102.72 164.1 11.83 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.058 -1.026 . . . . 0.0 110.979 -179.92 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 794' ' ' HIS . . . . . 0.498 ' CE1' ' OG ' ' A' ' 798' ' ' SER . 32.3 t60 179.56 135.52 0.1 Allowed 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.466 -0.771 . . . . 0.0 109.727 179.941 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 795' ' ' SER . . . . . 0.419 ' O ' ' N ' ' A' ' 797' ' ' ASN . 0.2 OUTLIER -90.87 23.78 3.01 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.19 -0.944 . . . . 0.0 110.884 -179.909 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 796' ' ' ILE . . . . . 0.491 HG22 ' O ' ' A' ' 796' ' ' ILE . 40.9 mt 42.65 27.29 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 O-C-N 121.125 -0.984 . . . . 0.0 110.018 179.958 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 797' ' ' ASN . . . . . 0.419 ' N ' ' O ' ' A' ' 795' ' ' SER . 1.2 t-20 -157.25 26.88 0.3 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.246 -0.909 . . . . 0.0 109.611 179.972 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 798' ' ' SER . . . . . 0.581 ' CB ' ' HA ' ' A' ' 777' ' ' SER . 2.8 m -84.28 -19.65 33.46 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.396 -0.815 . . . . 0.0 110.515 -179.96 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 799' ' ' ASN . . . . . 0.539 ' OD1' ' HB3' ' A' ' 776' ' ' ALA . 63.9 m-80 -108.87 -1.06 19.43 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.276 -0.89 . . . . 0.0 110.751 -179.996 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 800' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -91.83 -31.34 15.76 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.21 -0.931 . . . . 0.0 110.434 -179.962 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 801' ' ' VAL . . . . . . . . . . . . . 95.7 t -79.93 -17.93 12.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.359 -0.838 . . . . 0.0 110.089 -179.949 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 802' ' ' LEU . . . . . 0.488 ' N ' ' CD2' ' A' ' 802' ' ' LEU . 4.5 mm? -87.71 -60.43 1.97 Allowed 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.317 -0.864 . . . . 0.0 110.838 -179.955 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 803' ' ' GLU . . . . . 0.603 ' CG ' HD12 ' A' ' 807' ' ' ILE . 1.1 tt0 -57.3 -20.23 27.14 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.113 -0.992 . . . . 0.0 110.527 -179.988 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 804' ' ' ARG . . . . . . . . . . . . . 48.2 ttt85 -93.8 -20.21 20.3 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.268 -0.895 . . . . 0.0 111.757 -179.896 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 805' ' ' LYS . . . . . 0.448 ' O ' ' SG ' ' A' ' 806' ' ' CYS . 8.8 tttm -126.29 40.13 3.79 Favored 'General case' 0 N--CA 1.501 2.108 0 O-C-N 120.765 -1.21 . . . . 0.0 111.502 -179.887 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 806' ' ' CYS . . . . . 0.448 ' SG ' ' O ' ' A' ' 805' ' ' LYS . 1.3 m -163.55 -55.06 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.038 -1.039 . . . . 0.0 110.235 179.892 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 807' ' ' ILE . . . . . 0.603 HD12 ' CG ' ' A' ' 803' ' ' GLU . 5.6 mt -51.09 119.15 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.315 -0.866 . . . . 0.0 110.432 -179.965 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 808' ' ' GLY . . . . . 0.43 ' C ' ' HG ' ' A' ' 809' ' ' LEU . . . 111.14 6.93 25.51 Favored Glycine 0 N--CA 1.492 2.415 0 N-CA-C 109.803 -1.319 . . . . 0.0 109.803 179.923 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 809' ' ' LEU . . . . . 0.43 ' HG ' ' C ' ' A' ' 808' ' ' GLY . 15.9 mt -136.25 148.88 48.25 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.203 -1.175 . . . . 0.0 110.311 -179.971 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 810' ' ' GLU . . . . . 0.844 ' HG3' HG22 ' A' ' 769' ' ' THR . 5.1 mt-10 -76.38 -19.09 58.49 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.253 -0.904 . . . . 0.0 109.558 179.881 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 811' ' ' ARG . . . . . 0.489 ' HG3' ' HB3' ' A' ' 763' ' ' LYS . 1.0 OUTLIER -152.78 133.74 14.07 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.527 -0.733 . . . . 0.0 109.665 179.923 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 812' ' ' CYS . . . . . . . . . . . . . 27.6 p -152.02 141.48 21.62 Favored 'General case' 0 C--N 1.296 -1.759 0 O-C-N 121.334 -0.854 . . . . 0.0 110.64 -179.927 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 813' ' ' VAL . . . . . . . . . . . . . 24.2 t -110.21 152.97 12.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.277 -0.89 . . . . 0.0 109.843 -179.983 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 814' ' ' VAL . . . . . . . . . . . . . 22.0 t -131.79 106.46 11.56 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 O-C-N 121.042 -1.036 . . . . 0.0 110.458 -179.936 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 815' ' ' ALA . . . . . . . . . . . . . . . -67.13 143.32 56.7 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.254 -0.904 . . . . 0.0 109.964 179.939 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 816' ' ' ILE . . . . . 1.058 HD13 HG21 ' A' ' 833' ' ' VAL . 20.8 mt -100.02 104.48 16.17 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.211 -0.931 . . . . 0.0 110.156 -179.928 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 817' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -144.61 153.73 55.26 Favored Pre-proline 0 N--CA 1.496 1.835 0 O-C-N 121.322 -0.861 . . . . 0.0 110.279 179.958 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 818' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -76.65 -25.73 9.08 Favored 'Trans proline' 0 C--N 1.309 -1.508 0 O-C-N 123.897 1.472 . . . . 0.0 110.391 -179.999 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 819' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -90.97 18.32 6.81 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.228 -0.92 . . . . 0.0 109.873 179.958 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 820' ' ' ASN . . . . . . . . . . . . . 31.0 t30 -116.16 -32.11 5.45 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.338 -0.851 . . . . 0.0 110.396 -179.998 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 821' ' ' PHE . . . . . . . . . . . . . 54.3 m-85 -86.07 -79.62 0.25 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.16 -0.963 . . . . 0.0 110.008 179.999 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 822' ' ' GLY . . . . . . . . . . . . . . . -177.76 56.5 0.1 OUTLIER Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.213 -1.555 . . . . 0.0 109.213 -179.97 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 823' ' ' GLY . . . . . . . . . . . . . . . 99.01 -149.65 19.12 Favored Glycine 0 N--CA 1.487 2.041 0 N-CA-C 109.353 -1.499 . . . . 0.0 109.353 179.972 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 824' ' ' ASP . . . . . 0.488 ' OD2' ' N ' ' A' ' 824' ' ' ASP . 0.8 OUTLIER -121.59 142.02 34.83 Favored Pre-proline 0 N--CA 1.492 1.649 0 O-C-N 121.23 -1.159 . . . . 0.0 110.332 179.943 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 825' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -75.61 -89.63 0.0 OUTLIER 'Trans proline' 0 C--N 1.306 -1.675 0 O-C-N 124.105 1.581 . . . . 0.0 110.888 -179.947 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 826' ' ' CYS . . . . . 0.405 ' HB3' HG21 ' A' ' 829' ' ' VAL . 79.0 m -113.62 120.72 38.88 Favored Pre-proline 0 N--CA 1.494 1.748 0 O-C-N 121.196 -0.94 . . . . 0.0 110.475 -179.953 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 827' ' ' PRO . . . . . 0.476 ' O ' ' CB ' ' A' ' 828' ' ' GLU . 49.1 Cg_endo -75.58 142.47 26.19 Favored 'Trans proline' 0 C--N 1.306 -1.66 0 O-C-N 123.839 1.442 . . . . 0.0 110.33 179.938 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 828' ' ' GLU . . . . . 0.476 ' CB ' ' O ' ' A' ' 827' ' ' PRO . 0.8 OUTLIER 67.36 38.65 3.18 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.256 -0.903 . . . . 0.0 110.35 -179.991 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 829' ' ' VAL . . . . . 0.475 ' O ' ' HD3' ' A' ' 831' ' ' LYS . 24.0 t -136.05 132.92 50.46 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.174 -0.954 . . . . 0.0 110.291 -179.945 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 830' ' ' MET . . . . . 0.414 ' C ' ' O ' ' A' ' 829' ' ' VAL . 17.4 mtt -43.96 127.88 5.46 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.289 -0.882 . . . . 0.0 110.012 179.95 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 831' ' ' LYS . . . . . 0.476 ' HB3' ' HB2' ' A' ' 737' ' ' GLU . 0.0 OUTLIER -94.08 112.99 24.87 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.144 -0.973 . . . . 0.0 110.511 -179.983 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 832' ' ' ARG . . . . . . . . . . . . . 33.4 mtp85 -125.12 139.83 53.42 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.317 -0.864 . . . . 0.0 109.823 179.914 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 833' ' ' VAL . . . . . 1.058 HG21 HD13 ' A' ' 816' ' ' ILE . 42.8 t -112.32 105.1 18.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.15 -0.969 . . . . 0.0 110.567 -179.914 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 834' ' ' ALA . . . . . . . . . . . . . . . -113.5 116.43 29.57 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.377 -0.827 . . . . 0.0 109.786 179.976 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 835' ' ' VAL . . . . . . . . . . . . . 29.4 t -130.51 156.75 42.72 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.176 -0.953 . . . . 0.0 110.544 -179.93 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 836' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -149.21 113.14 5.13 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.489 -0.757 . . . . 0.0 109.652 179.954 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 837' ' ' ALA . . . . . . . . . . . . . . . -110.22 163.42 13.64 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.098 -1.001 . . . . 0.0 110.465 -179.983 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 838' ' ' VAL . . . . . 0.529 HG13 HG21 ' A' ' 727' ' ' THR . 74.5 t -114.09 156.72 14.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.339 -0.851 . . . . 0.0 110.203 -179.968 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 839' ' ' CYS . . . . . . . . . . . . . 1.2 m -136.59 148.0 47.27 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.322 -0.861 . . . . 0.0 110.194 179.978 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 840' ' ' SER . . . . . 0.586 ' O ' HG23 ' A' ' 841' ' ' THR . 9.6 t -119.09 -99.36 0.44 Allowed 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.272 -0.892 . . . . 0.0 110.678 -179.953 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 841' ' ' THR . . . . . 0.586 HG23 ' O ' ' A' ' 840' ' ' SER . 19.5 p -156.58 153.43 28.63 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.008 -1.057 . . . . 0.0 110.191 -179.975 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 842' ' ' ALA . . . . . 0.81 ' HB3' ' O ' ' A' ' 767' ' ' GLY . . . 176.84 171.69 0.48 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.264 -0.897 . . . . 0.0 110.243 179.941 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 843' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.684 0 CA-C-O 117.961 -1.019 . . . . 0.0 110.159 -179.976 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 726' ' ' ARG . . . . . 0.453 ' O ' ' HB ' ' A' ' 727' ' ' THR . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.688 0 CA-C-O 121.197 0.523 . . . . 0.0 110.111 . . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 727' ' ' THR . . . . . 0.453 ' HB ' ' O ' ' A' ' 726' ' ' ARG . 31.4 m 58.31 114.21 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.157 -0.965 . . . . 0.0 110.023 -179.995 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 728' ' ' VAL . . . . . 0.479 ' O ' ' HB2' ' A' ' 729' ' ' SER . 68.2 t -138.48 120.87 18.29 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.199 -0.938 . . . . 0.0 110.178 -179.997 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 729' ' ' SER . . . . . 0.479 ' HB2' ' O ' ' A' ' 728' ' ' VAL . 14.8 t -178.98 125.37 0.09 Allowed 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.147 -0.971 . . . . 0.0 110.891 179.947 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 730' ' ' GLY . . . . . . . . . . . . . . . 103.45 116.53 4.21 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 110.194 -1.162 . . . . 0.0 110.194 179.947 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 731' ' ' VAL . . . . . 0.521 ' CG2' ' O ' ' A' ' 837' ' ' ALA . 3.5 m -147.87 161.81 7.04 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.367 -1.078 . . . . 0.0 109.27 179.92 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 732' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -148.51 161.29 41.94 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.001 -1.062 . . . . 0.0 110.955 -179.978 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 733' ' ' ALA . . . . . . . . . . . . . . . -163.51 104.35 0.95 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.536 -0.728 . . . . 0.0 109.416 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 734' ' ' ASP . . . . . 0.589 ' C ' HG23 ' A' ' 735' ' ' VAL . 1.8 t70 -117.25 121.51 41.37 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.235 -0.916 . . . . 0.0 110.79 -179.959 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 735' ' ' VAL . . . . . 0.589 HG23 ' C ' ' A' ' 734' ' ' ASP . 49.0 t -156.09 148.61 11.67 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 O-C-N 121.326 -0.859 . . . . 0.0 109.796 179.926 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 736' ' ' SER . . . . . . . . . . . . . 90.7 p -98.77 -167.61 1.51 Allowed 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.114 -0.991 . . . . 0.0 110.588 -179.909 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 737' ' ' GLU . . . . . 0.485 ' OE1' ' HB3' ' A' ' 739' ' ' HIS . 0.8 OUTLIER -93.28 171.93 8.61 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.272 -0.892 . . . . 0.0 110.027 179.983 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 738' ' ' TYR . . . . . 0.452 ' O ' ' OE1' ' A' ' 737' ' ' GLU . 30.0 t80 -116.12 -90.82 0.54 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.129 -0.982 . . . . 0.0 110.427 179.972 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 739' ' ' HIS . . . . . 0.485 ' HB3' ' OE1' ' A' ' 737' ' ' GLU . 4.6 t-80 55.82 105.94 0.03 OUTLIER Pre-proline 0 N--CA 1.49 1.546 0 O-C-N 121.099 -1.0 . . . . 0.0 110.451 179.982 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 740' ' ' PRO . . . . . 0.798 ' HG2' HD11 ' A' ' 742' ' ' ILE . 47.2 Cg_endo -85.73 -160.38 0.11 Allowed 'Trans proline' 0 C--N 1.303 -1.816 0 O-C-N 123.914 1.481 . . . . 0.0 110.002 179.923 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 741' ' ' ASN . . . . . 0.449 ' O ' HG13 ' A' ' 742' ' ' ILE . 9.2 p30 -127.93 112.35 14.59 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.141 -0.974 . . . . 0.0 110.075 179.945 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 742' ' ' ILE . . . . . 0.82 HG23 ' CD1' ' A' ' 745' ' ' TRP . 1.5 mp -144.26 57.23 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 O-C-N 121.007 -1.058 . . . . 0.0 110.106 -179.983 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 743' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.4 3.83 50.85 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.276 -0.89 . . . . 0.0 110.264 -179.94 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 744' ' ' ASN . . . . . . . . . . . . . 51.3 p-10 -153.58 43.11 0.58 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.362 -0.836 . . . . 0.0 109.955 179.969 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 745' ' ' TRP . . . . . 0.82 ' CD1' HG23 ' A' ' 742' ' ' ILE . 1.9 m95 -82.56 -41.18 19.91 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.394 -0.816 . . . . 0.0 110.383 -179.981 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 746' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -137.97 131.72 31.24 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.113 -0.992 . . . . 0.0 110.395 -179.997 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 747' ' ' ILE . . . . . 0.462 ' O ' ' HG2' ' A' ' 748' ' ' GLU . 14.6 mm -123.47 122.54 65.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.404 -0.81 . . . . 0.0 110.334 179.975 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 748' ' ' GLU . . . . . 0.462 ' HG2' ' O ' ' A' ' 747' ' ' ILE . 1.4 mm-40 -150.75 -58.31 0.17 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.342 -0.848 . . . . 0.0 109.562 -179.999 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 749' ' ' SER . . . . . 0.459 ' O ' ' HB3' ' A' ' 750' ' ' TYR . 1.1 p -154.41 18.29 0.48 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.558 -0.714 . . . . 0.0 109.685 179.922 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 750' ' ' TYR . . . . . 0.536 ' CD2' ' O ' ' A' ' 751' ' ' GLY . 2.7 p90 -178.5 -149.59 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.376 -0.827 . . . . 0.0 110.048 -179.879 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 751' ' ' GLY . . . . . 0.536 ' O ' ' CD2' ' A' ' 750' ' ' TYR . . . -137.08 167.19 24.74 Favored Glycine 0 N--CA 1.492 2.382 0 N-CA-C 109.017 -1.633 . . . . 0.0 109.017 179.981 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 752' ' ' GLU . . . . . 0.537 ' N ' ' CD ' ' A' ' 753' ' ' PRO . 11.3 tt0 -149.7 49.61 0.68 Allowed Pre-proline 0 N--CA 1.491 1.601 0 O-C-N 121.022 -1.281 . . . . 0.0 110.634 -179.958 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 753' ' ' PRO . . . . . 0.537 ' CD ' ' N ' ' A' ' 752' ' ' GLU . 44.5 Cg_endo -72.28 135.63 25.08 Favored 'Trans proline' 0 C--N 1.305 -1.744 0 O-C-N 123.86 1.452 . . . . 0.0 110.007 179.942 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 754' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -91.54 174.46 7.36 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.175 -0.953 . . . . 0.0 110.334 -179.966 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 755' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -138.97 62.68 1.53 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.348 -0.845 . . . . 0.0 110.136 179.991 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 756' ' ' HIS . . . . . 0.807 ' O ' HG23 ' A' ' 757' ' ' THR . 2.0 t-80 -68.91 177.33 2.65 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.214 -0.929 . . . . 0.0 110.277 -179.983 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 757' ' ' THR . . . . . 0.807 HG23 ' O ' ' A' ' 756' ' ' HIS . 0.6 OUTLIER -166.06 157.53 13.69 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.338 -0.851 . . . . 0.0 110.522 179.995 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 758' ' ' ALA . . . . . 0.472 ' O ' ' HG2' ' A' ' 759' ' ' LYS . . . -88.97 172.33 9.22 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.257 -0.902 . . . . 0.0 109.866 179.96 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 759' ' ' LYS . . . . . 0.472 ' HG2' ' O ' ' A' ' 758' ' ' ALA . 3.1 mtmt -142.91 162.95 34.12 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.069 -1.02 . . . . 0.0 110.644 -179.962 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 760' ' ' VAL . . . . . 0.948 ' O ' HG23 ' A' ' 813' ' ' VAL . 95.2 t -109.22 157.12 9.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.417 -0.802 . . . . 0.0 109.124 179.874 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 761' ' ' HIS . . . . . . . . . . . . . 35.2 m80 -128.53 113.91 16.08 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.937 -1.102 . . . . 0.0 111.369 -179.89 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 762' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -122.38 106.45 11.08 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 179.892 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 763' ' ' LYS . . . . . . . . . . . . . 5.4 ttmt -131.2 135.45 47.41 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.977 -1.077 . . . . 0.0 111.199 -179.833 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 764' ' ' CYS . . . . . . . . . . . . . 59.5 m -106.58 175.58 5.45 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.566 -0.709 . . . . 0.0 109.801 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 765' ' ' ALA . . . . . 0.622 ' HB1' ' HD2' ' A' ' 766' ' ' PRO . . . -55.21 167.96 0.62 Allowed Pre-proline 0 N--CA 1.494 1.771 0 O-C-N 121.216 -0.927 . . . . 0.0 110.497 179.999 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 766' ' ' PRO . . . . . 0.622 ' HD2' ' HB1' ' A' ' 765' ' ' ALA . 48.1 Cg_endo -73.43 110.17 3.0 Favored 'Trans proline' 0 C--N 1.304 -1.778 0 O-C-N 124.211 1.638 . . . . 0.0 110.309 179.975 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 767' ' ' GLY . . . . . . . . . . . . . . . 117.32 -30.69 6.13 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.711 -1.356 . . . . 0.0 109.711 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 768' ' ' GLN . . . . . 0.47 ' OE1' HG22 ' A' ' 841' ' ' THR . 44.5 mm-40 -85.88 162.01 18.8 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.183 -1.187 . . . . 0.0 110.245 -179.926 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 769' ' ' THR . . . . . 0.448 HG22 ' OE1' ' A' ' 810' ' ' GLU . 64.9 p -146.43 146.99 30.79 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.248 -0.907 . . . . 0.0 110.214 -179.986 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 770' ' ' ILE . . . . . 0.475 HG13 ' SG ' ' A' ' 839' ' ' CYS . 1.8 mp -69.06 147.79 11.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.35 -0.843 . . . . 0.0 109.13 179.942 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 771' ' ' SER . . . . . 0.475 ' OG ' ' HB2' ' A' ' 843' ' ' ALA . 34.8 m -130.75 -11.85 3.84 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 120.882 -1.136 . . . . 0.0 111.794 -179.891 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 772' ' ' ALA . . . . . . . . . . . . . . . -161.75 153.5 19.01 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 120.743 -1.223 . . . . 0.0 111.492 -179.927 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 773' ' ' ILE . . . . . . . . . . . . . 15.1 mm -113.97 125.17 71.2 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.534 -0.729 . . . . 0.0 109.372 179.901 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 774' ' ' LYS . . . . . 0.552 ' HG3' ' N ' ' A' ' 775' ' ' PHE . 0.5 OUTLIER -89.69 -36.13 15.4 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.089 -1.007 . . . . 0.0 110.815 -179.892 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 775' ' ' PHE . . . . . 0.552 ' N ' ' HG3' ' A' ' 774' ' ' LYS . 65.2 t80 -137.47 149.78 47.09 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.982 -1.074 . . . . 0.0 110.746 -179.924 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 776' ' ' ALA . . . . . 0.487 ' HB3' ' HB3' ' A' ' 799' ' ' ASN . . . -179.03 106.74 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.548 -0.72 . . . . 0.0 109.531 179.954 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 777' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -139.69 136.67 34.49 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.13 -0.981 . . . . 0.0 110.55 -179.877 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 778' ' ' PHE . . . . . 0.753 ' HD2' HG22 ' A' ' 833' ' ' VAL . 86.4 t80 -104.27 76.38 1.32 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.427 -0.796 . . . . 0.0 109.915 179.988 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 779' ' ' GLY . . . . . . . . . . . . . . . -171.34 -109.77 0.23 Allowed Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.755 -1.338 . . . . 0.0 109.755 -179.989 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 780' ' ' THR . . . . . . . . . . . . . 2.9 p -112.54 92.42 19.71 Favored Pre-proline 0 N--CA 1.494 1.732 0 O-C-N 121.259 -1.142 . . . . 0.0 110.662 -179.992 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 781' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -79.04 127.63 7.8 Favored 'Trans proline' 0 C--N 1.305 -1.73 0 O-C-N 124.064 1.56 . . . . 0.0 110.19 -179.999 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 782' ' ' LEU . . . . . 0.434 ' O ' ' HA ' ' A' ' 788' ' ' PHE . 2.6 mt -96.68 108.3 20.9 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.137 -0.977 . . . . 0.0 110.356 179.989 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 783' ' ' GLY . . . . . . . . . . . . . . . 120.99 -154.31 16.45 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.643 -1.383 . . . . 0.0 109.643 -179.995 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 784' ' ' THR . . . . . 0.574 ' O ' ' CZ ' ' A' ' 788' ' ' PHE . 9.9 t -151.09 -40.54 0.12 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.279 -1.13 . . . . 0.0 110.137 -179.959 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 785' ' ' CYS . . . . . 0.555 ' N ' HG23 ' A' ' 784' ' ' THR . 16.2 t -166.95 118.97 0.94 Allowed 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.306 -0.871 . . . . 0.0 109.692 -179.982 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 786' ' ' GLY . . . . . . . . . . . . . . . 85.84 -9.18 69.65 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.335 -1.506 . . . . 0.0 109.335 -179.96 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 787' ' ' THR . . . . . . . . . . . . . 18.7 p -139.56 33.94 2.04 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.23 -1.159 . . . . 0.0 110.174 -179.965 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 788' ' ' PHE . . . . . 0.676 ' CE1' ' HB1' ' A' ' 834' ' ' ALA . 7.2 m-85 -71.18 174.69 6.05 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.228 -0.92 . . . . 0.0 110.337 179.98 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 789' ' ' GLN . . . . . 0.485 ' CG ' ' O ' ' A' ' 788' ' ' PHE . 0.0 OUTLIER 179.44 167.14 1.09 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.185 -0.947 . . . . 0.0 110.327 -179.971 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 790' ' ' GLN . . . . . . . . . . . . . 31.5 mt-30 -99.05 143.84 28.87 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.258 -0.901 . . . . 0.0 110.181 179.952 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 791' ' ' GLY . . . . . . . . . . . . . . . -101.89 -109.41 3.26 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.577 -1.409 . . . . 0.0 109.577 179.993 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 792' ' ' GLU . . . . . . . . . . . . . 8.5 mt-10 -129.65 15.4 5.94 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.322 -1.105 . . . . 0.0 110.068 -179.993 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 793' ' ' CYS . . . . . . . . . . . . . 1.7 m -147.53 122.78 10.24 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.279 -0.888 . . . . 0.0 110.224 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 794' ' ' HIS . . . . . 0.609 ' CD2' ' O ' ' A' ' 795' ' ' SER . 77.4 t60 -147.91 144.3 27.97 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.188 -0.945 . . . . 0.0 110.798 -179.97 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 795' ' ' SER . . . . . 0.609 ' O ' ' CD2' ' A' ' 794' ' ' HIS . 27.2 t -88.42 167.86 13.12 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 179.853 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 796' ' ' ILE . . . . . . . . . . . . . 3.1 mt -90.19 -22.76 6.27 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.837 0 O-C-N 120.47 -1.394 . . . . 0.0 110.286 -179.859 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 797' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -102.43 51.54 0.81 Allowed 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.167 -0.958 . . . . 0.0 109.407 179.943 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 798' ' ' SER . . . . . 0.572 ' OG ' ' CE1' ' A' ' 794' ' ' HIS . 0.3 OUTLIER -83.64 -45.08 13.86 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.407 -0.808 . . . . 0.0 111.339 -179.858 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 799' ' ' ASN . . . . . 0.495 ' HA ' HD23 ' A' ' 802' ' ' LEU . 7.3 p30 -105.63 -14.2 15.34 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 120.889 -1.132 . . . . 0.0 111.012 -179.838 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 800' ' ' SER . . . . . . . . . . . . . 22.4 t -65.69 -19.1 65.77 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.069 -1.019 . . . . 0.0 110.37 -179.989 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 801' ' ' VAL . . . . . . . . . . . . . 96.2 t -83.86 -23.21 8.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.122 -0.986 . . . . 0.0 110.104 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 802' ' ' LEU . . . . . 0.737 HD22 ' N ' ' A' ' 802' ' ' LEU . 3.4 mm? -80.48 -62.32 1.71 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.346 -0.846 . . . . 0.0 110.337 179.969 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 803' ' ' GLU . . . . . 0.805 ' HA ' HD12 ' A' ' 807' ' ' ILE . 1.2 tm-20 -52.03 -17.88 1.2 Allowed 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.128 -0.983 . . . . 0.0 110.887 -179.983 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 804' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.29 -31.21 17.04 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 120.97 -1.082 . . . . 0.0 111.471 -179.92 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 805' ' ' LYS . . . . . . . . . . . . . 7.3 mttm -137.1 51.8 1.95 Allowed 'General case' 0 N--CA 1.498 1.961 0 O-C-N 120.756 -1.215 . . . . 0.0 111.313 -179.935 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 806' ' ' CYS . . . . . 0.52 ' HA ' ' CB ' ' A' ' 812' ' ' CYS . 1.1 m -162.75 -54.93 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.101 -0.999 . . . . 0.0 110.204 179.902 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 807' ' ' ILE . . . . . 0.805 HD12 ' HA ' ' A' ' 803' ' ' GLU . 61.6 mt -65.26 103.21 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.239 -0.913 . . . . 0.0 110.077 179.973 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 808' ' ' GLY . . . . . 0.446 ' C ' ' HG ' ' A' ' 809' ' ' LEU . . . 127.0 11.37 3.52 Favored Glycine 0 N--CA 1.492 2.377 0 N-CA-C 110.009 -1.236 . . . . 0.0 110.009 179.972 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 809' ' ' LEU . . . . . 0.446 ' HG ' ' C ' ' A' ' 808' ' ' GLY . 1.5 mt -133.23 150.13 51.96 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.111 -1.229 . . . . 0.0 110.245 179.972 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 810' ' ' GLU . . . . . 0.448 ' OE1' HG22 ' A' ' 769' ' ' THR . 0.2 OUTLIER -65.74 -26.74 67.87 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.192 -0.943 . . . . 0.0 109.255 179.914 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 811' ' ' ARG . . . . . 0.454 ' O ' ' HG3' ' A' ' 811' ' ' ARG . 4.1 ppt_? -161.23 120.58 2.56 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.629 -0.67 . . . . 0.0 109.198 179.89 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 812' ' ' CYS . . . . . 0.52 ' CB ' ' HA ' ' A' ' 806' ' ' CYS . 24.0 p -121.55 156.87 31.95 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 120.996 -1.065 . . . . 0.0 111.428 -179.856 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 813' ' ' VAL . . . . . 0.948 HG23 ' O ' ' A' ' 760' ' ' VAL . 9.9 p -139.4 126.46 24.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 179.966 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 814' ' ' VAL . . . . . . . . . . . . . 44.3 t -110.18 130.13 63.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.077 -1.015 . . . . 0.0 110.779 -179.936 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 815' ' ' ALA . . . . . . . . . . . . . . . -78.37 125.02 28.76 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.347 -0.846 . . . . 0.0 109.806 179.959 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 816' ' ' ILE . . . . . 0.401 ' CG2' HG21 ' A' ' 833' ' ' VAL . 96.4 mt -79.17 111.74 16.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.274 -0.891 . . . . 0.0 110.359 -179.949 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 817' ' ' SER . . . . . 0.44 ' OG ' ' HB2' ' A' ' 820' ' ' ASN . 0.0 OUTLIER -152.03 166.71 14.66 Favored Pre-proline 0 N--CA 1.493 1.692 0 O-C-N 121.348 -0.845 . . . . 0.0 110.016 179.961 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 818' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -76.35 -57.28 0.05 OUTLIER 'Trans proline' 0 C--N 1.307 -1.651 0 O-C-N 123.931 1.49 . . . . 0.0 110.665 -179.94 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 819' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -66.06 -9.85 34.69 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.184 -0.947 . . . . 0.0 110.524 -179.981 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 820' ' ' ASN . . . . . 0.44 ' HB2' ' OG ' ' A' ' 817' ' ' SER . 17.2 t30 -92.92 -16.4 25.22 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.117 -0.989 . . . . 0.0 110.317 -179.997 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 821' ' ' PHE . . . . . . . . . . . . . 1.9 m-85 -109.53 -79.04 0.58 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.241 -0.912 . . . . 0.0 110.211 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 822' ' ' GLY . . . . . . . . . . . . . . . 176.41 42.19 0.06 OUTLIER Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.493 -1.443 . . . . 0.0 109.493 179.956 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 823' ' ' GLY . . . . . . . . . . . . . . . 79.05 -162.6 48.54 Favored Glycine 0 N--CA 1.492 2.431 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 -179.979 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 824' ' ' ASP . . . . . . . . . . . . . 4.2 p30 -121.86 152.84 59.94 Favored Pre-proline 0 N--CA 1.493 1.723 0 O-C-N 121.254 -1.145 . . . . 0.0 110.149 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 825' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -78.76 -84.68 0.0 OUTLIER 'Trans proline' 0 C--N 1.304 -1.787 0 O-C-N 124.0 1.526 . . . . 0.0 110.751 -179.896 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 826' ' ' CYS . . . . . 0.524 ' SG ' HG21 ' A' ' 829' ' ' VAL . 28.5 p -105.85 142.75 25.46 Favored Pre-proline 0 N--CA 1.492 1.674 0 O-C-N 121.125 -0.985 . . . . 0.0 110.656 -179.913 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 827' ' ' PRO . . . . . 0.666 ' O ' HG23 ' A' ' 829' ' ' VAL . 50.3 Cg_endo -85.15 -179.14 3.43 Favored 'Trans proline' 0 C--N 1.303 -1.817 0 O-C-N 124.209 1.636 . . . . 0.0 109.983 179.895 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 828' ' ' GLU . . . . . 0.468 ' HB2' ' O ' ' A' ' 827' ' ' PRO . 7.5 mt-10 58.55 14.94 3.29 Favored 'General case' 0 C--N 1.297 -1.697 0 O-C-N 121.331 -0.856 . . . . 0.0 109.894 -179.978 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 829' ' ' VAL . . . . . 0.666 HG23 ' O ' ' A' ' 827' ' ' PRO . 60.8 t -128.85 122.5 57.01 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.405 0 O-C-N 121.333 -0.855 . . . . 0.0 110.205 -179.965 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 830' ' ' MET . . . . . 0.466 ' O ' ' O ' ' A' ' 829' ' ' VAL . 0.0 OUTLIER -48.79 176.9 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.022 -1.049 . . . . 0.0 109.531 -179.986 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 831' ' ' LYS . . . . . . . . . . . . . 6.2 mptt -138.82 110.1 6.92 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.977 -1.077 . . . . 0.0 110.873 -179.898 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 832' ' ' ARG . . . . . . . . . . . . . 73.9 mtp85 -115.84 157.59 24.21 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.382 -0.824 . . . . 0.0 109.43 179.904 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 833' ' ' VAL . . . . . 0.753 HG22 ' HD2' ' A' ' 778' ' ' PHE . 65.0 t -122.82 104.4 14.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.042 -1.036 . . . . 0.0 110.855 -179.997 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 834' ' ' ALA . . . . . 0.676 ' HB1' ' CE1' ' A' ' 788' ' ' PHE . . . -109.16 124.25 50.53 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.34 -0.85 . . . . 0.0 109.171 179.944 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 835' ' ' VAL . . . . . . . . . . . . . 11.8 t -138.9 142.81 33.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.059 -1.026 . . . . 0.0 111.346 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 836' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 -126.62 135.61 51.44 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 179.93 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 837' ' ' ALA . . . . . 0.521 ' O ' ' CG2' ' A' ' 731' ' ' VAL . . . -118.72 164.49 15.29 Favored 'General case' 0 C--N 1.298 -1.632 0 O-C-N 120.966 -1.084 . . . . 0.0 111.087 -179.85 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 838' ' ' VAL . . . . . . . . . . . . . 24.9 t -116.96 105.32 18.02 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 179.96 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 839' ' ' CYS . . . . . 0.475 ' SG ' HG13 ' A' ' 770' ' ' ILE . 0.1 OUTLIER -106.51 152.83 23.15 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.204 -0.935 . . . . 0.0 110.865 -179.82 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 840' ' ' SER . . . . . 0.489 ' O ' HG23 ' A' ' 841' ' ' THR . 2.7 p -164.08 -91.89 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.402 -0.811 . . . . 0.0 109.813 179.861 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 841' ' ' THR . . . . . 0.489 HG23 ' O ' ' A' ' 840' ' ' SER . 8.8 p -154.42 75.51 1.0 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.38 -0.825 . . . . 0.0 109.736 -179.996 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 842' ' ' ALA . . . . . 0.482 ' HB3' ' O ' ' A' ' 841' ' ' THR . . . 57.49 152.69 0.01 OUTLIER 'General case' 0 C--N 1.293 -1.878 0 O-C-N 121.582 -0.699 . . . . 0.0 110.341 -179.914 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 843' ' ' ALA . . . . . 0.475 ' HB2' ' OG ' ' A' ' 771' ' ' SER . . . . . . . . 0 N--CA 1.494 1.725 0 O-C-N 121.062 -1.024 . . . . 0.0 110.079 179.985 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 726' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.492 1.639 0 CA-C-O 121.285 0.564 . . . . 0.0 110.272 . . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 727' ' ' THR . . . . . . . . . . . . . 38.7 m -138.85 139.32 38.11 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.219 -0.926 . . . . 0.0 110.071 -179.963 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 728' ' ' VAL . . . . . . . . . . . . . 34.2 m -130.0 145.99 34.8 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.231 -0.918 . . . . 0.0 110.415 -179.963 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 729' ' ' SER . . . . . 0.766 ' O ' HG23 ' A' ' 731' ' ' VAL . 12.1 t -127.39 74.41 1.51 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.275 -0.891 . . . . 0.0 110.217 179.965 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 730' ' ' GLY . . . . . . . . . . . . . . . -62.38 114.69 7.07 Favored Glycine 0 N--CA 1.493 2.436 0 N-CA-C 109.222 -1.551 . . . . 0.0 109.222 179.989 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 731' ' ' VAL . . . . . 0.766 HG23 ' O ' ' A' ' 729' ' ' SER . 21.8 t -129.39 137.22 57.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.189 -1.183 . . . . 0.0 110.592 -179.986 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 732' ' ' CYS . . . . . . . . . . . . . 4.9 p -129.32 146.06 51.27 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.434 -0.791 . . . . 0.0 109.366 179.967 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 733' ' ' ALA . . . . . 0.505 ' CB ' HG13 ' A' ' 760' ' ' VAL . . . -110.45 104.22 12.95 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 120.952 -1.093 . . . . 0.0 111.351 -179.978 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 734' ' ' ASP . . . . . 0.45 ' OD1' ' O ' ' A' ' 734' ' ' ASP . 0.6 OUTLIER -110.07 100.9 9.76 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.339 -0.851 . . . . 0.0 108.865 179.895 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 735' ' ' VAL . . . . . . . . . . . . . 14.4 m -140.08 152.82 22.14 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 121.229 -0.92 . . . . 0.0 110.941 -179.885 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 736' ' ' SER . . . . . 0.542 ' O ' ' CB ' ' A' ' 758' ' ' ALA . 3.3 m -82.33 177.05 8.97 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 179.839 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 737' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -96.72 76.84 2.83 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 120.738 -1.226 . . . . 0.0 110.213 -179.993 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 738' ' ' TYR . . . . . 0.62 ' H ' ' HB2' ' A' ' 758' ' ' ALA . 13.1 t80 -161.42 145.91 13.27 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.37 -0.831 . . . . 0.0 110.194 179.986 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 739' ' ' HIS . . . . . 0.663 ' CE1' HD12 ' A' ' 742' ' ' ILE . 4.6 t-80 -90.11 149.56 41.73 Favored Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.289 -0.882 . . . . 0.0 110.247 179.985 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 740' ' ' PRO . . . . . 0.614 ' HD2' ' CG ' ' A' ' 739' ' ' HIS . 48.5 Cg_endo -71.79 -96.64 0.01 OUTLIER 'Trans proline' 0 C--N 1.313 -1.327 0 O-C-N 123.829 1.436 . . . . 0.0 110.361 -179.951 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 741' ' ' ASN . . . . . 0.452 ' CG ' ' O ' ' A' ' 740' ' ' PRO . 47.2 m-80 -159.15 140.98 13.45 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.156 -0.965 . . . . 0.0 110.518 -179.981 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 742' ' ' ILE . . . . . 0.663 HD12 ' CE1' ' A' ' 739' ' ' HIS . 0.1 OUTLIER -149.52 85.83 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.267 -0.895 . . . . 0.0 109.997 179.973 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 743' ' ' LYS . . . . . 0.405 ' O ' ' HB2' ' A' ' 744' ' ' ASN . 0.6 OUTLIER -82.93 42.21 0.78 Allowed 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.292 -0.88 . . . . 0.0 109.868 179.908 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 744' ' ' ASN . . . . . 0.405 ' HB2' ' O ' ' A' ' 743' ' ' LYS . 1.6 t-20 -179.95 35.28 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.303 -0.873 . . . . 0.0 109.784 -179.989 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 745' ' ' TRP . . . . . 0.444 ' HB2' ' HB ' ' A' ' 742' ' ' ILE . 51.9 t-105 -96.29 -20.22 18.68 Favored 'General case' 0 C--N 1.299 -1.617 0 O-C-N 121.431 -0.793 . . . . 0.0 109.708 -179.975 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 746' ' ' GLN . . . . . 0.426 ' C ' ' O ' ' A' ' 745' ' ' TRP . 2.8 mt-30 -39.89 130.51 2.0 Favored 'General case' 0 C--N 1.298 -1.661 0 O-C-N 121.667 -0.645 . . . . 0.0 110.997 179.944 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 747' ' ' ILE . . . . . 0.763 ' O ' HG23 ' A' ' 747' ' ' ILE . 10.5 tt -80.25 102.06 5.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.15 -0.969 . . . . 0.0 109.041 179.864 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 748' ' ' GLU . . . . . 0.476 ' HB2' ' O ' ' A' ' 747' ' ' ILE . 0.6 OUTLIER 66.95 -84.65 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.357 -0.839 . . . . 0.0 109.646 -179.898 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 749' ' ' SER . . . . . 0.565 ' O ' ' CD2' ' A' ' 750' ' ' TYR . 74.9 m -145.37 79.71 1.58 Allowed 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.054 -1.029 . . . . 0.0 110.55 179.983 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 750' ' ' TYR . . . . . 0.565 ' CD2' ' O ' ' A' ' 749' ' ' SER . 36.7 m-85 -148.4 -160.65 1.2 Allowed 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.204 -0.935 . . . . 0.0 110.16 179.954 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 751' ' ' GLY . . . . . . . . . . . . . . . -134.5 178.53 18.37 Favored Glycine 0 N--CA 1.493 2.489 0 C-N-CA 119.697 -1.239 . . . . 0.0 110.335 -179.999 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 752' ' ' GLU . . . . . 0.493 ' OE2' HG13 ' A' ' 742' ' ' ILE . 10.0 mt-10 -103.73 137.37 19.22 Favored Pre-proline 0 N--CA 1.495 1.781 0 O-C-N 121.529 -0.983 . . . . 0.0 110.327 -179.982 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 753' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -71.65 179.65 4.51 Favored 'Trans proline' 0 C--N 1.306 -1.658 0 O-C-N 123.874 1.46 . . . . 0.0 110.324 179.945 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 754' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -92.56 58.09 3.06 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.168 -0.957 . . . . 0.0 110.668 -179.909 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 755' ' ' PHE . . . . . 0.576 ' CZ ' ' HD2' ' A' ' 818' ' ' PRO . 0.1 OUTLIER -125.93 66.62 1.19 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.236 -0.915 . . . . 0.0 110.012 179.958 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 756' ' ' HIS . . . . . 0.42 ' O ' ' HA ' ' A' ' 738' ' ' TYR . 3.4 m80 -75.3 80.52 2.39 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.354 -0.841 . . . . 0.0 109.958 -179.971 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 757' ' ' THR . . . . . 0.455 ' HB ' ' O ' ' A' ' 816' ' ' ILE . 32.1 p -115.74 174.82 5.82 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.325 -0.859 . . . . 0.0 110.205 179.957 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 758' ' ' ALA . . . . . 0.62 ' HB2' ' H ' ' A' ' 738' ' ' TYR . . . -102.83 -179.18 3.89 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.181 -0.949 . . . . 0.0 110.153 179.99 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 759' ' ' LYS . . . . . . . . . . . . . 9.6 mtpp -133.81 161.99 33.21 Favored 'General case' 0 C--N 1.297 -1.686 0 O-C-N 121.452 -0.78 . . . . 0.0 110.233 179.997 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 760' ' ' VAL . . . . . 0.983 HG23 HD11 ' A' ' 816' ' ' ILE . 39.8 t -125.55 114.85 41.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.344 -0.847 . . . . 0.0 109.191 179.927 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 761' ' ' HIS . . . . . . . . . . . . . 1.5 t-160 -110.64 114.44 27.84 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 120.914 -1.117 . . . . 0.0 111.185 -179.964 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 762' ' ' LEU . . . . . . . . . . . . . 17.8 mt -111.2 103.66 12.1 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.508 -0.745 . . . . 0.0 109.327 179.825 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 763' ' ' LYS . . . . . . . . . . . . . 5.3 pttp -117.81 136.87 53.12 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.098 -1.001 . . . . 0.0 110.925 -179.889 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 764' ' ' CYS . . . . . . . . . . . . . 86.2 m -105.32 173.46 6.3 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.372 -0.83 . . . . 0.0 109.673 179.927 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 765' ' ' ALA . . . . . 0.417 ' HB3' ' OE1' ' A' ' 768' ' ' GLN . . . -67.88 160.91 71.25 Favored Pre-proline 0 N--CA 1.494 1.745 0 O-C-N 121.18 -0.95 . . . . 0.0 110.44 179.969 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 766' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -72.02 96.1 0.77 Allowed 'Trans proline' 0 C--N 1.308 -1.584 0 O-C-N 124.006 1.53 . . . . 0.0 110.117 179.959 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 767' ' ' GLY . . . . . . . . . . . . . . . 140.21 -31.95 2.22 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 108.762 -1.735 . . . . 0.0 108.762 -179.999 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 768' ' ' GLN . . . . . 0.477 ' HG3' ' HB ' ' A' ' 841' ' ' THR . 12.8 mp0 -93.64 152.34 19.06 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.559 -0.965 . . . . 0.0 109.421 179.956 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 769' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -129.91 151.62 50.28 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.046 -1.034 . . . . 0.0 110.741 -179.976 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 770' ' ' ILE . . . . . 0.451 HD12 ' O ' ' A' ' 809' ' ' LEU . 30.9 mt -76.48 152.78 5.87 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.433 -0.792 . . . . 0.0 109.537 179.85 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 771' ' ' SER . . . . . 0.441 ' HA ' HG23 ' A' ' 807' ' ' ILE . 3.3 m -146.57 -15.88 0.43 Allowed 'General case' 0 N--CA 1.494 1.749 0 O-C-N 120.845 -1.159 . . . . 0.0 112.597 -179.903 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 772' ' ' ALA . . . . . . . . . . . . . . . -158.34 150.05 21.35 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 120.235 -1.54 . . . . 0.0 112.438 -179.912 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 773' ' ' ILE . . . . . . . . . . . . . 14.5 mm -116.21 118.39 58.62 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 179.863 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 774' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -84.13 -38.31 20.87 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 120.957 -1.09 . . . . 0.0 111.895 -179.826 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 775' ' ' PHE . . . . . 0.622 ' O ' ' HB2' ' A' ' 776' ' ' ALA . 58.4 t80 -129.52 166.64 19.25 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 120.712 -1.243 . . . . 0.0 111.468 -179.942 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 776' ' ' ALA . . . . . 0.926 ' HB3' ' HB2' ' A' ' 799' ' ' ASN . . . 171.76 101.48 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.736 -0.603 . . . . 0.0 109.382 179.962 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 777' ' ' SER . . . . . . . . . . . . . 29.1 t -134.55 125.63 27.67 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.37 -0.831 . . . . 0.0 110.204 -179.882 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 778' ' ' PHE . . . . . 0.543 ' CZ ' ' O ' ' A' ' 817' ' ' SER . 2.2 t80 -111.12 81.35 1.42 Allowed 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.421 -0.799 . . . . 0.0 109.887 179.934 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 779' ' ' GLY . . . . . . . . . . . . . . . -179.49 -89.97 0.08 OUTLIER Glycine 0 N--CA 1.493 2.449 0 N-CA-C 109.526 -1.429 . . . . 0.0 109.526 -179.946 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 780' ' ' THR . . . . . 0.492 ' O ' ' HA3' ' A' ' 791' ' ' GLY . 38.8 p -123.17 83.0 51.52 Favored Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.048 -1.266 . . . . 0.0 110.675 179.992 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 781' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -74.45 123.54 8.23 Favored 'Trans proline' 0 C--N 1.304 -1.809 0 O-C-N 124.077 1.567 . . . . 0.0 109.952 179.989 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 782' ' ' LEU . . . . . 0.754 HD12 ' HA2' ' A' ' 791' ' ' GLY . 10.8 mt -111.1 83.83 1.83 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.237 -0.914 . . . . 0.0 110.412 -179.959 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 783' ' ' GLY . . . . . . . . . . . . . . . 148.45 -173.63 28.38 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.549 -1.42 . . . . 0.0 109.549 -179.944 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 784' ' ' THR . . . . . 0.546 ' O ' ' CD2' ' A' ' 788' ' ' PHE . 80.3 p -132.41 -148.41 0.34 Allowed 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.275 -1.132 . . . . 0.0 110.375 -179.97 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 785' ' ' CYS . . . . . . . . . . . . . 4.2 t -70.87 106.88 3.77 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.227 -0.92 . . . . 0.0 109.889 179.984 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 786' ' ' GLY . . . . . . . . . . . . . . . 114.31 -26.25 9.87 Favored Glycine 0 N--CA 1.488 2.135 0 N-CA-C 109.246 -1.542 . . . . 0.0 109.246 -179.965 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 787' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -124.46 25.95 7.46 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.326 -1.103 . . . . 0.0 110.581 -179.958 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 788' ' ' PHE . . . . . 0.808 ' CE1' ' HB1' ' A' ' 834' ' ' ALA . 2.4 m-85 -71.46 112.43 7.58 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.225 -0.922 . . . . 0.0 109.616 -179.95 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 789' ' ' GLN . . . . . . . . . . . . . 14.4 tp60 -125.71 137.19 53.82 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.143 -0.973 . . . . 0.0 110.593 -179.962 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 790' ' ' GLN . . . . . 0.426 ' O ' ' HG3' ' A' ' 790' ' ' GLN . 19.3 pt20 -41.32 139.4 1.03 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.477 -0.764 . . . . 0.0 110.316 179.928 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 791' ' ' GLY . . . . . 0.754 ' HA2' HD12 ' A' ' 782' ' ' LEU . . . -89.59 -153.92 28.64 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.356 -1.498 . . . . 0.0 109.356 -179.999 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 792' ' ' GLU . . . . . . . . . . . . . 26.6 pt-20 -87.55 -35.18 18.29 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.22 -1.165 . . . . 0.0 109.744 179.951 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 793' ' ' CYS . . . . . 0.449 ' SG ' ' HB2' ' A' ' 825' ' ' PRO . 0.5 OUTLIER -109.87 100.72 9.65 Favored 'General case' 0 C--N 1.307 -1.255 0 O-C-N 121.271 -0.893 . . . . 0.0 110.604 179.997 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 794' ' ' HIS . . . . . . . . . . . . . 4.4 t60 -108.69 143.08 38.26 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.091 -1.006 . . . . 0.0 109.826 -179.998 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 795' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -80.19 5.88 13.3 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.321 -0.862 . . . . 0.0 110.021 -179.964 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 796' ' ' ILE . . . . . 0.634 HG22 ' O ' ' A' ' 796' ' ' ILE . 31.4 mt 46.37 24.23 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.162 -0.961 . . . . 0.0 109.86 -179.988 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 797' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -159.6 22.53 0.18 Allowed 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.485 -0.759 . . . . 0.0 109.542 -179.976 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 798' ' ' SER . . . . . 0.72 ' O ' ' HB1' ' A' ' 776' ' ' ALA . 1.1 m -88.31 0.09 56.55 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.414 -0.804 . . . . 0.0 110.19 -179.982 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 799' ' ' ASN . . . . . 0.926 ' HB2' ' HB3' ' A' ' 776' ' ' ALA . 60.6 t-20 -124.66 1.34 8.2 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.254 -0.903 . . . . 0.0 109.954 179.973 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 800' ' ' SER . . . . . . . . . . . . . 1.5 t -91.64 -40.17 11.46 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.371 -0.831 . . . . 0.0 110.452 -179.869 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 801' ' ' VAL . . . . . 0.468 ' HB ' ' CE1' ' A' ' 821' ' ' PHE . 93.2 t -67.55 -19.54 25.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.3 -0.875 . . . . 0.0 110.799 -179.945 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 802' ' ' LEU . . . . . . . . . . . . . 78.7 mt -87.72 -49.74 6.93 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.011 -1.056 . . . . 0.0 110.979 -179.882 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 803' ' ' GLU . . . . . 0.418 ' HG2' HD11 ' A' ' 807' ' ' ILE . 18.6 mt-10 -54.23 -27.21 33.09 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.157 -0.964 . . . . 0.0 111.045 -179.909 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 804' ' ' ARG . . . . . . . . . . . . . 1.6 mpt_? -91.62 -18.32 24.21 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.017 -1.052 . . . . 0.0 111.264 -179.905 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 805' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.66 12.89 19.83 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 120.91 -1.119 . . . . 0.0 111.331 -179.926 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 806' ' ' CYS . . . . . 0.414 ' O ' ' C ' ' A' ' 807' ' ' ILE . 21.0 m -141.38 -67.99 0.4 Allowed 'General case' 0 N--CA 1.496 1.855 0 O-C-N 120.851 -1.156 . . . . 0.0 110.58 -179.971 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 807' ' ' ILE . . . . . 0.441 HG23 ' HA ' ' A' ' 771' ' ' SER . 42.9 mt -41.24 103.68 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 O-C-N 121.258 -0.901 . . . . 0.0 110.477 -179.986 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 808' ' ' GLY . . . . . 0.71 ' O ' HD23 ' A' ' 809' ' ' LEU . . . 127.06 4.84 5.88 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.613 -1.395 . . . . 0.0 109.613 -179.984 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 809' ' ' LEU . . . . . 0.71 HD23 ' O ' ' A' ' 808' ' ' GLY . 81.4 mt -139.77 149.2 43.28 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.252 -1.146 . . . . 0.0 109.982 179.997 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 810' ' ' GLU . . . . . . . . . . . . . 2.1 pt-20 -78.93 1.47 23.57 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.173 -0.954 . . . . 0.0 109.593 179.981 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 811' ' ' ARG . . . . . . . . . . . . . 21.8 ttp180 -170.13 135.7 1.36 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.41 -0.806 . . . . 0.0 110.014 179.986 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 812' ' ' CYS . . . . . . . . . . . . . 21.9 p -155.12 150.22 26.92 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.401 -0.812 . . . . 0.0 110.292 -179.979 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 813' ' ' VAL . . . . . 0.521 ' C ' HG23 ' A' ' 814' ' ' VAL . 11.9 p -131.78 153.99 39.58 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 O-C-N 121.29 -0.881 . . . . 0.0 110.335 -179.991 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 814' ' ' VAL . . . . . 0.521 HG23 ' C ' ' A' ' 813' ' ' VAL . 11.1 t -151.59 106.58 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 O-C-N 121.314 -0.866 . . . . 0.0 110.241 179.982 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 815' ' ' ALA . . . . . . . . . . . . . . . -54.02 170.92 0.11 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.234 -0.917 . . . . 0.0 110.384 179.942 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 816' ' ' ILE . . . . . 0.983 HD11 HG23 ' A' ' 760' ' ' VAL . 80.5 mt -121.73 141.73 40.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.351 -0.843 . . . . 0.0 109.887 -179.995 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 817' ' ' SER . . . . . 0.547 ' CB ' ' HD2' ' A' ' 818' ' ' PRO . 0.3 OUTLIER -173.91 -178.06 0.37 Allowed Pre-proline 0 N--CA 1.494 1.762 0 O-C-N 121.12 -0.988 . . . . 0.0 110.64 -179.899 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 818' ' ' PRO . . . . . 0.576 ' HD2' ' CZ ' ' A' ' 755' ' ' PHE . 42.8 Cg_endo -72.9 -76.12 0.01 OUTLIER 'Trans proline' 0 C--N 1.313 -1.329 0 O-C-N 124.043 1.549 . . . . 0.0 111.302 -179.93 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 819' ' ' SER . . . . . . . . . . . . . 40.8 t -84.33 51.93 2.22 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.055 -1.028 . . . . 0.0 110.351 -179.972 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 820' ' ' ASN . . . . . 0.465 ' HB2' ' OG ' ' A' ' 817' ' ' SER . 2.1 t30 -101.92 -49.25 4.01 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.256 -0.903 . . . . 0.0 109.777 179.961 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 821' ' ' PHE . . . . . 0.468 ' CE1' ' HB ' ' A' ' 801' ' ' VAL . 27.4 m-85 -77.26 -23.83 51.17 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.204 -0.935 . . . . 0.0 109.764 179.981 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 822' ' ' GLY . . . . . . . . . . . . . . . 93.95 55.69 1.48 Allowed Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 -179.972 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 823' ' ' GLY . . . . . . . . . . . . . . . 168.31 144.82 4.32 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.654 -1.378 . . . . 0.0 109.654 -179.987 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 824' ' ' ASP . . . . . 0.433 ' OD1' ' O ' ' A' ' 824' ' ' ASP . 11.1 p-10 -144.07 122.3 6.91 Favored Pre-proline 0 N--CA 1.493 1.712 0 O-C-N 121.325 -1.103 . . . . 0.0 110.041 179.999 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 825' ' ' PRO . . . . . 0.449 ' HB2' ' SG ' ' A' ' 793' ' ' CYS . 43.9 Cg_endo -75.59 -78.28 0.01 OUTLIER 'Trans proline' 0 C--N 1.307 -1.632 0 O-C-N 123.88 1.463 . . . . 0.0 110.583 -179.952 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 826' ' ' CYS . . . . . 0.435 ' HA ' ' HD3' ' A' ' 827' ' ' PRO . 5.8 p -125.18 128.46 24.77 Favored Pre-proline 0 N--CA 1.494 1.772 0 O-C-N 121.111 -0.993 . . . . 0.0 110.101 -179.971 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 827' ' ' PRO . . . . . 0.506 ' O ' HG23 ' A' ' 829' ' ' VAL . 48.7 Cg_endo -85.7 177.0 5.11 Favored 'Trans proline' 0 C--N 1.305 -1.726 0 O-C-N 123.883 1.465 . . . . 0.0 110.513 -179.995 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 828' ' ' GLU . . . . . 0.454 ' HB2' ' O ' ' A' ' 827' ' ' PRO . 34.9 mt-10 56.72 23.59 8.06 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.457 -0.777 . . . . 0.0 110.338 -179.958 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 829' ' ' VAL . . . . . 0.506 HG23 ' O ' ' A' ' 827' ' ' PRO . 53.3 t -125.44 135.46 63.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.437 -0.79 . . . . 0.0 109.734 179.929 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 830' ' ' MET . . . . . 0.435 ' C ' ' O ' ' A' ' 829' ' ' VAL . 33.5 ttm -41.26 146.14 0.21 Allowed 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.269 -0.895 . . . . 0.0 109.83 -179.997 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 831' ' ' LYS . . . . . . . . . . . . . 27.6 mttp -134.46 106.47 7.06 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.042 -1.036 . . . . 0.0 111.165 -179.941 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 832' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -108.36 166.13 10.99 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.463 -0.773 . . . . 0.0 109.005 179.805 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 833' ' ' VAL . . . . . 0.9 HG21 HD13 ' A' ' 816' ' ' ILE . 69.4 t -116.19 145.44 21.93 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.602 0 O-C-N 120.879 -1.138 . . . . 0.0 110.967 -179.94 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 834' ' ' ALA . . . . . 0.808 ' HB1' ' CE1' ' A' ' 788' ' ' PHE . . . -155.5 128.15 7.93 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.635 -0.666 . . . . 0.0 109.449 179.954 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 835' ' ' VAL . . . . . 0.445 ' CG1' ' N ' ' A' ' 836' ' ' GLU . 21.7 t -148.14 163.94 5.77 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.026 0 O-C-N 120.973 -1.079 . . . . 0.0 111.439 -179.887 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 836' ' ' GLU . . . . . 0.445 ' N ' ' CG1' ' A' ' 835' ' ' VAL . 6.1 tt0 -145.89 141.38 27.77 Favored 'General case' 0 N--CA 1.496 1.864 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 179.96 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 837' ' ' ALA . . . . . . . . . . . . . . . -134.56 156.71 48.19 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 120.929 -1.107 . . . . 0.0 111.061 -179.966 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 838' ' ' VAL . . . . . . . . . . . . . 69.7 t -114.3 102.96 14.61 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.725 0 O-C-N 121.428 -0.795 . . . . 0.0 109.734 179.97 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 839' ' ' CYS . . . . . 0.438 ' SG ' HG12 ' A' ' 770' ' ' ILE . 0.1 OUTLIER -108.88 139.73 43.32 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.071 -1.018 . . . . 0.0 110.822 -179.97 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 840' ' ' SER . . . . . . . . . . . . . 17.8 m -150.22 -168.52 3.13 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.365 -0.835 . . . . 0.0 110.02 179.944 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 841' ' ' THR . . . . . 0.477 ' HB ' ' HG3' ' A' ' 768' ' ' GLN . 8.9 t -115.0 167.19 11.02 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.221 -0.925 . . . . 0.0 110.288 -179.986 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 842' ' ' ALA . . . . . . . . . . . . . . . -53.24 110.83 0.59 Allowed 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.246 -0.909 . . . . 0.0 110.352 179.999 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 843' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.641 0 CA-C-O 118.014 -0.993 . . . . 0.0 110.175 179.993 . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 726' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.493 1.681 0 CA-C-O 121.247 0.546 . . . . 0.0 110.198 . . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 727' ' ' THR . . . . . . . . . . . . . 9.3 t -162.93 151.96 14.89 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.354 -0.841 . . . . 0.0 110.02 -179.992 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 728' ' ' VAL . . . . . 0.462 ' O ' ' HB3' ' A' ' 729' ' ' SER . 11.0 p -160.51 154.91 3.88 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.215 -0.928 . . . . 0.0 110.65 -179.995 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 729' ' ' SER . . . . . 0.462 ' HB3' ' O ' ' A' ' 728' ' ' VAL . 10.6 t 57.92 142.67 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.47 -0.769 . . . . 0.0 111.193 179.959 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 730' ' ' GLY . . . . . . . . . . . . . . . -132.4 159.73 23.48 Favored Glycine 0 N--CA 1.492 2.424 0 N-CA-C 109.012 -1.635 . . . . 0.0 109.012 179.915 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 731' ' ' VAL . . . . . 0.421 ' CG2' ' HB3' ' A' ' 837' ' ' ALA . 35.7 m -133.37 150.78 32.64 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 O-C-N 121.125 -1.221 . . . . 0.0 110.79 -179.992 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 732' ' ' CYS . . . . . . . . . . . . . 2.4 m -128.82 135.02 48.57 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.489 -0.757 . . . . 0.0 109.647 -179.968 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 733' ' ' ALA . . . . . 0.495 ' CB ' HD21 ' A' ' 762' ' ' LEU . . . -131.87 105.3 7.37 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.922 -1.111 . . . . 0.0 110.946 -179.913 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 734' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -113.66 107.76 16.21 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.339 -0.851 . . . . 0.0 109.088 179.911 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 735' ' ' VAL . . . . . . . . . . . . . 47.9 t -139.73 120.58 14.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.047 -1.033 . . . . 0.0 111.274 -179.926 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 736' ' ' SER . . . . . 0.417 ' O ' ' C ' ' A' ' 737' ' ' GLU . 54.4 p -100.72 -176.38 3.17 Favored 'General case' 0 C--N 1.297 -1.68 0 O-C-N 121.454 -0.779 . . . . 0.0 108.898 179.848 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 737' ' ' GLU . . . . . 0.417 ' C ' ' O ' ' A' ' 736' ' ' SER . 0.7 OUTLIER -44.12 160.94 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.113 -0.992 . . . . 0.0 109.604 179.962 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 738' ' ' TYR . . . . . 0.663 ' CG ' ' N ' ' A' ' 739' ' ' HIS . 0.4 OUTLIER -129.83 -52.8 1.14 Allowed 'General case' 0 N--CA 1.497 1.878 0 O-C-N 120.821 -1.174 . . . . 0.0 110.988 179.986 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 739' ' ' HIS . . . . . 0.663 ' N ' ' CG ' ' A' ' 738' ' ' TYR . 10.2 t-80 57.39 129.1 0.01 OUTLIER Pre-proline 0 N--CA 1.499 1.998 0 O-C-N 121.375 -0.828 . . . . 0.0 110.216 -179.898 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 740' ' ' PRO . . . . . 0.416 ' HD2' ' CD2' ' A' ' 739' ' ' HIS . 45.7 Cg_endo -71.12 151.54 61.4 Favored 'Trans proline' 0 C--N 1.307 -1.614 0 O-C-N 123.495 1.26 . . . . 0.0 110.542 179.953 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 741' ' ' ASN . . . . . 0.408 ' O ' ' HB ' ' A' ' 742' ' ' ILE . 0.2 OUTLIER -71.3 -31.85 67.94 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.302 -0.874 . . . . 0.0 110.441 -179.992 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 742' ' ' ILE . . . . . 0.439 HG22 ' N ' ' A' ' 743' ' ' LYS . 43.7 mt 56.4 164.88 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 O-C-N 121.211 -0.93 . . . . 0.0 110.688 -179.971 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 743' ' ' LYS . . . . . 0.518 ' O ' ' CZ3' ' A' ' 745' ' ' TRP . 1.0 OUTLIER -157.53 -53.91 0.07 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.396 -0.815 . . . . 0.0 109.807 179.954 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 744' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -104.74 118.91 37.75 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.198 -0.939 . . . . 0.0 109.678 179.926 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 745' ' ' TRP . . . . . 0.583 ' CG ' ' O ' ' A' ' 745' ' ' TRP . 1.2 p90 -169.39 116.57 0.6 Allowed 'General case' 0 C--N 1.304 -1.386 0 O-C-N 121.237 -0.914 . . . . 0.0 110.614 -179.965 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 746' ' ' GLN . . . . . 0.413 ' N ' ' OE2' ' A' ' 752' ' ' GLU . 4.3 mt-30 -52.97 158.43 1.43 Allowed 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.29 -0.881 . . . . 0.0 110.44 -179.963 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 747' ' ' ILE . . . . . 0.729 ' O ' HG23 ' A' ' 747' ' ' ILE . 3.6 tt -176.81 100.96 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.327 -0.858 . . . . 0.0 110.286 -179.989 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 748' ' ' GLU . . . . . . . . . . . . . 14.0 mt-10 -121.09 -58.84 1.77 Allowed 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.298 -0.876 . . . . 0.0 109.941 179.968 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 749' ' ' SER . . . . . 0.449 ' C ' ' CD2' ' A' ' 750' ' ' TYR . 0.1 OUTLIER -138.77 9.06 2.6 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.231 -0.918 . . . . 0.0 110.165 -179.968 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 750' ' ' TYR . . . . . 0.625 ' N ' ' CD2' ' A' ' 750' ' ' TYR . 0.1 OUTLIER -143.55 -77.24 0.23 Allowed 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.248 -0.908 . . . . 0.0 110.069 -179.976 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 751' ' ' GLY . . . . . . . . . . . . . . . 116.5 -174.39 15.21 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.564 -1.415 . . . . 0.0 109.564 179.964 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 752' ' ' GLU . . . . . 0.413 ' OE2' ' N ' ' A' ' 746' ' ' GLN . 7.9 mt-10 -114.72 137.37 22.73 Favored Pre-proline 0 N--CA 1.494 1.734 0 O-C-N 121.241 -1.152 . . . . 0.0 110.187 -179.964 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 753' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -75.07 131.74 14.55 Favored 'Trans proline' 0 C--N 1.305 -1.715 0 O-C-N 124.02 1.537 . . . . 0.0 110.67 179.969 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 754' ' ' GLU . . . . . . . . . . . . . 6.1 tt0 -162.09 166.24 26.06 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.349 -0.844 . . . . 0.0 110.12 -179.997 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 755' ' ' PHE . . . . . . . . . . . . . 4.9 m-85 -103.69 163.67 12.17 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.27 -0.894 . . . . 0.0 110.27 179.968 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 756' ' ' HIS . . . . . 0.407 ' HB2' ' HA ' ' A' ' 739' ' ' HIS . 0.5 OUTLIER -160.75 35.36 0.15 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.304 -0.872 . . . . 0.0 110.299 -179.975 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 757' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -89.2 141.03 28.87 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.295 -0.878 . . . . 0.0 110.24 -179.975 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 758' ' ' ALA . . . . . 0.555 ' HB2' ' HB3' ' A' ' 738' ' ' TYR . . . -90.8 165.0 13.88 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.169 -0.957 . . . . 0.0 110.516 -179.906 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 759' ' ' LYS . . . . . 0.444 ' HG2' ' HA ' ' A' ' 815' ' ' ALA . 3.2 mttp -130.39 165.01 23.47 Favored 'General case' 0 C--N 1.302 -1.5 0 O-C-N 121.424 -0.797 . . . . 0.0 109.839 -179.95 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 760' ' ' VAL . . . . . 0.686 HG23 HD11 ' A' ' 816' ' ' ILE . 41.6 t -106.37 153.74 7.62 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.518 0 O-C-N 121.25 -0.906 . . . . 0.0 109.459 179.953 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 761' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -147.87 116.83 6.79 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.051 -1.031 . . . . 0.0 111.219 -179.953 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 762' ' ' LEU . . . . . 0.495 HD21 ' CB ' ' A' ' 733' ' ' ALA . 32.0 mt -110.5 164.48 12.66 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.423 -0.798 . . . . 0.0 108.849 179.888 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 763' ' ' LYS . . . . . . . . . . . . . 14.9 mttt -154.04 128.98 9.5 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.78 -1.2 . . . . 0.0 110.944 -179.928 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 764' ' ' CYS . . . . . 0.433 ' O ' ' C ' ' A' ' 765' ' ' ALA . 10.4 t -103.83 143.78 32.37 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.489 -0.757 . . . . 0.0 109.601 179.996 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 765' ' ' ALA . . . . . 0.433 ' C ' ' O ' ' A' ' 764' ' ' CYS . . . -42.08 150.39 0.38 Allowed Pre-proline 0 N--CA 1.492 1.664 0 O-C-N 121.196 -0.94 . . . . 0.0 110.25 -179.945 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 766' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -70.11 95.95 0.6 Allowed 'Trans proline' 0 C--N 1.306 -1.683 0 O-C-N 124.016 1.535 . . . . 0.0 110.035 -179.923 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 767' ' ' GLY . . . . . . . . . . . . . . . 139.47 -17.76 3.08 Favored Glycine 0 N--CA 1.486 1.972 0 N-CA-C 109.029 -1.628 . . . . 0.0 109.029 -179.936 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 768' ' ' GLN . . . . . . . . . . . . . 20.7 mt-30 -108.61 174.74 5.74 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.362 -1.081 . . . . 0.0 110.133 179.981 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 769' ' ' THR . . . . . . . . . . . . . 8.9 p -144.85 147.97 33.44 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.207 -0.933 . . . . 0.0 110.454 -179.913 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 770' ' ' ILE . . . . . . . . . . . . . 72.1 mt -68.18 145.88 13.28 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.264 -0.898 . . . . 0.0 109.563 179.944 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 771' ' ' SER . . . . . . . . . . . . . 13.5 p -143.47 -3.0 0.94 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.955 -1.09 . . . . 0.0 111.951 -179.956 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 772' ' ' ALA . . . . . . . . . . . . . . . -165.98 143.25 5.41 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 120.559 -1.338 . . . . 0.0 111.648 -179.955 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 773' ' ' ILE . . . . . . . . . . . . . 34.9 mm -105.36 120.41 56.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 179.755 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 774' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.59 -43.55 22.72 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.045 -1.035 . . . . 0.0 111.077 -179.812 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 775' ' ' PHE . . . . . 0.588 ' CZ ' ' HB3' ' A' ' 788' ' ' PHE . 79.3 t80 -149.81 166.42 29.54 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 120.893 -1.129 . . . . 0.0 111.367 -179.925 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 776' ' ' ALA . . . . . 0.551 ' HB2' ' O ' ' A' ' 775' ' ' PHE . . . 174.21 126.2 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 -179.967 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 777' ' ' SER . . . . . . . . . . . . . 2.1 t -148.31 135.02 19.9 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.968 -1.083 . . . . 0.0 111.342 -179.956 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 778' ' ' PHE . . . . . . . . . . . . . 90.1 t80 -103.4 109.46 21.1 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.616 -0.677 . . . . 0.0 109.667 179.95 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 779' ' ' GLY . . . . . . . . . . . . . . . 148.52 -98.87 0.19 Allowed Glycine 0 N--CA 1.492 2.37 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 -179.907 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 780' ' ' THR . . . . . 0.477 ' O ' ' HA3' ' A' ' 791' ' ' GLY . 1.5 p -144.03 91.46 6.53 Favored Pre-proline 0 N--CA 1.494 1.743 0 O-C-N 121.153 -1.204 . . . . 0.0 110.608 179.928 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 781' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -82.57 154.36 15.78 Favored 'Trans proline' 0 C--N 1.304 -1.794 0 O-C-N 123.89 1.468 . . . . 0.0 110.269 179.931 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 782' ' ' LEU . . . . . 0.618 HD13 ' HA2' ' A' ' 791' ' ' GLY . 0.1 OUTLIER -127.76 125.33 39.7 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.082 -1.011 . . . . 0.0 110.508 -179.906 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 783' ' ' GLY . . . . . . . . . . . . . . . 128.24 -168.62 20.07 Favored Glycine 0 N--CA 1.488 2.166 0 N-CA-C 109.779 -1.328 . . . . 0.0 109.779 179.973 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 784' ' ' THR . . . . . 0.474 ' O ' ' HB2' ' A' ' 785' ' ' CYS . 24.1 p -142.93 72.19 1.36 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.323 -1.104 . . . . 0.0 109.834 179.969 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 785' ' ' CYS . . . . . 0.474 ' HB2' ' O ' ' A' ' 784' ' ' THR . 2.2 m 58.88 118.05 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.362 -0.836 . . . . 0.0 109.989 -179.973 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 786' ' ' GLY . . . . . . . . . . . . . . . 102.7 -37.33 3.75 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.061 -1.616 . . . . 0.0 109.061 -179.899 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 787' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -126.12 23.38 7.1 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.347 -1.09 . . . . 0.0 109.801 179.974 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 788' ' ' PHE . . . . . 0.588 ' HB3' ' CZ ' ' A' ' 775' ' ' PHE . 0.3 OUTLIER -56.4 149.76 16.2 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.511 -0.743 . . . . 0.0 110.009 179.987 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 789' ' ' GLN . . . . . 0.404 ' HG2' ' C ' ' A' ' 788' ' ' PHE . 2.3 mm-40 -134.65 173.69 11.39 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.255 -0.903 . . . . 0.0 110.126 -179.991 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 790' ' ' GLN . . . . . 0.408 ' O ' ' C ' ' A' ' 791' ' ' GLY . 0.0 OUTLIER -86.45 16.04 4.91 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.318 -0.864 . . . . 0.0 109.993 179.961 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 791' ' ' GLY . . . . . 0.618 ' HA2' HD13 ' A' ' 782' ' ' LEU . . . 42.45 -120.1 2.28 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.744 -1.343 . . . . 0.0 109.744 -179.963 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 792' ' ' GLU . . . . . . . . . . . . . 12.8 mt-10 -117.26 -30.64 5.54 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.272 -1.134 . . . . 0.0 110.562 179.991 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 793' ' ' CYS . . . . . . . . . . . . . 2.5 t -126.65 156.77 40.48 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.255 -0.903 . . . . 0.0 110.232 -179.979 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 794' ' ' HIS . . . . . 0.51 ' NE2' ' O ' ' A' ' 795' ' ' SER . 49.9 t60 -170.08 150.49 3.76 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.374 -0.829 . . . . 0.0 110.229 -179.994 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 795' ' ' SER . . . . . 0.51 ' O ' ' NE2' ' A' ' 794' ' ' HIS . 3.1 t -99.68 158.07 16.03 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.394 -0.816 . . . . 0.0 109.466 179.948 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 796' ' ' ILE . . . . . 0.414 HG21 HD13 ' A' ' 796' ' ' ILE . 0.6 OUTLIER -92.07 37.24 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.087 0 O-C-N 121.005 -1.059 . . . . 0.0 109.847 -179.926 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 797' ' ' ASN . . . . . . . . . . . . . 18.9 m120 -148.06 22.92 1.08 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.383 -0.823 . . . . 0.0 109.93 179.997 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 798' ' ' SER . . . . . 0.486 ' HB3' ' O ' ' A' ' 776' ' ' ALA . 13.9 m -69.54 -50.35 45.76 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.306 -0.871 . . . . 0.0 110.637 179.991 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 799' ' ' ASN . . . . . 0.49 ' OD1' ' HB3' ' A' ' 776' ' ' ALA . 53.6 m-20 -76.33 -31.96 58.42 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.302 -0.874 . . . . 0.0 110.619 -179.944 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 800' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -56.63 -25.78 54.14 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.246 -0.909 . . . . 0.0 110.999 -179.93 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 801' ' ' VAL . . . . . 0.433 HG21 ' CD2' ' A' ' 821' ' ' PHE . 40.7 t -87.36 -21.66 7.13 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 O-C-N 121.067 -1.02 . . . . 0.0 110.769 -179.944 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 802' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -93.07 -20.91 20.07 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.092 -1.005 . . . . 0.0 111.18 -179.942 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 803' ' ' GLU . . . . . 0.449 ' HA ' HD12 ' A' ' 807' ' ' ILE . 4.4 mt-10 -83.51 -37.92 22.44 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.314 -0.866 . . . . 0.0 111.292 -179.858 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 804' ' ' ARG . . . . . . . . . . . . . 2.1 mtm180 -91.61 -25.61 19.09 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 120.997 -1.064 . . . . 0.0 111.62 -179.915 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 805' ' ' LYS . . . . . . . . . . . . . 2.0 tttp -110.53 44.53 1.24 Allowed 'General case' 0 N--CA 1.497 1.88 0 O-C-N 120.859 -1.15 . . . . 0.0 110.814 -179.939 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 806' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -160.52 -66.97 0.07 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.129 -0.982 . . . . 0.0 110.342 179.945 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 807' ' ' ILE . . . . . 0.449 HD12 ' HA ' ' A' ' 803' ' ' GLU . 30.1 mt -52.18 128.81 11.36 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.078 -1.014 . . . . 0.0 110.467 -179.998 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 808' ' ' GLY . . . . . 0.44 ' C ' ' HG ' ' A' ' 809' ' ' LEU . . . 105.24 9.48 33.82 Favored Glycine 0 N--CA 1.491 2.34 0 C-N-CA 119.918 -1.134 . . . . 0.0 110.284 179.915 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 809' ' ' LEU . . . . . 0.44 ' HG ' ' C ' ' A' ' 808' ' ' GLY . 43.7 mt -138.72 142.6 38.9 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.015 -1.285 . . . . 0.0 110.511 179.979 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 810' ' ' GLU . . . . . . . . . . . . . 5.0 mp0 -67.93 -20.88 65.12 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.182 -0.949 . . . . 0.0 109.418 179.998 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 811' ' ' ARG . . . . . . . . . . . . . 24.6 mtm180 -136.52 157.21 47.32 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.605 -0.684 . . . . 0.0 109.643 179.965 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 812' ' ' CYS . . . . . . . . . . . . . 3.2 t -131.12 146.71 52.45 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.198 -0.939 . . . . 0.0 110.193 -179.971 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 813' ' ' VAL . . . . . 0.633 HG13 ' O ' ' A' ' 813' ' ' VAL . 4.6 p -148.69 116.92 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.151 -0.968 . . . . 0.0 110.024 179.926 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 814' ' ' VAL . . . . . . . . . . . . . 6.7 t -131.39 111.73 19.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.193 -0.942 . . . . 0.0 110.077 179.959 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 815' ' ' ALA . . . . . 0.444 ' HA ' ' HG2' ' A' ' 759' ' ' LYS . . . -61.74 166.79 4.05 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.335 -0.853 . . . . 0.0 110.556 -179.955 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 816' ' ' ILE . . . . . 0.825 HG23 HG21 ' A' ' 833' ' ' VAL . 70.7 mt -119.7 112.89 38.97 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 121.378 -0.826 . . . . 0.0 110.102 179.953 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 817' ' ' SER . . . . . 0.532 ' CB ' ' HD2' ' A' ' 818' ' ' PRO . 0.7 OUTLIER -161.89 -177.36 0.7 Allowed Pre-proline 0 N--CA 1.494 1.744 0 O-C-N 121.101 -1.0 . . . . 0.0 110.313 179.97 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 818' ' ' PRO . . . . . 0.532 ' HD2' ' CB ' ' A' ' 817' ' ' SER . 48.3 Cg_endo -75.34 -48.84 0.15 Allowed 'Trans proline' 0 C--N 1.309 -1.546 0 O-C-N 123.991 1.522 . . . . 0.0 110.77 -179.971 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 819' ' ' SER . . . . . . . . . . . . . 2.8 t -92.76 71.06 4.84 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.334 -0.854 . . . . 0.0 110.411 -179.944 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 820' ' ' ASN . . . . . . . . . . . . . 5.4 t-20 -143.58 -43.23 0.28 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.137 -0.977 . . . . 0.0 110.129 -179.973 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 821' ' ' PHE . . . . . 0.433 ' CD2' HG21 ' A' ' 801' ' ' VAL . 33.3 m-85 -83.08 -57.29 3.34 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.428 -0.795 . . . . 0.0 110.501 -179.949 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 822' ' ' GLY . . . . . . . . . . . . . . . 147.21 66.76 0.01 OUTLIER Glycine 0 N--CA 1.491 2.349 0 C-N-CA 119.512 -1.328 . . . . 0.0 110.111 179.953 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 823' ' ' GLY . . . . . . . . . . . . . . . 120.4 170.5 14.26 Favored Glycine 0 N--CA 1.493 2.497 0 O-C-N 121.12 -1.224 . . . . 0.0 110.267 179.917 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 824' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -132.05 65.82 76.17 Favored Pre-proline 0 N--CA 1.494 1.733 0 O-C-N 121.583 -0.951 . . . . 0.0 109.814 179.986 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 825' ' ' PRO . . . . . 0.459 ' C ' ' HD3' ' A' ' 827' ' ' PRO . 48.7 Cg_endo -74.43 -3.42 13.82 Favored 'Trans proline' 0 C--N 1.305 -1.732 0 O-C-N 124.195 1.629 . . . . 0.0 111.122 -179.915 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 826' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER -126.44 64.83 57.25 Favored Pre-proline 0 N--CA 1.499 2.016 0 O-C-N 120.984 -1.072 . . . . 0.0 110.184 -179.944 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 827' ' ' PRO . . . . . 0.459 ' HD3' ' C ' ' A' ' 825' ' ' PRO . 50.0 Cg_endo -82.36 153.53 16.08 Favored 'Trans proline' 0 C--N 1.311 -1.416 0 O-C-N 123.897 1.472 . . . . 0.0 110.886 179.989 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 828' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 57.71 39.77 27.0 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.448 -0.782 . . . . 0.0 110.781 -179.993 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 829' ' ' VAL . . . . . 0.417 ' O ' ' C ' ' A' ' 830' ' ' MET . 54.3 t -137.45 139.76 42.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.176 -0.953 . . . . 0.0 110.116 179.974 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 830' ' ' MET . . . . . 0.417 ' C ' ' O ' ' A' ' 829' ' ' VAL . 0.2 OUTLIER -44.33 144.61 0.97 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.238 -0.913 . . . . 0.0 109.816 -179.911 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 831' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.2 105.79 18.05 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.233 -0.917 . . . . 0.0 110.689 -179.972 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 832' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -128.2 116.68 20.27 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.493 -0.754 . . . . 0.0 109.404 179.945 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 833' ' ' VAL . . . . . 0.825 HG21 HG23 ' A' ' 816' ' ' ILE . 3.3 t -109.86 116.87 53.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.165 -0.959 . . . . 0.0 110.876 -179.931 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 834' ' ' ALA . . . . . 0.572 ' O ' HG23 ' A' ' 835' ' ' VAL . . . -118.25 148.87 41.99 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.478 -0.764 . . . . 0.0 109.229 179.949 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 835' ' ' VAL . . . . . 0.572 HG23 ' O ' ' A' ' 834' ' ' ALA . 46.7 t -155.06 162.84 1.72 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.519 0 O-C-N 120.904 -1.123 . . . . 0.0 111.051 -179.914 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 836' ' ' GLU . . . . . 0.439 ' N ' HG12 ' A' ' 835' ' ' VAL . 2.6 tt0 -145.76 118.12 8.45 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.629 -0.669 . . . . 0.0 109.587 179.934 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 837' ' ' ALA . . . . . 0.421 ' HB3' ' CG2' ' A' ' 731' ' ' VAL . . . -108.12 161.17 15.22 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.152 -0.968 . . . . 0.0 110.372 -179.947 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 838' ' ' VAL . . . . . . . . . . . . . 38.8 t -128.28 130.7 69.47 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.394 -0.816 . . . . 0.0 110.0 179.926 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 839' ' ' CYS . . . . . . . . . . . . . 2.5 m -109.82 146.47 34.99 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.179 -0.95 . . . . 0.0 110.343 -179.961 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 840' ' ' SER . . . . . . . . . . . . . 67.2 p -131.01 -169.83 2.24 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.351 -0.843 . . . . 0.0 109.861 179.938 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 841' ' ' THR . . . . . 0.677 ' O ' ' HB3' ' A' ' 842' ' ' ALA . 0.2 OUTLIER -111.23 20.03 17.76 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.221 -0.925 . . . . 0.0 110.143 -179.96 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 842' ' ' ALA . . . . . 0.677 ' HB3' ' O ' ' A' ' 841' ' ' THR . . . 66.91 166.34 0.22 Allowed 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.536 -0.727 . . . . 0.0 110.435 179.914 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 843' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.577 0 CA-C-O 117.973 -1.013 . . . . 0.0 110.158 -179.98 . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 726' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.699 0 CA-C-O 121.265 0.555 . . . . 0.0 110.263 . . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 727' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -127.97 171.49 11.78 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.324 -0.86 . . . . 0.0 110.268 179.992 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 728' ' ' VAL . . . . . 0.439 ' O ' ' O ' ' A' ' 839' ' ' CYS . 32.5 t -149.77 159.78 5.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.254 -0.904 . . . . 0.0 110.07 -179.962 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 729' ' ' SER . . . . . 0.425 ' OG ' ' O ' ' A' ' 728' ' ' VAL . 0.9 OUTLIER 178.1 120.88 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.127 -0.983 . . . . 0.0 110.432 -179.95 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 730' ' ' GLY . . . . . . . . . . . . . . . 149.34 99.32 0.2 Allowed Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.767 -1.333 . . . . 0.0 109.767 -179.979 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 731' ' ' VAL . . . . . . . . . . . . . 73.1 t -142.15 148.98 19.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.282 -1.128 . . . . 0.0 109.869 179.979 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 732' ' ' CYS . . . . . . . . . . . . . 92.5 m -122.62 166.3 15.08 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.256 -0.902 . . . . 0.0 110.922 -179.971 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 733' ' ' ALA . . . . . 0.439 ' HB3' ' O ' ' A' ' 835' ' ' VAL . . . -160.96 102.09 1.28 Allowed 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 179.883 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 734' ' ' ASP . . . . . 0.565 ' C ' HG23 ' A' ' 735' ' ' VAL . 3.2 t70 -131.28 122.64 26.81 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.174 -0.954 . . . . 0.0 110.366 -179.944 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 735' ' ' VAL . . . . . 0.565 HG23 ' C ' ' A' ' 734' ' ' ASP . 40.6 t -153.25 153.06 9.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.35 -0.844 . . . . 0.0 110.152 179.979 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 736' ' ' SER . . . . . . . . . . . . . 12.3 t -110.31 152.25 26.41 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.159 -0.963 . . . . 0.0 110.207 -179.962 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 737' ' ' GLU . . . . . 0.472 ' OE2' ' HB2' ' A' ' 739' ' ' HIS . 2.1 tm-20 -52.59 -176.59 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.226 -0.921 . . . . 0.0 110.225 179.981 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 738' ' ' TYR . . . . . 0.469 ' O ' ' HB3' ' A' ' 739' ' ' HIS . 7.5 t80 -126.61 -47.91 1.55 Allowed 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.21 -0.931 . . . . 0.0 110.437 179.998 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 739' ' ' HIS . . . . . 0.524 ' O ' ' CD1' ' A' ' 742' ' ' ILE . 19.6 t-160 62.77 103.47 0.03 OUTLIER Pre-proline 0 N--CA 1.493 1.709 0 O-C-N 121.292 -0.88 . . . . 0.0 110.424 179.941 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 740' ' ' PRO . . . . . 0.449 ' HD3' ' O ' ' A' ' 756' ' ' HIS . 48.7 Cg_endo -86.54 51.42 2.54 Favored 'Trans proline' 0 C--N 1.303 -1.842 0 O-C-N 123.954 1.502 . . . . 0.0 110.152 179.977 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 741' ' ' ASN . . . . . 0.662 ' H ' HD12 ' A' ' 742' ' ' ILE . 15.3 t30 -160.63 80.01 0.65 Allowed 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.143 -0.973 . . . . 0.0 110.682 -179.976 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 742' ' ' ILE . . . . . 0.662 HD12 ' H ' ' A' ' 741' ' ' ASN . 4.3 mp -144.26 -97.28 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.233 -0.917 . . . . 0.0 110.024 179.933 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 743' ' ' LYS . . . . . 0.495 ' N ' HG22 ' A' ' 742' ' ' ILE . 0.0 OUTLIER 174.6 -71.92 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.134 -0.978 . . . . 0.0 109.656 179.984 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 744' ' ' ASN . . . . . 0.466 ' O ' ' O ' ' A' ' 745' ' ' TRP . 0.5 OUTLIER -86.3 3.9 41.34 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.322 -0.861 . . . . 0.0 109.938 179.951 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 745' ' ' TRP . . . . . 0.466 ' O ' ' O ' ' A' ' 744' ' ' ASN . 28.1 m95 41.19 -165.53 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.348 -0.845 . . . . 0.0 110.635 179.944 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 746' ' ' GLN . . . . . 0.721 ' C ' HD12 ' A' ' 747' ' ' ILE . 17.6 mt-30 -152.83 34.08 0.49 Allowed 'General case' 0 C--N 1.3 -1.576 0 O-C-N 121.247 -0.908 . . . . 0.0 110.133 -179.932 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 747' ' ' ILE . . . . . 0.721 HD12 ' C ' ' A' ' 746' ' ' GLN . 2.1 mp -116.14 170.79 5.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.237 -0.914 . . . . 0.0 110.331 179.987 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 748' ' ' GLU . . . . . 0.536 ' N ' HG22 ' A' ' 747' ' ' ILE . 2.2 mp0 -87.61 31.53 0.75 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.253 -0.904 . . . . 0.0 110.352 -179.939 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 749' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -156.58 93.85 1.42 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.224 -0.922 . . . . 0.0 110.226 -179.977 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 750' ' ' TYR . . . . . . . . . . . . . 76.6 m-85 -55.45 147.53 17.34 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.264 -0.897 . . . . 0.0 110.146 179.994 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 751' ' ' GLY . . . . . 0.421 ' O ' ' C ' ' A' ' 752' ' ' GLU . . . 101.9 124.67 5.45 Favored Glycine 0 N--CA 1.488 2.155 0 N-CA-C 109.08 -1.608 . . . . 0.0 109.08 -179.979 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 752' ' ' GLU . . . . . 0.421 ' C ' ' O ' ' A' ' 751' ' ' GLY . 3.0 pt-20 -42.89 108.78 0.68 Allowed Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.278 -1.131 . . . . 0.0 110.285 -179.995 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 753' ' ' PRO . . . . . 0.561 ' O ' ' CG ' ' A' ' 754' ' ' GLU . 49.2 Cg_endo -78.79 70.84 7.23 Favored 'Trans proline' 0 C--N 1.309 -1.548 0 O-C-N 124.055 1.555 . . . . 0.0 110.702 -179.952 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 754' ' ' GLU . . . . . 0.561 ' CG ' ' O ' ' A' ' 753' ' ' PRO . 4.5 pt-20 42.56 -177.56 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.309 0 CA-C-O 121.663 0.744 . . . . 0.0 111.579 179.967 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 755' ' ' PHE . . . . . 0.471 ' O ' ' O ' ' A' ' 754' ' ' GLU . 0.2 OUTLIER 50.8 171.24 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.446 -0.784 . . . . 0.0 110.955 179.979 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 756' ' ' HIS . . . . . 0.449 ' O ' ' HD3' ' A' ' 740' ' ' PRO . 57.5 m80 -126.98 -32.72 2.51 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.36 -0.838 . . . . 0.0 109.772 179.968 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 757' ' ' THR . . . . . . . . . . . . . 39.0 p -108.77 -159.33 0.68 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.368 -0.833 . . . . 0.0 110.098 179.972 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 758' ' ' ALA . . . . . . . . . . . . . . . -114.13 176.14 5.17 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.218 -0.926 . . . . 0.0 110.007 179.974 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 759' ' ' LYS . . . . . 0.466 ' HD3' ' CZ ' ' A' ' 755' ' ' PHE . 32.2 mtmt -144.44 161.99 37.64 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.213 -0.929 . . . . 0.0 110.345 -179.963 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 760' ' ' VAL . . . . . . . . . . . . . 59.6 t -109.28 158.61 9.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.435 -0.791 . . . . 0.0 109.276 179.971 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 761' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -122.47 122.61 39.36 Favored 'General case' 0 C--N 1.298 -1.641 0 O-C-N 121.051 -1.03 . . . . 0.0 110.912 179.978 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 762' ' ' LEU . . . . . 0.495 ' HB2' ' O ' ' A' ' 812' ' ' CYS . 5.6 mt -141.4 135.97 30.92 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.462 -0.774 . . . . 0.0 109.323 179.918 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 763' ' ' LYS . . . . . . . . . . . . . 3.8 mtmt -150.38 151.17 32.42 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.009 -1.057 . . . . 0.0 110.944 -179.938 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 764' ' ' CYS . . . . . . . . . . . . . 9.2 m -127.54 172.88 10.32 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.538 -0.726 . . . . 0.0 109.622 179.963 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 765' ' ' ALA . . . . . 0.451 ' HB3' ' OE1' ' A' ' 768' ' ' GLN . . . -68.11 158.49 83.9 Favored Pre-proline 0 N--CA 1.493 1.681 0 O-C-N 121.109 -0.994 . . . . 0.0 109.947 179.947 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 766' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -72.33 119.02 5.88 Favored 'Trans proline' 0 C--N 1.306 -1.703 0 O-C-N 123.932 1.491 . . . . 0.0 110.338 179.987 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 767' ' ' GLY . . . . . . . . . . . . . . . 112.98 -6.67 25.52 Favored Glycine 0 N--CA 1.489 2.201 0 N-CA-C 109.485 -1.446 . . . . 0.0 109.485 -179.911 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 768' ' ' GLN . . . . . 0.511 ' C ' HG23 ' A' ' 769' ' ' THR . 33.6 mt-30 -114.27 169.75 8.8 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.145 -1.209 . . . . 0.0 110.463 179.969 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 769' ' ' THR . . . . . 0.511 HG23 ' C ' ' A' ' 768' ' ' GLN . 70.5 p -152.2 149.47 28.77 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.358 -0.839 . . . . 0.0 109.866 -179.97 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 770' ' ' ILE . . . . . 0.478 HD12 ' O ' ' A' ' 806' ' ' CYS . 26.9 mt -70.27 141.38 17.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.088 -1.008 . . . . 0.0 109.722 -179.985 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 771' ' ' SER . . . . . . . . . . . . . 1.6 p -126.44 -13.18 6.08 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.168 -0.958 . . . . 0.0 110.587 -179.943 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 772' ' ' ALA . . . . . . . . . . . . . . . -158.08 159.66 36.52 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 120.97 -1.081 . . . . 0.0 111.426 -179.906 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 773' ' ' ILE . . . . . . . . . . . . . 34.8 mm -124.15 123.31 66.32 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 O-C-N 121.644 -0.66 . . . . 0.0 109.296 179.936 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 774' ' ' LYS . . . . . 0.551 ' HG3' ' CG2' ' A' ' 838' ' ' VAL . 0.3 OUTLIER -80.82 -41.4 23.35 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.125 -0.984 . . . . 0.0 110.933 -179.869 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 775' ' ' PHE . . . . . 0.71 ' O ' ' HB2' ' A' ' 776' ' ' ALA . 48.7 t80 -135.5 173.59 11.55 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.069 -1.019 . . . . 0.0 111.088 -179.892 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 776' ' ' ALA . . . . . 0.71 ' HB2' ' O ' ' A' ' 775' ' ' PHE . . . 166.47 87.03 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.644 -0.66 . . . . 0.0 109.314 179.999 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 777' ' ' SER . . . . . 0.473 ' OG ' ' CZ ' ' A' ' 775' ' ' PHE . 16.1 p -119.61 129.84 54.81 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.236 -0.915 . . . . 0.0 110.709 -179.892 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 778' ' ' PHE . . . . . 0.603 ' CD2' HG22 ' A' ' 833' ' ' VAL . 39.4 t80 -104.72 78.54 1.45 Allowed 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.294 -0.879 . . . . 0.0 110.024 179.944 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 779' ' ' GLY . . . . . 0.461 ' C ' ' HD3' ' A' ' 781' ' ' PRO . . . -168.79 -105.42 0.18 Allowed Glycine 0 N--CA 1.492 2.408 0 N-CA-C 109.686 -1.366 . . . . 0.0 109.686 179.997 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 780' ' ' THR . . . . . . . . . . . . . 2.4 p -121.17 63.24 12.16 Favored Pre-proline 0 N--CA 1.493 1.686 0 O-C-N 121.229 -1.159 . . . . 0.0 110.548 -179.973 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 781' ' ' PRO . . . . . 0.496 ' HD2' ' HB3' ' A' ' 832' ' ' ARG . 46.1 Cg_endo -75.98 146.66 29.51 Favored 'Trans proline' 0 C--N 1.305 -1.726 0 O-C-N 124.068 1.562 . . . . 0.0 111.142 179.983 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 782' ' ' LEU . . . . . 0.76 HD21 ' O ' ' A' ' 790' ' ' GLN . 1.8 pt? -149.54 159.56 44.21 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.452 -0.78 . . . . 0.0 109.64 179.928 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 783' ' ' GLY . . . . . 0.416 ' O ' HG23 ' A' ' 784' ' ' THR . . . 140.48 -131.22 4.91 Favored Glycine 0 N--CA 1.496 2.66 0 N-CA-C 109.591 -1.404 . . . . 0.0 109.591 -179.96 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 784' ' ' THR . . . . . 0.416 HG23 ' O ' ' A' ' 783' ' ' GLY . 0.0 OUTLIER -162.14 -158.02 0.51 Allowed 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.121 -1.223 . . . . 0.0 110.68 -179.969 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 785' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -72.95 119.32 17.03 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.366 -0.834 . . . . 0.0 110.54 -179.989 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 786' ' ' GLY . . . . . . . . . . . . . . . 82.63 -10.63 55.5 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.895 -1.282 . . . . 0.0 109.895 -179.98 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 787' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -124.25 30.0 6.2 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.13 -1.218 . . . . 0.0 110.133 -179.989 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 788' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -58.62 91.82 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.276 -0.89 . . . . 0.0 110.387 -180.0 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 789' ' ' GLN . . . . . . . . . . . . . 4.1 tt0 -75.5 -177.24 3.53 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.405 -0.809 . . . . 0.0 110.162 -179.957 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 790' ' ' GLN . . . . . 0.76 ' O ' HD21 ' A' ' 782' ' ' LEU . 0.0 OUTLIER -108.05 174.01 6.07 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.443 -0.786 . . . . 0.0 110.307 179.992 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 791' ' ' GLY . . . . . . . . . . . . . . . -106.87 -140.82 9.87 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.519 -1.432 . . . . 0.0 109.519 179.945 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 792' ' ' GLU . . . . . 0.4 ' HG2' ' N ' ' A' ' 793' ' ' CYS . 1.5 pt-20 -105.17 -24.03 12.81 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.174 -1.192 . . . . 0.0 110.144 -179.967 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 793' ' ' CYS . . . . . 0.4 ' N ' ' HG2' ' A' ' 792' ' ' GLU . 5.7 t -126.22 145.66 50.3 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.281 -0.887 . . . . 0.0 109.974 -179.887 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 794' ' ' HIS . . . . . 0.492 ' CE1' ' OG ' ' A' ' 798' ' ' SER . 73.0 t60 -139.46 156.11 47.15 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.18 -0.95 . . . . 0.0 110.146 -179.943 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 795' ' ' SER . . . . . . . . . . . . . 1.3 t -81.56 -141.62 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.322 -0.861 . . . . 0.0 110.165 179.995 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 796' ' ' ILE . . . . . . . . . . . . . 1.5 pt -145.53 12.71 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.241 -0.912 . . . . 0.0 110.038 -179.971 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 797' ' ' ASN . . . . . . . . . . . . . 31.5 m120 -148.99 29.16 0.82 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.328 -0.857 . . . . 0.0 110.08 179.999 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 798' ' ' SER . . . . . 0.514 ' CB ' ' O ' ' A' ' 776' ' ' ALA . 7.6 m -71.41 -30.47 66.13 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.218 -0.926 . . . . 0.0 110.625 -179.995 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 799' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -102.33 -7.89 21.67 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.244 -0.91 . . . . 0.0 110.349 179.967 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 800' ' ' SER . . . . . . . . . . . . . 5.8 p -90.46 -22.3 21.46 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.174 -0.954 . . . . 0.0 110.477 179.987 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 801' ' ' VAL . . . . . 0.502 ' O ' ' HG2' ' A' ' 805' ' ' LYS . 55.6 t -81.59 -39.05 16.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.104 -0.997 . . . . 0.0 109.949 179.977 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 802' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -70.6 -56.29 6.84 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.33 -0.856 . . . . 0.0 110.536 -179.95 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 803' ' ' GLU . . . . . 0.531 ' HG2' HD12 ' A' ' 807' ' ' ILE . 2.3 tt0 -48.97 -19.8 0.44 Allowed 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.158 -0.964 . . . . 0.0 110.946 -179.921 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 804' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.71 -46.8 8.03 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.993 -1.067 . . . . 0.0 111.328 -179.893 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 805' ' ' LYS . . . . . 0.961 ' HE2' HG22 ' A' ' 814' ' ' VAL . 0.0 OUTLIER -115.93 47.53 1.36 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.952 -1.092 . . . . 0.0 111.329 -179.829 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 806' ' ' CYS . . . . . 0.478 ' O ' HD12 ' A' ' 770' ' ' ILE . 2.4 t -150.22 -44.52 0.13 Allowed 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.056 -1.028 . . . . 0.0 110.225 179.937 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 807' ' ' ILE . . . . . 0.531 HD12 ' HG2' ' A' ' 803' ' ' GLU . 36.7 mt -80.89 129.17 37.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.188 -0.945 . . . . 0.0 110.151 -179.95 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 808' ' ' GLY . . . . . . . . . . . . . . . 110.86 -9.27 29.74 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 109.897 -1.281 . . . . 0.0 109.897 179.988 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 809' ' ' LEU . . . . . . . . . . . . . 7.8 mt -113.64 154.51 27.1 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.05 -1.265 . . . . 0.0 110.77 -179.979 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 810' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -69.93 -29.74 66.97 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.321 -0.862 . . . . 0.0 109.237 179.869 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 811' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -132.42 165.03 25.21 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.606 -0.684 . . . . 0.0 109.527 -179.993 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 812' ' ' CYS . . . . . 0.495 ' O ' ' HB2' ' A' ' 762' ' ' LEU . 22.8 t -143.12 135.12 26.93 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.079 -1.013 . . . . 0.0 110.839 179.986 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 813' ' ' VAL . . . . . 0.442 ' O ' ' CG1' ' A' ' 813' ' ' VAL . 3.0 p -144.16 129.45 14.82 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 O-C-N 121.464 -0.772 . . . . 0.0 109.192 179.856 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 814' ' ' VAL . . . . . 0.961 HG22 ' HE2' ' A' ' 805' ' ' LYS . 30.2 t -134.59 145.59 32.35 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.068 -1.02 . . . . 0.0 110.849 -179.895 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 815' ' ' ALA . . . . . . . . . . . . . . . -87.28 165.3 15.75 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.404 -0.81 . . . . 0.0 109.965 179.934 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 816' ' ' ILE . . . . . 0.494 HG12 HG21 ' A' ' 833' ' ' VAL . 71.9 mt -111.05 101.15 12.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.121 -0.987 . . . . 0.0 110.28 -179.94 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 817' ' ' SER . . . . . 0.462 ' HB2' ' HD2' ' A' ' 818' ' ' PRO . 1.4 p -155.25 176.34 2.59 Favored Pre-proline 0 N--CA 1.494 1.774 0 O-C-N 121.395 -0.815 . . . . 0.0 110.179 179.955 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 818' ' ' PRO . . . . . 0.462 ' HD2' ' HB2' ' A' ' 817' ' ' SER . 48.4 Cg_endo -76.18 -59.95 0.04 OUTLIER 'Trans proline' 0 C--N 1.309 -1.548 0 O-C-N 123.998 1.525 . . . . 0.0 111.19 -179.888 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 819' ' ' SER . . . . . . . . . . . . . 36.8 t -58.55 -42.45 87.9 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.19 -0.944 . . . . 0.0 110.59 -179.968 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 820' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -47.19 -23.83 0.59 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.218 -0.926 . . . . 0.0 110.322 -179.954 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 821' ' ' PHE . . . . . 0.423 ' CD2' HG21 ' A' ' 801' ' ' VAL . 15.6 m-85 -107.07 -96.08 0.37 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.146 -0.971 . . . . 0.0 110.715 -179.928 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 822' ' ' GLY . . . . . . . . . . . . . . . -141.8 8.18 2.49 Favored Glycine 0 N--CA 1.491 2.339 0 C-N-CA 119.648 -1.263 . . . . 0.0 110.163 -179.971 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 823' ' ' GLY . . . . . . . . . . . . . . . 124.59 -123.08 4.97 Favored Glycine 0 N--CA 1.492 2.376 0 O-C-N 120.999 -1.295 . . . . 0.0 109.966 179.972 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 824' ' ' ASP . . . . . 0.421 ' HA ' ' HD3' ' A' ' 825' ' ' PRO . 69.8 m-20 -80.42 134.99 53.98 Favored Pre-proline 0 N--CA 1.496 1.826 0 O-C-N 121.286 -1.126 . . . . 0.0 110.476 -179.943 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 825' ' ' PRO . . . . . 0.421 ' HD3' ' HA ' ' A' ' 824' ' ' ASP . 50.6 Cg_endo -83.83 -64.05 0.02 OUTLIER 'Trans proline' 0 C--N 1.308 -1.586 0 O-C-N 123.963 1.507 . . . . 0.0 110.425 179.905 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 826' ' ' CYS . . . . . 0.454 ' HB3' ' HB ' ' A' ' 829' ' ' VAL . 0.7 OUTLIER -147.42 149.71 35.25 Favored Pre-proline 0 N--CA 1.494 1.76 0 O-C-N 121.325 -0.859 . . . . 0.0 110.319 179.96 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 827' ' ' PRO . . . . . 0.441 ' O ' ' HB2' ' A' ' 828' ' ' GLU . 46.8 Cg_endo -74.3 134.57 19.26 Favored 'Trans proline' 0 C--N 1.305 -1.713 0 O-C-N 123.977 1.514 . . . . 0.0 110.694 -179.961 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 828' ' ' GLU . . . . . 0.441 ' HB2' ' O ' ' A' ' 827' ' ' PRO . 64.8 mm-40 55.77 39.7 30.76 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.315 -0.866 . . . . 0.0 110.43 179.984 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 829' ' ' VAL . . . . . 0.454 ' HB ' ' HB3' ' A' ' 826' ' ' CYS . 18.1 t -142.48 136.61 28.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.177 -0.952 . . . . 0.0 110.373 179.987 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 830' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -63.26 -149.66 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.245 -0.909 . . . . 0.0 109.856 -179.993 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 831' ' ' LYS . . . . . 0.471 ' HG3' ' HG3' ' A' ' 737' ' ' GLU . 0.0 OUTLIER -145.34 94.92 2.58 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 120.962 -1.086 . . . . 0.0 110.834 179.962 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 832' ' ' ARG . . . . . 0.496 ' HB3' ' HD2' ' A' ' 781' ' ' PRO . 0.0 OUTLIER -109.56 166.75 10.65 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.305 -0.872 . . . . 0.0 109.408 179.911 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 833' ' ' VAL . . . . . 0.603 HG22 ' CD2' ' A' ' 778' ' ' PHE . 37.0 t -142.93 120.7 6.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 120.928 -1.108 . . . . 0.0 111.763 -179.914 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 834' ' ' ALA . . . . . . . . . . . . . . . -125.31 104.1 8.3 Favored 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 107.87 -1.159 . . . . 0.0 107.87 179.769 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 835' ' ' VAL . . . . . 0.439 ' O ' ' HB3' ' A' ' 733' ' ' ALA . 67.1 t -109.5 153.56 11.23 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.579 0 O-C-N 121.153 -0.967 . . . . 0.0 112.453 -179.674 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 836' ' ' GLU . . . . . 0.448 ' OE1' ' HB2' ' A' ' 774' ' ' LYS . 31.2 tt0 -135.11 122.41 21.69 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 107.185 -1.413 . . . . 0.0 107.185 179.694 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 837' ' ' ALA . . . . . . . . . . . . . . . -113.62 161.81 16.99 Favored 'General case' 0 N--CA 1.501 2.087 0 O-C-N 120.719 -1.238 . . . . 0.0 112.722 -179.669 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 838' ' ' VAL . . . . . 0.551 ' CG2' ' HG3' ' A' ' 774' ' ' LYS . 23.9 t -118.75 105.56 17.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 179.852 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 839' ' ' CYS . . . . . 0.439 ' O ' ' O ' ' A' ' 728' ' ' VAL . 0.0 OUTLIER -107.98 140.71 40.72 Favored 'General case' 0 C--N 1.3 -1.585 0 O-C-N 120.975 -1.078 . . . . 0.0 110.462 -179.867 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 840' ' ' SER . . . . . . . . . . . . . 71.2 p -163.76 177.7 8.45 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.474 -0.766 . . . . 0.0 110.047 179.962 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 841' ' ' THR . . . . . 0.455 ' O ' ' O ' ' A' ' 842' ' ' ALA . 11.6 p -87.58 108.0 18.86 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.101 -0.999 . . . . 0.0 110.199 -179.956 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 842' ' ' ALA . . . . . 0.455 ' O ' ' O ' ' A' ' 841' ' ' THR . . . 53.66 169.28 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.232 -0.917 . . . . 0.0 110.134 179.985 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 843' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.674 0 CA-C-O 117.978 -1.011 . . . . 0.0 110.283 179.976 . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' A' A ' 726' ' ' ARG . . . . . . . . . . . . . 35.8 mtm180 . . . . . 0 N--CA 1.492 1.662 0 CA-C-O 121.215 0.531 . . . . 0.0 110.224 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' A' A ' 727' ' ' THR . . . . . 0.569 HG22 ' OE1' ' A' ' 768' ' ' GLN . 7.0 m -75.2 88.15 2.48 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.224 -0.922 . . . . 0.0 110.099 179.988 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 728' ' ' VAL . . . . . 0.703 ' O ' HG13 ' A' ' 728' ' ' VAL . 9.5 p -121.68 61.58 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.223 -0.923 . . . . 0.0 110.403 180.0 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 729' ' ' SER . . . . . . . . . . . . . 36.2 t -63.88 159.45 19.68 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.146 -0.971 . . . . 0.0 110.068 -179.997 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 730' ' ' GLY . . . . . . . . . . . . . . . -113.95 155.67 16.16 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.494 -1.443 . . . . 0.0 109.494 -179.995 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 731' ' ' VAL . . . . . . . . . . . . . 73.4 t -119.73 158.91 21.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.142 -1.21 . . . . 0.0 110.086 -179.932 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 732' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -131.09 125.14 32.38 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.177 -0.952 . . . . 0.0 110.02 179.996 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 733' ' ' ALA . . . . . . . . . . . . . . . -115.25 109.57 18.16 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.236 -0.915 . . . . 0.0 110.377 179.973 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 734' ' ' ASP . . . . . 0.525 ' C ' HG23 ' A' ' 735' ' ' VAL . 5.0 t0 -118.11 108.93 15.8 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.19 -0.944 . . . . 0.0 110.159 -179.987 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 735' ' ' VAL . . . . . 0.525 HG23 ' C ' ' A' ' 734' ' ' ASP . 96.3 t -152.1 145.39 15.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.287 -0.883 . . . . 0.0 110.182 179.998 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 736' ' ' SER . . . . . . . . . . . . . 66.6 p -93.18 -161.99 0.89 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.175 -0.953 . . . . 0.0 110.386 179.898 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 737' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 -115.25 72.26 0.79 Allowed 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.292 -0.88 . . . . 0.0 110.26 179.955 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 738' ' ' TYR . . . . . . . . . . . . . 70.9 t80 -171.36 141.63 1.59 Allowed 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.275 -0.891 . . . . 0.0 110.122 179.99 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 739' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -92.97 118.91 68.02 Favored Pre-proline 0 N--CA 1.493 1.693 0 O-C-N 121.118 -0.989 . . . . 0.0 110.234 179.993 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 740' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -78.23 -17.9 12.97 Favored 'Trans proline' 0 C--N 1.308 -1.59 0 O-C-N 123.892 1.47 . . . . 0.0 111.103 -179.954 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 741' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -172.92 130.07 0.5 Allowed 'General case' 0 N--CA 1.497 1.92 0 O-C-N 120.863 -1.148 . . . . 0.0 110.95 -179.965 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 742' ' ' ILE . . . . . 0.429 ' O ' ' N ' ' A' ' 744' ' ' ASN . 1.8 pt -130.42 -16.57 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.013 0 O-C-N 121.335 -0.853 . . . . 0.0 110.45 179.963 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 743' ' ' LYS . . . . . 0.472 ' HG2' ' N ' ' A' ' 744' ' ' ASN . 0.9 OUTLIER 52.52 -92.13 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.035 -1.041 . . . . 0.0 110.346 -179.962 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 744' ' ' ASN . . . . . 0.472 ' N ' ' HG2' ' A' ' 743' ' ' LYS . 87.5 m-20 -133.23 119.11 19.41 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.25 -0.906 . . . . 0.0 110.114 -179.984 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 745' ' ' TRP . . . . . . . . . . . . . 7.8 m95 -56.79 150.81 15.43 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.213 -0.929 . . . . 0.0 110.405 179.971 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 746' ' ' GLN . . . . . . . . . . . . . 28.2 tp60 -127.87 85.75 2.39 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.263 -0.898 . . . . 0.0 110.045 179.937 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 747' ' ' ILE . . . . . . . . . . . . . 43.9 pt -136.07 -171.63 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.319 -0.863 . . . . 0.0 110.376 -179.972 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 748' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -83.8 -41.46 17.54 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.256 -0.903 . . . . 0.0 110.189 179.876 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 749' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -80.06 176.82 9.4 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.324 -0.86 . . . . 0.0 110.224 179.958 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 750' ' ' TYR . . . . . . . . . . . . . 28.1 m-85 -131.49 175.34 9.23 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.208 -0.932 . . . . 0.0 110.223 -179.97 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 751' ' ' GLY . . . . . . . . . . . . . . . 122.0 174.04 14.54 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.625 -1.39 . . . . 0.0 109.625 -179.991 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 752' ' ' GLU . . . . . . . . . . . . . 6.2 tt0 -122.24 115.92 29.95 Favored Pre-proline 0 N--CA 1.492 1.656 0 O-C-N 121.3 -1.117 . . . . 0.0 110.02 -179.998 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 753' ' ' PRO . . . . . 0.474 ' HB2' ' CD1' ' A' ' 755' ' ' PHE . 46.7 Cg_endo -73.5 159.56 46.07 Favored 'Trans proline' 0 C--N 1.308 -1.567 0 O-C-N 123.955 1.502 . . . . 0.0 110.525 -179.928 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 754' ' ' GLU . . . . . . . . . . . . . 7.2 mt-10 -119.46 29.69 7.49 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.276 -0.89 . . . . 0.0 110.289 179.992 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 755' ' ' PHE . . . . . 0.474 ' CD1' ' HB2' ' A' ' 753' ' ' PRO . 18.8 p90 -128.43 136.68 51.2 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.189 -0.944 . . . . 0.0 110.48 -179.984 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 756' ' ' HIS . . . . . 0.495 ' C ' HG23 ' A' ' 757' ' ' THR . 70.7 m80 -112.73 130.33 56.1 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.296 -0.878 . . . . 0.0 109.826 179.938 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 757' ' ' THR . . . . . 0.495 HG23 ' C ' ' A' ' 756' ' ' HIS . 29.4 p -153.13 -170.39 3.61 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.199 -0.938 . . . . 0.0 110.38 -179.957 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 758' ' ' ALA . . . . . . . . . . . . . . . -140.85 166.14 25.59 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.393 -0.817 . . . . 0.0 109.758 -179.987 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 759' ' ' LYS . . . . . . . . . . . . . 8.2 mttt -113.38 166.31 11.61 Favored 'General case' 0 C--N 1.299 -1.618 0 O-C-N 121.232 -0.918 . . . . 0.0 110.3 179.993 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 760' ' ' VAL . . . . . 0.666 ' O ' HG13 ' A' ' 813' ' ' VAL . 80.3 t -105.56 150.11 8.51 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.463 0 O-C-N 121.311 -0.868 . . . . 0.0 108.873 179.91 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 761' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -125.73 103.95 8.09 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 120.916 -1.115 . . . . 0.0 111.607 -179.812 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 762' ' ' LEU . . . . . 0.501 HD23 ' HA ' ' A' ' 762' ' ' LEU . 17.8 mt -118.04 100.46 7.56 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 179.829 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 763' ' ' LYS . . . . . 0.418 ' HG2' ' HB2' ' A' ' 811' ' ' ARG . 0.0 OUTLIER -124.12 139.88 53.51 Favored 'General case' 0 C--N 1.3 -1.562 0 O-C-N 121.085 -1.009 . . . . 0.0 111.298 -179.829 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 764' ' ' CYS . . . . . 0.437 ' O ' ' C ' ' A' ' 765' ' ' ALA . 3.0 t -125.76 145.12 50.34 Favored 'General case' 0 C--N 1.299 -1.603 0 O-C-N 121.623 -0.673 . . . . 0.0 109.409 179.881 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 765' ' ' ALA . . . . . 0.437 ' C ' ' O ' ' A' ' 764' ' ' CYS . . . -41.1 161.78 0.12 Allowed Pre-proline 0 N--CA 1.495 1.782 0 O-C-N 121.164 -0.96 . . . . 0.0 110.494 179.983 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 766' ' ' PRO . . . . . 0.428 ' HD2' ' HB1' ' A' ' 765' ' ' ALA . 43.9 Cg_endo -70.55 102.47 1.16 Allowed 'Trans proline' 0 C--N 1.305 -1.726 0 O-C-N 123.94 1.495 . . . . 0.0 110.28 -179.963 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 767' ' ' GLY . . . . . . . . . . . . . . . 133.18 -21.71 4.08 Favored Glycine 0 N--CA 1.488 2.102 0 N-CA-C 109.025 -1.63 . . . . 0.0 109.025 -179.978 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 768' ' ' GLN . . . . . 0.569 ' OE1' HG22 ' A' ' 727' ' ' THR . 22.6 mt-30 -101.64 131.8 47.67 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.48 -1.012 . . . . 0.0 110.076 -179.999 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 769' ' ' THR . . . . . . . . . . . . . 16.9 p -125.57 147.37 49.31 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.113 -0.992 . . . . 0.0 110.232 179.965 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 770' ' ' ILE . . . . . 0.461 HG22 ' N ' ' A' ' 771' ' ' SER . 22.4 mt -59.92 166.88 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.205 -0.934 . . . . 0.0 109.639 179.964 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 771' ' ' SER . . . . . 0.461 ' N ' HG22 ' A' ' 770' ' ' ILE . 0.1 OUTLIER -160.33 -30.92 0.06 Allowed 'General case' 0 C--N 1.299 -1.621 0 O-C-N 121.094 -1.004 . . . . 0.0 111.152 -179.948 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 772' ' ' ALA . . . . . . . . . . . . . . . -135.78 122.67 21.25 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.852 -1.155 . . . . 0.0 111.402 -179.858 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 773' ' ' ILE . . . . . . . . . . . . . 38.2 mm -95.74 100.95 11.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.448 -0.783 . . . . 0.0 109.021 179.918 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 774' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.94 -37.89 28.71 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.163 -0.961 . . . . 0.0 111.284 -179.928 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 775' ' ' PHE . . . . . 0.724 ' O ' ' HB2' ' A' ' 776' ' ' ALA . 44.1 t80 -122.65 160.66 25.34 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 120.957 -1.089 . . . . 0.0 111.305 -179.843 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 776' ' ' ALA . . . . . 0.724 ' HB2' ' O ' ' A' ' 775' ' ' PHE . . . 166.28 100.64 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.607 -0.683 . . . . 0.0 109.616 179.989 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 777' ' ' SER . . . . . 0.49 ' HA ' ' HB3' ' A' ' 798' ' ' SER . 1.6 p -136.08 142.03 44.28 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.347 -0.846 . . . . 0.0 110.369 -179.909 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 778' ' ' PHE . . . . . 0.496 ' O ' ' CD2' ' A' ' 778' ' ' PHE . 68.8 t80 -120.87 73.74 1.03 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.44 -0.787 . . . . 0.0 110.298 -179.996 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 779' ' ' GLY . . . . . . . . . . . . . . . -161.57 -108.01 0.22 Allowed Glycine 0 N--CA 1.492 2.39 0 N-CA-C 109.544 -1.422 . . . . 0.0 109.544 -179.983 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 780' ' ' THR . . . . . . . . . . . . . 81.8 p -121.07 81.97 36.54 Favored Pre-proline 0 N--CA 1.489 1.506 0 O-C-N 121.187 -1.184 . . . . 0.0 110.161 -179.982 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 781' ' ' PRO . . . . . 0.476 ' CG ' ' HB3' ' A' ' 832' ' ' ARG . 47.5 Cg_endo -75.7 166.8 27.65 Favored 'Trans proline' 0 C--N 1.305 -1.733 0 O-C-N 124.103 1.581 . . . . 0.0 110.36 -179.974 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 782' ' ' LEU . . . . . . . . . . . . . 6.7 mt -140.74 131.81 26.27 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.252 -0.905 . . . . 0.0 110.134 179.999 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 783' ' ' GLY . . . . . . . . . . . . . . . 114.93 -165.86 12.11 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.638 -1.385 . . . . 0.0 109.638 -179.948 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 784' ' ' THR . . . . . 0.4 ' HA ' ' OD2' ' A' ' 734' ' ' ASP . 12.3 p -135.78 -50.1 0.71 Allowed 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.292 -1.123 . . . . 0.0 110.114 179.941 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 785' ' ' CYS . . . . . . . . . . . . . 22.5 t -173.26 87.84 0.07 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.291 -0.881 . . . . 0.0 109.854 -180.0 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 786' ' ' GLY . . . . . . . . . . . . . . . 142.34 -26.74 2.28 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 108.902 -1.679 . . . . 0.0 108.902 -179.897 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 787' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -127.17 30.19 5.46 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.487 -1.008 . . . . 0.0 109.82 179.989 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 788' ' ' PHE . . . . . 0.691 ' CE2' ' HB1' ' A' ' 834' ' ' ALA . 2.2 m-85 -51.93 121.08 6.07 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.307 -0.871 . . . . 0.0 110.245 179.993 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 789' ' ' GLN . . . . . . . . . . . . . 13.2 tt0 -133.74 120.76 20.97 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.302 -0.874 . . . . 0.0 110.274 -179.978 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 790' ' ' GLN . . . . . 0.468 ' CG ' ' O ' ' A' ' 790' ' ' GLN . 9.3 pt20 -64.96 126.21 27.31 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.251 -0.906 . . . . 0.0 110.549 -179.949 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 791' ' ' GLY . . . . . . . . . . . . . . . -69.43 -122.47 0.03 OUTLIER Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.311 -1.516 . . . . 0.0 109.311 179.948 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 792' ' ' GLU . . . . . . . . . . . . . 11.9 mt-10 -126.26 8.72 7.24 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.149 -1.207 . . . . 0.0 110.279 179.963 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 793' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -129.46 96.36 4.26 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.239 -0.913 . . . . 0.0 109.771 179.874 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 794' ' ' HIS . . . . . 0.589 ' CD2' ' O ' ' A' ' 795' ' ' SER . 77.6 t60 -124.78 139.62 53.68 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.179 -0.95 . . . . 0.0 110.488 -179.934 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 795' ' ' SER . . . . . 0.589 ' O ' ' CD2' ' A' ' 794' ' ' HIS . 4.1 t -82.75 168.87 16.78 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.318 -0.864 . . . . 0.0 109.078 179.99 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 796' ' ' ILE . . . . . . . . . . . . . 1.7 mt -94.97 -7.88 9.79 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 O-C-N 120.857 -1.152 . . . . 0.0 110.095 -179.971 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 797' ' ' ASN . . . . . . . . . . . . . 4.8 m120 -107.38 38.65 2.08 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.288 -0.883 . . . . 0.0 109.387 179.877 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 798' ' ' SER . . . . . 0.552 ' OG ' ' CE1' ' A' ' 794' ' ' HIS . 70.6 m -82.08 -52.54 6.91 Favored 'General case' 0 N--CA 1.485 1.317 0 O-C-N 121.51 -0.743 . . . . 0.0 111.184 -179.983 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 799' ' ' ASN . . . . . . . . . . . . . 47.2 t-20 -98.37 12.04 36.17 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.074 -1.017 . . . . 0.0 111.134 -179.923 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 800' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -89.29 -45.06 9.8 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.075 -1.015 . . . . 0.0 110.355 179.959 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 801' ' ' VAL . . . . . . . . . . . . . 8.7 t -74.96 -19.32 16.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.171 -0.956 . . . . 0.0 110.342 -179.974 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 802' ' ' LEU . . . . . 0.471 HD22 ' HA ' ' A' ' 802' ' ' LEU . 0.3 OUTLIER -74.2 -57.23 4.09 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.284 -0.885 . . . . 0.0 110.721 179.976 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 803' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -63.43 -18.33 63.61 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.213 -0.929 . . . . 0.0 110.543 -179.935 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 804' ' ' ARG . . . . . . . . . . . . . 3.2 mtm-85 -92.41 -16.74 25.52 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.237 -0.914 . . . . 0.0 112.066 -179.805 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 805' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.59 39.28 1.69 Allowed 'General case' 0 N--CA 1.502 2.143 0 O-C-N 120.466 -1.396 . . . . 0.0 112.594 -179.809 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 806' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -164.39 22.95 0.06 Allowed 'General case' 0 N--CA 1.501 2.112 0 O-C-N 120.58 -1.325 . . . . 0.0 111.024 179.921 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 807' ' ' ILE . . . . . . . . . . . . . 4.4 mt -125.32 119.33 55.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.093 -1.004 . . . . 0.0 109.939 179.914 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 808' ' ' GLY . . . . . . . . . . . . . . . 110.93 7.91 24.69 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.059 -1.616 . . . . 0.0 109.059 -179.889 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 809' ' ' LEU . . . . . . . . . . . . . 29.7 mt -123.65 138.34 54.55 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.287 -1.125 . . . . 0.0 109.876 179.968 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 810' ' ' GLU . . . . . . . . . . . . . 15.0 mp0 -63.04 -22.36 66.8 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.067 -1.021 . . . . 0.0 109.329 -179.992 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 811' ' ' ARG . . . . . 0.418 ' HB2' ' HG2' ' A' ' 763' ' ' LYS . 0.0 OUTLIER -154.56 122.88 6.03 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.519 -0.738 . . . . 0.0 109.881 179.94 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 812' ' ' CYS . . . . . 0.472 ' O ' ' HB2' ' A' ' 762' ' ' LEU . 6.0 p -129.47 139.07 51.71 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.126 -0.984 . . . . 0.0 110.241 -179.94 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 813' ' ' VAL . . . . . 0.666 HG13 ' O ' ' A' ' 760' ' ' VAL . 53.4 t -121.79 139.79 47.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.204 -0.935 . . . . 0.0 110.308 -179.952 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 814' ' ' VAL . . . . . . . . . . . . . 58.0 t -124.71 134.52 66.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.253 -0.905 . . . . 0.0 110.279 179.989 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 815' ' ' ALA . . . . . . . . . . . . . . . -82.32 149.56 27.7 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.288 -0.883 . . . . 0.0 109.927 -179.99 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 816' ' ' ILE . . . . . 0.548 ' CG2' HG21 ' A' ' 833' ' ' VAL . 22.0 mt -109.96 125.04 67.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.172 -0.955 . . . . 0.0 110.285 179.954 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 817' ' ' SER . . . . . 0.454 ' HB2' ' HD2' ' A' ' 818' ' ' PRO . 2.9 p -172.96 170.74 2.0 Favored Pre-proline 0 N--CA 1.492 1.659 0 O-C-N 121.148 -0.97 . . . . 0.0 110.314 179.993 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 818' ' ' PRO . . . . . 0.46 ' O ' ' HB3' ' A' ' 819' ' ' SER . 47.6 Cg_endo -74.84 158.39 42.82 Favored 'Trans proline' 0 C--N 1.305 -1.737 0 O-C-N 124.144 1.602 . . . . 0.0 110.743 -179.875 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 819' ' ' SER . . . . . 0.46 ' HB3' ' O ' ' A' ' 818' ' ' PRO . 7.5 t 63.01 9.85 4.05 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.361 -0.837 . . . . 0.0 110.842 179.983 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 820' ' ' ASN . . . . . . . . . . . . . 2.4 t30 -96.72 -44.18 7.21 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.097 -1.002 . . . . 0.0 110.208 179.988 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 821' ' ' PHE . . . . . . . . . . . . . 4.0 m-85 -89.94 -45.31 9.3 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.19 -0.944 . . . . 0.0 110.184 179.985 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 822' ' ' GLY . . . . . . . . . . . . . . . -167.43 -35.98 0.02 OUTLIER Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.61 -1.396 . . . . 0.0 109.61 -179.966 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 823' ' ' GLY . . . . . . . . . . . . . . . 159.82 -119.21 0.87 Allowed Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.648 -1.381 . . . . 0.0 109.648 -179.96 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 824' ' ' ASP . . . . . 0.463 ' OD1' ' O ' ' A' ' 824' ' ' ASP . 43.8 p-10 -148.19 101.76 3.58 Favored Pre-proline 0 N--CA 1.498 1.938 0 O-C-N 121.308 -1.113 . . . . 0.0 109.952 -179.997 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 825' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_endo -83.74 -53.22 0.03 OUTLIER 'Trans proline' 0 C--N 1.307 -1.631 0 O-C-N 123.907 1.477 . . . . 0.0 111.037 -179.968 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 826' ' ' CYS . . . . . 0.65 ' SG ' HG21 ' A' ' 829' ' ' VAL . 0.1 OUTLIER -77.56 129.1 78.09 Favored Pre-proline 0 N--CA 1.497 1.885 0 O-C-N 121.077 -1.014 . . . . 0.0 110.737 -179.876 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 827' ' ' PRO . . . . . 0.863 ' O ' HG23 ' A' ' 829' ' ' VAL . 51.2 Cg_endo -87.86 135.07 3.32 Favored 'Trans proline' 0 C--N 1.31 -1.461 0 O-C-N 123.911 1.479 . . . . 0.0 111.086 -179.97 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 828' ' ' GLU . . . . . 0.421 ' C ' ' O ' ' A' ' 827' ' ' PRO . 0.3 OUTLIER 39.29 47.57 1.48 Allowed 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.428 -0.795 . . . . 0.0 110.937 179.863 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 829' ' ' VAL . . . . . 0.863 HG23 ' O ' ' A' ' 827' ' ' PRO . 56.1 t -123.06 132.03 72.16 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.925 0 O-C-N 121.13 -0.981 . . . . 0.0 110.56 179.929 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 830' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -53.63 108.51 0.35 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.246 -0.909 . . . . 0.0 109.743 179.981 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 831' ' ' LYS . . . . . . . . . . . . . 5.0 mmtp -79.72 143.6 34.4 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.161 -0.962 . . . . 0.0 110.314 -179.944 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 832' ' ' ARG . . . . . 0.476 ' HB3' ' CG ' ' A' ' 781' ' ' PRO . 2.7 ttm180 -146.24 161.19 40.81 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.378 -0.826 . . . . 0.0 109.638 -179.979 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 833' ' ' VAL . . . . . 0.548 HG21 ' CG2' ' A' ' 816' ' ' ILE . 59.7 t -124.64 109.21 21.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.125 -0.984 . . . . 0.0 110.89 -179.967 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 834' ' ' ALA . . . . . 0.691 ' HB1' ' CE2' ' A' ' 788' ' ' PHE . . . -111.35 129.87 55.86 Favored 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 179.831 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 835' ' ' VAL . . . . . 0.412 HG12 ' N ' ' A' ' 836' ' ' GLU . 68.3 t -140.35 160.2 25.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 120.817 -1.177 . . . . 0.0 111.718 -179.888 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 836' ' ' GLU . . . . . 0.456 ' HB2' ' HB3' ' A' ' 775' ' ' PHE . 0.2 OUTLIER -151.92 103.9 2.95 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 179.851 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 837' ' ' ALA . . . . . . . . . . . . . . . -111.23 164.07 13.27 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.008 -1.058 . . . . 0.0 111.798 -179.851 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 838' ' ' VAL . . . . . . . . . . . . . 93.4 t -112.6 131.3 64.51 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.327 0 N-CA-C 109.427 -0.582 . . . . 0.0 109.427 179.882 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 839' ' ' CYS . . . . . 0.496 ' O ' ' HA ' ' A' ' 728' ' ' VAL . 2.0 t -108.76 120.26 41.97 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.002 -1.061 . . . . 0.0 110.571 -179.965 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 840' ' ' SER . . . . . . . . . . . . . 10.1 t -123.97 159.12 30.47 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.418 -0.802 . . . . 0.0 110.065 179.977 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 841' ' ' THR . . . . . 0.533 ' CG2' ' HG2' ' A' ' 768' ' ' GLN . 22.2 p -90.13 156.49 18.31 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.154 -0.967 . . . . 0.0 110.295 179.99 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 842' ' ' ALA . . . . . 0.433 ' O ' ' C ' ' A' ' 843' ' ' ALA . . . -53.17 175.22 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.296 -0.877 . . . . 0.0 110.229 -179.993 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 843' ' ' ALA . . . . . 0.433 ' C ' ' O ' ' A' ' 842' ' ' ALA . . . . . . . . 0 N--CA 1.492 1.658 0 CA-C-O 118.067 -0.968 . . . . 0.0 110.338 179.95 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 726' ' ' ARG . . . . . 0.429 ' O ' ' C ' ' A' ' 727' ' ' THR . 13.5 ptt180 . . . . . 0 N--CA 1.493 1.721 0 CA-C-O 121.117 0.484 . . . . 0.0 110.328 . . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 727' ' ' THR . . . . . 0.429 ' C ' ' O ' ' A' ' 726' ' ' ARG . 32.6 p 42.05 58.62 2.85 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.373 -0.829 . . . . 0.0 110.286 179.931 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 728' ' ' VAL . . . . . 0.663 ' O ' HG13 ' A' ' 728' ' ' VAL . 7.7 p -163.05 103.22 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.298 -1.666 0 O-C-N 121.461 -0.774 . . . . 0.0 110.253 -179.961 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 729' ' ' SER . . . . . . . . . . . . . 1.9 t -66.93 166.67 13.07 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.179 -0.951 . . . . 0.0 109.981 179.98 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 730' ' ' GLY . . . . . 0.465 ' C ' HG13 ' A' ' 731' ' ' VAL . . . -144.32 132.38 4.79 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.114 -1.594 . . . . 0.0 109.114 179.939 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 731' ' ' VAL . . . . . 0.523 ' O ' HG23 ' A' ' 731' ' ' VAL . 21.0 m -150.9 117.49 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.425 0 O-C-N 121.018 -1.284 . . . . 0.0 110.845 -179.935 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 732' ' ' CYS . . . . . 0.425 ' O ' ' SG ' ' A' ' 732' ' ' CYS . 15.5 p -109.22 133.85 52.51 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.31 -0.869 . . . . 0.0 109.322 179.841 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 733' ' ' ALA . . . . . . . . . . . . . . . -109.24 123.44 49.27 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.091 -1.006 . . . . 0.0 110.669 -179.862 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 734' ' ' ASP . . . . . . . . . . . . . 12.2 t0 -111.71 114.47 27.51 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.378 -0.826 . . . . 0.0 110.124 179.941 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 735' ' ' VAL . . . . . . . . . . . . . 16.6 t -122.99 155.34 28.6 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.222 -0.924 . . . . 0.0 110.338 -179.993 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 736' ' ' SER . . . . . 0.433 ' O ' ' C ' ' A' ' 737' ' ' GLU . 0.1 OUTLIER -106.15 105.5 15.56 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.263 -0.898 . . . . 0.0 109.807 -179.98 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 737' ' ' GLU . . . . . 0.542 ' CB ' ' HA ' ' A' ' 831' ' ' LYS . 0.0 OUTLIER -39.05 138.92 0.52 Allowed 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.457 -0.777 . . . . 0.0 110.851 -179.963 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 738' ' ' TYR . . . . . 0.48 ' CD1' ' HD3' ' A' ' 740' ' ' PRO . 14.9 t80 -98.81 -115.64 0.15 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.44 -0.787 . . . . 0.0 109.62 179.954 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 739' ' ' HIS . . . . . 0.459 ' C ' ' O ' ' A' ' 738' ' ' TYR . 0.5 OUTLIER 37.85 54.23 3.72 Favored Pre-proline 0 N--CA 1.498 1.945 0 O-C-N 121.129 -0.982 . . . . 0.0 110.921 -179.994 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 740' ' ' PRO . . . . . 0.48 ' HD3' ' CD1' ' A' ' 738' ' ' TYR . 42.9 Cg_endo -70.8 -19.84 30.67 Favored 'Trans proline' 0 C--N 1.306 -1.675 0 O-C-N 123.858 1.452 . . . . 0.0 109.41 179.904 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 741' ' ' ASN . . . . . 0.481 ' O ' ' O ' ' A' ' 742' ' ' ILE . 10.1 m-20 -164.06 -73.69 0.04 OUTLIER 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 109.176 -0.675 . . . . 0.0 109.176 179.877 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 742' ' ' ILE . . . . . 0.481 ' O ' ' O ' ' A' ' 741' ' ' ASN . 31.9 mm 50.08 109.9 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 O-C-N 121.541 -0.724 . . . . 0.0 111.221 179.897 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 743' ' ' LYS . . . . . 0.448 ' HD3' ' O ' ' A' ' 742' ' ' ILE . 0.0 OUTLIER -176.51 -36.71 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.221 -0.925 . . . . 0.0 109.672 179.993 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 744' ' ' ASN . . . . . 0.433 ' O ' ' C ' ' A' ' 745' ' ' TRP . 55.7 t30 -117.78 26.27 9.8 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.513 -0.742 . . . . 0.0 109.487 179.896 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 745' ' ' TRP . . . . . 0.622 ' CD1' ' N ' ' A' ' 746' ' ' GLN . 44.1 p90 -40.45 -45.51 2.24 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.621 -0.675 . . . . 0.0 110.277 -179.932 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 746' ' ' GLN . . . . . 0.622 ' N ' ' CD1' ' A' ' 745' ' ' TRP . 27.8 pt20 -95.82 120.75 36.63 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.102 -0.999 . . . . 0.0 109.273 179.863 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 747' ' ' ILE . . . . . 0.731 HG21 ' OH ' ' A' ' 750' ' ' TYR . 13.1 mt -86.1 75.75 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.614 0 O-C-N 121.214 -0.929 . . . . 0.0 110.642 -179.914 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 748' ' ' GLU . . . . . 0.566 ' CB ' ' O ' ' A' ' 747' ' ' ILE . 1.1 tt0 79.91 -47.01 0.33 Allowed 'General case' 0 N--CA 1.505 2.29 0 O-C-N 121.908 -0.495 . . . . 0.0 111.97 179.879 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 749' ' ' SER . . . . . . . . . . . . . 73.6 m -152.56 -22.98 0.17 Allowed 'General case' 0 N--CA 1.5 2.03 0 O-C-N 120.431 -1.418 . . . . 0.0 112.747 -179.919 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 750' ' ' TYR . . . . . 0.731 ' OH ' HG21 ' A' ' 747' ' ' ILE . 45.8 p90 -110.58 134.89 52.0 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 120.367 -1.458 . . . . 0.0 111.471 -179.898 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 751' ' ' GLY . . . . . . . . . . . . . . . 152.65 104.38 0.26 Allowed Glycine 0 N--CA 1.495 2.624 0 N-CA-C 108.84 -1.704 . . . . 0.0 108.84 -179.948 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 752' ' ' GLU . . . . . 0.456 ' O ' ' HG2' ' A' ' 752' ' ' GLU . 45.1 tt0 -123.44 77.25 54.28 Favored Pre-proline 0 N--CA 1.498 1.971 0 O-C-N 121.084 -1.245 . . . . 0.0 111.147 -179.909 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 753' ' ' PRO . . . . . 0.561 ' HG3' ' HB2' ' A' ' 745' ' ' TRP . 49.2 Cg_endo -89.94 122.53 1.06 Allowed 'Trans proline' 0 C--N 1.302 -1.879 0 O-C-N 123.813 1.428 . . . . 0.0 110.307 179.972 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 754' ' ' GLU . . . . . . . . . . . . . 6.1 tt0 -95.67 5.84 50.43 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.189 -0.944 . . . . 0.0 110.074 179.969 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 755' ' ' PHE . . . . . . . . . . . . . 11.4 t80 -118.12 109.53 16.53 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.355 -0.841 . . . . 0.0 109.92 179.956 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 756' ' ' HIS . . . . . . . . . . . . . 29.8 m170 -118.07 -13.71 9.97 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.189 -0.944 . . . . 0.0 110.423 -179.977 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 757' ' ' THR . . . . . . . . . . . . . 3.7 p -150.11 161.55 42.15 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.181 -0.95 . . . . 0.0 110.391 -179.989 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 758' ' ' ALA . . . . . . . . . . . . . . . -87.62 169.92 11.73 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.329 -0.857 . . . . 0.0 109.979 179.981 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 759' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.46 155.69 47.42 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.1 -1.0 . . . . 0.0 110.584 -179.983 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 760' ' ' VAL . . . . . 0.816 HG23 HD11 ' A' ' 816' ' ' ILE . 47.3 t -109.54 139.14 33.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.42 -0.8 . . . . 0.0 109.523 179.939 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 761' ' ' HIS . . . . . . . . . . . . . 1.7 m170 -114.3 111.27 21.23 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.142 -0.973 . . . . 0.0 111.083 -179.978 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 762' ' ' LEU . . . . . 0.451 HD22 ' HB2' ' A' ' 837' ' ' ALA . 1.8 mt -129.6 117.45 20.42 Favored 'General case' 0 N--CA 1.493 1.69 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 -179.99 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 763' ' ' LYS . . . . . 0.428 ' N ' ' CD ' ' A' ' 763' ' ' LYS . 0.0 OUTLIER -142.56 166.44 24.65 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.009 -1.057 . . . . 0.0 111.324 -179.912 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 764' ' ' CYS . . . . . 0.407 ' O ' ' C ' ' A' ' 765' ' ' ALA . 1.4 m -141.37 140.74 33.77 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.677 -0.639 . . . . 0.0 109.458 179.943 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 765' ' ' ALA . . . . . 0.407 ' C ' ' O ' ' A' ' 764' ' ' CYS . . . -44.49 160.98 0.23 Allowed Pre-proline 0 N--CA 1.495 1.806 0 O-C-N 121.109 -0.994 . . . . 0.0 110.341 -179.986 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 766' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -71.34 103.39 1.4 Allowed 'Trans proline' 0 C--N 1.309 -1.5 0 O-C-N 124.004 1.528 . . . . 0.0 110.079 180.0 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 767' ' ' GLY . . . . . . . . . . . . . . . 143.61 -29.21 2.01 Favored Glycine 0 N--CA 1.488 2.118 0 N-CA-C 108.864 -1.694 . . . . 0.0 108.864 179.971 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 768' ' ' GLN . . . . . 0.503 ' OE1' HG23 ' A' ' 841' ' ' THR . 1.5 mt-30 -113.59 115.26 27.65 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.311 -1.111 . . . . 0.0 109.599 179.975 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 769' ' ' THR . . . . . . . . . . . . . 67.2 p -99.75 145.94 27.11 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.187 -0.946 . . . . 0.0 110.576 -179.937 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 770' ' ' ILE . . . . . . . . . . . . . 35.8 mt -60.6 113.45 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 O-C-N 121.32 -0.863 . . . . 0.0 109.197 179.983 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 771' ' ' SER . . . . . 0.518 ' O ' ' HB2' ' A' ' 772' ' ' ALA . 39.2 t -91.61 -7.58 49.69 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.231 -0.918 . . . . 0.0 111.485 -179.835 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 772' ' ' ALA . . . . . 0.518 ' HB2' ' O ' ' A' ' 771' ' ' SER . . . 179.75 146.14 0.21 Allowed 'General case' 0 N--CA 1.496 1.839 0 O-C-N 120.765 -1.209 . . . . 0.0 111.475 -179.924 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 773' ' ' ILE . . . . . 0.522 HD11 ' HB3' ' A' ' 806' ' ' CYS . 31.9 mm -87.93 135.4 25.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.495 -0.753 . . . . 0.0 109.135 179.892 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 774' ' ' LYS . . . . . 0.573 ' HB3' ' CB ' ' A' ' 836' ' ' GLU . 0.4 OUTLIER -78.14 -35.53 48.88 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.119 -0.988 . . . . 0.0 110.768 -179.897 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 775' ' ' PHE . . . . . 0.521 ' CZ ' ' HB3' ' A' ' 777' ' ' SER . 44.9 t80 176.16 150.86 0.14 Allowed 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.173 -0.955 . . . . 0.0 110.897 -179.988 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 776' ' ' ALA . . . . . 0.472 ' O ' ' HB3' ' A' ' 798' ' ' SER . . . -143.65 145.78 32.73 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.472 -0.767 . . . . 0.0 108.959 179.872 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 777' ' ' SER . . . . . 0.55 ' HA ' ' OG ' ' A' ' 798' ' ' SER . 67.6 p -154.09 119.03 4.99 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.877 -1.14 . . . . 0.0 111.575 -179.949 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 778' ' ' PHE . . . . . 0.48 ' CZ ' ' HG2' ' A' ' 830' ' ' MET . 40.8 t80 -105.39 120.15 40.87 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.466 -0.771 . . . . 0.0 109.496 179.918 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 779' ' ' GLY . . . . . 0.577 ' HA2' ' HA ' ' A' ' 830' ' ' MET . . . 133.49 -100.0 0.38 Allowed Glycine 0 N--CA 1.487 2.075 0 C-N-CA 119.604 -1.284 . . . . 0.0 109.912 179.991 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 780' ' ' THR . . . . . . . . . . . . . 43.5 p -136.62 93.92 13.75 Favored Pre-proline 0 N--CA 1.495 1.781 0 O-C-N 121.133 -1.216 . . . . 0.0 110.593 -179.924 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 781' ' ' PRO . . . . . 0.511 ' CD ' ' HB3' ' A' ' 832' ' ' ARG . 51.6 Cg_endo -81.77 157.91 18.63 Favored 'Trans proline' 0 C--N 1.307 -1.643 0 O-C-N 124.004 1.528 . . . . 0.0 110.605 179.921 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 782' ' ' LEU . . . . . 0.477 HD12 ' HA2' ' A' ' 791' ' ' GLY . 0.8 OUTLIER -112.78 133.89 54.56 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.278 -0.889 . . . . 0.0 110.081 179.989 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 783' ' ' GLY . . . . . . . . . . . . . . . 84.03 -170.37 47.34 Favored Glycine 0 N--CA 1.493 2.487 0 N-CA-C 109.784 -1.326 . . . . 0.0 109.784 179.987 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 784' ' ' THR . . . . . 0.435 ' O ' ' CE1' ' A' ' 788' ' ' PHE . 44.0 p -127.68 -141.82 0.27 Allowed 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.264 -1.139 . . . . 0.0 110.529 -179.99 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 785' ' ' CYS . . . . . . . . . . . . . 38.4 m -78.52 100.56 6.95 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.278 -0.889 . . . . 0.0 110.379 -179.942 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 786' ' ' GLY . . . . . . . . . . . . . . . 140.46 -13.52 2.98 Favored Glycine 0 N--CA 1.493 2.452 0 N-CA-C 110.012 -1.235 . . . . 0.0 110.012 -179.988 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 787' ' ' THR . . . . . . . . . . . . . 9.0 t -159.52 36.62 0.19 Allowed 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.036 -1.273 . . . . 0.0 110.809 -179.978 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 788' ' ' PHE . . . . . 0.459 ' O ' ' HB2' ' A' ' 789' ' ' GLN . 14.4 m-85 -61.29 158.66 13.8 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.07 -1.019 . . . . 0.0 109.909 179.972 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 789' ' ' GLN . . . . . 0.459 ' HB2' ' O ' ' A' ' 788' ' ' PHE . 24.4 tt0 179.25 157.46 0.56 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.175 -0.953 . . . . 0.0 110.218 -179.994 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 790' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -52.17 137.81 27.26 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.252 -0.905 . . . . 0.0 110.362 -179.999 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 791' ' ' GLY . . . . . 0.477 ' HA2' HD12 ' A' ' 782' ' ' LEU . . . -111.75 -107.9 2.97 Favored Glycine 0 N--CA 1.493 2.466 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 -179.986 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 792' ' ' GLU . . . . . . . . . . . . . 39.1 tp10 -90.49 -53.02 4.61 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.194 -1.18 . . . . 0.0 110.277 179.944 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 793' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -136.08 117.69 14.91 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.263 -0.898 . . . . 0.0 110.081 179.983 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 794' ' ' HIS . . . . . . . . . . . . . 40.5 t60 -120.2 150.51 40.54 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.252 -0.905 . . . . 0.0 110.381 -179.975 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 795' ' ' SER . . . . . 0.489 ' OG ' ' HG3' ' A' ' 825' ' ' PRO . 2.6 m -94.94 117.44 30.15 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.425 -0.797 . . . . 0.0 109.483 179.896 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 796' ' ' ILE . . . . . . . . . . . . . 6.7 mt -58.3 -13.57 3.08 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.875 0 O-C-N 121.158 -0.964 . . . . 0.0 110.775 -179.947 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 797' ' ' ASN . . . . . 0.405 ' O ' ' OG ' ' A' ' 800' ' ' SER . 3.6 m-20 -89.96 21.48 3.63 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.062 -1.024 . . . . 0.0 110.414 179.906 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 798' ' ' SER . . . . . 0.55 ' OG ' ' HA ' ' A' ' 777' ' ' SER . 0.5 OUTLIER -70.0 -33.72 72.4 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.176 -0.953 . . . . 0.0 110.806 -179.995 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 799' ' ' ASN . . . . . . . . . . . . . 7.5 m-20 -97.94 6.21 47.99 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.26 -0.9 . . . . 0.0 111.024 -179.856 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 800' ' ' SER . . . . . 0.405 ' OG ' ' O ' ' A' ' 797' ' ' ASN . 6.1 p -90.69 -29.41 17.72 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.97 -1.081 . . . . 0.0 110.396 -179.979 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 801' ' ' VAL . . . . . . . . . . . . . 15.6 t -88.03 -19.66 7.69 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.293 -0.879 . . . . 0.0 110.588 179.957 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 802' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -90.64 -48.44 7.06 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.107 -0.996 . . . . 0.0 110.572 -179.896 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 803' ' ' GLU . . . . . . . . . . . . . 20.8 mt-10 -58.61 -26.78 64.05 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.185 -0.947 . . . . 0.0 110.987 -179.895 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 804' ' ' ARG . . . . . . . . . . . . . 16.7 ttt-85 -86.63 -28.3 23.29 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 120.988 -1.07 . . . . 0.0 110.849 -179.892 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 805' ' ' LYS . . . . . 0.434 ' O ' ' SG ' ' A' ' 812' ' ' CYS . 2.1 mttm -122.28 31.81 6.02 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.055 -1.028 . . . . 0.0 110.615 179.985 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 806' ' ' CYS . . . . . 0.522 ' HB3' HD11 ' A' ' 773' ' ' ILE . 0.1 OUTLIER -162.2 41.44 0.13 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.151 -0.968 . . . . 0.0 110.4 -179.969 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 807' ' ' ILE . . . . . 0.659 HG22 ' O ' ' A' ' 807' ' ' ILE . 9.8 mm -140.59 84.23 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.248 -0.908 . . . . 0.0 110.428 -179.994 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 808' ' ' GLY . . . . . 0.448 ' C ' ' HG ' ' A' ' 809' ' ' LEU . . . 117.84 32.41 1.43 Allowed Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.751 -1.34 . . . . 0.0 109.751 -179.998 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 809' ' ' LEU . . . . . 0.448 ' HG ' ' C ' ' A' ' 808' ' ' GLY . 14.9 mt -137.61 138.12 39.2 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.195 -1.179 . . . . 0.0 110.318 -179.96 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 810' ' ' GLU . . . . . . . . . . . . . 11.5 mp0 -61.01 -33.09 72.72 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.058 -1.026 . . . . 0.0 108.684 179.937 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 811' ' ' ARG . . . . . . . . . . . . . 18.1 ttm180 -125.69 167.69 14.78 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 179.835 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 812' ' ' CYS . . . . . 0.434 ' SG ' ' O ' ' A' ' 805' ' ' LYS . 9.3 t -166.04 116.27 1.0 Allowed 'General case' 0 C--N 1.3 -1.569 0 O-C-N 120.803 -1.185 . . . . 0.0 111.046 -179.903 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 813' ' ' VAL . . . . . . . . . . . . . 75.2 t -117.63 138.45 48.27 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.472 -0.768 . . . . 0.0 109.384 179.951 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 814' ' ' VAL . . . . . . . . . . . . . 4.4 t -125.56 158.04 34.49 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.077 -1.015 . . . . 0.0 110.561 -179.917 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 815' ' ' ALA . . . . . . . . . . . . . . . -117.65 135.01 54.29 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.26 -0.9 . . . . 0.0 110.117 -179.983 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 816' ' ' ILE . . . . . 0.816 HD11 HG23 ' A' ' 760' ' ' VAL . 9.7 mt -107.52 137.22 39.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.263 -0.898 . . . . 0.0 110.276 -179.946 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 817' ' ' SER . . . . . 0.504 ' CB ' ' HD2' ' A' ' 818' ' ' PRO . 0.0 OUTLIER -161.85 -179.81 1.13 Allowed Pre-proline 0 N--CA 1.495 1.781 0 O-C-N 121.232 -0.917 . . . . 0.0 110.031 179.985 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 818' ' ' PRO . . . . . 0.504 ' HD2' ' CB ' ' A' ' 817' ' ' SER . 48.0 Cg_endo -75.45 -38.27 1.48 Allowed 'Trans proline' 0 C--N 1.305 -1.724 0 O-C-N 124.055 1.555 . . . . 0.0 110.525 -179.975 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 819' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -116.51 47.36 1.45 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.23 -0.919 . . . . 0.0 110.296 -179.909 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 820' ' ' ASN . . . . . . . . . . . . . 2.0 m120 -129.71 0.78 4.91 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.178 -0.951 . . . . 0.0 110.206 179.97 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 821' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -125.32 -39.19 2.22 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.269 -0.894 . . . . 0.0 110.258 -179.941 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 822' ' ' GLY . . . . . . . . . . . . . . . -164.52 -52.37 0.02 OUTLIER Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.684 -1.367 . . . . 0.0 109.684 -179.997 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 823' ' ' GLY . . . . . . . . . . . . . . . 158.51 -68.54 0.27 Allowed Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.717 -1.353 . . . . 0.0 109.717 -179.934 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 824' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -171.22 88.91 0.46 Allowed Pre-proline 0 N--CA 1.493 1.684 0 O-C-N 121.262 -1.14 . . . . 0.0 110.431 -179.994 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 825' ' ' PRO . . . . . 0.489 ' HG3' ' OG ' ' A' ' 795' ' ' SER . 44.8 Cg_endo -75.08 -62.79 0.03 OUTLIER 'Trans proline' 0 C--N 1.304 -1.806 0 O-C-N 123.947 1.498 . . . . 0.0 110.317 179.971 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 826' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -116.93 118.92 35.83 Favored Pre-proline 0 N--CA 1.493 1.688 0 O-C-N 121.305 -0.872 . . . . 0.0 109.632 -179.996 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 827' ' ' PRO . . . . . 0.428 ' O ' ' HB2' ' A' ' 828' ' ' GLU . 48.2 Cg_endo -75.24 141.01 25.45 Favored 'Trans proline' 0 C--N 1.308 -1.58 0 O-C-N 123.885 1.466 . . . . 0.0 110.866 -179.887 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 828' ' ' GLU . . . . . 0.428 ' HB2' ' O ' ' A' ' 827' ' ' PRO . 0.6 OUTLIER 58.41 14.16 2.81 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.486 -0.759 . . . . 0.0 110.508 179.99 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 829' ' ' VAL . . . . . 0.56 ' O ' HG12 ' A' ' 829' ' ' VAL . 54.0 t -137.59 82.03 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.165 -0.96 . . . . 0.0 110.217 -179.959 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 830' ' ' MET . . . . . 0.577 ' HA ' ' HA2' ' A' ' 779' ' ' GLY . 0.2 OUTLIER -176.26 107.65 0.08 Allowed 'General case' 0 N--CA 1.487 1.398 0 O-C-N 120.929 -1.107 . . . . 0.0 111.348 179.991 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 831' ' ' LYS . . . . . 0.542 ' HA ' ' CB ' ' A' ' 737' ' ' GLU . 20.6 ttpp -170.93 53.1 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.235 -0.915 . . . . 0.0 110.736 179.95 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 832' ' ' ARG . . . . . 0.511 ' HB3' ' CD ' ' A' ' 781' ' ' PRO . 1.7 mtt180 -172.97 107.16 0.16 Allowed 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.274 -0.891 . . . . 0.0 109.846 179.957 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 833' ' ' VAL . . . . . 0.782 HG21 HD13 ' A' ' 816' ' ' ILE . 3.8 t -107.35 109.25 27.5 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 O-C-N 121.111 -0.993 . . . . 0.0 110.836 -179.96 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 834' ' ' ALA . . . . . . . . . . . . . . . -109.62 136.47 48.94 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.371 -0.831 . . . . 0.0 109.34 179.934 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 835' ' ' VAL . . . . . . . . . . . . . 38.1 t -147.05 156.94 10.51 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.069 -1.02 . . . . 0.0 110.946 -179.95 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 836' ' ' GLU . . . . . 0.573 ' CB ' ' HB3' ' A' ' 774' ' ' LYS . 1.7 mp0 -135.2 158.89 43.21 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 179.845 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 837' ' ' ALA . . . . . 0.451 ' HB2' HD22 ' A' ' 762' ' ' LEU . . . -138.44 154.59 48.86 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 120.802 -1.186 . . . . 0.0 111.54 -179.772 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 838' ' ' VAL . . . . . . . . . . . . . 21.3 t -121.85 109.57 24.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.692 -0.63 . . . . 0.0 109.376 179.88 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 839' ' ' CYS . . . . . 0.41 ' O ' ' HA ' ' A' ' 728' ' ' VAL . 0.6 OUTLIER -108.1 129.42 55.15 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.115 -0.991 . . . . 0.0 110.522 -179.96 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 840' ' ' SER . . . . . . . . . . . . . 54.1 p -125.53 -161.03 1.0 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.282 -0.886 . . . . 0.0 110.221 179.989 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 841' ' ' THR . . . . . 0.503 HG23 ' OE1' ' A' ' 768' ' ' GLN . 0.6 OUTLIER -102.64 9.33 39.36 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.285 -0.884 . . . . 0.0 110.493 -179.985 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 842' ' ' ALA . . . . . . . . . . . . . . . -161.06 157.03 25.44 Favored 'General case' 0 C--N 1.293 -1.851 0 O-C-N 121.426 -0.796 . . . . 0.0 110.325 179.98 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 843' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.711 0 CA-C-O 118.052 -0.975 . . . . 0.0 110.235 -179.988 . . . . . . . . 0 0 . 1 stop_ save_